PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brumm, A; Hakim, B; Ramli, M; Aubert, M; van den Bergh, GD; Li, B; Burhan, B; Saifui, AM; Siagian, L; Sardi, R; Jusdi, A; Abdullah; Mubarak, AP; Moore, MW; Roberts, RG; Zhao, JX; McGahan, D; Jones, BG; Perston, Y; Szabo, K; Mahmud, MI; Westaway, K; Jatmiko; Saptomo, EW; van der Kaars, S; Grun, R; Wood, R; Dodson, J; Morwood, MJ				Brumm, Adam; Hakim, Budianto; Ramli, Muhammad; Aubert, Maxime; van den Bergh, Gerrit D.; Li, Bo; Burhan, Basran; Saifui, Andi Muhammad; Siagian, Linda; Sardi, Ratno; Jusdi, Andi; Abdullah; Mubarak, Andi Pampang; Moore, Mark W.; Roberts, Richard G.; Zhao, Jian-Xin; McGahan, David; Jones, Brian G.; Perston, Yinika; Szabo, Katherine; Mahmud, M. Irfan; Westaway, Kira; Jatmiko; Saptomo, E. Wahyu; van der Kaars, Sander; Gruen, Rainer; Wood, Rachel; Dodson, John; Morwood, Michael J.			A reassessment of the early archaeological record at Leang Burung 2, a Late Pleistocene rock-shelter site on the Indonesian island of Sulawesi	PLOS ONE			English	Article							NORTHERN AUSTRALIA; MODERN HUMANS; FELDSPAR; QUARTZ; CAVES; RED; TL; OCCUPATION; EVOLUTION; SEDIMENTS	This paper presents a reassessment of the archaeological record at Leang Burung 2, a key early human occupation site in the Late Pleistocene of Southeast Asia. Excavated originally by Ian Glover in 1975, this limestone rock-shelter in the Maros karsts of Sulawesi, Indonesia, has long held significance in our understanding of early human dispersals into 'Wallacea', the vast zone of oceanic islands between continental Asia and Australia. We present new stratigraphic information and dating evidence from Leang Burung 2 collected during the course of our excavations at this site in 2007 and 2011-13. Our findings suggest that the classic Late Pleistocene modern human occupation sequence identified previously at Leang Burung 2, and proposed to span around 31,000 to 19,000 conventional C-14 years BP (similar to 35-24 ka cal BP), may actually represent an amalgam of reworked archaeological materials. Sources for cultural materials of mixed ages comprise breccias from the rear wall of the rock-shelter-remnants of older, eroded deposits dated to 35-23 ka cal BP-and cultural remains of early Holocene antiquity. Below the upper levels affected by the mass loss of Late Pleistocene deposits, our deep-trench excavations uncovered evidence for an earlier hominin presence at the site. These findings include fossils of now-extinct proboscideans and other 'megafauna' in stratified context, as well as a cobble-based stone artifact technology comparable to that produced by late Middle Pleistocene hominins elsewhere on Sulawesi.	[Brumm, Adam; Aubert, Maxime; McGahan, David] Griffith Univ, Environm Futures Res Inst, Australian Res Ctr Human Evolut, Brisbane, Qld, Australia; [Hakim, Budianto; Saifui, Andi Muhammad; Sardi, Ratno; Mahmud, M. Irfan] Balai Arkeol Makassar, Makassar, Indonesia; [Ramli, Muhammad] Balai Pelestarian Cagar Budaya, Jambi, Indonesia; [Aubert, Maxime] Griffith Univ, PERAHU, Gold Coast, Qld, Australia; [van den Bergh, Gerrit D.; Li, Bo; Roberts, Richard G.; Szabo, Katherine] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Siagian, Linda] Museum Kepresidenan Republ Indonesia Balai Kirt, Paledang Bogor, Indonesia; [Jusdi, Andi; Abdullah; Mubarak, Andi Pampang] Balai Pelestarian Cagar Budaya, Makassar, Indonesia; [Moore, Mark W.; Perston, Yinika] Univ New England, Sch Humanities Archaeol & Palaeoanthropol, Stone Tools & Cognit Hub, Armidale, NSW, Australia; [Roberts, Richard G.; Jatmiko; Saptomo, E. Wahyu] Univ Wollongong, ARC Ctr Excellence Australian Biodivers & Heritag, Wollongong, NSW, Australia; [Zhao, Jian-Xin] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld, Australia; [Jones, Brian G.; Dodson, John] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW, Australia; [Westaway, Kira] Macquarie Univ, Dept Environm Sci, Sydney, NSW, Australia; [Jatmiko; Saptomo, E. Wahyu] Pusat Penelitian Arkeol Nas ARKENAS, Jakarta, Indonesia; [van der Kaars, Sander] Vrije Univ, Fac Earth & Life Sci, Cluster Earth & Climate, Amsterdam, Netherlands; [van der Kaars, Sander] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia; [Gruen, Rainer; Wood, Rachel] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Dodson, John] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Yanta District, Shaanxi, Peoples R China	Griffith University; Griffith University; University of Wollongong; University of New England; University of Wollongong; University of Queensland; University of Wollongong; Macquarie University; Vrije Universiteit Amsterdam; Monash University; Australian National University; Chinese Academy of Sciences	Brumm, A (corresponding author), Griffith Univ, Environm Futures Res Inst, Australian Res Ctr Human Evolut, Brisbane, Qld, Australia.	a.brumm@griffith.edu.au	Roberts, Richard Graham/B-8245-2013; Moore, Mark W/B-4729-2015; BURHAN, Basran/GSD-7949-2022; van den Bergh, Gerrit D/I-7670-2016; Aubert, Maxime/AAT-6198-2020; Jones, Brian G/K-2496-2017; CABAH, ARC/T-6419-2019; Zhao, Jian-xin/A-5938-2008; van der Kaars, Sander/G-2268-2016; Li, Bo/B-8974-2016; Wood, Rachel/K-5577-2016	Roberts, Richard Graham/0000-0002-0128-4119; Moore, Mark W/0000-0003-4768-5329; BURHAN, Basran/0000-0002-9172-5888; Aubert, Maxime/0000-0002-4189-531X; Jones, Brian G/0000-0003-0835-7197; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Zhao, Jian-xin/0000-0002-2413-6178; Saiful, Andi Muhammad/0000-0002-6799-6258; Szabo, Katherine/0000-0002-9542-6535; van der Kaars, Sander/0000-0002-2511-0439; Li, Bo/0000-0003-4186-4828; Wood, Rachel/0000-0002-1694-3295; McGahan, David/0000-0002-3161-1512; Westaway, Kira/0000-0001-5315-778X	Australian Research Council; Discovery Early Career Researcher Award [DP0879624, DE130101560]; Future Fellowship [FT140100384]; Laureate Fellowship [FL130100116, FT100100384]; University of Wollongong's Centre for Archaeological Science	Australian Research Council(Australian Research Council); Discovery Early Career Researcher Award(Australian Research Council); Future Fellowship(Australian Research Council); Laureate Fellowship; University of Wollongong's Centre for Archaeological Science	The 2011-13 excavations at Leang Burung 2 and post-excavation work related to the research were supported by Australian Research Council fellowships awarded to A.B. (DP0879624 and Discovery Early Career Researcher Award DE130101560). B.L. and R.G.R. were supported by Future Fellowship FT140100384 and Laureate Fellowship FL130100116, respectively, while G.D.v. d.B.'s research was supported by Future Fellowship FT100100384. The 2011 excavations were also supported by a start-up grant from the University of Wollongong's Centre for Archaeological Science, awarded to K.S. and A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M.J., 1998, INTRO OPTICAL DATING; Allen J, 2014, AUST ARCHAEOL, P86; [Anonymous], 2007, PREHISTORY INDO MALA, DOI [DOI 10.26530/OAPEN_459472, 10.22459/PIMA.03.2007, DOI 10.22459/PIMA.03.2007]; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; BARTSTRA GJ, 1998, MOD QUAT RE, V15, P193; BOTTERJENSEN L, 1992, NUCL TRACKS RAD MEAS, V20, P549; Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524; Brumm A, 2017, P NATL ACAD SCI USA, V114, P4015; Bulbeck D., 2004, MODERN QUATERNARY RE, P129; Bulbeck D., 2004, MOD QUAT RES SE ASIA, P111; Bulbeck D., 2000, ASIAN PERSPECT, P71, DOI [10.1353/asi.2000.0004, DOI 10.1353/ASI.2000.0004]; Burleigh R., 1981, Modern Quaternary Research in Southeast Asia, V6, P51; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; Clason A.T., 1989, PALAEOHISTORIA, V29, P67; Eriawati Y., 2003, LUKISAN GUA GUA KARS; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P898, DOI 10.1016/j.nimb.2009.10.059; Fischer A, 2003, RADIOCARBON, V45, P449, DOI 10.1017/S003382220003280X; Frank R, 1981, MOD QUAT RES SE ASIA, V6, P39; Franssen C.J.H., 1949, TIJDSCHRIFT INDISCHE, V83, P331; Friedman G, 1959, J SEDIMENT PETROL, V29, P87, DOI DOI 10.1306/74D70894-2B21-11D7-86480001020C1865D; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Glover, 1978, B INDOPACIFIC PREHIS, V1, P60; Glover E., 1981, Modern Quaternary Research in Southeast Asia, V6, P45; Glover I., 1976, ARCHIPEL, V11, P113, DOI DOI 10.3406/ARCH.1976.1271; Glover I., 1981, MODERN Q ATERNARY RE, P1; GLOVER IC, 1979, WORLD ARCHAEOL, V10, P302, DOI 10.1080/00438243.1979.9979739; GROVES C P, 1976, Zeitschrift fuer Saeugetierkunde, V41, P201; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Heyning N., 1951, TIJDSCHR AARDR GEN, V68, P21; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; HOOIJER D. A., 1948, PROC K NEDERLAND AKAD WETENSCHAP AMSTERDAM, V51, P1024; Hua Q, 2001, RADIOCARBON, V43, P275; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley D.J., 1997, ANCIENT TL, V15, P11; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; HUTTON JT, 1992, NUCL TRACKS RAD MEAS, V20, P367; Jones R., 1977, SUNDA SAHUL PREHISTO, P113; Keates S.G., 2001, QUARTAR, V51, P9; KEATES SG, 1994, PALAEOHISTORIA, V33, P19; Koppel B, 2016, J ARCHAEOL SCI-REP, V7, P741, DOI 10.1016/j.jasrep.2015.08.040; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Li B., 2016, ANC TL, V34, P1; Li B, 2011, QUAT GEOCHRONOL, V6, P468, DOI 10.1016/j.quageo.2011.05.001; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; McDonald R.C., 1976, Z GEOMORPHOL S, V26, P79; McDonald RC, 2011, PHYS GEOGR, V32, P195, DOI 10.2747/0272-3646.32.3.195; Morrison M., 2015, QUEENSLAND ARCHAEOL, V18, P1; MORWOOD M, 2007, DISCOVERY HOBBIT SCI; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; MULVANEY DJ, 1971, ANTIQUITY, V45, P26, DOI 10.1017/S0003598X00069015; MULVANEY DJ, 1970, ASIAN PERSPECT, V13, P163; Musser G.G., 1987, Oxford Monographs on Biogeography, P73; O'Connor S, 2017, J ARCHAEOL SCI, V77, P143, DOI 10.1016/j.jas.2016.05.002; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Presland G., 1980, ARTEFACT, V5, P19; Rabett RJ, 2012, HUMAN ADAPTATION IN THE ASIAN PALAEOLITHIC: HOMININ DISPERSAL AND BEHAVIOUR DURING THE LATE QUATERNARY, P1, DOI 10.1017/CBO9781139087582; Roberts RG, 2009, J HUM EVOL, V57, P484, DOI 10.1016/j.jhevol.2009.01.003; Russell JM, 2014, P NATL ACAD SCI USA, V111, P5100, DOI 10.1073/pnas.1402373111; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Sarasin P, 1905, REISEN IN CELEBES; Simons A., 2004, QUATERNARY RES INDON, P167; Sinha P, 1983, MOD QUATERN RES SE A, V8, P137; Smedley RK, 2012, RADIAT MEAS, V47, P790, DOI 10.1016/j.radmeas.2012.01.014; Spooner NA, 2002, RADIAT MEAS, V35, P59, DOI 10.1016/S1350-4487(01)00109-3; St Pierre E, 2012, J ARCHAEOL SCI, V39, P922, DOI 10.1016/j.jas.2011.10.027; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Thiel C, 2011, QUATERN INT, V234, P23, DOI 10.1016/j.quaint.2010.05.018; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; Van den Bergh GD, 2016, NATURE, V529, P208, DOI 10.1038/nature16448; van den Bergh Gert D., 1999, Scripta Geologica, V117, P1; van Heekeren H.R., 1972, STONE AGE INDONESIA, DOI DOI 10.26530/OAPEN_613384; van Heekeren H. R., 1952, LAPORAN TAHUNAN DINA, V1950, P22; VANHEEKEREN HR, 1949, NATURE, V163, P492, DOI 10.1038/163492b0; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Westaway KE, 2009, RADIAT MEAS, V44, P462, DOI 10.1016/j.radmeas.2009.06.001; Westaway K, 2012, RADIAT MEAS, V47, P909, DOI 10.1016/j.radmeas.2012.01.001; Westaway KE, 2006, QUATERNARY SCI REV, V25, P2513, DOI 10.1016/j.quascirev.2005.06.010; Wicaksono SA, 2015, PALAEOGEOGR PALAEOCL, V430, P47, DOI 10.1016/j.palaeo.2015.04.016	83	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193025	10.1371/journal.pone.0193025	http://dx.doi.org/10.1371/journal.pone.0193025			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641524	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900008
J	Chen, X; Dai, Y; Wang, ZQ; Zhu, GY; Ding, XQ; Jin, TY				Chen, Xiao; Dai, Yan; Wang, Zhongqiu; Zhu, Guoying; Ding, Xiaoqiang; Jin, Taiyi			The association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium in China	PLOS ONE			English	Article							D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; D DEFICIENCY; D METABOLISM; RISK; CALCIUM	Cadmium exposure can cause renal tubular dysfunction. Recent studies show that vitamin D can play multiple roles in the body. However, the association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium has not been clarified. We performed study to assess the effects of cadmium on serum 25(OH) D levels and the association between serum 25(OH) D levels and renal tubular dysfunction in a population environmentally exposed to cadmium. A total of 133 subjects living in control area and two cadmium polluted areas were included in the present study. Cadmium in urine (UCd) and blood (BCd), urinary beta 2Microglobulin (UBMG), urinary retinol binding protein (URBP) and serum 25 (OH) D were determined. Logistic regression was used to estimate the association between 25 (OH) D and prevalence of renal tubular dysfunction. No significant differences were observed in serum 25(OH) D levels among the four quartile of UCd and BCd after adjusting with cofounders. After adjusted with the confounders, the odds ratio (OR) of subjects with 25(OH) D >= 40 ng/ml were 0.20 (95%CI: 0.1-0.8) if UBMG was chosen as indicators of renal dysfunction and 0.28 (95%CI: 0.1-1.1) if URBP was chosen as indicators of renal dysfunction, compared with those with 25(OH) D < 30 ng/ml, respectively. Similar results were observed in those subjects living in cadmium polluted areas or with high level of UCd or BCd. Our data indicated that cadmium exposure did not affect serum 25 (OH) D level and high 25 (OH) D levels were associated with a decreased risk of renal tubular dysfunction induced by cadmium.	[Chen, Xiao; Dai, Yan; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai Key Lab Kidney & Dialysis, Shanghai, Peoples R China; [Chen, Xiao; Wang, Zhongqiu] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Guoying] Fudan Univ, Inst Radiat Med, Shanghai, Peoples R China; [Jin, Taiyi] Fudan Univ, Sch Publ Hlth, Dept Occupat Med, Shanghai, Peoples R China	Fudan University; Nanjing University of Chinese Medicine; Fudan University; Fudan University	Ding, XQ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai Key Lab Kidney & Dialysis, Shanghai, Peoples R China.; Jin, TY (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Occupat Med, Shanghai, Peoples R China.	ding_xiaoqiang@zs-hospital.sh.cn; tyjin@shmu.edu.cn			National Natural Science foundation of China [81773460, 81102148]; Natural Science Foundation of Jiangsu Province [BK20161609]; Science and Technology Commission of Shanghai Municipality [14DZ2260200]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by National Natural Science foundation of China (No. 81773460, 81102148) to XC, Natural Science Foundation of Jiangsu Province (No. BK20161609) and the Science and Technology Commission of Shanghai Municipality (14DZ2260200, the project of Shanghai Key Laboratory of Kidney and Blood Purification). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, KIDNEY INT, V68, P2823, DOI 10.1111/j.1523-1755.2005.00755.x; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Brzoska MM, 2005, ARCH TOXICOL, V79, P636, DOI 10.1007/s00204-005-0680-6; Chen X, 2018, BIOL TRACE ELEM RES, V186, P114, DOI 10.1007/s12011-018-1304-3; Dancer RCA, 2015, THORAX, V70, P617, DOI 10.1136/thoraxjnl-2014-206680; Engstrom A, 2009, ENVIRON RES, V109, P188, DOI 10.1016/j.envres.2008.10.008; Engstrom A, 2012, BONE, V50, P1372, DOI 10.1016/j.bone.2012.03.018; Esteve E, 2017, J SYNCHROTRON RADIAT, V24, P991, DOI 10.1107/S1600577517009572; Farhangi MA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0597-z; Fuchs MA, 2017, ANN ONCOL, V28, P1359, DOI 10.1093/annonc/mdx109; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Goncalves JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107228; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jha JC, 2017, DIABETES, V66, P2691, DOI 10.2337/db16-1585; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Jin TY, 1999, ENVIRON RES, V81, P167, DOI 10.1006/enrs.1999.3959; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Jung JY, 2015, RESPIROLOGY, V20, P782, DOI 10.1111/resp.12538; KAWASHIMA H, 1988, ENVIRON RES, V46, P48, DOI 10.1016/S0013-9351(88)80058-6; Kumar V, 2017, J AM SOC NEPHROL, V28, P3100, DOI 10.1681/ASN.2017010003; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; Letavernier E, 2016, KIDNEY INT, V90, P809, DOI 10.1016/j.kint.2016.05.027; Levin Adeera, 2017, Clin J Am Soc Nephrol, V12, P1447, DOI 10.2215/CJN.10791016; Li XH, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0378-4; Lin YS, 2014, ENVIRON RES, V134, P33, DOI 10.1016/j.envres.2014.06.013; Manucha W, 2016, THER ADV CARDIOVASC; Mihajlovic M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122531; Munger KL, 2016, JAMA NEUROL, V73, P515, DOI 10.1001/jamaneurol.2015.4800; Namir Y, 2016, CLIN NEPHROL, V86, P165, DOI 10.5414/CN108796; Navaneethan SD, 2011, AM J KIDNEY DIS, V58, P536, DOI 10.1053/j.ajkd.2011.04.028; Nganvongpanit K, 2016, BIOL TRACE ELEM RES, V173, P21, DOI 10.1007/s12011-016-0625-3; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Rebholz CM, 2016, AM J KIDNEY DIS, V67, P235, DOI 10.1053/j.ajkd.2015.08.026; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Satirapoj B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-206; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Shi ZM, 2018, CLIN NUTR, V37, P276, DOI 10.1016/j.clnu.2016.12.025; Uchida H, 2010, TOXICOL PATHOL, V38, P730, DOI 10.1177/0192623310374328; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; WHO/ICPS, 1992, 134 WHOIPCS, P1; Wu F, 2017, ANN MED, V7, P1, DOI [10.1080/07853890.2017.1399446, DOI 10.1080/07853890]; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zamoiski RD, 2014, ENVIRON HEALTH PERSP, V122, P1233, DOI 10.1289/ehp.1307861	47	6	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195682	10.1371/journal.pone.0195682	http://dx.doi.org/10.1371/journal.pone.0195682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634781	Green Submitted, gold, Green Published			2022-12-27	WOS:000429522200048
J	Carrasco, SE; Hu, SS; Mai, DM; Kumar, R; Sandusky, GE; Yang, XF; Derbigny, WA				Carrasco, Sebastian E.; Hu, Sishun; Mai, Denise M.; Kumar, Ramesh; Sandusky, George E.; Yang, X. Frank; Derbigny, Wilbert A.			Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice	PLOS ONE			English	Article							MOUSE PNEUMONITIS BIOVAR; DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; GAMMA-INTERFERON; IFN-BETA; IMMUNE-RESPONSE; TRACHOMATIS; PATHOLOGY; PROTEIN; INHIBITION	Chlamydia trachomatis urogenital serovars primarily replicate in epithelial cells lining the reproductive tract. Epithelial cells recognize Chlamydia through cell surface and cytosolic receptors, and/or endosomal innate receptors such as Toll-like receptors (TLRs). Activation of these receptors triggers both innate and adaptive immune mechanisms that are required for chlamydial clearance, but are also responsible for the immunopathology in the reproductive tract. We previously demonstrated that Chlamydia muridarum (Cm) induces IFN-beta in oviduct epithelial cells (OE) in a TLR3(-/-)dependent manner, and that the synthesis of several cytokines and chemokines are diminished in Cm-challenged OE derived from TLR3-/129S1 mice. Furthermore, our in vitro studies showed that Cm replication in TLR3(-/-) OE is more efficient than in wild-type OE. Because TLR3 modulates the release inflammatory mediators involved in host defense during Cm infection, we hypothesized that TLR3 plays a protective role against Cm-induced genital tract pathology in congenic C57BU6N mice. Using the Cm mouse model for human Chlamydia genital tract infections, we demonstrated that TLR3(-/-) mice had increased Cm shedding during early and mid-stage genital infection. In early stage infection, TLR3(-/-) mice showed a diminished synthesis of IFN-beta, IL-1 beta, and IL-6, but enhanced production of IL-10, TNF-alpha, and IFN-gamma. In mid-stage infection, TLR3(-/-) mice exhibited significantly enhanced lymphocytic endometritis and salpingitis than wild-type mice. These lymphocytes were predominantly scattered along the endometrial stroma and the associated smooth muscle, and the lamina propria supporting the oviducts. Surprisingly, our data show that CD4(+) T-cells are significantly enhanced in the genital tract TLR3-/- mice during mid-stage Chlamydia/infection. In late-stage infections, both mouse strains developed hydrosalpinx; however, the extent of hydrosalpinx was more severe in TLR3(-/-) mice. Together, these data suggest that TLR3 promotes the clearance of Cm during early and mid-stages of genital tract infection, and that loss of TLR3 is detrimental in the development hydrosalpinx.	[Carrasco, Sebastian E.; Mai, Denise M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Carrasco, Sebastian E.; Mai, Denise M.] Univ Calif Davis, Comparat Pathol Lab, Davis, CA 95616 USA; [Carrasco, Sebastian E.; Hu, Sishun; Kumar, Ramesh; Yang, X. Frank; Derbigny, Wilbert A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Hu, Sishun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Sandusky, George E.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	University of California System; University of California Davis; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; Huazhong Agricultural University; Indiana University System; Indiana University Bloomington	Derbigny, WA (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wderbign@iupui.edu	Kumar, Ramesh/U-8358-2019; Kumar, Ramesh/A-8258-2019		National Institutes of Health [1K22AI072072, 1R01AI104944]; National Institute of Health's, NRSA, Immunology and Infectious Disease Program at IUSM [T32 AI 060519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health's, NRSA, Immunology and Infectious Disease Program at IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants 1K22AI072072 and 1R01AI104944 (W.A.D.). S.E.C. was supported by the National Institute of Health's, NRSA T32 AI 060519, Immunology and Infectious Disease Program at IUSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Chin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046949; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Cunningham K, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-50; Darville T, 2000, INFECT IMMUN, V68, P5299, DOI 10.1128/IAI.68.9.5299-5305.2000; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2001, INFECT IMMUN, V69, P7419, DOI 10.1128/IAI.69.12.7419-7424.2001; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Giannitti F, 2016, J VET DIAGN INVEST, V28, P184, DOI 10.1177/1040638715625729; Hakimi H, 2014, INFLAMMATION, V37, P818, DOI 10.1007/s10753-013-9801-1; Hosey KL, 2015, J INTERF CYTOK RES, V35, P901, DOI 10.1089/jir.2015.0013; Huang Y, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/297686; Igietseme Joseph U., 1993, Regional Immunology, V5, P317; Igietseme JU, 1996, IMMUNOLOGY, V88, P1, DOI 10.1046/j.1365-2567.1996.d01-655.x; Igietseme JU, 1996, J LEUKOCYTE BIOL, V59, P656, DOI 10.1002/jlb.59.5.656; Ito JI, 1999, INFECT IMMUN, V67, P5518, DOI 10.1128/IAI.67.10.5518-5521.1999; Jiang JN, 2012, JOVE-J VIS EXP, DOI 10.3791/4391; Jin HL, 2008, FEBS LETT, V582, P2679, DOI 10.1016/j.febslet.2008.06.053; Johnson RM, 2016, INFECT IMMUN, V84, P868, DOI 10.1128/IAI.01378-15; Johnson RM, 2014, IMMUNOLOGY, V142, P248, DOI 10.1111/imm.12248; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063340; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lee HY, 2010, FEMS IMMUNOL MED MIC, V59, P108, DOI 10.1111/j.1574-695X.2010.00668.x; Manam S, 2013, PATHOG DIS, V67, P221, DOI 10.1111/2049-632X.12032; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Medoff BD, 2005, ANN NY ACAD SCI, V1062, P220, DOI 10.1196/annals.1358.026; Mori H, 2015, TOXICOL PATHOL, V43, P883, DOI 10.1177/0192623315587593; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P2870, DOI 10.1128/IAI.68.5.2870-2879.2000; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; Nagarajan UM, 2011, INFECT IMMUN, V79, P486, DOI 10.1128/IAI.00843-10; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Perry LL, 1997, J IMMUNOL, V158, P3344; Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prantner D, 2009, INFECT IMMUN, V77, P5334, DOI 10.1128/IAI.00883-09; Prebeck S, 2003, MICROBES INFECT, V5, P463, DOI 10.1016/S1286-4579(03)00063-7; RANK RG, 1985, INFECT IMMUN, V48, P847, DOI 10.1128/IAI.48.3.847-849.1985; RANK RG, 1992, INFECT IMMUN, V60, P4427, DOI 10.1128/IAI.60.10.4427-4429.1992; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Redgrove KA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00534; Rey-Ladino J, 2014, HUM VACC IMMUNOTHER, V10, P2664, DOI 10.4161/hv.29683; Schachter J, 1980, PSITTACOSIS LYMPHOGR; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Slade JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160511; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Sun X, 2017, MICROBES INFECT, V19, P536, DOI 10.1016/j.micinf.2017.08.007; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Vlcek KR, 2016, IMMUNOL CELL BIOL, V94, P208, DOI 10.1038/icb.2015.74; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; WHO, 2012, REG STRAT FRAM EL KA, P20; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Yang CF, 2015, MBIO, V6, DOI 10.1128/mBio.01648-15; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	83	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195165	10.1371/journal.pone.0195165	http://dx.doi.org/10.1371/journal.pone.0195165			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624589	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600016
J	Choi, HY; Oh, J; Kim, S				Choi, Hae-young; Oh, Jina; Kim, Sung			Genetic identification of eggs from four species of Ophichthidae and Congridae (Anguilliformes) in the northern East China Sea	PLOS ONE			English	Article							EEL ANGUILLA-JAPONICA; MARINE FISH EGGS; JAPANESE EEL; SPAWNING AREA; BIRTH DATE; LEPTOCEPHALI; PACIFIC; AGE; ICHTHYOPLANKTON; DISCOVERY	We report the first genetic identification of eggs of four species of Anguilliformes caught in the northern East China Sea during August 2016, where leptocephali and adults have been collected. The species were Ophisurus macrorhynchos and Echelus uropterus belonging to the Ophichthidae, and Ariosoma majus and Gnathophis heterognathos belonging to the Congridae. The eggs were identified using three molecular genetic markers (mitochondrial 12S rRNA, 16S rRNA, and cytochrome c oxidase subunit 1), sequences obtained from local adult specimens, and geographical distribution data. All eggs were in the early or middle developmental stages. For all species except A. majus, the eggs were found near the range of small leptocephali in the East China Sea and the southern Korean Peninsula, which indicates these species had spawned along the continental near these areas during the summer.	[Choi, Hae-young; Oh, Jina; Kim, Sung] Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Busan Metropolitan City, South Korea; [Choi, Hae-young; Kim, Sung] Korea Univ Sci & Technol, Marine Biol, Daejeon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); University of Science & Technology (UST)	Kim, S (corresponding author), Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Busan Metropolitan City, South Korea.; Kim, S (corresponding author), Korea Univ Sci & Technol, Marine Biol, Daejeon, South Korea.	skim@kiost.ac.kr			Korea Institute of Ocean Science and Technology [PE99513, PE99663]	Korea Institute of Ocean Science and Technology	This work received support from the Korea Institute of Ocean Science and Technology (PE99513, PE99663 to SK) http://www.kiost.ac.kr/kor.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1989, FISHES W N ATLANTIC; Aoyama J, 2001, FISHERIES SCI, V67, P761, DOI 10.1046/j.1444-2906.2001.00288.x; Asano Hirotoshi, 1997, Memoirs of the Faculty of Agriculture of Kinki University, V30, P19; Chow S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121801; Eschmeyer W.N., 2017, CATALOG FISHES GENER; Espeland SH, 2017, ICES J MAR SCI; Fox CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1543, DOI 10.1098/rspb.2008.0201; Han Song-Hun, 2015, [Korean Journal of Ichthyology, 한국어류학회지], V27, P284; Harada AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134647; Hatooka K, 2013, FISHES JAPAN PICTORI, P266; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Ji Hwan-Sung, 2015, Bulletin of the Korean Society of Fisheries Technology, V51, P527; Ji Hwan-Sung, 2014, Korean Journal of Fisheries and Aquatic Sciences, V47, P888; Kawakami T, 2010, ENVIRON BIOL FISH, V87, P221, DOI 10.1007/s10641-010-9592-2; Kim IS, 2005, ILLUSTRATED BOOK KOR; 지환성, 2011, [Korean Journal of Ichthyology, 한국어류학회지], V23, P217; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura Y, 2006, FISH OCEANOGR, V15, P183, DOI 10.1111/j.1365-2419.2005.00383.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurogi H, 2012, FISHERIES SCI, V78, P525, DOI 10.1007/s12562-012-0468-6; Lewis LA, 2016, FISH B-NOAA, V114, P153, DOI 10.7755/FB.114.2.3; Lie HJ, 2016, PROG OCEANOGR, V146, P121, DOI 10.1016/j.pocean.2016.06.004; Lin HY, 2016, CONT SHELF RES, V126, P64, DOI 10.1016/j.csr.2016.07.016; Ma T, 2005, J FISH BIOL, V67, P1619, DOI 10.1111/j.1095-8649.2005.00868.x; Ma T, 2008, COAST MAR SCI, V32, P48; Miller MJ, 2002, MAR ECOL PROG SER, V235, P279, DOI 10.3354/meps235279; MILLER MJ, 2004, INTRO LEPTOCEPHALI B; Minagawa G, 2007, ESTUAR COAST SHELF S, V71, P730, DOI 10.1016/j.ecss.2006.06.018; Miyazaki S, 2011, MAR BIOL, V158, P2555, DOI 10.1007/s00227-011-1756-x; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Qu TD, 2003, J PHYS OCEANOGR, V33, P5, DOI 10.1175/1520-0485(2003)033<0005:TBOTNE>2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; Shao KT, 2002, MAR FRESHWATER RES, V53, P355, DOI 10.1071/MF01141; TSUKAMOTO K, 1989, NIPPON SUISAN GAKK, V55, P1023; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; UMEZAWA A, 1990, NIPPON SUISAN GAKK, V56, P1199; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Yoshinaga T, 2011, FISHERIES SCI, V77, P983, DOI 10.1007/s12562-011-0418-8	43	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195382	10.1371/journal.pone.0195382	http://dx.doi.org/10.1371/journal.pone.0195382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621326	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800073
J	Kreft, D; McGuinness, MB; Doblhammer, G; Finger, RP				Kreft, Daniel; McGuinness, Myra B.; Doblhammer, Gabriele; Finger, Robert P.			Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013-A prospective cohort study based on health claims data	PLOS ONE			English	Article							FOLLOW-UP; CARE; PREVALENCE; GUIDELINES; OUTCOMES; ACCESS; LASER	Objective To assess factors associated with diabetic retinopathy (DR) screening uptake following a diagnosis of type 2 diabetes mellitus (type 2 diabetes) in Germany. Materials and methods A nationally representative prospective sample of individual-level health claims data for 250,000 members from Germany's largest public insurance provider in 2004-2013 was assessed. In the sample, 26,560 persons with incident type 2 diabetes were identified. Factors associated with subsequent DR screening were assessed using descriptive statistics, Kaplan-Meier estimator, and Cox regression analysis. Results On average 27.6 visits to an ophthalmologist per 100 person-years in persons with incident type 2 diabetes occurred. Half of all incident cases (Kaplan-Meier estimator) had not seen an ophthalmologist after more than two years (2.25 years) following their diabetes diagnosis. In the multivariate analysis, an older age (from hazard ratio HR(70-74) = 0.93 [95%-CI: 0.89-0.97] to HR(90+) = 0.50 [95%-CI: 0.42-0.60] compared to persons aged 50-69 years) and a higher disability level (i.e. HR(disability level 3) = 0.30 [95%-CI: 0.25-0.36]) were associated with a lower likelihood, while female sex (HR =1.12 [95%-CI: 1.08-1.15]), six or more comorbidities (HR = 1.26 [95%-CI: 1.15-1.37]), moderate (HR = 1.51 [95%-CI: 1.461.56]) or severe type 2 diabetes (HR = 1.53 [95%-CI: 1.45-1.61]) as well as being enrolled in a type 2 diabetes disease management program (HR = 1.78 [95%-CI: 1.69-1.87]) were associated with a higher likelihood of DR screening. Conclusions A high proportion of newly diagnosed persons with type 2 diabetes did not follow current German recommendations for DR screening, impeding timely detection and management of potential complications. This was more apparent among persons who were men, older or had a disability. The uptake of screening was considerably greater among those enrolled in a diseases management program. These factors need to be considered when planning DR screening services and/or referrals.	[Kreft, Daniel; Doblhammer, Gabriele] Rostock Ctr Study Demog Change, Rostock, Germany; [Kreft, Daniel; Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Empir Methods Social Sci & Demog, Rostock, Germany; [McGuinness, Myra B.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia; [McGuinness, Myra B.] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Doblhammer, Gabriele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Finger, Robert P.] Univ Bonn, Dept Ophthalmol, Ophthalm Epidemiol, Bonn, Germany	University of Rostock; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Finger, RP (corresponding author), Univ Bonn, Dept Ophthalmol, Ophthalm Epidemiol, Bonn, Germany.	Robert.finger@ukbonn.de	McGuinness, Myra/G-4900-2017	McGuinness, Myra/0000-0002-5422-040X; Finger, Robert P/0000-0003-4253-7597				[Anonymous], 1990, Arch Ophthalmol, V108, P958; [Anonymous], 2015, TYPE 2 DIABETES ADUL; Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2015, NAT VERSORGUNGSLEITL; Byun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062991; Cavan D, 2017, DIABETES RES CLIN PR, V129, P16, DOI 10.1016/j.diabres.2017.03.023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; FERRIS FL, 1993, JAMA-J AM MED ASSOC, V269, P1290, DOI 10.1001/jama.269.10.1290; Fink A, 2014, SERIES POPULATION ST, P109; Fuchs S, 2014, DTSCH ARZTEBL INT, V111, P453, DOI 10.3238/arztebl.2014.0453; Gulliford MC, 2010, DIABETIC MED, V27, P282, DOI 10.1111/j.1464-5491.2010.02946.x; Hoffmann F, 2017, GESUNDHEITSWESEN, V79, pe1, DOI 10.1055/s-0035-1564074; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; Hwang J, 2015, CAN J OPHTHALMOL, V50, P119, DOI 10.1016/j.jcjo.2014.11.014; Jani PD, 2017, JAMA OPHTHALMOL; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Knight K, 2005, AM J MANAG CARE, V11, P242; Kraft SK, 1997, ARCH FAM MED, V6, P29, DOI 10.1001/archfami.6.1.29; Lake AJ, 2017, J DIABETES COMPLICAT, V31, P997, DOI 10.1016/j.jdiacomp.2017.02.020; Lawrenson JG, 2016, COCHRANE DATABASE SY; Leese GP, 2008, DIABETES CARE, V31, P2131, DOI 10.2337/dc08-1098; Millett C, 2006, J MED SCREEN, V13, P152, DOI 10.1258/096914106778440608; Mitchell P., 2008, GUIDELINES MANAGEMEN; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Mukamel D B, 1999, Ophthalmic Epidemiol, V6, P61; NAJI S, 1994, BRIT MED J, V308, P1208; Olafsdottir E, 2007, ACTA OPHTHALMOL SCAN, V85, P40, DOI 10.1111/j.1600-0420.2006.00753.x; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Ponto KA, 2016, DIABETOLOGIA, V59, P1913, DOI 10.1007/s00125-016-4013-5; Rosenberg JB, 2011, J DIABETES COMPLICAT, V25, P222, DOI 10.1016/j.jdiacomp.2010.11.001; Saadine JB, 2008, RETINA-J RET VIT DIS, V28, P195, DOI 10.1097/IAE.0b013e318115169a; Sloan FA, 2009, OPHTHALMOLOGY, V116, P1515, DOI 10.1016/j.ophtha.2009.03.010; Tikellis G, 2008, DIABETES RES CLIN PR, V80, P208, DOI 10.1016/j.diabres.2007.11.017; Wang F, 1996, OPHTHALMOLOGY, V103, P1744, DOI 10.1016/S0161-6420(96)30432-6; World Health Organization, 2005, PREV BLINDN DIAB MEL; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Ziemssen F, 2016, OPHTHALMOLOGE, V113, P623, DOI 10.1007/s00347-016-0315-8	38	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195426	10.1371/journal.pone.0195426	http://dx.doi.org/10.1371/journal.pone.0195426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621309	Green Published, gold			2022-12-27	WOS:000429206800078
J	Ma, RD; Yuan, HL; An, J; Hao, XY; Li, HB				Ma, Rendi; Yuan, Hali; An, Jing; Hao, Xiaoyun; Li, Hongbin			A Gossypium hirsutum GDSL lipase/hydrolase gene (GhGLIP) appears to be involved in promoting seed growth in Arabidopsis	PLOS ONE			English	Article							SUCROSE SYNTHASE GENE; COTTON FIBER YIELD; LIPASE GENE; EXPRESSION ANALYSIS; CELL ELONGATION; BRASSICA-NAPUS; OVEREXPRESSION; RESISTANCE; ETHYLENE; QUALITY	GDSL lipase (GLIP) plays a pivotal role in plant cell growth as a multifunctional hydrolytic enzyme. Herein, a cotton (Gossypium hirsutum L. cv Xuzhou 142) GDSL lipase gene (GhGLIP) was obtained from developing ovules and fibers. The GhGLIP cDNA contained an open reading frame (ORF) of 1,143 base pairs (bp) and encodes a putative polypeptide of 380 amino acid residues. Sequence alignment indicated that GhGLIP includes four enzyme catalytic amino acid residue sites of Ser (S), Gly (G), Asn (N) and His (H), located in four conserved blocks. Phylogenetic tree analysis showed that GhGLIP belongs to the typical class IV lipase family with potential functions in plant secondary metabolism. Subcellular distribution analysis demonstrated that GhGLIP localized to the nucleus, cytoplasm and plasma membrane. GhGLIP was expressed predominantly at 5-15 day post anthesis (dpa) in developing ovules and elongating fibers, measured as mRNA levels and enzyme activity. Ectopic overexpression of GhGLIP in Arabidopsis plants resulted in enhanced seed development, including length and fresh weight. Meanwhile, there was increased soluble sugar and protein storage in transgenic Arabidopsis plants, coupled with the promotion of lipase activity. Moreover, the expression of cotton GhGLIP is induced by ethylene (ETH) treatment in vitro. A 1,954-bp GhGLIP promoter was isolated and expressed high activity in driving green fluorescence protein (GFP) expression in tobacco leaves. Cis-acting element analysis of the GhGLIP promoter (pGhGLIP) indicated the presence of an ethylene-responsive element (ERE), and transgenic tobacco leaves with ectopic expression of pGhGLIP::GFPGUS showed increased GUS activity after ETH treatment. In summary, these results suggest that GhGLIP is a functional enzyme involved in ovule and fiber development and performs significant roles in seed development.	[Ma, Rendi; Yuan, Hali; An, Jing; Hao, Xiaoyun; Li, Hongbin] Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China; [Li, Hongbin] Shihezi Univ, Minist Educ, Key Lab Xinjiang Phytomed Resource Utilizat, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University	Li, HB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China.; Li, HB (corresponding author), Shihezi Univ, Minist Educ, Key Lab Xinjiang Phytomed Resource Utilizat, Shihezi, Xinjiang, Peoples R China.	lihb@shzu.edu.cn			National Natural Science Foundation of China [31660408, 31260339]; Scientific and Technological Achievement Transformation Project of Bingtuan [2016AC017]; Distinguished Youth innovation foundation of Bingtuan [2014CD003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Achievement Transformation Project of Bingtuan; Distinguished Youth innovation foundation of Bingtuan	This work was supported by grants from National Natural Science Foundation of China (Grant number 31660408, 31260339), Scientific and Technological Achievement Transformation Project of Bingtuan (Grant number 2016AC017), and Distinguished Youth innovation foundation of Bingtuan (Grant number 2014CD003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee AE, 2010, PLANT PHYSIOL, V152, P120, DOI 10.1104/pp.109.145078; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen MX, 2012, PLANT CELL ENVIRON, V35, P2155, DOI 10.1111/j.1365-3040.2012.02546.x; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Clauss K, 2011, PLANT PHYSIOL, V155, P1127, DOI 10.1104/pp.110.169821; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dong X, 2016, MOL GENET GENOMICS, V291, P531, DOI 10.1007/s00438-015-1123-6; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Han P, 2008, PLANT CELL, V20, P1482, DOI 10.1105/tpc.108.058867; Hong JK, 2008, PLANTA, V227, P539, DOI 10.1007/s00425-007-0637-5; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; Kim KJ, 2008, BIOCHEM BIOPH RES CO, V374, P693, DOI 10.1016/j.bbrc.2008.07.120; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kram BW, 2008, PLANT MOL BIOL, V68, P173, DOI 10.1007/s11103-008-9361-1; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lai CP, 2017, PLANT MOL BIOL, V95, P181, DOI 10.1007/s11103-017-0648-y; Lee DS, 2009, BIOCHEM BIOPH RES CO, V379, P1038, DOI 10.1016/j.bbrc.2009.01.006; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li R, 2017, INT J MOL SCI, V18; Ling H, 2006, J BIOCHEM MOL BIOL, V39, P297; Mikleusevic G, 2009, CROAT CHEM ACTA, V82, P439; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Procopio L, 2013, ANTON LEEUW INT J G, V103, P635, DOI 10.1007/s10482-012-9847-3; Pugh DA, 2010, MOL PLANT, V3, P1075, DOI 10.1093/mp/ssq054; Qian Zhen, 2007, Biotechnology Journal, V2, P192, DOI 10.1002/biot.200600186; Qin YM, 2005, CELL RES, V15, P465, DOI 10.1038/sj.cr.7290315; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2007, J EXP BOT, V58, P473, DOI 10.1093/jxb/erl218; Riemann M, 2007, PLANT BIOLOGY, V9, P32, DOI 10.1055/s-2006-924561; Ruan YL, 2005, SEED SCI RES, V15, P269, DOI 10.1079/SSR2005217; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2008, FUNCT PLANT BIOL, V35, P382, DOI 10.1071/FP08017; Ruan YL, 2013, J INTEGR PLANT BIOL, V55, P572, DOI 10.1111/jipb.12074; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tan XL, 2014, PROTEIN J, V33, P18, DOI 10.1007/s10930-013-9532-z; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Xin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161695; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yadav VK, 2017, PLANT BIOTECHNOL J, V15, P1163, DOI 10.1111/pbi.12706; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0232-6	50	12	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195556	10.1371/journal.pone.0195556	http://dx.doi.org/10.1371/journal.pone.0195556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621331	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800102
J	Philip, P; Bioulac, S; Altena, E; Morin, CM; Ghorayeb, I; Coste, O; Monteyrol, PJ; Micoulaud-Franchi, JA				Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Morin, Charles M.; Ghorayeb, Imad; Coste, Olivier; Monteyrol, Pierre-Jean; Micoulaud-Franchi, Jean-Arthur			Specific insomnia symptoms and self-efficacy explain CPAP compliance in a sample of OSAS patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP-APNEA; LONG-TERM ADHERENCE; THERAPY; AGE; PREDICTORS; ASSOCIATION; VALIDATION; MEDICATION; VETERANS	This study explores the association between specific insomnia symptoms (sleep onset, sleep maintenance and early morning awakenings symptoms) and self-efficacy (perceived self-confidence in the ability to use CPAP) with CPAP compliance in French patients with obstructive sleep apnea syndrome (OSAS). We performed a retrospective, cross-sectional analysis of CPAP compliance in a cohort of 404 patients diagnosed with OSAS. Patients completed mailed questionnaires on sleepiness (ESS), insomnia (ISI) and self-efficacy in sleep apnea (SEMSA). Linear regression modeling analyses were performed to explore the impact of measured variables on the number of hours of CPAP use. Of the initial pool of 404 patients, 288 returned the questionnaires (71% response rate). Their mean age was 63.16 +/- 12.73 yrs, 31% were females, mean BMI was 30.39 6.31 kg/m(2), mean daily CPAP use was 6.19 +/- 2.03 h, mean number of years of use was 6.58 6.03 yrs, and mean initial AHI before CPAP use was 34.61 +/- 20.71 /h. Age (p<0.01), BMI (p<0.01), sleep onset insomnia symptoms (p<0.01), sleep maintenance insomnia symptoms (p<0.01) and self-efficacy (p<0.01) were significantly associated with mean daily CPAP use. We found that specific insomnia symptoms and self-efficacy were associated with CPAP compliance. Our findings underline the need to demonstrate that interventions that reduce insomnia symptoms and improve self-efficacy will increase CPAP compliance.	[Philip, Pierre; Bioulac, Stephanie; Ghorayeb, Imad; Coste, Olivier; Monteyrol, Pierre-Jean; Micoulaud-Franchi, Jean-Arthur] CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, Bordeaux, France; [Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Micoulaud-Franchi, Jean-Arthur] Univ Bordeaux, SANPSY, Bordeaux, France; [Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Micoulaud-Franchi, Jean-Arthur] SANPSY, CNRS, Bordeaux, France; [Morin, Charles M.] Univ Laval, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada; [Morin, Charles M.] Inst Univ Sante Mentale Quebec, Ctr Rech CERVO, Quebec City, PQ, Canada; [Ghorayeb, Imad] Inst Neurosci Cognit & Integrat Aquitaine, CNRS, Bordeaux, France; [Ghorayeb, Imad] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Philip, P (corresponding author), CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, Bordeaux, France.; Philip, P (corresponding author), Univ Bordeaux, SANPSY, Bordeaux, France.; Philip, P (corresponding author), SANPSY, CNRS, Bordeaux, France.	pr.philip@free.com	Morin, Charles M./A-4700-2008	Morin, Charles M./0000-0002-8649-8895; PHILIP, Pierre/0000-0003-3267-634X; MICOULAUD-FRANCHI, Jean-Arthur/0000-0002-5203-8444; Altena, Ellemarije/0000-0002-8882-7963; bioulac, stephanie/0000-0003-2618-4234				[Adult Obstructive Sleep Apnea Task Force of SPLF Societe francaise de recherche et de medecine du sommeil Societe francaise d'ORL Societe francaise de medecine du travail Societe de physiologie Societe francaise de cardiologie], 2010, MED SOMMEIL, V7, P161; Aloia MS, 2008, ANN BEHAV MED, V36, P44, DOI 10.1007/s12160-008-9052-9; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Bakker JP, 2011, SLEEP, V34, P1595, DOI 10.5665/sleep.1404; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Billiard M, 2012, TROUBLES SOMMEIL; Bjornsdottir E, 2013, SLEEP, V36, P1901, DOI 10.5665/sleep.3226; Bradshaw DA, 2006, CHEST, V130, P1369, DOI 10.1378/chest.130.5.1369; Budhiraja R, 2016, J CLIN SLEEP MED, V12, P333, DOI 10.5664/jcsm.5578; Campos-Rodriguez F, 2016, SLEEP MED, V17, P1, DOI 10.1016/j.sleep.2015.07.038; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; Dzierzewski JM, 2016, J CLIN SLEEP MED, V12, P169, DOI 10.5664/jcsm.5478; Gagnadoux F, 2016, CHEST, V149, P288, DOI 10.1016/j.chest.2015.09.032; Gagnadoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022503; Glidewell RN, 2014, SLEEP MED, V15, P899, DOI 10.1016/j.sleep.2014.05.001; GUILLEMINAULT C, 1973, SCIENCE, V181, P856, DOI 10.1126/science.181.4102.856; Jacobsen AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189614; Jaehne A, 2012, SLEEP MED, V13, P1286, DOI 10.1016/j.sleep.2012.06.026; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Lai AYK, 2013, SLEEP MED, V14, P1192, DOI 10.1016/j.sleep.2013.04.023; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Markov D, 2006, PSYCHIAT CLIN N AM, V29, P841, DOI 10.1016/j.psc.2006.09.008; Micoulaud-Franchi JA, 2017, MED SOMMEIL, V14, P99; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Nguyen XL, 2013, EUR RESPIR J, V41, P593, DOI 10.1183/09031936.00080011; Nguyen XL, 2010, SLEEP MED, V11, P777, DOI 10.1016/j.sleep.2010.04.008; Olsen S, 2008, EUR RESPIR J, V32, P710, DOI 10.1183/09031936.00127507; Paine SJ, 2004, SLEEP, V27, P1163, DOI 10.1093/sleep/27.6.1163; Pieh C, 2013, SLEEP BREATH, V17, P99, DOI 10.1007/s11325-012-0655-9; Richards D, 2007, SLEEP, V30, P635, DOI 10.1093/sleep/30.5.635; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Sawyer AM, 2011, PATIENT EDUC COUNS, V85, P85, DOI 10.1016/j.pec.2010.10.014; Smith SS, 2009, SLEEP BIOL RHYTHMS, V7, pA74; Steffen M, 2016, NEW ENGL J MED, V374, P401, DOI 10.1056/NEJMp1504547; STOOHS RA, 1993, SLEEP, V16, pS11; Suraiya S, 2006, SLEEP MED, V7, pS85, DOI DOI 10.1016/j.sleep.2006.07.203; Sweetman AM, 2017, SLEEP MED REV, V33, P28, DOI 10.1016/j.smrv.2016.04.004; Wallace DM, 2013, SLEEP BREATH, V17, P351, DOI 10.1007/s11325-012-0702-6; Wallace DM, 2013, J CLIN SLEEP MED, V9, P885, DOI 10.5664/jcsm.2988; Weaver TE, 2003, SLEEP, V26, P727, DOI 10.1093/sleep/26.6.727; Wickwire EM, 2008, CLIN CASE STUD, V7, P267; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Woehrle H, 2011, SLEEP MED, V12, P1034, DOI 10.1016/j.sleep.2011.05.008; Wohlgemuth WK, 2015, SLEEP MED, V16, P336, DOI 10.1016/j.sleep.2014.08.013; Ye LC, 2012, J SLEEP RES, V21, P419, DOI 10.1111/j.1365-2869.2011.00969.x; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	49	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195343	10.1371/journal.pone.0195343	http://dx.doi.org/10.1371/journal.pone.0195343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617414	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800076
J	Rasouli, O; Vasseljen, O; Forst, EA; Loras, HW; Stensdotter, AK				Rasouli, Omid; Vasseljen, Otter; Forst, Egil A.; Loras, Havard W.; Stensdotter, Ann-Katrin			Lower regulatory frequency for postural control in patients with fibromyalgia and chronic fatigue syndrome	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PAIN; STIMULATION; MODEL	As many similar symptoms are reported in fibromyalgia (FM) and chronic fatigue syndrome (CFS), underlying defcits may potentially also be similar. Postural disequilibrium reported in both conditions may thus be explained by similar deviations in postural control strategies. 75 females (25/group FM, CFS and control, age 19-49 years) performed 60 s of quiet standing on a force platform in each of three conditions: 1) firm surface with vision, 2) firm surface without vision and, 3) compliant surface with vision. Migration of center of pressure was decomposed into a slow and a fast component denoting postural sway and lateral forces controlling postural sway, analyzed in the time and frequency domains. Main effects of group for the antero-posterior (AP) and medio-lateral (ML) directions showed that patients displayed larger amplitudes (AP, p= 0.002; ML, p= 0.021) and lower frequencies (AP, p< 0.001; ML, p< 0.001) for the slow component, as well as for the fast component (amplitudes: AP, p = 0.010; ML, p= 0.001 and frequencies: AP, p = 0.001; ML, p= 0.029) compared to controls. Post hoc analyses showed no significant differences between patient groups. In conclusion, both the CFS- and the FM-group differed from the control group. Larger postural sway and insufficient control was found in patients compared to controls, with no significant differences between the two patient groups.	[Rasouli, Omid; Loras, Havard W.; Stensdotter, Ann-Katrin] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Rasouli, Omid; Vasseljen, Otter; Forst, Egil A.] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Stensdotter, AK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway.	ann-katrin.stensdotter@ntnu.no	Rasouli, Omid/S-5312-2017	Rasouli, Omid/0000-0003-2203-1839; Vasseljen, Ottar/0000-0001-6287-5871	institution Norwegian University of Science and Technology	institution Norwegian University of Science and Technology	This project was internally funded by the institution Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amris K, 2011, PAIN, V152, P2470, DOI 10.1016/j.pain.2011.05.027; ASHBERNAL R, 1995, ACTA OTO-LARYNGOL, V115, P9, DOI 10.3109/00016489509133339; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Bardal EM, 2016, J ELECTROMYOGR KINES, V26, P1, DOI 10.1016/j.jelekin.2015.12.006; Bardal EM, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-186; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgunder JM, 1998, Z RHEUMATOL, V57, P27; Casale R, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-78; Clauw DJ, 2010, PM&R, V2, P414, DOI 10.1016/j.pmrj.2010.04.010; Costa ID, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00014; Davey NJ, 2003, INT J CLIN PRACT, V57, P262; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gay CW, 2016, BRAIN CONNECT, V6, P48, DOI 10.1089/brain.2015.0366; Gur A, 2008, CURR PHARM DESIGN, V14, P1274, DOI 10.2174/138161208799316348; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ingvar M, 2015, PAIN, V156, pS18, DOI 10.1097/j.pain.0000000000000093; Isableu B, 2006, EXP BRAIN RES, V174, P763, DOI 10.1007/s00221-006-0630-4; Kim J, 2015, ARTHRITIS RHEUMATOL, V67, P1395, DOI 10.1002/art.39043; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lopez-Sola M, 2014, ARTHRITIS RHEUMATOL, V66, P3200, DOI 10.1002/art.38781; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Masani K, 2007, NEUROSCI LETT, V422, P202, DOI 10.1016/j.neulet.2007.06.019; Meeus M, 2014, CLIN RHEUMATOL; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Milton J, 2009, CHAOS, V19, DOI 10.1063/1.3141429; Monjo F, 2015, HUM MOVEMENT SCI, V44, P225, DOI 10.1016/j.humov.2015.09.006; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Puri BK, 2012, BRIT J RADIOL, V85, pE270, DOI 10.1259/bjr/93889091; Rasouli O, 2017, J PAIN RES IN PRESS; Rasouli O, 2016, CLIN BIOMECH, V37, P147, DOI 10.1016/j.clinbiomech.2016.07.008; Ruhe A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-162; Sipko T, 2013, EUR J PAIN, V17, P612, DOI 10.1002/j.1532-2149.2012.00226.x; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Vaillant J, 2016, ANN PHYS REHABIL M S, V59S, pe124; Vaillant J, 2016, ANN PHYS REHABIL MED, V59S, pE111; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195111	10.1371/journal.pone.0195111	http://dx.doi.org/10.1371/journal.pone.0195111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617424	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800065
J	Silva, NB; Osorio, FL				Silva, Nathiana B.; Osorio, Flavia L.			Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HOSPITALIZED CHILDREN; PET THERAPY; HEALTH; DOG; INTERVENTION; DEPRESSION; ANXIETY; CANCER; SCALE	The objective of this study was to propose an intervention and safety protocol for performing animal-assisted therapy (AAT) and evaluating its efficacy in children under outpatient oncological treatment based on psychological, physiological, and quality of life indicators for the children and caregivers. The sample consisted of 24 children diagnosed with leukaemia and solid tumours (58% girls with a mean age of 8.0 years) who underwent an AAT programme consisting of three 30-min sessions in an open group. Two dogs (one Labrador retriever and one golden retriever) were used, and activities such as sensory stimulation, gait training, and socialization were conducted. The exclusion criteria were severe mental problems, inability to answer the questions included in the instruments used, allergy to animals, unavailability/lack of interest, isolation precaution, surgical wound, use of invasive devices, ostomy, no current blood count for evaluation, neutropaenia, infection, fever, diarrhoea, vomiting, respiratory symptoms at the beginning of the intervention or 1 week before the intervention, hospitalization or scheduled surgery, and non-completion of the AAT programme. The variables analysed using validated self or other evaluations were stress, pain, mood, anxiety, depression, quality of life, heart rate, and blood pressure. A quasi-experimental study design was used. We observed a decrease in pain (p = 0.046, d = 0.894), irritation (p = 0.041, d = 0.917), and stress (p = 0.005; d = 1.404) and a tendency towards improvement of depressive symptoms (p = 0.069; d = 0.801). Among the caregivers, an improvement was observed in anxiety (p = 0.007, d = 1.312), mental confusion (p = 0.006, d = 1.350), and tension (p = 0.006, d = 1.361). Therefore, the selection criteria and care protocols used for the AAT programme in the oncological context were adequate, and the programme was effective.	[Silva, Nathiana B.; Osorio, Flavia L.] Barretos Canc Hosp, Pio Fdn 7, Sao Paulo, Brazil; [Osorio, Flavia L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Universidade de Sao Paulo	Osorio, FL (corresponding author), Barretos Canc Hosp, Pio Fdn 7, Sao Paulo, Brazil.; Osorio, FL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Sao Paulo, Brazil.	flaliosorio@ig.com.br	Osório, Flávia L./H-6079-2012; Osório, Flávia L./T-5001-2019	L. Osorio, Flavia/0000-0003-1396-555X	Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil; PQ-CNPq-2 [301321/2016-7]; Pio XII Foundation	Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil; PQ-CNPq-2; Pio XII Foundation	This work was supported by Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil. Prof. Osorio was supported by productivity grants (PQ-CNPq-2 -number 301321/2016-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Nucleus for Researcher Support (NAP) of the Barretos Cancer Hospital for the help with data collection and analysis, Luiz Fernando Lopes for help with the design of the AAT programme, the Hospital Infection Commission Team of the Barretos Cancer Hospital, in particular Paulo de Tarso Oliveira e Castro, for assistance with the elaboration of the intervention and safety protocol, Carla Rodrigues for the suggestions in the preparation of the final version of the manuscript, and the Pio XII Foundation for the funding provided.	Albuquerque NS, 2016, TERAPIA ASSISTIDA AN, P18; [Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; Antonioli C, 2005, BMJ-BRIT MED J, V331, P1231, DOI 10.1136/bmj.331.7527.1231; Aoki J, 2012, INT J PSYCHIAT CLIN, V16, P205, DOI 10.3109/13651501.2011.644565; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Assumpcao FB, 2000, ARQ NEURO-PSIQUIAT, V58, P119, DOI 10.1590/S0004-282X2000000100018; Barbeira C., 2002, REV PSIQUIATRIA CLIN, V29, P66; Barker SB, 2015, ANTHROZOOS, V28, P101, DOI 10.2752/089279315X14129350722091; Barker SB, 2005, PSYCHOL REP, V96, P713; Berget B, 2008, CLIN PRACT EPIDEMIOL, V4, P9, DOI DOI 10.1186/1745-0179-4-9; Berget B, 2011, OCCUP THER MENT HEAL, V27, P50, DOI 10.1080/0164212X.2011.543641; Bibbo J., 2013, ONCOL NURS FORUM, V40, P320; Borgi M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00298; Borgi M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00411; Bouchard France, 2004, Can Oncol Nurs J, V14, P14; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.008; Calcaterra V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125813; Caprilli S, 2006, EVID-BASED COMPL ALT, V3, P379, DOI 10.1093/ecam/nel029; Carine S, 2016, TERAPIA ASSISTIDA AN, P37; Cole KM, 2007, AM J CRIT CARE, V16, P575; da Silva FC, 2008, J PEDIAT-BRAZIL, V84, P344, DOI [10.1590/S0021-75572008000400010, 10.2223/JPED.1809]; da Silva WV, 2005, REV BRAS PSIQUIATR, V27, P329, DOI 10.1590/S1516-44462005000400014; DeCourcey M, 2010, DIMENS CRIT CARE NUR, V29, P211, DOI 10.1097/DCC.0b013e3181e6c71a; Eaglin Vanessa H, 2008, Hawaii Med J, V67, P45; Engelman SR, 2013, OMEGA-J DEATH DYING, V67, P63, DOI 10.2190/OM.67.1-2.g; Faraco CB, 2008, THESIS; Fleishman SB, 2015, J COMMUNITY SUPPORT, V13, P22, DOI 10.12788/jcso.0102; Gagnon Johanne, 2004, Can Oncol Nurs J, V14, P217; Goddard Anna Tielsch, 2015, Pediatr Nurs, V41, P65; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; Havey J, 2014, ANTHROZOOS, V27, P361, DOI 10.2752/175303714X13903827487962; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hoffmann AOM, 2009, EUR J INTEGR MED, V1, P145, DOI 10.1016/j.eujim.2009.08.002; Jegatheesan B, 2014, IAHAIO WHITE PAPER D, V1, P1; Johnson RA, 2003, AM BEHAV SCI, V47, P55, DOI 10.1177/0002764203255213; Johnson RA, 2008, ONCOL NURS FORUM, V35, P225, DOI 10.1188/08.ONF.225-232; Kaminski M, 2002, CHILD HEALTH CARE, V31, P321, DOI 10.1207/S15326888CHC3104_5; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Krause-Parello CA, 2014, ANTHROZOOS, V27, P581, DOI 10.2752/089279314X14072268688005; Lefebvre SL, 2008, AM J INFECT CONTROL, V36, P78, DOI 10.1016/j.ajic.2007.09.005; Lipp M.E.N., 2002, PSICOLOGIA ESCOLAR E, V6, P51; Lipp MEN, 1998, ESCALA STRESS INFANT; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Manificat S, 1997, NEUROPSYCHIAT ENFAN, V45, P106; Marcus DA, 2014, AM J HOSP PALLIAT ME, V31, P420, DOI 10.1177/1049909113492373; Maroco J., 2007, ANALISE ESTATISTICA, V3rd; Moody WJ, 2002, J CLIN NURS, V11, P537, DOI 10.1046/j.1365-2702.2002.00618.x; Motooka M, 2006, MED J AUSTRALIA, V184, P60, DOI 10.5694/j.1326-5377.2006.tb00116.x; Lasa SM, 2015, NEUROLOGIA, V30, P1, DOI 10.1016/j.nrl.2013.01.012; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nahm N, 2012, WEST J EMERG MED, V13, P363, DOI 10.5811/westjem.2011.5.6574; Nepps P, 2014, J EVID-BASED INTEGR, V19, P211, DOI 10.1177/2156587214533570; Novotny NL, 2015, J NURS ED PRACT, V5, P123, DOI DOI 10.5430/JNEP.V5N7P123; O'Haire ME, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01121; Odendaal JSJ, 2000, J PSYCHOSOM RES, V49, P275, DOI 10.1016/S0022-3999(00)00183-5; Orlandi M, 2007, ANTICANCER RES, V27, P4301; Rohlfs ICPD, 2008, REV BRAS MED ESPORTE, V14, P176, DOI 10.1590/S1517-86922008000300003; Redd R, 2012, REV LAT-AM ENFERM, V20, P1; Rivera GK, 2014, EXPERT REV HEMATOL, V7, P649, DOI 10.1586/17474086.2014.949233; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Sobo EJ, 2006, J HOLIST NURS, V24, P51, DOI 10.1177/0898010105280112; Spielberger C., 1973, STAIC PRELIMINARY MA; Stewart LA, 2014, J CREAT MENT HEALTH, V9, P332, DOI 10.1080/15401383.2014.892862; Stoffel J.M., ANIMAL ASSISTED THER; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Takashima GK, 2014, INT J ENV RES PUB HE, V11, P11110, DOI 10.3390/ijerph111111110; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Trembath F., 2015, HABRI CENTRAL BRIEF, P1; Tsai CC, 2010, ANTHROZOOS, V23, P245, DOI 10.2752/175303710X12750451258977; VORMBROCK JK, 1988, J BEHAV MED, V11, P509, DOI 10.1007/BF00844843; White JH, 2015, INTEGR CANCER THER, V14, P460, DOI 10.1177/1534735415580678; Willens JS, 2013, PAIN MANAG NURS, V14, P183, DOI 10.1016/j.pmn.2013.10.001; Wu Adam S, 2002, J Pediatr Nurs, V17, P354, DOI 10.1053/jpdn.2002.127173	73	35	39	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194731	10.1371/journal.pone.0194731	http://dx.doi.org/10.1371/journal.pone.0194731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617398	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800045
J	Moore, TC; Messer, RJ; Hasenkrug, KJ				Moore, Tyler C.; Messer, Ronald J.; Hasenkrug, Kim J.			Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CUTTING EDGE; B-CELLS; FUNCTIONAL IMPAIRMENT; TISSUE AUTOANTIGENS; MICE; LEUKEMIA; EXPANSION; RECOVERY; DISEASE	Recent vaccine studies with experimental antigens have shown that regulatory T cells (Tregs) constrain the magnitude of B cell responses. This homeostatic Treg-mediated suppression is thought to reduce the potential of germinal center (GC) responses to generate autoreactive antibodies. However, essentially opposite results were observed in live influenza infections where Tregs promoted B cell and antibody responses. Thus, it remains unclear whether Tregs dampen or enhance B cell responses, especially during live viral infections. Here, we use mice infected with Friend retrovirus (FV), which induces a robust expansion of Tregs. Depletion of Tregs led to elevated activation, proliferation, and class switching of B cells. In addition, Treg depletion enhanced the production of virus-specific and virus-neutralizing antibodies and reduced FV viremia. Thus, in contrast to influenza infection, Tregs either directly or indirectly suppress B cells during mouse retroviral infection indicating that the ultimate effect of Tregs on B cell responses is specific to the particular infectious agent.	[Moore, Tyler C.; Messer, Ronald J.; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Moore, Tyler C.] Bellevue Univ, Bellevue, NE USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hasenkrug, KJ (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	khasenkrug@nih.gov			National Institute of Allergy and Infectious Diseases, Division of Intramural Research [ZA1000753]; National Institute of Allergy and Infectious Diseases, National Institute of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Project #ZA1000753.; This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institute of Health, USA.	ALBERTS B, 2002, MOL BIOL CELL, pR34; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; CHESEBRO B, 1979, P NATL ACAD SCI USA, V76, P425, DOI 10.1073/pnas.76.1.425; CHESEBRO B, 1981, VIROLOGY, V112, P131, DOI 10.1016/0042-6822(81)90619-X; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Dittmer U, 2004, IMMUNITY, V20, P653, DOI 10.1016/S1074-7613(04)00115-3; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10; FRIEND C, 1957, J EXP MED, V105, P307, DOI 10.1084/jem.105.4.307; Gotot J, 2012, P NATL ACAD SCI USA, V109, P10468, DOI 10.1073/pnas.1201131109; Hasenkrug KJ, 2010, J IMMUNOL, V185, P1349, DOI 10.4049/jimmunol.1090058; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Joedicke JJ, 2012, IMMUNOLOGY, V136, P8; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Ludwig-Portugall I, 2009, EUR J IMMUNOL, V39, P225, DOI 10.1002/eji.200838699; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; MORRISON RP, 1987, NATURE, V329, P729, DOI 10.1038/329729a0; Myers L, 2013, J IMMUNOL, V190, P5485, DOI 10.4049/jimmunol.1202951; Nair SR, 2010, J GEN VIROL, V91, P440, DOI 10.1099/vir.0.015834-0; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Rekvig OP, 2014, SEMIN IMMUNOPATHOL, V36, P301, DOI 10.1007/s00281-014-0428-6; ROBERTSON MN, 1991, J VIROL METHODS, V34, P255, DOI 10.1016/0166-0934(91)90105-9; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Super HJ, 1998, J VIROL, V72, P9400, DOI 10.1128/JVI.72.11.9400-9403.1998; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195402	10.1371/journal.pone.0195402	http://dx.doi.org/10.1371/journal.pone.0195402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614127	gold, Green Published, Green Submitted			2022-12-27	WOS:000429081600057
J	Kuehne, A; Koschollek, C; Santos-Hovener, C; Thorlie, A; Mullerschon, J; Tshibadi, CM; Mayamba, P; Batemona-Abeke, H; Amoah, S; Greiner, VW; Dela Bursi, T; Bremer, V				Kuehne, Anna; Koschollek, Carmen; Santos-Hoevener, Claudia; Thorlie, Adama; Muellerschoen, Johanna; Tshibadi, Christina Mputu; Mayamba, Pierre; Batemona-Abeke, Helene; Amoah, Stephen; Greiner, Virginia Wangare; Dela Bursi, Taty; Bremer, Viviane			Impact of HIV knowledge and stigma on the uptake of HIV testing - Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; CARE	Background In 2015, 3,674 new HIV diagnoses were notified in Germany; 16% of those newly diagnosed cases originated from sub-Saharan Africa (sSA). One quarter of the newly diagnosed cases among migrants from sSA (MisSA) are notified as having acquired the HIV infection in Germany. In order to reach MisSA with HIV testing opportunities, we aimed to identify which determinants influence the uptake of HIV testing among MisSA in Germany. Methods To identify those determinants, we conducted a quantitative cross-sectional survey among MisSA in Germany. The survey was designed in a participatory process that included MisSA and other stakeholders in HIV-prevention. Peer researchers recruited participants to complete standardized questionnaires on HIV knowledge and testing. We conducted multivariable analyses (MVA) to identify determinants associated with ever having attended voluntary HIV testing; and another MVA to identify determinant associated with having had the last voluntary HIV test in Germany. Results Peer researchers recruited 2,782 participants eligible for inclusion in the MVA. Of these participants, 59.9% (1,667/2,782) previously had an HIV test. For each general statement about HIV that participants knew prior to participation in the study, the odds of having been tested increased by 19% (OR 1.19; 95%-CI: 1.11-1.27). Participants reporting that HIV is a topic that is discussed in their community had 92% higher odds of having been tested for HIV (OR 1.92; 95%-CI: 1.60-2.31). Migrants living in Germany for less than a year had the lowest odds of having had their last HIV test in Germany (OR 0.17; 95%-CI: 0.11-0.27). Additionally, MisSA 18 to 25 years (OR 0.55; 95%-CI: 0.42-0.73) and participants with varied sexual partners and inconsistent condom use (OR 0.75; 95%-CI: 0.44-0.97) had significantly lower odds of having had their last HIV test in Germany. Discussion Through participatory research, we were able to show that knowledge about HIV and discussing HIV in communities increased the odds of having attended HIV testing among MisSA. However, recent migrants and young sexually active people are among the least reached by testing offers in Germany. Community-based interventions may present opportunities to reach such migrants and improve knowledge and increase discussion about HIV.	[Kuehne, Anna; Koschollek, Carmen; Santos-Hoevener, Claudia; Thorlie, Adama; Muellerschoen, Johanna; Bremer, Viviane] Robert Koch Inst, Dept Infect Dis Epidemiol, Unit HIV AIDS STI & Blood Borne Infect, Berlin, Germany; [Koschollek, Carmen] Charite, Berlin, Germany; [Tshibadi, Christina Mputu] Munchner Aids Hilfe eV, Munich, Germany; [Mayamba, Pierre] Aidshilfe Essen eV, Essen, Germany; [Batemona-Abeke, Helene] Pamoja Afrika eV, Cologne, Germany; [Amoah, Stephen] Regionalverband Berlin Brandenburg eV, Verband Interkulturelle Arbeit, Afrikaherz Berlin, Berlin, Germany; [Greiner, Virginia Wangare] Maisha eV, Frankfurt, Germany; [Dela Bursi, Taty] Hannoversche Aids Hilfe eV, Hannover, NH, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bremer, V (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Unit HIV AIDS STI & Blood Borne Infect, Berlin, Germany.	BremerV@rki.de	Kuehne, Anna/AAD-7816-2022	Kuehne, Anna/0000-0002-8578-0362	German Federal Ministry of Health; Robert Koch Institute, Berlin;  [ZMVI5-2514-AUK-001]	German Federal Ministry of Health; Robert Koch Institute, Berlin; 	The study was funded by the German Federal Ministry of Health. The funding was granted to the Robert Koch Institute, Berlin, dated August 13, 2014 for the study "KABP (knowledge, attitudes, behaviour and practices)-study with optional HIV/STI-testing among migrants from sub-Saharan Africa living in Germany (MisSA-study)". The funds are budgeted in the federal budget 2014, chapter 1502, title 68618 - Research and projects for identification and elimination of AIDS and other sexual transmitted infections. Project lead: Claudia Santos-Hovener, Grant number: ZMVI5-2514-AUK-001 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozorgmehr K, 2017, EUROSURVEILLANCE, V22, P12, DOI 10.2807/1560-7917.ES.2017.22.40.16-00677; Brachertz N., 2007, ISR WORKING PAPER; Bundeszentrale fur gesundheitliche Aufkla E rung (BZgA), 2012, AIDS OFF BEW BUND DE; Deutsche AIDS-Hilfe e. V. (DAH), 2013, MUMM MIGR MIGR ALS M; Deutsche AIDS-Hilfe e. V. (DAH), 2017, HIV PRAV KIRCH; Deutsche AIDS-Hilfe e. V. (DAH), 2007, AUFS PRAV AFR COMM K; Dodds C, 2008, BASS LINE 2007 SURVE; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; ECDC, 2013, MIGR HLTH SEX TRANSM; European centre for disease prevention and control (ECDC), 2016, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control (ECDC), 2009, MIGR HLTH ACC HIV PR; European Centre for Disease Prevention and Control (ECDC), 2009, TECHN REP MAPP HIV S; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Gemeinsamer Bundesausschuss, 2016, MUTT; Gesesew HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173928; Graser S, 2009, HIV AIDS PRAVENTION; Gregson S, 2013, AIDS, V27, P1657, DOI 10.1097/QAD.0b013e3283601b90; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2017, AIDS BY THE NUMB; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2014, GAP REP 2013; Magalhaes L, 2010, J IMMIGR MINOR HEALT, V12, P132, DOI 10.1007/s10903-009-9280-5; Minkler M., 2003, COMMUNITY BASED PART; Nostlinger C, 2016, AIDS CARE, V28, P119, DOI 10.1080/09540121.2016.1146398; Razafindratsima N., 2010, METHODOLOGICAL INNOV, V5, P3, DOI [10.4256/mio.2010.0014, DOI 10.4256/MIO.2010.0014]; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Robert Koch-Institut, 2012, EPIDEMIOL B, V3, P19, DOI DOI 10.17886/EPIBULL-2015-011.3; Robert Koch-Institut (RKI), 2015, VORSCR ERST AS ERL M; Robert Koch-Institut (RKI), 2016, MISSA MAT FRAG STUD; Robert Koch-Institut (RKI), 2016, EPIDEMIOL B, V38, P407, DOI [10.17886/EpiBull-2016-056, DOI 10.17886/EPIBULL-2016-056]; Sadler KE, 2005, MAYISHA 2 MAIN STUDY; Santos-Hovener C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2098-2; Santos-Hovener C, 2015, PRAVENT GESUNDHEIT, V10, P68, DOI 10.1007/s11553-014-0466-x; Santos-Hovener C, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.6833; Sarma N, 2016, MITEST STUDIE ABSCHL; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Stangl AL, 2012, MEASURING HIV STIGMA, P1; Stateveig S, 2013, 30 DHS USAIDS; Statistisches Bundesamt, 2015, AUSL; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; von Unger H, 2011, PAKOMI HDB HIV PRAVE; von UngerH., 2012, INT J ACTION RES, V8, P266, DOI [10.1688/1861-9916_ijar_2012_03_unger, DOI 10.1688/1861-9916_IJAR_2012_03_UNGER, 10.1688/1861-9916_IJAR_2012_03_Unger]; Wright, 2013, 1 INT COLL PART HLTH; Wright MT, 2007, INFOD GESUNDHEITSFOR, V3, P4; Zoufaly A, 2012, HIV MED, V13, P172, DOI 10.1111/j.1468-1293.2011.00958.x	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194244	10.1371/journal.pone.0194244	http://dx.doi.org/10.1371/journal.pone.0194244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641527	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900028
J	Milenkovic, VM; Bader, S; Sudria-Lopez, D; Siebert, R; Brandl, C; Nothdurfter, C; Weber, BHF; Rupprecht, R; Wetzel, CH				Milenkovic, Vladimir M.; Bader, Stefanie; Sudria-Lopez, Daniel; Siebert, Ramona; Brandl, Caroline; Nothdurfter, Caroline; Weber, Bernhard H. F.; Rupprecht, Rainer; Wetzel, Christian H.			Effects of genetic variants in the TSPO gene on protein structure and stability	PLOS ONE			English	Article							MITOCHONDRIAL TRANSLOCATOR PROTEIN; POSITRON-EMISSION-TOMOGRAPHY; AMINO-ACID SUBSTITUTIONS; 18 KDA TSPO; PERIPHERAL BENZODIAZEPINE; DELETERIOUS MUTATIONS; SYNONYMOUS VARIANTS; A147T POLYMORPH; BINDING; AFFINITY	The 18 kDa translocator protein (TSPO) is an evolutionary conserved cholesterol binding protein localized in the outer mitochondrial membrane. Expression of TSPO is upregulated in activated microglia in various neuroinflammatory, neurodegenerative, and neoplastic disorders. Therefore, TSPO radioligands are used as biomarkers in positron emission tomography (PET) studies. In particular, a common A147T polymorphism in the TSPO gene affects binding of several high affinity TSPO radioligands. Given the relevance of TSPO as a diagnostic biomarker in disease processes, we systematically searched for mutations in the human TSPO gene by a wide array of evolution and structure based bioinformatics tools and identified potentially deleterious missense mutations. The two most frequently observed missense mutations A147T and R162H were further analysed in structural models of human wildtype and mutant TSPO proteins. The effects of missense mutations were studied on the atomic level using molecular dynamics simulations. To analyse putative effects of A147T and R162H variants on protein stability we established primary dermal fibroblast cultures from wt and homozygous A147T and R162H donors. Stability of endogenous TSPO protein, which is abundantly expressed in fibroblasts, was studied using cycloheximide protein degradation assay. Our data show that the A147T mutation significantly alters the flexibility and stability of the mutant protein. Furthermore both A147T and R162H mutations decreased the half-life of the mutant proteins by about 25 percent, which could in part explain its effect on reduced pregnenolone production and susceptibility to neuropsychiatric disorders. The present study is the first comprehensive bioinformatic analysis of genetic variants in the TSPO gene, thereby extending the knowledge about the clinical relevance of TSPO nsSNPs.	[Milenkovic, Vladimir M.; Bader, Stefanie; Sudria-Lopez, Daniel; Siebert, Ramona; Nothdurfter, Caroline; Rupprecht, Rainer; Wetzel, Christian H.] Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, Regensburg, Germany; [Brandl, Caroline; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Milenkovic, VM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, Regensburg, Germany.	vladimir.milenkovic@ukr.de	Wetzel, Christian H/N-9880-2017	Wetzel, Christian H/0000-0002-5762-0003; Sudria Lopez, Daniel/0000-0002-7492-5183; Brandl, Caroline/0000-0001-8223-6137				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert NL, 2017, EUR J NUCL MED MOL I, V44, P2230, DOI 10.1007/s00259-017-3799-9; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Colasanti A, 2013, PSYCHONEUROENDOCRINO, V38, P2826, DOI 10.1016/j.psyneuen.2013.07.007; Costa B, 2009, ENDOCRINOLOGY, V150, P5438, DOI 10.1210/en.2009-0752; Costa B, 2009, PSYCHIAT GENET, V19, P110, DOI 10.1097/YPG.0b013e32832080f6; Friedrich U, 2015, HUM MOL GENET, V24, P6361, DOI 10.1093/hmg/ddv346; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Gatliff J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.186; Gavish M, 1999, PHARMACOL REV, V51, P629; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Jaipuria G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14893; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jaremko M, 2016, BIOMOL NMR ASSIGN, V10, P79, DOI 10.1007/s12104-015-9642-y; Jaremko M, 2015, CHEMBIOCHEM, V16, P1483, DOI 10.1002/cbic.201500217; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kosek E, 2016, BRAIN BEHAV IMMUN, V58, P218, DOI 10.1016/j.bbi.2016.07.150; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurumaji A, 2001, AM J MED GENET, V105, P172, DOI 10.1002/ajmg.1194; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li F, 2015, BIOCHEMISTRY-US, V54, P1441, DOI 10.1021/bi5015453; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Milenkovic VM, 2015, MINI-REV MED CHEM, V15, P366, DOI 10.2174/1389557515666150324122642; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Nakamura K, 2006, AM J MED GENET B, V141B, P222, DOI 10.1002/ajmg.b.30211; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Pratt CW, 2014, PSYCHIATRIC REHABILITATION, 3RD EDITION, P33, DOI 10.1016/B978-0-12-387002-5.00002-0; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Vomacka L, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0340-x	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195627	10.1371/journal.pone.0195627	http://dx.doi.org/10.1371/journal.pone.0195627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641545	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900078
J	Brockman, T; Blanchard, V; Heretsch, P; Brockmann, C; Bertelmann, E				Brockman, Tobias; Blanchard, Veronique; Heretsch, Philipp; Brockmann, Claudia; Bertelmann, Eckart			Photochemical degradation of trypan blue	PLOS ONE			English	Article							INDOCYANINE GREEN; CATARACT-SURGERY; EPIRETINAL MEMBRANE; MASS-SPECTROMETRY; VITAL DYES; CELLS; LIGHT; CAROTENOIDS; VITRECTOMY; EXPOSURE	Purpose To investigate the photochemical degradation of trypan blue (TB) and to identify decomposition products. Methods Defined solution samples of TB and a mixture with lutein/zeaxanthin were exposed to blue light. Thermal degradation processes were ruled out using controls not subjected to irradiation. All samples were analyzed using optical microscopy, UVNis spectroscopy, matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and nuclear magnetic resonance (NMR) spectrometry. Degradation kinetics were determined based on changes in absorbance; intermediates were identified by analyzing mass differences of characteristic fragment ion peaks within the fragmentation patterns, and assignments were verified by NMR. Results TB demonstrated a photochemical degradation, which can be triggered by lutein/zeaxanthin. Intermediates vary depending on the presence of lutein/zeaxanthin. The self-sensitized photodegradation of TB occurs under generation of dimethyl sulfate and presumed formation of phenol. In contrast, within the presence of lutein/zeaxanthin the decomposition of TB indicates the formation of methoxyamine and sulfonyl arin. Thermal degradation processes were not observed. Conclusions TB demonstrated a photodegradation that may be triggered by lutein/zeaxanthin and results in the formation of cytotoxic decomposition products. Our findings contribute to understand degradation mechanisms of TB and may elucidate previous clinical and experimental observations of cellular toxicity after TB application.	[Brockman, Tobias; Brockmann, Claudia] Berlin Inst Hlth, Berlin, Germany; [Blanchard, Veronique; Brockmann, Claudia; Bertelmann, Eckart] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin, Germany; [Blanchard, Veronique] Berlin Inst Hlth, Inst Lab Med Clin Chem & Pathobiochem, Berlin, Germany; [Heretsch, Philipp] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Brockmann, Claudia; Bertelmann, Eckart] Berlin Inst Hlth, Dept Ophthalmol, Berlin, Germany	Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Berlin Institute of Health	Brockman, T (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Bertelmann, E (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin, Germany.; Bertelmann, E (corresponding author), Berlin Inst Hlth, Dept Ophthalmol, Berlin, Germany.	tobias.brockmann@charite.de; eckart.bertelmann@charite.de	Heretsch, Philipp/AFU-6940-2022	Brockmann, Tobias/0000-0001-6939-1159; Blanchard, Veronique/0000-0002-5980-6450	Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Research Foundation (DFG); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	Dr. Tobias Brockmann and Dr. Claudia Brockmann are participants in the BIH Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health. None of the authors has a financial and proprietary interest in a product or lack thereof. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach T, 2008, OPHTHALMOLOGE, V105, P905, DOI 10.1007/s00347-008-1795-y; [Anonymous], 2008, OPHTHALMOLOGY EXPERT; Awad D, 2011, INVEST OPHTH VIS SCI, V52, P4085, DOI 10.1167/iovs.10-6336; Bacsal KME, 2006, EYE, V20, P1310, DOI 10.1038/sj.eye.6702164; Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Brockmann T, 2014, ACTA OPHTHALMOL, V92, pe556, DOI 10.1111/aos.12419; Brockmann T, 2012, OPHTHALMOLOGICA, V228, P234, DOI 10.1159/000341605; Brockmann T, 2011, OPHTHALMOLOGICA, V226, P228, DOI 10.1159/000331218; Chang YS, 2005, J CATARACT REFR SURG, V31, P792, DOI 10.1016/j.jcrs.2004.07.020; Chou SY, 2016, RSC ADV, V6, P33478, DOI 10.1039/c5ra28024a; Creuzot-Garcher C, 2010, RETINA-J RET VIT DIS, V30, P1294, DOI 10.1097/IAE.0b013e3181d205aa; DeSesso JM, 2000, TERATOLOGY, V62, P346, DOI 10.1002/1096-9926(200011)62:5<346::AID-TERA9>3.0.CO;2-1; Ehrlich P., 1907, BERLINER KLIN WOCHEN, P320; Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911; Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003; Feron EJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P141; FORRESTER J, 1995, J CHEM SOC PERK T 1, P2289, DOI 10.1039/p19950002289; Fraser PD, 2007, PLANT J, V49, P552, DOI 10.1111/j.1365-313X.2006.02949.x; Gandorfer A, 2003, INVEST OPHTH VIS SCI, V44, P316, DOI 10.1167/iovs.02-0545; Giansanti F, 2014, J OCUL PHARMACOL TH, V30, P406, DOI 10.1089/jop.2013.0213; Gouws P, 2004, BRIT J OPHTHALMOL, V88, P1348, DOI 10.1136/bjo.2004.041756; GROSS P, 1985, CRC CR REV TOXICOL, V14, P87, DOI 10.3109/10408448509023765; Jacobs DS, 2006, OPHTHALMOLOGY, V113, P707, DOI 10.1016/j.ophtha.2006.01.024; Kaufmann R, 1996, ANAL BIOCHEM, V238, P117, DOI 10.1006/abio.1996.0264; Kodjikian L, 2005, GRAEF ARCH CLIN EXP, V243, P917, DOI 10.1007/s00417-004-1121-6; Krinsky NI, 2002, J NUTR, V132, p540S, DOI 10.1093/jn/132.3.540S; Lee YH, 2017, MOL CATAL, V432, P196, DOI 10.1016/j.mcat.2017.01.002; Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216; Liang JY, 2017, J PHOTOCH PHOTOBIO B, V174, P355, DOI 10.1016/j.jphotobiol.2017.08.018; Liu FY, 2018, CATAL TODAY, V300, P112, DOI 10.1016/j.cattod.2017.04.030; Luke M, 2013, OPHTHALMOLOGICA, V230, P21, DOI 10.1159/000353867; Maia M, 2007, CURR EYE RES, V32, P309, DOI 10.1080/02713680701199377; Mathison BH, 2004, INHAL TOXICOL, V16, P581, DOI 10.1080/08958370490464553; Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2; MITTAG T, 1984, EXP EYE RES, V39, P759, DOI 10.1016/0014-4835(84)90075-7; Morales MC, 2010, INVEST OPHTH VIS SCI, V51, P6018, DOI 10.1167/iovs.09-4916; Narayanan R, 2005, INVEST OPHTH VIS SCI, V46, P304, DOI 10.1167/iovs.04-0703; National Toxicology Program, 2011, Rep Carcinog, V12, P174; NORN MS, 1967, ACTA OPHTHALMOL, V45, P380; Penha FM, 2007, OPHTHALMOLOGY, V114, P899, DOI 10.1016/j.ophtha.2006.09.028; Polyakov NE, 2013, J PHYS CHEM B, V117, P10173, DOI 10.1021/jp4062708; Saeed Muhammad Usman, 2009, International Ophthalmology, V29, P239, DOI 10.1007/s10792-008-9195-5; Schutt CA, 2015, AM J OTOLARYNG, V36, P356, DOI 10.1016/j.amjoto.2014.12.009; Sinha R, 2003, BRIT J OPHTHALMOL, V87, P654, DOI 10.1136/bjo.87.5.654; Sousa- Martins D, inventor; Kemin Industries Inc, assignee. Water soluble lipophilic materials, Patent No. [WO/ 2017/ 142834, 2017142834]; Tsaousis KT, 2013, CLIN EXP OPHTHALMOL, V41, P484, DOI 10.1111/ceo.12018; Uno F, 2006, RETINA-J RET VIT DIS, V26, P237, DOI 10.1097/00006982-200602000-00026; Zsila F, 2001, J PHYS CHEM B, V105, P9413, DOI 10.1021/jp011626u	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195849	10.1371/journal.pone.0195849	http://dx.doi.org/10.1371/journal.pone.0195849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634764	Green Submitted, gold, Green Published			2022-12-27	WOS:000429522200058
J	Chen, Z; Liu, LR; Pan, CL; Li, XN; Pan, L; Lan, WZ; Yang, ZK				Chen, Zhao; Liu, Luoru; Pan, Chenglin; Li, Xiaoning; Pan, Lun; Lan, Weizhong; Yang, Zhikuan			Ocular residual and corneal astigmatism in a clinical population of high school students	PLOS ONE			English	Article							ANYANG CHILDHOOD EYE; REFRACTIVE ERROR; INTERNAL ASTIGMATISM; MYOPIA DEVELOPMENT; CHINESE CHILDREN; POWER VECTORS; PREVALENCE; SCHOOLCHILDREN; LENSES; REPEATABILITY	Purpose Total refractive astigmatism is usually the first consideration that guides the selection of contact lens type (e.g., spherical or toric), while the ocular source of the astigmatism is a second, but more important consideration, for the final clinical decision. This study was conducted to provide detailed data on this topic by evaluating astigmatic components in Chinese adolescents. Methods Participants were recruited from healthy high school students undergoing an annual ocular examination at a local hospital. Total astigmatism (TA), corneal astigmatism (CA), and ocular residual astigmatism (ORA) were determined by a Hartmann-Shack wavefront analyzer system (KR-1W, Topcon) with the natural pupil. The axis relationship between CA and ORA was placed into three categories: on-axis, defined as an axis with a difference of 0 +/- 10 degrees; opposite-axis, a difference of 90 +/- 10 degrees; and the rest defined as oblique -axis. Results The study consisted of 1,466 students (57.84% girls, age: 16.49 +/- 1.05 years). ORA was present in 83.97%, 66.64%, and 45.23% of participants, according to the various criteria for astigmatism (>= 0.50 D, >= 0.75 D, and >= 1.00 D, respectively). While with-the-rule was the most common axis orientation for both TA (76.28%) and CA (89.94%), against-the-rule predominated in ORA (93.82%; chi(2) = 1688.544, p < 0.001). Opposite-axis was the major type of axis difference (90.96%) of clinical significance (i.e., >= 1.00 D) between CA and ORA, which also prevailed in all levels of TA (range: 56.25-82.26%). Conclusions ORA is common in high school students and usually demonstrates a compensation relationship with CA, which should be taken into consideration when determining the design of contact lenses to correct refractive error.	[Chen, Zhao; Pan, Chenglin; Li, Xiaoning; Pan, Lun; Lan, Weizhong; Yang, Zhikuan] Cent S Univ, Aier Sch Ophthalmol, Aier Inst Optometry & Vis Sci, Changsha, Hunan, Peoples R China; [Liu, Luoru] Anyang Eye Hosp, Anyang, Henan, Peoples R China	Central South University	Lan, WZ; Yang, ZK (corresponding author), Cent S Univ, Aier Sch Ophthalmol, Aier Inst Optometry & Vis Sci, Changsha, Hunan, Peoples R China.	13725458845@139.com; 13380071988@189.cn		Chen, Zhao/0000-0002-3970-5249; Lan, Weizhong/0000-0002-3829-7415	Science Research Foundation of Aier Eye Hospital Group [2013002]; Hunan province Foundation for Science Technology [2017WK2071]	Science Research Foundation of Aier Eye Hospital Group; Hunan province Foundation for Science Technology	This study was funded by Science Research Foundation of Aier Eye Hospital Group (Grant No. 2013002) and Hunan province Foundation for Science & Technology (Grant No. 2017WK2071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Benito A, 2009, AM J OPHTHALMOL, V147, P424, DOI 10.1016/j.ajo.2008.09.027; Cowen L, 2003, INVEST OPHTH VIS SCI, V44, P4593, DOI 10.1167/iovs.02-0730; Cox DJ, 2015, OPTOMETRY VISION SCI, V92, P404, DOI 10.1097/OPX.0000000000000554; DUNNE MCM, 1994, ACTA OPHTHALMOL, V72, P483; Eom Y, 2013, AM J OPHTHALMOL, V156, P1112, DOI 10.1016/j.ajo.2013.06.039; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fotouhi A, 2011, OPTOMETRY VISION SCI, V88, P1054, DOI 10.1097/OPX.0b013e318221727d; GROSVENOR T, 1988, AM J OPTOM PHYS OPT, V65, P292; Harle DE, 2006, OPTOMETRY VISION SCI, V83, P82, DOI 10.1097/01.opx.0000200680.95968.3e; Harvey EM, 2013, J AAPOS, V17, P494, DOI 10.1016/j.jaapos.2013.05.015; Hoffmann PC, 2010, J CATARACT REFR SURG, V36, P1479, DOI 10.1016/j.jcrs.2010.02.025; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P55, DOI 10.1167/iovs.05-0182; Huynh SC, 2007, INVEST OPHTH VIS SCI, V48, P73, DOI 10.1167/iovs.06-0263; Keller PR, 1996, OPTOMETRY VISION SCI, V73, P86, DOI 10.1097/00006324-199602000-00003; Lan WZ, 2008, OPHTHAL PHYSL OPT, V28, P57, DOI 10.1111/j.1475-1313.2007.00536.x; Leung TW, 2012, OPTOMETRY VISION SCI, V89, P984, DOI 10.1097/OPX.0b013e31825da156; Li SM, 2015, INVEST OPHTH VIS SCI, V56, P4734, DOI 10.1167/iovs.14-15474; Li SM, 2015, BRIT J OPHTHALMOL, V99, P674, DOI 10.1136/bjophthalmol-2014-305322; Liu YL, 2017, JPN J OPHTHALMOL, V61, P494, DOI 10.1007/s10384-017-0532-y; Liu YC, 2011, INVEST OPHTH VIS SCI, V52, P9651, DOI 10.1167/iovs.11-7641; Manny RE, 2016, OPTOMETRY VISION SCI, V93, P1079, DOI 10.1097/OPX.0000000000000946; Maples W C, 1997, J Am Optom Assoc, V68, P87; Mashige KP, 2016, OPTOMETRY VISION SCI, V93, P243, DOI 10.1097/OPX.0000000000000771; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Ozdemir O, 2015, INT J OPHTHALMOL-CHI, V8, P128, DOI 10.3980/j.issn.2222-3959.2015.01.24; Pinero DP, 2011, J REFRACT SURG, V27, P509, DOI 10.3928/1081597X-20101214-01; Rajavi Zhale, 2012, J Ophthalmic Vis Res, V7, P3; Read SA, 2007, CLIN EXP OPTOM, V90, P5, DOI 10.1111/J.1444-0938.2007.00112.x; Remon L, 2009, OPTOMETRY VISION SCI, V86, P1182, DOI 10.1097/OPX.0b013e3181baac2c; Sanfilippo PG, 2015, ACTA OPHTHALMOL, V93, pE377, DOI 10.1111/aos.12644; Shankar S, 2004, OPTOMETRY VISION SCI, V81, P536, DOI 10.1097/00006324-200407000-00015; Shih YF, 2004, OPTOMETRY VISION SCI, V81, P94, DOI 10.1097/00006324-200402000-00007; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tong L, 2002, OPTOMETRY VISION SCI, V79, P606, DOI 10.1097/00006324-200209000-00012; Tong L, 2001, OPTOMETRY VISION SCI, V78, P881, DOI 10.1097/00006324-200112000-00010; Visser N, 2012, J CATARACT REFR SURG, V38, P1764, DOI 10.1016/j.jcrs.2012.05.036; Wills J, 2012, OPTOMETRY VISION SCI, V89, P271, DOI 10.1097/OPX.0b013e3182429c6b; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Xiao X, 2014, OPTOMETRY VISION SCI, V91, P390, DOI 10.1097/OPX.0000000000000221; Yang ZK, 2008, INVEST OPHTH VIS SCI, V49, P4779, DOI 10.1167/iovs.07-1616; Yang ZK, 2009, OPHTHAL PHYSL OPT, V29, P41, DOI 10.1111/j.1475-1313.2008.00608.x; Zhu BD, 2013, INVEST OPHTH VIS SCI, V54, P8104, DOI 10.1167/iovs.13-11958	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194513	10.1371/journal.pone.0194513	http://dx.doi.org/10.1371/journal.pone.0194513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630629	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000011
J	Choi, SKY; Boyle, E; Cairney, J; Grootendorst, P; Gardner, S; Collins, EJ; Kendall, C; Rourke, SB				Choi, Stephanie K. Y.; Boyle, Eleanor; Cairney, John; Grootendorst, Paul; Gardner, Sandra; Collins, Evan J.; Kendall, Claire; Rourke, Sean B.		OHTN Cohort Study	Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; LONG-TERM CONDITIONS; MENTAL-HEALTH; COLLABORATIVE CARE; INFECTED PATIENTS; UNSCHEDULED CARE; SERVICES; HIV/AIDS; OUTCOMES; ILLNESS	Introduction Nearly half of HIV-positive patients experience mental health and substance use problems, but many do not receive adequate or ongoing mental health or addiction care. This lack of ongoing care can result in the use of costly acute care services. Prospective evaluations of the relationship between psychiatric and substance use disorders and acute care services use are lacking, and this information is needed to understand unmet needs and improve access to appropriate services. Methods We conducted a secondary data analysis from a multicenter, longitudinal, prospective cohort study (n = 3,482 adults) between October 1, 2007 and March 31, 2013. We used explanatory extended Cox proportional hazard regression models to examine the impact of current depression and recreational drug use on acute care services use, and to explore whether current depression and recreational drug use were associated with potentially avoidable acute care services use. Results Over our 5.5 year study period, HIV-positive participants with current depression-only (aHR [95% CI]:1.2[1.1-1.4]), recreational drug use-only (1.3[1.1-1.6]), or co-occurring depression and recreational drug use (1.4[1.2-1.7]) were associated with elevated hazard of emergency department (ED) encounters compared to participants without these conditions. Over half of ED encounters were potentially avoidable. Participants with current depression-only (1.3[1.1-1.5];1.3[1.03-1.6]), recreational drug use-only (1.3[1.04-1.6];1.5[1.1-1.9]), or co-occurring depression and recreational drug use (1.3[1.04-1.7];1.4[1.06-1.9]) were associated with elevated hazard of low-acuity or repeated ED encounters respectively. Conclusions We found a significant increase in ED services use and potentially avoidable ED encounters (including low-acuity or repeated ED encounters), particularly among those with either current depression or recreational drug use. These findings emphasize the challenges in managing HIV and mental health/addiction co-morbidities in the current HIV care model. Future research should evaluate integrated and collaborative care programs for improving the coordination of care and effectively treat mental health and addiction problems among HIV-positive patients in Ontario.	[Choi, Stephanie K. Y.; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Choi, Stephanie K. Y.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Boyle, Eleanor; Cairney, John; Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Boyle, Eleanor] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Cairney, John] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Cairney, John; Kendall, Claire] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cairney, John] McMaster Univ, Infant & Child Hlth Lab, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Cairney, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Grootendorst, Paul] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Grootendorst, Paul] Univ Toronto, Sch Publ Policy & Governance, Toronto, ON, Canada; [Grootendorst, Paul] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Gardner, Sandra] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Collins, Evan J.; Rourke, Sean B.] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada; [Collins, Evan J.] Univ Hlth Network, Toronto, ON, Canada; [Kendall, Claire] Bruyere Res Inst, Ottawa, ON, Canada; [Kendall, Claire] Univ Ottawa, Ottawa, ON, Canada; [Kendall, Claire] Ottawa Hosp, Ottawa, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada	University of New South Wales Sydney; University of Toronto; University of Southern Denmark; McMaster University; University of Toronto; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rourke, SB (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.; Rourke, SB (corresponding author), Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada.; Rourke, SB (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada.	sean.rocrke@utoronto.ca	Cairney, John/AAQ-9703-2020; Boyle, Eleanor/G-4567-2016	Cairney, John/0000-0003-2856-3967; Boyle, Eleanor/0000-0002-9012-9128; Kendall, Claire/0000-0003-2686-1135; Choi, Stephanie Ka Yee/0000-0003-3019-5729; Grootendorst, Paul/0000-0003-1978-2834	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Atlantis E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004706; Bansil P, 2009, AIDS CARE, V21, P1432, DOI 10.1080/09540120902814387; Barua B, 2015, WAITING YOUR TURN; Bess KD, 2013, AIDS PATIENT CARE ST, V27, P171, DOI 10.1089/apc.2012.0406; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Brien S., 2015, TAKING STOCK REPORT; Bullard MJ, 2014, CAN J EMERG MED, V16, P485, DOI 10.2310/8000.2014.012014; Canadian Institute for Health Information [creator], 2015, DISCH ABSTR DAT; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Choi BY, 2016, WEST J EMERG MED, V17, P153, DOI 10.5811/westjem.2016.1.28310; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165816; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156652; Choi SKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142706; Christopoulos KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001863; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Cook JA, 2014, AIDS BEHAV, V18, P1094, DOI 10.1007/s10461-013-0679-6; Curran GM, 2011, AIDS CARE, V23, P1626, DOI 10.1080/09540121.2011.579943; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018; Fairbairn N, 2012, J EMERG MED, V43, P236, DOI 10.1016/j.jemermed.2011.05.020; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Himelhoch S, 2007, GEN HOSP PSYCHIAT, V29, P518, DOI 10.1016/j.genhosppsych.2007.03.008; Huang YF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-260; Iron K., 2006, ICES REPORT HLTH DAT, V9, P24, DOI [10.12927/hcq, DOI 10.12927/HCQ]; Josephs JS, 2010, HIV MED, V11, P74, DOI 10.1111/j.1468-1293.2009.00748.x; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katz MH, 1996, AIDS CARE, V8, P433, DOI 10.1080/09540129650125623; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Kurdyak P, 2014, OPEN MED, V8, P99; Lam CN, 2016, WEST J EMERG MED, V17, P607, DOI 10.5811/westjem.2016.6.30690; Langer S, 2013, HEALTH SOC CARE COMM, V21, P339, DOI 10.1111/j.1365-2524.2012.01093.x; Mental Health Commission of Canada, 2012, CHANG DIR; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Painter JT, 2015, JAIDS-J ACQ IMM DEF, V70, P377, DOI 10.1097/QAI.0000000000000732; Prina AM, 2015, J PSYCHOSOM RES, V78, P25, DOI 10.1016/j.jpsychores.2014.11.002; Ross LE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0353-3; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; StataCorp, 2013, STAT STAT SOFTW REL; Taylor SL, 2004, RELATIONSHIP TYPE ME; The Canadian Institute for Health Information, 2015, NAT AMB CAR REP SYST; Tricco AC, 2014, CAN MED ASSOC J, V186, pE568, DOI 10.1503/cmaj.140289; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vittinghoff E, 2012, REGRESSION METHODS B; Weaver MR, 2008, JAIDS-J ACQ IMM DEF, V47, P449, DOI 10.1097/QAI.0b013e3181642244; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195185	10.1371/journal.pone.0195185	http://dx.doi.org/10.1371/journal.pone.0195185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630615	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000029
J	Manchego, CE; Hildebrandt, P; Cueva, J; Espinosa, CI; Stimm, B; Gunter, S				Manchego, Carlos E.; Hildebrandt, Patrick; Cueva, Jorge; Espinosa, Carlos Ivan; Stimm, Bernd; Gunter, Sven			Climate change versus deforestation: Implications for tree species distribution in the dry forests of southern Ecuador (vol 12, e0190092, 2017)	PLOS ONE			English	Correction													Stimm, Bernd/O-7865-2014; Espinosa, Carlos Ivan/AAI-1305-2019	Stimm, Bernd/0000-0003-4808-1893; Espinosa, Carlos Ivan/0000-0002-5330-4505				Manchego CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190092	1	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195851	10.1371/journal.pone.0195851	http://dx.doi.org/10.1371/journal.pone.0195851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630672	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000076
J	Liao, SY; Schneider, NRE; Huttlin, P; Grutzner, PA; Weilbacher, F; Matschke, S; Popp, E; Kreinest, M				Liao, Shiyao; Schneider, Niko R. E.; Huettlin, Petra; Gruetzner, Paul A.; Weilbacher, Frank; Matschke, Stefan; Popp, Erik; Kreinest, Michael			Motion and dural sac compression in the upper cervical spine during the application of a cervical collar in case of unstable craniocervical junction-A study in two new cadaveric trauma models	PLOS ONE			English	Article							CRANIOVERTEBRAL JUNCTION; RIGID COLLAR; OCCIPITOVERTEBRAL RELATIONSHIPS; ATLANTOOCCIPITAL DISLOCATION; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; TRANSVERSE LIGAMENT; ATLANTOAXIAL JOINTS; NORMAL ANATOMY; INJURIES	Background Unstable conditions of the craniocervical junction such as atlanto-occipital dislocation (AOD) or atlanto-axial instability (AAI) are severe injuries with a high risk of tetraplegia or death. Immobilization by a cervical collar to protect the patient from secondary damage is a standard procedure in trauma patients. If the application of a cervical collar to a patient with an unstable craniocervical condition may cause segmental motion and secondary injury to the spinal cord is unknown. The aim of the current study is (i) to analyze compression on the dural sac and (ii) to determine relative motion of the cervical spine during the procedure of applying a cervical collar in case of ligamentous unstable craniocervical junction. Methods and findings Ligamentous AOD as well as AOD combined with ligamentous AAI was simulated in two newly developed cadaveric trauma models. Compression of the dural sac and segmental angulation in the upper cervical spine were measured on video fluoroscopy after myelography during the application of a cervical collar. Furthermore, overall three-dimensional motion of the cervical spine was measured by a motion tracking system. In six cadavers each, the two new trauma models on AOD and AOD combined with AAI could be implemented. Mean dural sac compression was significantly increased to-1.1 mm (-1.3 to-0.7 mm) in case of AOD and-1.2 mm (-1.6 to-0.6 mm) in the combined model of AOD and AAI. Furthermore, there is a significant increased angulation at the C0/C1 level in the AOD model. Immense three-dimensional movement up to 22.9 of cervical spine flexion was documented during the procedure. Conclusion The current study pointed out that applying a cervical collar in general will cause immense three-dimensional movement. In case of unstable craniocervical junction, this leads to a dural sac compression and thus to possible damage to the spinal cord.	[Liao, Shiyao; Huettlin, Petra; Gruetzner, Paul A.; Matschke, Stefan; Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed, Ludwigshafen, Germany; [Schneider, Niko R. E.; Weilbacher, Frank; Popp, Erik] Univ Hosp Heidelberg, Dept Anesthesiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kreinest, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed, Ludwigshafen, Germany.	michael.kreinest@bgu-ludwigshafen.de	Kreinest, Michael/ABI-7282-2020					ALKER GJ, 1978, ORTHOP CLIN N AM, V9, P1003; ALKER GJ, 1975, RADIOLOGY, V114, P611; Bell KM, 2009, SPINE J, V9, P225, DOI 10.1016/j.spinee.2008.03.010; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; Ben-Galim P, 2010, J TRAUMA, V69, P447, DOI 10.1097/TA.0b013e3181be785a; Bisson E, 2010, SPINE, V35, pE316, DOI 10.1097/BRS.0b013e3181c41d2c; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119, DOI 10.2106/00004623-197961080-00001; Bono CM, 2007, SPINE, V32, P593, DOI 10.1097/01.brs.0000257345.21075.a7; Brown T, 2005, SPINE, V30, pE503, DOI 10.1097/01.brs.0000176245.46965.e8; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Child Z, 2016, SPINE J, V16, P1116, DOI 10.1016/j.spinee.2016.03.057; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; CREMERS MJG, 1993, ARCH DIS CHILD, V69, P347, DOI 10.1136/adc.69.3.347; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Donaldson WF, 1997, SPINE, V22, P1215, DOI 10.1097/00007632-199706010-00008; EISMONT FJ, 1984, SPINE, V9, P663, DOI 10.1097/00007632-198410000-00001; FLOMAN Y, 1991, J BONE JOINT SURG BR, V73, P640, DOI 10.1302/0301-620X.73B4.2071650; Goutcher CM, 2005, BRIT J ANAESTH, V95, P344, DOI 10.1093/bja/aei190; Hall GC, 2015, WORLD J ORTHOP, V6, P236, DOI 10.5312/wjo.v6.i2.236; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; Helm M, 2013, ANAESTHESIST, V62, P973, DOI 10.1007/s00101-013-2255-x; Herrada-Pineda T, 2015, CIR CIR, V83, P135, DOI 10.1016/j.circir.2015.04.009; HINCK VC, 1960, AMER J ROENTGENOL RA, V84, P945; Hindman BJ, 2015, ANESTHESIOLOGY, V123, P1042, DOI 10.1097/ALN.0000000000000830; Holla M, 2012, EMERG MED J, V29, P104, DOI 10.1136/emj.2010.092973; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; James CY, 2004, J ATHL TRAINING, V39, P138; KANG JD, 1994, J BONE JOINT SURG AM, V76A, P1617, DOI 10.2106/00004623-199411000-00004; Karhu JO, 2005, ACTA RADIOL, V46, P55, DOI 10.1080/02841850510012012; Kato G, 2015, SPINE J, V15, pE69, DOI 10.1016/j.spinee.2015.06.009; Kaul A, 2016, J NEUROSURG-SPINE, V25, P756, DOI 10.3171/2015.10.SPINE15337; Kleweno CP, 2008, SPINE, V33, pE659, DOI 10.1097/BRS.0b013e318182272a; Kolb JC, 1999, AM J EMERG MED, V17, P135, DOI 10.1016/S0735-6757(99)90044-X; Kornhall DK, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0345-x; Kreinest M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0267-7; Kreinest M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143409; Labler L, 2004, EUR SPINE J, V13, P172, DOI 10.1007/s00586-003-0653-5; Lador R, 2011, J TRAUMA, V70, P247, DOI 10.1097/TA.0b013e3181fd0ebf; Lennarson PJ, 2000, J NEUROSURG, V92, P201, DOI 10.3171/spi.2000.92.2.0201; Maiman D J, 1988, J Spinal Disord, V1, P134; Matschke S, 2016, TRAUMA BERUFSKRANKH, V18, P281, DOI 10.1007/s10039-016-0212-z; McCahon RA, 2015, ANAESTHESIA, V70, P452, DOI 10.1111/anae.12956; Mendenhall SK, 2015, SPINE J, V15, P2385, DOI 10.1016/j.spinee.2015.07.003; Milz S, 2001, SPINE, V26, P1765, DOI 10.1097/00007632-200108150-00007; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Nidecker AE, 2016, J NEUROL SURG PART B, V77, P388, DOI 10.1055/s-0036-1584230; Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660; Salinsky JP, 2007, PEDIATR NEUROSURG, V43, P137, DOI 10.1159/000098389; Schweigkofler U, 2013, CHIRURG, V84, P739, DOI 10.1007/s00104-013-2475-2; Shrier I, 2015, PREHOSP EMERG CARE, V19, P116, DOI 10.3109/10903127.2014.936634; Skala-Rosenbaum J, 2014, EUR SPINE J, V23, pS242, DOI 10.1007/s00586-013-3112-y; SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952; Steinmetz MP, 2003, NEUROSURG FOCUS, V14, P1; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Subramanian N, 2007, SPINE, V32, P518, DOI 10.1097/01.brs.0000256449.95667.13; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Violas P, 2006, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000201164.05561.e9; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Weinshel S, 1988, J Spinal Disord, V1, P317; Wellborn CC, 2000, J PEDIATR ORTHOPED, V20, P66, DOI 10.1097/00004694-200001000-00015; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; Wolfi CG, 2008, UNFALLCHIRURG, V111, P688, DOI 10.1007/s00113-008-1466-0; Zaaroor M, 2006, MINIM INVAS NEUROSUR, V49, P220, DOI 10.1055/s-2006-948000; Zapalowicz Krzysztof, 2003, Neurol Neurochir Pol, V37, P1127	66	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195215	10.1371/journal.pone.0195215	http://dx.doi.org/10.1371/journal.pone.0195215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624623	gold, Green Published			2022-12-27	WOS:000429379600018
J	Ruttens, D; Verleden, SE; Demeyer, H; Van Raemdonck, DE; Yserbyt, J; Dupont, LJ; Vanaudenaerde, BM; Vos, R; Verleden, GM				Ruttens, David; Verleden, Stijn E.; Demeyer, Heleen; Van Raemdonck, Dirk E.; Yserbyt, Jonas; Dupont, Lieven J.; Vanaudenaerde, Bail M.; Vos, Robin; Verleden, Geert M.			Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial	PLOS ONE			English	Article							TOTAL LYMPHOID IRRADIATION; CHRONIC ALLOGRAFT-REJECTION; INTERNATIONAL SOCIETY; CELL TRANSPLANTATION; PULMONARY-FUNCTION; SYNDROME BOS; ADULT LUNG; AZITHROMYCIN; EFFICACY; LEUKOTRIENES	Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<15%), and already on azithromycin treatment, in whom the further decline in pulmonary function was attenuated. This was, however, a non-randomized and non-placebo controlled trial. The study design is a single center, prospective, interventional, randomized, double blind, placebo-controlled trial, with a two arm parallel group design and an allocation ratio of 1:1. Randomization to additional montelukast (10 mg/day, n = 15) or placebo (n = 15) was performed from 2010 to 2014 at the University Hospitals Leuven (Leuven, Belgium) in all consecutive patients with late-onset (>2years posttransplant) BOS >1. Primary end-point was freedom from graft loss 1 year after randomization; secondary end-points were acute rejection, lymphocytic bronchiolitis, respiratory infection rate; and change in FEV1, airway and systemic inflammation during the study period. Graft loss at 1 y and 2y was similar in both groups (respectively p = 0. 981 and p = 0.230). Montelukast had no effect on lung function decline in the overall cohort. However, in a post-hoc subanalysis of BOS stage 1 patients, montelukast attenuated further decline of FEVi during the study period, both in absolute (L) (p = 0.008) and % predicted value (p = 0.0180). A linear mixed model confirmed this association. Acute rejection, lymphocytic bronchiolitis, respiratory infections, systemic and airway inflammation were comparable between groups over the study period. This randomized controlled trial showed no additional survival benefit with montelukast compared to placebo, although the study was underpowered. The administration of montelukast was associated with an attenuation of the rate of FEVi decline, however, only in recipients with late-onset BOS stage 1.	[Ruttens, David; Verleden, Stijn E.; Van Raemdonck, Dirk E.; Yserbyt, Jonas; Dupont, Lieven J.; Vanaudenaerde, Bail M.; Vos, Robin; Verleden, Geert M.] KULeuven, Leuven, Belgium; [Ruttens, David; Verleden, Stijn E.; Van Raemdonck, Dirk E.; Yserbyt, Jonas; Dupont, Lieven J.; Vanaudenaerde, Bail M.; Vos, Robin; Verleden, Geert M.] UZ Leuven, Dept Clin & Expt Med, Div Resp Dis, Lung Transplant Unit, Leuven, Belgium; [Demeyer, Heleen] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Verleden, GM (corresponding author), KULeuven, Leuven, Belgium.; Verleden, GM (corresponding author), UZ Leuven, Dept Clin & Expt Med, Div Resp Dis, Lung Transplant Unit, Leuven, Belgium.	geert.verleden@uzleuven.be	Van Raemdonck, Dirk/AAL-4147-2020	Verleden, Stijn/0000-0002-9656-5844; Van Raemdonck, Dirk/0000-0003-1261-0992; Demeyer, Heleen/0000-0001-8925-0564; Vanaudenaerde, Bart/0000-0001-6435-6901	IWT (Instituut voor de aanmoediging van Innovate door Wetenschap en Technologie in Vlaanderen)-TBM (Toegepast Biomedisch onderzoek met een primair maatschappelijke finaliteit) [100756]	IWT (Instituut voor de aanmoediging van Innovate door Wetenschap en Technologie in Vlaanderen)-TBM (Toegepast Biomedisch onderzoek met een primair maatschappelijke finaliteit)	Research is supported by IWT (Instituut voor de aanmoediging van Innovate door Wetenschap en Technologie in Vlaanderen)-TBM (Toegepast Biomedisch onderzoek met een primair maatschappelijke finaliteit) (100756). SEV, HD, DEVR, LJD, and RV are senior and JY a junior research fellows of the Research Fund Flanders (FWO).	Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Cairn J, 2003, J HEART LUNG TRANSPL, V22, P50, DOI 10.1016/S1053-2498(02)00548-X; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Copeland CAF, 2010, AM J RESP CRIT CARE, V182, P784, DOI 10.1164/rccm.201002-0211OC; Corris PA, 2015, THORAX, V70, P442, DOI 10.1136/thoraxjnl-2014-205998; Diamond DA, 1998, INT J RADIAT ONCOL, V41, P795, DOI 10.1016/S0360-3016(98)00113-8; Fisher AJ, 2005, AM J TRANSPLANT, V5, P537, DOI 10.1111/j.1600-6143.2004.00709.x; Izumo T, 2007, LIFE SCI, V80, P1882, DOI 10.1016/j.lfs.2007.02.038; Jaksch P, 2014, AM J TRANSPLANT, V14, P1839, DOI 10.1111/ajt.12824; Jaksch P, 2012, J HEART LUNG TRANSPL, V31, P950, DOI 10.1016/j.healun.2012.05.002; Kim SW, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0380-1; Mehrotra AK, 2009, CURR MOL MED, V9, P384, DOI 10.2174/156652409787847209; Or R, 2007, TRANSPLANTATION, V83, P577, DOI 10.1097/01.tp.0000255575.03795.df; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Ramsay CF, 2009, RESP MED, V103, P995, DOI 10.1016/j.rmed.2009.01.019; Sato M, 2013, J HEART LUNG TRANSPL, V32, P484, DOI 10.1016/j.healun.2013.01.1054; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Verleden GM, 2009, TRANSPL P, V41, P1816, DOI 10.1016/j.transproceed.2009.03.070; Verleden GM, 2014, EXPERT OPIN PHARMACO, V15, P2117, DOI 10.1517/14656566.2014.954549; Verleden GM, 2014, J HEART LUNG TRANSPL, V33, P127, DOI 10.1016/j.healun.2013.10.022; Verleden GM, 2011, TRANSPL INT, V24, P651, DOI 10.1111/j.1432-2277.2011.01248.x; Verleden GM, 2003, J HEART LUNG TRANSPL, V22, P908, DOI 10.1016/S1053-2498(02)00815-X; Vos R, 2011, EUR RESPIR J, V37, P164, DOI 10.1183/09031936.00068310; Vos R, 2015, CURR OPIN ORGAN TRAN, V20, P483, DOI 10.1097/MOT.0000000000000236; Williams KM, 2016, BIOL BLOOD MARROW TR, V22, P710, DOI 10.1016/j.bbmt.2015.10.009; Williams KM, 2013, BIOL BLOOD MARROW TR, V19, pS143, DOI 10.1016/j.bbmt.2012.11.087; Yoshisue H, 2007, J ALLERGY CLIN IMMUN, V119, P132, DOI 10.1016/j.jaci.2006.08.028; Yusen RD, 2014, J HEART LUNG TRANSPL, V33, P1009, DOI 10.1016/j.healun.2014.08.004	29	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0193564	10.1371/journal.pone.0193564	http://dx.doi.org/10.1371/journal.pone.0193564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624575	gold, Green Published			2022-12-27	WOS:000429379600003
J	Buss, E; Grose, J				Buss, Emily; Grose, John			Auditory sensitivity to spectral modulation phase reversal as a function of modulation depth	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; COCHLEAR-IMPLANT USERS; SPECTROTEMPORAL MODULATION; RIPPLE DISCRIMINATION; SPEECH RECOGNITION; VOWEL IDENTIFICATION; RESOLUTION; FREQUENCY; NOISE; INTELLIGIBILITY	The present study evaluated auditory sensitivity to spectral modulation by determining the modulation depth required to detect modulation phase reversal. This approach may be preferable to spectral modulation detection with a spectrally flat standard, since listeners appear unable to perform the task based on the detection of temporal modulation. While phase reversal thresholds are often evaluated by holding modulation depth constant and adjusting modulation rate, holding rate constant and adjusting modulation depth supports rate-specific assessment of modulation processing. Stimuli were pink noise samples, filtered into seven octave-wide bands (0.125-8 kHz) and spectrally modulated in dB. Experiment 1 measured performance as a function of modulation depth to determine appropriate units for adaptive threshold estimation. Experiment 2 compared thresholds in dB for modulation detection with a flat standard and modulation phase reversal; results supported the idea that temporal cues were available at high rates for the former but not the latter. Experiment 3 evaluated spectral modulation phase reversal thresholds for modulation that was restricted to either one or two neighboring bands. Flanking bands of unmodulated noise had a larger detrimental effect on one-band than two-band targets. Thresholds for high-rate modulation improved with increasing carrier frequency up to 2 kHz, whereas low-rate modulation appeared more consistent across frequency, particularly in the two-band condition. Experiment 4 measured spectral weights for spectral modulation phase reversal detection and found higher weights for bands in the spectral center of the stimulus than for the lowest (0.125 kHz) or highest (8 kHz) band. Experiment 5 compared performance for highly practiced and relatively naive listeners, and found weak evidence of a larger practice effect at high than low spectral modulation rates. These results provide preliminary data for a task that may provide a better estimate of sensitivity to spectral modulation than spectral modulation detection with a flat standard.	[Buss, Emily; Grose, John] Univ North Carolina Chapel Hill, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Buss, E (corresponding author), Univ North Carolina Chapel Hill, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA.	ebuss@med.unc.edu		Buss, Emily/0000-0001-8244-3013	NIH NIDCD (National Institute on Deafness and Other Communication Disorders) [R01007391]; NIH NIDCD [R01007391]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007391] Funding Source: NIH RePORTER	NIH NIDCD (National Institute on Deafness and Other Communication Disorders)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD (National Institute on Deafness and Other Communication Disorders) R01007391 (EB).; This work was supported by NIH NIDCD R01007391. Helpful comments on a previous version of this manuscript were provided by Joseph W. Hall III, Arne Oetjen, and an anonymous reviewer.	Anderson ES, 2012, J ACOUST SOC AM, V132, P3925, DOI 10.1121/1.4763999; ANSI, 2010, S362010 ANSI; Aronoff JM, 2013, J ACOUST SOC AM, V134, pEL217, DOI 10.1121/1.4813802; Bernstein JGW, 2013, J AM ACAD AUDIOL, V24, P293, DOI 10.3766/jaaa.24.4.5; Davies-Venn E, 2015, J ACOUST SOC AM, V138, P492, DOI 10.1121/1.4922700; Drennan WR, 2014, EAR HEARING, V35, pE92, DOI 10.1097/AUD.0000000000000009; Eddins DA, 2007, J ACOUST SOC AM, V121, P363, DOI 10.1121/1.2382347; FARRAR CL, 1987, J ACOUST SOC AM, V81, P1085, DOI 10.1121/1.394628; FORMBY C, 1985, J ACOUST SOC AM, V78, P70, DOI 10.1121/1.392456; GREEN DM, 1987, J ACOUST SOC AM, V81, P692, DOI 10.1121/1.394837; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Liu C, 2008, J ACOUST SOC AM, V124, P1704, DOI 10.1121/1.2956468; Mehraei G, 2014, J ACOUST SOC AM, V136, P301, DOI 10.1121/1.4881918; MOORE BCJ, 1987, HEARING RES, V28, P209, DOI 10.1016/0378-5955(87)90050-5; Sabin AT, 2012, J NEUROSCI, V32, P6542, DOI 10.1523/JNEUROSCI.5732-11.2012; Sabin AT, 2012, EXP BRAIN RES, V218, P567, DOI 10.1007/s00221-012-3049-0; Shrivastav MN, 2006, J ACOUST SOC AM, V119, P1131, DOI 10.1121/1.2151794; SUMMERS V, 1994, J ACOUST SOC AM, V95, P3518, DOI 10.1121/1.409969; Supin AY, 2010, HEARING RES, V260, P109, DOI 10.1016/j.heares.2009.12.018; Supin AY, 2005, HEARING RES, V204, P191, DOI 10.1016/j.heares.2005.01.010; Supin AY, 1999, J ACOUST SOC AM, V106, P2800, DOI 10.1121/1.428105; Supin AY, 2001, HEARING RES, V151, P157, DOI 10.1016/S0378-5955(00)00223-9; VANVEEN TM, 1985, J ACOUST SOC AM, V77, P628, DOI 10.1121/1.391880; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Won JH, 2014, J ACOUST SOC AM, V136, P2714, DOI 10.1121/1.4895702; Won JH, 2011, J ACOUST SOC AM, V130, P2088, DOI 10.1121/1.3624820	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195686	10.1371/journal.pone.0195686	http://dx.doi.org/10.1371/journal.pone.0195686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621338	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800114
J	Kalzen, H; Larsson, B; Eksborg, S; Lindberg, L; Edberg, KE; Frostell, C				Kalzen, Hakan; Larsson, Bjorn; Eksborg, Staffan; Lindberg, Lars; Edberg, Karl Erik; Frostell, Claes			Survival after PICU admission: The impact of multiple admissions and complex chronic conditions	PLOS ONE			English	Article							PEDIATRIC INTENSIVE-CARE; RISK-FACTORS; CRITICAL ILLNESS; MORTALITY SCORE; OUTCOMES; CHILDREN; READMISSIONS; PREDICTION; INDEX; UNIT	Objective Factors predicting survival over time after pediatric intensive care unit (PICU) admissions are not fully understood. The primary aim of the current study was to investigate whether multiple admissions (MADM) compared to single PICU admissions (SADM) were associated with poor survival over time after being admitted to PICU facilities. Our secondary aim was to investigate if the presence of a complex chronic condition (CCC) would further impair prognosis. Design A closed cohort of all children up to 16 years of age admitted to the three PICUs in Sweden between 2008 and 2010 was prospectively collected and followed until 2012, providing survival data for at least one but up to four years of follow-up. Setting Three Swedish tertiary referral centers for pediatric intensive care and extracorporeal membrane oxygenation (ECMO) care were used. Patients In total, 3,688 Swedish children with 5,019 PICU admissions were included. Interventions No interventions were conducted. Measurements An extensive data set was recorded, including up to four-year survival information following first PICU admission. The patients were assigned to seven admission diagnostic groups, which were then divided into SADM or MADM groups. The difference in survival over time and mortality rates (MR) and mortality rate ratios (MRR) were calculated. SADM and MADM groups with and without an existing CCC were formed. The difference in survival over time between groups was calculated. Main results A highly significant difference in survival over time was noted between SADM and MADM patients (p<0.0001), which was intensified by the presence of a CCC. MADM patients with a CCC had the worst outcome, while SADM patients without a CCC had the best outcome. MADM patients with no CCC demonstrated decreased survival over time compared to SADM patients with a CCC. Survival over time was statistically worsened for patients with MADM compared to SADM for the following admission diagnostic groups: Cardiovascular, Gastrointestinal/Renal, Respiratory, Neurological, and Miscellaneous. The mortality rate (deaths/patient year of follow-up) during the time of follow-up was 0.023 for SADM and 0.062 for MADM patients. The mortality rate ratio (MRR) between these groups was 2.69. Conclusion Compared to single admissions, multiple admissions to PICU were associated with a significant decrease in survival over time in some but not all diagnostic groups. Regarding our secondary aim, we found that when the presence of a CCC is factored into the survival analysis, survival over time is further impaired.	[Kalzen, Hakan; Larsson, Bjorn] Karolinska Univ Hosp Solna, Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Paediat Anaesthesia Intens Care & ECMO Serv, Stockholm, Sweden; [Eksborg, Staffan] Karolinska Univ Hosp Solna, Astrid Lindgren Childrens Hosp, Karolinska Inst, Childhood Canc Res Unit Q6 05,Dept Womens & Child, Stockholm, Sweden; [Lindberg, Lars] Univ Hosp Lund, Paediat Intens Care Unit, Childrens Hosp, Dept Anaesthesia & Intens Care, Lund, Sweden; [Edberg, Karl Erik] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat Intens Care, Gothenburg, Sweden; [Frostell, Claes] KIDS, Danderyd Hosp, Dept Anaesthesia & Intens Care, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; Danderyds Hospital	Kalzen, H (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Paediat Anaesthesia Intens Care & ECMO Serv, Stockholm, Sweden.	hakan.kalzen@ki.se		Kalzen, Hakan/0000-0001-5859-070X; Eksborg, Staffan/0000-0001-7326-9471; Lindberg, Lars/0000-0002-2246-2826	Stockholm County Council [20130324, 20150224]; Karolinska Institutet [20130324, 20150224]; Stockholm County Council; Research and Consulting Inc.	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Research and Consulting Inc.	Financial support from the regional agreement on medical training and clinical research (ALF), projects 20130324 and 20150224 between Stockholm County Council and Karolinska Institutet (Dr S Eksborg), additional financial support from Stockholm County Council (Hakan Kalzen 2+2 weeks of payed time for research) and C.F. Research and Consulting Inc. (computer resourse and covering costs for data extraction) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Czaja AS, 2013, PEDIATR CRIT CARE ME, V14, P571, DOI 10.1097/PCC.0b013e3182917a68; Costa GD, 2010, CLINICS, V65, P1087, DOI 10.1590/S1807-59322010001100005; Edwards JD, 2013, CRIT CARE MED, V41, P2773, DOI 10.1097/CCM.0b013e31829eb970; Edwards JD, 2012, CRIT CARE MED, V40, P2196, DOI 10.1097/CCM.0b013e31824e68cf; European Medicines Agency (EMA), MED CHINDR; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Feudtner C, 2009, J PALLIAT MED, V12, P160, DOI 10.1089/jpm.2008.0206; Gullberg N, 2008, ACTA ANAESTH SCAND, V52, P1086, DOI 10.1111/j.1399-6576.2008.01711.x; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Namachivayam SP, 2015, CRIT CARE MED, V43, P1978, DOI 10.1097/CCM.0000000000001076; Nicholson Carol E, 2003, Pediatr Crit Care Med, V4, P196, DOI 10.1097/01.PCC.0000059728.63798.DA; O'Brien S, 2017, PEDIATR CRIT CARE ME, V18, P1, DOI 10.1097/PCC.0000000000000976; Odetola FO, 2007, PEDIATR CRIT CARE ME, V8, P343, DOI 10.1097/01.PCC.0000269400.67463.AC; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Rhodes A, 2012, INTENS CARE MED, V38, P598, DOI 10.1007/s00134-011-2462-3; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Socialstyrelsen. Dodsorsaker, 2013, DODS CAUS DEATH REG	22	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193294	10.1371/journal.pone.0193294	http://dx.doi.org/10.1371/journal.pone.0193294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621235	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800004
J	Martin-Gonzalez, S; Navarro-Mesa, JL; Julia-Serda, G; Ramirez-Avila, GM; Ravelo-Garcia, AG				Martin-Gonzalez, Sofia; Navarro-Mesa, Juan L.; Julia-Serda, Gabriel; Marcelo Ramirez-Avila, G.; Ravelo-Garcia, Antonio G.			Improving the understanding of sleep apnea characterization using Recurrence Quantification Analysis by defining overall acceptable values for the dimensionality of the system, the delay, and the distance threshold	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIOVASCULAR-SYSTEM; EMBEDDING DIMENSION; NONLINEAR DYNAMICS; NETWORK PHYSIOLOGY; TIME; COMPLEX; ELECTROCARDIOGRAM; ALGORITHM; SELECTION	Our contribution focuses on the characterization of sleep apnea from a cardiac rate point of view, using Recurrence Quantification Analysis (RQA), based on a Heart Rate Variability (HRV) feature selection process. Three parameters are crucial in RQA: those related to the embedding process (dimension and delay) and the threshold distance. There are no overall accepted parameters for the study of HRV using RQA in sleep apnea. We focus on finding an overall acceptable combination, sweeping a range of values for each of them simultaneously. Together with the commonly used RQA measures, we include features related to recurrence times, and features originating in the complex network theory. To the best of our knowledge, no author has used them all for sleep apnea previously. The best performing feature subset is entered into a Linear Discriminant classifier. The best results in the "Apnea-ECG Physionet database" and the "HuGCDN2014 database" are, according to the area under the receiver operating characteristic curve, 0.93 (Accuracy: 86.33%) and 0.86 (Accuracy: 84.18%), respectively. Our system outperforms, using a relatively small set of features, previously existing studies in the context of sleep apnea. We conclude that working with dimensions around 7-8 and delays about 4-5, and using for the threshold distance the Fixed Amount of Nearest Neighbours (FAN) method with 5% of neighbours, yield the best results. Therefore, we would recommend these reference values for future work when applying RQA to the analysis of HRV in sleep apnea. We also conclude that, together with the commonly used vertical and diagonal RQA measures, there are newly used features that contribute valuable information for apnea minutes discrimination. Therefore, they are especially interesting for characterization purposes. Using two different databases supports that the conclusions reached are potentially generalizable, and are not limited by database variability.	[Martin-Gonzalez, Sofia; Navarro-Mesa, Juan L.; Ravelo-Garcia, Antonio G.] Univ Las Palmas Gran Canaria, Inst Technol Dev & Innovat Commun, Las Palmas Gran Canaria, Spain; [Julia-Serda, Gabriel] Hosp Univ Gran Canaria Dr Negrin, Pulm Med Dept, Las Palmas Gran Canaria, Spain; [Marcelo Ramirez-Avila, G.] Univ Mayor San Andres, Inst Invest Fis, La Paz, Bolivia	Universidad de Las Palmas de Gran Canaria; Universidad Mayor de San Andres	Martin-Gonzalez, S (corresponding author), Univ Las Palmas Gran Canaria, Inst Technol Dev & Innovat Commun, Las Palmas Gran Canaria, Spain.	sofia.martin@ulpgc.es	Martín-González, Sofía/GYD-4163-2022; Ramirez-Avila, Gonzalo Marcelo/I-3867-2019; Navarro-Mesa, Juan L./L-3633-2017	Martín-González, Sofía/0000-0002-5001-9223; Ramirez-Avila, Gonzalo Marcelo/0000-0003-4522-9012; Navarro-Mesa, Juan L./0000-0003-3860-3424; Ravelo-Garcia, Antonio G./0000-0002-8512-965X	European Regional Development Fund [MAC/1/C121]	European Regional Development Fund(European Commission)	This work was supported by European Regional Development Fund, MAC/1/C121, http://ec.europa.eu/regional_policy/es/funding/eraf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Al-Angari HM, 2007, IEEE T BIO-MED ENG, V54, P1900, DOI 10.1109/TBME.2006.889772; [Anonymous], 2005, TUTORIALS CONT NONLI; Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Bartsch RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142143; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonsignore MR, 1997, SLEEP, V20, P1167; Brengelmann GL, 2003, J APPL PHYSIOL, V94, P849, DOI 10.1152/japplphysiol.00868.2002; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Carlson JT, 1996, AM J RESP CRIT CARE, V154, P1490, DOI 10.1164/ajrccm.154.5.8912770; Censi F, 2000, ANN BIOMED ENG, V28, P61, DOI 10.1114/1.248; Cheng CQ, 2016, COMPUT BIOL MED, V75, P10, DOI 10.1016/j.compbiomed.2016.05.006; Cruz A.A., 2007, GLOBAL SURVEILLANCE; de Chazal P, 2003, IEEE T BIO-MED ENG, V50, P686, DOI 10.1109/TBME.2003.812203; Ding H, 2008, CHAOS SOLITON FRACT, V38, P1457, DOI 10.1016/j.chaos.2006.07.059; Donner RV, 2011, INT J BIFURCAT CHAOS, V21, P1019, DOI 10.1142/S0218127411029021; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Gao JB, 1999, PHYS REV LETT, V83, P3178, DOI 10.1103/PhysRevLett.83.3178; Giuliani A, 1998, AM J PHYSIOL-HEART C, V275, pH1455, DOI 10.1152/ajpheart.1998.275.4.H1455; Glass L, 2009, CHAOS, V19, DOI 10.1063/1.3156832; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Graben PB, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/38003; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grassberger P, 1991, INT J BIFURCAT CHAOS, V1, P521, DOI 10.1142/S0218127491000403; GUILLEMINAULT C, 1984, LANCET, V1, P126; Gutierrez-Tobal GC, 2015, ENTROPY-SWITZ, V17, P123, DOI 10.3390/e17010123; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Hall J. E, 2006, TXB MED PHYSL; Ivanov PC, 2017, SPRINGER PROC PHYS, V191, P145, DOI 10.1007/978-3-319-47810-4_12; Ivanov PC, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/100201; Javorka M, 2008, PHYSIOL MEAS, V30, P29; Javorka M, 2008, CLIN PHYSIOL FUNCT I, V28, P326, DOI 10.1111/j.1475-097X.2008.00813.x; Julia-Serda Gabriel, 2018, APNEA HRV DATA SET M; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Karandikar K, 2013, I IEEE EMBS C NEUR E, P1358, DOI 10.1109/NER.2013.6696194; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Klabunde RE, 2005, HYPERTROPHY CARDIOVA; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Le TQ, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2273354; Le TQ, 2013, 2013 IEEE POINT-OF-CARE HEALTHCARE TECHNOLOGIES (PHT), P152, DOI 10.1109/PHT.2013.6461307; Maier C, 2006, BIOMED TECH, V51, P224, DOI 10.1515/BMT.2006.042; Mammoliti R, 1998, COMPUT CARDIOL, V25, P145, DOI 10.1109/CIC.1998.731753; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 0201062 ARXIV; Marwan N., 2015, RECURRENCE QUANTIFIC, P3, DOI [DOI 10.1007/978-3-319-07155-8, 10.1007/978-3-319-07155-8_1, DOI 10.1007/978-3-319-07155-8_1]; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Matassini L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021102; Mendez MO, 2010, PHYSIOL MEAS, V31, P273, DOI 10.1088/0967-3334/31/3/001; Mendez MO, 2009, IEEE T BIO-MED ENG, V56, P2838, DOI 10.1109/TBME.2009.2029563; Mohebbi M, 2011, PHYSIOL MEAS, V32, P1147, DOI 10.1088/0967-3334/32/8/010; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Ngamga EJ, 2016, PHYS LETT A, V380, P1419, DOI 10.1016/j.physleta.2016.02.024; Nguyen Hoa Dinh, 2014, IEEE J Biomed Health Inform, V18, P1285, DOI 10.1109/JBHI.2013.2292928; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Pamidi S, 2015, AM J RESP CRIT CARE, V192, P96, DOI 10.1164/rccm.201408-1564OC; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Penzel T, 2000, COMPUT CARDIOL, V27, P255, DOI 10.1109/CIC.2000.898505; PHILLIPSON EA, 1993, NEW ENGL J MED, V328, P1271, DOI 10.1056/NEJM199304293281712; Poincare H., 1890, ACTA MATH-DJURSHOLM, V13, pA3, DOI DOI 10.1007/BF02392506; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Avila GMR, 2013, AUTON NEUROSCI-BASIC, V178, P103, DOI 10.1016/j.autneu.2013.05.003; Ravelo-Garcia AG, 2014, CHAOS, V24, DOI 10.1063/1.4869825; Ravelo-Garcia A, 2013, LECT NOTES COMPUT SC, V8112, P266; Ravelo-Garcia AG, 2015, ENTROPY-SWITZ, V17, P2932, DOI 10.3390/e17052932; Ravelo-Garcia AG, 2015, ENTROPY-SWITZ, V17, P914, DOI 10.3390/e17030914; Redline S, 2012, AM J RESP CRIT CARE, V186, P123, DOI 10.1164/rccm.201204-0657ED; Riedl M, 2010, PHILOS T R SOC A, V368, P2237, DOI 10.1098/rsta.2010.0029; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Schinkel S, 2008, EUR PHYS J-SPEC TOP, V164, P45, DOI 10.1140/epjst/e2008-00833-5; Schlenker J, 2016, BIOMED SIGNAL PROCES, V25, P1, DOI 10.1016/j.bspc.2015.10.007; Schrader M, 2000, COMPUT CARDIOL, V27, P263, DOI 10.1109/CIC.2000.898507; Schumacher Autumn, 2004, Biol Res Nurs, V5, P211, DOI 10.1177/1099800403260619; Sharma H, 2016, COMPUT BIOL MED, V77, P116, DOI 10.1016/j.compbiomed.2016.08.012; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Subramaniyam NP, 2014, PHYS LETT A, V378, P3464, DOI 10.1016/j.physleta.2014.10.005; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Tayel M.B., 2016, INT J RES ENG SCI, V4, P45; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; Thiel M, 2004, CHAOS, V14, P234, DOI 10.1063/1.1667633; Thiel M, 2002, PHYSICA D, V171, P138, DOI 10.1016/S0167-2789(02)00586-9; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Trzebski A, 2001, AUTON NEUROSCI-BASIC, V90, P106, DOI 10.1016/S1566-0702(01)00275-2; Varon C, 2015, IEEE T BIO-MED ENG, V62, P2269, DOI 10.1109/TBME.2015.2422378; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Wessel N, 2001, LECT NOTES COMPUT SC, V2199, P295; Wessel N., 2000, HERZSCHRITTMACHERTHE, V11, P159, DOI [10.1007/s003990070035, DOI 10.1007/S003990070035]; Yang H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026214; Yildiz A, 2011, EXPERT SYST APPL, V38, P12880, DOI 10.1016/j.eswa.2011.04.080; Zbilut J., 1990, COMPUTERS CARDIO SEP, P263; Zbilut JP, 2008, PHYS LETT A, V372, P6622, DOI 10.1016/j.physleta.2008.09.027; Zbilut JP, 2002, LECT NOTES COMPUT SC, V2526, P151; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6; Zbilut JP, 1998, PHYS LETT A, V237, P131, DOI 10.1016/S0375-9601(97)00843-8; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zou Y, 2010, EGUGA, V20, P8226	101	11	11	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194462	10.1371/journal.pone.0194462	http://dx.doi.org/10.1371/journal.pone.0194462			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621264	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800018
J	Ning, CY; Lai, JZ; Wei, WD; Zhou, B; Huang, JG; Jiang, JJ; Liang, BY; Liao, YY; Zang, N; Cao, CW; Chen, H; Ye, L; Liang, H				Ning, Chuanyi; Lai, Jingzhen; Wei, Wudi; Zhou, Bo; Huang, Jiegang; Jiang, Junjun; Liang, Bingyu; Liao, Yanyan; Zang, Ning; Cao, Cunwei; Chen, Hui; Ye, Li; Liang, Hao			Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis	PLOS ONE			English	Review							PENICILLIUM-MARNEFFEI; HISTOPLASMA-CAPSULATUM; URINARY ANTIGEN; IDENTIFICATION; INFECTION; ASSAY; PCR; EPIDEMIOLOGY; ANTIBODIES; TESTS	Background To examine the accuracy of Rapid Diagnosis of Talaromyces marneffei (RDTM) in order to improve diagnosis and treatment for clinical measures and reduce the mortality due to associated infections. Methods In this systematic review and meta-analysis, we screened PubMed, Ovid (Cochrane library) and Web of Science, Chinese database CNKI and Wanfang for articles published between 1956 and December, 2017. Data were taken from cross-sectional studies as well as from baseline measurements in longitudinal studies with clinical follow-up. Articles were excluded if they did not contain a cohort with T. marneffei and a control cohort or a cohort with standard fungus culture. Data were extracted by two authors and checked by three for accuracy. For quality assessment, modified QUADAS-2 criteria were used. Results The 26 included diagnostic studies enrolled 5,594 objectives in 632 patients with T. marneffei infections and 2,612 negative controls between 1996 and 2017 in Thailand, Vietnam and China. The total combined sensitivity and specificity of rapid diagnosis of T. marneffei was 0.82 (95% CI: 0.68-0.90) and 0.99 (95% CI: 0.98-1.00). According to the experimental method, the included studies can be divided into three subgroups, including PCR-based, ELISA-based and others. The results showed these three subgroups had a highly pooled specificity of 1.00 (95% CI: 0.99-1.00), 0.99 (0.98-1.00) and 0.97 (95% CI: 0.91-1.00), respectively, while combined sensitivity was 0.84 (95% CI: 0.37-0.98), 0.82 (95% CI: 0.64-0.92) and 0.77 (95% CI: 0.54-0.91), respectively. Conclusions Although serological methods with a high specificity is essential for potential rapid diagnostic, false-negative results can be obtained in the serum samples, there is no suitable rapid serological test to refer to as is the case with TM infection.	[Ning, Chuanyi; Zhou, Bo; Liao, Yanyan; Zang, Ning; Liang, Hao] Guangxi Med Univ, Life Sci Inst, Nanning, Guangxi, Peoples R China; [Ning, Chuanyi; Lai, Jingzhen; Wei, Wudi; Zhou, Bo; Huang, Jiegang; Jiang, Junjun; Liang, Bingyu; Liao, Yanyan; Zang, Ning; Cao, Cunwei; Chen, Hui; Ye, Li; Liang, Hao] Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Ning, Chuanyi; Liao, Yanyan; Ye, Li; Liang, Hao] Guangxi Med Univ, Biosafety Level Lab 3, Nanning, Guangxi, Peoples R China; [Lai, Jingzhen; Wei, Wudi; Huang, Jiegang; Jiang, Junjun; Liang, Bingyu; Ye, Li; Liang, Hao] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Cao, Cunwei; Chen, Hui] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Liang, H (corresponding author), Guangxi Med Univ, Life Sci Inst, Nanning, Guangxi, Peoples R China.; Ye, L; Liang, H (corresponding author), Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China.; Ye, L; Liang, H (corresponding author), Guangxi Med Univ, Biosafety Level Lab 3, Nanning, Guangxi, Peoples R China.; Ye, L; Liang, H (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.	yeli@gxmu.edu.cn; lianghao@gxmu.edu.cn	Jiang, Junjun/AAH-9095-2020; Ning, Chuanyi/AAF-5601-2020	Ning, Chuanyi/0000-0002-8748-2780; Wei, Wudi/0000-0001-6703-4529	Natural Science Foundation of Guangxi Province, China [GXNSFBA139165]; Guangxi Medical University Youth Science Foundation [GXMUYSF2014020]	Natural Science Foundation of Guangxi Province, China(National Natural Science Foundation of Guangxi Province); Guangxi Medical University Youth Science Foundation	The study was supported by Natural Science Foundation of Guangxi Province, China (GXNSFBA139165, http://www.gxst.gov.cn/), Guangxi Medical University Youth Science Foundation (GXMUYSF2014020, http://www.gxmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elias NA, 2012, MYCOPATHOLOGIA, V174, P451, DOI 10.1007/s11046-012-9567-2; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Cao CW, 2007, MED MYCOL, V45, P401, DOI 10.1080/13693780701358600; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; CAPPONI M., 1956, BULL SOC PATHOL EXOT, V49, P418; Chaiyaroj SC, 2003, J CLIN MICROBIOL, V41, P432, DOI 10.1128/JCM.41.1.432-434.2003; Chen W, 2011, CHINESE J EXPT CLIN, V05; Chen YS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00679; DENG ZL, 1988, REV INFECT DIS, V10, P640; Desakorn V, 1999, J CLIN MICROBIOL, V37, P117, DOI 10.1128/JCM.37.1.117-121.1999; Desakorn V, 2002, J CLIN MICROBIOL, V40, P3179, DOI 10.1128/JCM.40.9.3179-3183.2002; Duong TA, 1996, CLIN INFECT DIS, V23, P125, DOI 10.1093/clinids/23.1.125; He K., 2016, ACAD J GUANGZHOU MED, V44, P21; Hien HT, 2016, MYCOSES; Houbraken J, 2014, ADV APPL MICROBIOL, V86, P199, DOI 10.1016/B978-0-12-800262-9.00004-4; [胡家光 Hu Jiaguang], 2015, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V25, P5128; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; Imwidthaya P, 1997, MYCOPATHOLOGIA, V138, P51, DOI 10.1023/A:1006826907109; Jan IS, 2008, J FORMOS MED ASSOC, V107, P443, DOI 10.1016/S0929-6646(08)60151-5; Kaufman L, 1996, J CLIN MICROBIOL, V34, P2503, DOI 10.1128/JCM.34.10.2503-2505.1996; Lau SKP, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0656-0; Lindsley MD, 2001, J CLIN MICROBIOL, V39, P3505, DOI 10.1128/JCM.39.10.3505-3511.2001; Liu YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149634; LOBUGLIO KF, 1995, J CLIN MICROBIOL, V33, P85, DOI 10.1128/JCM.33.1.85-89.1995; Nor-Hayati S, 2012, Med J Malaysia, V67, P66; Panichakul T, 2002, AM J TROP MED HYG, V67, P443, DOI 10.4269/ajtmh.2002.67.443; Pongpom M, 2009, MED MYCOL, V47, P549, DOI 10.1080/13693780802484875; Pornprasert S, 2009, MYCOSES, V52, P487, DOI 10.1111/j.1439-0507.2008.01653.x; Prakit K, 2016, EUR J CLIN MICROBIOL, V35, P647, DOI 10.1007/s10096-016-2583-2; Prariyachatigul C, 2003, MYCOSES, V46, P447, DOI 10.1046/j.0933-7407.2003.00939.x; Qin LY, 2015, EXP THER MED, V9, P1950, DOI 10.3892/etm.2015.2357; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Sun JF, 2011, MYCOSES, V54, pE751, DOI 10.1111/j.1439-0507.2011.02017.x; Sun JF, 2010, FEMS IMMUNOL MED MIC, V58, P381, DOI [10.1111/j.1574-695X.2010.00647.x, 10.1111/j.1574-695X.2009.00647.x]; Supparatpinyo K, 1998, NEW ENGL J MED, V339, P1739, DOI 10.1056/NEJM199812103392403; Thuy L, 2011, CLIN INFECT DIS, V52, P945, DOI 10.1093/cid/cir028; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom N, 1998, MED MYCOL, V36, P169, DOI 10.1080/02681219880000251; Wang Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/583846; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wei S, 2013, LAB MED, V28; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wong SL, 2011, PUBLIC MANAG REV, V13, P595, DOI 10.4061/2011/764293; Wu T. C., 2008, Hong Kong Medical Journal, V14, P103; YUEN KY, 1994, LANCET, V344, P444, DOI 10.1016/S0140-6736(94)91771-X; Zeng HX, 2009, MYCOPATHOLOGIA, V168, P31, DOI 10.1007/s11046-009-9195-7; Zhou G, 2015, CHIN J AIDS STD, V21	47	23	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195569	10.1371/journal.pone.0195569	http://dx.doi.org/10.1371/journal.pone.0195569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621346	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800104
J	Sinha, D; Mondal, R; Mahapa, A; Sau, K; Chattopadhyaya, R; Sau, S				Sinha, Debabrata; Mondal, Rajkrishna; Mahapa, Avisek; Sau, Keya; Chattopadhyaya, Rajagopal; Sau, Subrata			A staphylococcal anti-sigma factor possesses a single-domain, carries different denaturant-sensitive regions and unfolds via two intermediates	PLOS ONE			English	Article							CIRCULAR-DICHROISM; BACILLUS-SUBTILIS; BIOPHYSICAL CHARACTERIZATION; PROTEIN-STRUCTURE; LIGAND-BINDING; RNA-POLYMERASE; FACTOR SPOIIAB; AUREUS; UREA; STRESS	RsbW, an anti-sigma factor possessing kinase activity, is expressed by many Gram-positive bacteria including Staphylococcus aureus. To obtain clues about the domain structure and the folding-unfolding mechanism of RsbW, we have elaborately studied rRsbW, a recombinant S. aureus RsbW. Sequence analysis of the protein fragments, generated by the limited proteolysis of rRsbW, has proposed it to be a single-domain protein. The unfolding of rRsbW in the presence of GdnCl or urea was completely reversible in nature and occurred through the formation of at least two intermediates. The structure, shape, and the surface hydrophobicity of no intermediate completely matches with those of other intermediates or the native rRsbW. Interestingly, one of the intermediates, formed in the presence of less GdnCl concentrations, has a molten globule-like structure. Conversely, all of the intermediates, like native rRsbW, exist as dimers in aqueous solution. The putative molten globule and the urea-generated intermediates also have retained some kinase activity. Additionally, the putative ATP binding site/catalytic site of rRsbW shows higher denaturant sensitivity than the tentative dimerization region of this enzyme.	[Sinha, Debabrata; Chattopadhyaya, Rajagopal; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India; [Mondal, Rajkrishna] Nagaland Univ, Dept Biotechnol, Dimapur, Nagaland, India; [Mahapa, Avisek; Sau, Keya] Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India	Department of Science & Technology (India); Bose Institute; Nagaland University; Haldia Institute of Technology	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@gmail.com	MONDAL, RAJKRISHNA/ABH-6673-2020	MONDAL, RAJKRISHNA/0000-0001-5557-371X	University Grants Commission (India); Bose Institute (India)	University Grants Commission (India)(University Grants Commission, India); Bose Institute (India)	DS received Senior Research Fellowship from the University Grants Commission (India). SS received financial assistance for the work from Bose Institute (India). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Borges Julio C, 2016, Biophys Rev, V8, P107, DOI 10.1007/s12551-016-0194-x; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Chaturvedi S, 2003, J BIOL CHEM, V278, P40793, DOI 10.1074/jbc.M306192200; Chen JC, 2017, INT J MED MICROBIOL, V307, P521, DOI 10.1016/j.ijmm.2017.09.005; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Dangel A, 2013, FASEB J, V27, P4476, DOI 10.1096/fj.13-234575; Del Vecchio P, 2002, BIOCHEMISTRY-US, V41, P1364, DOI 10.1021/bi011146t; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Gaudet M, 2010, PROTEIN SCI, V19, P1544, DOI 10.1002/pro.433; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lapidus Lisa J, 2017, F1000Res, V6, P1723, DOI 10.12688/f1000research.12070.1; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Mahendrarajah K, 2011, ANAL BIOCHEM, V411, P155, DOI 10.1016/j.ab.2010.12.001; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Miyazaki E, 1999, J BACTERIOL, V181, P2846, DOI 10.1128/JB.181.9.2846-2851.1999; Mondal R, 2010, BMB REP, V43, P176, DOI 10.5483/BMBRep.2010.43.3.176; NANDI PK, 1984, BIOCHEMISTRY-US, V23, P6661, DOI 10.1021/bi00321a058; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Pace CN, 2000, PROTEINS, P1; Polley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102891; Rasheedi S, 2009, BIOPOLYMERS, V91, P574, DOI 10.1002/bip.21180; Rashid DJ, 2005, J PEPT RES, V65, P538, DOI 10.1111/j.1399-3011.2005.00255.x; Sambrook J., 2001, MOL CLONING LAB MANU; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Shu Q, 2004, BIOCHEMISTRY-US, V43, P1432, DOI 10.1021/bi035651x; Shukla VK, 2017, BIOPHYS J, V112, P605, DOI 10.1016/j.bpj.2016.12.020; Tuchscherr L, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030031; Tuchscherr L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004870; Voelker U, 1996, J BACTERIOL, V178, P7020, DOI 10.1128/jb.178.23.7020-7023.1996; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang TF, 2014, J BIOL PHYS, V40, P25, DOI 10.1007/s10867-013-9332-x; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Yon JM, 2002, J CELL MOL MED, V6, P307, DOI 10.1111/j.1582-4934.2002.tb00511.x	52	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195416	10.1371/journal.pone.0195416	http://dx.doi.org/10.1371/journal.pone.0195416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621342	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800076
J	Del Guidice, T; Lepetit-Stoffaes, JP; Bordeleau, LJ; Roberge, J; Theberge, V; Lauvaux, C; Barbeau, X; Trottier, J; Dave, V; Roy, DC; Gaillet, B; Garnier, A; Guay, D				Del Guidice, Thomas; Lepetit-Stoffaes, Jean-Pascal; Bordeleau, Louis-Jean; Roberge, Joannie; Theberge, Vanessa; Lauvaux, Coraline; Barbeau, Xavier; Trottier, Jessica; Dave, Vibhuti; Roy, Denis-Claude; Gaillet, Bruno; Garnier, Alain; Guay, David			Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; EX-VIVO EXPANSION; PENETRATING PEPTIDES; ENDOSOMAL ESCAPE; IN-VITRO; CELLULAR UPTAKE; ENGINEERED NUCLEASES; MAMMALIAN-CELLS; GENE DELIVERY; CAS9 PROTEIN	Delivery of recombinant proteins to therapeutic cells is limited by a lack of efficient methods. This hinders the use of transcription factors or Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) ribonucleoproteins to develop cell therapies. Here, we report a soluble peptide designed for the direct delivery of proteins to mammalian cells including human stem cells, hard-to-modify primary natural killer (NK) cells, and cancer cell models. This peptide is composed of a 6x histidine-rich domain fused to the endosomolytic peptide CM18 and the cell penetrating peptide PTD4. A less than two-minute co-incubation of 6His-CM18-PTD4 peptide with spCas9 and/or as Cpf1 CRISPR ribonucleoproteins achieves robust gene editing. The same procedure, co-incubating with the transcription factor HoxB4, achieves transcriptional regulation. The broad applicability and flexibility of this DNA- and chemical-free method across different cell types, particularly hard-to-transfect cells, opens the way for a direct use of proteins for biomedical research and cell therapy manufacturing.	[Del Guidice, Thomas; Lepetit-Stoffaes, Jean-Pascal; Bordeleau, Louis-Jean; Roberge, Joannie; Theberge, Vanessa; Lauvaux, Coraline; Barbeau, Xavier; Guay, David] Feldan Therapeut, Quebec City, PQ, Canada; [Lepetit-Stoffaes, Jean-Pascal; Barbeau, Xavier; Gaillet, Bruno; Garnier, Alain] Univ Laval, Dept Genie Chim, Quebec City, PQ, Canada; [Trottier, Jessica; Dave, Vibhuti; Roy, Denis-Claude] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada	Laval University; Universite de Montreal	Del Guidice, T (corresponding author), Feldan Therapeut, Quebec City, PQ, Canada.	tdelguidice@feldan.com		Del'Guidice, Thomas/0000-0003-4969-7016	CNRC.NRC, Programme d'aide a la recherche industrielle [PARICNRC 874333]; Feldan Therapeutics Inc.	CNRC.NRC, Programme d'aide a la recherche industrielle; Feldan Therapeutics Inc.	This work was supported in part by CNRC.NRC, Programme d'aide a la recherche industrielle, PARICNRC 874333 and by Feldan Therapeutics Inc. The funders provided support in the form of salaries for authors T.D., J.-P.L.-S., L.-J.B., J.R., C.L., V.T., X.B., D.G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are related in the author contributions section.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Blenke EO, 2016, J CONTROL RELEASE, V244, P139, DOI 10.1016/j.jconrel.2016.08.002; Carlsten M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00266; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doetschman T, 2017, CIRC RES, V120, P876, DOI 10.1161/CIRCRESAHA.116.309727; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fasoli A, 2014, MOLECULES, V19, P9228, DOI 10.3390/molecules19079228; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Ferrer-Miralles N, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-101; Flynn CR, 2010, J PHARM SCI-US, V99, P3100, DOI 10.1002/jps.22087; Haas SA, 2017, HAMOSTASEOLOGIE, V37, P45, DOI 10.5482/HAMO-16-09-0035; Herrera AI, 2016, CURR PROTEIN PEPT SC, V17, P827, DOI 10.2174/1389203717666160526123821; Ho A, 2001, CANCER RES, V61, P474; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Keller AA, 2013, PHARMACEUTICALS, V6, P184, DOI 10.3390/ph6020184; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kristensen M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020185; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Lacy HM, 2002, BIOTECHNIQUES, V32, P254; LeCher Julia C., 2017, BioMolecular Concepts, V8, P131, DOI 10.1515/bmc-2017-0023; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee YJ, 2011, BBA-GEN SUBJECTS, V1810, P752, DOI 10.1016/j.bbagen.2011.05.013; Lee Y, 2009, CHEMBIOCHEM, V10, P929, DOI 10.1002/cbic.200800791; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Lonn P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32301; Luan L, 2015, J MATER CHEM B, V3, P1068, DOI 10.1039/c4tb01353k; Mager I, 2012, BBA-BIOMEMBRANES, V1818, P502, DOI 10.1016/j.bbamem.2011.11.020; Marie E, 2014, J MEMBRANE BIOL, V247, P861, DOI 10.1007/s00232-014-9679-3; Meng Z, 2017, J MATER CHEM B, V5, P74, DOI 10.1039/c6tb02862d; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nayerossadat Nouri, 2012, Adv Biomed Res, V1, P27, DOI 10.4103/2277-9175.98152; Ng KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154081; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Radis-Baptista G, 2017, J BIOTECHNOL, V252, P15, DOI 10.1016/j.jbiotec.2017.05.002; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shao SM, 2017, INT J BIOCHEM CELL B, V92, P43, DOI 10.1016/j.biocel.2017.09.012; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Singh V, 2017, J CELL BIOCH; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; Tung CH, 2002, BIOORGAN MED CHEM, V10, P3609, DOI 10.1016/S0968-0896(02)00248-1; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wei T, 2014, METHODS MOL BIOL, V1163, P23, DOI 10.1007/978-1-4939-0799-1_3; Yin H, 2017, NAT REV DRUG DISCOV; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	58	35	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195558	10.1371/journal.pone.0195558	http://dx.doi.org/10.1371/journal.pone.0195558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617431	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800093
J	van den Bos, W; Crone, EA; Meuwese, R; Guroglu, B				van den Bos, Wouter; Crone, Eveline A.; Meuwese, Rosa; Guroglu, Berna			Social network cohesion in school classes promotes prosocial behavior	PLOS ONE			English	Article							AGGRESSIVE-BEHAVIOR; CENTRALITY; ADOLESCENCE; TRUST; AGE; REORIENTATION; RECIPROCITY; POPULARITY; HIERARCHY; STUDENTS	Adolescence is a key period of social development at the end of which individuals are expected to take on adult social roles. The school class, as the most salient peer group, becomes the prime environment that impacts social development during adolescence. Using social network analyses, we investigated how individual and group level features are related to prosocial behavior and social capital (generalized trust). We mapped the social networks within 22 classrooms of adolescents aged between 12 and 18 years (N = 611), and collected data on social behaviors towards peers. Our results indicate that individuals with high centrality show both higher levels of prosocial behavior and relational aggression. Importantly, greater social cohesion in the classroom was associated with (1) reduced levels of antisocial behavior towards peers and (2) increased generalized trust. These results provide novel insights in the relationship between social structure and social behavior, and stress the importance of the school environment in the development of not only intellectual but also social capital.	[van den Bos, Wouter] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [van den Bos, Wouter] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Crone, Eveline A.; Meuwese, Rosa; Guroglu, Berna] Leiden Univ, Inst Psychol, Leiden, Netherlands	Max Planck Society; University of Amsterdam; Leiden University; Leiden University - Excl LUMC	van den Bos, W (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.; van den Bos, W (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	vandenbos@mpib-berlin.mpg.de	Guroglu, Berna/AAL-4664-2021	Guroglu, Berna/0000-0002-5418-8737; van den Bos, Wouter/0000-0002-8017-3790	European Research Council Starting Grant [ERC-2010-StG-263234]; Open Reseach Area grant [176]; NOW Grant [VICI 453-14-001]; Jacobs Foundation Research Fellowship; Netherlands Organization for Scientific Research grant [NWO-VICI 453-14-001]	European Research Council Starting Grant(European Research Council (ERC)); Open Reseach Area grant; NOW Grant; Jacobs Foundation Research Fellowship; Netherlands Organization for Scientific Research grant(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the European Research Council Starting Grant ERC-2010-StG-263234 (Crone), an Open Reseach Area grant (ID 176, van den Bos), NOW Grant VICI 453-14-001 to EC, and Jacobs Foundation Research Fellowship to WVDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by and an Open Reseach Area grant (ID 176) and a Jacobs Foundation Early Career Fellowship awarded to W.VD.B. As well as, an European Research Council grant (ERC-2010-StG-263234) and the Netherlands Organization for Scientific Research grant (NWO-VICI 453-14-001) awarded to E.A.C. The authors would like to thank Barbara Braams, Sabine Peters, Anneke de Gier, Jorien van Hoorn, Sandy Overgaauw, Merel Schrijver, Erik de Water, and Dafna Windhorst for their assistance with data collection and Raoul Grasman for his assistance in task development.	Ahn HJ, 2010, J EARLY ADOLESCENCE, V30, P76, DOI 10.1177/0272431609350922; Allcott H, 2007, AM ECON REV, V97, P80, DOI 10.1257/aer.97.2.80; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Artinger S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166279; Bastian M., 2009, 3 INT AAAI C WEBL SO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Bronfenbenner, 1979, ECOLOGY HUMAN DEV EX; Burnett Heyes S, 2015, CHILD DEV, V86, P1489, DOI 10.1111/cdev.12396; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Buskens V, 1998, SOC NETWORKS, V20, P265, DOI 10.1016/S0378-8733(98)00005-7; CAIRNS RB, 1983, MERRILL PALMER QUART, V29, P429; CAIRNS RB, 1988, DEV PSYCHOL, V24, P815, DOI 10.1037/0012-1649.24.6.815; Cillessen AHN, 2005, CURR DIR PSYCHOL SCI, V14, P102, DOI 10.1111/j.0963-7214.2005.00343.x; Cillessen AHN, 2004, CHILD DEV, V75, P147, DOI 10.1111/j.1467-8624.2004.00660.x; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; CSIKSZENTMIHALYI M, 1977, J YOUTH ADOLESCENCE, V6, P281, DOI 10.1007/BF02138940; Daniel E, 2016, SOC DEV, V25, P548, DOI 10.1111/sode.12146; DODGE KA, 1990, PERS SOC PSYCHOL B, V16, P8, DOI 10.1177/0146167290161002; Durlak JA, 2010, AM J COMMUN PSYCHOL, V45, P294, DOI 10.1007/s10464-010-9300-6; Edelstein W, 2011, EUR J EDUC, V46, P127, DOI 10.1111/j.1465-3435.2010.01463.x; EDER D, 1985, SOCIOL EDUC, V58, P154, DOI 10.2307/2112416; Eisenberg N, 2005, J RES ADOLESCENCE, V15, P235, DOI 10.1111/j.1532-7795.2005.00095.x; Ennett ST, 1996, J ADOLESCENT RES, V11, P194, DOI 10.1177/0743554896112003; Farmer TW, 1996, SOC DEV, V5, P174, DOI 10.1111/j.1467-9507.1996.tb00079.x; Forbes EE, 2010, BRAIN COGNITION, V72, P66, DOI 10.1016/j.bandc.2009.10.007; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Garandeau CF, 2011, DEV PSYCHOL, V47, P1699, DOI 10.1037/a0025271; Guroglu B, 2007, J RES ADOLESCENCE, V17, P357, DOI 10.1111/j.1532-7795.2007.00526.x; Guroglu B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00291; Guroglu B, 2009, J RES ADOLESCENCE, V19, P35, DOI 10.1111/j.1532-7795.2009.00580.x; Huitsing G, 2012, AGGRESSIVE BEHAV, V38, P494, DOI 10.1002/ab.21438; Kellam Sheppard G, 2011, Addict Sci Clin Pract, V6, P73; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Kuznetsova A., 2013, PACKAGE LMERTEST; La Macchia ST, 2016, PERS SOC PSYCHOL B, V42, P1321, DOI 10.1177/0146167216657360; Landherr A, 2010, BUS INFORM SYST ENG+, V2, P371, DOI 10.1007/s12599-010-0127-3; Lippert S, 2011, GAME ECON BEHAV, V72, P202, DOI 10.1016/j.geb.2010.08.010; McFarland DA, 2014, AM SOCIOL REV, V79, P1088, DOI 10.1177/0003122414554001; McGloin JM, 2014, J YOUTH ADOLESCENCE, V43, P1436, DOI 10.1007/s10964-014-0126-7; Mendelson MJ, 1999, CAN J BEHAV SCI, V31, P130, DOI 10.1037/h0087080; Meuwese R, 2015, CHILD DEV, V86, P145, DOI 10.1111/cdev.12290; Nelson EE, 2016, DEV COGN NEUROS-NETH, V17, P118, DOI 10.1016/j.dcn.2015.12.008; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; NEWCOMB AF, 1983, DEV PSYCHOL, V19, P856, DOI 10.1037/0012-1649.19.6.856; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Moore AM, 1997, IRISH J PSYCHOL, V18, P141; OLWEUS D, 1994, J CHILD PSYCHOL PSYC, V35, P1171, DOI 10.1111/j.1469-7610.1994.tb01229.x; Patrick H, 2002, GOALS, GOAL STRUCTURES, AND PATTERNS OF ADAPTIVE LEARNING, P85; Pattiselanno K, 2015, J YOUTH ADOLESCENCE, V44, P2257, DOI 10.1007/s10964-015-0310-4; PUTNAM RD, 1995, J DEMOCRACY, V0006; R Core Team, 2022, R LANG ENV STAT COMP; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Scheithauer H, 2006, AGGRESSIVE BEHAV, V32, P261, DOI 10.1002/ab.20128; STEINBERG LD, 1978, DEV PSYCHOL, V14, P683; van den Bos W, 2013, J NEUROSCI, V33, P13581, DOI 10.1523/JNEUROSCI.2667-13.2013; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; van den Bos W, 2010, COGNITIVE DEV, V25, P90, DOI 10.1016/j.cogdev.2009.07.004; Zeileis A., 2006, OBJECT ORIENTED COMP	67	20	21	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194656	10.1371/journal.pone.0194656	http://dx.doi.org/10.1371/journal.pone.0194656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617405	Green Published, gold			2022-12-27	WOS:000429203800041
J	Yin, ZJ; Liu, LJ; Wang, HD; Wen, FM				Yin, Zhujia; Liu, Lijuan; Wang, Haidong; Wen, Fengming			Study on the ownership balance and the efficiency of mixed ownership enterprises from the perspective of heterogeneous shareholders	PLOS ONE			English	Article							MARKETS; FIRMS	Based on the database data of Chinese industrial enterprises from 2000 to 2007 and the LP method, this paper measures the total factor productivity of enterprises and investigates the effect of different mixed ownership forms on enterprises' efficiency and the effect of heterogeneous ownership balance on the mixed ownership enterprises' efficiency. The state-owned enterprise and mixed ownership enterprise are identified by the enterprise's paid-up capital. The results show that, on the whole, for the mixed ownership enterprise, the higher the diversification degree of the shareholders is, the higher the efficiency becomes, and in different types of industries, the mixed forms of shareholders have different effects on the efficiency of enterprises. The heterogeneous ownership balance and the enterprise efficiency show nonlinear U-type relationships. Both the higher and lower heterogeneous ownership balance degrees will promote the enterprise's efficiency. However, when the ownership balance degree is in the range of [0.2 0.5], the increase in ownership balance will lead to the decline of enterprise efficiency. Therefore, when introducing non-state-owned capital, state-owned enterprises should take full account of their own characteristics by rationally controlling the shareholding ratio of non-state-owned capital and play the positive role of a mixed ownership structure in corporate governance with appropriate ownership balances.	[Yin, Zhujia; Liu, Lijuan] Changsha Univ Sci & Technol, Sch Econ & Management, Changsha, Hunan, Peoples R China; [Wang, Haidong] Hunan Univ, Sch Econ Trade, Changsha, Hunan, Peoples R China; [Wen, Fengming] Cent South Univ Forestry & Technol, Period Soc, Changsha, Hunan, Peoples R China	Changsha University of Science & Technology; Hunan University; Central South University of Forestry & Technology	Wen, FM (corresponding author), Cent South Univ Forestry & Technol, Period Soc, Changsha, Hunan, Peoples R China.	T20061213@csuft.edu.cn			National Social Science Fund Project of China [15BGL041]; Social Science Foundation of Hunan Province [15YBA014]; Key Project of Education Office of Hunan Province [17A014]	National Social Science Fund Project of China; Social Science Foundation of Hunan Province; Key Project of Education Office of Hunan Province	This research is supported by National Social Science Fund Project of China (15BGL041), Social Science Foundation of Hunan Province (15YBA014) and Key Project of Education Office of Hunan Province(17A014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov Alexander, 2017, Russian Journal of Economics, V3, P129; Arocena P, 2012, INT J PROD ECON, V140, P457, DOI 10.1016/j.ijpe.2012.06.029; Chang SC, 2017, N AM J ECON FINANC, V41, P82, DOI 10.1016/j.najef.2017.04.001; Chen D, 2014, CHINA FINANCE, P65; Chen J., 2015, CHINA IND EC, P99; Chen L, 2014, ECONOMIST, P13; Chen X. Y., 2004, J QUANTITATIVE TECHN, V11, P102; Dong M, 2015, MIXED OWNERSHIP EC E; Fan J, 2015, QUANTITATIVE EC TECH, P21; Guo Y, 2016, J ECON, P90; Gutierrez LH, 2009, J ECON BUS, V61, P112, DOI 10.1016/j.jeconbus.2008.01.002; Hao S, 2012, CHINA IND EC, P57; HAO Y H, 2015, CHINA IND EC, P148; Hausman J.A., 1978, ECONOMETRICA, V26, P393; Hong G, 2012, TEACHING RES, P40; Huang J, 2017, J HUNAN U SOCIAL SCI, P68; Huang J, 2015, FINANCE EC THEORY PR, P33; Huang Q., 2013, ADM REFORM, P49; Huang SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169473; Janang JT, 2015, PROC ECON FINANC, V31, P101, DOI 10.1016/S2212-5671(15)01136-3; Kong D, 2014, MANAGEMENT WORLD, P4; Levinsohn James, 2000, REV ECON STUD, V70, P317; Li N, 2010, J QUANTITATIVE TECHN, P3; Liu H, 2009, CHINESE ACCOUNTING R, P97; Liu X., 2004, EC RES, V8, P16; Ma G, 2015, CHINA IND EC, P5; Ma Rong, 2011, SHANGHAI EC RES, V2, P20; Nie H., 2012, J WORLD EC, V2012, P142; Nguyen P, 2013, INT REV FINANC ANAL, V30, P170, DOI 10.1016/j.irfa.2013.08.003; Petrin A, 2004, STATA J, V4, P113, DOI 10.1177/1536867X0400400202; Qiu D, 2012, SOFT SCI, V26, P108; Song Min, 2006, EC RES J, P49; [佟岩 Tong Yan], 2010, [南开管理评论, Nankai Business Review], V13, P108; Wen FH, 2018, APPL ECON, V50, P319, DOI 10.1080/00036846.2017.1321838; Wen FH, 2016, ENERG ECON, V59, P400, DOI 10.1016/j.eneco.2016.07.014; Wen FH, 2014, ECON COMPUT ECON CYB, V48, P235; Wu H, 2009, EC MANAGEMENT, P44; Wu W, 2016, J MODERN FINANCE EC, P15; Wu Y., 2012, EC RES, P15; Xu LP., 2006, EC RES J, V1, P90; Zhang C, 2011, ECONOMIST, P16; [朱红军 Zhu Hongjun], 2004, [管理世界, Management World], V0, P114	42	7	7	15	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194433	10.1371/journal.pone.0194433	http://dx.doi.org/10.1371/journal.pone.0194433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614126	gold, Green Submitted, Green Published			2022-12-27	WOS:000429081600010
J	Chien, SHL; Tai, CL; Yang, SF				Chien, Sarina Hui-Lin; Tai, Chu-Lik; Yang, Shu-Fei			The development of the own-race advantage in school-age children: A morphing face paradigm	PLOS ONE			English	Article							RECOGNITION; INFANCY; MEMORY; BIAS; EXPERIENCE	Previous studies examining the other-race effect in school-age children mostly focused on recognition memory performance. Here we investigated perceptual discriminability for Asian-like versus Caucasian-like morph faces in school-age Taiwanese children and adults. One-hundred-and-two5- to 12-year-old children and twenty-three adults performed a sequential same/different face matching task, where they viewed an Asian- or a Caucasian parent face followed by either the same parent face or a different morphed face (containing 15%, 30%, 45%, or 60% contribution from the other parent face) and judged if the two faces looked the same. We computed the d' as the sensitivity index for each age groups. We also analyzed the group mean rejection rates as a function of the morph level and fitted with a cumulative normal distribution function. Results showed that the adults and the oldest 11-12-year-old children exhibited a greater sensitivity (d) and a smaller discrimination threshold (mu) in the Asian-parent condition than those in the Caucasian-parent condition, indicating the presence of an own-race advantage. On the contrary, 5- to 10-year-old children showed an equal sensitivity and similar discrimination thresholds for both conditions, indicating an absence of the own-race advantage. Moreover, a gradual development in enhancing the discriminability for the Asian-parent condition was observed from age 5 to 12; however, the progression in the Caucasian-parent condition was less apparent. In sum, our findings suggest that expertise in face processing may take the entire childhood to develop, and supports the perceptual teaming view of the other-race effect the own-race advantage seen in adulthood likely reflects a result of prolonged learning specific to faces most commonly seen in one's visual environment such as own-race faces.	[Chien, Sarina Hui-Lin; Tai, Chu-Lik; Yang, Shu-Fei] China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan; [Chien, Sarina Hui-Lin] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Chien, SHL (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan.; Chien, SHL (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	sarinachien@mail.cmu.edu.tw			Taiwanese Ministry of Science and Technology [MOST 103-2410-H-039-002-MY3, MOST 105-2632-B-039-003]	Taiwanese Ministry of Science and Technology	This project was supported by Taiwanese Ministry of Science and Technology Grants: MOST 103-2410-H-039-002-MY3 and MOST 105-2632-B-039-003 to Dr. S. H. L. Chien.	Anzures G, 2012, J EXP CHILD PSYCHOL, V112, P484, DOI 10.1016/j.jecp.2012.04.005; Bruce V, 2000, BRIT J DEV PSYCHOL, V18, P319, DOI 10.1348/026151000165715; CAMPBELL R, 1995, J EXP CHILD PSYCHOL, V59, P196, DOI 10.1006/jecp.1995.1009; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Chance JE., 1996, PSYCHOL ISSUES EYEWI, P153; Chen C. M., 2016, CHINESE J PSYCHOL, V58, P39; Chen L.-F, 2007, TAIWANESE FACIAL EXP; Chien S. H. L., 2012, CHINESE J PSYCHOL, V54, P95, DOI DOI 10.1167/11.6.13; Chien SHL, 2016, FRONT PSYCHOL, DOI [10.3389/fpsyg.2016.01223, DOI 10.3389/FPSYG.2016.01223]; de Heering A, 2010, DEVELOPMENTAL SCI, V13, P181, DOI 10.1111/j.1467-7687.2009.00876.x; Ding XP, 2014, NEUROIMAGE, V85, P335, DOI 10.1016/j.neuroimage.2013.07.051; Gaither SE, 2012, DEVELOPMENTAL SCI, V15, P775, DOI 10.1111/j.1467-7687.2012.01170.x; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Goffaux V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138812; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P111, DOI 10.3758/BF03335029; Goodman GS, 2007, J EXP CHILD PSYCHOL, V98, P233, DOI 10.1016/j.jecp.2007.08.004; GOODMAN GS, 1991, MERRILL PALMER QUART, V37, P109; Green DM, 1966, SIGNAL DETECTION THE; Hayden A, 2007, INFANCY, V12, P95, DOI 10.1111/j.1532-7078.2007.tb00235.x; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Hsu H. Y., 2011, CHINESE J PSYCHOL, V53, P35; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Lee K, 2017, CURR DIR PSYCHOL SCI, V26, P256, DOI 10.1177/0963721417690276; LINDSAY DS, 1991, J APPL PSYCHOL, V76, P587, DOI 10.1037/0021-9010.76.4.587; Markant J, 2016, DEV PSYCHOBIOL, V58, P355, DOI 10.1002/dev.21375; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2012, COGN NEUROPSYCHOL, V29, P174, DOI 10.1080/02643294.2012.660138; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; O'Toole A. J., 1991, Connection Science, V3, P163, DOI 10.1080/09540099108946583; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Pezdek K, 2003, J APPL PSYCHOL, V88, P760, DOI 10.1037/0021-9010.88.4.760; Rossion B, 2013, VIS COGN, V21, P139, DOI 10.1080/13506285.2013.772929; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Slone AE, 2000, BASIC APPL SOC PSYCH, V22, P71, DOI 10.1207/15324830051036162; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Suhrke J, 2015, J EXP CHILD PSYCHOL, V137, P156, DOI 10.1016/j.jecp.2015.03.011; Suhrke J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00198; Tham DSY, 2015, INFANT BEHAV DEV, V40, P131, DOI 10.1016/j.infbeh.2015.05.006; Toglia, 2007, HDB EYEWITNESS PSYCH, V2, P257; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; VALENTINE T, 1992, Q J EXP PSYCHOL-A, V44, P671, DOI 10.1080/14640749208401305; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wright DB, 2001, PSYCHOL PUBLIC POL L, V7, P119, DOI 10.1037//1076-8971.7.1.119; Xiao WS, 2013, INT J BEHAV DEV, V37, P100, DOI 10.1177/0165025412467584; Young SG, 2012, PERS SOC PSYCHOL REV, V16, P116, DOI 10.1177/1088868311418987	54	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195020	10.1371/journal.pone.0195020	http://dx.doi.org/10.1371/journal.pone.0195020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634731	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200021
J	Friedman, A; Siewe, N				Friedman, Avner; Siewe, Nourridine			Chronic hepatitis B virus and liver fibrosis: A mathematical model	PLOS ONE			English	Article							STELLATE CELLS; COMBINATION THERAPY; ADEFOVIR DIPIVOXIL; IFN-GAMMA; INTERFERON; INFECTION; BETA; ACTIVATION; DYNAMICS; IL-13	Hepatitis B virus (HBV) infection is a liver disorder that can result in cirrhosis, liver failure and hepatocellular carcinoma. HBV infection remains a major global health problem, as it affects more 350 million people chronically and kills roughly 600,000 people annually. Drugs currently used against HBV include IFN-alpha that decreases viremia, inflammation and the growth of liver fibrosis, and adefovir that decreases the viral load. Each of these drugs can have severe side-effects. In the present paper, we consider the treatment of chronic HBV by a combination of IFN-alpha and adefovir, and raise the following question: What should be the optimal ratio between IFN-alpha and adefovir in order to achieve the best 'efficacy' under constraints on the total amount of the drugs; here the efficacy is measured by the reduction of the levels of inflammation and of fibrosis? We develop a mathematical model of HBV pathogenesis by a system of partial differential equations (PDEs) and use the model to simulate a 'synergy map' which addresses the above question.	[Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Siewe, Nourridine] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville	Siewe, N (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	nourridine@aims.ac.za		Siewe, Nourridine/0000-0002-3005-8508	Mathematical Biosciences Institute of The Ohio State University; National Science Foundation through NSF Award [DBI-1300426]; University of Tennessee, Knoxville	Mathematical Biosciences Institute of The Ohio State University; National Science Foundation through NSF Award(National Science Foundation (NSF)); University of Tennessee, Knoxville	This research was supported by the Mathematical Biosciences Institute of The Ohio State University. This work was conducted while Nourridine Siewe was a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation through NSF Award #DBI-1300426, with additional support from The University of Tennessee, Knoxville.	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Albeiroti S, 2015, BLOOD, V125, P1460, DOI 10.1182/blood-2014-07-590513; ALTSHULER B, 1981, ENVIRON HEALTH PERSP, V42, P23, DOI 10.2307/3429186; [Anonymous], 2000, DRUG COM KNOW MORE B; Asselah Tarik, 2007, Clin Liver Dis, V11, P839, DOI 10.1016/j.cld.2007.08.010; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bai QX, 2012, INT J MOL MED, V30, P1443, DOI 10.3892/ijmm.2012.1148; Balmasova IP, 2014, WORLD J GASTROENTERO, V20, P14156, DOI 10.3748/wjg.v20.i39.14156; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Byrnes AA, 2007, J LEUKOCYTE BIOL, V81, P825, DOI 10.1189/jlb.1006622; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chen HY, 2014, GENET MOL RES, V13, P8645, DOI 10.4238/2014.October.27.4; Ciupe SM, 2007, J THEOR BIOL, V247, P23, DOI 10.1016/j.jtbi.2007.02.017; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Ciupe SM, 2011, MATH POPUL STUD, V18, P87, DOI 10.1080/08898480.2011.564563; Clarke DL, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-20; Colombatto P, 2006, ANTIVIR THER, V11, P197; CRUMP KS, 1976, CANCER RES, V36, P2973; d'Onofrio A, 2009, CELL PROLIFERAT, V42, P317, DOI 10.1111/j.1365-2184.2009.00595.x; d'Onofrio A, 2006, APPL MATH COMPUT, V181, P1155, DOI 10.1016/j.amc.2006.01.061; d'Onofrio A, 2010, J THEOR BIOL, V264, P253, DOI 10.1016/j.jtbi.2010.01.023; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Friedman A, 2017, MATH BIOSCI ENG, V14, P143, DOI [10.3034/mbe.2017010, 10.3934/mbe.2017010]; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Greco RM, 1998, J CELL PHYSIOL, V177, P465, DOI 10.1002/(SICI)1097-4652(199812)177:3<465::AID-JCP9>3.0.CO;2-5; Hao WR, 2017, P NATL ACAD SCI USA, V114, P5011, DOI 10.1073/pnas.1620264114; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hong M, 2012, PLOS ONE, V71, P1; Huang R, 2013, HEPATOL RES, V43, P1040, DOI 10.1111/hepr.12058; Inuzuka T, 2014, PATHOGENS, V3, P377, DOI 10.3390/pathogens3020377; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; JANSSEN HLA, 1992, GUT, V33, P1094, DOI 10.1136/gut.33.8.1094; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Kamyad AV, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/475451; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lau GKKK, 2000, HEPATOLOGY, V32, P394, DOI 10.1053/jhep.2000.9143; Lewin SR, 2001, HEPATOLOGY, V34, P1012, DOI 10.1053/jhep.2001.28509; Liu HY, 2015, WORLD J HEPATOL, V7, P2319, DOI 10.4254/wjh.v7.i21.2319; Liu YH, 2014, J HUAZHONG U SCI-MED, V34, P542, DOI 10.1007/s11596-014-1312-2; Loggi E, 2015, DIGEST LIVER DIS, V47, P836, DOI 10.1016/j.dld.2015.05.019; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manalakopoulos S, 2008, ALIMENT PHARM THER, V27, P266, DOI 10.1111/j.1365-2036.2007.03567.x; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Paul Navin, 2011, Curr Hepat Rep, V10, P98, DOI 10.1007/s11901-011-0095-1; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Poovorawan Kittiyod, 2013, Hepat Res Treat, V2013, P757246, DOI 10.1155/2013/757246; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3; Siewe N, 2017, J THEOR BIOL, V412, P48, DOI 10.1016/j.jtbi.2016.10.004; Siewe N, 2016, MATH BIOSCI, V276, P28, DOI 10.1016/j.mbs.2016.02.015; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Terrault NA, 2015, HEPATOLOGY PRACTICE, P1, DOI DOI 10.1002/HEP.28156/SUPPINFO; Tzeng HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103008; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Wada T, 2003, NEPHROL DIAL TRANSPL, V18, P457, DOI 10.1093/ndt/18.3.457; WebMD, 2005, DRUGS MED HEPSERA; WebMD, 2014, INT CHRON HEP B; WedMD LLC, 2017, SID EFF; WedMD LLC, 2017, SID EFF; Weng WL, 2009, HEPATHOL, V50, P230, DOI [10.1002/hep.22934, DOI 10.1002/HEP.22934]; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Zan YL, 2013, BIOCHEM BIOPH RES CO, V435, P391, DOI 10.1016/j.bbrc.2013.04.098; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744	89	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195037	10.1371/journal.pone.0195037	http://dx.doi.org/10.1371/journal.pone.0195037			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634771	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200023
J	Goineau, A; Campion, L; d'Aillieres, B; Vie, B; Ghesquiere, A; Bera, G; Jaffres, D; de Laroche, G; Magne, N; Artignan, X; Chamois, J; Bergerot, P; Martin, E; Crehange, G; Deniaud-Alexandre, E; Buthaud, X; Belkacemi, Y; Dore, M; de Decker, L; Supiot, S				Goineau, Aurore; Campion, Loic; d'Aillieres, Benedicte; Vie, Brigitte; Ghesquiere, Agnes; Bera, Guillaume; Jaffres, Didier; de Laroche, Guy; Magne, Nicolas; Artignan, Xavier; Chamois, Jerome; Bergerot, Philippe; Martin, Etienne; Crehange, Gilles; Deniaud-Alexandre, Elisabeth; Buthaud, Xavier; Belkacemi, Yazid; Dore, Melanie; de Decker, Laure; Supiot, Stephane			Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; ANDROGEN-DEPRIVATION THERAPY; WHOLE PELVIS IRRADIATION; ACUTE BOWEL TOXICITY; RADICAL PROSTATECTOMY; 1ST-LINE CHEMOTHERAPY; OLDER MEN; PREDICTORS; MANAGEMENT; DIAGNOSIS	Introduction Radiotherapy can diminish quality of life (QoL) for prostate cancer patients. Our objective was to evaluate the effect of radiotherapy on QoL in men aged 75 years or older treated with radiotherapy for a localized prostate cancer, and to identify predictors of reduced QoL. Patients and methods We prospectively administered a battery of geriatric (MNA, GDS, Get up and Go Test, CIRSG, ADL, IADL, MMSE), toxicity (IPSS; IIEF 5), and QoL (QLQ C30) screening tests in 100 elderly patients before and two months after prostate cancer radiotherapy (NCT 02876237). Patients > 75 years undergoing radiotherapy with a curative intent for localized prostate cancer with or without androgen deprivation therapy (ADL) were eligible for study inclusion. Correlations between patient-assessed QoL and tumor characteristics, radiotherapy treatment or CGA parameters were sought using the Fisher or the Mann and Whitney tests. Changes in QoL parameters over time were analyzed using the Wilcoxon signed-rank test. Results At study entry, scores for IADL impairments were present in 51%, reduced autonomy in activities of daily living in 16%, cognitive impairment found in 20%, depression-related symptoms in 31%, and 66% of patients had significant co-morbidities. Eight percent were judged to be at risk of fall and 2% were found to be undernourished. Severely impaired (IPSS >= 20) urinary function was observed in 11.2% and 13.5% of patients before and two months after completion of radiotherapy respectively. Significantly decreased QoL (> 20 points) at two months after treatment was found in 13% of patients and a moderate but clinically relevant reduction (10 to 20 points) in 17% of patients. No tumor characteristic, treatment, or oncogeriatric parameter was predictive of reduced QoL following prostate cancer radiotherapy. Conclusion Despite sometimes markedly diminished oncogeriatric parameters, prostate cancer radiotherapy was generally well tolerated in these elderly patients. We found no predictive factor to determine which patients would experience impaired quality of life following radiotherapy.	[Goineau, Aurore; d'Aillieres, Benedicte] Inst Cancerol Ouest, Dept Radiat Oncol, Angers, France; [Campion, Loic] Inst Cancerol Ouest, Dept Stat, St Herblain, France; [Vie, Brigitte; Ghesquiere, Agnes] Clin Armoricaine Radiol, Dept Radiat Oncol, St Brieuc, France; [Bera, Guillaume; Jaffres, Didier] Ctr Hosp Bretagne Sud, Dept Radiat Oncol, Lorient, France; [de Laroche, Guy; Magne, Nicolas] Inst Cancerol Loire, Dept Radiat Oncol, St Priest En Jarez, France; [Artignan, Xavier; Chamois, Jerome] CHP St Gregoire, Dept Radiat Oncol, St Gregoire, France; [Bergerot, Philippe] Clin Mutualiste Estuaire, Dept Radiat Oncol, St Nazaire, France; [Martin, Etienne; Crehange, Gilles] Ctr Georges Francois Leclerc, Dept Radiat Oncol, Dijon, France; [Deniaud-Alexandre, Elisabeth] Ctr Hosp Dept Vendee, Dept Radiat Oncol, La Roche Sur Yon, France; [Buthaud, Xavier] Ctr Catherine Sienne, Dept Radiat Oncol, Nantes, France; [Belkacemi, Yazid] CHU Henri Mondor, Dept Radiat Oncol, Creteil, France; [Dore, Melanie; de Decker, Laure; Supiot, Stephane] Inst Cancerol Ouest, Dept Radiat Oncol, St Herblain, France	UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut de Cancerologie de la Loire; UNICANCER; Centre Georges-Francois Leclerc; CHD Vendee; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Goineau, A (corresponding author), Inst Cancerol Ouest, Dept Radiat Oncol, Angers, France.	aurore.goineau@ico.unicancer.fr	Campion, Loic/K-4726-2015; Supiot, Stéphane/M-1586-2015	Campion, Loic/0000-0003-4903-0908; Supiot, Stéphane/0000-0003-2094-1708; Bera, Guillaume/0000-0001-9266-8638	Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire [NCT 02876237]; Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire	Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire; Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire	This work was supported by the Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire (institutionnal funding). NCT 02876237 (https://www.oncopi.fr/oncogeriatne). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by Unite de Concertation en Onco-Geriatrie (UCOG) des Pays-de-la-Loire.	Aparicio T, 2013, J CLIN ONCOL, V31, P1464, DOI 10.1200/JCO.2012.42.9894; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Beckendorf V, 2011, INT J RADIAT ONCOL, V80, P1056, DOI 10.1016/j.ijrobp.2010.03.049; Bekelman JE, 2015, J CLIN ONCOL, V33, P716, DOI 10.1200/JCO.2014.57.2743; Bekelman JE, 2011, INT J RADIAT ONCOL, V81, pE325, DOI 10.1016/j.ijrobp.2011.02.006; Blanc-Bisson C, 2008, CRIT REV ONCOL HEMAT, V67, P243, DOI 10.1016/j.critrevonc.2008.04.005; Caillet P, 2011, J CLIN ONCOL, V29, P3636, DOI 10.1200/JCO.2010.31.0664; Carrie C, 2016, LANCET ONCOL, V17, P747, DOI 10.1016/S1470-2045(16)00111-X; Clement JP, 1997, ENCEPHALE, V23, P91; Cozzarini C, 2012, INT J RADIAT ONCOL, V82, P191, DOI 10.1016/j.ijrobp.2010.09.027; Dale W, 2009, J CLIN ONCOL, V27, P3420, DOI 10.1200/JCO.2009.22.9104; Dinh KT, 2016, J CLIN ONCOL, V34, P1905, DOI 10.1200/JCO.2015.64.1969; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Droz JP, 2014, LANCET ONCOL, V15, pE404, DOI 10.1016/S1470-2045(14)70018-X; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fung C, 2014, J CLIN ONCOL, V32, P2523, DOI 10.1200/JCO.2014.55.1531; Gajra A, 2016, J CLIN ONCOL, V34, P4047, DOI 10.1200/JCO.2016.67.5926; Geinitz H, 2010, STRAHLENTHER ONKOL, V186, P46, DOI 10.1007/s00066-009-2023-7; Gerritse FL, 2013, EUR J CANCER, V49, P3176, DOI 10.1016/j.ejca.2013.06.008; Goineau A, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-53; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Guren MG, 2003, EUR J CANCER, V39, P587, DOI 10.1016/S0959-8049(02)00741-4; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kerleau C, 2016, EUR J CANCER, V63, P143, DOI 10.1016/j.ejca.2016.05.020; Langston B, 2013, SUPPORT CARE CANCER, V21, P1761, DOI 10.1007/s00520-013-1751-5; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee CE, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-324; Lilleby W, 2016, ACTA ONCOL, V55, P807, DOI 10.3109/0284186X.2015.1127417; Lips IM, 2009, BJU INT, V103, P762, DOI 10.1111/j.1464-410X.2008.08117.x; Liuu E, 2014, J GERIATR ONCOL, V5, P11, DOI 10.1016/j.jgo.2013.08.003; Locke JA, 2015, NAT REV UROL, V12, P193, DOI 10.1038/nrurol.2015.50; Longobardi B, 2011, RADIOTHER ONCOL, V101, P460, DOI 10.1016/j.radonc.2011.07.014; Marchand V, 2010, INT J RADIAT ONCOL, V77, P1053, DOI 10.1016/j.ijrobp.2009.06.024; Martin JM, 2011, DRUGS, V71, P1019, DOI 10.2165/11591500-000000000-00000; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Michalski JM, 2010, INT J RADIAT ONCOL, V76, pS123, DOI 10.1016/j.ijrobp.2009.03.078; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Namiki S, 2010, J CANCER RES CLIN, V136, P379, DOI 10.1007/s00432-009-0665-6; Nanda A, 2010, INT J RADIAT ONCOL, V77, P147, DOI 10.1016/j.ijrobp.2009.04.085; Nguyen TD, 2010, CRIT REV ONCOL HEMAT, V74, P66, DOI 10.1016/j.critrevonc.2009.04.004; Osborne GEC, 2017, CLIN ONCOL-UK, V29, P609, DOI 10.1016/j.clon.2017.05.003; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Perna L, 2010, RADIOTHER ONCOL, V97, P71, DOI 10.1016/j.radonc.2010.02.025; Pignon T, 1997, RADIOTHER ONCOL, V42, P107, DOI 10.1016/S0167-8140(96)01861-0; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sargos P, 2015, CANCER TREAT REV, V41, P814, DOI 10.1016/j.ctrv.2015.10.005; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Terret Catherine, 2004, Clin Prostate Cancer, V2, P236, DOI 10.3816/CGC.2004.n.005; Thorsen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-123; Viswanathan AN, 2010, INT J RADIAT ONCOL, V76, pS116, DOI 10.1016/j.ijrobp.2009.02.090; Wortel RC, 2016, INT J RADIAT ONCOL, V95, P680, DOI 10.1016/j.ijrobp.2016.01.031; Yoshimura K, 2007, PROSTATE CANCER P D, V10, P288, DOI 10.1038/sj.pcan.4500923; Zelefsky MJ, 2016, RADIOTHER ONCOL, V118, P85, DOI 10.1016/j.radonc.2015.11.035	55	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194173	10.1371/journal.pone.0194173	http://dx.doi.org/10.1371/journal.pone.0194173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630602	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000007
J	Nazir, S; Mukhtar, M; Shahnawaz, M; Farooqi, S; Fatima, N; Mehmood, R; Sheikh, N				Nazir, Sabeen; Mukhtar, Maryam; Shahnawaz, Maryam; Farooqi, Shaima; Fatima, Naz; Mehmood, Rabia; Sheikh, Nadeem			A novel single nucleotide polymorphism in exon 3 of MYOC enhances the risk of glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OLFACTOMEDIN-HOMOLOGY DOMAIN; TRABECULAR MESHWORK; TIGR/MYOCILIN PROTEIN; MUTATION; DISEASE; MECHANISMS; SECRETION; SEVERITY; FAMILIES	Genetic polymorphisms of MYOCalter the myocilin protein,which leads to disruption of the normal regulation of intraocular pressure (IOP) that ultimately causes glaucoma. The aim of the present study was to identify the polymorphism in exon 3 of the MYOC gene of the glaucoma patients in Lahore, Pakistan. We conducted a case-control study with 100 patients and 100 controls subjects. We extracted DNA from blood samples,amplified the target DNA fragment by PCR, and identified polymorphisms through sequencing. We observed that the allelic and genotypic frequencies of rs74315341 and rs879255525 were associated with glaucoma in our patient population. The polymorphism atrs74315341 led to the substitution of serine for arginine,whereas the polymorphism at rs879255525 led to the substitution of asparagine for lysine. The haplotype TGAAGCCATTTC was associated with disease onset, whereas the haplotype GGAAGCCATTTC was protective against disease development. In conclusion, we identified MYOC gene polymorphisms in susceptible regions that were associated with glaucoma onset among the Lahore patient population. This is the first report to identify a novel mutation in rs879255525 in exon 3 of the MYOC gene that is associated with glaucoma.	[Nazir, Sabeen; Mukhtar, Maryam; Shahnawaz, Maryam; Fatima, Naz; Mehmood, Rabia; Sheikh, Nadeem] Univ Punjab, Dept Zool, Quaid E Azam Campus, Lahore, Pakistan; [Farooqi, Shaima] Univ Engn & Technol, Dept Biomed Engn Ctr, Kale Shah Kaku Campus, Lahore, Pakistan; [Sheikh, Nadeem] Univ Punjab, Ctr Appl Mol Biol, Quaid E Azam Campus, Lahore, Pakistan	University of Punjab; University of Engineering & Technology Lahore; University of Punjab	Sheikh, N (corresponding author), Univ Punjab, Dept Zool, Quaid E Azam Campus, Lahore, Pakistan.; Sheikh, N (corresponding author), Univ Punjab, Ctr Appl Mol Biol, Quaid E Azam Campus, Lahore, Pakistan.	s_nadeem77@yahoo.com	Fatima, Naz/AAG-1752-2020; Sheikh, Nadeem/A-5138-2010; Sheikh, Nadeem/GXF-4796-2022; Mukhtar, Maryam/J-7666-2016	Sheikh, Nadeem/0000-0001-9503-9538; MUKHTAR, MARYAM/0000-0003-3571-5447; Mehmood, Rabia/0000-0002-9356-2787	University of the Punjab, Lahore Pakistan	University of the Punjab, Lahore Pakistan	The authors are thankful to Vice Chancellor, University of the Punjab, Lahore Pakistan for providing full support to conduct this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; CAPRIOLI J, 1984, AM J OPHTHALMOL, V97, P730, DOI 10.1016/0002-9394(84)90505-1; Craig JE, 2001, OPHTHALMOLOGY, V108, P1607, DOI 10.1016/S0161-6420(01)00654-6; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Hewitt AW, 2007, ARCH OPHTHALMOL-CHIC, V125, P98, DOI 10.1001/archopht.125.1.98; Ikezoe T, 2003, INT J MOL MED, V12, P259; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Khan MD, 1999, PAK J OPHTHALMOL, V5, p15 ; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Lutjen-Drecoll E, 1998, INVEST OPHTH VIS SCI, V39, P517; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Povoa Cristine Araújo, 2006, Arq. Bras. Oftalmol., V69, P289, DOI 10.1590/S0004-27492006000300002; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Souzeau E, 2013, OPHTHALMOLOGY, V120, P1135, DOI 10.1016/j.ophtha.2012.11.029; Stoilova D, 1998, J MED GENET, V35, P989, DOI 10.1136/jmg.35.12.989; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; Taniguchi F, 2000, JPN J OPHTHALMOL, V44, P445, DOI 10.1016/S0021-5155(00)00201-X; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wirtz MK, 2007, AM J OPHTHALMOL, V144, P75, DOI 10.1016/j.ajo.2007.03.037; Zhou XM, 2013, INT J OPHTHALMOL-CHI, V6, P264, DOI 10.3980/j.issn.2222-3959.2013.03.02; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	28	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195157	10.1371/journal.pone.0195157	http://dx.doi.org/10.1371/journal.pone.0195157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630620	gold, Green Submitted, Green Published			2022-12-27	WOS:000429505000027
J	Sun, QQ; Wang, R; Hu, YX; Yao, LG; Guo, SL				Sun, Qiqi; Wang, Rui; Hu, Yaxian; Yao, Lunguang; Guo, Shengli			Spatial variations of soil respiration and temperature sensitivity along a steep slope of the semiarid Loess Plateau	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; NITROGEN-FERTILIZATION; MICROBIAL RESPONSES; CO2 EMISSION; LAND-USE; HETEROTROPHIC RESPIRATION; TOPOGRAPHIC POSITION; COMMUNITY STRUCTURE; TEMPORAL VARIATION; CARBON INPUTS	The spatial heterogeneity of soil respiration and its temperature sensitivity pose a great challenge to accurately estimate the carbon flux in global carbon cycling, which has primarily been researched in flatlands versus hillslope ecosystems. On an eroded slope (35) of the semiarid Loess Plateau, soil respiration, soil moisture and soil temperature were measured in situ at upper and lower slope positions in triplicate from 2014 until 2016, and the soil biochemical and microbial properties were determined. The results showed that soil respiration was significantly greater (by 44.2%) at the lower slope position (2.6 mu mol m(-2) s(-1)) than at the upper slope position, as were soil moisture, carbon, nitrogen fractions and root biomass. However, the temperature sensitivity was 13.2% greater at the upper slope position than at the lower slope position (P<0.05). The soil fungal community changed from being Basidiomycota-dominant at the upper slope position to being Zygomycota-dominant at the lower slope position, corresponding with increased P-D-glucosidase activity at the upper slope position than at the lower slope position. We concluded that soil respiration was enhanced by the greater soil moisture, root biomass, carbon and nitrogen contents at the lower slope position than at the upper slope position. Moreover, the increased soil respiration and decreased temperature sensitivity at the lower slope position were partially due to copiotrophs replacing oligotrophs. Such spatial variations along slopes must be properly accounted for when estimating the carbon budget and feedback of future climate change on hillslope ecosystems.	[Sun, Qiqi; Hu, Yaxian; Guo, Shengli] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shannxi, Peoples R China; [Sun, Qiqi; Hu, Yaxian; Guo, Shengli] Minist Water Resources, Yangling, Shannxi, Peoples R China; [Sun, Qiqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Rui; Hu, Yaxian; Guo, Shengli] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shannxi, Peoples R China; [Yao, Lunguang; Guo, Shengli] Nanyang Normal Univ, Collaborat Innovat Ctr Water Secur Water Source R, Nanyang, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Nanyang Normal College	Guo, SL (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Minist Water Resources, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Nanyang Normal Univ, Collaborat Innovat Ctr Water Secur Water Source R, Nanyang, Peoples R China.	slguo@ms.iswc.ac.cn			Natural Science Foundation of China [41371279, 41301322]; Chinese Universities Scientific Fund [2014116055]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work is supported by Natural Science Foundation of China (No. 41371279, No. 41301322), and Chinese Universities Scientific Fund (2014116055) to SG. The funders played important role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson LJ, 2007, NEW PHYTOL, V173, P110, DOI 10.1111/j.1469-8137.2006.01891.x; Auffret MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165448; Bai Z, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix063; Ball BA, 2014, POLAR BIOL, V37, P573, DOI 10.1007/s00300-014-1459-0; Bastida F, 2016, MOL ECOL, V25, P4660, DOI 10.1111/mec.13783; Bell CW, 2013, JOVE-J VIS EXP, DOI 10.3791/50961; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Berhe AA, 2013, EARTH SURF PROC LAND, V38, P908, DOI 10.1002/esp.3408; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Brindt N, 2017, MOVING BOUNDARY APPR; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen YP, 2016, SOIL BIOL BIOCHEM, V95, P233, DOI 10.1016/j.soilbio.2016.01.004; Chigineva NI, 2009, APPL SOIL ECOL, V42, P264, DOI 10.1016/j.apsoil.2009.05.001; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; du Plessis L, 2010, APPL MICROBIOL BIOT, V86, P1503, DOI 10.1007/s00253-009-2403-z; Duan LX, 2016, J HYDROL, V537, P356, DOI 10.1016/j.jhydrol.2016.03.057; Dungait JAJ, 2013, SOIL BIOL BIOCHEM, V60, P195, DOI 10.1016/j.soilbio.2013.01.027; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fang YT, 2009, PLANT SOIL, V319, P37, DOI 10.1007/s11104-008-9847-2; Fernandez-Escobar R, 2009, EUR J AGRON, V31, P223, DOI 10.1016/j.eja.2009.08.001; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Foti S, 2016, CATENA, V143, P78, DOI 10.1016/j.catena.2016.03.034; Fujii K, 2011, GEODERMA, V163, P119, DOI 10.1016/j.geoderma.2011.04.012; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Guo SL, 2012, GEODERMA, V189, P442, DOI 10.1016/j.geoderma.2012.06.012; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hu YX, 2013, AGRICULTURE-BASEL, V3, P726, DOI 10.3390/agriculture3040726; Huang JQ, 2013, ECOL ENG, V60, P67, DOI 10.1016/j.ecoleng.2013.07.040; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jiang JS, 2015, SOIL TILL RES, V150, P139, DOI 10.1016/j.still.2015.02.002; Kjoller A. H., 2002, FUNGAL COMMUNITIES S; Lal R, 2008, SCIENCE, V319, P1040, DOI 10.1126/science.319.5866.1040; Larionova AA, 2007, BIOGEOSCIENCES, V4, P1073, DOI 10.5194/bg-4-1073-2007; Li H, 2017, SOIL BIOL BIOCHEM, V104, P18, DOI 10.1016/j.soilbio.2016.10.009; Li Y, 2006, SOIL TILL RES, V86, P176, DOI 10.1016/j.still.2005.02.006; Li Y, 1991, COMPREHENSIVE STUDY; Li YC, 2017, SOIL BIOL BIOCHEM, V107, P19, DOI 10.1016/j.soilbio.2016.12.024; Li ZW, 2015, EUR J SOIL BIOL, V71, P37, DOI 10.1016/j.ejsobi.2015.10.003; Liu LL, 2016, GLOBAL CHANGE BIOL, V22, P1394, DOI 10.1111/gcb.13156; Ludley KE, 2008, SOIL BIOL BIOCHEM, V40, P11, DOI 10.1016/j.soilbio.2007.07.023; Ma G., 2003, THESIS NANJING NORMA; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nazaries L, 2015, SOIL BIOL BIOCHEM, V89, P123, DOI 10.1016/j.soilbio.2015.06.027; Pang X, 2015, BIOGEOCHEMISTRY, P1; Polyakov VO, 2008, GEODERMA, V143, P216, DOI 10.1016/j.geoderma.2007.11.005; Prolingheuer N, 2014, AGR FOREST METEOROL, V195, P24, DOI 10.1016/j.agrformet.2014.04.016; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Qiu Y, 2001, J ARID ENVIRON, V49, P723, DOI 10.1006/jare.2001.0828; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Shi B, 2016, PLANT SOIL, V400, P1; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Sinsabaugh RL, 2005, BIOGEOCHEMISTRY, V75, P201, DOI 10.1007/s10533-004-7112-1; Sommerkorn M, 2008, SOIL BIOL BIOCHEM, V40, P1792, DOI 10.1016/j.soilbio.2008.03.002; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Uchida Y, 2010, PLANT SOIL, V337, P375, DOI 10.1007/s11104-010-0533-9; van't Hoff JH, 1898, CHEM DYNAMICS 1, P224; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Venbygaart AJ, 2011, GLOBAL CHANGE BIOL, V18, P1441; Vicca S, 2010, SOIL BIOL BIOCHEM, V42, P2030, DOI 10.1016/j.soilbio.2010.07.023; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang H, 2012, APPL ENVIRON MICROB, V78, P7652, DOI 10.1128/AEM.01602-12; Wang QK, 2014, SOIL BIOL BIOCHEM, V72, P145, DOI 10.1016/j.soilbio.2014.01.020; Wang R., 2016, ELECT J DIFFERENTIAL, V2016, P1, DOI DOI 10.1016/J.SCIT0TENV.2016.09.001; Wang R, 2018, SCI TOTAL ENVIRON, V621, P425, DOI 10.1016/j.scitotenv.2017.11.290; Wang R, 2015, NUTR CYCL AGROECOSYS, V102, P285, DOI 10.1007/s10705-015-9699-0; Wang ZQ, 2017, SOIL TILL RES, V174, P1, DOI 10.1016/j.still.2017.05.005; Wang ZQ, 2017, ECOL ENG, V105, P231, DOI 10.1016/j.ecoleng.2017.04.050; Wei SC, 2014, SOIL TILL RES, V144, P119, DOI 10.1016/j.still.2014.07.012; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhang JH, 2006, GLOBAL CHANGE BIOL, V12, P1834, DOI 10.1111/j.1365-2486.2006.01206.x; Zhang YJ, 2015, ECOL ENG, V74, P196, DOI 10.1016/j.ecoleng.2014.10.003; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067616; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002; Zhu HH, 2014, CATENA, V120, P64, DOI 10.1016/j.catena.2014.04.007	90	13	15	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195400	10.1371/journal.pone.0195400	http://dx.doi.org/10.1371/journal.pone.0195400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624600	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600026
J	Budeli, P; Moropeng, RC; Mpenyana-Monyatsi, L; Momba, MNB				Budeli, Phumudzo; Moropeng, Resoketswe Charlotte; Mpenyana-Monyatsi, Lizzy; Momba, Maggie Ndombo Benteke			Inhibition of biofilm formation on the surface of water storage containers using biosand zeolite silver-impregnated clay granular and silver impregnated porous pot filtration systems	PLOS ONE			English	Article							HOUSEHOLD DRINKING-WATER; RURAL COMMUNITIES; QUALITY; GROUNDWATER; DIVERSITY; REMOVAL; FILTER; COLI	Development of biofilms occurring on the inner surface of storage vessels offers a suitable medium for the growth of microorganisms and consequently contributes to the deterioration of treated drinking water quality in homes. The aim of this study was to determine whether the two point-of-use technologies (biosand zeolite silver-impregnated clay granular (BSZ-SICG) filter and silver-impregnated porous pot (SIPP) filter) deployed in a rural community of South Africa could inhibit the formation of biofilm on the surface of plastic-based containers generally used by rural households for the storage of their drinking water. Culture-based methods and molecular techniques were used to detect the indicator bacteria (Total coliforms, faecal coliform, E. coli) and pathogenic bacteria (Salmonella spp., Shigella spp. and Vibrio cholerae) in intake water and on the surface of storage vessels containing treated water. Scanning electron microscopy was also used to visualize the development of biofilm. Results revealed that the surface water source used by the Makwane community was heavily contaminated and harboured unacceptably high counts of bacteria (heterotrophic plate count: 4.4-4.3 Log(10) CFU/100mL, total coliforms: 2.2 Log(10) CFU/100 mL-2.1 Log(10) CFU/100 mL, faecal coliforms: 1.9 Log(10) CFU/100 mL-1.8 Log(10) CFU/100 mL, E. coli: 1.7 Log(10) CFU/100 mL-1.6 Log(10) CFU/100 mL, Salmonella spp.: 3 Log(10) CFU/100 mL -8 CFU/100 mL; Shigella spp. and Vibrio cholerae had 1.0 Log(10) CFU/100 mL and 0.8 Log(10) CFU/100 mL respectively). Biofilm formation was apparent on the surface of the storage containers with untreated water within 24 h. The silver nanoparticles embedded in the clay of the filtration systems provided an effective barrier for the inhibition of biofilm formation on the surface of household water storage containers. Biofilm formation occurred on the surface of storage plastic vessels containing drinking water treated with the SIPP filter between 14 and 21 days, and on those containing drinking water treated with the BSZ-SICG filter between 3 and 14 days. The attachment of target bacteria on the surface of the coupons inoculated in storage containers ranged from (0.07 CFU/cm2-227.8 CFU/cm(2)). To effectively prevent the development of biofilms on the surface of container-stored water, which can lead to the recontamination of treated water, plastic storage containers should be washed within 14 days for water treated with the SIPP filter and within 3 days for water treated with the BSZ-SICG filter.	[Budeli, Phumudzo; Moropeng, Resoketswe Charlotte; Mpenyana-Monyatsi, Lizzy; Momba, Maggie Ndombo Benteke] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Arcadia Campus, Pretoria, South Africa	Tshwane University of Technology	Momba, MNB (corresponding author), Tshwane Univ Technol, Dept Environm Water & Earth Sci, Arcadia Campus, Pretoria, South Africa.	mombamnb@tut.ac.za		Monyatsi, Lizzy/0000-0002-4413-5295; Budeli, Phumudzo/0000-0003-2969-3886; Momba, Maggy/0000-0003-3537-0354	National Research Foundation (NRF) of South Africa; Tshwane University of Technology (TUT)	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Tshwane University of Technology (TUT)	The authors wish to express appreciation to the National Research Foundation (NRF) of South Africa and Tshwane University of Technology (TUT) for funding this research.	American_ Public_ Health_ Association (APHA), 2011, 139 ANN M EXP 2011; [Anonymous], 2001, INVESTIGATION POTTER; [Anonymous], 2002, MANAGING WATER HOME; Arvanitidou M, 2005, ENVIRON RES, V99, P278, DOI 10.1016/j.envres.2005.01.002; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Clasen T, 2006, WATER PRACT TECHNOL, V1, DOI 10.2166/WPT.2006031; Control) C (Center for D, 2009, POW PREV CHRON DIS P; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Jagals P, 1997, WATER SA, V23, P373; Kim MN, 2008, J ENVIRON BIOL, V29, P543; Lantagne D., 2012, Waterlines, V31, P30, DOI 10.3362/1756-3488.2012.005; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Mackay WG, 1998, J APPL MICROBIOL, V85; Michen B, 2012, ENVIRON SCI TECHNOL, V46, P1170, DOI 10.1021/es2030565; Michen B, 2011, SEP PURIF TECHNOL, V81, P77, DOI 10.1016/j.seppur.2011.07.006; Momba M.N.B., 2000, P WISA 2000 BIENN C, P21; Momba MNB, 2003, J WATER SUPPLY RES T, V52, P67, DOI 10.2166/aqua.2003.0007; Momba MNB, 2002, WATER RES, V36, P3023, DOI 10.1016/S0043-1354(02)00011-8; Murcott, 2006, IMPLEMENTATION CRITI; Mwabi JK, 2013, WATER SA, P39; Mwabi JK, 2012, INT J ENV RES PUB HE, V9, P139, DOI 10.3390/ijerph9010139; Obi CL, 2006, WATER SA, V32, P323; Radhika M, 2014, BRAZ J MICROBIOL, V45, P667, DOI [10.1590/S1517-83822014005000041, 10.1590/S1517-83822014000200041]; Sarapata JS, 1994, J N ENGL WATER WORKS, V108, P277; South African Bureau of Standards (SABS), 2015, 2412015 SABS SANS; Stauber CE, 2006, WATER SCI TECHNOL, V54, P1, DOI 10.2166/wst.2006.440; Theron J, 2000, CRIT REV MICROBIOL, V26, P37, DOI 10.1080/10408410091154174; (UNESCO) United Nations Educational S and CO, 2003, WAT PEOPL WAT LIF BA; van der Merwe V, 2013, J WATER HEALTH, V11, P30, DOI 10.2166/wh.2012.014; van Halem D, 2009, PHYS CHEM EARTH, V34, P36, DOI 10.1016/j.pce.2008.01.005; WHO, 2011, WHO CHRONICLES; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	32	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194715	10.1371/journal.pone.0194715	http://dx.doi.org/10.1371/journal.pone.0194715			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621296	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800024
J	Cittern, D; Nolte, T; Friston, K; Edalat, A				Cittern, David; Nolte, Tobias; Friston, Karl; Edalat, Abbas			Intrinsic and extrinsic motivators of attachment under active inference	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; INFANT-MOTHER ATTACHMENT; DISORGANIZED ATTACHMENT; STRANGE SITUATION; ADRENOCORTICAL RESPONSES; MATERNAL REPRESENTATIONS; CAREGIVING BEHAVIOR; STRESS; METAANALYSIS; STATES	This paper addresses the formation of infant attachment types within the context of active inference: a holistic account of action, perception and learning in the brain. We show how the organised forms of attachment (secure, avoidant and ambivalent) might arise in (Bayesian) infants. Specifically, we show that these distinct forms of attachment emerge from a minimisation of free energy-over interoceptive states relating to internal stress levels-when seeking proximity to caregivers who have a varying impact on these interoceptive states. In line with empirical findings in disrupted patterns of affective communication, we then demonstrate how exteroceptive cues (in the form of caregiver-mediated AMBIANCE affective communication errors, ACE) can result in disorganised forms of attachment in infants of caregivers who consistently increase stress when the infant seeks proximity, but can have an organising (towards ambivalence) effect in infants of inconsistent caregivers. In particular, we differentiate disorganised attachment from avoidance in terms of the high epistemic value of proximity seeking behaviours (resulting from the caregiver's misleading exteroceptive cues) that preclude the emergence of coherent and organised behavioural policies. Our work, the first to formulate infant attachment in terms of active inference, makes a new testable prediction with regards to the types of affective communication errors that engender ambivalent attachment.	[Cittern, David; Edalat, Abbas] Imperial Coll London, Dept Comp, London, England; [Nolte, Tobias; Friston, Karl] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Nolte, Tobias] Anna Freud Ctr, London, England	Imperial College London; University of London; University College London; The Anna Freud Centre	Cittern, D (corresponding author), Imperial Coll London, Dept Comp, London, England.	davd.cittern10@imperial.ac.uk	Friston, Karl/D-9230-2011	Friston, Karl/0000-0001-7984-8909	Engineering and Physical Sciences [EP/L504786/1]; Wellcome Trust Principle Investigator Award [509665]; Wellcome Trust Principal Research Fellowship [088130/Z/09/Z]; Engineering and Physical Sciences Council [EP/L504786/1]	Engineering and Physical Sciences(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust Principle Investigator Award; Wellcome Trust Principal Research Fellowship(Wellcome Trust); Engineering and Physical Sciences Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	DC received support from the Engineering and Physical Sciences (Ref: EP/L504786/1), http://www.epsrc.ac.uk. TN is supported by a Wellcome Trust Principle Investigator Award to P. Read Montague (Ref: 509665), https://wellcome.ac.uk. KJF is funded by a Wellcome Trust Principal Research Fellowship (Ref: 088130/Z/09/Z), https://wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; David Cittern received support from the Engineering and Physical Sciences Council to study computational aspects of attachment (Ref: EP/L504786/1). Tobias Nolte is supported by a Wellcome Trust Principle Investigator Award to P. Read Montague (Ref: 509665). KJF is funded by a Wellcome Trust Principal Research Fellowship (Ref: 088130/Z/09/Z).	Abrams KY, 2006, DEV PSYCHOPATHOL, V18, P345, DOI 10.1017/S0954579406060184; Ainley V, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0003; Ainsworth M., 1978, PATTERNS ATTACHMENT; Ainsworth M. D. S, 1967, INFANCY UGANDA INFAN; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 1969, ATTACHMENT LOSS ATTA; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; Bateman A., 2012, HDB MENTALIZING MENT; Beal Matthew James, 2003, VARIATIONAL ALGORITH; BOWLBY J, 1960, PSYCHOANAL STUD CHIL, V15, P9, DOI 10.1080/00797308.1960.11822566; BOWLBY J, 1960, INT J PSYCHOANAL, V41, P89; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Bowlby J., 1973, ATTACHMENT LOSS, V2; Bowlby J, 1980, ATTACHMENT LOSS LOSS, V3; Bronfman E., 1999, ATYPICAL MATERNAL BE; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Buono L, 2006, FIELDS MITACS IND PR; Carlson EA, 2009, DEV PSYCHOPATHOL, V21, P1311, DOI 10.1017/S0954579409990174; CARLSON V, 1989, DEV PSYCHOL, V25, P525, DOI 10.1037/0012-1649.25.4.525; Cittern D, 2015, 2015 INT JOINT C NEU, P1; Cittern David, 2017, Comput Psychiatr, V1, P132, DOI 10.1162/CPSY_a_00006; Cittern D, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE, COGNITIVE ALGORITHMS, MIND, AND BRAIN (CCMB), P57, DOI 10.1109/CCMB.2014.7020694; Cozolino L., 2014, NEUROSCIENCE HUMAN R, V2nd; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; DONOVAN WL, 1985, J AM ACAD CHILD PSY, V24, P65, DOI 10.1016/S0002-7138(09)60411-8; Edalat A, 2013, NEUR NETW IJCNN 2013, P1; Edalat A., 2013, I PSYCH KINGS COLL L; Edalat A, 2013, ADV NEURAL INFORM PR, P2661; Edalat A, 2015, 2015 INT JOINT C NEU, P1; Edalat A, 2017, SPR SER BIONUERO, P273, DOI 10.1007/978-3-319-49959-8_10; Edalat A, 2014, IEEE IJCNN, P2743, DOI 10.1109/IJCNN.2014.6889896; Feeney BC, 2008, J PERS SOC PSYCHOL, V95, P1481, DOI 10.1037/a0012635; FitzGerald THB, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00136; Fonagy P, 2000, J AM PSYCHOANAL ASS, V48, P1129, DOI 10.1177/00030651000480040701; FONAGY P, 1991, CHILD DEV, V62, P891, DOI 10.1111/j.1467-8624.1991.tb01578.x; Fonagy P, 2000, PSYCHIAT CLIN N AM, V23, P103, DOI 10.1016/S0193-953X(05)70146-5; Fonagy P, NEW ASSESSMENT TOOL; Fonagy P., 2004, KARNAC BOOKS; Fonagy P, 2015, J PERS DISORD, V29, P575, DOI 10.1521/pedi.2015.29.5.575; Fonagy P, 2012, MINDING THE CHILD: MENTALIZATION-BASED INTERVENTIONS WITH CHILDREN, YOUNG PEOPLE AND THEIR FAMILIES, P11; Fotopoulou A., 2017, NEUROPSYCHOANALYSIS, V19, P3, DOI [10.1080/15294145.2017.1294031, DOI 10.1080/15294145.2017.1294031]; Friston K, 2015, COGN NEUROSCI-UK, V6, P187, DOI 10.1080/17588928.2015.1020053; Friston K, 2017, NEURAL COMPUT, V29, P1, DOI 10.1162/NECO_a_00912; Friston K, 2016, NEUROSCI BIOBEHAV R, V68, P862, DOI 10.1016/j.neubiorev.2016.06.022; Friston K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0481; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Goldberg S, 2003, DEV PSYCHOPATHOL, V15, P239, DOI 10.1017/S0954579403000130; Goldberg S., 2000, ATTACHMENT DEV; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Hamilton CE, 2000, CHILD DEV, V71, P690, DOI 10.1111/1467-8624.00177; HERTSGAARD L, 1995, CHILD DEV, V66, P1100, DOI 10.1111/j.1467-8624.1995.tb00925.x; Hesse E, 2008, HDB ATTACHMENT THEOR, P395; Hill-Soderlund AL, 2008, DEV PSYCHOBIOL, V50, P361, DOI 10.1002/dev.20302; Hiolle A, 2014, ALIFE 14, V14, P726; Hiolle A, 2012, ACM T INTERACT INTEL, V2, DOI 10.1145/2133366.2133369; Hobson RP, 2009, BRIT J PSYCHIAT, V195, P325, DOI 10.1192/bjp.bp.108.060624; Hofmann SG, 2011, INTRO MODERN CBT PSY; Hopkins J, 2015, PSYCHOANALYSIS PHILO, P47; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jacobvitz D, 1997, BIENN M SOC RES CHIL; Joffily M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003094; Krugers HJ, 2006, EUR J NEUROSCI, V23, P3051, DOI 10.1111/j.1460-9568.2006.04842.x; Letourneau N, 2014, BIOL RES NURS, V16, P83, DOI 10.1177/1099800412463602; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Liotti G, 2004, PSYCHOTHERAPY, V41, P472, DOI 10.1037/0033-3204.41.4.472; Liotti G., 1992, DISSOCIATION, V5, P196; Lyons-Ruth K, 1999, MONOGR SOC RES CHILD, V64, P67, DOI 10.1111/1540-5834.00034; Lyons-Ruth K, 2007, ATTACH HUM DEV, V9, P1, DOI 10.1080/14616730601151417; Macfie J, 2014, DEV PSYCHOPATHOL, V26, P539, DOI 10.1017/S095457941400011X; Madigan S, 2006, DEV PSYCHOL, V42, P293, DOI 10.1037/0012-1649.42.2.293; MAIN M, 1985, MONOGR SOC RES CHILD, V50, P66, DOI 10.2307/3333827; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; Main M, 1990, ATTACHMENT PRESCHOOL, P121; Main M, 1992, FRIGHTENING FRIGHTEN; Main M., 1986, AFFECTIVE DEV INFANC, P95; Main Mary, 1996, P107; Mikulincer M, 2012, WORLD PSYCHIATRY, V11, P11, DOI 10.1016/j.wpsyc.2012.01.003; Mirza MB, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00056; Moutoussis M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00160; Moutoussis M, 2014, CONSCIOUS COGN, V25, P67, DOI 10.1016/j.concog.2014.01.009; Peters A, 2017, PROG NEUROBIOL, V156, P164, DOI 10.1016/j.pneurobio.2017.05.004; Petters D., 2006, P 7 INT C COGN MOD, P226; Petters D., 2006, DESIGNING AGENTS UND; Pezzulo G, 2015, PROG NEUROBIOL, V134, P17, DOI 10.1016/j.pneurobio.2015.09.001; Quattrocki E, 2014, NEUROSCI BIOBEHAV R, V47, P410, DOI 10.1016/j.neubiorev.2014.09.012; Radley JJ, 2005, EXP NEUROL, V196, P199, DOI 10.1016/j.expneurol.2005.07.008; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rutledge RB, 2016, NATURE COMMUNICATION, V7; Safyer MP, 2013, GOOD ENOUGH MOTHERIN; Schore A. N, 2015, AFFECT REGULATION OR; Schore A.N., 2012, SCI ART PSYCHOTHERAP; Schuengel C, 1999, J CONSULT CLIN PSYCH, V67, P54, DOI 10.1037/0022-006X.67.1.54; Schwartenbeck P, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0049-16.2016; Schwartenbeck P, 2015, CEREB CORTEX, V25, P3434, DOI 10.1093/cercor/bhu159; Seth AK, 2014, COGN NEUROSCI-UK, V5, P97, DOI 10.1080/17588928.2013.877880; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sigman M, 2004, MENT RETARD DEV D R, V10, P221, DOI 10.1002/mrdd.20046; Smith JD, 2016, BIOL PSYCHOL, V114, P39, DOI 10.1016/j.biopsycho.2015.12.008; SPANGLER G, 1993, CHILD DEV, V64, P1439, DOI 10.2307/1131544; Spangler G, 1998, INT J BEHAV DEV, V22, P681, DOI 10.1080/016502598384126; Stepp SD, 2012, PERSONAL DISORD, V3, P76, DOI 10.1037/a0023081; Stevens GT, 2009, IEEE T AUTON MENT DE, V1, P196, DOI 10.1109/TAMD.2009.2038190; Thompson RA, 2008, HDB ATTACHMENT THEOR, P265; True MM, 2001, CHILD DEV, V72, P1451; van IJzendoorn M. H., 1999, HDB ATTACHMENT THEOR, P713; VAN IJZENDOORN MH, 1995, PSYCHOL BULL, V117, P387, DOI 10.1037/0033-2909.117.3.387; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; Varga Z, 2017, BEHAV BRAIN RES, V316, P104, DOI 10.1016/j.bbr.2016.08.030; Vivanti G, 2017, BEHAV BRAIN RES, V325, P251, DOI 10.1016/j.bbr.2016.10.025; Waters E, 2000, CHILD DEV, V71, P678, DOI 10.1111/1467-8624.00175; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Young J.E., 2006, SCHEMA THERAPY PRACT, DOI DOI 10.1017/; Zelenko M, 2005, J AM ACAD CHILD PSY, V44, P470, DOI 10.1097/01.chi.0000157325.10232.b1	119	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193955	10.1371/journal.pone.0193955	http://dx.doi.org/10.1371/journal.pone.0193955			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621266	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800011
J	Contreras, EG; Sierralta, J; Glavic, A				Contreras, Esteban G.; Sierralta, Jimena; Glavic, Alvaro			p53 is required for brain growth but is dispensable for resistance to nutrient restriction during Drosophila larval development	PLOS ONE			English	Article							NEURAL STEM-CELLS; DAMAGE RESPONSE; ORGAN GROWTH; SELF-RENEWAL; PROLIFERATION; METABOLISM; APOPTOSIS; COFACTOR; DIFFERENTIATION; EXPRESSION	Background Animal growth is influenced by the genetic background and the environmental circumstances. How genes promote growth and coordinate adaptation to nutrient availability is still an open question. p53 is a transcription factor that commands the cellular response to different types of stresses. In adult Drosophila melanogaster, p53 regulates the metabolic adaptation to nutrient restriction that supports fly viability. Furthermore, the larval brain is protected from nutrient restriction in a phenomenon called 'brain sparing'. Therefore, we hypothesised that p53 may regulate brain growth and show a protective role over brain development under nutrient restriction. Results Here, we studied the function of p53 during brain growth in normal conditions and in animals subjected to developmental nutrient restriction. We showed that p53 loss of function reduced animal growth and larval brain size. Endogenous p53 was expressed in larval neural stem cells, but its levels and activity were not affected by nutritional stress. Interestingly, p53 knockdown only in neural stem cells was sufficient to decrease larval brain growth. Finally, we showed that in p53 mutant larvae under nutrient restriction, the energy storage levels were not altered, and these larvae generated adults with brains of similar size than wild-type animals. Conclusions Using genetic approaches, we demonstrate that p53 is required for proper growth of the larval brain. This developmental role of p53 does not have an impact on animal resistance to nutritional stress since brain growth in p53 mutants under nutrient restriction is similar to control animals.	[Contreras, Esteban G.; Sierralta, Jimena] Univ Chile, Fac Med, Biomed Neurosci Inst, Independencia Santiago, Chile; [Contreras, Esteban G.; Sierralta, Jimena] Univ Chile, Fac Med, Dept Neurosci, Independencia Santiago, Chile; [Contreras, Esteban G.; Glavic, Alvaro] Univ Chile, Fac Sci, Dept Biol, Ctr Genome Regulat, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Sierralta, J (corresponding author), Univ Chile, Fac Med, Biomed Neurosci Inst, Independencia Santiago, Chile.; Sierralta, J (corresponding author), Univ Chile, Fac Med, Dept Neurosci, Independencia Santiago, Chile.; Glavic, A (corresponding author), Univ Chile, Fac Sci, Dept Biol, Ctr Genome Regulat, Santiago, Chile.	jimena@neuro.med.uchile.cl; alglavic@uchile.cl	Contreras, Esteban/Y-6512-2019; Sierralta, Jimena Alejandra/AAG-8877-2021; Glavic, Alvaro/F-5608-2013	Contreras, Esteban/0000-0002-0934-741X; Sierralta, Jimena/0000-0002-0257-146X; Glavic, Alvaro/0000-0002-7330-7623	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [3160412, 1140522, 1171800]; Anillo de Investigacion en Ciencia y Tecnologia DRiDANS [ACT1401]; Institute Milenio de Neurociencia Biomedica (BNI) [ICM P09015-F]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap) [15090007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo de Investigacion en Ciencia y Tecnologia DRiDANS; Institute Milenio de Neurociencia Biomedica (BNI); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by the following grants: Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Postdoctorado 3160412 (http://www.conicyt.cl/fondecyt/)to E.G.C., Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Regular 1140522 (http://www.conicyt.cl/fondecyt/) to A.G., Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Regular 1171800 (http://www.conicyt.cl/fondecyt/) to J.S., Anillo de Investigacion en Ciencia y Tecnologia DRiDANS ACT1401 (http://www.conicyt.cl/pia/sobre-piailineas-accion/anillos-de-investigacion-en-ciencial-tecnologiat)to J.S. and A.G., Institute Milenio de Neurociencia Biomedica (BNI) ICM P09015-F (http://www.bni.cl/) to J.S., Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap) 15090007 to A.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Barrio L, 2014, CELL REP, V8, P527, DOI 10.1016/j.celrep.2014.06.020; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; BOULAN L, 2015, COLD SPRING HARB PER, V7; Brand AH, 1993, DEV CAMBRIDGE ENGLAN, V118, P1; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Bruno T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00034; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Cohen E, 2015, NEONATOLOGY, V108, P269, DOI 10.1159/000438451; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Dichtel-Danjoy ML, 2013, CELL DEATH DIFFER, V20, P108, DOI 10.1038/cdd.2012.100; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Floter J, 2017, METABOLITES, V7, DOI 10.3390/metabo7020021; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Joruiz S. M., 2016, COLD SPRING HARB PER, V6; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Lanet E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00117; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Maniam S, 2015, CELL DEATH DIFFER, V22, P156, DOI 10.1038/cdd.2014.135; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merlo P, 2014, P NATL ACAD SCI USA, V111, P18055, DOI 10.1073/pnas.1419083111; Mesquita D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000566; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Mollereau B, 2014, APOPTOSIS, V19, P1421, DOI 10.1007/s10495-014-1035-7; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; PURDIE CA, 1994, ONCOGENE, V9, P603; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Scrable H, 2009, EXP GERONTOL, V44, P93, DOI 10.1016/j.exger.2008.05.017; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Simon R, 2014, APOPTOSIS, V19, P1430, DOI 10.1007/s10495-014-1000-5; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Speder P, 2011, CURR OPIN CELL BIOL, V23, P724, DOI 10.1016/j.ceb.2011.08.004; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Werner H, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00159; Wylie A, 2014, ELIFE, V3, DOI 10.7554/eLife.01530; Xie HB, 2004, GENETICS, V168, P1477, DOI 10.1534/genetics.104.030882; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194344	10.1371/journal.pone.0194344	http://dx.doi.org/10.1371/journal.pone.0194344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621246	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800016
J	Gray, DW; Welsh, MD; Mansoor, F; Doherty, S; Chevallier, OP; Elliott, CT; Mooney, MH				Gray, Darren W.; Welsh, Michael D.; Mansoor, Fawad; Doherty, Simon; Chevallier, Olivier P.; Elliott, Christopher T.; Mooney, Mark H.			DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; EXPERIMENTALLY INFECTED CALVES; VASCULAR ENDOTHELIAL-CELLS; FARNESOID-X-RECEPTOR; BENZOIC-ACID; POTENTIAL BIOMARKERS; QUADRIVALENT VACCINE; GLYCINE CONJUGATION; MASS-SPECTROMETRY	Bovine Respiratory Disease (BRD) is a major source of economic loss within the agricultural industry. Vaccination against BRD-associated viruses does not offer complete immune protection and vaccine failure animals present potential routes for disease spread. Serological differentiation of infected from vaccinated animals (DIVA) is possible using antigen-deleted vaccines, but during virus outbreaks DIVA responses are masked by wild-type virus preventing accurate serodiagnosis. Previous work by the authors has established the potential for metabolomic profiling to reveal metabolites associated with systemic immune responses to vaccination. The current study builds on this work by demonstrating for the first time the potential to use plasma metabolite profiling to differentiate between vaccinated and non vaccinated animals following infection-challenge. Male Holstein Friesian calves were intranasally vaccinated (Pfizer RISPOVAL (R) PI3-FRSV) and subsequently challenged with Bovine Parainfluenza Virus type-3 (BPI3V) via nasal inoculation. Metabolomic plasma profiling revealed that viral challenge led to a shift in acquired plasma metabolite profiles from day 2 to 20 p.i., with 26 metabolites identified whose peak intensities were significantly different following viral challenge depending on vaccination status. Elevated levels of biliverdin and bilirubin and decreased 3-indolepropionic acid in non-vaccinated animals at day 6 p.i. may be associated with increased oxidative stress and reactive oxygen scavenging at periods of peak virus titre. During latter stages of infection, increased levels of N-[3 alpha,5 beta,12 alpha)-3,12-dihydroxy-7,24-dioxocholan-24-yl]glycine and lysophosphatidycholine and decreased enterolactone in non-vaccinated animals may reflect suppression of innate immune response mechanisms and progression to adaptive immune responses. Levels of hexahydrohippurate were also shown to be significantly elevated in non-vaccinated animals from days 6 to 20 p.i. These findings demonstrate the potential of metabolomic profiling to identify plasma markers that can be employed in disease diagnostic applications to both differentially identify infected non-vaccinated animals during disease outbreaks and provide greater information on the health status of infected animals.	[Gray, Darren W.; Chevallier, Olivier P.; Elliott, Christopher T.; Mooney, Mark H.] QUB, Sch Biol Sci, IGFS, Belfast, Antrim, North Ireland; [Welsh, Michael D.; Mansoor, Fawad; Doherty, Simon] AFBI, VSD, Belfast, Antrim, North Ireland	Agri-Food & Biosciences Institute	Gray, DW (corresponding author), QUB, Sch Biol Sci, IGFS, Belfast, Antrim, North Ireland.	d.gray@qub.ac.uk	Chevallier, Olivier P/I-6550-2015	Chevallier, Olivier P/0000-0002-3786-4318; Doherty, Simon/0000-0001-5908-1050	Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship	Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship	This research was funded by a Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship awarded to Darren Gray. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BM, 2000, RES VET SCI, V68, P197, DOI 10.1053/rvsc.1999.0354; Aich P, 2007, OMICS, V11, P413, DOI 10.1089/omi.2007.0023; Aich P, 2009, OMICS, V13, P199, DOI 10.1089/omi.2009.0012; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; BREWSTER D, 1977, BIOCHEM J, V164, P595, DOI 10.1042/bj1640595; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Chamorro MF, 2014, CAN J VET RES, V78, P81; CHIBA M, 1994, J PHARMACOL EXP THER, V268, P409; Corsini E, 2010, J AGR FOOD CHEM, V58, P6678, DOI 10.1021/jf100471n; Coutant F, 2002, J IMMUNOL, V169, P1688, DOI 10.4049/jimmunol.169.4.1688; Cusack PMV, 2003, AUST VET J, V81, P480, DOI 10.1111/j.1751-0813.2003.tb13367.x; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021; Favre N, 1997, J IMMUNOL METHODS, V204, P57, DOI 10.1016/S0022-1759(97)00033-1; Fulton RW, 2012, CAN VET J, V53, P754; Gagnon N, 2009, J DAIRY RES, V76, P455, DOI 10.1017/S0022029909990082; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Gray DW, 2015, VET RES, V46, DOI 10.1186/s13567-014-0138-z; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; JEFFERY H, 1993, PHARMACEUT RES, V10, P362, DOI 10.1023/A:1018980020506; Kahrs RF., 2001, VIRAL DIS CATTLE, V2nd Edition; Kaji H, 2013, J LIPIDS, V2013, DOI 10.1155/2013/684903; Kapil S, 1997, VET CLIN N AM-FOOD A, V13, P455, DOI 10.1016/S0749-0720(15)30308-X; KLEMPNER MS, 1978, J CLIN INVEST, V61, P1330, DOI 10.1172/JCI109050; Leifer I, 2010, J VIROL METHODS, V166, P98, DOI 10.1016/j.jviromet.2010.03.004; Leifer I, 2009, J VIROL METHODS, V158, P114, DOI 10.1016/j.jviromet.2009.02.002; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Lindahl G, 2011, CANCER RES, V71, P51, DOI 10.1158/0008-5472.CAN-10-2289; MARTIN AK, 1982, BRIT J NUTR, V47, P139, DOI 10.1079/BJN19820019; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Panciera RJ, 2010, VET CLIN N AM-FOOD A, V26, P191, DOI 10.1016/j.cvfa.2010.04.001; Peters AR, 2004, PREV VET MED, V66, P63, DOI 10.1016/j.prevetmed.2004.08.001; POON K, 1995, DRUG METAB DISPOS, V23, P255; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Salt JS, 2007, VET J, V174, P616, DOI 10.1016/j.tvjl.2006.10.007; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Scott PR, 1994, FACTORS RESP DIS REV; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STEINBRECHER UP, 1989, J LIPID RES, V30, P305; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; West K, 1998, CAN J VET RES, V62, P245; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willart MAM, 2012, ALLERGY, V67, P1501, DOI 10.1111/all.12019; Xiao JF, 2012, J PROTEOME RES, V11, P5914, DOI 10.1021/pr300673x; Yang J, 2006, J PROTEOME RES, V5, P554, DOI 10.1021/pr050364w; Zhang L, 2012, MOL ENDOCRINOLOGY, V26; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572	55	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194488	10.1371/journal.pone.0194488	http://dx.doi.org/10.1371/journal.pone.0194488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621258	Green Published, gold			2022-12-27	WOS:000429206800020
J	Mccoy, VE; Soriano, C; Pegoraro, M; Luo, T; Boom, A; Foxman, B; Gabbott, SE				McCoy, Victoria E.; Soriano, Carmen; Pegoraro, Mirko; Luo, Ting; Boom, Arnoud; Foxman, Betsy; Gabbott, Sarah E.			Unlocking preservation bias in the amber insect fossil record through experimental decay	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; RESINS; INCLUSIONS; VOLATILE; PLANTS	Fossils entombed in amber are a unique resource for reconstructing forest ecosystems, and resolving relationships of modern taxa. Such fossils are famous for their perfect, life-like appearance. However, preservation quality is vast with many sites showing only cuticular preservation, or no fossils. The taphonomic processes that control this range are largely unknown; as such, we know little about potential bias in this important record. Here we employ actualistic experiments, using, fruit flies and modern tree resin to determine whether resin type, gut microbiota, and dehydration prior to entombment affects decay. We used solid phase microextraction gas chromatography-mass spectrometry (SPME GC-MS) to confirm distinct tree resin chemistry; gut microbiota of flies was modified using antibiotics and categorized though sequencing. Decay was assessed using phase contrast synchrotron tomography. Resin type demonstrates a significant control on decay rate. The composition of the gut microbiota was also influential, with minor changes in composition affecting decay rate. Dehydration prior to entombment, contrary to expectations, enhanced decay. Our analyses show that there is potential significant bias in the amber fossil record, especially between sites with different resin types where ecological completeness and preservational fidelity are likely affected.	[McCoy, Victoria E.; Boom, Arnoud; Gabbott, Sarah E.] Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England; [McCoy, Victoria E.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Soriano, Carmen] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Pegoraro, Mirko] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Pegoraro, Mirko] John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Luo, Ting; Foxman, Betsy] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Leicester; University of Bonn; United States Department of Energy (DOE); Argonne National Laboratory; University of Leicester; Liverpool John Moores University; University of Michigan System; University of Michigan	Mccoy, VE; Gabbott, SE (corresponding author), Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England.; Mccoy, VE (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	vmccoy@uni-bonn.de; sg21@ie.ac.uk		Boom, Arnoud/0000-0003-1299-691X; Pegoraro, Mirko/0000-0001-9381-5249; soriano, carmen/0000-0003-3963-3393	Royal Society Newton International Fellowship	Royal Society Newton International Fellowship	This research is supported by a Royal Society Newton International Fellowship (no grant number assigned) to Victoria E. McCoy; https:// royalsociety.org/grants-schemes-awards'grants/newton-international/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, U KANSAS PALAEONTOLO; Azar Dany, 2010, P271; Baratta M. T., 1998, Journal of Essential Oil Research, V10, P618; Beck CW, 1999, ESTUDIOS MUSEO CIENC, V14, P33; Bouzouita N, 2003, FLAVOUR FRAG J, V18, P380, DOI 10.1002/ffj.1200; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2016, PALAEONTOLOGY, V59, P1, DOI 10.1111/pala.12219; Broderick N, 2014, DROSOPHILA MELANOGAS; Butler AD, 2015, P R SOC B; COLEMAN ML, 1993, NATURE, V361, P436, DOI 10.1038/361436a0; Coty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104410; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Hamm S, 2004, J SEP SCI, V27, P235, DOI 10.1002/jssc.200301611; Hamm S, 2003, J CHROMATOGR A, V1018, P73, DOI 10.1016/j.chroma.2003.08.027; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; HENWOOD AA, 1992, PALAEONTOLOGY, V35, P901; Henwood Alison, 1993, Modern Geology, V19, P35; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Kirkman TW, STAT USE 1996; Kraemer MMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118820; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LABANDEIRA C.C., 2014, PALEONTOL SOC PAP, P163, DOI DOI 10.1017/S1089332600002850; Lambert JB, 2012, ARCHAEOMETRY, V54, P332, DOI 10.1111/j.1475-4754.2011.00625.x; Lambert J.B., 1995, ARCHAEOMETRY, V38, P325, DOI DOI 10.1111/j.1475-4754.1996.tb00780.x; Lambert JB, 2005, J NAT PROD, V68, P635, DOI 10.1021/np050005f; Lambert JB, 2002, ACCOUNTS CHEM RES, V35, P628, DOI 10.1021/ar0001970; Lambert JB, 2015, MAGN RESON CHEM, V53, P2, DOI 10.1002/mrc.4121; Lambert JB, 2008, ANGEW CHEM INT EDIT, V47, P9608, DOI 10.1002/anie.200705973; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; McCoy VE, 2017, EARTH ENV S IN PRESS; McCoy VE, ORGANIC GEO IN PRESS; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Penney D, 2005, PALAEOGEOGR PALAEOCL, V223, P1, DOI 10.1016/j.palaeo.2005.03.022; Penney D, 2002, PALEOBIOLOGY, V28, P389, DOI 10.1666/0094-8373(2002)028<0389:PODAPS>2.0.CO;2; Penney D, 2006, BIOL LETTERS, V2, P266, DOI 10.1098/rsbl.2006.0442; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot Vincent, 2010, P192; Poinar G, 2004, J PETROL GEOL, V27, P207, DOI 10.1111/j.1747-5457.2004.tb00054.x; Poinar George Jr., 2007, Journal of the Botanical Research Institute of Texas, V1, P449; POINAR GO, 1985, J BALTIC STUD, V16, P222, DOI 10.1080/01629778500000141; POINAR GO, 1982, SCIENCE, V215, P1241, DOI 10.1126/science.215.4537.1241; Raff EC, 2013, EVOL DEV, V15, P243, DOI 10.1111/ede.12028; Ross Andrew, 2010, P208; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sonibare OO, 2012, ORG GEOCHEM, V51, P55, DOI 10.1016/j.orggeochem.2012.08.003; Soriano C, 2010, CR PALEVOL, V9, P361, DOI 10.1016/j.crpv.2010.07.014; Stankiewicz BA, 1998, P ROY SOC B-BIOL SCI, V265, P641, DOI 10.1098/rspb.1998.0342; Stewart J. D., 1978, U KANSAS PALEONTOLOG, P9; Wilby P.R., 1992, Historical Biology, V6, P25; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493	56	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195482	10.1371/journal.pone.0195482	http://dx.doi.org/10.1371/journal.pone.0195482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621345	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000429206800092
J	Doyle, K; Levtov, RG; Barker, G; Bastian, GG; Bingenheimer, JB; Kazimbaya, S; Nzabonimpa, A; Pulerwitz, J; Sayinzoga, F; Sharma, V; Shattuck, D				Doyle, Kate; Levtov, Ruti G.; Barker, Gary; Bastian, Gautam G.; Bingenheimer, Jeffrey B.; Kazimbaya, Shamsi; Nzabonimpa, Anicet; Pulerwitz, Julie; Sayinzoga, Felix; Sharma, Vandana; Shattuck, Dominick			Gender-transformative Bandebereho couples' intervention to promote male engagement in reproductive and maternal health and violence prevention in Rwanda: Findings from a randomized controlled trial	PLOS ONE			English	Article							IMPACT; MEN	Background Rigorous evidence of the effectiveness of male engagement interventions, particularly on how these interventions impact relationship power dynamics and women's decision-making, remains limited. This study assessed the impact of the Bandebereho gender-transformative couples' intervention on impact on multiple behavioral and health-related outcomes influenced by gender norms and power relations. Methods We conducted a multi-site randomised controlled trial in four Rwandan districts with expectant/current fathers and their partners, who were randomised to the intervention (n = 575 couples) or control group (n = 624 couples). Primary outcomes include women's experience of physical and sexual IPV, women's attendance and men's accompaniment at ANC, modern contraceptive use, and partner support during pregnancy. At 21-months post-baseline, 1123 men and 1162 partners were included in intention to treat analysis. Generalized estimating equations with robust standard errors were used to fit the models. Findings The Bandebereho intervention led to substantial improvements in multiple reported outcomes. Compared to the control group, women in the intervention group reported: less past-year physical (OR 0.37, p<0.001) and sexual IPV (OR 0.34, p<0.001); and greater attendance (IRR 1.09, p<0.001) and male accompaniment at antenatal care (IRR 1.50, p<0.001); and women and men in the intervention group reported: less child physical punishment (women: OR 0.56, p = 0.001; men: OR 0.66, p = 0.005); greater modern contraceptive use (women: OR 1.53, p = 0.004; men: OR 1.65, p = 0.001); higher levels of men's participation in childcare and household tasks (women: beta 0.39, p<0.001; men: beta 0.33, p<0.001); and less dominance of men in decision-making. Conclusions Our study strengthens the existing evidence on male engagement approaches; together with earlier studies our findings suggest that culturally adapted gender-transformative interventions with men and couples can be effective at changing deeply entrenched gender inequalities and a range of health-related behavioral outcomes.	[Doyle, Kate; Levtov, Ruti G.; Barker, Gary] Promundo US, Washington, DC 20036 USA; [Bastian, Gautam G.] World Bank, Gender Innovat Lab, 1818 H St NW, Washington, DC 20433 USA; [Bingenheimer, Jeffrey B.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA; [Kazimbaya, Shamsi] Rwanda Mens Resource Ctr, Kigali, Rwanda; [Nzabonimpa, Anicet; Sayinzoga, Felix] Rwanda Minist Hlth, Rwanda Biomed Ctr, Maternal Child & Community Hlth Div, Kigali, Rwanda; [Pulerwitz, Julie] Populat Council, HIV & AIDS Program, Washington, DC USA; [Sharma, Vandana] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Shattuck, Dominick] Georgetown Univ, Inst Reprod Hlth, Washington, DC USA	The World Bank; George Washington University; Rwanda Biomedical Center; Population Council; Harvard University; Harvard T.H. Chan School of Public Health; Georgetown University	Levtov, RG (corresponding author), Promundo US, Washington, DC 20036 USA.	r.levtov@promundoglobal.org	Doyle, Kate/AAE-2424-2020	Doyle, Kate/0000-0001-9497-4831; Levtov, Ruti/0000-0002-7030-8786	Dutch Ministry of Foreign Affairs [24935]; John D. and Catherine T. MacArthur Foundation [13-103720-000-INP]; Dutch Ministry of Foreign Affairs; John D. and Catherine T. MacArthur Foundation;  [5669]	Dutch Ministry of Foreign Affairs; John D. and Catherine T. MacArthur Foundation; Dutch Ministry of Foreign Affairs; John D. and Catherine T. MacArthur Foundation; 	Funding was received from: Anonymous donor (No.5669); Dutch Ministry of Foreign Affairs (No.24935), https://www.government.nl/ministries/ministry-of-foreign-affairs; John D. and Catherine T. MacArthur Foundation (#13-103720-000-INP), https://www.macfound.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the men and women who participated in the Bandebereho trial and made this study possible. We are grateful to you for sharing your time with us. We thank the Bandebereho community facilitators in Karongi, Musanze, Nyaruguru and Rwamagana districts, for implementing the intervention and facilitating recruitment into the study. We also extend our thanks to the dedicated staff of RWAMREC who successfully designed and coordinated the MenCare+ project: Alice Uwera, Agnes Umutesi, Calvin Mugabo, Chantal Muhimpundu, Damascene Habimana, Denise Nikuze, Dominique Niyibizi, Edouard Munyamaliza, Emmanuel Karamage, Emmanuel Hanganimana, Fabien Ntagwabira, Francoise Uwumukiza, Gloria Mukankuranga, Gimu Ntayoberwa Shyikiro, Honore Usabimana, Jean Baptiste Nsengimana, Jean Paul Seruhungo Bizimana, Justine Mukamusinga, Moise Ngendahayo, Napoleon Nsanzimana, Phenias Mutabazi, Ruth Uwingabiye, and Sebastian Sebagenzi Bagula. Thank you to the Dutch Ministry of Foreign Affairs for funding the MenCare+ project, through which the Bandebereho intervention was adapted and implemented. Thank you to our partners at Rutgers for leading the MenCare+ project, and specifically to Rachel Ploem and Harald Kedde for their support on the study. We are grateful to the interviewers and staff at Laterite for their work collecting the data for this study. We thank Emily Fischer for all of her time and effort in support of this study. We thank Dr. Rachel Jewkes for her support and advice during the design of this study. A final thank you to our anonymous donor, the Dutch Ministry of Foreign Affairs, and the John D. and Catherine T. MacArthur Foundation for funding this study.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; [Anonymous], 2000, RWAND DEM HLTH SURV; Arango D., 2014, INTERVENTIONS REDUCE; Ashburn K, 2016, PREV SCI; Barker G., 2007, ENGAGING MEN BOYS CH; Barker G., 2011, EVOLVING MEN INITIAL; Brunie Aurelie, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe11, DOI 10.1016/j.ijgo.2013.07.005; Comrie-Thomson L, 2015, CULT HEALTH SEX, V17, pS177, DOI 10.1080/13691058.2015.1053412; Connell Raewyn., 2015, GENDER WORLD PERSPEC, V3rd ed.; Deutsch FM, 2007, GENDER SOC, V21, P106, DOI 10.1177/0891243206293577; Doyle K., 2014, Gender and Development, V22, P515, DOI 10.1080/13552074.2014.963326; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Ellsberg M, 2015, LANCET, V385, P1555, DOI 10.1016/S0140-6736(14)61703-7; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Government of Rwanda M of H, 2012, 3 HLTH SECT STRAT PL; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-339; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kunene B, 2004, INVOLVING MEN MATERN; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Lansford JE, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/672780; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; National Institute of Statistics of Rwanda Ministry of Finance and Economic Planning Ministry of Health The DHS Program ICF International, 2016, RWAND DEM HLTH SURV; Pafs J, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31482; Raj A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153190; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971; Virginia L, 2013, ENGAGING MEN FAMILY; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Watts C., 2001, PUTTING WOMENS SAFET; WHO, 2015, WHO REC HLTH PROM IN; Yargawa J, 2015, J EPIDEMIOL COMMUN H, V69, P604, DOI 10.1136/jech-2014-204784	33	86	86	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0192756	10.1371/journal.pone.0192756	http://dx.doi.org/10.1371/journal.pone.0192756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617375	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800004
J	Martens, RJH; van der Berg, JD; Stehouwer, CDA; Henry, RMA; Bosma, H; Dagnelie, PC; van Dongen, MCJM; Eussen, SJPM; Schram, MT; Sep, SJS; van der Kellen, CJH; Schaper, NC; Savelberg, HHCM; van der Sande, FM; Kroon, AA; Kooman, JP; Koster, A				Martens, Remy J. H.; van der Berg, Julianne D.; Stehouwer, Coen D. A.; Henry, Ronald M. A.; Bosma, Hans; Dagnelie, Pieter C.; van Dongen, Martien C. J. M.; Eussen, Simone J. P. M.; Schram, Miranda T.; Sep, Simone J. S.; van der Kellen, Carla J. H.; Schaper, Nicolaas C.; Savelberg, Hans H. C. M.; van der Sande, Frank M.; Kroon, Abraham A.; Kooman, Jeroen P.; Koster, Annemarie			Amount and pattern of physical activity and sedentary behavior are associated with kidney function and kidney damage: The Maastricht Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SITTING TIME; CARDIOVASCULAR-DISEASE; ESTIMATED GFR; RISK; ADULTS; MICROALBUMINURIA; METAANALYSIS; INACTIVITY; EXERCISE	Background Chronic kidney disease, which is defined as having a reduced kidney function (estimated glomerular filtration rate (eGFR)) and/or signs of kidney damage (albuminuria), is highly prevalent in Western society and is associated with adverse health outcomes, such as cardiovascular disease. This warrants a search for risk factors of lower eGFR and higher albuminuria. Physical activity and sedentary behavior may be such risk factors. Objective To examine associations of physical activity (total, high, low), sedentary time and sedentary behavior patterns (breaks, prolonged bouts, average bout duration) with eGFR and albuminuria. Methods We examined these associations in 2,258 participants of the Maastricht Study (average age 60.1 +/- 8.1 years; 51.3% men), who wore an accelerometer 24h/day on 7 consecutive days. Associations with continuous eGFR and categories of urinary albumin excretion (UAE; <15 [reference category], 15-<30, >= 30 mg/24h) were evaluated with linear regression analyses and multinomial logistic regression analyses, respectively. Results After adjustment for potential confounders, each extra hour of total physical activity was associated with a more favorable kidney function (beta(eGFR) = 2.30 (95%CI= 1.46; 3.14)), whereas each extra hour of sedentary behavior was associated with a more adverse kidney function (beta(eGFR) =-0.71 (-1.08;-0.35)). Also, compared to individuals with the lowest levels of total physical activity, individuals with the highest levels had less kidney damage (OR15-<30mg/24h = 0.63 (0.41; 0.96), OR >= 30mg/24h = 0.84 (0.53; 1.35). An extra hour of sedentary behavior was associated with more kidney damage (OR15-<30 mg/24h = 1.11 (1.01; 1.22), OR >= 30 mg/24h =1.10 (0.99; 1.22)). Further, a highly sedentary pattern was associated with a more adverse kidney function, but no association was seen with kidney damage. Conclusions Physical activity and sedentary behavior were associated with kidney function and kidney damage. Additionally, sedentary behavior patterns were associated with kidney function. Causal studies are required to examine whether this indeed implicates that prevention strategies should focus not only on increasing physical activity, but on reducing sedentary behavior as well.	[Martens, Remy J. H.; Stehouwer, Coen D. A.; Henry, Ronald M. A.; Schram, Miranda T.; Sep, Simone J. S.; van der Kellen, Carla J. H.; Schaper, Nicolaas C.; van der Sande, Frank M.; Kroon, Abraham A.; Kooman, Jeroen P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Martens, Remy J. H.; Savelberg, Hans H. C. M.; Kooman, Jeroen P.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [van der Berg, Julianne D.; Bosma, Hans; Koster, Annemarie] Maastricht Univ, Dept Social Med, Maastricht, Netherlands; [van der Berg, Julianne D.; Bosma, Hans; Dagnelie, Pieter C.; van Dongen, Martien C. J. M.; Eussen, Simone J. P. M.; Schaper, Nicolaas C.; Koster, Annemarie] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Stehouwer, Coen D. A.; Henry, Ronald M. A.; Dagnelie, Pieter C.; Eussen, Simone J. P. M.; Schram, Miranda T.; Sep, Simone J. S.; van der Kellen, Carla J. H.; Schaper, Nicolaas C.; Kroon, Abraham A.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Henry, Ronald M. A.; Schram, Miranda T.] Maastricht Univ, Med Ctr, Heart & Vasc Ctr, Maastricht, Netherlands; [Dagnelie, Pieter C.; van Dongen, Martien C. J. M.; Eussen, Simone J. P. M.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Savelberg, Hans H. C. M.] Maastricht Univ, Dept Human Movement Sci, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Martens, RJH (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands.; Martens, RJH (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	remy.martens@mumc.nl	Stehouwer, Coen/AAB-3435-2021; Bosma, Hans/A-6184-2013; eussen, simone/C-7851-2017; Koster, Annemarie/E-7438-2010; Schaper, Nicolaas C/E-7112-2014; Martens, Remy J.H./K-2765-2019; Savelberg, Hans/ABC-8946-2020	eussen, simone/0000-0003-0559-6838; Koster, Annemarie/0000-0003-1583-7391; Martens, Remy J.H./0000-0003-4632-6412; Savelberg, Hans/0000-0002-8864-2109; schaper, nicolaas/0000-0002-2128-8029; Kroon, Abraham/0000-0001-7750-8249; van der Kallen, Carla/0000-0003-1468-8793; Schram, Miranda/0000-0001-8113-7604; Stehouwer, Coen/0000-0001-8752-3223	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [31O.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); Cardiovascular Center (CVC, Maastricht, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands); NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands); Stichting Sint Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands); Fresenius Medical Care (Bad Homburg, Germany); European Union Seventh Framework Programme [PCIG09-GA-2011-293621]	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); Cardiovascular Center (CVC, Maastricht, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands)(Netherlands Government); NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands); Stichting Sint Annadal (Maastricht, the Netherlands)(Netherlands Government); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government); Fresenius Medical Care (Bad Homburg, Germany); European Union Seventh Framework Programme(European Commission)	The Maastricht Study was supported by the European Regional Development Fund via OP-Zuid; the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041); Stichting De Weijerhorst (Maastricht, the Netherlands); the Pearl String Initiative Diabetes (Amsterdam, the Netherlands); the Cardiovascular Center (CVC, Maastricht, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands); NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands); Stichting Sint Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands; unrestricted grant), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands; unrestricted grant); and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands; unrestricted grant). In addition, this study was supported by an unrestricted grant from Fresenius Medical Care (Bad Homburg, Germany). AK has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2011-CIG) under grant agreement PCIG09-GA-2011-293621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Altman DG, 1990, PRACTICAL STAT MED R, P143; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Bharakhada N, 2012, AM J KIDNEY DIS, V60, P583, DOI 10.1053/j.ajkd.2012.04.024; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Chawla H, 2016, J ARTHROPLASTY, P1; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Edwardson CL, 2016, MED SCI SPORTS EXERC; Finkelstein J, 2006, AM J KIDNEY DIS, V48, P372, DOI 10.1053/j.ajkd.2006.05.013; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Goessler K, 2015, HYPERTENS RES; Guo V, 2015, DIABETIC MED; Hawkins MS, 2011, MED SCI SPORT EXER, V43, P1457, DOI 10.1249/MSS.0b013e31820c0130; Henson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078350; Herber-Gast GCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133864; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Kelley GA, 2004, J WOMENS HEALTH, V13, P1148, DOI 10.1089/jwh.2004.13.1148; Kelley George A, 2006, J Mens Health Gend, V3, P61, DOI 10.1016/j.jmhg.2005.09.003; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Martens RJH, 2017, AM J KIDNEY DIS, V69, P179, DOI 10.1053/j.ajkd.2016.04.017; Martens RJH, 2016, J AM SOC NEPHROL, V27, P3748, DOI 10.1681/ASN.2015111219; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Padilla J, 2011, PHYSIOLOGY, V26, P132, DOI 10.1152/physiol.00052.2010; Restaino RM, 2015, EXP PHYSIOL, V100, P829, DOI 10.1113/EP085238; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Robinson ES, 2010, AM J EPIDEMIOL, V171, P515, DOI 10.1093/aje/kwp442; Robinson-Cohen C, 2014, J AM SOC NEPHROL, V25, P399, DOI 10.1681/ASN.2013040392; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Thosar SS, 2015, MED SCI SPORT EXER, V47, P843, DOI 10.1249/MSS.0000000000000479; Tonelli M, 2007, ANNU REV MED, V58, P123, DOI 10.1146/annurev.med.58.071105.111123; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; van der Berg JD, 2016, DIABETOLOGIA, V59, P709, DOI 10.1007/s00125-015-3861-8; White SL, 2011, NUTR METAB CARDIOVAS, V21, P104, DOI 10.1016/j.numecd.2009.08.010; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	46	27	27	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195306	10.1371/journal.pone.0195306	http://dx.doi.org/10.1371/journal.pone.0195306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617428	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800073
J	Yamaguchi, S; Horie, N; Morikawa, M; Tateishi, Y; Hiu, T; Morofuji, Y; Lzumo, T; Hayashi, K; Matsuo, T				Yamaguchi, Susumu; Horie, Nobutaka; Morikawa, Minoru; Tateishi, Yohei; Hiu, Takeshi; Morofuji, Yoichi; Lzumo, Tsuyoshi; Hayashi, Kentaro; Matsuo, Takayuki			Assessment of veins in T2*-weighted MR angiography predicts infarct growth in hyperacute ischemic stroke	PLOS ONE			English	Article							MULTIPLE HYPOINTENSE VESSELS; ENDOVASCULAR THROMBECTOMY; CEREBRAL-ISCHEMIA; PERFUSION; OCCLUSION; PENUMBRA; THROMBOLYSIS; METAANALYSIS; REPERFUSION; OUTCOMES	Background and purpose T2*-weighted magnetic resonance angiography (SWAN) detects hemodynamic insufficiency as hypointense areas in medullary or cortical veins. We therefore investigated whether SWAN can help predict ischemic penumbra-like lesions in patients with acute ischemic stroke (AIS). Materials and methods Magnetic resonance imaging (MRI) records including SWAN, diffusion-weighted imaging (DWI), and magnetic resonance angiography (MRA) of consecutive patients with major vessel occlusion within 6 h from AIS onset were analyzed. Acute recanalization was defined as an arterial occlusive lesion score of 2-3. A modified Alberta Stroke Program Early CT Score (mASPECTS) was used to evaluate ischemic areas revealed by SWAN and DWI. SWAN- and DWI-based mASPECTSs were calculated, and correlations between DWI SWAN mismatches with final infarct lesions or clinical outcomes were evaluated. Results Among the 35 patients included in this study, we confirmed cardioembolic stroke in 26, atherothrombotic stroke in 4, and unknown stroke etiology in 5. Overall, recanalization was achieved in 23 patients, who showed a higher follow-up DWI-based mASPECTS and lower modified Rankin Scale (mRS) score at 90 days than patients without recanalization. Initial SWAN- and follow-up DWI-based mASPECTSs were significantly higher for atherothrombotic stroke than for cardioembolic stroke. Of 12 patients without recanalization, DWI-SWAN mismatch was significantly correlated with infarct growth. Patients with recanalization showed no such correlation. In the assessment of clinical outcome, follow-up DWI-based mASPECTS and patient's age were significantly correlated with mRS at 90 days after stroke. A multivariate logistic regression analysis revealed that the follow-up DWI-based mASPECTS was independently associated with a favorable outcome 90 days after stroke. Conclusions For patients with AIS, DWI-SWAN mismatch might show penumbra-like lesions that would predict infarct growth without acute recanalization. Assessment of ischemic lesions from the venous side appears to be useful for considering the etiology and revascularization therapy.	[Yamaguchi, Susumu; Horie, Nobutaka; Hiu, Takeshi; Morofuji, Yoichi; Lzumo, Tsuyoshi; Hayashi, Kentaro; Matsuo, Takayuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki, Japan; [Morikawa, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol Sci, Nagasaki, Japan; [Tateishi, Yohei] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurol & Strokol, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Yamaguchi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki, Japan.	ssmymgc@gmail.com	Morofuji, Yoichi/AAB-1840-2021; Horie, Nobutaka/AAR-2778-2020; Tateishi, Yohei/X-7266-2019; Hiu, Takeshi/L-4334-2016	Morofuji, Yoichi/0000-0001-7135-2220; Tateishi, Yohei/0000-0002-7685-6396; Izumo, Tsuyoshi/0000-0001-8778-2698; Hiu, Takeshi/0000-0001-7090-1662; Horie, Nobutaka/0000-0002-0388-5188				Albers GW, 2018, N ENGL J MED; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; BARON JC, 1981, STROKE, V12, P454, DOI 10.1161/01.STR.12.4.454; Chen CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131118; Chen Y, 2007, BRAIN RES, V1166, P9, DOI 10.1016/j.brainres.2007.06.043; Cheng B, 2016, J NEUROIMAGING; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hartkamp NS, 2014, CURR OPIN NEUROL, V27, P42, DOI 10.1097/WCO.0000000000000051; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Horie N, 2016, J CLIN NEUROSCI, V32, P24, DOI 10.1016/j.jocn.2015.12.043; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Kawano H, 2012, J NEUROL, V259, P2045, DOI 10.1007/s00415-012-6446-1; Kawano H, 2010, CEREBROVASC DIS, V30, P230, DOI 10.1159/000317183; Kaya D, 2009, AM J NEURORADIOL, V30, P1227, DOI 10.3174/ajnr.A1537; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Langham MC, 2010, J AM COLL CARDIOL, V55, P598, DOI 10.1016/j.jacc.2009.08.068; Lansberg MG, 2008, STROKE, V39, P2491, DOI 10.1161/STROKEAHA.107.508572; Lee JM, 2003, ANN NEUROL, V53, P227, DOI 10.1002/ana.10433; Lou M, 2014, AM J NEURORADIOL, V35, P2061, DOI 10.3174/ajnr.A4017; Luo S, 2015, J NEURORADIOLOGY, V42, P255, DOI 10.1016/j.neurad.2014.07.002; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Park MG, 2014, CEREBROVASC DIS, V38, P254, DOI 10.1159/000367709; Parsons MW, 2010, J CEREBR BLOOD F MET, V30, P1214, DOI 10.1038/jcbfm.2010.3; Sanossian N, 2016, STROKE; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Shi ZS, 2014, STROKE, V45, P1977, DOI 10.1161/STROKEAHA.114.005603; Stampfl S, 2017, J NEUROINTERV SURG, V9, P346, DOI 10.1136/neurintsurg-2015-012208; Thijssen DHJ, 2006, AGING CELL, V5, P495, DOI 10.1111/j.1474-9726.2006.00242.x; TOYODA K, 1994, J NEUROL SCI, V121, P222, DOI 10.1016/0022-510X(94)90356-5; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Yamaguchi S, 2017, J CEREB BLOOD FLOW M	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195554	10.1371/journal.pone.0195554	http://dx.doi.org/10.1371/journal.pone.0195554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617449	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800092
J	Frohlich, L; Plontke, SK; Rahne, T				Froehlich, Laura; Plontke, Stefan K.; Rahne, Torsten			Influence of transducer types on bone conduction hearing thresholds	PLOS ONE			English	Article							ACOUSTIC RADIATION; VIBRATORS	Objective Different types of bone conduction transducers with different physical and electro-acoustic properties are available for audiometric hearing threshold measurements. The reference equivalent threshold vibratory force levels (RETVFL) specified in ISO 389-3 are based on measurements conducted with the B71 and KH70 transducers but apply to all types of transducers available for bone conduction audiometry. The objective of this study was to compare bone conduction hearing thresholds measured by different transducers. Design In a prospective study the hearing thresholds were measured psychometrically between 125 Hz and 8000 Hz using the Radioear B71, B81 and Pracitronic KH70 transducers. Study sample Twenty-one normal hearing participants and fifteen hearing impaired participants. Results In both groups significant differences were found between the thresholds measured with the different transducers at the low frequencies 125 Hz and 250 Hz and the high frequencies 3000 Hz, 4000 Hz, 6000 Hz and 8000 Hz. In the normal hearing group, deviations from the reference threshold 0 dB HL towards lower thresholds were observed for the B71 and B81 at 125 Hz and at the high frequencies 3000 Hz, 4000 Hz, 6000 Hz and 8000 Hz. Conclusions RETVFL-values should be reassessed and provided specifically for the different transducers.	[Froehlich, Laura; Plontke, Stefan K.; Rahne, Torsten] Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Saale, Halle, Germany	Martin Luther University Halle Wittenberg	Frohlich, L (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Saale, Halle, Germany.	laura.froehlich@uk-halle.de	Rahne, Torsten/AAD-1369-2021					Brinkmann K, 1983, AUDIOLOGICAL ACOUSTI, P114; DIRKS DD, 1979, J SPEECH HEAR DISORD, V44, P143, DOI 10.1044/jshd.4402.143; Eichenauer A, 2014, J ACOUST SOC AM, V136, pEL96, DOI 10.1121/1.4885771; Fagelson M, 1994, J Am Acad Audiol, V5, P379; FRANK T, 1986, EAR HEARING, V7, P344, DOI 10.1097/00003446-198610000-00010; FRANK T, 1981, EAR HEARING, V2, P59, DOI 10.1097/00003446-198103000-00001; FRANK T, 1988, J SPEECH HEAR DISORD, V53, P295, DOI 10.1044/jshd.5303.295; Harkrider A W, 1998, J Am Acad Audiol, V9, P410; IEC, 2001, EL AUD EQ 1; ISO, 2016, 3893 ISO; ISO, 2011, 82531 ISO; Jansson KJF, 2015, INT J AUDIOL, V54, P334, DOI 10.3109/14992027.2014.980521; Margolis RH, 2016, EAR HEARING, V37, P177, DOI 10.1097/AUD.0000000000000246; RICHTER U, 1981, SCAND AUDIOL, V10, P235, DOI 10.3109/01050398109076186; Richter U., 1992, KENNDATEN SCHALLWAND; ROBINSON DW, 1982, AUDIOLOGY, V21, P61; Sauer U, 1976, VERKEHRSMEDIZIN, P143; Shipton M S, 1980, Br J Audiol, V14, P86, DOI 10.3109/03005368009078908; STUDEBAKER GA, 1967, J SPEECH HEAR DISORD, V32, P82, DOI 10.1044/jshd.3201.82	19	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195233	10.1371/journal.pone.0195233	http://dx.doi.org/10.1371/journal.pone.0195233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641550	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900062
J	Gentile, D; Fornai, M; Colucci, R; Pellegrini, C; Tirotta, E; Benvenuti, L; Segnani, C; Ippolito, C; Duranti, E; Virdis, A; Carpi, S; Nieri, P; Nemeth, ZH; Pistelli, L; Bernardini, N; Blandizzi, C; Antonioli, L				Gentile, Daniela; Fornai, Matteo; Colucci, Rocchina; Pellegrini, Carolina; Tirotta, Erika; Benvenuti, Laura; Segnani, Cristina; Ippolito, Chiara; Duranti, Emiliano; Virdis, Agostino; Carpi, Sara; Nieri, Paola; Nemeth, Zoltan H.; Pistelli, Laura; Bernardini, Nunzia; Blandizzi, Corrado; Antonioli, Luca			The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity	PLOS ONE			English	Article							MOUSE MODEL; NEUROMUSCULAR-TRANSMISSION; OXIDATIVE STRESS; BOWEL-DISEASE; INHIBITION; COLITIS	Background and purpose Apigenin can exert beneficial actions in the prevention of obesity. However, its putative action on obesity-associated bowel motor dysfunctions is unknown. This study examined the effects of apigenin on colonic inflammatory and motor abnormalities in a mouse model of diet-induced obesity. Experimental approach Male C57BL/6J mice were fed with standard diet (SD) or high-fat diet (HFD). SD or HFD mice were treated with apigenin (10 mg/Kg/day). After 8 weeks, body and epididymal fat weight, as well as cholesterol, triglycerides and glucose levels were evaluated. Malondialdehyde (MDA), IL-1 beta and IL-6 levels, and let-7f expression were also examined. Colonic infiltration by eosinophils, as well as substance P (SP) and inducible nitric oxide synthase (iNOS) expressions were evaluated. Motor responses elicited under blockade of NOS and tachykininergic contractions were recorded in vitro from colonic longitudinal muscle preparations. Key results When compared to SD mice, HFD animals displayed increased body weight, epididymal fat weight and metabolic indexes. HFD mice showed increments in colonic MDA, IL-1 beta and IL-6 levels, as well as a decrease in let-7f expression in both colonic and epididymal tissues. HFD mice displayed an increase in colonic eosinophil infiltration. Immunohistochemistry revealed an increase in SP and iNOS expression in myenteric ganglia of HFD mice. In preparations from HFD mice, electrically evoked contractions upon NOS blockade or mediated by tachykininergic stimulation were enhanced. In HFD mice, Apigenin counteracted the increase in body and epididymal fat weight, as well as the alterations of metabolic indexes. Apigenin reduced also MDA, IL-1 beta and IL-6 colonic levels as well as eosinophil infiltration, SP and iNOS expression, along with a normalization of electrically evoked tachykininergic and nitrergic contractions. In addition, apigenin normalized let-7f expression in epididymal fat tissues, but not in colonic specimens. Conclusions and implications Apigenin prevents systemic metabolic alterations, counteracts enteric inflammation and normalizes colonic dysmotility associated with obesity.	[Gentile, Daniela; Fornai, Matteo; Pellegrini, Carolina; Tirotta, Erika; Benvenuti, Laura; Segnani, Cristina; Ippolito, Chiara; Duranti, Emiliano; Virdis, Agostino; Bernardini, Nunzia; Blandizzi, Corrado; Antonioli, Luca] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Colucci, Rocchina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Carpi, Sara; Nieri, Paola] Univ Pisa, Dept Pharm, Pisa, Italy; [Nieri, Paola; Pistelli, Laura; Bernardini, Nunzia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Pistelli, Laura] Univ Pisa, DAFE, Pisa, Italy	University of Pisa; University of Padua; University of Pisa; University of Pisa; Atlantic Health System; University of Pisa	Fornai, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	mfornai74@gmail.com	Nieri, Paola/K-5814-2016; Bernardini, Nunzia/AAC-4602-2021; Pistelli, Laura/H-3070-2011; Blandizzi, Corrado/AAB-8736-2019; Virdis, Agostino/K-5315-2016; carpi, sara/AAG-7683-2021; Pellegrini, Carolina/ABE-3462-2021	Pistelli, Laura/0000-0002-3943-2797; Pellegrini, Carolina/0000-0003-2644-5430; FORNAI, MATTEO/0000-0002-0812-3959; BERNARDINI, NUNZIA/0000-0001-9061-9402; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; Benvenuti, Laura/0000-0001-6576-5053; BLANDIZZI, CORRADO/0000-0001-9927-5386	University of Pisa [PRA_2016_20]	University of Pisa	The present research program has been supported by the PRA_2016_20 granted by the University of Pisa (CB).	Al Mushref M, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.11.01; Anitha M, 2016, CELL MOL GASTROENTER, V2, P328, DOI 10.1016/j.jcmgh.2015.12.008; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2017, PURINERG SIGNAL, V13, P497, DOI 10.1007/s11302-017-9577-0; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; Bhattarai Y, 2016, AM J PHYSIOL-GASTR L, V311, pG210, DOI 10.1152/ajpgi.00085.2016; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Bouchoucha M, 2015, OBES SURG, V25, P2143, DOI 10.1007/s11695-015-1679-6; Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; Chapman CG, 2015, THER ADV GASTROENTER, V8, P4, DOI 10.1177/1756283X14547360; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Choi JS, 2014, FOOD CHEM TOXICOL, V64, P27, DOI 10.1016/j.fct.2013.11.020; Choi M. S., 2016, NUTRIENTS, V8; Clere Nicolas, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P62; Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170; Della Vedova MC, 2016, NUTR METAB INSIGHTS, V9, P93, DOI 10.4137/NMI.S32907; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017; Fornai M, 2014, BRIT J PHARMACOL, V171, P3728, DOI 10.1111/bph.12733; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Ho Wayne, 2008, Gastroenterol Hepatol (N Y), V4, P572; Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569; Ippolito C, 2015, J CELL MOL MED, V19, P485, DOI 10.1111/jcmm.12428; Kang X, 2016, CLIN SCI, V130, P1257, DOI 10.1042/CS20160192; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Laurila A, 2001, ARTERIOSCL THROM VAS, V21, P991, DOI 10.1161/01.ATV.21.6.991; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Moya-Perez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126976; Myoung HJ, 2010, ARCH PHARM RES, V33, P1741, DOI 10.1007/s12272-010-1105-5; Neunlist M, 2003, GUT, V52, P84, DOI 10.1136/gut.52.1.84; Olivo-Marston SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094765; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Patel D, 2007, INT J ONCOL, V30, P233; Pellegrini C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0608-5; Pendyala S, 2011, AM J CLIN NUTR, V93, P234, DOI 10.3945/ajcn.110.002683; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Ridha M, 2015, HYPERTENSION, V65, P949, DOI 10.1161/HYPERTENSIONAHA.114.04926; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Shang HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154373; Soares A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0228-z; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Sung TS, 2006, J VET SCI, V7, P143, DOI 10.4142/jvs.2006.7.2.143; ter Beek WP, 2007, NEUROPEPTIDES, V41, P301, DOI 10.1016/j.npep.2007.05.002; Van Crombruggen K, 2008, EUR J PHARMACOL, V579, P337, DOI 10.1016/j.ejphar.2007.10.021; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27	54	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195502	10.1371/journal.pone.0195502	http://dx.doi.org/10.1371/journal.pone.0195502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641549	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900072
J	Samuelsen, S; Jorgensen, CD; Mellins, ED; Torok, KS; Astakhova, K				Samuelsen, Simone; Jorgensen, Christian Damsgaard; Mellins, Elizabeth D.; Torok, Kathryn S.; Astakhova, Kira			Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens	PLOS ONE			English	Article							LOCKED NUCLEIC-ACIDS; IN-VIVO; DISEASE; APTAMERS; CHILDHOOD	In this study, we developed a series of synthetic oligonucleotides that allowed us to investigate the details on the antigen recognition by autoimmune antibodies in localized scleroderma subjects. Besides dramatically improved analytical specificity of the assay, our data suggests a potential linking for antibodies to DNA to the biological status of disease state in localized scleroderma. Moreover, introducing chemical modifications into short synthetic deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules completely changed the binding titers of corresponding antibodies and their clinical relevance. The strongest observed effect was registered for the localized scleroderma skin damage index (LoSDI) on the IgG antibodies to TC dinucleotide-rich double-stranded antigen (p < 0.001). In addition to providing valuable tools for diagnosis of clinically relevant biomarkers, we believe that this work opens up new opportunities for research on antibodies to nucleic acids in localized scleroderma and other autoimmune diseases.	[Samuelsen, Simone; Astakhova, Kira] Tech Univ Denmark, Dept Chem, Lyngby, Region Hovedsta, Denmark; [Jorgensen, Christian Damsgaard] Univ Southern Denmark, Dept Math & Comp Sci, Odense, Region Syddanma, Denmark; [Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Torok, Kathryn S.] Univ Pittsburgh, Dept Pediat, Div Rheumatol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Technical University of Denmark; University of Southern Denmark; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Astakhova, K (corresponding author), Tech Univ Denmark, Dept Chem, Lyngby, Region Hovedsta, Denmark.	kiraas@kemi.dtu.dk	Torok, Kathryn/AAI-5810-2020; Astakhova, Kira/D-1432-2014	Torok, Kathryn/0000-0002-1662-143X; Jorgensen, Christian Damsgaard/0000-0002-8425-8388; Mellins, Elizabeth/0000-0003-2577-139X; Astakhova, Kira/0000-0003-4878-0301	Villum Foundation [13152]	Villum Foundation(Villum Fonden)	This work was supported by the Villum Foundation, grant no. 13152; URL: http://veluxfoundations.dk/en. None of the individuals employed or contracted by the funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2017, WORLD J GASTROENTERO, V23, P1345, DOI 10.3748/wjg.v23.i8.1345; [Anonymous], 2021, LANG ENV STAT COMP; Arkachaisri T, 2010, RHEUMATOLOGY, V49, P373, DOI 10.1093/rheumatology/kep361; Arkachaisri T, 2009, J RHEUMATOL, V36, P2819, DOI 10.3899/jrheum.081284; Arkachaisri T, 2008, J RHEUMATOL, V35, P2439, DOI 10.3899/jrheum.080098; Bonat WH, 2016, J R STAT SOC C-APPL, V65, P649, DOI 10.1111/rssc.12145; Cao QH, 2008, DNA CELL BIOL, V27, P91, DOI 10.1089/dna.2007.0633; Careta MF, 2015, AN BRAS DERMATOL, V90, P62, DOI 10.1590/abd1806-4841.20152890; Castro C, 2010, J ALLERGY CLIN IMMUN, V125, pS238, DOI 10.1016/j.jaci.2009.09.041; Chang T-C, 2011, Fluorescent carbazole compounds for cancer diagnosis, Patent No. [EP2319842, 6001657, 6,001,657]; FALANGA V, 1987, ARCH DERMATOL, V123, P350, DOI 10.1001/archderm.123.3.350; FALANGA V, 1986, ANN INTERN MED, V104, P849, DOI 10.7326/0003-4819-104-6-849; Jorgensen B, 2004, SCAND J STAT, V31, P93, DOI 10.1111/j.1467-9469.2004.00375.x; KIKUCHI K, 1994, ARCH DERMATOL, V130, P1269, DOI 10.1001/archderm.130.10.1269; Kumar Y, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-1; Kurzinski K, 2014, ARTHRITIS RHEUM, V66, pS1324; Lakhin AV, 2013, ACTA NATURAE, V5, P34, DOI 10.32607/20758251-2013-5-4-34-43; Leitenberger JJ, 2009, ARCH DERMATOL, V145, P545, DOI 10.1001/archdermatol.2009.79; Nezlin R, 2016, MOL IMMUNOL, V70, P149, DOI 10.1016/j.molimm.2015.12.009; Pavlovic M, 2010, AUTOIMMUN DIS, V2010, DOI 10.4061/2010/462841; Pisetsky DS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3282; Radice A, 2006, AUTOIMMUNITY, V39, P113, DOI 10.1080/08916930500448422; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; Romero-Lopez C, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010032; Samuelsen SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35827; SATO S, 1994, J AM ACAD DERMATOL, V31, P567, DOI 10.1016/S0190-9622(94)70217-9; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Takehara K, 2005, RHEUMATOLOGY, V44, P274, DOI 10.1093/rheumatology/keh487; TAKEHARA K, 1983, ARTHRITIS RHEUM, V26, P612, DOI 10.1002/art.1780260506; Torok KS, 2012, PEDIATR CLIN N AM, V59, P381, DOI 10.1016/j.pcl.2012.03.011; Weibel L, 2011, BRIT J DERMATOL, V165, P1308, DOI 10.1111/j.1365-2133.2011.10600.x; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; ZOUALI M, 1986, J CLIN INVEST, V78, P1173, DOI 10.1172/JCI112699; Zulian F, 2005, ARTHRITIS RHEUM-US, V52, P2873, DOI 10.1002/art.21264	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195381	10.1371/journal.pone.0195381	http://dx.doi.org/10.1371/journal.pone.0195381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641558	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900067
J	Bhat, A; Mishra, S; Kaul, S; Dhar, MK				Bhat, Archana; Mishra, Sonal; Kaul, Sanjana; Dhar, Manoj K.			Elucidation and functional characterization of CsPSY and CsUGT promoters in Crocus sativus L.	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CAROTENOID METABOLISM; GENE-EXPRESSION; STRESS; SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; REGULATOR	The dried stigmas of Crocus sativus constitute the saffron, which is considered to be the costliest spice of the world. Saffron is valuable for its constituents, which are mainly apocarotenoids. In order to enhance the production of apocarotenoids, it is imperative to understand the regulation of apocarotenoid biosynthetic pathway. In C. sativus, although the pathway has been elucidated, the information regarding the regulation of the pathwaygenes is scanty. During the present investigation, the characterization of promoters regulating the expression of two important genes i.e. CsPSY and CsUGT was performed. We successfully cloned the promoters of both the genes, which were functionally characterized in Crocus sativus and Nicotiana tabaccum. In silico analysis of the promoters demonstrated the presence of several important cis regulatory elements responding tolight, hormonesand interaction with transcription factors (TFs). Further analysis suggested the regulation of CsPSY promoter by Abscisic acid (ABA) and that of CsUGT by Gibberellic acid (GA). In addition, we also observed ABA and GA mediated modulation in the expression of significant TFs and CsPSY and CsUGTtranscripts. Overall, the study addresses issues related to regulation of key genes of apocarotenoid pathway in C.sativus.	[Bhat, Archana; Mishra, Sonal; Kaul, Sanjana; Dhar, Manoj K.] Univ Jammu, Sch Biotechnol, Genome Res Lab, Jammu, India	University of Jammu	Dhar, MK (corresponding author), Univ Jammu, Sch Biotechnol, Genome Res Lab, Jammu, India.	manojkdhar@rediffmail.com		Bhat, Archana/0000-0002-6054-0979; Mishra, Dr. Sonal/0000-0003-0727-6520	Department of Biotechnology, Ministry of Science and Technology [BT/PR5397/PBD/16/974/2012]	Department of Biotechnology, Ministry of Science and Technology	This work was supported by the Department of Biotechnology, Ministry of Science and Technology: BT/PR5397/PBD/16/974/2012 to MKD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ruiz-Sola MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090765; Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Ashraf N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0423-7; Bhattacharjee P, 2017, PLANT MOL BIOL, V93, P511, DOI 10.1007/s11103-016-0579-z; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Dhar MK, 2017, PLANT PHYSIOL, V165, P277; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Feng HZ, 2006, PLANT PHYSIOL, V140, P1345, DOI 10.1104/pp.105.074138; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Gomez-Gornez L, 2012, J PLANT PHYSIOL, V169, P509, DOI 10.1016/j.jplph.2011.11.021; Jain M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22456; Kumar P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00477; Leoni C, 2011, FEBS J, V278, P3953, DOI 10.1111/j.1742-4658.2011.08307.x; Li F, 2009, PLANT PHYSIOL, V147, P1334; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Lu SW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01367; Mandal A, 2018, FUNCT INTEGR GENOMIC, V18, P101, DOI 10.1007/s10142-017-0578-4; Mandal A, 2015, PLANT SCI, V241, P221, DOI 10.1016/j.plantsci.2015.10.008; Mishra S, 2015, PLANT MOL BIOL, V89, P173, DOI 10.1007/s11103-015-0361-7; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; Ordoudi SA, 2004, PRODUCTION PRACTICES AND QUALITY ASSESSMENT OF FOOD CROPS, VOL 1: PREHARVEST PRACTICE, P209; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Renau-Morata B, 2012, IND CROP PROD, V39, P40, DOI 10.1016/j.indcrop.2012.02.009; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Salwee Yasmin, 2013, African Journal of Agricultural Research, V8, P234; Tao NG, 2007, PLANT CELL REP, V26, P837, DOI 10.1007/s00299-006-0289-0; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Wang T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01121; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Zeng WF, 2013, PLANT MOL BIOL REP, V31, P64, DOI 10.1007/s11105-012-0477-8	40	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195348	10.1371/journal.pone.0195348	http://dx.doi.org/10.1371/journal.pone.0195348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634744	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200028
J	Velho, ALC; Menezes, E; Dinh, T; Kaya, A; Topper, E; Moura, AA; Memili, E				Velho, Ana Luiza Cazaux; Menezes, Erika; Thu Dinh; Kaya, Abdullah; Topper, Einko; Moura, Arlindo Alencar; Memili, Erdogan			Metabolomic markers of fertility in bull seminal plasma	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PRODUCER-RECORDED DATA; BOAR SPERMATOZOA; MALE-INFERTILITY; SPERM MOTILITY; GC-MS; GENETIC SELECTION; DIFFERENT FORMS; HEALTH TRAITS; AMINO-ACIDS	Metabolites play essential roles in biological systems, but detailed identities and significance of the seminal plasma metabolome related to bull fertility are still unknown. The objectives of this study were to determine the comprehensive metabolome of seminal plasma from Holstein bulls and to ascertain the potential of metabolites as biomarkers of bull fertility. The seminal plasma metabolome from 16 Holstein bulls with two fertility rates were determined by gas chromatography-mass spectrometry (GC-MS). Multivariate and univariate analyses of the data were performed, and the pathways associated with the seminal plasma metabolome were identified using bioinformatics approaches. Sixty-three metabolites were identified in the seminal plasma of all bulls. Fructose was the most abundant metabolite in the seminal fluid, followed for citric acid, lactic acid, urea and phosphoric acid. Androstenedione, 4-ketoglucose, D-xylofuranose, 2-oxoglutaric acid and erythronic acid represented the least predominant metabolites. Partial-Least Squares Discriminant Analysis (PLSDA) revealed a distinct separation between high and low fertility bulls. The metabolites with the greatest Variable Importance in Projection score (VIP > 2) were 2-oxoglutaric acid and fructose. Heat-map analysis, based on VIP score, and univariate analysis indicated that 2-oxoglutaric acid was less (P = 0.02); whereas fructose was greater (P = 0.02) in high fertility than in low fertility bulls. The current study is the first to describe the metabolome of bull seminal plasma using GC-MS and presented metabolites such as 2-oxoglutaric acid and fructose as potential biomarkers of bull fertility.	[Velho, Ana Luiza Cazaux; Menezes, Erika; Thu Dinh; Memili, Erdogan] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Velho, Ana Luiza Cazaux; Moura, Arlindo Alencar] Univ Fed Ceara, Dept Anim Sci, Fortaleza, Ceara, Brazil; [Kaya, Abdullah; Topper, Einko] Alta Genet Inc, Watertown, WI USA; [Kaya, Abdullah] Selcuk Univ, Dept Reprod & Artificial Inseminat, Konya, Turkey	Mississippi State University; Universidade Federal do Ceara; Selcuk University	Memili, E (corresponding author), Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA.	em149@ads.msstate.edu	Memili, Erdogan/AAY-8726-2020; MOURA, ARLINDO A/P-6697-2018	Memili, Erdogan/0000-0002-8335-5645; MOURA, ARLINDO A/0000-0002-8271-5733; Dinh, Thu/0000-0001-5416-4949	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA) [2017-67016-26507]; Mississippi Agricultural Experiment Station; Alta Genetics Inc.; Hatch project from the USDA NIFA [1005778]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA); Mississippi Agricultural Experiment Station; Alta Genetics Inc.; Hatch project from the USDA NIFA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2017-67016-26507 from the USDA National Institute of Food and Agriculture (NIFA). Partial funding was also provided by Mississippi Agricultural Experiment Station, Alta Genetics Inc., Hatch project under accession number 1005778 from the USDA NIFA, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil. A. Velho and E. Menezes were funded by competitive fellowships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil.	ALHAKIM MK, 1970, J DAIRY SCI, V53, P84, DOI 10.3168/jds.S0022-0302(70)86152-5; ANAND SR, 1973, J REPROD FERTIL, V32, P97, DOI 10.1530/jrf.0.0320097; BARONOS S, 1971, J REPROD FERTIL, V24, P303, DOI 10.1530/jrf.0.0240303; Bieniek JM, 2016, ASIAN J ANDROL, V18, P426, DOI 10.4103/1008-682X.175781; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bromfield JJ, 2016, REPRODUCTION, V152, pR223, DOI 10.1530/REP-16-0313; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chang YM, 2004, ANIM SCI, V79, P355, DOI 10.1017/S1357729800090226; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; de Oliveira RV, 2013, REPRODUCTION, V146, P263, DOI 10.1530/REP-12-0399; Deepinder F, 2007, EXPERT REV MOL DIAGN, V7, P351, DOI 10.1586/14737159.7.4.351; DILLS WL, 1981, BIOL REPROD, V25, P458, DOI 10.1095/biolreprod25.3.458; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Einarsson S, 1971, Acta Vet Scand Suppl, V36, P1; Fernandez-Gago R, 2013, THERIOGENOLOGY, V80, P400, DOI 10.1016/j.theriogenology.2013.05.003; Feugang JM, 2010, REPROD BIOMED ONLINE, V21, P312, DOI 10.1016/j.rbmo.2010.06.022; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Forero-Gonzalez RA, 2012, ANDROLOGIA, V44, P154, DOI 10.1111/j.1439-0272.2010.01154.x; Gilany K, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3931; Gilany K, 2014, MOL REPROD DEV, V81, P84, DOI 10.1002/mrd.22284; Gonzalez-Cadavid V, 2014, THERIOGENOLOGY, V82, P697, DOI [10.1016/j.theriogenology.2014.05.024, 10.1016/j.theriogen]; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; GRAHAM EF, 1967, CRYOBIOLOGY, V4, P75, DOI 10.1016/S0011-2240(67)80214-1; Hamamah S, 1998, HUM REPROD, V13, P132, DOI 10.1093/humrep/13.1.132; HAMAMAH S, 1993, J REPROD FERTIL, V97, P51; Han Y, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0454-6; Holden SA, 2017, THERIOGENOLOGY, V87, P221, DOI 10.1016/j.theriogenology.2016.08.024; Jayaraman V, 2014, J ASSIST REPROD GEN, V31, P1195, DOI 10.1007/s10815-014-0282-4; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; KAMP G, 1995, BBA-GEN SUBJECTS, V1243, P101, DOI 10.1016/0304-4165(94)00117-G; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; KING TE, 1959, PROC R SOC SER B-BIO, V151, P226, DOI 10.1098/rspb.1959.0061; Kovac JR, 2013, FERTIL STERIL, V99, P998, DOI 10.1016/j.fertnstert.2013.01.111; Kumar A, 2015, MOL REPROD DEV, V82, P123, DOI 10.1002/mrd.22450; Kwon WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15654; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Li YH, 2014, MOL MED REP, V9, P305, DOI 10.3892/mmr.2013.1793; Liberda J, 2001, FOLIA BIOL-PRAGUE, V47, P113; MANN T, 1946, BIOCHEM J, V40, P481, DOI 10.1042/bj0400481; Marin S, 2003, FEBS LETT, V554, P342, DOI 10.1016/S0014-5793(03)01185-2; Matsuoka T, 2006, J REPROD DEVELOP, V52, P805, DOI 10.1262/jrd.18039; MENDOZA G, 1989, THERIOGENOLOGY, V32, P455, DOI 10.1016/0093-691X(89)90012-5; Moce E, 2008, ANIM REPROD SCI, V105, P104, DOI 10.1016/j.anireprosci.2007.11.016; MOORE HDM, 1977, J REPROD FERTIL, V50, P349, DOI 10.1530/jrf.0.0500349; Moura AA, 2007, MOL REPROD DEV, V74, P214, DOI 10.1002/mrd.20590; Moura AA, 2006, J ANDROL, V27, P534, DOI 10.2164/jandrol.05201; Munoz M, 2014, METABOLOMICS, V10, P443, DOI 10.1007/s11306-013-0587-9; Newairy ASA, 2009, FOOD CHEM TOXICOL, V47, P1093, DOI 10.1016/j.fct.2009.01.032; Nielsen NI, 2004, ANIM FEED SCI TECH, V115, P191, DOI 10.1016/j.anifeedsci.2004.03.008; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Paiva C, 2015, ANDROLOGY-US, V3, P496, DOI 10.1111/andr.12027; Papp G, 1983, Int Urol Nephrol, V15, P195, DOI 10.1007/BF02085452; Patel AB, 1999, ANAL BIOCHEM, V266, P205, DOI 10.1006/abio.1998.2888; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Paventi G, 2015, BIOCHEM BIOPH RES CO, V462, P257, DOI 10.1016/j.bbrc.2015.04.128; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Petherick JC, 2005, APPL ANIM BEHAV SCI, V90, P185, DOI 10.1016/j.applanim.2004.08.021; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qiao SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181115; Rego JPA, 2014, ANIM REPROD SCI, V148, P1, DOI 10.1016/j.anireprosci.2014.04.016; Sangeeta S, 2015, ANIM REPROD SCI, V161, P82, DOI 10.1016/j.anireprosci.2015.08.008; Shi ST, 2015, ANAL METHODS-UK, V7, P1751, DOI 10.1039/c4ay02477j; Soggiu A, 2013, MOL BIOSYST, V9, P1188, DOI 10.1039/c3mb25494a; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SRIVASTAVA A, 1984, ANDROLOGIA, V16, P265; Tang B, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12744; TULI RK, 1994, THERIOGENOLOGY, V42, P547, DOI 10.1016/0093-691X(94)90692-C; VANDERHORST CJ, 1970, EXPERIENTIA, V26, P249, DOI 10.1007/BF01900073; VANDERHORST CJG, 1979, TIJDSCHR DIERGENEESK, V104, P97; Vilagran I, 2015, ANDROLOGY-US, V3, P345, DOI 10.1111/andr.12009; Wennemuth G, 2001, ANDROLOGIA, V33, P43, DOI 10.1046/j.1439-0272.2001.00370.x; Westfalewicz B, 2017, J DAIRY SCI, V100, P2282, DOI 10.3168/jds.2016-11866; Williams AC, 2001, J ANDROL, V22, P680; WILLIAMS J, 1990, FUND APPL TOXICOL, V15, P651, DOI 10.1016/0272-0590(90)90182-J; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034524; Yoon SJ, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0128-2; Yoon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152690; Yousef MI, 2005, TOXICOLOGY, V215, P97, DOI 10.1016/j.tox.2005.06.025; Zhang XL, 2015, CLIN CHIM ACTA, V450, P254, DOI 10.1016/j.cca.2015.09.001; Zhou XY, 2016, TALANTA, V147, P82, DOI 10.1016/j.talanta.2015.09.040; Zwald NR, 2004, J DAIRY SCI, V87, P4295, DOI 10.3168/jds.S0022-0302(04)73574-2; Zwald NR, 2004, J DAIRY SCI, V87, P4287, DOI 10.3168/jds.S0022-0302(04)73573-0	89	56	60	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195279	10.1371/journal.pone.0195279	http://dx.doi.org/10.1371/journal.pone.0195279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634739	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200027
J	Takeda, Y; Akiyoshi, T; Matsueda, K; Fukuoka, H; Ogura, A; Miki, H; Hiyoshi, Y; Nagasaki, T; Konishi, T; Fujimoto, Y; Fukunaga, Y; Ueno, M				Takeda, Yasuhiro; Akiyoshi, Takashi; Matsueda, Kiyoshi; Fukuoka, Hironori; Ogura, Atsushi; Miki, Hisanori; Hiyoshi, Yukiharu; Nagasaki, Toshiya; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Fukunaga, Yosuke; Ueno, Masashi			Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy	PLOS ONE			English	Article							LONG-TERM OUTCOMES; COLORECTAL-CANCER; PANCREATIC ADENOCARCINOMA; CLINICAL-IMPLICATIONS; CURATIVE RESECTION; SARCOPENIA; CACHEXIA; IMPACT; COMPLICATIONS; PREDICTOR	Background The impact of body composition on the short- or long-term outcomes of patients with surgically treated advanced rectal cancer after neoadjuvant chemoradiotherapy remains unclear. This study examined the correlation between low skeletal muscle mass and morbidity and survival in patients with advanced lower rectal cancer. Methods We enrolled 144 clinical stage II/III patients with advanced lower rectal cancer who underwent neoadjuvant chemoradiotherapy followed by curative resection between 2004 and 2011. The cross-sectional skeletal muscle area at the third lumbar vertebra (L3) level was evaluated by computed tomography before chemoradiotherapy, and this was normalized by the square of the height to obtain the skeletal muscle index. Low skeletal muscle mass was defined as the sex-specific lowest quartile of the L3 skeletal muscle index. The association between low skeletal muscle mass and morbidity, relapse-free survival, or overall survival was assessed. Results Low skeletal muscle mass was identified in 37 (25.7%) patients. Age and body mass index were associated with low skeletal muscle mass. By multivariate analysis, we found that low skeletal muscle mass was independently associated with poor overall survival (hazard ratio = 2.93; 95%CI: 1.11-7.71; p = 0.031) and relapse-free survival (hazard ratio = 2.15; 95%CI: 1.06-4.21; p = 0.035), but was not associated with the rate of postoperative complications. Conclusions Low skeletal muscle mass is an independent negative prognostic factor for relapse-free and overall survival in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.	[Takeda, Yasuhiro; Akiyoshi, Takashi; Fukuoka, Hironori; Ogura, Atsushi; Miki, Hisanori; Hiyoshi, Yukiharu; Nagasaki, Toshiya; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Fukunaga, Yosuke; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr, Tokyo, Japan; [Matsueda, Kiyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Diagnost Imaging, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Akiyoshi, T (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr, Tokyo, Japan.	takashi.akiyoshi@jfcr.or.jp	Fukunaga, Yosuke/AAR-8933-2021; nagasaki, toshiya/AAE-6844-2020	Fukunaga, Yosuke/0000-0002-6397-0907; nagasaki, toshiya/0000-0001-5853-314X; Akiyoshi, Takashi/0000-0002-2321-1412	Japan Society for the Promotion of Science [15K10156]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by Japan Society for the Promotion of Science grant 15K10156 to Dr. Takashi Akiyoshi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; Barberan-Garcia A, 2018, ANN SURG, V267, P50, DOI 10.1097/SLA.0000000000002293; Chemama S, 2016, ANN SURG ONCOL, V23, P3891, DOI 10.1245/s10434-016-5360-7; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi MH, 2018, J CACHEXIA SARCOPENI, V9, P53, DOI 10.1002/jcsm.12234; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dello SAWG, 2013, HPB, V15, P165, DOI 10.1111/j.1477-2574.2012.00517.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Guadagni M, 2009, CURR OPIN CLIN NUTR, V12, P617, DOI 10.1097/MCO.0b013e32833193bd; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Honda M, 2016, J SURG ONCOL, V114, P630, DOI 10.1002/jso.24376; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Joglekar S, 2015, J SURG ONCOL, V111, P771, DOI 10.1002/jso.23862; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Malietzis G, 2016, BRIT J SURG, V103, P572, DOI 10.1002/bjs.10075; Malietzis G, 2016, ANN SURG, V263, P320, DOI 10.1097/SLA.0000000000001113; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Miyamoto Y, 2016, CLIN CANCER RES, V22, P3999, DOI 10.1158/1078-0432.CCR-16-0495; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Nagasaki T, 2015, DIGEST SURG, V32, P496, DOI 10.1159/000441396; Ogura A, 2018, EUR J CANCER, V91, P11, DOI 10.1016/j.ejca.2017.12.005; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Sabel MS, 2013, J SURG ONCOL, V108, P169, DOI 10.1002/jso.23366; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Watanabe T, 2018, INT J CLIN ONCOL, V23, P1, DOI 10.1007/s10147-017-1101-6	36	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195406	10.1371/journal.pone.0195406	http://dx.doi.org/10.1371/journal.pone.0195406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630652	Green Submitted, gold, Green Published			2022-12-27	WOS:000429505000047
J	Li, HB; Dai, CG; Zhang, CR; He, YF; Ran, HY; Chen, SH				Li, Hong-Bo; Dai, Chang-Geng; Zhang, Chang-Rong; He, Yong-Fu; Ran, Hai-Yan; Chen, Shi-Hong			Screening potential reference genes for quantitative real-time PCR analysis in the oriental armyworm, Mythimna separata	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION; SELECTION; VALIDATION; NORMALIZATION; WALKER; IDENTIFICATION	The oriental armyworm, Mythimna separata, is a major insect pest in China and other Asian countries. Unfortunately, suitable reference genes for quantitative real-time PCR (qRT-PCR) have not been previously identified in M. separata for normalizing target gene expression. In this study, we evaluated the expression stability of eight candidate genes (18S, ACT, EF1-alpha, GAPDH, RPS7, RPS13, RPL32 and TUB) in M. separata using the comparative Delta Ct method, BestKeeper, Normfinder geNorm and ReFinder, a comprehensive software platform. The results indicated that the appropriate reference gene varied depending on the experimental conditions. We found that ACTIN, EF1-alpha and TUB were optimal for different developmental stages; TUB, RPS13 and EF1-alpha showed the most stable expresssion in different tissues; RPS13 and 18S were the best reference genes for monitoring expression under high temperature conditions; TUB, RPS13 and RPS7 exhibited the most stable expression under larval-crowding conditions; RPS7, EF1-alpha, RPL32 and GAPDHwere the best for pesticide exposure experiments. This study provides tools for reliable normalization of qRT-PCR data and forms a foundation for functional studies of target gene expression in M. separata.	[Li, Hong-Bo; Dai, Chang-Geng; Zhang, Chang-Rong; He, Yong-Fu; Ran, Hai-Yan; Chen, Shi-Hong] Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Guizhou, Peoples R China	Guizhou Academy of Agricultural Sciences	Li, HB; He, YF (corresponding author), Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Guizhou, Peoples R China.	gzlhb2017@126.com; heyongfu08@163.com		Li, Hongboo/0000-0002-5860-9746	Special Fund for Agro-scientific Research in the Public Interest of China [201403031]; National Natural Science Foundation of China [31601633]; Natural Science Foundation of Guizhou province [20142121]; Talent Foundation of Guizhou Academy of Agricultural Science [201301]	Special Fund for Agro-scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guizhou province; Talent Foundation of Guizhou Academy of Agricultural Science	This research was funded by Special Fund for Agro-scientific Research in the Public Interest of China (201403031), National Natural Science Foundation of China (31601633), Natural Science Foundation of Guizhou province (20142121) and Talent Foundation of Guizhou Academy of Agricultural Science (201301).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2004, AZ QUANT PCR; Bansal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134890; Bao WH, 2016, BIOTECHNOL LETT, V38, P1961, DOI 10.1007/s10529-016-2186-0; Baumann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135093; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chang XQ, 2017, COMP BIOCHEM PHYS D, V22, P120, DOI 10.1016/j.cbd.2017.03.001; Chang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181862; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dhar AK, 2009, MOL IMMUNOL, V46, P1688, DOI 10.1016/j.molimm.2009.02.020; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Jiang Xing-Fu, 2014, Chinese Journal of Applied Entomology, V51, P1444, DOI 10.7679/j.issn.2095-1353.2014.168; Jiang Xing-Fu, 2014, Chinese Journal of Applied Entomology, V51, P881, DOI 10.7679/j.issn.2095-1353.2014.108; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Jiang Yu-Ying, 2014, Chinese Journal of Applied Entomology, V51, P890, DOI 10.7679/j.issn.2095-1353.2014.109; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Ladror DT, 2014, BIOCHEM BIOPH RES CO, V445, P535, DOI 10.1016/j.bbrc.2014.01.040; Li RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061619; Li WW, 2017, THESIS; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Liu YJ, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew079; Liu Z, 2017, SCI REP, V7; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Morales MA, 2016, INT J BIOL SCI, V12, P1129, DOI 10.7150/ijbs.16319; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reim T, 2013, APIDOLOGIE, V44, P342, DOI 10.1007/s13592-012-0184-3; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; Shakeel M, 2015, J ASIA-PAC ENTOMOL, V18, P123, DOI 10.1016/j.aspen.2015.01.001; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wang YW, 2010, IN VITRO CELL DEV-AN, V46, P595, DOI 10.1007/s11626-010-9318-y; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yang C.X, 2015, SCI REP, V5; Yang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098164; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhang L, 2008, ARCH INSECT BIOCHEM, V68, P63, DOI 10.1002/arch.20255; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zheng YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111369	65	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195096	10.1371/journal.pone.0195096	http://dx.doi.org/10.1371/journal.pone.0195096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617430	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800062
J	Luengo-Gil, G; Gonzalez-Billalabeitia, E; Perez-Henarejos, SA; Manzano, EN; Chaves-Benito, A; Garcia-Martinez, E; Garcia-Garre, E; Vicente, V; de la Pena, FA				Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Chaves-Benito, Asuncion; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco			Angiogenic role of miR-20a in breast cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; NEOADJUVANT CHEMOTHERAPY; BEVACIZUMAB; MICRORNAS; CLUSTER; CELLS; EXPRESSION; DOCETAXEL; THERAPY	Background Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its relevance for clinical resistance to anti-angiogenic drugs is still incompletely understood. Recent developments on the contribution of microRNA to tumor angiogenesis and on the oncogenic effects of miR-17-92, a miRNA cluster, point to their potential role on breast cancer angiogenesis. The aim of this work was to establish the contribution of miR-20a, a member of miR-17-92 cluster, to tumor angiogenesis in patients with invasive breast carcinoma. Methods Tube-formation in vitro assays with conditioned medium from MCF7 and MDA-MB-231 breast cancer cell lines were performed after transfection with miR-20a and anti-miR20a. For clinical validation of the experimental findings, we performed a retrospective analysis of a series of consecutive breast cancer patients (n = 108) treated with neoadjuvant chemotherapy and with a full characterization of their vessel pattern and expression of angiogenic markers in pre-treatment biopsies. Expression of members of the cluster miR-17-92 and of angiogenic markers was determined by RT-qPCR after RNA purification from FFPE samples. Results In vitro angiogenesis assays with endothelial cells and conditioned media from breast cancer cell lines showed that transfection with anti-miR20a in MDA-MB-231 significantly decreased mean mesh size and total mesh area, while transfection with miR-20a in MCF7 cells increased mean mesh size. MiR-20a angiogenic effects were abrogated by treatment with aflibercept, a VEGF trap. These results were supported by clinical data showing that mir-20a expression was higher in tumors with no estrogen receptor or with more extensive nodal involvement (cN2-3). A higher miR-20a expression was associated with higher mean vessel size (p= 0.015) and with an angiogenic pattern consisting in larger vessels, higher VEGFA expression and presence of glomeruloid microvascular proliferations (p<0.001). This association was independent of tumor subtype and VEGFA expression. Conclusions Transfection of breast cancer cells with miR-20a induces vascular changes in endothelial tube-formation assays. Expression of miR-20a in breast invasive carcinomas is associated with a distinctive angiogenic pattern consisting in large vessels, anomalous glomeruloid microvascular proliferations and high VEGFA expression. Our results suggest a role for miR-20a in the regulation of breast cancer angiogenesis, and raise the possibility of its use as an angiogenic biomarker.	[Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] Hosp Univ Morales Meseguer, Dept Hematol & Med Oncol, Murcia, Spain; [Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] Ctr Reg Hemodonac, Murcia, Spain; [Luengo-Gil, Gines; Vicente, Vicente; Ayala de la Pena, Francisco] Univ Murcia, Dept Internal Med, Murcia, Spain; [Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] IMIB Arrixaca, Murcia, Spain; [Gonzalez-Billalabeitia, Enrique; Garcia-Martinez, Elena] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain; [Chaves-Benito, Asuncion] Hosp Univ Morales Meseguer, Dept Pathol, Murcia, Spain	Meseguer General University Hospital Morales; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Universidad Catolica de Murcia; Meseguer General University Hospital Morales	de la Pena, FA (corresponding author), Hosp Univ Morales Meseguer, Dept Hematol & Med Oncol, Murcia, Spain.; de la Pena, FA (corresponding author), Ctr Reg Hemodonac, Murcia, Spain.; de la Pena, FA (corresponding author), Univ Murcia, Dept Internal Med, Murcia, Spain.; de la Pena, FA (corresponding author), IMIB Arrixaca, Murcia, Spain.	frayala@um.es	Luengo-Gil, Ginés/AAB-6780-2019; Gonzalez, Enrique/ABG-4621-2020; Vicente, Vicente/L-6185-2019; Ayala, Francisco/C-5280-2011	Luengo-Gil, Ginés/0000-0001-9940-0415; Gonzalez, Enrique/0000-0003-3143-3143; Vicente, Vicente/0000-0002-4278-3264; Ayala, Francisco/0000-0001-6311-920X; Navarro Manzano, Esther/0000-0002-0243-0085	Instituto de Salud Carlos III [PI12/02877]; FEDER funds; Fundacion Salud; Spain Ministerio de Educacion, Cultura y Deporte [FPU16/06537]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Fundacion Salud; Spain Ministerio de Educacion, Cultura y Deporte	This work was funded by Instituto de Salud Carlos III (http://www.isciii.es) (PI12/02877) (FA), including FEDER funds, and by Fundacion Salud 2000 (http://www.fundacionmercksalud.com) (Ayuda Merck Serono de Investigacion en Oncologia 2012) (FA). EN was funded by Spain Ministerio de Educacion, Cultura y Deporte (https://www.mecd.gob.es) (FPU16/06537). The funding bodies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-51; Baar J, 2009, CLIN CANCER RES, V15, P3583, DOI 10.1158/1078-0432.CCR-08-2917; Barlow KD, 2013, CANCER MICROENVIRON, V6, P1, DOI 10.1007/s12307-012-0102-2; Bear HD, 2015, LANCET ONCOL; Beresford MJ, 2006, BRIT J CANCER, V95, P1683, DOI 10.1038/sj.bjc.6603491; Calvano CMC, 2014, TUMOR BIOL, V35, P7733, DOI 10.1007/s13277-014-2025-7; Carpentier G., 2012, ANGIOGENESIS ANAL IM; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Dal Bo M, 2015, ONCOTARGET, V6, P19381; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; dos Santos LV, 2015, BREAST CANCER RES TR, V151, P481, DOI 10.1007/s10549-015-3410-7; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Fan Y, 2014, RNA, V20, P765, DOI 10.1261/rna.043026.113; Freres P, 2016, ONCOTARGET, V7, P5416, DOI 10.18632/oncotarget.6786; Gasparri ML, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695525; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Grant DS, 2003, INT J CANCER, V104, P121, DOI 10.1002/ijc.10907; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Luengo-Gil G, 2015, BREAST CANCER RES TR, V151, P577, DOI 10.1007/s10549-015-3421-4; Ma HB, 2016, CANCER LETT, V376, P293, DOI 10.1016/j.canlet.2016.04.011; Mikalsen LTG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075954; Miles DW, 2013, ANN ONCOL, V24, P2773, DOI 10.1093/annonc/mdt276; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Ricci V, 2015, CRIT REV ONCOL HEMAT, V96, P569, DOI 10.1016/j.critrevonc.2015.07.001; Sledge GW, 2015, J CLIN ONCOL, V33, P133, DOI 10.1200/JCO.2014.58.1298; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vasudev NS, 2013, BRIT J CANCER, V109, P1230, DOI 10.1038/bjc.2013.429; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wu Q, 2015, J CELL MOL MED, V19, P2874, DOI 10.1111/jcmm.12681; Wu S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-40	42	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194638	10.1371/journal.pone.0194638	http://dx.doi.org/10.1371/journal.pone.0194638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617404	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800040
J	Mastop, M; Reinhard, NR; Zuconelli, CR; Terwey, F; Gadella, TWJ; van Unen, J; Adjobo-Hermans, MJW; Goedhart, J				Mastop, Marieke; Reinhard, Nathalie R.; Zuconelli, Cristiane R.; Terwey, Fenna; Gadella, Theodorus W. J., Jr.; van Unen, Jakobus; Adjobo-Hermans, Merel J. W.; Goedhart, Joachim			A FRET-based biosensor for measuring G alpha 13 activation in single cells (vol 13, e0193705, 2018)	PLOS ONE			English	Correction													Zuconelli, Cristiane/Q-4717-2019; Adjobo-Hermans, Merel/AAN-5989-2020; Zuconelli, Cristiane/G-6213-2016; Adjobo-Hermans, M.J.W./L-4170-2015	Zuconelli, Cristiane/0000-0002-6316-3937; Adjobo-Hermans, Merel/0000-0002-5947-2876; Zuconelli, Cristiane/0000-0002-6316-3937; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Gadella, Theodorus/0000-0002-7639-219X	NWO Chemical Sciences ECHO grant [711.013.009]; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) [BEX 13247/13-1]	NWO Chemical Sciences ECHO grant; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)	The correct funding information is as follows: JG was supported by a NWO Chemical Sciences ECHO grant (711.013.009). CRZ was supported financially by the Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) (grant: BEX 13247/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mastop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193705	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195649	10.1371/journal.pone.0195649	http://dx.doi.org/10.1371/journal.pone.0195649			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617442	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800097
J	Ribeiro, VP; Silva-Correia, J; Goncalves, C; Pina, S; Radhouani, H; Montonen, T; Hyttinen, J; Roy, A; Oliveira, AL; Reis, RL; Oliveira, JM				Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Montonen, Toni; Hyttinen, Jari; Roy, Anirban; Oliveira, Ana L.; Reis, Rui L.; Oliveira, Joaquim M.			Rapidly responsive silk fibroin hydrogels as an artificial matrix for the programmed tumor cells death	PLOS ONE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; IN-VITRO; INJECTABLE HYDROGELS; FABRICATION; TRANSITION; SCAFFOLDS; PROTEINS; POLYMERS; GELATION; MODEL	Timely and spatially-regulated injectable hydrogels, able to suppress growing tumors in response to conformational transitions of proteins, are of great interest in cancer research and treatment. Herein, we report rapidly responsive silk fibroin (SF) hydrogels formed by a horseradish peroxidase (HRP) crosslinking reaction at physiological conditions, and demonstrate their use as an artificial biomimetic three-dimensional (3D) matrix. The proposed SF hydrogels presented a viscoelastic nature of injectable hydrogels and spontaneous conformational changes from random coil to beta-sheet conformation under physiological conditions. A human neuronal glioblastoma (U251) cell line was used for screening cell encapsulation and in vitro evaluation within the SF hydrogels. The transparent random coil SF hydrogels promoted cell viability and proliferation up to 10 days of culturing, while the crystalline SF hydrogels converted into beta-sheet structure induced the formation of TUNEL-positive apoptotic cells. Therefore, this work provides a powerful tool for the investigation of the microenvironment on the programed tumor cells death, by using rapidly responsive SF hydrogels as 3D in vitro tumor models.	[Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Reis, Rui L.; Oliveira, Joaquim M.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal; [Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Reis, Rui L.; Oliveira, Joaquim M.] ICVS 3Bs PT Govt Associated Lab, Braga, Portugal; [Montonen, Toni; Hyttinen, Jari] Tampere Univ Technol, ELT Dept, Computat Biophys & Imaging Grp, Tampere, Finland; [Montonen, Toni; Hyttinen, Jari] BioMediTech Inst Biosci & Med Technol, Tampere, Finland; [Roy, Anirban] Anasys Instruments Corp Santa Barbara, Santa Barbara, CA USA; [Oliveira, Ana L.] Univ Catolica Portuguese, Escola Super Biotecnol, Lab Associado, CBQF Ctr Biotecnol & Quim Fina, Porto, Portugal; [Reis, Rui L.; Oliveira, Joaquim M.] Univ Minho, Discoveries Ctr Regenerat & Precis Med, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal	Universidade do Minho; Tampere University; Universidade Catolica Portuguesa; Universidade do Minho	Ribeiro, VP (corresponding author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal.; Ribeiro, VP (corresponding author), ICVS 3Bs PT Govt Associated Lab, Braga, Portugal.	viviana.riberiro@dep.uminho.pt	Hyttinen, Jari A/G-4280-2014; Radhouani, Hajer Radhouani H/E-1837-2011; Ribeiro, Viviana/A-3670-2019; Gonçalves, Cristiana/A-7131-2010; Reis, Rui L./A-8938-2008; Pina, Sandra/H-8133-2013; Silva-Correia, Joana/D-4980-2012; Oliveira, Ana L/J-3404-2013; Pina, Sandra/U-8428-2019; Oliveira, Joaquim Miguel/H-8636-2012	Hyttinen, Jari A/0000-0003-1850-3055; Ribeiro, Viviana/0000-0002-3679-0759; Gonçalves, Cristiana/0000-0002-3219-1310; Reis, Rui L./0000-0002-4295-6129; Pina, Sandra/0000-0002-4361-1253; Silva-Correia, Joana/0000-0003-1312-3109; Oliveira, Ana L/0000-0001-8012-4203; Pina, Sandra/0000-0002-4361-1253; Oliveira, Joaquim Miguel/0000-0001-7052-8837; Radhouani, Hajer/0000-0003-1007-4073; Montonen, Toni/0000-0003-3784-0890	Portuguese Foundation for Science and Technology (FCT) under POFC [PEst-C/SAU/ LA0026/2013]; FEDER programs; Investigator FCT program [IF/00423/2012, IF/01285/2015, IF/00411/2013, IF/00115/2015]; FCT/MCTES [PD/BD/113806/2015]; FSUPOCH [PD/59/2013]; R&D grant of Anasys Instruments Corp; Anasys Instruments Corp.;  [SFRH/BPD/94277/2013];  [SFRH/BPD/108763/2015];  [SFRH/BPD/100957/2014]; Fundação para a Ciência e a Tecnologia [PEst-C/SAU/LA0026/2013] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT) under POFC; FEDER programs; Investigator FCT program(Portuguese Foundation for Science and Technology); FCT/MCTES(Portuguese Foundation for Science and TechnologyEuropean Commission); FSUPOCH; R&D grant of Anasys Instruments Corp; Anasys Instruments Corp.; ; ; ; Fundação para a Ciência e a Tecnologia	This study was funded by the Portuguese Foundation for Science and Technology (FCT; http://www.fct.pt) project PEst (PEst-C/SAU/ LA0026/2013) under POFC and/or FEDER programs, attributed to RLR; Grants under the Investigator FCT program: IF/00423/2012 and IF/01285/2015 (JMO), IF/00411/2013 (ALO) and IF/00115/2015 (JSC); Postdoctoral fellows: SFRH/BPD/94277/2013 (CG), SFRH/BPD/108763/2015 (SP), SFRH/BPD/100957/2014 (HR); PhD scholarship PD/BD/113806/2015 attributed to VPR under the financial support from FCT/MCTES and FSUPOCH, PD/59/2013. An internal R&D grant of Anasys Instruments Corp provided support in the form of salary for author AR, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. The remaining coauthors did not receive any funding from Anasys Instruments Corp.	Aho J, 2015, INT J PHARMACEUT, V494, P623, DOI 10.1016/j.ijpharm.2015.02.009; Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033; Bastiancich C, 2016, J CONTROL RELEASE, V243, P29, DOI 10.1016/j.jconrel.2016.09.034; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Cai YR, 2017, MAT SCI ENG C-MATER, V70, P148, DOI 10.1016/j.msec.2016.08.070; Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414; Cho SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8145; Davis NE, 2012, BIOMATERIALS, V33, P6691, DOI 10.1016/j.biomaterials.2012.06.015; de Moraes MA, 2010, POLYMERS-BASEL, V2, P719, DOI 10.3390/polym2040719; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Du GY, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2316-1; Elisseeff J, 2008, NAT MATER, V7, P271, DOI 10.1038/nmat2147; Figueiras E, 2014, BIOMED OPT EXPRESS, V5, P3443, DOI 10.1364/BOE.5.003443; Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029; Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040; Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469; Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/j.addr.2012.09.009; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643; Liu L, 2016, ASIAN J PHARM SCI, V11, P673, DOI 10.1016/j.ajps.2016.07.001; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Marcott C., 2012, MICROS TODAY, V20, P16, DOI [10.1017/s1551929512000776, DOI 10.1017/S1551929512000776]; McGill M, 2017, ACTA BIOMATER, V63, P76, DOI 10.1016/j.actbio.2017.09.020; Mitropoulos AN, 2015, ACS BIOMATER SCI ENG, V1, P964, DOI 10.1021/acsbiomaterials.5b00215; Nogueira GM, 2011, MAT SCI ENG C-MATER, V31, P997, DOI 10.1016/j.msec.2011.02.019; Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040; Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526; Qin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13079; Qiu PH, 2013, ADV MATER, V25, P2492, DOI 10.1002/adma.201204472; Reis RL, 2014, Portugal patent, Patent No. [107426, PT107426]; Ribeiro VP, 2017, BIOMATERIALS, V123, P92, DOI 10.1016/j.biomaterials.2017.01.027; Ryu S, 2016, J MATER CHEM B, V4, P4574, DOI 10.1039/c6tb00896h; Sah MK, 2011, AFR J BIOTECHNOL, V10, P7878; Sakai S, 2009, ACTA BIOMATER, V5, P554, DOI 10.1016/j.actbio.2008.10.010; Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030; Seib FP, 2015, BIOMATERIALS, V51, P313, DOI 10.1016/j.biomaterials.2015.01.076; Shirmanova MV, 2017, ADV EXP MED BIOL, V1035, P143, DOI 10.1007/978-3-319-67358-5_10; Soto AM, 2016, LANGMUIR, V32, P5173, DOI 10.1021/acs.langmuir.6b00554; Sundarakrishnan A, 2016, ACTA BIOMATER, V42, P102, DOI 10.1016/j.actbio.2016.06.020; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Ta HT, 2008, J CONTROL RELEASE, V126, P205, DOI 10.1016/j.jconrel.2007.11.018; Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067; Tellado SF, 2017, TISSUE ENG PT A, V23, P859, DOI [10.1089/ten.tea.2016.0460, 10.1089/ten.TEA.2016.0460]; Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226; Xiong G., 2013, J BIOMATER NANOBIOTE, V4, P316, DOI DOI 10.4236/JBNB.2013.44040; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yan LP, 2017, J TISSUE ENG REGEN M, V11, P3168, DOI 10.1002/term.2226; Yan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31037; Yang M, 2017, ADV FUNCTIONAL MAT; Yu E, 2016, INT POLYM PROC, V31, P638, DOI 10.3139/217.3247; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028; Zainuddin, 2008, BIOMATERIALS, V29, P4268, DOI 10.1016/j.biomaterials.2008.07.041; Zheng R, 2004, PROTEIN SCI, V13, P1288, DOI 10.1110/ps.03550404; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078	65	39	38	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194441	10.1371/journal.pone.0194441	http://dx.doi.org/10.1371/journal.pone.0194441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617395	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800031
J	Robson, JP; Kokhanenko, P; Marshall, JK; Phillips, AR; van der Linden, J				Robson, Jonathan P.; Kokhanenko, Pavlo; Marshall, Jean K.; Phillips, Anthony R.; van der Linden, Jan			Increased visceral tissue perfusion with heated, humidified carbon dioxide insufflation during open abdominal surgery in a rodent model	PLOS ONE			English	Article							SURGICAL SITE INFECTION; BLOOD-FLOW; LOCAL INSUFFLATION; ANASTOMOTIC LEAKS; CO2 INSUFFLATION; WOUND-INFECTION; OXYGEN-TENSION; METABOLIC-RATE; COLON SURGERY; TEMPERATURE	Tissue perfusion during surgery is important in reducing surgical site infections and promoting healing. This study aimed to determine if insufflation of the open abdomen with heated, humidified (HH) carbon dioxide (CO2) increased visceral tissue perfusion and core body temperature during open abdominal surgery in a rodent model. Using two different rodent models of open abdominal surgery, visceral perfusion and core temperature were measured. Visceral perfusion was investigated using a repeated measures crossover experiment with rodents receiving the same sequence of two alternating treatments: exposure to ambient air (no insufflation) and insufflation with HH CO2. Core body temperature was measured using an independent experimental design with three treatment groups: ambient air, HH CO2 and cold, dry (CD) CO2. Visceral perfusion was measured by laser speckle contrast analysis (LASCA) and core body temperature was measured with a rectal thermometer. Insufflation with HH CO2 into a rodent open abdominal cavity significantly increased visceral tissue perfusion (2.4 perfusion units (PU)/min (95% CI 1.23-3.58); p<0.0001) compared with ambient air, which significantly reduced visceral blood flow (-5.20 PU/min (95% CI -6.83- -3.58); p<0.0001). Insufflation of HH CO2 into the open abdominal cavity significantly increased core body temperature (+1.15 +/- 0.14 degrees C) compared with open cavities exposed to ambient air (-0.65 +/- 0.52 degrees C; p = 0.037), or cavities insufflated with CD CO2 (-0.73 +/- 0.33 degrees C; p = 0.006). Abdominal visceral temperatures also increased with HH CO2 insufflation compared with ambient air or CD CO2, as shown by infrared thermography. This study reports for the first time the use of LASCA to measure visceral perfusion in open abdominal surgery and shows that insufflation of open abdominal cavities with HH CO2 significantly increases visceral tissue perfusion and core body temperature.	[Robson, Jonathan P.; Kokhanenko, Pavlo; Marshall, Jean K.] Fisher & Paykel Healthcare, Auckland, New Zealand; [Phillips, Anthony R.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [van der Linden, Jan] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Haier; University of Auckland; Karolinska Institutet	Robson, JP (corresponding author), Fisher & Paykel Healthcare, Auckland, New Zealand.	Jonathan.robson@fphcare.co.nz			University of Auckland ethics board	University of Auckland ethics board	We are grateful to the VJU animal staff for all their support with the experiments and animal maintenance. We are thankful to the University of Auckland ethics board for their support and assistance in running the experiments. Special thanks to Blake Sears and Avinesh Pillai at the University of Auckland, department of statistics, who analysed the perfusion data. Thank you to Dr Callum Spence and Ali Ghalib at Fisher and Paykel Healthcare for their engineering assistance with the animal experiments.	Agaev B A, 2013, Khirurgiia (Mosk), P35; Akca O, 2013, BRIT J ANAESTH, V111, P759, DOI 10.1093/bja/aet233; [Anonymous], 2017, R LANG ENV STAT COMP; Balayssac D, 2017, SURG ENDOSC, V31, P1, DOI 10.1007/s00464-016-4866-1; Birch DW, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007821.pub3; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Carpinteri S, 2015, ANN SURG ONCOLOGY; Carpinteri S, 2015, ANN SURG ONCOL, V22, pS1540, DOI 10.1245/s10434-015-4508-1; Cater JE, 2015, MED ENG PHYS, V37, P121, DOI 10.1016/j.medengphy.2014.07.011; Choi B, 2004, MICROVASC RES, V68, P143, DOI 10.1016/j.mvr.2004.04.003; Davey AK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/816283; Dickerson RN, 2005, J AM DIET ASSOC, V105, P1002, DOI 10.1016/j.jada.2005.04.022; Dickerson RN, 2005, J AM DIET ASSOC, V105, P835, DOI 10.1016/j.jada.2005.03.021; DILSAVER SC, 1992, PHARMACOL BIOCHEM BE, V42, P549, DOI 10.1016/0091-3057(92)90154-8; Draijer M, 2009, LASER MED SCI, V24, P639, DOI 10.1007/s10103-008-0626-3; EDSALL J T, 1972, Journal of the History of Biology, V5, P205, DOI 10.1007/BF00346659; Erikoglu M, 2005, J SURG RES, V125, P73, DOI 10.1016/j.jss.2004.11.029; Farley DR, 2004, ARCH SURG-CHICAGO, V139, P739, DOI 10.1001/archsurg.139.7.739; Farley DR, 2004, ARCH SURG-CHICAGO, V139, P43; Fredriksson I, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.12.126018; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Frey JM, 2012, ANESTH ANALG, V115, P1204, DOI 10.1213/ANE.0b013e31826ac49f; Frey JM, 2010, WOUND REPAIR REGEN, V18, P378, DOI 10.1111/j.1524-475X.2010.00602.x; Frey JMK, 2012, WORLD J SURG, V36, P2567, DOI 10.1007/s00268-012-1735-5; Gnyawali SC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41048; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Hamza MA, 2005, J LAPAROENDOSC ADV A, V15, P6, DOI 10.1089/lap.2005.15.6; Hayashi H, 2016, J CARDIOTHOR VASC AN, V30, P613, DOI 10.1053/j.jvca.2016.01.021; Hecht N, 2016, J CEREBR BLOOD F MET, V36, P1022, DOI 10.1177/0271678X15612487; Hecht N, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09148; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; Hubner M, 2011, ARCH SURG-CHICAGO, V146, P1240, DOI 10.1001/archsurg.2011.176; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Jafari MD, 2015, J AM COLL SURGEONS, V220, P82, DOI 10.1016/j.jamcollsurg.2014.09.015; Jenks M, 2017, EXPERT REV PHARM OUT, V17, P99, DOI 10.1080/14737167.2017.1270759; Jepsen O B, 1969, Acta Chir Scand Suppl, V396, P80; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; Kabon B, 2005, ANESTH ANALG, V101, P1546, DOI 10.1213/01.ANE.0000180217.57952.FE; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Klugsberger B, 2014, SURG ENDOSC, V28, P2656, DOI 10.1007/s00464-014-3522-x; Kokhanenko P, 2017, J HOSP INFECT, V95, P112, DOI 10.1016/j.jhin.2016.11.006; Kubota J, 2002, LASER MED SCI, V17, P146, DOI 10.1007/s101030200024; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Li Y, 2013, EVID-BASED COMPL ALT, V2013; Lonsky V, 2011, PERFUSION-UK, V26, P510, DOI 10.1177/0267659111419272; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Marshall J, 2014, COLORECTAL DIS S2, V16, P4; Marshall JK, 2017, J SURG RES, V220, P300, DOI 10.1016/j.jss.2017.06.057; Marshall JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122838; Milstein DMJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003875; Ott D E, 1998, JSLS, V2, P321; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Paul JS, 2006, NEUROIMAGE, V29, P38, DOI 10.1016/j.neuroimage.2005.07.019; Rullier E, 1998, BRIT J SURG, V85, P355; Sajid MS, 2008, SURG LAPARO ENDO PER, V18, P539, DOI 10.1097/SLE.0b013e3181886ff4; Sammour T, 2008, BRIT J SURG, V95, P950, DOI 10.1002/bjs.6304; Savel RH, 2005, OBES SURG, V15, P64, DOI 10.1381/0960892052993530; SHERIDAN WG, 1987, DIS COLON RECTUM, V30, P867, DOI 10.1007/BF02555426; SONG CW, 1989, INT J RADIAT ONCOL, V17, P1041, DOI 10.1016/0360-3016(89)90153-3; STONER HB, 1991, CLIN PHYSIOL, V11, P27, DOI 10.1111/j.1475-097X.1991.tb00651.x; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3; Wetterslev J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008884.pub2; Yang W, 2016, J HOSP INFECT, V93, P329, DOI 10.1016/j.jhin.2016.03.015; Zehetner J, 2015, ANN SURG, V262, P74, DOI 10.1097/SLA.0000000000000811	67	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195465	10.1371/journal.pone.0195465	http://dx.doi.org/10.1371/journal.pone.0195465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617447	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800088
J	Stager, JC; Wiltse, B; Hubeny, JB; Yankowsky, E; Nardelli, D; Primack, R				Stager, J. Curt; Wiltse, Brendan; Hubeny, J. Bradford; Yankowsky, Eric; Nardelli, David; Primack, Richard			Climate variability and cultural eutrophication at Walden Pond (Massachusetts, USA) during the last 1800 years	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; NEW-ENGLAND; ORGANIC-MATTER; CRAWFORD LAKE; DEPTH MODELS; ICE-AGE; DROUGHT; ONTARIO; 21ST-CENTURY; SEDIMENTS	Recent shifts in the ecological condition of Walden Pond, MA, are of potentially wide interest due to the lake's importance as a cultural, historical, and recreational resource in addition to its scientific value as an indicator of local and global environmental change. Algal microfossils in six sediment cores document changes in hydroclimate and trophic status of the lake during the last 1800 years and extend two previous sediment core records of shorter length. Low percentages of planktonic diatoms in the longest cores (WAL-3, WAL-15) indicate shallowing and/or greater water clarity associated with a relatively arid interval during the Medieval Climate Anomaly, ca. A.D. 1150-1300, Cultural eutrophication of the lake since the A.D. 1920s caused diatoms in the genera Asterionella and Synedra to increase in relative abundance at the expense of Cyclotella, Discostella, and the chrysophyte alga Mallomonas allorgel. Percentages of Asterionella and Synedra have remained fairly stable since A.D. 2000 when a previous sediment core study was conducted, but scaled chrysophytes have become more numerous. These findings suggest that, although mitigation efforts have curtailed anthropogenic nutrient inputs to Walden Pond, the lake has not returned to the pre-impact condition described by Henry David Thoreau and may become increasingly vulnerable to further changes in water quality in a warmer and possibly wetter future.	[Stager, J. Curt; Wiltse, Brendan; Yankowsky, Eric; Nardelli, David] Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA; [Wiltse, Brendan] Ausable River Assoc, Wilmington, NY USA; [Hubeny, J. Bradford] Salem State Univ, Dept Geol Sci, Salem, MA USA; [Primack, Richard] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Massachusetts System of Public Higher Education; Salem State University; Boston University	Stager, JC (corresponding author), Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu			U.S. National Science Foundation [1358362, 1126128]; National Science Foundation [P2C2, ATM 1358362, EAR 126128]	U.S. National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The research upon which this study is based was funded by the U.S. National Science Foundation grants #1358362 and #1126128 (www.nsf.gov).; JCS acknowledges the National Science Foundation (www.nsf.gov) for grant funding (P2C2, ATM 1358362) the Massachusetts Department of Conservation and Recreation, Jacqui Kluft, Elliott Lewis, and Rory Fraser for assistance in the field. Radiocarbon analyses for cores WAL-2, WAL-3, and WAL-15 were performed by the National Ocean Services Accelerator Mass Spectrometry laboratory, Woods Hole, MA (www.whoi.edu/nosams/home). JBH acknowledges contributions by K. Monecke, C. Knights, and R. Knudstrup, as well as funding from the National Science Foundation (EAR 126128). The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barosh PJ, 1993, THOREAUS WORLD OURS, P212; Bennion H, 2000, FRESHWATER BIOL, V45, P394, DOI 10.1046/j.1365-2427.2000.00626.x; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Booth RK, 2006, EARTH PLANET SC LETT, V242, P415, DOI 10.1016/j.epsl.2005.12.028; Burge D, 2017, DIATOMS US; Clifford MJ, 2015, HOLOCENE, V25, P1102, DOI 10.1177/0959683615580182; Colman JA, 2001, 014137 US GEOL SURV; Cook BI, 2014, J CLIMATE, V27, P383, DOI 10.1175/JCLI-D-13-00100.1; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; DAVIS RB, 1984, CHEM GEOL, V44, P151, DOI 10.1016/0009-2541(84)90071-8; Deevey ES, 1942, Q REV BIOL, V17, P1; Dixit SS, 1999, CAN J FISH AQUAT SCI, V56, P131, DOI 10.1139/cjfas-56-1-131; Ekdahl EJ, 2004, GEOLOGY, V32, P745, DOI 10.1130/G20496.1; Ekdahl EJ, 2007, J PALEOLIMNOL, V37, P233, DOI 10.1007/s10933-006-9016-7; Fraser AI, 1999, WATER SCI TECHNOL, V39, P41, DOI 10.1016/S0273-1223(99)00316-9; Hall Roland I., 1999, P128; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hodgkins GA, 2002, INT J CLIMATOL, V22, P1819, DOI 10.1002/joc.857; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hubeny JB, 2011, P NATL ACAD SCI USA, V108, P17895, DOI 10.1073/pnas.1019301108; IPCC, 2014, CONTRIBUTION WORKING; JAAKKOLA T, 1983, HYDROBIOLOGIA, V103, P15, DOI 10.1007/BF00028422; Jarnefelt H, 1952, ANN ACAD SCI FENN A4, V18, P1; Jeppesen E, 2017, WATER-SUI, V9, DOI 10.3390/w9020122; Koster Dorte, 2005, Aquatic Ecosystem Health & Management, V8, P117, DOI 10.1080/14634980590953743; Krammer K, 1991, SUBETAWASSERFLORA MI; Laird KR, 2008, QUATERNARY RES, V69, P292, DOI 10.1016/j.yqres.2007.11.003; Laird KR, 2012, GLOBAL CHANGE BIOL, V18, P2869, DOI 10.1111/j.1365-2486.2012.02740.x; Laird KR, 2011, QUATERNARY SCI REV, V30, P1201, DOI 10.1016/j.quascirev.2011.02.009; Laird KR, 2010, J PALEOLIMNOL, V44, P1009, DOI 10.1007/s10933-010-9470-0; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marlon JR, 2017, CLIM PAST, V13, P1355, DOI 10.5194/cp-13-1355-2017; Maynard WB, 2004, WALDEN POND HIST; Newby PE, 2014, GEOPHYS RES LETT, V41, P4300, DOI 10.1002/2014GL060183; Nurnberg GK, 2009, LAKE RESERV MANAGE, V25, P419, DOI 10.1080/00357520903458848; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Oswald WW, 2011, QUATERNARY RES, V76, P314, DOI 10.1016/j.yqres.2011.07.004; Paterson AM, 2004, FRESHWATER BIOL, V49, P199, DOI 10.1046/j.1365-2427.2003.01170.x; Paterson AM, 2008, CAN J FISH AQUAT SCI, V65, P846, DOI 10.1139/F08-022; Patrick R, 1975, MONOGRAPHS ACAD NATU, V13; Patrick R.M., 1966, FRAGILARIACEAE EUNOT, V13, P1, DOI 10.2307/1351135; Pederson DC, 2005, QUATERNARY RES, V63, P238, DOI 10.1016/j.yqres.2005.01.001; Primack RB., 2014, WALDEN WARMING CLIMA; Reavie ED, 1995, CAN J FISH AQUAT SCI, V52, P2388, DOI 10.1139/f95-831; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Schindler DW, 1997, BIOGEOCHEMISTRY, V36, P1, DOI 10.1023/A:1005768527751; Schwarz AM, 2002, AQUAT BOT, V72, P209, DOI 10.1016/S0304-3770(01)00201-7; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Sivarajah B, 2017, FUND APPL LIMNOL, V190, P13, DOI 10.1127/fal/2017/0981; Sivarajah B, 2016, J PALEOLIMNOL, V55, P357, DOI 10.1007/s10933-016-9886-2; Siver P.A, 1991, DEV HYDROBIOL, V63; Stager JC, 2016, HOLOCENE; Stone JR, 2004, LIMNOL OCEANOGR, V49, P1540; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sutherland RA, 1998, HYDROBIOLOGIA, V389, P153, DOI 10.1023/A:1003570219018; Thoreau H. D., 1854, WALDEN LIFE WOODS; Thoreau HD, 2009, UJMOWAC HEAD D THORE; United States Global Change Research Program, 2017, 3 NAT CLIM ASS; Wang HY, 2015, AQUAT BIOL, V24, P91, DOI 10.3354/ab00638; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Winkler MG, 1993, THOREAUS WORLD OURS, P199; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	63	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0191755	10.1371/journal.pone.0191755	http://dx.doi.org/10.1371/journal.pone.0191755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617379	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800001
J	Kuklenyik, Z; Jones, JI; Gardner, MS; Schieltz, DM; Parks, BA; Toth, CA; Rees, JC; Andrews, ML; Carter, K; Lehtikoski, AK; McWilliams, LG; Williamson, YM; Bierbaum, KP; Pirkle, JL; Barr, JR				Kuklenyik, Zsuzsanna; Jones, Jeffery I.; Gardner, Michael S.; Schieltz, David M.; Parks, Bryan A.; Toth, Christopher A.; Rees, Jon C.; Andrews, Michael L.; Carter, Kayla; Lehtikoski, Antony K.; McWilliams, Lisa G.; Williamson, Yulanda M.; Bierbaum, Kevin P.; Pirkle, James L.; Barr, John R.			Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; C-III; A-I; PLASMA-LIPOPROTEIN; LC-MS/MS; LIPASE ACTIVITY; GEL-FILTRATION; LDL; HDL; CHOLESTEROL	Lipoproteins are complex molecular assemblies that are key participants in the intricate cascade of extracellular lipid metabolism with important consequences in the formation of atherosclerotic lesions and the development of cardiovascular disease. Multiplexed mass spectrometry (MS) techniques have substantially improved the ability to characterize the composition of lipoproteins. However, these advanced MS techniques are limited by traditional pre-analytical fractionation techniques that compromise the structural integrity of lipoprotein particles during separation from serum or plasma. In this work, we applied a highly effective and gentle hydrodynamic size based fractionation technique, asymmetric flow field-flow fractionation (AF4), and integrated it into a comprehensive tandem mass spectrometry based workflow that was used for the measurement of apolipoproteins (apos A-I, A-II, A-IV, B, C-I, C-II, C-III and E), free cholesterol (FC), cholesterol esters (CE), triglycerides (TG), and phospholipids (PL) (phosphatidylcholine (PC), sphingomyelin (SM), phosphatidylethanolamine (PE), phosphatidylinositol (P1) and lysophosphatidylcholine (LPC)). Hydrodynamic size in each of 40 size fractions separated by AF4 was measured by dynamic light scattering. Measuring all major lipids and apolipoproteins in each size fraction and in the whole serum, using total of 0.1 ml, allowed the volumetric calculation of lipoprotein particle numbers and expression of composition in molar analyte per particle number ratios. Measurements in 110 serum samples showed substantive differences between size fractions of HDL and LDL. Lipoprotein composition within size fractions was expressed in molar ratios of analytes (A-I/A-11, C-II/C-1, C-II/C-111. E/C-Ill, FC/PL, SM/PL, PE/PL, and PI/PL), showing differences in sample categories with combinations of normal and high levels of Total-C and/or Total-TG. The agreement with previous studies indirectly validates the AF4-LC-MS/MS approach and demonstrates the potential of this workflow for characterization of lipoprotein composition in clinical studies using small volumes of archived frozen samples.	[Kuklenyik, Zsuzsanna; Jones, Jeffery I.; Gardner, Michael S.; Schieltz, David M.; Parks, Bryan A.; Toth, Christopher A.; Rees, Jon C.; Andrews, Michael L.; Carter, Kayla; Lehtikoski, Antony K.; McWilliams, Lisa G.; Williamson, Yulanda M.; Bierbaum, Kevin P.; Pirkle, James L.; Barr, John R.] Ctr Dis Control & Prevent, Clin Chem Branch, Div Lab Sci, Atlanta, GA 30333 USA; [Jones, Jeffery I.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Carter, Kayla] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Centers for Disease Control & Prevention - USA; University of Notre Dame; University of Michigan System; University of Michigan	Barr, JR (corresponding author), Ctr Dis Control & Prevent, Clin Chem Branch, Div Lab Sci, Atlanta, GA 30333 USA.	JBarr@cdc.gov	Carter, Kayla/GVS-9292-2022	Carter, Kayla/0000-0002-4836-0932; Andrews, Michael/0000-0003-1958-909X; Toth, Christopher/0000-0001-9294-0144; Kuklenyik, Zsuzsanna/0000-0001-9801-7705; Jones, Jeffrey/0000-0002-5940-2448	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The project is funded by the Centers for Disease Control and Prevention to ZK and JRB.	ALAUPOVI.P, 1972, BIOCHIM BIOPHYS ACTA, V260, P689, DOI 10.1016/0005-2760(72)90018-5; Alaupovic P, 1996, METHOD ENZYMOL, V263, P32; ALAUPOVIC P, 1991, PROG LIPID RES, V30, P105, DOI 10.1016/0163-7827(91)90008-S; Alaupovic Petar, 2003, Curr Atheroscler Rep, V5, P459, DOI 10.1007/s11883-003-0036-8; Arsenault BJ, 2010, CLIN CHEM, V56, P789, DOI 10.1373/clinchem.2009.140939; Asztalos BF, 2007, J LIPID RES, V48, P592, DOI 10.1194/jlr.M600403-JLR200; Chan DC, 2012, J CLIN ENDOCR METAB, V97, pE1658, DOI 10.1210/jc.2012-1522; CHARLWOOD PA, 1971, BIOCHEM J, V125, P1019, DOI 10.1042/bj1251019; Coronado-Gray A, 2005, LIPIDS, V40, P495, DOI 10.1007/s11745-005-1409-x; Ensign W, 2006, CLIN CHEM, V52, P1722, DOI 10.1373/clinchem.2005.059949; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; Gardner M., 2015, CHROMATOGRAPHY, V2, P96, DOI 10.3390/chromatography2010096; Gardner MS, 2017, J AM SOC MASS SPECTR, V28, P2319, DOI 10.1007/s13361-017-1756-2; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; Holcapek M, 2015, J CHROMATOGR B, V990, P52, DOI [10.1016/j.jchromb.2015:03.010, 10.1016/j.jchromb.2015.03.010]; Holcapek M, 2015, J CHROMATOGR A, V1377, P85, DOI 10.1016/j.chroma.2014.12.023; Hoofnagle AN, 2009, J LIPID RES, V50, P1967, DOI 10.1194/jlr.R900015-JLR200; Hopkins PN, 2015, ATHEROSCLEROSIS, V243, P99, DOI 10.1016/j.atherosclerosis.2015.08.042; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; Hutchins PM, 2014, CLIN CHEM, V60, P1393, DOI 10.1373/clinchem.2014.228114; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; Kuklenyik Z, 2018, INSTRUM SCI TECHNOL, V46, P102, DOI 10.1080/10739149.2017.1311912; Kwiterovich PO, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0371-5; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; Li P, 1997, J LIQ CHROMATOGR R T, V20, P2777, DOI 10.1080/10826079708005592; Martin SS, 2014, TRENDS ENDOCRIN MET, V25, P329, DOI 10.1016/j.tem.2014.05.005; Massey JB, 2009, J LIPID RES, V50, P1229, DOI 10.1194/jlr.D800044-JLR200; McNamara JR, 1996, J LIPID RES, V37, P1924; Mendivil CO, 2016, ARTERIOSCL THROM VAS, V36, P156, DOI 10.1161/ATVBAHA.115.306138; Mendivil CO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000130; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; MILNE RW, 1982, FEBS LETT, V146, P97, DOI 10.1016/0014-5793(82)80712-6; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pan LR, 2016, BBA-BIOMEMBRANES, V1858, P2401, DOI 10.1016/j.bbamem.2016.03.010; Parks BA, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600128; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Qureshi RN, 2009, ANAL CHIM ACTA, V654, P85, DOI 10.1016/j.aca.2009.06.060; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; Rambaldi DC, 2011, ANAL BIOANAL CHEM, V399, P1439, DOI 10.1007/s00216-010-4312-5; Reschiglian P, 2008, J PROTEOMICS, V71, P265, DOI 10.1016/j.jprot.2008.06.002; Santos RD, 2008, J LIPID RES, V49, P349, DOI 10.1194/jlr.M700362-JLR200; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; Segrest JP, 2013, J LIPID RES, V54, P2733, DOI 10.1194/jlr.M039172; Segrest JP, 2002, CURR TOP MEMBR, V52, P397; Segrest JP, 2001, J LIPID RES, V42, P1346; Silva RAGD, 2008, ANN MED, V40, P5, DOI 10.1080/07853890701687201; Singh SA, 2016, J LIPID RES, V57, P714, DOI 10.1194/jlr.D061432; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Tani M, 2016, ATHEROSCLEROSIS, V253, P7, DOI 10.1016/j.atherosclerosis.2016.08.014; Teerlink T, 2004, J LIPID RES, V45, P954, DOI 10.1194/jlr.M300521-JLR200; Temel RE, 2015, TRENDS PHARMACOL SCI, V36, P440, DOI 10.1016/j.tips.2015.04.002; Toth CA, 2017, J PROTEOMICS, V150, P258, DOI 10.1016/j.jprot.2016.09.011; van den Broek I, 2016, CLIN CHEM, V62, P188, DOI 10.1373/clinchem.2015.246702; vanAntwerpen R, 1997, J LIPID RES, V38, P659; Zannis VI, 2015, HANDB EXP PHARMACOL, V224, P53, DOI 10.1007/978-3-319-09665-0_2; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194797	10.1371/journal.pone.0194797	http://dx.doi.org/10.1371/journal.pone.0194797			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634782	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200013
J	Bataille, G; Conard, NJ				Bataille, Guido; Conard, Nicholas J.			Blade and bladelet production at Hohle Fels Cave, AH IV in the Swabian Jura and its importance for characterizing the technological variability of the Aurignacian in Central Europe	PLOS ONE			English	Article							SOUTHWESTERN GERMANY; HYPOTHESIS	Hohle Fels Cave in the Ach Valley of Southwestern Germany exhibits an Aurignacian sequence of 1 m thickness within geological horizons (GH) 6-8. The deposition of the layers took place during mild and cold phases between at least 42 ka (GI 10) and 36 ka calBP (GI 7). We present below a technological study of blade and bladelet production from AH IV (GH 7) at Hohle Fels. Our analyses show that blade manufacture is relatively constant, while bladelet production displays a high degree of variability in order to obtain different blanks. Knappers used a variety of burins as cores to produce fine bladelets. The results reveal a new variant of the Aurignacian in the Swabian Jura primarily characterized by the production of bladelets and microliths from burin-cores. The artefacts from the Swabian Aurignacian are technologically and functionally more diverse than earlier studies of the GeiBenklosterle and Vogelherd sequences have suggested. The technological analyses presented here challenge the claim that the typo-chronological system from Southwestern Europe can be applied to the Central European Aurignacian. Instead, we emphasize the impact of technological and functional variables within the Aurignacian of the Swabian Jura.	[Bataille, Guido; Conard, Nicholas J.] Eberhard Karls Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Urgeschichte & Quartarokol, Tubingen, Germany	Eberhard Karls University of Tubingen	Bataille, G (corresponding author), Eberhard Karls Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Urgeschichte & Quartarokol, Tubingen, Germany.	guido.bataille@ifu.uni-tuebingen.de		Conard, Nicholas/0000-0002-4633-0385	Baden-Wurttemberg State Office for Cultural Heritage; UNESCO foundation; State Office for Cultural Heritage, Baden Wurttemberg	Baden-Wurttemberg State Office for Cultural Heritage; UNESCO foundation; State Office for Cultural Heritage, Baden Wurttemberg	The authors thank the excavation team of Hohle Fels, especially Maria Malina, Sarah Rudolf (University of Tubingen, Heidelberg Academy of Science and Humanities) and Alexander Janas M.A. (Department of Early Prehistory and Quaternary Ecology, University of Tubingen). The authors would also like to thank Dr. Andreas Taller (Department for Early Prehistory and Quaternary Ecology, University of Tubingen) and Dr. Michael Bolus (Department for Early Prehistory and Quaternary Ecology, coordinator of the ROCEEH-project, University of Tubingen, Heidelberg Academy of Science and Humanities) for their cooperation with this research. The authors thank Dr. Claus-Joachim Kind (State Office for Cultural Heritage, Baden Wurttemberg), the Alb-Donau-Kreis, the Baden-Wurttemberg State Office for Cultural Heritage, and the UNESCO foundation for support. We thank Dr. Yvonne Tafelmaier (Department for Early Prehistory and Quaternary Ecology, University of Tubingen) for her critical review of the draft version of this paper. The authors are grateful to Diane Kerns for improving the English and to five anonymous reviewers for providing helpful improvement suggestions.	Aurignacien Hahn J., 1977, ALTERE JUNGPALAOLITH; Bataille G, 2017, 59 ANN M AUR APR 18, P16; Bataille G., 2016, MITTEILUNGEN GESELLS, V25, P27; Bataille G., 2013, THESIS; Bodu P., 2005, PRODUCTIONS LAMELLAI, V1, P297; Bolus M, 2001, QUATERN INT, V75, P29, DOI 10.1016/S1040-6182(00)00075-6; Bolus M, 2006, ARCHAOL KORRESPONDEN, V36, P1; Bolus M., 2003, TRABALHOS ARQUEOLOGI, P153; Bordes J.G., 2006, TRABALHOS ARQUEOLOGI, P147; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; Brou L, 2006, BURINS PREHISTORIQUE, V2, P77; Chiotti L., 2003, GALLIA PREHISTOIRE, V45, P113, DOI DOI 10.3406/GALIP.2003.2037; Conard N., 2002, ARCHAOLOGISCHE AUSGR, V2002, P21; Conard N.J., 2015, EISZEITARCHAOLOGIE S; Conard N.J., 2004, ARCHAOLOGISCHE AUSGR, V2004, P17; Conard N.J, 2006, TRABALHOS ARQUEOLOGI, V45, P241; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Conard NJ, 2008, J HUM EVOL, V55, P886, DOI 10.1016/j.jhevol.2008.08.006; Conard NJ, 2006, SCHMUCK VIELLEICHT A, V2006, P21; Conard NJ., 2006, INSTITUTO PORTUGU S, V45, P211; De Araujo Igreja M, 2006, ARCHEOLOGIQUES, V2; de Sonneville-Bordes D, 1960, PALEOLITHIQUE SUPERI; Demars P-Y., 1992, PALEO, V4, P101, DOI [10.3406/pal.1992.1197, DOI 10.3406/PAL.1992.1197]; Demars P-Y, 1989, CAHIERS QUATERNAIRE, V14; Demidenko YE, 2012, SIUREN I ROCK SHELTE, V129, P213; Dinnis R., 2011, ANTHR PRAEHISTORICA, V122, P5; Dinnis R, 2016, P PREHIST SOC, DOI [10.1017/ppr.2016.4, DOI 10.1017/PPR.2016.4]; Djindjian F., 2003, TRABALHOS ARQUEOLOGI, V33, P29; DJINDJIAN F., 1985, SIGNIFICATION CULTUR, V239, P338; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Driscoll K, 2014, J ARCHAEOL SCI, V47, P134, DOI 10.1016/j.jas.2014.04.008; Falcucci A, 2016, ARCHAEOL ANTHROP SCI, DOI [10.1007/s12520.016-0365-5, DOI 10.1007/S12520.016-0365-5]; Falcucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189241; Flakes Bataille G., 2012, FLAKES NOT BLADES WI, V5, P261; Flas D., 2006, ARCHEOLOGIQUES, V2, P55; Floss H, 2013, STEINARTEFAKTE ALTPA, P133; Hahn J., 1988, FORSCHUNGEN BERICHTE, V26; Hahn J., 1991, ERKENNEN BESTIMMEN S, V10; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2013, J HUM EVOL, V65, P806, DOI 10.1016/j.jhevol.2013.06.010; Le Brun-Ricalens F, 2005, CARINATED TOOLS NUCL, P23; Le Brun-Ricalens F, 2006, BURINS CAREENS FORMS, V2, P345; LeBrun-Ricalens F., 2005, PRODUCTIONS LAMELLAI, P157; Liolios D., 2006, AURIGNACIENS, P137; Lucas G., 2006, DEFINITION AURIGNACI, V45, P173; Miller CE, 2015, TALE 2 SWABIAN CAVES; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Pastoors A., 2001, SALZGITTER FORSCHUNG, V3; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Richter J., 1997, QUARTAR BIBLIOTHEK, V7; Riehl S, 2014, ARCHAEOL ANTHROP SCI, DOI [10.1007/s12520-014-0182, DOI 10.1007/S12520-014-0182]; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Schiegl S, 2003, GEOARCHAEOLOGY, V18, P541, DOI 10.1002/gea.10080; Schmidt R.R., 1912, DILUVIALE VORZEIT DE; Sitlivy V., 2014, MODES CONTACTES DEPL, V8, P243; Slimak L., 2005, 14 C UISPP LIEG 2 8, P75; Slimak L., 2006, BURINS PREHISTORIQUE, V2, P33; Svoboda JA, 2006, CHRONOLOGY AURIGNACI, V33, P259; Tafelmaier Y., 2017, WISSENSCHATTLICHE SC, V9; Teyssandier N., 2003, TRABALHOS ARQUEOLOGI, V33, P179; Teyssandier N., 2007, BAR INT SERIES, P1638; Tixier J., 1974, NEWSLETTER LITHIC TE, V1; Weissmuller W., 1995, QUARTAR BIBLIOTHEK, V6; Weninger G, 2016, CALPAL EDITION 2016, P3; Wolf S., TUBINGER MONOGRAPHIE; Zilhao J, 2011, VERTEBR PALEOBIOL PA, P331, DOI 10.1007/978-94-007-0492-3_25; Zotz L., QUARTER, V15, P143; Zwyns N, 2012, QUATERN INT, V259, P33, DOI 10.1016/j.quaint.2011.03.036	69	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194097	10.1371/journal.pone.0194097	http://dx.doi.org/10.1371/journal.pone.0194097			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630601	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000004
J	Kruger, A; Maletz, R; Ottl, P; Warkentin, M				Krueger, Joerm; Maletz, Reinhard; Ottl, Peter; Warkentin, Mareike			In vitro aging behavior of dental composites considering the influence of filler content, storage media and incubation time	PLOS ONE			English	Article							SURFACE FREE-ENERGY; RESTORATIVE MATERIALS; RESIN COMPOSITES; POSTERIOR RESTORATIONS; MECHANICAL-PROPERTIES; ALCOHOLIC BEVERAGES; ROUGHNESS; MICROHARDNESS; BIODEGRADATION; DEGRADATION	Objective Over time dental composites age due to mechanical impacts such as chewing and chemical impacts such as saliva enzymes and food ingredients. For this research, the focus was placed on chemical degradation. The objective of this study was to simulate hydrolysis by using different food simulating liquids and to assess their impact on the mechanical parameter Vickers microhardness (MHV) and the physicochemical parameter contact angle (CA). Methods Specimen of three composites (d = 6 mm, h = 2 mm; n = 435) classified with respect to their filler content (wt%), namely low-filled, medium-filled and highly-filled, were stored for 0, 14, 30, 90 and 180 days in artificial saliva (pH 7), citric acid (pH 3; pH 5), lactic acid (pH 3; pH 5) and ethanol (40%vol; 60%vol) and assessed regarding to MHV and CA. Statistics: Kruskal-Wallis test, stepwise linear regression, bivariate Spearman Rank Correlation (p < 0.05). Results While stored in artificial saliva, acid and ethanol the CA decreased especially for the low- and medium-filled composites. It was shown that rising the filler content caused less surface changes in the CA. Storage in ethanol led to a significant decrease of MHV of all composites. Regression analysis showed that the effect of in vitro aging on MHV was mainly influenced by the composite material and therefore by filler content (R-2 = 0.67; p < 0.05). In contrast, the CA is more influenced by incubation time and filler content (R-2 = 0.2; p < 0.05) leading to a higher risk of plaque accumulation over time. Significance: In vitro aging showed significant changes on the mechanical and physicochemical properties of dental composites which may shorten their long-term functionality. In conclusion, it can be stated, that the type of composite material, especially rising filler content seems to improve the materials resistance against the processes of chemical degradation.	[Krueger, Joerm; Ottl, Peter] Univ Rostock, Dept Prosthodont & Mat Sci, Fac Med, Rostock, Germany; [Maletz, Reinhard; Warkentin, Mareike] Univ Rostock, Fac Mech Engn & Marine Technol, Dept Mat Sci & Med Engn, Rostock, Germany	University of Rostock; University of Rostock	Kruger, A (corresponding author), Univ Rostock, Dept Prosthodont & Mat Sci, Fac Med, Rostock, Germany.	joem.krueger@uni-rostock.de	Rosentritt, Martin/ABI-2885-2020; Rosentritt, Martin/AAE-9020-2020	Rosentritt, Martin/0000-0002-6017-5529				Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861; Ben-Gal G, 2011, J DENT EDUC, V75, P1590; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; Birdi K.S., 1997, HDB SURFACE COLLOID; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; da Silva MAB, 2016, DENT MATER J, V35, P621, DOI 10.4012/dmj.2015-383; BRAEM M, 1989, DENT MATER, V5, P346, DOI 10.1016/0109-5641(89)90128-0; Burgers R, 2009, CLIN ORAL INVEST, V13, P419, DOI 10.1007/s00784-009-0256-6; Butt H.-J., 2013, PHYS CHEM INTERFACES; Catelan A, 2010, J ESTHET RESTOR DENT, V22, P324, DOI 10.1111/j.1708-8240.2010.00360.x; CHADWICK RG, 1990, DENT MATER, V6, P123, DOI 10.1016/S0109-5641(05)80042-9; Chuenarrom C, 2009, MATER RES-IBERO-AM J, V12, P473, DOI 10.1590/S1516-14392009000400016; CHUNG KH, 1990, J DENT RES, V69, P852, DOI 10.1177/00220345900690030401; Correr GM, 2012, ACTA ODONTOL SCAND, V70, P101, DOI 10.3109/00016357.2011.600701; Craig RG, 1993, RESTORATIVE DENT MAT, V9th; Darvell B.W., 2018, MAT SCI DENT, P143, DOI DOI 10.1533/9781845696672; de Paula A B, 2014, Oper Dent, V39, pE109, DOI 10.2341/12-340; Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802; Erdemir U, 2012, DENT MATER J, V31, P729, DOI 10.4012/dmj.2012-054; Ferracane JL, 2017, DENT MATER, V33, P1171, DOI 10.1016/j.dental.2017.08.188; Ferracane JL, 2016, DENT MATER, V32, P1, DOI 10.1016/j.dental.2015.06.020; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x; FERRACANE JL, 1995, J DENT RES, V74, P1418, DOI 10.1177/00220345950740071501; Ferracane JL, 1998, J BIOMED MATER RES, V42, P465, DOI 10.1002/(SICI)1097-4636(19981205)42:3<465::AID-JBM17>3.0.CO;2-F; Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Hahnel S, 2010, OPER DENT, V35, P412, DOI 10.2341/09-337-L; Hahnel S, 2010, J MATER SCI-MATER M, V21, P823, DOI 10.1007/s10856-009-3894-y; Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005; Ilie N, 2009, CLIN ORAL INVEST, V13, P427, DOI 10.1007/s00784-009-0258-4; Kakaboura A, 2003, DENT MATER, V19, P393, DOI 10.1016/S0109-5641(02)00082-9; Korkmaz Y, 2008, OPER DENT, V33, P44, DOI 10.2341/07-28; Kruly PC, 2018, PLOS ONE, V13, P1; LARSEN IB, 1991, SCAND J DENT RES, V99, P254; Lee SY, 1998, J ORAL REHABIL, V25, P575; Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1; Mandikos MN, 2001, J PROSTHET DENT, V85, P386, DOI 10.1067/mpr.2001.114267; MCKINNEY JE, 1985, J DENT RES, V64, P1326, DOI 10.1177/00220345850640111601; Mohamed-Tahir MA, 2005, OPER DENT, V30, P661; Münchow Eliseu A., 2014, Braz. Dent. J., V25, P321, DOI 10.1590/0103-6440201300058; Musanje L, 2004, BIOMATERIALS, V25, P4065, DOI 10.1016/j.biomaterials.2003.11.003; NASSAR U, 1995, PERIODONTOL 2000, V8, P114, DOI 10.1111/j.1600-0757.1995.tb00049.x; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Opdam NJM, 2014, J DENT RES, V93, P943, DOI 10.1177/0022034514544217; Ottenga ME, 2007, OPER DENT, V32, P524, DOI 10.2341/06-134; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; OYSAED H, 1986, J DENT RES, V65, P1315, DOI 10.1177/00220345860650110601; Padovani GC, 2014, OPER DENT, V39, P349, DOI 10.2341/13-089-C; Park JW, 2014, J DENT RES, V93, P195, DOI 10.1177/0022034513513905; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x; Roulet J-F, 1987, DEGRADATION DENT POL, pxii; Ruttermann S, 2012, ARCH ORAL BIOL, V57, P1512, DOI 10.1016/j.archoralbio.2012.05.005; Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201; Sarrett DC, 2000, DENT MATER, V16, P62, DOI 10.1016/S0109-5641(99)00088-3; Sarrett DC, 2005, DENT MATER, V21, P9, DOI 10.1016/j.dental.2004.10.001; Scheie A A, 1994, Adv Dent Res, V8, P246; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3; Sideridou ID, 2005, J BIOMED MATER RES B, V74B, P617, DOI 10.1002/jbm.b.30252; Stamm M., 2008, SPRINGER EBOOK COLLE, pXVI; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tuncer S, 2013, J ESTHET RESTOR DENT, V25, P404, DOI 10.1111/jerd.12063; Turssi CP, 2002, J ORAL REHABIL, V29, P864, DOI 10.1046/j.1365-2842.2002.00926.x; Venturini D, 2006, OPER DENT, V31, P11, DOI 10.2341/04-155; Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502; Warkentin M., 2014, WERKSTOFFKUNDLICHE S; WU W, 1982, J DENT RES, V61, P1180, DOI 10.1177/00220345820610101501; Yap AUJ, 2001, J ORAL REHABIL, V28, P1015, DOI 10.1046/j.1365-2842.2001.00760.x	71	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195160	10.1371/journal.pone.0195160	http://dx.doi.org/10.1371/journal.pone.0195160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630621	Green Submitted, gold, Green Published			2022-12-27	WOS:000429505000028
J	Lee, WS; Choi, HS; Sohn, SY				Lee, Won Sang; Choi, Hyo Shin; Sohn, So Young			Forecasting new product diffusion using both patent citation and web search traffic	PLOS ONE			English	Article							TECHNOLOGY DIFFUSION; SPILLOVERS; MODELS	Accurate demand forecasting for new technology products is a key factor in the success of a business. We propose a way to forecasting a new product's diffusion through technology diffusion and interest diffusion. Technology diffusion and interest diffusion are measured by the volume of patent citations and web search traffic, respectively. We apply the proposed method to forecast the sales of hybrid cars and industrial robots in the US market. The results show that that technology diffusion, as represented by patent citations, can explain long-term sales for hybrid cars and industrial robots. On the other hand, interest diffusion, as represented by web search traffic, can help to improve the predictability of market sales of hybrid cars in the short-term. However, interest diffusion is difficult to explain the sales of industrial robots due to the different market characteristics. Finding indicates our proposed model can relatively well explain the diffusion of consumer goods.	[Lee, Won Sang; Choi, Hyo Shin; Sohn, So Young] Yonsei Univ, Dept Informat & Ind Engn, Seoul, South Korea	Yonsei University	Sohn, SY (corresponding author), Yonsei Univ, Dept Informat & Ind Engn, Seoul, South Korea.	sohns@yonsei.ac.kr		Sohn, So Young/0000-0002-3958-2269	National Research Foundation of Korea(NRF) - Korea government (MSIP) [2016R1A2A1A05005270]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1A2A1A05005270]	National Research Foundation of Korea(NRF) - Korea government (MSIP); National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government (MSIP) grant # 2016R1A2A1A05005270 (http://www.nrf.re.kr/) to SYS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2A1A05005270).	BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Caldarelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095809; Caselli F, 2001, AM ECON REV, V91, P328, DOI 10.1257/aer.91.2.328; Chang SB, 2009, TECHNOL FORECAST SOC, V76, P107, DOI 10.1016/j.techfore.2008.03.014; Cheng AC, 2012, TECHNOVATION, V32, P163, DOI 10.1016/j.technovation.2011.10.008; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Cincera M, 1997, J APPL ECONOM, V12, P265, DOI 10.1002/(SICI)1099-1255(199705)12:3<265::AID-JAE439>3.0.CO;2-J; Engel J.F., 1995, CONSUMER BEHAV, V8th; Han EJ, 2015, J TECHNOL TRANSFER, V40, P821, DOI 10.1007/s10961-014-9367-6; Huang CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164328; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Jun S P, 2013, TECHNOLOGICAL FORECA, V86, P237; Kang K, 2016, J INFORMETR, V10, P74, DOI 10.1016/j.joi.2015.10.006; Kim YS, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020166; Kotler P., 2008, MANAGEMENT MARKETING, V12th; Lee M, 2010, TECHNOL FORECAST SOC, V77, P796, DOI 10.1016/j.techfore.2010.01.003; Lee WS, 2015, TECHNOL FORECAST SOC, V100, P317, DOI 10.1016/j.techfore.2015.07.022; MacGarvie M, 2005, ECON LETT, V87, P121, DOI 10.1016/j.econlet.2004.09.011; MAHAJAN V, 1990, J MARKETING, V54, P1, DOI 10.2307/1252170; Rogers EM., 1983, DIFFUSION INNOVATION; Soffer T, 2010, EDUC TECHNOL SOC, V13, P212; Sohn SY, 2003, TECHNOL FORECAST SOC, V70, P251, DOI 10.1016/S0040-1625(02)00200-7	23	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194723	10.1371/journal.pone.0194723	http://dx.doi.org/10.1371/journal.pone.0194723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630616	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000015
J	Carvalho, FG; de Souza, CM; Hidalgo, MPL				Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz			Work routines moderate the association between eveningness and poor psychological well-being	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; CIRCADIAN TYPOLOGY; SOCIAL JETLAG; SLEEP; CHRONOTYPES; MORNINGNESS; ADOLESCENTS; PERFORMANCE; MEDIATION	Well-being is a useful screening method for the detection of mood disorders. Evidence associating psychological well-being with sleep-wake patterns exists, as well as associations with sleep-wake patterns, work-related parameters, and perceived self-efficacy. Despite the growing research regarding the relationship between these factors and mental health, there are few studies that analyze them together. OBJECTIVE: To investigate if the association between sleep-wake patterns and psychological well-being is mediated or moderated by perceived self-efficacy, work flexibility and work routines. MATERIAL AND METHODS: This cohort study was performed in southern Brazil. A sample of 987 individuals was analyzed (66.9% women; mean age = 43.9 years). Work routines parameters and work schedule flexibility were evaluated, most participants were farmers (46%) and most worked 7 days a week (69.1%). Munich Chronotype Questionnaire (MCTQ) was administered for evaluation of sleep-wake patterns, General Self-Efficacy Scale (GSE) for assessment the participants' beliefs about how they coped with daily hassles, and World Health Organization Five-item Well-being Index (WHO-5) for evaluation of psychological well-being levels. Moderation and mediation models were tested. RESULTS: The moderation model showed influences of work end time on the relationship between sleep onset time and psychological well-being (R-2 = 0.147; F = 24.16; p<0.001). The final regression model showed an association of psychological well-being with sex (Beta = -0.086; p = 0.004), sleep onset time (Beta = -0.086; p = 0.006), and self-efficacy (Beta = 0.316; p<0.001); the work end time showed association in the interaction with sleep onset time (Beta = -0.075; p = 0.016). CONCLUSION: The findings support the direct association of psychological well-being with sleep-wake patterns and self-efficacy, and show an interaction between work routines and sleep-wake patterns. Our results draw attention to the importance of the interplay between individual and social rhythms in relation to psychological well-being.	[Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz] Hosp Clin Porto Alegre, Chronobiol & Sleep Lab, Porto Alegre, RS, Brazil; [Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz] Univ Fed Rio Grande do Sul, Psychiat & Behav Sci Postgrad Program, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Carvalho, FG (corresponding author), Hosp Clin Porto Alegre, Chronobiol & Sleep Lab, Porto Alegre, RS, Brazil.; Carvalho, FG (corresponding author), Univ Fed Rio Grande do Sul, Psychiat & Behav Sci Postgrad Program, Porto Alegre, RS, Brazil.	labcronoesono@hcpa.edu.br	Hidalgo, Maria Paz Loayza/V-5612-2019	Hidalgo, Maria Paz Loayza/0000-0002-7886-770X	Fundo de Incentivo a Pesquisa e Eventos [FIPE/HCPA - GPPG 15-0459]	Fundo de Incentivo a Pesquisa e Eventos	The project received financial support from the "Fundo de Incentivo a Pesquisa e Eventos" (FIPE/HCPA - GPPG 15-0459). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Agorastos A, 2016, J PINEAL RES, V61, P3, DOI 10.1111/jpi.12330; Aiken L.S., 1991, MULTIPLE REGRESSION; Antypa N, 2016, DEPRESS ANXIETY, V33, P75, DOI 10.1002/da.22422; Bandura A, 1997, AM J HEALTH PROMOT, V12, P8, DOI 10.4278/0890-1171-12.1.8; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bech P., 2004, QUAL LIFE NEWSL, V32, P15; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Brink E, 2012, PSYCHOL HEALTH MED, V17, P346, DOI 10.1080/13548506.2011.608807; Carvalho FG, 2014, CHRONOBIOL INT, V31, P442, DOI 10.3109/07420528.2013.846350; de Souza CM, 2015, CHRONOBIOL INT, V32, P341, DOI 10.3109/07420528.2014.979941; de Souza CM, 2012, EUR ARCH PSY CLIN N, V262, P239, DOI 10.1007/s00406-011-0255-x; Diaz-Morales JF, 2013, CHRONOBIOL INT, V30, P1283, DOI 10.3109/07420528.2013.840786; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Hasler BP, 2013, PSYCHIAT RES-NEUROIM, V214, P357, DOI 10.1016/j.pscychresns.2013.08.005; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Henkel V, 2003, BMJ-BRIT MED J, V326, P200; Hidalgo MP, 2009, PSYCHIAT CLIN NEUROS, V63, P283, DOI 10.1111/j.1440-1819.2009.01965.x; Hidalgo MPL, 2004, PSYCHOL REP, V95, P75, DOI 10.2466/PR0.95.5.75-85; Hoogwegt MT, 2013, EUROPACE, V15, P1468, DOI 10.1093/europace/eut072; Jankowski KS, 2016, J AFFECT DISORDERS, V196, P47, DOI 10.1016/j.jad.2016.02.015; Jeon HJ, 2017, CHRONOBIOL INT, V34, P677, DOI 10.1080/07420528.2017.1309425; KNUTSSON A, 1986, LANCET, V2, P89; Lazarus RS, 1984, STRESS APPRAISAL COP, Vxiii; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Lunau T, 2014, EUR J PUBLIC HEALTH, V24, P422; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Meng X, 2016, EPIDEMIOL PSYCHIAT S, V25, P370; Ottoni GL, 2012, CHRONOBIOL INT, V29, P786, DOI 10.3109/07420528.2012.679329; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roeser K, 2012, CHRONOBIOL INT, V29, P1358, DOI 10.3109/07420528.2012.728664; Romo-Nava F, 2016, CHRONOBIOL INT, V33, P1359, DOI 10.1080/07420528.2016.1217230; Rottmann N, 2010, QUAL LIFE RES, V19, P827, DOI 10.1007/s11136-010-9653-1; Schutte S, 2014, INT ARCH OCC ENV HEA, V87, P897, DOI 10.1007/s00420-014-0930-0; Souza I., 2004, REV UNIVERSIDADE RUR, V26, P12; Stansfeld SA, 2003, J EPIDEMIOL COMMUN H, V57, P361, DOI 10.1136/jech.57.5.361; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tuchsen F, 2006, OCCUP ENVIRON MED, V63, P451, DOI 10.1136/oem.2006.026716; Vetter C, 2015, DIABETES CARE, V38, P1707, DOI 10.2337/dc15-0302; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wittmann M, 2010, SUBST USE MISUSE, V45, P15, DOI 10.3109/10826080903498952	45	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195078	10.1371/journal.pone.0195078	http://dx.doi.org/10.1371/journal.pone.0195078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624593	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600014
J	Choi, ST; Lee, KH				Choi, Sang-Tae; Lee, Kwang-Hoon			Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; CLASSIFICATION; CRITERIA; COHORT	Both rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) are associated with poor radiologic outcomes in patients with rheumatoid arthritis (RA). In general, RA patients positive for RF or ACPA (SPRA) are considered to manifest an aggressive disease course compared with seronegative RA patients (SNRA). However, the relationship between seropositivity and measures of disease severity other than radiologic outcome is disputed. In this study, we sought to compare the clinical presentations and treatment outcomes of SNRA and SPRA patients. A total of 241 patients diagnosed with DMARD-naive RA under either 1987 American College of Rheumatology (ACR) criteria or 2010 ACR/European League Against Rheumatism (EULAR) criteria were identified (40 with SNRA and 201 with SPRA). We investigated the disease activity measures including ESR, CRP, patient VAS, 28 tender/swollen joint count (28 TJC, 28 SJC) and DAS28 as well as radiologic outcomes at baseline, 1 and 2 years after conventional treatment with DMARD. Age, sex and disease duration were similar between SNRA and SPRA. However, the baseline 28 TJC (4.7+/-2.9 vs. 3.3+/-2.7, p = 0.004), 28 SJC (4.3+/-3.0 vs. 2.9+/-2.3, p = 0.001) and DAS28 (5.1+/-1.0 vs. 4.7+/-1.0, p = 0.043) components were significantly higher in SNRA than in SPRA. Over 2 years of similar treatment with DMARDs, all disease activity measures significantly improved in both groups. Comparison among populations matched for baseline disease activity showed that ADAS28 at 1 year was greater in SNRA than in SPRA (-2.84+/-1.32 vs. -3.70+/-1.29, p = 0.037) in high disease activity population (DAS28-ESR>5.1). Radiologic outcomes at baseline and at 1- or 2-year follow-up were similar between the 2 groups. In conclusion, SNRA patients manifested more active disease at baseline, but showed a better response to treatment compared with SPRA. SNRA does not appear to be a benign subtype of RA.	[Choi, Sang-Tae] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Kwang-Hoon] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea	Chung Ang University; Chung Ang University Hospital; Dongguk University; NHIS Ilsan Hospital	Choi, ST (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	lkh24217@hanmail.net		Lee, Kwang-Hoon/0000-0002-9506-9072				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barra L, 2014, J RHEUMATOL, V41, P2361, DOI 10.3899/jrheum.140082; Farragher TM, 2010, ARTHRIT CARE RES, V62, P664, DOI 10.1002/acr.20207; Finckh A, 2007, ANN INTERN MED, V146, P816, DOI 10.7326/0003-4819-146-11-200706050-00011; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Geng Y, 2012, RHEUMATOL INT, V32, P3897, DOI 10.1007/s00296-011-2329-5; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Katchamart W, 2015, RHEUMATOL INT, V35, P1693, DOI 10.1007/s00296-015-3271-8; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Miller A, 2013, CLIN RHEUMATOL, V32, P1089, DOI 10.1007/s10067-013-2236-0; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nordberg LB, 2017, ANN RHEUM DIS, V76, P341, DOI 10.1136/annrheumdis-2015-208873; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Whiting PF, 2010, ANN INTERN MED, V152, P456, DOI 10.7326/0003-4819-152-7-201004060-00010	16	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195550	10.1371/journal.pone.0195550	http://dx.doi.org/10.1371/journal.pone.0195550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624625	Green Submitted, gold, Green Published			2022-12-27	WOS:000429379600038
J	Shi, Q; Lie, KJ; Treuer, T; Wang, BCM; Gaich, CL; Lee, CH; Wu, WS; Furnback, W; Tang, CH				Shi, Qiang; Lie, Ko-Jen; Treuer, Tamas; Wang, Bruce C. M.; Gaich, Carol L.; Lee, Chien-Hsun; Wu, Wen-Shuo; Furnback, Wesley; Tang, Chao-Hsiun			Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)	PLOS ONE			English	Article							RISK; PREVALENCE; COMORBIDITY; MANIFESTATIONS; OSTEOPOROSIS; CONSORTIUM; MORTALITY; FREQUENCY; FRACTURE; PEOPLE	Background Previous studies in Taiwan utilizing the Taiwan's National Health Insurance Database (NHIRD) have estimated the direct healthcare costs of RA patients, but they have not focused on patients on bDMARDs, or considered patients' response to therapy. Objectives The objective of this study was to estimate the rate of inadequate response for patients newly treated with biologic disease-modifying antirheumatic drugs (bDMARDs) as well as their costs and resource use. Methods Data were from the catastrophic illness file within the NHIRD from 1/1/2009 to 12/31/2013. Patients with RA, which was categorized by the presence of a catastrophic illness card, that were previously bDMARD-naive, were included in this study if they initiated their first bDMARD during the index period. The index period included all of 2010, a pre-index period consisting of the index date 365 days, and a follow-up period including the index date to 365 days post-index, were also included. Previously biologically-naive patients were indexed into the study on the date of their first claim for a bDMARD. A validated algorithm was used to examine the rate of inadequate response (IR) in the biologically-naive cohort of patients. Inadequate responders met one or more of the following criteria during their year of follow-up: low adherence (proportion of days covered <0.80); switched to or added a second bDMARD; added a new conventional synthetic DMARD (csDMARD); received >= 1 glucocorticoid injection; or increased oral glucocorticoid dosing. All-cause mean annual direct costs and resource use were measured in the year of follow-up. Costs were converted from NT$ to USD using 1 NT$ = 0.033 USD. Results A total of 818 patients with RA initiated their first bDMARD (54% etanercept and 46% adalimumab) in 2010. After one year of follow-up, 32% (n = 258) were classified as stable, 66% (n = 540) had an IR, and 2% (n = 20) were lost to follow-up. During the follow-up period mean annual total direct costs were $16,136 for stable patients compared to $14,154 for patients with IR. Mean annual non-medication direct costs were $937 for stable patients and $1,574 for patients with IR. Mean annual hospitalizations were higher for patients with IR (0.46) compared to stable patients (0.10) during the one year follow-up period. Conclusions The majority of patients that were previously naive to bDMARDs had an IR to their first bDMARD during the year of follow-up. Patients with an IR had numerically increased all cause resource utilization and non-medication costs during the follow-up period compared to patients with stable disease. This level of IR suggests an unmet need in the RA treatment paradigm.	[Shi, Qiang] Eli Lilly & Co, Shanghai, Peoples R China; [Lie, Ko-Jen] Natl Taiwan Univ, Taipei, Taiwan; [Treuer, Tamas] Eli Lilly & Co, Budapest, Hungary; [Wang, Bruce C. M.; Furnback, Wesley] Elysia Grp Ltd, Taipei, Taiwan; [Gaich, Carol L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Lee, Chien-Hsun; Wu, Wen-Shuo] Eli Lilly & Co, Taipei, Taiwan; [Tang, Chao-Hsiun] Taipei Med Univ, Taipei, Taiwan	Eli Lilly; National Taiwan University; Eli Lilly; Eli Lilly; Eli Lilly; Taipei Medical University	Tang, CH (corresponding author), Taipei Med Univ, Taipei, Taiwan.	chtang@tmu.edu.tw		LI, KO-JEN/0000-0002-4544-4620	Eli Lilly and Co; Eli Lilly; Elysia Group	Eli Lilly and Co(Eli Lilly); Eli Lilly(Eli Lilly); Elysia Group	This study was funded by Eli Lilly and Co (https://www.lilly.com/). Eli Lilly provided financial support in the form of salaries for QS, TT, CG, CL, WW. Eli Lilly paid the following authors as consultants: KL, BW, WF, CT. Elysia Group provided financial support in the form of salaries for BW and WF. The specific roles of these authors are articulated in the author contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bingham C, 2013, ARTHRITIS INFORM; Chang JY, 2014, VALUE HEALTH, V17, pA773, DOI 10.1016/j.jval.2014.08.328; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Coulson KA, 2009, JCR-J CLIN RHEUMATOL, V15, P155, DOI 10.1097/RHU.0b013e3181a5679d; Curtis JR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3471; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Emery P, 2012, RHEUMATOLOGY, V51, pV22, DOI 10.1093/rheumatology/kes115; Furst DE, 2014, RHEUMATOLOGY; Gabriel SE, 2008, ANN RHEUM DIS, V67, P30, DOI 10.1136/ard.2008.098038; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]; Hsieh CR, 2012, VALUE HEALTH, V15, pS35, DOI 10.1016/j.jval.2011.11.025; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin YC, 2015, OSTEOPOROSIS INT, V26, P811, DOI 10.1007/s00198-014-2968-y; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179308; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175207; Prete M, 2011, AUTOIMMUN REV, V11, P123, DOI 10.1016/j.autrev.2011.09.001; Rudan I, 2015, J GLOB HEALTH, V5, P132, DOI 10.7189/jogh.05.010409; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2014, ANN RHEUM DIS, V73, P3, DOI 10.1136/annrheumdis-2013-204317; Solomon G, 2013, BULL HOSP JT DIS, V71, P200; Strand V, 2013, ANN RHEUM DIS, V72, P71; Taiwan National Health Insurance Administration. Ministry of Health and Welfare, 2013, IMM AG REIMB GUID; Turesson C, 2013, RHEUMATOLOGY, V52, P5, DOI 10.1093/rheumatology/kes189; Wang BCM., 2016, DRUGS-REAL WOR OUTC, V3, P107, DOI [10.1007/s40801-016-0063-8, DOI 10.1007/S40801-016-0063-8]; Wotton CJ, 2012, J EPIDEMIOL COMMUN H, V66, P1177, DOI 10.1136/jech-2011-200168	36	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0193489	10.1371/journal.pone.0193489	http://dx.doi.org/10.1371/journal.pone.0193489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624580	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600002
J	Haddad, M; Pud, D; Treister, R; Suzan, E; Eisenberg, E				Haddad, May; Pud, Dorit; Treister, Roi; Suzan, Erica; Eisenberg, Elon			The effects of a dopamine agonist (apomorphine) on experimental and spontaneous pain in patients with chronic radicular pain: A randomized, double-blind, placebo-controlled, cross-over study	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; NUCLEUS-ACCUMBENS DOPAMINE; NEUROPATHIC PAIN; PARKINSONS-DISEASE; LEVODOPA; NOCICEPTION; MODULATION; THRESHOLD; EFFICACY; NEURONS	Background Although evidence suggests that dopaminergic systems are involved in pain processing, the effects of dopaminergic interventions on pain remains questionable. This randomized, double blinded, placebo-controlled, cross-over study was aimed at exploring the effect of the dopamine agonist apomorphine on experimental pain evoked by cold stimulation and on spontaneous pain in patients with lumbar radicular (neuropathic) pain. Methods Data was collected from 35 patients with chronic lumbar radiculopathy (18 men, mean age 56.2 +/- 13 years). The following parameters were evaluated before (baseline) and 30, 75 and 120 minutes subsequent to a subcutaneous injection of 1.5 mg apomorphine or placebo: cold pain threshold and tolerance in the painful site (ice pack, affected leg) and in a remote non-painful site (12 degrees C water bath, hand), and spontaneous (affected leg) pain intensity (NPS, 0-100). Results One-hundred and twenty minutes following apomorphine (but not placebo) injection, cold pain threshold and tolerance in the hand increased significantly compared to baseline (from a median of 8.0 seconds (IQR = 5.0) to 10 seconds (IQR = 9.0), p = 0.001 and from a median of 19.5 seconds (IQR = 30.2) to 27.0 seconds (IQR = 37.5), p<0.001, respectively). In addition, apomorphine prolonged cold pain tolerance but not threshold in the painful site (from a median of 43.0 seconds (IQR = 63.0) at baseline to 51.0 seconds (IQR = 78.0) at 120 min, p = 0.02). Apomorphine demonstrated no superiority over placebo in reducing spontaneous pain intensity. Conclusion These findings are in line with previous results in healthy subjects, showing that apomorphine increases the ability to tolerate cold pain and therefore suggesting that dopaminergic interventions can have potential clinical relevance.	[Haddad, May; Pud, Dorit; Treister, Roi; Suzan, Erica] Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel; [Haddad, May; Eisenberg, Elon] Rambam Hlth Care Campus, Inst Pain Med, Haifa, Israel; [Eisenberg, Elon] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	University of Haifa; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Haddad, M (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel.; Haddad, M (corresponding author), Rambam Hlth Care Campus, Inst Pain Med, Haifa, Israel.	ma_haddad@rambam.health.gov.il			Israeli Science Foundation (ISF) [529-10]	Israeli Science Foundation (ISF)(Israel Science Foundation)	This study was funded by a grant from the Israeli Science Foundation (ISF) no 529-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Attal N, 2006, EUR J NEUROL, V13, P1153, DOI 10.1111/j.1468-1331.2006.01511.x; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Becker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080766; Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Burkey AR, 1999, J NEUROSCI, V19, P4169; Charbit AR, 2009, J PHARMACOL EXP THER, V331, P752, DOI 10.1124/jpet.109.151951; Conti CF, 2007, MOVEMENT DISORD, V22, P1943, DOI 10.1002/mds.21662; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2002, LANCET NEUROL, V1, P85, DOI 10.1016/S1474-4422(02)00038-8; de la Fuente-Fernandez R, 2001, J CEREBR BLOOD F MET, V21, P1151, DOI 10.1097/00004647-200110000-00003; de la Fuente-Fernandez R, 2009, PARKINSONISM RELAT D, V15, pS72, DOI 10.1016/S1353-8020(09)70785-0; dela Pena I, 2015, EUR J PHARMACOL, V764, P562, DOI 10.1016/j.ejphar.2015.07.044; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finnerup NB, 2013, EUR J PAIN, V17, P953, DOI 10.1002/j.1532-2149.2012.00282.x; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Flores JA, 2004, PAIN, V110, P205, DOI 10.1016/j.pain.2004.03.036; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Gilron I, 2013, LANCET NEUROL, V12, P1084, DOI 10.1016/S1474-4422(13)70193-5; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; Hornyak M, 2012, SLEEP MED, V13, P228, DOI 10.1016/j.sleep.2011.09.013; Inoue Y, 2013, SLEEP MED, V14, P1085, DOI 10.1016/j.sleep.2013.07.007; Jorum E, 2003, PAIN, V101, P229, DOI 10.1016/S0304-3959(02)00122-7; Kassubek J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-42; KERNBAUM S, 1981, JAMA-J AM MED ASSOC, V246, P132; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; LINDVALL O, 1983, ANN NEUROL, V14, P255, DOI 10.1002/ana.410140302; Lopez-Avila A, 2004, PAIN, V111, P136, DOI 10.1016/j.pain.2004.06.010; Main DCJ, 1997, J VET PHARMACOL THER, V20, P220, DOI 10.1111/j.1365-2885.1997.tb00099.x; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; PRZEDBORSKI S, 1995, MOVEMENT DISORD, V10, P28, DOI 10.1002/mds.870100107; Reinersmann A, 2013, PAIN MANAG, V3, P495, DOI [10.2217/pmt.13.53, 10.2217/PMT.13.53]; Ribaric S, 2012, MOLECULES, V17, P5289, DOI 10.3390/molecules17055289; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Slaoui T, 2007, REV NEUROL-FRANCE, V163, P66, DOI 10.1016/S0035-3787(07)90356-2; Stuginski-Barbosa J, 2008, J HEADACHE PAIN, V9, P43, DOI 10.1007/s10194-008-0003-4; Tiemann L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096167; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Treister R, 2015, PAIN PRACT, V15, P4, DOI 10.1111/papr.12129; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Tuttle AH, 2015, PAIN, V156, P2616, DOI 10.1097/j.pain.0000000000000333; Wei H, 2009, PHARMACOL RES, V59, P355, DOI 10.1016/j.phrs.2009.01.001; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Yin K, 2015, BIOCHEM PHARMACOL, V93, P125, DOI 10.1016/j.bcp.2014.09.024	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195287	10.1371/journal.pone.0195287	http://dx.doi.org/10.1371/journal.pone.0195287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621293	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800055
J	Murray, G; Agyare, A				Murray, Grant; Agyare, Andrew			Religion and perceptions of community-based conservation in Ghana, West Africa	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; TABOOS; MANAGEMENT; GOVERNANCE; CONTEXT; SUCCESS	Adapting community-based protected areas to local context and evaluating their success across a range of possible socio-economic and ecological outcomes depends, in part, on understanding the perceptions of local actors. This article presents results from a mixed methods study that focuses on how and why religious identity, a prominent aspect of Ghanaian culture, is related to perceptions of the performance of several Community Resource Management Areas (CREMAs). CREMAs are a form of Ghanaian protected area that emphasizes community participation and a range of socio-economic and ecological objectives. Using importance-satisfaction analysis, large-scale survey results show that respondents that identify as Christians consistently assign greater importance to CREMA outcomes than do those that identify with Traditional religions. Education and whether respondents were native to an area (both of which were correlated with religious identity) were also systematically related to perceptions of CREMA importance, with those that are educated and non-native to an area tending to assign higher importance to CREMA outcomes. Follow up focus group participants from the Avu Lagoon CREMA suggest that the patterns result from differing 'openness' to new ideas, relative dependence on natural resources, acceptance of Traditional practices associated with conservation, and a sense, for some, that ecological conditions are divinely ordained. Christianity, education and non-nativity are associated with much larger performance gaps, particularly with respect to socio-economic impacts. The article concludes with a discussion of the implications for conservation interventions and the use of perceptions in assessing protected area performance.	[Murray, Grant] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Agyare, Andrew] Ghana Wildlife Div Forestry Commiss, Accra, Ghana	Duke University	Murray, G (corresponding author), Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA.	grant.murray@duke.edu			Social Sciences and Humanities Research Council of Canada; Canadian International Development Research Center [104518-012]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian International Development Research Center	This study was conducted as part of a larger research project entitled "Protected Areas and Poverty Reduction: A Canada-African Research and Learning Alliance" (PAPR). PAPR was jointly funded by the Social Sciences and Humanities Research Council of Canada and the Canadian International Development Research Center (Grant number 104518-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyamfi Y, 2011, SCRIPTURA, V107, P145; Agyare A, 2015, ENV DEV SUSTAINABILI; Agyare A, 2015, SOC NATUR RESOUR, V28, P975, DOI 10.1080/08941920.2015.1042127; Ampadu-Agyei O, HDB TOTEMS GHANA TRA; [Anonymous], 2012, EC ONLINE       0905; Awuah-Nyamekye S., 2014, MANAGING ENV CRISIS; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Borrini-Feyerabend G, 2013, BEST PRACT PROTECT A, V20; Brechin S. R., 2010, Journal of Sustainable Forestry, V29, P362, DOI 10.1080/10549810903550811; Fabinyi M, 2014, ECOL SOC, V19, DOI 10.5751/ES-07029-190428; Foli S, 2017, ENV MANAGEMENT; Government of Ghana (nd), INF BAS 2012 CENS; Hens Luc, 2006, Journal of Human Ecology, V20, P21; Jimoh Saka Oladunni, 2012, Journal of Human Ecology, V39, P209; Mascia MB, 2014, BIOL CONSERV, V169, P258, DOI 10.1016/j.biocon.2013.11.017; McPherson JM, 2016, ECOL SOC, V21, DOI 10.5751/ES-08089-210124; Murphy C, 2016, CLIMATIC CHANGE, V134, P101, DOI 10.1007/s10584-015-1498-8; Murray GD, 2005, SOC NATUR RESOUR, V18, P889, DOI 10.1080/08941920500248814; Nature Conservation Research Center (NCRC), 2008, SOC STUD AV LAG COMM; NTIAMOABAIDU Y, 1991, LANDSCAPE URBAN PLAN, V20, P41, DOI 10.1016/0169-2046(91)90089-5; Oldekop JA, 2016, CONSERV BIOL, V30, P133, DOI 10.1111/cobi.12568; Pullin A.S., 2013, KEY TOP CONSERV BIOL, V2, P3; ROE D, 2009, NATURAL RESOURCE ISS, V18; Saj TL, 2006, SOC SCI INFORM, V45, P285, DOI 10.1177/0539018406063644; Sluka Robert D., 2011, Biodiversity, V12, P108; Taringa N, 2006, EXCHANGE, V35, P191, DOI 10.1163/157254306776525672; Tengo M, 2007, AMBIO, V36, P683, DOI 10.1579/0044-7447(2007)36[683:TAFGIP]2.0.CO;2; Tonge J, 2007, TOURISM MANAGE, V28, P768, DOI 10.1016/j.tourman.2006.05.007; United Nations Development Program (UNDP), 2011, PROT AR 21 CENT LESS; Wade D. J., 2003, Journal of Ecotourism, V2, P196, DOI 10.1080/14724040308668144; Waylen KA, 2010, CONSERV BIOL, V24, P1119, DOI 10.1111/j.1523-1739.2010.01446.x	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195498	10.1371/journal.pone.0195498	http://dx.doi.org/10.1371/journal.pone.0195498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621348	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800095
J	Okugn, A; Woldeyohannes, D				Okugn, Akoma; Woldeyohannes, Demelash			Food hygiene practices and its associated factors among model and non model households in Abobo district, southwestern Ethiopia: Comparative cross-sectional study	PLOS ONE			English	Article								Background In developing country most of human infectious diseases are caused by eating contaminated food. Estimated nine out ten of the diarrheal disease is attributable to the environment and associated with risk factors of poor food hygiene practice. Understanding the risk of eating unsafe food is the major concern to prevent and control food borne diseases. The main goal of this study was to assessing food hygiene practices and its associated factors among model and non model households at Abobo district. Methods This study was conducted from 18 October 2013 to 13 June 2014. A community-based comparative cross-sectional study design was used. Pretested structured questionnaire was used to collect data. A total of 1247 households (417 model and 830 non model households) were included in the study from Abobo district. Bivariate and multivariate logistic regression analysis was used to identify factors associated with outcome variable. Results The study revealed that good food hygiene practice was 51%, of which 79% were model and 36.70% were non model households. Type of household [AOR: 2.07, 95% CI: (1.32-3.39)], sex of household head [AOR: 1.63, 95% CI: (1.06-2.48)], Availability of liquid wastes disposal pit [AOR: 2.23, 95% CI: (1.39,3.63)], Knowledge of liquid waste to cause diseases [AOR: 1.95, 95% (1.23,3.08)], and availability of functional hand washing facility [AOR: 3.61, 95% CI: (1.86-7.02)] were the factors associated with food handling practices. Conclusion This study revealed that good food handling practice is low among model and non model households. While type of household (model versus non model households), sex, knowledge of solid waste to cause diseases, availability of functional hand washing facility, and availability of liquid wastes disposal pit were the factors associated with outcome variable. Health extension workers should play a great role in educating households regarding food hygiene practices to improve their knowledge and practices of the food hygiene.	[Okugn, Akoma] Gambella Coll Hlth Sci, Dept Nursing, Gambella, Ethiopia; [Woldeyohannes, Demelash] Madda Walabu Univ, Coll Med & Hlth Sci, Dept Nursing, Bale Goba, Ethiopia	University of Gondar	Woldeyohannes, D (corresponding author), Madda Walabu Univ, Coll Med & Hlth Sci, Dept Nursing, Bale Goba, Ethiopia.	woldemel@gmail.com		Handiso, Demelash Woldeyohannes/0000-0002-4071-795X				Abobo district a Health Office, 2013, AB DISTR HLTH OFF RE; Abobo district Office of Finance and Economic Development, 2010, ANN REPORT; [Anonymous], 2001, GLOBAL SURVEILLANCE; Central Statistical Agency [Ethiopia] and ORC Macro [USA], 2011, ETH DEM HLTH SURV; Gambella People National Regional State, 2011, GAMB PEOPL NAT REG S; Gambella Regional Health Bureau, 2011, ENV SAN HYG REP; Korma S, 2011, THESIS; Ministry of Health, 2007, EST BURD WAT BORN DI; MOH, 2004, FOOD HYG SAF MEAS EX; MOH, 2005, NAT HYG SAN STRAT; MOH, 2004, IMPR ACC COV RUR POO; Tadesse D, RAPID ASSESSMENT DRI; WHO, 2006, REV DIS HLTH ENV EST	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194391	10.1371/journal.pone.0194391	http://dx.doi.org/10.1371/journal.pone.0194391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621267	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800017
J	Pellegrini, B; Boccia, G; Zoppirolli, C; Rosa, R; Stella, F; Bortolan, L; Rainoldi, A; Schena, F				Pellegrini, Barbara; Boccia, Gennaro; Zoppirolli, Chiara; Rosa, Raffaela; Stella, Federico; Bortolan, Lorenzo; Rainoldi, Alberto; Schena, Federico			Muscular and metabolic responses to different Nordic walking techniques, when style matters	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; HEALTH-BENEFITS; GAIT; POLE; REHABILITATION; EXTREMITY; TREADMILL; EXERCISE; CAPACITY; FITNESS	Due to poling action and upper body engagement, Nordic walking (NW) has additional health benefits with respect to conventional walking. The aim of this study was to evaluate the differences in muscle activation and metabolic responses between NW, performed with the technique suggested by NW instructors, and with some modifications in the way to move upper limb and poles. Ten NW instructors volunteered to walk on a treadmill at 5.5 km.h(-1) in five conditions: walking (W), Nordic walking (NW), NW with a weak poling action (NWweak), with straight-upper limbs moving the shoulders (NWshoulder) and with elbow flexion-extension pattern and shoulder freezed (NWelbow). Poling forces, body segments and poles movement, upper and lower body muscle activation, as well as metabolic parameters were measured. All modified NW techniques elicited lower muscular activation and metabolic responses with respect to the suggested NW technique (P < 0.05). All NW techniques elicited higher muscular activation and metabolic responses than W. All parameters observed with the NWweak were lower than NW. A decreased activation of shoulder extensor muscles and increased activation of anterior deltoid muscle were the main features of NWshoulder. Lower triceps brachii muscle activation and reduced propulsive poling action with respect to NW were seen for NWelbow, resulting also in shorter steps. Nordic walking instructors, sport technicians and practitioners should be aware that any deviation from the technique usually suggested might lead to lower benefits. However it is worth to note that any walking technique with poles elicits higher metabolic responses and muscular activation than walking.	[Pellegrini, Barbara; Boccia, Gennaro; Zoppirolli, Chiara; Stella, Federico; Bortolan, Lorenzo; Schena, Federico] CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy; [Pellegrini, Barbara; Zoppirolli, Chiara; Rosa, Raffaela; Bortolan, Lorenzo; Schena, Federico] Univ Verona, Dept Neurosci Biomed & Movement, Verona, VR, Italy; [Boccia, Gennaro; Rainoldi, Alberto] Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp, Turin, TO, Italy	University of Verona; University of Turin	Pellegrini, B (corresponding author), CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy.; Pellegrini, B (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement, Verona, VR, Italy.	barbara.pellegrini@univr.it	Pellegrini, Barbara/AFV-5894-2022	PELLEGRINI, Barbara/0000-0002-9626-2632; Schena, Federico/0000-0002-2052-5117; Boccia, Gennaro/0000-0001-8706-4098; Bortolan, Lorenzo/0000-0002-1591-8565				Andersen CH, 2014, J OCCUP REHABIL, V24, P316, DOI 10.1007/s10926-013-9441-1; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296, DOI 10.1080/02701367.2002.10609023; Encarnacion-Martinez A, 2015, RES Q EXERCISE SPORT, V86, P94, DOI 10.1080/02701367.2014.975178; Figard-Fabre H, 2011, INT J SPORTS MED, V32, P407, DOI 10.1055/s-0030-1268461; Figard-Fabre H, 2010, EUR J APPL PHYSIOL, V108, P1141, DOI 10.1007/s00421-009-1315-z; Fritschi JO, 2012, SCAND J MED SCI SPOR, V22, pe70, DOI 10.1111/j.1600-0838.2012.01495.x; Fritschi JO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-375; Girold S, 2017, ANN PHYS REHABIL MED, V60, P223, DOI 10.1016/j.rehab.2016.12.004; Grainer A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101235; Grimmer Karen, 1997, Aust J Physiother, V43, P7; Hansen EA, 2009, J STRENGTH COND RES, V23, P1187, DOI 10.1519/JSC.0b013e31819f1e2b; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Homma D, 2016, J PHYS THER SCI, V28, P1213, DOI 10.1589/jpts.28.1213; Jakobsen V, 2007, 4 INT C SCI SKIING S; Jurimae T, 2009, CLIN PHYSIOL FUNCT I, V29, P330, DOI 10.1111/j.1475-097X.2009.00872.x; Kocur P, 2015, J PHYS THER SCI, V27, P3733, DOI 10.1589/jpts.27.3733; Kocur P, 2009, CLIN REHABIL, V23, P995, DOI 10.1177/0269215509337464; Kuhtz-Buschbeck JP, 2012, J ELECTROMYOGR KINES, V22, P199, DOI 10.1016/j.jelekin.2011.08.014; Mathieson S, 2014, BRIT J SPORT MED, V48, P1577, DOI 10.1136/bjsports-2013-093294; Ossowski ZM, 2016, CLIN INTERV AGING, V11, P1763, DOI 10.2147/CIA.S118995; Padulo J, 2014, P NATL ACAD SCI USA, V111, pE1160, DOI 10.1073/pnas.1400112111; Parkatti T, 2012, J AGING PHYS ACTIV, V20, P93, DOI 10.1123/japa.20.1.93; Pellegrini B, 2011, SCAND J MED SCI SPOR, V21, P589, DOI 10.1111/j.1600-0838.2009.01071.x; Pellegrini B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138906; Piccoli MB, 2014, MUSCLE NERVE, V49, P413, DOI 10.1002/mus.23934; Porcari JP, 1997, RES Q EXERCISE SPORT, V68, P161, DOI 10.1080/02701367.1997.10607992; Reuter I, 2011, J AGING RES, V2011; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Saeterbakken AH, 2017, EUR J PHYS REHABIL M; Schiffer T, 2006, EUR J APPL PHYSIOL, V98, P56, DOI 10.1007/s00421-006-0242-5; Schiffer T, 2011, EUR J APPL PHYSIOL, V111, P1121, DOI 10.1007/s00421-010-1739-5; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; Shim JM, 2013, J PHYS THER SCI, V25, P1553, DOI 10.1589/jpts.25.1553; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; Takeshima N, 2013, J SPORT SCI MED, V12, P422; Tschentscher M, 2013, AM J PREV MED, V44, P76, DOI 10.1016/j.amepre.2012.09.043; Willson J, 2001, MED SCI SPORT EXER, V33, P142; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	39	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195438	10.1371/journal.pone.09195438	http://dx.doi.org/10.1371/journal.pone.09195438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621317				2022-12-27	WOS:000429206800082
J	Yoon, JC; Kim, YJ; Lee, YJ; Ryoo, SM; Sohn, CH; Seo, DW; Lee, YS; Lee, JH; Lim, KS; Kim, WY				Yoon, Jae Chol; Kim, Youn-Jung; Lee, You-Jin; Ryoo, Seung Mok; Sohn, Chang Hwan; Seo, Dong-Woo; Lee, Yoon-Seon; Lee, Jae Ho; Lim, Kyoung Soo; Kim, Won Young			Serial evaluation of SOFA and APACHE II scores to predict neurologic outcomes of out-of-hospital cardiac arrest survivors with targeted temperature management	PLOS ONE			English	Article							SEVERITY SCORE; RESUSCITATION; CARE; CARDIOPULMONARY; COUNCIL	Objective This study was aimed at a serial evaluation and comparison of the prognostic values of Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores for neurologic outcomes in comatose, out-of-hospital cardiac arrest (OHCA) survivors, treated with targeted temperature management (TTM). Methods We analysed a prospective cohort of comatose OHCA patients, with TTM, admitted to an emergency intensive care unit (ICU), between January 2010 and December 2015. SOFA and APACHE II scores were calculated initially, and then at day 1, 2, 3, 5, and 7 after ICU admission. Primary and secondary outcomes were the 28-day neurologic outcome and the 28-day mortality, respectively. Prognostic value of the SOFA and APACHE II scores was analysed using the receiver operating characteristic curve. Results Of the 143 selected patients, 62 survived and 34 had good neurologic outcomes at day 28. There was no significant difference in the SOFA and extracerebral SOFA scores between the good and poor neurologic outcome groups. However, the APACHE II scores were significantly higher in the good outcome group; they displayed good discriminatory power in predicting poor outcomes, unlike the SOFA scores. The APACHE II score at day 3 had the highest prognostic value for predicting poor neurologic outcomes with an area under the cure of 0.793, and with a cut-off value of 20, the APACHE II score predicted poor neurologic outcomes with a sensitivity of 43.75%, a specificity of 94.12%, a positive predictive value of 94.59%, and a negative predictive value of 41.56%. Conclusions Identifying APACHE II score might assist as one piece of multimodal prognostic approach for the assessment of neurologic outcomes in OHCA survivors treated with TTM.	[Yoon, Jae Chol] Chonbuk Natl Univ, Res Inst Clin Med, Dept Emergency Med, Jeonju Si, South Korea; [Yoon, Jae Chol] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea; [Kim, Youn-Jung; Ryoo, Seung Mok; Sohn, Chang Hwan; Seo, Dong-Woo; Lee, Yoon-Seon; Lee, Jae Ho; Lim, Kyoung Soo; Kim, Won Young] Univ Ulsan, Dept Emergency Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Lee, You-Jin] Univ Ulsan, Gangneung Asan Hosp, Dept Emergency Med, Coll Med, Kangnung, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, WY (corresponding author), Univ Ulsan, Dept Emergency Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	wonpia73@naver.com		Kim, Won Young/0000-0002-6904-5966; Ryoo, Seung Mok/0000-0002-2436-3311				Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Andrew E, 2017, RESUSCITATION, V110, P42, DOI 10.1016/j.resuscitation.2016.10.018; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Cour M, 2016, RESUSCITATION, V102, P110, DOI 10.1016/j.resuscitation.2016.03.001; Donnino MW, 2013, RESUSCITATION, V84, P651, DOI 10.1016/j.resuscitation.2012.10.024; GIANGIULIANI G, 1989, INTENS CARE MED, V15, P519, DOI 10.1007/BF00273563; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Kim WY, 2016, RESUSCITATION, V105, P203, DOI 10.1016/j.resuscitation.2016.03.020; Kim YJ, 2017, JACC-CARDIOVASC INTE, V10, P452, DOI 10.1016/j.jcin.2016.11.046; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee BK, 2017, J CRIT CARE, V40, P36, DOI 10.1016/j.jcrc.2017.02.021; Nobile L, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1528-6; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Rittenberger JC, 2011, RESUSCITATION, V82, P1399, DOI 10.1016/j.resuscitation.2011.06.024; Roberts BW, 2013, CRIT CARE MED, V41, P1492, DOI 10.1097/CCM.0b013e31828a39e9; RUTLEDGE R, 1993, AM J SURG, V166, P244, DOI 10.1016/S0002-9610(05)80966-3; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	18	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195628	10.1371/journal.pone.0195628	http://dx.doi.org/10.1371/journal.pone.0195628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621337	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800110
J	Werling, M; Fandriks, L; Olbers, T; Mala, T; Kristinsson, J; Stenlof, K; Wallenius, V; Docherty, NG; Le Roux, CW				Werling, Malin; Fandriks, Lars; Olbers, Torsten; Mala, Tom; Kristinsson, Jon; Stenlof, Kaj; Wallenius, Ville; Docherty, Neil G.; Le Roux, Carel W.			Biliopancreatic Diversion is associated with greater increases in energy expenditure than Roux-en-Y Gastric Bypass	PLOS ONE			English	Article							LAPAROSCOPIC DUODENAL SWITCH; BODY-MASS INDEX; GLUCOSE; RATS; HYPERTROPHY; METABOLISM; SURGERY	Objective The greater weight loss achieved following Biliopancreatic Diversion with Duodenal Switch (BPDS) versus Roux-en-Y Gastric Bypass (RYGB) has been attributed to the malabsorptive effects of BPDS. Increased weight loss after BPDS could also be underpinned by larger increases in energy expenditure. Hypothetically, the more radical reconfiguration of the small intestine in BPDS could result in an accentuated increase in meal associated thermogenesis (MAT). Design Female subjects (baseline mean age 40 years, mean BMI-55kg/m(2)) were assessed four years after randomization to BPDS (n = 6) or RYGB (n = 6). Energy expenditure (EE) and respiratory quotient (RQ) were measured by indirect calorimetry over 24 hours. A detailed protocol allowed for discrimination of basal metabolic rate (BMR), fasting EE and MAT as components of total energy expenditure (TEE) normalised for total and lean tissue by dual energy x-ray absorptiometry. Results Median weight loss at follow-up was 1.5-fold higher following BPDS relative to RYGB, resulting in respective median BMIs of 29.5 kg/m 2 (21.7 to 36.7) after BPDS and 37.8 kg/m(2) (34.1 to 45.7) after RYGB (p = 0.015). The BPDS group had a lower fat:lean ratio compared to the RYGB group (p = 0.009). Overall 24-hour TEE adjusted for total tissue was higher in the BPDS group, as were BMR, fasting EE and MAT (all p<0.05). Differences between RYGB and BPDS in BMR and TEE were nullified when normalised for lean mass. Postprandial RQ increased significantly but to a similar extent in both groups. Conclusion Enhanced and prolonged MAT and lower fat:lean mass ratios after BPDS may explain relative increases in total energy expenditure as compared to RYGB.	[Werling, Malin; Fandriks, Lars; Olbers, Torsten; Wallenius, Ville; Docherty, Neil G.; Le Roux, Carel W.] Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ,Dept Surg, Gothenburg, Sweden; [Mala, Tom; Kristinsson, Jon] Oslo Univ Hosp, Dept Morbid Obes & Bariatr Surg, Oslo, Norway; [Mala, Tom; Kristinsson, Jon] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Stenlof, Kaj] Sahlgrens Univ Hosp, Gothia Forum, Gothenburg, Sweden; [Docherty, Neil G.; Le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland; [Le Roux, Carel W.] Imperial Coll London, Invest Sci, London, England	Sahlgrenska University Hospital; University of Gothenburg; University of Oslo; University of Oslo; Sahlgrenska University Hospital; University College Dublin; Imperial College London	Docherty, NG (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ,Dept Surg, Gothenburg, Sweden.; Docherty, NG (corresponding author), Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland.	neil.docherty@ucd.ie	Mala, Tom/J-5418-2019; Wallenius, Ville Raymond/C-5486-2014	Mala, Tom/0000-0003-3058-4775; Wallenius, Ville Raymond/0000-0001-8668-3196; Olbers, Torsten/0000-0002-7218-3390; Le Roux, Carel/0000-0001-5521-5445; Docherty, Neil/0000-0002-0961-2607	Vetenskapsradet [K2010-55X21432-01-2]; Science Foundation Ireland [12/Y1/ B2480]; Gothenburg Medical Association; Sahlgrenska Universitetssjukhuset; Sahlgrenska Akademin	Vetenskapsradet(Swedish Research Council); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Gothenburg Medical Association; Sahlgrenska Universitetssjukhuset; Sahlgrenska Akademin	For this study, the authors received funding from: Vetenskapsradet (K2010-55X21432-01-2), Science Foundation Ireland (12/Y1/ B2480), Gothenburg Medical Association, Sahlgrenska Universitetssjukhuset, and Sahlgrenska Akademin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraboi ED, 2015, ENDOCRINOLOGY, V156, P1316, DOI 10.1210/en.2014-1785; Baud G, 2016, CELL METAB, V23, P547, DOI 10.1016/j.cmet.2016.01.018; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; Branski LK, 2010, JPEN-PARENTER ENTER, V34, P55, DOI 10.1177/0148607109336601; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Cavin JB, 2016, GASTROENTEROLOGY, V150, P454, DOI 10.1053/j.gastro.2015.10.009; Dirksen C, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12087; Hansen CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065696; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Li W, 2015, SURG OBES RELAT DIS, V11, P356, DOI 10.1016/j.soard.2014.07.020; Risstad H, 2016, JAMA SURG, V151, P1146, DOI 10.1001/jamasurg.2016.2798; Risstad H, 2015, JAMA SURG, V150, P352, DOI 10.1001/jamasurg.2014.3579; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sovik TT, 2010, BRIT J SURG, V97, P160, DOI 10.1002/bjs.6802; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Sudan R, 2011, SURG CLIN N AM, V91, P1281, DOI 10.1016/j.suc.2011.08.015; Van Hee RHGG, 2004, WORLD J SURG, V28, P435, DOI 10.1007/s00268-004-7364-x; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Werling M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129784; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194538	10.1371/journal.pone.0194538	http://dx.doi.org/10.1371/journal.pone.0194538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617391	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800035
J	Weber, KS; Bridgewater, LC; Jensen, JL; Breakwell, DP; Nielsen, BL; Johnson, SM				Weber, K. Scott; Bridgewater, Laura C.; Jensen, Jamie L.; Breakwell, Donald P.; Nielsen, Brent L.; Johnson, Steven M.			Personal microbiome analysis improves student engagement and interest in Immunology, Molecular Biology, and Genomics undergraduate courses	PLOS ONE			English	Article							INSTRUCTION; HEALTH	A critical area of emphasis for science educators is the identification of effective means of teaching and engaging undergraduate students. Personal microbiome analysis is a means of identifying the microbial communities found on or in our body. We hypothesized the use of personal microbiome analysis in the classroom could improve science education by making courses more applied and engaging for undergraduate students. We determined to test this prediction in three Brigham Young University undergraduate courses: Immunology, Advanced Molecular Biology Laboratory, and Genomics. These three courses have a two-week microbiome unit and students during the 2016 semester students could submit their own personal microbiome kit or use the demo data, whereas during the 2017 semester students were given access to microbiome data from an anonymous individual. The students were surveyed before, during, and after the human microbiome unit to determine whether analyzing their own personal microbiome data, compared to analyzing demo microbiome data, impacted student engagement and interest. We found that personal microbiome analysis significantly enhanced the engagement and interest of students while completing microbiome assignments, the self-reported time students spent researching the microbiome during the two week microbiome unit, and the attitudes of students regarding the course overall. Thus, we found that integrating personal microbiome analysis in the classroom was a powerful means of improving student engagement and interest in undergraduate science courses.	[Weber, K. Scott; Bridgewater, Laura C.; Breakwell, Donald P.; Nielsen, Brent L.; Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Jensen, Jamie L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Weber, KS (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	scott_weber@byu.edu	Johnson, Steven M/B-3940-2013; Bridgewater, Laura C/I-2999-2015; Weber, Scott/O-1022-2014	Bridgewater, Laura C/0000-0002-4664-6144; Weber, Scott/0000-0003-3688-2191; Johnson, Steven/0000-0002-7399-8153	Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University; College of Life Sciences at Brigham Young University	Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University; College of Life Sciences at Brigham Young University	This work was supported by a Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University.; The authors would like to thank the College of Life Sciences at Brigham Young University for providing support in the form of a Teaching Enhancement Grant we received in 2015 that allowed for the purchase of the personal microbiome kits. We would also like to thank Josie Tueller for suggestions to improve the manuscript.	[Anonymous], 2006, ED PSYCHOL DEV LEARN; Ash C, 2016, SCIENCE, V352, P531, DOI 10.1126/science.352.6285.530; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Boguski MS, 2013, GENOME MED, V5, DOI 10.1186/gm426; Bransford JDBA, 2000, PEOPLE LEARN BRAIN M, P206, DOI DOI 10.17226/9853; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Callaway E, 2015, NATURE, V521, P136, DOI 10.1038/521136a; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DEaR RM, 1985, INTRINSIC MOTIVATION; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Eccles J. S., 1983, ACHIEVEMENT ACHIEVEM, P75, DOI DOI 10.1006/CEPS.1999.1015; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Frey N., 2010, J ENGLISH JOURNAL, V100, P30, DOI DOI 10.2307/20787688; Garber KB, 2016, TRENDS GENET, V32, P317, DOI 10.1016/j.tig.2016.03.008; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Glasner ME, 2017, SCIENCE, V355, P577, DOI 10.1126/science.aam7446; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Hagiwara N, 2017, ADV MED EDUC PRACT, V8, P817, DOI 10.2147/AMEP.S145696; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Hartman MR, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw266; Hidi S, 2006, EDUC PSYCHOL-US, V41, P111, DOI 10.1207/s15326985ep4102_4; Houtman JHS, 2015, HUMAN MICROBIOME YOU, P1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen JL, 2017, J MICROBIOL BIOL EDU, V18, DOI 10.1128/jmbe.v18i3.1367; Katsanis Sara H, 2013, N C Med J, V74, P491; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Parker L. C., 2008, IDEAS NOS UNDERGRADU, P1681, DOI [DOI 10.1175/2008BAMS2349.1, 10.1175/2008BAMS2349.1]; Plunkett-Rondeau J, 2015, GENET MED, V17, P927, DOI 10.1038/gim.2014.208; Priniski SJ, 2018, J EXP EDUC, V86, P11, DOI 10.1080/00220973.2017.1380589; Redfield RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001356; Rhodes R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0702-7; Ryan R.M., 1990, LEARN INDIVID DIFFER, V2, P1, DOI [DOI 10.1016/1041-6080(90)90014-8, 10.1016/1041-6080(90)90014-8]; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Salari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068853; Salari K, 2011, ACAD MED, V86, P925, DOI 10.1097/ACM.0b013e3182223acf; Schiefele U., 1999, SCI STUD READ, V3, P257, DOI [DOI 10.1207/S1532799XSSR0303_4, 10.1207/s1532799xssr0303_4]; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shi J, 2010, CBE-LIFE SCI EDUC, V9, P453, DOI 10.1187/cbe.10-04-0055; Singer SR, 2013, CBE-LIFE SCI EDUC, V12, P129, DOI 10.1187/cbe.13-03-0058; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Walt DR, 2011, GENET MED, V13, P63, DOI 10.1097/GIM.0b013e3181f872ac; Weber KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133486; Weitzel KW, 2016, AM J PHARM EDUC, V80; Williams K.C., 2011, RES HIGHER ED J, V12, P1, DOI [DOI 10.5430/ILTIE.V4N, DOI 10.1080/15389588.2010.515631]; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306; Yang XM, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-09-0281; Zhang TR, 2014, J MICROBIOL BIOL EDU, V15, P197, DOI 10.1128/jmbe.v15i2.773	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193696	10.1371/journal.pone.0193696	http://dx.doi.org/10.1371/journal.pone.0193696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641525	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900016
J	Hsiung, KM; Kimura, S; Hang, YS; Takeshige, A; Iizuka, Y				Hsiung, Kuan-Mei; Kimura, Shingo; Hang, Yu-San; Takeshige, Aigo; Iizuka, Yoshiyuki			Effect of ENSO events on larval and juvenile duration and transport of Japanese eel (Anguilla japonica)	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; DAILY GROWTH INCREMENTS; PACIFIC-OCEAN; TROPICAL PACIFIC; WESTERN PACIFIC; SALINITY FRONT; FISH OTOLITHS; SARGASSO SEA; GLASS EELS; EL-NINO	Spawning ground of Japanese eel (Anguilla japonica) is located near the West Mariana Ridge seamount. The species travels through the North Equatorial Current (NEC) and then enters the Kuroshio Current (KC) on the migration toward East Asian growth habitats. Therefore, El Nino-Southern Oscillation (ENSO) events serve as the potentially important drivers of interannual variability across the equatorial Pacific. Because the NEC bifurcation and salinity profiles are related to ENSO events, we investigated the influence of locations of the NEC bifurcation and salinity front on the success of larval entry to the KC by numerically modeling particle transport in ocean currents from 1972 to 2013 and possible effects on the size of glass eels at continental recruitment and, via otolithometry on the duration of larval migration. Circulation and hydrography used for particle tracking were obtained from the results of the Model for Interdisciplinary Research on Climate (MIROC) high-resolution forecasting experiment. Our results demonstrated that during El Nino years, (1) the southward movement of the salinity front might cause the larvae to experience slower currents and (2) the northward movement of the NEC bifurcation might broaden the separation between their spawning ground and NEC bifurcation, thus prolonging the time needed for the larvae to enter the KC from their spawning ground, because of which the duration of entrainment in the water column and body size increase when eels reach estuarine waters. In addition, this might cause more water to flow into the Mindanao Current (MC), leading to a decline in the rate at which larvae get entrained into the KC.	[Hsiung, Kuan-Mei; Kimura, Shingo; Takeshige, Aigo] Univ Tokyo, Grad Sch Frontier Sci, Atmosphere & Ocean Res Inst, Chiba, Japan; [Hsiung, Kuan-Mei; Hang, Yu-San] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan; [Hsiung, Kuan-Mei; Hang, Yu-San] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan; [Takeshige, Aigo] Fisheries Res Ctr, Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa, Japan; [Iizuka, Yoshiyuki] Acad Sinica, Inst Earth Sci, Taipei, Taiwan	University of Tokyo; National Taiwan University; National Taiwan University; Japan Fisheries Research & Education Agency (FRA); Academia Sinica - Taiwan	Hsiung, KM (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Atmosphere & Ocean Res Inst, Chiba, Japan.; Hsiung, KM (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan.; Hsiung, KM (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan.	km-hsiung@s.nenv.k.u-tokyo.ac.jp	Kimura, Shingo/AAI-2209-2020	Hsiung, Kuan-Mei/0000-0002-3268-6719; Iizuka, Yoshiyuki/0000-0002-7327-7583	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [JP16H04734]	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant Numbers JP16H04734) from the Japan Society for the Promotion of Science (JSPS) to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 1997, J GEOPHYS RES-OCEANS, V102, P23063, DOI 10.1029/97JC01443; [Anonymous], 1972, BEGINNING KUROSHIO; Arai T, 2000, MAR BIOL, V137, P39, DOI 10.1007/s002270000326; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; CAMPANA SE, 1983, CAN J ZOOL, V61, P1591, DOI 10.1139/z83-214; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chen JZ, 2014, ESTUAR COAST SHELF S, V151, P361, DOI 10.1016/j.ecss.2014.06.004; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Han YS, 2012, FISH OCEANOGR, V21, P281, DOI 10.1111/j.1365-2419.2012.00624.x; Han YS, 2009, ZOOL STUD, V48, P632; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Hasumi H., 2000, CCSR REP, V13, P68; Ho M.-P, 2012, THESIS U SO QUEENSLA; Hsu AC, 2017, FISH OCEANOGR, V26, P251, DOI 10.1111/fog.12189; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Itakura H, 2015, ENVIRON BIOL FISH, V98, P1871, DOI 10.1007/s10641-015-0404-6; Itakura H, 2015, LANDSC ECOL ENG, V11, P147, DOI 10.1007/s11355-014-0252-0; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; KAJIHARA T, 1988, NIPPON SUISAN GAKK, V54, P929; Kawamiya M., 2005, J EARTH SIMULATOR, V4, P18; KESSLER WS, 1987, J PHYS OCEANOGR, V17, P97, DOI 10.1175/1520-0485(1987)017<0097:DHAZGT>2.0.CO;2; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; Kimura S, 1999, MAR ECOL PROG SER, V186, P303, DOI 10.3354/meps186303; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Kuroki Mari, 2005, Coastal Marine Science, V29, P154; MAILLET GL, 1990, FISH B-NOAA, V88, P155; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; McCleave JD, 2008, MAR BIOL, V155, P249, DOI 10.1007/s00227-008-1026-8; McCleave JD, 1987, T AM FISH SOC, V1, P138; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Miller MJ, 2009, AM FISH S S, V69, P231; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Otake T, 2003, EEL BIOLOGY, P61; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Sakamoto TT, 2012, J METEOROL SOC JPN, V90, P325, DOI 10.2151/jmsj.2012-301; Sasaki H., 2006, J EARTH SIMULATOR, V6, P35; Shinoda A, 2004, FISHERIES SCI, V70, P339, DOI 10.1111/j.1444-2906.2003.00810.x; TABETA O, 1987, NIPPON SUISAN GAKK, V53, P1727; Tatebe H, 2012, J METEOROL SOC JPN, V90A, P275, DOI 10.2151/jmsj.2012-A14; Tatsukawa K, 2003, EEL BIOLOGY, P293; Tesch F.W., 2008, EEL; TOOLE JM, 1990, J PHYS OCEANOGR, V20, P307, DOI 10.1175/1520-0485(1990)020<0307:OOTPNE>2.0.CO;2; TOWNSEND CR, 1980, OECOLOGIA, V47, P219, DOI 10.1007/BF00346824; TSUKAMOTO K, 1989, NIPPON SUISAN GAKK, V55, P1017; TSUKAMOTO K, 1990, J FISH BIOL, V36, P659; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NIPPON SUISAN GAKK, V58, P457; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; TZENG WN, 1990, MAR BIOL, V107, P75, DOI 10.1007/BF01313244; Tzeng WN., 1985, B JAP SOC FISH OCEAN, V47, P11; UMEZAWA A, 1989, JPN J ICHTHYOL, V35, P440, DOI 10.1007/BF02905501; Wu CR, 2013, PROG OCEANOGR, V110, P49, DOI 10.1016/j.pocean.2012.12.001; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	65	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195544	10.1371/journal.pone.0195544	http://dx.doi.org/10.1371/journal.pone.0195544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634730	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200037
J	Jiang, PL; Hou, YW; Fu, WK; Tao, XF; Luo, JT; Lu, HX; Xu, YC; Han, BS; Zhang, JF				Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe; Zhang, Junfang			Characterization of IncRNAs involved in cold acclimation of zebrafish ZF4 cells	PLOS ONE			English	Article							NONCODING RNAS; LNCRNAS; GENE; IDENTIFICATION; EXPRESSION; TEMPERATURE; EVOLUTION; SEQ	Long non-coding RNAs (IncRNAs) are increasingly regarded as a key role in regulating diverse biological processes in various tissues and species. Although the cold responsive IncRNAs have been reported in plants, no data is available on screening and functional prediction of IncRNAs in cold acclimation in fish so far. Here we compared the expression profile of IncRNAs in cold acclimated zebrafish embryonic fibroblast cells (ZF4) cultured at 18 degrees C for 30 days with that of cells cultured at 28 degrees C as control by high-throughput sequencing. Totally 8,363 novel IncRNAs were identified. Including known and novel IncRNAs, there are 347 IncRNAs up-regulated and 342 IncRNAs down-regulated in cold acclimated cells. Among the differentially expressed IncRNAs, 74 and 61 were detected only in control cells or cold-acclimated cells, respectively. The Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analyses of adjacent genes to the differentially expressed IncRNAs showed that the enriched genes are involved in electron transport, cell adhesion, oxidation-reduction process, and so on. We also predicted the target genes of the differentially expressed IncRNAs by looking for interactions between IncRNAs and mRNAs, and constructed an interaction network. In summary, our genome-wide systematic identification and functional prediction of cold responsive IncRNAs in zebrafish cells suggests a crucial role of lincRNAs in cold acclimation in fish.	[Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe; Zhang, Junfang] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zhang, Junfang] Shanghai Ocean Univ, Minist Sci & Technol, Int Res Ctr Marine Biosci, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Han, BS; Zhang, JF (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Han, BS (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Zhang, JF (corresponding author), Shanghai Ocean Univ, Minist Sci & Technol, Int Res Ctr Marine Biosci, Shanghai, Peoples R China.	bs-han@shou.edu.cn; jfzhang@shou.edu.cn	jiang, penglei/GPX-0521-2022		National Natural Science Foundation of China [31372516, 81770165]; Shanghai Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This study was supported by grants from National Natural Science Foundation of China (grant No. 31372516 awarded to JZ and 81770165 awarded to BH), Shanghai Municipal Education Commission (Oriental scholar program awarded to JZ), Shanghai Municipal Education Commission (Project for Gaofeng Discipline of Fishery).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Eddy Sean R, 2009, Genome Inform, V23, P205; Frigault JJ, 2017, J COMP PHYSIOL B, V187, P19, DOI 10.1007/s00360-016-1049-2; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; Han BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160358; Hu P, 2015, NUCLEIC ACIDS RES, V43, P9198, DOI 10.1093/nar/gkv780; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Le Bourg E, 2015, BIOGERONTOLOGY, V16, P411, DOI 10.1007/s10522-015-9557-0; Li SX, 2017, SCI REP-UK, V7, DOI 10.1038/srep45981; Li SM, 2017, P NATL ACAD SCI USA, V114, pE7111, DOI 10.1073/pnas.1703494114; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pinto R, 2005, FEBS LETT, V579, P5553, DOI 10.1016/j.febslet.2005.09.019; Song XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2625-2; Su S, 2016, FEBS J, V283, P1261, DOI 10.1111/febs.13660; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00823-3; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Wang XD, 2017, AQUAT TOXICOL, V182, P214, DOI 10.1016/j.aquatox.2016.12.003; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2017, TRENDS GENET, V33, P540, DOI 10.1016/j.tig.2017.05.004; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yang RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-605; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	40	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195468	10.1371/journal.pone.0195468	http://dx.doi.org/10.1371/journal.pone.0195468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634734	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200033
J	Lomax, DR; De la Sallee, P; Massare, JA; Gallois, R				Lomax, Dean R.; De la Sallee, Paul; Massare, Judy A.; Gallois, Ramues			A giant Late Triassic ichthyosaur from the UK and a reinterpretation of the Aust Cliff 'dinosaurian' bones	PLOS ONE			English	Article							JURASSIC ICHTHYOSAUR; SKULL	The largest reported ichthyosaurs lived during the Late Triassic (similar to 235-200 million years ago), and isolated, fragmentary bones could be easily mistaken for those of dinosaurs because of their size. We report the discovery of an isolated bone from the lower jaw of a giant ichthyosaur from the latest Triassic of Lilstock, Somerset, UK. It documents that giant ichthyosaurs persisted well into the Rhaetian Stage, and close to the time of the Late Triassic extinction event. This specimen has prompted the reinterpretation of several large, roughly cylindrical bones from the latest Triassic (Rhaetian Stage) Westbury Mudstone Formation from Aust Cliff, Gloucestershire, UK. We argue here that the Aust bones, previously identified as those of dinosaurs or large terrestrial archosaurs, are jaw fragments from giant ichthyosaurs. The Lilstock and Aust specimens might represent the largest ichthyosaurs currently known.	[Lomax, Dean R.] Univ Manchester, Sch Earth & Environm Sci, Oxford Rd, Manchester, Lancs, England; [De la Sallee, Paul] Etches Collect Museum Jurassic Marine Life, Kimmeridge, Dorset, England; [Massare, Judy A.] SUNY Coll Brockport, Dept Earth Sci, Brockport, NY 14420 USA; [Gallois, Ramues] Gallois Geol Consultancy, Exeter, Devon, England	University of Manchester; State University of New York (SUNY) System	Lomax, DR (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Oxford Rd, Manchester, Lancs, England.	dean.lomax@manchester.ac.uk		Lomax, Dean/0000-0001-6985-3966				Bardet N, 2014, GONDWANA RES, V26, P869, DOI 10.1016/j.gr.2014.05.005; Benton M.J., 1995, FOSSIL REPTILES GREA; Buchy MC, 2003, B SOC GEOL FR, V174, P271, DOI 10.2113/174.3.271; Butler RJ, 2006, NEUES JAHRB GEOL P-M, P613; CAMP C L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V170, P139; Carpenter K., 2006, NEW MEXICO MUSEUM NA, V36, P131; Dal Sasso C, 1996, PALEONTOL LOMBARDA, V4, P23; Danise S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5789; Fischer V, 2016, PEERJ, V4, DOI 10.7717/peerj.2604; Fischer V, 2014, NATURWISSENSCHAFTEN, V101, P1027, DOI 10.1007/s00114-014-1242-7; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Gallois R.W., 2009, GEOSCINCE S W ENGLAN, V12, P71; Galton Peter M., 2005, Revue de Paleobiologie, V24, P51; GALTON PM, 1985, GEOBIOS-LYON, V18, P671, DOI 10.1016/S0016-6995(85)80065-6; Hesselbo SP, 2004, J GEOL SOC LONDON, V161, P365, DOI 10.1144/0016-764903-033; Ibarra Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19808; Ji C, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1025956; Ji C, 2013, J VERTEBR PALEONTOL, V33, P340, DOI 10.1080/02724634.2013.723082; Jiang DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26232; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kelley NP, 2014, PALAEOGEOGR PALAEOCL, V400, P9, DOI 10.1016/j.palaeo.2012.07.026; Lomax D. R., 2014, DINOSAURS BRIT ISLES; Lomax DR, 2019, GEOL J, V54, P83, DOI 10.1002/gj.3155; Macquaker J.H.S., 1999, FOSSILS RHAETIAN PEN, P39; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Maisch Michael W., 1997, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V258, P1; Marek RD, 2015, PALAEONTOLOGY, V58, P723, DOI 10.1111/pala.12174; Martin JE, 2015, ACTA PALAEONTOL POL, V60, P837, DOI 10.4202/app.00062.2014; MASSARE JA, 1990, GEOL SOC AM BULL, V102, P409, DOI 10.1130/0016-7606(1990)102<0409:TAAEOT>2.3.CO;2; MCGOWAN C, 1995, CAN J EARTH SCI, V32, P292, DOI 10.1139/e95-024; McGowan C, 1999, J VERTEBR PALEONTOL, V19, P42, DOI 10.1080/02724634.1999.10011121; McGowan C, 1996, CAN J EARTH SCI, V33, P24, DOI 10.1139/e96-003; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 1973, GEOLOGY, V24, P1; McGowan C, 2003, HDB PALEOHERPETOLOGY, V8, P175; McGowan Chris, 1997, P61, DOI 10.1016/B978-012155210-7/50006-5; Moon Benjamin C., 2016, Monograph of the Palaeontographical Society, V170, P1; Motani Ryosuke, 1999, Paludicola, V2, P174; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Redelstorff R, 2014, ACTA PALAEONTOL POL, V59, P607, DOI 10.4202/app.2012.0073; Reynolds S.H., 1946, COTTSWOLD NATURALIST, V29, P29; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Sanders W., 1876, ANN REPORT ASS ADV S, V45, P80; Sauvage H., 1883, ANN SCI GEOL, V14, P1; Sheldon Amy, 1997, P333, DOI 10.1016/B978-012155210-7/50018-1; Sheldon M. Amy, 1999, Paludicola, V2, P190; STORRS GW, 1994, ZOOL J LINN SOC-LOND, V112, P217, DOI 10.1111/j.1096-3642.1994.tb00319.x; Stutchbury S, 1850, ANN REPORT ASS ADV S, V19, P67; Swift A., 1999, FOSSILS RHAETIAN PEN; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194742	10.1371/journal.pone.0194742	http://dx.doi.org/10.1371/journal.pone.0194742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630618	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000016
J	Lopez-Samanes, A; Pallares, JG; Perez-Lopez, A; Mora-Rodriguez, R; Ortega, JF				Lopez-Samanes, Alvaro; Pallares, Jesus G.; Perez-Lopez, Alberto; Mora-Rodriguez, Ricardo; Ortega, Juan F.			Hormonal and neuromuscular responses during a singles match in male professional tennis players	PLOS ONE			English	Article							ELITE JUNIOR TENNIS; SOCCER PLAYERS; PSYCHOPHYSIOLOGICAL STRESS; SALIVARY TESTOSTERONE; PHYSICAL PERFORMANCE; CORTISOL RESPONSES; ERGOGENIC AIDS; EXERCISE; RECOVERY; COMPETITION	We sought to measure the response of cortisol concentrations around a professional tennis match and its association with hydration status and neuromuscular performance. Nine professional male tennis players were tested in a rest day, and 2-week after, during the first match of a professional tournament played in a clay-court. Salivary concentrations of cortisol (SaICC) were measured in a resting day (9:00 am and 8:00 pm), at the match day (9:00 am and 8:00 pm) and immediately before and after the match. Hydration status was assessed before the match (urine specific gravity; USG) while fluid turnover was tracked during the match. Finally, counter movement jump (CMJ) and handgrip isometric strength (HS) were measured before and after the match. SaICC, either in the morning (P = 0.161) and afternoon (P = 0.683) was similar in rest and match days. However, SaICC increased after the match (P = 0.033). Participants started the match hypohydrated (USG = 1.026 0.002) and during the match lost 1.0+/-0.3% of body weight despite 1.035+/-0.124 Uh of fluid ingested. CMJ and HS did not change post-match (P = 0.210 and P = 0.881, respectively). Correlations between the elevations in SaICC and dehydration (% BW loss) during the match were significant (r = -0.632; P = 0.034). Professional male tennis players did not show an anticipatory increase in SaICC the day of the match and neither signs of neuromuscular fatigue after it. During the match, the mild dehydration (i.e., <1.5%) was associated with the increases in cortisol levels which suggests that dehydration may be an added stress to be considered.	[Lopez-Samanes, Alvaro; Pallares, Jesus G.; Mora-Rodriguez, Ricardo; Ortega, Juan F.] Univ Castilla La Mancha, Exercise Physiol Lab Toledo, Toledo, Spain; [Lopez-Samanes, Alvaro] Francisco de Vitoria Univ, Fac Hlth Sci, Sch Physiotherapy, Madrid, Spain; [Pallares, Jesus G.] Univ Murcia, Fac Sports Sci, Murcia, Spain; [Perez-Lopez, Alberto] Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Med & Med Specialties, Madrid, Spain; [Perez-Lopez, Alberto] Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Biomed Sci, Madrid, Spain	Universidad de Castilla-La Mancha; Universidad Francisco de Vitoria; University of Murcia; Universidad de Alcala; Universidad de Alcala	Ortega, JF (corresponding author), Univ Castilla La Mancha, Exercise Physiol Lab Toledo, Toledo, Spain.	juanfernando.ortega@uclm.es	PALLARES, JESUS G./AAW-3182-2020; Mora-Rodriguez, Ricardo/AAC-9096-2022; Ortega, Juan Fernando F/L-4973-2014; Pallarés, Jesús G/J-3054-2016; Pérez-López, Alberto/I-7559-2015	PALLARES, JESUS G./0000-0002-6087-1583; Ortega, Juan Fernando F/0000-0003-3884-923X; Pallarés, Jesús G/0000-0002-6087-1583; Pérez-López, Alberto/0000-0003-0220-6240; Lopez Samanes, Alvaro/0000-0003-0721-0150				Balsalobre-Fernandez C, 2014, INT J SPORT PHYSIOL, V9, P839, DOI 10.1123/ijspp.2013-0539; BELOW PR, 1995, MED SCI SPORT EXER, V27, P200; Bonato M, 2015, J SPORT MED PHYS FIT, V55, P1157; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Camaione D.N., 1992, J APPL SPORT SCI RES, V6, p225, DOI DOI 10.1519/00124278-199211000-00006; Claudino JG, 2017, J SCI MED SPORT, V20, P397, DOI 10.1016/j.jsams.2016.08.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Pereira TJC, 2017, J SPORT SCI, V35, P361, DOI 10.1080/02640414.2016.1165858; Crewther BT, 2018, J SCI MED SPORT, V21, P312, DOI 10.1016/j.jsams.2017.05.021; Dougherty KA, 2006, MED SCI SPORT EXER, V38, P1650, DOI 10.1249/01.mss.0000227640.60736.8e; Duffield R, 2014, INT J SPORT PHYSIOL, V9, P273, DOI [10.1123/IJSPP.2012-0359, 10.1123/ijspp.2012-0359]; Edwards DA, 2010, HORM BEHAV, V58, P606, DOI 10.1016/j.yhbeh.2010.06.015; Elloumi M, 2003, EUR J APPL PHYSIOL, V90, P23, DOI 10.1007/s00421-003-0868-5; Erickson K, 2003, NEUROSCI BIOBEHAV R, V27, P233, DOI 10.1016/S0149-7634(03)00033-2; Fernandez-Elias VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095336; Filaire E, 2003, PERCEPT MOTOR SKILL, V97, P1061, DOI 10.2466/PMS.97.8.1061-1072; Filaire E, 2001, J SPORT MED PHYS FIT, V41, P263; Filaire E, 2009, PSYCHONEUROENDOCRINO, V34, P150, DOI 10.1016/j.psyneuen.2008.08.022; Fothergill M, 2017, PHYSIOL BEHAV, V177, P215, DOI 10.1016/j.physbeh.2017.04.021; Gallo-Salazar C, 2017, APPL PHYSIOL NUTR ME, V42, P750, DOI 10.1139/apnm-2016-0540; Garcia-Pallares J, 2009, J SPORT SCI MED, V8, P622; Gatti R, 2011, SCAND J MED SCI SPOR, V21, P157, DOI 10.1111/j.1600-0838.2010.01252.x; Gescheit DT, 2015, INT J SPORT PHYSIOL, V10, P913, DOI 10.1123/ijspp.2014-0329; Girard O, 2006, BRIT J SPORT MED, V40, P521, DOI 10.1136/bjsm.2005.023754; Girard O, 2009, J STRENGTH COND RES, V23, P1867, DOI 10.1519/JSC.0b013e3181b3df89; Hayes LD, 2016, INT J SPORTS MED, V37, P1007, DOI 10.1055/s-0042-105649; Hornery DJ, 2007, BRIT J SPORT MED, V41, P531, DOI 10.1136/bjsm.2006.031351; Kovacs MS, 2007, SPORTS MED, V37, P189, DOI 10.2165/00007256-200737030-00001; Lopez-Samanes A, 2017, NUTR HOSP, V34, P1463, DOI 10.20960/nh.1404; Lopez-Samanes A, 2017, J SPORT SCI, V35, P2121, DOI 10.1080/02640414.2016.1258481; Lopez-Samanes A, 2015, STRENGTH COND J, V37, P1; Maresh CM, 2006, INT J SPORTS MED, V27, P765, DOI 10.1055/s-2005-872932; Moreira A, 2009, EUR J APPL PHYSIOL, V106, P25, DOI 10.1007/s00421-009-0984-y; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Ojala T, 2013, J SPORT SCI MED, V12, P240; Paccotti P, 2005, INT J SPORTS MED, V26, P747, DOI 10.1055/s-2004-830449; Pallares JG, 2015, SCAND J MED SCI SPOR, V25, pE603, DOI 10.1111/sms.12385; Pereira LA, 2016, J HUM KINET, V50, P211, DOI 10.1515/hukin-2015-0158; Periard JD, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093242; Pluim BM, 2016, SCAND J MED SCI SPOR, V26, P564, DOI 10.1111/sms.12471; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Schmikli SL, 2012, BRIT J SPORT MED, V46, P1019, DOI 10.1136/bjsports-2011-090492; Ulbricht A, 2016, J STRENGTH COND RES, V30, P989, DOI 10.1519/JSC.0000000000001267	43	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195242	10.1371/journal.pone.0195242	http://dx.doi.org/10.1371/journal.pone.0195242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624621	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600021
J	Vading, M; Naucler, P; Kalin, M; Giske, CG				Vading, M.; Naucler, P.; Kalin, M.; Giske, C. G.			Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BACTEREMIA; COMMUNITY; EPIDEMIOLOGY; OUTCOMES; IMPACT	Klebsiella pneumoniae (KP) is after Escherichia coli (EC) the most common gram-negative species causing invasive infections. Herein, we analyzed risk factors and prognosis in invasive infections caused by KP versus EC, in an area with low antimicrobial resistance. Moreover, we compared antimicrobial resistance and relative prevalence of KP and EC (KP/ECratio) in different European countries, using EARS-Net data. Adult patients admitted to Karolinska University Hospital 2006-2012 with invasive infection caused by KP (n = 599) were matched regarding sex and age with patients infected by EC. The medical records were retrospectively reviewed. Comorbidity was adjusted for with multivariable analysis. European data were retrieved from the EARS-Net database. No differences were observed in 7- and 30-day mortality between the groups. The 90-day mortality was significantly higher in the KP cohort (26% versus 17%, p<0.001), but not after adjusting for comorbidity. Malignancy was seen in 53% of the patients with KP versus 38% with EC, OR 1.86 (1.34-2.58). A significant increase in the rate of ESBL-production was observed in EC, but not in KP. The KP/EC-ratio remained stable. In contrast, European data showed increasing percentages of isolates non-susceptible to third-generation cephalosporins in EC and KP, and increasing KP/EC-ratio. Invasive infection caused by KP is a disease affecting patients with high comorbidity and associated with high 90-d mortality. The stable KP/EC-ratio and low occurrence of anti-microbial resistance in data from Karolinska University Hospital compared to aggregate data from 20 EARS-Net countries could be related to absence of clonal spread of multidrug-resistant KP.	[Vading, M.; Giske, C. G.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Vading, M.] Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden; [Naucler, P.] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden; [Naucler, P.; Kalin, M.] Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Giske, C. G.] Karolinska Univ Hosp Solna, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Vading, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.; Vading, M (corresponding author), Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden.	malin.vading@sll.se		Vading, Malin/0000-0003-4221-8828	European Society for Clinical Microbiology and Infectious diseases (ESCMID)	European Society for Clinical Microbiology and Infectious diseases (ESCMID)	The study was supported by a grant from the European Society for Clinical Microbiology and Infectious diseases (ESCMID).	Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Brisse S, 2014, INT J SYSTEMATIC EVO; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; ECDC, 2015, ANN REPORT EUROPEAN; ECDC. European Center for Disease Control and Prevention, 2015, EARS NET REP PROT; EUCAST, 2013, EUCAST GUID DET RES; Hansen DS, 1998, J HOSP INFECT, V38, P119, DOI 10.1016/S0195-6701(98)90065-2; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; Jung Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-239; Kang CI, 2006, J KOREAN MED SCI, V21, P816, DOI 10.3346/jkms.2006.21.5.816; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kjellander C, 2012, EUR J HAEMATOL, V88, P422, DOI 10.1111/j.1600-0609.2012.01768.x; Laupland KB, 2008, CLIN MICROBIOL INFEC, V14, P1041, DOI 10.1111/j.1469-0691.2008.02089.x; Maatallah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113539; Marra AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-24; Meatherall BL, 2009, AM J MED, V122, P866, DOI 10.1016/j.amjmed.2009.03.034; Moon HW, 2014, J MED MICROBIOL, V63, P421, DOI 10.1099/jmm.0.069054-0; Olsson-Liljequist B, 1997, SCAND J INFECT DIS, P13; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rodrigues C, 2014, INT J MED MICROBIOL, V304, P1100, DOI 10.1016/j.ijmm.2014.08.003; Thom KA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-116; Tsai Sung-Sheng, 2010, Chang Gung Med J, V33, P532; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Tuon FF, 2011, BRAZ J INFECT DIS, V15, P594, DOI 10.1590/S1413-86702011000600016; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wang L S, 1990, J Formos Med Assoc, V89, P756; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933	30	41	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195258	10.1371/journal.pone.0195258	http://dx.doi.org/10.1371/journal.pone.0195258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624618	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600022
J	Christensen, KA; Leong, JS; Sakhrani, D; Biagi, CA; Minkley, DR; Withler, RE; Rondeau, EB; Koop, BF; Devlin, RH				Christensen, Kris A.; Leong, Jong S.; Sakhrani, Dionne; Biagi, Carlo A.; Minkley, David R.; Withler, Ruth E.; Rondeau, Eric B.; Koop, Ben F.; Devlin, Robert H.			Chinook salmon (Oncorhynchus tshawytscha) genome and transcriptome	PLOS ONE			English	Article							LINKAGE MAP; SOFTWARE; PLATFORM; DATABASE	When unifying genomic resources among studies and comparing data between species, there is often no better resource than a genome sequence. Having a reference genome for the Chinook salmon (Oncorhynchus tshawytscha) will enable the extensive genomic resources available for Pacific salmon, Atlantic salmon, and rainbow trout to be leveraged when asking questions related to the Chinook salmon. The Chinook salmon's wide distribution, long cultural impact, evolutionary history, substantial hatchery production, and recent wild-population decline make it an important research species. In this study, we sequenced and assembled the genome of a Chilliwack River Hatchery female Chinook salmon (gynogenetic and homozygous at all loci). With a reference genome sequence, new questions can be asked about the nature of this species, and its role in a rapidly changing world.	[Christensen, Kris A.; Sakhrani, Dionne; Biagi, Carlo A.; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Christensen, Kris A.; Leong, Jong S.; Minkley, David R.; Rondeau, Eric B.; Koop, Ben F.] Univ Victoria, Victoria, BC, Canada; [Withler, Ruth E.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada	Fisheries & Oceans Canada; University of Victoria; Fisheries & Oceans Canada	Christensen, KA (corresponding author), Fisheries & Oceans Canada, W Vancouver, BC, Canada.; Christensen, KA (corresponding author), Univ Victoria, Victoria, BC, Canada.	kris.christensen@wsu.edu	Biagi, Carlo/AAN-2030-2020; Koop, Ben F./A-8151-2008	Biagi, Carlo/0000-0002-6345-9674; Koop, Ben F./0000-0003-0045-5200; Christensen, Kristen/0000-0003-0021-0326; Leong, Jong/0000-0001-6521-9239	Fisheries and Oceans Canada; Canadian Regulatory System for Biotechnology; DFO Salmonid Enhancement Program Chilliwack River Hatchery; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; ministere de l'Economie, de la science et de l'innovation du Quebec; Fonds de recherche du Quebec-Nature et technologies	Fisheries and Oceans Canada; Canadian Regulatory System for Biotechnology; DFO Salmonid Enhancement Program Chilliwack River Hatchery; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); ministere de l'Economie, de la science et de l'innovation du Quebec; Fonds de recherche du Quebec-Nature et technologies	The authors appreciate support from Fisheries and Oceans Canada, the Canadian Regulatory System for Biotechnology, and from the DFO Salmonid Enhancement Program Chilliwack River Hatchery. BK received funding in the form of the grant "Salmonid Genome Duplication Drives Specialization and Adaptation" from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the McGill University and Genome Quebec Innovation Centre for their services in preparing the various sequencing libraries and performing the sequencing. Thank you to Compute Canada (www.computecanada.ca), the Centre for Advanced Computing (http://cac.queensu.ca/), Calcul Quebec (MP2 server, operation of MP2 was funded by the Canada Foundation for Innovation, the ministere de l'Economie, de la science et de l'innovation du Quebec and the Fonds de recherche du Quebec-Nature et technologies) for computational resources. We would also like to thank Fisheries and Oceans Canada and the University of Victoria for the facilities and personnel. Thanks to MBD Education & Training Services for editing the manuscript. Finally, we would like to thank the two anonymous reviewers for their valuable comments.	Allendorf F.W., 1984, P1; Allendorf FW, 2015, J HERED, V106, P217, DOI 10.1093/jhered/esv015; Andrews S., 2016, BABRAHAM BIOINFORMAT; Angeloni F, 2012, EVOL APPL, V5, P130, DOI 10.1111/j.1752-4571.2011.00217.x; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2017, PACIFIC BIOSCIENCES; [Anonymous], 2013, R10 US EPA; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Barria A, 2018, G3 GENES GENOME 0213; Behnke R., 2002, TROUT SALMON N AM, P25; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brieuc MSO, 2014, G3-GENES GENOM GENET, V4, P447, DOI 10.1534/g3.113.009316; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chasco BE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14984-8; Ciancio JE, 2015, BIOL INVASIONS, V17, P2989, DOI 10.1007/s10530-015-0928-x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gutierrez AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119730; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HEALEY MC, 1998, PACIFIC SALMON LIFE, P311; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hecht BC, 2015, MOL ECOL, V24, P5573, DOI 10.1111/mec.13409; Hubley R., 2013, REPEATMASKER OPEN 40; Irvine JR, 2011, ICES J MAR SCI, V68, P1122, DOI 10.1093/icesjms/fsq199; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan S, 2016, INT J GENOMICS; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krzywinski MI, 2009, GENOME RES; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H., 2013, QUANT BIOL; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Mantua NJ, 2015, NAT CLIM CHANGE, V5, P613, DOI 10.1038/nclimate2670; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; McKinney GJ, 2016, MOL ECOL RESOUR, V16, P769, DOI 10.1111/1755-0998.12479; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Qin Yuxue, 2016, North Pacific Anadromous Fish Commission Bulletin, P469, DOI 10.23849/npafcb6/469.481; QUILLET E, 1991, J EXP ZOOL, V257, P367, DOI 10.1002/jez.1402570310; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A, 2013, REPEATMODELER OPEN 1; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Sutherland BJG, 2016, GENOME BIOL EVOL, V8, P3600, DOI 10.1093/gbe/evw262; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780	57	50	50	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195461	10.1371/journal.pone.0195461	http://dx.doi.org/10.1371/journal.pone.0195461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621340	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800088
J	Stynes, S; Konstantinou, K; Ogollah, R; Hay, EM; Dunn, KM				Stynes, Siobhan; Konstantinou, Kika; Ogollah, Reuben; Hay, Elaine M.; Dunn, Kate M.			Clinical diagnostic model for sciatica developed in primary care patients with low back-related leg pain	PLOS ONE			English	Article							PHYSICAL-EXAMINATION; DISC HERNIATION; HISTORY; DEFINITIONS; PROGNOSIS; SYMPTOMS	Background Identification of sciatica may assist timely management but can be challenging in clinical practice. Diagnostic models to identify sciatica have mainly been developed in secondary care settings with conflicting reference standard selection. This study explores the challenges of reference standard selection and aims to ascertain which combination of clinical assessment items best identify sciatica in people seeking primary healthcare. Methods Data on 394 low back-related leg pain consulters were analysed. Potential sciatica indicators were seven clinical assessment items. Two reference standards were used: (i) high confidence sciatica clinical diagnosis; (ii) high confidence sciatica clinical diagnosis with confirmatory magnetic resonance imaging findings. Multivariable logistic regression models were produced for both reference standards. A tool predicting sciatica diagnosis in low back-related leg pain was derived. Latent class modelling explored the validity of the reference standard. Results Model (i) retained five items; model (ii) retained six items. Four items remained in both models: below knee pain, leg pain worse than back pain, positive neural tension tests and neurological deficit. Model (i) was well calibrated (p = 0.18), discrimination was area under the receiver operating characteristic curve (AUC) 0.95 (95% CI 0.93, 0.98). Model (ii) showed good discrimination (AUC 0.82; 0.78, 0.86) but poor calibration (p = 0.004). Bootstrapping revealed minimal overfitting in both models. Agreement between the two latent classes and clinical diagnosis groups defined by model (i) was substantial, and fair for model (ii). Conclusion Four clinical assessment items were common in both reference standard definitions of sciatica. A simple scoring tool for identifying sciatica was developed. These criteria could be used clinically and in research to improve accuracy of identification of this subgroup of back pain patients.	[Stynes, Siobhan; Konstantinou, Kika; Ogollah, Reuben; Hay, Elaine M.; Dunn, Kate M.] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Keele University	Stynes, S (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.	s.stynes@keele.ac.uk		Ogollah, Reuben/0000-0002-5777-4117	National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship [CDRF-2010055]; Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship	National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship; Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship	SS was supported by an National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship (CDRF-2010055). KK was supported by a Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship. EMH is an National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Nezari NH, 2013, SPINE J, V13, P657, DOI 10.1016/j.spinee.2013.02.007; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010; Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020; Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012; Coster S, 2010, J NEUROL, V257, P332, DOI 10.1007/s00415-009-5316-y; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dunn K. M., 2010, PRIM HEALTH CARE RES, V11, P93, DOI DOI 10.1017/S1463423609990296; Genevay S, 2010, SPINE, V35, P803, DOI 10.1097/BRS.0b013e3181bc9454; Hill JC, 2011, SPINE, V36, P2168, DOI 10.1097/BRS.0b013e31820712bb; HOSMER DW, 2000, WILEY PS TX, P1; Iversen T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-206; JENSEN MC, 1994, MAGN RESON QUART, V10, P173; Karppinen J, 2001, Spine (Phila Pa 1976), V26, pE149, DOI 10.1097/00007632-200104010-00015; Knottnerus JA., 2002, EVIDENCE BASE CLIN D; Kongsted A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-171; Konstantinou K, 2012, EUR SPINE J, V21, P2306, DOI 10.1007/s00586-012-2398-5; Konstantinou K, 2012, EUR SPINE J, V21, P1241, DOI 10.1007/s00586-011-2057-2; Konstantinou K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-4; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin CWC, 2014, EUR J PAIN, V18, P455, DOI 10.1002/j.1532-2149.2013.00384.x; Mathieson S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-213; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Shultz S, 2015, MANUAL THER, V20, P18, DOI 10.1016/j.math.2014.08.002; Steyerberg E., 2009, CLIN PREDICTION MODE; Stynes S, 2016, BMC MUSCULOSKEL DIS, V17, P1; Stynes S, 2016, EUR SPINE J, V25, P2734, DOI 10.1007/s00586-015-4359-2; Suarthana E, 2010, J CLIN EPIDEMIOL, V63, P1011, DOI 10.1016/j.jclinepi.2009.10.008; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; van Smeden M, 2014, AM J EPIDEMIOL, V179, P423, DOI 10.1093/aje/kwt286; Verwoerd AJH, 2014, SPINE J, V14, P2028, DOI 10.1016/j.spinee.2013.11.049; Vroomen PCAJ, 2002, J NEUROL NEUROSUR PS, V72, P630, DOI 10.1136/jnnp.72.5.630; Vroomen PCAJ, 1999, J NEUROL, V246, P899, DOI 10.1007/s004150050480; Vucetic N, 1999, CLIN ORTHOP RELAT R, P116; Worster A, 2008, CAN J EMERG MED, V10, P174	40	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191852	10.1371/journal.pone.0191852	http://dx.doi.org/10.1371/journal.pone.0191852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621243	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000429206800001
J	Hinkley, T; Brown, H; Carson, V; Teychenne, M				Hinkley, Trina; Brown, Helen; Carson, Valerie; Teychenne, Megan			Cross sectional associations of screen time and outdoor play with social skills in preschool children	PLOS ONE			English	Article							BEHAVIOR INVENTORY ASBI; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EARLY-CHILDHOOD; TELEVISION EXPOSURE; SLEEP DURATION; EMOTIONAL COMPETENCE; GENDER-DIFFERENCES; COMPUTER GAME; LOW-INCOME	Screen time and physical activity behaviours develop during the crucial early childhood period (0-5 years) and impact multiple health and developmental outcomes, including psychosocial wellbeing. Social skills, one component of psychosocial wellbeing, are vital for children's school readiness and future mental health. This study investigates potential associations of screen time and outdoor play (as a proxy for physical activity) with social skills. Cross sectional data were available for 575 mothers with a child (54% boys) aged 2-5 years. Mothers reported their child's screen time, outdoor play time and social skills (Adaptive Social Behavior Inventory; ASBI). Multiple linear regression analyses assessed associations of screen and outdoor play time (Model 1) and compliance with screen time and physical activity recommendations (Model 2) with three ASBI subscales. Boys and girls spent a mean of 2.0 and 2.2 hours per day in screen time, and 3.3 and 2.9 hours per day in outdoor play, respectively. Girls scores for express and comply skills were significantly higher than boys (p<0.005). After applying the Benjamini-Hochberg Procedure to adjust for multiple associations, children's television/DVD/video viewing was inversely associated with their compliant scores (B=-0.35 95% CI-0.26,-0.14; p=0.001) and outdoor play time was positively associated with both expressive (B=0.20 95% CI 0.07, 0.34; p=0.004) and compliant (B=0.22 95% CI 0.08, 0.36; p=0.002) scores. Findings indicate that television/DVD/video viewing may be adversely, and outdoor play favourably, associated with preschool children's social skills. Future research is required to identify the direction of causation and explore potential mechanisms of association.	[Hinkley, Trina; Brown, Helen; Teychenne, Megan] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia; [Carson, Valerie] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	Deakin University; University of Alberta	Hinkley, T (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia.	think.research@outlook.com	Carson, Valerie/ABG-2853-2021; Brown, Helen/AAY-4382-2020	Carson, Valerie/0000-0002-3009-3282; Hinkley, Trina/0000-0003-2742-8579; Brown, Helen/0000-0002-5460-3654	National Health and Medical Research Council Early Career Fellowship [APP1070571]; Canadian Institutes of Health Research (CIHR) New Investigator Salary Award; School of Exercise and Nutrition Sciences, Deakin University	National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR) New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); School of Exercise and Nutrition Sciences, Deakin University	TH is supported by a National Health and Medical Research Council Early Career Fellowship (APP1070571); VC is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Salary Award. The study was funded by the School of Exercise and Nutrition Sciences, Deakin University. Deakin University had no role in the study design; collection, analysis or interpretation of data; writing the report; or the decision to submit the report for publication.	Aasen W, 2009, EDUC 3-13, V37, P5, DOI 10.1080/03004270802291749; Australian Bureau of Statistics, 2015, 4442 0 FAM CHAR TRAN; Australian Bureau of Statistics, 2011, 2033 0 55 001 CENS P; Bailey R, 2009, RES PAP EDUC, V24, P1, DOI 10.1080/02671520701809817; Baker JK, 2007, AM J MENT RETARD, V112, P375, DOI 10.1352/0895-8017(2007)112[0375:POSSIY]2.0.CO;2; Barbour AC, 1999, EARLY CHILD RES Q, V14, P75, DOI 10.1016/S0885-2006(99)80007-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bingham DD, 2016, AM J PREV MED, V51, P384, DOI 10.1016/j.amepre.2016.04.022; Birch LL, 1998, PEDIATRICS, V101, P539; Brody GH, 1998, CHILD DEV, V69, P803, DOI 10.1111/j.1467-8624.1998.tb06244.x; Brody L. R., 2000, GENDER EMOTION SOCIA, V1st, P24, DOI [10.1017/CBO9780511628191.003, DOI 10.1017/CBO9780511628191.003]; Brody LR, 1997, J SOC ISSUES, V53, P369, DOI 10.1111/0022-4537.00022; Brown GL, 2015, PARENT-SCI PRACT, V15, P135, DOI 10.1080/15295192.2015.1053312; Brussoni M, 2015, INT J ENV RES PUB HE, V12, P6423, DOI 10.3390/ijerph120606423; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Certain LK, 2002, PEDIATRICS, V109, P634, DOI 10.1542/peds.109.4.634; Cespedes EM, 2014, PEDIATRICS, V133, pE1163, DOI 10.1542/peds.2013-3998; Cheng SY, 2010, J EPIDEMIOL, V20, pS482, DOI 10.2188/jea.JE20090179; Christakis DA, 2014, JAMA PEDIATR, V168, P399, DOI 10.1001/jamapediatrics.2013.5081; Cliff DP, 2014, J SCI MED SPORT, V18; Conners-Burrow NA, 2011, EARLY EDUC DEV, V22, P256, DOI 10.1080/10409289.2011.550844; Demir M, 2012, J SOC PSYCHOL, V152, P379, DOI 10.1080/00224545.2011.591451; Denham S.A., 2006, EARLY EDUC DEV, V17, P57, DOI [10.1207/s15566935eed1701_4, DOI 10.1207/S15566935EED1701_4]; Department of Health, 2014, NAT PHYS ACT REC CHI; Diener ML, 2004, J CROSS CULT PSYCHOL, V35, P525, DOI 10.1177/0022022104268387; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Evans CA, 2011, J FAM ISSUES, V32, P1223, DOI 10.1177/0192513X11400558; Fivush R, 2000, SEX ROLES, V42, P233, DOI 10.1023/A:1007091207068; Gomes R. M., 2014, PSYCHOLOGY, V5, P99, DOI DOI 10.4236/PSYCH.2014.52015; Gray C, 2015, INT J ENV RES PUB HE, V12, P6455, DOI 10.3390/ijerph120606455; Green S, 2014, J INTELL DISABIL RES, V58, P691, DOI 10.1111/jir.12064; Greenfield DB, 1997, J PSYCHOEDUC ASSESS, V15, P322, DOI 10.1177/073428299701500404; Griswold LA, 2012, AM J OCCUP THER, V66, P709, DOI 10.5014/ajot.2012.004051; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Hinkley T, 2014, PREV MED, V62, P182, DOI 10.1016/j.ypmed.2014.02.007; Hinkley T, 2014, JAMA PEDIATR, V168, P485, DOI 10.1001/jamapediatrics.2014.94; Hinkley T, 2012, J SCI MED SPORT, V15, P407, DOI 10.1016/j.jsams.2011.12.009; HOGAN AE, 1992, J PSYCHOEDUC ASSESS, V10, P230, DOI 10.1177/073428299201000303; Intusoma U, 2013, INFANT BEHAV DEV, V36, P679, DOI 10.1016/j.infbeh.2013.07.001; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Jones SM, 2011, CHILD DEV, V82, P533, DOI 10.1111/j.1467-8624.2010.01560.x; Keefer KV, 2013, PSYCHOL ASSESSMENT, V25, P1255, DOI 10.1037/a0033903; Kirkorian HL, 2009, CHILD DEV, V80, P1350, DOI 10.1111/j.1467-8624.2009.01337.x; Kuepper-Nybelen J, 2005, ARCH DIS CHILD, V90, P359, DOI 10.1136/adc.2004.052423; LANGLOIS JH, 1980, CHILD DEV, V51, P1217; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; Lewinsohn P.M., 1974, ESSENTIAL PAPERS DEP, P150; Lin LY, 2015, INFANT BEHAV DEV, V38, P20, DOI 10.1016/j.infbeh.2014.12.005; Lindsey E. W., 2002, CHILD STUDY J, V32, P145; Lotan Meir, 2005, Int J Adolesc Med Health, V17, P23; Lubans DR, 2012, CHILD ADOL MENT H-UK, V17, P2, DOI 10.1111/j.1475-3588.2011.00623.x; Magee CA, 2014, JAMA PEDIATR, V168, P465, DOI 10.1001/jamapediatrics.2013.4183; Malone, 2011, AUST J OUTDOOR ED, V15, P24, DOI DOI 10.1007/BF03400925; Marinelli M, 2014, JAMA PEDIATR, V168, P458, DOI 10.1001/jamapediatrics.2013.3861; Matsumoto D, 2012, J CROSS CULT PSYCHOL, V43, P91, DOI 10.1177/0022022111420147; McCabe PC, 2011, PSYCHOL SCHOOLS, V48, P513, DOI 10.1002/pits.20570; McWayne CM, 2012, J EDUC PSYCHOL, V104, P862, DOI 10.1037/a0028884; Meagher SM, 2009, EARLY EDUC DEV, V20, P1, DOI 10.1080/10409280801947114; Mistry KB, 2007, PEDIATRICS, V120, P762, DOI 10.1542/peds.2006-3573; Morrongiello BA, 1999, J APPL DEV PSYCHOL, V20, P227, DOI 10.1016/S0193-3973(99)00015-5; Okely AD, 2009, J PAEDIATR CHILD H, V45, P5, DOI 10.1111/j.1440-1754.2008.01445.x; Perry MA, 2010, APPL DEV SCI, V14, P1, DOI 10.1080/10888690903510281; Robinson TN, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P319, DOI 10.1016/B978-0-12-374387-9.00025-8; Saakslahti A, 1999, PEDIATR EXERC SCI, V11, P327, DOI 10.1123/pes.11.4.327; SALLIS JF, 1993, HEALTH PSYCHOL, V12, P390, DOI 10.1037/0278-6133.12.5.390; Sanchez-Villegas A, 2008, MED SCI SPORT EXER, V40, P827, DOI 10.1249/MSS.0b013e31816348b9; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sanson A, 2009, MERRILL PALMER QUART, V55, P26; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Smith LJ, 2017, SLEEP MED, V30, P64, DOI 10.1016/j.sleep.2016.01.009; Stefan CA, 2014, EUR EARLY CHILD EDUC, V22, P14, DOI 10.1080/1350293X.2013.865359; Stone MR, 2014, PREV MED, V65, P122, DOI 10.1016/j.ypmed.2014.05.008; Sweetser P., 2012, AUST J EARLY CHILD, V37, P94, DOI DOI 10.1177/183693911203700413; Takahashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135357; Telama R., 1999, PSYCHOL PHYS ED, P321; Teychenne M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155696; The Royal Children's Hospital Melbourne, 2015, TOP 10 CHILD HLTH PR; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Toumbourou JW, 2011, AUST J PSYCHOL, V63, P214, DOI 10.1111/j.1742-9536.2011.00023.x; Tremblay MS, 2015, INT J ENV RES PUB HE, V12, P6475, DOI 10.3390/ijerph120606475; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vanderloo LM, 2015, RES Q EXERCISE SPORT, V86, P360, DOI 10.1080/02701367.2015.1053105; Vanderloo LM, 2013, APPL PHYSIOL NUTR ME, V38, P1173, DOI 10.1139/apnm-2013-0137; Varni JW, 2013, QUAL LIFE RES; Waite S, 2013, J ADVENTURE EDUC OUT, V13, P255, DOI 10.1080/14729679.2013.798590; Wong MS, 2009, J FAM PSYCHOL, V23, P452, DOI 10.1037/a0015552; Wu CST, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-44; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613	91	53	53	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193700	10.1371/journal.pone.0193700	http://dx.doi.org/10.1371/journal.pone.0193700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617366	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800012
J	Stefanski, HE; Jonart, L; Goren, E; Mule, JJ; Blazer, BR				Stefanski, Heather E.; Jonart, Leslie; Goren, Emily; Mule, James J.; Blazer, Bruce R.			A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; KERATINOCYTE GROWTH-FACTOR; TERTIARY LYMPHOID STRUCTURES; NONOBESE DIABETIC MICE; TISSUE-INDUCER CELLS; VERSUS-HOST-DISEASE; T-CELLS; THYMIC REGENERATION; NODE DEVELOPMENT	Chemotherapy or chemoradiotherapy conditioning regimens required for bone marrow transplantation (BMT) cause significant morbidity and mortality as a result of insufficient immune surveillance mechanisms leading to increased risks of infection and tumor recurrence. Such conditioning causes host stromal cell injury, impairing restoration of the central (thymus) and peripheral (spleen and lymph node) T cell compartments and slow immune reconstitution. The chemokine, CCL21, produced by host stromal cells, recruits T- and B-cells that provide lymphotoxin mediated instructive signals to stromal cells for lymphoid organogenesis. Moreover, T- and B-cell recruitment into these sites is required for optimal adaptive immune responses to pathogens and tumor antigens. Previously, we reported that CCL21 was markedly reduced in secondary lymphoid organs of transplanted animals. Here, we utilized adenoviral CCL21 gene transduced dendritic cells (DC/CCL21) given by footpad injections as a novel approach to restore CCL21 expression in secondary lymphoid organs post-transplant. CCL21 expression in secondary lymphoid organs reached levels of naive controls and resulted in increased T cell trafficking to draining lymph nodes (LNs). An increase in both lymphoid tissue inducer cells and the B cell chemokine CXCL13 known to be important in LN formation was observed. Strikingly, only mice vaccinated with DC/CCL21 loaded with bacterial, viral or tumor antigens and not recipients of DC/control adenovirus loaded cells or no DCs had a marked increase in the systemic clearance of pathogens (bacteria; virus) and leukemia cells. Because DC/CCL21 vaccines have been tested in clinical trials for patients with lung cancer and melanoma, our studies provide the foundation for future trials of DC/CCL21 vaccination in patients receiving pre-transplant conditioning regimens.	[Stefanski, Heather E.; Jonart, Leslie; Goren, Emily; Blazer, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mule, James J.] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL USA	University of Minnesota System; University of Minnesota Twin Cities; H Lee Moffitt Cancer Center & Research Institute	Stefanski, HE (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	stef0030@umn.edu		Stefanski, Heather/0000-0001-7527-9315	National Institute of Health [CA72669]; NATIONAL CANCER INSTITUTE [P01CA065493, R01CA072669] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Institute of Health (Grant No. CA72669 to BRB). The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Barker JN, 2005, BIOL BLOOD MARROW TR, V11, P362, DOI 10.1016/j.bbmt.2005.02.004; Bollard CM, 2016, BLOOD, V127, P3331, DOI 10.1182/blood-2016-01-628982; Burkhardt UE, 2013, J CLIN INVEST, V123, P3756, DOI [10.1172/JCI69098, 10.1172/JCI69008]; Chappaz S, 2010, J IMMUNOL, V184, P3562, DOI 10.4049/jimmunol.0901647; Chung J, 2017, J CLIN INVEST, V127, P1574, DOI 10.1172/JCI89535; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Goldberg JD, 2017, LEUKEMIA LYMPHOMA, V58, P1859, DOI 10.1080/10428194.2016.1265113; Gonzalez-Rodriguez AP, 2010, LEUKEMIA LYMPHOMA, V51, P1829, DOI 10.3109/10428194.2010.503820; Guimond M, 2008, BLOOD, V111, P969, DOI 10.1182/blood-2007-09-113316; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Henry RA, 2010, J IMMUNOL, V185, P1460, DOI 10.4049/jimmunol.0903710; Hollander GA, 2010, CURR OPIN PHARMACOL, V10, P443, DOI 10.1016/j.coph.2010.04.008; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Kelly RM, 2008, BLOOD, V111, P5734, DOI 10.1182/blood-2008-01-136531; Kelly RM, 2010, BLOOD, V115, P1088, DOI 10.1182/blood-2009-05-223198; Kollmann TR, 2007, J IMMUNOL, V178, P3695, DOI 10.4049/jimmunol.178.6.3695; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Leen AM, 2014, IMMUNOL REV, V258, P12, DOI 10.1111/imr.12138; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Maury S, 2001, BRIT J HAEMATOL, V115, P630, DOI 10.1046/j.1365-2141.2001.03135.x; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Moyer JS, 2006, BIOL BLOOD MARROW TR, V12, P1010, DOI 10.1016/j.bbmt.2006.06.009; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mule JJ, 2009, ANN NY ACAD SCI, V1174, P33, DOI 10.1111/j.1749-6632.2009.04936.x; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Parkman R, 2006, BIOL BLOOD MARROW TR, V12, P919, DOI 10.1016/j.bbmt.2006.05.008; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Peske JD, 2015, NAT COMMUN, P6; Sauer MG, 2004, CANCER RES, V64, P3914, DOI 10.1158/0008-5472.CAN-03-3991; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480; Storek J, 2008, SEMIN IMMUNOPATHOL, V30, P425, DOI 10.1007/s00281-008-0132-5; Sutherland JS, 2008, CLIN CANCER RES, V14, P1138, DOI 10.1158/1078-0432.CCR-07-1784; Takamura K, 2007, J IMMUNOL, P179; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Vezys V, 2007, LIFE SCI, V80, P2330, DOI 10.1016/j.lfs.2007.01.001; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Wils EJ, 2011, HAEMATOL-HEMATOL J, V96, P1846, DOI 10.3324/haematol.2011.047696; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624; Zhang SL, 2014, BLOOD, V124, P296, DOI 10.1182/blood-2014-01-552794	57	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193461	10.1371/journal.pone.0193461	http://dx.doi.org/10.1371/journal.pone.0193461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617362	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800007
J	To, B; Andrechek, ER				To, Briana; Andrechek, Eran R.			Transcription factor compensation during mammary gland development in E2F knockout mice	PLOS ONE			English	Article							GENE-EXPRESSION; BRANCHING MORPHOGENESIS; PROGENITOR CELLS; EMBRYONIC STEM; BREAST-CANCER; SPECIFICITY; METASTASIS; SIGNATURES; REVEALS; ROLES	The E2F transcription factors control key elements of development, including mammary gland branching morphogenesis, with several E2Fs playing essential roles. Additional prior data has demonstrated that loss of individual E2Fs can be compensated by other E2F family members, but this has not been tested in a mammary gland developmental context. Here we have explored the role of the E2Fs and their ability to functionally compensate for each other during mammary gland development. Using gene expression from terminal end buds and chromatin immunoprecipitation data for E2F1, E2F2 and E2F3, we noted both overlapping and unique mammary development genes regulated by each of the E2Fs. Based on our computational findings and the fact that E2Fs share a common binding motif, we hypothesized that E2F transcription factors would compensate for each other during mammary development and function. To test this hypothesis, we generated RNA from E2F1(-/-), E2F2(-/-) and E2F3(+/-) mouse mammary glands. QRT-PCR on mammary glands during pregnancy demonstrated increases in E2F2 and E2F3a in the E2F1(-/-) mice and an increase in E2F2 levels in E2F3(+/-) mice. During lactation we noted that E2F3b transcript levels were increased in the E2F2(-/-) mice. Given that E2Fs have previously been noted to have the most striking effects on development during puberty, we hypothesized that loss of individual E2Fs would be compensated for at that time. Double mutant mice were generated and compared with the single knockouts. Loss of both E2F1 and E2F2 revealed a more striking phenotype than either knockout alone, indicating that E2F2 was compensating for E2F1 loss. Interestingly, while E2F2 was not able to functionally compensate for E2F3(+/-) during mammary outgrowth, increased E2F2 expression was observed in E2F3(+/-) mammary glands during pregnancy day 14.5 and lactation day 5. Together, these findings illustrate the specificity of E2F family members to compensate during development of the mammary gland.	[To, Briana; Andrechek, Eran R.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University	Andrechek, ER (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	andrech1@msu.edu			NIH; WCR grant; NIH [R01CA160514]; Worldwide Cancer Research [WCR - 14-1153]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCR grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worldwide Cancer Research	ERA received 2 months salary from the NIH grant that supported this study. SR student salary was supported by the WCR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported with NIH R01CA160514 and Worldwide Cancer Research WCR - 14-1153 to E.R.A., httns://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci, https://www.worldwidecancerresearch.org/.	Andrechek ER, 2015, ONCOGENE, V34, P217, DOI 10.1038/onc.2013.540; Andrechek ER, 2008, DEVELOPMENT, V135, P2403, DOI 10.1242/dev.019018; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Hatcher RJ, 2014, P NATL ACAD SCI USA, V111, P1008, DOI 10.1073/pnas.1318124111; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hollern DP, 2014, MOL CELL BIOL; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Julian LM, 2016, CELL DEATH DIFFER, V23, P565, DOI 10.1038/cdd.2015.36; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Morris JS, 2006, J CELL PHYSIOL, V206, P16, DOI 10.1002/jcp.20427; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Sheridan JM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1187-z; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yuwanita I, 2015, ONCOTARGET	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194937	10.1371/journal.pone.0194937	http://dx.doi.org/10.1371/journal.pone.0194937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617434	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800057
J	Perdue, BM; Evans, TA; Beran, MJ				Perdue, Bonnie M.; Evans, Theodore A.; Beran, Michael J.			Chimpanzees show some evidence of selectively acquiring information by using tools, making inferences, and evaluating possible outcomes	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; MACAQUES MACACA-MULATTA; LION-TAILED MACAQUES; RHESUS-MONKEYS; UNCERTAINTY RESPONSES; ANIMAL-METACOGNITION; MEMORY AWARENESS; PAN-TROGLODYTES; PAPIO-HAMADRYAS; META-COGNITION	Metacognition refers to thinking about one's thinking or knowing what one knows. Research suggests that this ability is not unique to humans and may be shared with nonhuman animals. In particular, great apes have shown behaviors on a variety of tasks that are suggestive of metacognitive ability. Here we combine a metacognitive task, the information-seeking task, with tool use and variable forms of initial information provided to chimpanzees to explore how informational states impact behavioral responses in these apes. Three chimpanzees were presented with an apparatus that contained five locations where food could be hidden. If they pointed to the correct location, they received the reward, but otherwise they did not. We first replicated several existing findings using this method, and then tested novel hypotheses. The chimpanzees were given different types of information across the experiments. Sometimes, they were shown the location of the food reward. Other times, they were shown only one empty location, which was not useful information. The chimpanzees also could use a tool to search any of those locations before making a selection. Chimpanzees typically used the tool to search out the location of the reward when they could not already know where it was, but they did not use the tool when they already had been given that information. One chimpanzee made inferences about the location of hidden food, even when that food was never shown in that location. The final experiment involved hiding foods of differing preference values, and then presenting the chimpanzees with different initial knowledge states (i.e., where the best food was located, where the less-preferred food was located, or where no food was located). All chimpanzees used the tool when they needed to use it to find the best possible item on that trial, but responded by choosing a location immediately when they did not need the tool. This finding highlights that their behavior was not the result of a simple rule following such as pointing to where any food had been seen.	[Perdue, Bonnie M.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Evans, Theodore A.; Beran, Michael J.] Georgia State Univ, Language Res Ctr, Decatur, GA USA; [Beran, Michael J.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Perdue, BM (corresponding author), Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA.	bonnie.m.perdue@gmail.com	Beran, Michael J./ABY-1786-2022; Beran, Michael J./M-8743-2016	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338	National Institutes of Health [HD-060563]; National Science Foundation [BCS 1552405]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (HD-060563) and the National Science Foundation - (BCS 1552405) to B.P. and M. B. - Confidence judgements and metacognition in comparative and developmental perspective.	Adams A, 2011, LEARN BEHAV, V39, P1, DOI 10.1007/s13420-010-0001-7; Basile BM, 2015, J EXP PSYCHOL GEN, V144, P85, DOI 10.1037/xge0000031; Basile BM, 2014, J COMP PSYCHOL, V128, P135, DOI 10.1037/a0034412; Basile BM, 2013, COGNITION, V126, P391, DOI 10.1016/j.cognition.2012.10.012; Basile BM, 2009, ANIM COGN, V12, P169, DOI 10.1007/s10071-008-0180-1; Beran MJ, 2015, COGNITION, V142, P236, DOI 10.1016/j.cognition.2015.05.023; Beran MJ, 2013, PSYCHOL SCI, V24, P660, DOI 10.1177/0956797612458936; Beran MJ, 2011, COGNITION, V120, P90, DOI 10.1016/j.cognition.2011.02.016; Brown EK, 2017, BEHAV PROCESS, V135, P132, DOI 10.1016/j.beproc.2016.12.004; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Call J, 2010, ANIM COGN, V13, P689, DOI 10.1007/s10071-010-0317-x; Call J, 2000, ANIM COGN, V3, P23, DOI 10.1007/s100710050047; Carruthers P, 2008, MIND LANG, V23, P58, DOI 10.1111/j.1468-0017.2007.00329.x; Carruthers P, 2009, BEHAV BRAIN SCI, V32, P121, DOI 10.1017/S0140525X09000545; Castro L, 2013, ANIM COGN, V16, P241, DOI 10.1007/s10071-012-0569-8; Crystal JD, 2014, J COMP PSYCHOL, V128, P152, DOI 10.1037/a0034427; Crystal JD, 2009, COMP COGN BEHAV REV, V4, P54, DOI 10.3819/ccbr.2009.40005; Crystal JD, 2011, CURR ZOOL, V57, P531, DOI 10.1093/czoolo/57.4.531; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Foote AL, 2012, ANIM COGN, V15, P187, DOI 10.1007/s10071-011-0445-y; Fujita K, 2009, ANIM COGN, V12, P575, DOI 10.1007/s10071-009-0217-0; Hampton RR, 2009, COMP COGN BEHAV REV, V4, P17, DOI 10.3819/ccbr.2009.40002; Hampton RR, 2006, BEHAV PROCESS, V72, P184, DOI 10.1016/j.beproc.2006.01.007; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Hampton RR, 2001, P NATL ACAD SCI USA, V98, P5359, DOI 10.1073/pnas.071600998; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; Hill A, 2011, J COMP PSYCHOL, V125, P91, DOI 10.1037/a0020867; Iwasaki S, 2013, ANIM COGN, V16, P211, DOI 10.1007/s10071-012-0566-y; Jozefowiez J, 2009, COMP COGN BEHAV REV, V4, P29, DOI 10.3819/ccbr.2009.40003; Kirk CR, 2014, J EXP PSYCHOL-ANIM L, V40, P249, DOI 10.1037/xan0000018; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kornell N, 2014, J COMP PSYCHOL, V128, P143, DOI 10.1037/a0033444; Kornell N, 2009, CURR DIR PSYCHOL SCI, V18, P11, DOI 10.1111/j.1467-8721.2009.01597.x; Le Pelley ME, 2012, J EXP PSYCHOL LEARN, V38, P686, DOI 10.1037/a0026478; Le Pelley ME, 2014, J COMP PSYCHOL, V128, P132, DOI 10.1037/a0034227; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Malassis R, 2015, ANIM COGN, V18, P1347, DOI 10.1007/s10071-015-0907-8; Marsh HL, 2015, J COMP PSYCHOL, V129, P256, DOI 10.1037/a0039316; Marsh HL, 2014, ANIM COGN, V17, P1313, DOI 10.1007/s10071-014-0767-7; Marsh HL, 2012, J COMP PSYCHOL, V126, P263, DOI 10.1037/a0025906; Marsh HL, 2012, ANIM COGN, V15, P293, DOI 10.1007/s10071-011-0453-y; Metcalfe J., 1994, METACOGNITION KNOWIN; Morgan G, 2014, ANIM COGN, V17, P249, DOI 10.1007/s10071-013-0657-4; Mulcahy NJ, 2016, J COMP PSYCHOL, V130, P391, DOI 10.1037/com0000046; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Nakao H, 2015, JPN J ANIM PSYCHOL, V65, P45, DOI DOI 10.2502/JANIP.65.1.1; Nelson T.O., 1992, METACOGNITION CORE R; Nelson TO., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Perner J, 2012, FDN METACOGNITION; Rosati AG, 2016, PSYCHOL SCI, V27, P1181, DOI 10.1177/0956797616653737; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; SCHWARTZ BL, 1994, PSYCHON B REV, V1, P357, DOI 10.3758/BF03213977; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Smith JD, 2008, PSYCHON B REV, V15, P679, DOI 10.3758/PBR.15.4.679; Smith JD, 2006, J EXP PSYCHOL GEN, V135, P282, DOI 10.1037/0096-3445.135.2.282; Smith JD, 2013, J EXP PSYCHOL GEN, V142, P458, DOI 10.1037/a0029601; Smith JD, 2012, PHILOS T R SOC B, V367, P1297, DOI 10.1098/rstb.2011.0366; Smith JD, 2010, ANIM COGN, V13, P93, DOI 10.1007/s10071-009-0249-5; Smith JD, 2009, TRENDS COGN SCI, V13, P389, DOI 10.1016/j.tics.2009.06.009; SMITH JD, 1995, J EXP PSYCHOL GEN, V124, P391, DOI 10.1037/0096-3445.124.4.391; Smith JD, J COMP PSYCH, V128, P115, DOI [10.1007/s10071-004-0215-1, DOI 10.1007/S10071-004-0215-1]; Suda-King C, 2008, ANIM COGN, V11, P21, DOI 10.1007/s10071-007-0082-7; Suda-King C, 2013, ANIM COGN, V16, P65, DOI 10.1007/s10071-012-0551-5; Templer VL, 2017, ANIM COGN, V20, P891, DOI 10.1007/s10071-017-1109-3; Templer VL, 2012, ANIM COGN, V15, P409, DOI 10.1007/s10071-011-0468-4; Tu HW, 2015, J COMP PSYCHOL, V129, P347, DOI 10.1037/a0039595; Vining AQ, 2015, ANIM COGN, V18, P667, DOI 10.1007/s10071-015-0835-7; Yuki S, 2017, J EXP PSYCHOL-ANIM L, V43, P109, DOI 10.1037/xan0000130; Zakrzewski AC, 2014, J EXP PSYCHOL-ANIM L, V40, P490, DOI 10.1037/xan0000041	76	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193229	10.1371/journal.pone.0193229	http://dx.doi.org/10.1371/journal.pone.0193229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641519	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900011
J	Gebhard, C; Gebhard, CE; Stahli, BE; Maafi, F; Bertrand, MJ; Wildi, K; Fortier, A; Onandia, ZG; Toma, A; Zhang, ZW; Smith, DC; Spagnoli, V; Ly, HQ				Gebhard, Catherine; Gebhard, Caroline E.; Stahli, Barbara E.; Maafi, Foued; Bertrand, Marie-Jeanne; Wildi, Karin; Fortier, Annik; Onandia, Zurine Galvan; Toma, Aurel; Zhang, Zheng W.; Smith, David C.; Spagnoli, Vincent; Ly, Hung Q.			Weather and risk of ST-elevation myocardial infarction revisited: Impact on young women	PLOS ONE			English	Article							DAILY HOSPITAL ADMISSIONS; TEMPERATURE; STRESS; MORTALITY	Background During the last decade, the incidence and mortality rates of ST-elevation myocardial infarction (STEMI) has been steadily increasing in young women but not in men. Environmental variables that contribute to cardiovascular events in women remain ill-defined. Methods and results A total of 2199 consecutive patients presenting with acute ST-elevation myocardial infarction (STEMI, 25.8% women, mean age 62.6 +/- 12.4 years) were admitted at the Montreal Heart Institute between June 2010 and December 2014. Snow fall exceeding 2cm/day was identified as a positive predictor for STEMI admission rates in the overall population (RR 1.28, 95% Cl 1.07-1.48, p = 0.005), with a significant effect being seen in men (RR 1.30, 95% Cl 1.06-1.53, p = 0.01) but not in women (p = NS). An age-specific analysis revealed a significant increase in hospital admission rates for STEMI in younger women <= 55 years, (n = 104) during days with higher outside temperature (p = 0.004 vs men <= 55 years) and longer daylight hours (p = 0.0009 vs men <= 55 years). Accordingly, summer season, increased outside temperature and sunshine hours were identified as strong positive predictors for STEMI occurrence in women <= 55 years (RR 1.66, 95% Cl 1.1-2.5, p = 0.012, RR 1.70, 95% Cl 1.2-2.5, p = 0.007, and RR 1.67, 95% Cl 1.2-2.5, p = 0.011, respectively), while an opposite trend was observed in men <= 55 years (RR for outside temperature 0.8, 95% Cl 0.73-0.95, p = 0.01). Conclusion The impact of environmental variables on STEMI is age-and sex-dependent. Higher temperature may play an important role in triggering such acute events in young women.	[Gebhard, Catherine; Gebhard, Caroline E.; Stahli, Barbara E.; Maafi, Foued; Bertrand, Marie-Jeanne; Onandia, Zurine Galvan; Zhang, Zheng W.; Smith, David C.; Spagnoli, Vincent; Ly, Hung Q.] Montreal Heart Inst, Montreal, PQ, Canada; [Gebhard, Catherine] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Gebhard, Catherine; Toma, Aurel] Univ Heart Ctr, Freiburg, Bad Krozingen, Germany; [Gebhard, Caroline E.; Wildi, Karin] Univ Hosp Basel, Dept Anaesthesiol, Basel, Switzerland; [Fortier, Annik] Montreal Hlth Innovat Coordinating Ctr, Montreal, PQ, Canada; [Ly, Hung Q.] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; University of Zurich; University Zurich Hospital; Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; Universite de Montreal; Universite de Montreal	Gebhard, C (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Gebhard, C (corresponding author), Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.; Gebhard, C (corresponding author), Univ Heart Ctr, Freiburg, Bad Krozingen, Germany.	catherine.gebhard@usz.ch	Gebhard, Catherine/AAT-7060-2020; Smith, David/GQQ-8257-2022; Wildi, Karin/AAN-3644-2020	Gebhard, Catherine/0000-0001-7240-5822; Wildi, Karin/0000-0002-6520-2696	Swiss National Science Foundation (SNSF) [P3SMP3_151740, 1142741]; Novartis Foundation for Medical-Biological Research, Switzerland; Gottfried und Julia Bangerter-Rhyner-Foundation, Switzerland	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Novartis Foundation for Medical-Biological Research, Switzerland; Gottfried und Julia Bangerter-Rhyner-Foundation, Switzerland	This work was supported by the Swiss National Science Foundation (SNSF, grants P3SMP3_151740 and 1142741 to BES and CG), the Novartis Foundation for Medical-Biological Research, Switzerland (to BES and CG) and the Gottfried and Julia Bangerter-Rhyner-Foundation, Switzerland (to BES).	Auger N, 2017, CAN MED ASSOC J, V189, pE235, DOI 10.1503/cmaj.161064; Banerjee A, 2009, CIRC-CARDIOVASC GENE, V2, P98, DOI 10.1161/CIRCGENETICS.108.806562; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Dreyer RP, 2016, EUR HEART J-ACUTE CA, V5, P43, DOI 10.1177/2048872615568967; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Gabet A, 2017, EUR HEART J, V38, P1060, DOI 10.1093/eurheartj/ehx097; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Kloner RA, 2001, AM J CARDIOL, V88, P1021, DOI 10.1016/S0002-9149(01)01981-6; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Lee JH, 2010, INT J CARDIOL, V144, P16, DOI 10.1016/j.ijcard.2009.03.122; Morabito M, 2005, INT J CARDIOL, V105, P288, DOI 10.1016/j.ijcard.2004.12.047; Nichols RB, 2012, CLIN RES CARDIOL, V101, P11, DOI 10.1007/s00392-011-0356-6; Osler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086758; PAN WH, 1995, LANCET, V345, P353, DOI 10.1016/S0140-6736(95)90341-0; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Phung D, 2016, SCI TOTAL ENVIRON, V550, P1084, DOI 10.1016/j.scitotenv.2016.01.154; Rooks CR, 2016, BRAIN BEHAV IMMUN, V51, P92, DOI 10.1016/j.bbi.2015.08.008; Shah Amit J, 2014, J Am Heart Assoc, V3, pe000741, DOI 10.1161/JAHA.113.000741; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; Vaccarino V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003630; van der Meer MG, 2015, EUR J CLIN INVEST, V45, P226, DOI 10.1111/eci.12399; Women Gebhard C., 2017, EUR HEART J, V38, P1066, DOI [10.1093/eurheartj/ehx109, DOI 10.1093/EURHEARTJ/EHX109]; Xu X, 2015, CIRCULATION, V131, P614, DOI 10.1161/CIRCULATIONAHA.114.012826	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195602	10.1371/journal.pone.0195602	http://dx.doi.org/10.1371/journal.pone.0195602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630673	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000429505000063
J	Ramnath, U; Rauch, L; Lambert, EV; Kolbe-Alexander, TL				Ramnath, U.; Rauch, L.; Lambert, E. V.; Kolbe-Alexander, T. L.			The relationship between functional status, physical fitness and cognitive performance in physically active older adults: A pilot study	PLOS ONE			English	Article							MEXICAN-AMERICANS; HANDGRIP STRENGTH; MOBILITY; EXERCISE	Objective Ageing is associated with a progressive decline in physical function and cognitive performance which could result in a shift from an independent to a more dependent lifestyle. The aim of this research study was to assess the fitness, functional performance and cognitive ability in independently living older South Africans and to determine which fitness parameters and functional performance tests best explain the variance in cognitive function. Design Descriptive observational study. Participants Older adults with a mean age 71 +/- 4.7 years (n = 70; 28 men and 42 women) were recruited. Sixty percent of the sample completed at least secondary schooling and more than two-thirds were taking medication for a chronic medical condition. Measurements Self-reported physical activity was assessed using the Yale Physical Activity Survey. Fitness tests included the 6-minute walk test and Bicep Curls. The functional performance tests were; Static and Dynamic balance, Timed Up and Go, Sit to Stand, Grip strength and Functional Reach. The Stroop Task and 6-Item cognitive impairment test were used to measure cognitive performance. Bivariate and multivariate analyses were conducted between performance on the novel cognitive Stroop Task and functional and cognitive tests. Results We found significant relationships between the number of correct responses on the Stroop Task and scores on the 6-Item Cognitive Impairment test (-0.520, p < 0.01) and grip strength (r = 0.42, p< 0.01). The number of incorrect responses was inversely associated with functional reach (r = -0.445, p< 0.01). The final regression model included: age, dynamic balance, right arm grip strength and the score on the 6-item cognitive impairment test, and explained 44% of the variance in performance of the Stroop Task. Conclusions The results of this study showed that measures of physical function were associated with cognitive performance even in highly functioning older South African adults. Further research is needed to determine the extent to which exercise training can improve functional capacity and the effect on cognitive performance.	[Ramnath, U.; Rauch, L.; Lambert, E. V.; Kolbe-Alexander, T. L.] Univ Cape Town, Fac Hlth Sci, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa; [Kolbe-Alexander, T. L.] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Australia	University of Cape Town; University of Southern Queensland	Ramnath, U (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa.	rmnudh001@myuct.ac.ma	Lambert, Estelle/ABF-1268-2020; Rauch, Henri GL/HCI-8272-2022; Kolbe-Alexander, Tracy/C-1333-2014	Lambert, Estelle/0000-0003-4315-9153; Rauch, Henri GL/0000-0002-7709-3407; Ramnath, Udhir/0000-0002-9705-0789; Kolbe-Alexander, Tracy/0000-0002-5025-3204				Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Alfaro-Acha A, 2006, J GERONTOL A-BIOL, V61, P859, DOI 10.1093/gerona/61.8.859; Arnett SW, 2008, AGE AGEING, V37, P384, DOI 10.1093/ageing/afn022; Barnes ED, 2003, LONGITUDINAL STUDY C; BRODERICK K, 2002, S AFR J OCCUP THER, V32, P8; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Buchman SA, 2007, PHYS ACTIVITY MOTOR; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Daley MJ, 2000, SPORTS MED, V29, P1, DOI 10.2165/00007256-200029010-00001; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; DURNIN JVG, 1969, J PHYSIOL-LONDON, V200, pP105; Eggermont HL, 2010, LOWER EXTREMITY FUNC; Ferreira NV, 2015, ASS FUNCTIONAL PERFO; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Forstmann BU, 2008, STRIATUM PRESMA FACI; Geal Rauch H, 2005, 7 PHYS SOC SO AFR; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Grigsby J, 1998, EXECUTIVE COGNITIVE; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hoeymans N, 1996, J CLIN EPIDEMIOL, V49, P1103, DOI 10.1016/0895-4356(96)00210-7; Holtzer R, 2007, RELATIONSHIP SPECIFI; Jones CJ, 2005, PHYS ACTIVITY INSTRU; Kinsell K, 1997, AGEING TRENDS S AFRI; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; Kolbe-Alexander TL, 2006, EFFECTIVENESS COMMUN; Konopack JE, 2008, INT J BEHAV MED, V15, P311, DOI 10.1080/10705500802365557; Kramer FA, 2005, FITNESS AGING NEUROC; Kramer FA, 2006, EXERCISE COGNITION A; Lehohla PJ, 2010, STAT S AFRICA MIDYEA; Liu-Ambrose T, 2007, EXECUTIVE FUNCTION I; Liu-Ambrose T, 2008, OTAGO HOME BASED STR; Martins AR, 2010, LA ESCLAVITUD NEGROA, P9; Mayson JD, 2008, LEG STRENGTH VELOCIT; McGough EL, 2011, ASS PHYS PERFORMANCE; Medicine A. C. of S, 2009, ACSMS GUIDELINES EXE, P60; Misic MM, 2009, IMPACT TRAINING MODA; Miyake A, 2000, UNITY DIVERSITY EXEC; de Castro KCM, 2008, ARQ NEURO-PSIQUIAT, V66, P809, DOI 10.1590/S0004-282X2008000600006; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Peavy GM, 2009, AM J PSYCHIAT, V166, P1384, DOI 10.1176/appi.ajp.2009.09040461; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Rikli E., 2001, SENIOR FITNESS TEST; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Taylor WA, 2008, PHYSL EXERCISE HLTH; Voelcker-Rahage C, 2010, PHYS MOTOR FITNESS A; WEINER DK, 1992, J AM GERIATR SOC, V40, P203, DOI 10.1111/j.1532-5415.1992.tb02068.x; Whaley HM, 2006, ACSMS GUIDELINES EXE; Williamson JD, 2009, J GERONTOL A-BIOL, V64, P688, DOI 10.1093/gerona/glp014; Wilmore HJ, 2008, PHYSL SPORT EXERCISE; WINOGRAD CH, 1994, J AM GERIATR SOC, V42, P743, DOI 10.1111/j.1532-5415.1994.tb06535.x; Yaffe K, 2001, PROSPECTIVE STUDY PH	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194918	10.1371/journal.pone.0194918	http://dx.doi.org/10.1371/journal.pone.0194918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630625	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000429505000020
J	Castelucci, BG; Consonni, SR; Rosa, VS; Sensiate, LA; Delatti, PCR; Alvares, LE; Joazeiro, PP				Castelucci, Bianca Gazieri; Consonni, Silvio Roberto; Rosa, Viviane Souza; Sensiate, Lucimara Aparecida; Rugno Delatti, Paula Cristina; Alvares, Lucia Elvira; Joazeiro, Paulo Pinto			Time-dependent regulation of morphological changes and cartilage differentiation markers in the mouse pubic symphysis during pregnancy and postpartum recovery	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; REPAIR TISSUE; II COLLAGEN; CELLS; RELAXIN; BONE; MICE; RELAXATION	Animal models commonly serve as a bridge between in vitro experiments and clinical applications; however, few physiological processes in adult animals are sufficient to serve as proof-of-concept models for cartilage regeneration. Intriguingly, some rodents, such as young adult mice, undergo physiological connective tissue modifications to birth canal elements such as the pubic symphysis during pregnancy; therefore, we investigated whether the differential expression of cartilage differentiation markers is associated with cartilaginous tissue morphological modifications during these changes. Our results showed that osteochondral progenitor cells expressing Runx2, Sox9, Col2a1 and Dcx at the non-pregnant pubic symphysis proliferated and differentiated throughout pregnancy, giving rise to a complex osteoligamentous junction that attached the interpubic ligament to the pubic bones until labour occurred. After delivery, the recovery of pubic symphysis cartilaginous tissues was improved by the time-dependent expression of these chondrocytic lineage markers at the osteoligamentous junction. This process potentially recapitulates embryologic chondrocytic differentiation to successfully recover hyaline cartilaginous pads at 10 days postpartum. Therefore, we propose that this physiological phenomenon represents a proof-of-concept model for investigating the mechanisms involved in cartilage restoration in adult animals.	[Castelucci, Bianca Gazieri; Consonni, Silvio Roberto; Rosa, Viviane Souza; Sensiate, Lucimara Aparecida; Rugno Delatti, Paula Cristina; Alvares, Lucia Elvira; Joazeiro, Paulo Pinto] State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Castelucci, BG; Consonni, SR; Joazeiro, PP (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.	biancastelucci@gmail.com; consonni@unicamp.br; pjoaz@unicamp.br	Consonni, Sílvio Roberto/R-9281-2019; Castelucci, Bianca/V-4055-2019	Castelucci, Bianca/0000-0003-1534-305X; Consonni, Silvio Roberto/0000-0003-3149-021X	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/25038-8, 2015/23616-2]; CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302590/2013-7, 140714/2016-2]; FAPESP [2012/25038-8, 2015/23616-2]; CNPq [302590/2013-7, 140714/2016-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/57906-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573913/2008-0]	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant no. 2012/25038-8 (http://www.fapesp.br/) to BGC and 2015/23616-2 to PPJ and CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant no. 302590/2013-7 (http://www.cnpq.br/) to PPJ and 140714/2016-2 to BGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul Y, 2012, ENDOCRINOLOGY, V153, P3493, DOI 10.1210/en.2011-1950; An BS, 2003, MOL CELL ENDOCRINOL, V205, P79, DOI 10.1016/S0303-7207(03)00203-X; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Bernhard JC, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0314-3; Borjesson AE, 2013, CELL MOL LIFE SCI, V70, P4023, DOI 10.1007/s00018-013-1317-1; Carroll SH, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.2; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Consonni SR, 2012, HISTOL HISTOPATHOL, V27, P885, DOI 10.14670/HH-27.885; Consonni SR, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095653; CORWIN JA, 1971, ANAT RECORD, V171, P509, DOI 10.1002/ar.1091710407; CRELIN ES, 1969, T NEW YORK ACAD SCI, V31, P1049, DOI 10.1111/j.2164-0947.1969.tb02024.x; Dyment NA, 2015, DEV BIOL, V405, P96, DOI 10.1016/j.ydbio.2015.06.020; Foldager CB, 2015, CARTILAGE, V6, P123, DOI 10.1177/1947603514560655; Garcia EA, 2008, CELL BIOL INT, V32, P913, DOI 10.1016/j.cellbi.2008.04.006; Gardener WU, 1936, AM J ANAT, V59, P459, DOI 10.1002/aja.1000590307; Ge DX, 2014, INT J MOL SCI, V15, P6941, DOI 10.3390/ijms15046941; HALL K, 1954, J ENDOCRINOL, V11, P210, DOI 10.1677/joe.0.0110210; HALL K, 1956, J ENDOCRINOL, V13, P384, DOI 10.1677/joe.0.0130384; Hashem G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1978; Joazeiro P. P., 2014, GUIDE INVESTIGATION, P403; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Maneix L, 2014, J MOL MED, V92, P1179, DOI 10.1007/s00109-014-1195-5; Matsumaru D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016260; Mays S, 2015, ANN HUM BIOL, V42, P332, DOI 10.3109/03014460.2015.1044470; McGonagle D, 2017, NAT REV RHEUMATOL, V13, P719, DOI 10.1038/nrrheum.2017.182; Moraes Suzana Guimaraes, 2003, Brazilian Journal of Morphological Sciences, V20, P85; Moran Conor J, 2016, J Exp Orthop, V3, P1, DOI 10.1186/s40634-015-0037-x; Moro CF, 2012, MOL REPROD DEV, V79, P272, DOI 10.1002/mrd.22020; Ortega HH, 2003, CELLS TISSUES ORGANS, V173, P105, DOI 10.1159/000068947; Pinheiro MC, 2005, CELL BIOL INT, V29, P458, DOI 10.1016/j.cellbi.2004.11.025; Pinheiro MC, 2004, MICRON, V35, P685, DOI 10.1016/j.micron.2004.04.007; Pinheiro MC, 2003, CELL BIOL INT, V27, P647, DOI 10.1016/S1065-6995(03)00121-5; Rosa RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105170; Rosa RG, 2011, REPROD SCI, V18, P963, DOI 10.1177/1933719111401657; Rosa RG, 2008, MICROSC RES TECHNIQ, V71, P169, DOI 10.1002/jemt.20549; Rosa RG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093229; Sensiate LA, 2014, DEV DYNAM, V243, P428, DOI 10.1002/dvdy.23948; Sherwood O. David, 1994, P861; Shintaku Y, 2011, CELLS TISSUES ORGANS, V194, P38, DOI 10.1159/000322557; Solem RC, 2011, DEV BIOL, V356, P28, DOI 10.1016/j.ydbio.2011.05.003; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; STOREY E, 1957, J PATHOL BACTERIOL, V74, P147, DOI 10.1002/path.1700740117; Takahashi I, 1998, J CELL SCI, V111, P2067; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Wang T, 2017, J CELL PHYSIOL, V232, P913, DOI 10.1002/jcp.25641; Wang W, 2009, OSTEOARTHR CARTILAGE, V17, P646, DOI 10.1016/j.joca.2008.09.015; Yang J, 2015, INT J ORAL SCI, V7, P73, DOI 10.1038/ijos.2015.14; Yao LJ, 2008, ENDOCRINOLOGY, V149, P2072, DOI 10.1210/en.2007-1176; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Yu XD, 2017, J ORTHOP RES, V35, P1671, DOI 10.1002/jor.23463; Zhang QY, 2011, GENESIS, V49, P75, DOI 10.1002/dvg.20702; Zhang Y, 2007, BIOCHEM BIOPH RES CO, V363, P694, DOI 10.1016/j.bbrc.2007.09.030; Zhao L, 2000, BIOL REPROD, V63, P697, DOI 10.1095/biolreprod63.3.697; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195304	10.1371/journal.pone.0195304	http://dx.doi.org/10.1371/journal.pone.0195304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621303	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800057
J	Hector, J; Davies, MA; Dekker-Boersema, J; Aly, MM; Abdalad, CCA; Langa, EBR; Ehmer, J; Hobbins, MA; Jefferys, LF				Hector, Jonas; Davies, Mary-Ann; Dekker-Boersema, Johanna; Aly, Mussa Manuel; Abdalad, Cassimo Charifo A.; Langa, Ernesto Belario Rafael; Ehmer, Jochen; Hobbins, Michael Andre; Jefferys, Laura Frances			Acceptability and performance of a directly assisted oral HIV self-testing intervention in adolescents in rural Mozambique	PLOS ONE			English	Article							LINKAGE; AFRICA	Introduction Whereas progress in HIV testing and treatment has been made globally, the UNAIDS goal of "90 90 90" is still out of sight in rural northern Mozambique. New strategies that promote testing in hard to reach groups will aid Mozambique's response to the HIV epidemic. HIV self-testing (HIVST) is recommended by the WHO as an additional approach to augment the HIV testing services available to adolescents. This study evaluates acceptability and performance of a directly assisted oral HIVST intervention for adolescents in rural Mozambique. Methods Adolescents aged 16-20 years were included at schools and invited to attend the local hospital's youth friendly service for directly assisted oral HIVST. Baseline and post-test questionnaires were obtained. OraQuick Rapid HIV-1/2 Anti body test (R) was used. Results were read by the participant and by a nurse. Results were confirmed by finger prick HIV test (Determine (R) HIV 1/2 Alere and Unigold (TM) HIV Trinity Biotech) according to the Mozambican national standard. Results Between September and November 2016, 496 adolescents were included, of which 299 performed an oral HIV self-test. 70% were first time testers. The positivity rate was 1.7%. The inter-rater agreement between adolescent and nurse was 99.6% (kappa 0.93); there were no false negative or false positive results of the oral HIV self-test. Five tests were invalid. 7.1% found the test difficult to use. Over 80% preferred directly assisted HIVST compared to the standard finger prick testing. While 20% thought it would be good to do HIVST at home, 76% preferred to do HIVST at the health centre, for reasons including increased security, privacy, and the presence of a counsellor. Conclusions Directly assisted oral HIVST is a feasible intervention for adolescents in rural Mozambique and showed encouraging results for first time HIV testers.	[Hector, Jonas; Dekker-Boersema, Johanna; Jefferys, Laura Frances] SolidarMed, Pemba, Mozambique; [Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Aly, Mussa Manuel] Operat Res Unit Pemba, Pemba, Cabo Delgado, Mozambique; [Abdalad, Cassimo Charifo A.] Dist Hlth Directorate, Ancuabe, Cabo Delgado, Mozambique; [Langa, Ernesto Belario Rafael] Prov Hlth Directorate, Cabo Delgado, Pemba, Mozambique; [Ehmer, Jochen; Hobbins, Michael Andre] SolidarMed, Luzern, Switzerland	University of Cape Town	Hector, J (corresponding author), SolidarMed, Pemba, Mozambique.	j.hector@solidarmed.ch						Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Baltazar CS, 2014, J CLIN MICROBIOL, V52, P3544, DOI 10.1128/JCM.01098-14; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Cambiano V, 2015, J INFECT DIS, V212, P570, DOI 10.1093/infdis/jiv040; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dittus PJ, 2014, J ADOLESCENT HEALTH, V55, P528, DOI 10.1016/j.jadohealth.2014.04.005; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Hiltabiddle S J, 1996, J Obstet Gynecol Neonatal Nurs, V25, P61, DOI 10.1111/j.1552-6909.1996.tb02514.x; Institute Nacional de SaUde e Institute Nacional de Estatistica. Inquerito de Indicadores de lmunizacao Malaria e HIV/SIDA em Mocambique (IMASIDA, 2015, INQ IND IM MAL HIV S; Instituto Nacional de Estatistica, 2013, EST DISTR ANC; Kelvin EA, 2016, AJAR-AFR J AIDS RES, V15, P99, DOI 10.2989/16085906.2016.1189442; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kurth AE, 2016, AIDS BEHAV, V20, P870, DOI 10.1007/s10461-015-1213-9; Madiba S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1746-x; Marlin RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1226; Minesterio de Saude e Institute Nacional de Estatistica, 2016, INQ IND IM MAL HIV S; Ministerio da Saude, TRAT ANT INF OP AD A; Mugo PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170868; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Njau B, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0230-8; Njau B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-838; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Sarkar A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20993; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Sisay Solomon, 2014, BMC Res Notes, V7, P518, DOI 10.1186/1756-0500-7-518; Tarkang EE, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.259.2772; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, END AIDS EP AD AD; UNAIDS, HIV AIDS EST; Unicef, CHILD MARR AD PREGN; Wagenaar BH, 2014, TROP MED INT HEALTH, V19, P791, DOI 10.1111/tmi.12314; Wong HTH, 2015, AIDS BEHAV, V19, P505, DOI 10.1007/s10461-014-0881-1; World Health Organisation, HIV AD GUID HIV TEST; World Health Organisation, CONS GUID HIV TEST S; World Health Organziation, GUID HIV SELF TEST P	40	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195391	10.1371/journal.pone.0195391	http://dx.doi.org/10.1371/journal.pone.0195391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621308	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800074
J	Zhang, F; Ma, G; Liu, X; Tao, YQ; Feng, D; Li, R				Zhang, Fan; Ma, Geng; Liu, Xiao; Tao, Yunqi; Feng, Dan; Li, Rui			Experimental analysis of multiple factors on hydraulic fracturing in coalbed methane reservoirs	PLOS ONE			English	Article							IMPACT; PROPAGATION; PARAMETERS; INITIATION; PRESSURE; VOLUME; SHALE; SEAMS	Hydraulic fracturing can improve the permeability of coalbed methane (CBM) reservoirs effectively, which is of great significance to the commercial production of CBM. However, the efficiency of hydraulic fracturing is affected by multiple factors. The mechanism of fracture initiation, morphology and propagation in CBM reservoirs is not clear and need to be further explored. Hydraulic fracturing experiment is an accurate tool to explore these mechanisms. The quantity of experimental coal rock is large and processing method is complex, so specimen made of similar materials was applied to replace coal rock. The true triaxial hydraulic fracturing experimental apparatus, 3D scanning device for coal rock section were applied to carry out hydraulic fracturing experiment. The results show that the initiation pressure is inversely proportional to the horizontal stress difference (Delta sigma) and positively related to fracturing fluid injection rate. When vertical stress (sigma(v)) is constant, the initiation pressure and fracture width decrease with the increasing of Delta sigma. Natural fractures can be connected by main fracture when propagates perpendicular to the direction of minimum horizontal stress (sigma(h)), then secondary fractures and fracture network form in CBM reservoirs. When two stresses of crustal stress are close and far different from the third one, the fracture morphology and propagation become complex. Influenced by perforations and filtration of fracturing fluid in specimen, fracturing fluid flows to downward easily after comparing horizontal well fracturing with vertical well fracturing. Fracture width increases with the decreasing of elastic modulus, the intensity of fracture is positively related with the elastic modulus of coal rock. The research results can provide theoretical basis and technical support for the efficient development of CBM.	[Zhang, Fan; Ma, Geng; Liu, Xiao; Tao, Yunqi] Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China; [Feng, Dan] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing, Peoples R China; [Li, Rui] China Univ Min & Technol, Appl Tech Coll, Xuzhou, Jiangsu, Peoples R China	Henan Polytechnic University; Chongqing University; China University of Mining & Technology	Zhang, F (corresponding author), Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China.	379591198@qq.com			Major Work on Innovation Methods of the Ministry of Science and Technology of China [20161M010400]; National Natural Foundation of China [71472171]; Innovative Talent Team Construction Project of Science and Technology of Henan Province [164100510024]; Science and Technology Research Project of Henan Province [152102310095]	Major Work on Innovation Methods of the Ministry of Science and Technology of China; National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Talent Team Construction Project of Science and Technology of Henan Province; Science and Technology Research Project of Henan Province	The authors would like to thank the Major Work on Innovation Methods of the Ministry of Science and Technology of China (no. 20161M010400) to GM; National Natural Foundation of China (no. 71472171) to YT; Innovative Talent Team Construction Project of Science and Technology of Henan Province (no. 164100510024) to GM; Science and Technology Research Project of Henan Province in 2015 (no. 152102310095) to GM for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YQ, 2015, ROCK MECH ROCK ENG, V48, P1455, DOI 10.1007/s00603-015-0727-9; Deng JQ, 2016, COMPUT GEOTECH, V75, P28, DOI 10.1016/j.compgeo.2016.01.018; Guo TK, 2014, FUEL, V128, P373, DOI 10.1016/j.fuel.2014.03.029; Huang BX, 2015, INT J ROCK MECH MIN, V74, P45, DOI 10.1016/j.ijrmms.2014.10.011; Ishida T, 2001, CONSTR BUILD MATER, V15, P283, DOI 10.1016/S0950-0618(00)00077-5; Islam MR, 2009, INT J COAL GEOL, V78, P91, DOI 10.1016/j.coal.2008.10.006; Jiang TT, 2017, CURR SCI INDIA, V112, P332, DOI 10.18520/cs/v112/i02/332-347; Kong B, 2015, INT J COAL GEOL, V147, P35, DOI 10.1016/j.coal.2015.06.006; Lei X, 2015, ENERGY TECHNOL-GER, V3, P618, DOI 10.1002/ente.201402206; Lekontsev YM, 2014, J MIN SCI+, V50, P914, DOI 10.1134/S106273911405010X; Ma G, 2016, ROCK SOIL MECH, V37, P216, DOI 10.16285/j.rsm.2016.S2.026; Song DZ, 2015, INT J ROCK MECH MIN, V78, P230, DOI 10.1016/j.ijrmms.2015.06.004; Wilkinson A, 2010, J GEOTECH GEOENVIRON, V136, P1459, DOI 10.1061/(ASCE)GT.1943-5606.0000359; Xu BX, 2013, FUEL, V107, P859, DOI 10.1016/j.fuel.2013.01.063; Xu ZC, 2016, J NAT GAS SCI ENG, V36, P486, DOI 10.1016/j.jngse.2016.10.063; Yang W, 2016, J NAT GAS SCI ENG, V28, P379, DOI 10.1016/j.jngse.2015.12.004; Zanella A, 2014, MAR PETROL GEOL, V55, P262, DOI 10.1016/j.marpetgeo.2013.12.017; Zhang F, 2017, ELECT J GEOTECHNICAL, V22, P1511; Zhang SK, 2014, J PETROL SCI ENG, V124, P484, DOI 10.1016/j.petrol.2014.09.002; Zhang XW, 2017, FUEL, V190, P370, DOI 10.1016/j.fuel.2016.10.120; Zhou Z, 2016, SCI PROGRAM, V2016, P1, DOI DOI 10.1016/J.T0XLET.2016.07.710; Zou YS, 2016, ROCK MECH ROCK ENG, V49, P33, DOI 10.1007/s00603-015-0720-3	22	7	7	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195363	10.1371/journal.pone.0195363	http://dx.doi.org/10.1371/journal.pone.0195363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621295	Green Submitted, gold, Green Published			2022-12-27	WOS:000429206800070
J	Conley, D; Johnson, R; Domingue, B; Dawes, C; Boardman, J; Siegal, M				Conley, Dalton; Johnson, Rebecca; Domingue, Ben; Dawes, Christopher; Boardman, Jason; Siegal, Mark			A sibling method for identifying vQTLs	PLOS ONE			English	Article							FTO GENE; NICHE-CONSTRUCTION; PHENOTYPIC VARIABILITY; EXPRESSION VARIABILITY; HSP90; ROBUSTNESS; VARIANCE; TWIN; IDENTIFICATION; HERITABILITY	The propensity of a trait to vary within a population may have evolutionary, ecological, or clinical significance. In the present study we deploy sibling models to offer a novel and unbiased way to ascertain loci associated with the extent to which phenotypes vary (variance controlling quantitative trait loci, or vQTLs). Previous methods for vQTL-mapping either exclude genetically related individuals or treat genetic relatedness among individuals as a complicating factor addressed by adjusting estimates for non-independence in phenotypes. The present method uses genetic relatedness as a tool to obtain unbiased estimates of variance effects rather than as a nuisance. The family-based approach, which utilizes random variation between siblings in minor allele counts at a locus, also allows controls for parental genotype, mean effects, and non-linear (dominance) effects that may spuriously appear to generate variation. Simulations show that the approach performs equally well as two existing methods (squared Z-score and DGLM) in controlling type I error rates when there is no unobserved confounding, and performs significantly better than these methods in the presence of small degrees of confounding. Using height and BMI as empirical applications, we investigate SNPs that alter within-family variation in height and BMI, as well as pathways that appear to be enriched. One significant SNP for BMI variability, in the MAST4 gene, replicated. Pathway analysis revealed one gene set, encoding members of several signaling pathways related to gap junction function, which appears significantly enriched for associations with within-family height variation in both datasets (while not enriched in analysis of mean levels). We recommend approximating laboratory random assignment of genotype using family data and more careful attention to the possible conflation of mean and variance effects.	[Conley, Dalton; Johnson, Rebecca] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Domingue, Ben] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Dawes, Christopher] NYU, Wilff Family Dept Polit, New York, NY USA; [Boardman, Jason] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Siegal, Mark] NYU, Ctr Genom & Syst Biol, New York, NY USA	Princeton University; Stanford University; New York University; University of Colorado System; University of Colorado Boulder; New York University	Conley, D (corresponding author), Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA.	dconley@princeton.edu		Johnson, Rebecca/0000-0003-2475-6622; Siegal, Mark/0000-0001-6930-2988	National Institutes of Health [R35GM118170]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R35GM118170 (MS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; [Anonymous], 2012, NATURE, V490; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Ayroles JF, 2015, P NATL ACAD SCI USA, V112, P6706, DOI 10.1073/pnas.1503830112; Bauer CR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145264; Berger D, 2011, EVOLUTION, V65, P2830, DOI 10.1111/j.1558-5646.2011.01392.x; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Cao Y, 2015, ANN HUM GENET, V79, P46, DOI 10.1111/ahg.12089; Cao Y, 2014, GENET EPIDEMIOL, V38, P51, DOI 10.1002/gepi.21778; Caplin A, GENES ADDICTION EC; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Champely S., 2009, PWR BASIC FUNCTIONS; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Chen B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-25; Conley D, 2013, BEHAV GENET, V43, P415, DOI 10.1007/s10519-013-9602-1; Day RL, 2003, PERSPECT BIOL MED, V46, P80, DOI 10.1353/pbm.2003.0003; Dieleman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110257; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Dumitrascu B, 2015, ARXIV151201616QBIOST; Fehrmann S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.53; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Geiler-Samerotte KA, 2013, CURR OPIN BIOTECH, V24, P752, DOI 10.1016/j.copbio.2013.03.010; Geiler-Samerotte KA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000465; Gelman A., 2007, DATA ANAL USING REGR, V1; Gibson G, 2009, NATURE REV GENETICS, V10; Gibson G, 2004, NATURE REV GENETICS, V5; Gibson G, 2008, CURR BIOL, V18, pR989, DOI 10.1016/j.cub.2008.08.011; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; Hamer D, 2000, MOL PSYCHIATR, V5, P11, DOI 10.1038/sj.mp.4000662; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Hong C, 2017, BIOMETRICS, V73, P571, DOI 10.1111/biom.12612; Hsieh YY, 2013, MOL CELL, V50, P82, DOI 10.1016/j.molcel.2013.01.026; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/twin.5.5.482; Imbens GW, 2016, REV ECON STAT, V98, P701, DOI 10.1162/REST_a_00552; Janhunen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038766; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Levy SF, 2012, ADV EXP MED BIOL, V751, P431, DOI 10.1007/978-1-4614-3567-9_20; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Perry GML, 2012, GENETICS, V191, P1003, DOI 10.1534/genetics.112.138909; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richardson JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003733; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Ronnegard L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-63; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sgro CM, 2010, P ROY SOC B-BIOL SCI, V277, P2049, DOI 10.1098/rspb.2010.0008; Shen X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002839; Siegal ML, 2014, ANNU REV ECOL EVOL S, V45, P495, DOI 10.1146/annurev-ecolsys-120213-091705; Siegal ML, 2013, MOL ECOL, V22, P1187, DOI 10.1111/mec.12195; Siegal ML, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-14; Soave D, 2015, AM J HUM GENET, V97, P125, DOI 10.1016/j.ajhg.2015.05.015; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Sun XQ, 2013, AM J HUM GENET, V93, P390, DOI 10.1016/j.ajhg.2013.06.017; Takahashi KH, 2012, EVOLUTION, V66, P2878, DOI 10.1111/j.1558-5646.2012.01636.x; Takahashi KH, 2011, J HERED, V102, P448, DOI 10.1093/jhered/esr026; Tonjes A, 2009, EUROPEAN J HUMAN GEN, V18; Tonsor SJ, 2013, EVOLUTION, V67, P2923, DOI 10.1111/evo.12175; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang G, 2014, GENETICS, V196, P413, DOI 10.1534/genetics.113.157503; Wei WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25014; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	84	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194541	10.1371/journal.pone.0194541	http://dx.doi.org/10.1371/journal.pone.0194541			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617452	Green Published, gold			2022-12-27	WOS:000429203800036
J	Helgegren, I; Rauch, S; Cossio, C; Landaeta, G; McConville, J				Helgegren, Ida; Rauch, Sebastien; Cossio, Claudia; Landaeta, Graciela; McConville, Jennifer			Importance of triggers and veto-barriers for the implementation of sanitation in informal peri-urban settlements - The case of Cochabamba, Bolivia	PLOS ONE			English	Article							HOUSEHOLD LATRINES; DIFFUSION; DEMAND; ETHIOPIA; HEALTH; BENIN	An estimated 2.4 billion people lack access to improved sanitation which has devastating consequences for human health and the environment. Understanding what constitute sanitation demand is crucial for accelerating the spread of improved sanitation. This study aims to understand the adoption mechanisms for improved sanitation. An informal peri-urban settlement in Cochabamba, Bolivia was selected as a case study to understand adoption patterns. Various qualitative methods of data collection and analysis were employed. The findings showed that pour-flush toilets was the only preferred sanitation alternative at the study site. An adoption framework for waterborne toilets was developed based on diffusion of innovation theory. Factors that influence adoption were identified. Some functioned as triggers and initiated adoption, whereas some factors blocked adoption and constituted veto-barriers. Most factors were connected to the individual household situation and its members, but neighborhood development also affected pour-flush adoption. Based on adoption time the residents were divided into the following adoption groups: first adopters, early majority, late majority, laggards and non-adopters. Each adoption group followed its own adoption route with specific characteristics and respective triggers or veto-barriers. We argue that the strong demand for waterborne toilets in peri-urban areas need to be recognized and the developed framework could be used for customizing sanitation improvement programs for certain target groups.	[Helgegren, Ida; Rauch, Sebastien; Cossio, Claudia] Chalmers Univ Technol, Dept Architecture & Civil Engn, Water Environm Technol, Gothenburg, Sweden; [Cossio, Claudia] Univ Mayor San Simon, Ctr Water & Environm Sanitat, Cochabamba, Bolivia; [Landaeta, Graciela] PROCASHA Fdn, Cochabamba, Bolivia; [McConville, Jennifer] Swedish Univ Agr Sci, Dept Energy & Technol, Uppsala, Sweden	Chalmers University of Technology; Swedish University of Agricultural Sciences	Helgegren, I (corresponding author), Chalmers Univ Technol, Dept Architecture & Civil Engn, Water Environm Technol, Gothenburg, Sweden.	ida.helgegren@chalmers.se	McConville, Jennifer/I-3753-2019	Rauch, Sebastien/0000-0003-3636-0684	Swedish International Development Agency (SIDA) [SWE-2011-157]; Swedish International Development Agency (SIDA)	Swedish International Development Agency (SIDA); Swedish International Development Agency (SIDA)	This work was supported by the Swedish International Development Agency (SIDA), www.sida.se. The grant number is SWE-2011-157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the residents of the case study site for their contribution to this work. The NGO PROCASHA provided access to the study site as well as data. Researchers at the University of San Simon contributed with expert knowledge and information about the study area. This work was supported by the Swedish International Development Agency (SIDA), but they had no involvement in the performance of the study nor the presentation of the results.	Alarcon A, 2013, PLAN ACCION COCHABAM; Chambers R., 2008, REVOLUTIONS DEV INQU, DOI 10.4324/9781849772426; Chunga RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161262; Devine J, 2009, INTRO SANIFOAM FRAME; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Flick U., 2009, INTRO QUALITATIVE RE, V4th ed; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; Gross E, 2014, WATER RESOUR RES, V50, P8314, DOI 10.1002/2014WR015899; Hammersley Martin, 2007, ETHNOGRAPHY; Hirai M, 2016, J WATER SANIT HYG DE, V6, P151, DOI 10.2166/washdev.2016.128; Jenkins MW, 2007, SOC SCI MED, V64, P2427, DOI 10.1016/j.socscimed.2007.03.010; Jenkins MW, 2010, J WATER HEALTH, V8, P166, DOI 10.2166/wh.2009.111; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kar K, 2008, HDB COMMUNITYLED TOO; Keraita B, 2013, J WATER SANIT HYG DE, V3, P26, DOI 10.2166/washdev.2013.035; Lagerkvist CJ, 2014, J WATER SANIT HYG DE, V4, P108, DOI 10.2166/washdev.2013.069; Ledo C., 2011, CRISIS TAP SEEKING S, P20; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Luthi C., 2011, COMMUNITY LED URBAN; Mahler A, 1999, TELECOMMUN POLICY, V23, P719, DOI 10.1016/S0308-5961(99)00052-X; Mara D, 2008, P I CIVIL ENG-MUNIC, V161, P231, DOI [10.1680/muen.2008.161.4.231, 10.1680/muen.2008.161.4231]; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Menendez L., 2015, THESIS; O'Loughlin R, 2006, TROP MED INT HEALTH, V11, P1406, DOI 10.1111/j.1365-3156.2006.01689.x; Obeng PA, 2015, ENVIRON PROCESS, V2, P261, DOI 10.1007/s40710-015-0060-z; Okurut K, 2014, HABITAT INT, V44, P332, DOI 10.1016/j.habitatint.2014.07.014; Paterson C, 2007, GEOFORUM, V38, P901, DOI 10.1016/j.geoforum.2006.08.006; Rodgers AF, 2007, TROP MED INT HEALTH, V12, P772, DOI 10.1111/j.1365-3156.2007.01848.x; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Rogers EM, 2002, ADDICT BEHAV, V27, P989, DOI 10.1016/S0306-4603(02)00300-3; Ross RK, 2011, INT HEALTH, V3, P251, DOI 10.1016/j.inhe.2011.06.007; Sanson-Fisher RW, 2004, MED J AUSTRALIA, V180, pS55; Sara S, 2014, INT J ENV RES PUB HE, V11, P9854, DOI 10.3390/ijerph110909854; Scott P, 2013, HABITAT INT, V40, P58, DOI 10.1016/j.habitatint.2013.02.004; SEMAPA, 2015, PROYECT ACT ALC SAN; Suddaby R, 2006, ACAD MANAGE J, V49, P633, DOI 10.5465/AMJ.2006.22083020; TYPSA GITEC Land and Water Bolivia Aguilar & Asociados, 2014, INFORME FINAL; UN, 2015, 2030 AG SUST DEV; White S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155043; Whittington D, 2012, WORLD DEV, V40, P1546, DOI 10.1016/j.worlddev.2012.03.004; WHO/ UNICEF, 2015, 25 YEARS PROGR SAN D; WHO/UNICEF JMP, 2015, COUNTR FIL BOL PLUR; Yin R.K., 2017, APPL CASE STUDY RES	43	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193613	10.1371/journal.pone.0193613	http://dx.doi.org/10.1371/journal.pone.0193613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617459	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800011
J	Murdaugh, LB; Mendoza-Romero, HN; Fish, EW; Parnell, SE				Murdaugh, Laura B.; Mendoza-Romero, Haley N.; Fish, Eric W.; Parnell, Scott E.			A novel method for determining sex in late term gestational mice based on the external genitalia	PLOS ONE			English	Article							MOUSE EMBRYOS; EXPOSURE	In many experiments using fetal mice, it is necessary to determine the sex of the individual fetus. However, other than genotyping for sex-specific genes, there is no convenient, reliable method of sexing mice between gestational day (GD) 16.5 and GD 18.0. We designed a rapid, relatively simple visual method to determine the sex of mouse fetuses in the GD 16.5-GD 18.0 range that can be performed as part of a routine morphological assessment. By examining the genitalia for the presence or absence of key features, raters with minimal experience with the method were able to correctly identify the sex of embryos with 99% accuracy, while raters with no experience were 95% accurate. The critical genital features include: the presence or absence of urethral seam or proximal urethral meatus; the shape of the genitalia, and the presence or absence of an area related to the urethral plate. By comparing these morphological features of the external genitalia, we show a simple, accurate, and fast way to determine the sex of late stage mouse fetuses. Integrating this method into regular morphological assessments will facilitate the determination of sex differences in fetuses between GD 16.5 and GD 18.0.	[Murdaugh, Laura B.; Mendoza-Romero, Haley N.; Fish, Eric W.; Parnell, Scott E.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Parnell, Scott E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Parnell, Scott E.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Parnell, SE (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.; Parnell, SE (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Parnell, SE (corresponding author), Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	sparnell@med.unc.edu		Murdaugh, Laura/0000-0002-3282-3576; Mendoza-Romero, Haley/0000-0001-7290-9246	National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA [U01-M021651, P60-M011605]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021651] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All or part of this work was done in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), which is funded by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Additional information about CIFASD can be found at www.cifasd.org. Support was provided by grant nos. U01-M021651 and P60-M011605 from the NIAAA to SEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Deeney S, 2016, LAB ANIMAL, V45, P380, DOI 10.1038/laban.1105; Dipietro JA, 2017, NEUROSCIENCE, V342, P4, DOI 10.1016/j.neuroscience.2015.07.068; Fish EW, 2016, BEHAV BRAIN RES, V311, P70, DOI 10.1016/j.bbr.2016.05.004; Georgas KM, 2015, DEVELOPMENT, V142, P1893, DOI 10.1242/dev.117903; GOTO T, 1985, TERATOLOGY, V31, P425, DOI 10.1002/tera.1420310313; GREENHAM L W, 1977, Laboratory Animals (London), V11, P181, DOI 10.1258/002367777780936620; Hubbard AC, 2013, COMPARATIVE MED, V63, P127; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Prakash R, 2008, SINGAP MED J, V49, P47; Song J, 2015, BIOTECH HISTOCHEM, V90, P309, DOI 10.3109/10520295.2015.1004557; Suzuki H, 2015, DEV GROWTH DIFFER, V57, P639, DOI 10.1111/dgd.12247; Suzuki K, 2002, EVOL DEV, V4, P133, DOI 10.1046/j.1525-142X.2002.01061.x; Wolterink-Donselaar IG, 2009, LAB ANIMAL, V38, P35, DOI 10.1038/laban0109-35	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194767	10.1371/journal.pone.0194767	http://dx.doi.org/10.1371/journal.pone.0194767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617407	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800048
J	Szabo, R; Bugge, TH				Szabo, Roman; Bugge, Thomas H.			Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; FACTOR ACTIVATOR INHIBITOR-1; SERINE-PROTEASE CAP1/PRSS8; EPIDERMAL BARRIER FUNCTION; EPITHELIAL DEVELOPMENT; HYPOTRICHOSIS SYNDROME; MATRIPTASE-ACTIVATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; EPCAM	Prostasin (CAP1/PRSS8) is a glycosylphosphatidylinositol (GPI)-anchored serine protease that is essential for epithelial development and overall survival in mice. Prostasin is regulated primarily by the transmembrane serine protease inhibitor, hepatocyte growth factor activator inhibitor (HAI)-2, and loss of HAI-2 function leads to early embryonic lethality in mice due to an unregulated prostasin activity. We have recently reported that critical in vivo functions of prostasin can be performed by proteolytically-inactive or zymogen-locked variants of the protease. Here we show that the zymogen form of prostasin does not bind to HAI-2 and, as a result, loss of HAI-2 does not affect prenatal development and survival of mice expressing only zymogen-locked variant of prostasin (Prss8 R44Q). Indeed, HAI-2-deficient mice homozygous for R44Q mutation (Spint2(-/-) prss8(R44Q/R44Q)) are born in the expected numbers and do not exhibit any obvious developmental abnormality at birth. However, postnatal growth in these mice is severely impaired and they all die within 4 to 7 days after birth due to a critical failure in the development of small and large intestines, characterized by a widespread villous atrophy, tufted villi, near-complete loss of mucin-producing goblet cells, loss of colonic crypt structure, and bleeding into the intestinal lumen. Intestines of Spint2(-/-);Prss8(R44Q/R44Q) mice showed altered expression of epithelial junctional proteins, including reduced levels of EpCAM, E-cadherin, occludin, claudin-1 and -7, as well as an increased level of claudin-4, indicating that the loss of HAI-2 compromises intestinal epithelial barrier function. Our data indicate that the loss of HAI-2 in Prss8(R44Q/R44Q) mice leads to development of progressive intestinal failure that at both histological and molecular level bears a striking resemblance to human congenital tufting enteropathy, and may provide important clues for understanding and treating this debilitating human disease.	[Szabo, Roman; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Szabo, R (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA.	rszabo@nidcr.nih.gov; tbugge@mail.nih.gov			National Institute of Dental and Craniofacial Research Intramural Research Program; NIDCR Gene Targeting and Veterinary Resources Cores; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR Gene Targeting and Veterinary Resources Cores; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institute of Dental and Craniofacial Research Intramural Research Program to TB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Mary Jo Danton for critically reviewing this manuscript. This research was supported by the NIDCR Gene Targeting and Veterinary Resources Cores.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bauer A, 2017, G3-GENES GENOM GENET, V7, P1315, DOI 10.1534/g3.117.039511; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Choi WS, 2017, EXP CELL RES, V358, P71, DOI 10.1016/j.yexcr.2017.03.036; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; DAVIDSON GP, 1978, GASTROENTEROLOGY, V75, P783; FALCONER DS, 1952, J HERED, V43, P53, DOI 10.1093/oxfordjournals.jhered.a106262; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Kozan PA, 2015, J MOL MED, V93, P535, DOI 10.1007/s00109-014-1239-x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Mehta S, 2015, CELL TISSUE RES, V360, P749, DOI 10.1007/s00441-014-1994-6; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Neri I, 2016, J DERMATOL SCI, V81, P63, DOI 10.1016/j.jdermsci.2015.10.012; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oshima T, 2016, J GASTROENTEROL, V51, P768, DOI 10.1007/s00535-016-1207-z; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Szabo R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004470; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194660	10.1371/journal.pone.0194660	http://dx.doi.org/10.1371/journal.pone.0194660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617460	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800042
J	de Lima, FF; Lescano, CH; Arrigo, JD; Cardoso, CAL; Coutinho, JP; Moslaves, ISB; Ximenes, TVD; Kadri, MCT; Webers, SS; Perdomo, RT; Kassuya, CAL; Vieira, MD; Sanjinez-Argandona, EJ				de Lima, Fernando Freitas; Lescano, Caroline Honaiser; Arrigo, Jucicleia da Silva; Lima Cardoso, Claudia Andrea; Coutinho, Janclei Pereira; Bonfa Moslaves, Iluska Senna; do Nascimento Ximenes, Thalita Vieira; Toffoli Kadri, Monica Cristina; Webers, Simone Schneider; Perdomo, Renata Trentin; Leite Kassuya, Candida Aparecida; Vieira, Maria do Carmo; Sanjinez-Argandona, Eliana Janet			Anti-inflammatory, antiproliferative and cytoprotective potential of the Attalea phalerata Mart. ex Spreng. pulp oil	PLOS ONE			English	Article							INDUCED PAW EDEMA; BETA-CAROTENE; INFLAMMATORY RESPONSE; PHENOLIC-COMPOUNDS; NITRIC-OXIDE; CARRAGEENAN; CYTOKINES; FRUITS; ASSAY; RATS	The anti-inflammatory, antiproliferative and cytoprotective activity of the Attalea phalerata Mart. ex Spreng pulp oil was evaluated by in vitro and in vivo methods. As for the chemical profile, the antioxidant activity was performed by spectrophotometry, and the profile of carotenoids and amino acids by chromatography. Our data demonstrated that A. phalerata oil has high carotenoid content, antioxidant activity and the presence of 5 essential amino acids. In the in vitro models of inflammation, the oil demonstrated the capacity to inhibit COX1 and COX2 enzymes, the production of nitric oxide and also induces macrophages to spreading. In the in vivo models of inflammation, the oil inhibited edema and leukocyte migration in the Wistar rats. In the in vitro model of antiproliferative and cytoprotective activity, the oil was shown inactive against the kidney carcinoma and prostate carcinoma lineage cells and with cytoprotective capacity in murine fibroblast cells, inhibiting the cytotoxic action of doxorubicin. Therefore, it is concluded that A. phalerata pulp oil has anti-inflammatory effects with nutraceutical properties potential due to the rich composition. Moreover, the oil also has cytoprotective activity probably because of its ability to inhibit the action of free radicals.	[de Lima, Fernando Freitas; Arrigo, Jucicleia da Silva; Leite Kassuya, Candida Aparecida] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Lescano, Caroline Honaiser] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Coutinho, Janclei Pereira] Univ Estadual Campinas, Fac Food Engn, Campinas, SP, Brazil; [Bonfa Moslaves, Iluska Senna; do Nascimento Ximenes, Thalita Vieira; Toffoli Kadri, Monica Cristina; Webers, Simone Schneider; Perdomo, Renata Trentin] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Campo Grande, MS, Brazil; [Vieira, Maria do Carmo] Fed Univ Grande Dourados, Fac Agr Sci, Dourados, MS, Brazil; [Sanjinez-Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Engn, Dourados, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Campinas; Universidade Estadual de Mato Grosso do Sul; Universidade Estadual de Campinas; Universidade Federal de Mato Grosso do Sul; Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados	de Lima, FF (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil.	flfernando_@hotmail.com	de Lima, Fernando Freitas/E-6661-2017; Kassuya, Candida A. L./G-8329-2011; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012; Kadri, Mônica/AAH-4495-2021; Toffoli-Kadri, Mônica C/D-4972-2014; Lescano, Caroline C.H.L Honaiser/I-2108-2017; Vieira, Maria do Carmo MCV/D-4860-2016; Cardoso, Claudia Andrea Lima/AAK-5578-2020	de Lima, Fernando Freitas/0000-0001-5889-8165; Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Kadri, Mônica/0000-0003-4160-4444; Toffoli-Kadri, Mônica C/0000-0003-4160-4444; Lescano, Caroline C.H.L Honaiser/0000-0003-4193-7361; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Weber, Simone/0000-0002-4181-142X; Perdomo, Renata Trentin/0000-0003-2747-7039; Kassuya, Candida/0000-0002-8998-9219	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank the development agencies Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) (FFL), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (FFL) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (FFL).	Balslev H, 1989, AAU REPORTS, P1; Batista J.S., 2010, Arq. Inst. Biol., V77, P441, DOI 10.1590/1808-1657v77p4412010; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Negrelle RRB, 2015, CIENC FLOREST, V25, P1061, DOI 10.5902/1980509820669; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Carey AN, 2017, NUTR NEUROSCI, V20, P238, DOI [10.1080/1028415X.2015.1115213, 10.1080/1028415x.2015.1115213]; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Choo J, 2010, AM J BOT, V97, pE105, DOI 10.3732/ajb.1000281; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; da Silva NA, 2014, J AGR FOOD CHEM, V62, P5072, DOI 10.1021/jf501211p; De Lima FF, 2017, FOOD RES INT, V91, P11, DOI 10.1016/j.foodres.2016.11.019; de Lima FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165258; Sousa AGD, 2011, FOOD RES INT, V44, P2319, DOI 10.1016/j.foodres.2011.02.013; DING AH, 1988, J IMMUNOL, V141, P2407; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; Formagio ASN, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-14; Freshney R.I., 2005, CULTURE ANIMAL CELLS, P375, DOI 10.1002/0471747599.cac023; Galler KM, 2006, EUR J ORAL SCI, V114, P138, DOI 10.1111/j.1600-0722.2006.00327.x; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; dos Santos MDG, 2015, ANTIOXIDANTS-BASEL, V4, P591, DOI 10.3390/antiox4030591; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; Haraguchi Fabiano Kenji, 2006, Rev. Nutr., V19, P479, DOI 10.1590/S1415-52732006000400007; Hiane Priscila Aiko, 2003, Food Sci. Technol, V23, P206; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Ivy JL, 2002, J APPL PHYSIOL, V93, P1337, DOI 10.1152/japplphysiol.00394.2002; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Klein A, 2010, PHARMACEUTICALS, V3, P1084, DOI 10.3390/ph3041084; Kudo Y, 2002, BONE, V30, P712, DOI 10.1016/S8756-3282(02)00689-0; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Lescano CH, 2015, J MED FOOD, V18, P656, DOI 10.1089/jmf.2014.0077; e Silva MCBE, 2014, FOOD SCI TECH-BRAZIL, V34, P55, DOI 10.1590/S0101-20612014000100008; Lin HW, 2012, FOOD CHEM, V134, P2169, DOI 10.1016/j.foodchem.2012.04.024; de Oliveira MLM, 2010, J ETHNOPHARMACOL, V129, P214, DOI 10.1016/j.jep.2010.03.014; MARCO GJ, 1968, J AM OIL CHEM SOC, V45, P594, DOI 10.1007/BF02668958; Moraes M, 1996, ECON BOT, V50, P423, DOI 10.1007/BF02866525; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Othman A, 2016, J FUNCT FOODS, V21, P263, DOI 10.1016/j.jff.2015.12.014; Padhi EMT, 2017, J FUNCT FOODS, V38, P602, DOI 10.1016/j.jff.2016.11.006; Pereira DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088341; RABINOVITCH M, 1973, EXP CELL RES, V77, P323, DOI 10.1016/0014-4827(73)90584-3; Ribeiro JC, 2010, AVALIACAO POTENCIAL, DOI [10.3732/AJB.1000281, DOI 10.3732/AJB.1000281]; Rodriguez-Amaya DB., 1997, CAROTENOIDS FOOD PRE, P1; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; RUSSO M, 1989, PARASITE IMMUNOL, V11, P385, DOI 10.1111/j.1365-3024.1989.tb00675.x; Sarada SKS, 2002, J ETHNOPHARMACOL, V79, P149, DOI 10.1016/S0378-8741(01)00360-9; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Silva CRM, 2001, REV NUTR, V14, P135, DOI DOI 10.1590/S1415-52732001000200007; Silva FRF, 2010, CARBOHYD POLYM, V79, P26, DOI 10.1016/j.carbpol.2009.07.010; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skulas-Ray AC, 2015, PROSTAG OTH LIPID M, V116, P104, DOI 10.1016/j.prostaglandins.2015.02.001; Soontornchaiboon W, 2012, BIOL PHARM BULL, V35, P1137, DOI 10.1248/bpb.b12-00187; Stahl W, 2007, MOL BIOTECHNOL, V37, P26, DOI 10.1007/s12033-007-0051-z; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Yoshihisa Y, 2014, EXP DERMATOL, V23, P178, DOI 10.1111/exd.12347	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195678	10.1371/journal.pone.0195678	http://dx.doi.org/10.1371/journal.pone.0195678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634766	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200047
J	Hacker, GM; Brown, RN; Fedorova, N; Girard, YA; Higley, M; Clueit, B; Lane, RS				Hacker, Gregory M.; Brown, Richard N.; Fedorova, Natalia; Girard, Yvette A.; Higley, Mark; Clueit, Bernadette; Lane, Robert S.			Spatial clustering of Borrelia burgdorferi sensu lato within populations of Allen's chipmunks and dusky-footed woodrats in northwestern California	PLOS ONE			English	Article							IXODES-PACIFICUS ACARI; MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; BLACK-LEGGED TICK; NORTHERN CALIFORNIA; VECTOR COMPETENCE; SEASONAL ACTIVITY; SMALL MAMMALS; SP NOV.; DIVERSITY	The ecology of Lyme borreliosis is complex in northwestern California, with several potential reservoir hosts, tick vectors, and genospecies of Borrelia burgdorferisensu lato. The primary objective of this study was to determine the fine-scale spatial distribution of different genospecies in four rodent species, the California ground squirrel (Otospermophilus bee-cheyi), northern flying squirrel (Glaucomys sabrinus), dusky-footed woodrat (Neotoma fuscipes), and Allen's chipmunk (Neotamias senex). Rodents were live-trapped between June 2004 and May 2005 at the Hoopa Valley Tribal Reservation (HVTR) in Humboldt County, California. Ear-punch biopsies obtained from each rodent were tested by polymerase chain reaction (PCR) and sequencing analysis. The programs ArcGIS and SaTScan were used to examine the spatial distribution of genospecies. Multinomial log-linear models were used to model habitat and host-specific characteristics and their effect on the presence of each bor-relial genospecies. The Akaike information criterion (AICc) was used to compare models and determine model fit. Borrelia burgdorferisensu stricto was primarily associated with chipmunks and B. bissettiae largely with woodrats. The top model included the variables "host species", "month", and "elevation" (weight = 0.84). Spatial clustering of B. bissettiae was detected in the northwestern section of the HVTR, whereas B. burgdorferisensu stricto was clustered in the southeastern section. We conclude that the spatial distribution of these borreliae are driven at least in part by host species, time-of-year, and elevation.	[Hacker, Gregory M.; Brown, Richard N.; Clueit, Bernadette] Humboldt State Univ, Dept Nat Resources, Arcata, CA 95521 USA; [Fedorova, Natalia; Girard, Yvette A.; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Higley, Mark] Hoopa Valley Tribal Reservat, Hoopa Tribal Forestry, Hoopa, CA USA; [Hacker, Gregory M.] Calif Dept Publ Hlth, Vector Borne Dis Sect, Elk Grove, CA 95624 USA	California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Berkeley; California Department of Public Health	Hacker, GM (corresponding author), Humboldt State Univ, Dept Nat Resources, Arcata, CA 95521 USA.; Hacker, GM (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, Elk Grove, CA 95624 USA.	Greg.Hacker@cdph.ca.gov		Higley, Mark/0000-0002-7722-3785	National Institutes of Health [AI22501]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health grant AI22501 to Robert Lane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alekseev AN, 2000, J MED ENTOMOL, V37, P9, DOI 10.1603/0022-2585-37.1.9; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Brown RN, 2006, J MED ENTOMOL, V43, P743, DOI 10.1603/0022-2585(2006)43[743:SMOBBS]2.0.CO;2; Brown RN, 1996, AM J TROP MED HYG, V54, P84, DOI 10.4269/ajtmh.1996.54.84; BROWN RN, 1992, SCIENCE, V256, P1439, DOI 10.1126/science.1604318; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Burkot TR, 2001, AM J TROP MED HYG, V65, P293, DOI 10.4269/ajtmh.2001.65.293; Carraway L.N., 1991, Mammalian Species, P1; Casher L, 2002, EXP APPL ACAROL, V26, P127, DOI 10.1023/A:1020911306291; Clark KL, 2014, J MED MICROBIOL, V63, P674, DOI 10.1099/jmm.0.073122-0; Clark KL, 2013, INT J MED SCI, V10, P915, DOI 10.7150/ijms.6273; CLOVER JR, 1995, AM J TROP MED HYG, V53, P237, DOI 10.4269/ajtmh.1995.53.237; Dolan MC, 1997, J MED ENTOMOL, V34, P128, DOI 10.1093/jmedent/34.2.128; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eisen RJ, 2010, TICKS TICK-BORNE DIS, V1, P35, DOI 10.1016/j.ttbdis.2009.12.002; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Fedorova N, 2014, TICKS TICK-BORNE DIS, V5, P951, DOI 10.1016/j.ttbdis.2014.07.015; Foley JE, 2008, VECTOR-BORNE ZOONOT, V8, P49, DOI 10.1089/vbz.2007.0175; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Gannon William L., 1995, Mammalian Species, V502, P1; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; Hall E. R., 1981, MAMMALS N AM; Hamm KA, 1995, THESIS; Hughes KD., 2006, THESIS; Klenner W, 2009, FOREST ECOL MANAG, V257, P1078, DOI 10.1016/j.foreco.2008.11.012; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lane RS, 2005, J MED ENTOMOL, V42, P388, DOI 10.1603/0022-2585(2005)042[0388:WGSRSA]2.0.CO;2; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lane RS, 1999, J MED ENTOMOL, V36, P329, DOI 10.1093/jmedent/36.3.329; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Margos G, 2017, INT J SYST EVOL MICR, V67, P3872, DOI 10.1099/ijsem.0.002214; Margos G, 2016, INT J SYST EVOL MICR, V66, P1447, DOI 10.1099/ijsem.0.000897; Margos G, 2014, INT J SYST EVOL MICR, V64, P128, DOI 10.1099/ijs.0.054593-0; Margos G, 2010, TICKS TICK-BORNE DIS, V1, P151, DOI 10.1016/j.ttbdis.2010.09.002; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Mather TN, 1989, J EPIDEMIOL, P130; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; O'hara KL, W J APPL FOREST, V11, P97; Peavey CA, 1997, EXP APPL ACAROL, V21, P569, DOI 10.1023/A:1018448416618; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Roy AN, 2017, VECTOR-BORNE ZOONOT, V17, P735, DOI 10.1089/vbz.2017.2134; Rudenko N, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.009; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Rudenko N, 2009, J CLIN MICROBIOL, V47, P134, DOI 10.1128/JCM.01183-08; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2010, ECOLOGY, V91, P293, DOI 10.1890/08-2106.1; Schwartz AM, 2017, SURVEILLANCE LYME DI; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Sholty KE, 2015, THESIS; Slajchert T, 1997, J WILDLIFE DIS, V33, P40, DOI 10.7589/0090-3558-33.1.40; Swei A, 2011, J MED ENTOMOL, V48, P20, DOI 10.1603/ME10131; Swei A, 2015, TICKS TICK-BORNE DIS, V6, P414, DOI 10.1016/j.ttbdis.2015.03.011; Swei A, 2012, VECTOR-BORNE ZOONOT, V12, P623, DOI 10.1089/vbz.2011.0783; Swofford D., 1998, PAUP 4 0 PHYLOGENETI; Talleklint-Eisen L, 1999, J PARASITOL, V85, P824, DOI 10.2307/3285817; Talleklint-Eisen L, 2000, ENVIRON ENTOMOL, V29, P272, DOI 10.1603/0046-225X(2000)029[0272:SATVIT]2.0.CO;2; Urban NA, 2011, FOREST ECOL MANAG, V261, P353, DOI 10.1016/j.foreco.2010.10.015; Vredevoe LK, 2004, J MED ENTOMOL, V41, P736, DOI 10.1603/0022-2585-41.4.736; Waldien DL, 2006, J MAMMAL, V87, P454, DOI 10.1644/05-MAMM-A-136R1.1; Waters JR, 1998, J MAMMAL, V79, P1244, DOI 10.2307/1383015; Whitaker DA, 2008, THESIS	69	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195586	10.1371/journal.pone.0195586	http://dx.doi.org/10.1371/journal.pone.0195586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634745	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200038
J	Hao, ZJ; Fu, DG; Ming, Y; Yang, JL; Huang, Q; Lin, WL; Zhang, H; Zhang, B; Zhou, AF; Hu, XJ; Yao, C; Dong, YP; Ring, HJZ; Ring, BZ				Hao, Zongjie; Fu, Denggang; Ming, Yang; Yang, Jinlong; Huang, Qi; Lin, Weilong; Zhang, Huan; Zhang, Bin; Zhou, Aifen; Hu, Xijiang; Yao, Cong; Dong, Yunping; Ring, Huijun Z.; Ring, Brian Z.			Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; RIBOSOMAL-RNA GENE; VESTIBULAR AQUEDUCT; SLC26A4 MUTATIONS; GJB2 CONNEXIN-26; IMPAIRMENT; HETEROPLASMY; FREQUENCY; SPECTRUM; PROGRAM	Almost one third of the three million people in China suffering severe deafness are children, and 50% of these cases are believed to have genetic components to their etiology. Newborn hearing genetic screening can complement Universal Neonatal Hearing Screening for the diagnosis of congenital hearing loss as well as identifying children at risk for late-onset and progressive hearing impairment. The aim of this joint academic and Ministry of Health project was to prototype a cost effective newborn genetic screen in a community health setting on a city-wide level, and to ascertain the prevalence of variation at loci that have been associated with non-syndromic hearing loss. With the participation of 143 local hospitals in the city of Wuhan, China we screened 142,417 neonates born between May 2014 and Dec. 2015. The variants GJB2 c.235delC, SLC26A4 c.919-2A>G, and mitochondrial variants m.1555A>G and m.1494C>T were assayed using real time PCR. Newborns found to carry a variant were re-assayed by sequencing in duplicate. Within a subset of 707 newborns we assayed using real-time PCR and ARMS-PCR to compare cost, sensitivity and operating procedure. The most frequent hearing loss associated allele detected in this population was the 235deIC variant in GJB2 gene. In total, 4289 (3.01%) newborns were found to carry at least one allele of either GJB2 c.235delC, SLC26A4 c.919-2A>G or two assayed MT-RNR1 variants. There was complete accordance between the real-time PCR and the ARMS PCR, though the real-time PCR had a much lower failure rate. Real-time PCR had a lower cost and operating time than ARMS PCR. Ongoing collaboration with the participating hospitals will determine the specificity and sensitivity of the association of the variants with hearing loss at birth and arising in early childhood, allowing an estimation of the benefits of newborn hearing genetic screening in a large-scale community setting.	[Hao, Zongjie; Fu, Denggang; Ming, Yang; Yang, Jinlong; Huang, Qi; Lin, Weilong; Zhang, Huan; Ring, Huijun Z.; Ring, Brian Z.] Huazhong Univ Sci & Technol, Coll Life Sci, Inst Genom & Personalized Med, Wuhan, Hubei, Peoples R China; [Zhang, Bin; Zhou, Aifen; Hu, Xijiang; Yao, Cong] Wuhan Women & Children Hosp, Wuhan, Hubei, Peoples R China; [Dong, Yunping] Hlth & Family Planning Commiss Wuhan Municipal, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Ring, HJZ; Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci, Inst Genom & Personalized Med, Wuhan, Hubei, Peoples R China.	hzring@gmail.com; bzring@hust.edu.cn	付, 刚/ACC-5964-2022	Fu, Denggang/0000-0001-7274-033X				Hernandez-Juarez AA, 2014, INT J PEDIATR OTORHI, V78, P2107, DOI 10.1016/j.ijporl.2014.09.016; Angeli S, 2012, ANAT REC, V295, P1812, DOI 10.1002/ar.22579; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; Caijuan L, 2015, MATERN CHILD HLTH J, V30, P6007; Chen Y, 2015, CLIN GENET, V87, P467, DOI 10.1111/cge.12452; Choi SY, 2009, CLIN EXP OTORHINOLAR, V2, P44, DOI 10.3342/ceo.2009.2.1.44; Chu J., 2016, MATERN CHILD HLTH J, V31, P525; Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8; Dai P, 2008, GENET MED, V10, P586, DOI [10.1097/GIM.0b013e31817d2ef1, 10.1097GIM.0b013e31817d2ef1]; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Du J., 2015, SHAN DONG YI YAO, V55, P17; Du W, 2013, INT J PEDIATR OTORHI, V77, P1670, DOI 10.1016/j.ijporl.2013.07.023; ElSchahawi M, 1997, NEUROLOGY, V48, P453, DOI 10.1212/WNL.48.2.453; Feng JZ., 2015, HE BEI YI KE XUE XUE, V36, P1271; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Gao H, 2014, J NANTONG U MED SCI, P577; [韩冰 Han Bing], 2013, [中华耳科学杂志, Chinese Journal of Otology], V11, P380; Han B, 2013, INT J PEDIATR OTORHI, V77, P1440, DOI 10.1016/j.ijporl.2013.05.040; Han P, 2015, CHINESE J WOMEN CHIL, V6, P62; Hessel Franz, 2003, Ger Med Sci, V1, pDoc09; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; [胡书君 Hu Shujun], 2010, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V18, P222; Huang LH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-97; Kezirian EJ, 2001, OTOLARYNG HEAD NECK, V124, P359, DOI 10.1067/mhn.2001.113945; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416; Korres S, 2008, LARYNGOSCOPE, V118, P1253, DOI 10.1097/MLG.0b013e31816d726c; Lan Peiji, 2016, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V30, P150; Li SX, 2015, CLIN EXP OTORHINOLAR, V8, P211, DOI 10.3342/ceo.2015.8.3.211; [李晓泽 Li Xiaoze], 2015, [中华耳科学杂志, Chinese Journal of Otology], V13, P654; Li Z, 2014, J AUDIOLOGY SPEECH P; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Lu YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002248; Lu JR, 2011, INT J PEDIATR OTORHI, V75, P1045, DOI 10.1016/j.ijporl.2011.05.022; Lyu Kangmo, 2014, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V31, P547, DOI 10.3760/cma.j.issn.1003-9406.2014.05.001; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ou QS, 2011, CHINESE MED J-PEKING, V124, P3347, DOI 10.3760/cma.j.issn.0366-6999.2011.20.025; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Propst EJ, 2006, INT J PEDIATR OTORHI, V70, P435, DOI 10.1016/j.ijporl.2005.07.013; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Sarafraz M., 2011, DETERMINATION HEARIN; Schimmenti LA, 2008, GENET MED, V10, P517, DOI [10.1097/GIM.0b013e31817708fa, 10.1097GIM.0b013e31817708fa]; Schimmenti LA, 2011, GENET MED, V13, P1006, DOI 10.1097/GIM.0b013e318226fc2e; Sun Xuejing, 2015, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V32, P766, DOI 10.3760/cma.j.issn.1003-9406.2015.06.002; Tang Junxiang, 2015, SHANDONG MED J, P76; Tranebjaerg L, 2000, Ugeskr Laeger, V162, P3044; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p61S, DOI 10.1177/0003489415575060; Uus K, 2006, J MED SCREEN, V13, P14, DOI 10.1258/096914106776179764; van der Ploeg CPB, 2012, INT J AUDIOL, V51, P584, DOI 10.3109/14992027.2012.684402; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; [王莹 Wang Ying], 2015, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V23, P248; Wu CC, 2017, GENET MED, V19, P6, DOI 10.1038/gim.2016.66; Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753; Xiangjun LI, 2017, J MED THEORY PRACTIC; Xin F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-312; Yan B, BMC MED GENETICS, V11, P1; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yao J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-136; Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111; Yongjun P, 2015, CHINESE J BIRTH HLTH, P66; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P380, DOI 10.1353/aad.2012.0151; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P416, DOI 10.1353/aad.2012.0118; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088; Yu H, 2014, CHINESE J BIRTH HLTH, P34; Yu Hong, 2015, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V32, P335, DOI 10.3760/cma.j.issn.1003-9406.2015.03.007; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhang J, 2013, CHIN MED ASS NAT OT; Zhang JQ, 2013, INT J PEDIATR OTORHI, V77, P1929, DOI 10.1016/j.ijporl.2013.08.038; Zhang ZW, 2012, INT J PEDIATR OTORHI, V76, P984, DOI 10.1016/j.ijporl.2012.03.016; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128691	73	15	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195740	10.1371/journal.pone.0195740	http://dx.doi.org/10.1371/journal.pone.0195740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634755	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200053
J	McCaskey, MA; Wirth, B; Schuster-Amft, C; de Bruin, ED				McCaskey, Michael A.; Wirth, Brigitte; Schuster-Amft, Corina; de Bruin, Eling D.			Dynamic multi-segmental postural control in patients with chronic non-specific low back pain compared to pain-free controls: A cross-sectional study	PLOS ONE			English	Article							MOVEMENT VARIABILITY; CEREBRAL CONCUSSION; JOINT COORDINATION; GLOBAL BURDEN; QUIET STANCE; PRESSURE; INDIVIDUALS; RELIABILITY; ADAPTATION; MANAGEMENT	Reduced postural control is thought to contribute to the development and persistence of chronic non-specific low back pain (CNLBP). It is therefore frequently assessed in affected patients and commonly reported as the average amount of postural sway while standing upright under a variety of sensory conditions. These averaged linear outcomes, such as mean centre of pressure (CP) displacement or mean CP surface areas, may not reflect the true postural status. Adding nonlinear outcomes and multi-segmental kinematic analysis has been reported to better reflect the complexity of postural control and may detect subtler postural differences. In this cross-sectional study, a combination of linear and nonlinear postural parameters were assessed in patients with CNLBP (n = 24, 24-75 years, 9 females) and compared to symptom-free controls (CG, n = 34, 22-67 years, 11 females). Primary outcome was postural control measured by variance of joint configurations (uncontrolled manifold index, UI), confidence ellipse surface areas (CEA) and approximate entropy (ApEn) of CP dispersion during the response phase of a perturbed postural control task on a swaying platform. Secondary outcomes were segment excursions and clinical outcome correlates for pain and function. Non-parametric tests for group comparison with P-adjustment for multiple comparisons were conducted. Principal component analysis was applied to identify patterns of segmental contribution in both groups. CNLBP and CG performed similarly with respect to the primary outcomes. Comparison of joint kinematics revealed significant differences of hip (P < .001) and neck (P < .025) angular excursion, representing medium to large group effects (r's = .36 - .51). Significant (P's < .05), but moderate correlations of ApEn (r = -.42) and Ul (r = -.46) with the health-related outcomes were observed. These findings lend further support to the notion that averaged linear outcomes do not suffice to describe subtle postural differences in CNLBP patients with low to moderate pain status.	[McCaskey, Michael A.; de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci, Dept Hlth Sci & Technol, Zurich, Switzerland; [McCaskey, Michael A.; Schuster-Amft, Corina] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [Schuster-Amft, Corina] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [Wirth, Brigitte] Univ Zurich, Balgrist Univ Hosp, Dept Chiropract Med, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Karolinska Institutet	McCaskey, MA (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci, Dept Hlth Sci & Technol, Zurich, Switzerland.; McCaskey, MA (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.	michael.mccaskey@hest.ethz.ch	McCaskey, Michael Alexander/Q-8055-2019; de Bruin, Eling D./A-4751-2011; Schuster, Corina/B-6939-2008	McCaskey, Michael Alexander/0000-0002-6152-8816; de Bruin, Eling D./0000-0002-6542-7385; Wirth, Brigitte/0000-0001-6935-1800; Schuster-Amft, Corina/0000-0003-1120-4423	cantonal department of health and social services of the Canton of Argovia, Switzerland; Reha Rheinfelden, Switzerland; ETH Zurich	cantonal department of health and social services of the Canton of Argovia, Switzerland; Reha Rheinfelden, Switzerland; ETH Zurich(ETH Zurich)	MM and CS were partially funded by a grant from the cantonal department of health and social services of the Canton of Argovia (www.ag.ch/dgs), Switzerland. Internal funding was provided by MM and CS' employer, Reha Rheinfelden, Switzerland. BW and EdB were funded by their employers, ETH Zurich, as part of their teaching activity (PhD supervision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors had unrestricted access to the data. There was no additional external funding received for this study.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Churchill AJG, 2002, COMPUT METH PROG BIO, V69, P197, DOI 10.1016/S0169-2607(01)00191-2; Claeys K, 2015, J ELECTROMYOGR KINES, V25, P329, DOI 10.1016/j.jelekin.2014.10.013; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Fairbank J C, 1980, Physiotherapy, V66, P271; Fernandes RJ, 2012, J HUM KINET, V33, P15, DOI 10.2478/v10078-012-0040-6; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; Janda V, 2006, REHABILITATION SPINE, P203; Krishnamoorthy V, 2005, EXP BRAIN RES, V164, P1, DOI 10.1007/s00221-004-2205-6; Krishnamoorthy V, 2003, BIOL CYBERN, V89, P152, DOI 10.1007/s00422-003-0419-5; Lamoth CJC, 2004, CLIN BIOMECH, V19, P551, DOI 10.1016/j.clinbiomech.2003.10.006; Langevin HM, 2007, MED HYPOTHESES, V68, P74, DOI 10.1016/j.mehy.2006.06.033; Latash M., 2008, NEUROPHYSIOLOGICAL B, V2nd; Latash ML, 2010, MOTOR CONTROL, V14, P294; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; McCaskey MA, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1104-4; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Meucci RD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005874; Moseley GL, 2004, EUR J PAIN, V8, P39, DOI 10.1016/S1090-3801(03)00063-6; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; PARKER EMILY, 2016, ENVIRON TOXICOL, P1; Peterka R J, 1990, J Vestib Res, V1, P87; Pijnenburg M, 2015, BRAIN CONNECT, V5, P303, DOI 10.1089/brain.2014.0309; Rasev E., 2011, THESIS; ROCCHI MBL, 2005, ITAL J SPORT SCI, V12, P169; Ruhe A, 2011, EUR SPINE J, V20, P358, DOI 10.1007/s00586-010-1543-2; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sipko T, 2013, EUR J PAIN, V17, P612, DOI 10.1002/j.1532-2149.2012.00226.x; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tajali S, 2013, BIOMED ENG-APP BAS C, V25, DOI 10.4015/S1016237213500105; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang TY, 2015, HUM MOVEMENT SCI, V40, P284, DOI 10.1016/j.humov.2015.01.002; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	51	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194512	10.1371/journal.pone.0194512	http://dx.doi.org/10.1371/journal.pone.0194512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634749	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200011
J	Holm, M; Saraswat, M; Joenvaara, S; Ristimaki, A; Haglund, C; Renkonen, R				Holm, Matilda; Saraswat, Mayank; Joenvaara, Sakari; Ristimaki, Ari; Haglund, Caj; Renkonen, Risto			Colorectal cancer patients with different C reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics	PLOS ONE			English	Article							BINDING PROTEIN-2; COLON-CANCER; AMYLOID-A; PANCREATIC-CANCER; POOR-PROGNOSIS; BIOMARKER; INSULIN; ANTIGEN; IDENTIFICATION; CHOLESTEROL	Over 1.4 million people are diagnosed with colorectal cancer (CRC) each year, making it the third most common cancer in the world. Increased screening and therapeutic modalities including improved combination treatments have reduced CRC mortality, although incidence and mortality rates are still increasing in some areas. Serum-based biomarkers are mainly used for follow-up of cancer, and are ideal due to the ease and minimally invasive nature of sample collection. Unfortunately, CEA and other serum markers have too low sensitivity for screening and preoperative diagnostic purposes. Increasing interest is focused on the possible use of biomarkers for predicting treatment response and prognosis in cancer. In this study, we have performed mass spectrometry analysis (UPLC-UDMSE) of serum samples from 19 CRC patients. Increased levels of C-reactive protein (CRP), which occur during local inflammation and the presence of a systemic inflammatory response, have been linked to poor prognosis in CRC patients. We chose to analyze samples according to CRP values by dividing them into the categories CRP <30 and >30, and, separately, according to short and long 5-year survival. The aim was to discover differentially expressed proteins associated with poor prognosis and shorter survival. We quantified 256 proteins and performed detailed statistical analyses and pathway analysis. We discovered multiple proteins that are up- or downregulated in patients with CRP >30 as compared to CRP <30 and in patients with short as compared to long 5-year survival. Pathways that were enriched include LXR/RXR activation, FXR/RXR activation, complement and coagulation cascades and acute phase signaling response, with some of the proteins we identified having roles in these pathways. In this study, we have identified multiple proteins, of which a few have been previously identified as potential biomarkers, and others that have been identified as potential biomarkers for CRC for the first time, to the best of our knowledge. While these proteins still need to be validated in larger patient series, this pilot study will pave the way for future studies aiming to provide better biomarkers for patients with CRC.	[Holm, Matilda; Ristimaki, Ari] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Holm, Matilda; Ristimaki, Ari; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Holm, Matilda; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Holm, Matilda; Ristimaki, Ari] Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland; [Holm, Matilda; Haglund, Caj] Univ Helsinki, Translat Canc Biol Res Program, Res Programs Unit, Helsinki, Finland; [Saraswat, Mayank; Joenvaara, Sakari; Renkonen, Risto] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Saraswat, Mayank; Joenvaara, Sakari; Ristimaki, Ari; Haglund, Caj; Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Holm, M (corresponding author), Univ Helsinki, Dept Pathol, Helsinki, Finland.; Holm, M (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Translat Canc Biol Res Program, Res Programs Unit, Helsinki, Finland.	matilda.holm@helsinki.fi	Haglund, Caj/N-1240-2019; Saraswat, Mayank/F-2985-2015	Saraswat, Mayank/0000-0002-5021-8150	Sigrid Juselius Foundation; Finnish Cancer Foundation; Helsinki University Hospital; University of Helsinki	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundation; Helsinki University Hospital; University of Helsinki	CH and AR received funding in the form of grants from the Sigrid Juselius Foundation and the Finnish Cancer Foundation. CH and RR also received funding from Helsinki University Hospital and RR also received funding from the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Chan DC, 2007, ANN SURG ONCOL, V14, P84, DOI 10.1245/s10434-006-9091-z; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cho WCS, 2004, CLIN CANCER RES, V10, P43, DOI 10.1158/1078-0432.CCR-0413-3; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Dayon L., 2013, EUPA OPEN PROTEOM, V1, P8, DOI [10.1016/j.euprot.2013.08.001, DOI 10.1016/J.EUPROT.2013.08.001]; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Di Luca A, 2015, DARU, V23, DOI 10.1186/s40199-015-0120-y; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Flyvbjerg A, 1997, J CLIN ENDOCR METAB, V82, P2308, DOI 10.1210/jc.82.7.2308; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Glojnaric I, 2001, CLIN CHEM LAB MED, V39, P129, DOI 10.1515/CCLM.2001.022; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Inamura K., 2018, CANCERS BASEL, V10; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; KANETY H, 1993, J CLIN ENDOCR METAB, V77, P229, DOI 10.1210/jc.77.1.229; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Kersten C, 2013, ACTA ONCOL, V52, P1691, DOI 10.3109/0284186X.2013.835494; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kimura M, 2001, CANCER, V92, P2072, DOI 10.1002/1097-0142(20011015)92:8<2072::AID-CNCR1547>3.0.CO;2-P; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Lin MS, 2012, HEPATO-GASTROENTEROL, V59, P1687, DOI 10.5754/hge12277; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; McArdle CS, 2002, BRIT J CANCER, V86, P331, DOI 10.1038/sj.bjc.6600120; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Saraswat M, 2017, CANCER MED-US, V6, P1738, DOI 10.1002/cam4.1107; Saraswat M, 2017, MOL CELL PROTEOMICS, V16, P57, DOI 10.1074/mcp.M116.061028; Serang O, 2012, J PROTEOME RES, V11, P5586, DOI 10.1021/pr300426s; SHEPHERD FA, 2009, J CLIN ONCOL S, V27; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Srinivas PR, 2001, LANCET ONCOL, V2, P698, DOI 10.1016/S1470-2045(01)00560-5; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stewart B, 2014, WORLD CANC REPORT 20; Takano S, 2008, ONCOGENE, V27, P2810, DOI 10.1038/sj.onc.1210951; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; VANDUIJNHOVEN EM, 1993, HAEMOSTASIS, V23, P168; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; Wroblewski MS, 2006, FEBS J, V273, P4707, DOI 10.1111/j.1742-4658.2006.05473.x; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167	51	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195354	10.1371/journal.pone.0195354	http://dx.doi.org/10.1371/journal.pone.0195354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630649	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000041
J	Moure-Rodriguez, L; Carbia, C; Lopez-Caneda, E; Varela, MC; Cadaveira, F; Caamano-Isorna, F				Moure-Rodriguez, Lucia; Carbia, Carina; Lopez-Caneda, Eduardo; Corral Varela, Montserrat; Cadaveira, Fernando; Caamano-Isorna, Francisco			Trends in alcohol use among young people according to the pattern of consumption on starting university: A 9-year follow-up study	PLOS ONE			English	Article							BINGE DRINKING; COLLEGE; RISK; EXPECTANCIES; TRAJECTORIES; ADOLESCENCE; PREDICTORS; ADULTHOOD; STUDENTS; SAMPLE	Aim To identify differences in Risky Consumption (RC) and Binge drinking (BD) trends in students who already followed these patterns of alcohol consumption on starting university and those who did not, and also to try to understand what leads students to engage in these types of behaviour at university. Material and methods Cohort study among university students in Spain (n = 1382). BD and RC were measured with the Alcohol Use Disorders Identification Test at ages 18, 20, 22, 24 and 27 years. Multi-level logistic regression for repeated measures was used to calculate the adjusted Odds Ratios (ORs). Results The prevalence rates of RC and BD were lower throughout the study in students who did not follow these patterns of consumption at age 18. For RC and BD, the differences at age 27 years, expressed as percentage points (pp), were respectively 24 pp and 15 pp in women and 29 pp and 25 pp in men. Early age of onset of alcohol use increased the risk of engaging in RC and BD patterns at university, for men (OR = 2.91 & 2.80) and women (OR = 8.14 & 5.53). The same was observed in students living away from the parental home for BD (OR = 3.43 for men & 1.77 for women). Only women were influenced by having positive expectancies for engaging in RC (OR = 1.82) and BD (OR = 1.96). Conclusions The prevalence rates of both RC and BD at age 27 years were much higher among university students who already followed these patterns of consumption at age 18 years, with the differences being proportionally higher among women. Focusing on the age of onset of alcohol consumption and hindering access to alcohol by minors should be priority objectives aimed at preventing students from engaging in these patterns of alcohol consumption at university.	[Moure-Rodriguez, Lucia; Caamano-Isorna, Francisco] Univ Santiago de Compostela, Dept Publ Hlth, CIBERESP, Santiago De Compostela, Spain; [Carbia, Carina; Lopez-Caneda, Eduardo; Corral Varela, Montserrat; Cadaveira, Fernando] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Lopez-Caneda, Eduardo] Univ Minho, Sch Psychol, Res Ctr Psychol, Neuropsychophysiol Lab, Braga, Portugal	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade do Minho	Carbia, C (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain.	carina.carbia@usc.es	Cadaveira, Fernando/C-5981-2011; Cadaveira, Fernando/ABE-7827-2021; Varela, Montserrat Corral/A-6384-2012; Caamano-Isorna, Francisco/AAL-3770-2020; López Caneda, Eduardo/AAS-2406-2020	Cadaveira, Fernando/0000-0001-6198-1541; Cadaveira, Fernando/0000-0001-6198-1541; Caamano-Isorna, Francisco/0000-0001-8995-3673; Moure-Rodriguez, Lucia/0000-0002-9084-6047; Lopez Caneda, Eduardo/0000-0003-1788-1556; Carbia, Carina/0000-0001-7921-8966	Plan Nacional sobre Drogas (Spain) [2005/PN014]; Fondo de Investigacion Sanitaria (Spain) [PI15/00165]; FPU program of the Spanish Ministry of Education [FPU13/04569]; Postdoctoral Fellowship of the Portuguese Foundation for Science and Technology [SFRH/BPD/109750/2015]	Plan Nacional sobre Drogas (Spain); Fondo de Investigacion Sanitaria (Spain)(Instituto de Salud Carlos III); FPU program of the Spanish Ministry of Education(German Research Foundation (DFG)); Postdoctoral Fellowship of the Portuguese Foundation for Science and Technology	This work was supported by grants awarded by the Plan Nacional sobre Drogas (Spain) (2005/PN014) and the Fondo de Investigacion Sanitaria (Spain) (PI15/00165). Carina Carbia was supported by the FPU program (FPU13/04569) of the Spanish Ministry of Education. Eduardo Lopez-Caneda was supported by the SFRH/BPD/109750/2015 Postdoctoral Fellowship of the Portuguese Foundation for Science and Technology.	AHLSTROM S, MANOLE LTDA, P90; ANDERSSON C, 2008, ALCOHOL; BARTOLI F, 2014, BIOMED RES INT, pNIL1, DOI DOI 10.1155/2014/930795; BAVA S, 2006, NEUROPSYCHOL REV; BEWICK BM, 1963, BMC PUBLIC HEALTH; Borsari B, 2001, J SUBST ABUSE, V13, P391, DOI 10.1016/S0899-3289(01)00098-0; Borsari B, 2007, ADDICT BEHAV, V32, P2062, DOI 10.1016/j.addbeh.2007.01.017; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; CLARK A, 2011, ADDICT BEHAV, V11, P35; Cranford JA, 2006, ALCOHOL CLIN EXP RES, V30, P1896, DOI 10.1111/j.1530-0277.2006.00234.x; Cservenka A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01111; CURRIE C, 2012, STUDY INTERNATIONAL, V3, P3857; D'Alessio M, 2006, ADDICT BEHAV, V31, P2328, DOI 10.1016/j.addbeh.2006.03.002; Defensor del Menor de la Comunidad de Madrid, 2002, NEWSLETTER, P307; DEGENHARDT L, 1971, PLOS MED; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; *ESTUDES, DELEGACION DEL GOBIE; *EUROSTAT, STADISTICS EXPLAINED; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hingson R, 2003, J STUD ALCOHOL, V64, P23, DOI 10.15288/jsa.2003.64.23; Hingson R, 2014, J STUD ALCOHOL DRUGS, V75, P158, DOI 10.15288/jsad.2014.75.158; Jefferis BJMH, 2005, ADDICTION, V100, P543, DOI 10.1111/j.1360-0443.2005.01034.x; Jessor R, 2006, J STUD ALCOHOL, V67, P86, DOI 10.15288/jsa.2006.67.86; Johnson PB, 1999, J STUD ALCOHOL, V60, P64, DOI 10.15288/jsa.1999.60.64; JOHNSTON L, 2001, MONITORING FUTURE NA, V2, P1975; Johnston L, 2001, CONSELLERIA DE SANID, VII, P1975; JONES BT, 1980, ADDICTION; Kraus L, 2016, ESPAD REPORT 2015 RE; KUNTSCHE E, 2003, SOC SCI MED, V10, P9; Labbe AK, 2011, CLIN PSYCHOL REV, V31, P673, DOI 10.1016/j.cpr.2011.02.007; Labrie JW, 2007, J STUD ALCOHOL DRUGS, V68, P393, DOI 10.15288/jsad.2007.68.393; LOA P, 1968, ALCOHOL ALCOHOL; McBride NM, 2014, J AM COLL HEALTH, V62, P370, DOI 10.1080/07448481.2014.907297; Merrill JE, 2016, ALCOHOL RES-CURR REV, V38, P103; Ministerio de Sanidad Politica Social e Igualdad, 2014, NEWSLETTER; MOORE GF, 2006, SUBST ABUSE TREAT PR; MORAWSKA A, 2004, ADDICT BEHAV, V5, P11; MOURERODRIGUEZ L, PLOS ONE; Mubayi A, 2011, ADDICTION, V106, P749, DOI 10.1111/j.1360-0443.2010.03254.x; NATIONAL I, 2002, NEWSLETTER; NATIONAL I, 2005, NEWSLETTER; NATIONAL I, 2011, NEWSLETTER, V90, P101; NATIONAL I, 2010, NEWSLETTER, V3254, P2556; NATIONAL I, 2015, NEWSLETTER, V4, P3; *NIAAA, NIAAA NEWSLETTER; Oei TPS, 2004, ADDICT BEHAV, V29, P159, DOI 10.1016/S0306-4603(03)00076-5; PAPACHRISTOU H, 2017, COGN THER RES; PATRICK M, 2018, MATURING OUT OF PROB, V284, P202; Patrick M, 2002, NEWSLETTER; Patrick M., 2014, AGING MENT HEALTH, V35, P193; Patrick ME, 2013, ALCOHOL RES-CURR REV, V35, P193; Peeters M, 2015, DEV COGN NEUROS-NETH, V16, P139, DOI 10.1016/j.dcn.2015.04.003; PILATTI A, 1925, ALCOHOL ALCOHOL; READ JP, 1998, EXP CLIN PSYCHOPHARM; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schulenberg J, 1996, J STUD ALCOHOL, V57, P289, DOI 10.15288/jsa.1996.57.289; Tuunanen M, 2007, DRUG ALCOHOL REV, V26, P295, DOI 10.1080/09595230701247756; Varela J, 2005, NEWSLETTER; VINER RM, 2005, J EPIDEMIOL COMMUNIT; Weitzman ER, 2003, J ADOLESCENT HEALTH, V32, P26, DOI 10.1016/S1054-139X(02)00457-3; WHO, 2014, SUBST ABUS, P2014; DEFENSOR DEL MENOR D	62	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0193741	10.1371/journal.pone.0193741	http://dx.doi.org/10.1371/journal.pone.0193741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630657	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000003
J	Urrestarazu, J; Errea, P; Miranda, C; Santesteban, LG; Pina, A				Urrestarazu, Jorge; Errea, Pilar; Miranda, Carlos; Santesteban, Luis G.; Pina, Ana			Genetic diversity of Spanish Prunus domestica L. germplasm reveals a complex genetic structure underlying	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; MICROSATELLITE MARKERS; PLUM GERMPLASM; PERSICA L.; PEACH; IDENTIFICATION; CULTIVARS; HYBRIDIZATION; AMPLIFICATION; MITOCHONDRIAL	European plum (Prunus domestica L.) is an ancient domesticated species cultivated in temperate areas worldwide whose genetic structure has been scarcely analyzed to date. In this study, a broad representation of Spanish European plum germplasm collected in Northeastern Spain and a representative set of reference cultivars were compared using nuclear and chloroplast markers. The number of alleles per locus detected with the SSR markers ranged from 8 to 39, with an average of 23.4 alleles, and 8 haplotypes were identified. Bayesian model-based clustering, minimum spanning networks, and the analysis of molecular variance showed the existence of a hierarchical structure. At the first level, two genetic groups were found, one containing 'Reine Claude' type reference cultivars altogether with ca. 25% of local genotypes, and a second one much more diverse. This latter group split in two groups, one containing most (ca. 70%) local genotypes and some old Spanish and French reference cultivars, whereas the other included 24 reference cultivars and only six local genotypes. A third partition level allowed a significant finer delineation into five groups. As a whole, the genetic structure of European plum from Northeastern Spain was shown to be complex and conditioned by a geographical proximity factor. This study not only contributes to genetic conservation and breeding for this species at the national level, but also supports the relevance of undertaking similar tasks of collection and characterization in other unexplored areas. Moreover, this kind of research could lead to future coordinated actions for the examination of the whole European plum diversity, to define conservation strategies, and could be used to better understand the genetic control of traits of horticultural interest through association mapping.	[Urrestarazu, Jorge; Errea, Pilar; Pina, Ana] Univ Zaragoza, Ctr Invest & Tecnol Agroalimentaria Aragon CITA, IA2, Unidad Hortofruticultura,CITA, Avda Montanana, Zaragoza, Spain; [Urrestarazu, Jorge; Miranda, Carlos; Santesteban, Luis G.] Univ Publ Navarra, Dept Prod Agr, Campus Arrosadia S-N, Pamplona, Spain	University of Zaragoza; Universidad Publica de Navarra	Pina, A (corresponding author), Univ Zaragoza, Ctr Invest & Tecnol Agroalimentaria Aragon CITA, IA2, Unidad Hortofruticultura,CITA, Avda Montanana, Zaragoza, Spain.	apina@aragon.es	Miranda, Carlos/B-4293-2010; Santesteban, Luis Gonzaga/B-2408-2009; Errea, Pilar/ABE-1635-2020	Miranda, Carlos/0000-0001-7217-0859; Santesteban, Luis Gonzaga/0000-0001-6924-6744; Errea, Pilar/0000-0002-2889-1728; Pina, Ana/0000-0002-4988-9467	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [RF2009 -00015-00-00]; Research Group of Aragon, Spain [A12]	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Research Group of Aragon, Spain	This research was supported by the grant RF2009-00015-00-00 from the Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the Research Group A12 of Aragon, Spain.	Aranzana MJ, 2002, THEOR APPL GENET, V106, P321; BADENES ML, 1995, THEOR APPL GENET, V90, P1035, DOI 10.1007/BF00222918; Becher SA, 2000, THEOR APPL GENET, V101, P643, DOI 10.1007/s001220051526; Biswajit Das, 2011, International Journal of Biodiversity and Conservation, V3, P721; Bouhadida M, 2007, J AM SOC HORTIC SCI, V132, P670, DOI 10.21273/JASHS.132.5.670; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Breton C, 2008, PLANT SCI, V175, P524, DOI 10.1016/j.plantsci.2008.05.025; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Cherry Watkins R., 1976, EVOLUTION CROP PLANT, P242; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Crane MB, 1952, GENETICS GARDEN PLAN, P301; Cullinan FP, 1937, USDA YB AGR, P605; De Riek J, 2007, CROP SCI, V47, P1964, DOI 10.2135/cropsci2006.04.0265; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; DumolinLapegue S, 1997, MOL ECOL, V6, P393, DOI 10.1046/j.1365-294X.1997.00193.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Esselink GD, 2003, THEOR APPL GENET, V106, P277, DOI 10.1007/s00122-002-1122-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Faust M., 1999, Horticultural Reviews, V23, P179, DOI 10.1002/9780470650752.ch4; GarciaRuiz JM, 1996, LANDSCAPE ECOL, V11, P267, DOI 10.1007/BF02059854; Gharbi O, 2014, SCI HORTIC-AMSTERDAM, V169, P57, DOI 10.1016/j.scienta.2014.02.018; Han QX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135132; Hartmann HT, 2002, PRINCIPLES AND PRACT; Hedrich UP, 1911, PLUMS NEW YORK; Herrero J, 1964, CARTOGRAFIA FRUTALES, V5; Herrero J, 1971, PLUM CULTIVARS SPAIN, V11, P165; Hormaza JI, 2002, THEOR APPL GENET, V104, P321, DOI 10.1007/s001220100684; Horvath A, 2011, SCI HORTIC-AMSTERDAM, V129, P283, DOI 10.1016/j.scienta.2011.03.049; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kazija DH, 2014, TREE GENET GENOMES, V10, P761, DOI 10.1007/s11295-014-0721-5; Lepais O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075029; Lespinasse J, 2005, GROWING FRUIT TREES; Leterme E, 2008, FRUITS RETROUVES PAT; Li XW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-84; Liorzou M, 2016, J EXP BOT, V67, P4711, DOI 10.1093/jxb/erw269; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Mariette S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-77; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; Mnejja M, 2004, MOL ECOL NOTES, V4, P163, DOI 10.1111/j.1471-8286.2004.00603.x; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Mohanty A, 2003, ANN BOT-LONDON, V92, P749, DOI 10.1093/aob/mcg198; Mudge K., 2009, Horticultural Reviews, V35, P437; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Panda S, 2003, PLANT BREEDING, V122, P92, DOI 10.1046/j.1439-0523.2003.00768.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pina A, 2014, SCI HORTIC-AMSTERDAM, V174, P1, DOI 10.1016/j.scienta.2014.04.037; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2016, R LANG ENV STAT COMP; Reales A, 2010, TREE GENET GENOMES, V6, P37, DOI 10.1007/s11295-009-0226-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rouger R, 2014, MOL ECOL, V23, P3158, DOI 10.1111/mec.12802; Sampson JF, 2012, BIOL J LINN SOC, V105, P218, DOI 10.1111/j.1095-8312.2011.01787.x; Sehic J, 2015, SCI HORTIC-AMSTERDAM, V190, P195, DOI 10.1016/j.scienta.2015.03.034; Sosinski B, 2000, THEOR APPL GENET, V101, P421, DOI 10.1007/s001220051499; Stock M, 2010, EVOLUTION, V64, P944, DOI 10.1111/j.1558-5646.2009.00876.x; Tabuenca M. C., 1991, Anales de la Estacion Experimental de Aula Dei, V20, P119; Tabuenca M.C., 1991, REINA CLAUDIA VERDE, V20, P153; Tabuenca MC, 1991, REINA CLAUDIA BAVAY, V20, P177; Tabuenca MC, 1991, REINA CLAUDIA OULLIN, V20, P165; Topp BL, 2012, HANDB PLANT BREED, V8, P571, DOI 10.1007/978-1-4419-0763-9_15; Urrestarazu J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0818-0; Urrestarazu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138417; Urrestarazu J, 2012, TREE GENET GENOMES, V8, P1163, DOI 10.1007/s11295-012-0502-y; Vallejo-Marin M, 2013, HEREDITY, V110, P111, DOI 10.1038/hdy.2012.91; WATKINS R, 1981, OXFORD ENCY TREES WO, P196; Wunsch A, 2009, SCI HORTIC-AMSTERDAM, V120, P348, DOI 10.1016/j.scienta.2008.11.012; Zhang X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00583; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195591	10.1371/journal.pone.0195591	http://dx.doi.org/10.1371/journal.pone.0195591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630655	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000062
J	Gong, EJ; Lee, JY; Bae, SE; Park, YS; Choi, KD; Song, HJ; Lee, GH; Jung, HY; Jeong, WJ; Cheon, GJ; Yook, JH; Kim, BS				Gong, Eun Jeong; Lee, Ji Young; Bae, Suh Eun; Park, Young Soo; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jung, Hwoon-Yong; Jeong, Woo Jin; Cheon, Gab Jin; Yook, Jeong Hwan; Kim, Byung Sik			Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology	PLOS ONE			English	Article							PEPSINOGEN; INFECTION; CARCINOGENESIS; CLASSIFICATION; SUBTYPE; STOMACH; SMOKING; KOREA	Background Data on implications of a high positive titer of serum anti-Helicobacter pyloriantibody on gastric cancer (GC) is limited. This study aimed to investigate the characteristics of GC with a high serum anti-H. pylori IgG (Hp-IgG) titer, and its association with diffuse-type GC. Methods We analyzed clinical and histological characteristics of 917 non-cardia GC patients who underwent gastrectomy. H. pylori infection was determined serologically by measuring Hp-IgG titer with immunoassay. Seropositive patients were divided into three groups (low-positive, mid-positive, and high-positive) according to the Hp-IgG titer value. Tumors were classified according to the Lauren criteria as diffuse or intestinal types. Results The median age of the patients was 59.0 years, and 33.8% were female. The patents were grouped as follows: seronegative, 188 (20.5%); low-positive, 288 (31.4%); mid-positive, 290 (31.6%); and high-positive 151 (16.5%). The high-positive group was significantly younger (median age, 55.0 years), with a higher proportion of female (45.0%) and nonsmokers (58.9%). The proportion of diffuse-type GC increased in the order low-, mid-, and high-positive groups (p<0.001). In univariate analysis, the factors associated with diffuse type GC were younger age, female sex, non-smokers, and a high-positive Hp-IgG titer. Younger age, female sex, and non-smokers remained significant on multivariate analysis whereas the high-positive Hp-IgG titer showed only a tendency toward the association (p = 0.078). Conclusions Non-cardia GC patients with a high Hp-IgG titer have distinct clinicopathologic characteristics. A high-positive Hp-IgG titer should be interpreted together with patients' age, sex, and smoking status.	[Gong, Eun Jeong; Jeong, Woo Jin; Cheon, Gab Jin] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Internal Med, Kangnung, South Korea; [Lee, Ji Young; Bae, Suh Eun] Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea; [Park, Young Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jung, Hwoon-Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Yook, Jeong Hwan; Kim, Byung Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, HJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	hjsong@amc.seoul.kr		SONG, HO JUNE/0000-0002-3195-8794				[Anonymous], 2010, WHO CLASSIFICATION T; BIASCO G, 1993, J CLIN PATHOL, V46, P826, DOI 10.1136/jcp.46.9.826; Burucoa C, 2013, HELICOBACTER, V18, P169, DOI 10.1111/hel.12030; Chen YC, 2016, PATHOL ONCOL RES, V22, P197, DOI 10.1007/s12253-015-9996-6; Cho SJ, 2010, GUT LIVER, V4, P466, DOI 10.5009/gnl.2010.4.4.466; CORREA P, 1992, CANCER RES, V52, P6735; Edge SB, 2010, AJCC CANC STAGING MA, P117, DOI DOI 10.1007/978-0-387-88441-7; Hsu PI, 1997, J CLIN GASTROENTEROL, V25, P587, DOI 10.1097/00004836-199712000-00007; Inoue M, 1999, INT J CANCER, V81, P39; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim HJ, 2016, GUT LIVER, V10, P212, DOI 10.5009/gnl14416; Kishikawa H, 2015, DIS MARKERS, V2015; Korea Ministry of Food and Drug Safety, 2000, SAF EFF IMM 1000 200; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P1671, DOI 10.1111/jgh.12605; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JY, 2017, GUT LIVER, V11, P807, DOI 10.5009/gnl17033; LEE WJ, 1995, BRIT J SURG, V82, P802, DOI 10.1002/bjs.1800820627; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Plebani M, 1996, AM J GASTROENTEROL, V91, P954; Sasazuki S, 2002, INT J CANCER, V101, P560, DOI 10.1002/ijc.10649; Tatemichi M, 2008, ACTA ONCOL, V47, P360, DOI 10.1080/02841860701843035; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; Tu HK, 2014, SCAND J GASTROENTERO, V49, P259, DOI 10.3109/00365521.2013.869352; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Waldum HL, 2016, THER ADV GASTROENTER, V9, P836, DOI 10.1177/1756283X16663395; Waldum HL, 2015, DIGEST DIS SCI, V60, P1522, DOI 10.1007/s10620-014-3468-9; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Watanabe M, 2012, INT J CANCER, V131, P2632, DOI 10.1002/ijc.27514; Yoon H, 2011, HELICOBACTER, V16, P382, DOI 10.1111/j.1523-5378.2011.00859.x	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195264	10.1371/journal.pone.0195264	http://dx.doi.org/10.1371/journal.pone.0195264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621300	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800053
J	Jang, SH; Yang, DK				Jang, Seung Hee; Yang, Dong Kwon			The combination of Cassia obtusifolia L. and Foeniculum vulgare M. exhibits a laxative effect on loperamide-induced constipation of rats	PLOS ONE			English	Article							OPIOID-INDUCED CONSTIPATION; MUSCARINIC RECEPTORS; ESSENTIAL OILS; SMOOTH-MUSCLE; FENNEL; ANTIOXIDANT; EXTRACT; SEEDS; CONSTITUENTS; SECRETION	Chronic constipation is a functional gastrointestinal disease that is detrimental to the quality of patient life. Cassia obtusifolia L. (CO) and Foeniculum vulgare M. (FV) are commonly used as medicinal foods in many countries. We aimed to examine the laxative effect and their underlying mechanism of CO and FV mixture on loperamide (lop)-induced constipated rats. To determine the laxative effects of these compounds, Sprague-Dawley rats were divided into six groups: the control, lop -induced constipated (2mg/kg), and three doses (100, 300, and 500mg/kg) of CO and FV mixture-, and Bisacodyl (bis, 3.3mg/kg)-treated groups. The mixture of CO and FV and bis were orally administered once a day for 4 weeks. For induction of constipation, the lop were treated with a dose of 2 mg/kg twice a day on the 3rd week after treatments of CO and FV extracts and bis. The results were revealed that the CO and FV mixture has the laxative effects more than those in CO and FV-alone treatments on constipated rats by determining the stool parameters, including stool number and weight. Indeed, stool parameters, such as, stool number, weight, and water contents and colonic peristalsis from the intestinal transit length and ratio were dramatically improved by CO and FV mixture treatment. Histological study also revealed that CO and FV mixture enhanced the thicknesses of mucosa and muscular layers of the colon in constipated rats. For their underlying mechanism, the mRNAs and proteins expression of muscarinic acetylcholine receptors (mAchR) M2 and M3 and their downstream signaling were preserved by CO and FV mixture treatment in constipated rats. Therefore, this study suggests that treatment with CO and FV mixture has beneficial effects against constipation. We further suggest that CO and FV mixture may be utilized as an alternative therapeutic strategy for constipation.	[Jang, Seung Hee] Res & Dev TEAZEN Inc, Anyang Si, Gyeonggi Do, South Korea; [Yang, Dong Kwon] Chonbuk Natl Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Iksan Si, Jeollabuk Do, South Korea	Jeonbuk National University	Yang, DK (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Iksan Si, Jeollabuk Do, South Korea.	dkyang0502@gmail.com			Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region; TEAZEN Inc.	Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region; TEAZEN Inc.	This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. TEAZEN Inc. provided support in the form of salaries for author SHJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ABDULGHANI AS, 1988, J ETHNOPHARMACOL, V24, P213, DOI 10.1016/0378-8741(88)90154-7; Al-Amoudi WM, 2017, SAUDI J BIOL SCI, V24, P915, DOI 10.1016/j.sjbs.2016.10.021; Al-Huniti N, 2017, CLIN PHARMACOL THER, V102, P741, DOI 10.1002/cpt.719; Arantes S, 2017, NAT PROD RES, V31, P2183, DOI 10.1080/14786419.2017.1278598; Badgujar SB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842674; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Choi EM, 2004, FITOTERAPIA, V75, P557, DOI 10.1016/j.fitote.2004.05.005; Choi J, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/457620; Chokhavatia S, 2016, DRUG AGING, V33, P557, DOI 10.1007/s40266-016-0381-2; Cirillo C, 2015, PHYTOTHER RES, V29, P1488, DOI 10.1002/ptr.5410; Dadalioglu I, 2004, J AGR FOOD CHEM, V52, P8255, DOI 10.1021/jf049033e; Eglen RM, 2001, LIFE SCI, V68, P2573, DOI 10.1016/S0024-3205(01)01054-2; Ehlert FJ, 1999, LIFE SCI, V64, P387, DOI 10.1016/S0024-3205(98)00584-0; Fei GJ, 2010, J PHARMACOL EXP THER, V334, P333, DOI 10.1124/jpet.110.166116; Fukudo S, 2011, NEUROGASTROENT MOTIL, V23, P544, DOI 10.1111/j.1365-2982.2011.01668.x; Harada Y, 2017, J PHARMACOL EXP THER, V362, P78, DOI 10.1124/jpet.117.240630; Harrington AM, 2010, NEUROGASTROENT MOTIL, V22, P999, DOI 10.1111/j.1365-2982.2009.01456.x; Harrington AM, 2010, NEUROGASTROENT MOTIL, V22, pe1262; Hatano T, 1999, CHEM PHARM BULL, V47, P1121, DOI 10.1248/cpb.47.1121; Ip FCF, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1417-1; Jabri MA, 2017, BIOMED PHARMACOTHER, V89, P29, DOI 10.1016/j.biopha.2017.02.020; Jeon JR, 2010, J MED FOOD, V13, P950, DOI 10.1089/jmf.2009.1307; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Ju MS, 2010, FOOD CHEM TOXICOL, V48, P2037, DOI 10.1016/j.fct.2010.05.002; Kim JE, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0576-y; Kim Ji Eun, 2016, Lab Anim Res, V32, P231, DOI 10.5625/lar.2016.32.4.231; Kim JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161144; Kim SJ, 2011, AM J CHINESE MED, V39, P565, DOI 10.1142/S0192415X11009032; KITANAKA S, 1986, YAKUGAKU ZASSHI, V106, P302, DOI 10.1248/yakushi1947.106.4_302; Kojima R, 2009, PHARMACOLOGY, V84, P227, DOI 10.1159/000236524; Kurniawan Indra, 2011, Acta Med Indones, V43, P195; Leung FW, 2007, DIGEST DIS SCI, V52, P313, DOI 10.1007/s10620-006-9298-7; McCallum IJD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b831; Mohamad RH, 2011, J MED FOOD, V14, P986, DOI 10.1089/jmf.2008.0255; Parejo I, 2004, J AGR FOOD CHEM, V52, P3679, DOI 10.1021/jf030813h; Patil UK, 2004, J ETHNOPHARMACOL, V90, P249, DOI 10.1016/j.jep.2003.10.007; Pradeep K, 2007, CHEM-BIOL INTERACT, V167, P12, DOI 10.1016/j.cbi.2006.12.011; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Sabiu S, 2016, PHARM BIOL, V54, P2901, DOI 10.1080/13880209.2016.1193885; Seo Y, 2017, FOOD RES INT, V97, P340, DOI 10.1016/j.foodres.2017.04.032; Song XD, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0668-6; Soylu S, 2007, J APPL MICROBIOL, V103, P1021, DOI 10.1111/j.1365-2672.2007.03310.x; Talley NJ, 1999, GUT, V45, P37; Tripathi VR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-56; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348	47	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195624	10.1371/journal.pone.0195624	http://dx.doi.org/10.1371/journal.pone.0195624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621360	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800109
J	Wang, J; Li, XY; Li, X; Wang, HH; Su, ZC; Wang, XJ; Zhang, HW				Wang, Jian; Li, Xinyu; Li, Xu; Wang, Huanhuan; Su, Zhencheng; Wang, Xiujuan; Zhang, Huiwen			Dynamic changes in microbial communities during the bioremediation of herbicide (chlorimuron-ethyl and atrazine) contaminated soils by combined degrading bacteria	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; DEGRADATION; BIOMASS; BIOAUGMENTATION; FERTILIZATION; MANAGEMENT; PESTICIDE; IMPACTS; PLANT	Chlorimuron-ethyl and atrazine are two herbicides with long half-lives in soil; their long-term and excessive application has led to a series of environmental problems. In this study, the strains Chenggangzhangella methanolivorans CHL1 and Arthrobactersp. ART1 were combined and used for the remediation of chlorimuron-ethyl, atrazine and combined contaminated soils in a microcosm experiment. Changes in chlorimuron-ethyl and atrazine concentrations in soils were monitored, and variations in the soil microbial community were studied by phospholipid fatty acid (PLFA) analysis. The two inoculated degrading strains accelerated the degradation of chlorimuron-ethyl and atrazine in soil, especially in the combined contaminated soil. Addition of the two herbicides and their combination generally decreased the concentrations of total PLFAs, total bacterial PLFAs, Gram-negative and Gram-positive bacterial PLFAs and Shannon-Wiener indices, and changed microbial community composition, whilst stimulating fungal PLFA concentrations. In addition, the combined herbicide treatment had more impact on microbial biomass than the single herbicide treatments. Inoculation treatments significantly relieved the effects of herbicides on soil microbial biomass, diversity and community structure. This study demonstrated that strains CHL1 and ATR1 have the potential to remediate chlorimuron-ethyl, atrazine and combined contaminated soils, and provided valuable information for remediation of chlorimuron-ethyl, atrazine and combined contaminated soils in situ.	[Wang, Jian; Li, Xinyu; Li, Xu; Wang, Huanhuan; Su, Zhencheng; Wang, Xiujuan; Zhang, Huiwen] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China; [Wang, Jian; Wang, Huanhuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China.	hwzhang@iae.ac.cn	li, xin/HHS-9461-2022; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; Li, Lambert LL/F-7146-2015		National Key R&D Program of China [2017YFD0800702]; National Natural Science Foundation of China [31670515]; Derivative Bank of Chinese Biological Resources [ZSYS-007]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Derivative Bank of Chinese Biological Resources	This work was supported by the National Key R&D Program of China (2017YFD0800702 to HZ), the National Natural Science Foundation of China (31670515 to HZ) and Derivative Bank of Chinese Biological Resources (ZSYS-007).	Acosta EJ, 2004, J AGR FOOD CHEM, V52, P545, DOI 10.1021/jf0349331; Aguilera P, 2009, CHEMOSPHERE, V77, P785, DOI 10.1016/j.chemosphere.2009.08.020; Fernandez LA, 2013, ANN MICROBIOL, V63, P207, DOI 10.1007/s13213-012-0463-2; ARMSTRONG DE, 1967, SOIL SCI SOC AM PRO, V31, P61, DOI 10.2136/sssaj1967.03615995003100010019x; Arthur EL, 2000, WATER AIR SOIL POLL, V119, P75, DOI 10.1023/A:1005165603963; Bach EM, 2010, SOIL BIOL BIOCHEM, V42, P2182, DOI 10.1016/j.soilbio.2010.08.014; Baluch HU, 2008, J ENV SCI HLTH B, V28, P127; Banks ML, 2014, APPL SOIL ECOL, V74, P12, DOI 10.1016/j.apsoil.2013.08.018; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Burges A, 2015, CHEMOSPHERE, V120, P8, DOI 10.1016/j.chemosphere.2014.05.037; Byss M, 2008, CHEMOSPHERE, V73, P1518, DOI 10.1016/j.chemosphere.2008.07.030; Choudhury PP, 1996, J AGR FOOD CHEM, V44, P3379, DOI 10.1021/jf950556j; Cycon M, 2013, APPL SOIL ECOL, V66, P8, DOI 10.1016/j.apsoil.2013.01.014; dos Santos KC, 2014, ECOTOX ENVIRON SAFE, V100, P7, DOI 10.1016/j.ecoenv.2013.11.014; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; FRANK R, 1985, B ENVIRON CONTAM TOX, V34, P541, DOI 10.1007/BF01609773; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Herrmann RF, 1997, MICROB ECOL, V33, P78, DOI 10.1007/s002489900010; Huang HL, 2009, SOIL BIOL BIOCHEM, V41, P726, DOI 10.1016/j.soilbio.2009.01.009; Hunter LD., 2006, REV HUMAN EXPOSURE E; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Mahia J, 2011, BIOL FERT SOILS, V47, P577, DOI 10.1007/s00374-011-0569-x; Mcelroy JA, 2007, J EXPO SCI ENV EPID, V17, P207, DOI 10.1038/sj.jes.7500511; Monard C, 2008, SOIL BIOL BIOCHEM, V40, P2253, DOI 10.1016/j.soilbio.2008.04.022; NAIR DR, 1993, J ENVIRON ENG, V119, P842, DOI 10.1061/(ASCE)0733-9372(1993)119:5(842); OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Papadakis EN, 2006, INT J ENVIRON AN CH, V86, P573, DOI 10.1080/03067310500249187; Ratcliff AW, 2006, APPL SOIL ECOL, V34, P114, DOI 10.1016/j.apsoil.2006.03.002; Seghers D, 2003, FEMS MICROBIOL ECOL, V46, P139, DOI 10.1016/S0168-6496(03)00205-8; Sharma S, 2012, FEMS MICROBIOL LETT, V337, P18, DOI 10.1111/1574-6968.12006; Silva E, 2004, ENVIRON SCI TECHNOL, V38, P632, DOI 10.1021/es0300822; Sullivan TP, 1998, CAN J FOREST RES, V28, P168, DOI 10.1139/cjfr-28-2-168; Tan HB, 2013, J HAZARD MATER, V260, P368, DOI 10.1016/j.jhazmat.2013.05.043; USEPA, 2004, CHLOR ETH HUM HLTH R; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wallsten S, 2005, PUBLIC PRIVATE DRINK; Wang MC, 2008, SOIL BIOL BIOCHEM, V40, P778, DOI 10.1016/j.soilbio.2007.10.012; Xiong MH, 2013, J HAZARD MATER, V252, P347, DOI 10.1016/j.jhazmat.2013.02.054; Yale RL, 2017, ENVIRON SCI POLLUT R, V24, P7359, DOI 10.1007/s11356-017-8377-y; Yang LQ, 2016, INT J SYST EVOL MICR, V66, P2825, DOI 10.1099/ijsem.0.001062; Yang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117943; Yang LQ, 2014, J HAZARD MATER, V274, P314, DOI 10.1016/j.jhazmat.2014.04.011; Ye GB, 2006, CHINESE J ANAL CHEM, V34, P1207, DOI 10.1016/S1872-2040(07)60001-2; Zhang XL, 2011, ENVIRON SCI POLLUT R, V18, P407, DOI 10.1007/s11356-010-0381-4	52	5	7	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194753	10.1371/journal.pone.0194753	http://dx.doi.org/10.1371/journal.pone.0194753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621247	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800026
J	Lopez-Espuela, F; Gonzalez-GiI, T; Amarilla-Donoso, J; Cordovilla-Guardia, S; Portilla-Cuenca, JC; Casado-Naranjo, I				Lopez-Espuela, Fidel; Gonzalez-Gi, Teresa, I; Amarilla-Donoso, Javier; Cordovilla-Guardia, Sergio; Carlos Portilla-Cuenca, Juan; Casado-Naranjo, Ignacio			Critical points in the experience of spouse caregivers of patients who have suffered a stroke. A phenomenological interpretive study	PLOS ONE			English	Article							QUALITY-OF-LIFE; FAMILY CAREGIVERS; EVERYDAY LIFE; 1ST YEAR; SURVIVORS; CARE; OUTCOMES; PARTNER; REHABILITATION; TRANSITIONS	Aims To explore and document the experiences and values of spouse caregivers of stroke survivors. To gain more in-depth knowledge of how the act of caring and the adaption process affects caregiving spouses. Materials and methods Phenomenological, qualitative study. This study included spouses of stroke survivors who also served as primary caregivers. Individual, semi-structured, in-depth interviews were conducted, transcribed, and analysed using a thematic content analysis as proposed by Giorgi. Data was analysed and managed using Atlas-ti (version 7.0). This study was approved by our institution's Complejo Hospitalario de Caceres Ethics and Research Committee. Results Spouse caregivers of stroke survivors undergo a process of disruption in their private lives and relationships, marked by their caregiving duties. The experiences of spouses caring for stroke survivors is condensed into topics and subtopics: "Caregiving and that's all" summarizes the sense of having no life horizons and also caregiver impossibility of moving away from caring role. Otherwise, "Breaking the couple's life together" enlightens the further consequences of stroke in couples shared live biography, which needs to be understood and rebuilt. Finally, "Going through the (non) loss alone" alludes to how spouses reinterpret meaning of loss, which is not appreciated by others and that refers to the balance between stroke survival and any acquired global disability. Conclusions A comprehensive approach to the couple (family), from a psycho-socio-emotional and relational perspective, is essential for ensuring adequate quality of life for people who suffered a stroke as well as their caregivers. Spouses-caregivers must be considered as individuals living a transition process due to their unexpected disrupting change, which nurses should address through a comprehensive and integrated approach focused on transition care. Care resources must be adapted to the interpretation that the spouses have of their caregiving role and their relationship with the different components of the caregiving process.	[Lopez-Espuela, Fidel; Cordovilla-Guardia, Sergio] Univ Extremadura, Dept Nursing, Fac Enfermeria & Terapia Ocupac, Caceres, Spain; [Gonzalez-Gi, Teresa, I] Univ Autonoma Madrid, Nursing Sect Dept, Fac Med, Madrid, Spain; [Amarilla-Donoso, Javier] Hosp Campo Aranuelo, Dept Nursing, Navalmoral De La Mata, Caceres, Spain; [Carlos Portilla-Cuenca, Juan; Casado-Naranjo, Ignacio] Hosp San Pedro Alcantara, Stroke Unit, Caceres, Spain	Universidad de Extremadura; Autonomous University of Madrid	Lopez-Espuela, F (corresponding author), Univ Extremadura, Dept Nursing, Fac Enfermeria & Terapia Ocupac, Caceres, Spain.	fidel.lopez.es@gmail.com	Espuela, Fidel Lopez/R-1843-2017; Cuenca, Juan Carlos Portilla/R-6151-2019; Sergio, Cordovilla-Guardia/I-7268-2019	Espuela, Fidel Lopez/0000-0002-7509-1192; Cuenca, Juan Carlos Portilla/0000-0002-0796-0990; Sergio, Cordovilla-Guardia/0000-0001-7651-5017	Institute Carlos III: Grants for investigation of the Health Research [PI11/001756]	Institute Carlos III: Grants for investigation of the Health Research	This work was funded by Institute Carlos III: Grants for investigation of the Health Research of 2011 (PI11/001756). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom B, 2010, NURS INQ, V17, P257, DOI 10.1111/j.1440-1800.2010.00490.x; Backstrom B, 2009, INT J NURS STUD, V46, P1475, DOI 10.1016/j.ijnurstu.2009.04.009; Bakas T, 2014, STROKE, V45, P2836, DOI 10.1161/STR.0000000000000033; Bergstrom AL, 2015, J REHABIL MED, V47, P508, DOI 10.2340/16501977-1964; Bridges J, 2010, INT J NURS STUD, V47, P89, DOI 10.1016/j.ijnurstu.2009.09.009; Bulley C, 2010, DISABIL REHABIL, V32, P1406, DOI 10.3109/09638280903531238; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Cheung J, 2004, J ADV NURS, V47, P475, DOI 10.1111/j.1365-2648.2004.03126.x; Coombs Ursula Eileen, 2007, J Neurosci Nurs, V39, P112; de la Cuesta-Benjumea C, 2011, ENFERM CLIN, V21, P163, DOI 10.1016/j.enfcli.2011.02.005; Eriksson M, 2006, J CLIN NURS, V15, P324, DOI 10.1111/j.1365-2702.2006.01290.x; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Forster A, 2013, LANCET, V382, P2069, DOI 10.1016/S0140-6736(13)61603-7; Gillespie David, 2011, Nurs Stand, V26, P39; Giorgi A, 2000, SCAND J CARING SCI, V14, P3, DOI 10.1111/j.1471-6712.2000.tb00554.x; Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x; Green TL, 2010, J STROKE CEREBROVASC, V19, P10, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.005; Guba EG, 1981, EFFECTIVE EVALUATION, P1; Hunt D, 2004, DISABIL REHABIL, V26, P1000, DOI 10.1080/09638280410001702423; Jenkins C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006384; Kitson AL, 2013, INT J NURS STUD, V50, P392, DOI 10.1016/j.ijnurstu.2012.09.017; KRAMER BJ, 1993, FAM RELAT, V42, P367, DOI 10.2307/585336; Kruithof WJ, 2012, J STROKE CEREBROVASC, V21, P801, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.011; Kvale S, 2015, INTERVIEW KVALITATIV, V3rd; Larson J, 2008, INT J NURS STUD, V45, P257, DOI 10.1016/j.ijnurstu.2006.08.021; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levine C, 2011, AM J NURS, V111, P47, DOI 10.1097/01.NAJ.0000406420.35084.a1; Levine C, 2010, HEALTH AFFAIR, V29, P116, DOI 10.1377/hlthaff.2009.0520; Luker J, 2017, ARCH PHYS MED REHAB, V98, P1852, DOI 10.1016/j.apmr.2017.02.024; Lutz BJ, 2010, REHABIL NURS, V35, P152, DOI 10.1002/j.2048-7940.2010.tb00041.x; MacDougall C, 2001, QUAL HEALTH RES, V11, P117, DOI 10.1177/104973201129118975; MAHONEY F I, 1965, Md State Med J, V14, P61; McPherson CJ, 2010, REHABIL PSYCHOL, V55, P194, DOI 10.1037/a0019359; Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006; MELEIS AI, 1994, NURS OUTLOOK, V42, P255, DOI 10.1016/0029-6554(94)90045-0; Messias DKH, 1995, FAM SYSTEMS MED, V3, P367; Morrissey MB, 2015, GERONTOLOGIST, V55, P245, DOI 10.1093/geront/gnu178; MUNHALL PL, 2001, NURSING RES; National Alliance for Caregiving AARP, 2015, CAR US 2015 EX SUMM; Persson J, 2015, STROKE, V46, P2584, DOI 10.1161/STROKEAHA.115.009791; Quinn K, 2014, DISABIL REHABIL, V36, P185, DOI 10.3109/09638288.2013.783630; Reinhard S.C., HOME ALONE FAMILY CA; Saban KL, 2012, J NEUROSCI NURS, V44, P2, DOI 10.1097/JNN.0b013e31823ae4f9; Satink T, 2017, DISABIL REHABIL, V23, P1; Schumacher KL, 1996, RES NURS HEALTH, V19, P261, DOI 10.1002/(SICI)1098-240X(199608)19:4<261::AID-NUR1>3.0.CO;2-G; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; Smith J, 2009, CLIN REHABIL, V23, P195, DOI 10.1177/0269215508092820; Strauss A., 2016, BASES INVESTIGACION; Tseng CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131911; Van Durme T, 2012, INT J NURS STUD, V49, P490, DOI 10.1016/j.ijnurstu.2011.10.011; Visser-Meily A, 2008, PATIENT EDUC COUNS, V73, P153, DOI 10.1016/j.pec.2008.03.011; Wright L, 2012, NURSES FAMILIES GUID; Young ME, 2014, DISABIL REHABIL, V36, P1892, DOI 10.3109/09638288.2014.881565; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195190	10.1371/journal.pone.0195190	http://dx.doi.org/10.1371/journal.pone.0195190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617425	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800067
J	Sciarretta, A; Tabilio, MR; Lampazzi, E; Ceccaroli, C; Colacci, M; Trematerra, P				Sciarretta, Andrea; Tabilio, Maria Rosaria; Lampazzi, Elena; Ceccaroli, Claudio; Colacci, Marco; Trematerra, Pasquale			Analysis of the Mediterranean fruit fly [Ceratitis capitata (Wiedemann)] spatio-temporal distribution in relation to sex and female mating status for precision IPM	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; INTEGRATED MANAGEMENT; DISTRIBUTION PATTERNS; FIELD-EVALUATION; POPULATION; FLIES; RANGE; ATTRACTANTS; PHEROMONE; ORCHARD	The Mediterranean fruit fly (medfly), Ceratitis capitata (Wiedemann), is a key pest of fruit crops in many tropical, subtropical and mild temperate areas worldwide. The economic importance of this fruit fly is increasing due to its invasion of new geographical areas. Efficient control and eradication efforts require adequate information regarding C. capitata adults in relation to environmental and physiological cues. This would allow effective characterisation of the population spatio-temporal dynamic of the C. capitata population at both the orchard level and the area-wide landscape. The aim of this study was to analyse population patterns of adult medflies caught using two trapping systems in a peach orchard located in central Italy. They were differentiated by adult sex (males or females) and mating status of females (unmated or mated females) to determine the spatio-temporal dynamic and evaluate the effect of cultivar and chemical treatments on trap catches. Female mating status was assessed by spermathecal dissection and a blind test was carried out to evaluate the reliability of the technique. Geostatistical methods, variogram and kriging, were used to produce distributional maps. Results showed a strong correlation between the distribution of males and unmated females, whereas males versus mated females and unmated females versus mated females showed a lower correlation. Both cultivar and chemical treatments had significant effects on trap catches, showing associations with sex and female mating status. Medfly adults showed aggregated distributions in the experimental field, but hot spots locations varied. The spatial pattern of unmated females reflected that of males, whereas mated females were largely distributed around ripening or ripe fruit. The results give relevant insights into pest management. Mated females may be distributed differently to unmated females and the identification of male hot spots through monitoring would allow localisation of virgin female populations. Based on our results, a more precise IPM strategy, coupled with effective sanitation practices, could represent a more effective approach to medfly control.	[Sciarretta, Andrea; Colacci, Marco; Trematerra, Pasquale] Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy; [Tabilio, Maria Rosaria; Ceccaroli, Claudio] Res Ctr Olive Citrus & Tree Fruit, CREA, Consiglio Ric Agr & Anal Econ Agr, Rome, Italy; [Lampazzi, Elena] Italian Natl Agcy New Technol Energy & Sustainabl, ENEA, Casaccia Res Ctr, Rome, Italy	University of Molise; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Italian National Agency New Technical Energy & Sustainable Economics Development	Sciarretta, A (corresponding author), Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy.	sciarretta@unimol.it	Sciarretta, Andrea/C-5307-2008	Sciarretta, Andrea/0000-0002-9443-4816; Colacci, Marco/0000-0002-9068-3049				Alemany A, 2008, J APPL ENTOMOL, V132, P746, DOI 10.1111/j.1439-0418.2008.01376.x; Alemany A., 2004, BOLET N SANIDAD VEGE, V30, P255; BAKER R, 1985, J CHEM SOC CHEM COMM, P824, DOI 10.1039/c39850000824; BATEMAN MA, 1972, ANNU REV ENTOMOL, V17, P493, DOI 10.1146/annurev.en.17.010172.002425; Broughton S, 2002, J ECON ENTOMOL, V95, P507, DOI 10.1603/0022-0493-95.2.507; CABI, 2017, INV SPEC COMP; CDFA, 2003, PREV BIOL POLL MED F; CDFA (California Department of Food and Agriculture), 2017, MEDFL INT QUAR REG; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Copeland RS, 2002, ANN ENTOMOL SOC AM, V95, P672, DOI 10.1603/0013-8746(2002)095[0672:IHOCCD]2.0.CO;2; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; Delrio G., 1986, P135; Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242; EPPO, 2016, EPPO GLOB DAT; Epsky ND, 2010, J ECON ENTOMOL, V103, P1886, DOI 10.1603/EC09286; Flores S, 2013, BIOCONTROL SCI TECHN, V23, P1186, DOI 10.1080/09583157.2013.822473; Gutierrez AP, 2011, BIOL INVASIONS, V13, P2661, DOI 10.1007/s10530-011-9937-6; Hancock D.L., 2000, DISTRIBUTION HOST PL; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; IAEA (International Atomic Energy Agency), 2013, TRAPP MAN AR WID FRU; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P302, DOI 10.1603/0013-8746(2005)098[0302:MSDPOM]2.0.CO;2; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P77, DOI 10.1603/0013-8746(2005)098[0077:SDPOMF]2.0.CO;2; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Journel A. G., 1978, MINING GEOSTATISTICS; Juan-Blasco M, 2014, B ENTOMOL RES, V104, P233, DOI 10.1017/S0007485313000692; Kaspi R, 1999, FUNCT ECOL, V13, P539, DOI 10.1046/j.1365-2435.1999.00344.x; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; Klassen K, STERILE INSECT TECHN; LANDOLT PJ, 1992, ENTOMOL EXP APPL, V65, P259, DOI 10.1007/BF02343859; Leza MM, 2008, J APPL ENTOMOL, V132, P753, DOI 10.1111/j.1439-0418.2008.01370.x; Liquido N.J., 1991, MISCELLANEOUS PUBLIC, V77, P1; Manoukis NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149869; Manrakhan A, 2017, J APPL ENTOMOL, V141, P825, DOI 10.1111/jen.12373; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Midgarden D, TRAPPING DETECTION C; Morales Pedro, 2004, Entomotropica, V19, P51; Nansen C, 2003, J ECON ENTOMOL, V96, P1617, DOI 10.1603/0022-0493-96.6.1617; Navarro-Llopis V, 2008, J ECON ENTOMOL, V101, P126, DOI 10.1603/0022-0493(2008)101[126:EOTALF]2.0.CO;2; Navarro-Llopis V, 2010, PEST MANAG SCI, V66, P511, DOI 10.1002/ps.1901; Papadopoulos NT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1466; Papadopoulos NT, 1996, ANN ENTOMOL SOC AM, V89, P526, DOI 10.1093/aesa/89.4.526; Papadopoulos NT, 2003, ENVIRON ENTOMOL, V32, P319, DOI 10.1603/0046-225X-32.2.319; Pimentel R, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew097; Pimentel R, 2017, INT J PEST MANAGE, V63, P172, DOI 10.1080/09670874.2016.1256512; Pinero J.C., 2014, TRAPPING DETECTION C, P457, DOI DOI 10.1007/978-94-017-9193-9_13; Reyes-Flores J., 2014, TRAPPING DETECTION C, pix; Rossler Y., 1994, Bulletin OEPP, V24, P813, DOI 10.1111/j.1365-2338.1994.tb01102.x; Sciarretta A, 2014, PLANT PROTECT SCI, V50, P97, DOI 10.17221/40/2013-PPS; Sciarretta A, 2011, J APPL ENTOMOL, V135, P241, DOI 10.1111/j.1439-0418.2010.01515.x; Shelly TE, 2004, ANIM BEHAV, V68, P417, DOI 10.1016/j.anbehav.2003.08.029; Shelly TE, 2007, J INSECT BEHAV, V20, P453, DOI 10.1007/s10905-007-9091-2; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Szyniszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111582; Tan K.H., 2014, TRAPPING DETECTION C, P15, DOI DOI 10.1007/978-94-017-9193-9_2; The University of Arizona, 2021, MED FRUIT FLY CER CA; Vargas RI, 2001, J ECON ENTOMOL, V94, P817, DOI 10.1603/0022-0493-94.4.817; Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66; White IM, 1992, FRUIT FLIES EC SIGNI, DOI DOI 10.1017/S0007485300041237; Zanoni S., 2017, IOBC/WPRS Bulletin, V123, P43	62	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195097	10.1371/journal.pone.0195097	http://dx.doi.org/10.1371/journal.pone.0195097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617420	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800063
J	Yekwayo, I; Pryke, JS; Gaigher, R; Samways, MJ				Yekwayo, Inam; Pryke, James S.; Gaigher, Rene; Samways, Michael J.			Only multi-taxon studies show the full range of arthropod responses to fire	PLOS ONE			English	Article							SOUTH-AFRICA; CONSERVATION; INVERTEBRATES; GRASSLAND; DIVERSITY; FOREST; MOUNTAIN; HABITAT; BIODIVERSITY; COMMUNITIES	Fire is a major driver in many ecosystems. Yet, little is known about how different ground-living arthropods survive fire. Using three sampling methods, and time-since-fire (last fire event: 3 months, 1 year, and 7 years), we investigate how ground-living arthropod diversity responds to fire, and how species richness, diversity, abundance, and composition of the four dominant taxa: ants, beetles, cockroaches and mites, respond. We did this in the naturally fire-prone Mediterranean-type scrubland vegetation (fynbos) of the Cape Floristic Region. Surprisingly, overall species richness and diversity was the same for all time-since fire categories. However, when each dominant taxon was analysed separately, effect of fire on species richness and abundance varied among taxa. This emphasizes that many taxa must be investigated to really understand fire-driven events. We also highlight the importance of using different diversity measures, as fire did not influence species richness and abundance of particular taxa, while it affected others, overall greatly affecting assemblages of all taxa. Rockiness affected species richness, abundance and composition of a few taxa. We found that all time-since-fire categories supported distinctive assemblages. Some indicator species occurred across all time-since-fire categories, while others were restricted to a single time-since-fire category, showing that there is a wide range of responses to fire between taxa. Details of local landscape structure, abiotic and biotic, and frequency and intensity of fire add complexity to the fire-arthropod interaction. Overall, we show that the relationship between fire and arthropods is phylogenetically constrained, having been honed by many millennia of fire events, and highly complex. Present-day species manifest a variety of adaptations for surviving the great natural selective force of fire.	[Yekwayo, Inam] Univ Mpumalanga, Sch Biol & Environm Sci, Nelspruit, South Africa; [Yekwayo, Inam; Pryke, James S.; Gaigher, Rene; Samways, Michael J.] Stellenbosch Univ, Dept Conservat Ecol & Entomol, Matieland, South Africa	Stellenbosch University	Yekwayo, I (corresponding author), Univ Mpumalanga, Sch Biol & Environm Sci, Nelspruit, South Africa.; Yekwayo, I (corresponding author), Stellenbosch Univ, Dept Conservat Ecol & Entomol, Matieland, South Africa.	Inam.Yekwayo@ump.ac.za	Gaigher, Rene/X-3635-2018; Pryke, James/A-6644-2008	Gaigher, Rene/0000-0003-4100-8634; Pryke, James/0000-0003-3148-5744; Yekwayo, Inam/0000-0002-7671-3643; Yekwayo, Inam/0000-0002-9722-6545	National Research Foundation	National Research Foundation	Funded by National Research Foundation (freestanding postdoctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation o the manuscript.; We thank Rustenburg, Boschendal, and Montagne farms for access, and D. Ngadze, P. Tshililo, Z. Tyeku, F. Becker, B. Dlamini, M. Mukundamago, S. Mensah, R. Agrela, L. Sikhutshwa, M. Pheme, S. Adu-Acheampong, and A. Katumanyane for field assistance. Thanks also to F. Roets and T. Mwabvu for arthropod identification. Funding was from the National Research Foundation (freestanding postdoctoral fellowship), and the work was carried out under Cape Nature collection permit no. AAA007-00196-0056.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barratt BIP, 2006, RANGELAND ECOL MANAG, V59, P383, DOI 10.2111/05-190R1.1; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crous CJ, 2013, J APPL ECOL, V50, P205, DOI 10.1111/1365-2664.12012; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Forsyth Greg G., 2008, Koedoe, V50, P3; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hugo-Coetzee EA, 2011, ZOOSYMPOSIA, V6, P210, DOI 10.11646/zoosymposia.6.1.31; Joubert L, 2014, S AFR J BOT, V92, P126, DOI 10.1016/j.sajb.2014.02.009; Kamczyc J, 2017, EXP APPL ACAROL, V72, P145, DOI 10.1007/s10493-017-0148-4; Kraaij T, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1104; Kwon TS, 2013, J ASIA-PAC ENTOMOL, V16, P321, DOI 10.1016/j.aspen.2013.04.008; Lawes MJ, 2005, BIOTROPICA, V37, P109, DOI 10.1111/j.1744-7429.2005.04054.x; Linder R, 1992, ECOLOGY FYNBOS; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; Masse Mbenoun P.S., 2017, Journal of Biodiversity and Environmental Sciences, V10, P181; Mucina L., 2011, VEGETATION S AFRICA; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; Murvanidze M., 2008, INTEGRATIVE ACAROLOG, P216; Mustart P., 2000, VELD FLORA, V86, P73; Mwabvu T, 1997, ENTOMOL SCAND, P287; New TM, 2014, INS FIR CONS; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Pryke JS, 2008, BIODIVERS CONSERV, V17, P3027, DOI 10.1007/s10531-008-9414-4; Pryke JS, 2010, J INSECT CONSERV, V14, P247, DOI 10.1007/s10841-009-9253-y; Pryke JS, 2012, AUSTRAL ECOL, V37, P460, DOI 10.1111/j.1442-9993.2011.02307.x; Pryke JS, 2012, J INSECT CONSERV, V16, P177, DOI 10.1007/s10841-011-9404-9; Richardson DM., 1992, ECOL STUD, P273, DOI [10.1007/978-3-642-76174-4_15, DOI 10.1007/978-3-642-76174-4_15]; Sackmann P, 2006, ECOSCIENCE, V13, P360, DOI 10.2980/i1195-6860-13-3-360.1; SAMWAYS MJ, 1990, CONSERV BIOL, V4, P375, DOI 10.1111/j.1523-1739.1990.tb00311.x; Samways MJ, 2010, INSECT CONSERVATION; Sasal Y, 2015, ECOL RES, V30, P1015, DOI 10.1007/s11284-015-1302-2; SCHLETTWEIN C H G, 1987, Annale Universiteit van Stellenbosch Serie A 3 (Landbouwetenskappe), V2, P1; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Swart RC, 2017, AFR ENTOMOL, V25, P164, DOI 10.4001/003.025.0164; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Thom MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126755; Uys C, 2009, AFR J ECOL, V47, P341, DOI 10.1111/j.1365-2028.2008.00968.x	50	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195414	10.1371/journal.pone.0195414	http://dx.doi.org/10.1371/journal.pone.0195414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614132	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600058
J	Belhomme, N; Jouneau, S; Bouzille, G; Decaux, O; Lederlin, M; Guillot, S; Perlat, A; Jego, P				Belhomme, Nicolas; Jouneau, Stephane; Bouzille, Guillaume; Decaux, Olivier; Lederlin, Mathieu; Guillot, Stephanie; Perlat, Antoinette; Jego, Patrick			Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CIRCULATING IMMUNE-COMPLEXES; FOLLOW-UP; BRONCHOALVEOLAR LAVAGE; CLINICAL-COURSE; PULMONARY; DIAGNOSIS; PROGNOSIS; CHITOTRIOSIDASE; INVOLVEMENT	Background Sarcoidosis is a systemic granulomatous disease which carries variable outcomes. Serum protein electrophoresis is an easily accessible and routinely performed examination at diagnosis, in order to search for hypergammaglobulinemia, which is frequently found, and to rule out other granulomatous diseases such as common variable immunodeficiency. We aimed to assess the impact of baseline immunoglobulin level on the outcome of sarcoidosis. Methods We conducted a retrospective cohort-study, at Rennes University Hospital, in which all newly diagnosed patients for whom a serum protein electrophoresis had been performed at baseline were enrolled, from 2006 to 2014. The main outcome was the need for corticosteroid treatment within 2 years from diagnosis, the secondary outcome was the occurrence of relapse among treated patients. Results Eighty patients were included in the study, and 41.25% of them exhibited an elevated globulins rate. In univariate analysis, an elevated ACE level > 70 U/l, Afro-Caribbean origin, and extra-pulmonary involvement, were associated with the need for corticosteroid treatment. In multivariate analysis, only ACE elevation (OR = 1.03, IC95% 1.01-1.05, p = 0.009) and extra-pulmonary involvement (OR = 5.8, IC95% 1.4-24, p = 0.015) were significant. Immunoglobulin level was not associated with the main outcome. Regarding the secondary outcome, none of the studied features were predictive of relapse among the 34 treated patients followed for two years. Conclusions There was no relation between the immunoglobulin level at diagnosis and the evolution of sarcoidosis. An elevated ACE level and the presence of initial extra-pulmonary involvement were both associated with a more severe course of the disease necessitating a corticosteroid treatment.	[Belhomme, Nicolas; Decaux, Olivier; Perlat, Antoinette; Jego, Patrick] Rennes Univ Hosp, Internal Med Dept, Rennes, France; [Belhomme, Nicolas; Jouneau, Stephane; Decaux, Olivier; Lederlin, Mathieu; Jego, Patrick] Univ Rennes 1, Rennes, France; [Jouneau, Stephane] Rennes Univ Hosp, Dept Resp Med, Rennes, France; [Jouneau, Stephane; Jego, Patrick] INSERM IRSET UMR1085, Rennes, France; [Bouzille, Guillaume; Lederlin, Mathieu] INSERM, U1099, Rennes, France; [Bouzille, Guillaume] Univ Rennes 1, LTSI, Rennes, France; [Bouzille, Guillaume] CHU Rennes, CIC Inserm 1414, Rennes, France; [Bouzille, Guillaume] CHU Rennes, Ctr Donnees Clin, Rennes, France; [Lederlin, Mathieu] Rennes Univ Hosp, Dept Radiol, Rennes, France; [Guillot, Stephanie] Rennes Univ Hosp, Dept Resp Physiol, Rennes, France	CHU Rennes; Universite de Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Belhomme, N (corresponding author), Rennes Univ Hosp, Internal Med Dept, Rennes, France.; Belhomme, N (corresponding author), Univ Rennes 1, Rennes, France.	nicolas.belhomme@chu-rennes.fr	LEDERLIN, Mathieu/ABC-8116-2020; Jouneau, Stephane/K-9956-2015; BELHOMME, Nicolas/ABD-1850-2020	BELHOMME, Nicolas/0000-0002-9438-3350				AINSLIE GM, 1985, Q J MED, V55, P253; Bargagli E, 2013, J CLIN IMMUNOL, V33, P264, DOI 10.1007/s10875-012-9754-4; Baughman RP, 2011, SARCOIDOSIS VASC DIF, V28, P56; Baughman RP, 2014, EUR RESPIR J, V43, P337, DOI 10.1183/09031936.00138913; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2006, QJM-INT J MED, V99, P307, DOI 10.1093/qjmed/hcl038; BAUGHMAN RP, 1987, LUNG, V165, P371, DOI 10.1007/BF02714452; Biller H, 2006, EUR RESPIR J, V28, P1085, DOI 10.1183/09031936.00050106; Bouzille G, 2015, STUD HEALTH TECHNOL, V216, P913, DOI 10.3233/978-1-61499-564-7-913; Costabel U, 2010, SEMIN RESP CRIT CARE, V31, P404, DOI 10.1055/s-0030-1262207; EULE H, 1986, ANN NY ACAD SCI, V465, P695, DOI 10.1111/j.1749-6632.1986.tb18548.x; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Harlander M, 2014, RESP MED, V108, P775, DOI 10.1016/j.rmed.2014.02.002; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Inoue Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143371; ISRAEL HL, 1986, ANN NY ACAD SCI, V465, P609, DOI 10.1111/j.1749-6632.1986.tb18537.x; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Judson MA, 2012, SARCOIDOSIS VASC DIF, V29, P119; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; Kataria YP, 1997, CLIN CHEST MED, V18, P719, DOI 10.1016/S0272-5231(05)70415-9; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Prasse A, 2008, AM J RESP CRIT CARE, V177, P330, DOI 10.1164/rccm.200705-742OC; Rabin DL, 2004, EUR RESPIR J, V24, P601, DOI 10.1183/09031936.04.00070503; Rizzato G, 1998, SARCOIDOSIS VASC DIF, V15, P52; ROMER FK, 1981, ACTA MED SCAND, V210, P299; SCHOENFELD N, 1994, THORAX, V49, P688, DOI 10.1136/thx.49.7.688; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; STUDDY PR, 1980, J CLIN PATHOL, V33, P528, DOI 10.1136/jcp.33.6.528; TAKADA K, 1993, J CLIN EPIDEMIOL, V46, P359, DOI 10.1016/0895-4356(93)90150-Y; Tukey MH, 2013, SARCOIDOSIS VASC DIF, V30, P128; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; WINTERBAUER RH, 1993, CHEST, V104, P352, DOI 10.1378/chest.104.2.352	38	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193122	10.1371/journal.pone.0193122	http://dx.doi.org/10.1371/journal.pone.0193122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641520	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900010
J	Lloyd, JE; Song, HJ; Dennis, SM; Dunbar, N; Harris, E; Harris, MF				Lloyd, Jane E.; Song, Hyun J.; Dennis, Sarah M.; Dunbar, Nicola; Harris, Elizabeth; Harris, Mark F.			A paucity of strategies for developing health literate organisations: A systematic review	PLOS ONE			English	Review							CULTURAL COMPETENCE; CARE; ADDRESS	Introduction People with low health literacy are more likely to delay seeking care and experience adverse outcomes. While health literacy is the product of individuals' capacities, it is also affected by the complexities of the health care system. System-level changes are needed to align health care demands better with the public's skills and abilities. We aimed to identify the evidence base for effective strategies for creating health literate organisations. Methods A systematic review and narrative synthesis of empirical studies was performed. Medline, Embase, PsychInfo and CINHAL databases were searched for empirical studies from OECD countries published from 2008 onwards, focusing on health literacy interventions at the organisational level. Analysis of the findings was informed by the National Academies' five-dimensional framework for the attributes of a health literate organisation, which include: organisational commitment, accessible education and technology infrastructure, augmented workforce, embedded policies and practices, and effective bidirectional communication. Results The title and abstract of 867 records were screened according to the selection criteria, leading to full text review of 125 articles. Seven studies were identified in the peer review literature. Adapting health literacy guidelines and tools was the most common approach to addressing organisational health literacy. Conclusion While the use of health literacy tools proved important for raising awareness of health literacy issues within organisations, these tools were insufficient for generating the organisational changes necessary to improve organisational health literacy.	[Lloyd, Jane E.; Harris, Elizabeth] Sydney Local Hlth Dist, Hlth Equ Res & Dev Unit, Sydney, NSW, Australia; [Lloyd, Jane E.; Song, Hyun J.; Dennis, Sarah M.; Harris, Elizabeth; Harris, Mark F.] Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Dennis, Sarah M.] Univ Sydney, Fac Hlth Sci, Clin & Rehabil Sci, Lidcombe, NSW, Australia; [Dunbar, Nicola] Australian Commiss Safety & Qual Hlth Care, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney	Lloyd, JE (corresponding author), Sydney Local Hlth Dist, Hlth Equ Res & Dev Unit, Sydney, NSW, Australia.; Lloyd, JE (corresponding author), Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia.	j.lloyd@unsw.edu.au	Song, Hyun/ABC-9317-2020; Harris, Mark F/I-2793-2019	Song, Hyun/0000-0001-8309-3983; Harris, Mark F/0000-0002-0705-8913; Dennis, Sarah/0000-0003-2685-9246; Lloyd, Jane/0000-0003-1364-2072				Australian Bureau of Statistics (ABS), 2008, AD LIT LIF SKILLS SU; Australian Commission on Safety and Quality in Health Care, 2014, HLTH LIT TACK ACT IM; Australian Commission on Safety and Quality in Health Care, 2012, HLTH LIT STOCKT; Australian Commission on Safety and Quality in Health Care(ACSQHC), 2014, HLTH LIT TAK ACT IMP; Australian Insitute of Health and Welfare, 2014, 14 AIHW; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Blake SC, 2010, J HEALTH CARE POOR U, V21, P559, DOI 10.1353/hpu.0.0283; Brach Cindy, 2012, 10 ATTRIBUTES HLTH L; Brega AG, 2015, SERVICES USDOHAH; Campinha-Bacote J, 1999, J NURS EDUC, V38, P203; Canadian Institutes of Health Research, KNOWL TRANSL DEF; Cawthon C, 2014, JT COMM J QUAL PATIE, V40, P68, DOI 10.1016/S1553-7250(14)40008-4; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DeWalt DA, 2010, HLTH LITERACY UNIVER; Greenhalgh T., 2012, J GEN INTERN MED, V27, P173, DOI 10.1007/s11606-011-1886-3; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Groene R. O., 2011, J COMMUN HEALTHC, V4, P227, DOI [10.1179/1753807611Y.0000000005, DOI 10.1179/1753807611Y.0000000005]; Harley K, 2011, ANN C AUSTR SOC ASS; Institute of Medicine, 2012, WORKSH SUMM WASH NAT; Johnson A, 2014, AUST HEALTH REV, V38, P190, DOI 10.1071/AH13194; Joshi C, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0171-z; Kickbusch I., 2008, INT ENCY PUBLIC HLTH, P204; Kmet L.M., 2004, STANDARD QUALITY ASS; Koh HK, 2013, J HEALTH COMMUN, V18, P1, DOI 10.1080/10810730.2013.759029; Koh HK, 2012, HEALTH AFFAIR, V31, P434, DOI 10.1377/hlthaff.2011.1169; Kripalani S, 2014, MEASURES ASSESS HLTH; Ministry of Health, 2015, HLTH LIT REV GUID; Nutbeam D, 2000, HLTH PROMOT INT, V15; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; Rudd R. E., 2006, HLTH LITERACY ENV HO; Rudd RE, 2003, J HEALTH COMMUN, V8, P104, DOI 10.1080/10810730390224947; Rudd RE, 2010, HLTH LITERACY ENV AC; Schrock K., KATHY SCHROCKS GUIDE; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Shoemaker SJ, 2013, RES SOC ADMIN PHARM, V9, P553, DOI 10.1016/j.sapharm.2013.05.003; Smith DL, 2010, OCCUP THER HEALTH CA, V24, P348, DOI 10.3109/07380577.2010.507267; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; The Joint Commission, 2007, WHAT DID DOCT SAY IM; Weaver NL, 2015, J HEALTH COMMUN, V17, P55; Willis CD, 2014, PUBLIC HEALTH, V128, P515, DOI 10.1016/j.puhe.2014.01.014; World Health Organization, 2015, HLTH LITERACY TOOLKI	44	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195018	10.1371/journal.pone.0195018	http://dx.doi.org/10.1371/journal.pone.0195018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641544	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900058
J	Neaves, LE; Danks, M; Lott, MJ; Dennison, S; Frankham, GJ; King, A; Eldridge, MDB; Johnson, RN; Divljan, A				Neaves, Linda E.; Danks, Melissa; Lott, Matthew J.; Dennison, Siobhan; Frankham, Greta J.; King, Andrew; Eldridge, Mark D. B.; Johnson, Rebecca N.; Divljan, Anja			Unmasking the complexity of species identification in Australasian flying-foxes	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; LONG-DISTANCE MOVEMENTS; PTEROPUS; CHIROPTERA; GENUS; BATS; AMPLIFICATION; SEQUENCES; ISLANDS; FLIGHT	Pteropus (flying-foxes) are a speciose group of non-echolocating large bats, with five extant Australian species and 24 additional species distributed amongst the Pacific Islands. In 2015, an injured flying-fox with unusual facial markings was found in Sydney, Australia, following severe and widespread storms. Based on an initial assessment, the individual belonged to Pteropus but could not be readily identified to species. As a consequence, four hypotheses for its identification/origin were posited: the specimen represented (1) an undescribed Australian species; or (2) a morphological variant of a recognised Australian species; or (3) a hybrid individual; or (4) a vagrant from the nearby Southwest Pacific Islands. We used a combination of morphological and both mitochondrial- and nuclear DNA-based identification methods to assess these hypotheses. Based on the results, we propose that this morphologically unique Pteropus most likely represents an unusual P. alecto (black flying-fox) potentially resulting from introgression from another Pteropus species. Unexpectedly, this individual, and the addition of reference sequence data from newly vouchered specimens, revealed a previously unreported P. alecto mitochondrial DNA lineage. This lineage was distinct from currently available haplotypes. It also suggests long-term hybridisation commonly occurs between P. alecto and P. conspicillatus (spectacled flying-fox). This highlights the importance of extensive reference data, and the inclusion of multiple vouchered specimens for each species to encompass both intraspecific and interspecific variation to provide accurate and robust species identification. Moreover, our additional reference data further demonstrates the complexity of Pteropus species relationships, including hybridisation, and potential intraspecific biogeographical structure that may impact on their management and conservation.	[Neaves, Linda E.; Danks, Melissa; Lott, Matthew J.; Dennison, Siobhan; Frankham, Greta J.; King, Andrew; Johnson, Rebecca N.] Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Eldridge, Mark D. B.; Divljan, Anja] Australian Museum Res Inst, Terr Vertebrates, Sydney, NSW, Australia	Australian Museum; Australian Museum	Neaves, LE (corresponding author), Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia.; Neaves, LE (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	Ineaves@gmail.com	Johnson, Rebecca N/U-6514-2017; Neaves, Linda/AAY-6886-2020; Danks, Melissa A/AAC-5439-2019	Neaves, Linda/0000-0002-5626-1029; Danks, Melissa A/0000-0002-4044-6694; Johnson, Rebecca/0000-0003-3035-2827; Dennison, Siobhan/0000-0002-3308-2810; King, Andrew/0000-0003-0481-3490				Ahlers N, 2017, FORENS SCI INT-GEN S, V6, pE466, DOI 10.1016/j.fsigss.2017.09.195; Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; Australian Bureau of Meteorology, 2015, MONTHLY WEATHER REV; Australian Transport Safety Bureau, 2017, AR2016063 ATSB; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Aziz SA, 2017, PEERJ, V5, DOI 10.7717/peerj.3176; Banack SA, 2002, J WILDLIFE MANAGE, V66, P1154, DOI 10.2307/3802948; Beugin MP, 2017, CONSERV GENET RESOUR, V9, P671, DOI 10.1007/s12686-017-0738-9; Biondi KM, 2013, ACTA CHIROPTEROL, V15, P185, DOI 10.3161/150811013X667984; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Brown VA, 2011, CONSERV GENET, V12, P933, DOI 10.1007/s10592-011-0196-y; Churchill S., 2009, AUSTR BATS; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; Dillman CB, 2014, J APPL ICHTHYOL, V30, P1300, DOI 10.1111/jai.12568; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fox S., 2006, THESIS, V181; Fox S, 2012, TERRA AUSTRALIS, V34, P459; Hall LS, 1983, AUSTR MUSEUM COMPLET, P280; Hall lS, 2000, FLYING FOXES FRUIT B; Helgen KM, 2004, ZOOTAXA, P1; Helgen KM, 2009, AM MUS NOVIT, P1, DOI 10.1206/614.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Korstian JM, 2016, CONSERV GENET RESOUR, V8, P27, DOI 10.1007/s12686-015-0509-4; Lee RJ, 2005, BIOL CONSERV, V123, P477, DOI 10.1016/j.biocon.2005.01.009; Martin L, 1995, SYM ZOOL S, P167; McConkey KR, 2007, BIOTROPICA, V39, P436, DOI 10.1111/j.1744-7429.2007.00269.x; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Parsons JG, 2010, ACTA CHIROPTEROL, V12, P301, DOI 10.3161/150811010X537882; Parsons JG, 2009, J WILDLIFE MANAGE, V73, P526, DOI 10.2193/2008-268; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Porter CA, 1996, MOL PHYLOGENET EVOL, V5, P89, DOI 10.1006/mpev.1996.0008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V16; Ratcliffe F, 1932, J ANIM ECOL, V1, P32, DOI 10.2307/993; Richmond JQ, 1998, AUST J ZOOL, V46, P283, DOI 10.1071/ZO97059; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109522; Stephens D, 2015, MOL ECOL, V24, P5643, DOI 10.1111/mec.13416; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Walker FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162342; Webb N. J., 1995, Australian Mammalogy, V18, P19; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075	52	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194908	10.1371/journal.pone.0194908	http://dx.doi.org/10.1371/journal.pone.0194908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634748	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200015
J	Fix, SM; Papadopoulou, V; Velds, H; Kasoji, SK; Rivera, JN; Borden, MA; Chang, S; Dayton, PA				Fix, Samantha M.; Papadopoulou, Virginie; Velds, Hunter; Kasoji, Sandeep K.; Rivera, Judith N.; Borden, Mark A.; Chang, Sha; Dayton, Paul A.			Oxygen microbubbles improve radiotherapy tumor control in a rat fibrosarcoma model - A preliminary study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; NECK-CANCER; HYPOXIA; HEAD; DELIVERY; VOLUME; ULTRASOUND; ANEMIA; FUTURE	Cancer affects 39.6% of Americans at some point during their lifetime. Solid tumor microenvironments are characterized by a disorganized, leaky vasculature that promotes regions of low oxygenation (hypoxia). Tumor hypoxia is a key predictor of poor treatment outcome for all radiotherapy (RT), chemotherapy and surgery procedures, and is a hallmark of metastatic potential. In particular, the radiation therapy dose needed to achieve the same tumor control probability in hypoxic tissue as in normoxic tissue can be up to 3 times higher. Even very small tumors (<2-3 mm(3)) comprise 10-30% of hypoxic regions in the form of chronic and/or transient hypoxia fluctuating over the course of seconds to days. We investigate the potential of recently developed lipid-stabilized oxygen microbubbles (OMBs) to improve the therapeutic ratio of RT. OMBs, but not nitrogen microbubbles (NMBs), are shown to significantly increase dissolved oxygen content when added to water in vitro and increase tumor oxygen levels in vivo in a rat fibrosarcoma model. Tumor control is significantly improved with OMB but not NMB intra-tumoral injections immediately prior to RT treatment and effect size is shown to depend on initial tumor volume on RT treatment day, as expected.	[Fix, Samantha M.; Dayton, Paul A.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Papadopoulou, Virginie; Kasoji, Sandeep K.; Chang, Sha; Dayton, Paul A.] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Papadopoulou, Virginie; Kasoji, Sandeep K.; Chang, Sha; Dayton, Paul A.] NC State Univ, Chapel Hill, NC 27599 USA; [Velds, Hunter] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Rivera, Judith N.; Borden, Mark A.; Chang, Sha] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Dayton, PA (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.; Dayton, PA (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Dayton, PA (corresponding author), NC State Univ, Chapel Hill, NC 27599 USA.	padayton@email.unc.edu	Papadopoulou, Virginie/E-5471-2013	Papadopoulou, Virginie/0000-0003-3395-3003; Kasoji, Sunny/0000-0002-4219-3424; Fix, Samantha/0000-0002-1608-4646	National Institutes of Health [R21 HL129144, R01 CA170665, F31CA220970]; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill; Office of Naval Research [11766740, N00014-15-1-2274]; Division Of Materials Research [1409972] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA170665] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill; Office of Naval Research(Office of Naval Research); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (nih.gov) R21 HL129144 (M.B.), R01 CA170665 (P.A.D.), and F31CA220970 (S.F.); Eshelman Institute for Innovation, University of North Carolina at Chapel Hill (S.C.); Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill (S.C.); as well as Office of Naval Research (onr.navy.mil; Undersea Medicine) 11766740 and N00014-15-1-2274 to M.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Radiation Oncology, 2017, FAST FACTS RAD THER; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cardenas-Navia LI, 2004, CANCER RES, V64, P6010, DOI 10.1158/0008-5472.CAN-03-0947; Chang JY, 2008, INT J RADIAT ONCOL, V72, P967, DOI 10.1016/j.ijrobp.2008.08.001; Chen M, 2002, AM J CLIN ONCOL-CANC, V25, P76, DOI 10.1097/00000421-200202000-00016; Curtis KK, 2016, CRIT REV ONCOL HEMAT, V103, P86, DOI 10.1016/j.critrevonc.2016.05.005; Doweck I, 2002, LARYNGOSCOPE, V112, P1742, DOI 10.1097/00005537-200210000-00006; Dubben HH, 1998, RADIOTHER ONCOL, V47, P167, DOI 10.1016/S0167-8140(97)00215-6; Dubray B, 1996, RADIOLOGY, V201, P553, DOI 10.1148/radiology.201.2.8888257; Dunn TJ, 1999, BRIT J CANCER, V80, P117, DOI 10.1038/sj.bjc.6690330; Evans SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0; Feshitan JA, 2014, BIOMATERIALS, V35, P2600, DOI 10.1016/j.biomaterials.2013.12.070; Fix SM, 2015, J CONTROL RELEASE, V209, P139, DOI 10.1016/j.jconrel.2015.04.027; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gerbaulet A, 2002, EV GEC ESTRO HDB BRA; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Harrison L, 2001, SEMIN ONCOL, V28, P54, DOI 10.1053/sonc.2001.25399; Harrison LB., 2000, ONCOLOGIST S, V5, P1, DOI [DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-1, 10.1634/theoncologist.5-suppl_2-1]; HIRST DG, 1991, RADIOTHER ONCOL, V20, P29, DOI 10.1016/0167-8140(91)90183-H; HODGKISS RJ, 1987, INT J RADIAT BIOL, V52, P735, DOI 10.1080/09553008714552241; Kaanders JHAM, 2004, SEMIN RADIAT ONCOL, V14, P233, DOI 10.1016/j.semradonc.2004.04.002; KALLMAN RF, 1972, RADIOLOGY, V105, P135, DOI 10.1148/105.1.135; Kasoji SK, 2017, THERANOSTICS; Kheir JN, 2016, P NATL ACAD SCI USA, V113, pE8010, DOI 10.1073/pnas.1618152114; Krause M, 2017, ADV DRUG DELIVER REV, V109, P63, DOI 10.1016/j.addr.2016.02.002; Kwan JJ, 2012, THERANOSTICS, V2, P1174, DOI 10.7150/thno.4410; Kwok SJJ, 2013, ULTRASOUND MED BIOL, V39, P1983, DOI 10.1016/j.ultrasmedbio.2013.03.025; Legband ND, 2015, IEEE T BIO-MED ENG, V62, P1376, DOI 10.1109/TBME.2015.2388611; Liu L, 2015, CANCER LETT, V361, P147, DOI 10.1016/j.canlet.2015.02.052; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; McEwan C, 2016, BIOMATERIALS, V80, P20, DOI 10.1016/j.biomaterials.2015.11.033; McEwan C, 2015, J CONTROL RELEASE, V203, P51, DOI 10.1016/j.jconrel.2015.02.004; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P332, DOI 10.1002/cncr.21146; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; National Cancer Institute at National Institute of Health, 2017, CANC STAT; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Pitson G, 2001, INT J RADIAT ONCOL, V51, P699, DOI 10.1016/S0360-3016(01)01662-5; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Reinhold H S, 1977, Bibl Anat, P270; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; Rwigema JCM, 2011, AM J CLIN ONCOL-CANC, V34, P372, DOI 10.1097/COC.0b013e3181e84dc0; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shirley LA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/207129; Smith BD, 2010, J CLIN ONCOL, V28, P5160, DOI 10.1200/JCO.2010.31.2520; Span PN, 2016, P NATL ACAD SCI USA, V113, pE8009, DOI 10.1073/pnas.1617279114; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swanson EJ, 2010, LANGMUIR, V26, P15726, DOI 10.1021/la1029432; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Vishwanath K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251013; Walsh JC, 2014, ANTIOXID REDOX SIGN, V21, P1516, DOI 10.1089/ars.2013.5378; Yuan H, 2006, J NUCL MED, V47, P989	59	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195667	10.1371/journal.pone.0195667	http://dx.doi.org/10.1371/journal.pone.0195667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630640	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000068
J	Khan, G; Ribeiro, PM; Bonatelli, IAS; Perez, MF; Franco, FF; Moraes, EM				Khan, Gulzar; Ribeiro, Paulianny M.; Bonatelli, Isabel A. S.; Perez, Manolo F.; Franco, Fernando F.; Moraes, Evandro M.			Weak population structure and no genetic erosion in Pilosocereus aureispinus: A microendemic and threatened cactus species from eastern Brazil	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; ASTROPHYTUM-ASTERIAS; CONSERVATION; SOFTWARE; MARKERS; RARE; AMPLIFICATION; CONSEQUENCES; DIVERSITY; PHYLOGEOGRAPHY	Succulent cacti (Cactaceae) are among the most threatened taxonomic groups assessed to date. Here we evaluated the genetic diversity and population structure of a narrow endemic columnar cactus Pilosocereus aureispinus. This species is only found in a small area of c. 300 km(2) of rocky savanna from eastern Brazil and it is currently classified as vulnerable (VU) on the International Union for Conservation of Nature (IUCN) red list. Eight microsatellite loci were genotyped for 91 individuals from four localities of the known P. aureispinus range. In contrast with expectations for narrow endemic species, we found relatively high levels of genetic diversity (e.g., H-E = 0.390 to 0.525; H-O = 0.394 to 0.572) and very low population structure based on the variation of six loci. All the analyzed individuals were clustered in one unique genetic group in assignment tests. We also generated the sequences of two plastid markers (trnT-trnL and psbD-trnT) and found no variation on a subsample of 39 individuals. We used Landsat 8 images and Normalized Difference Vegetation Index to estimate a potential extent of occurrence of c. 750 km(2) for this species. Our results showed that P. aureispinus is not suffering from erosion of nuclear genetic variability due to its narrow distribution. However, we advocate that because of the extremely limited extent of occurrence, the ongoing anthropogenic disturbances in its habitat, and phylogenetic distinctiveness of P. aureispinus, this species should be classified as endangered (EN) on the IUCN Red List.	[Khan, Gulzar; Ribeiro, Paulianny M.; Bonatelli, Isabel A. S.; Perez, Manolo F.; Franco, Fernando F.; Moraes, Evandro M.] Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos	Moraes, EM (corresponding author), Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil.	emarsola@ufscar.br	Perez, Manolo Fernandez/H-2243-2012; Khan, Gulzar/K-1895-2015; Moraes, Evandro M./A-4387-2009; Bonatelli, Isabel A. S./D-2361-2015; Khan, Gulzar/G-2730-2014	Perez, Manolo Fernandez/0000-0002-4642-7793; Moraes, Evandro M./0000-0003-4197-0794; Khan, Gulzar/0000-0003-0281-4270; gulzar, khan/0000-0001-6870-8935; da Silva Bonatelli, Isabel Aparecida/0000-0002-0930-1411	Sao Paulo Research Foundation (FAPESP) [2005/55200-8]; Brazilian Council of Scientific and Technological Development (CNPq) [471963/2007-0, 500903/2009-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported through grants from the Sao Paulo Research Foundation (FAPESP) (2005/55200-8 to EMM) and Brazilian Council of Scientific and Technological Development (CNPq) (471963/2007-0 and 500903/2009-3 to EMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki M, 2013, J HERED, V104, P127, DOI 10.1093/jhered/ess072; Arakaki M, 2010, AM J BOT, V97, pE17, DOI 10.3732/ajb.1000026; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Balloux F, 2003, GENETICS, V164, P1635; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Bonatelli IAS, 2013, GENET MOL RES, V12, P4579, DOI 10.4238/2013.February.28.27; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Calvente A, 2017, BOT J LINN SOC, V183, P25; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Collevatti RG, 2012, ECOL EVOL, V2, P1024, DOI 10.1002/ece3.236; Barbosa NPD, 2015, ACTA BOT BRAS, V29, P299, DOI 10.1590/0102-33062014abb3731; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figueredo CJ, 2010, J ARID ENVIRON, V74, P1392, DOI 10.1016/j.jaridenv.2010.05.020; Forrest A, 2017, BOT J LINN SOC, V183, P260, DOI 10.1093/botlinnean/bow002; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goettsch B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.142, 10.1038/NPLANTS.2015.142]; Gorostiague P, 2016, PLANT BIOLOGY, V18, P63, DOI 10.1111/plb.12297; Hamilton JA, 2007, MOL ECOL, V16, P1649, DOI 10.1111/j.1365-294X.2007.03241.x; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hardesty BD, 2008, MOL ECOL RESOUR, V8, P164, DOI 10.1111/j.1471-8286.2007.01913.x; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Hughes SL, 2008, MOL ECOL RESOUR, V8, P1068, DOI 10.1111/j.1755-0998.2008.02157.x; Hunt D., 2006, NEW CACTUS LEXICON A; IUCN Standards and Petitions Committee, 2022, GUID US IUCN RED LIS; Jesus AA, 2014, TAXON, V63, P1150; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones RC, 2005, AUST J BOT, V53, P367, DOI 10.1071/BT04182; Kang U, 2000, J PLANT RES, V113, P127, DOI 10.1007/PL00013923; Leal BSS, 2016, BOT J LINN SOC, V181, P621, DOI 10.1111/boj.12437; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Martins APV, 2012, AM J BOT, V99, pE289, DOI 10.3732/ajb.1100611; Maya-Garcia R, 2017, PLANT DIVERSITY, V39, P13, DOI 10.1016/j.pld.2016.09.005; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moraes EM, 2014, GENET MOL RES, V13, P10359, DOI 10.4238/2014.December.4.31; Moraes EM, 2012, GENETICA, V140, P277, DOI 10.1007/s10709-012-9678-1; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Orsini L, 2013, MOL ECOL, V22, P583, DOI 10.1111/mec.12117; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez MF, 2011, AM J BOT, V98, pE204, DOI 10.3732/ajb.1100033; Pimienta-Barrios E., 2002, CACTI BIOL USES, P163, DOI DOI 10.1525/CALIFORNIA/9780520231573.003.0005; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rocha E. A., 2007, Bradleya, V25, P129; Romeiro-Brito M, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500074; Leal BSS, 2014, BIOCHEM SYST ECOL, V55, P305, DOI 10.1016/j.bse.2014.03.036; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Silva GAR, 2016, BIOCHEM SYST ECOL, V65, P137, DOI 10.1016/j.bse.2016.02.001; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Solorzano S, 2009, MOL ECOL RESOUR, V9, P156, DOI 10.1111/j.1755-0998.2008.02422.x; Solorzano S, 2015, PLANT ECOL DIVERS, V8, P559, DOI 10.1080/17550874.2015.1044581; Solorzano S, 2014, REV MEX BIODIVERS, V85, P565, DOI 10.7550/rmb.39066; Souza VC, 2005, BOT SISTEMATICA, V1st; Taylor N.P., 2004, CACTI E BRAZIL; Terry M, 2006, MOL ECOL NOTES, V6, P865, DOI 10.1111/j.1471-8286.2006.01377.x; Terry MK, 2012, SOUTHWEST NAT, V57, P182, DOI 10.1894/0038-4909-57.2.182; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zappi D, 2013, IUCN RED LIST THREAT; Zappi D.C., 1994, PILOSOCEREUS CACTACE	77	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195475	10.1371/journal.pone.0195475	http://dx.doi.org/10.1371/journal.pone.0195475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630653	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000051
J	Lee, HA; Hyun, SA; Byun, B; Chae, JH; Kim, KS				Lee, Hyang-Ae; Hyun, Sung-Ae; Byun, Byungjin; Chae, Jong-Hak; Kim, Ki-Suk			Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell derived cardiomyocytes	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; PROLONGATION; DRUGS; CANCER; MATURATION; ONCOLOGY; CHANNELS; MODELS	Vandetanib, a multi-kinase inhibitor used for the treatment of various cancers, has been reported to induce several adverse cardiac effects. However, the underlying mechanisms of vandetanib-induced cardiotoxicity are unclear. This study aimed to investigate the mechanism of vandetanib-induced cardiotoxicity using intracellular electrophysiological recordings on human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), rabbit Purkinje fibers, and HEK293 cells transiently expressing human ether-a-go-go-related gene (hERG; the rapidly activating delayed rectifier K+ channel, l(Kr)), KCNQ1/KCNE1 (the slowly activating delayed rectifier K+ current, l(Ks)), KCNJ2 (the inwardly rectifying K+ current, l(K1)) or SCN5A (the inward Na+ current, l(Na)). Purkinje fiber assays and ion channel studies showed that vandetanib at concentrations of 1 and 3 mu M inhibited the hERG currents and prolonged the action potential duration. Alanine scanning and in silico hERG docking studies demonstrated that Y652 and F656 in the hERG S6 domain play critical roles in vandetanib binding. In hiPSC-CMs, vandetanib markedly reduced the maximum rate of depolarization during the AP upstroke. Ion channel studies revealed that hiPSC-CMs were more sensitive to inhibition of the l(Na) by vandetanib than in a heterogeneously expressed HEK293 cell model, consistent with the changes in the AP parameters of hiPSC-CMs. The subclasses of Class I antiarrhythmic drugs inhibited l(Na) currents in a dose-dependent manner in hiPSC-CMs and SCN5A-encoded HEK293 cells. The inhibitory potency of vandetanib for l(Na) was much higher in hiPSC-CMs (IC50: 2.72 mu M) than in HEK293 cells (IC50: 36.63 mu M). These data suggest that AP and l(Na) assays using hiPSC-CMs	[Lee, Hyang-Ae; Kim, Ki-Suk] Korea Res Inst Chem Technol, Korea Inst Toxicol, Predict Model Res Ctr, Daejeon, South Korea; [Hyun, Sung-Ae] Res Inst Chem Technol, Korea Inst Toxicol, Res Ctr Safety Pharmacol, Daejeon, South Korea; [Byun, Byungjin] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Chae, Jong-Hak] Korea Res Inst Chem Technol, Daejeon, South Korea; [Kim, Ki-Suk] Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea	Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Korea Institute of Toxicology; University of Notre Dame; Korea Research Institute of Chemical Technology (KRICT); University of Science & Technology (UST)	Kim, KS (corresponding author), Korea Res Inst Chem Technol, Korea Inst Toxicol, Predict Model Res Ctr, Daejeon, South Korea.; Kim, KS (corresponding author), Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea.	idkks@kitox.re.kr		Hyun, Sung-Ae/0000-0003-4442-2398	Technology Innovation Program - Ministry of Trade, Industry & Energy (MI, Korea) [10067737]	Technology Innovation Program - Ministry of Trade, Industry & Energy (MI, Korea)	This work was supported by the Technology Innovation Program (10067737, Establishment of Risk management platform with aim to reduce attrition of new drugs and its service) funded By the Ministry of Trade, Industry & Energy (MI, Korea) to KSK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Berecki G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015772; CAMPBELL TJ, 1983, BRIT J PHARMACOL, V80, P33, DOI 10.1111/j.1476-5381.1983.tb11046.x; Carlsson L, 2006, J INTERN MED, V259, P70, DOI 10.1111/j.1365-2796.2005.01590.x; Dai DF, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5153625; Ederhy S, 2009, TARGET ONCOL, V4, P89, DOI 10.1007/s11523-009-0111-3; Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158; Harding SE, 2007, PHARMACOL THERAPEUT, V113, P341, DOI 10.1016/j.pharmthera.2006.08.008; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Hennequin LF, 2002, J MED CHEM, V45, P1300, DOI 10.1021/jm011022e; Kamiya K, 2001, MOL PHARMACOL, V60, P244, DOI 10.1124/mol.60.2.244; Khan JM, 2013, BRIT J PHARMACOL, V169, P304, DOI 10.1111/j.1476-5381.2012.02118.x; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lee S, 2016, TOXICOL APPL PHARM, V296, P42, DOI 10.1016/j.taap.2016.01.015; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu Y, 2015, EUR J CLIN PHARMACOL, V71, P541, DOI 10.1007/s00228-015-1831-1; Lu HR, 2001, J CARDIOVASC ELECTR, V12, P93, DOI 10.1046/j.1540-8167.2001.00093.x; MILNE JR, 1984, EUR HEART J, V5, P99, DOI 10.1093/oxfordjournals.eurheartj.a061633; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Orphanos GS, 2009, ACTA ONCOL, V48, P964, DOI 10.1080/02841860903229124; Pekkanen-Mattila M, 2010, EXP BIOL MED, V235, P522, DOI 10.1258/ebm.2010.009345; Poon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077784; Roche M, 2010, J PHARMACOL TOX MET, V61, P238, DOI 10.1016/j.vascn.2010.01.011; Sager PT, 2014, AM HEART J, V167, P292, DOI 10.1016/j.ahj.2013.11.004; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; SASTRE A, 1976, P NATL ACAD SCI USA, V73, P1355, DOI 10.1073/pnas.73.4.1355; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461; Strevel EL, 2007, J CLIN ONCOL, V25, P3362, DOI 10.1200/JCO.2006.09.6925; Wedge SR, 2002, CANCER RES, V62, P4645; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; Zang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030353; Zhu RJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt507	36	19	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195577	10.1371/journal.pone.0195577	http://dx.doi.org/10.1371/journal.pone.0195577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630634	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000060
J	Kim, H; Kwak, W; Yoon, SH; Kang, DK; Kim, H				Kim, Hyaekang; Kwak, Woori; Yoon, Sook Hee; Kang, Dae-Kyung; Kim, Heebal			Horizontal gene transfer of Chlamydia: Novel insights from tree reconciliation	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; TRACHOMATIS STRAINS; IN-VITRO; EVOLUTION; BACTERIAL; GENOME; POPULATIONS; ANNOTATION; DIVERSITY; MECHANISM	Recent comparative genomics studies have suggested that horizontal gene transfer (HGT) is one of the major processes in bacterial evolution. In this study, HGT events of 64 Chlamydia strains were investigated based on the pipeline employed in HGTree database constructed in our recent study. Tree reconciliation method was applied in order to calculate feasible HGT events. Following initial detection and an evaluation procedure, evidence of the HGT was identified in 548 gene families including 42 gene families transferred from outside of Chlamydiae phylum with high reliability. The donor species of inter-phylum HGT consists of 12 different bacterial and archaeal phyla, suggesting that Chlamydia might have even more various host range than in previous reports. In addition, each species of Chlamydia showed varying preference towards HGT, and genes engaged in HGT within Chlamydia and between other species showed different functional distribution. Also, examination of individual gene flows of niche-specific genes suggested that many of such genes are transferred mainly within Chlamydia genus. Our results uncovered novel features of HGT acting on Chlamydia genome evolution, and it would be also strong evidence that HGT is an ongoing process for intracellular pathogens. We expect that the results provide more insight into lineage- and niche-specific adaptations regarding their infectivity and pathogenicity.	[Kim, Hyaekang; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Hyaekang; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kwak, Woori; Kim, Heebal] Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea; [Kang, Dae-Kyung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dankook University	Kim, H (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea.	heebal@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303	NextGeneration BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01115901]	NextGeneration BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the NextGeneration BioGreen 21 Program (PJ01115901), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Bennett J., 2014, PRINCIPLES PRACTICE; Betts-Hampikian HJ, 2010, OBLIGATE INTRACELLUL, V71; Borel N, 2016, CURR CLIN MICROBIOL, V3, P10, DOI 10.1007/s40588-016-0028-4; Bose T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142102; Caro-Quintero A, 2015, ISME J, V9, P958, DOI 10.1038/ismej.2014.193; Cenci U, 2016, FRONTIERS CELLULAR I, P6; Cohen E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098102; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Corsaro D, 2003, CRIT REV MICROBIOL, V29, P37, DOI 10.1080/713610404; Corsaro Daniele, 2002, Microbiology (Reading), V148, P343, DOI 10.1099/00221287-148-2-343; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Gupta RS, 2015, ANTON LEEUW INT J G, V108, P765, DOI 10.1007/s10482-015-0532-1; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Horn M, 2001, FEMS MICROBIOL LETT, V204, P71, DOI 10.1111/j.1574-6968.2001.tb10865.x; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jeffrey BM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-142; Jelocnik M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2053-8; Jeong H, 2015, NUCLEIC ACIDS RES; Joseph SJ, 2012, MOL BIOL EVOL; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kim KM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn485; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kordi M, 2017, IEEE ACM T COMPUTATI; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lawrence JG, 2005, CURR OPIN MICROBIOL, V8, P572, DOI 10.1016/j.mib.2005.08.005; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lind PA, 2010, EVOLUTIONARY DYNAMIC; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Raz Y, 2010, GENETICS, V185, P327, DOI 10.1534/genetics.109.113613; Read TD, 2013, MBIO, V4, DOI 10.1128/mBio.00604-12; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rosenwald A.G., 2014, BACTERIOPHAGE, V4, DOI [10.4161/21597073.2014.965076, DOI 10.4161/21597073.2014.965076]; Roulis E, 2013, TRENDS MICROBIOL, V21, P120, DOI 10.1016/j.tim.2012.10.009; Sennblad B, 2009, SYST BIOL, V58, P411, DOI 10.1093/sysbio/syp046; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Srinivasan T, 2012, J BACTERIOL, V194, P617, DOI 10.1128/JB.06268-11; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor LD, 2010, INFECT IMMUN, V78, P2691, DOI 10.1128/IAI.01455-09; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195139	10.1371/journal.pone.0195139	http://dx.doi.org/10.1371/journal.pone.0195139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621277	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800042
J	Mizuguchi, Y; Morimoto, S; Kimura, S; Takano, N; Yamashita, K; Seki, Y; Bokuda, K; Yatabe, M; Yatabe, J; Watanabe, D; Ando, T; Ichihara, A				Mizuguchi, Yuki; Morimoto, Satoshi; Kimura, Shihori; Takano, Noriyoshi; Yamashita, Kaoru; Seki, Yasufumi; Bokuda, Kanako; Yatabe, Midori; Yatabe, Junichi; Watanabe, Daisuke; Ando, Takashi; Ichihara, Atsuhiro			Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; RENIN-ANGIOTENSIN SYSTEM; PRORENIN RECEPTOR; DRUG-THERAPY; HYPERTHYROIDISM; RATS	Antithyroid drugs are generally selected as the first-line treatment for Graves' Disease (GD); however, the existence of patients showing resistance or severe side effects to these drugs is an important issue to be solved. The (pro)renin receptor [(P)RR] is a multi-functional protein that activates the tissue renin-angiotensin system and is an essential constituent of vacuolar H+-ATPase, necessary for the autophagy-lysosome pathway. (P)RR is cleaved to soluble (s)(P)RR, which reflects the status of (P)RR expression. In this retrospective study, we aimed to investigate whether serum s(P)RR concentration can be used as a biomarker to predict the outcome of antithyroid drug treatment in GD patients. Serum s(P)RR levels were measured in 54 untreated GD patients and 47 control participants. Effects of medical treatment with antithyroid drugs on these levels were investigated in GD patients. Serum s (P)RR levels were significantly higher in patients with Graves' disease than in control subjects (P<0.005) and were significantly reduced after medical treatment for Graves' disease. High serum s(P)RR levels were associated with resistance to antithyroid drug treatment, suggesting that serum s(P)RR concentration can be used as a useful biomarker to predict the outcome of antithyroid drug treatment in these patients. Patients with Graves' disease with low body mass index showed higher levels of serum soluble (pro)renin receptor levels than those with high body mass index. In addition, in patients with Graves' disease, serum triglyceride levels were negatively correlated with serum soluble (pro)renin receptor levels. All these data indicated an association between low nutrient condition due to hyperthyroidism and increased (pro)renin receptor expression in these patients, suggesting that (pro) renin receptor expression could be increased in the process of stimulating intracellular energy production via activating autophagy function to compensate energy loss.	[Mizuguchi, Yuki; Morimoto, Satoshi; Kimura, Shihori; Takano, Noriyoshi; Yamashita, Kaoru; Seki, Yasufumi; Bokuda, Kanako; Yatabe, Midori; Yatabe, Junichi; Watanabe, Daisuke; Ando, Takashi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan	Tokyo Women's Medical University	Morimoto, S (corresponding author), Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan.	smorimoto@endm.twmu.ac.jp	Seki, Yasufumi/GXN-0888-2022	Seki, Yasufumi/0000-0002-1950-7704; Yamashita, Kaoru/0000-0001-7922-8275	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K09657, 16H05316]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 16K09657 to S.M. and 16H05316 to A.I.) and a grant from the Institute of Science of Blood Pressure and Hormone (to Y.M.).; This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 16K09657 to S.M. and 16H05316 to A.I.) and a grant from the Institute of Science of Blood Pressure and Hormone (to Y.M.) In this research work, we gratefully acknowledge the technical support from Instruments of Medical Research Institute (MRI), Tokyo Women's Medical University.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Amari Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158068; Andersen SL, 2016, J CLIN ENDOCR METAB, V101, P1606, DOI 10.1210/jc.2015-4274; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Barreto-Chaves MLM, 2010, VASC PHARMACOL, V52, P166, DOI 10.1016/j.vph.2009.10.009; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; De Leo S, 2016, LANCET, V388, P906, DOI 10.1016/S0140-6736(16)00278-6; Ichihara A, 2010, HYPERTENS RES, V33, P177, DOI 10.1038/hr.2009.214; Kanda A, 2015, J BIOL CHEM, V290, P9690, DOI 10.1074/jbc.M114.626713; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kobori H, 1997, AM J PHYSIOL-ENDOC M, V272, pE227, DOI 10.1152/ajpendo.1997.272.2.E227; Kobori H, 1997, AM J PHYSIOL-HEART C, V273, pH593, DOI 10.1152/ajpheart.1997.273.2.H593; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Ma C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/1465858.CD010094.PUB2; MARCHANT C, 1993, J CARDIOVASC PHARM, V22, P449, DOI 10.1097/00005344-199309000-00016; Maruyama Nobuhiro, 2013, Front Biosci (Elite Ed), V5, P583; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MONTIEL M, 1984, J ENDOCRINOL INVEST, V7, P559, DOI 10.1007/BF03349486; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; SERNIA C, 1993, CARDIOVASC RES, V27, P423, DOI 10.1093/cvr/27.3.423; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; Vos XG, 2016, J CLIN ENDOCR METAB, V101, P1381, DOI 10.1210/jc.2015-3644; Watanabe N, 2013, J CLIN ENDOCR METAB, V98, P2528, DOI 10.1210/jc.2012-4139; Xiao FS, 2015, J CLIN ENDOCR METAB, V100, P3800, DOI 10.1210/jc.2015-1797	29	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195464	10.1371/journal.pone.0195464	http://dx.doi.org/10.1371/journal.pone.0195464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621332	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800089
J	Sommermann, L; Geistlinger, J; Wibberg, D; Deubel, A; Zwanzig, J; Babin, D; Schluter, A; Schellenberg, I				Sommermann, Loreen; Geistlinger, Joerg; Wibberg, Daniel; Deubel, Annette; Zwanzig, Jessica; Babin, Doreen; Schlueter, Andreas; Schellenberg, Ingo			Fungal community profiles in agricultural soils of a long-term field trial under different tillage, fertilization and crop rotation conditions analyzed by high-throughput ITS-amplicon sequencing	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PIRIFORMOSPORA-INDICA; NO-TILLAGE; PLANT; TRICHODERMA; PROPAGULES; GRASSLAND; DATABASE; GENOME; BARLEY	Fungal communities in agricultural soils are assumed to be affected by soil and crop management. Our intention was to investigate the impact of different tillage and fertilization practices on fungal communities in a long-term crop rotation field trial established in 1992 in Central Germany. Two winter wheat fields in replicated strip-tillage design, comprising conventional vs. conservation tillage, intensive vs. extensive fertilization and different pre-crops (maize vs. rapeseed) were analyzed by a metabarcoding approach applying Illumina paired-end sequencing of amplicons generated by two recently developed primer pairs targeting the two fungal Internal Transcribed Spacer regions (ITS1, ITS2). Analysis of 5.1 million high-quality sequence reads uncovered a diverse fungal community in the two fields, composed of 296 fungal genera including 3,398 Operational Taxonomic Units (OTUs) at the 97% sequence similarity threshold. Both primer pairs detected the same fungal phyla (Basidio-, Asco-, Zygo-, Glomero- and Chytridiomycota), but in different relative abundances. OTU richness was higher in the ITS1 dataset, while ITS2 data were more diverse and of higher evenness. Effects of farming practice on fungal community structures were revealed. Almost two-thirds of the fungal genera were represented in all different soil treatments, whereas the remaining genera clearly responded to farming practice. Principal Component Analysis revealed four distinct clusters according to tillage practice and pre-crop. Analysis of Variance (ANOVA) substantiated the results and proved significant influences of tillage and pre-crop, while fertilization had the smallest and non-significant effect. In-depth analysis of putative phytopathogenic and plant beneficial fungal groups indicated distinct responses; for example Fusarium was significantly enriched in the intensively fertilized conservation tillage variants with the pre-crop maize, while Phoma displayed significant association with conventional tillage and pre-crop rapeseed. Many putative plant beneficial fungi also reacted differentially to farming practice with the most distinct responders identified among the Glomeromycota (arbuscular mycorrhizal fungi, AMF).	[Sommermann, Loreen; Geistlinger, Joerg; Zwanzig, Jessica; Schellenberg, Ingo] Anhalt Univ Appl Sci, Inst Bioanalyt Sci IBAS, Bernburg, Saxony Anhalt, Germany; [Wibberg, Daniel; Schlueter, Andreas] Bielefeld Univ, GRIM, Ctr Biotechnol CeBiTec, Bielefeld, North Rhine Wes, Germany; [Deubel, Annette] Anhalt Univ Appl Sci, Dept Agr Ecotrophol & Landscape Dev, Bernburg, Saxony Anhalt, Germany; [Schlueter, Andreas] JKI, Fed Res Ctr Cultivated Plants, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Lower Saxony, Germany	University of Bielefeld; Julius Kuhn-Institut	Sommermann, L (corresponding author), Anhalt Univ Appl Sci, Inst Bioanalyt Sci IBAS, Bernburg, Saxony Anhalt, Germany.	loreen.sommermann@hs-anhalt.de	Babin, Doreen/J-3640-2019	Babin, Doreen/0000-0001-7144-8898; Sommermann, Loreen/0000-0002-6293-877X; Deubel, Annette/0000-0001-5504-3081; Schluter, Andreas/0000-0003-4830-310X	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF)) [031A5606, 031A560C, 031A560D]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF))(Federal Ministry of Education & Research (BMBF))	The Disease Control (DiControl) project as a part of the funding initiative Soil as sustainable resource for bioeconomy (Bonares) was funded by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF), www.bmbf.de) to LS and JG (grant-no. 031A5606), to DB (grant-no. 031A560C) and to AS (grant-no. 031A560D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Bainard LD, 2009, WEED SCI, V57, P386, DOI 10.1614/WS-08-151.1; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; Bankina B, 2013, ACTA AGR SCAND B-S P, V63, P723, DOI 10.1080/09064710.2013.861920; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bjonsgaard Aas A, 2016, MOL ECOL RESOUR; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Borriello R., 2012, Biology and Fertility of Soils, V48, P911, DOI 10.1007/s00374-012-0683-4; Bowles T. M, 2016, J APPL ECOL; Castillo CG, 2006, BIOL FERT SOILS, V43, P83, DOI 10.1007/s00374-005-0067-0; Chaiyasen A, 2017, BIOL AGRIC HORTIC, V33, P52, DOI 10.1080/01448765.2016.1187670; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deubel A, 2011, SOIL TILL RES, V117, P85, DOI 10.1016/j.still.2011.09.001; Dill-Macky R, 2000, PLANT DIS, V84, P71, DOI 10.1094/PDIS.2000.84.1.71; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Geistlinger Joerg, 2015, Diversity-Basel, V7, P360, DOI 10.3390/d7040360; Gosling P, 2014, MYCORRHIZA, V24, P1, DOI 10.1007/s00572-013-0505-z; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannukkala AO, 2016, ANN APPL BIOL, V169, P257, DOI 10.1111/aab.12293; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Hu JL, 2015, CATENA, V133, P215, DOI 10.1016/j.catena.2015.05.023; Jansa J., 2006, GEOLOGICAL SOC, P89, DOI [10.1144/GSL.SP.2006.266.01.08, DOI 10.1144/GSL.SP.2006.266.01.08]; Jones EE, 2014, BIOCONTROL SCI TECHN, V24, P1363, DOI 10.1080/09583157.2014.940847; Kirschner R, 2001, MYCOLOGIA, V93, P634, DOI 10.2307/3761818; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lahlali R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094144; Laura V, 2017, AGR ECOSYST ENVIRON, V244, P32, DOI 10.1016/j.agee.2017.04.015; Lentendu G, 2014, MOL ECOL, V23, P3341, DOI 10.1111/mec.12819; Liebe S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw004; Lopes AR, 2014, FEMS MICROBIOL ECOL, V87, P650, DOI 10.1111/1574-6941.12253; Luo X, 2016, ECOL RES, V31, P407, DOI 10.1007/s11284-016-1356-9; Madi L, 1997, PHYTOPATHOLOGY, V87, P1054, DOI 10.1094/PHYTO.1997.87.10.1054; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maus I, 2016, J MICROBIOL BIOTECHN; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Nagahama Takahiko, 2012, Prog Mol Subcell Biol, V53, P173, DOI 10.1007/978-3-642-23342-5_9; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Palagani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113842; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pawluczyk M, 2015, ANAL BIOANAL CHEM, V407, P1841, DOI 10.1007/s00216-014-8435-y; Ranjard L, 2003, ENVIRON MICROBIOL, V5, P1111, DOI 10.1046/j.1462-2920.2003.00521.x; Samuels GJ, 2012, FUNGAL DIVERS, V55, P77, DOI 10.1007/s13225-012-0152-2; Santos JC, 2006, NEW PHYTOL, V172, P159, DOI 10.1111/j.1469-8137.2006.01799.x; Schalamuk S, 2010, MYCOLOGIA, V102, P261, DOI 10.3852/08-118; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Sechi V, 2017, AGR ECOSYST ENVIRON, V239, P265, DOI 10.1016/j.agee.2017.01.036; Stockinger H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107783; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Theuerl S, 2015, APPL MICROBIOL BIOT, V99, P7791, DOI 10.1007/s00253-015-6627-9; Thomas E, 2006, FELDVERSUCHSWESEN; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Valetti L, 2016, EUR J SOIL BIOL, V76, P103, DOI 10.1016/j.ejsobi.2016.08.005; Valyi K, 2015, NEW PHYTOL, V205, P1577, DOI 10.1111/nph.13236; Veresoglou SD, 2017, ECOL EVOL, V7, P1181, DOI 10.1002/ece3.2757; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Vierheilig H, 2000, NEW PHYTOL, V146, P343, DOI 10.1046/j.1469-8137.2000.00642.x; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; WIBBERG D, 2016, BMC GENOMICS, V17; Williams A, 2017, NEW PHYTOL, V213, P874, DOI 10.1111/nph.14196; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	73	42	44	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195345	10.1371/journal.pone.0195345	http://dx.doi.org/10.1371/journal.pone.0195345			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621291	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800069
J	Troupin, D; Carmel, Y				Troupin, David; Carmel, Yohay			Conservation planning under uncertainty in urban development and vegetation dynamics	PLOS ONE			English	Article							CLIMATE-CHANGE; REPRESENTATION; MANAGEMENT; SCENARIOS; NETWORKS; AREAS; FACE	Systematic conservation planning is a framework for optimally locating and prioritizing areas for conservation. An often-noted shortcoming of most conservation planning studies is that they do not address future uncertainty. The selection of protected areas that are intended to ensure the long-term persistence of biodiversity is often based on a snapshot of the current situation, ignoring processes such as climate change. Scenarios, in the sense of being accounts of plausible futures, can be utilized to identify conservation area portfolios that are robust to future uncertainty. We compared three approaches for utilizing scenarios in conservation area selection: considering a full set of scenarios (all-scenarios portfolio), assuming the realization of specific scenarios, and a reference strategy based on the current situation (current distributions portfolio). Our objective was to compare the robustness of these approaches in terms of their relative performance across future scenarios. We focused on breeding bird species in Israel's Mediterranean region. We simulated urban development and vegetation dynamics scenarios 60 years into the future using DINAMICA-EGO, a cellular-automata simulation model. For each scenario, we mapped the target species' available habitat distribution, identified conservation priority areas using the site-selection software MARXAN, and constructed conservation area portfolios using the three aforementioned strategies. We then assessed portfolio performance based on the number of species for which representation targets were met in each scenario. The all-scenarios portfolio consistently outperformed the other portfolios, and was more robust to 'errors' (e.g., when an assumed specific scenario did not occur). On average, the all-scenarios portfolio achieved representation targets for five additional species compared with the current distributions portfolio (approximately 33 versus 28 species). Our findings highlight the importance of considering a broad and meaningful set of scenarios, rather than relying on the current situation, the expected occurrence of specific scenarios, or the worst-case scenario.	[Troupin, David] Technion Israel Inst Technol, Fac Architecture & Town Planning, Haifa, Israel; [Carmel, Yohay] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel; [Troupin, David] Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Haifa	Troupin, D (corresponding author), Technion Israel Inst Technol, Fac Architecture & Town Planning, Haifa, Israel.; Troupin, D (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel.	davidtroupin@gmail.com	Carmel, Yohay/G-4362-2011	Carmel, Yohay/0000-0002-5883-0184				Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Bagchi R, 2013, GLOBAL CHANGE BIOL, V19, P1236, DOI 10.1111/gcb.12123; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohensky E, 2011, GLOBAL ENVIRON CHANG, V21, P876, DOI 10.1016/j.gloenvcha.2011.03.009; Carmel Y, 1999, PLANT ECOL, V145, P243, DOI 10.1023/A:1009872306093; Carmel Y, 2001, ECOL APPL, V11, P268, DOI 10.1890/1051-0761(2001)011[0268:SPMOMV]2.0.CO;2; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Chiozza F, 2010, NAT CONSERVACAO, V8, P177, DOI 10.4322/natcon.00802012; Cook CN, 2014, TRENDS ECOL EVOL, V29, P531, DOI 10.1016/j.tree.2014.07.005; Cooney R., 2004, PRECAUTIONARY PRINCI; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; Cumming GS, 2007, LANDSCAPE ECOL, V22, P671, DOI 10.1007/s10980-006-9057-3; Dolev A., 2002, RED BOOK VERTEBRATES; Drechsler M, 2009, ECOL MODEL, V220, P438, DOI 10.1016/j.ecolmodel.2008.11.013; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hansen L, 2010, CONSERV BIOL, V24, P63, DOI 10.1111/j.1523-1739.2009.01404.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IPCC (Intergovernmental Panel on Climate Change), 2000, SPECIAL REPORT EMISS; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lourival R, 2011, DIVERS DISTRIB, V17, P297, DOI 10.1111/j.1472-4642.2010.00722.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Newton AC, 2011, BIOL CONSERV, V144, P1949, DOI 10.1016/j.biocon.2011.03.026; O'Hanley JR, 2007, BIOL CONSERV, V134, P130, DOI 10.1016/j.biocon.2006.08.009; Olson LT, 2009, J GEOGRAPHY REGIONAL, V2, P20; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004; Pyke CR, 2005, BIOL CONSERV, V121, P429, DOI 10.1016/j.biocon.2004.05.019; R Development Core Team, 2009, R LANG ENV STAT COMP; Redford KH, 2003, CONSERV BIOL, V17, P116, DOI 10.1046/j.1523-1739.2003.01467.x; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Samoch Y., 1980, La-Yaaran, V30, P6; Sapir G, 2010, ECOL ENV, V3, P14; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Schuetz JG, 2015, ECOL APPL, V25, P1819, DOI 10.1890/14-1903.1; Shirihai H., 1996, BIRDS ISRAEL; Soares BS, 2002, ECOL MODEL, V154, P217, DOI 10.1016/S0304-3800(02)00059-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Troupin D, 2016, LAND USE POLICY, V54, P221, DOI 10.1016/j.landusepol.2016.02.008; Troupin D, 2014, BIOL CONSERV, V169, P158, DOI 10.1016/j.biocon.2013.11.009; Veloz SD, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00341.1; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Zuur AF., 2009, MIXED EFFECTS MODELS, DOI [10.1007/978-0-387-87458-6, DOI 10.1007/978-0-387-87458-6]	61	2	2	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195429	10.1371/journal.pone.0195429	http://dx.doi.org/10.1371/journal.pone.0195429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621330	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800079
J	Curtis, B; Giorgi, S; Buffone, AEK; Ungar, LH; Ashford, RD; Hemmons, J; Summers, D; Hamilton, C; Schwartz, HA				Curtis, Brenda; Giorgi, Salvatore; Buffone, Anneke E. K.; Ungar, Lyle H.; Ashford, Robert D.; Hemmons, Jessie; Summers, Dan; Hamilton, Casey; Schwartz, H. Andrew			Can Twitter be used to predict county excessive alcohol consumption rates?	PLOS ONE			English	Article							SOCIAL MEDIA; STATES; RISK	Objectives The current study analyzes a large set of Twitter data from 1,384 US counties to determine whether excessive alcohol consumption rates can be predicted by the words being posted from each county. Methods Data from over 138 million county-level tweets were analyzed using predictive modeling, differential language analysis, and mediating language analysis. Results Twitter language data captures cross-sectional patterns of excessive alcohol consumption beyond that of sociodemographic factors (e.g. age, gender, race, income, education), and can be used to accurately predict rates of excessive alcohol consumption. Additionally, mediation analysis found that Twitter topics (e.g. 'ready gettin leave') can explain much of the variance associated between socioeconomics and excessive alcohol consumption. Conclusions Twitter data can be used to predict public health concerns such as excessive drinking. Using mediation analysis in conjunction with predictive modeling allows for a high portion of the variance associated with socioeconomic status to be explained.	[Curtis, Brenda; Summers, Dan; Hamilton, Casey] Univ Penn, Perelman Sch Med, Ctr Continuum Care Addict, Philadelphia, PA 19104 USA; [Giorgi, Salvatore; Buffone, Anneke E. K.] Univ Penn, Dept Psychol, Posit Psychol Ctr, 3815 Walnut St, Philadelphia, PA 19104 USA; [Ungar, Lyle H.] Univ Penn, Comp & Informat Sci Dept, Philadelphia, PA 19104 USA; [Ashford, Robert D.] Univ Penn, Ctr Continuum Care Addict, Philadelphia, PA 19104 USA; [Hemmons, Jessie] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schwartz, H. Andrew] SUNY Stony Brook, Dept Comp Sci, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Curtis, B (corresponding author), Univ Penn, Perelman Sch Med, Ctr Continuum Care Addict, Philadelphia, PA 19104 USA.	bcurtis@upenn.edu	Curtis, Brenda/AAU-2837-2021; Schwartz, H. Andrew/AAE-7276-2021	Ashford, Robert/0000-0003-3979-1754	NIDA [R01DA039457]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039457] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Preparation of the manuscript was supported in part by NIDA grant R01DA039457 to BC and the Templeton Research Trust to LHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CDC D BRFSS D SMART, BRFSS CITY COUNTY DA; Centers for Disease Control, 2009, AM COMMUNITY SURVEY; Centers for Disease Control and Prevention, 2012, ALC REL DIS IMP ARDI; Centers for Disease Control and Prevention, 2015, BRFSS PREV TRENDS DA; Chee Brant W, 2011, AMIA Annu Symp Proc, V2011, P217; Coppersmith Glen, 2014, P WORKSH COMP LING C, P51, DOI DOI 10.3115/V1/W14-3207; Culotta A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P1335, DOI 10.1145/2556288.2557139; Culotta A, 2013, LANG RESOUR EVAL, V47, P217, DOI 10.1007/s10579-012-9185-0; Curtis B, 2015, DRUG ALCOHOL REV, V34, P105, DOI 10.1111/dar.12189; Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18; DeChoudhury M., 2013, 2013 7 INT AAAI C WE, P1; Eichstaedt JC, 2015, PSYCHOL SCI, V26, P159, DOI 10.1177/0956797614557867; Fairbrother M, 2013, SOC SCI RES, V42, P347, DOI 10.1016/j.ssresearch.2012.09.008; Gallup, 2015, ALC DRINK; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2006, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greaves F, 2013, BMJ QUAL SAF, V22, P251, DOI 10.1136/bmjqs-2012-001527; Guntuku SC, 2017, CURR OPIN BEHAV SCI, V18, P43, DOI 10.1016/j.cobeha.2017.07.005; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Hoffman EW, 2014, J AM COLL HEALTH, V62, P328, DOI 10.1080/07448481.2014.902837; Ireland ME, 2015, HEALTH PSYCHOL, V34, P1252, DOI 10.1037/hea0000279; Jena AB, 2013, CLIN INFECT DIS; Kim AE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4466; McCallum, 2002, MALLET MACHINE LEARN; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Meyers K, 2015, INT J DRUG POLICY, V26, P670, DOI 10.1016/j.drugpo.2015.01.012; Michalak L, 2007, DRUG ALCOHOL DEPEN, V87, P268, DOI 10.1016/j.drugalcdep.2006.07.013; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Pearl R., 1926, ALCHOHOL LONGEVITY; Poulson RL, 1998, J AM COLL HEALTH, V46, P227, DOI 10.1080/07448489809600227; ROOM R, 1990, RES ADV ALCOHOL DRUG, V10, P39; Schootman M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006678; Schwartz H. A., 2013, CHARACTERIZING GEOGR; Schwartz H. A., 2013, 2013 AAAI SPRING S S; Schwartz H.A., 2014, P WORKSH COMP LING C, P118, DOI DOI 10.3115/V1/W14-3214; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Schwartz HA., 2017, EMNLP 2017 P 2017 C, P55; Sinnenberg L, 2016, JAMA CARDIOL, V1, P1032, DOI 10.1001/jamacardio.2016.3029; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, https://doi.org/10.2307/270723]; Substance Abuse and Mental Health Services Administration, 2015, 2014 NATL SURVEY DRU; Nguyen T, 2015, J EPIDEMIOL COMMUN H, V69, P693, DOI 10.1136/jech-2014-204523; United States Census Bureau, PROF GEN POP HOUS CH; US Census Bureau, FOREIGN BORN POPULAT; White A, 2013, ALCOHOL RES-CURR REV, V35, P201; Xu F, 2014, MMWR SURVEILL SUMM, V63, P1; Yang CC, 2012, PROCEEDINGS OF THE 2012 INTERNATIONAL WORKSHOP ON SMART HEALTH AND WELLBEING, P33	51	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194290	10.1371/journal.pone.0194290	http://dx.doi.org/10.1371/journal.pone.0194290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617408	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800025
J	Liverani, E; Mondrinos, MJ; Sun, S; Kunapuli, SP; Kilpatrick, LE				Liverani, Elisabetta; Mondrinos, Mark J.; Sun, Shuang; Kunapuli, Satya P.; Kilpatrick, Laurie E.			Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PKC-DELTA; ORGAN DYSFUNCTION; NEUTROPHIL; INFLAMMATION; MICE; THROMBOCYTOPENIA; BIODISTRIBUTION; PATHOGENESIS	Sepsis is characterized by an intense systemic inflammatory response activating a cascade of proinflammatory events resulting in leukocyte dysregulation and host tissue damage. The lung is particularly susceptible to systemic inflammation, leading to acute lung injury. Key to inflammation-induced lung damage is the excessive migration of neutrophils across the vascular endothelium. The mechanisms which regulate neutrophil activation and migration in sepsis are not well defined but there is growing evidence that platelets are actively involved and play a key role in microvascular permeability and neutrophil-mediated organ damage. We previously identified PKC-delta (PKC delta) as a critical regulator of the inflammatory response in sepsis and demonstrated PKC delta inhibition was lung protective. However, the role of PKC delta in sepsis-induced platelet activation and platelet-leukocyte interactions is not known. In this study, rats underwent sham surgery or cecal ligation and puncture (CLP) to induce sepsis. Following surgeries, a PKC delta inhibitor (200 mu g/kg) or vehicle (PBS) was administered intra-tracheally. At 24 hours post-surgeries, lung tissue, BAL fluid, and blood samples were collected. While sepsis caused thrombocytopenia, the remaining circulating platelets were activated as demonstrated by increased p-selectin expression, elevated plasma PF4, and enhanced platelet-leukocyte aggregate formation compared to Sham animals. Platelet activation was associated with increased platelet PKC delta activity. Inhibition of PKC delta attenuated sepsis-induced platelet activation, secretion and aggregate formation. Sepsis-induced thrombocytopenia was also significantly reduced and circulating platelet numbers were similar to sham animals. In the lung, sepsis induced significant influx of platelets and neutrophils and the development of lung injury. Administration of the PKC delta inhibitor decreased platelet and neutrophil influx, and was lung protective. Thus, PKC delta inhibition modulated platelet activity both locally and systemically, decreased neutrophil influx into the lung, and was lung protective. We demonstrate for the first time that PKC delta plays an important role in platelet activation and platelet-neutrophil interaction during sepsis.	[Liverani, Elisabetta; Mondrinos, Mark J.; Kunapuli, Satya P.; Kilpatrick, Laurie E.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Liverani, Elisabetta; Mondrinos, Mark J.; Sun, Shuang; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.; Kilpatrick, Laurie E.] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liverani, E (corresponding author), Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.; Liverani, E (corresponding author), Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	eliliverani@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456	National Institutes of Health, National Heart, Lung, and Blood Institute [HL111552, GM114359, HL93231, HL118593]; American Heart Association [16SDG26980003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114359] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov) grant HL111552 (L.E.K.), GM114359 (L.E.K.), HL93231 (S.P.K.) and HL118593 (SPK) and the American Heart Association (www.heart.org) grant 16SDG26980003 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2009, CRIT CARE MED, V37, P1389, DOI 10.1097/CCM.0b013e31819ceb71; Bdeir K, 2017, AM J RESP CELL MOL, V56, P261, DOI 10.1165/rcmb.2015-0245OC; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Bhavanasi D, 2015, PLATELETS, V26, P2, DOI 10.3109/09537104.2013.868877; Bhavanasi D, 2011, BIOCHEM PHARMACOL, V82, P720, DOI 10.1016/j.bcp.2011.06.032; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Bye AP, 2016, J THROMB HAEMOST, V14, P918, DOI 10.1111/jth.13302; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Danahay H, 1999, PHARMACEUT RES, V16, P1542, DOI 10.1023/A:1015048419558; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Drechsler Susanne, 2015, Intensive Care Med Exp, V3, P48, DOI 10.1186/s40635-015-0048-z; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; Faraday N, 2001, ANESTHESIOLOGY, V94, P145, DOI 10.1097/00000542-200101000-00025; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Hagiwara S, 2011, SHOCK, V35, P289, DOI 10.1097/SHK.0b013e3181f48987; Harr JN, 2011, SHOCK, V36, P595, DOI 10.1097/SHK.0b013e318231ee76; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kilpatrick LE, 2000, AM J PHYSIOL-CELL PH, V279, pC2011, DOI 10.1152/ajpcell.2000.279.6.C2011; Kim WY, 2016, TUBERC RESPIR DIS, V79, P53, DOI 10.4046/trd.2016.79.2.53; Kostyak JC, 2014, ARTERIOSCL THROM VAS, V34, P2579, DOI 10.1161/ATVBAHA.114.304492; Liverani E, 2016, ARTERIOSCL THROM VAS, V36, P961, DOI 10.1161/ATVBAHA.116.307401; Liverani E, 2014, J LEUKOCYTE BIOL, V95, P313, DOI 10.1189/jlb.1012518; Liverani E, 2013, J PHARMACOL EXP THER, V344, P231, DOI 10.1124/jpet.112.195883; Liverani E, 2012, BIOCHEM PHARMACOL, V83, P1364, DOI 10.1016/j.bcp.2012.02.006; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; Middleton EA, 2016, PHYSIOL REV, V96, P1211, DOI 10.1152/physrev.00038.2015; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Salter JW, 2001, AM J PHYSIOL-GASTR L, V281, pG1432, DOI 10.1152/ajpgi.2001.281.6.G1432; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slaba I, 2015, HEPATOLOGY, V62, P1593, DOI 10.1002/hep.28003; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Strauss R, 2002, CRIT CARE MED, V30, P1765, DOI 10.1097/00003246-200208000-00015; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Venkata C, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-9; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wuescher LM, 2015, J THROMB HAEMOST, V13, P303, DOI 10.1111/jth.12795; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zhang ZH, 2015, HEART LUNG VESSEL, V7, P64	59	24	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195379	10.1371/journal.pone.0195379	http://dx.doi.org/10.1371/journal.pone.0195379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617417	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800079
J	Zhong, RQ; Cui, DT; Ye, ZH				Zhong, Ruiqin; Cui, Dongtao; Ye, Zheng-Hua			A group of Populus trichocarpa DUF231 proteins exhibit differential O-acetyltransferase activities toward xylan	PLOS ONE			English	Article							CELLULOSE SYNTHASE-LIKE; REDUCING END-GROUPS; WOOD FORMATION; ACETYLATED HETEROXYLAN; GLUCURONIC-ACID; ARABIDOPSIS; BIOSYNTHESIS; POPLAR; DOMAIN; GENES	Wood represents the most abundant biomass produced by plants and one of its major components is acetyl xylan. Acetylation in xylan can occur at O-2 or O-3 of a xylosyl residue, at both O-2 and O-3 of a xylosyl residue, and at O-3 of a xylosyl residue substituted at O-2 with glucuronic acid. Acetyltransferases responsible for the regiospecific acetylation of xylan in tree species have not yet been characterized. Here we report the biochemical characterization of twelve Populus trichocarpa DUF231-containing proteins, named PtrXOATs, for their roles in the regiospecific acetylation of xylan. The PtrXOAT genes were found to be differentially expressed in Populus organs and among them, PtrXOAT1, PtrXOAT2, PtrXOAT9 and PtrXOAT1 0 exhibited the highest level of expression in stems undergoing wood formation. Activity assays of recombinant proteins demonstrated that all twelve PtrXOAT proteins were able to transfer acetyl groups from acetyl CoA onto a xylohexaose acceptor with PtrXOAT1, PtrXOAT2, PtrXOAT3, PtrXOAT11 and PtrXOAT12 having the highest activity. Structural analysis of the PtrXOAT-catalyzed reaction products using H-1 NMR spectroscopy revealed that PtrXOAT1, PtrXAOT2 and PtrXOAT3 mediated 2-O- and 3-O-monoacetylation and 2,3-di-O-acetylation of xylosyl residues and PtrXOAT11 and PtrXOAT12 only catalyzed 2-O-and 3-O-monoacetylation of xylosyl residues. Of the twelve PtrXOATs, only PtrXOAT9 and PtrXOAT10 were capable of transferring acetyl groups onto the O-3 position of 2-O-glucuronic acid-substituted xylosyl residues. Furthermore, when expressed in the Arabidopsis eskimol mutant, PtrXOAT1, PtrXAOT2 and PtrXOAT3 were able to rescue the defects in xylan acetylation. Together, these results demonstrate that the twelve PtrXOATs are acetyltransferases with different roles in xylan acetylation in P. trichocarpa.	[Zhong, Ruiqin; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Cui, Dongtao] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	yh@uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science; US Department of Energy [DE-FG02-03ER15415]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science; US Department of Energy(United States Department of Energy (DOE))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science, the US Department of Energy through grant DE-FG02-03ER15415 to ZHY (http://science.energy.gov/bes/csgb/researchareas/physical-biosciences/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SI, 1983, CARBOHYD RES, V111, P283, DOI 10.1016/0008-6215(83)88312-8; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Evtuguin DV, 2003, CARBOHYD RES, V338, P597, DOI 10.1016/S0008-6215(02)00529-3; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728; Goncalves VMF, 2008, CARBOHYD RES, V343, P256, DOI 10.1016/j.carres.2007.11.002; Grondahl M, 2003, CARBOHYD POLYM, V52, P359, DOI 10.1016/S0144-8617(03)00014-6; Helle S, 2003, ENZYME MICROB TECH, V33, P786, DOI 10.1016/S0141-0229(03)00214-X; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Joshi CP, 2011, MOL PLANT, V4, P331, DOI 10.1093/mp/ssq081; Kabel MA, 2007, CARBOHYD POLYM, V69, P94, DOI 10.1016/j.carbpol.2006.09.006; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT SIGNAL BEHAV, V7, P332, DOI 10.4161/psb.19269; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lee C, 2009, PLANT CELL PHYSIOL, V50, P1982, DOI 10.1093/pcp/pcp131; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Neumuller KG, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-014-0187-6; Pawar PMA, 2017, NEW PHYTOL, V214, P1491, DOI 10.1111/nph.14489; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Shimizu K., 1976, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V22, P618; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Teleman A, 2002, CARBOHYD RES, V337, P373, DOI 10.1016/S0008-6215(01)00327-5; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Ye ZH, 2015, J EXP BOT, V66, P4119, DOI 10.1093/jxb/erv081; Yuan YX, 2016, PLANT SCI, V243, P120, DOI 10.1016/j.plantsci.2015.12.007; Yuan YX, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv172; Yuan YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146460; Yuan YX, 2014, PLANT SCI, V219, P42, DOI 10.1016/j.plantsci.2014.01.005; Yuan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087370; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2017, PLANT CELL PHYSIOL, V58, P2126, DOI 10.1093/pcp/pcx147; Zhong RQ, 2017, PLANT CELL PHYSIOL, V58, P156, DOI 10.1093/pcp/pcw179; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194532	10.1371/journal.pone.0194532	http://dx.doi.org/10.1371/journal.pone.0194532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617384	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800034
J	Fechner, S; Grant, K; von der Emde, G; Engelmann, J				Fechner, Sylvia; Grant, Kirsty; von der Emde, Gerhard; Engelmann, Jacob			Physiological evidence of sensory integration in the electrosensory lateral line lobe of Gnathonemus petersii	PLOS ONE			English	Article							WEAKLY ELECTRIC FISH; MORMYRID FISH; COROLLARY DISCHARGE; TOPOGRAPHIC MAPS; AUDITORY-CORTEX; RESPONSES; NEURONS; ELECTRORECEPTOR; ORGANIZATION; CONNECTIONS	Mormyrid fish rely on reafferent input for active electrolocation. Their electrosensory input consists of phase and amplitude information. These are encoded by differently tuned receptor cells within the Mormyromasts, A- and B-cells, respectively, which are distributed over the animal's body. These convey their information to two topographically ordered medullary zones in the electrosensory lateral line lobe (ELL). The so-called medial zone receives only amplitude information, while the dorsolateral zone receives amplitude and phase information. Using both sources of information, Mormyrid fish can disambiguate electrical impedances. Where and how this disambiguation takes place is presently unclear. We here investigate phase-sensitivity downstream from the electroreceptors. We provide first evidence of phase-sensitivity in the medial zone of ELL. In this zone I-cells consistently decreased their rate to positive phase-shifts (6 of 20 cells) and increased their rate to negative shifts (11/20), while E-cells of the medial zone (3/9) responded oppositely to I-cells. In the dorsolateral zone the responses of E-and I-cells were opposite to those found in the medial zone. Tracer injections revealed interzonal projections that interconnect the dorsolateral and medial zones in a somatotopic manner. In summary, we show that phase information is processed differently in the dorsolateral and the medial zones. This is the first evidence for a mechanism that enhances the contrast between two parallel sensory channels in Mormyrid fish. This could be beneficial for impedance discrimination that ultimately must rely on a subtractive merging of these two sensory streams.	[Fechner, Sylvia; von der Emde, Gerhard; Engelmann, Jacob] Univ Bonn, Inst Zool, Bonn, Germany; [Grant, Kirsty] UNIC, CNRS, 1 Ave Terrasse, Gif Sur Yvette, France; [Engelmann, Jacob] Univ Bielefeld, Biol AG Act Sensing, Bielefeld, Germany; [Fechner, Sylvia] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	University of Bonn; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Bielefeld; Stanford University	Engelmann, J (corresponding author), Univ Bonn, Inst Zool, Bonn, Germany.; Engelmann, J (corresponding author), Univ Bielefeld, Biol AG Act Sensing, Bielefeld, Germany.	Jacob.Engelmann@uni-bielefeld.de		Engelmann, Jacob/0000-0002-1054-0938; Fechner, Sylvia/0000-0003-4440-6611	Deutsche Forschungsgemeinschaft [EN 826/4-1]; Deutscher Akademischer Austauschdienst (DAAD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Grant EN 826/4-1 from the Deutsche Forschungsgemeinschaft, http//www.dfg.de/; and a travel grant by the Deutscher Akademischer Austauschdienst (DAAD), https://www.daad.de/de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacelo J, 2008, J COMP NEUROL, V511, P342, DOI 10.1002/cne.21843; BARLOW HB, 1986, VISION RES, V26, P81, DOI 10.1016/0042-6989(86)90072-6; Bell C.C., 1986, P375; Bell CC, 2005, SPR HDB AUD, V21, P68; BELL CC, 1992, J NEUROPHYSIOL, V68, P843, DOI 10.1152/jn.1992.68.3.843; Bell CC, 1997, J NEUROSCI, V17, P6409; BELL CC, 1978, J COMP NEUROL, V182, P367, DOI 10.1002/cne.901820302; BELL CC, 1981, EXP BRAIN RES, V42, P9; BELL CC, 1990, J NEUROPHYSIOL, V63, P319, DOI 10.1152/jn.1990.63.2.319; Braford M. R. Jr., 1993, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V173, P704; Brown WM, 2006, NEURAL COMPUT, V18, P1511, DOI 10.1162/neco.2006.18.7.1511; Engelmann J, 2006, J NEUROPHYSIOL, V95, P1231, DOI 10.1152/jn.00405.2005; FINGER TE, 1981, EXP BRAIN RES, V42, P23; Goenechea L, 2004, J COMP PHYSIOL A, V190, P907, DOI 10.1007/s00359-004-0548-x; Graziano MSA, 2007, NEUROSCIENTIST, V13, P138, DOI 10.1177/1073858406295918; HEILIGENBERG W, 1978, SCIENCE, V199, P1001, DOI 10.1126/science.622577; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; Kaas J., 1982, CONTRIBUTIONS SENSOR, P200; Kaas J H, 1989, J Cogn Neurosci, V1, P121, DOI 10.1162/jocn.1989.1.2.121; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Khosravi-Hashemi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040339; Krahe R, 2014, CURR OPIN NEUROBIOL, V24, P13, DOI 10.1016/j.conb.2013.08.013; Lee CC, 2004, NEUROSCIENCE, V128, P871, DOI 10.1016/j.neuroscience.2004.06.062; LISSMANN HW, 1958, J EXP BIOL, V35, P451; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; Meek J, 1999, J EXP BIOL, V202, P1291; Meek J, 2004, J COMP NEUROL, V468, P151, DOI 10.1002/cne.10951; Meek J, 2001, J COMP NEUROL, V431, P255, DOI 10.1002/1096-9861(20010312)431:3<255::AID-CNE1069>3.0.CO;2-9; Metzen MG, 2008, J COMP PHYSIOL A, V194, P1063, DOI 10.1007/s00359-008-0377-4; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Mohr C, 2003, J NEUROPHYSIOL, V90, P1193, DOI 10.1152/jn.00211.2003; Sawtell NB, 2005, CURR OPIN NEUROBIOL, V15, P437, DOI 10.1016/j.conb.2005.06.006; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; SHUMWAY CA, 1989, J NEUROSCI, V9, P4388; SZABO T, 1967, PHYSIOL BEHAV, V2, P331, DOI 10.1016/0031-9384(67)90047-9; SZABO T, 1970, J ULTRA MOL STRUCT R, V30, P473, DOI 10.1016/S0022-5320(70)90048-1; van Hemmen JL, 2002, CHEMPHYSCHEM, V3, P291, DOI 10.1002/1439-7641(20020315)3:3<291::AID-CPHC291>3.0.CO;2-M; VonderEmde G, 1996, J NEUROPHYSIOL, V76, P1581, DOI 10.1152/jn.1996.76.3.1581; VONDEREMDE G, 1992, J COMP PHYSIOL A, V171, P683, DOI 10.1007/BF00194116; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P801, DOI 10.1007/BF00191852; vonderEmde G, 1997, J COMP PHYSIOL A, V181, P511, DOI 10.1007/s003590050135; VONDEREMDE G, 1992, NATURWISSENSCHAFTEN, V79, P131, DOI 10.1007/BF01131542; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P83, DOI 10.1007/BF00217439; VONDEREMDE G, 1993, J EXP BIOL, V181, P157; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; Vonderschen K, 2011, SPARSE DENSE CODING, P3102; Weinberg RJ, 1997, BRAIN RES BULL, V44, P113, DOI 10.1016/S0361-9230(97)00095-6; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009	49	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194347	10.1371/journal.pone.0194347	http://dx.doi.org/10.1371/journal.pone.0194347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641541	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900030
J	Mactaggart, I; Banks, LM; Kuper, H; Murthy, GVS; Sagar, J; Oye, J; Polack, S				Mactaggart, Islay; Banks, Lena Morgon; Kuper, Hannah; Murthy, G. V. S.; Sagar, Jayanthi; Oye, Joseph; Polack, Sarah			Livelihood opportunities amongst adults with and without disabilities in Cameroon and India: A case control study	PLOS ONE			English	Article							POVERTY; IMPAIRMENT; EMPLOYMENT	Proven links between disability and poverty suggest that development programmes and policies that are not disability-inclusive will leave persons with disabilities behind. Despite this, there is limited quantitative evidence on livelihood opportunities amongst adults with disabilities in Low and Middle Income Countries. This study adds to the limited evidence base, contributing data from one African and one Asian Setting. We undertook a population-based case control study of adults (18+) with and without disabilities in North-West Cameroon and in Telangana State, India. We found that adults with disabilities were five times less likely to be working compared to age-sex matched controls in both settings. Amongst adults with disabilities, current age, marital status and disability type were key predictors of working. Inclusive programmes are therefore needed to provide adequate opportunities to participate in livelihood prospects for adults with disabilities in Cameroon and India, on an equal basis as others. These findings are of crucial importance at this stage of the Sustainable Development Agenda, to ensure that the mandate of inclusive development is achieved.	[Mactaggart, Islay; Banks, Lena Morgon; Kuper, Hannah; Polack, Sarah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [Murthy, G. V. S.; Sagar, Jayanthi] Indian Inst Publ Hlth Hyderabad, South Asia Ctr Disabil Inclus Dev & Res, Hyderabad, Telangana, India; [Oye, Joseph] Sightsavers Cameroon, Yaounde, Cameroon	University of London; London School of Hygiene & Tropical Medicine	Mactaggart, I (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.	Islay.Mactaggart@Ishtm.ac.uk		Mactaggart, Islay/0000-0001-6287-0384; Banks, Lena Morgon/0000-0002-4585-1103	CBM International [2058-2012, 06.05]	CBM International	This study was funded by CBM International (www.cbm.org) under Project Number 2058-2012 Code 06.05. The funder did not have any role in study design, collection, analysis or interpretation of the data, writing the manuscript or the decision to submit the article for publication.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; [Anonymous], 2015, HUM DEV REP 2015 WOR; [Anonymous], 2016, 102016 EQ TIM; [Anonymous], INCLUSION COUNTS EC; [Anonymous], 2000, DESIGNING HOUSEHOLD; [Anonymous], DESIGNING HOUSEHOLD; [Anonymous], 2015, DISABIL REHABIL; [Anonymous], DISABILITY INDIA ISS; [Anonymous], 2011, WORLD REP DIS; Atijosan O, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-30; Banks LM, 2016, OXFORD DEV STUDIES, P1; Braithwaite J, 2009, ALTER, V3, P219, DOI 10.1016/j.alter.2008.10.002; CHAMBERS R, 1995, ENVIRON URBAN, V7, P173, DOI 10.1177/095624789500700106; Chambers R., 1992, SUSTAINABLE RURAL LI; Eide A.H., 2009, LIVING CONDITIONS PE; Elwan A, 1999, POVERTY DISABILITY S; Fritz D, 2009, J INT DEV, V21, P673, DOI 10.1002/jid.1595; Groce N, 2011, WORKING PAPER SERIES; Groce N, 2012, INTERGENERATIONAL PO; Groce NE, 2009, LANCET, V374, P1800, DOI 10.1016/S0140-6736(09)61909-7; Gupta A., 2016, MIER J ED STUDIES TR, V1; Habtamu E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004228; Helin C., 2014, DANCES DEPENDENCY OU; Hiranandani V., 2010, DISABILITY STUDIES Q, V30; Jones MK, 2011, APPL ECON, V43, P1001, DOI 10.1080/00036840802600053; Jones MK, 2008, J ECON STUD, V35, P405, DOI 10.1108/01443580810903554; Kavanagh AM, 2015, DISABIL HEALTH J, V8, P191, DOI 10.1016/j.dhjo.2014.08.008; Kemp P.A., 2006, SICK SOC TRENDS DISA; Kumar Arun., 2012, DISABILITY STUDIES Q, V32, DOI 10.18061/dsq.v32i3.3235; Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300; Loeb M, 2004, LIVING CONDITIONS PE; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mactaggart I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164470; Madans JH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S4; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Milligan MS, 2001, SEX DISABIL, V19, P91, DOI 10.1023/A:1010621705591; Mitra S., 2011, DISCUSSION PAPER SER; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; Mizunoya S, 2013, WORLD DEV, V42, P28, DOI 10.1016/j.worlddev.2012.05.037; Mont D, 2011, WORLD BANK ECON REV, V25, P323, DOI 10.1093/wber/lhr019; Norek P, LIVELIHOOD CHALLENGE; Organisation for Economic Co- Operation and Development, 2010, SICKN DIS WORK BREAK; Palmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133623; Ray M, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.73.12167; Rischewski D, 2008, T ROY SOC TROP MED H, V102, P608, DOI 10.1016/j.trstmh.2008.02.023; Shakespeare Tom, 2013, DISABILITY RIGHTS WR, DOI [10.4324/9781315887456, DOI 10.4324/9781315887456]; Simms V, 2008, TROP MED INT HEALTH, V13, P1047, DOI 10.1111/j.1365-3156.2008.02108.x; Smith A., 1999, WHO EAR HEARING DISO; Soulsby L. K., 2015, PSYCHOLOGY, V6, P1349, DOI DOI 10.4236/PSYCH.2015.611132; Trani JF, 2012, J INT DEV, V24, pS19, DOI 10.1002/jid.1709; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; UN, 2015, 2030 AG SUST DEV; UNDP India, 2013, LIV OPP PERS DIS; United Nations, 2011, DIS MILL DEV GOALS R; United Nations, UN TREAT COLL; United Nations, 2015, MILLENNIUM DEV GOALS; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; United Nations Development Programme (UNDP), 2017, HUM DEV REP 2016 HUM; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Waddell G., 2006, IS WORK GOOD YOUR HL; World Health Organization, INT CLASS FUNCT DIS; Yeo R., 2001, CHRONIC POVERTY RES; Zamo-akono C, 2013, INT J HUM RESOUR MAN, V3, P1	64	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194105	10.1371/journal.pone.0194105	http://dx.doi.org/10.1371/journal.pone.0194105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630606	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000005
J	Arpino, B; Guma, J; Julia, A				Arpino, Bruno; Guma, Jordi; Julia, Albert			Early-life conditions and health at older ages: The mediating role of educational attainment, family and employment trajectories	PLOS ONE			English	Article							SCORE MATCHING APPROACH; SEQUENCE-ANALYSIS; SOCIOECONOMIC-STATUS; CHILDHOOD HEALTH; MORTALITY; ADULTHOOD; HISTORY; MODELS; IMPACT; FERTILITY	Objectives We examine to what extent the effect of early-life conditions (health and socioeconomic status) on health in later life is mediated by educational attainment and life-course trajectories (fertility, partnership, employment). Methods Using data from the Survey of Health, Ageing and Retirement in Europe (N = 12,034), we apply, separately by gender, multichannel sequence analysis and cluster analysis to obtain groups of similar family and employment histories. The KHB method is used to disentangle direct and indirect effects of early-life conditions on health. Results Early-life-conditions indirectly impact on health in later life as result of their influence on education and family and employment trajectories. For example, between 22% and 42% of the effect of low parental socio-economic status at childhood on the three considered health outcomes at older age is explained by educational attainment for women. Even higher percentages are found for men (35% - 57%). On the contrary, the positive effect of poor health at childhood on poor health at older ages is not significantly mediated by education and life course trajectories. Education captures most of the mediating effect of parental socio-economic status. More specifically, between 66% and 75% of the indirect effect of low parental socio-economic status at childhood on the three considered health outcomes at older age is explained by educational attainment for women. Again, higher percentages are found for men (86% - 93%). Early-life conditions, especially socioeconomic status, influence family and employment trajectories indirectly through their impact on education. We also find a persistent direct impact of early-life conditions on health at older ages. Conclusions Our findings demonstrate that early-life experiences influence education and life-course trajectories and health in later life, suggesting that public investments in children are expected to produce long lasting effects on people's lives throughout the different phases of their life course.	[Arpino, Bruno; Guma, Jordi; Julia, Albert] Univ Pompeu Fabra, Dept Polit & Social Sci, Barcelona, Spain	Pompeu Fabra University	Arpino, B (corresponding author), Univ Pompeu Fabra, Dept Polit & Social Sci, Barcelona, Spain.	bruno.arpino@upf.edu	arpino, bruno/G-2775-2013; Arpino, Bruno/AAF-3867-2019; Gumà, Jordi/A-3657-2016	arpino, bruno/0000-0002-8374-3066; Gumà, Jordi/0000-0003-2640-5391	Spanish Ministry of Economy, Industry and Competitiveness within the second Joint Programming Initiative "More Years Better Lives" [PCIN-2016-005]	Spanish Ministry of Economy, Industry and Competitiveness within the second Joint Programming Initiative "More Years Better Lives"	This study belongs to the multi-country project Care, Retirement & Wellbeing of Older People Across Different Welfare Regimes (CREW). The authors acknowledge funding from the Spanish Ministry of Economy, Industry and Competitiveness (PCIN-2016-005; PI: Bruno Arpino) within the second Joint Programming Initiative More Years Better Lives. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aassve A, 2007, EUR J POPUL, V23, P369, DOI 10.1007/s10680-007-9134-6; Aisenbrey S, 2010, SOCIOL METHOD RES, V38, P420, DOI 10.1177/0049124109357532; Alcser KH, 2005, SURVEY HLTH AGING RE; Balbo N, 2016, DEMOGRAPHY, V53, P955, DOI 10.1007/s13524-016-0480-z; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Berger N, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-1; Blomgren J, 2012, J EPIDEMIOL COMMUN H, V66, P30, DOI 10.1136/jech.2010.110635; Borsch-Supan A., 2008, STARTING LONGITUDINA; Breen R, 2013, SOCIOL METHOD RES, V42, P164, DOI 10.1177/0049124113494572; Brockmann H, 2004, J MARRIAGE FAM, V66, P567, DOI 10.1111/j.0022-2445.2004.00038.x; Caro DH, 2015, BRIT J SOCIOL EDUC, V36, P934, DOI 10.1080/01425692.2013.868784; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Croezen S, 2016, EUR J PUBLIC HEALTH, V26, P686, DOI 10.1093/eurpub/ckw017; Deindl C, 2013, ADV LIFE COURSE RES, V18, P107, DOI 10.1016/j.alcr.2012.10.008; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Doblhammer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074915; Eshak ES, 2017, STROKE IN PRESS; Flores M, 2014, EMPIR ECON, V47, P1251, DOI 10.1007/s00181-013-0785-3; Gabadinho A, 2011, J STAT SOFTW, V40, P1; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gauthier JA, 2010, SOCIOL METHODOL, V40, P1, DOI 10.1111/j.1467-9531.2010.01227.x; Gebel M, 2014, SOC SCI MED, V108, P128, DOI 10.1016/j.socscimed.2014.02.039; Gibb SJ, 2012, SOC SCI MED, V74, P1979, DOI 10.1016/j.socscimed.2012.02.028; Granville G, 2010, OCCUP MED-OXFORD, V60, P178, DOI 10.1093/occmed/kqq027; Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046; Guma J, 2015, EUR J AGEING, V12, P71, DOI 10.1007/s10433-014-0316-x; Haas SA, 2007, DEMOGRAPHY, V44, P113, DOI 10.1353/dem.2007.0003; Hank K, 2010, POP STUD-J DEMOG, V64, P275, DOI 10.1080/00324728.2010.506243; Havari E, 2015, EUR J POPUL, V31, P233, DOI 10.1007/s10680-014-9332-y; Janzen BL, 2003, SOC SCI MED, V57, P1491, DOI 10.1016/S0277-9536(02)00544-0; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kaufman L., 2005, FINDING GROUPS DATA; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Keizer R, 2008, J BIOSOC SCI, V40, P863, DOI 10.1017/S0021932007002660; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Liefbroer AC, 1999, EUR J POPUL, V15, P45, DOI 10.1023/A:1006137104191; Luo Y, 2005, J GERONTOL B-PSYCHOL, V60, pS93, DOI 10.1093/geronb/60.2.S93; Myrskyla M, 2014, SOC SCI MED, V119, P175, DOI 10.1016/j.socscimed.2014.09.031; O'Flaherty M, 2016, DEMOGRAPHY, V53, P777, DOI 10.1007/s13524-016-0478-6; Ponomarenko V, AGEING SOC IN PRESS; Pudrovska T, 2014, J GERONTOL B-PSYCHOL, V69, P451, DOI 10.1093/geronb/gbt122; Ross CE, 2012, DEMOGRAPHY, V49, P1157, DOI 10.1007/s13524-012-0130-z; Ross CE, 2010, SOCIOL QUART, V51, P1, DOI 10.1111/j.1533-8525.2009.01164.x; Sankoff D., 1983, TIME WARPS STRING ED; Sloboda DM, 2011, HUM REPROD UPDATE, V17, P210, DOI 10.1093/humupd/dmq048; van den Berg GJ, 2015, J HEALTH ECON, V40, P141, DOI 10.1016/j.jhealeco.2014.02.004; Yan M, 2005, METHODS DETERMINING	47	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195320	10.1371/journal.pone.0195320	http://dx.doi.org/10.1371/journal.pone.0195320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621290	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800059
J	Aswani, S; Lemahieu, A; Sauer, WHH				Aswani, Shankar; Lemahieu, Anne; Sauer, Warwick H. H.			Global trends of local ecological knowledge and future implications	PLOS ONE			English	Article							TRADITIONAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; ETHNOBOTANICAL KNOWLEDGE; CULTURAL EROSION; FISHING COMMUNITIES; MEDICINAL-PLANTS; BIODIVERSITY; FOREST; MANAGEMENT; FOOD	Local and indigenous knowledge is being transformed globally, particularly being eroded when pertaining to ecology. In many parts of the world, rural and indigenous communities are facing tremendous cultural, economic and environmental changes, which contribute to weaken their local knowledge base. In the face of profound and ongoing environmental changes, both cultural and biological diversity are likely to be severely impacted as well as local resilience capacities from this loss. In this global literature review, we analyse the drivers of various types of local and indigenous ecological knowledge transformation and assess the directionality of the reported change. Results of this analysis show a global impoverishment of local and indigenous knowledge with 77% of papers reporting the loss of knowledge driven by globalization, modernization, and market integration. The recording of this loss, however, is not symmetrical, with losses being recorded more strongly in medicinal and ethnobotanical knowledge. Persistence of knowledge (15% of the studies) occurred in studies where traditional practices were being maintained consiously and where hybrid knowledge was being produced as a resut of certain types of incentives created by economic development. This review provides some insights into local and indigenous ecological knowledge change, its causes and implications, and recommends venues for the development of replicable and comparative research. The larger implication of these results is that because of the interconnection between cultural and biological diversity, the loss of local and indigenous knowledge is likely to critically threaten effective conservation of biodiversity, particularly in community-based conservation local efforts.	[Aswani, Shankar; Lemahieu, Anne; Sauer, Warwick H. H.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa; [Aswani, Shankar; Lemahieu, Anne] Rhodes Univ, Dept Anthropol, Grahamstown, South Africa; [Lemahieu, Anne] IRD, UMR Espace Dev 228, Reunion Isl, France	Rhodes University; Rhodes University; Institut de Recherche pour le Developpement (IRD)	Aswani, S (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa.; Aswani, S (corresponding author), Rhodes Univ, Dept Anthropol, Grahamstown, South Africa.	s.aswani@ru.ac.za	Sauer, Warwick/GJI-2267-2022	Sauer, Warwick/0000-0002-9756-1757; Lemahieu, Anne/0000-0002-1465-7367; Aswani, Shankar/0000-0002-6201-0576	South African National Research Foundation; Rhodes University	South African National Research Foundation(National Research Foundation - South Africa); Rhodes University	We thank the South African National Research Foundation (incentive funding for rated researchers) and Rhodes University for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the South African National Research Foundation (incentive funding for rated researchers) and Rhodes University for funding this research.	Ahmed S, 2010, ECOL SOC, V15; Aswani S, 2015, ETHNOBIOLOGY, P157, DOI 10.1007/978-3-319-23763-3_10; Awas Tesfaye, 2010, Biodiversity (Ottawa), V11, P45, DOI 10.1080/14888386.2010.9712663; Badshah L, 2011, J MED PLANTS RES, V5, P22; Barreau A, 2016, J ETHNOBIOL IN PRESS, P36; Becker CD, 2003, CONSERV ECOL, V8; Begossi A, 2002, HUM ECOL, V30, P281, DOI 10.1023/A:1016564217719; Benz BF, 2000, ECON BOT, V54, P183, DOI 10.1007/BF02907821; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.2307/2641280; Berkes F., 2008, NAVIGATING SOCIAL EC; Berkes F., 1993, TRADITIONAL ECOLOGIC, P9; Biro E, 2014, J NAT CONSERV, V22, P318, DOI 10.1016/j.jnc.2014.02.006; Bognounou F., 2011, Forests, Trees and Livelihoods, V20, P265, DOI 10.1080/14728028.2011.9756713; de Almeida CDCBR, 2010, J ETHNOPHARMACOL, V127, P674, DOI 10.1016/j.jep.2009.12.005; Brosi BJ, 2007, CONSERV BIOL, V21, P875, DOI 10.1111/j.1523-1739.2007.00654.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Byg A, 2001, ECON BOT, V55, P263, DOI 10.1007/BF02864564; Caniago I, 1998, ECON BOT, V52, P229, DOI 10.1007/BF02862141; Cardinale BJ, 2012, NATURE, V489, P326, DOI 10.1038/nature11373; Case RJ, 2005, ECON BOT, V59, P356, DOI 10.1663/0013-0001(2005)059[0356:FIMIKA]2.0.CO;2; Cox PA, 2000, SCIENCE, P287; Crona BI, 2006, ECOL SOC, V11; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; de Albuquerque UP, 2011, J ETHNOPHARMACOL, V133, P866, DOI 10.1016/j.jep.2010.11.021; DEWALT BR, 1994, HUM ORGAN, V53, P123, DOI 10.17730/humo.53.2.ku60563817m03n73; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dweba TP, 2011, INT J INFORM MANAGE, V31, P564, DOI 10.1016/j.ijinfomgt.2011.02.009; Edwards S. E., 2006, Environment Development and Sustainability, V8, P569, DOI 10.1007/s10668-006-9056-1; Etiendem DN, 2011, ECOL SOC, V16, DOI 10.5751/ES-04182-160322; Fernandez-Llamazares A, 2015, GLOBAL ENVIRON CHANG, V31, P272, DOI 10.1016/j.gloenvcha.2015.02.001; Flatie T, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-14; Flyman MV, 2006, S AFR J BOT, V72, P492, DOI 10.1016/j.sajb.2006.02.003; Gadgil M, 2000, ECOL APPL, V10, P1307; Garcia GSC, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-39; Gazzaneo LRS, 2005, J ETHNOBIOL ETHNOMED, V9, P597; GODOY R, 1994, HUM ORGAN, V53, P233, DOI 10.17730/humo.53.3.e221170878h4701u; Godoy R, 1998, J ANTHROPOL RES, V54, P219, DOI 10.1086/jar.54.2.3631731; Godoy R, 2009, J ANTHROPOL RES, V65, P51, DOI 10.3998/jar.0521004.0065.105; Gomez-Baggethun E, 2013, ECOL SOC, V18, DOI 10.5751/ES-06288-180472; Gomez-Baggethun E, 2013, HUM ECOL, V41, P643, DOI 10.1007/s10745-013-9577-9; Gomez-Baggethun E, 2010, CONSERV BIOL, V24, P721, DOI 10.1111/j.1523-1739.2009.01401.x; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Greenacre M, 2006, STAT SOC BEHAV SCI, P41; Guest G., 2002, J ECOL ANTHR, P6; Hamlin CC, 2003, ECON BOT, V57, P163, DOI 10.1663/0013-0001(2003)057[0163:YAITUP]2.0.CO;2; Hanazaki N, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-75; Harmon D., 1996, SW J LINGUISTICS, V15, P89; Haruyama T, 2004, POLICY SCI, V11, P147; Hoppers C, 2002, INDIG KNOWL INTEGR; Ianni E, 2015, ENVIRON MANAGE, V56, P144, DOI 10.1007/s00267-015-0479-z; Iliev R, 2013, GARDEN EXPT REVISITE, P771; INGOLD T, 1993, ASA MONOGR, V32, P31, DOI 10.4324/9780203449653_chapter_2; Ingold T, 2000, PSYCHOLOGY; Iniesta-Arandia I, 2015, AMBIO, V44, P285, DOI 10.1007/s13280-014-0556-1; Johann E, 2007, FOREST ECOL MANAG, V249, P54, DOI 10.1016/j.foreco.2007.04.049; Kai Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086598; Keller Gudrun B., 2005, Plant Genetic Resources Characterization and Utilization, V3, P400, DOI 10.1079/PGR200594; Kikvidze Z, 2015, AMBIO, V44, P452, DOI 10.1007/s13280-014-0580-1; Kizos T, 2013, LANDSCAPE RES, V38, P476, DOI 10.1080/01426397.2013.783905; Kodirekkala KR, 2015, CULT AGRIC FOOD ENVI, V37, P124, DOI 10.1111/cuag.12059; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Maffi L., 2012, BIOCULTURAL DIVERSIT; Mathez-Stiefel SL, 2012, HUM ECOL, V40, P909, DOI 10.1007/s10745-012-9520-5; McCarter J, 2014, AMBIO, V43, P288, DOI 10.1007/s13280-013-0431-5; McMillen H, 2012, ECON BOT, V66, P121, DOI 10.1007/s12231-012-9201-8; Moller H, 2004, ECOLOGY SOC, V9, P2, DOI DOI 10.5751/ES-00675-090302; National Research Council, 1991, SUST PLAN COLL RES A; Nazarea VD, 2006, ANNU REV ANTHROPOL, V35, P317, DOI 10.1146/annurev.anthro.35.081705.123252; Olowa L. F., 2012, Advances in Environmental Biology, V6, P1442; Olsson P, 2001, ECOSYSTEMS, V4, P85, DOI 10.1007/s100210000061; Oteros-Rozas E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05597-180333; Padilla E, 2014, ECOL SOC, P19; Panghal M, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-4; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pearce T, 2011, HUM ECOL, V39, P271, DOI 10.1007/s10745-011-9403-1; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Quinlan MB, 2007, MED ANTHROPOL Q, V21, P169, DOI [10.1525/maq.2007.21.2.169, 10.1525/MAQ.2007.21.2.169]; Ramirez C. R., 2007, Ethnobotany Research and Applications, V5, P241; Ramstad KM, 2007, CONSERV BIOL, V21, P455, DOI 10.1111/j.1523-1739.2006.00620.x; Reyes-Garcia V, 2007, HUM ECOL, V35, P371, DOI 10.1007/s10745-006-9069-2; Reyes-Garcia V, 2013, LEARN INDIVID DIFFER, V27, P206, DOI 10.1016/j.lindif.2013.01.011; Reyes-Garcia V, 2013, EVOL HUM BEHAV, V34, P249, DOI 10.1016/j.evolhumbehav.2013.03.002; Rotherham ID, 2007, FOREST ECOL MANAG, V249, P100, DOI 10.1016/j.foreco.2007.05.030; Salick J, 1997, ECON BOT, V51, P6, DOI 10.1007/BF02910400; Santha SD, 2008, LOCAL ENVIRON, V13, P423, DOI 10.1080/13549830701809726; Saynes-Vasquez A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-40; Schunko C, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-23; Sears RR, 2007, HUM ECOL, V35, P697, DOI 10.1007/s10745-006-9109-y; Simsek I, 2004, ECON BOT, V58, P705, DOI 10.1663/0013-0001(2004)058[0705:AESOTB]2.0.CO;2; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Sujarwo W, 2014, ECON BOT, V68, P426, DOI 10.1007/s12231-014-9288-1; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Titilola S, 1990, STUD TECHNOL SOC CHA; Trillo C., 2010, OPEN COMPLEMENT MED, V2, P80; Tsuji LJS, 1996, CAN J NATIV STUD, V16, P283; Turner NJ, 2008, BOTANY, V86, P103, DOI 10.1139/B07-020; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Turvey ST, 2014, P ROY SOC LOND B BIO, P281; Uprety Y, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-16; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; von Glasenapp M, 2011, HUM ECOL, V39, P769, DOI 10.1007/s10745-011-9427-6; Warren D, 1996, SUSTAIN DEV 3 WORLD; Wester Lyndon, 1995, Journal of Ethnobiology, V15, P71; Zarger RK, 2004, CURR ANTHROPOL, V45, P413, DOI 10.1086/420908; Zent S., 2001, BIOCULTURAL DIVERSIT, P190; Zobolo A. M., 2006, African Journal of Range & Forage Science, V23, P77, DOI 10.2989/10220110609485889	108	116	120	9	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195440	10.1371/journal.pone.0195440	http://dx.doi.org/10.1371/journal.pone.0195440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621311	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800083
J	Alvarez-Castillo, JL; Fernandez-Caminero, G; Gonzalez-Gonzalez, H				Luis Alvarez-Castillo, Jose; Fernandez-Caminero, Gemma; Gonzalez-Gonzalez, Hugo			Is empathy one of the Big Three? Identifying its role in a dual-process model of ideology and blatant and subtle prejudice	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; RIGHT-WING AUTHORITARIANISM; REDUCING PREJUDICE; HEXACO-PERSONALITY; PROSOCIAL BEHAVIOR; SELF-EFFICACY; FIT INDEXES; ATTITUDES; DIMENSIONS; MEDIATION	In the field of the social psychology of prejudice, John Duckitt's Dual-Process Cognitive-Motivational Model of Ideology and Prejudice has gained a firm grounding over the past decade and a half, while empathy has become one of the most powerful predictors of prejudice, alongside right-wing authoritarianism and social dominance orientation. This study integrates empathy into the dual-process model, exploring the effects of this variable, along with the impact of personality and ideological attitudes, on prejudice in both its blatant and subtle forms. A cross-sectional research design was used to collect data from 260 university students by self-report measures. Despite its cross-sectional nature, a pattern of causal relationships was hypothesized according to experimental and longitudinal findings from previous studies. The path analysis results show that in the model fitted to the data, empathy does not have any direct impact on prejudice, although it plays a significant role in the prediction of prejudice towards a particular immigrant group. On the other hand, the dual-process model is confirmed in the explanation of blatant prejudice and, in a weaker and indirect way, of subtle prejudice; sustaining the distinctive nature of these constructs on some differential predictors and paths. In the discussion, this study proposes that when ideological and personality-based variables are both included in the model, general empathy is not so robust in the explanation of prejudice, since some of the empathetic components might become diluted among other covariates. But even so, its indirect effectiveness through personality and ideological attitudes remains relevant.	[Luis Alvarez-Castillo, Jose; Fernandez-Caminero, Gemma; Gonzalez-Gonzalez, Hugo] Univ Cordoba, Fac Educ Sci, Dept Educ, Cordoba, Spain	Universidad de Cordoba	Alvarez-Castillo, JL (corresponding author), Univ Cordoba, Fac Educ Sci, Dept Educ, Cordoba, Spain.	jlalvarez@uco.es	González, Hugo González/I-8295-2018; González-González, Hugo/AAF-7240-2020; Fernández-Caminero, Gemma/AAL-5694-2021; Álvarez-Castillo, José-Luis/F-6467-2015	González, Hugo González/0000-0002-7537-1514; González-González, Hugo/0000-0002-7537-1514; Fernández-Caminero, Gemma/0000-0003-2241-9104; Álvarez-Castillo, José-Luis/0000-0001-7493-4664				Albiero P, 2013, INT J INTERCULT REL, V37, P648, DOI 10.1016/j.ijintrel.2013.05.003; Allport G.W., 1954, NATURE PREJUDICE; Altemeyer B., 1994, PSYCHOL PREJUDICE ON, P131; Altemeyer R., 1981, RIGHT WING AUTHORITA; Arancibia-Martini H, 2016, PSYCHOL REP, V118, P544, DOI 10.1177/0033294116636988; Asbrock F, 2009, EUR J PERS, V24; Barnett G, 2013, AGGRESS VIOLENT BEH, V18, P228, DOI 10.1016/j.avb.2012.11.010; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Belacchi C, 2012, AGGRESSIVE BEHAV, V38, P150, DOI 10.1002/ab.21415; Bentler P.M., 2008, EQS 6 STRUCTURAL EQU; Berger C, 2015, J YOUTH ADOLESCENCE, V44, P2230, DOI 10.1007/s10964-015-0298-9; Berger R, 2016, J SCHOOL PSYCHOL, V57, P53, DOI 10.1016/j.jsp.2016.04.003; Bergh R, 2016, PERS INDIV DIFFER, V101, P467, DOI 10.1016/j.paid.2016.05.090; Bergh R, 2016, PERS INDIV DIFFER, V101, P153, DOI 10.1016/j.paid.2016.05.052; Buckstru┬m M., 2007, J INDIVID DIFFER, V28, P10, DOI [10.1027/1614-0001.28.1.10, DOI 10.1027/1614-0001.28.1.10]; Butrus N, 2013, AUST PSYCHOL, V48, P290, DOI 10.1111/j.1742-9544.2012.00081.x; Byrne B. M., 2016, STRUCTURAL EQUATION, V3rd, DOI [10.4324/9781315757421, DOI 10.4324/9781315757421]; Cantal C, 2015, EUR J PERSONALITY, V29, P17, DOI 10.1002/per.1978; Castro MC, 2010, PSICOTHEMA, V22, P118; Centro de Investigaciones Sociologicas, 2015, CAT ENC INM; Coenders M, 2001, EUR J SOC PSYCHOL, V31, P281, DOI 10.1002/ejsp.44.abs; Cohrs JC, 2012, J PERS SOC PSYCHOL, V103, P343, DOI 10.1037/a0028706; Costa P., 2002, INVENTARIO PERSONALI; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [10.1037/1040-3590.4.1.5, https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5]; Costa P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089254, 10.1371/journal.pone.0094842]; Cuff BMP, 2016, EMOT REV, V8, P144, DOI 10.1177/1754073914558466; Davis MH., 2015, OXFORD HDB PROSOCIAL, P282; Decety Jean, 2015, AJOB Neurosci, V6, P3; Decety J, 2015, CURR OPIN BEHAV SCI, V3, P1, DOI 10.1016/j.cobeha.2014.12.001; del Barrio V, 2004, SOC BEHAV PERSONAL, V32, P677; Desimoni M, 2014, PERS INDIV DIFFER, V59, P116, DOI 10.1016/j.paid.2013.10.031; Dinesen PT, 2016, POLIT PSYCHOL, V37, P55, DOI 10.1111/pops.12220; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Duckitt J, 2006, PERS SOC PSYCHOL B, V32, P684, DOI 10.1177/0146167205284282; Duckitt J, 2001, ADV EXP SOC PSYCHOL, V33, P41, DOI 10.1016/S0065-2601(01)80004-6; Duckitt J, 2007, EUR J PERSONALITY, V21, P113, DOI 10.1002/per.614; Duckitt J, 2017, CAMBRIDGE HANDBOOK OF THE PSYCHOLOGY OF PREJUDICE, P188; Duckitt J, 2013, POLIT PSYCHOL, V34, P841, DOI 10.1111/pops.12022; Duckitt J, 2010, J PERS, V78, P1861, DOI 10.1111/j.1467-6494.2010.00672.x; Dyche L, 2001, CLIN SOC WORK J, V29, P245, DOI 10.1023/A:1010407728614; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Ekehammar B, 2004, EUR J PERSONALITY, V18, P463, DOI 10.1002/per.526; Ekehammar B, 2003, EUR J PERSONALITY, V17, P449, DOI 10.1002/per.494; Ekehammar B., 2009, INDIVIDUAL DIFFERENC, V7, P255; Ekehammar B, 2007, J PERS, V75, P899, DOI 10.1111/j.1467-6494.2007.00460.x; Feigin S., 2014, ANN NEUROSCIENCE PSY, V1, P1, DOI [10.7243/2055-3447-1-5, DOI 10.7243/2055-3447-1-5]; Fernandez-Pinto I, 2008, AN PSICOL-SPAIN, V24, P284; Fleming B DaNine, 2015, J Cult Divers, V22, P59; Flynn FJ, 2005, J PERS SOC PSYCHOL, V88, P816, DOI 10.1037/0022-3514.88.5.816; Gerdes KE, 2010, BRIT J SOC WORK, V40, P2326, DOI 10.1093/bjsw/bcq048; Gonzalez HG, 2012, BORDON, V64, P89; Gonzalez-Gonzalez H, 2015, REV ELECT INVESTIG E, V21; Graziano WG, 2007, J PERS SOC PSYCHOL, V93, P583, DOI 10.1037/0022-3514.93.4.583; Green JW., 1988, CULTURAL AWARENESS H; Gubler J.R., 2015, J EXP POLIT SCI, V2, P36, DOI DOI 10.1017/XPS.2014.20; Sanmartin MG, 2011, PSICOTHEMA, V23, P13; Habashi MM, 2016, PERSONAL SOC PSYCHOL, V42; Hardy SA, 2012, PSYCHOL RELIG SPIRIT, V4, P237, DOI 10.1037/a0027566; Harris ST, 2013, AGGRESS VIOLENT BEH, V18, P335, DOI 10.1016/j.avb.2012.12.003; Olaizola JH, 2014, PSICOTHEMA, V26, P33, DOI 10.7334/psicothema2013.163; Hodges SD, 2011, POSITIVE PSYCHOLOGY AS SOCIAL CHANGE, P193, DOI 10.1007/978-90-481-9938-9_12; Hodson G, 2015, EUR REV SOC PSYCHOL, V26, P1, DOI 10.1080/10463283.2015.1070018; Hodson G, 2009, J RES PERS, V43, P686, DOI 10.1016/j.jrp.2009.02.005; Hoffman ML, 1981, ALTRUISM HELP BEHAV, P41; Hooper D., 2008, ELECT J BUS RES METH, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; Kline R.B., 2011, PRINCIPLES PRACTICE; Kteily N, 2015, J PERS SOC PSYCHOL, V109, P901, DOI 10.1037/pspp0000048; Kteily NS, 2011, J EXP SOC PSYCHOL, V47, P208, DOI 10.1016/j.jesp.2010.09.009; Leone L, 2012, PERS INDIV DIFFER, V53, P995, DOI 10.1016/j.paid.2012.07.016; Levin S, 2013, GROUP PROCESS INTERG, V16, P139, DOI 10.1177/1368430212443866; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Lim D, 2016, EMOTION, V16, P175, DOI 10.1037/emo0000144; Lopez-Perez B, 2008, TECA TEST EMPAT COGN; Magalhaes E, 2012, MED TEACH, V34, P807, DOI 10.3109/0142159X.2012.702248; Magallares A, 2014, UNIV PSYCHOL, V13, P771, DOI 10.11144/Javeriana.UPSY13-2.rwas; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; McFarland S, 2010, POLIT PSYCHOL, V31, P453, DOI 10.1111/j.1467-9221.2010.00765.x; Melchers MC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00290; Molenberghs P, 2013, NEUROSCI BIOBEHAV R, V37, P1530, DOI 10.1016/j.neubiorev.2013.06.002; Navas Luque M, 2006, ESTRATEGIAS ACTITUDE; Navas M, 2006, PSICOTHEMA, V18, P187; Numata J, 2013, PSYCHOLOGIA, V56, P45, DOI 10.2117/psysoc.2013.45; O'Boyle EH, 2011, J APPL PSYCHOL, V96, P1, DOI 10.1037/a0020539; Onraet E, 2017, PERS INDIV DIFFER, V110, P27, DOI 10.1016/j.paid.2017.01.017; Paciello M, 2013, PERS INDIV DIFFER, V55, P3, DOI 10.1016/j.paid.2012.11.004; Paluck EL, 2016, SCIENCE, V352, P147, DOI 10.1126/science.aaf5207; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Passini S, 2017, POLIT PSYCHOL, V38, P73, DOI 10.1111/pops.12309; Passini S, 2016, PERS INDIV DIFFER, V89, P182, DOI 10.1016/j.paid.2015.10.022; Peek EH, 2013, J KOREAN ACAD NURS, V43, P690, DOI 10.4040/jkan.2013.43.5.690; Perry R, 2012, PERS INDIV DIFFER, V52, P3, DOI 10.1016/j.paid.2011.08.009; Persson BN, 2016, J SOC PSYCHOL, V156, P610, DOI 10.1080/00224545.2016.1152212; Pettigrew TF, 2001, EUR J SOC PSYCHOL, V31, P299, DOI 10.1002/ejsp.45; PETTIGREW TF, 1995, EUR J SOC PSYCHOL, V25, P57, DOI 10.1002/ejsp.2420250106; Pohling R, 2016, J BUS ETHICS, V137, P449, DOI 10.1007/s10551-015-2569-5; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Quiles MN, 2003, PSICOTHEMA, V15, P65; Rasoal C., 2011, J SOCIAL EVOLUTIONAR, V5, P1, DOI [https://doi.org/10.1037/h0099278, DOI 10.1037/H0099278]; Ridley CR., 1996, COUNSELING CULTURES, P21; Rosler N, 2017, J CONFLICT RESOLUT, V61, P114, DOI 10.1177/0022002715569772; Rueda J.F., 1996, REV PSICOL SOC, V11, P131, DOI [10.1174/02134749660569314, DOI 10.1174/02134749660569314]; Seoane J., 1992, PSICO LOGIA POLITICA, V5, P27; Shen YL, 2013, J EARLY ADOLESCENCE, V33, P994, DOI 10.1177/0272431613479670; Shih M, 2009, GROUP PROCESS INTERG, V12, P565, DOI 10.1177/1368430209337463; Shih MJ, 2013, ASIAN AM J PSYCHOL, V4, P79, DOI 10.1037/a0029790; Sibley CG, 2014, PERSPECTIVES AUTHORI, P169; Sibley CG, 2008, PERS SOC PSYCHOL REV, V12, P248, DOI 10.1177/1088868308319226; Sibley CG, 2013, J SOC PSYCHOL, V153, P448, DOI 10.1080/00224545.2012.757544; Sibley CG, 2010, J SOC PSYCHOL, V150, P540, DOI 10.1080/00224540903365364; Sibley CG, 2010, EUR J PERSONALITY, V24, P515, DOI 10.1002/per.750; Sidanius J., 1999, SOCIAL DOMINANCE INT; Sidanius J, 2017, CAMBRIDGE HANDBOOK OF THE PSYCHOLOGY OF PREJUDICE, P149; Sidanius J, 2013, J PERS, V81, P313, DOI 10.1111/jopy.12008; Silvan-Ferrero M. P., 2007, REV PSICOL SOC, V22, P3, DOI DOI 10.1174/021347407779697485; Song Y.S., 2017, PLOS ONE, V12; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Telle NT, 2016, EMOT REV, V8, P154, DOI 10.1177/1754073915586817; Todd AR, 2012, J EXP SOC PSYCHOL, V48, P738, DOI 10.1016/j.jesp.2011.12.011; Uzefovsky F, 2017, FRONT DEVELOP SCI, P71; Van Hiel A, 2005, J APPL SOC PSYCHOL, V35, P2323; Villadangos M, 2016, PSICOTHEMA, V28, P323, DOI 10.7334/psicothema2016.6; Wang YW, 2003, J COUNS PSYCHOL, V50, P221, DOI 10.1037/0022-0167.50.2.221; Welp LR, 2014, J POSIT PSYCHOL, V9, P54, DOI 10.1080/17439760.2013.831465; Zembylas M, 2013, ANTHROPOL EDUC QUART, V44, P19, DOI 10.1111/j.1548-1492.2012.01175.x	129	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195470	10.1371/journal.pone.0195470	http://dx.doi.org/10.1371/journal.pone.0195470			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621307	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800090
J	Reeves, AB; Hall, JS; Poulson, RL; Donnelly, T; Stallknecht, DE; Ramey, AM				Reeves, Andrew B.; Hall, Jeffrey S.; Poulson, Rebecca L.; Donnelly, Tyrone; Stallknecht, David E.; Ramey, Andrew M.			Influenza A virus recovery, diversity, and intercontinental exchange: A multi-year assessment of wild bird sampling at Izembek National Wildlife Refuge, Alaska	PLOS ONE			English	Article							PINTAILS ANAS-ACUTA; AVIAN INFLUENZA; NORTHERN PINTAILS; HEMAGGLUTININ SUBTYPE; SPRING MIGRATION; REASSORTMENT; ALIGNMENT; AMERICA; ROUTES; LAGOON	Western Alaska is a potential point-of-entry for foreign-origin influenza A viruses (IAVs) into North America via migratory birds. We sampled waterfowl and gulls for IAVs at Izembek National Wildlife Refuge (NWR) in western Alaska, USA, during late summer and autumn months of 2011-2015, to evaluate the abundance and diversity of viruses at this site. We collected 4842 samples across five years from 25 species of wild birds resulting in the recovery, isolation, and sequencing of 172 IAVs. With the intent of optimizing sampling efficiencies, we used information derived from this multi-year effort to: 1) evaluate from which species we consistently recover viruses, 2) describe viral subtypes of isolates by host species and year, 3) characterize viral gene segment sequence diversity with respect to host species, and assess potential differences in the viral lineages among the host groups, and 4) examine how evidence of intercontinental exchange of IAVs relates to host species. We consistently recovered viruses from dabbling ducks (Anas spp.), emperor geese (Chen canagica) and glaucous-winged gulls (Larus glaucescens). There was little evidence for differences in viral subtypes and diversity from different waterfowl hosts, however subtypes and viral diversity varied between waterfowl host groups and glaucous-winged gulls. Furthermore, higher proportions of viral sequences from northern pintails (Anas acute), emperor geese and glaucous-winged gulls were grouped in phylogenetic clades that included IAV sequences originating from wild birds sampled in Asia as compared to non-pintail dabbling ducks, a difference that may be related to intercontinental migratory tendencies of host species. Our summary of research and surveillance efforts at Izembek NWR will assist in future prioritization of which hosts to sample and swab types to collect in Alaska and elsewhere in order to maximize isolate recovery, subtype and sequence diversity for resultant viruses, and detection of evidence for intercontinental viral exchange.	[Reeves, Andrew B.; Donnelly, Tyrone; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Hall, Jeffrey S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Poulson, Rebecca L.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia	Reeves, AB; Ramey, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	areeves@usgs.gov; aramey@usgs.gov	Poulson, Rebecca/K-4014-2019; Poulson, Rebecca/AAD-2231-2021	Poulson, Rebecca/0000-0002-8087-3295; Reeves, Andrew/0000-0002-7526-0726	U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]	U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded, in part, by the U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission area and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract HHSN272201400006C. The contents of this product are the responsibility of the authors and do not necessarily represent the official views of the NIH.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bao Y, 2007, NUCLEIC ACIDS RES, V35, pW280, DOI 10.1093/nar/gkm354; Bevins SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104360; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; EASTERDAY BC, 1968, NATURE, V219, P523, DOI 10.1038/219523a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hatch SA, 2011, CONDOR, V113, P340, DOI 10.1525/cond.2011.090224; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Huang YY, 2014, VIROLOGY, V456, P353, DOI 10.1016/j.virol.2014.04.009; Hupp JW, 2007, J AVIAN BIOL, V38, P462, DOI 10.1111/j.0908-8857.2007.03969.x; Hupp JW, 2011, J AVIAN BIOL, V42, P289, DOI 10.1111/j.1600-048X.2011.05320.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Peters JL, 2014, MOL ECOL, V23, P2961, DOI 10.1111/mec.12799; Ramey AM, 2014, J WILDL DIS; Ramey AM, 2016, INFECT GENET EVOL, V40, P176, DOI 10.1016/j.meegid.2016.02.035; Ramey AM, 2015, VIROLOGY, V482, P79, DOI 10.1016/j.virol.2015.03.028; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; REED A, 1989, J WILDLIFE MANAGE, V53, P720, DOI 10.2307/3809203; Reeves AB, 2018, INFLUENZA A VIRUS DA; Reeves AB, 2013, J WILDLIFE DIS, V49, P600, DOI 10.7589/2012-04-108; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tonnessen R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-112; Ward DH, 1997, AQUAT BOT, V58, P229, DOI 10.1016/S0304-3770(97)00037-5; WARD DH, 1989, RESPONSE BRANT OTHER; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Winker K, 2010, AVIAN DIS, V54, P477, DOI 10.1637/8741-032509-Reg.1; Woolcock PR, 2008, AVIAN DIS, V52, P209, DOI 10.1637/8106-090607-Reg.1; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164	46	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195327	10.1371/journal.pone.0195327	http://dx.doi.org/10.1371/journal.pone.0195327			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621333	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800063
J	van Knippenberg, RJM; de Vugt, ME; Ponds, RW; Verhey, FRJ; Myin-Germeys, I				van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.; Myin-Germeys, Inez			Emotional reactivity to daily life stress in spousal caregivers of people with dementia: An experience sampling study	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL; INFORMAL CAREGIVERS; ELDER RELATIVES; SOCIAL SUPPORT; DEPRESSION; DISTRESS; BURDEN; MOOD; SCHIZOPHRENIA	Introduction Caregivers differ in their emotional response when facing difficult situations during the care giving process. Individual differences in vulnerabilities and resources could play an exacerbating or buffering role in caregivers' reactivity to daily life stress. This study examines which caregiver characteristics modify emotional stress reactivity in dementia caregivers. Methods Thirty caregivers collected momentary data, as based on the experience sampling methodology, to assess (1) appraised subjective stress related to events and minor disturbances in daily life, and (2) emotional reactivity to these daily life stressors, conceptualized as changes in negative affect. Caregiver characteristics (i.e. vulnerabilities and resources) were administered retrospectively. Results Caregivers who more frequently used the coping strategies 'seeking distraction', 'seeking social support', and 'fostering reassuring thoughts' experienced less emotional reactivity towards stressful daily events. A higher educational level and a higher sense of competence and mastery lowered emotional reactivity towards minor disturbances in daily life. No effects were found for age, gender, and hours of care and contact with the person with dementia. Discussion Caregiver resources can impact emotional reactivity to daily life stress. Interventions aimed at empowerment of caregiver resources, such as sense of competence, mastery, and coping, could help to reduce stress reactivity in dementia caregivers.	[van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Myin-Germeys, Inez] Katholieke Univ Leuven, Ctr Contextual Psychiat, Dept Neurosci, Leuven, Belgium	Maastricht University; Maastricht University; KU Leuven	de Vugt, ME (corresponding author), Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.; de Vugt, ME (corresponding author), Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	mdevugt@maastrichtuniversity.nl	Myin Germeys, Inez/HIR-3364-2022	Myin Germeys, Inez/0000-0002-3731-4930; ponds, rudolf/0000-0002-9748-4659	Dutch Alzheimer Society [WE03-2011-06]	Dutch Alzheimer Society	This study is supported by a grant of the Dutch Alzheimer Society (Grant no. WE03-2011-06; https.//www.alzheimer-nederland.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afram B, 2014, J AM MED DIR ASSOC, V15, P108, DOI 10.1016/j.jamda.2013.09.012; Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Antonucci TC, 1900, HDB AGING SOCIAL SCI, P205; Cheng ST, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0818-2; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2004, INT J GERIATR PSYCH, V19, P85, DOI 10.1002/gps.1044; Delespaul PAEG, 1995, ASS SCHIZ DAIL LIF E; Ebner-Priemer UW, 2009, PSYCHOL ASSESSMENT, V21, P463, DOI 10.1037/a0017075; Feast A, 2017, INT J GERIATR PSYCH, V32, P76, DOI 10.1002/gps.4447; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Gilhooly KJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0280-8; Haines KJ, 2015, CRIT CARE MED, V43, P1112, DOI 10.1097/CCM.0000000000000865; Hektner JM, 2007, EXPERIENCE SAMPLING; Hilgeman MM, 2009, GERONTOLOGIST, V49, P248, DOI 10.1093/geront/gnp015; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kat M G, 2002, Tijdschr Gerontol Geriatr, V33, P150; Koerner SS, 2007, FAM RELAT, V56, P1, DOI 10.1111/j.1741-3729.2007.00435.x; Koerner SS, 2010, J GERONTOL B-PSYCHOL, V65, P561, DOI 10.1093/geronb/gbq045; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; Lazarus RS., 1984, STRESS APPRAISAL COP; Martin-Carrasco Manuel, 2013, Rev Esp Geriatr Gerontol, V48, P276, DOI 10.1016/j.regg.2013.06.002; Mechanic D., 1967, APPLETON CENTURY CRO, P123; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Mroczek DK, 2004, J PERS, V72, P355, DOI 10.1111/j.0022-3506.2004.00265.x; Myin-Germeys I, 2002, AM J PSYCHIAT, V159, P443, DOI 10.1176/appi.ajp.159.3.443; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Oorschot M, 2012, SCHIZOPHRENIA BULL, V38, P405, DOI 10.1093/schbul/sbr166; Palmier-Claus JE, 2011, ACTA PSYCHIAT SCAND, V123, P12, DOI 10.1111/j.1600-0447.2010.01596.x; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Prince M., 2016, WORLD ALZHEIMER REPO; Roepke SK, 2008, AM J GERIAT PSYCHIAT, V16, P310, DOI 10.1097/JGP.0b013e3181662a80; Sato H, 2011, ANXIETY STRESS COPIN, V24, P359, DOI 10.1080/10615806.2010.543132; Schreurs P.J.G., 1993, UTRECHT COPING LIST; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sonnenschein M, 2007, BIOL PSYCHOL, V75, P176, DOI 10.1016/j.biopsycho.2007.02.001; STONE AA, 1995, HEALTH PSYCHOL, V14, P341, DOI 10.1037/0278-6133.14.4.341; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; van der Lee J, 2017, AGING MENT HEALTH, V21, P232, DOI 10.1080/13607863.2015.1102196; van der Steen Y, 2017, ACTA PSYCHIAT SCAND, V136, P63, DOI 10.1111/acps.12714; van Knippenberg R., 2017, THESIS; van Knippenberg RJM, 2017, INT J GERIATR PSYCH, V32, P949, DOI 10.1002/gps.4552; van Knippenberg RJM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0834-5; van Winkel M, 2015, EUR PSYCHIAT, V30, P441, DOI 10.1016/j.eurpsy.2015.02.011; Vernooij-Dassen MJFJ, 1999, J AM GERIATR SOC, V47, P256, DOI 10.1111/j.1532-5415.1999.tb04588.x; VITALIANO PP, 1990, J PERS SOC PSYCHOL, V59, P582, DOI 10.1037/0022-3514.59.3.582; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946	56	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194118	10.1371/journal.pone.0194118	http://dx.doi.org/10.1371/journal.pone.0194118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617373	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800017
J	Wilkinson, J; Bors, C; Burgis, F; Lorke, A; Bodmer, P				Wilkinson, Jeremy; Bors, Christoph; Burgis, Florian; Lorke, Andreas; Bodmer, Pascal			Measuring CO2 and CH4 with a portable gas analyzer: Closed-loop operation, optimization and assessment	PLOS ONE			English	Article							CAVITY OUTPUT SPECTROSCOPY; CARBON-DIOXIDE; DISSOLVED METHANE; WATER; ECOSYSTEMS; FLUXES; CHROMATOGRAPHY; ATMOSPHERE; EMISSIONS; CHAMBER	The use of cavity ring-down spectrometer (CRDS) based portable greenhouse gas analyzers (PGAs) in closed-loop configuration to measure small sample volumes (<1 l) for CH4 and CO2 concentrations is increasing and offers certain advantages over conventional measurement methods in terms of speed as well as the ability to measure directly in field locations. This first systematic assessment of the uncertainties, problems and issues associated with achieving reliable and repeatable measurement with this technique presents the adaptation, measurement range, calibration and maintenance, accuracy and issues of efficient operation, for one example instrument. Regular open-loop calibration, a precise loop volume estimate, leak free system, and a high standard of injection practices are necessary for accurate results. For 100 mu l injections, measured values ranging from 4.5 to 9 x10(4) ppm (CH4), and 1000 ppm to 1 x10(6) ppm (CO2) are possible with uncertainties 5.9% and 3.0%, respectively, beyond 100 ppm CH4 correction may be necessary. Uncertainty arising from variations water vapour content and atmospheric pressure are small (0.24% and -0.9% to +0.5%, respectively). With good practice, individual operator repeatability of 1.9% (CH4) and 2.48% (CO2) can be achieved. Between operator injection error was around 3% for both gases for four operators. Slow syringe plunger operation (>1s) is recommended; generally delivered more (ca. 3-4%) sample into the closed instrument loop than did rapid operation. Automated value retrieval is recommended; we achieved a 3 to 5-fold time reduction for each injection cycle (ca. <2 min), and operator reading, recording, and digitization errors are eliminated.	[Wilkinson, Jeremy; Bors, Christoph; Burgis, Florian; Lorke, Andreas; Bodmer, Pascal] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Wilkinson, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	wilkinson@uni-landau.de	Bodmer, Pascal/M-6902-2019; Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817; Wilkinson, Jeremy/0000-0001-6019-0297	German Research Foundation [L01150/5-2, L01150/9-1]	German Research Foundation(German Research Foundation (DFG))	This study was undertaken within a German Research Foundation funded project (grants L01150/5-2 and L01150/9-1; http//gam.dfg.de/en) that studied greenhouse gas emissions from impounded rivers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshboul Z, 2016, ENVIRON SCI TECHNOL, V50, P5555, DOI 10.1021/acs.est.5b04923; Attermeyer K, 2016, SCI REPORTS; Baird AJ, 2010, ECOHYDROLOGY, V3, P360, DOI 10.1002/eco.109; Baldocchi D, 2014, GLOBAL CHANGE BIOL, V20, P3600, DOI 10.1111/gcb.12649; Bodmer P, 2016, SCI TOTAL ENVIRON, V553, P574, DOI 10.1016/j.scitotenv.2016.02.095; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Eapi GR, 2014, J AIR WASTE MANAGE, V64, P927, DOI 10.1080/10962247.2014.907098; Flores E, 2015, ANAL CHEM, V87, P3272, DOI 10.1021/ac5043076; Gonzalez-Valencia R, 2014, ENVIRON SCI TECHNOL, V48, P11421, DOI 10.1021/es500987j; Gulzow W, 2011, LIMNOL OCEANOGR-METH, V9, P176, DOI 10.4319/lom.2011.9.176; Hamilton Company Inc, 2017, SYR CAR US GUID COMP; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; KAMPBELL DH, 1989, INT J ENVIRON AN CH, V36, P249, DOI 10.1080/03067318908026878; Kittler F, 2017, GLOBAL BIOGEOCHEM CY, V31, P1704, DOI 10.1002/2017GB005774; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Kriesel JM, 2017, VERSATILE ULTRALOW S; Kwok CEY, 2015, ATMOS MEAS TECH, V8, P2853, DOI 10.5194/amt-8-2853-2015; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Liu L, 2018, ENV SCI TECHNOLOGY; Lorke A, 2015, BIOGEOSCIENCES, V12, P7013, DOI 10.5194/bg-12-7013-2015; Los Gatos Inc, 2014, ULTR GAS AN MIRR CLE; Mbaka JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111392; Murdiyarso D., 2017, MITIGATION ADAPTATIO, P1; Nickerson N, 2017, LOW POWER ANAL AUTOM, P10423; Olefeldt D, 2017, GLOBAL CHANGE BIOL, V23, P2428, DOI 10.1111/gcb.13612; Oliveira ES, 2018, AQUAT BOT, V145, P1, DOI 10.1016/j.aquabot.2017.11.005; Pirk N, 2016, BIOGEOSCIENCES, V13, P903, DOI 10.5194/bg-13-903-2016; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; SGE Analytical Science, 2017, IMPR PREC CUST SYR T; Smith PA, 2015, PORTABLE GAS CHROMAT; Sparda A, 2017, COMMUN SOIL SCI PLAN, V48, P214, DOI 10.1080/00103624.2016.1254235; Wang C., 2010, SIMULTANEOUS ANAL GR; WEISS RF, 1981, J CHROMATOGR SCI, V19, P611, DOI 10.1093/chromsci/19.12.611; Wilkinson J, 2015, ENVIRON SCI TECHNOL, V49, P13121, DOI 10.1021/acs.est.5b01525; Zellweger C, 2016, ATMOS MEAS TECH, V9, P4737, DOI 10.5194/amt-9-4737-2016; Zhao J, 2017, GLOBAL CHANGE BIOL, V23, P3139, DOI 10.1111/gcb.13621	36	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193973	10.1371/journal.pone.0193973	http://dx.doi.org/10.1371/journal.pone.0193973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617382	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800016
J	Zupane, K; Strumbelji, E				Zupane, Kaja; Strumbelji, Erik			A Bayesian hierarchical latent trait model for estimating rater bias and reliability in large-scale performance assessment	PLOS ONE			English	Article							FRAMEWORK; DRIFT	We propose a novel approach to modelling rater effects in scoring-based assessment. The approach is based on a Bayesian hierarchical model and simulations from the posterior distribution. We apply it to large-scale essay assessment data over a period of 5 years. Empirical results suggest that the model provides a good fit for both the total scores and when applied to individual rubrics. We estimate the median impact of rater effects on the final grade to be +/- 2 points on a 50 point scale, while 10% of essays would receive a score at least +/- 5 different from their actual quality. Most of the impact is due to rater unreliability, not rater bias.	[Zupane, Kaja; Strumbelji, Erik] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	University of Ljubljana	Strumbelji, E (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia.	erik.strumbelj@fri.uni-li.si						[Anonymous], 2014, R LANG ENV STAT COMP; Bonk W., 2003, LANG TEST, V20, P89, DOI [10.1191/0265532203LT245OA, DOI 10.1080/15434303.2016.1236797, DOI 10.1191/0265532203LT245OA]; CHIB S, 1992, J ECONOMETRICS, V51, P79, DOI 10.1016/0304-4076(92)90030-U; Congdon PJ, 2000, J EDUC MEAS, V37, P163, DOI 10.1111/j.1745-3984.2000.tb01081.x; DeCarlo LT, 2011, J EDUC MEAS, V48, P333, DOI 10.1111/j.1745-3984.2011.00143.x; Eckes T., 2005, LANG ASSESS Q, V2, P197, DOI [DOI 10.1207/S15434311LAQ0203_2, 10.1207/S15434311LAQ0203_2]; Eckes T, 2008, LANG TEST, V25, P155, DOI 10.1177/0265532207086780; Elder C., 2007, LANG TEST, V24, P37, DOI DOI 10.1177/0265532207071511; ENGELHARD G, 1994, J EDUC MEAS, V31, P93, DOI 10.1111/j.1745-3984.1994.tb00436.x; Engelhard G., 2003, MONITORING FACULTY C, V2003; Fitzpatrick AR, 1998, ASSESSMENT MATTERS H, V11; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Harik P, 2009, J EDUC MEAS, V46, P43, DOI 10.1111/j.1745-3984.2009.01068.x; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Hoskens M, 2001, J EDUC MEAS, V38, P121, DOI 10.1111/j.1745-3984.2001.tb01119.x; Kondo-Brown K., 2002, LANG TEST, V19, P3, DOI [10.1191/0265532202LT218OA, DOI 10.1191/0265532202LT218OA, DOI 10.1191/0265532202LT2180A]; Leckie G, 2011, J EDUC MEAS, V48, P399, DOI 10.1111/j.1745-3984.2011.00152.x; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lumley T, 1995, 15 LANG TEST RES C C; Myford CM, 2009, J EDUC MEAS, V46, P371, DOI 10.1111/j.1745-3984.2009.00088.x; Patz RJ, 2002, J EDUC BEHAV STAT, V27, P341, DOI 10.3102/10769986027004341; Pinot de Moira A., 2002, RES EDUC, V67, P79, DOI DOI 10.7227/RIE.67.8; Rezaei AliReza., 2010, ASSESS WRIT, V15, P18, DOI [10.1016/j.asw.2010.01.003, DOI 10.1016/J.ASW.2010.01.003]; Saeidi M, 2013, IRANIAN J APPL LINGU, V16, P145; Schaefer E, 2008, LANG TEST, V25, P465, DOI 10.1177/0265532208094273; Stan Development Team, 2015, STAN C LIB PROB SAMP; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Trace J, 2015, LANG TEST; Vehtari A, 2015, EFFICIENT LEAVE ONE; Wolfe E.W., 2012, EDUC MEAS-ISSUES PRA, V31, P31, DOI [DOI 10.1111/J.1745-3992.2012.00241.X, https://doi.org/10.1111/j.1745-3992.2012.00241.x]; Wolfe EW, 2007, MONITORING READER PE, V2007	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195297	10.1371/journal.pone.0195297	http://dx.doi.org/10.1371/journal.pone.0195297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614129	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600042
J	Ku, BM; Choi, MK; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ				Ku, Bo Mi; Choi, Moon Ki; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju			Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model	PLOS ONE			English	Article							CELL LUNG-CANCER; EGFR; INHIBITOR; OSIMERTINIB; MECHANISMS; MASPIN; 1ST	AZD9291 (osimertinib) is approved for standard care in patients with EGFR T790M-positive non-small cell lung cancer (NSCLC) after prior EGFR TKI progression. Furthermore, AZD9291 is now being evaluated as a first-line treatment for NSCLC patients with activation EGFR mutations. Based on previous experiments, resistance to AZD9291 as a first-line treatment may also emerge. Thus, identification and understanding of resistance mechanisms to AZD9291 as a first-line treatment can help direct development of future therapies. AZD9291-resistant cells (PC9/AZDR) were established using EGFR inhibitor-naive PC9 cells. Resistance mechanisms were analyzed using next-generation sequencing (NGS) and a proteome profiler array. Resistance to AZD9291 developed through aberrant activation of ERK signaling by an EGFR-independent mechanism. The combination of a MEK inhibitor with AZD9291 restored the sensitivity of PC9/AZDR cells in vitro and in vivo. PC9/AZDR cells also showed increased MET expression and an HRAS G13R mutation. In addition, maspin expression was higher after AZD9291 treatment in PC9/AZDR cells. Sustained ERK activation confers resistance to AZD9291 as a first-line therapy. Thus, co-targeting EGFR and MEK may be an effective strategy to overcome resistance to AZD9291.	[Ku, Bo Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Moon Ki] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang, South Korea; [Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center	Ahn, MJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea.	silk.ahn@samsung.com	sun, jm/O-5938-2014; Park, Keunchil/ABD-5852-2021; Park, Keunchil/ABD-7072-2021	Park, Keunchil/0000-0002-4846-7449; 	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1984]; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT) [NRF-2017M3C9A6044632]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [2017M3A9G5060252]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1984) (MJA), by the Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (MSIT) (No. NRF-2017M3C9A6044632) and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2017M3A9G5060252) (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berardi R, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-8; Boidot R, 2016, INT J COLORECTAL DIS, V31, P1245, DOI 10.1007/s00384-015-2448-7; Cathcart-Rake E, 2014, J THORAC ONCOL, V9, pE75, DOI 10.1097/JTO.0000000000000315; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Juchum M, 2015, DRUG RESIST UPDATE, V20, P12, DOI 10.1016/j.drup.2015.05.002; Khalkhali-Ellis Z, 2004, CLIN CANCER RES, V10, P449, DOI 10.1158/1078-0432.CCR-1002-03; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee DH, 2017, PHARMACOL THERAPEUT, V174, P1, DOI 10.1016/j.pharmthera.2017.02.001; Longhi MT, 2012, FEBS OPEN BIO, V2, P93, DOI 10.1016/j.fob.2012.04.006; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Mazza V, 2017, APPL CLIN GENET, V10, P49, DOI 10.2147/TACG.S103471; Meador CB, 2015, MOL CANCER THER, V14, P542, DOI 10.1158/1535-7163.MCT-14-0723; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Planchard D, 2015, ANN ONCOL, V26, P2073, DOI 10.1093/annonc/mdv319; Ramalignam S, 2017, J THORACIC ONCOLO S5, V28, pv605; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Shi PY, 2017, CLIN CANCER RES, V23, P6567, DOI 10.1158/1078-0432.CCR-17-1574; Shi PY, 2016, CANCER LETT, V380, P494, DOI 10.1016/j.canlet.2016.07.021; Sullivan I, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00076; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tricker EM, 2015, CANCER DISCOV, V5, P960, DOI 10.1158/2159-8290.CD-15-0063; Yang JCH, 2017, J CLIN ONCOL, V35, P1288, DOI 10.1200/JCO.2016.70.3223	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194730	10.1371/journal.pone.0194730	http://dx.doi.org/10.1371/journal.pone.0194730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641535	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900043
J	Sherman, SM; Nailer, E				Sherman, Susan Mary; Nailer, Emma			Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK	PLOS ONE			English	Article							DECISION-MAKING; VALIDATION; MEN	The incidence of cancers attributable to Human Papillomavirus (HPV) that affect males is on the rise. Currently in the UK teenage boys are not vaccinated against HPV while teenage girls are. The rationale for not vaccinating boys is that vaccinating girls should provide herd immunity to boys, however this does not protect men who have sex with men or men who have sex with unvaccinated women. The issue of whether to vaccinate boys or not is a controversial one with considerable lobbying taking place to change the existing policy. On one side of the debate are financial considerations while on the other side health equality is important. One avenue that has not been presented is the parental perspective. The current study uses a self-report questionnaire to explore what parents of teenage boys know about HPV and the vaccine and whether they want the vaccine for their sons. Only half of the parents had heard of HPV prior to completing the survey. Of those who had heard of HPV, knowledge about the health sequelae of HPV for men was poor relative to their knowledge about its impact on female health. Parents who would be willing to vaccinate their sons had higher levels of knowledge about HPV than those parents who would be unwilling or unsure. Irrespective of whether they had previously heard of HPV or not, once provided with a brief description of HPV, the majority of parents thought that boys should be offered the vaccination. There is a pressing need for public education about the potential impact of HPV on male health in order to facilitate uptake of the vaccine in the event of the vaccination programme being extended to men or to facilitate informed decision making about seeking the vaccine privately in the event that it isn't.	[Sherman, Susan Mary; Nailer, Emma] Keele Univ, Sch Psychol, Keele, Staffs, England	Keele University	Sherman, SM (corresponding author), Keele Univ, Sch Psychol, Keele, Staffs, England.	s.m.sherman@keele.ac.uk	Sherman, Sue/ABH-3490-2020		Wellcome Small Grant [200281/Z/15/Z]	Wellcome Small Grant	This research was supported by Wellcome Small Grant 200281/Z/15/Z awarded to SS, https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gorjana R, 2017, PREV MED, V95, P26, DOI 10.1016/j.ypmed.2016.11.019; Gottvall M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014255; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; JCVI, 2017, JCVI INT STAT EXT HP; Joint Committee on Vaccination and Immunisation (JCVI), 2015, JCVI STAT HPV VACC M; Krawczyk A, 2015, HUM VACC IMMUNOTHER, V11, P322, DOI 10.1080/21645515.2014.1004030; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Mehanna H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1439; Mortensen GL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1863-6; Muhwezi WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106686; Newman PA, 2014, FUTURE VIROL, V9, P1033, DOI 10.2217/FVL.14.91; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Perez S, 2017, VACCINE, V35, P4713, DOI 10.1016/j.vaccine.2017.07.043; Perez S, 2016, PREV MED, V91, P43, DOI 10.1016/j.ypmed.2016.07.017; Perez S, 2016, SEX TRANSM DIS, V43, P626, DOI 10.1097/OLQ.0000000000000506; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Sherman SM, 2016, J OBSTET GYNAECOL, V36, P76, DOI 10.3109/01443615.2015.1041886; Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waller J, 2013, PREV MED, V56, P35, DOI 10.1016/j.ypmed.2012.10.028; WHO, 2017, WKLY EPIDEMIOL REC, P241, DOI DOI 10.1016/j.vaccine.2017.05.069; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	24	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195801	10.1371/journal.pone.0195801	http://dx.doi.org/10.1371/journal.pone.0195801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641563	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000429742900094
J	Giffard, PM; Andersson, P; Wilson, J; Buckley, C; Lilliebridge, R; Harris, TM; Kleinecke, M; O'Grady, KAF; Huston, WM; Lambert, SB; Whiley, DM; Holt, DC				Giffard, Philip M.; Andersson, Patiyan; Wilson, Judith; Buckley, Cameron; Lilliebridge, Rachael; Harris, Tegan M.; Kleinecke, Mariana; O'Grady, Kerry-Ann F.; Huston, Wilhelmina M.; Lambert, Stephen B.; Whiley, David M.; Holt, Deborah C.			CtGEM typing: Discrimination of Chlamydia trachomatis ocular and urogenital strains and major evolutionary lineages by high resolution melting analysis of two amplified DNA fragments	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; PCR; IDENTIFICATION; RECOMBINATION; ASSAY	Chlamydia trachomatis infects the urogenital tract (UGT) and eyes. Anatomical tropism is correlated with variation in the major outer membrane protein encoded by ompA. Strains possessing the ocular ompA variants A, B, Ba and C are typically found within the phylogenetically coherent "classical ocular lineage". However, variants B, Ba and C have also been found within three distinct strains in Australia, all associated with ocular disease in children and outside the classical ocular lineage. CtGEM genotyping is a method for detecting and discriminating ocular strains and also the major phylogenetic lineages. The rationale was facilitation of surveillance to inform responses to C. trachomatis detection in UGT specimens from young children. CtGEM typing is based on high resolution melting analysis (HRMA) of two PCR amplified fragments with high combinatorial resolving power, as defined by computerised comparison of 65 whole genomes. One fragment is from the hypothetical gene defined by Jali-1891 in the C. trachomatis B_Jali20 genome, while the other is from ompA. Twenty combinatorial CtGEM types have been shown to exist, and these encompass unique genotypes for all known ocular strains, and also delineate the TI and T2 major phylogenetic lineages, identify LGV strains and provide additional resolution beyond this. CtGEM typing and Sanger sequencing were compared with 42 C. trachomatis positive clinical specimens, and there were no disjunctions. CtGEM typing is a highly efficient method designed and tested using large scale comparative genomics. It divides C. trachomatis into clinically and biologically meaningful groups, and may have broad application in surveillance.	[Giffard, Philip M.; Andersson, Patiyan; Wilson, Judith; Kleinecke, Mariana; Holt, Deborah C.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Giffard, Philip M.; Holt, Deborah C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia; [Buckley, Cameron; Lilliebridge, Rachael; Whiley, David M.] Univ Queensland, Clin Res Ctr, Fac Med, Herston, Qld, Australia; [Harris, Tegan M.] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT, Australia; [O'Grady, Kerry-Ann F.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res, Brisbane, Qld, Australia; [Huston, Wilhelmina M.] Univ Technol, Sch Life Sci, Sydney, NSW, Australia; [Lambert, Stephen B.; Whiley, David M.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Pathol Queensland Cent Lab, Brisbane, Qld, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Queensland; Charles Darwin University; Menzies School of Health Research; Queensland University of Technology (QUT); University of Technology Sydney; University of Queensland	Giffard, PM (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Giffard, PM (corresponding author), Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia.	phil.giffard@menzies.edu.au	Huston, Wilhelmina/S-7269-2019; O'Grady, Kerry-Ann F/F-2529-2010; Whiley, David M/E-8955-2011; Lambert, Stephen/B-8348-2008; Harris, Tegan/A-5964-2016; Huston, Wilhelmina/B-9984-2008	O'Grady, Kerry-Ann F/0000-0002-8159-2620; Whiley, David M/0000-0001-5969-3161; Lambert, Stephen/0000-0002-2709-193X; Harris, Tegan/0000-0002-9312-7451; Giffard, Phil/0000-0002-3030-9127; Holt, Deborah/0000-0003-4951-1891; Huston, Wilhelmina/0000-0002-0879-1287	Australian National Health and Medical Research Council [1060768]; Children's Hospital Foundation, Brisbane; Queensland University of Technology	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Children's Hospital Foundation, Brisbane; Queensland University of Technology	This work was funded from the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) project grant 1060768 to Philip Giffard and an un-numbered seeding grant from the Children's Hospital Foundation, Brisbane (https://www.childrens.org.au/), and the Queensland University of Technology (https://www.qut.edu.au/) to Stephen Lambert.	Andersson P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10688; Andersson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033530; Asche VL., 1990, P 7 INT S HUM CHLAM, P555; Brown A, 2007, MED J AUSTRALIA, V187, P621, DOI 10.5694/j.1326-5377.2007.tb01446.x; Brunelle Brian W, 2012, BMC Res Notes, V5, P53, DOI 10.1186/1756-0500-5-53; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Cai L, 2010, INT J STD AIDS, V21, P101, DOI 10.1258/ijsa.2009.009013; CALDWELL HD, 1982, INFECT IMMUN, V35, P1024, DOI 10.1128/IAI.35.3.1024-1031.1982; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Douglas FP, 1986, P 6 INT S HUM CHLAM, P237; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Giffard PM, 2017, SEX TRANSM INFECT, V93, P236, DOI 10.1136/sextrans-2015-052473; Giffard PM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009624; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hadfield J, 2017, GENOME RES, V27, P1220, DOI 10.1101/gr.212647.116; Hammerschlag MR, 2011, CLIN INFECT DIS, V53, pS103, DOI 10.1093/cid/cir700; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; Hunt Martin, 2017, Microb Genom, V3, pe000131, DOI 10.1099/mgen.0.000131; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Millman K, 2004, J BACTERIOL, V186, P2457, DOI 10.1128/JB.186.8.2457-2465.2004; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Rogstad K., 2010, UK NATL GUIDELINE MA; Schaeffer A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-56; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; STEPHENS RS, 1982, J IMMUNOL, V128, P1083; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Tong SYC, 2012, J CLIN MICROBIOL, V50, P3418, DOI 10.1128/JCM.01709-12; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Versteeg B, 2015, SEX TRANSM INFECT, V91, P510, DOI 10.1136/sextrans-2014-051998; WANG SP, 1985, J INFECT DIS, V152, P791, DOI 10.1093/infdis/152.4.791; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wild Rex, 2007, AMPE AKELYERNEMANE M; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xiong LK, 2006, J CLIN MICROBIOL, V44, P1413, DOI 10.1128/JCM.44.4.1413-1418.2006	45	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195454	10.1371/journal.pone.0195454	http://dx.doi.org/10.1371/journal.pone.0195454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634761	Green Published, gold			2022-12-27	WOS:000429522200032
J	Neyt, M; Vlayen, J; Devriese, S; Camberlin, C				Neyt, Mattias; Vlayen, Joan; Devriese, Stephan; Camberlin, Cecile			First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis	PLOS ONE			English	Article							PHASE-3 RANDOMIZED-TRIAL; STANDARD CHEMOTHERAPY; EPITHELIAL OVARIAN; END-POINTS; ICON7; SURVIVAL; ONCOLOGY	Background Currently, in Belgium, bevacizumab is reimbursed for ovarian cancer patients, based on a contract between the Minister and the manufacturer including confidential agreements. This reimbursement will be re-evaluated in 2018. Objective To support the reimbursement reassessment by calculating the cost-effectiveness of bevacizumab: (1) in addition to first-line chemotherapy; (2) in the treatment of recurrent ovarian cancer (platinum-sensitive or platinum-resistant). Methods A health economic model has been developed for the Belgian situation according to the Belgian guidelines for economic evaluations. The lifetime Markov model was set up from the perspective of the health care payer (government and patient), including direct healthcare related costs. Results are expressed as the extra costs per quality-adjusted life year (QALY). Calculations were based on results of four international trials. Both probabilistic and one-way sensitivity analyses were performed. Results Incremental cost-effectiveness ratios (ICERs) of first-line bevacizumab are on average 158 000/QALY (GOG-0218 trial) and 443 000/QALY (ICON7 trial). The most favourable scenario is based on the stage IV subgroup of the GOG-0218 trial (epsilon 52 000/QALY). Since subgroup findings are often exploratory and require confirmatory studies, results of the economic evaluation based on this subgroup analysis should be considered with caution. For second-line bevacizumab, ICERs are on average epsilon 587 000/QALY (OCEANS trial) and epsilon 172 000/QALY (AURELIA trial). Sensitivity analysis shows that results are most sensitive to the price of bevacizumab. Conclusion From a health economic perspective, ICERs of bevacizumab are relatively high. The most favourable results are found for first-line treatment of stage IV ovarian cancer patients. Price reductions have a major impact on the estimated ICERs. It is recommended to take these findings into account when re-evaluating the reimbursement of bevacizumab in ovarian cancer.	[Neyt, Mattias; Vlayen, Joan; Devriese, Stephan; Camberlin, Cecile] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium		Neyt, M (corresponding author), Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium.	mattias.neyt@kce.fgov.be		Camberlin, Cecile/0000-0003-3473-876X				Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Barnett JC, 2013, CANCER-AM CANCER SOC, V119, P3653, DOI 10.1002/cncr.28283; Belgian Cancer Registry, 2016, INC FACT SHEET OV CA; Belgian Cancer Registry, 2015, CANC BURD BELG 2004; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chan JK, 2014, ONCOLOGIST, V19, P523, DOI 10.1634/theoncologist.2013-0322; Chappell NP, 2016, J ONCOL PRACT, V12, P689, DOI 10.1200/JOP.2015.010470; Cleemput I, 2012, HLTH TECHNOLOGY ASSE; Cohn DE, 2015, GYNECOL ONCOL, V136, P293, DOI 10.1016/j.ygyno.2014.10.020; Cohn DE, 2011, J CLIN ONCOL, V29, P1247, DOI 10.1200/JCO.2010.32.1075; Coleman R. L., 2015, ANN M WOM CANC CHIC; Cooper K, 2012, SINGLE TECHNOLOGY AP; Duong M, 2016, CURR ONCOL, V23, pE461, DOI 10.3747/co.23.3139; Edwards S, 2012, BEVACIZUMAB TREATMEN; EUnetHTA, 2015, METH HLTH EC EV GUID; European network for Health Technology Assessment (EUnetHTA), 2015, ENDP US REL EFF ASS; European Network for Health Technology Assessment (EUnetHTA) guideline, 2013, ENDP US REL EFF ASS; Gerkens S, 2017, KCE REPORTS; Havrilesky LJ, 2014, CANCER-AM CANCER SOC, V120, P3651, DOI 10.1002/cncr.28940; Hinde S, 2016, VALUE HEALTH, V19, P431, DOI 10.1016/j.jval.2016.01.013; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Kim C, 2015, JAMA INTERN MED, V175, P1992, DOI 10.1001/jamainternmed.2015.5868; Lesnock JL, 2011, GYNECOL ONCOL, V122, P473, DOI 10.1016/j.ygyno.2011.05.014; Ludwig Boltzmann Institute for Health Technology Assessment, 2014, BEV AV PLAT RES REC; Mehta DA, 2014, GYNECOL ONCOL, V132, P677, DOI 10.1016/j.ygyno.2014.01.021; Minion LE, 2016, GYNECOL ONCOL, V140, P193, DOI 10.1016/j.ygyno.2015.11.030; National Institute for Health and Care Excellence, 2016, GUID EX GE REV TA284; National Institute for Health and Care Excellence (NICE), 2005, PACL PEG LIP DOX HYD; National Institute for Health and Care Excellence (NICE), 2012, BEV TREATM REC ADV O; National Institute for Health and Care Excellence (NICE), 2012, BEV COMB CARB PACL T; Neyt M, 2017, KCE REPORTS; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Protocol. ICON7, 2009, ICON7 RAND 2 ARM MUL; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Randall LM, 2013, GYNECOL ONCOL; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scottish Intercollegiate Guidelines Network, 2013, 135 SIGN; Stark D, 2013, LANCET ONCOL, V14, P236, DOI 10.1016/S1470-2045(12)70567-3; Vergote I, 2016, OVARIAN CANC DIAGNOS	40	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195134	10.1371/journal.pone.0195134	http://dx.doi.org/10.1371/journal.pone.0195134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630612	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000026
J	Schneider, KA				Schneider, Kristan Alexander			Large and finite sample properties of a maximum-likelihood estimator for multiplicity of infection	PLOS ONE			English	Article							ARTEMISININ RESISTANCE; EVOLUTION; VIRULENCE; MALARIA; CHILDREN; MODEL; AREA	Reliable measures of transmission intensities can be incorporated into metrics for monitoring disease-control interventions. Genetic (molecular) measures like multiplicity of infection (MOI) have several advantages compared with traditional measures, e.g., R-0. Here, we investigate the properties of a maximum-likelihood approach to estimate MOI and pathogen-lineage frequencies. By verifying regulatory conditions, we prove asymptotical unbiasedness, consistency and efficiency of the estimator. Finite sample properties concerning bias and variance are evaluated over a comprehensive parameter range by a systematic simulation study. Moreover, the estimator's sensitivity to model violations is studied. The estimator performs well for realistic sample sizes and parameter ranges. In particular, the lineage-frequency estimates are almost unbiased independently of sample size. The MOI estimate's bias vanishes with increasing sample size, but might be substantial if sample size is too small. The estimator's variance matrix agrees well with the Cramer-Rao lower bound, even for small sample size. The numerical and analytical results of this study can be used for study design. This is exemplified by a malaria data set from Venezuela. It is shown how the results can be used to determine the necessary sample size to achieve certain performance goals. An implementation of the likelihood method and a simulation algorithm for study design, implemented as an R script, is available as Si File alongside a documentation(S2 File) and example data (S3 File).	[Schneider, Kristan Alexander] Univ Appl Sci Mittweida, Dept CB, Mittweida, Germany		Schneider, KA (corresponding author), Univ Appl Sci Mittweida, Dept CB, Mittweida, Germany.	kristan.schneider@hs-mittweida.de		Schneider, Kristan/0000-0003-4138-1180	SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften" [100257255]	SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften"	This work was funded by the SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften" (Project number 100257255).	Abd Razak MRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152415; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Amoah LE, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2338-7; [Anonymous], 2014, R LANG ENV STAT COMP; Assefa SA, 2014, BIOINFORMATICS, V30, P1292, DOI 10.1093/bioinformatics/btu005; Awaga KL, 2012, TROP MED INT HEALTH, V17, P153, DOI 10.1111/j.1365-3156.2011.02913.x; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Ben-Ami F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-97; Brown CM, 2014, VIROLOGY, V466, P71, DOI 10.1016/j.virol.2014.07.023; Chang HH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005348; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Davison A., 2003, STAT MODELS; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; Friedrich LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004526; Galinsky K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-4; Hamid MMA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1641-z; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hawkes M, 2014, NEW ENGL J MED, V371, P1944, DOI 10.1056/NEJMc1410735; Hill William G., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P249, DOI 10.1098/rspb.1995.0203; Kateera F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1287-5; Ken-Dror G, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1473-5; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Klein EY, 2012, P ROY SOC B-BIOL SCI, V279, P3834, DOI 10.1098/rspb.2012.1064; Kobbe R, 2006, TROP MED INT HEALTH, V11, P613, DOI 10.1111/j.1365-3156.2006.01618.x; Kuk AYC, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-82; Li XH, 2007, STAT APPL GENET MOL, V6; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Lively CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-64; Marasini S, 2017, MOL CELLS, V40, P598, DOI 10.14348/molcells.2017.0095; Matussek A, 2011, J CLIN MICROBIOL, V49, P3647, DOI 10.1128/JCM.00389-11; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Nabet C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1397-0; NEI M, 1978, GENETICS, V89, P583; Nishimura T, 2017, J INFECT CHEMOTHER, V23, P703, DOI 10.1016/j.jiac.2017.07.015; Pinkevych M, 2015, J INFECT DIS, V211, P1121, DOI 10.1093/infdis/jiu561; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Schjorring S, 2003, P ROY SOC B-BIOL SCI, V270, P189, DOI 10.1098/rspb.2002.2233; Schneider KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097899; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Sisya TJ, 2015, ACTA TROP, V142, P108, DOI 10.1016/j.actatropica.2014.11.008; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; TAKALA SL, 2006, MALARIA J, V5, DOI DOI 10.1186/1475-2875-5-31; Taylor AR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-102; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Theron A, 2004, PARASITOLOGY, V129, P571, DOI 10.1017/S0031182004005943; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wacker MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-180; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004; Wigger L, 2013, STAT MED, V32, P3737, DOI 10.1002/sim.5792; Winzeler EA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0544-6	57	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194148	10.1371/journal.pone.0194148	http://dx.doi.org/10.1371/journal.pone.0194148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630605	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000006
J	Lu, BC; Maharbiz, MM				Lu, Bochao; Maharbiz, Michel M.			Germanium as a scalable sacrificial layer for nanoscale protein patterning	PLOS ONE			English	Article							SILICON; DISSOLUTION; BIOCOMPATIBILITY	We demonstrate the use of germanium (Ge) films as water-soluble features that allow the patterning of proteins onto surfaces with commonly used organic solvents. This technique is scalable for manufacturing and is compatible with nano-and microfabrication processes, including standard lithography. We use Ge as a sacrificial layer to mask and protect areas of the substrate during surface functionalization. Since Ge dissolves in 0.35% hydrogen peroxide (H202) in water but not in organic solvents, Ge can be removed after patterning without significantly affecting protein activities. In this paper, we present examples of protein patterning with two different techniques. We show that 50 nm thick Ge layers can be completely removed in 10 min without residues and, importantly, nanoscale resolution and misalignment can be achieved with conventional photolithography equipment. Both biotin and streptavidin maintain-80% and >50% activity after 10 min and 360 min incubation in 0.35% H2O2, respectively. Lastly, the process can be used to functionalize sidewalls with proteins, a capability of recent interest for cell-cell adhesion studies.	[Lu, Bochao; Maharbiz, Michel M.] Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Univ Calif Berkeley, Elect Engn & Comp Sci Dept, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Chan Zuckerberg Biohub, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lu, BC (corresponding author), Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA.	steven_lu@berkeley.edu			Defense Advanced Research Project Agency Advanced Study [HR0011- 16-C-0023]; Berkeley Sensor and Actuator Center; Chan Zuckerberg Biohub; Berkeley Sensor and Actuator Center (BSAC) funds; DARPA Advanced Study [HR0011- 16-C-0023]	Defense Advanced Research Project Agency Advanced Study; Berkeley Sensor and Actuator Center; Chan Zuckerberg Biohub; Berkeley Sensor and Actuator Center (BSAC) funds; DARPA Advanced Study	This work was supported by the Defense Advanced Research Project Agency Advanced Study HR0011- 16-C-0023 (https://www.darpa.mil/); the Berkeley Sensor and Actuator Center (https://www-bsac.eecs.berkeley.edu) and Chan Zuckerberg Biohub (https://www.czbiohub.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Berkeley Sensor and Actuator Center (BSAC) funds and DARPA Advanced Study HR0011- 16-C-0023. Michel M. Maharbiz is a Chan Zuckerberg Biohub investigator.	Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l; CERNIGLIA N, 1962, J ELECTROCHEM SOC, V109, P508, DOI 10.1149/1.2425457; Chen JR, 2004, BIOTECHNOL ADV, V22, P505, DOI 10.1016/j.biotechadv.2004.03.004; Cohen DJ, 2016, P NATL ACAD SCI USA, V113, P14698, DOI 10.1073/pnas.1612208113; Filipponi L, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0036-4; Frasconi M, 2010, ANAL BIOANAL CHEM, V398, P1545, DOI 10.1007/s00216-010-3708-6; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Han SW, 2013, BIOSENS BIOELECTRON, V45, P129, DOI 10.1016/j.bios.2013.01.062; HARVEY WW, 1958, J ELECTROCHEM SOC, V105, P654, DOI 10.1149/1.2428685; Heck J. M., 2001, POLYCRYSTALLINE SILI; Kang SK, 2015, ACS APPL MATER INTER, V7, P9297, DOI 10.1021/acsami.5b02526; Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Lee SH, 2004, SENSOR ACTUAT B-CHEM, V99, P623, DOI 10.1016/j.snb.2003.11.040; Lu BC, 2017, IEEE ENG MED BIO, P1865, DOI 10.1109/EMBC.2017.8037210; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Sorribas H, 2002, BIOMATERIALS, V23, P893, DOI 10.1016/S0142-9612(01)00199-5; Veiseh M, 2002, LANGMUIR, V18, P6671, DOI 10.1021/la025529j; Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847; Zhou G., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P2783, DOI 10.1109/Transducers.2013.6627383; Zhou GN, 2015, J PROTEOME RES, V14, P1872, DOI 10.1021/pr501259e; Zoller FA, 2008, MICROELECTRON ENG, V85, P1370, DOI 10.1016/j.mee.2007.12.061	24	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195062	10.1371/journal.pone.0195062	http://dx.doi.org/10.1371/journal.pone.0195062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624587	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600013
J	Michel, ES; Jenks, JA; Kaskie, KD; Klaver, RW; Jensen, WF				Michel, Eric S.; Jenks, Jonathan A.; Kaskie, Kyle D.; Klaver, Robert W.; Jensen, William F.			Weather and landscape factors affect white-tailed deer neonate survival at ecologically important life stages in the Northern Great Plains	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; CAUSE-SPECIFIC MORTALITY; BED-SITE SELECTION; POPULATION-DYNAMICS; SOUTHERN ILLINOIS; COHORT VARIATION; PLANT PHENOLOGY; FAWNS; CLIMATE; PREDATOR	Offspring survival is generally more variable than adult survival and may limit population growth. Although white-tailed deer neonate survival has been intensively investigated, recent work has emphasized how specific cover types influence neonate survival at local scales (single study area). These localized investigations have often led to inconsistences within the literature. Developing specific hypotheses describing the relationships among environmental, habitat, and landscape factors influencing white-tailed deer neonate survival at regional scales may allow for detection of generalized patterns. Therefore, we developed 11 hypotheses representing the various effects of environmental (e.g., winter and spring weather), habitat (e.g., hiding and escape cover types), and landscape factors (e.g., landscape configuration regardless of specific cover type available) on white-tailed deer neonate survival up to one-month and from one-to three-months of age. At one-month, surviving fawns experienced a warmer lowest recorded June temperature and more June precipitation than those that perished. At three-months, patch connectance (percent of patches of the corresponding patch type that are connected within a predefined distance) positively influenced survival. Our results are consistent with white-tailed deer neonate ecology: increased spring temperature and precipitation are likely associated with a flush of nutritional resources available to the mother, promoting increased lactation efficiency and neonate growth early in life. In contrast, reduced spring temperature with increased precipitation place neonates at risk to hypothermia. Increased patch connectance likely reflects increased escape cover available within a neonate's home range after they are able to flee from predators. If suitable escape cover is available on the landscape, then managers could focus efforts towards manipulating landscape configuration (patch connectance) to promote increased neonate survival while monitoring spring weather to assess potential influences on current year survival.	[Michel, Eric S.; Jenks, Jonathan A.; Kaskie, Kyle D.] South Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Klaver, Robert W.] Iowa State Univ, Iowa Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ames, IA USA; [Jensen, William F.] North Dakota Game & Fish Dept, Bismarck, ND USA	South Dakota State University; Iowa State University; United States Department of the Interior; United States Geological Survey	Michel, ES (corresponding author), South Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	eric.michel@sdstate.edu	Jenks, Jonathan A/B-7321-2009		Federal Aid to Wildlife Restoration [W-67-R-57, W-67-R57]	Federal Aid to Wildlife Restoration	This project was funded by Federal Aid to Wildlife Restoration administered through North Dakota Game and Fish Department (Project W-67-R-57, Study No. C-VIII to WFJ and W-67-R57 to JAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the North Dakota Game and Fish Department, South Dakota Department of Game, Fish and Parks, the Minnesota Department of Natural Resources, the Department of Natural Resource Management at South Dakota State University, and numerous private landowners, graduate students, and technicians for their help and cooperation with this project. We also thank M. Apollonio, B. Pokorny, and an anonymous reviewer for their helpful comments. This project was funded by Federal Aid to Wildlife Restoration administered through North Dakota Game and Fish Department (Project W-67-R-57, Study No. C-VIII). Any mention of trade, product, or firm names is for descriptive purposes only, and does not imply endorsement by the U.S. Government.	Adams KP, 2011, BIOL MANAGEMENT WHIT; ARMSTRONG RA, 1950, AM MIDL NAT, V43, P650, DOI 10.2307/2421857; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K., 2016, MUMIN MULTIMODEL INF; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.1890/0012-9658(1998)079[0517:HLAPDA]2.0.CO;2; Brinkman TJ, 2005, J WILDLIFE MANAGE, V69, P1099, DOI 10.2193/0022-541X(2005)069[1099:MOFWDE]2.0.CO;2; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Brinkman TJ, 2002, WILDLIFE SOC B, V30, P258; Bryce SA., 1996, ECOREGIONS N DAKOTA; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CARL GR, 1988, CAN J ZOOL, V66, P239, DOI 10.1139/z88-034; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Chitwood MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119070; Chitwood MC, 2015, J WILDLIFE MANAGE, V79, P211, DOI 10.1002/jwmg.835; Ciuti S, 2015, J WILDLIFE MANAGE, V79, P1226, DOI 10.1002/jwmg.956; Conner LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137169; Cooch E, 2016, USING MARK GENTLE IN; Cook JG, 2004, WILDLIFE MONOGR, P1; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; DOWNING RL, 1969, J WILDLIFE MANAGE, V33, P711, DOI 10.2307/3799399; Eacker DR, 2016, J WILDLIFE MANAGE, V80, P1345, DOI 10.1002/jwmg.21133; Edwards SL, 2004, WILDLIFE SOC B, V32, P739, DOI 10.2193/0091-7648(2004)032[0739:WDFPIM]2.0.CO;2; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 1997, OECOLOGIA, V112, P502, DOI 10.1007/s004420050338; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2012, ANIM BEHAV, V84, P59, DOI 10.1016/j.anbehav.2012.04.005; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P632, DOI 10.1002/jwmg.288; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Gulsby WD, 2017, J WILDLIFE MANAGE, V81, P601, DOI 10.1002/jwmg.21240; Hao FH, 2012, ENVIRON MODEL ASSESS, V17, P389, DOI 10.1007/s10666-011-9297-8; Haskell SP, 2007, J MAMMAL, V88, P1482, DOI 10.1644/07-MAMM-A-004R.1; Hegel TM, 2010, J ANIM ECOL, V79, P471, DOI 10.1111/j.1365-2656.2009.01647.x; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hosmer D. W., 2013, APPL LOGISTIC REGRES; HUEGEL CN, 1985, WILDLIFE SOC B, V13, P287; Hurley MA, 2017, J WILDLIFE MANAGE, V81, P364, DOI 10.1002/jwmg.21211; Jacques CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144026; Johnson JR, 2007, AGR EXPT STATION B; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; Linnell JDC, 1995, WILDLIFE BIOL, V1, P209, DOI 10.2981/wlb.1995.0026; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Michel ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136034; Moratz K. L, 2016, THESIS; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; NOAA: National Centers for Environmental Information, 2016, DAT TOOLS DAIL WEATH; North Dakota Office of Climatology, 2016, N DAK CLIM WEATH; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Schaffer Brian A., 2014, Prairie Naturalist, V46, P34; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith BL, 1998, J WILDLIFE MANAGE, V62, P1036, DOI 10.2307/3802556; Sternhagen K. M., 2015, THESIS; Swanson CC, 2008, WILDLIFE BIOL, V14, P272, DOI 10.2981/0909-6396(2008)14[272:DTUOVT]2.0.CO;2; Team RC., 2013, R LANG ENV STAT COMP; Therrien JF, 2008, ANIM BEHAV, V75, P235, DOI 10.1016/j.anbehav.2007.04.030; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; WHITE M, 1972, J WILDLIFE MANAGE, V36, P897, DOI 10.2307/3799446; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	74	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195247	10.1371/journal.pone.0195247	http://dx.doi.org/10.1371/journal.pone.0195247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621287	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800052
J	Wang, CH; Li, NN; Wang, H; Yin, HY; Zhao, YW				Wang, Cunhui; Li, Niannian; Wang, Heng; Yin, Hongyan; Zhao, Yunwu			Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China	PLOS ONE			English	Article							ESSENTIAL MEDICINES POLICY; LENGTH-OF-STAY; CARE FACILITIES; COST; MORTALITY; STROKE; IMPACT	Background and purpose Drug costs is one of the main components of hospitalization expenditure for cerebral infarction inpatients. In China, the National Essential Medicine System (NEMS) was created to relieve the heavy drug-cost burden for patients. The objective of this study was to investigate essential drug-use status and its influencing factors among cerebral infarction inpatients in county-level hospitals of Anhui province, China. Methods Three county-level hospitals were selected through a multi-stage cluster random sampling method. The hospitalization cost data of cerebral infarction inpatients in the three hospitals were extracted from the Anhui provincial information platform of the New Rural Cooperative Insurance System (NCMS), and whether the proportion of essential drug cost in the total drug cost reached the median value of 33.05% which was set as the evaluation index for essential drug-use status. Questionnaires for hospitals and physicians were designed and given to them to assess influencing factors. Results We retrieved the cost data of 2,189 inpatients from the NCMS platform and investigated 51 corresponding physicians in total. The drug costs accounted for 52.6% of the total hospitalization cost, and essential drug costs alone accounted for 37.0% of the total drug costs. The essential drug-cost proportion was high among physicians with a higher recognition degree on NEMS, older age, lower final academic degree, longer work experience and lower professional title. Married physicians and those with tight organizational affiliation also prescribed more essential drugs. Conclusions Increasing the proportion of essential drugs was an effective way to reduce the disease burden for cerebral infarction patients. Perfecting the NEMS, increasing government investment, reinforcing education and propaganda, and formulating relevant incentive and restrictive mechanisms were all effective ways to promote and increase the number of essential drug prescriptions written by physicians.	[Wang, Cunhui; Wang, Heng; Yin, Hongyan] Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China; [Li, Niannian] Anhui Med Univ, Affiliated Hosp 1, Dept Res Adm, Hefei, Anhui, Peoples R China; [Wang, Heng] Anhui Med Univ, Affiliated Hosp 1, Dept Deams Off, Hefei, Anhui, Peoples R China; [Zhao, Yunwu] Anhui Med Univ, Affiliated Hosp 1, Dept Human Resources, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, H (corresponding author), Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China.; Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Deams Off, Hefei, Anhui, Peoples R China.	wanghengteam@163.com	Yin, Hong/AAC-5784-2020		National Science Foundation of China [71473003, 71774001]; Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University [2015kj10]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University	This research was supported by grants from the National Science Foundation of China (No. 71473003; No. 71774001 Received by HW) and Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University (No. 2015kj10; Received by NL). The URL of the National Science Foundation of China is http://www.nsfc.gov.cni The URL of the latter funder is http://www.ayfy.com/menhuweb/show.php?itemid=7555. Neither of the above two funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhui Provincial Statistics Bureau, 2016, STAT B NAT EC SOC DE; [Anonymous], 2017, AV AG STROK CHIN IS; Bian C, PLOSONE, V10; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Eriksen J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014345; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Guan XD, 2011, J PUBLIC HEALTH POL, V32, P305, DOI 10.1057/jphp.2011.34; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Kitagawa KT, 2009, STROKE DATA BANK 200, P23; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Li L, 2008, CHINESE HLTH EC, V27, P79; [李林蔚 Li Linwei], 2015, [中国全科医学, Chinese General Practice], V18, P4239; Ma C., 2015, MOL CELL PROBE, V29, P1; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; National Health and Family Planning Commission of China, 2015, CHIN STAT YB HLTH FA; Norman C, 2009, INT J CLIN PRACT, V63, P1320, DOI 10.1111/j.1742-1241.2009.02129.x; Orzella L, 2010, HEALTH POLICY, V95, P236, DOI 10.1016/j.healthpol.2009.12.005; Peltola M, 2015, HEALTH ECON, V24, P38, DOI 10.1002/hec.3264; Rao ML, 2007, GUIDELINES PREVENTIO; Research group of the development research center of the State Council, 2005, CHINA DEV REV CHIN A, VA01, P1; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Sekimoto M, 2008, HEALTH POLICY, V88, P100, DOI 10.1016/j.healthpol.2008.01.013; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Tu F, 2002, HEALTH POLICY, V59, P243, DOI 10.1016/S0168-8510(01)00182-8; Turk AS, 2014, J NEUROINTERV SURG, P1; Wang H, 2012, CHINESE J HLTH POLIC, V5, P30; Wang H, 2012, CHIN J HOSP ADM, V2012, P544; Wang H. Y., 2013, J CONTROL SCI ENG, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0056800; Wang LD., 2016, STROKE PREVENTION CO; Wettermark Bjorn, 2009, Qual Prim Care, V17, P179; WHO, 2002, WHO POL PERSP MED 4, V4; WHO, 2010, INT STAT CLASS DIS R; Xi XY, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1008-8; Xu SM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1073-z; Yang L, 2013, B WORLD HEALTH ORGAN, V91, P184, DOI 10.2471/BLT.11.097998; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yoneda Y, 2003, STROKE, V34, P718, DOI 10.1161/01.STR.0000056171.55342.FF; [于倩倩 Yu Qianqian], 2014, [中国全科医学, Chinese General Practice], V17, P2277; Zhang QY, 2011, PRACTICAL PREVENTIVE, V18, P1593; Zhao YW, 2015, CHINESE MED J-PEKING, V128, P2887, DOI 10.4103/0366-6999.168046; Zou SN, 2015, CHINESE HLTH EC, V34, P72; Zu XL, 2014, CHINESE J HLTH STAT, V26, p[515, 518]; 胡丹, 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P707	44	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193513	10.1371/journal.pone.0193513	http://dx.doi.org/10.1371/journal.pone.0193513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621245	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800006
J	Wang, YH; Wu, JY; Kong, SC; Chiang, MH; Ho, ML; Yeh, ML; Chen, CH				Wang, Yan-Hsiung; Wu, Jyun-Yi; Kong, Su Chii; Chiang, Min-Hsuan; Ho, Mei-Ling; Yeh, Ming-Long; Chen, Chia-Hsin			Low power laser irradiation and human adipose-derived stem cell treatments promote bone regeneration in critical-sized calvarial defects in rats	PLOS ONE			English	Article							ENERGY DIODE-LASER; IN-VITRO; THERAPY; TISSUE; PROLIFERATION; REPAIR; DIFFERENTIATION; VIVO	Both stem cell therapy and physical treatments have been shown to be beneficial in accelerating bone healing. However, the efficacy of combined treatment with stem cells and physical stimuli for large bone defects remains uncertain. The aim of this study was to evaluate the bone regeneration effects of low-power laser irradiation (LPLI) and human adipose derived stem cell (ADSC) treatments during fracture repair using a comparative rat calvarial defect model. We evaluated the viability of human ADSCs, which were cultured on a porous PLGA scaffold using an MTS assay. The critical-sized calvarial bone defect rats were divided into 4 groups: control group, LPLI group, ADSC group, and ADSC+LPLI group. Bone formation was evaluated using micro-CT. New bone formation areas and osteogenic factor expression levels were then examined by histomorphological analysis and immunohistochemical staining. Our data showed that PLGA had no cytotoxic effect on human ADSCs. Micro-CT analyses revealed that both the LPLI and ADSC groups showed improved calvarial bone defect healing compared to the control group. In addition, the ADSC+LPLI group showed significantly increased bone volume at 16 weeks after surgery. The area of new bone formation ranked as follows: control group < LPLI group < ADSC group < ADSC+LPLI group. There were significant differences between the groups. In addition, both ADSC and ADSC+LPLI groups showed strong signals of vWF expression. ADSC and LPLI treatments improved fracture repair in critical-sized calvarial defects in rats. Importantly, the combined treatment of ADSCs and LPLI further enhances the bone healing process.	[Wang, Yan-Hsiung; Chiang, Min-Hsuan] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wu, Jyun-Yi; Kong, Su Chii; Chiang, Min-Hsuan; Ho, Mei-Ling; Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wu, Jyun-Yi] Fresenius Kabi Taiwan Ltd, Taipei, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Dept Phys Med & Rehabil, Sch Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Phys Med & Rehabil, Sch Med, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488	Ministry of Economic Affairs, Ministry of Science and Technology [102-EC-17-A-19-S1-176]; ITRI Southern Taiwan Industry Joint Service Center [MOST-104-2314-6-037-059, MOST -105-2314-B-037-012]; Kaohsiung Medical University [KMUTP103808, KMU-TP104811, KMU-TP105611]	Ministry of Economic Affairs, Ministry of Science and Technology; ITRI Southern Taiwan Industry Joint Service Center; Kaohsiung Medical University	We gratefully acknowledge support for this research provided by the Ministry of Economic Affairs, Ministry of Science and Technology, ITRI Southern Taiwan Industry Joint Service Center and Kaohsiung Medical University Aim for the Top Universities Grant under grant numbers 102-EC-17-A-19-S1-176, MOST-104-2314-6-037-059, MOST -105-2314-B-037-012, ST105007, KMUTP103808, KMU-TP104811 and KMU-TP105611, respectively. The funder, Fresenius Kabi Taiwan Ltd., provided support in the form of salaries for J Y Wu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ahn TY, 2016, INT J BIOL MACROMOL, V93, P1488, DOI 10.1016/j.ijbiomac.2016.07.027; Amid R, 2014, J LASERS MED SCI, V5, P163; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Barba M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/416391; Barbosa D, 2013, LASER MED SCI, V28, P651, DOI 10.1007/s10103-012-1125-0; Barboza CAG, 2017, INT J EXP PATHOL; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Costa-Almeida R, 2014, EUR CELLS MATER, V28, P51, DOI 10.22203/eCM.v028a05; David R, 1996, LASER SURG MED, V19, P458, DOI 10.1002/(SICI)1096-9101(1996)19:4<458::AID-LSM12>3.0.CO;2-Z; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; de Oliveira FA, 2017, J PHOTOCH PHOTOBIO B, V169, P35, DOI 10.1016/j.jphotobiol.2017.02.020; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; El-Maghraby EMF, 2013, ARCH ORAL BIOL, V58, P796, DOI 10.1016/j.archoralbio.2012.10.003; Fujihara NA, 2006, LASER SURG MED, V38, P332, DOI 10.1002/lsm.20298; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Kazancioglu HO, 2013, J CRANIOFAC SURG, V24, P2141, DOI 10.1097/SCS.0b013e3182a244ae; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Kim H, 2012, J DERMATOL SCI, V68, P149, DOI 10.1016/j.jdermsci.2012.09.013; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Liu YC, 2015, J TISSUE ENG REGEN M, V9, P85, DOI 10.1002/term.1617; Huertas RM, 2014, BIOL RES NURS, V16, P191, DOI 10.1177/1099800413482695; Renno ACM, 2010, PHOTOMED LASER SURG, V28, P131, DOI 10.1089/pho.2009.2487; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nascimento SB, 2010, PHOTOMED LASER SURG, V28, P45, DOI 10.1089/pho.2008.2396; Nauth A, 2012, INDIAN J ORTHOP, V46, P19, DOI 10.4103/0019-5413.91630; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Nurkovic J, 2017, LASER MED SCI, V32, P151, DOI 10.1007/s10103-016-2097-2; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Schindl A, 1999, DERMATOLOGY, V198, P314, DOI 10.1159/000018140; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Shao J, 2015, BIOL RES, V48, DOI [10.1186/S40659-015-0053-4, 10.1186/s40659-015-0053-4]; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Torricelli P, 2001, BIOMED PHARMACOTHER, V55, P117, DOI 10.1016/S0753-3322(00)00025-1; Wu J., 2013, ADV MATER SCI ENG, V2013, P10, DOI [DOI 10.1016/J.DYEPIG.2013.12.023, DOI 10.1016/J.CARBP0L.2013.10.093]; Wu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054067, 10.1371/journal.pone.0067644]; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089; Yamada K, 1991, Nihon Seikeigeka Gakkai Zasshi, V65, P787; Zuk, 2013, ISRN STEM CELLS, DOI [10.1155/2013/713959, DOI 10.1155/2013/713959]; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	27	27	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195337	10.1371/journal.pone.0195337	http://dx.doi.org/10.1371/journal.pone.0195337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621288	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800066
J	Fiore, E; Artuso, F; Gianesella, M; Vecchio, D; Morgante, M; Mazzotta, E; Badon, T; Rossi, P; Bedin, S; Piccione, G				Fiore, Enrico; Artuso, Francesca; Gianesella, Matteo; Vecchio, Domenico; Morgante, Massimo; Mazzotta, Elisa; Badon, Tamara; Rossi, Pasquale; Bedin, Silvia; Piccione, Giuseppe			Metabolic and hormonal adaptation in Bubalus bubalis around calving and early lactation	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; NONESTERIFIED FATTY-ACIDS; TRANSITION DAIRY-CATTLE; BETA-HYDROXYBUTYRATE; BLOOD PARAMETERS; MILK-COMPOSITION; BODY CONDITION; COWS; BUFFALOS; PERIOD	Pregnancy and lactation are physiological periods that result in an increased metabolic demand that, if not satisfied, could provoke a threat to homeostasis. In this study changes in the values of Non-Esterified Fatty Acids (NEFA) and p-hydroxybutyrate (BHB), glucose, insulin, thyroid hormones, milk composition and yield were investigated in buffaloes during the late pregnancy and early lactation. From a total of 50 buffaloes, blood samples were collected -7 +/- 5 days before expected calving; +7 +/- 5; +30 +/- 5 and +50 +/- 5 days post-partum; milk samples were collected at the same post-partum time points. On serum samples, the values of Non-Esterified Fatty Acids (NEFA), beta-hydroxybutyrate (BHB), glucose, insulin, Triiodothy-ronine (T3), Thyroxine (T4) and Thyroid-stimulating hormone (TSH) were evaluated. On milk, fat %, protein %, lactose %, somatic cells score (SCS), milk yield and daily milk production (DMP) were assessed. Peripartum period significantly influenced all studied parameters (P<0.05). Milk constituents and productivity statistically changed throughout monitoring period (P<0.005). Milk yield resulted positively correlated with insulin and TSH values, negatively correlated with NEFA and BHB. Insulin was negatively correlated with lactose % and positively correlated with SCS. The obtained results showed that the peripartum period and lactation are accompanied by marked changes in some biochemical variables and in the thyroid hormones values in Italian Mediterranean Buffaloes. Moreover, the relationship found between TSH values and milk yield seems to suggest a possible role of thyroid gland on the maintenance of lactogenesis. This study underlines the importance of monitoring the hormonal status of buffalo during the transition period in order to understand when adjustments of regulatory mechanisms break through physiological limits predisposing the buffalo to metabolic problems.	[Fiore, Enrico; Gianesella, Matteo; Morgante, Massimo; Mazzotta, Elisa; Badon, Tamara; Bedin, Silvia] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy; [Artuso, Francesca; Piccione, Giuseppe] Univ Messina, Polo Univ Annunziata, Dept Vet Sci, Messina, Italy; [Vecchio, Domenico] Ist Zooprofilatt Sperimentale Mezzogiorno, Natl Reference Ctr Water Buffalo Farming & Prod H, Salerno, Italy; [Rossi, Pasquale] Sud Rienergy, Corigliano Calabro, Italy	University of Padua; University of Messina; IZS del Mezzogiorno	Gianesella, M (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy.	matteo.gianesella@unipd.it	FIORE, ENRICO/AAI-9467-2020; Mazzotta, Elisa/AAB-9668-2022; Vecchio, Domenico/I-4102-2013; Fiore, Enrico/CAF-7137-2022	Mazzotta, Elisa/0000-0003-2369-8467; Vecchio, Domenico/0000-0002-8766-7224; Fiore, Enrico/0000-0002-0377-9553; , Matteo/0000-0001-8117-5969				Abdulkareem T.A., 2013, AL ANBAR J VET SCI, V6, P143; Abdulkareem T.A., 2013, J BUFFALO SCI INDIA, V2, P78; Abdulkareem TA, 2012, PAK VET J, V32, P345; Accorsi PA, 2005, REPROD DOMEST ANIM, V40, P217, DOI 10.1111/j.1439-0531.2005.00581.x; AKASHA M, 1984, P SOC EXP BIOL MED, V177, P360, DOI 10.3181/00379727-177-41957; [Anonymous], 2004, ITAL J ANIM SCI, V3, P275; Arfuso F, 2016, ARCH ANIM BREED, V59, P429, DOI 10.5194/aab-59-429-2016; Ashmawy N. A., 2015, Asian Journal of Animal and Veterinary Advances, V10, P271; Ashmawy N.A., 2015, INT J ADV RES, V3, P1377; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BERTONI G, 1993, EAAP PUBLIC, V62, P270; Bertoni G, 1994, AGRICOLTURA RICERCA, V16, P87; Campanile G., 1997, Bubalus Bubalis, P236; Campanile G, 1995, P 11 NAT C ASPA 19 2, P77; Deka RS, 2014, BIOL TRACE ELEM RES, V161, P57, DOI 10.1007/s12011-014-0069-6; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fiore E, 2015, ANIMAL PRODUCTION SC, V57, P74; Fiore E, 2017, ANIM SCI J, V88, P2025, DOI 10.1111/asj.12872; Fiore E, 2015, ANIM SCI PAP REP, V33, P129; Hogan J. S., 1999, LAB HDB BOVINE MASTI, Vrev; Holtorf K., 2014, J RESTOR MED, V3, P53, DOI [10.14200/jrm.2014.3.0104, DOI 10.14200/JRM.2014.3.0104]; Huszenicza G, 2002, VET MED-CZECH, V47, P199, DOI 10.17221/5824-VETMED; Medhammar E, 2012, J SCI FOOD AGR, V92, P445, DOI 10.1002/jsfa.4690; Nikolic JA, 1997, ACTA VET-BEOGRAD, V47, P3; Nozad Shahram, 2012, Vet Res Forum, V3, P55; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Ospina PA, 2010, J DAIRY SCI, V93, P546, DOI 10.3168/jds.2009-2277; PETHES G, 1985, J DAIRY SCI, V68, P1148, DOI 10.3168/jds.S0022-0302(85)80941-3; Rosati A, 2002, LIVEST PROD SCI, V74, P185, DOI 10.1016/S0301-6226(01)00293-7; RUCKEBUSCH Y, 1991, PHYSL SMALL LARGE AN; Tsuda T., 1991, PHYSL ASPECTS DIGEST; TYRRELL HF, 1965, J DAIRY SCI, V48, P1215, DOI 10.3168/jds.S0022-0302(65)88430-2; WIGGANS GR, 1987, J DAIRY SCI, V70, P2666, DOI 10.3168/jds.S0022-0302(87)80337-5; WILSON DB, 1980, BIOCHEM BIOPH RES CO, V95, P807, DOI 10.1016/0006-291X(80)90859-1; Youssef MA, 2010, TROP ANIM HEALTH PRO, V42, P1771, DOI 10.1007/s11250-010-9636-9	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193803	10.1371/journal.pone.0193803	http://dx.doi.org/10.1371/journal.pone.0193803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617370	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800013
J	Irigoyen, A; Jimenez-Luna, C; Benavides, M; Caba, O; Gallego, J; Ortuno, FM; Guillen-Ponce, C; Rojas, I; Arande, E; Torres, C; Prados, J				Irigoyen, Antonio; Jimenez-Luna, Cristina; Benavides, Manuel; Caba, Octavio; Gallego, Javier; Manuel Ortuno, Francisco; Guillen-Ponce, Carmen; Rojas, Ignacio; Arande, Enrique; Torres, Carolina; Prados, Jose			Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; PERIPHERAL-BLOOD; MICROARRAY DATA; CANCER; RECEPTOR; TOSO; IDENTIFICATION; ACTIVATION; MARKER	Applying differentially expressed genes (DEGs) to identify feasible biomarkers in diseases can be a hard task when working with heterogeneous datasets. Expression data are strongly influenced by technology, sample preparation processes, and/or labeling methods. The proliferation of different microarray platforms for measuring gene expression increases the need to develop models able to compare their results, especially when different technologies can lead to signal values that vary greatly. Integrative meta-analysis can significantly improve the reliability and robustness of DEG detection. The objective of this work was to develop an integrative approach for identifying potential cancer biomarkers by integrating gene expression data from two different platforms. Pancreatic ductal adenocarcinoma (PDAC), where there is an urgent need to find new biomarkers due its late diagnosis, is an ideal candidate for testing this technology. Expression data from two different datasets, namely Affymetrix and Illumina (18 and 36 PDAC patients, respectively), as well as from 18 healthy controls, was used for this study. A meta-analysis based on an empirical Bayesian methodology (ComBat) was then proposed to integrate these datasets. DEGs were finally identified from the integrated data by using the statistical programming language R. After our integrative meta-analysis, 5 genes were commonly identified within the individual analyses of the independent datasets. Also, 28 novel genes that were not reported by the individual analyses ('gained' genes) were also discovered. Several of these gained genes have been already related to other gastroenterological tumors. The proposed integrative meta-analysis has revealed novel DEGs that may play an important role in PDAC and could be potential biomarkers for diagnosing the disease.	[Irigoyen, Antonio] Virgen de la Salud Hosp, Dept Med Oncol, Toledo, Spain; [Jimenez-Luna, Cristina; Prados, Jose] Univ Granada, Ctr Biomed Res CIBM, Inst Biopathol & Regenerat Med IBIMER, Granada, Spain; [Benavides, Manuel] Virgen de la Victoria Hosp, Dept Med Oncol, Malaga, Spain; [Caba, Octavio] Univ Jaen, Dept Hlth Sci, Jaen, Spain; [Gallego, Javier] Univ Gen Hosp Elche, Dept Med Oncol, Alicante, Spain; [Manuel Ortuno, Francisco; Rojas, Ignacio] Univ Granada, Res Ctr Informat & Commun Technol, Dept Comp Architecture & Comp Technol, Granada, Spain; [Guillen-Ponce, Carmen] Hosp Ramon y Cajal Hosp, Dept Med Oncol, Madrid, Spain; [Arande, Enrique] Univ Cordoba, Reina Sofia Hosp, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain; [Torres, Carolina] Univ Granada, Fac Sci, Dept Biochem & Mol Biol 1, Granada, Spain	Complejo Hospitalario de Toledo; University of Granada; Universidad de Jaen; University of Granada; Universidad de Cordoba; University of Granada	Caba, O (corresponding author), Univ Jaen, Dept Hlth Sci, Jaen, Spain.	ocaba@ujaen.es	Guzman, Francisco Manuel Ortuno/I-4667-2012; Guillén-Ponce, Carmen/AAC-4096-2020; Jimenez Luna, Cristina/AAV-1878-2021; Rojas, Ignacio/B-7481-2013; Torres, Carolina/M-1169-2014; Caba, Octavio/H-1918-2015	Guzman, Francisco Manuel Ortuno/0000-0001-7424-1753; Guillén-Ponce, Carmen/0000-0002-3594-1084; Rojas, Ignacio/0000-0002-1033-5635; Torres, Carolina/0000-0002-7908-6884; Caba, Octavio/0000-0003-3426-8294; Jimenez Luna, Cristina/0000-0002-2395-1728	Instituto de Salud Carlos III [DTS15/00201]; Ministerio de Economia y Competitividad (the Spanish Ministry of Economy and Competitiveness) [TIN2015-71873-R]; Consejeria de Salud, Junta de Andalucia [PIN-0474-2016]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [P12-TIC-2082]; University de Granada [15/13]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad (the Spanish Ministry of Economy and Competitiveness); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); University de Granada	This work was supported by the Instituto de Salud Carlos III (grant number DTS15/00201 to OC), Ministerio de Economia y Competitividad (the Spanish Ministry of Economy and Competitiveness) (grant number TIN2015-71873-R to IR), Consejeria de Salud, Junta de Andalucia (PIN-0474-2016 to JP), Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (P12-TIC-2082 to IR) and the University de Granada (grant number 15/13 to OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Caba O, 2014, DIGEST DIS SCI, V59, P2714, DOI 10.1007/s10620-014-3291-3; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chan A, 2013, J PROTEOMICS, V81, P126, DOI 10.1016/j.jprot.2012.09.025; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Delfani P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159138; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du XY, 2017, EUR REV MED PHARMACO, V21, P1495; Ducreux M, 2015, ANN ONCOL, V26, pV56, DOI 10.1093/annonc/mdv295; Duffy MJ, 2010, ANN ONCOL, V21, P441, DOI 10.1093/annonc/mdp332; Fan CW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-254; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Goonesekere NCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093046; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Guo Jiubing, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P898; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; Hibino S, 2014, ONCOL REP, V31, P693, DOI 10.3892/or.2013.2901; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huang H, 2010, AM J GASTROENTEROL, V105, P1661, DOI 10.1038/ajg.2010.32; Jain A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00553; Jiang YD, 2003, MOL CANCER RES, V1, P453; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Ksionda Olga, 2013, Front Biol (Beijing), V8, P508; Kubagawa H, 2015, J IMMUNOL, V194, P4055, DOI 10.4049/jimmunol.1500222; Kuo CC, 2015, WORLD J GASTROENTERO, V21, P3960, DOI 10.3748/wjg.v21.i13.3960; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Muller C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156594; O'Brien DP, 2015, CLIN CANCER RES, V21, P622, DOI 10.1158/1078-0432.CCR-14-0365; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pashaei E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179543; Pavlou MP, 2014, J PROTEOME RES, V13, P2897, DOI 10.1021/pr500352e; Richter GHS, 2009, SCAND J IMMUNOL, V70, P206, DOI 10.1111/j.1365-3083.2009.02281.x; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Rothschild DE, 2017, EBIOMEDICINE, V15, P36, DOI 10.1016/j.ebiom.2016.11.039; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slater EP, 2013, TRANSL ONCOL, V6, P99, DOI 10.1593/tlo.12373; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soares-Schanoski A, 2012, BIOCHEM BIOPH RES CO, V423, P331, DOI 10.1016/j.bbrc.2012.05.124; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Tanday S, 2014, LANCET ONCOL, V15, pE108, DOI 10.1016/S1470-2045(14)70033-6; Tavares TS, 2008, CANCER BIOL THER, V7, P1607, DOI 10.4161/cbt.7.10.6584; Thierolf M, 2008, PROTEOM CLIN APPL, V2, P11, DOI 10.1002/prca.200780046; Toro-Dominguez D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0489-x; Toyoda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-122; TURMAN MA, 1993, HUM IMMUNOL, V36, P34, DOI 10.1016/0198-8859(93)90006-M; Turnbull AK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-35; Vire B, 2011, J IMMUNOL, V187, P4040, DOI 10.4049/jimmunol.1100532; Waldron L, 2014, J NATL CANC I, V106; Wang Y, 2012, J CELL MOL MED, V16, P3037, DOI 10.1111/j.1582-4934.2012.01633.x; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Yasrebi H, 2016, BRIEF BIOINFORM, V17, P771, DOI 10.1093/bib/bbv092; Zhang Jinqiang, 2009, Zhongguo Fei Ai Za Zhi, V12, P93, DOI 10.3779/j.issn.1009-3419.2009.02.01; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2	71	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194844	10.1371/journal.pone.0194844	http://dx.doi.org/10.1371/journal.pone.0194844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617451	Green Published, gold			2022-12-27	WOS:000429203800052
J	Prochazka, M; Otero, L; Konda, KA; Gonzalez-Lagos, E; Echevarria, J; Gotuzzo, E				Prochazka, Mateo; Otero, Larissa; Konda, Kelika A.; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo			Patient-nominated supporters as facilitators for engagement in HIV care in a referral hospital in Peru: A retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COMMUNITY SUPPORT; PEER SUPPORT; FOLLOW-UP; ADHERENCE; RETENTION; DISCLOSURE; HEALTH; IMPACT; STIGMA	Patient-nominated supporters can potentially improve the continuum of HIV care. We retrospectively determined factors associated with having a patient-nominated supporter among people living with HIV (PLWH), and its association with retention in care and viral suppression. We analysed registries of adults evaluated by social workers (n = 1345) at a referral hospital in Peru between 2011-2014. Nondisclosure of HIV status was associated with lacking supporters (aPR: 5.41, 95% CI: 3.83-7.64). Retention in care was 76.4% and 34.2% after one and two years of enrolment, respectively. PLWH with supporters were more likely to be retained in care after two years (aRR = 1.36, 95% CI: 1.02-1.81), but not after one year (aRR = 1.10, 95% CI: 0.98-1.23) compared to PLWH without supporters. Having supporters who were parents or friends was associated with an increased probability of being retained in care after one and two years of enrolment. Viral suppression after one year of enrolment was 58.7%. Having a supporter was not associated with viral suppression (aRR = 1.18, 95% CI: 0.99-1.41), but PLWH with supporters were more likely to have viral load measurements (p = 0.005). Patient-nominated supporters appear beneficial for engagement in HIV care; these benefits may be related to the nature of their relationship with PLWH.	[Prochazka, Mateo; Otero, Larissa; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Prochazka, Mateo; Konda, Kelika A.] Univ Peruana Cayetano Heredia, Carlos Vidal Layseca Sch Publ Hlth & Management, Lima, Peru; [Otero, Larissa; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Alberto Hurtado Sch Med, Lima, Peru; [Konda, Kelika A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Konda, Kelika A.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Los Angeles, CA 90095 USA; [Echevarria, Juan; Gotuzzo, Eduardo] Minist Hlth, Dept Infect Trop & Dermatol Dis, Hosp Cayetano Heredia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prochazka, M (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Prochazka, M (corresponding author), Univ Peruana Cayetano Heredia, Carlos Vidal Layseca Sch Publ Hlth & Management, Lima, Peru.	mateo.prochazka@upch.pe		Otero, Larissa/0000-0002-8348-4340	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [D43TW00976301]; NIH [U01AI069923]; FOGARTY INTERNATIONAL CENTER [D43TW009763] Funding Source: NIH RePORTER	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [grant number D43TW00976301]. Additional data management support was granted by the NIH-funded Caribbean, Central and South America network for HIV epidemiology (CCASAnet), a member cohort of the International Epidemiologic Databases to Evaluate AIDS (leDEA) [grant number U01AI069923]. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AM, 2017, J HIV AIDS, V3; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bofill LM, 2014, AIDS CARE, V26, P602, DOI 10.1080/09540121.2013.844767; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Cakeres CF, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000327436.36161.80; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Clark JL, 2015, AIDS BEHAV, V19, P2245, DOI 10.1007/s10461-015-1049-3; Cohen SM, 2014, JAIDS-J ACQ IMM DEF, V67, P519, DOI 10.1097/QAI.0000000000000349; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; deSalud M, 2014, NORMA TECNICA SALUD; Duwell MM, 2013, AIDS PATIENT CARE ST, V27, P96, DOI 10.1089/apc.2012.0348; Earnshaw VA, 2015, AIDS BEHAV, V19, P41, DOI 10.1007/s10461-014-0758-3; Ford MA, 2012, MONITORING HIV CARE; Foster SD, 2010, AIDS CARE, V22, P35, DOI 10.1080/09540120903500027; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Granich R, 2017, LANCET, V390, P341, DOI 10.1016/S0140-6736(17)31872-X; Greenland S, 2016, INT J EPIDEMIOL, V45, P565, DOI 10.1093/ije/dyw040; Greenland S, 2015, ANNU REV PUBL HEALTH, V36, P89, DOI 10.1146/annurev-publhealth-031914-122559; Hoces D., 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv133.282, DOI 10.1093/OFID/OFV133.282]; Karwa R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002355; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; de Mola CL, 2012, SOC PSYCH PSYCH EPID, V47, P967, DOI 10.1007/s00127-011-0404-6; Maher D, 2011, TROP MED INT HEAL; Masquillier C, 2015, AIDS BEHAV, V19, P214, DOI 10.1007/s10461-014-0865-1; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mugavero MJ, 2014, CLIN INFECT DIS, V59, P1471, DOI 10.1093/cid/ciu603; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nakigozi G, 2015, JAIDS-J ACQ IMM DEF, V70, P75, DOI 10.1097/QAI.0000000000000710; O'Laughlin KN, 2012, AIDS BEHAV, V16, P1308, DOI 10.1007/s10461-011-0038-4; Parsons JT, 2004, AIDS EDUC PREV, V16, P459, DOI 10.1521/aeap.16.5.459.48741; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Pineirua A, 2015, LANCET INFECT DIS, V15, P833, DOI 10.1016/S1473-3099(15)00108-5; Ramirez Durand G., 2008, MANUAL USUARIO EQUIP; Rebeiro PF, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20636; Ruiz I, ENFERM INFECC MICROB, V28, P409; Simoni J. M., 2000, AIDS BEHAV, V4, P147, DOI [10.1023/A:1009508406855, DOI 10.1023/A:1009508406855]; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Taylor SE, 2011, OXFORD HDB HLTH PSYC, P936; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; UNAIDS, 2014, 90 90 90 AMB TREATM; Valdiserri RO, 2013, ASS SCH PUBLIC HLTH, V128, P354; Valenzuela C, 2015, AIDS BEHAV, V19, P235, DOI 10.1007/s10461-014-0908-7; Verre MC, 2014, AIDS BEHAV, V18, P2030, DOI 10.1007/s10461-014-0787-y; Wills TA., 1991, PROSOCIAL BEHAV, P265; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Wouters E, 2009, AIDS CARE, V21, P411, DOI 10.1080/09540120802242077; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195389	10.1371/journal.pone.0195389	http://dx.doi.org/10.1371/journal.pone.0195389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617437	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800080
J	Hani, YMI; Marchand, A; Turies, C; Kerambrun, E; Palluel, O; Bado-Nilles, A; Beaudouin, R; Porcher, JM; Geffard, A; Dedourge-Geffard, O				Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Kerambrun, Elodie; Palluel, Olivier; Bado-Nilles, Anne; Beaudouin, Remy; Porcher, Jean-Marc; Geffard, Alain; Dedourge-Geffard, Odile			Digestive enzymes and gut morphometric parameters of threespine stickleback (Gasterosteus aculeatus): Influence of body size and temperature	PLOS ONE			English	Article							RUDD SCARDINIUS-ERYTHROPHTHALMUS; PRICKLEBACK FISHES TELEOSTEI; 3-SPINED STICKLEBACK; INTESTINAL-MUCOSA; AMYLOLYTIC ACTIVITY; AMYLASE ACTIVITIES; FOOD-CONSUMPTION; RUTILUS-RUTILUS; ATLANTIC COD; MARINE FISH	Determining digestive enzyme activity is of potential interest to obtain and understand valuable information about fish digestive physiology, since digestion is an elementary process of fish metabolism. We described for the first time (i) three digestive enzymes: amylase, trypsin and intestinal alkaline phosphatase (IAP), and (ii) three gut morphometric parameters: relative gut length (RGL), relative gut mass (RGM) and Zihler's index (ZI) in threespine stickleback (Gasterosteus aculeatus), and we studied the effect of temperature and body size on these parameters. When mimicking seasonal variation in temperature, body size had no effect on digestive enzyme activity. The highest levels of amylase and trypsin activity were observed at 18 degrees C, while the highest IAP activity was recorded at 20 degrees C. When sticklebacks were exposed to three constant temperatures (16, 18 and 21 degrees C), a temporal effect correlated to fish growth was observed with inverse evolution patterns between amylase activity and the activities of trypsin and IAP. Temperature (in both experiments) had no effect on morphometric parameters. However, a temporal variation was recorded for both RGM (in the second experiment) and ZI (in both experiments), and the later was correlated to fish body mass.	[Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Kerambrun, Elodie; Palluel, Olivier; Bado-Nilles, Anne; Porcher, Jean-Marc; Geffard, Alain; Dedourge-Geffard, Odile] Unite Mixte Rech Stress Environm & Biosurveillanc, Reims, France; [Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Palluel, Olivier; Bado-Nilles, Anne; Porcher, Jean-Marc] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo ECOT, Verneuil En Halatte, France; [Hani, Younes Mohamed Ismail; Kerambrun, Elodie; Geffard, Alain; Dedourge-Geffard, Odile] URCA, Moulin Housse, Reims, France; [Beaudouin, Remy] Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France	Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne	Dedourge-Geffard, O (corresponding author), Unite Mixte Rech Stress Environm & Biosurveillanc, Reims, France.; Dedourge-Geffard, O (corresponding author), URCA, Moulin Housse, Reims, France.	odile.dedourge@univ-reims.fr	PALLUEL, Olivier/R-3225-2018; Beaudouin, Rémy/H-1491-2012; HANI, Younes/H-7802-2018; Porcher, Jean-Marc/S-7342-2018; Bado-Nilles, Anne/Q-8563-2018	PALLUEL, Olivier/0000-0001-5372-4852; Beaudouin, Rémy/0000-0002-2855-1571; HANI, Younes/0000-0002-9892-0715; Porcher, Jean-Marc/0000-0002-4135-3078; Bado-Nilles, Anne/0000-0002-4776-9592; Geffard, Alain/0000-0001-9236-2890; Dedourge-Geffard, Odile/0000-0001-6308-2080; TURIES, Cyril/0000-0002-6238-4885	University of Reims Champagne-Ardenne; P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development	University of Reims Champagne-Ardenne; P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development	This work was partly supported by the University of Reims Champagne-Ardenne and the financial support of the P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development.	Ahmad T, 2014, AQUACULT NUTR, V20, P265, DOI 10.1111/anu.12072; AL-HUSSAINI A. H., 1949, QUART JOUR MICROSC SCI, V90, P109; ALLEN JRM, 1984, FRESHWATER BIOL, V14, P335, DOI 10.1111/j.1365-2427.1984.tb00158.x; [Anonymous], [No title captured]; Bado-Nilles A, 2014, ENVIRON TOXICOL PHAR, V38, P672, DOI 10.1016/j.etap.2014.08.002; Barlow GW, 2002, FISH FISH, V3, P197, DOI 10.1046/j.1467-2979.2002.00083.x; Blier PU, 2002, AQUACULTURE, V209, P379, DOI 10.1016/S0044-8486(01)00807-9; Bone Q., 2008, BIOL FISHES, DOI [10.1201/9781134186310, DOI 10.1201/9781134186310]; Bowyer JN, 2014, AQUAC RES, V45, P2010, DOI 10.1111/are.12146; Cahu C, 2007, CYBIUM, V31, P217; Caruso G, 2014, FISH PHYSIOL BIOCHEM, V40, P1373, DOI 10.1007/s10695-014-9931-x; Debnath D, 2007, COMP BIOCHEM PHYS B, V146, P107, DOI 10.1016/j.cbpb.2006.09.008; Dedourge O, 2008, ORIGINE PERTURBATION, p[243, 94]; Dedourge-Geffard O, 2009, CHEMOSPHERE, V77, P1569, DOI 10.1016/j.chemosphere.2009.09.042; ENRE (Equipe nationale de retablissement des paires d'especes d'epinoches), 2007, SER PROGR RET LOI ES; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Gelman Alexander, 2008, P155; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; German DP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P789, DOI 10.1086/422228; German DP, 2003, DIGESTIVE ENZYME ACT; Golovanova IL, 2013, FISH PHYSIOL BIOCHEM, V39, P1497, DOI 10.1007/s10695-013-9803-9; Guderley Helga E., 1994, P85; Hidalgo MC, 1999, AQUACULTURE, V170, P267, DOI 10.1016/S0044-8486(98)00413-X; HOFER R, 1979, J FISH BIOL, V15, P373, DOI 10.1111/j.1095-8649.1979.tb03619.x; HOFER R, 1979, J FISH BIOL, V14, P565, DOI 10.1111/j.1095-8649.1979.tb03556.x; Hovel RA, 2015, T AM FISH SOC, V144, P1311, DOI 10.1080/00028487.2015.1079554; HTUNHAN M, 1978, J FISH BIOL, V13, P369, DOI 10.1111/j.1095-8649.1978.tb03445.x; Imsland AK, 2002, FISH FISH, V3, P36, DOI 10.1046/j.1467-2979.2002.00070.x; Infante JLZ, 2007, AQUACULTURE, V268, P98, DOI 10.1016/j.aquaculture.2007.04.032; INFANTE JLZ, 1994, COMP BIOCHEM PHYS A, V109, P209, DOI 10.1016/0300-9629(94)90122-8; IPCC, 2013, CLIM CHANG PHYS SCI; Jolles JW, 2016, J FISH BIOL, V88, P1661, DOI 10.1111/jfb.12934; JORDAN CM, 1972, CAN J ZOOLOG, V50, P1405, DOI 10.1139/z72-189; Junge W, 2001, CLIN BIOCHEM, V34, P607, DOI 10.1016/S0009-9120(01)00278-8; Karachle PK, 2010, MARINE BIODIVERSITY, P3; Karasov HW, 2013, COMP DIGESTIVE PHYSL; Klepsatel P, 2016, SCI REPORTS, P6; Kofuji PYM, 2005, AQUAC RES, V36, P696, DOI 10.1111/j.1365-2109.2005.01276.x; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P129, DOI 10.1007/BF00001991; Kuz'mina V, 2003, COMP BIOCHEM PHYS B, V134, P529, DOI 10.1016/S1096-4959(03)00005-8; Kuzmina VV, 1996, AQUACULTURE, V148, P25, DOI 10.1016/S0044-8486(96)01370-1; Kuzmina VV, 1996, COMP BIOCHEM PHYS B, V113, P255, DOI 10.1016/0305-0491(95)02019-5; Langeland T.L.M., 2013, J AQUAC RES DEV, V5, P1, DOI [10.4172/2155-9546.1000208, DOI 10.4172/2155-9546.1000208]; Le Guernic A, 2016, FISH PHYSIOL BIOCHEM, V42, P643, DOI 10.1007/s10695-015-0166-2; Lefebure R, 2014, J EXP MAR BIOL ECOL, V451, P82, DOI 10.1016/j.jembe.2013.11.008; Leloutre C, 2016, ECOLOGY FRESHWATER F; Lemieux H, 1999, FISH PHYSIOL BIOCHEM, V20, P293, DOI 10.1023/A:1007791019523; Pujante IM, 2017, AQUAC RES, V48, P367, DOI 10.1111/are.13038; Miegel RP, 2010, AQUACULTURE, V308, P145, DOI 10.1016/j.aquaculture.2010.07.036; MITCHELL MA, 1992, COMP BIOCHEM PHYS A, V101, P137, DOI 10.1016/0300-9629(92)90641-3; Nespolo RF, 2002, J EXP BIOL, V205, P2697; Pantegini M, 2008, TIETZ FUNDAMENTALS C, P317; Rungruangsak-Torrissen K, 2006, FISH PHYSIOL BIOCHEM, V32, P7, DOI 10.1007/s10695-005-0630-5; Sanchez W, 2008, ENVIRON INT, V34, P490, DOI 10.1016/j.envint.2007.11.003; Shan XJ, 2008, AQUACULTURE, V281, P70, DOI 10.1016/j.aquaculture.2008.05.034; Smith C., 2009, FISH FISH, V10, P354; Solovyev M, 2016, FISH PHYSIOL BIOCHEM, V42, P1383, DOI 10.1007/s10695-016-0226-2; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Wootton R.J., 1994, P114; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS; Zeyl JN, 2014, J GREAT LAKES RES, V40, P164, DOI 10.1016/j.jglr.2013.12.004; Zihler F., 1981, NETHERLANDS J ZOOLOG, V32, P544, DOI [10.1163/002829682X00210, DOI 10.1163/002829682X00210]	63	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194932	10.1371/journal.pone.0194932	http://dx.doi.org/10.1371/journal.pone.0194932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614133	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600021
J	Arceneaux, K; Dunaway, J; Soroka, S				Arceneaux, Kevin; Dunaway, Johanna; Soroka, Stuart			Elites are people, too: The effects of threat sensitivity on policymakers' spending priorities	PLOS ONE			English	Article							POLITICAL ORIENTATIONS	Recent research suggests that psychological needs can influence the political attitudes of ordinary citizens, often outside of their conscious awareness. In this paper, we investigate whether psychological needs also shape the spending priorities of political elites in the US. Most models of policymaking assume that political elites respond to information in relatively homogeneous ways. We suggest otherwise, and explore one source of difference in information processing, namely, threat sensitivity, which previous research links to increased support for conservative policy attitudes. Drawing on a sample of state-level policymakers, we measure their spending priorities using a survey and their level of threat sensitivity using a standard psychophysiological measure (skin conductance). We find that, like ordinary citizens, threat sensitivity leads even state-level policymakers to prioritize spending on government polices that are designed to minimize threats.	[Arceneaux, Kevin] Temple Univ, Dept Polit Sci, Philadelphia, PA 19122 USA; [Dunaway, Johanna] Texas A&M Univ, Dept Commun, College Stn, TX USA; [Soroka, Stuart] Univ Michigan, Dept Commun Studies, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Texas A&M University System; Texas A&M University College Station; University of Michigan System; University of Michigan	Arceneaux, K (corresponding author), Temple Univ, Dept Polit Sci, Philadelphia, PA 19122 USA.	arceneau@temple.edu	Dunaway, Johanna/AAQ-5084-2021; Dunaway, Johanna/E-1422-2019; Soroka, Stuart/N-6501-2019	Dunaway, Johanna/0000-0003-3975-5227; Dunaway, Johanna/0000-0003-3975-5227; Arceneaux, Kevin/0000-0002-2884-5238	College of Liberal Arts of Temple University; College of Liberal Arts and Department of Communication at Texas AM University; College of Literature, Science and the Arts at the University of Michigan; Temple University; University of Michigan; Texas AM University	College of Liberal Arts of Temple University; College of Liberal Arts and Department of Communication at Texas AM University; College of Literature, Science and the Arts at the University of Michigan; Temple University; University of Michigan(University of Michigan System); Texas AM University	The research was funded in part by research funds generously made available by the College of Liberal Arts of Temple University, the College of Liberal Arts and Department of Communication at Texas A&M University, and the College of Literature, Science and the Arts at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dan Butler and the Laboratories of Democracies for giving us access to study participants, and Temple University, the University of Michigan and Texas A&M University for financial support that made this research possible. We also thank Sarah Anderson, Nicholas Ryan Davis, Mona Vakilifathi, and Laurel Harbridge Yong for their help in the design and implementation of the study.	Aaroe L, 2017, AM POLIT SCI REV, V111, P277, DOI 10.1017/S0003055416000770; Ahn WY, 2014, CURR BIOL, V24, P2693, DOI 10.1016/j.cub.2014.09.050; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; [Anonymous], 2017, HDB PSYCHOPHYSIOLOGY; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Butler DM, 2011, Q J POLIT SCI, V6, P55, DOI 10.1561/100.00011019; Cox GW, 2007, LEGISLATIVE LEVIATHAN: PARTY GOVERNMENT IN THE HOUSE, 2ND EDITION, P1, DOI 10.2277/ 0521694094; Dodd MD, 2012, PHILOS T R SOC B, V367, P640, DOI 10.1098/rstb.2011.0268; Doherty C, 2016, PUBLIC UNCERTAIN DIV; Duckitt J, 2003, POLIT PSYCHOL, V24, P199, DOI 10.1111/0162-895X.00322; Fatas E, 2007, J ECON, V92, P167, DOI 10.1007/s00712-007-0264-4; Fenno, 1978, HOME STYLE HOUSE MEM; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Gadarian SK, 2010, J POLIT, V72, P469, DOI 10.1017/S0022381609990910; Herbst S., 1998, READING PUBLIC OPINI; Hetherington M.J., 2009, AUTHORITARIANISM POL; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Krehbiel Keith., 1992, INFORM LEGISLATIVE O; Ksiazkiewicz A, 2016, POLIT PSYCHOL, V37, P761, DOI 10.1111/pops.12318; Linde J, 2017, POLIT PSYCHOL, V38, P101, DOI 10.1111/pops.12335; Mayhew D., 1974, ELECTORAL CONNECTION; Merolla J.L., 2009, DEMOCRACY RISK TERRO; MILLER WE, 1963, AM POLIT SCI REV, V57, P45, DOI 10.2307/1952717; Nergan PE, 2009, AM POLIT RES, V37, P327, DOI 10.1177/1532673X08326967; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Rohde David W., 1991, PARTIES LEADERS POST; Rosenthal A., 1981, LEGISLATIVE LIFE PEO; Schlesinger, 1966, AMBITION POLITICS PO; Sheffer L, 2017, NONREPRESENTAT UNPUB; Skovron C., 2013, WHAT POLITICIANS BEL; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x	34	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193781	10.1371/journal.pone.0193781	http://dx.doi.org/10.1371/journal.pone.0193781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634723	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200003
J	Safra, N; Hayward, LJ; Aguilar, M; Sacks, BN; Westropp, JL; Mohr, FC; Mellersh, CS; Bannasch, DL				Safra, Noa; Hayward, Louisa J.; Aguilar, Miriam; Sacks, Benjamin N.; Westropp, Jodi L.; Mohr, F. Charles; Mellersh, Cathryn S.; Bannasch, Danika L.			DNA Sequence Variants in the Five Prime Untranslated Region of the Cyclooxygenase-2 Gene Are Commonly Found in Healthy Dogs and Gray Wolves (vol 10, e0133127, 2015)	PLOS ONE			English	Correction													Bannasch, Danika/GZL-8044-2022					[Anonymous], 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049703; Gierse JK, 2001, Patent, Patent No. [WO 0111026- A1 3 15, 0111026]; Marschall T, 2018, BRIEF BIOINFORM, V19, P118, DOI 10.1093/bib/bbw089; Safra N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133127; Whiteley MH, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-7; Whiteley MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016684	6	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195924	10.1371/journal.pone.0195924	http://dx.doi.org/10.1371/journal.pone.0195924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634753	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200062
J	Takahashi, D; Hara, K; Okano, T; Suzuki, H				Takahashi, Daigo; Hara, Keisuke; Okano, Taiji; Suzuki, Hiroaki			A fluidics-based impact sensor	PLOS ONE			English	Article							COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; ICE HOCKEY PLAYERS; HEAD IMPACTS; INSTRUMENTED MOUTHGUARD; ACCELERATION; CONCUSSIONS; EXPOSURE; SPORTS; SOCCER	Microelectromechanical systems (MEMS)-based high-performance accelerometers are ubiquitously used in various electronic devices. However, there is an existing need to detect physical impacts using low-cost devices with no electronic circuits or a battery. We designed and fabricated an impact sensor prototype using a commercial stereolithography apparatus that only consists of a plastic housing and working fluids. The sensor device responds to the instantaneous acceleration (impact) by deformation and pinch off of a water droplet that is suspended in oil in a sensor cavity. We tested the various geometrical and physical parameters of the impact sensor to identify their relations to threshold acceleration values. We show that the state diagram that is plotted against the dimensionless Archimedes and Bond numbers adequately describes the response of the proposed sensor.	[Takahashi, Daigo; Hara, Keisuke; Okano, Taiji; Suzuki, Hiroaki] Chuo Univ, Fac Sci & Engn, Tokyo, Japan	Chuo University	Suzuki, H (corresponding author), Chuo Univ, Fac Sci & Engn, Tokyo, Japan.	suzuki@mech.chuo-u.ac.jp	Suzuki, Hiroaki/T-8989-2019; Okano, Taiji/AAA-8562-2019	Suzuki, Hiroaki/0000-0002-8899-0955; 	JKA and its promotion funds from KEIRIN RACE [27-120]	JKA and its promotion funds from KEIRIN RACE	This research was supported by JKA and its promotion funds from KEIRIN RACE (27-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2010, SENSORS-BASEL, V10, P9026, DOI 10.3390/s101009026; Barbour N, 2001, IEEE SENS J, V1, P332, DOI 10.1109/7361.983473; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; del Rosario MB, 2015, SENSORS-BASEL, V15, P18901, DOI 10.3390/s150818901; Deng X, 2013, LANGMUIR, V29, P7847, DOI 10.1021/la401120j; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gwin JT, 2009, AM SOC TEST MATER, V1516, P244, DOI 10.1520/JAI101848; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; Hernandez W, 2007, SENSORS-BASEL, V7, P84, DOI 10.3390/s7010084; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Linzmeier Kathleen A, 2016, Pediatr Neurol Briefs, V30, P3, DOI 10.15844/pedneurbriefs-30-1-2; Liu SY, 2017, ALGORITHMS, V10, DOI 10.3390/a10040118; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mazutis L, 2012, LAB CHIP, V12, P1800, DOI 10.1039/c2lc40121e; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Murayama H, 2013, NEUROL MED-CHIR, V53, P580; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Riches PE, 2006, SPORTS ENG, V9, P39, DOI 10.1007/BF02844261; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Smith AM, 2016, BMJ OPEN SPORT EXERC, V2; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Utada AS, 2007, PHYS REV LETT, V99, DOI [10.1103/Physrevlett.99.994502, DOI 10.1103/PHYSREVLETT.99.994502]; Vannoni M, 2007, EUR J PHYS, V28, P781, DOI 10.1088/0143-0807/28/5/001; Varga M, 2017, LAB CHIP, DOI [10.1039/671400735c, DOI 10.1039/671400735C]; Wang Y, 2017, SENSORS, V17, DOI [10.33907917020409, DOI 10.33907917020409]; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zeng H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3367704; Zeng HS, 2011, SENSOR ACTUAT B-CHEM, V154, P33, DOI 10.1016/j.snb.2009.11.069; Zeng HS, 2011, SENSORS-BASEL, V11, P638, DOI 10.3390/s110100638	42	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195741	10.1371/journal.pone.0195741	http://dx.doi.org/10.1371/journal.pone.0195741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634750	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200054
J	Kim, KH; Kang, SY; Shin, DA; Yi, S; Ha, Y; Kim, KN; Sohn, YH; Lee, PH				Kim, Ki Hoon; Kang, Suk Yun; Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun; Sohn, Young Ho; Lee, Phil Hyu			Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; BECK DEPRESSION INVENTORY; SCREENING QUESTIONNAIRE; DIAGNOSTIC INSTRUMENT; DAYTIME SLEEPINESS; PATHOLOGY; VALIDATION; CONFUSION; SCALE; PART	Background The clinical features of postoperative delirium are similar to the core features of alpha synuclein-related cognitive disorders, such as Parkinson's disease dementia (PDD) or dementia with Lewy bodies (DLB). Therefore, we hypothesized that the non-motor symptoms (NMSs) in Parkinson's disease (PD), which precede the cardinal motor features of PD, are likely to be risk factors for developing postoperative delirium. We investigated the association between PD related NMSs and postoperative delirium in old people undergoing elective spinal surgery. Methods This study was a prospective study. Participants were aged 65 years and older and scheduled to undergo elective spinal surgery. During the enrollment period, 338 individuals were screened, 104 participants were included in the analysis. We assessed eight easily assessed and representative PD-related NMSs 1 day before the scheduled surgery using tests or questionnaires for each symptom. The presence of delirium was determined by using the short version of the Confusion Assessment Method (CAM). Results Fifteen (14.4%) of the 104 participants (age, 71.7 +/- 4.7 years; men, 34.6%) met the CAM criteria for post-operative delirium. Multivariate logistic analysis showed that decreased olfactory function (odds ratio [OR] 0.63, 95% Cl 0.44-0.91) and exhibiting rapid eye movement sleep behavior disorder (RBD, OR 1.45, 95% Cl 1.09-1.93) were significantly independent predictors of postoperative delirium. Conclusions Our study shows that hyposmia and RBD are significantly independent risk factors for postoperative delirium in general elderly population. Considering that NMSs may represent burden of alpha synuclein deposit, we postulate that an underlying alpha synucleinopathy may correlates with postoperative delirium. Significance This study gives a novel insight for the risk factor of postoperative delirium.	[Kim, Ki Hoon; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kang, Suk Yun] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong, Gyeonggi Do, South Korea; [Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun] Yonsei Univ, Spine & Spinal Cord Inst, Dept Neurosurg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Yonsei University; Yonsei University Health System	Kang, SY (corresponding author), Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong, Gyeonggi Do, South Korea.	sukyunkang@hanmail.net		Sohn, Young H./0000-0001-6533-2610; Lee, Phil Hyu/0000-0001-9931-8462; Shin, Dong Ah/0000-0002-5225-4083; Kim, Ki Hoon/0000-0001-6428-061X				Adogwa O, 2018, J NEUROSURG-SPINE, V28, P103, DOI 10.3171/2017.5.SPINE161244; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brown CH, 2015, J AM GERIATR SOC, V63, P16, DOI 10.1111/jgs.13198; Chaudhuri KR, 2011, PARKINSONISM RELAT D, V17, P717, DOI 10.1016/j.parkreldis.2011.02.018; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chiu HFK, 2000, SLEEP, V23, P513; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Fineberg SJ, 2013, SPINE, V38, P1790, DOI 10.1097/BRS.0b013e3182a0d507; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; GOLDEN WE, 1989, ANN INTERN MED, V111, P218, DOI 10.7326/0003-4819-111-3-218; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; Gore RL, 2015, J NEUROL NEUROSUR PS, V86, P50, DOI 10.1136/jnnp-2013-306389; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joo S, 2009, SLEEP MED, V10, P182, DOI 10.1016/j.sleep.2008.03.017; Kitajima Y, 2015, NEURODEGENER DIS, V15, P162, DOI 10.1159/000381522; Lee DH, 2015, NEUROLOGY, V85, P1270, DOI 10.1212/WNL.0000000000001999; Lee SA, 2015, J NEUROL SCI, V358, P328, DOI 10.1016/j.jns.2015.09.347; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; Leentjens AFG, 2014, MOVEMENT DISORD, V29, P1035, DOI 10.1002/mds.25919; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Oh ES, 2016, J AM GERIATR SOC, V64, P1616, DOI 10.1111/jgs.14243; Ohayon MM, 1997, J CLIN PSYCHIAT, V58, P369; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Sanchez MI, 2011, CAN J SURG SB, V25, P11, DOI DOI 10.1155/2011/974573; Song JY., 1991, KOREAN J CLIN PSYCHO, V10, P93; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Sunwoo MK, 2013, NEUROLOGY, V80, P810, DOI 10.1212/WNL.0b013e3182840782; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Vardy ERLC, 2015, J NEUROL, V262, P2401, DOI 10.1007/s00415-015-7760-1; Whitlock EL, 2011, MINERVA ANESTESIOL, V77, P448; Wu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139879	38	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195749	10.1371/journal.pone.0195749	http://dx.doi.org/10.1371/journal.pone.0195749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630637	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000071
J	Wang, XH; Smith, K; Pearson, M; Hughes, A; Cosden, ML; Marcus, J; Hess, JF; Savage, MJ; Rosahl, T; Smith, SM; Schachter, JB; Uslaner, JM				Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali L.; Marcus, Jacob; Hess, J. Fred; Savage, Mary J.; Rosahl, Thomas; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M.			Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; O-GLCNACYLATION; POSTTRANSLATIONAL MODIFICATIONS; FRONTOTEMPORAL DEMENTIA; LOCOMOTOR-ACTIVITY; MEMORY DEFICITS; MUTANT TAU; PHOSPHORYLATION	Although tau pathology, behavioral deficits, and neuronal loss are observed in patients with tauopathies, the relationship between these endpoints has not been clearly established. Here we found that rTg4510 mice, which overexpress human mutant tau in the forebrain, develop progressive age-dependent increases in locomotor activity (LMA), which correlates with neurofibrillary tangle (NFT) pathology, hyperphosphorylated tau levels, and brain atrophy. To further clarify the relationship between these endpoints, we treated the rTg4510 mice with either doxycycline to reduce mutant tau expression or an O-GlcNAcase inhibitor Thiamet G, which has been shown to ameliorate tau pathology in animal models. We found that both doxycycline and Thiamet G treatments starting at 2 months of age prevented the progression of hyperactivity, slowed brain atrophy, and reduced brain hyperphosphorylated tau. In contrast, initiating doxycycline treatment at 4 months reduced neither brain hyperphosphorylated tau nor hyperactivity, further confirming the relationship between these measures. Collectively, our results demonstrate a unique behavioral phenotype in the rTg4510 mouse model of tauopathy that strongly correlates with disease progression, and that early interventions which reduce tau pathology ameliorate the progression of the locomotor dysfunction. These findings suggest that better understanding the relationship between locomotor deficits and tau pathology in the rTg4510 model may improve our understanding of the mechanisms underlying behavioral disturbances in patients with tauopathies.	[Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali L.; Marcus, Jacob; Hess, J. Fred; Savage, Mary J.; Rosahl, Thomas; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M.] Merck Res Labs, West Point, PA 19486 USA	Merck & Company	Wang, XH (corresponding author), Merck Res Labs, West Point, PA 19486 USA.	xiaohai_wang@merck.com	Smith, Sean/GYJ-6782-2022		Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	This study was funded by Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Brownlow ML, 2014, BEHAV BRAIN RES, V271, P79, DOI 10.1016/j.bbr.2014.06.001; Brownlow ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075713; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cipriani G, 2014, PSYCHOGERIATRICS, V14, P135, DOI 10.1111/psyg.12044; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P267, DOI 10.1016/S0197-4580(97)80306-5; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Graham DL, 2014, NEUROPHARMACOLOGY, V79, P307, DOI 10.1016/j.neuropharm.2013.11.025; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLSTEGE G, 1991, PROG BRAIN RES, V87, P307; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Jul P, 2016, J ALZHEIMERS DIS, V49, P783, DOI 10.3233/JAD-150292; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leroy K, 2007, AM J PATHOL, V171, P976, DOI 10.2353/ajpath.2007.070345; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LIPSKA BK, 1992, BRAIN RES, V585, P1, DOI 10.1016/0006-8993(92)91184-G; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Meguro K, 1996, PSYCHIAT RES-NEUROIM, V67, P71, DOI 10.1016/0925-4927(96)02549-8; MOGENSON GJ, 1980, BRAIN RES, V191, P569, DOI 10.1016/0006-8993(80)91308-6; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2010, CNS NEUROL DISORD-DR, V9, P403, DOI 10.2174/187152710791556131; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Robinson L, 2007, INT J GERIATR PSYCH, V22, P9, DOI 10.1002/gps.1643; Rolland Y, 2007, ALZ DIS ASSOC DIS, V21, P31, DOI 10.1097/WAD.0b013e31802f243e; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Song LX, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0011-1; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; [No title captured]	44	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195486	10.1371/journal.pone.0195486	http://dx.doi.org/10.1371/journal.pone.0195486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624602	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600034
J	Deshayes, S; Aoubal, A; Khoy, K; Mariotte, D; Lobbedez, T; Silva, NM				Deshayes, Samuel; Aoubal, Achille; Khoy, Kathy; Mariotte, Delphine; Lobbedez, Thierry; Silva, Nicolas Martin			Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis	PLOS ONE			English	Article							ALTERNATIVE COMPLEMENT PATHWAY; FACTOR-H; VASCULITIS; ACTIVATION; GLOMERULONEPHRITIS; PROTECTS; OUTCOMES; GN; C3	Recent data suggest the existence of a complement alternative pathway activation in the pathogenesis of antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a condition that remains poorly understood. This study aims to assess the clinical characteristics and outcomes of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) patients with regard to their plasma complement levels at diagnosis. A retrospective monocentric study carried out at Caen University Hospital led to the identification of proteinase-3- or myeloperoxidase-ANCA-positive GPA and MPA patients from January 2000 to June 2016 and from September 2011 to June 2016, respectively. All patients with available C3 and C4 levels at diagnosis were included. Patients were categorized in the hypocomplementemia group if their C3 and/or C4 levels at diagnosis were below the lower limit of the normal range. Among the 76 AAV patients (43 GPA, 33 MPA), 4 (5%) had hypocomplementemia, and the 72 remaining patients exhibited normal plasma complement levels. All 4 hypocomplementemia patients had renal involvement. Hypocomplementemia was followed in 1 patient whose post-treatment complement level normalized within 1 month. Among all clinical and ANCA specificity, including relapse-free survival (p = 0.093), only overall and renal survival rates were significantly lower in the hypocomplementemia group (p = 0.0011 and p<0.001, respectively). Hypocomplementemia with low C3 and/or C4 levels at GPA or MPA diagnosis may be responsible for worse survival and renal prognosis. These results argue for larger and prospective studies to better determine the epidemiology of the disease and to assess complement-targeting therapy in these patients.	[Deshayes, Samuel; Aoubal, Achille; Silva, Nicolas Martin] CHU Caen, Dept Internal Med, Caen, France; [Khoy, Kathy; Mariotte, Delphine] CHU Caen, Dept Immunol, Caen, France; [Lobbedez, Thierry] CHU Caen, Dept Nephrol, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Silva, NM (corresponding author), CHU Caen, Dept Internal Med, Caen, France.	martinsilva-n@chu-caen.fr	DESHAYES, Samuel/H-4845-2019; Silva, Nicolas Martins da/HDO-6805-2022; LOBBEDEZ, Thierry/L-7730-2015	DESHAYES, Samuel/0000-0001-8887-3233; Silva, Nicolas Martins da/0000-0001-8288-3174; 				Augusto JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158871; Chen M, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.37; Chen SF, 2017, CLIN IMMUNOL, V175, P41, DOI 10.1016/j.clim.2016.11.013; Chen SF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0656-8; Cheng L, 2017, CLIN EXP IMMUNOL; Crnogorac M, 2017, J NEPHROL; Fukui S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004871; Gou SJ, 2013, CLIN J AM SOC NEPHRO, V8, P1884, DOI 10.2215/CJN.02790313; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jayne DRW, 2017, J AM SOC NEPHROL; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Manenti L, 2017, INTERN EMERG MED; Manenti L, 2015, CLIN J AM SOC NEPHRO, V10, P2143, DOI 10.2215/CJN.00120115; Molad Y, 2014, NEPHRON CLIN PRACT, V126, P67, DOI 10.1159/000357154; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Schreiber A, 2017, P NATL ACAD SCI USA, V114, pE9618, DOI 10.1073/pnas.1708247114; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Stone JH, 2002, CONTROL CLIN TRIALS, V23, P450; Villacorta J, 2016, CLIN RHEUMATOL, V35, P2733, DOI 10.1007/s10067-016-3384-9; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Yu F, 2007, NEPHROLOGY, V12, P74, DOI 10.1111/j.1440-1797.2006.00713.x; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873	28	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195680	10.1371/journal.pone.0195680	http://dx.doi.org/10.1371/journal.pone.0195680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621352	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800113
J	Guo, C; He, P; Song, XM; Chen, G; Zheng, XY				Guo, Chao; He, Ping; Song, Xinming; Chen, Gong; Zheng, Xiaoying			Co-morbid mental disability among Chinese elderly with motor disability: Based on a nationwide survey	PLOS ONE			English	Article							HEALTH; ADULTS; PREVALENCE	This study aimed to investigate the prevalence rate and associated factors of co-morbid mental disability among the elderly with motor disability. Data was obtained from the second China National Sample Survey on Disability (CNSSD). 250,752 older adults aged 65 years and above were sampled from 5964 sites, 2980 towns, 734 counties in 31 provinces in China. Descriptive statistics were used for population-weighted numbers and prevalence of co-morbid mental disability by different characteristics. Univariate logistic regression and multivariate logistic regression were used to calculate the association between mental disability, and the factors of co-morbid mental disability among physical disability. Among the elderly with motor disability, 275,607 persons (2.28%, 99% CI: 1.97-2.59) had co-morbid mental disability at the survey time, which was significantly higher than those without motor disability (OR: 2.11, 99% CI: 1.83-2.43). The factors associated with a higher risk of co-morbid mental disability included urban areas (OR: 1.38; 99% CI: 1.04-1.84), east (2.60, 1.76-3.83) or west (1.65, 1.06-2.55) regions, having other co-morbid disabilities (5.93, 4.48-7.85), and having more severe motor disability (Moderate: 1.81, 1.28-2.57; Severe: 2.90, 2.08-4.04; Extremely severe: 4.22, 2.96-6.01). The elderly with motor disability have a high risk of co-morbid mental disability, especially for higher socioeconomic groups. These findings highlight the need of and will be beneficial for implementing more comprehensive prevention and rehabilitation strategies, to prevent and control the emergence and development of multiple disabilities and promote the physical and mental health of the elderly.	[Guo, Chao; He, Ping; Song, Xinming; Chen, Gong; Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing, Peoples R China; [Guo, Chao; Chen, Gong; Zheng, Xiaoying] Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China; [He, Ping] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China	Peking University; Peking University; Peking University	Zheng, XY (corresponding author), Peking Univ, Inst Populat Res, Beijing, Peoples R China.; Zheng, XY (corresponding author), Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China.	xzheng@pku.edu.cn	Guo, Chao/ADM-0958-2022	Guo, Chao/0000-0003-4343-4848	State Key Funds of Social Science Project of China [09ZD072]; National Natural Science Foundation of China [71661167003]; Changjiang Scholar Incentive Program of Ministry of Education; PKU President Scholarship	State Key Funds of Social Science Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholar Incentive Program of Ministry of Education; PKU President Scholarship	This work was supported by State Key Funds of Social Science Project of China (Grant No. 09&ZD072), National Natural Science Foundation of China (Grant No. 71661167003), Changjiang Scholar Incentive Program of Ministry of Education, and PKU President Scholarship.	[Anonymous], 2006, COMMUNIQUE MAJOR STA; [Anonymous], 2011, WORLD REP DIS; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P105; Dong XQ, 2007, J ELDER ABUSE NEGL, V19, P79, DOI 10.1300/J084v19n03_05; Ennaoui R, 2013, EUR PSYCHIAT, V28, P1; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Guo C, 2016, J PUBLIC HEALTH-UK, V38, pE345, DOI 10.1093/pubmed/fdv120; Hawton A, 2011, QUAL LIFE RES, V20, P57, DOI 10.1007/s11136-010-9717-2; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Hu J H, 2015, SHANGHAI CAI JING DA, V6, P35; Jones R, 2010, BRIT J GEN PRACT, V60, P394, DOI 10.3399/bjgp10X502056; [李文学 Li Wenxue], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P943; Liu Tianli, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P344; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Meltzer H, 2012, DISABIL HEALTH J, V5, P102, DOI 10.1016/j.dhjo.2012.02.001; Office of the Second China National Sample Survey on Disability, 2006, PHYS MAN 2 CHIN NAT; Theeke LA, 2010, RES GERONTOL NURS, V3, P113, DOI 10.3928/19404921-20091103-99; Turner RJ, 2006, REHABIL PSYCHOL, V51, P214, DOI 10.1037/0090-5550.51.3.214; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; VANWEEL C, 1996, EUR J GEN PRACT, V2, P17; WHO, 2001, WHO INT CLASS FUNCT; Wu QP, 1999, ZHONGGUO KANG FU, V14, P96; Wu Y, 2012, SHEN JING JI BING YU, V12, P261	23	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195555	10.1371/journal.pone.0195555	http://dx.doi.org/10.1371/journal.pone.0195555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621318	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800101
J	Ranjard, L; Wong, TKF; Rodrigo, AG				Ranjard, Louis; Wong, Thomas K. F.; Rodrigo, Allen G.			Reassembling haplotypes in a mixture of pooled amplicons when the relative concentrations are known: A proof-of-concept study on the efficient design of next-generation sequencing strategies	PLOS ONE			English	Article							GENOME; ZIKA	Next-generation sequencing can be costly and labour intensive. Usually, the sequencing cost per sample is reduced by pooling amplified DNA = amplicons) derived from different individuals on the same sequencing lane. Barcodes unique to each amplicon permit short-read sequences to be assigned appropriately. However, the cost of the library preparation increases with the number of barcodes used. We propose an alternative to barcoding: by using different known proportions of individually-derived amplicons in a pooled sample, each is characterised a priori by an expected depth of coverage. We have developed a Hidden Markov Model that uses these expected proportions to reconstruct the input sequences. We apply this method to pools of mitochondrial DNA amplicons extracted from kangaroo meat, genus Macropus. Our experiments indicate that the sequence coverage can be efficiently used to index the short-reads and that we can reassemble the input haplotypes when secondary factors impacting the coverage are controlled. We therefore demonstrate that, by combining our approach with standard barcoding, the cost of the library preparation is reduced to a third.	[Ranjard, Louis; Wong, Thomas K. F.; Rodrigo, Allen G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Ranjard, L (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	louis.ranjard@anu.edu.au	Rodrigo, Allen/E-8905-2015; Ranjard, Louis/M-4525-2015	Rodrigo, Allen/0000-0002-8327-7317; Ranjard, Louis/0000-0002-7622-4823	Australian Research Council [DP160103474]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council Discovery Project Grant #DP160103474.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], MATLAB BIOINF TOOLB; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Dodt WG, 2016, MITOCHONDRIAL DNA A, V27, P1366, DOI 10.3109/19401736.2014.947583; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Futschik A, 2010, NEXT GENERATION MOLE, V218, P207; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005; Mariac C, 2014, MOL ECOL RESOUR, V14, P1103, DOI 10.1111/1755-0998.12258; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Penalba JV, 2014, MOL ECOL RESOUR, V14, P1000, DOI 10.1111/1755-0998.12249; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; State of New South Wales and Office of Environment and Heritage, 2017, 2016 ANN REP; Van den Hoecke S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26314; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Wu SH, 2017, BIOINFORMATICS, V266, P554; Zhou H, 2017, MATLAB MGLM TOOLBOX	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195090	10.1371/journal.pone.0195090	http://dx.doi.org/10.1371/journal.pone.0195090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621260	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800036
J	Bambhroliya, A; Van Wyhe, RD; Kumar, S; Debeb, BG; Reddy, JP; Van Laere, S; El-Zein, R; Rao, A; Woodward, WA				Bambhroliya, Arvind; Van Wyhe, Renae D.; Kumar, Swaminathan; Debeb, Bisrat G.; Reddy, Jay P.; Van Laere, Steve; El-Zein, Randa; Rao, Arvind; Woodward, Wendy A.			Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer	PLOS ONE			English	Article							EXPRESSION; STEM; CELLS; RECURRENCE; INVOLUCRIN; REGRESSION; FEATURES; REVEALS; MOUSE	Background Epidemiological studies have found that triple-negative breast cancer (TNBC) and TN inflammatory breast cancer (IBC) are associated with lower frequency and duration of breast-feeding compared to non-TNBC and non-TN IBC, respectively. Limited breast-feeding could reflect abrupt or premature involution and contribute to a "primed" stroma that is permissive to the migration of cancer cells typical of IBC. We hypothesized that gene expression related to abrupt mammary gland involution after forced weaning may be enriched in the tissues of IBC patients and, if so, provide a potential correlation between limited breast-feeding and the development of aggressive breast cancer. Methods We utilized the Short Time-series Expression Miner (STEM) program to cluster significant signatures from two independent studies that analyzed gene expression at multiple time points of mouse mammary gland involution. Using 10 significant signatures, we performed gene ontology analysis and gene set enrichment analysis (GSEA) on training and validation sets from human breast cancer gene expression data to identify specific genes that are enriched in IBC compared to non-IBC and in TN compared to non-TN in IBC and non-IBC groups. Results Examining the combined data, we identified 10 involution gene clusters (Inv1-10) that share time-dependent regulation after forced weaning. Inv5 was the only cluster significantly enriched in IBC in the training and validation set (nominal p-values <0.05) and only by unadjusted p-values (FDR q-values 0.26 and 0.46 respectively). Eight genes in Inv5 are upregulated in both the training and validation sets in IBC. Combining the training and validation sets, both Inv5 and Inv6 have nominal p-values <0.05 and q-values 0.39 and 0.20, respectively. The time course for both clusters includes genes that change within 12 hours after forced weaning. Conclusions Results from this in silico study suggest correlation between molecular events during abrupt involution and aggressive breast cancer. Specifically, candidate genes from Inv5 merit functional investigation regarding the role of limited breast-feeding in IBC development.	[Bambhroliya, Arvind; Kumar, Swaminathan] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Bambhroliya, Arvind; Van Wyhe, Renae D.; Kumar, Swaminathan; Debeb, Bisrat G.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Van Wyhe, Renae D.] Baylor Coll Med, Houston, TX 77030 USA; [Debeb, Bisrat G.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reddy, Jay P.; Rao, Arvind; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Van Laere, Steve] Univ Antwerp, Dept Oncol, Antwerp, Belgium; [El-Zein, Randa] Houston Methodist Hosp, Dept Radiol, Houston, TX USA; [Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Antwerp; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Reddy, Jay Paul/0000-0001-9378-4585; Bambhroliya, Arvind/0000-0002-2584-2517; Woodward, Wendy/0000-0002-7935-739X; Kumar, Swaminathan/0000-0002-9358-787X	National Institutes of Health [R01CA180061, R01CA138239]; State of Texas Grant; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; National Center for Clinical and Translational Science [TL1-TR000369]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; National Center for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Institutes of Health Grants R01CA180061 and R01CA138239 to Wendy Ann Woodward, the State of Texas Grant for Rare and Aggressive Breast Cancer Research Program to Wendy Ann Woodward, and the National Center for Clinical and Translational Science Grant TL1-TR000369 to Wendy Ann Woodward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2017, CANC FACTS FIG 2017; Anderson WF, 2010, BREAST DIS, V22, P9, DOI DOI 10.1007/978-94-007-3907-9-2.; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Atkinson RL, 2016, CANCER CAUSE CONTROL, V27, P359, DOI 10.1007/s10552-015-0712-3; Atkinson RL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3471; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Blanchard A, 2007, FRONT BIOSCI, V12, P2221, DOI 10.2741/2225; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Clarkson RWE, 2003, J MAMMARY GLAND BIOL, V8, P309, DOI 10.1023/B:JOMG.0000010031.53310.92; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DJIAN P, 1993, MOL BIOL EVOL, V10, P1136; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gaudet MM, 2011, BREAST CANCER RES TR, V130, P587, DOI 10.1007/s10549-011-1616-x; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2009, J MAMMARY GLAND BIOL, V14, P99, DOI 10.1007/s10911-009-9120-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsuda H, 1997, BRIT J CANCER, V75, P1519, DOI 10.1038/bjc.1997.260; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wagner KU, 2005, J MAMMARY GLAND BIOL, V10, P25, DOI 10.1007/s10911-005-2538-1; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Weber A., 1949, FUNDAMENTALS HISTOLO, pIII; Weber A., 1952, SCIENCE, P116; Wolfe AR, 2016, INT J RADIAT ONCOL, V95, P791, DOI 10.1016/j.ijrobp.2016.01.025; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P256, DOI 10.1016/j.semradonc.2009.05.008; Wu C, 2005, GCRMA BACKGROUND ADJ; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	38	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0192689	10.1371/journal.pone.0192689	http://dx.doi.org/10.1371/journal.pone.0192689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617367	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800003
J	Kotha, S; Sun, SJ; Adams, A; Hayes, B; Phong, KT; Nagao, R; Reems, JA; Gao, DY; Torok-Storb, B; Lopez, JA; Zheng, Y				Kotha, Surya; Sun, Sijie; Adams, Arnie; Hayes, Brian; Phong, Kiet T.; Nagao, Ryan; Reems, Jo-Anna; Gao, Dayong; Torok-Storb, Beverly; Lopez, Jose A.; Zheng, Ying			Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment	PLOS ONE			English	Article							VASCULAR NICHE; ENDOTHELIAL-CELLS; PLATELET PRODUCTION; STEM-CELLS; BONE; MEGAKARYOCYTES; CULTURE; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION	Vasculature is an interface between the circulation and the hematopoietic tissue providing the means for hundreds of billions of blood cells to enter the circulation every day in a regulated fashion. The precise mechanisms that control the interactions of hematopoietic cells with the vessel wall are largely undefined. Here, we report on the development of an in vitro 3D human marrow vascular microenvironment (VME) to study hematopoietic trafficking and the release of blood cells, specifically platelets. We show that mature megakaryocytes from aspirated marrow as well as megakaryocytes differentiated in culture from CD34+ cells can be embedded in a collagen matrix containing engineered microvessels to create a thrombopoietic VME. These megakaryocytes continue to mature, penetrate the vessel wall, and release platelets into the vessel lumen. This process can be blocked with the addition of antibodies specific for CXCR4, indicating that CXCR4 is required for megakaryocyte migration, though whether it is sufficient is unclear. The 3D marrow VME system shows considerable potential for mechanistic studies defining the role of marrow vasculature in thrombopoiesis. Through a stepwise addition or removal of individual marrow components, this model provides potential to define key pathways responsible for the release of platelets and other blood cells.	[Kotha, Surya; Sun, Sijie; Adams, Arnie; Phong, Kiet T.; Nagao, Ryan; Zheng, Ying] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Sun, Sijie; Reems, Jo-Anna; Lopez, Jose A.] Bloodworks Res Inst, Seattle, WA USA; [Hayes, Brian; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Zheng, Ying] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Zheng, Ying] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Reems, Jo-Anna] Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah	Zheng, Y (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Zheng, Y (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.; Zheng, Y (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	yingzy@uw.edu		Hayes, Brian J/0000-0002-0930-0160; Kotha, Surya/0000-0003-1385-4630	Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core; Nanotech User Facility at the University of Washington; Electron Microscope facility; Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute [DK56465, DK106829]; National Institutes of Health [DP2DK102258]; NIH [HL099993, UH2/UH3 TR000504]; BloodWorks Northwest Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102258, U54DK106829] Funding Source: NIH RePORTER	Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core; Nanotech User Facility at the University of Washington; Electron Microscope facility; Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BloodWorks Northwest Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core, and the Nanotech User Facility at the University of Washington. We acknowledge Electron Microscope facility and the Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute (DK56465 and DK106829). We acknowledge Dr. Mortimer Poncz for helpful discussions and Dr. Xiaoping Wu for assistance in flow cytometry. We acknowledge the financial support of National Institutes of Health New Innovator Award (DP2DK102258) (YZ), NIH HL099993 (BTS), NIH UH2/UH3 TR000504 and BloodWorks Northwest Research Institute.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; BRANEMARK P I, 1959, Scand J Clin Lab Invest, V11 Supp 38, P1; Brookes M., 1998, BLOOD SUPPLY BONE SC; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Choi JS, 2015, BIOTECHNOL J, V10, P1529, DOI 10.1002/biot.201400758; Di Buduo CA, 2015, BLOOD, V125, P2254, DOI 10.1182/blood-2014-08-595561; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Dominietto A, 2001, BRIT J HAEMATOL, V112, P219, DOI 10.1046/j.1365-2141.2001.02468.x; Dutting S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15838; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; French DL, 2013, BLOOD, V121, P2379, DOI 10.1182/blood-2013-02-479022; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Hagiwara T, 1996, EXP HEMATOL, V24, P690; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KAUSHANSKY K, 1995, P NATL ACAD SCI USA, V92, P3234, DOI 10.1073/pnas.92.8.3234; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kufrin D, 2003, BLOOD, V102, P926, DOI 10.1182/blood-2003-01-0054; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pallotta I, 2011, TISSUE ENG PART C-ME, V17, P1223, DOI 10.1089/ten.tec.2011.0134; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramirez P, 2011, BONE MARROW TRANSPL, V46, P981, DOI 10.1038/bmt.2010.218; Roberts MA, 2016, JOVE-J VIS EXP, DOI 10.3791/54457; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Schachtner H, 2013, BLOOD, V121, P2542, DOI 10.1182/blood-2012-07-443457; SCHWEITZER CM, 1995, EXP HEMATOL, V23, P41; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Stegner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00201-7; Sun SJ, 2013, PHYSIOL GENOMICS, V45, P217, DOI 10.1152/physiolgenomics.00056.2012; Thon JN, 2017, PLATELETS, V28, P472, DOI 10.1080/09537104.2016.1265922; Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Vinet L, 2010, J EXP MED, V209, P2165; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884; Zheng Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8858; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109; Zijlmans JMJM, 1998, P NATL ACAD SCI USA, V95, P725, DOI 10.1073/pnas.95.2.725	61	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195082	10.1371/journal.pone.0195082	http://dx.doi.org/10.1371/journal.pone.0195082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617409	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800061
J	Li, CY; Xue, JG; Quan, C; Yue, JW; Zhang, CG				Li, Chunyong; Xue, Jiguo; Quan, Cheng; Yue, Jingwei; Zhang, Chenggang			Biometric recognition via texture features of eye movement trajectories in a visual searching task	PLOS ONE			English	Article							DISCRIMINANT-ANALYSIS; IDENTIFICATION	Biometric recognition technology based on eye-movement dynamics has been in development for more than ten years. Different visual tasks, feature extraction and feature recognition methods are proposed to improve the performance of eye movement biometric system. However, the correct identification and verification rates, especially in long-term experiments, as well as the effects of visual tasks and eye trackers' temporal and spatial resolution are still the foremost considerations in eye movement biometrics. With a focus on these issues, we proposed a new visual searching task for eye movement data collection and a new class of eye movement features for biometric recognition. In order to demonstrate the improvement of this visual searching task being used in eye movement biometrics, three other eye movement feature extraction methods were also tested on our eye movement datasets. Compared with the original results, all three methods yielded better results as expected. In addition, the biometric performance of these four feature extraction methods was also compared using the equal error rate (EER) and Rank-1 identification rate (Rank-1 IR), and the texture features introduced in this paper were ultimately shown to offer some advantages with regard to long-term stability and robustness over time and spatial precision. Finally, the results of different combinations of these methods with a score-level fusion method indicated that multi-biometric methods perform better in most cases.	[Li, Chunyong; Xue, Jiguo; Quan, Cheng; Yue, Jingwei; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Yue, JW; Zhang, CG (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China.	jwyuecn@gmail.com; zhangcg@bmi.ac.cn	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304; Quan, Cheng/0000-0003-1859-9683				Balamurugan V, 2012, INT J COMPUT APPL, V49, P38; Bayat A, 2018, ADV INTELL SYST, V591, P583, DOI 10.1007/978-3-319-60591-3_53; Bednarik R, 2005, LECT NOTES COMPUT SC, V3540, P780; Burge M. J., 2013, HDB IRIS RECOGNITION; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Camlikaya E, 2008, MULTIBIOMETRIC TEMPL; Cantoni V, 2015, PATTERN RECOGN, V48, P1027, DOI 10.1016/j.patcog.2014.02.017; Carol JJ, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016161074; Cherepovskaya EN, 2017, 2017 IEEE 15 INT S A; Duchowski A.T, 2007, EYE TRACKING METHODO, DOI DOI 10.1007/978-3-319-57883-5; George A, 2016, PATTERN RECOGN LETT, V82, P207, DOI 10.1016/j.patrec.2015.11.020; Haghighat Mohammad, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P440, DOI 10.1007/978-3-642-40246-3_55; Hamamoto Y, 1995, P 3 INT C DOC AN REC; He ZY, 2004, P 2004 INT C MACH LE; Hill R. B., 2002, BIOMETRICS, P123; Holland C, 2011, 2011 INT JOINT C BIO; Holland CD, 2013, INT CONF BIOMETR; Holland CD, 2013, IEEE T INF FOREN SEC, V8, P2115, DOI 10.1109/TIFS.2013.2285884; Jain A. K., 2005, HDB FACE RECOGNITION; Jain Anil K., 2007, HDB BIOMETRICS; Javal E., 1905, PHYSL LECTURE ECRITU, Vxv; Josephson S, 2002, P 2002 S EYE TRACK R; Karnan M, 2011, APPL SOFT COMPUT, V11, P1565, DOI 10.1016/j.asoc.2010.08.003; Kasprowski P, 2005, P SOC PHOTO OPT INS; Kasprowski P, 2004, LECT NOTES COMPUT SC; Kasprowski P, 2012, 2012 IEEE 5 INT C BI; Kasprowski P, 2014, 2014 IEEE/IAPR INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB 2014); Kinnunen T., 2010, P 2010 S EYE TRACK R, P187, DOI DOI 10.1145/1743666.1743712; Kinnunen T, 2010, SPEECH COMMUN, V52, P12, DOI 10.1016/j.specom.2009.08.009; Komogortsev O.V., 2010, P 2010 S EYE TRACKIN, P57; Komogortsev OV, 2015, 2015 IEEE 7 INT C BO; Kumar A, 2006, IEEE T IMAGE PROCESS, V15, P2454, DOI 10.1109/TIP.2006.875214; Leigh R.J., 2015, NEUROLOGY EYE MOVEME, V5th, DOI 10.1093/med/9780199969289.001.0001/med-9780199969289; Liu CJ, 2002, IEEE T IMAGE PROCESS, V11, P467, DOI 10.1109/TIP.2002.999679; Lyamin AV, 2017, IEEE T INF FOREN SEC, V12, P881, DOI 10.1109/TIFS.2016.2639342; Maltoni D., 2009, HDB FINGERPRINT RECO, DOI DOI 10.1007/978-1-84882-254-2; Meshgini S, 2013, COMPUT ELECTR ENG, V39, P727, DOI 10.1016/j.compeleceng.2012.12.011; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Rigas I, 2014, BIOMETRIC RECOGNITIO; Rigas I, 2014, IEEE T INF FOREN SEC, V9, P1743, DOI 10.1109/TIFS.2014.2350960; Rigas I, 2012, PATTERN RECOGN LETT, V33, P786, DOI 10.1016/j.patrec.2012.01.003; Rodrigues RN, 2010, 2010 4 IEEE INT C BI, DOI 10.1109/BTAS.2010.5634531; Said HES, 2000, PATTERN RECOGN, V33, P149, DOI 10.1016/S0031-3203(99)00006-0; Said HES, 1998, 14 INT C PATT REC 19; Sangeetha K., 2015, INT J APPL ENG RES, V10, P30438; Sarkar S, 2005, IEEE T PATTERN ANAL, V27, P162, DOI 10.1109/TPAMI.2005.39; Shen L, 2007, IMAGE VISION COMPUT, V25, P553, DOI 10.1016/j.imavis.2006.05.002; Tan TN, 1992, 11 IAPR INT C PATT R; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; Venugopalan S, 2011, IEEE T INF FOREN SEC, V6, P385, DOI 10.1109/TIFS.2011.2108288; Weston J, 1998, CSDTR9804 U LOND; Yong Z, 2000, 15 INT C PATT REC 20; Zhen L, 2012, 2012 IEEE INT C SIGN	55	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194475	10.1371/journal.pone.0194475	http://dx.doi.org/10.1371/journal.pone.0194475			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617383	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800032
J	Maas, ET; Koehoorn, M; McLeod, CB				Maas, Esther T.; Koehoorn, Mieke; McLeod, Christopher B.			Return-to-work for multiple jobholders with a work-related musculoskeletal disorder: A population-based, matched cohort in British Columbia	PLOS ONE			English	Article							JOB TENURE; INJURY; DISABILITY; EMPLOYMENT; IMPACT; MODEL	Introduction Multiple jobholders (MJHs) have a higher risk of injury compared to single jobholders (SJHs), but it is unknown if return-to-work (RTW) after a work injury is affected by multiple jobholding. This study examined the association between multiple versus single jobholding and time to RTW for workers with a work-related musculoskeletal disorder (MSD). Methods We used administrative workers' compensation data to identify injured workers with an accepted MSD lost-time claim between 2010-2014 in British Columbia, Canada (n = 125,639 SJHs and 9,029 MJHs). The outcome was days until RTW during twelve months after the first day of time-loss. The MJH and SJH cohorts were balanced using coarsened exact matching that yielded a final matched cohort of 8,389 MJHs and 8,389 SJHs. The outcome was estimated with Cox regression, using piecewise models, and the hazard ratios were stratified by type of MSD, a serious injury indicator, gender, weekly workdays preceding MSD, and wage categories. Results MJHs were less likely to RTW compared to SJHs within the first six months after the first time-loss day, with greater and longer lasting effects for males, workers with a serious injury, and a higher wage. No difference between MJHs and SJHs was found for workers who had a six-or seven-day work week preceding MSD, for workers with dislocations, and for workers who were still off work after six months. Conclusions Overall, MJHs with a workweek of maximum five days are disadvantaged compared to SJHs in terms of RTW following a work-related MSD within the first six months after the first time-loss day. This difference might be caused by more precarious job contracts for MJHs that challenges RTW because of lack of support for modified work, higher workload, and reduced likelihood that MJHs file a workers' compensation claim. Despite adjusting for type of MSD, severity of injury and occupation, the differences persisted for the vast majority of the study sample.	[Maas, Esther T.; Koehoorn, Mieke; McLeod, Christopher B.] Univ British Columbia, Sch Populat & Publ Hlth, Partnership Work Hlth & Safety, Vancouver, BC, Canada	University of British Columbia	Maas, ET (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Partnership Work Hlth & Safety, Vancouver, BC, Canada.	esther.maas@ubc.ca		McLeod, Christopher/0000-0001-9268-3694; Maas, Esther/0000-0002-2290-9552	Canadian Institutes for Health Research (CIHR) postdoctoral fellowship; CIHR Chair in Gender, Work and Health; CIHR New Investigator Award; Michael Smith Foundation for Health Research Scholar Award; WorkSafeBC through the Partnership for Work, Health and Safety	Canadian Institutes for Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR Chair in Gender, Work and Health(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); WorkSafeBC through the Partnership for Work, Health and Safety	Esther Maas is supported by a Canadian Institutes for Health Research (CIHR) postdoctoral fellowship. Mieke Koehoorn is supported by a CIHR Chair in Gender, Work and Health. Christopher McLeod is supported by a CIHR New Investigator Award and a Michael Smith Foundation for Health Research Scholar Award. All authors are supported with funds from WorkSafeBC through the Partnership for Work, Health and Safety. All inferences, opinions, and conclusions drawn in this manuscript are those of the authors, and do not reflect the opinions or policies of the Data Steward(s).	Baines J, 2005, TRENDS NZ LABOUR MAR; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Bohle P, 2004, REV SAUDE PUBL, V38, P19, DOI 10.1590/S0034-89102004000700004; Breslin FC, 2008, ACCIDENT ANAL PREV, V40, P368, DOI 10.1016/j.aap.2007.07.007; Bureau of Labor Statistics, DAT RETR LAB FORC ST; Bush AM, 2013, AM J IND MED, V56, P881, DOI 10.1002/ajim.22156; Dickey H, 2015, ECONOMICS, P15; Hipple SF, 2010, MON LABOR REV, V133, P21; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hoy D, 2014, BEST PRACT RES CL RH, V28, P377, DOI 10.1016/j.berh.2014.07.006; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kimmel J, 1999, CAN PUBLIC POL, V25, P207, DOI 10.2307/3551889; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Locke SJ, 2014, OCCUP ENVIRON MED, V71, P855, DOI 10.1136/oemed-2013-101801; Marucci-Wellman HR, 2014, AM J PUBLIC HEALTH, V104, P134, DOI 10.2105/AJPH.2013.301431; McLeod C, 2017, SCANDINAVIAN J WORK; Rouault S., 2002, MULTIPLE JOBHOLDING; Schultz IZ, 2002, SPINE, V27, P2720, DOI 10.1097/00007632-200212010-00012; Statistics Canada, 2016, EMPL IND SEX; Statistics Canada, 1991, STAND OCC CLASS SOC; Statistics Canada, 2016, MULT JOB HOLD PERC T; Statistics Canada, 2016, LAB FORC SURV EST LF; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; The PLOS Medicine Editors, 2014, PLOS MED, V11; Tompa E, 2008, OCCUP ENVIRON MED, V65, P801, DOI 10.1136/oem.2007.037259; Tompa E., 2010, INVESTIGATION TEMPOR, P6; Tompa E, 2010, WORK, V37, P251, DOI 10.3233/WOR-2010-1077; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; WorksafeBC, 2016, IND HLTH SAF IND; WorkSafeBC, 2014, WORKSAFEBC CLAIM LEV; Zierold KM, 2011, OCCUP ENVIRON MED, V68, P818, DOI 10.1136/oem.2010.059170	33	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193618	10.1371/journal.pone.0193618	http://dx.doi.org/10.1371/journal.pone.0193618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614128	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600005
J	Facente, SN; Grebe, E; Burk, K; Morris, MD; Murphy, EL; Mirzazadeh, A; Smith, AA; Sanchez, MA; Evans, JL; Nishimura, A; Raymond, HF				Facente, Shelley N.; Grebe, Eduard; Burk, Katie; Morris, Meghan D.; Murphy, Edward L.; Mirzazadeh, Ali; Smith, Aaron A.; Sanchez, Melissa A.; Evans, Jennifer L.; Nishimura, Amy; Raymond, Henry F.		End Hep CSF	Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; GENDER-DIFFERENCES; CARE SERVICES; INJECT DRUGS; MEN; SEX; TRANSMISSION; PREVENTION; PEOPLE	Background Initiated in 2016, End Hep C SF is a comprehensive initiative to eliminate hepatitis C (HCV) infection in San Francisco. The introduction of direct-acting antivirals to treat and cure HCV provides an opportunity for elimination. To properly measure progress, an estimate of baseline HCV prevalence, and of the number of people in various subpopulations with active HCV infection, is required to target and measure the impact of interventions. Our analysis was designed to incorporate multiple relevant data sources and estimate HCV burden for the San Francisco population as a whole, including specific key populations at higher risk of infection. Methods Our estimates are based on triangulation of data found in case registries, medical records, observational studies, and published literature from 2010 through 2017. We examined subpopulations based on sex, age and/or HCV risk group. When multiple sources of data were available for subpopulation estimates, we calculated a weighted average using inverse variance weighting. Credible ranges (CRs) were derived from 95% confidence intervals of population size and prevalence estimates. Results We estimate that 21,758 residents of San Francisco are HCV seropositive (CR: 10,274-42,067), representing an overall seroprevalence of 2.5% (CR: 1.2%-4.9%). Of these, 16,408 are estimated to be viremic (CR: 6,505-37,407), though this estimate includes treated cases; up to 12,257 of these (CR: 2,354-33,256) are people who are untreated and infectious. People who injected drugs in the last year represent 67.9% of viremic HCV infections. Conclusions We estimated approximately 7,400 (51%) more HCV seropositive cases than are included in San Francisco's HCV surveillance case registry. Our estimate provides a useful baseline against which the impact of End Hep C SF can be measured.	[Facente, Shelley N.] Facente Consulting, Richmond, CA 94804 USA; [Facente, Shelley N.; Morris, Meghan D.; Murphy, Edward L.; Mirzazadeh, Ali; Evans, Jennifer L.; Raymond, Henry F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grebe, Eduard] Stellenbosch Univ, SACEMA, Stellenbosch, South Africa; [Burk, Katie; Smith, Aaron A.; Sanchez, Melissa A.; Nishimura, Amy] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Murphy, Edward L.] Blood Syst Res Inst, San Francisco, CA USA; [Raymond, Henry F.] Rutgers State Univ, Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ USA	University of California System; University of California San Francisco; Stellenbosch University; San Francisco Department of Public Health; Vitalant; Vitalant Research Institute; Rutgers State University New Brunswick	Facente, SN (corresponding author), Facente Consulting, Richmond, CA 94804 USA.; Facente, SN (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	shelley@facenteconsulting.com	Mirzazadeh, Ali/AAJ-5907-2021; Facente, Shelley/M-1147-2019	Raymond, Henry/0000-0001-8621-2749; Grebe, Eduard/0000-0001-7046-7245	AbbVie, Inc.; Facente Consulting	AbbVie, Inc.(Abbott LaboratoriesAbbVie); Facente Consulting	This study was supported through a charitable donation from AbbVie, Inc., awarded to End Hep C SF, which the initiative used to pay for the time of SNF and EG to execute this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shelley N. Facente is affiliated to Facente Consulting. Facente Consulting provided support in the form of salary for author SNF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adams Deborah A, 2016, MMWR Morb Mortal Wkly Rep, V63, P1, DOI 10.15585/mmwr.mm6354a1; Atsma F, 2011, TRANSFUSION, V51, P1883, DOI 10.1111/j.1537-2995.2011.03270.x; Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Burstow NJ, 2017, INT J GEN MED, V10, P39, DOI 10.2147/IJGM.S127689; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Chen YH, 2016, AIDS BEHAV, V20, P2914, DOI 10.1007/s10461-015-1268-7; Dodd RY, 2016, TRANSFUSION; End Hep C SF, 2017, END HEP C SF STRAT P; Grey JA, 2016, JMIR PUBLIC HLTH SUR, V2, P1; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hughes AJ, 2017, J URBAN HEALTH, V94, P350, DOI 10.1007/s11524-017-0145-2; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; National Cancer Institute, 2014, STAT CANC PROF INC R; National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; New York State Hepatitis C Elimination Campaign, 2017, END HEP C NY; Perlman DC, 2014, J ADDICT DIS, V33, P322, DOI 10.1080/10550887.2014.969623; Prasad M, 2012, AM J OBSTET GYNECOL, V206, pS270, DOI 10.1016/j.ajog.2011.10.615; Raymond HF, 2013, SEX TRANSM INFECT, V89, P383, DOI 10.1136/sextrans-2012-050675; Raymond HF, 2012, SEX TRANSM DIS, V39, P985, DOI 10.1097/OLQ.0b013e3182716e59; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; San Francisco Department of Public Health, 2016, HIV EP ANN REP 2015; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Strom BL, 2017, NATL STRATEGY ELIMIN; United States Census Bureau/American Fact Finder, 2015, AG SEX 2015 AM COMM; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Wesson P, 2017, INT J TRANSGENDERISM; World Health Organization, 2016, COMB HEP B C REACH E; World Health Organization U and the Global Fund to Fight AIDS Tuberculosis and Malaria, 2009, HIV TRIANG RES GUID; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Yehia BR, 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0101554]	33	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195575	10.1371/journal.pone.0195575	http://dx.doi.org/10.1371/journal.pone.0195575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641546	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900074
J	Kustiawan, I; Derksen, NIL; Guhr, T; Kruithof, S; Jiskoot, W; Vidarsson, G; Rispens, T				Kustiawan, Iwan; Derksen, Ninotska I. L.; Guhr, Theresa; Kruithof, Simone; Jiskoot, Wim; Vidarsson, Gestur; Rispens, Theo			Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS; IMMUNE-COMPLEXES; FC-GAMMA; THROMBOCYTOPENIC PURPURA; THERAPEUTIC-EFFICACY; STIMULATION; GLOBULIN; ANTIBODIES	Purpose Intravenous immunoglobulin (IVIg) products contain various amounts of dimeric IgG complexes. Current insights into the possible biological activities of these dimers remain controversial, and both immunemodulating and immune-activating effects have been reported. Here, we analyzed the putative immune-activating effects of dimers isolated from IVIg. Methods Dimers isolated from IVIg were purified by high-performance size-exclusion chromatography (HP-SEC) and tested for the ability to induce neutrophil degranulation in vitro. Results Dimers isolated from IVIg were found to be incapable of inducing in vitro neutrophil degranulation or complement activation, even at concentrations exceeding those expected to be reached upon administration in patients. These results depend on the removal of artefactual activation by using 0.1 micron filtration and the use of poloxamer to prevent adsorption of IgG onto the solid phase. Conclusions The data suggest dimeric IgG found in IVIg may bind to Fc-receptors without causing activation.	[Kustiawan, Iwan; Derksen, Ninotska I. L.; Guhr, Theresa; Kruithof, Simone; Rispens, Theo] Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immunopathol, Amsterdam, Netherlands; [Jiskoot, Wim] Leiden Acedem Ctr Drug Res, Cluster BioTherapeut, Div Drug Delivery Technol, Leiden, Netherlands; [Vidarsson, Gestur] Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immune Heamatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rispens, T (corresponding author), Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immunopathol, Amsterdam, Netherlands.	t.rispens@Sanquin.nl	Jiskoot, Wim/A-6877-2016; Vidarsson, Gestur/A-9909-2009	Jiskoot, Wim/0000-0002-1012-3456; Vidarsson, Gestur/0000-0001-5621-003X				Ballow Mark, 2002, J Am Pharm Assoc (Wash), V42, P449, DOI 10.1331/108658002763316888; Bleeker WK, 2000, BLOOD, V95, P1856, DOI 10.1182/blood.V95.5.1856.005k03_1856_1861; Bolli R, 2010, BIOLOGICALS, V38, P150, DOI 10.1016/j.biologicals.2009.09.002; BRUTON OC, 1952, PEDIATRICS, V9, P722; Casulli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026469; CROCKETTTORABI E, 1990, J IMMUNOL, V145, P3026; FURUSHO K, 1984, LANCET, V2, P1055; HAMADA F, 1993, P NATL ACAD SCI USA, V90, P6305, DOI 10.1073/pnas.90.13.6305; Higurashi S, 2012, BIOCHEM BIOPH RES CO, V417, P794, DOI 10.1016/j.bbrc.2011.12.038; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2359; IMBACH P, 1981, LANCET, V1, P1228; Jarius S, 2007, BLOOD, V109, P4376, DOI 10.1182/blood-2005-12-019604; Knezevic-Maramica I, 2003, TRANSFUSION, V43, P1460, DOI 10.1046/j.1537-2995.2003.00519.x; Kustiawan I, 2013, J IMMUNOL METHODS, V392, P49, DOI 10.1016/j.jim.2013.03.009; Lutz HU, 2008, AUTOIMMUN REV, V7, P405, DOI 10.1016/j.autrev.2008.03.005; Machino Y, 2012, BIOCHEM BIOPH RES CO, V418, P748, DOI 10.1016/j.bbrc.2012.01.092; Mollnes TE, 1998, SCAND J IMMUNOL, V48, P312; Nagelkerke SQ, 2013, EUR J CLIN INVEST, V43, P36; Nemes E, 2000, PEDIATR RES, V47, P357, DOI 10.1203/00006450-200003000-00012; Ortiz DF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9418; Prezzo A, 2016, CELL IMMUNOL, P306; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Ritter C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0361-1; ROBINSON JJ, 1994, FEMS IMMUNOL MED MIC, V8, P249; ROUX KH, 1990, J IMMUNOL, V144, P1387; Roux KH, 1999, INT ARCH ALLERGY IMM, V120, P85, DOI 10.1159/000024226; Schaub A, 2011, ALLERGY, V66, P1030, DOI 10.1111/j.1398-9995.2011.02579.x; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; TANKERSLEY DL, 1988, MOL IMMUNOL, V25, P41, DOI 10.1016/0161-5890(88)90088-0; Teeling JL, 2001, BRIT J HAEMATOL, V112, P1031, DOI 10.1046/j.1365-2141.2001.02674.x; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Teeling JL, 1998, CLIN EXP IMMUNOL, V114, P264; Tremblay T, 2013, TRANSFUSION, V53, P261, DOI 10.1111/j.1537-2995.2012.03725.x; UEMURA Y, 1983, TOHOKU J EXP MED, V141, P337, DOI 10.1620/tjem.141.337; VERHOEVEN AJ, 1988, BLOOD, V71, P505; Voice JK, 1997, EUR J IMMUNOL, V27, P2514, DOI 10.1002/eji.1830271008; Watson F, 1997, J BIOL CHEM, V272, P17944, DOI 10.1074/jbc.272.29.17944; WOLBINK GJ, 1993, J IMMUNOL METHODS, V163, P67, DOI 10.1016/0022-1759(93)90240-8; Wymann S, 2008, MOL IMMUNOL, V45, P2621, DOI 10.1016/j.molimm.2007.12.020	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195729	10.1371/journal.pone.0195729	http://dx.doi.org/10.1371/journal.pone.0195729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634774	Green Published, gold			2022-12-27	WOS:000429522200052
J	Kwon, S; Park, JH; Kim, WS; Hang, K; Lee, Y; Paik, NJ				Kwon, SuYeon; Park, Ji-Hong; Kim, Won-Seok; Hang, Kyungdo; Lee, Yookyung; Paik, Nam-Jong			Health-related quality of life and related factors in stroke survivors: Data from Korea National Health and Nutrition Examination Survey (KNHANES) 2008 to 2014	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; FUNCTIONAL OUTCOMES; 1ST-EVER STROKE; IMPACT; PREDICTORS; RECOVERY; DISEASE	As persons with stroke are surviving longer, monitoring and managing their quality of life is becoming important. We reviewed the Korea National Health and Nutrition Examination Survey (KNHANES) in order to evaluate the health-related quality of life (HRQoL) in stroke survivors as measured by the Euro Quality of Life-5D (EQ-5D), and to find out influencing factors. A total of 42,500 subjects were enrolled in the KNHANES, and 575 of them were persons with stroke. The EQ-5D index was lower in persons with stroke than those without stroke, when adjusted for age and sex (with stroke: 0.757 +/- 0.012, without stroke: 0.948 +/- 0.001, p < .0001). Dimension-specific influencing factors of HRQoL were observed in persons with stroke; mobility problems increased with old age; self-care problems increased with old age and depression; usual activity problems increased with old age, low income, absence of economic activity, and depression; pain/discomfort problems increased with low income. The EQ-5D index was lower in stroke survivors with older age, hypertension, diabetes mellitus, and lack of regular exercise. This is the first study to utilize nationally representative data of the Korean population to investigate the effect of stroke on HRQoL and explore the dimension-specific influencing factors. Further development of rehabilitative interventions for post-stroke depression, vocational rehabilitation, and tailored programs for encouraging physical activity may be needed to improve the HRQoL in Korean stroke survivors.	[Kwon, SuYeon; Park, Ji-Hong; Kim, Won-Seok; Lee, Yookyung; Paik, Nam-Jong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea; [Hang, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea	Kim, WS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea.	wondol77@gmail.com	Paik, Nam-Jong/D-5798-2012; , 김원석/AAJ-2334-2020	Paik, Nam-Jong/0000-0002-5193-8678; , 김원석/0000-0002-1199-5707; Lee, Yookyung/0000-0003-4282-9848				Abubakar S A, 2012, Int J Biomed Sci, V8, P183; Aidar FJ, 2007, REV NEUROLOGIA, V45, P518, DOI 10.33588/rn.4509.2006366; Alguren B, 2012, NEUROREHAB NEURAL RE, V26, P266, DOI 10.1177/1545968311414204; Ashe MC, 2009, GERONTOLOGY, V55, P64, DOI 10.1159/000141518; Bagg S, 2002, STROKE, V33, P179, DOI 10.1161/hs0102.101224; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Baumann M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-92; Chang WH, 2016, J NEUROL, V263, P1166, DOI 10.1007/s00415-016-8119-y; Chau JPC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-49; Chen CM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0314-5; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; De Wit L, 2016, DISABIL REHABIL, P1; Gokkaya NKO, 2005, INT J REHABIL RES, V28, P229, DOI 10.1097/00004356-200509000-00005; Gurcay E, 2009, ANN SAUDI MED, V29, P36, DOI 10.4103/0256-4947.51814; HEWER RL, 1990, Q J MED, V76, P659; Horner RD, 2003, STROKE, V34, P1027, DOI 10.1161/01.STR.0000060028.60365.5D; Jaracz K, 2003, ACTA NEUROL SCAND, V107, P324, DOI 10.1034/j.1600-0404.2003.02078.x; Kang Y, 2009, NURS HEALTH SCI, V11, P301, DOI 10.1111/j.1442-2018.2009.00460.x; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kim JS, 2014, J STROKE, V16, P55, DOI 10.5853/jos.2014.16.2.55; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Lee HT, 2015, ANGIOLOGY, V66, P326, DOI 10.1177/0003319714533182; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Oppe M, 2015, EQ 5D 3L USER GUIDE; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Rand D, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-80; Rastenyte D, 2007, MEDICINA-LITHUANIA, V43, P1, DOI 10.3390/medicina43010001; Rimmer James H, 2005, Top Stroke Rehabil, V12, P17; Tengs TO, 2001, STROKE, V32, P964, DOI 10.1161/01.STR.32.4.964; Tennant A, 1997, DISABIL REHABIL, V19, P278, DOI 10.3109/09638289709166539; Tseng Mei-Chiun, 2007, Acta Neurol Taiwan, V16, P7; van de Weg FB, 1999, CLIN REHABIL, V13, P268, DOI 10.1191/026921599672495022; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5; Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10	40	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195713	10.1371/journal.pone.0195713	http://dx.doi.org/10.1371/journal.pone.0195713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634768	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200050
J	Reed, JL; D'Ambrosio, E; Marenco, S; Ursini, G; Zheutlin, AB; Blasi, G; Spencer, BE; Romano, R; Hochheiser, J; Reifman, A; Sturm, J; Berman, KF; Bertolino, A; Weinberger, DR; Callicott, JH				Reed, Jessica L.; D'Ambrosio, Enrico; Marenco, Stefano; Ursini, Gianluca; Zheutlin, Amanda B.; Blasi, Giuseppe; Spencer, Barbara E.; Romano, Raffaella; Hochheiser, Jesse; Reifman, Ann; Sturm, Justin; Berman, Karen F.; Bertolino, Alessandro; Weinberger, Daniel R.; Callicott, Joseph H.			Interaction of childhood urbanicity and variation in dopamine genes alters adult prefrontal function as measured by functional magnetic resonance imaging (fMRI)	PLOS ONE			English	Article							WORKING-MEMORY; OBSTETRIC COMPLICATIONS; PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL STRESS; EMISSION-TOMOGRAPHY; SCHIZOPHRENIA RISK; PSYCHOTIC DISORDER; RECEPTOR; ASSOCIATION; METAANALYSIS	Brain phenotypes showing environmental influence may help clarify unexplained associations between urban exposure and psychiatric risk. Heritable prefrontal fMRI activation during working memory (WM) is such a phenotype. We hypothesized that urban upbringing (childhood urbanicity) would alter this phenotype and interact with dopamine genes that regulate prefrontal function during WM. Further, dopamine has been hypothesized to mediate urban-associated factors like social stress. WM-related prefrontal function was tested for main effects of urbanicity, main effects of three dopamine genes catechol-O-methyltransferase (COM7), dopamine receptor D1 (DRD1), and dopamine receptor D2 (DRD2)-and, importantly, dopamine gene-by-urbanicity interactions. For COMT, three independent human samples were recruited (total n = 487). We also studied 253 subjects genotyped for DRD1 and DRD2. 3T fMRI activation during the N-back WM task was the dependent variable, while childhood urbanicity, dopamine genotype, and urbanicity-dopamine interactions were independent variables. Main effects of dopamine genes and of urbanicity were found. Individuals raised in an urban environment showed altered prefrontal activation relative to those raised in rural or town settings. For each gene, dopamine genotype-by-urbanicity interactions were shown in prefrontal cortex COMTreplicated twice in two independent samples. An urban childhood upbringing altered prefrontal function and interacted with each gene to alter genotype-phenotype relationships. Gene-environment interactions between multiple dopamine genes and urban upbringing suggest that neural effects of developmental environmental exposure could mediate, at least partially, increased risk for psychiatric illness in urban environments via dopamine genes expressed into adulthood.	[Reed, Jessica L.; Marenco, Stefano; Zheutlin, Amanda B.; Spencer, Barbara E.; Hochheiser, Jesse; Reifman, Ann; Sturm, Justin; Berman, Karen F.; Weinberger, Daniel R.; Callicott, Joseph H.] NIMH, Clin & Translat Neurosci Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA; [Reed, Jessica L.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Reed, Jessica L.] NIMH, Expt Therapeut & Pathophysiol Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA; [D'Ambrosio, Enrico; Ursini, Gianluca; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA; [D'Ambrosio, Enrico; Ursini, Gianluca; Blasi, Giuseppe; Romano, Raffaella; Bertolino, Alessandro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Psychiat Neurosci Grp, Bari, Italy; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine; Universita degli Studi di Bari Aldo Moro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Callicott, JH (corresponding author), NIMH, Clin & Translat Neurosci Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA.	callicottj@mail.nih.gov	Ursini, Gianluca/AAA-8242-2019; Callicott, Joseph H/AAE-7243-2022; Blasi, Giuseppe/HHS-5404-2022; D'Ambrosio, Enrico/K-1942-2015; Marenco, Stefano/A-2409-2008; Callicott, Joseph/C-9102-2009	D'Ambrosio, Enrico/0000-0001-9774-3860; Marenco, Stefano/0000-0002-2488-2365; Ursini, Gianluca/0000-0002-4733-5196; Reed, Jessica/0000-0003-0550-7284; Callicott, Joseph/0000-0003-1298-3334; Blasi, Giuseppe/0000-0003-0878-1131	Division of Intramural Research Program of the National Institute of Mental Health; Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002942, ZIAMH002652] Funding Source: NIH RePORTER	Division of Intramural Research Program of the National Institute of Mental Health; Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded as part of the Division of Intramural Research Program of the National Institute of Mental Health and the Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Agerbo E, 2001, SCHIZOPHR RES, V47, P243, DOI 10.1016/S0920-9964(00)00133-X; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Ashburner J, 2009, SPM5 MANUAL; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Blasi G, 2015, NEUROPSYCHOPHARMACOL, V40, P1600, DOI 10.1038/npp.2015.5; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Bobb AJ, 2005, AM J MED GENET B, V134B, P67, DOI 10.1002/ajmg.b.30142; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Booij L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.6; Boonstra N, 2012, EUR PSYCHIAT, V27, P500, DOI 10.1016/j.eurpsy.2011.05.001; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cosentino M, 2015, HUM IMMUNOL, V76, P747, DOI 10.1016/j.humimm.2015.09.032; Dreher JC, 2012, BIOL PSYCHIAT, V71, P890, DOI 10.1016/j.biopsych.2012.01.002; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P971, DOI 10.1093/schbul/sbu173; Frissen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166651; Frissen A, 2015, SOC PSYCH PSYCH EPID, V50, P1481, DOI 10.1007/s00127-015-1049-7; GARDNER EB, 1975, PHYSIOL BEHAV, V14, P321, DOI 10.1016/0031-9384(75)90040-2; George MS, 2007, SCHIZOPHR RES, V93, P42, DOI 10.1016/j.schres.2007.03.011; Glaeser E, 2011, SCIENCE, V333, P592, DOI 10.1126/science.1209264; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; Haddad L, 2015, SCHIZOPHRENIA BULL, V41, P115, DOI 10.1093/schbul/sbu072; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harrison G, 2003, PSYCHOL MED, V33, P723, DOI 10.1017/S0033291703007591; HEBB DO, 1955, AM J PSYCHIAT, V111, P826, DOI 10.1176/ajp.111.11.826; HENDERSO.ND, 1970, SCIENCE, V169, P768, DOI 10.1126/science.169.3947.776; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kates WR, 2006, AM J MED GENET B, V141B, P274, DOI 10.1002/ajmg.b.30284; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Lai IC, 2011, EUR J CLIN PHARMACOL, V67, P383, DOI 10.1007/s00228-010-0967-2; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Levy F, 2013, J CHILD ADOL PSYCHOP, V23, P423, DOI 10.1089/cap.2013.0006; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Malhotra AK, 2004, NEUROTOX RES, V6, P51, DOI 10.1007/BF03033296; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Miller P, 2013, DEV PSYCHOL, V49, P1452, DOI 10.1037/a0030244; Mizrahi R, 2016, NEUROPSYCHOPHARMACOL, V41, P666, DOI 10.1038/npp.2015.274; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Neilson E, 2017, SCHIZOPHR RES, V184, P128, DOI 10.1016/j.schres.2016.12.011; Newbury J, 2016, SCHIZOPHRENIA BULL, V42, P1372, DOI 10.1093/schbul/sbw052; Newman AEM, 2015, AM J PHYSIOL-REG I, V308, pR449, DOI 10.1152/ajpregu.00328.2014; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oswald LM, 2014, PSYCHOPHARMACOLOGY, V231, P2417, DOI 10.1007/s00213-013-3407-z; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Peeters SCT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120030; Potkin SG, 2014, CNS SPECTRUMS, V19, P176, DOI 10.1017/S109285291300059X; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Rieckmann A, 2011, J NEUROSCI, V31, P14284, DOI 10.1523/JNEUROSCI.3114-11.2011; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rypma B, 2015, J NEUROSCI, V35, P14702, DOI 10.1523/JNEUROSCI.1298-15.2015; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Slifstein M, 2015, JAMA PSYCHIAT, V72, P316, DOI 10.1001/jamapsychiatry.2014.2414; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Streit F, 2014, STRESS, V17, P352, DOI 10.3109/10253890.2014.921903; Tura E, 2008, NEUROREPORT, V19, P603, DOI 10.1097/WNR.0b013e3282fa6d8d; Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Vaessen T, 2015, NEUROSCI BIOBEHAV R, V56, P241, DOI 10.1016/j.neubiorev.2015.07.008; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vassos E, 2012, SCHIZOPHRENIA BULL, V38, P1118, DOI 10.1093/schbul/sbs096; Villanueva K, 2016, ACAD PEDIATR, V16, P10, DOI 10.1016/j.acap.2015.09.006; Wand GS, 2007, NEUROPSYCHOPHARMACOL, V32, P2310, DOI 10.1038/sj.npp.1301373; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; World Health Organization, 2010, WHO CTR HLTH DEV; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zhang RB, 2016, SCHIZOPHRENIA BULL, V42, P1068, DOI 10.1093/schbul/sbv221; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	90	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195189	10.1371/journal.pone.0195189	http://dx.doi.org/10.1371/journal.pone.0195189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634738	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200025
J	Anasa, VV; Manickam, M; Talwar, P; Ravanan, P				Anasa, Vivek Vishnu; Manickam, Madhumathi; Talwar, Priti; Ravanan, Palaniyandi			Identification of ASB7 as ER stress responsive gene through a genome wide in silico screening for genes with ERSE	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CCAAT REGULATORY ELEMENT; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; ANKYRIN REPEAT; TRANSCRIPTION FACTORS; GRP78/BIP PROMOTER; UBIQUITIN LIGASE; DEGRADATION	The endoplasmic reticulum (ER) not only performs its basic function of regulating calcium homeostasis, lipid biosynthesis, folding, modifying and transporting proteins but also plays a decisive role in regulating multiple cellular processes ranging from cell growth and differentiation to apoptosis and autophagy. Disturbances in ER homeostasis initiate the unfolded protein response (UPR) implicated in the pathogenesis of many human diseases. Drugging the UPR components for therapeutic interventions has received considerable attention. The purpose of this study is to identify genes that are previously unsuspected to be regulated under ER stress. Because ER stress-inducible gene expression is majorly regulated under ERSE elements, we screened human genome by adopting an in silico approach using ERSE elements (I, II, III) as probes and identified 337 candidate genes. Having knowledge of the importance of E3 ubiquitin ligase in the ERAD machinery; we validated our preliminary search by focusing on one of the hits i.e. ASB7 gene that encodes E3 ubiquitin ligase. In HeLa cells, we found that pharmacological induction of ER stress led to an increase in the expression of ASB7 with simultaneous activation of UPR pathways. Although knockdown of ASB7 expression leads to significant reduction in GRP78 and CHOP mRNA levels, it did not protect cells from ER stress-induced cell death. Also, an up-regulation in the expression of pro-inflammatory genes like TNF-alpha and IL-1 beta in ASB7 knockdown cells was observed under ER stress. Collectively, our findings suggest that ASB7 is regulated under ER stress and this study also identifies several other genes that could apparently be regulated under ER stress.	[Anasa, Vivek Vishnu; Manickam, Madhumathi; Talwar, Priti; Ravanan, Palaniyandi] VIT Univ, Sch Biosci & Technol, Dept Biosci, Apoptosis & Cell Survival Res Lab, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Talwar, P; Ravanan, P (corresponding author), VIT Univ, Sch Biosci & Technol, Dept Biosci, Apoptosis & Cell Survival Res Lab, Vellore, Tamil Nadu, India.	priti.t@vit.ac.in; ravanan.p@vitac.in	Talwar, Priti/AAA-1126-2021	Palaniyandi, Ravanan/0000-0003-0665-5801; Talwar, Priti/0000-0002-6826-581X	Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants [YSS/2014/000915, SB/FT/LS-419/2012]	Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants	PT and PR wish to acknowledge Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants (YSS/2014/000915 and SB/FT/LS-419/2012 respectively) for supporting this work.; The authors wish to greatly acknowledge VIT University for providing research facilities to carry out this work. We would also like to acknowledge Namrata Chaudhari for reviewing the manuscript. Additionally, PT and PR wish to acknowledge Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants (YSS/2014/000915 and SB/FT/LS-419/2012 respectively), for supporting this work.	Andresen CA, 2014, J BIOL CHEM, V289, P2043, DOI 10.1074/jbc.M113.534602; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bassi S, 2007, PLOS COMPUT BIOL, V3, P2052, DOI 10.1371/journal.pcbi.0030199; Bode M, 2011, CELL BIOCHEM FUNCT, V29, P334, DOI 10.1002/cbf.1755; Boengler K, 2003, BIOCHEM BIOPH RES CO, V302, P17, DOI 10.1016/S0006-291X(03)00095-0; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; Boulpaep E.L., 2009, SIGNAL TRANSDUCT, V48, P27; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chung AS, 2005, MOL CELL BIOL, V25, P4716, DOI 10.1128/MCB.25.11.4716-4726.2005; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Eder J, 1997, TRENDS PHARMACOL SCI, V18, P319, DOI 10.1016/S0165-6147(97)01097-3; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee MR, 2008, MOL CELLS, V26, P621; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEM CELL DEV BIOL; McDaneld TG, 2008, J ANIM SCI, V86, P2897, DOI 10.2527/jas.2008-1076; Misiewicz M, 2013, J BIOL CHEM, V288, P20378, DOI 10.1074/jbc.M113.457242; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Najwer I, 2005, AM J PHYSIOL-CELL PH, V289, pC785, DOI 10.1152/ajpcell.00098.2005; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nayak RR, 2014, NUCLEIC ACIDS RES, V42, P1757, DOI 10.1093/nar/gkt999; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; ROY B, 1995, MOL CELL BIOL, V15, P2263; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uematsu K, 2016, J CELL BIOL, V215, P95, DOI 10.1083/jcb.201603062; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1999, J BIOL CHEM, V274, P2592; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zabel MD, 2001, INT IMMUNOPHARMACOL, V1, P483, DOI 10.1016/S1567-5769(00)00046-1; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194310	10.1371/journal.pone.0194310	http://dx.doi.org/10.1371/journal.pone.0194310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630609	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000009
J	Domingos, JLC; Peeters, FM; Ferreira, WP				Domingos, Jorge L. C.; Peeters, Francois M.; Ferreira, W. P.			Self-assembly and clustering of magnetic peapod-like rods with tunable directional interaction	PLOS ONE			English	Article							PHASE-DIAGRAM; COLLOIDAL SUSPENSIONS; MONTE-CARLO; DYNAMICS; PERCOLATION; GELATION; NANOPARTICLES; DISPERSIONS; TRANSITIONS; SIMULATION	Based on extensive Langevin Dynamics simulations we investigate the structural properties of a two-dimensional ensemble of magnetic rods with a peapod-like morphology, i.e, rods consisting of aligned single dipolar beads. Self-assembled configurations are studied for different directions of the dipole with respect to the rod axis. We found that with increasing misalignment of the dipole from the rod axis, the smaller the packing fraction at which the percolation transition is found. For the same density, the system exhibits different aggregation states for different misalignment. We also study the stability of the percolated structures with respect to temperature, which is found to be affected by the microstructure of the assembly of rods.	[Domingos, Jorge L. C.; Ferreira, W. P.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [Domingos, Jorge L. C.; Peeters, Francois M.] Univ Antwerp, Dept Phys, Groenenborgerlaan 171, B-2020 Antwerp, Belgium	Universidade Federal do Ceara; University of Antwerp	Domingos, JLC (corresponding author), Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil.; Domingos, JLC (corresponding author), Univ Antwerp, Dept Phys, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	jorgecapuan@fisica.ufc.br	Domingos, Jorge L. C./J-2904-2016; Ferreira, Wandemberg Paiva/K-3080-2013	Ferreira, Wandemberg Paiva/0000-0001-8262-237X; Domingos, Jorge/0000-0003-0492-8693	Brazilian agency FUNCAP; Brazilian agency CAPES; Brazilian agency program Science without borders; Brazilian agency CNPq [400748/2013-4]; joint CNPq-FWO bilateral project; Flemish Science Foundation [FWO-V1]	Brazilian agency FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency program Science without borders; Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); joint CNPq-FWO bilateral project; Flemish Science Foundation(FWO)	This work was supported by the Brazilian agencies FUNCAP, CAPES, the program Science without borders, and CNPq (Project No. 400748/2013-4), the joint CNPq-FWO bilateral project, and the Flemish Science Foundation (FWO-V1).	Abrikosov AI, 2013, SOFT MATTER, V9, P8904, DOI 10.1039/c3sm27128e; Aharony A, 2003, INTRO PERCOLATION TH; Albrecht T, 1997, APPL PHYS A-MATER, V65, P215, DOI 10.1007/s003390050569; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Alvarez CE, 2012, SOFT MATTER, V8, P7480, DOI 10.1039/c2sm25636c; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Birringer R, 2008, Z PHYS CHEM, V222, P229, DOI 10.1524/zpch.2008.222.2-3.229; Bos MTA, 1996, PHYS REV E, V53, P5044, DOI 10.1103/PhysRevE.53.5044; BUG ALR, 1985, PHYS REV LETT, V55, P1896, DOI 10.1103/PhysRevLett.55.1896; Chelakkot R, 2012, SOFT MATTER, V8, P11746, DOI 10.1039/c2sm07379j; Colby R.H., 2003, POLYM PHYS; CONIGLIO A, 1977, J PHYS A-MATH GEN, V10, P1123, DOI 10.1088/0305-4470/10/7/011; DAS SS, 1995, J CHEM PHYS, V102, P2951, DOI 10.1063/1.468603; de Araujo JLB, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.062606; De Las Cuevas G, 2008, J PHYS CHEM C, V112, P945, DOI 10.1021/jp0755286; DEMIGUEL E, 1991, MOL PHYS, V74, P405, DOI 10.1080/00268979100102321; Demirors AF, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021012; Dhont Jan K. G., 2007, SOFT MATTER, DOI [10.1002/9783527617067.ch3a, DOI 10.1002/9783527617067.CH3A]; Dias CS, 2016, SOFT MATTER, V12, P1550, DOI 10.1039/c5sm02754c; Domingos JLC, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012603; Eberle APR, 2012, LANGMUIR, V28, P1866, DOI 10.1021/la2035054; Eberle APR, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105704; Gao WH, 2016, APPL SURF SCI, V380, P12, DOI 10.1016/j.apsusc.2016.02.106; Godfrin PD, 2014, SOFT MATTER, V10, P5061, DOI 10.1039/c3sm53220h; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hyeon T, 2003, CHEM COMMUN, P927, DOI 10.1039/b207789b; Juarez JJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3241081; Lee SH, 2009, SMALL, V5, P1957, DOI 10.1002/smll.200900135; Lemaire BJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.125507; LEUNG K, 1991, J STAT PHYS, V63, P837, DOI 10.1007/BF01029986; LEVESQUE D, 1993, PHYS REV E, V47, P496, DOI 10.1103/PhysRevE.47.496; Li LM, 2016, CRYST GROWTH DES, V16, P2700, DOI 10.1021/acs.cgd.5b01817; Liu Y, 1996, J CHEM PHYS, V105, P825, DOI 10.1063/1.471891; Martinez-Pedrero F, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.034002; Martinez-Pedrero F, 2016, SOFT MATTER, V12, P3688, DOI 10.1039/c5sm02823j; May K, 2016, LANGMUIR, V32, P5085, DOI 10.1021/acs.langmuir.6b00739; May K, 2014, LANGMUIR, V30, P7070, DOI 10.1021/la501120k; McGrother SC, 1998, MOL PHYS, V95, P657, DOI 10.1080/00268979809483199; Miller MA, 2004, J CHEM PHYS, V121, P535, DOI 10.1063/1.1758693; Miller MA, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089620; Mornet S, 2006, PROG SOLID STATE CH, V34, P237, DOI 10.1016/j.progsolidstchem.2005.11.010; Philip J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838304; Philip J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2812699; Rapaport DC, 1996, COMPUT PHYS, V10, P456, DOI DOI 10.1063/1.4822471; Schmidle H, 2012, SOFT MATTER, V8, P1521, DOI 10.1039/c1sm06576a; Sciortino F, 2005, J PHYS CHEM B, V109, P21942, DOI 10.1021/jp052683g; Shim TS, 2017, NAT NANOTECHNOL, V12, P41, DOI [10.1038/NNANO.2016.192, 10.1038/nnano.2016.192]; Singh H, 2005, LANGMUIR, V21, P11500, DOI 10.1021/la0517843; Velev OD, 2009, ADV MATER, V21, P1897, DOI 10.1002/adma.200801837; Williamson DC, 1997, J CHEM PHYS, V107, P9549, DOI 10.1063/1.475252; Woodcock LV, 2012, AICHE J, V58, P1610, DOI 10.1002/aic.12666; Yener AB, 2016, SOFT MATTER, V12, P2066, DOI 10.1039/c5sm02648b; Yuan HY, 2017, ACS APPL MATER INTER, V9, P11290, DOI 10.1021/acsami.7b02186; ZARRAGOICOECHEA GJ, 1992, MOL PHYS, V75, P989, DOI 10.1080/00268979200100771	54	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195552	10.1371/journal.pone.0195552	http://dx.doi.org/10.1371/journal.pone.0195552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630650	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000058
J	Han, BG; Song, SH; Yoo, JS; Park, H; Kim, J; Choi, E				Han, Byoung-Geun; Song, Shin Han; Yoo, Jin Sae; Park, Hyeoncheol; Kim, Juwon; Choi, Eunhee			Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis	PLOS ONE			English	Article							FLUID STATUS; CARDIOVASCULAR OUTCOMES; HEMODIALYSIS-PATIENTS; STANDARDS COMMITTEE; DIASTOLIC FUNCTION; VOLUME OVERLOAD; NT-PROBNP; RECOMMENDATIONS; MORTALITY; QUANTIFICATION	Background Echocardiography is the most valuable tool for assessing cardiac abnormalities of chronic kidney disease (CKD) patients even though it has its limitations, including high equipment cost and the need for specialized personnel. Assessment of volume status is important not only for volume management, but also for prevention of cardiovascular disease of the CKD patients. Recently, bioimpedance is gaining acceptance as a way to quantitatively assess patient hydration status at bedside. Methods 127 patients who were admitted for planning their first dialysis treatment were enrolled. The echocardiography and bioimpedance spectroscopy (BIS) were performed. The association between echocardiographic data and clinical values such as NT-proBNP and OH/ECW was examined. Results OH/ECW, which indicates relative fluid overload, was positively associated with LA dimension (r = 0.25, P = 0.007), LAVI (r = 0.32, P < 0.001), and E/e' ratio (r = 0.38, P < 0.001). While OH/ECW was not significantly associated with echocardiographic values such as LVEDD, LVEDV, LVMI, and LVEF, NT-proBNP were significantly associated with all echocardiographic parameters. Multivariate logistic regression analysis showed E/e' ratio (odds ratio, 1.14 [95% confidence interval (CI), 1.01 to 1.29]; P = 0.031), NT-proBNP (odds ratio, 4.78 [95% CI, 1.51 to 15.11]; P = 0.008), and albumin (odds ratio, 0.22 [95% CI, 0.08 to 0.66]; P = 0.007) were significantly associated with OH/ECW. Conclusions Since OH/ECW measured by BIS is associated with echocardiographic parameters related to diastolic dysfunction, preliminary screening through laboratory findings, including serum albumin in conjunction with OH/ECW and NT-proBNP, may find patient with risk of diastolic dysfunction. Our study suggests that a timely detection of fluid overload in patients with CKD as well as their proper treatment may help reduce diastolic dysfunction. Further research may be needed to validate the consistency of this association across other stages of CKD.	[Han, Byoung-Geun; Song, Shin Han; Yoo, Jin Sae; Park, Hyeoncheol] Yonsei Univ, Dept Nephrol, Wonju Coll Med, Wonju, Kang Won, South Korea; [Kim, Juwon] Yonsei Univ, Dept Lab Med, Wonju Coll Med, Wonju, Kang Won, South Korea; [Choi, Eunhee] Yonsei Univ, Inst Lifestyle Med, Wonju Coll Med, Wonju, Kang Won, South Korea; [Choi, Eunhee] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA	Yonsei University; Yonsei University; Yonsei University; Harvard University; Beth Israel Deaconess Medical Center	Han, BG (corresponding author), Yonsei Univ, Dept Nephrol, Wonju Coll Med, Wonju, Kang Won, South Korea.	neptune@yonsei.ac.kr		Choi, Eunhee/0000-0002-3449-0672				Bansal N, 2015, J AM SOC NEPHROL, V26, P946, DOI 10.1681/ASN.2014010108; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; Chiu DYY, 2014, AM J KIDNEY DIS, V64, P804, DOI 10.1053/j.ajkd.2014.01.450; di Gioia MC, 2017, NEFROLOGIA, V37, P47, DOI 10.1016/j.nefro.2016.06.003; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drepper VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158741; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Juan-Garcia I, 2012, NEFROLOGIA, V32, P94, DOI 10.3265/Nefrologia.pre2011.Nov.10867; Kim SJ, 2011, NEPHROL DIAL TRANSPL, V26, P3732, DOI 10.1093/ndt/gfr118; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nakanishi K, 2017, EUR J PREV CARDIOL, V24, P392, DOI 10.1177/2047487316679903; Onofriescu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135691; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Untersteller K, 2016, CLIN J AM SOC NEPHRO, V11, P1978, DOI 10.2215/CJN.01660216; Vega A, 2014, NEFROLOGIA, V34, P579, DOI 10.3265/Nefrologia.pre2014.Jun.12422; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yilmaz Z, 2014, Clin Ter, V165, pe52, DOI 10.7417/CT.2014.1672; Yilmaz Z, 2014, MEDICINA-LITHUANIA, V50, P269, DOI 10.1016/j.medici.2014.10.007; Yilmaz Z, 2014, RENAL FAILURE, V36, P495, DOI 10.3109/0886022X.2013.875815	29	6	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195202	10.1371/journal.pone.0195202	http://dx.doi.org/10.1371/journal.pone.0195202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630661	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000031
J	Hessels, AC; Rutgers, A; Sanders, JSF; Stegeman, CA				Hessels, Arno C.; Rutgers, Abraham; Sanders, Jan Stephan F.; Stegeman, Coen A.			Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANCA-ASSOCIATED VASCULITIS; TPMT ACTIVITY; MYELOSUPPRESSION; PHARMACOGENETICS; TRIAL	Objective Azathioprine is a widely used immunosuppressive drug. Genetic polymorphisms and activity of the enzyme thiopurine methyltransferase (TPMT) have been associated with azathioprine efficacy and toxicity in several populations. We investigated whether these associations also exist for ANCA associated vasculitis (AAV) patients, who receive azathioprine maintenance therapy after remission induction with cyclophosphamide. Methods 207 AAV patients treated with cyclophosphamide induction and azathioprine maintenance therapy were included and followed for 60 months. TPMT genotype and tertiles of TPMT activity were compared to relapse free survival and occurrence of adverse events, particularly leukopenia. Multivariable regression was performed to account for confounders. Results In univariable analysis, relapse free survival was not significantly associated with TPMT genotype (P = 0.41) or TPMT activity (P = 0.07), although it tended to be longer in lower tertiles of TPMT activity. There was no significant association of TPMT genotype and activity with occurrence of any adverse event. In multiple regression, leukocyte counts at the end of cyclophosphamide induction were related to risk of leukopenia during azathioprine therapy [P<0.001; OR 0.54 (95% Cl 0.43-0.68)] and risk of relapse during follow-up [P = 0.001; HR 1.17 (95% Cl 1.07-1.29)] irrespective of TMPT genotype or activity. Conclusion TPMT genotype and activity were not independent predictors of relapse, and could not predict leukopenia or other adverse effects from azathioprine. Leukocyte counts after cyclophosphamide induction were related to both outcomes, implying a greater influence of cyclophosphamide response compared to azathioprine and TPMT in AAV patients.	[Hessels, Arno C.; Sanders, Jan Stephan F.; Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Rutgers, Abraham] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands	University of Groningen; University of Groningen	Hessels, AC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands.	a.c.hessels@umng.nl	Sanders, Jan-Stephan/ABC-6782-2021	Sanders, Jan-Stephan/0000-0002-0904-3969; Stegeman, Coen/0000-0002-0224-0927				Ansari A, 2002, ALIMENT PHARM THER, V16, P1743, DOI 10.1046/j.1365-2036.2002.01353.x; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Coenen MJH, 2015, GASTROENTEROLOGY, V149, P907, DOI 10.1053/j.gastro.2015.06.002; Coulthard SA, 2002, MOL PHARMACOL, V62, P102, DOI 10.1124/mol.62.1.102; Cuffari C, 2004, CLIN GASTROENTEROL H, V2, P410, DOI 10.1016/S1542-3565(04)00127-2; Dong XW, 2010, WORLD J GASTROENTERO, V16, P3187, DOI 10.3748/wjg.v16.i25.3187; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gisbert JP, 2006, HEPATO-GASTROENTEROL, V53, P399; Higgs JE, 2010, PHARMACOGENOMICS, V11, P177, DOI 10.2217/PGS.09.155; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jennette JC, 2013, CLIN EXP NEPHROL, V17, P603, DOI 10.1007/s10157-013-0869-6; Kallenberg CGM, 2015, CLIN EXP RHEUMATOL, V33, pS11; Kroplin T, 1998, EUR J CLIN PHARMACOL, V54, P265, DOI 10.1007/s002280050457; Little MA, 2010, ANN RHEUM DIS, V69, P1036, DOI 10.1136/ard.2009.109389; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144234; LUQMANI RA, 1994, Q J MED, V87, P671; Moon W, 2016, ALIMENT PHARM THER; Newman WG, 2011, PHARMACOGENOMICS, V12, P815, DOI [10.2217/PGS.11.32, 10.2217/pgs.11.32]; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Roberts RL, 2012, J GASTROEN HEPATOL, V27, P1546, DOI 10.1111/j.1440-1746.2012.07220.x; Stassen PM, 2009, ANN RHEUM DIS, V68, P758, DOI 10.1136/ard.2008.097667; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Wall N, 2012, NAT REV NEPHROL, V8, P523, DOI 10.1038/nrneph.2012.107; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	25	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195524	10.1371/journal.pone.0195524	http://dx.doi.org/10.1371/journal.pone.0195524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630648	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000055
J	Jia, JJ; Ahmed, I; Liu, LX; Liu, Y; Xu, ZQ; Duan, XH; Li, QH; Dou, TF; Gu, DH; Rong, H; Wang, K; Li, ZT; Talpur, MZ; Huang, Y; Wang, SR; Yan, SX; Tong, HQ; Zhao, SM; Zhao, GP; te Pas, MFW; Su, ZC; Ge, CR				Jia, Junjing; Ahmed, Irfan; Liu, Lixian; Liu, Yong; Xu, Zhiqiang; Duan, Xiaohua; Li, Qihua; Dou, Tengfei; Gu, Dahai; Rong, Hua; Wang, Kun; Li, Zhengtian; Talpur, Mir Zulqarnain; Huang, Ying; Wang, Shanrong; Yan, Shixiong; Tong, Huiquan; Zhao, Sumei; Zhao, Guiping; te Pas, Marinus F. W.; Su, Zhengchang; Ge, Changrong			Selection for growth rate and body size have altered the expression profiles of somatotropic axis genes in chickens	PLOS ONE			English	Article							HORMONE RECEPTOR-BINDING; MESSENGER-RNA; FACTOR-I; SKELETAL-MUSCLE; TRANSGENIC MICE; GH RECEPTOR; DWARF; WEIGHT; PITUITARY; ONTOGENY	The growth hormone / insulin-like growth factor-1 (GH/IG F-1) pathway of the somatotropic axis is the major controller for growth rate and body size in vertebrates, but the effect of selection on the expression of GH/IGF-1 somatotropic axis genes and their association with body size and growth performance in farm animals is not fully understood. We analyzed a time series of expression profiles of GH/IGF-1 somatotropic axis genes in two chicken breeds, the Daweishan mini chickens and Wuding chickens, and the commercial Avian broilers hybrid exhibiting markedly different body sizes and growth rates. We found that growth rate and feed conversion efficiency in Daweishan mini chickens were significantly lower than those in Wuding chickens and Avian broilers. The Wuding and Daweishan mini chickens showed higher levels of plasma GH, pituitary GH mRNA but lower levels of hepatic growth hormone receptor (GHR) mRNA than in Avian broilers. Daweishan mini chickens showed significantly lower levels of plasma IGF-1, thigh muscle and hepatic IGF-1 mRNA than did Avian broilers and Wuding chickens. These results suggest that the GH part of the somatotropic axis is the main regulator of growth rate, while IGF-1 may regulate both growth rate and body weight. Selection for growth performance and body size have altered the expression profiles of somatotropic axis genes in a breed-, age-, and tissue-specific manner, and manner, and alteration of regulatory mechanisms of these genes might play an important role in the developmental characteristics of chickens.	[Jia, Junjing; Ahmed, Irfan; Liu, Lixian; Liu, Yong; Xu, Zhiqiang; Duan, Xiaohua; Li, Qihua; Dou, Tengfei; Rong, Hua; Wang, Kun; Li, Zhengtian; Talpur, Mir Zulqarnain; Huang, Ying; Wang, Shanrong; Yan, Shixiong; Tong, Huiquan; Zhao, Sumei; te Pas, Marinus F. W.; Ge, Changrong] Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China; [Gu, Dahai] Yunnan Agr Univ, Dept Food Sci, Kunming, Yunnan, Peoples R China; [Zhao, Guiping] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [te Pas, Marinus F. W.] Wageningen UR Livestock Sci, Anim Breeding & Genet, Wageningen, Netherlands; [te Pas, Marinus F. W.] Dali Univ, Dali, Yunnan, Peoples R China; [Su, Zhengchang] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC 28223 USA	Yunnan Agricultural University; Yunnan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Dali University; University of North Carolina; University of North Carolina Charlotte	te Pas, MFW; Ge, CR (corresponding author), Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China.; te Pas, MFW (corresponding author), Wageningen UR Livestock Sci, Anim Breeding & Genet, Wageningen, Netherlands.; te Pas, MFW (corresponding author), Dali Univ, Dali, Yunnan, Peoples R China.; Su, ZC (corresponding author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC 28223 USA.	marinus.tepas@wur.nl; zcsu@uncc.edu; gcrzal@126.com	Ahmed, Irfan/HHD-1948-2022; AHMED, IRFAN/AFW-6944-2022	, hua/0000-0003-0049-5202; Zhao, Guiping/0000-0002-1510-6903	National Natural Science Foundation of China [31260532, 31560618, 31572359]; Yunnan Provincial Natural Science Foundation [2011FA015, 2016FA046]; National Science and Technology Program in the 13th Five-Year Plan [2015BAD03B03-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province); National Science and Technology Program in the 13th Five-Year Plan	This work was partially funded by National Natural Science Foundation of China (31260532, 31560618, 31572359) (JJ), Yunnan Provincial Natural Science Foundation (2011FA015, 2016FA046) (JJ), and National Science and Technology Program in the 13th Five-Year Plan (2015BAD03B03-4) (CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit T, 2000, J CLIN ENDOCR METAB, V85, P927, DOI 10.1210/jc.85.3.927; [Anonymous], 2004, CHIN CHICK FEED STAN; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001; BRUMBY P. J., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P683; BURNSIDE J, 1992, MOL CELL ENDOCRINOL, V89, P91, DOI 10.1016/0303-7207(92)90214-Q; BURNSIDE J, 1992, GEN COMP ENDOCR, V88, P20, DOI 10.1016/0016-6480(92)90190-U; Campion B, 2009, LIVEST SCI, V126, P100, DOI 10.1016/j.livsci.2009.06.003; Carter-Su C, 2016, GROWTH HORM IGF RES, V28, P11, DOI 10.1016/j.ghir.2015.09.002; Castigliego L, 2010, DOMEST ANIM ENDOCRIN, V39, P40, DOI 10.1016/j.domaniend.2010.02.001; Chen RJ, 2011, LIVEST SCI, V136, P72, DOI 10.1016/j.livsci.2010.08.001; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; CLUTTER AC, 1995, J ANIM SCI, V73, P1776; DAUNCEY MJ, 1994, FASEB J, V8, P81, DOI 10.1096/fasebj.8.1.7507871; Dou TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3845-9; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Frystyk Jan, 2008, J Clin Endocrinol Metab, V93, P3008, DOI 10.1210/jc.2008-0375; HUYBRECHTS LM, 1989, REPROD NUTR DEV, V29, P219, DOI 10.1051/rnd:19890209; HUYBRECHTS LM, 1985, HORM METAB RES, V17, P690, DOI 10.1055/s-2007-1013646; HUYBRECHTS LM, 1987, REPROD NUTR DEV, V27, P547, DOI 10.1051/rnd:19870413; Katsumata M, 2000, J NUTR, V130, P2482, DOI 10.1093/jn/130.10.2482; Keady SM, 2011, J ANIM SCI, V89, P4007, DOI 10.2527/jas.2011-4032; Kim JW, 2010, ASIAN AUSTRAL J ANIM, V23, P1668, DOI 10.5713/ajas.2010.10329; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEUNG FC, 1987, P SOC EXP BIOL MED, V184, P234, DOI 10.3181/00379727-184-42473; Li QH, 2013, MOL BIOL REP, V40, P2769, DOI 10.1007/s11033-012-2030-0; Li ZC, 2013, MOL BIOL REP, V40, P3569, DOI 10.1007/s11033-012-2430-1; Lu FZ, 2008, POULTRY SCI, V87, P2087, DOI 10.3382/ps.2007-00493; Mao JNC, 1998, J ENDOCRINOL, V156, P67, DOI 10.1677/joe.0.1560067; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MCCANNLEVORSE LM, 1993, P SOC EXP BIOL MED, V202, P109, DOI 10.3181/00379727-202-43519; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; National Research Council, 1994, NUTR REQ POULTR; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Anh NTL, 2015, ASIAN AUSTRAL J ANIM, V28, P1686, DOI 10.5713/ajas.15.0028; Oksbjerg N, 2004, DOMEST ANIM ENDOCRIN, V27, P219, DOI 10.1016/j.domaniend.2004.06.007; Pas MFWT, 2003, J ANIM BREED GENET, V120, P346, DOI 10.1046/j.1439-0388.2003.00404.x; Pas MFWT, 2001, DOMEST ANIM ENDOCRIN, V20, P165, DOI 10.1016/S0739-7240(01)00094-7; Rahimi G., 2005, International Journal of Poultry Science, V4, P476; REIPRICH K, 1995, J ENDOCRINOL, V145, P343, DOI 10.1677/joe.0.1450343; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; Slifierz MJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-247; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; te Pas MFW, 2004, DOMEST ANIM ENDOCRIN, V27, P287, DOI 10.1016/j.domaniend.2004.06.003; Te Pas MFW, 2001, J ANIM SCI S1, V79, P30; Tuggle CK, 1996, DOMEST ANIM ENDOCRIN, V13, P1, DOI 10.1016/0739-7240(95)00059-3; VANDERPOOTEN A, 1993, DOMEST ANIM ENDOCRIN, V10, P199, DOI 10.1016/0739-7240(93)90024-6; VANDERPOOTEN A, 1991, REPROD NUTR DEV, V31, P47, DOI 10.1051/rnd:19910104; Vasilatos-Younken R, 1999, DOMEST ANIM ENDOCRIN, V17, P181, DOI 10.1016/S0739-7240(99)00035-1; Wit JM, 2002, BEST PRACT RES CL EN, V16, P483, DOI 10.1053/beem.2002.0206; Wu Gui-Qin, 2007, Yichuan, V29, P989, DOI 10.1360/yc-007-0989; Zhao RQ, 2004, GEN COMP ENDOCR, V136, P2, DOI 10.1016/j.ygcen.2003.11.009	52	19	20	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195378	10.1371/journal.pone.0195378	http://dx.doi.org/10.1371/journal.pone.0195378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630644	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000045
J	Chalazan, B; Mol, D; Sridhar, A; Alzahrani, Z; Darner, SD; Ornelas-Loredo, A; Farooqui, A; Argos, M; Daviglus, ML; Konda, S; Rehman, J; Darbar, D				Chalazan, Brandon; Mol, Denise; Sridhar, Arvind; Alzahrani, Zain; Darner, Sara D.; Ornelas-Loredo, Aylin; Farooqui, Abdullah; Argos, Maria; Daviglus, Martha L.; Konda, Sreenivas; Rehman, Jalees; Darbar, Dawood			Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort	PLOS ONE			English	Article							CHROMOSOME 4Q25; PREVALENCE; VARIANTS; CHANNELS; CARDIOMYOPATHY; EPIDEMIOLOGY; MUTATION; MARKERS; IMPACT; COMMON	Atrial fibrillation (AF) is the most prevalent cardiac rhythm disorder worldwide but the underlying genetic and molecular mechanisms and the response to therapies is not fully understood. Despite a greater burden of AF risk factors in Hispanics/Latinos the prevalence of AF remains low. Over the last decade, genome-wide association studies have identified numerous AF susceptibility loci in mostly whites of European descent. The goal of this study was to determine if the top 9 single nucleotide polymorphisms (SNPs) associated with AF in patients of European descent also increase susceptibility to AF in Hispanics/Latinos. AF cases were prospectively enrolled in the University of Illinois at Chicago (UIC) AF Registry and control subjects were identified from the UIC Cohort of Patients, Family and Friends. AF cases and controls were genotyped for 9 AF risk SNPs at chromosome 1q21: rs13376333, rs6666258; chr1q24: rs3903239; chr4q25: rs2200733; rs10033464; chr10q22: rs10824026; chr14q23: rs1152591; chr16q22: rs2106261 and rs7193343. The study sample consisted of 713 Hispanic/Latino subjects including 103 AF cases and 610 controls. Among the 8 AF risk SNPs genotyped, only rs10033464 SNP at chromosome (chr) 4q25 (near PITX2) was significantly associated with development of AF after multiple risk factor adjustment and multiple testing (adj. odds ratio [OR] 2.27, 95% confidence interval [CI] 1.31-3.94; P = 3.3 x 10-3). Furthermore, the association remained significant when the analysis was restricted to Hispanics of Mexican descent (adj. OR 2.32, 95% CI 1.35-3.99; P = 0.002. We confirm for the first time the association between a chromosome 4q25 SNP and increased susceptibility to AF in Hispanics/Latinos. While the underlying molecular mechanisms by which the chr4q25 SNP modulates AF risk remains unclear, this study supports a genetic basis for non-familial AF in patients of Hispanic descent.	[Chalazan, Brandon; Mol, Denise; Sridhar, Arvind; Alzahrani, Zain; Darner, Sara D.; Ornelas-Loredo, Aylin; Farooqui, Abdullah; Daviglus, Martha L.; Rehman, Jalees; Darbar, Dawood] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Argos, Maria; Konda, Sreenivas] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Rehman, Jalees; Darbar, Dawood] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Darbar, D (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.; Darbar, D (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	darbar@uic.edu	Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012	Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292	self-determined research funds of CCNU from the colleges' basic research and operation of MOE [CCNU17SJ004]; American Heart Association [17MCPRP33420153]; National Institutes of Health [R01 HL092217, HL138737]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138737] Funding Source: NIH RePORTER	self-determined research funds of CCNU from the colleges' basic research and operation of MOE; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association grant 17MCPRP33420153 (Brandon Chalazan) and National Institutes of Health grants R01 HL092217 and HL138737 (Dawood Darbar).	Body SC, 2009, CIRC-CARDIOVASC GENE, V2, P499, DOI 10.1161/CIRCGENETICS.109.849075; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Darbar D, 2013, NAT REV CARDIOL, V10, P317, DOI 10.1038/nrcardio.2013.53; Darghosian L, 2015, AM J CARDIOL, V115, P196, DOI 10.1016/j.amjcard.2014.10.022; Delaney JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032338; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Diness JG, 2015, J CARDIOVASC PHARM, V66, P441, DOI 10.1097/FJC.0000000000000249; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Disertori M, 2013, CIRC-CARDIOVASC GENE, V6, P27, DOI 10.1161/CIRCGENETICS.112.963520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Fatkin D, 2017, HEART LUNG CIRC, V26, P894, DOI 10.1016/j.hlc.2017.04.008; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gbadebo TD, 2011, AM HEART J, V162, P31, DOI 10.1016/j.ahj.2011.03.030; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Huang H, 2017, EUR HEART J, V38, P2595, DOI 10.1093/eurheartj/ehx289; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P94; Kilpelainen TO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10494; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Liu YW, 2015, PACE, V38, P164, DOI 10.1111/pace.12494; Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Stamos TD, 2016, JAMA CARDIOL, V1, P377, DOI 10.1001/jamacardio.2016.1259	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194480	10.1371/journal.pone.0194480	http://dx.doi.org/10.1371/journal.pone.0194480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624624	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600006
J	Katagiri, K; Kim, JH				Katagiri, Keiko; Kim, Ju-Hyun			Factors determining the social participation of older adults: A comparison between Japan and Korea using EASS 2012	PLOS ONE			English	Article							RISK	Aims Japan and Korea are the world's most aged and most rapidly aging nations. They both have low fertility rates, thereby intensifying the importance of social structures to aid a large, dependent population of older adults. Common strategies involve improving their social participation, which enhances their physical and mental health, so they are supporting society rather than being supported. Since the social participation rates in both countries are not as high as those of Western countries, it is critical to shed light on the factors related to social participation of the elderly. Methods A secondary analyses were performed using Japanese and Korean data from the 2012 East Asia Social Survey (EASS), which includes nationally representative samples through random sampling. The analyses only include data from those 65 and older (Japan: N=683, Korea: N=362). Results Social participation is classified into four types: 1) no affiliation; 2) inactive participation; 3) active recreational; and 4) active social. The Japanese respondents had a higher participation rate than Koreans, but more Japanese were inactive. Though the rates of active participations were similar in both countries. Multinomial logistic regressions were conducted to examine the related factors among the four types of social participation. Basic attributes (e.g., living alone) and other factors (e.g., network size) were included as independent variables. The results show that larger non-family networks were linked with increased social participation in both societies. Men were more vulnerable to engaging in no social activities and at a higher risk of social isolation in both countries. One difference between the two nations is that among the Japanese, people with higher social orientations engage in more active social type participation. Conclusion This study reveals that non-kin social networks are important for social participation in Japan and Korea.	[Katagiri, Keiko] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Kim, Ju-Hyun] Chungnam Natl Univ, Dept Sociol, Daejeon, South Korea	Kobe University; Chungnam National University	Katagiri, K (corresponding author), Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan.; Kim, JH (corresponding author), Chungnam Natl Univ, Dept Sociol, Daejeon, South Korea.	katagiri_k@people.kobe-u.ac.jp; haha0929@cnu.ac.kr			JSPS KAKENHI [JP17H02626, NFR-2016-S1A3A2924582]; Japan Society for the Promotion of Science; National Research Foundation of Korea; Grants-in-Aid for Scientific Research [17H02626] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea(National Research Foundation of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KK: This work was supported by JSPS KAKENHI Grant Number JP17H02626, Funder: Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/. JHK & KK: This work was supported by JSPS KAKENHI Grant Number NFR-2016-S1A3A2924582, Funder: National Research Foundation of Korea, https://www.nrf.re.kr/eng/main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagasa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175392; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Bukov A, 2002, J GERONTOL B-PSYCHOL, V57, pP510, DOI 10.1093/geronb/57.6.P510; Cabinet Office Government of Japan, 7 INT SURV ELD LIF A; Cabinet office Government of Japan, 2016, WHIT PAP AG SOC; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; JANOSKI T, 1995, SOC FORCES, V74, P271, DOI 10.2307/2580632; JGSS Research Center, 2014, E AS SOC SURV EASS 2; Katagiri K, 2013, JAPANESE J GERONTOLO, V35, P342; Katagiri K, 2007, JPN J GERONTOL, V29, P392; Katagiri K., 2012, JAPANESE RETIREES SO; Kim Geum-Hee, 2012, [The Korean Journal of Rehabilitation Psychology, 재활심리연구], V19, P317; Lee KH, 2001, J WELF AGED, V12, P7; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Menec VH, 2003, J GERONTOL B-PSYCHOL, V58, pS74, DOI 10.1093/geronb/58.2.S74; Minagawa Y, 2015, RES AGING, V37, P481, DOI 10.1177/0164027514545238; Ministry of Health Labour and Welfare, 2008 SUMM RES ELD EM; Okamoto H., 2012, JPN J SOC WELF, V53, p3 ; Okamoto H., 2014, JPN J GERONTOL, V36, P346; PARKER RN, 1983, AM SOCIOL REV, V48, P864, DOI 10.2307/2095331; Piskur B, 2014, CLIN REHABIL, V28, P211, DOI 10.1177/0269215513499029; Sugawara I, 2013, JPN J GERONTOL, V35, P321	23	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194703	10.1371/journal.pone.0194703	http://dx.doi.org/10.1371/journal.pone.0194703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624588	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600009
J	Al-Mawali, A; Pinto, AD; Al-Busaidi, R; Al-Lawati, RH; Morsi, M				Al-Mawali, Adhra; Pinto, Avinash Daniel; Al-Busaidi, Raiya; Al-Lawati, Rabab H.; Morsi, Magdi			Comprehensive haematological indices reference intervals for a healthy Omani population: First comprehensive study in Gulf Cooperation Council (GCC) and Middle Eastern countries based on age, gender and ABO blood group comparison	PLOS ONE			English	Article							MOLECULAR-SPECTRUM	Background Reference intervals for venous blood parameters differs with age, gender, geographic region, and ethnic groups. Hence local laboratory reference intervals are important to improve the diagnostic accuracy of health assessments and diseases. However, there have been no comprehensive published reference intervals established in Oman, the Gulf Cooperation Council or Middle Eastern countries. Hence, the aim of this study was to establish reference intervals for full blood count in healthy Omani adults. Methods Venous blood specimens were collected from 2202 healthy individuals aged 18 to 69 years from January 2012 to April 2017, and analysed by Sysmex XS-1000i and Cell-Dyn Sapphire automated haematology analysers. Results were statistically analysed and compared by gender, age, and ABO blood group. The lower and upper reference limits of the haematology reference intervals were established at the 2.5th and 97.5th percentiles respectively. Results Reference intervals were calculated for 17 haematology parameters which included red blood cell, white blood cell, and platelet parameters. Red blood cell (RBC), haemoglobin (HGB), haematocrit (HCT), platelet and platelet haematocrit counts of the healthy donors were significantly different between males and females at all ages (p < 0.05), with males having higher mean values of RBC, HGB and HCT than females. Other complete blood count parameters showed no significant differences between genders, age groups, instruments, or blood groups. Our study showed a lower haemoglobin limit for the normal reference interval in males and females than the currently used in Oman. Conclusions Data from this study established specific reference intervals which could be considered for general use in Oman. The differences in haematology reference intervals highlights the necessity to establish reference intervals for venous blood parameters among the healthy population in each country or at least in each region.	[Al-Mawali, Adhra; Pinto, Avinash Daniel; Morsi, Magdi] Minist Hlth, Ctr Studies & Res, Muscat, Oman; [Al-Busaidi, Raiya; Al-Lawati, Rabab H.] Royal Hosp, Muscat, Oman	The Royal Hospital, Sultanate of Oman	Al-Mawali, A (corresponding author), Minist Hlth, Ctr Studies & Res, Muscat, Oman.	adhra.almawali@gmail.com		Al-Mawali, Adhra/0000-0002-5344-4591	Research Council Oman [47]	Research Council Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This work was supported by The Research Council Oman (47) to Adhra Al-Mawali (https://www.tr.gov.om/trcweb/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Al Riyami Asya, 2012, Oman Med J, V27, P425; Al-Ankoodi Y, 2004, SAUDI MED J, V25, P1507; Al-Jafar H., 2016, J HEMATOL THROMB, V2, P04; Al-Mawali A., 2013, J STEM CELL RES THER, V3, P01; Al-Mawali A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0292-z; Al-Mawali Adhra, 2015, Oman Med J, V30, P227, DOI 10.5001/omj.2015.47; Al-Mawali Adhra, 2013, Oman Med J, V28, P432, DOI 10.5001/omj.2013.121; Al-Mawali A, 2013, CYTOM PART A, V83A, P739, DOI 10.1002/cyto.a.22322; Ambayya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091968; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Cheng C, 2003, LAB HEMATOLOGY OFFIC, V10, P42; Dasgupta A, 2013, ACCURATE RESULTS IN THE CLINICAL LABORATORY: A GUIDE TO ERROR DETECTION AND CORRECTION, P1; Denic Srdjan, 2009, BMC Blood Disord, V9, P3, DOI 10.1186/1471-2326-9-3; Gari M, 2015, BMC P; GRASBECK R, 1990, SCAND J CLIN LAB INV, V50, P45, DOI 10.3109/00365519009085800; Hassan SM, 2014, HEMOGLOBIN, V38, P422, DOI 10.3109/03630269.2014.976414; Hassan SM, 2010, HEMOGLOBIN, V34, P127, DOI 10.3109/03630261003673147; Horn PS, 2001, CLIN CHEM, V47, P2137; Horowitz G.L., 2010, CLIN LAB STAND I; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Katayev A, 2010, AM J CLIN PATHOL, V133, P180, DOI 10.1309/AJCPN5BMTSF1CDYP; Kobayashi Y, 2015, EXCLI J, V14, P220, DOI 10.17179/excli2015-102; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Ozarda Y, 2016, BIOCHEM MEDICA, V26, P5, DOI 10.11613/BM.2016.001; Pekelharing J.M.P., 2010, SYSMEX J INT, V20, P1; Rajab A, 2014, J COMMUN GENET, V5, P283, DOI 10.1007/s12687-014-0182-4; Samaneka WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165821; SAXENA S, 1990, ARCH PATHOL LAB MED, V114, P715; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Troussard X, 2013, J CLIN PATHOL; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2012, BLOOD DON SEL GUID A; Wu XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119669; Yadav D., 2015, BIOCH ANALYT BIOCH, V4, P01	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194497	10.1371/journal.pone.0194497	http://dx.doi.org/10.1371/journal.pone.0194497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621271	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800021
J	Grzesiuk, M; Mielecki, D; Pilzys, T; Garbicz, D; Marcinkowski, M; Grzesiuk, E				Grzesiuk, Malgorzata; Mielecki, Damian; Pilzys, Tomasz; Garbicz, Damian; Marcinkowski, Michel; Grzesiuk, Elzbieta			How cyclophosphamide at environmentally relevant concentration influences Daphnia magna life history and its proteome	PLOS ONE			English	Article							AQUATIC ENVIRONMENT; INDUCED APOPTOSIS; PHARMACEUTICALS; VITELLOGENIN; DRUGS; FATE; ECOTOXICOLOGY; RESISTANCE; CRUSTACEAN; TOLERANCE	The waste of commonly used medicines is known to contaminate freshwater ecosystems. Pharmaceuticals can be toxic, mutagenic, or modifying to freshwater organisms even at low concentrations if consider their permanent presence in the environment. Chemotherapeutics used to treat cancer, and in particular alkylating agents, contribute significantly to this form of pollution, the latter introducing cytotoxic and/or mutagenic lesions to the DNA and RNA of organisms which can be disruptive to their cells. The aim of the present study was to investigate the influence of the alkylating anticancer agent cyclophosphamide (CP) on Daphnia magna clones. We evaluated the life history parameters and protein profiles of this crustacean following exposure to environmentally relevant CP concentration of 10 ng L-1 Even at this low concentration, the alkylating agent caused modification of the life history parameters and proteome profile of the Daphnia. These changes were clone-specific and involved growth rate, age at first reproduction, neonate number, and proteins related to cell cycle and redox state regulation. The disturbance caused by pharmaceuticals contaminating freshwater ecosystem is probably weaker and unlikely to be cytotoxic in character due to the high dilution of these substances in the water. However, our results indicate that prolonged exposure of organisms to these toxins may lead to modifications on the organismal and molecular levels with unpredictable significance for the entire ecosystem.	[Grzesiuk, Malgorzata] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Hydrobiol, Warsaw, Poland; [Grzesiuk, Malgorzata; Mielecki, Damian; Pilzys, Tomasz; Garbicz, Damian; Marcinkowski, Michel; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Grzesiuk, M (corresponding author), Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Hydrobiol, Warsaw, Poland.; Grzesiuk, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	m.grzesiuk@uw.edu.pl	Grzesiuk-Bieniek, Małgorzata/ACF-1924-2022	Marcinkowski, Michal/0000-0002-4001-9609; Grzesiuk, Elzbieta/0000-0002-7833-7602; Grzesiuk, Malgorzata/0000-0002-9331-7183; Pilzys, Tomas/0000-0003-1294-1222; Garbicz, Damian/0000-0001-5417-8531; Mielecki, Damian/0000-0003-2929-4500	National Science Centre, NCN Poland [UMO-2016/21/B/NZ8/01542, 2015/21/B/NZ8/01542]	National Science Centre, NCN Poland	This work was supported by the National Science Centre, NCN Poland, UMO-2016/21/B/NZ8/01542 to EG and 2015/21/B/NZ8/01542. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DAPHNIA DEV MODEL OR; [Anonymous], ADV PURE APPL CHEM; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0492; Booker V, 2014, SCI TOTAL ENVIRON, V473, P159, DOI 10.1016/j.scitotenv.2013.11.145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; DAWIDOWICZ P, 1992, LIMNOL OCEANOGR, V37, P1589, DOI 10.4319/lo.1992.37.8.1589; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Geerts AN, 2015, NAT CLIM CHANGE, V5, P665, DOI 10.1038/NCLIMATE2628; Grung M, 2007, CHEMOSPHERE, V67, P108, DOI 10.1016/j.chemosphere.2006.09.021; Grzesiuk M, 2018, ECOTOX ENVIRON SAFE, V156, P271, DOI 10.1016/j.ecoenv.2018.03.019; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; HEBERT PDN, 1987, HYDROBIOLOGIA, V145, P183, DOI 10.1007/BF02530279; Hughes SR, 2013, ENVIRON SCI TECHNOL, V47, P661, DOI 10.1021/es3030148; Kato Y, 2004, GENE, V334, P157, DOI 10.1016/j.gene.2004.03.030; Kosjek T, 2011, TRAC-TREND ANAL CHEM, V30, P1065, DOI 10.1016/j.trac.2011.04.007; la Farre M, 2008, TRAC-TREND ANAL CHEM, V27, P991, DOI 10.1016/j.trac.2008.09.010; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lampert W, 1987, FEEDING NUTR DAPHNIA; Messiaen M, 2013, AQUAT TOXICOL, V144, P322, DOI 10.1016/j.aquatox.2013.10.016; Ohtani T, 2006, FEBS LETT, V580, P1597, DOI 10.1016/j.febslet.2006.01.092; Osorio V, 2016, SCI TOTAL ENVIRON, V540, P267, DOI 10.1016/j.scitotenv.2015.06.143; Radzikowski J, 2013, J PLANKTON RES, V35, P707, DOI 10.1093/plankt/fbt032; Rosi EJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2041; Togola A, 2008, J CHROMATOGR A, V1177, P150, DOI 10.1016/j.chroma.2007.10.105; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Van Donk E, 2016, REV ENVIRON CONTAM T, V238, P91, DOI 10.1007/398_2015_5002; Villegas-Navarro A, 2003, COMP BIOCHEM PHYS C, V136, P127, DOI 10.1016/S1532-0456(03)00172-8; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Yang XS, 2011, J CELL BIOCHEM, V112, P1376, DOI 10.1002/jcb.23054; Zhang JF, 2013, SCI TOTAL ENVIRON, V445, P281, DOI 10.1016/j.scitotenv.2012.12.061; [No title captured]	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195366	10.1371/journal.pone.0195366	http://dx.doi.org/10.1371/journal.pone.0195366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621334	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800071
J	Halvarsson, A; Hagman, I; Tegern, M; Broman, L; Larsson, H				Halvarsson, Alexandra; Hagman, Ingela; Tegern, Matthias; Broman, Lisbet; Larsson, Helena			Self-reported musculoskeletal complaints and injuries and exposure of physical workload in Swedish soldiers serving in Afghanistan	PLOS ONE			English	Article							BRIGADE COMBAT TEAM; MILITARY PERSONNEL; PREMATURE DISCHARGE; RISK-FACTORS; PAIN; INTERVENTION; THERAPIST	Background Musculoskeletal complaints and injuries (MSCI) are common in military populations. However, only a limited number of studies have followed soldiers during international deployments and investigated the prevalence of MSCI during and at the end of their deployment. The aim was to describe the prevalence of MSCI in different military occupational specialties and categorise their most common tasks in terms of exposures to physical workloads during a six-month long international deployment in Afghanistan. Methods Cross-sectional survey, including 325 soldiers (300 men), aged 20-62 participating in an international deployment in Afghanistan during the spring of 2012. Soldiers were clustered into different military occupational specialties: Infantry, Administration, Logistics, Logistics/Camp, Medical and Other. Data were collected through the use of the Musculoskeletal Screening Protocol at the end of the international mission. Results Forty-seven percent reported MSCI during deployment, with 28% at the end. The most common locations of MSCI during the mission were lower back, knee, shoulders, upper back, neck and foot, while the knee and lower back prevailed at the end of the mission. Almost half of the soldiers who had MSCI reported affected work ability. The most common duties during the mission were vehicle patrolling, staff duties, guard/security duties, foot patrols and transportation. Soldiers reported that vehicle patrolling, staff duties and transportation were demanding with respect to endurance strength, guard/security duties challenged both maximum and endurance strength while foot patrolling challenged maximum and endurance strength, aerobic and anaerobic endurance and speed. Conclusions MSCI during international deployment are common among Swedish soldiers. The results indicate the need to further develop strategies focusing on matching the soldiers' capacity to the job requirements, with relevant and fair physical selection-tests during the recruitment process and proactive interventions targeting MSCI before and during deployment, in order to enhance soldiers' readiness and promote operational readiness.	[Halvarsson, Alexandra; Hagman, Ingela; Tegern, Matthias; Broman, Lisbet; Larsson, Helena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden; [Halvarsson, Alexandra] Karolinska Univ Hosp, Allied Hlth Profess Funct, Stockholm, Sweden; [Tegern, Matthias] Umea Univ, Dept Community Med & Rehabil Physiotherapy, Umea, Sweden; [Larsson, Helena] Swedish Armed Forces, Med Serv, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University	Halvarsson, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden.; Halvarsson, A (corresponding author), Karolinska Univ Hosp, Allied Hlth Profess Funct, Stockholm, Sweden.	alexandra.halvarsson@ki.se		Halvarsson, Alexandra/0000-0002-0893-7653; Tegern, Matthias/0000-0001-6871-1341				Campbell DJ, 2009, MIL PSYCHOL, V21, pS47, DOI 10.1080/08995600903249149; George SZ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-128; Glad D, 2012, EUR SPINE J, V21, P739, DOI 10.1007/s00586-011-2142-6; Goff BJ, 2011, PM&R, V3, P183, DOI 10.1016/j.pmrj.2010.10.024; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Kaufman KR, 2000, AM J PREV MED, V18, P54, DOI 10.1016/S0749-3797(00)00114-8; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Konitzer LN, 2008, J HAND THER, V21, P143, DOI 10.1197/j.jht.2007.10.017; Larsson H., 2009, THESIS; Larsson H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132185; Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; LINTON SJ, 1993, PAIN, V54, P353, DOI 10.1016/0304-3959(93)90037-P; Rhon DI, 2010, MIL MED, V175, P442, DOI 10.7205/MILMED-D-09-00097; Rosendal L, 2003, CLIN J SPORT MED, V13, P157, DOI 10.1097/00042752-200305000-00006; Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012; Roy TC, 2011, MIL MED, V176, P903, DOI 10.7205/MILMED-D-11-00006; Sharma S, 2015, IIMB MANAG REV, V27, P185, DOI 10.1016/j.iimb.2015.06.002; Taanila H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-89; Yancosek KE, 2012, CURR OPIN RHEUMATOL, V24, P232, DOI 10.1097/BOR.0b013e3283503406; Zambraski Edward J, 2012, J Strength Cond Res, V26 Suppl 2, pS101, DOI 10.1097/JSC.0b013e31825cf03b	21	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195548	10.1371/journal.pone.0195548	http://dx.doi.org/10.1371/journal.pone.0195548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621324	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800100
J	Simon, EG; Calle, S; Perrotin, F; Remenieras, JP				Simon, Emmanuel G.; Calle, Samuel; Perrotin, Franck; Remenieras, Jean-Pierre			Measurement of shear wave speed dispersion in the placenta by transient elastography: A preliminary ex vivo study	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; HUMAN FETOPLACENTAL VASCULOGENESIS; FORCE IMPULSE ELASTOGRAPHY; 1 BASIC PRINCIPLES; RADIATION FORCE; CLINICAL-USE; COMPLICATED PREGNANCIES; WFUMB GUIDELINES; 2ND TRIMESTER; LIVER-DISEASE	Background Placental elasticity may be modified in women with placental insufficiency. Shear wave elastography (SWE) can measure this, using acoustic radiation force, but the safety of its use in pregnant women has not yet been demonstrated. Transient elastography (TE) is a safer alternative, but has not yet been applied to the placenta. Moreover, the dispersion of shear wave speed (SWS) as a function of frequency has received relatively little study for placental tissue, although it might improve the accuracy of biomechanical assessment. Objective To explore the feasibility and reproducibility of TE for placental analysis, to compare the values of SWS and Young's modulus (YM) from TE and SWE, and to analyze SWS dispersion as a function of frequency ex vivo in normal placentas. Materials and methods Ten normal placentas were analyzed ex vivo by an Aixplorer ultrasound system as shear waves were generated by a vibrating plate and by using an Aixplorer system. The frequency analysis provided the value of the exponent n from a fractional rheological model applied to the TE method. We calculated intra- and interobserver agreement for SWS and YM with 95% prediction intervals, created Bland-Altman plots with 95% limits of agreement, and estimated the intraclass correlation coefficient (ICC). Main results The mean SWS was 1.80 m/s +/- 0.28 (standard deviation) with the TE method at 50 Hz and 1.82 m/s +/-0.13 with SWE (P = 0.912). No differences were observed between the central and peripheral regions of placentas with either TE or SWE. With TE, the intraobserver ICC for SWS was 0.68 (0.50-0.82), and the interobserver ICC for SWS 0.65 (0.37-0.85). The mean parameter n obtained from the fractional rheological model was 1.21 +/- 0.12, with variable values of n for any given SWS. Conclusions TE is feasible and reproducible on placentas ex vivo. The frequency analysis of SWS provides additional information about placental elasticity and appears to be able to distinguish differences between placental structures.	[Simon, Emmanuel G.; Calle, Samuel; Perrotin, Franck; Remenieras, Jean-Pierre] Univ Tours, INSERM, UMR 1253, iBrain, Tours, France; [Simon, Emmanuel G.; Perrotin, Franck] Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France; [Calle, Samuel] Univ Tours, CNRS, UMR 7347, GREMAN, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Tours	Simon, EG (corresponding author), Univ Tours, INSERM, UMR 1253, iBrain, Tours, France.; Simon, EG (corresponding author), Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France.	emmanuel.g.simon@gmail.com	REMENIERAS, Jean-pierre/AAB-4105-2021; Perrotin, Franck/AAL-8833-2021	REMENIERAS, Jean-pierre/0000-0001-8440-5184; Perrotin, Franck/0000-0001-9694-6658; Simon, Emmanuel/0000-0001-6442-1013				Abeysekera JM, 2017, ULTRASOUND MED BIOL, V43, P1112, DOI 10.1016/j.ultrasmedbio.2017.01.014; Alan B, 2016, INT J GYNECOL OBSTET, V135, P43, DOI 10.1016/j.ijgo.2016.03.037; Alan B, 2016, KOREAN J RADIOL, V17, P218, DOI 10.3348/kjr.2016.17.2.218; Albayrak E, 2016, CLIN IMAG, V40, P926, DOI 10.1016/j.clinimag.2016.04.006; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Barr RG, 2015, ULTRASOUND MED BIOL, V41, P1148, DOI 10.1016/j.ultrasmedbio.2015.03.008; Barry CT, 2014, ULTRASOUND MED BIOL, V40, P704, DOI 10.1016/j.ultrasmedbio.2013.10.016; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Cimsit C, 2015, ARCH GYNECOL OBSTET, V291, P811, DOI 10.1007/s00404-014-3479-y; Cimsit C, 2015, J ULTRAS MED, V34, P151, DOI 10.7863/ultra.34.1.151; Correas J-M, 2013, Diagn Interv Imaging, V94, P551, DOI 10.1016/j.diii.2013.01.017; Dasgeb B, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150344; Di Ieva A, 2010, NEUROSURG REV, V33, P137, DOI 10.1007/s10143-010-0249-6; Durhan G, 2017, ULTRASOUND MED BIOL, V43, P111, DOI 10.1016/j.ultrasmedbio.2016.08.037; Falco ML, 2017, ULTRASOUND OBST GYN, V50, P295, DOI 10.1002/uog.17494; Fink M, 2013, Diagn Interv Imaging, V94, P485, DOI 10.1016/j.diii.2013.02.007; Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Grenier N, 2013, Diagn Interv Imaging, V94, P545, DOI 10.1016/j.diii.2013.02.003; Habibi HA, 2017, EUR J RADIOL, V97, P16, DOI 10.1016/j.ejrad.2017.10.007; HOEKS APG, 1994, ULTRASOUND MED BIOL, V20, P953, DOI 10.1016/0301-5629(94)90054-X; Holm S, 2010, J ACOUST SOC AM, V127, P542, DOI 10.1121/1.3268508; Karaman E, 2016, J OBSTET GYNAECOL RE, V42, P1464, DOI 10.1111/jog.13078; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kilic F, 2015, DIAGN INTERV RADIOL, V21, P202, DOI 10.5152/dir.2014.14338; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Li WJ, 2012, CLIN EXP OBSTET GYN, V39, P470; Lupsor-Platon M, 2015, WORLD J GASTROENTERO, V21, P11914, DOI 10.3748/wjg.v21.i42.11914; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Mastrolia SA, 2016, J MATERN-FETAL NEO M, V29, P921, DOI 10.3109/14767058.2015.1023709; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Mayhew TM, 2004, PLACENTA, V25, P829, DOI 10.1016/j.placenta.2004.04.011; Mayhew TM, 2003, PLACENTA, V24, P191, DOI 10.1053/plac.2002.0895; McAleavey SA, 2016, ULTRASOUND MED BIOL, V42, P1282, DOI 10.1016/j.ultrasmedbio.2016.01.009; McCarthy R, 2016, EUR J OBSTET GYN R B, V197, P130, DOI 10.1016/j.ejogrb.2015.12.015; Messas E, 2013, Diagn Interv Imaging, V94, P561, DOI 10.1016/j.diii.2013.01.025; Monpeyssen H, 2013, Diagn Interv Imaging, V94, P535, DOI 10.1016/j.diii.2013.01.023; Nicolas E, 2018, ULTRASONICS, V84, P119, DOI 10.1016/j.ultras.2017.10.009; Nicolle S, 2010, J BIOMECH, V43, P927, DOI 10.1016/j.jbiomech.2009.11.002; Ohmaru T, 2015, PLACENTA, V36, P915, DOI 10.1016/j.placenta.2015.06.008; Pavlov CS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010542.pub2; Quarello E, 2015, GYNECOL OBSTET FERTI, V43, P200, DOI 10.1016/j.gyobfe.2015.01.004; Quarello E, 2015, PRENATAL DIAG, V35, P1112, DOI 10.1002/pd.4655; Quibel T, 2015, PRENATAL DIAG, V35, P1106, DOI 10.1002/pd.4654; Roland CS, 2016, CELL MOL LIFE SCI, V73, P365, DOI 10.1007/s00018-015-2069-x; Ronot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094679; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Simon EG, 2017, J OBSTET GYNAECOL RE, V43, P1509, DOI 10.1111/jog.13383; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Sugitani M, 2013, PLACENTA, V34, P1009, DOI 10.1016/j.placenta.2013.08.014; Torricelli M, 2015, PLACENTA, V36, P463, DOI 10.1016/j.placenta.2014.12.018; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Wu SZ, 2016, ULTRASONOGRAPHY, V35, P253, DOI 10.14366/usg.16002; Yuksel MA, 2016, J OBSTET GYNAECOL, V36, P585, DOI 10.3109/01443615.2015.1110120	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194309	10.1371/journal.pone.0194309	http://dx.doi.org/10.1371/journal.pone.0194309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621270	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800015
J	Dojat, M; Pizzagalli, F; Hupe, JM				Dojat, Michel; Pizzagalli, Fabrizio; Hupe, Jean-Michel			Magnetic resonance imaging does not reveal structural alterations in the brain of grapheme-color synesthetes	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; INDIVIDUAL-DIFFERENCES; CEREBRAL-CORTEX; MR-IMAGES; VOLUME; FALSE; SEGMENTATION; CONNECTIVITY; SENSITIVITY; STATISTICS	Several publications have reported structural changes in the brain of synesthetes compared to controls, either local differences or differences in connectivity. In the present study, we pursued this quest for structural brain differences that might support the subjective experience of synesthesia. In particular, for the first time in this field, we investigated brain folding in comparing 45 sulcal shapes in each hemisphere of control and grapheme-color synesthete populations. To overcome flaws relative to data interpretation based only on p-values, common in the synesthesia literature, we report confidence intervals of effect sizes. Moreover, our statistical maps are displayed without introducing the classical, but misleading, p value level threshold. We adopt such a methodological procedure to facilitate appropriate data interpretation and promote the "New Statistics" approach. Based on structural or diffusion magnetic resonance imaging data, we did not find any strong cerebral anomaly, in sulci, tissue volume, tissue density or fiber organization that could support synesthetic color experience. Finally, by sharing our complete datasets, we strongly support the multi-center construction of a sufficient large dataset repository for detecting, if any, subtle brain differences that may help understanding how a subjective experience, such as synesthesia, is mentally constructed.	[Dojat, Michel; Pizzagalli, Fabrizio] Univ Grenoble Alpes, Grenoble Inst Neurosci, Inst Natl Sante & Rech Med, Grenoble, France; [Dojat, Michel; Pizzagalli, Fabrizio] Ctr Hosp Univ Grenoble Alpes, Grenoble, France; [Hupe, Jean-Michel] Univ Toulouse Paul Sabatier, Ctr Rech Cerveau & Cognit, Toulouse, France; [Hupe, Jean-Michel] CNRS, Toulouse, France; [Pizzagalli, Fabrizio] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); University of Southern California	Dojat, M (corresponding author), Univ Grenoble Alpes, Grenoble Inst Neurosci, Inst Natl Sante & Rech Med, Grenoble, France.; Dojat, M (corresponding author), Ctr Hosp Univ Grenoble Alpes, Grenoble, France.	Michel.Dojat@univ-grenoble-alpes.fr	Pizzagalli, Fabrizio/AAE-4990-2022; Dojat, Michel/G-7758-2011	Dojat, Michel/0000-0003-2747-6845; Pizzagalli, Fabrizio/0000-0003-4582-0224	Agence Nationale de Recherche [ANR-11-BSH2-010]; French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante" [ANR11-INBS-0006]; NIH Big Data [U54 EB020403]	Agence Nationale de Recherche(French National Research Agency (ANR)); French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante"(French National Research Agency (ANR)); NIH Big Data	Research funded by Agence Nationale de Recherche ANR-11-BSH2-010. Grenoble MRI facility IRMaGe was partly funded by the French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante" ANR11-INBS-0006. We thank the technical staff at the 3T scanner facility from IRMaGe unit. F. Pizzagalli is also presently funded by the NIH Big Data to Knowledge (BD2K) Center of Excellence grant U54 EB020403 (to Prof. Paul M. Thompson).	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Aleman-Gomez Y, 2013, J NEUROSCI, V33, P15004, DOI 10.1523/JNEUROSCI.1459-13.2013; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Auzias G, 2014, NEUROIMAGE-CLIN, V4, P593, DOI 10.1016/j.nicl.2014.03.008; Banissy MJ, 2012, COGN NEUROSCI-UK, V3, P29, DOI 10.1080/17588928.2011.594499; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Chun CA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00776; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Eagleman DM, 2009, TRENDS COGN SCI, V13, P288, DOI 10.1016/j.tics.2009.03.009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fiedler K, 2012, PERSPECT PSYCHOL SCI, V7, P661, DOI 10.1177/1745691612462587; Focke NK, 2011, NEUROIMAGE, V56, P1164, DOI 10.1016/j.neuroimage.2011.02.029; Fusar-Poli P, 2014, HUM BRAIN MAPP, V35, P3052, DOI 10.1002/hbm.22384; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gregory MD, 2016, CURR BIOL, V26, P1301, DOI 10.1016/j.cub.2016.03.021; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Hupe JM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00103; Hupe JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00018; Hupe JM, 2012, CEREB CORTEX, V22, P1622, DOI 10.1093/cercor/bhr236; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kurth F, 2015, NAT PROTOC, V10, P293, DOI 10.1038/nprot.2015.014; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Luders E, 2008, CEREB CORTEX, V18, P2019, DOI 10.1093/cercor/bhm227; Mangin JF, 2004, IEEE T MED IMAGING, V23, P968, DOI 10.1109/TMI.2004.831204; Manjon JV, 2015, MED IMAGE ANAL, V22, P35, DOI 10.1016/j.media.2015.01.004; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Melero H, 2013, EXP BRAIN RES, V227, P343, DOI 10.1007/s00221-013-3514-4; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; O'Hanlon E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00755; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Pizzagalli F, GENETIC ANAL CORTICA; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Rouw R, 2011, J NEUROPSYCHOL, V5, P214, DOI 10.1111/j.1748-6653.2011.02006.x; Rouw R, 2010, J NEUROSCI, V30, P6205, DOI 10.1523/JNEUROSCI.3444-09.2010; Ruiz MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119377; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Scarpazza C, 2015, NEUROSCI BIOBEHAV R, V52, P49, DOI 10.1016/j.neubiorev.2015.02.008; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Takao H, 2014, NEUROIMAGE, V84, P133, DOI 10.1016/j.neuroimage.2013.08.046; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Whitaker KJ, 2014, NEUROIMAGE, V90, P52, DOI 10.1016/j.neuroimage.2013.12.054; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573; Zamm A, 2013, NEUROIMAGE, V74, P359, DOI 10.1016/j.neuroimage.2013.02.024	70	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194422	10.1371/journal.pone.0194422	http://dx.doi.org/10.1371/journal.pone.0194422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617401	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800030
J	Han, Q; Chen, R; Wang, FJ; Chen, S; Sun, XS; Guan, X; Yang, Y; Peng, BJ; Pan, XD; Li, JF; Yi, WJ; Li, P; Zhang, HW; Feng, DF; Chen, A; Li, XH; Li, SH; Yin, ZM				Han, Qi; Chen, Rui; Wang, Fangjie; Chen, Sha; Sun, Xiongshan; Guan, Xiao; Yang, Yao; Peng, Bingjie; Pan, Xiaodong; Li, Jinfang; Yi, Weijing; Li, Peng; Zhang, Hongwei; Feng, Dongfang; Chen, An; Li, Xiaohui; Li, Shuhui; Yin, Zuoming			Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells	PLOS ONE			English	Article							MULTICENTER RANDOMIZED-TRIAL; METASTATIC COLORECTAL-CANCER; ALTERNATING ELECTRIC-FIELDS; 1ST-LINE TREATMENT; DRUG-RESISTANCE; MAGNETIC-FIELDS; EXPOSURE; PROLIFERATION; CYCLE; COMMUNICATION	Resistance to 5-fluorouracil (5-FU) and its induced immune suppression have prevented its extensive application in the clinical treatment of breast cancer. In this study, the combined effect of 50 Hz-EMFs and 5-FU in the treatment of breast cancer was explored. MCF-7 and MCF10A cells were pre-exposed to 50 Hz-EMFs for 0, 2, 4, 8 and 12 h and then treated with different concentrations of 5-FU for 24 h; cell viability was analyzed by MTT assay and flow cytometry. After pre-exposure to 50 Hz-EMFs for 12 h, apoptosis and cell cycle distribution in MCF-7 and MCF10A cells were detected via flow cytometry and DNA synthesis was measured by EdU incorporation assay. Apoptosis-related and cell cycle-related gene and protein expression levels were monitored by qPCR and western blotting. Pre-exposure to 50 Hz-EMFs for 12 h enhanced the antiproliferative effect of 5-FU in breast cancer cell line MCF-7 in a dose-dependent manner but not in normal human breast epithelial cell line MCF10A. Exposure to 50 Hz-EMFs had no effect on apoptosis and P53 expression of MCF-7 and MCF10A cells, whereas it promoted DNA synthesis, induced entry of MCF-7 cells into the S phase of cell cycle, and upregulated the expression levels of cell cycle-related proteins Cyclin D1 and Cyclin E. Considering the pharmacological mechanisms of 5-FU in specifically disrupting DNA synthesis, this enhanced inhibitory effect might have resulted from the specific sensitivity of MCF7 cells in active S phase to 5-FU. Our findings demonstrate the enhanced cytotoxic activity of 5-FU on MCF7 cells through promoting entry into the S phase of the cell cycle via exposure to 50 Hz-EMFs, which provides a novel method of cancer treatment based on the combinatorial use of 50 Hz-EMFs and chemotherapy.	[Han, Qi; Zhang, Hongwei; Feng, Dongfang; Yin, Zuoming] Gen Hosp Tibet Area Mil Command, Lhasa, Peoples R China; [Han, Qi; Chen, Sha; Peng, Bingjie; Li, Jinfang; Yi, Weijing; Chen, An; Li, Shuhui] Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, Chongqing, Peoples R China; [Han, Qi; Wang, Fangjie; Sun, Xiongshan; Guan, Xiao; Yang, Yao; Pan, Xiaodong; Li, Xiaohui] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing, Peoples R China; [Chen, Rui] Tibetan Tradit Med Coll, Lhasa, Peoples R China; [Li, Peng] 201th Hosp Peoples Liberat Army, Urol, Liaoyang, Peoples R China	Army Medical University; Army Medical University; University of Tibetan Medicine	Yin, ZM (corresponding author), Gen Hosp Tibet Area Mil Command, Lhasa, Peoples R China.; Li, SH (corresponding author), Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, Chongqing, Peoples R China.; Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing, Peoples R China.	lpsh008@aliyun.com; lishuhui316@yeah.net; yinzuoming@163.com		Xiongshan, Sun/0000-0002-7958-0620	National Natural Science Foundation of China [81472481, 81272909, 81402513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81472481 to SL, 81272909 to SL, and 81402513 to SC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (81472481, 81272909 and 81402513). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FM, 2011, TECHNOL HEALTH CARE, V19, P455, DOI 10.3233/THC-2011-0649; Barbault A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-51; Berg H, 2010, ELECTROMAGN BIOL MED, V29, P132, DOI 10.3109/15368371003776725; Bourthoumieu S, 2013, BIOELECTROMAGNETICS, V34, P52, DOI 10.1002/bem.21744; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Destefanis M, 2015, INT J RADIAT BIOL, V91, P964, DOI 10.3109/09553002.2015.1101648; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gomez MJR, 2001, BIOELECTROCHEMISTRY, V53, P137, DOI 10.1016/S0302-4598(00)00119-7; Griffin GD, 2000, BIOELECTROCHEMISTRY, V51, P117, DOI 10.1016/S0302-4598(99)00085-9; Hirata M, 2001, ANTICANCER RES, V21, P317; Hirose H, 2006, BIOELECTROMAGNETICS, V27, P494, DOI 10.1002/bem.20238; Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008; Jin ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046102; Jordan VC, 2016, CANCER RES, V76, P767, DOI 10.1158/0008-5472.CAN-16-0150; Kang L, 2015, ACTA PHARM SIN B, V5, P169, DOI 10.1016/j.apsb.2015.03.001; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson ED, 2009, CLIN EXP METASTAS, V26, P633, DOI 10.1007/s10585-009-9262-y; Li JR, 1999, RADIAT RES, V151, P710, DOI 10.2307/3580210; Lim S, 2015, BIOMED ENVIRON SCI, V28, P231, DOI 10.3967/bes2015.032; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042332; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Jimenez-Garcia MN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-159; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Percherancier Y, 2015, BIOELECTROMAGNETICS, V36, P287, DOI 10.1002/bem.21908; Schuz J, 2011, PROG BIOPHYS MOL BIO, V107, P339, DOI 10.1016/j.pbiomolbio.2011.09.008; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Taghi M, 2013, RECENT PATENTS ENDOC, V7, P252, DOI 10.2174/18722148113079990007; Taghi M, 2012, RECENT PATENTS ENDOC, V6, P251, DOI 10.2174/187221412802481757; Visweswaran M, 2018, INT J BIOCHEM CELL B, V95, P63, DOI 10.1016/j.biocel.2017.12.013; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yan Y, 2012, ACS NANO, V6, P3663, DOI 10.1021/nn3016162; Yang Min-li, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P323; Zhao G, 2014, EUR J GYNAECOL ONCOL, V35, P264; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523	42	15	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0192888	10.1371/journal.pone.0192888	http://dx.doi.org/10.1371/journal.pone.0192888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617363	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800005
J	Kuret, T; Lakota, K; Mali, P; Cucnik, S; Praprotnik, S; Tomsic, M; Sodin-Semrl, S				Kuret, Tadeja; Lakota, Katja; Mali, Polonca; Cucnik, Sasa; Praprotnik, Sonja; Tomsic, Matija; Sodin-Semrl, Snezna			Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; MESSENGER-RNA EXPRESSION; INTRAVENOUS IMMUNOGLOBULIN; AA AMYLOIDOSIS; RHEUMATOID-ARTHRITIS; RECEPTOR ANTIBODY; DISEASE; AUTOANTIBODIES	Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. Resolution of the acute phase and SAA reduction are well documented, however the exact mechanism remains elusive. Two inducible SAA proteins, SAA1 and SAA2, with their variants could contribute to systemic inflammation. While unconjugated human variant SAA1 alpha is already commercially available, the variants of SAA2 are not. Antibodies against SAA have been identified in apparently healthy blood donors (HBDs) in smaller, preliminary studies. So, our objective was to detect antiSAA and anti-SAA1 alpha autoantibodies in the sera of 300 HBDs using ELISA, characterize their specificity and avidity. Additionally, we aimed to determine the presence of anti-SAA and anti-SAA1 alpha autoantibodies in intravenous immunoglobulin (IVIg) preparations and examine their effects on released IL-6 from SAA/SAA1 alpha-treated peripheral blood mononuclear cells (PBMCs). Autoantibodies against SAA and SAA1 alpha had a median (IQR) absorbance OD (A(450)) of 0.655 (0.262-1.293) and 0.493 (0.284-0.713), respectively. Both antiSAA and anti-SAA1 alpha exhibited heterogeneous to high avidity and reached peak levels between 41-50 years, then diminished with age in the oldest group (51-67 years). Women consistently exhibited significantly higher levels than men. Good positive correlation was observed between anti-SAA and anti-SAA1 alpha. Both anti-SAA and anti-SAA1 alpha were detected in IVIg, their fractions subsequently isolated, and shown to decrease IL-6 protein levels released from SAA/SAA1 alpha-treated PBMCs. In conclusion, naturally occurring antibodies against SAA and anti-SAA1 alpha could play a physiological role in down-regulating their antigen and proinflammatory cytokines leading to the resolution of the acute phase and could be an important therapeutic option in patients with chronic inflammatory diseases.	[Kuret, Tadeja; Lakota, Katja; Cucnik, Sasa; Praprotnik, Sonja; Tomsic, Matija; Sodin-Semrl, Snezna] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Lakota, Katja; Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Mali, Polonca] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Cucnik, Sasa] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Tomsic, Matija] Univ Ljubljana, Fac Med, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Primorska; University of Ljubljana; University of Ljubljana	Sodin-Semrl, S (corresponding author), Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.; Sodin-Semrl, S (corresponding author), Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.	ssodin1@yahoo.com	Lakota, Katja/AAH-8033-2020; Sodin-Semrl, Snezna/AAJ-8954-2020; Kuret, Tadeja/AAJ-8170-2020	Lakota, Katja/0000-0002-8062-7908; Kuret, Tadeja/0000-0002-4749-594X	Slovenian Research Agency (ARRS) [P3-0314]; Slovenian Research Agency (ARRS), National Research Program [P3-0314]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian Research Agency (ARRS), National Research Program	The authors would like to acknowledge funding from the Slovenian Research Agency (ARRS) for the National Research Program P3-0314.; This work was supported by the Slovenian Research Agency (ARRS), National Research Program P3-0314.	ALGIMAN M, 1992, P NATL ACAD SCI USA, V89, P3795, DOI 10.1073/pnas.89.9.3795; Rodriguez JA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0055; Ather JL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.327; AUKRUST P, 1994, BLOOD, V84, P2136; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Afonso AFB, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010015; BOYDEN STEPHEN V., 1966, ADVANCE IMMUNOL, V5, P1, DOI 10.1016/S0065-2776(08)60271-0; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Cucnik S, 2004, ANN RHEUM DIS, V63, P1478, DOI 10.1136/ard.2003.017939; De Buck M, 2016, CYTOKINE GROWTH F R, V30, P55, DOI 10.1016/j.cytogfr.2015.12.010; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Buck M, 2015, J LEUKOCYTE BIOL, V98, P1049, DOI 10.1189/jlb.3A0315-085R; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gouwy M, 2015, EUR J IMMUNOL, V45, P101, DOI 10.1002/eji.201444818; GUILBERT B, 1982, J IMMUNOL, V128, P2779; Hatanaka E, 2004, IMMUNOL LETT, V91, P33, DOI 10.1016/j.imlet.2003.09.011; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hocevar A, 2013, AMYLOID, V20, P275, DOI 10.3109/13506129.2013.838947; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jura J, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P61; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaveri S, 1996, J CLIN INVEST, V97, P865, DOI 10.1172/JCI118488; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kurtenkov O, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6097647; Lakota K, AUTOANTIBODIES; Lakota K, 2011, AUTOIMMUN REV, V10, P779, DOI 10.1016/j.autrev.2011.06.001; Lakota K, 2011, AUTOIMMUNITY, V44, P149, DOI 10.3109/08916934.2010.487504; Lane T, 2015, CLIN EXP RHEUMATOL, V33, pS46; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Le Pottier L, 2007, J CLIN IMMUNOL, V27, P257, DOI 10.1007/s10875-007-9082-2; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; LING ZD, 1993, J CLIN IMMUNOL, V13, P302, DOI 10.1007/BF00920238; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Miyagawa I, 2014, MOD RHEUMATOL, V24, P405, DOI 10.3109/14397595.2013.844294; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Noskova L, 2017, BIOMED PAP, V161, P179, DOI 10.5507/bp.2017.017; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; Okuda Y, 2006, ARTHRITIS RHEUM-US, V54, P2997, DOI 10.1002/art.22118; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Patil V, 2014, AUTOANTIBODIES, P305; de Asua DR, 2014, CLIN EPIDEMIOL, V6, P369, DOI 10.2147/CLEP.S39981; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Rieper CD, 2009, CYTOKINE GROWTH F R, V20, P61, DOI 10.1016/j.cytogfr.2009.01.003; Rosenau BJ, 2006, ANN RHEUM DIS, V65, P674, DOI 10.1136/ard.2005.037895; Rosenau BJ, 2004, J AUTOIMMUN, V23, P179, DOI 10.1016/j.jaut.2004.05.005; Scarpioni Roberto, 2016, World J Nephrol, V5, P66, DOI 10.5527/wjn.v5.i1.66; Schrodl W, 2016, PROTEOM CLIN APPL, V10, P1077, DOI 10.1002/prca.201600028; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; SELLAR GC, 1994, GENOMICS, V19, P221, DOI 10.1006/geno.1994.1051; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Sewell WAC, 2002, IMMUNOLOGY, V107, P387, DOI 10.1046/j.1365-2567.2002.01545.x; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Sjowall C, 2004, ARTHRITIS RES THER, V6, pR87, DOI 10.1186/ar1032; Sjowall C, 2002, J AUTOIMMUN, V19, P155, DOI 10.1006/jaut.2002.0608; Sjowall C, 2011, J RHEUMATOL, V38, P215, DOI 10.3899/jrheum.100690; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; STRACHAN AF, 1989, J BIOL CHEM, V264, P18368; Su Q, 2017, PHARM RES; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Sun L, 2016, GENE, V583, P48, DOI 10.1016/j.gene.2016.02.044; Sung HJ, 2011, J PROTEOME RES, V10, P1383, DOI 10.1021/pr101154j; Takeshita S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176957; Thompson JC, 2015, J LIPID RES, V56, P286, DOI 10.1194/jlr.M054015; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Ugurlu S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0642-0; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; van den Brand B, 2013, ARTHRITIS RHEUM-US, V65, P283, DOI 10.1002/art.37737; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; von Stemann JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179981; Westermark GT, 2015, ANNU REV PATHOL-MECH, V10, P321, DOI 10.1146/annurev-pathol-020712-163913; Wu KH, 2006, PEDIAT ALLERG IMM-UK, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x; Xu YY, 2006, CLIN CHEM LAB MED, V44, P59, DOI 10.1515/CCLM.2006.012; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320; Zavdy O, AUTOANTIBODIES	87	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195346	10.1371/journal.pone.0195346	http://dx.doi.org/10.1371/journal.pone.0195346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617422	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800077
J	Ronning, SB; Pedersen, ME; Berg, RS; Kirkhus, B; Rodbotten, R				Ronning, Sissel Beate; Pedersen, Mona Elisabeth; Berg, Ragnhild Stenberg; Kirkhus, Bente; Rodbotten, Rune			Vitamin K2 improves proliferation and migration of bovine skeletal muscle cells in vitro	PLOS ONE			English	Article							SATELLITE CELL; BONE; DIFFERENTIATION; LIPOPROTEINS; EXPRESSION; MECHANISM; TRANSPORT; RANKL	Skeletal muscle function is highly dependent on the ability to regenerate, however, during ageing or disease, the proliferative capacity is reduced, leading to loss of muscle function. We have previously demonstrated the presence of vitamin K2 in bovine skeletal muscles, but whether vitamin K has a role in muscle regulation and function is unknown. In this study, we used primary bovine skeletal muscle cells, cultured in monolayers in vitro, to assess a potential effect of vitamin K2 (MK-4) during myogenesis of muscle cells. Cell viability experiments demonstrate that the amount of ATP produced by the cells was unchanged when MK-4 was added, indicating viable cells. Cytotoxicity analysis show that MK-4 reduced the lactate dehydrogenase (LDH) released into the media, suggesting that MK-4 was beneficial to the muscle cells. Cell migration, proliferation and differentiation was characterised after MK-4 incubation using wound scratch analysis, immunocytochemistry and real-time PCR analysis. Adding MK-4 to the cells led to an increased muscle proliferation, increased gene expression of the myogenic transcription factor myod as well as increased cell migration. In addition, we observed a reduction in the fusion index and relative gene expression of muscle differentiation markers, with fewer complex myotubes formed in MK-4 stimulated cells compared to control cells, indicating that the MK-4 plays a significant role during the early phases of muscle proliferation. Likewise, we see the same pattern for the relative gene expression of collagen 1A, showing increased gene expression in proliferating cells, and reduced expression in differentiating cells. Our results also suggest that MK-4 incubation affect low density lipoprotein receptor-related protein 1 (LRP1) and the low-density lipoprotein receptor (LDLR) with a peak in gene expression after 45 min of MK-4 incubation. Altogether, our experiments show that MK-4 has a positive effect on muscle cell migration and proliferation, which are two important steps during early myogenesis.	[Ronning, Sissel Beate; Pedersen, Mona Elisabeth; Berg, Ragnhild Stenberg; Kirkhus, Bente; Rodbotten, Rune] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway	Nofima	Ronning, SB (corresponding author), Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway.	sissel.ronning@nofima.no		Ronning, Sissel Beate/0000-0002-2255-0172; Kirkhus, Bente/0000-0003-2396-8906; Rodbotten, Rune/0000-0003-4775-8954	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council [262300/F40]	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants from the Fund for Research Levy on Agricultural Products in Norway and the Norwegian Research Council, 262300/F40 (https://www.landbruksdirektoratet.no/no/fou-midler/jordbruks-og-matforskning). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Beulens JWJ, 2013, BRIT J NUTR, V110, P1357, DOI 10.1017/S0007114513001013; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Boldrin L, 2010, J HISTOCHEM CYTOCHEM, V58, P941, DOI 10.1369/jhc.2010.956201; Booth SL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5505; Braga M, 2017, ENDOCR CONNECT, V6, P139, DOI 10.1530/EC-17-0008; Brancaccio P, 2010, BIOCH MARKERS MUSCUL; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Bugel S, 2008, VITAM HORM, V78, P393, DOI 10.1016/S0083-6729(07)00016-7; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Dhakshinamoorthy S, 2015, MOL BIOSYST, V11, P2406, DOI 10.1039/c5mb00237k; Gijsbers BLM, 1996, BRIT J NUTR, V76, P223, DOI 10.1079/BJN19960027; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Grober U, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381972.2014.968490; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Kaji H, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.48; Katsuyama H, 2005, INT J MOL MED, V15, P231; Kohlmeier M, 1996, J NUTR, V126, pS1192, DOI 10.1093/jn/126.suppl_4.1192S; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Niemeier A, 2005, J BONE MINER RES, V20, P283, DOI 10.1359/JBMR.041102; Niemeier A, 2008, BONE, V43, P230, DOI 10.1016/j.bone.2008.03.022; Palermo A, 2017, METABOLISM, V70, P57, DOI 10.1016/j.metabol.2017.01.032; Rodbotten R, 2014, MEAT SCI, V97, P49, DOI 10.1016/j.meatsci.2014.01.005; Ronning SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129288; Ronning SB, 2013, DIFFERENTIATION, V86, P13, DOI 10.1016/j.diff.2013.06.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurgers LJ, 2007, BLOOD, V109, P3279, DOI 10.1182/blood-2006-08-040709; Schurgers LJ, 2002, BBA-GEN SUBJECTS, V1570, P27, DOI 10.1016/S0304-4165(02)00147-2; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Tsivitse S, 2010, INT J BIOL SCI, V6, P268; van Ballegooijen AJ, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/7454376; van der Meijden K, 2016, J CELL PHYSIOL, V231, P2517, DOI 10.1002/jcp.25388; Vermeer G, 2000, HEMATOL ONCOL CLIN N, V14, P339, DOI 10.1016/S0889-8588(05)70137-4; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wu WJ, 2015, FOOD FUNCT, V6, P3351, DOI 10.1039/c5fo00544b; Xia JH, 2015, WORLD J CLIN CASES, V3, P757, DOI 10.12998/wjcc.v3.i9.757; Yamaguchi M, 2011, INT J MOL MED, V27, P3, DOI 10.3892/ijmm.2010.562	41	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195432	10.1371/journal.pone.0195432	http://dx.doi.org/10.1371/journal.pone.0195432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617432	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800086
J	da Silva, CF; Hare, TA				da Silva, Carolina Feher; Hare, Todd A.			A note on the analysis of two-stage task results: How changes in task structure affect what model-free and model-based strategies predict about the effects of reward and transition on the stay probability	PLOS ONE			English	Article							PROTECTS; CHOICES	Many studies that aim to detect model-free and model-based influences on behavior employ two-stage behavioral tasks of the type pioneered by Daw and colleagues in 2011. Such studies commonly modify existing two-stage decision paradigms in order to better address a given hypothesis, which is an important means of scientific progress. It is, however, critical to fully appreciate the impact of any modified or novel experimental design features on the expected results. Here, we use two concrete examples to demonstrate that relatively small changes in the two-stage task design can substantially change the pattern of actions taken by model-free and model-based agents as a function of the reward outcomes and transitions on previous trials. In the first, we show that, under specific conditions, purely model-free agents will produce the reward by transition interactions typically thought to characterize model-based behavior on a two-stage task. The second example shows that model-based agents' behavior is driven by a main effect of transition-type in addition to the canonical reward by transition interaction whenever the reward probabilities of the final states do not sum to one. Together, these examples emphasize the task-dependence of model-free and model-based behavior and highlight the benefits of using computer simulations to determine what pattern of results to expect from both model-free and model-based agents performing a given two-stage decision task in order to design choice paradigms and analysis strategies best suited to the current question.	[da Silva, Carolina Feher; Hare, Todd A.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Hare, Todd A.] Univ Zurich, Zurich Ctr Neurosci, Zurich, Switzerland; [Hare, Todd A.] ETH, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	da Silva, CF (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland.	carolina.feherdasilva@econ.uzh.ch	Feher da Silva, Carolina/GVS-8900-2022; Hare, Todd/E-7091-2017	Feher da Silva, Carolina/0000-0002-4137-0847; Hare, Todd/0000-0002-0260-2772	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [88881.119317/2016-01]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CFS received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), http://capes.gov.br/, grant number 88881.119317/2016-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cushman F, 2015, P NATL ACAD SCI USA, V112, P13817, DOI 10.1073/pnas.1506367112; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Deserno L, 2015, P NATL ACAD SCI USA, V112, P1595, DOI 10.1073/pnas.1417219112; Dezfouli A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003364; Doll BB, 2015, NAT NEUROSCI, V18, P767, DOI 10.1038/nn.3981; Eppinger B, 2013, FRONTIERS NEUROSCIEN, V7; Gillan CM, 2015, COGN AFFECT BEHAV NE, V15, P523, DOI 10.3758/s13415-015-0347-6; Kool W, 2017, PSYCHOL SCI; Kool W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005090; Miller KJ, 2016, BIORXIV, P14; Morris LS, 2017, CORTEX, V88, P143, DOI 10.1016/j.cortex.2016.12.018; Otto AR, 2015, J COGNITIVE NEUROSCI, V27, P319, DOI 10.1162/jocn_a_00709; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Sebold M, 2014, NEUROPSYCHOBIOLOGY, V70, P122, DOI 10.1159/000362840; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Voon V, 2015, MOL PSYCHIATR, V20, P345, DOI 10.1038/mp.2014.44; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195328	10.1371/journal.pone.0195328	http://dx.doi.org/10.1371/journal.pone.0195328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614130	Green Accepted, Green Published, gold			2022-12-27	WOS:000429081600048
J	Feodorova, VA; Konnova, SS; Saltykov, YV; Zaitsev, SS; Subbotina, IA; Polyanina, TI; Ulyanov, SS; Lamers, SL; Gaydos, CA; Quinn, TC; Motin, VL				Feodorova, Valentina A.; Konnova, Svetlana S.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.; Lamers, Susanna L.; Gaydos, Charlotte A.; Quinn, Thomas C.; Motin, Vladimir L.			Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; STRAINS; IDENTIFICATION; EPIDEMIOLOGY; PREVALENCE; GENOTYPES; SWEDISH; ASSAY; MEN; DNA	Background This is the first report to characterize the prevalence and genovar distribution of genital chlamydial infections among random heterosexual patients in the multi-ethnic Saratov Region, located in Southeast Russia. Methods Sixty-one clinical samples (cervical or urethral swabs) collected from a random cohort of 856 patients (7.1%) were C. trachomatis (CT) positive in commercial nucleic acid amplification tests (NAATs) and duplex TaqMan PCRs. Results Sequence analysis of the VDII region of the ompA gene revealed seven genovars of C. trachomatis in PCR-positive patients. The overall genovars were distributed as E (41.9%), G (21.6%), F (13.5%), K (9.5%), D (6.8%), J (4.1%), and H (2.7%). CT-positive samples were from males (n = 12, 19.7%), females (n = 42, 68.8%), and anonymous (n = 7, 11.5%) patients, with an age range of 19 to 45 years (average 26.4), including 12 different ethnic groups representative of this region. Most patients were infected with a single genovar (82%), while 18% were co-infected with either two or three genovars. The 1156 bp-fragment of the ompA gene was sequenced in 46 samples to determine single nucleotide polymorphisms (SNP) among isolates. SNP-based subtyping and phylogenetic reconstruction revealed the presence of 13 variants of the ompA gene, such as E (E1, E2, E6), G (G1, G2, G3, G5), F1, K, D (D1, Da2), J1, and H2. Differing genovar distribution was identified among urban (E>G>F) and rural (E>K) populations, and in Slavic (E>G>D) and non-Slavic (E>G>K) ethnic groups. Multilocus sequence typing (MLST) determined five sequences types (STs), such as ST4 (56%, 95% confidence interval, CI, 70.0 to 41.3), ST6 (10%, 95% CI 21.8 to 3.3), ST9 (22%, 95% CI 35.9 to 11.5), ST10 (2%, 95% CI 10.7 to 0.05) and ST38 (10%, 95% CI 21.8 to 3.3). Thus, the most common STs were ST4 and ST9. Conclusion C. trachomatis is a significant cause of morbidity among random heterosexual patients with genital chlamydial infections in the Saratov Region. Further studies should extend this investigation by describing trends in a larger population, both inside and outside of the Saratov Region to clarify some aspects for the actual application of C. trachomatis genotype analysis for disease control.	[Feodorova, Valentina A.; Konnova, Svetlana S.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.] Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol Chlamydia, Pokrov, Vladimir Region, Russia; [Feodorova, Valentina A.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.] Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol & NanoBiotechnol, Branch Saratov, Saratov, Russia; [Feodorova, Valentina A.; Saltykov, Yury V.; Subbotina, Irina A.] SSAU, Dept Microbiol Biotechnol & Chem, Saratov, Russia; [Ulyanov, Sergey S.] SSU, Dept Med Phys, Saratov, Russia; [Lamers, Susanna L.] Bioinfoexperts LLC, Thibodaux, Los Angeles, CA USA; [Gaydos, Charlotte A.; Quinn, Thomas C.] Johns Hopkins Univ, Div Infect Dis, Sch Med JHUScM, Baltimore, MD USA; [Quinn, Thomas C.] NIAID, Div Intramural Res, Baltimore, MD USA; [Motin, Vladimir L.] UTMB, Dept Microbiol & Immunol, Dept Pathol, Galveston, TX 77555 USA	Saratov State University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Medical Branch Galveston	Feodorova, VA (corresponding author), Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol Chlamydia, Pokrov, Vladimir Region, Russia.; Feodorova, VA (corresponding author), Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol & NanoBiotechnol, Branch Saratov, Saratov, Russia.; Feodorova, VA (corresponding author), SSAU, Dept Microbiol Biotechnol & Chem, Saratov, Russia.; Motin, VL (corresponding author), UTMB, Dept Microbiol & Immunol, Dept Pathol, Galveston, TX 77555 USA.	feodorovav@mail.ru; vlmotin@utmb.edu	Zaitsev, Sergey/G-8735-2018; Saltykov, Yury/O-6816-2017; Motin, Vladimir L/O-1535-2013; Feodorova, Valentina A/F-7545-2014; Konnova, Svetlana/D-3799-2016; Gaydos, Charlotte A./E-9937-2010; Subbotina, Irina/AHD-7481-2022; Polyanina, Tatiana/N-7068-2016	Zaitsev, Sergey/0000-0002-1373-8229; Saltykov, Yury/0000-0001-8163-1979; Feodorova, Valentina A/0000-0002-3827-407X; Konnova, Svetlana/0000-0003-1282-7980; Motin, Vladimir/0000-0002-4762-457X; Polyanina, Tatiana/0000-0003-1448-5785	Russian Science Foundation [17-16-01099]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, USA; BioInfoExperts LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000358, ZIAAI000361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, USA; BioInfoExperts LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Russian Science Foundation, Project No. 17-16-01099 (for Prof. V.A. Feodorova) and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, 21205, USA (for Prof. T.C. Quinn). BioInfoExperts LLC provided financial support in the form of a salary for S.L. Lamers. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsamed H, 2013, FUTURE MICROBIOL, V8, P1129, DOI 10.2217/fmb.13.80; Bax CJ, 2011, SEX TRANSM INFECT, V87, P503, DOI 10.1136/sti.2010.048173; Bilozorova OA, 2010, J VN KARAZIN KHARK B, V11, P55; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Chiaradonna C, 2008, J PEDIATR ADOL GYNEC, V21, P233, DOI 10.1016/j.jpag.2007.10.005; Dahlberg J, 2018, SEX TRANSM INFECT, V94, P100, DOI 10.1136/sextrans-2016-052992; DEAN D, 1995, J INFECT DIS, V172, P1013, DOI 10.1093/infdis/172.4.1013; EFREMENKO A A, 1956, Vestn Oftalmol, V69, P94; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Fedorova V. A., 2010, Klinicheskaya Laboratornaya Diagnostika, P45; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Giffard PM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009624; Gravningen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034452; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; IBRAGIMOV NG, 1978, VESTN OFTALMOL, P77; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Kese D, 2011, FEMS IMMUNOL MED MIC, V63, P210, DOI 10.1111/j.1574-695X.2011.00843.x; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Morre SA, 2000, J CLIN MICROBIOL, V38, P2292; Nunes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013171; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Papadogeorgakis H, 2010, J CLIN MICROBIOL, V48, P2231, DOI 10.1128/JCM.00586-10; Quint KD, 2007, J MOL DIAGN, V9, P631, DOI 10.2353/jmoldx.2007.070011; Sharkeev VI, 2005, B EXP BIOL MED+, V140, P222, DOI 10.1007/s10517-005-0451-7; Shipitsyna E, 2012, ACTA DERM-VENEREOL, V92, P330, DOI 10.2340/00015555-1269; Smelov V, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02195; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Tikhomirov AL, 2007, UROGENITAL CHLAMYDIO, P55; WANG SP, 1970, AM J OPHTHALMOL, V70, P367, DOI 10.1016/0002-9394(70)90096-6; Ward H, 2009, SEX TRANSM INFECT, V85, P173, DOI 10.1136/sti.2008.035311	38	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195386	10.1371/journal.pone.0195386	http://dx.doi.org/10.1371/journal.pone.0195386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641543	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900068
J	Gustafsson, MK; Romundstad, PR; Stafne, SN; Helvik, AS; Stunes, AK; Morkved, S; Salvesen, KA; Thorsby, PM; Syversen, U				Gustafsson, Miriam K.; Romundstad, Pal R.; Stafne, Signe Nilssen; Helvik, Anne-Sofie; Stunes, Astrid Kamilla; Morkved, Siv; Salvesen, Kjell Asmund; Thorsby, Per Medboe; Syversen, Unni			Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women	PLOS ONE			English	Article							D-BINDING PROTEIN; D SUPPLEMENTATION; D DEFICIENCY; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; NEONATAL OUTCOMES; TOTAL 25(OH)D; FETAL; SERUM; LACTATION	To ensure optimal calcium accrual in the fetal skeleton, a substantial rise occurs in 1,25-dihydroxyvitamin D (1,25(OH)(2)D), but is dependent on sufficient 25-hydroxyvitamin (25(OH)D). Large longitudinal studies addressing free 25(OH) D and 1,25(OH)(2)D during pregnancy are scarce. We aimed to assess levels of and relationship between 25(OH) D, 1,25(OH)(2)D, vitamin D-binding protein (DBP), parathyroid hormone (PTH), and free 25(OH) D during pregnancy; determinants of vitamin D status; and association between vitamin D indices or PTH and pregnancy outcomes (gestational diabetes mellitus and birthweight). Altogether 855 pregnant Norwegian Caucasian women from Trondheim and Stavanger (latitude 63 degrees N and 58 degrees N) were recruited; 94 were lost to follow-up. The study was originally a randomized controlled trial (2007-2009)with gestational diabetes as primary outcome. Data were collected in second and third trimester. In third trimester, 246 (34%) had vitamin D insufficiency and 52 (7%) deficiency (25(OH) D < 50 and <30nmol/L, respectively). During wintertime in third trimester, 61 (47%) from Trondheim and 23 (51%) from Stavanger exhibited vitamin D insufficiency. PTH was elevated in 27 (3.7%). Estimate of change between trimesters was (95% CI): 25(OH)D -1.8 (-2.8 to -0.7) nmol/L, DBP 0.62 (0.57 to 0.66) mu mol/L, calculated free 25(OH) D -1.7 (-2.0 to -1.4) pmol/L, PTH 0.81 (0.72 to 0.90) pmol/L, 1,25(OH)(2)D (subanalysis) 31.4 (CI 24.7 to 38.2) pmol/L. A decrease in 1,25(OH)(2)D occurred in 45% of those with vitamin D deficiency, and they also exhibited lower levels than women with adequate vitamin D status. No association of vitamin D indices and PTH with pregnancy outcomes was observed. Women in Trondheim displayed lower 25(OH) D levels, despite minor latitudinal differences. Less than one-fifth adhered to the authorities' vitamin D recommendations. These findings demonstrate that hypovitaminosis D is prevalent among pregnant women living in northern latitudes, especially during the dark season, and there is an unmet need to ensure adequate vitamin D intake.	[Gustafsson, Miriam K.; Romundstad, Pal R.; Stafne, Signe Nilssen; Helvik, Anne-Sofie; Morkved, Siv] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [Gustafsson, Miriam K.] St Olays Hosp, Trondheim Univ Hosp, Div Mental Hlth Care, Trondheim, Norway; [Stafne, Signe Nilssen] St Olays Hosp, Trondheim Univ Hosp, Clin Clin Serv, Trondheim, Norway; [Stunes, Astrid Kamilla; Salvesen, Kjell Asmund; Syversen, Unni] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Stunes, Astrid Kamilla; Morkved, Siv] St Olays Hosp, Trondheim Univ Hosp, Trondheim, Norway; [Salvesen, Kjell Asmund] St Olays Hosp, Trondheim Univ Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Thorsby, Per Medboe] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Syversen, Unni] St Olays Hosp, Trondheim Univ Hosp, Dept Endocrinol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; Norwegian University of Science & Technology (NTNU)	Gustafsson, MK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway.; Gustafsson, MK (corresponding author), St Olays Hosp, Trondheim Univ Hosp, Div Mental Hlth Care, Trondheim, Norway.	miriam.gustafsson@ntnu.no	Thorsby, Per Medbøe/A-1268-2017; Stunes, Astrid Kamilla/B-9901-2008; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Thorsby, Per Medbøe/0000-0002-9615-1035; Stunes, Astrid Kamilla/0000-0003-1074-5199; Gustafsson, Miriam K./0000-0003-4151-393X	Liaison Committee	Liaison Committee	The study was supported by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	AGHAJAFARI F, 2013, BMJ CLIN RES ED, V346, DOI DOI 10.1136/BMJ.F1169; Aloia J, 2015, J CLIN ENDOCR METAB, V100, P3356, DOI 10.1210/JC.2015-2066; Andersen LF, 2005, BRIT J NUTR, V93, P519, DOI 10.1079/BJN20041381; Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921; Awad AB, 2012, CRIT REV FOOD SCI, V52, P103, DOI 10.1080/10408391003785458; Baird J, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5010014; Barebring L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152198; Bikle D, 2017, J STEROID BIOCHEM, V173, P105, DOI 10.1016/j.jsbmb.2017.01.007; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bouillon R, 2016, J BONE MINER RES, V31, P1124, DOI 10.1002/jbmr.2871; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Brembeck P, 2013, BRIT J NUTR, V110, P856, DOI 10.1017/S0007114512005855; Cooper C, 2016, LANCET DIABETES ENDO, V4, P393, DOI 10.1016/S2213-8587(16)00044-9; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Elder CJ, 2014, LANCET, V383, P1665, DOI 10.1016/S0140-6736(13)61650-5; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Gezmish O, 2013, J CARDIOVASC TRANSL, V6, P588, DOI 10.1007/s12265-013-9475-y; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Haggarty P, 2013, BRIT J NUTR, V109, P898, DOI 10.1017/S0007114512002255; Hart PH, 2015, PEDIATRICS, V135, pE167, DOI 10.1542/peds.2014-1860; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Helsedirektoratet, KOSTH GRAV GRAV FODS; Herrmann M, 2017, CLIN CHEM LAB MED, V55, P3, DOI 10.1515/cclm-2016-0264; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.30; Hollis BW, 2017, MOL CELL ENDOCRINOL, V453, P113, DOI 10.1016/j.mce.2017.01.039; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Johansson L, 1999, 2199984 NORW STAT CO; Karlsson T, 2015, CLIN NUTR, V34, P892, DOI 10.1016/j.clnu.2014.09.012; Karras SN, 2016, THER ADV MUSCULOSKEL, V8, P124, DOI 10.1177/1759720X16656810; Kim HJ, 2017, ANN LAB MED, V37, P34, DOI 10.3343/alm.2017.37.1.34; Kothari P., 2015, DATA ANAL STATA; Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S, DOI 10.1093/ajcn/88.2.520S; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kramer CK, 2016, J CLIN ENDOCR METAB, V101, P1729, DOI 10.1210/jc.2015-4060; Kramer CK, 2014, J CLIN ENDOCR METAB, V99, P4506, DOI 10.1210/jc.2014-2341; Lawlor DA, 2013, LANCET, V382, P684; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150385; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; Minisola S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2723; Moon RJ, 2015, EUR J ENDOCRINOL, V173, pR69, DOI 10.1530/EJE-14-0826; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Nordic Council of Ministers, 2014, NORDIC NUTR RECOMMEN, V5th, DOI [10.6027/Nord2014-002, DOI 10.6027/NORD2014-002]; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Papapetrou PD, 2010, HORM-INT J ENDOCRINO, V9, P136, DOI 10.14310/horm.2002.1263; PEARCE SHS, 2010, BMJ CLIN RES ED, V340, DOI DOI 10.1136/BMJ.B5664; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Schwartz JB, 2014, J CLIN ENDOCR METAB, V99, P1631, DOI 10.1210/jc.2013-3874; Sollid ST, 2016, EUR J ENDOCRINOL, V174, P445, DOI 10.1530/EJE-15-1089; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; VERHAEGHE J, 1992, J STEROID BIOCHEM, V41, P469, DOI 10.1016/0960-0760(92)90372-P; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x; Zhang JY, 2014, BRIT J NUTR, V112, P1081, DOI 10.1017/S0007114514001883; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	66	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195041	10.1371/journal.pone.0195041	http://dx.doi.org/10.1371/journal.pone.0195041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641551	gold, Green Submitted, Green Published			2022-12-27	WOS:000429742900059
J	Wang, J; Hilchey, SP; DeDiego, M; Perry, S; Hyrien, O; Nogales, A; Garigen, J; Amanat, F; Huertas, N; Krammer, F; Martinez-Sobrido, L; Topham, DJ; Treanor, JJ; Sangster, MY; Zand, MS				Wang, Jiong; Hilchey, Shannon P.; DeDiego, Marta; Perry, Sheldon; Hyrien, Ollivier; Nogales, Aitor; Garigen, Jessica; Amanat, Fatima; Huertas, Nelson; Krammer, Florian; Martinez-Sobrido, Luis; Topham, David J.; Treanor, John J.; Sangster, Mark Y.; Zand, Martin S.			Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice	PLOS ONE			English	Article							A VIRUS-INFECTION; HETEROSUBTYPIC IMMUNITY; CONSTRUCTS PROTECT; MF59 ADJUVANT; B-CELLS; ANTIBODY; MEMORY; NEUTRALIZATION; INDUCTION; A(H3N2)	Annual immunization against influenza virus is a large international public health effort. Accumulating evidence suggests that antibody mediated cross-reactive immunity against influenza hemagglutinin (HA) strongly correlates with long-lasting cross-protection against influenza virus strains that differ from the primary infection or vaccination strain. However, the optimal strategies for achieving highly cross-reactive antibodies to the influenza virus HA have not yet to be defined. In the current study, using Luminex-based mPlex-Flu assay, developed by our laboratory, to quantitatively measure influenza specific IgG antibody mediated cross-reactivity, we found that prime-boost-boost vaccination of ferrets with rHA proteins admixed with adjuvant elicited higher magnitude and broader cross-reactive antibody responses than that induced by actual influenza viral infection, and this cross-reactive response likely correlated with increased anti-stalk reactive antibodies. We observed a similar phenomenon in mice receiving three sequential vaccinations with rHA proteins from either A/California/07/2009 (H1N1) or A/Hong Kong/1/1968 (H3N2) viruses admixed with Addavax, an MF59-like adjuvant. Using this same mouse vaccination model, we determined that Addavax plays a more significant role in the initial priming event than in subsequent boosts. We also characterized the generation of cross-reactive antibody secreting cells (ASCs) and memory B cells (MBCs) when comparing vaccination to viral infection. We have also found that adjuvant plays a critical role in the generation of long-lived ASCs and MBCs cross-reactive to influenza viruses as a result of vaccination with rHA of influenza virus, and the observed increase in stalk-reactive antibodies likely contributes to this IgG mediated broad cross-reactivity.	[Wang, Jiong; Hilchey, Shannon P.; Perry, Sheldon; Garigen, Jessica; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [DeDiego, Marta] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Hyrien, Ollivier; Nogales, Aitor; Martinez-Sobrido, Luis; Topham, David J.; Sangster, Mark Y.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Biostat Bioinformat & Epidemiol Program, 1124 Columbia St, Seattle, WA 98104 USA; [Amanat, Fatima; Huertas, Nelson] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Treanor, John J.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA; [Zand, Martin S.] Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Fred Hutchinson Cancer Center; University of Rochester; Icahn School of Medicine at Mount Sinai; University of Rochester; University of Rochester	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA.	Martin_zand@urmc.rochester.edu	Krammer, Florian/H-3237-2019; NOGALES, AITOR/AAY-1590-2020; DeDiego, Marta L./B-2307-2017	Krammer, Florian/0000-0003-4121-776X; NOGALES, AITOR/0000-0002-2424-7900; Sangster, Mark/0000-0002-1599-5894; Wang, Jiong/0000-0002-4938-5074; DeDiego, Marta L./0000-0002-7888-7372; Martinez-Sobrido, Luis/0000-0001-7084-0804	National Institutes of Health, National Institutes of Allergy and Infectious Diseases [HHSN272201000055C, AI098112, AI069351, R21AI138500, HHSN272201400008C, AI109946]; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129518, R21AI138500, U19AI109946] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, including: HHSN272201000055C, AI098112, and AI069351 (MZ, JW, SH, OH, SP, JG, NH), R21AI138500 (MZ, JW, JG), HHSN272201400008C and AI109946(FC, FA). The project described in this publication was also supported by the University of Rochester CTSA award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (MZ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of the above funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, including: HHSN272201000055C, AI098112, and A1069351 (MZ, JW, SH, OH, SP, JG, NH), R21AI138500 (MZ, JW, JG), HHSN272201400008C and AI109946(FC, FA). The project described in this publication was also supported by the University of Rochester CTSA award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (MZ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of the above funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Clark AM, 2017, J VIROL, V91, DOI 10.1128/JVI.00721-17; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cortina-Ceballos B, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0239-y; DeDiego ML, 2016, IMMUNOLOGY, V148, P160, DOI 10.1111/imm.12594; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Epstein SL, 1997, J IMMUNOL, V158, P1222; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fragapane E, 2010, CLIN VACCINE IMMUNOL, V17, P1817, DOI 10.1128/CVI.00461-09; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Goff PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079194; Guo HL, 2014, J VIROL, V88, P12006, DOI 10.1128/JVI.01847-14; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; He XS, 2011, J IMMUNOL METHODS, V365, P67, DOI 10.1016/j.jim.2010.12.008; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Khurana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095496; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Krammer F, 2016, CURR OPIN VIROL, V17, P95, DOI 10.1016/j.coviro.2016.02.002; Krammer F, 2014, J VIROL, V88, P2340, DOI 10.1128/JVI.03183-13; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Laurie KL, 2015, CLIN VACCINE IMMUNOL, V22, P957, DOI 10.1128/CVI.00278-15; Linderman SL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005806; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Molenberghs G, 2000, LINEAR MIXED MODELS; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/erv.11.23, 10.1586/ERV.11.23]; Park MS, 2016, IMMUNE NETW, V16, P261, DOI 10.4110/in.2016.16.5.261; Pica N, 2012, J VIROL, V86, P10293, DOI 10.1128/JVI.01131-12; Quataert SA, 2004, CLIN DIAGN LAB IMMUN, V11, P1064, DOI 10.1128/CDLI.11.6.1064-1069.2004; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sliepen K, 2015, J BIOL CHEM, V290, P7436, DOI 10.1074/jbc.M114.620534; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129858; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zand Martin S, 2015, Math J, V17	56	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193680	10.1371/journal.pone.0193680	http://dx.doi.org/10.1371/journal.pone.0193680			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641537	Green Published, gold			2022-12-27	WOS:000429742900015
J	Abu-Lafi, S; Makhamra, S; Rayan, I; Barriah, W; Nasser, A; Abu Farkh, B; Rayan, A				Abu-Lafi, Saleh; Makhamra, Sadam; Rayan, Ibrahim; Barriah, Waseim; Nasser, Ahmed; Abu Farkh, Basheer; Rayan, Anwar			Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications	PLOS ONE			English	Article							CANCER-CELLS; RECEPTOR; LIGNAN; L.	The aim of this study is to disclose the potential bioactive components of Cuscuta palaestina, a native parasitic natural plant of flora palaestina and to open direction towards new prospective application. GC-MS analysis identified 18 components in the methanolic extract of C. palaestina for the first time. The most appealing among them are Sesamin and two other phytosterols (Campesterol and Stigmasterol), all of which are documented in the scientific literature for their anticancer activity. Quantitation of Sesamin extracted from C. palaestina by HPLC-PDA with the use of three organic solvents showed that the Sesamin content in the methanolic extract was the highest. Following the disclosure of Sesamin presence in C. palaestina, we raised the question of whether it is produced naturally in C. palaestina or acquired from the host plant. The quantitation of Sesamin in C. palaestina was performed while being with five different host plants, and was compared with the amount of Sesamin in C. palaestina grown alone. The findings reveal that Sesamin is an endogenous secondary metabolite in C. palaestina. Thus, further studies are required to prove if C. palaestina can be used as an alternative source of anticancer phytochemicals, mainly Sesamin, and if proteins in the Sesamin production pathway could be valid biological targets for the development of novel and selective pesticides for control/eradication of C. palaestina and maybe some other Cuscuta species. As well, the findings from this study raise a big question of whether inferring Sesamin production in C. palaestina could reduce its attack ability to host plants.	[Abu-Lafi, Saleh] Al Quds Univ, Fac Pharm, Abu Dies, Palestine; [Makhamra, Sadam] Al Quds Univ, Fac Sci & Technol, Chem Dept, Abu Dies, Palestine; [Rayan, Ibrahim; Rayan, Anwar] Inst Appl Res Galilee Soc, Shefa Amr, Israel; [Barriah, Waseim; Rayan, Anwar] Al Qasemi Coll Engn & Sci, Baka El Garbiah, Israel; [Nasser, Ahmed] ARO, Volcani Ctr, Interinst Analyt Instrumentat Unit, Rishon Leziyyon, Israel; [Abu Farkh, Basheer; Rayan, Anwar] Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Rayan, A (corresponding author), Inst Appl Res Galilee Soc, Shefa Amr, Israel.; Rayan, A (corresponding author), Al Qasemi Coll Engn & Sci, Baka El Garbiah, Israel.; Rayan, A (corresponding author), Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel.	a_rayan@qsm.ac.il		Rayan, Anwar/0000-0001-8255-5947	Al-Qasemi Academic College; Institute of Applied Research Galilee Society	Al-Qasemi Academic College; Institute of Applied Research Galilee Society	This study was supported by unrestricted grants from Al-Qasemi Academic College and the Institute of Applied Research Galilee Society. The authors acknowledge the Ministry of Science, Space and Technology. The authors declare that the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2015, DRUG DES DEV THER, V9, P2793, DOI 10.2147/DDDT.S83514; Aswad M, 2018, INFLAMM RES, V67, P67, DOI 10.1007/s00011-017-1096-5; Choi JM, 2007, PHYTOTHER RES, V21, P954, DOI 10.1002/ptr.2189; FARNSWORTH NR, 1985, B WORLD HEALTH ORGAN, V63, P965; Frank A, 2017, INFLAMM RES, V66, P923, DOI 10.1007/s00011-017-1075-x; Ide T, 2013, EUR J NUTR, V52, P1015, DOI 10.1007/s00394-012-0408-3; Kacergius T, 2017, MOL MED REP, V16, P949, DOI 10.3892/mmr.2017.6674; Khosravi-Boroujeni H, 2017, J SCI FOOD AGR, V97, P3087, DOI 10.1002/jsfa.8361; Lee CC, 2011, INFLAMMATION, V34, P209, DOI 10.1007/s10753-010-9226-z; Pappalardo M, 2017, MOL INFORM, V36, DOI 10.1002/minf.201700014; Pappalardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109340; Qadir A, 2018, DRUG RES, V68, P344, DOI 10.1055/s-0043-123466; Rayan A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187925; Saeed M, 2014, PHYTOMEDICINE, V21, P689, DOI 10.1016/j.phymed.2014.01.006; Shahaf N, 2016, MOL INFORM, V35, P414, DOI 10.1002/minf.201501029; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; Verpoorte R, 2000, J PHARM PHARMACOL, V52, P253, DOI 10.1211/0022357001773931; Xu PY, 2015, ONCOL REP, V33, P3117, DOI 10.3892/or.2015.3888; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x; Zaid H, 2016, FRONT BIOSCI-LANDMRK, V21, P597, DOI 10.2741/4409; Zeidan M, 2017, MOLECULES, V22, DOI 10.3390/molecules22091563	21	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195707	10.1371/journal.pone.0195707	http://dx.doi.org/10.1371/journal.pone.0195707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634770	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200049
J	Brown, WE; Huey, DJ; Hu, JC; Athanasiou, KA				Brown, Wendy E.; Huey, Daniel J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Functional self-assembled neocartilage as part of a biphasic osteochondral construct	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CERAMICS; MARROW STROMAL CELLS; INTERFACIAL SHEAR-STRENGTH; IN-VITRO GENERATION; BIOMECHANICAL PROPERTIES; ARTICULAR-CARTILAGE; BONE; REPAIR; TISSUE; SCAFFOLDS	Bone-to-bone integration can be obtained by osteoconductive ceramics such as hydroxyapatite (HAp) and beta-tricalcium phosphate ((beta-TCP), but cartilage-to-cartilage integration is notoriously difficult. Many cartilage repair therapies, including microfracture and mosaicplasty, capitalize on the reparative aspects of subchondral bone due to its resident population of stem cells and vascularity. A strategy of incorporating tissue engineered neocartilage into a ceramic to form an osteochondral construct may serve as a suitable alternative to achieve cartilage graft fixation. The use of a tissue engineered osteochondral construct to repair cartilage defects may also benefit from the ceramic's proximity to underlying bone and abundant supply of progenitor cells and nutrients. The objective of the first study was to compare HAp and beta-TCP ceramics, two widely used ceramics in bone regeneration, in terms of their ability to influence neocartilage interdigitation at an engineered osteochondral interface. Additional assays quantified ceramic pore size, porosity, and compressive strength. The compressive strength of HAp was six times higher than that of beta-TCP due to differences in porosity and pore size, and HAp was thus carried forward in the second study as the composition with which to engineer an osteochondral construct. Importantly, it was shown that incorporation of the HAp ceramic in conjunction with the self-assembling process resulted in functionally viable neocartilage. For example, only collagen/dry weight and ultimate tensile strength of the chondral control constructs remained significantly greater than the neocartilage cut off the osteochondral constructs. By demonstrating that the functional properties of engineered neocartilage are not negatively affected by the inclusion of an HAp ceramic in culture, neocartilage engineering strategies may be directly applied to the formation of an osteochondral construct.	[Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Huey, Daniel J.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Huey, Daniel J.] Genentech Inc, Vacaville, CA USA	University of California System; University of California Irvine; University of California System; University of California Davis; Roche Holding; Genentech	Athanasiou, KA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	athens@uci.edu			National Institutes of Health [R01 AR067821]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 AR067821 (https://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI [10.1089/ten.tea.2008.0511, 10.1089/ten.TEA.2008.0511]; Arzi B, 2015, ACTA BIOMATER, V23, P72, DOI 10.1016/j.actbio.2015.05.025; ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254; Athanasiou KA., 2017, ARTICULAR CARTILAGE; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-15242, 10.1146/annurev-bioeng-071812-152423]; Bae WC, 2008, OSTEOARTHR CARTILAGE, V16, P841, DOI 10.1016/j.joca.2007.11.015; Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037; Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/jbm.a.30990; Bohner M, 2000, INJURY, V31, pS37; Brand Richard A, 2005, Iowa Orthop J, V25, P82; Buckwalter J A, 2003, Iowa Orthop J, V23, P66; BUCKWALTER JA, 1990, BRIS MYER Z, P19; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P294, DOI 10.1002/term.1716; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P284, DOI 10.1002/term.1708; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Davies LC, 2008, OSTEOARTHR CARTILAGE, V16, P855, DOI 10.1016/j.joca.2007.12.005; Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018; Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997; GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6; Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830; Hamilton DJ, 2006, BIOMATERIALS, V27, P397, DOI 10.1016/j.biomaterials.2005.07.007; Hu JC, 2006, CONNECT TISSUE RES, V47, P133, DOI 10.1080/03008200600685392; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Lee JK, 2016, TISSUE ENG PT A, V22, P318, DOI [10.1089/ten.tea.2015.0491, 10.1089/ten.TEA.2015.0491]; Lee JK, NATURE MAT IN PRESS; Lee WD, 2015, OSTEOARTHR CARTILAGE, V23, P1307, DOI 10.1016/j.joca.2015.04.010; MacBarb RE, 2013, BIOMATERIALS, V34, P9980, DOI 10.1016/j.biomaterials.2013.09.026; Makris EA, 2013, FASEB J, V27, P2421, DOI 10.1096/fj.12-224030; Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040; Murphy MK, 2015, CELL TRANSPLANT, V24, P235, DOI 10.3727/096368913X676204; Murphy MK, 2013, INT J ORAL MAX IMPL, V28, pE393, DOI 10.11607/jomi.te20; Nehrer S, 1999, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199908000-00020; Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1; Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022; Wang YC, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-80; Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7; Zhang WJ, 2015, MAT SCI ENG C-MATER, V46, P10, DOI 10.1016/j.msec.2014.09.042	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195261	10.1371/journal.pone.0195261	http://dx.doi.org/10.1371/journal.pone.0195261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634740	gold, Green Published			2022-12-27	WOS:000429522200026
J	Torstensson, A; Fransson, A; Currie, K; Wulff, A; Chierici, M				Torstensson, Anders; Fransson, Agneta; Currie, Kim; Wulff, Angela; Chierici, Melissa			Microalgal photophysiology and macronutrient distribution in summer sea ice in the Amundsen and Ross Seas, Antarctica	PLOS ONE			English	Article							PHOTOSYNTHESIS-IRRADIANCE RELATIONSHIPS; M-CRESOL PURPLE; MICROBIAL COMMUNITIES; PACK ICE; MCMURDO SOUND; CARBONIC-ACID; ALGAE; SEAWATER; GROWTH; LIGHT	Our study addresses how environmental variables, such as macronutrients concentrations, snow cover, carbonate chemistry and salinity affect the photophysiology and biomass of Antarctic sea-ice algae. We have measured vertical profiles of inorganic macronutrients (phosphate, nitrite + nitrate and silicic acid) in summer sea ice and photophysiology of ice algal assemblages in the poorly studied Amundsen and Ross Seas sectors of the Southern Ocean. Brine-scaled bacterial abundance, chl a and macronutrient concentrations were often high in the ice and positively correlated with each other. Analysis of photosystem II rapid light curves showed that microalgal cells in samples with high phosphate and nitrite + nitrate concentrations had reduced maximum relative electron transport rate and photosynthetic efficiency. We also observed strong couplings of PSII parameters to snow depth, ice thickness and brine salinity, which highlights a wide range of photoacclimation in Antarctic pack-ice algae. It is likely that the pack ice was in a post-bloom situation during the late sea ice season, with low photosynthetic efficiency and a high degree of nutrient accumulation occurring in the ice. In order to predict how key biogeochemical processes are affected by future changes in sea ice cover, such as in situ photosynthesis and nutrient cycling, we need to understand how physicochemical properties of sea ice affect the microbial community. Our results support existing hypothesis about sea-ice algal photophysiology, and provide additional observations on high nutrient concentrations in sea ice that could influence the planktonic communities as the ice is retreating.	[Torstensson, Anders; Wulff, Angela] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fransson, Agneta] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Fransson, Agneta] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Currie, Kim] Univ Otago, Res Ctr Oceanog, Natl Inst Water & Atmospher Res Ltd NIWA, Dunedin, New Zealand; [Chierici, Melissa] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Chierici, Melissa] Inst Marine Res, Tromso, Norway; [Torstensson, Anders] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Gothenburg; Norwegian Polar Institute; University of Gothenburg; University of Otago; University of Gothenburg; Institute of Marine Research - Norway; University of Washington; University of Washington Seattle	Torstensson, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.; Torstensson, A (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	andtor@uw.edu		Torstensson, Anders/0000-0002-8283-656X	Swedish Research Council [2007-8365, 2008-6228, 2009-2994]; Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment	Swedish Research Council(Swedish Research CouncilEuropean Commission); Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment	This project was funded by the Swedish Research Council (www.vr.se), grant numbers 2007-8365 (MC), 2008-6228 (AF) and 2009-2994 (MC). The study was partly financed by the Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; [Anonymous], 2021, LANG ENV STAT COMP; Arrigo Kevin R., 2014, Elementa-Science of the Anthropocene, V2, P000028, DOI 10.12952/journal.elementa.000028; Arrigo KR, 2014, ANNU REV MAR SCI, V6, P439, DOI 10.1146/annurev-marine-010213-135103; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR., 2017, SEA ICE, V3rd, P352, DOI DOI 10.1002/9781118778371.CH14; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bjork MM, 2014, BIOGEOSCIENCES, V11, P57, DOI 10.5194/bg-11-57-2014; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Chierici M, 1999, MAR CHEM, V65, P281, DOI 10.1016/S0304-4203(99)00020-1; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Conover RJ, 1999, MAR ECOL PROG SER, V179, P55, DOI 10.3354/meps179055; COTA GF, 1990, J PHYCOL, V26, P399, DOI 10.1111/j.0022-3646.1990.00399.x; Cowie ROM, 2014, AQUAT MICROB ECOL, V73, P123, DOI 10.3354/ame01710; COX GFN, 1983, J GLACIOL, V29, P306, DOI 10.3189/S0022143000008364; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; EICKEN H, 1992, J GEOPHYS RES-OCEANS, V97, P15545, DOI 10.1029/92JC01588; Firth E, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000120; Frankenstein G, 1967, J GLACIOL, V6, P943, DOI 10.1017/s0022143000020244; Fransson A, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006844; Fripiat F, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.217; Galindo V, 2014, J GEOPHYS RES-OCEANS, V119, P3746, DOI 10.1002/2013JC009497; Golden KM, 1998, SCIENCE, V282, P2238, DOI 10.1126/science.282.5397.2238; Gowing MM, 2003, MAR BIOL, V142, P1029, DOI 10.1007/s00227-003-1015-x; Grasshoff K, 1999, METHODS SEAWATER ANA; HANSEN PJ, 1991, MAR ECOL PROG SER, V73, P253, DOI 10.3354/meps073253; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kohlbach D, 2016, LIMNOL OCEANOGR, V61, P2027, DOI 10.1002/lno.10351; Lannuzel D, 2013, POLAR BIOL, V36, P1483, DOI 10.1007/s00300-013-1368-7; Lannuzel D, 2016, DEEP-SEA RES PT II, V131, P111, DOI 10.1016/j.dsr2.2014.12.003; Lannuzel D, 2011, MAR CHEM, V124, P134, DOI 10.1016/j.marchem.2011.01.004; Lazzara L, 2007, ANTARCT SCI, V19, P83, DOI 10.1017/S0954102007000119; Malkin, 2015, PHYTOTOOLS PHYTOPLAN; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Martin A, 2012, ANTARCT SCI, V24, P547, DOI 10.1017/S0954102012000491; McMinn A, 2008, POLAR BIOL, V31, P1011, DOI 10.1007/s00300-008-0433-0; McMinn A, 2010, POLAR BIOL, V33, P1547, DOI 10.1007/s00300-010-0844-6; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meiners KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053478; Miller LA, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000038; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; PALMISANO AC, 1985, J PHYCOL, V21, P341; PALMISANO AC, 1987, MAR BIOL, V94, P299, DOI 10.1007/BF00392944; Petrich C, 2017, SEA ICE, P1, DOI [10.1002/9781118778371.ch1, DOI 10.1002/9781118778371.CH1]; Petrou K, 2010, LIMNOL OCEANOGR, V55, P1400, DOI 10.4319/lo.2010.55.3.1400; Ralph PJ, 2007, J PHYCOL, V43, P948, DOI 10.1111/j.1529-8817.2007.00382.x; Ralph PJ, 2005, J PHYCOL, V41, P763, DOI 10.1111/j.1529-8817.2005.00106.x; Riaux-Gobin C, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.5910; Ryan KG, 2012, J PHYCOL, V48, P74, DOI 10.1111/j.1529-8817.2011.01104.x; Ryan KG, 2004, POLAR BIOL, V27, P679, DOI 10.1007/s00300-004-0636-y; Saenz BT, 2014, J GEOPHYS RES-OCEANS, V119, P3645, DOI 10.1002/2013JC009677; Saenz BT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007544; Schmoker C, 2013, J PLANKTON RES, V35, P691, DOI 10.1093/plankt/fbt023; Sogaard DH, 2011, POLAR BIOL, V34, P1157, DOI 10.1007/s00300-011-0976-3; Stammerjohn SE, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000055; Stewart FJ, 2004, ANTARCT SCI, V16, P143, DOI 10.1017/S0954102004001889; SULLIVAN CW, 1984, APPL ENVIRON MICROB, V47, P788, DOI 10.1128/AEM.47.4.788-795.1984; Thomas DN, 2001, ANN GLACIOL, V33, P297, DOI 10.3189/172756401781818338; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Thomas DN, 1998, ANTARCT RES SER, V73, P161; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Torstensson A, 2013, BIOGEOSCIENCES, V10, P6391, DOI 10.5194/bg-10-6391-2013; Torstensson A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1513; Torstensson A, 2015, ENVIRON MICROBIOL, V17, P3869, DOI 10.1111/1462-2920.12865; Torstensson A, 2012, POLAR BIOL, V35, P205, DOI 10.1007/s00300-011-1056-4; Vancoppenolle M, 2013, QUATERNARY SCI REV, V79, P207, DOI 10.1016/j.quascirev.2013.04.011; Vancoppenolle M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005369; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; Zhang Qing, 1999, Boreal Environment Research, V4, P1	75	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195587	10.1371/journal.pone.0195587	http://dx.doi.org/10.1371/journal.pone.0195587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634756	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200039
J	Shafiei, F; Mohammadparast, P; Jowkar, Z				Shafiei, Fereshteh; Mohammadparast, Pourya; Jowkar, Zahra			Adhesion performance of a universal adhesive in the root canal: Effect of etch-and rinse vs. self-etch mode	PLOS ONE			English	Article							GLASS-FIBER POSTS; OUT BOND STRENGTH; RESIN CEMENTS; IRRIGATING SOLUTIONS; RADICULAR DENTIN; DURABILITY; MORPHOLOGY; IMMEDIATE; PROTOCOLS; IRRIGANTS	Purpose Universal adhesives are new systems that can be used in etch-and-rinse (ER) and self-etch (SE) modes. This in vitro study evaluated the bonding performance of a universal adhesive in ER mode and SE mode with two irrigants for luting fiber posts in the root canal. Materials and methods After separation of the roots from the crowns of 56 maxillary central incisors and endodontic treatment, 10-mm post space was prepared. The roots were divided into seven groups according to irrigant/adhesive protocol used for cementation of posts: 1) sodium hypochlorite (NaOCl) irrigant + acid etching + One-Step Plus, 2) NaOCl + Clearfil SE Bond (CSE) and 3) EDTA + CSE as controls; 4) NaOCl + All-Bond Universal (AB) in ER mode, 5) NaOCl + AB in SE mode, 6) EDTA + AB in SE mode, 7) distilled water + AB in SE mode. Posts were luted using Duo-link. The bonded roots were sectioned into microslices. After push-out bond strength (PBS) testing, data in MPa were analyzed with two-way ANOVA and Tukey test (alpha = 0.05). Results PBS was significantly affected by irrigation/adhesive protocol and root region (P<0.05), with no significant interaction of these factors. PBS of ABU in ER mode with NaOCl and in SE mode with NaOCl or EDTA was comparable to that in the respective controls. The highest and lowest PBSs were recorded for ABU in the SE mode with EDTA (15.38 +/- 4) and NaOCl (10.17 +/- 3.5), respectively. PBS of AB in ER and SE modes was similar when distilled water was used in the SE mode. Conclusion Adhesive performance of AB in the ER mode was comparable to or different from the SE mode, depending on the irrigant used to prepare post space in SE approach. AB could behave as a reliable bonding for post cementation.	[Shafiei, Fereshteh] Shiraz Univ Med Sci, Sch Dent, Dept Operat Dent, Oral & Dent Dis Res Ctr, Shiraz, Iran; [Mohammadparast, Pourya; Jowkar, Zahra] Shiraz Univ Med Sci, Sch Dent, Dept Operat Dent, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science	Jowkar, Z (corresponding author), Shiraz Univ Med Sci, Sch Dent, Dept Operat Dent, Shiraz, Iran.	zahrajowkar66@gmail.com	jowkar, zahra/H-4576-2016; Shafiei, Fereshteh/H-9594-2016	jowkar, zahra/0000-0003-4447-3670; Shafiei, Fereshteh/0000-0002-5398-0239	Vice Chancellory of Research Shiraz University of Medical Sciences [10802]	Vice Chancellory of Research Shiraz University of Medical Sciences	This project (grant number 10802) was carried out by the financial support from the Vice Chancellory of Research Shiraz University of Medical Sciences.	Akgungor G, 2006, J PROSTHET DENT, V95, P368, DOI 10.1016/j.prosdent.2006.02.027; Alex G., 1995, COMPEND CONTIN ED DE, V36, P8; Alex G., 1995, COMPEND CONTIN ED DE, V36, P40; Alex Gary, 2015, Compend Contin Educ Dent, V36, P15; Munoz MA, 2014, J DENT, V42, P595, DOI 10.1016/j.jdent.2014.01.013; Munoz MA, 2013, J DENT, V41, P404, DOI 10.1016/j.jdent.2013.03.001; Ari H, 2003, J ENDODONT, V29, P248, DOI 10.1097/00004770-200304000-00004; Bitter K, 2006, INT ENDOD J, V39, P809, DOI 10.1111/j.1365-2591.2006.01155.x; Bitter K, 2004, INT ENDOD J, V37, P840, DOI 10.1111/j.1365-2591.2004.00888.x; Bitter K, 2013, EUR J ORAL SCI, V121, P349, DOI 10.1111/eos.12057; Bitter K, 2009, EUR J ORAL SCI, V117, P326, DOI 10.1111/j.1600-0722.2009.00623.x; Bottino MA, 2007, J ADHES DENT, V9, P327; Carvalho RM, 2000, J ADHESIVE DENT, V2; Chen C, 2015, J DENT, V43, P525, DOI 10.1016/j.jdent.2015.03.004; da Cunha LF, 2010, J ENDODONT, V36, P130, DOI 10.1016/j.joen.2009.09.008; da Silveira Bueno Carlos Eduardo, 2016, General Dentistry, V64, P26; da Rosa WLD, 2015, J DENT, V43, P765, DOI 10.1016/j.jdent.2015.04.003; do Amaral RC, 2009, J DENT, V37, P82, DOI 10.1016/j.jdent.2008.09.010; Ebrahimi Shahram Farzin, 2014, Dent Res J (Isfahan), V11, P32; Ertas H, 2014, ACTA ODONTOL SCAND, V72, P783, DOI 10.3109/00016357.2014.906651; Goracci C, 2005, OPER DENT, V30, P627; Gu XH, 2009, EUR J ORAL SCI, V117, P597, DOI 10.1111/j.1600-0722.2009.00661.x; Hanabusa M, 2012, J DENT, V40, P475, DOI 10.1016/j.jdent.2012.02.012; Hayashi M, 2005, EUR J ORAL SCI, V113, P70, DOI 10.1111/j.1600-0722.2004.00186.x; Khalighinejad N, 2014, AM J DENT, V27, P3; Lohbauer U, 2008, J ADHES DENT, V10, P97; Martinho FC, 2015, J ENDODONT, V41, P83, DOI 10.1016/j.joen.2014.07.018; Naumann M, 2012, J ENDODONT, V38, P432, DOI 10.1016/j.joen.2012.01.003; Onay EO, 2010, INT ENDOD J, V43, P259, DOI 10.1111/j.1365-2591.2009.01643.x; Perdigao J, 2006, DENT MATER, V22, P752, DOI 10.1016/j.dental.2005.11.002; Pleffken PR, 2011, J ADHES DENT, V13, P517, DOI 10.3290/j.jad.a21417; Plotino G, 2007, DENT MATER, V23, P1129, DOI 10.1016/j.dental.2006.06.047; Radovic I, 2008, EUR J ORAL SCI, V116, P557, DOI 10.1111/j.1600-0722.2008.00577.x; Rasimick BJ, 2010, J PROSTHODONT, V19, P56, DOI 10.1111/j.1532-849X.2010.00647.x; Sezinando A, 2015, DENT MATER, V31, pE236, DOI 10.1016/j.dental.2015.07.002; Shafiei F, 2016, OPER DENT, V41, P432, DOI 10.2341/15-099-L; Shafiei F, 2016, J ADV PROSTHODONT, V8, P251, DOI 10.4047/jap.2016.8.4.251; Soejima H, 2013, DENT MATER J, V32, P659, DOI 10.4012/dmj.2013-078; Tasman F, 2000, J ENDODONT, V26, P586, DOI 10.1097/00004770-200010000-00002; Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de; Valandro LF, 2007, OPER DENT, V32, P579, DOI 10.2341/06-165; Vichi A, 2002, J ENDODONT, V28, P355, DOI 10.1097/00004770-200205000-00002; Wagner A, 2014, J DENT, V42, P800, DOI 10.1016/j.jdent.2014.04.012; Wang L, 2013, INT ENDOD J, V46, P847, DOI 10.1111/iej.12070; Wu HX, 2009, DENT MATER, V25, P1484, DOI 10.1016/j.dental.2009.06.019; Yoshida E, 2004, J BIOMED MATER RES B, V68B, P29, DOI 10.1002/jbm.b.10080; Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375; Yu HH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04107-8; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014; Zhang Y, 2013, J DENT, V41, P231, DOI 10.1016/j.jdent.2012.11.006; Zicari F, 2008, DENT MATER, V24, P967, DOI 10.1016/j.dental.2007.11.011	51	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195367	10.1371/journal.pone.0195367	http://dx.doi.org/10.1371/journal.pone.0195367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630636	Green Submitted, gold, Green Published			2022-12-27	WOS:000429505000042
J	Zahin, M; Dean, WL; Ghim, SJ; Joh, J; Gray, RD; Khanal, S; Bossart, GD; Mignucci-Giannoni, AA; Rouchka, EC; Jenson, AB; Trent, JO; Chaires, JB; Chariker, JH				Zahin, Maryam; Dean, William L.; Ghim, Shin-Je; Joh, Joongho; Gray, Robert D.; Khanal, Sujita; Bossart, Gregory D.; Mignucci-Giannoni, Antonio A.; Rouchka, Eric C.; Jenson, Alfred B.; Trent, John O.; Chaires, Jonathan B.; Chariker, Julia H.			Identification of G-quadruplex forming sequences in three manatee papillomaviruses	PLOS ONE			English	Article							FLORIDA MANATEE; MUCOSOTROPIC PAPILLOMAVIRUSES; PARALLEL QUADRUPLEXES; HUMAN TELOMERE; DNA APTAMER; K+ SOLUTION; G-TETRAD; RNA; BINDING; HIV-1	The Florida manatee (Trichechus manatus latirotris) is a threatened aquatic mammal in United States coastal waters. Over the past decade, the appearance of papillomavirus-induced lesions and viral papillomatosis in manatees has been a concern for those involved in the management and rehabilitation of this species. To date, three manatee papillomaviruses (TmPVs) have been identified in Florida manatees, one forming cutaneous lesions (TmPV1) and two forming genital lesions (TmPV3 and TmPV4). We identified DNA sequences with the potential to form G-quadruplex structures (G4) across the three genomes. G4 were located on both DNA strands and across coding and non-coding regions on all TmPVs, offering multiple targets for viral control. Although G4 have been identified in several viral genomes, including human PVs, most research has focused on canonical structures comprised of three G tetrads. In contrast, the vast majority of sequences we identified would allow the formation of non-canonical structures with only two G-tetrads. Our biophysical analysis confirmed the formation of G4 with parallel topology in three such sequences from the E2 region. Two of the structures appear comprised of multiple stacked two G-tetrad structures, perhaps serving to increase structural stability. Computational analysis demonstrated enrichment of G4 sequences on all TmPVs on the reverse strand in the E2/E4 region and on both strands in the L2 region. Several G4 sequences occurred at similar regional locations on all PVs, most notably on the reverse strand in the E2 region. In other cases, G4 were identified at similar regional locations only on PVs forming genital lesions. On all TmPVs, G4 sequences were located in the non-coding region near putative E2 binding sites. Together, these findings suggest that G4 are possible regulatory elements in TmPVs.	[Zahin, Maryam; Dean, William L.; Ghim, Shin-Je; Joh, Joongho; Gray, Robert D.; Khanal, Sujita; Jenson, Alfred B.; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Joh, Joongho; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Khanal, Sujita; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Bossart, Gregory D.] Georgia Aquarium, Atlanta, GA USA; [Bossart, Gregory D.] Univ Miami, Miller Sch Med, Dept Pathol, Div Comparat Pathol, Miami, FL 33136 USA; [Mignucci-Giannoni, Antonio A.] Inter Amer Univ Puerto Rico, Puerto Rico Manatee Conservat Ctr, Bayamon, PR USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Duthie Ctr Engn, Louisville, KY 40292 USA; [Rouchka, Eric C.; Chariker, Julia H.] Univ Louisville, KBRIN Bioinformat Core, Louisville, KY 40292 USA; [Chariker, Julia H.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Miami; Inter American University of Puerto Rico-San German; University of Louisville; University of Louisville; University of Louisville	Chariker, JH (corresponding author), Univ Louisville, KBRIN Bioinformat Core, Louisville, KY 40292 USA.; Chariker, JH (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	julia.chariker@louisville.edu		trent, John/0000-0002-7346-4231	Helmsley Trust Foundation [G2585-20162014]; James Graham Brown Cancer Center, School of Medicine, University of Louisville; National Institutes of Health (NIH) [R01GM077422]; National Institutes of Health [P20GM103436]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077422] Funding Source: NIH RePORTER	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Helmsley Trust Foundation (www.helmsleytrust.org) grant G2585-20162014 (Alfred Jenson, PI) and the James Graham Brown Cancer Center, School of Medicine, University of Louisville (http://browncancercenter.louisville.edu/). Support for JBC was provided by the National Institutes of Health (NIH, www.nih.gov) grant R01GM077422 (Jonathan. B. Chaires, PI). Support for JHC and ECR was provided by the National Institutes of Health grant P20GM103436 (Nigel Cooper, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Blaum BS, 2012, NUCLEIC ACIDS RES, V40, P3042, DOI 10.1093/nar/gkr1152; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Broxson C, 2011, BIOCHEMISTRY-US, V50, P4162, DOI 10.1021/bi2002136; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Callegaro S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02667-3; Case D. A., 2017, AMBER 2017; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Chaires JB, 2015, METHOD ENZYMOL, V562, P287, DOI 10.1016/bs.mie.2015.04.011; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chariker JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165101; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111; Del Villar-Guerra R., 2017, CURR PROTOC NUCL ACI, V68, P17, DOI DOI 10.1002/CPNC.23; Deng B, 2014, ANAL CHIM ACTA, V837, P1, DOI 10.1016/j.aca.2014.04.055; Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Ghim SJ, 2014, AQUAT MAMM, V40, P195, DOI 10.1578/AM.40.2.2014.195; Harris LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004562; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Holm AIS, 2010, BIOPOLYMERS, V93, P429, DOI 10.1002/bip.21354; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Karsisiotis A. I., 2011, ANGEW CHEM, V123, P10833, DOI DOI 10.1002/ANGE.201105193; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kwok CK, 2016, NAT METHODS, V13, P841, DOI 10.1038/nmeth.3965; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Le HT, 2014, J PHYS CHEM B, V118, P5390, DOI 10.1021/jp502213y; Lemmens B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9909; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Matsugami A, 2001, Nucleic Acids Res Suppl, P271; Matsugami A, 2001, J MOL BIOL, V313, P255, DOI 10.1006/jmbi.2001.5047; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pagano B, 2008, BIOPHYS J, V94, P562, DOI 10.1529/biophysj.107.117382; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Perrone R, 2015, J MED CHEM, V58, P9639, DOI 10.1021/acs.jmedchem.5b01283; Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280; Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Qin MY, 2015, J PHYS CHEM B, V119, P3706, DOI 10.1021/jp512914t; Rector A, 2004, J VIROL, V78, P12698, DOI 10.1128/JVI.78.22.12698-12702.2004; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rogers A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-379; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shiyong Wang, 2016, International Journal of Distributed Sensor Networks, V2016, DOI 10.1155/2016/3159805; Shum KT, 2008, CHEMBIOCHEM, V9, P3037, DOI 10.1002/cbic.200800491; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Stoddart CA, 1998, ANTIMICROB AGENTS CH, V42, P2113, DOI 10.1128/AAC.42.8.2113; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Tan SH, 1992, NUCLEIC ACIDS RES, P20; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897; Tothova P, 2014, BIOCHEMISTRY-US, V53, P7013, DOI 10.1021/bi500773c; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; von Hacht A, 2014, NUCLEIC ACIDS RES, V42, P6630, DOI 10.1093/nar/gku290; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535; Wieland M, 2009, NAT PROTOC, V4, P1632, DOI 10.1038/nprot.2009.111; Woo HM, 2013, ANTIVIR RES, V100, P337, DOI 10.1016/j.antiviral.2013.09.004; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172; Zahin M, 2015, J GEN VIROL, V96, P3545, DOI 10.1099/jgv.0.000293; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	87	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195625	10.1371/journal.pone.0195625	http://dx.doi.org/10.1371/journal.pone.0195625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630682	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000066
J	Zahradnik, J; Kolenko, P; Palyzova, A; Cerny, J; Kolarova, L; Kyslikova, E; Maresova, H; Grulich, M; Nunvar, J; Sulc, M; Kyslik, P; Schneider, B				Zahradnik, Jiri; Kolenko, Petr; Palyzova, Andrea; Cerny, Jiri; Kolarova, Lucie; Kyslikova, Eva; Maresova, Helena; Grulich, Michel; Nunvar, Jaroslav; Sulc, Miroslav; Kyslik, Pavel; Schneider, Bohdan			The crystal structure of XdpB, the bacterial old yellow enzyme, in an FMN-free form	PLOS ONE			English	Article							GLYCEROL TRINITRATE REDUCTASE; ACTIVE-SITE; OXIDATIVE STRESS; MORPHINONE REDUCTASE; NEMA GENE; EXPRESSION; PROTEIN; SEQUENCE; FAMILY; PURIFICATION	Old Yellow Enzymes (OYES) are NAD(P)H dehydrogenases of not fully resolved physiological roles that are widespread among bacteria, plants, and fungi and have a great potential for biotechnological applications. We determined the apo form crystal structure of a member of the OYE class, glycerol trinitrate reductase XdpB, from Agrobacterium bohemicum R89-1 at 2.1 A resolution. In agreement with the structures of the related bacterial OYEs, the structure revealed the TIM barrel fold with an N-terminal beta-hairpin lid, but surprisingly, the structure did not contain its cofactor FMN. Its putative binding site was occupied by a pentapeptide TTSDN from the C-terminus of a symmetry related molecule. Biochemical experiments confirmed a specific concentration-dependent oligomerization and a low FMN content. The blocking of the FMN binding site can exist in vivo and regulates enzyme activity. Our bioinformatic analysis indicated that a similar self-inhibition could be expected in more OYEs which we designated as subgroup OYE C1. This subgroup is widespread among G-bacteria and can be recognized by the conserved sequence GxxDYP in proximity of the C termini. In proteobacteria, the C1 subgroup OYEs are typically coded in one operon with short-chain dehydrogenase. This operon is controlled by the tetR-like transcriptional regulator. OYEs coded in these operons are unlikely to be involved in the oxidative stress response as the other known members of the OYE family because no upregulation of XdpB was observed after exposing A. bohemicum R89-1 to oxidative stress.	[Zahradnik, Jiri; Kolenko, Petr; Cerny, Jiri; Kolarova, Lucie; Nunvar, Jaroslav; Schneider, Bohdan] BIOCEV, Inst Biotechnol CAS, Vvi, Vestec, Prague West, Czech Republic; [Zahradnik, Jiri; Sulc, Miroslav] Charles Univ Prague, Dept Biochem, Fac Sci, Prague, Czech Republic; [Zahradnik, Jiri; Palyzova, Andrea; Kyslikova, Eva; Maresova, Helena; Grulich, Michel; Kyslik, Pavel] Inst Microbiol CAS, Vvi, Prague, Czech Republic; [Kolenko, Petr] FNSPE Czech Tech Univ, Dept Solid State Engn, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Technical University Prague	Zahradnik, J; Schneider, B (corresponding author), BIOCEV, Inst Biotechnol CAS, Vvi, Vestec, Prague West, Czech Republic.; Zahradnik, J (corresponding author), Charles Univ Prague, Dept Biochem, Fac Sci, Prague, Czech Republic.; Zahradnik, J (corresponding author), Inst Microbiol CAS, Vvi, Prague, Czech Republic.	zahradj@ibt.cas.cz; bohdan.schneider@gmail.com	Černý, Jiří/I-4733-2012; Sulc, Miroslav/K-1029-2014; Schneider, Bohdan/D-2565-2009; Kolenko, Petr/G-5732-2014; Marešová, Helena/H-4646-2014; Palyzova, Andrea/H-2628-2014; Kolarova, Lucie/M-6228-2017	Černý, Jiří/0000-0002-1969-9304; Sulc, Miroslav/0000-0002-2659-0489; Kolenko, Petr/0000-0002-4619-9276; Kolarova, Lucie/0000-0002-6491-3568; Zahradnik, Jiri/0000-0002-8698-4236	Grant Agency of Charles University [720414]; long-term research development project from the ERDF [RVO 61388971, 86 652 036, CZ.1.05/2.1.00/19.0390]; MEYS; Grant Agency of the Czech Technical University in Prague [SGS16/246/OHK4/3T/14]	Grant Agency of Charles University; long-term research development project from the ERDF; MEYS; Grant Agency of the Czech Technical University in Prague	The study was supported by grant No. 720414 of the Grant Agency of Charles University, the long-term research development project RVO 61388971 to the Institute of Microbiology CAS, v. v. i. and 86 652 036 to the Institute of Biotechnology CAS, v. v. i. and to project Introduction of new research methods to BIOCEV CZ.1.05/2.1.00/19.0390 from the ERDF and MEYS and in part by the Grant Agency of the Czech Technical University in Prague, grant No. SGS16/246/OHK4/3T/14. We thank the Helmholz Zentrum Berlin for the allocation of synchrotron radiation beamtime.	Adalbjornsson BV, 2010, CHEMBIOCHEM, V11, P197, DOI 10.1002/cbic.200900570; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Amato ED, 2015, BIOTECHNOL ADV, V33, P624, DOI 10.1016/j.biotechadv.2015.04.011; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Blehert DS, 1997, J BACTERIOL, V179, P6912, DOI 10.1128/jb.179.22.6912-6920.1997; Bohm G., 1997, CDNN D CD SPECTRA DE; Breithaupt C, 2006, P NATL ACAD SCI USA, V103, P14337, DOI 10.1073/pnas.0606603103; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Brown BJ, 2002, J BIOL CHEM, V277, P2138, DOI 10.1074/jbc.M108453200; Chilton AS, 2014, ACTA CRYSTALLOGR F, V70, P1328, DOI 10.1107/S2053230X14018962; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Ehira S, 2010, MICROBIOL-SGM, V156, P1335, DOI 10.1099/mic.0.036913-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; Garadnay S, 2013, CENT EUR J CHEM, V11, P430, DOI 10.2478/s11532-012-0181-4; Gutierrez-Preciado A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126124; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanekar P.P., 2014, BIOL REMEDIATION EXP, P67, DOI DOI 10.1007/978-3-319-01083-0_4; Kitzing K, 2005, J BIOL CHEM, V280, P27904, DOI 10.1074/jbc.M502587200; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Kyslikova E, 2013, J MOL CATAL B-ENZYM, V87, P1, DOI 10.1016/j.molcatb.2012.10.004; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MacLellan SR, 2006, MICROBIOL-SGM, V152, P1751, DOI 10.1099/mic.0.28743-0; Malone TE, 2005, PROTEINS, V58, P243, DOI 10.1002/prot.20162; Marshall SJ, 2004, J BACTERIOL, V186, P1802, DOI 10.1128/JB.186.6.1802-1810.2004; Messiha HL, 2005, J BIOL CHEM, V280, P27103, DOI 10.1074/jbc.M502293200; Miura K, 1997, BIOL PHARM BULL, V20, P110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murta SMF, 2006, MOL BIOCHEM PARASIT, V146, P151, DOI 10.1016/j.molbiopara.2005.12.001; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nizam S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04013; Oberdorfer G, 2013, CHEMBIOCHEM, V14, P836, DOI 10.1002/cbic.201300136; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Okamoto N, 2011, J BIOCHEM, V150, P563, DOI 10.1093/jb/mvr096; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reich S, 2012, CHEMBIOCHEM, V13, P2400, DOI 10.1002/cbic.201200404; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Schittmayer M, 2011, ADV SYNTH CATAL, V353, P268, DOI 10.1002/adsc.201000862; Schneider B, 2014, ACTA CRYSTALLOGR D, V70, P2413, DOI 10.1107/S1399004714014631; Snape JR, 1997, J BACTERIOL, V179, P7796, DOI 10.1128/jb.179.24.7796-7802.1997; Solovjev V, 2011, METAGENOMICITAPP, P61; Spiegelhauer O, 2010, J MOL BIOL, V403, P286, DOI 10.1016/j.jmb.2010.08.047; Spiegelhauer O, 2010, J MOL BIOL, V398, P66, DOI 10.1016/j.jmb.2010.02.044; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Umezawa Y, 2008, J BACTERIOL, V190, P5890, DOI 10.1128/JB.00459-08; van den Hemel D, 2006, J BIOL CHEM, V281, P28152, DOI 10.1074/jbc.M603946200; Warburg O, 1933, BIOCHEM Z, V266, P377; Wick A, 2011, ENVIRON SCI TECHNOL, V45, P3374, DOI 10.1021/es103489x; WILLEY DL, 1993, BIOCHEM J, V290, P539, DOI 10.1042/bj2900539; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu D, 1999, P NATL ACAD SCI USA, V96, P3556, DOI 10.1073/pnas.96.7.3556; Zahradnik J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00196-16; Zahradnik J, 2018, SYST APPL MICROBIOL, V41, P184, DOI 10.1016/j.syapm.2018.01.003	67	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195299	10.1371/journal.pone.0195299	http://dx.doi.org/10.1371/journal.pone.0195299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630677	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000037
J	Fassbinder-Orth, CA; Killpack, TL; Goto, DS; Rainwater, EL; Shearn-Bochsler, VI				Fassbinder-Orth, Carol A.; Killpack, Tess L.; Goto, Dylan S.; Rainwater, Ellecia L.; Shearn-Bochsler, Valerie I.			High costs of infection: Alphavirus infection reduces digestive function and bone and feather growth in nestling house sparrows (Passer domesticus)	PLOS ONE			English	Article							BUGGY-CREEK-VIRUS; EASTERN EQUINE ENCEPHALITIS; POOR DEVELOPMENTAL CONDITIONS; GALLUS-GALLUS-DOMESTICUS; WEST-NILE-VIRUS; FOOD RESTRICTION; TRADE-OFFS; OECIACUS-VICARIUS; AMERICAN KESTRELS; MOURNING DOVES	Increasingly, ecoimmunology studies aim to use relevant pathogen exposure to examine the impacts of infection on physiological processes in wild animals. Alphaviruses are arthropod-borne, single-stranded RNA (ssRNA) viruses ("arboviruses") responsible for millions of cases of human illnesses each year. Buggy Creek virus (BCRV) is a unique alphavirus that is transmitted by a cimicid insect, the swallow bug, and is amplified in two avian species: the house sparrow (Passer domesticus) and the cliff swallow (Petrochelidon pyrrhonota). BCRV, like many alphaviruses, exhibits age-dependent susceptibility where the young are most susceptible to developing disease and exhibit a high mortality rate. However, alpha virus disease etiology in nestling birds is unknown. In this study, we infected nestling house sparrows with Buggy Creek virus and measured virological, pathological, growth, and digestive parameters following infection. Buggy Creek virus caused severe encephalitis in all infected nestlings, and the peak viral concentration in brain tissue was over 34 times greater than any other tissue. Growth, tissue development, and digestive function were all significantly impaired during BCRV infection. However, based on histopathological analysis performed, this impairment does not appear to be the result of direct tissue damage by the virus, but likely caused by encephalitis and neuronal invasion and impairment of the central nervous system. This is the first study to examine the course of alphavirus diseases in nestling birds and these results will improve our understanding of age-dependent infections of alphaviruses in vertebrate hosts.	[Fassbinder-Orth, Carol A.] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Killpack, Tess L.] Salem State Univ, Dept Biol, Salem, MA USA; [Goto, Dylan S.; Rainwater, Ellecia L.] Creighton Univ, Sch Med, Omaha, NE USA; [Shearn-Bochsler, Valerie I.] USGS Natl Wildlife Hlth Ctr, Madison, WI USA	Creighton University; Massachusetts System of Public Higher Education; Salem State University; Creighton University; United States Department of the Interior; United States Geological Survey	Fassbinder-Orth, CA (corresponding author), Creighton Univ, Dept Biol, Omaha, NE 68178 USA.	carolfassbinder-orth@creighton.edu		Fassbinder-Orth, Carol/0000-0001-5286-5266	National Institute for General Medical Science (NIGMS), a component of the Institutes of Health (NIH) [5P20GM103427]; Creighton's Center for Undergraduate Research and Scholarship; Dr. George F. Haddix President's Faculty Research Fund; Creighton Center for Undergraduate Research and Scholarship	National Institute for General Medical Science (NIGMS), a component of the Institutes of Health (NIH); Creighton's Center for Undergraduate Research and Scholarship; Dr. George F. Haddix President's Faculty Research Fund; Creighton Center for Undergraduate Research and Scholarship	This publication was made possible by grants from the National Institute for General Medical Science (NIGMS) (5P20GM103427), a component of the Institutes of Health (NIH), and its contents are the sole responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. Additional funding was provided by a research fellowship to CFO and MJW from Creighton's Center for Undergraduate Research and Scholarship, Dr. George F. Haddix President's Faculty Research Fund to CFO, and a summer research fellowship from Randolph Ferlic and the Creighton Center for Undergraduate Research and Scholarship to ELR and DSG.	Adelman JS, 2017, J AVIAN BIOL, V48, P519, DOI 10.1111/jav.01058; Adelman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003462; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Bosman DS, 2016, J FIELD ORNITHOL, V87, P391, DOI 10.1111/jofo.12177; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Caviedes-Vidal E, 2001, PHYSIOL BIOCHEM ZOOL, V74, P769, DOI 10.1086/322966; Chin EH, 2009, P ROY SOC B-BIOL SCI, V276, P499, DOI 10.1098/rspb.2008.1294; Dahdul WM, 2003, AUK, V120, P1069, DOI 10.1642/0004-8038(2003)120[1069:EAAPGI]2.0.CO;2; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; Deguchi T, 2004, AUK, V121, P452, DOI 10.1642/0004-8038(2004)121[0452:PFDAAM]2.0.CO;2; DELRIO CM, 1995, PHYSIOL ZOOL, V68, P490, DOI 10.1086/physzool.68.3.30163781; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Fassbinder-Orth CA, 2006, POULTRY SCI, V85, P1449, DOI 10.1093/ps/85.8.1449; Fassbinder-Orth CA, 2014, INTEGR COMP BIOL, V54, P396, DOI 10.1093/icb/icu023; Fassbinder-Orth CA, 2014, VECTOR-BORNE ZOONOT, V14, P439, DOI 10.1089/vbz.2013.1531; Fassbinder-Orth CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058045; Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; HAYES RO, 1977, J MED ENTOMOL, V14, P257, DOI 10.1093/jmedent/14.3.257; Huyvaert KP, 2008, J WILDLIFE DIS, V44, P331, DOI 10.7589/0090-3558-44.2.331; Iseri VJ, 2013, DEV COMP IMMUNOL, V40, P248, DOI 10.1016/j.dci.2013.02.005; Killpack TL, 2013, J AVIAN BIOL, V44, P513, DOI 10.1111/j.1600-048X.2013.00239.x; Killpack TL, 2012, J EXP BIOL, V215, P1806, DOI 10.1242/jeb.066316; Killpack TL, 2012, PLOS ONE, V7, DOI .0047294; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; LACOMBE D, 1994, CAN J ZOOL, V72, P2084, DOI 10.1139/z94-279; Lennette EH, 1944, J IMMUNOL, V49, P175; Lepczyk CA, 1998, PHYSIOL ZOOL, V71, P561, DOI 10.1086/515965; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3; Luers AJ, 2005, COMP FUNCT GENOM, V6, P217, DOI 10.1002/cfg.478; MCLEAN RG, 1995, J WILDLIFE DIS, V31, P502, DOI 10.7589/0090-3558-31.4.502; Miller DA, 2011, J AVIAN BIOL, V42, P151, DOI 10.1111/j.1600-048X.2010.05124.x; Miller DA, 2010, P ROY SOC B-BIOL SCI, V277, P1659, DOI 10.1098/rspb.2010.0022; MILLER MR, 1984, CONDOR, V86, P396, DOI 10.2307/1366814; Mireles AJ, 2005, POULTRY SCI, V84, P553, DOI 10.1093/ps/84.4.553; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Naef-Daenzer B, 2016, J FIELD ORNITHOL, V87, P227, DOI 10.1111/jofo.12157; National Research Council, 1981, NATL ACAD SCI; NEGRO JJ, 1994, CONDOR, V96, P749, DOI 10.2307/1369478; Nemeth NM, 2007, AM J TROP MED HYG, V76, P310, DOI 10.4269/ajtmh.2007.76.310; O'Brien VA, 2012, AUK, V129, P707, DOI 10.1525/auk.2012.12036; O'Brien VA, 2012, J WILDLIFE DIS, V48, P138, DOI 10.7589/0090-3558-48.1.138; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Passoni G, 2017, DIS MODEL MECH, V10, P847, DOI 10.1242/dmm.029231; Reid K, 2000, IBIS, V142, P188, DOI 10.1111/j.1474-919X.2000.tb04858.x; Reisen WK, 2006, VECTOR-BORNE ZOONOT, V6, P248, DOI 10.1089/vbz.2006.6.248; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Scott T.W., 1988, Miscellaneous Publications of the Entomological Society of America, P9; SCOTT TW, 1984, AM J TROP MED HYG, V33, P981, DOI 10.4269/ajtmh.1984.33.981; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; SEEL DC, 1969, IBIS, V111, P36, DOI 10.1111/j.1474-919X.1969.tb01603.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Tkachev S, 2011, NONFLAVIVIRUS ENCEPH, DOI 10.5772/24175; TUCKER PC, 1993, J VIROL, V67, P4605, DOI 10.1128/JVI.67.8.4605-4610.1993; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Valero N, 2001, Invest Clin, V42, P161; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003	71	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195467	10.1371/journal.pone.0195467	http://dx.doi.org/10.1371/journal.pone.0195467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624598	gold, Green Published, Green Submitted			2022-12-27	WOS:000429379600032
J	Halfter, W; Moes, S; Asgeirsson, DO; Halfter, K; Oertle, P; Herraiz, EM; Plodinec, M; Jenoe, P; Henrich, PB				Halfter, Willi; Moes, Suzette; Asgeirsson, Daphne O.; Halfter, Kathrin; Oertle, Philipp; Herraiz, Esther Melo; Plodinec, Marija; Jenoe, Paul; Henrich, Paul Bernhard			Diabetes-related changes in the protein composition and the biomechanical properties of human retinal vascular basement membranes (vol 12, e0189857, 2017)	PLOS ONE			English	Correction															Swiss National Science Foundation Nanotera Project	Swiss National Science Foundation Nanotera Project	Work of MP and PO was supported by the Swiss National Science Foundation Nanotera Project awarded to the PATLiSci II Consortium.	Halfter W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189857	1	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195772	10.1371/journal.pone.0195772	http://dx.doi.org/10.1371/journal.pone.0195772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624597	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600044
J	Jabbari, H; Wark, I; Montemagno, C				Jabbari, Hosna; Wark, Ian; Montemagno, Carlo			RNA secondary structure prediction with pseudoknots: Contribution of algorithm versus energy model	PLOS ONE			English	Article							PARTITION-FUNCTION	Motivation RNA is a biopolymer with various applications inside the cell and in biotechnology. Structure of an RNA molecule mainly determines its function and is essential to guide nanostructure design. Since experimental structure determination is time-consuming and expensive, accurate computational prediction of RNA structure is of great importance. Prediction of RNA secondary structure is relatively simpler than its tertiary structure and provides information about its tertiary structure, therefore, RNA secondary structure prediction has received attention in the past decades. Numerous methods with different folding approaches have been developed for RNA secondary structure prediction. While methods for prediction of RNA pseudoknot-free structure (structures with no crossing base pairs) have greatly improved in terms of their accuracy, methods for prediction of RNA pseudoknotted secondary structure (structures with crossing base pairs) still have room for improvement. A long-standing question for improving the prediction accuracy of RNA pseudoknotted secondary structure is whether to focus on the prediction algorithm or the underlying energy model, as there is a trade-off on computational cost of the prediction algorithm versus the generality of the method. Results The aim of this work is to argue when comparing different methods for RNA pseudoknotted structure prediction, the combination of algorithm and energy model should be considered and a method should not be considered superior or inferior to others if they do not use the same scoring model. We demonstrate that while the folding approach is important in structure prediction, it is not the only important factor in prediction accuracy of a given method as the underlying energy model is also as of great value. Therefore we encourage researchers to pay particular attention in comparing methods with different energy models.	[Jabbari, Hosna] Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA; [Wark, Ian] Univ Alberta, Dept Chem & Mat Engn, Ingenu Lab, Edmonton, AB, Canada; [Montemagno, Carlo] Southern Illinois Univ Carbondale, Carbondale, IL USA	University of Vermont; University of Alberta; Southern Illinois University System; Southern Illinois University	Jabbari, H (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.	jabbari@ualberta.ca		Jabbari, Hosna/0000-0002-7155-2297				Akutsu T, 2000, DISCRETE APPL MATH, V104, P45, DOI 10.1016/S0166-218X(00)00186-4; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Andronescu MS, 2010, RNA, V16, P26, DOI 10.1261/rna.1689910; Bellaousov S, 2010, RNA, V16, P1870, DOI 10.1261/rna.2125310; Chen HL, 2009, J COMPUT BIOL, V16, P803, DOI 10.1089/cmb.2008.0219; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Hajiaghayi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-22; Hesterberg T, 2005, BOOTSTRAP METHODS PE; Huang CH, 2005, BIOINFORMATICS, V21, P3501, DOI 10.1093/bioinformatics/bti568; Huang XL, 2007, NUCLEIC ACIDS RES, V35, P656, DOI 10.1093/nar/gkl943; Jabbari H, 2008, J COMPUT BIOL, V15, P139, DOI 10.1089/cmb.2007.0198; Jabbari H, 2015, ACS COMB SCI, V17, P535, DOI 10.1021/acscombsci.5b00079; Jabbari H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-147; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lyngso RB, 2004, LECT NOTES COMPUT SC, V3142, P919; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Mathews DH, 2006, THEOR CHEM ACC THEOR, P1; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Puton T, 2013, NUCLEIC ACIDS RES, V41, P4307, DOI 10.1093/nar/gkt101; Rastegari B, 2007, J COMPUT BIOL, V14, P16, DOI 10.1089/cmb.2006.0108; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Ruan JH, 2004, BIOINFORMATICS, V20, P58, DOI 10.1093/bioinformatics/btg373; Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215; Sperschneider J, 2008, RNA, V14, P630, DOI 10.1261/rna.968808; Sperschneider J, 2012, BIOINFORMATICS, V28, P3058, DOI 10.1093/bioinformatics/bts575; Sperschneider J, 2011, RNA, V17, P27, DOI 10.1261/rna.2394511; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Team RDC, 2011, R PROJ STAT COMP, P309; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Uemura Y, 1999, THEOR COMPUT SCI, V210, P277, DOI 10.1016/S0304-3975(98)00090-5; Varian H., 2005, Mathematica Journal, V9, P768; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555	40	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194583	10.1371/journal.pone.0194583	http://dx.doi.org/10.1371/journal.pone.0194583			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621250	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800022
J	Koike, Y; Sumida, I; Mizuno, H; Shiomi, H; Kurosu, K; Ota, S; Yoshioka, Y; Suzuki, O; Tamari, K; Ogawa, K				Koike, Yuhei; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Kurosu, Keita; Ota, Seiichi; Yoshioka, Yasuo; Suzuki, Osamu; Tamari, Keisuke; Ogawa, Kazuhiko			Dosimetric impact of intra-fraction prostate motion under a tumour-tracking system in hypofractionated robotic radiosurgery	PLOS ONE			English	Article							RADIATION-THERAPY; SEMINAL-VESICLES; FIDUCIAL MARKERS; PATIENT MOTION; CINE-MRI; INTRAFRACTION; RADIOTHERAPY; LOCALIZATION; DEFORMATION; ACCURACY	For CyberKnife-mediated prostate cancer treatment, a tumour-tracking approach is applied to correct the target location by acquiring X-ray images of implanted fiducial markers intermittently. This study investigated the dosimetric impact of intra-fraction prostate motion during CyberKnife treatment. We retrospectively analyzed 16 patients treated using the CyberKnife (35 Gy delivered in five fractions). Using log files of recorded prostate motion, the intra-fraction prostate motion was simulated. We defined the worst-case intra-fraction prostate motion as the difference between pre- and post-deviation on log files and shifted structure sets according to the corresponding offsets for each beam. The dose-volume indices were calculated and compared with the original plan in terms of clinical target volume (CTV), planning target volume (CTV plus a 2-mm margin), rectum, bladder, and urethra. Prostate motions of >3, >5, and >10 mm were observed for 31.3, 9.1, and 0.5% of the 1929 timestamps, respectively. Relative differences between the simulated and original plans were mostly less than 1%. Although significant decreases were observed in D-50% and D-98% of the target, absolute dose differences were <0.1 Gy compared with the planned dose. The dosimetric impact of intra-fraction prostate motion may be small even with longer treatment durations, indicating that the tumour tracking using the CyberKnife could be a robust system for examining prostate motion.	[Koike, Yuhei; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Kurosu, Keita; Yoshioka, Yasuo; Tamari, Keisuke; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan; [Shiomi, Hiroya] Miyakojima IGRT Clin, Miyakojima Ku, Osaka, Japan; [Kurosu, Keita; Ota, Seiichi] Osaka Univ Hosp, Dept Radiol, Suita, Osaka, Japan; [Suzuki, Osamu] Osaka Univ, Grad Sch Med, Dept Carbon Ion Radiotherapy, Suita, Osaka, Japan; [Yoshioka, Yasuo] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Radiat Oncol, Koto Ku, Tokyo, Japan	Osaka University; Osaka University; Osaka University; Japanese Foundation for Cancer Research	Sumida, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan.	sumida@radonc.med.osaka-u.ac.jp	Koike, Yuhei/GQP-9918-2022	Koike, Yuhei/0000-0003-3963-4257; Sumida, Iori/0000-0001-7669-0325				[Anonymous], 2010, J ICRU, V10, P27, DOI 10.1093/jicru/ndq008; Baker M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2533-5; Beltran C, 2008, INT J RADIAT ONCOL, V70, P289, DOI 10.1016/j.ijrobp.2007.08.040; Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6; Detti B, 2015, CANCER INVEST, V33, P329, DOI 10.3109/07357907.2015.1060063; Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P228, DOI 10.1016/j.ijrobp.2004.09.023; Ghilezan MJ, 2005, INT J RADIAT ONCOL, V62, P406, DOI 10.1016/j.ijrobp.2003.10.017; Gill S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-174; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Inoue M, 2014, JPN J RADIOL, V32, P461, DOI 10.1007/s11604-014-0330-0; Iwata H, 2016, TECHNOL CANCER RES T, V15, P101, DOI 10.1177/1533034614563443; Kotte ANTJ, 2007, INT J RADIAT ONCOL, V69, P419, DOI 10.1016/j.ijrobp.2007.03.029; Langen KM, 2008, INT J RADIAT ONCOL, V71, P1084, DOI 10.1016/j.ijrobp.2007.11.054; Langen KM, 2003, INT J RADIAT ONCOL, V57, P635, DOI 10.1016/S0360-3016(03)00633-3; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Li HS, 2008, INT J RADIAT ONCOL, V71, P801, DOI 10.1016/j.ijrobp.2007.10.049; Mah D, 2002, INT J RADIAT ONCOL, V54, P568, DOI 10.1016/S0360-3016(02)03008-0; Malinowski K, 2012, MED PHYS, V39, P2042, DOI 10.1118/1.3676690; Muren LP, 2004, RADIOTHER ONCOL, V70, P11, DOI 10.1016/j.radonc.2003.11.013; Nichol AM, 2007, INT J RADIAT ONCOL, V67, P48, DOI 10.1016/j.ijrobp.2006.08.021; Oehler C, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0229-z; Ogino I, 2011, J RADIAT RES, V52, P199, DOI 10.1269/jrr.10126; Padhani AR, 1999, INT J RADIAT ONCOL, V44, P525, DOI 10.1016/S0360-3016(99)00040-1; Sheng Y, 2017, INT J RADIAT ONCOL, V98, P473, DOI 10.1016/j.ijrobp.2017.02.089; Shiomi H, 2000, Radiat Med, V18, P107; Smeenk RJ, 2012, INT J RADIAT ONCOL, V83, P661, DOI 10.1016/j.ijrobp.2011.07.028; Sumida I, 2016, J APPL CLIN MED PHYS, V17, P74, DOI 10.1120/jacmp.v17i2.5914; Suzuki Osamu, 2007, Radiat Med, V25, P31, DOI 10.1007/s11604-006-0092-4; van de Water S, 2014, INT J RADIAT ONCOL, V88, P1154, DOI 10.1016/j.ijrobp.2013.12.045; van der Wielen GJ, 2008, INT J RADIAT ONCOL, V72, P1604, DOI 10.1016/j.ijrobp.2008.07.023; Wang JZ, 2003, INT J RADIAT ONCOL, V55, P194, DOI 10.1016/S0360-3016(02)03828-2; Xie YQ, 2008, INT J RADIAT ONCOL, V72, P236, DOI 10.1016/j.ijrobp.2008.04.051; Yamazaki H, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-10	33	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195296	10.1371/journal.pone.0195296	http://dx.doi.org/10.1371/journal.pone.0195296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621319	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800056
J	Wang, ZH; Fey, AM				Wang, Ziheng; Fey, Ann Majewicz			Human-centric predictive model of task difficulty for human-in-the-loop control tasks	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; COGNITIVE PERFORMANCE; SURGICAL SKILL; QUANTITATIVE ASSESSMENT; ROBOT; MOVEMENT; WORKLOAD; SURGERY; EMG; CLASSIFICATION	Quantitatively measuring the difficulty of a manipulation task in human-in-the-loop control systems is ill-defined. Currently, systems are typically evaluated through task-specific performance measures and post-experiment user surveys; however, these methods do not capture the real-time experience of human users. In this study, we propose to analyze and predict the difficulty of a bivariate pointing task, with a haptic device interface, using human centric measurement data in terms of cognition, physical effort, and motion kinematics. Noninvasive sensors were used to record the multimodal response of human user for 14 subjects performing the task. A data-driven approach for predicting task difficulty was implemented based on several task-independent metrics. We compare four possible models for predicting task difficulty to evaluated the roles of the various types of metrics, including: (I) a movement time model, (II) a fusion model using both physiological and kinematic metrics, (Ill) a model only with kinematic metrics, and (IV) a model only with physiological metrics. The results show significant correlation between task difficulty and the user sensorimotor response. The fusion model, integrating user physiology and motion kinematics, provided the best estimate of task difficulty (R-2 = 0.927), followed by a model using only kinematic metrics (R-2 = 0.921). Both models were better predictors of task difficulty than the movement time model (R-2 = 0.847), derived from Fitt's law, a well studied difficulty model for human psychomotor control.	[Wang, Ziheng; Fey, Ann Majewicz] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75080 USA; [Fey, Ann Majewicz] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, ZH (corresponding author), Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75080 USA.	zxw151130@utdallas.edu		Majewicz Fey, Ann/0000-0002-1802-6730	National Science Foundation, CISE Directorate, CRII: CPS: Intuitive Human-in-the-Loop Control for Medical Cyber-Physical Systems; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]; Direct For Computer & Info Scie & Enginr [1464432] Funding Source: National Science Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Science Foundation, CISE Directorate, CRII: CPS: Intuitive Human-in-the-Loop Control for Medical Cyber-Physical Systems; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Science Foundation, CISE Directorate, CRII: CPS: Intuitive Human-in-the-Loop Control for Medical Cyber-Physical Systems, awarded to PI Ann Majewicz Fey. This award supported author Z.W (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1464432). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL1TR001105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funds were used to support co-author A.M.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi H, 2013, BJU INT, V111, P194, DOI 10.1111/j.1464-410X.2012.11270.x; Ahmidi N, 2017, IEEE T BIOMED ENG; Aras R, 2014, ADV ENG SOFTW, V76, P43, DOI 10.1016/j.advengsoft.2014.05.009; Balasubramanian S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0090-9; Berka C, 2007, AVIAT SPACE ENVIR MD, V78, pB231; Bharathan R, 2013, EUR J OBSTET GYN R B, V169, P347, DOI 10.1016/j.ejogrb.2013.03.017; Borghini G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00633-7; BRADLEY MM, 2000, COGNITIVE NEUROSCIEN, V25, P49, DOI DOI 10.1016/0005-7916(94)90063-9; Cavuoto LA, 2017, UROLOGY; Chien JH, 2010, INT J MED ROBOT COMP, V6, P324, DOI 10.1002/rcs.336; Chmarra MK, 2008, SURG ENDOSC, V22, P943, DOI 10.1007/s00464-007-9526-z; Granero AC, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00074; Criswell E., 2010, CRAMS INTRO SURFACE; Datta V, 2002, AM J SURG, V184, P70, DOI 10.1016/S0002-9610(02)00891-7; Datta V, 2001, J AM COLL SURGEONS, V193, P479, DOI 10.1016/S1072-7515(01)01041-9; Estrada S, 2016, IEEE T HUM-MACH SYST, V46, P647, DOI 10.1109/THMS.2016.2545247; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GEVINS AS, 1990, ELECTROEN CLIN NEURO, V76, P339, DOI 10.1016/0013-4694(90)90035-I; Guru KA, 2015, UROLOGY, V86, P751, DOI 10.1016/j.urology.2015.07.028; Guru KA, 2015, BJU INT, V115, P166, DOI 10.1111/bju.12657; Gwilliam JC, 2009, P IEEE INT C ROB AUT, P677; HART S G, 1988, P139; Hoehn-Saric R, 2000, J AFFECT DISORDERS, V61, P217, DOI 10.1016/S0165-0327(00)00339-6; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Hokayem PF, 2006, AUTOMATICA, V42, P2035, DOI 10.1016/j.automatica.2006.06.027; Huys R, 2015, EPJ NONLINEAR BIOMED, V3, DOI 10.1140/epjnbp/s40366-015-0022-4; Ison M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/051001; Johnson RR, 2011, BIOL PSYCHOL, V87, P241, DOI 10.1016/j.biopsycho.2011.03.003; Jun SK, 2012, P IEEE RAS-EMBS INT, P25, DOI 10.1109/BioRob.2012.6290869; Karlsson JS, 2003, J ELECTROMYOGR KINES, V13, P461, DOI 10.1016/S1050-6411(03)00063-4; KATKIN ES, 1965, J PERS SOC PSYCHOL, V2, P324, DOI 10.1037/h0022303; Kondraske GV, 2002, SURG ENDOSC, V16, P1523, DOI 10.1007/s00464-001-8272-x; Lee D, 2011, IEEE INT CONF ROBOT, P1341; Lin CP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/845037; Lobo-Prat J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-168; Lu Sheng, 2008, J Clin Monit Comput, V22, P23, DOI 10.1007/s10877-007-9103-y; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; Majewicz A, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P395, DOI 10.1109/WHC.2013.6548441; Malysz P, 2011, IEEE T ROBOT, V27, P901, DOI 10.1109/TRO.2011.2152950; Mavridis N., 2015, P 8 IEEE GCC C EXH M, DOI [10.1109/IEEEGCC.2015.7060097, DOI 10.1109/IEEEGCC.2015.7060097]; Mazur LM, 2012, INT J RADIAT ONCOL, V83, pE571, DOI 10.1016/j.ijrobp.2012.01.063; McMahan RP, 2012, IEEE T VIS COMPUT GR, V18, P626, DOI 10.1109/TVCG.2012.43; McMahan W, 2011, IEEE T HAPTICS, V4, P210, DOI [10.1109/TOH.2011.31, 10.1109/ToH.2011.31]; Meyer R, 2016, ADV ERGONOMIC DESIGN, P327, DOI DOI 10.1007/978-3-662-48661-0_22; MILNERBROWN HS, 1975, J PHYSIOL-LONDON, V246, P549, DOI 10.1113/jphysiol.1975.sp010904; Nisky I, 2014, IEEE T BIO-MED ENG, V61, P2869, DOI 10.1109/TBME.2014.2332359; Nisky I, 2014, SURG ENDOSC, V28, P2145, DOI 10.1007/s00464-014-3446-5; O'Malley MK, 2006, J DYN SYST-T ASME, V128, P75, DOI 10.1115/1.2168160; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Oskoei MA, 2008, IEEE T BIO-MED ENG, V55, P1956, DOI 10.1109/TBME.2008.919734; Palafox OM, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2821, DOI 10.1109/IROS.2009.5353995; Peternel L, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P3900, DOI 10.1109/IROS.2016.7759574; Phinyomark A, 2012, EXPERT SYST APPL, V39, P7420, DOI 10.1016/j.eswa.2012.01.102; Rani P, 2006, PATTERN ANAL APPL, V9, P58, DOI 10.1007/s10044-006-0025-y; Rossa C, 2016, IEEE ROBOT AUTOM LET, V1, P852, DOI 10.1109/LRA.2016.2528295; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Sen S, 2016, IEEE INT CONF ROBOT, P4178, DOI 10.1109/ICRA.2016.7487611; Sharon I., 2017, ROBOTICS; Shi Y, 2007, CHI 07 EXTENDED ABST, P2651, DOI [10.1145/1240866.1241057, DOI 10.1145/1240866.1241057]; Smisek J, 2016, IEEE T HUMAN MACHINE; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Uemura M, 2014, J SURG RES, V188, P8, DOI 10.1016/j.jss.2013.12.009; Vander Poorten EB, 2012, IEEE INT CONF ROBOT, P3706, DOI 10.1109/ICRA.2012.6225349; Vedula SS, 2016, J SURG EDUC, V73, P482, DOI 10.1016/j.jsurg.2015.11.009; Vernooij CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27759; Vitense HS, 2003, ERGONOMICS, V46, P68, DOI 10.1080/00140130303534; Williams MR, 2008, IEEE T NEUR SYS REH, V16, P485, DOI 10.1109/TNSRE.2008.2006216; Zarjam P, 2015, IEEE T AUTON MENT DE, V7, P301, DOI 10.1109/TAMD.2015.2441960	70	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195053	10.1371/journal.pone.0195053	http://dx.doi.org/10.1371/journal.pone.0195053			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621301	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800035
J	Zhang, XY; Zhao, J; Li, MY; Tian, M; Shen, Y; Zhou, XT				Zhang, Xiaoyu; Zhao, Jing; Li, Meiyan; Tian, Mi; Shen, Yang; Zhou, Xingtao			Conventional and transepithelial corneal cross-linking for patients with keratoconus	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PROGRESSIVE KERATOCONUS; FOLLOW-UP; ULTRAVIOLET-A; BIOMECHANICAL CHANGES; CONFOCAL MICROSCOPY; CLINICAL-TRIALS; COLLAGEN; RIBOFLAVIN; IONTOPHORESIS	Previous studies investigating the effectiveness of conventional corneal collagen cross-linking (CXL) and transepithelial CXL in keratoconus treatment have reported conflicting outcomes. Therefore, we conducted a meta-analysis to compare the effectiveness of these treatments. We searched MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials for prospective randomized controlled trials (RCTs) with no restrictions. We included visual acuity (corrected distance visual acuity, uncorrected distance visual acuity) and corneal keratometry (K) as primary outcome parameters, and spherical equivalent, central corneal thickness (CCT), and endothelial cell density, as secondary parameters. We finally included seven reports (including six RCTs involving 305 participants and 344 eyes). Our analysis revealed significant postoperative differences in average K and CCT values between conventional and transepithelial CXL-treated patients [K: weighted mean difference (WMD) = 0.79, 95% confidence interval (CI) = 0.04-1.53, p = 0.04; CCT: WMD = 4.53, 95% CI = 0.42-8.64, p = 0.03]. In contrast, we did not find any significant differences in visual acuity, flattest K value, steepest K value, cylinder K value, apex K value, spherical equivalent, or endothelial cell density between groups. In conclusion, transepithelial CXL has a more protective influence on corneal thickness than conventional CXL, and results in lesser postoperative corneal flattening. Further investigation of the clinical outcomes of transepithelial CXL is required.	[Zhang, Xiaoyu; Zhao, Jing; Li, Meiyan; Tian, Mi; Shen, Yang; Zhou, Xingtao] Fudan Univ, Eye & ENT Hosp, Hlth Minist, Myopia Key Lab, Shanghai, Peoples R China	Fudan University	Zhou, XT (corresponding author), Fudan Univ, Eye & ENT Hosp, Hlth Minist, Myopia Key Lab, Shanghai, Peoples R China.	doctzhouxingtao@163.com	zhou, xt/GWZ-9212-2022; zhou, xing/GQP-4516-2022; Shen, Yang/R-3539-2016; Zhang, xiaoyu/GXA-3206-2022	Shen, Yang/0000-0002-5859-0790; Zhou, Xingtao/0000-0002-3465-1579	National Natural Science Foundation of China [81570879, 81770955]; National Natural Science Foundation of China for Young Scholars [11702063, 81600762, 81500753]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81570879 and 81770955) and the National Natural Science Foundation of China for Young Scholars (Grant No. 11702063, 81600762, and 81500753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Fayez MF, 2015, CORNEA, V34, pS53, DOI 10.1097/ICO.0000000000000547; Baiocchi S, 2009, J CATARACT REFR SURG, V35, P893, DOI 10.1016/j.jcrs.2009.01.009; Bikbova G, 2016, ACTA OPHTHALMOL, V94, pE600, DOI 10.1111/aos.13032; Bikbova G, 2014, ACTA OPHTHALMOL, V92, pE30, DOI 10.1111/aos.12235; Bonnel S, 2015, J REFRACT SURG, V31, P36, DOI 10.3928/1081597X-20141218-04; Caporossi A, 2006, J CATARACT REFR SURG, V32, P837, DOI 10.1016/j.jcrs.2006.01.091; Caporossi A, 2013, J CATARACT REFR SURG, V39, P1157, DOI 10.1016/j.jcrs.2013.03.026; Cerman E, 2015, J CATARACT REFR SURG, V41, P1416, DOI 10.1016/j.jcrs.2014.10.041; Coskunseven E, 2009, J REFRACT SURG, V25, P371, DOI 10.3928/1081597X-20090401-02; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbaz U, 2014, CORNEA, V33, P769, DOI 10.1097/ICO.0000000000000154; Elsaftawy HS, 2015, CORNEA, V34, P1420, DOI 10.1097/ICO.0000000000000600; Goldich Y, 2012, CORNEA, V31, P609, DOI 10.1097/ICO.0b013e318226bf4a; Greenstein SA, 2011, J CATARACT REFR SURG, V37, P691, DOI 10.1016/j.jcrs.2010.10.052; Hashemi H, 2013, OPHTHALMOLOGY, V120, P1515, DOI 10.1016/j.ophtha.2013.01.012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Knappe S, 2011, OPHTHALMOLOGICA, V225, P95, DOI 10.1159/000319465; Koller T, 2011, J CATARACT REFR SURG, V37, P1488, DOI 10.1016/j.jcrs.2011.03.041; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Koppen C, 2009, J REFRACT SURG, V25, pS819, DOI 10.3928/1081597X-20090813-11; Kranitz K, 2012, J REFRACT SURG, V28, P645, DOI 10.3928/1081597X-20120823-01; Kymionis GD, 2007, J CATARACT REFR SURG, V33, P1982, DOI 10.1016/j.jcrs.2007.06.036; Kymionis GD, 2012, OPHTHALMOLOGY, V119, P1777, DOI 10.1016/j.ophtha.2012.03.038; Lombardo M, 2017, OPHTHALMOLOGY, V124, P804, DOI 10.1016/j.ophtha.2017.01.040; Lombardo M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/7472542; Magli A, 2013, CORNEA, V32, P597, DOI 10.1097/ICO.0b013e31826cf32d; Mangioris GF, 2010, J REFRACT SURG, V26, P609, DOI 10.3928/1081597X-20100326-01; Mastropasqua L, 2013, CORNEA, V32, P855, DOI 10.1097/ICO.0b013e3182844c60; Mazzotta C, 2012, ACTA OPHTHALMOL, V90, P259, DOI 10.1111/j.1755-3768.2010.01890.x; Nawaz Shah, 2015, Oman J Ophthalmol, V8, P9, DOI 10.4103/0974-620X.149855; Pollhammer M, 2009, J CATARACT REFR SURG, V35, P588, DOI 10.1016/j.jcrs.2008.09.029; Raiskup F, 2015, J CATARACT REFR SURG, V41, P41, DOI 10.1016/j.jcrs.2014.09.033; Randleman JB, 2017, J REFRACT SURG, V33, P727, DOI 10.3928/1081597X-20170925-01; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Rossi S, 2015, CLIN OPHTHALMOL, V9, P503, DOI 10.2147/OPTH.S73991; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Shen Y, 2016, CORNEA, V35, P1434, DOI 10.1097/ICO.0000000000000934; Soeters N, 2015, AM J OPHTHALMOL, V159, pe3; Soeters N, 2015, AM J OPHTHALMOL, V159, P821, DOI 10.1016/j.ajo.2015.02.005; Stojanovic A, 2010, J REFRACT SURG, V26, P145, DOI 10.3928/1081597X-20100121-10; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Touboul D, 2012, J REFRACT SURG, V28, P769, DOI 10.3928/1081597X-20121016-01; Vazirani J, 2013, CLIN OPHTHALMOL, V7, P2019, DOI 10.2147/OPTH.S50119; Vinciguerra P, 2014, J REFRACT SURG, V30, P747, DOI 10.3928/1081597X-20141021-06; Wittig-Silva C, 2008, J REFRACT SURG, V24, pS720, DOI 10.3928/1081597X-20080901-15; Wollensak G, 2011, BRIT J OPHTHALMOL, V95, P876, DOI 10.1136/bjo.2010.190843; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; Xu Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16568-y; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32692	53	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195105	10.1371/journal.pone.0195105	http://dx.doi.org/10.1371/journal.pone.0195105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621306	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800039
J	Chassaing, B; Gewirtzl, AT				Chassaing, Benoit; Gewirtzl, Andrew T.			Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency	PLOS ONE			English	Article							ALTERED SCHAEDLER FLORA; GERM-FREE MICE; METABOLIC SYNDROME; GUT MICROBIOTA; RECEPTOR 5; TLR5-DEFICIENT MICE; COLITIS; COLONIZATION; DISEASE; SUSCEPTIBILITY	Background Inability to maintain a stable and beneficial microbiota is associated with chronic gut inflammation, which classically manifests as colitis but may more commonly exist as low-grade inflammation that promotes metabolic syndrome. Alterations in microbiota, and associated inflammation, can originate from dysfunction in host proteins that manage the microbiota, such as the flagellin receptor TLR5. That the complete absence of a microbiota (i.e. germ free conditions) eliminates all evidence of inflammation in TLR5-deficient mice demonstrates that this model of gut inflammation is microbiota-dependent. We hypothesize that such microbiota dependency reflects an inability to manage pathobionts, such as Adherent Invasive E. coli (AIEC). Herein, we examined the extent to which microbiota mismanagement and associated inflammation in TLR5-deficient mice would manifest in a limited and pathobiont-free microbiota. For this purpose, WT and TLR5-deficient mice were generated and maintained with the 8-member consortium of bacteria referred to as "Altered Schaedler Flora" (ASF). Such ASF animals were subsequently inoculated with AIEC reference strain LF82. Feces were assayed for bacterial loads, fecal lipopolysaccharide and flagellin loads, fecal inflammatory marker lipocalin-2 and microbiota composition. Results Relative to similarly maintained WT mice, mice lacking TLR5 (T5KO) did not display low-grade intestinal inflammation nor metabolic syndrome under ASF conditions. Concomitantly, the ASF microbial community was similar between WT and T5KO mice, while inoculation with AIEC strain LF82 resulted in alteration of the ASF community in T5KO mice compared to WT control animals. AIEC LF82 inoculation in ASF T5KO mice resulted in microbiota components having elevated levels of bioactive lipopolysaccharide and flagellin, a modest level of low-grade inflammation and increased adiposity. Conclusions In a limited-complexity pathobiont-free microbiota, loss of the flagellin receptor TLR5 does not impact microbiota composition nor its ability to promote inflammation. Addition of AIEC to this ecosystem perturbs microbiota composition, increases levels of lipopolysaccharide and flagellin, but only modestly promotes gut inflammation and adiposity, suggesting that the phenotypes previously associated with loss of this innate immune receptor require disruption of complex microbiota.	[Chassaing, Benoit; Gewirtzl, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Chassaing, Benoit] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Chassaing, B (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA.; Chassaing, B (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	bchassaing@gsu.edu			NIH [DK099071, DK083890]; Crohn's and Colitis Foundation of America (CCFA); Kenneth Rainin Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); Kenneth Rainin Foundation	This work was supported by NIH grant DK099071 (A.T.G.) and DK083890 (A.T.G.). B.C. is a recipient of the Career Development Award from the Crohns and Colitis Foundation of America (CCFA). B.C. is a recipient of the Innovator Award from Kenneth Rainin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Chassaing B, 2017, GUT, V66, P1414, DOI 10.1136/gutjnl-2016-313099; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gomes-Neta JC, 2016, EVALUATION NEW REAL; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hecht G, 2014, LAB ANIM-UK, V48, P292, DOI 10.1177/0023677214544728; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Lu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18379; Mirpuri J, 2013, GUT MICROBES, V5; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Norio E, 2010, ANAEROBE, V16, P311, DOI 10.1016/j.anaerobe.2009.10.006; Paik J, 2015, GUT MICROBES, V6, P255, DOI 10.1080/19490976.2015.1064576; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; Singh V, 2015, CELL METAB, V22, P983, DOI 10.1016/j.cmet.2015.09.028; Singh V, 2015, GUT MICROBES, V6, P279, DOI 10.1080/19490976.2015.1060390; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wannemuehler MJ, 2014, GENOME ANNOUNC, V2; Zechner EL, 2017, CURR OPIN MICROBIOL, V35, P64, DOI 10.1016/j.mib.2017.01.011	37	16	16	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195310	10.1371/journal.pone.0195310	http://dx.doi.org/10.1371/journal.pone.0195310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617463	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800074
J	Rajendran, M; Sun, WN; Cornella, P; Nachbagauer, R; Wohlbold, TJ; Amanat, F; Kirkpatrick, E; Palese, P; Krammer, F				Rajendran, Madhusudan; Sun, Weina; Cornella, Phillip; Nachbagauer, Raffael; Wohlbold, Teddy John; Amanat, Fatima; Kirkpatrick, Ericka; Palese, Peter; Krammer, Florian			An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations	PLOS ONE			English	Article							SINGLE-RADIAL-IMMUNODIFFUSION; A VIRUS; NEUTRALIZING EPITOPE; ANTIBODY RECOGNITION; PANDEMIC H1N1; POTENCY; ASSAY; STABILITY; IMMUNITY; ANTIGEN	The standard method to quantify the hemagglutinin content of influenza virus vaccines is the single radial immunodiffusion assay. This assay primarily relies on polyclonal antibodies against the head domain of the influenza virus hemagglutinin, which is the main target antigen of influenza virus vaccines. Novel influenza virus vaccine candidates that redirect the immune response towards the evolutionary more conserved hemagglutinin stalk, including chimeric hemagglutinin and headless hemagglutinin constructs, are highly dependent on the structural integrity of the protein to present conformational epitopes for neutralizing antibodies. In this study, we describe a novel enzyme-linked immunosorbent assay that allows quantifying the amount of hemagglutinin with correctly folded stalk domains and which could be further developed into a potency assay for stalk-based influenza virus vaccines.	[Rajendran, Madhusudan; Sun, Weina; Cornella, Phillip; Nachbagauer, Raffael; Wohlbold, Teddy John; Amanat, Fatima; Kirkpatrick, Ericka; Palese, Peter; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Rajendran, Madhusudan; Cornella, Phillip; Wohlbold, Teddy John; Kirkpatrick, Ericka] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019; Nachbagauer, Raffael/H-7798-2019	Krammer, Florian/0000-0003-4121-776X; Nachbagauer, Raffael/0000-0001-5568-5420; Roubidoux, Ericka/0000-0001-8878-744X; Rajendran, Madhusudan/0000-0003-4451-9608	Centers of Influenza Virus Research and Surveillance (CEIRS) [HHSN272201400008C]; GlaxoSmithKline; Biomedical Advanced Research and Development Authority (BARDA) [HHS0100201500010C];  [P01 AI097092];  [U19 AI109946]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946] Funding Source: NIH RePORTER	Centers of Influenza Virus Research and Surveillance (CEIRS); GlaxoSmithKline(GlaxoSmithKline); Biomedical Advanced Research and Development Authority (BARDA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by the Centers of Influenza Virus Research and Surveillance (CEIRS) contract HHSN272201400008C (Option 22), GlaxoSmithKline, the Biomedical Advanced Research and Development Authority (BARDA, HHS0100201500010C), P01 AI097092 and U19 AI109946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2016, J VIROL; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cotter CR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003831; Desbien AL, 2013, BIOTECHNIQUES, V54, P345, DOI 10.2144/000114041; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Duehr J, 2017, J VIROL, V91, DOI 10.1128/JVI.00652-17; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epand RM, 2002, BIOCHEM J, V365, P841, DOI 10.1042/BJ20020290; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Krammer F, 2015, CELL HOST MICROBE, V18, P395, DOI 10.1016/j.chom.2015.10.003; Krammer F, 2014, J VIROL, V88, P3432, DOI 10.1128/JVI.03004-13; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Minor PD, 2015, VACCINES-BASEL, V3, P90, DOI 10.3390/vaccines3010090; Nachbagauer R, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0026-4; Nachbagauer R, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.15; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pavlovic B, 2016, J AOAC INT, V99, P396, DOI 10.5740/jaoacint.15-0201; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P223; SCHOLTISSEK C, 1985, VACCINE, V3, P215, DOI 10.1016/0264-410X(85)90109-4; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Wohlbold TJ, 2017, NAT MICROBIOL, V2, P1415, DOI 10.1038/s41564-017-0011-8; Wohlbold TJ, 2016, J VIROL, V90, P851, DOI 10.1128/JVI.02275-15; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Yang H, 2014, J VIROL, V88, P4828, DOI 10.1128/JVI.02278-13; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	47	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194830	10.1371/journal.pone.0194830	http://dx.doi.org/10.1371/journal.pone.0194830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617394	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800050
J	Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Ostgren, CJ; Sundrom, J				Bell, Katy J. L.; Azizi, Lamiae; Nilsson, Peter M.; Hayen, Andrew; Irwig, Les; Ostgren, Carl J.; Sundrom, Johan			Prognostic impact of systolic blood pressure variability in people with diabetes	PLOS ONE			English	Article							TO-VISIT VARIABILITY; ALL-CAUSE MORTALITY; PRIMARY-CARE; CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; EPISODIC HYPERTENSION; RISK; PREDICTION; EVENTS; COHORT	Objective Blood pressure variability (BPV) has been associated with risk of cardiovascular events in observational studies, independently of mean BP levels. In states with higher autonomic imbalance, such as in diabetes, the importance of BP variability may theoretically be even greater. We aimed to investigate the incremental value of BPV for prediction of cardiovascular and all-cause mortality in patients with type 2 diabetes. Methods We identified 9,855 patients without pre-existing cardiovascular disease who did not change BP-lowering treatment during the observation period from a Swedish primary health care cohort of patients with type 2 diabetes. BPV was summarized as the standard deviation (SD), coefficient of variation (CV), or variation independent of mean (VIM). Patients were followed for a median of 4 years and associations with cardiovascular and all-cause mortality were investigated using Cox proportional hazards models. Results BPV was not associated with cardiovascular specific or all-cause mortality in the total sample. In patients who were not on BP-lowering drugs during the observation period (n = 2,949), variability measures were associated with all-cause mortality: hazard ratios were 1.05, 1.04 and 1.05 for 50% increases in SD, CV and VIM, respectively, adjusted for Framingham risk score risk factors, including mean BP. However, the addition of the variability measures in this subgroup only led to very minimal improvement in discrimination, indicating they may have limited clinical usefulness (change in C-statistic ranged from 0.000-0.003 in all models). Conclusions Although BPV was independently associated with all-cause mortality in diabetes patients in primary care who did not have pre-existing cardiovascular disease or BP-lowering drugs, it may be of minimal clinical usefulness above and beyond that of other routinely measured predictors, including mean BP.	[Bell, Katy J. L.; Irwig, Les] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Azizi, Lamiae] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Nilsson, Peter M.] Lund Univ, Dept Clin Sci, Univ Hosp, Malmo, Sweden; [Hayen, Andrew] UTS, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Ostgren, Carl J.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundrom, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	University of Sydney; University of Sydney; Lund University; Skane University Hospital; University of Technology Sydney; Linkoping University; Uppsala University	Bell, KJL (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	katy.bell@sydney.edu.au	Stefanadis, Christodoulos/ABH-2232-2020; Bell, Katy/B-9650-2013	Stefanadis, Christodoulos/0000-0001-5974-6454; Bell, Katy/0000-0002-0137-3218; Hayen, Andrew/0000-0003-4046-8030	Australian National Health and Medical Research Council [1013390, 633003]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by the Australian National Health and Medical Research Council (Early Career Fellowship No. 1013390 and Program Grant No 633003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bell K, 2012, EUR J PREV CARDIOL, V19, P1474, DOI 10.1177/1741826711424494; Bell KJL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006044; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Lau KK, 2014, ATHEROSCLEROSIS, V235, P230, DOI 10.1016/j.atherosclerosis.2014.04.015; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MCKINLAY S, 1994, J HUM HYPERTENS, V8, P887; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Ostgren CJ, 2013, DIABETIC MED, V30, pE170, DOI 10.1111/dme.12145; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sohn MW, 2017, J DIABETES COMPLICAT, V31, P195, DOI 10.1016/j.jdiacomp.2016.09.003; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Sundstrom J, 2013, J HYPERTENS, V31, P1603, DOI 10.1097/HJH.0b013e32836123aa; Takao T, 2015, J DIABETES COMPLICAT, V29, P699, DOI 10.1016/j.jdiacomp.2015.03.010; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wan EYF, 2017, DIABETES CARE, V40, P270, DOI 10.2337/dc16-1617	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194084	10.1371/journal.pone.0194084	http://dx.doi.org/10.1371/journal.pone.0194084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641538	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900023
J	Gommer, R; Bom, RA; Fijen, TPM; van Gils, JA				Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.			Stomach fullness shapes prey choice decisions in crab plovers (Dromas ardeola)	PLOS ONE			English	Article							FORAGING DECISIONS; SIZE SELECTION; DIGESTIVE RATE; RED KNOTS; CONSTRAINTS; MECHANISMS; SHOREBIRD; CAPACITY; BEHAVIOR; MODEL	Foragers whose energy intake rate is constrained by search and handling time should, according to the contingency model (CM), select prey items whose profitability exceeds or equals the forager's long-term average energy intake rate. This rule does not apply when prey items are found and ingested at a higher rate than the digestive system can process them. According to the digestive rate model (DRM), foragers in such situations should prefer prey with the highest digestive quality, instead of the highest profitability. As the digestive system fills up, the limiting constraint switches from ingestion rate to digestion rate, and prey choice is expected to change accordingly for foragers making decisions over a relative short time window. We use these models to understand prey choice in crab plovers (Dromas ardeola), preying on either small burrowing crabs that are swallowed whole (high profitability, but potentially inducing a digestive constraint) or on larger swimming crabs that are opened to consume only the flesh (low profitability, but easier to digest). To parameterize the CM and DRM, we measured energy content, ballast mass and handling times for different sized prey, and the birds' digestive capacity in three captive individuals. Subsequently, these birds were used in ad libitum experiments to test if they obeyed the rules of the CM or DRM. We found that crab plovers with an empty stomach mainly chose the most profitable prey, matching the CM. When stomach fullness increased, the birds switched their preference from the most profitable prey to the highest-quality prey, matching the predictions of the DRM. This shows that prey choice is context dependent, affected by the stomach fullness of an animal. Our results suggest that prey choice experiments should be carefully interpreted, especially under captive conditions as foragers often 'fill up' in the course of feeding trials.	[Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands; [Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.] Univ Utrecht, Den Burg, Texel, Netherlands; [Gommer, Roy] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands; [Bom, Roeland A.] Sultan Qaboos Univ, Remote Sensing & GIS Ctr, Al Khoud, Oman; [Fijen, Thijs P. M.] Wageningen Univ & Res, Plant Ecol & Nat Conservat, Wageningen, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Groningen; Sultan Qaboos University; Wageningen University & Research	Gommer, R (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands.; Gommer, R (corresponding author), Univ Utrecht, Den Burg, Texel, Netherlands.; Gommer, R (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands.	roygommer@hotmail.com	Fijen, Thijs/O-9864-2019	Fijen, Thijs/0000-0002-4371-2708	Research Council (TRC) of the Sultanate of Oman [ORG/EBR/12/002]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands [821.01.001]	Research Council (TRC) of the Sultanate of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands(Netherlands Organization for Scientific Research (NWO))	This study was financed by The Research Council (TRC) of the Sultanate of Oman (ORG/EBR/12/002 grant awarded to Andy Kwarteng) and by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands (ALW Open Programme grant 821.01.001 awarded to Jan A. van Gils).	[Anonymous], FORAGING THEORY; Aspinall S.J., 1996, ARABIAN WILDLIFE, V3, P32; BALL JP, 1994, OIKOS, V70, P233, DOI 10.2307/3545634; BENCE JR, 1986, ECOLOGY, V67, P324, DOI 10.2307/1938576; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bom Roeland A., 2015, Wader Study, V122, P212; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; de Fouw Jimmy, 2017, Wader Study, V124, P10, DOI 10.18194/ws.00060; De Marchi G, 2006, IBIS, V148, P753, DOI 10.1111/j.1474-919X.2006.00572.x; De Sanctis A, 2005, IBIS, V147, P490, DOI 10.1111/j.1474-919x.2005.00419.x; Delany S., 2009, ATLAS WADER POPULATI; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Gill AB, 1998, J FISH BIOL, V53, P897, DOI 10.1111/j.1095-8649.1998.tb01844.x; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; Hirakawa H, 1997, EVOL ECOL, V11, P249; Hockey PAR, 1996, OSTRICH, V67, P33, DOI 10.1080/00306525.1996.9633778; HOUSTON A, 1985, BEHAV ECOL SOCIOBIOL, V17, P135; Illius AW, 2002, J ANIM ECOL, V71, P723, DOI 10.1046/j.1365-2656.2002.00643.x; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Kacelnik A, 1996, AM ZOOL, V36, P402; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; LABINGER Z, 1991, ANIM BEHAV, V42, P969, DOI 10.1016/S0003-3472(05)80149-6; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Machovsky-Capuska GE, 2016, ETHOLOGY, V122, P703, DOI 10.1111/eth.12523; Machovsky-Capuska GE, 2016, TRENDS ECOL EVOL, V31, P355, DOI 10.1016/j.tree.2016.02.009; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Molokwu MN, 2011, BEHAV ECOL, V22, P639, DOI 10.1093/beheco/arr025; Oudman T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136144; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Quaintenne G, 2010, J ANIM ECOL, V79, P53, DOI 10.1111/j.1365-2656.2009.01608.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RECHTEN C, 1983, ANIM BEHAV, V31, P576, DOI 10.1016/S0003-3472(83)80081-5; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Simpson SJ, 2011, AUST J ZOOL, V59, P350, DOI 10.1071/ZO11068; SUTHERLAND WJ, 1982, ANIM BEHAV, V30, P857, DOI 10.1016/S0003-3472(82)80159-0; Vahl WK, 2005, BEHAV ECOL, V16, P845, DOI 10.1093/beheco/ari073; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; VANDERMEER J, 1992, ANIM BEHAV, V44, P1101, DOI 10.1016/S0003-3472(05)80322-7; Verkuil Yvonne, 2006, Wader Study Group Bulletin, V110, P15; VERLINDEN C, 1989, EVOL ECOL, V3, P264, DOI 10.1007/BF02270727; Wetzel M. A., 2008, HELGOLAND MARINE RES, V59, P206; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2; Zwarts L, 1996, ARDEA, V84A, P269; ZWARTS L, 1990, ARDEA, V78, P193; Zwarts L, 1996, ARDEA, V84A, P229	48	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194824	10.1371/journal.pone.0194824	http://dx.doi.org/10.1371/journal.pone.0194824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641542	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900048
J	Magno, L; Dourado, I; da Silva, LAV; Brignol, S; Amorim, L; MacCarthy, S				Magno, Laio; Dourado, Ines; da Silva, Luis Augusto V.; Brignol, Sandra; Amorim, Leila; MacCarthy, Sarah			Gender-based discrimination and unprotected receptive anal intercourse among transgender women in Brazil: A mixed methods study	PLOS ONE			English	Article							HIV RISK; SUBSTANCE USE; SEX WORK; HEALTH; VULNERABILITY; POPULATION; BEHAVIOR; CONTEXT; ACCESS; STIGMA	Introduction Discrimination related to gender identity may directly influence vulnerability to HIV through increased exposure to unprotected receptive anal intercourse (URAI). Little is known about the relationship between gender-based discrimination (GBD) and URAI with stable partners among transgender women. Methods This mixed-methods research began with a cross-sectional survey conducted between 2014 and 2016 with transgender women in Salvador, the capital city in one of the poorest regions in Brazil. Respondent-driven sampling was used to recruit the study population. GBD was defined through Latent Class Analysis. Additionally, 19 semi-structured interviews with participants were transcribed and analyzed through thematic content analysis. Results URAI with stable partners was commonly reported (37.3%). GDB was positively associated with URAI among stable partners (OR = 6.47; IC 95%: 1.67-25.02). The analysis of the interviews illustrated how GBD impacted transgender women in diverse ways. Experiences with GBD perpetrated by the family often initiated a trajectory of economic vulnerability that led many to engage in survival sex work. The constant experience with GBD contributed to participants feeling an immense sense of trust with their stable partners, ultimately diminished their desire to use condoms. Further, the high frequency of GBD contributed to poor mental health overall, though some participants said engagement in transgender advocacy efforts provided a vital source of resilience and support. Conclusion Our mixed-method study capitalizes upon the strengths of diverse data sets to produce a holistic understanding of GBD and URAI with stable partners. Furthermore, by confirming the association between greater GBD and URAI, we have demonstrated how GBD can impact condom negotiation in diverse relationships.	[Magno, Laio] Univ Estado Bahia, Dept Ciencias Vida, Salvador, BA, Brazil; [Magno, Laio; Dourado, Ines; da Silva, Luis Augusto V.; Amorim, Leila] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [da Silva, Luis Augusto V.] Univ Fed Bahia, Inst Humanidades Artes & Ciencias Prof Milton San, Salvador, BA, Brazil; [Brignol, Sandra] Univ Fed Fluminense, Inst Saude Colet, Niteroi, RJ, Brazil; [Amorim, Leila] Univ Fed Bahia, Inst Matemat & Estat, Salvador, BA, Brazil; [MacCarthy, Sarah] RAND Corp, Santa Monica, CA USA	Universidade do Estado Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal Fluminense; Universidade Federal da Bahia; RAND Corporation	Magno, L (corresponding author), Univ Estado Bahia, Dept Ciencias Vida, Salvador, BA, Brazil.; Magno, L (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.	laiomagnoss@gmail.com	Dourado, Ines/Q-6535-2016; BRIGNOL, SANDRA/AAL-2368-2020; Amorim, Leila/ABG-9480-2021; Magno, Laio/M-9366-2019	Dourado, Ines/0000-0003-1675-2146; Amorim, Leila/0000-0002-1112-2332; Magno, Laio/0000-0003-3752-0782	STI/HIV/Aids; Viral Hepatitis Department of the Brazilian Minister of Health; CAPES [1031340]	STI/HIV/Aids; Viral Hepatitis Department of the Brazilian Minister of Health; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We are grateful for the support of STI/HIV/Aids and Viral Hepatitis Department of the Brazilian Minister of Health. The HIV/AIDS Reference Center of the Bahia Department of Health (CEDAP/SESAB). Additionally, we appreciate the support of CAPES for the PhD fellowship granted to LM (Grant Number #1031340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their gratitude to the participants of the study, to Lucilia Nascimento for the field work coordination, to Fabiane Soares, Vanessa Barros, Ailton Jesus da Silva, Ana Lucia Vilela e Munyra Araujo for field work, to ATRAS a TGW-NGO in Salvador. We are also grateful for the support of STI/HIV/Aids and Viral Hepatitis Department of the Brazilian Minister of Health. The HIV/AIDS Reference Center of the Bahia Department of Health (CEDAP/SESAB). Additionally, we appreciate the support of CAPES for the PhD fellowship granted to LM (Grant Number #1031340). Finally, we thank Mary Vaiana for her careful and thoughtful review of this manuscript.	[Anonymous], 2014, LANCET, V384, P207, DOI 10.1016/S0140-6736(14)61193-4; Arán Márcia, 2009, Physis, V19, P15, DOI 10.1590/S0103-73312009000100003; Paula CEA, 2017, CIENC SAUDE COLETIVA, V22, P3841, DOI 10.1590/1413-812320172212.24842017; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Barbosa A, 2011, CAD SAUDE PUBLICA, V27, pS36, DOI 10.1590/S0102-311X2011001300005; Barroso SM, 2014, REV PANAM SALUD PUBL, V35, P256; Beattie TSH, 2012, J EPIDEMIOL COMMUN H, V66, pII42, DOI 10.1136/jech-2011-200475; Benedetti Marcos Renato, 2005, TODA FEITA CORPO GEN; Bockting WO, 2005, AIDS CARE, V17, P289, DOI 10.1080/09540120412331299825; Boivin Renaud René, 2014, Sex., Salud Soc. (Rio J.), P86; Bray BC, 2015, STRUCT EQU MODELING, V22, P1, DOI 10.1080/10705511.2014.935265; Carrara Sérgio, 2006, Physis, V16, P233, DOI 10.1590/S0103-73312006000200006; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Clements-Nolle K, 2006, J HOMOSEXUAL, V51, P53, DOI 10.1300/J082v51n03_04; Clernents-Nolle K, 2008, SEX HEALTH, V5, P49, DOI 10.1071/SH07045; Collins L.M., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Costa AB, 2015, ARCH SEX BEHAV, V44, P521, DOI 10.1007/s10508-014-0386-z; de Sousa PJ, 2013, CIENC SAUDE COLETIVA, V18, P2239, DOI 10.1590/S1413-81232013000800008; DiStefano AS, 2016, QUAL HEALTH RES, V26, P877, DOI 10.1177/1049732315627644; Dourado I, 2016, BRAZIL CAD SAUDE PUB, V32, P1; Estrada-Montoya John Harold, 2010, Rev. Gerenc. Polit. Salud, V9, P90; Ganju D, 2017, CULT HEALTH SEX, V19, P903, DOI 10.1080/13691058.2016.1271141; Gibson BA, 2016, GLOB PUBLIC HEALTH, V11, P1010, DOI 10.1080/17441692.2015.1134614; Grinsztejn B, 2017, LANCET HIV, V4, pE169, DOI 10.1016/S2352-3018(17)30015-2; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hoffman Beth, 2014, Depress Res Treat, V2014, P394283, DOI 10.1155/2014/394283; Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010; Infante C, 2009, CULT HEALTH SEX, V11, P125, DOI 10.1080/13691050802431314; Kaplan RL, 2015, HEALTH CARE WOMEN IN, V36, P917, DOI 10.1080/07399332.2014.896012; Khan SI, 2009, J HEALTH POPUL NUTR, V27, P441, DOI 10.3329/jhpn.v27i4.3388; Kohlbrenner V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159359; Koken JA, 2009, J FAM PSYCHOL, V23, P853, DOI 10.1037/a0017198; KULICK DON, 1998, TRAVESTI SEX GENDER; Lane R, 2016, LANCET, V388, P331, DOI 10.1016/S0140-6736(16)30841-8; Lionço Tatiana, 2009, Physis, V19, P43, DOI 10.1590/S0103-73312009000100004; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P416, DOI 10.1089/apc.2016.0145; Logie CH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17392; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Malta Monica, 2013, J Int AIDS Soc, V16, P18817, DOI 10.7448/IAS.16.1.18817; Martins TA, 2013, AIDS CARE, V25, P606, DOI 10.1080/09540121.2012.726342; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; Mountian I., 2014, CRITICAL ANAL PUBLIC, P25; Muthen L.K., MPLUS USERS GUIDE, V8th; Nemoto T, 2004, AIDS CARE, V16, P724, DOI 10.1080/09540120413331269567; Nogueira SNB, 2017, GEOGRAFIA CORPOS PES; Nuttbrock L, 2013, AM J PUBLIC HEALTH, V103, P300, DOI 10.2105/AJPH.2011.300568; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Operario D, 2005, AIDS EDUC PREV, V17, P430, DOI 10.1521/aeap.2005.17.5.430; Operario D, 2011, AIDS BEHAV, V15, P674, DOI 10.1007/s10461-010-9795-8; Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x; Palazzolo SL, 2016, LGBT HEALTH, V3, P132, DOI 10.1089/lgbt.2015.0133; Parker RG, 1996, INT J STD AIDS, V7, P62, DOI 10.1258/0956462961917663; Peitzmeier SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139320; Pelúcio Larissa, 2005, Cad. Pagu, P217, DOI 10.1590/S0104-83332005000200009; Pollock L, 2016, GLOB PUBLIC HEALTH, V11, P981, DOI 10.1080/17441692.2016.1167932; Popadiuk GS, 2017, CIENC SAUDE COLETIVA, V22, P1509, DOI 10.1590/1413-81232017225.32782016; Rhodes SD, 2015, HEALTH PROMOT INT, V30, P832, DOI 10.1093/heapro/dau013; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Sanchez T, 2010, AIDS BEHAV, V14, P351, DOI 10.1007/s10461-009-9610-6; Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]; Stahlman S, 2016, J INT AIDS SOC, V19, P5, DOI 10.7448/IAS.19.3.20774; Sugano E, 2006, AIDS BEHAV, V10, P217, DOI 10.1007/s10461-005-9040-z; Tagliamento G, 2016, J HOMOSEXUAL, V63, P1556, DOI 10.1080/00918369.2016.1223359; de Souza MHT, 2015, CAD SAUDE PUBLICA, V31, P767, DOI 10.1590/0102-311X00077514; Weiser AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151977; Wilson E, 2011, CULT HEALTH SEX, V13, P253, DOI 10.1080/13691058.2010.524247; Wilson EC, 2013, INT J TRANSGENDERISM, V14, P182, DOI 10.1080/15532739.2014.890090; Woodford MR, 2016, GLOB PUBLIC HEALTH, V11, P363, DOI 10.1080/17441692.2015.1057757	69	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194306	10.1371/journal.pone.0194306	http://dx.doi.org/10.1371/journal.pone.0194306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641528	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900029
J	Fernandez, I; Sycz, G; Goldbaum, FA; Carrica, MD				Fernandez, Ignacio; Sycz, Gabriela; Alberto Goldbaum, Fernando; del Carmen Carrica, Mariela			Acidic pH triggers the phosphorylation of the response regulator NtrX in alphaproteobacteria	PLOS ONE			English	Article							CAULOBACTER-CRESCENTUS; 2-COMPONENT SYSTEM; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; BRUCELLA-SUIS; EXPRESSION; SENSOR; MACROPHAGES; ADAPTATION; METABOLISM	Many signaling pathways that control cellular development, cell-cycle progression and nutritional versatility have been studied in Caulobacter crescentus. For example, it was suggested that the response regulator NtrX is conditionally essential for this bacterium and that it might be necessary for responding to a signal produced in phosphate-replete minimal medium. However, such signal has not been identified yet and the role of NtrX in C. crescentus biology remains elusive. Here, using wild-type C. crescentus and a strain with a chromosomally myc-tagged ntrX gene, we demonstrate that high concentrations of phosphate (10 mM) regulate ntrX transcription and the abundance of the protein. We also show that the pH of the medium acts as a switch able to regulate the phosphorylation status of NtrX, promoting its phosphorylation under mildly acidic conditions and its dephosphorylation at neutral pH. Moreover, we demonstrate that the ntrX gene is required for survival in environments with low pH and under acidic stress. Finally, we prove that NtrX phosphorylation is also triggered by low pH in Brucella abortus, a pathogenic alphaproteobacterium. Overall, our work contributes to deepen the general knowledge of this system and provides tools to elucidate the NtrX regulon.	[Fernandez, Ignacio; Sycz, Gabriela; Alberto Goldbaum, Fernando; del Carmen Carrica, Mariela] Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Carrica, MD (corresponding author), Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina.	mcarrica@leloir.org.ar		Fernandez, Ignacio/0000-0003-2632-8111; Goldbaum, Fernando/0000-0001-6235-3002	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2013-1629]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT-2013-1629) to Dr. Mariela del Carmen Carrica.; We thank Michael Laub for kindly providing us the C. crescentus CB15N and Delta ntrX strains. F.A.G and M.C.C are researchers from CONICET. I.F. received a fellowship from CONICET and G.S. is a fellow from this institution.	Atack JM, 2013, J BACTERIOL, V195, P2632, DOI 10.1128/JB.02062-12; Bonato P, 2016, FEBS J, V283, P3919, DOI 10.1111/febs.13897; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Calatrava-Morales N, 2017, MOL PLANT MICROBE IN, V30, P566, DOI 10.1094/MPMI-01-17-0021-R; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Cheng ZH, 2014, MBIO, V5, DOI 10.1128/mBio.02141-14; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Choi J, 2016, MOL MICROBIOL, V101, P1024, DOI 10.1111/mmi.13439; Carrica MD, 2013, MOL MICROBIOL, V88, P222, DOI 10.1111/mmi.12181; Carrica MD, 2012, MOL MICROBIOL, V85, P39, DOI 10.1111/j.1365-2958.2012.08095.x; Drepper T, 2006, FEMS MICROBIOL LETT, V258, P250, DOI 10.1111/j.1574-6968.2006.00228.x; Eguchi Y, 2014, J BACTERIOL, V196, P3140, DOI 10.1128/JB.01742-14; ELY B, 1991, BACT GEN SYST, V204, P372, DOI DOI 10.1016/0076-6879(91)04019-K; Fernandez I, 2017, J MOL BIOL, V429, P1192, DOI 10.1016/j.jmb.2016.12.022; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gregor J, 2007, J MOL MICROB BIOTECH, V13, P126, DOI 10.1159/000103604; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Lubin EA, 2016, J BACTERIOL, V198, P187, DOI 10.1128/JB.00658-15; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Purcell EB, 2008, ADV EXP MED BIOL, V631, P122, DOI 10.1007/978-0-387-78885-2_8; RILEY RG, 1976, MICROBIOS, V16, P219; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang D, 2013, APPL ENVIRON MICROB, V79, P7150, DOI 10.1128/AEM.02225-13; Wen Y, 2007, J BACTERIOL, V189, P2426, DOI 10.1128/JB.01492-06; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194486	10.1371/journal.pone.0194486	http://dx.doi.org/10.1371/journal.pone.0194486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634773	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200010
J	Jansen, C; Al-Kassou, B; Lehmann, J; Pohlmann, A; Chang, J; Praktiknjo, M; Nickenig, G; Strassburg, CP; Schrickel, JW; Andrie, R; Linhart, M; Trebicka, J				Jansen, Christian; Al-Kassou, Baravan; Lehmann, Jennifer; Pohlmann, Alessandra; Chang, Johannes; Praktiknjo, Michael; Nickenig, Georg; Strassburg, Christian P.; Schrickel, Jan W.; Andrie, Rene; Linhart, Markus; Trebicka, Jonel			Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RATE-VARIABILITY; AUTONOMIC NEUROPATHY; FAILURE; DECOMPENSATION; PROGNOSIS; INTERVAL	Background In patients with liver cirrhosis, cardiac dysfunction is frequent and is associated with increased morbidity and mortality. Cardiac dysfunction in cirrhosis seems to be linked to autonomic dysfunction. This study investigates the role of autonomic dysfunction assessed by Heart Rate Turbulence (HRT) analyses in patients with liver cirrhosis. Methods and patients Inclusion criteria was (1) diagnosis of cirrhosis by clinical, imaging or biopsy and (2) evaluation by standard 12-lead-ECG and 24h holter monitoring and (3) at least 3 premature ventricular contractions. The exclusion criterion was presence of cardiac diseases, independent of liver cirrhosis. Biochemical parameters were analysed using standard methods. HRT was assessed using Turbulence onset (TO) and slope (TS). The endpoint was deterioration of liver cirrhosis defined as increased MELD and readmission for complications of liver cirrhosis. Results Out of 122 cirrhotic patients, 82 patients (63% male) with median Child score of 6 (range 5-12) and median MELD score of 10 (range 6-32) were included. Increasing Child score, INR and decreasing albumin were correlated with TO. In addition, decompensated patients with ascites showed more abnormal TO and TS. During the observation period, patients with more abnormal TO showed significantly higher rate of rising MELD Score at 6 months (p = 0.03). Nevertheless, at least in our collective HRT-parameters were not independent predictors of deterioration of cirrhosis. Conclusion Parameters of HRT are closely associated with deterioration of cirrhosis and might be helpful in its prediction.	[Jansen, Christian; Al-Kassou, Baravan; Lehmann, Jennifer; Pohlmann, Alessandra; Chang, Johannes; Praktiknjo, Michael; Strassburg, Christian P.; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Nickenig, Georg; Schrickel, Jan W.; Andrie, Rene; Linhart, Markus] Univ Bonn, Dept Internal Med 2, Bonn, Germany; [Linhart, Markus] Hosp Clin Barcelona, Dept Cardiol, Barcelona, Spain; [Trebicka, Jonel] European Fdn Study Chron Liver Failure, Barcelona, Spain; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Trebicka, Jonel] Inst Bioengn Catalonia, Barcelona, Spain	University of Bonn; University of Bonn; University of Barcelona; Hospital Clinic de Barcelona; University of Southern Denmark; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), European Fdn Study Chron Liver Failure, Barcelona, Spain.; Trebicka, J (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Trebicka, J (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	jonel.trebicka@ukbonn.de	Al-Kassou, Baravan/GPW-7910-2022		Deutsche Forschungsgemeinschaft [SFB TRR57]; Cellex Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cellex Foundation	The authors were supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57) and Cellex Foundation. The funders had no influence on study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ates F, 2006, DIGEST DIS SCI, V51, P1614, DOI 10.1007/s10620-006-9073-9; Balcioglu S, 2007, AM J CARDIOL, V100, P890, DOI 10.1016/j.amjcard.2007.03.106; Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Bazett H. C., 1997, ANN NONINVAS ELECTRO, V2, P177, DOI DOI 10.1111/J.1542-474X.1997.TB00325.X; EWING DJ, 1986, CLIN ENDOCRINOL META, V15, P855, DOI 10.1016/S0300-595X(86)80078-0; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Genovesi S, 2009, CLIN SCI, V116, P851, DOI 10.1042/CS20080325; GERBES AL, 1986, LANCET, V1, P1409; Gunduz H, 2006, EUROPACE, V8, P515, DOI 10.1093/europace/eul059; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; Laffi G, 1997, GASTROENTEROLOGY, V113, P891, DOI 10.1016/S0016-5085(97)70184-7; LEE SS, 1990, HEPATOLOGY, V12, P481, DOI 10.1002/hep.1840120306; Mani AR, 2009, AM J PHYSIOL-GASTR L, V296, pG330, DOI 10.1152/ajpgi.90488.2008; Moller S, 2007, AM J PHYSIOL-HEART C, V292, pH2966, DOI 10.1152/ajpheart.01227.2006; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Moore RKG, 2006, EUR J HEART FAIL, V8, P585, DOI 10.1016/j.ejheart.2005.11.012; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Osman F, 2004, AM J CARDIOL, V94, P465, DOI 10.1016/j.amjcard.2004.04.061; Piano S, 2017, J HEPATOL, V67, P1177, DOI 10.1016/j.jhep.2017.07.008; Poliwczak AR, 2011, MED SCI MONITOR, V17, pPR5, DOI 10.12659/MSM.881788; Ramirez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186152; Schmidt G, 1999, LANCET, V353, P1390, DOI 10.1016/S0140-6736(98)08428-1; Stockigt F, 2014, EUROPACE, V16, P1092, DOI 10.1093/europace/eut357; Tuomainen P, 2005, LIFE SCI, V77, P2723, DOI 10.1016/j.lfs.2005.05.023; Watanabe MA, 2004, HEART RHYTHM, V1, P732, DOI 10.1016/j.hrthm.2004.09.003	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195631	10.1371/journal.pone.0195631	http://dx.doi.org/10.1371/journal.pone.0195631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634776	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200042
J	Ramula, S; Ost, M; Linden, A; Karell, P; Kilpi, M				Ramula, Satu; Ost, Markus; Linden, Andreas; Karell, Patrik; Kilpi, Mikael			Increased male bias in eider ducks can be explained by sex-specific survival of prime-age breeders	PLOS ONE			English	Article							SOMATERIA-MOLLISSIMA; COMMON EIDERS; RATIO; POPULATION; DYNAMICS; SYSTEM; COST; CONSEQUENCES; DISPERSAL; MOVEMENTS	In contrast to theoretical predictions of even adult sex ratios, males are dominating in many bird populations. Such bias among adults may be critical to population growth and viability. Nevertheless, demographic mechanisms for biased adult sex ratios are still poorly understood. Here, we examined potential demographic mechanisms for the recent dramatic shift from a slight female bias among adult eider ducks (Somateria mollissima) to a male bias (about 65% males) in the Baltic Sea, where the species is currently declining. We analysed a nine-year dataset on offspring sex ratio at hatching based on molecularly sexed ducklings of individually known mothers. Moreover, using demographic data from long-term individual-based capture-recapture records, we investigated how sex-specific survival at different ages after fledgling can modify the adult sex ratio. More specifically, we constructed a stochastic two-sex matrix population model and simulated scenarios of different survival probabilities for males and females. We found that sex ratio at hatching was slightly female-biased (52.8%) and therefore unlikely to explain the observed male bias among adult birds. Our stochastic simulations with higher survival for males than for females revealed that despite a slight female bias at hatching, study populations shifted to a male-biased adult sex ratio (> 60% males) in a few decades. This shift was driven by prime reproductive-age individuals(>5-year-old), with sex-specific survival of younger age classes playing a minor role. Hence, different age classes contributed disproportion ally to population dynamics. We argue that an alternative explanation for the observed male dominance among adults sex-biased dispersal can be considered redundant and is unlikely, given the ecology of the species. The present study highlights the importance of considering population structure and age-specific vital rates when assessing population dynamics and management targets.	[Ramula, Satu] Univ Turku, Dept Biol, Turku, Finland; [Ost, Markus; Linden, Andreas; Karell, Patrik; Kilpi, Mikael] Novia Univ Appl Sci, Bioecon Res Team, Ekenas, Finland; [Ost, Markus] Abo Akad Univ, Environm & Marine Biol, Fac Sci & Engn, Turku, Finland	University of Turku; Novia University of Applied Sciences; Abo Akademi University	Ramula, S (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	satu.ramula@utu.fi	Öst, Markus/C-7376-2008; Linden, Andreas/D-9315-2017	Öst, Markus/0000-0002-2205-1437; Karell, Patrik/0000-0003-0297-125X; Linden, Andreas/0000-0002-5548-2671	Academy of Finland [285746, 309992]; Swedish Cultural Foundation in Finland; Walter and Andree de Nottbeck Foundation	Academy of Finland(Academy of Finland); Swedish Cultural Foundation in Finland; Walter and Andree de Nottbeck Foundation	This work was supported by the Academy of Finland (#285746 to SR, #309992 to PK), the Swedish Cultural Foundation in Finland (to MO) and the Walter and Andree de Nottbeck Foundation (to MK).	Alisauskas RT, 2015, STUDIES AVIAN BIOL, P46; Ancona S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0313; BAILLIE SR, 1982, BIRD STUDY, V29, P55, DOI 10.1080/00063658209476738; BAILLIE SR, 1989, IBIS, V131, P321, DOI 10.1111/j.1474-919X.1989.tb02782.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bensch S, 1999, J EVOLUTION BIOL, V12, P1104; BirdLife International, 2015, EUR RED LIST BIRDS; Blums P, 1996, AUK, V113, P505, DOI 10.2307/4088920; Carmona-Isunza MC, 2017, BEHAV ECOL, V28, P523, DOI 10.1093/beheco/arw183; Caswell, 2000, MATRIX POPULATION MO; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Eberhart-Phillips LJ, 2017, P NATL ACAD SCI USA, V114, pE5474, DOI 10.1073/pnas.1620043114; Ekroos J, 2012, OECOLOGIA, V170, P979, DOI 10.1007/s00442-012-2378-9; Fisher, 1930, GENETICAL THEORY NAT; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gerber LR, 2014, J APPL ECOL, V51, P270, DOI 10.1111/1365-2664.12177; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hario M, 2009, ORNIS FENNICA, V86, P81; Hario M, 2009, OECOLOGIA, V159, P747, DOI 10.1007/s00442-008-1265-x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Jaatinen K, 2011, ANIM BEHAV, V81, P1289, DOI 10.1016/j.anbehav.2011.03.020; Jaatinen K, 2011, J ANIM ECOL, V80, P49, DOI 10.1111/j.1365-2656.2010.01757.x; Kilpi M, 1997, OECOLOGIA, V111, P297, DOI 10.1007/s004420050238; Kilpi M, 2003, ORNIS FENNICA, V80, P137; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kosztolanyi A, 2011, J EVOLUTION BIOL, V24, P1842, DOI 10.1111/j.1420-9101.2011.02305.x; Kurvinen L, 2016, ORNIS FENNICA, V93, P55; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Lehikoinen A, 2008, CONDOR, V110, P574, DOI 10.1525/cond.2008.8574; Lehikoinen A, 2008, WILDLIFE BIOL, V14, P288, DOI 10.2981/0909-6396(2008)14[288:LCITSR]2.0.CO;2; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Milton GR, 2016, J WILDLIFE MANAGE, V80, P1427, DOI 10.1002/jwmg.21135; Morrison CA, 2016, J ANIM ECOL, V85, P1298, DOI 10.1111/1365-2656.12556; Nevoux M, 2013, ECOL LETT, V16, P438, DOI 10.1111/ele.12060; Oppel S, 2010, CONDOR, V112, P323, DOI 10.1525/cond.2010.090199; Ost M, 2016, POPUL ECOL, V58, P121, DOI 10.1007/s10144-015-0517-y; Ost M, 2010, OECOLOGIA, V162, P59, DOI 10.1007/s00442-009-1444-4; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Pipoly I, 2015, NATURE, V527, P91, DOI 10.1038/nature15380; Proaktor G, 2007, BIOLOGY LETT, V3, P674, DOI 10.1098/rsbl.2007.0376; R Development Core Team, 2009, R LANG ENV STAT COMP; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Shyu E, 2016, ECOL EVOL, V6, P1470, DOI 10.1002/ece3.1902; Steele BB, 2007, ORNIS FENNICA, V84, P49; SWENNEN C, 1990, ORNIS SCAND, V21, P17, DOI 10.2307/3676374; Szekely T, 2014, J EVOLUTION BIOL, V27, P1500, DOI 10.1111/jeb.12415; Szekely T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0342; Veran S, 2009, ECOL LETT, V12, P129, DOI 10.1111/j.1461-0248.2008.01268.x	49	16	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195415	10.1371/journal.pone.0195415	http://dx.doi.org/10.1371/journal.pone.0195415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634733	Green Published, gold			2022-12-27	WOS:000429522200030
J	Arkun, Y; Yasemi, M				Arkun, Yaman; Yasemi, Mohammadreza			Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; NEGATIVE-FEEDBACK; COMPUTATIONAL ANALYSIS; MAPK; RAS; PHOSPHORYLATION; SWITCH; EGF; ULTRASENSITIVITY	Cell signaling is the process by which extracellular information is transmitted into the cell to perform useful biological functions. The ERK (extracellular-signal-regulated kinase) signaling controls several cellular processes such as cell growth, proliferation, differentiation and apoptosis. The ERK signaling pathway considered in this work starts with an extracellular stimulus and ends with activated (double phosphorylated) ERK which gets translocated into the nucleus. We model and analyze this complex pathway by decomposing it into three functional subsystems. The first subsystem spans the initial part of the pathway from the extracellular growth factor to the formation of the SOS complex, ShC-Grb2-SOS. The second subsystem includes the activation of Ras which is mediated by the SOS complex. This is followed by the MAPK subsystem (or the Raf-MEK-ERK pathway) which produces the double phosphorylated ERK upon being activated by Ras. Although separate models exist in the literature at the subsystems level, a comprehensive model for the complete system including the important regulatory feedback loops is missing. Our dynamic model combines the existing subsystem models and studies their steady-state and dynamic interactions under feedback. We establish conditions under which bistability and oscillations exist for this important pathway. In particular, we show how the negative and positive feedback loops affect the dynamic characteristics that determine the cellular outcome.	[Arkun, Yaman; Yasemi, Mohammadreza] Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, Istanbul, Turkey.	yarkun@ku.edu.tr		Arkun, Yaman/0000-0002-3740-379X; Yasemi, Mohammadreza/0000-0003-0226-7748	TUBITAK; Scientific and Technological Research Council of Turkey; Koc University	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Koc University(Koc University)	The authors received funding from TUBITAK, The Scientific and Technological Research Council of Turkey and Koc University for this work.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Choi S., 2007, INTRO SYSTEMS BIOL; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Doyle FJ, 2004, CELL, V118, P675, DOI [10.1016/j.cell.2004.09.008, DOI 10.1016/J.CELL.2004.09.008]; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fey D, 2016, SEMIN CELL DEV BIOL, V58, P96, DOI 10.1016/j.semcdb.2016.06.011; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Goldstein B, 1999, J MOL RECOGNIT, V12, P293, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<293::AID-JMR472>3.0.CO;2-M; Golembo M, 1996, DEVELOPMENT, V122, P223; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ingalls B. P, 2014, J CHEM INF MODEL, V53, P1; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Kawashima N, 2010, CHEM-EUR J, V16, P1186, DOI 10.1002/chem.200902963; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; Kochanczyk M, 2017, SCI REP-UK, V7, DOI 10.1038/srep38244; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Lauffenberger DA, 1993, RECEPTORS MODELS BIN; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nakayama K, 2008, CURRENT BIOL; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pribyl M, 2003, BIOPHYS J, V84, P883; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Reeves GT, 2005, DEV BIOL, V284, P523, DOI 10.1016/j.ydbio.2005.05.013; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Ryu H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156458; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Seborg D.E., 2011, PROCESS DYNAMICS CON; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Shurki A, 2004, PROTEINS, V55, P1, DOI 10.1002/prot.20004; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; SPORN MB, 1992, ANN INTERN MED, V117, P408, DOI 10.7326/0003-4819-117-5-408; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Waters KM, 2014, CHEM RES TOXICOL, V27, P1496, DOI 10.1021/tx500085u; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	62	38	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195513	10.1371/journal.pone.0195513	http://dx.doi.org/10.1371/journal.pone.0195513			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630631	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000054
J	Onishi, S; Ishino, M; Kitazawa, H; Yoto, A; Shimba, Y; Mochizuki, Y; Unno, K; Meguro, S; Tokimitsu, I; Miura, S				Onishi, Shintaro; Ishino, Mayu; Kitazawa, Hidefumi; Yoto, Ai; Shimba, Yuki; Mochizuki, Yusuke; Unno, Keiko; Meguro, Shinichi; Tokimitsu, Ichiro; Miura, Shinji			Green tea extracts ameliorate high-fat diet induced muscle atrophy in senescence-accelerated mouse prone-8 mice	PLOS ONE			English	Article							AMINO-ACID SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; PHYSICAL FUNCTION; SELENOPROTEIN P; CHEMOTAXIN 2; RISK-FACTORS; OLDER WOMEN	Muscle atrophy (loss of skeletal muscle mass) causes progressive deterioration of skeletal function. Recently, excessive intake of fats was suggested to induce insulin resistance, followed by muscle atrophy. Green tea extracts (GTEs), which contain polyphenols such as epigallocatechin gallate, have beneficial effects on obesity, hyperglycemia, and insulin resistance, but their effects against muscle atrophy are still unclear. Here, we found that GTEs prevented high-fat (HF) diet induced muscle weight loss in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, an HF diet, or HF with 0.5% GTEs (HFGT) diet for 4 months. The HF diet induced muscle weight loss with aging (measured as quadriceps muscle weight), whereas GTEs prevented this loss. In HF diet fed mice, blood glucose and plasma insulin concentrations increased in comparison with the control group, and these mice had insulin resistance as determined by homeostasis model assessment of insulin resistance (HOMA-IR). In these mice, serum concentrations of leukocyte cell derived chemotaxin 2 (LECT2), which is known to induce insulin resistance in skeletal muscle, were elevated, and insulin signaling in muscle, as determined by the phosphorylation levels of Akt and p70 S6 kinases, tended to be decreased. In HFGT diet fed mice, these signs of insulin resistance and elevation of serum LECT2 were not observed. Although our study did not directly show the effect of serum LECT2 on muscle weight, insulin resistance examined using HOMA-IR indicated an intervention effect of serum LECT2 on muscle weight, as revealed by partial correlation analysis. Accordingly, GTEs might have beneficial effects on age-related and HF diet induced muscle weight loss, which correlates with insulin resistance and is accompanied by a change in serum LECT2.	[Onishi, Shintaro; Kitazawa, Hidefumi; Yoto, Ai; Meguro, Shinichi; Tokimitsu, Ichiro] Univ Shizuoka, Ind Acad Collaborat Res Lab, Shizuoka, Japan; [Onishi, Shintaro; Kitazawa, Hidefumi; Yoto, Ai; Meguro, Shinichi; Tokimitsu, Ichiro] Univ Shizuoka, Kao Corp, Shizuoka, Japan; [Ishino, Mayu; Shimba, Yuki; Mochizuki, Yusuke; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka, Japan; [Unno, Keiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka, Japan; [Onishi, Shintaro; Kitazawa, Hidefumi; Meguro, Shinichi] Kao Corp, Biol Sci Res, Haga Gun, Tochigi, Japan; [Tokimitsu, Ichiro] Univ Human Arts & Sci, Dept Hlth & Food Sci, Saitama, Japan	University of Shizuoka; KAO Corporation; University of Shizuoka; University of Shizuoka; University of Shizuoka; KAO Corporation	Meguro, S (corresponding author), Univ Shizuoka, Ind Acad Collaborat Res Lab, Shizuoka, Japan.; Meguro, S (corresponding author), Univ Shizuoka, Kao Corp, Shizuoka, Japan.; Meguro, S (corresponding author), Kao Corp, Biol Sci Res, Haga Gun, Tochigi, Japan.	meguro.shinichi@kao.com	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Meguro, Shinichi/0000-0002-3072-2632; SHIMBA, Yuki/0000-0001-7995-2220	University of Shizuoka; Kao Corporation	University of Shizuoka; Kao Corporation	This work was supported by industry academia collaboration between the University of Shizuoka and Kao Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Borsheim E, 2008, CLIN NUTR, V27, P189, DOI 10.1016/j.clnu.2008.01.001; Bosaeus I, 2016, P NUTR SOC, V75, P174, DOI 10.1017/S002966511500422X; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brady AO, 2014, J SPORT HEALTH SCI, V3, P179, DOI 10.1016/j.jshs.2014.04.002; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Chen S, 2015, BIOCHEM BIOPH RES CO, V461, P1, DOI 10.1016/j.bbrc.2015.03.158; Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005; Derave W, 2005, AM J PHYSIOL-ENDOC M, V289, pE272, DOI 10.1152/ajpendo.00039.2005; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452; Fujita S, 2004, NUTR RES REV, V17, P69, DOI 10.1079/NRR200481; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Guo AY, 2015, EXP ANIM TOKYO, V64, P425, DOI 10.1538/expanim.15-0025; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Keller Karsten, 2013, Muscles Ligaments Tendons J, V3, P346; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501; McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9; Misu H, 2017, NAT MED, V23, P508, DOI 10.1038/nm.4295; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Teixeira VDN, 2013, EXP BIOL MED, V238, P1421, DOI 10.1177/1535370213505961; Okumura A, 2016, CLIN CHIM ACTA, V463, P145, DOI 10.1016/j.cca.2016.10.031; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Santamarina AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141227; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428	45	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195753	10.1371/journal.pone.0195753	http://dx.doi.org/10.1371/journal.pone.0195753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630667	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000072
J	Yeh, TC; Chang, HH; Ger, LP; Wang, JO; Kao, S; Ho, ST				Yeh, Te-Chun; Chang, Hsiao-Huang; Ger, Luo-Ping; Wang, Ju-O; Kao, Senyeong; Ho, Shung-Tai			Clinical risk factors of extracorporeal membrane oxygenation support in older adults	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PHYSIOLOGY SCORE II; ELDERLY-PATIENTS; LIFE-SUPPORT; MORTALITY; PREDICTOR; SURVIVAL; SYSTEMS	Background The ageing population and the expected increase in the number of elderly patients make an evidence-based assessment of Extracorporeal Membrane Oxygenation (ECMO) therapy in old patients progressively more important. Veno-arterial (VA) ECMO results for patient aged <65 years is well known. However, the risk profile and in-hospital prognosis of advanced age patients with ECMO still need more investigation. The aim of this study was to identify risk factors that predicted the outcomes for elderly patients who received VA-ECMO. Methods In this retrospective study, medical records for patients with ECMO aged 65 years and over were collected between 2009 and 2012 at a tertiary hospital. Results A total of 99 patients (mean age: 76.4+/-6.4 years) were included. The most common condition requiring VA-ECMO support was cardiogenic shock. Among survivors on VA-ECMO, 28 (28.3%) patients were successfully weaned from support. Thirteen (13.1%) patients were successfully discharged. We found that cardiogenic shock (OR = 3.158, P = 0.013), acute physiology and chronic health evaluation II (APACHE II) score (OR = 1.147, P<0.001), and simplified acute physiology score II (SAPS II) score (OR = 1.054, P = 0.001) were risk factors associated with survival on VA-ECMO. By using the areas under the receiver operating characteristic (AUC) curve, the APACHE II score and SAPS II score displayed acceptable discriminative power (AUC 0.722; 0.715, respectively). Conclusion Our findings indicate that the risk of mortality increases with cardiogenic shock, higher APACHE II score, and higher SAPS II score. These risk factors can be utilized as potential predictors to identify the potential candidates for ECMO support.	[Yeh, Te-Chun; Kao, Senyeong; Ho, Shung-Tai] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yeh, Te-Chun] Taipei City Hosp, Acad Human & Innovat, Taipei, Taiwan; [Chang, Hsiao-Huang] Taipei Vet Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan; [Ger, Luo-Ping] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wang, Ju-O; Kao, Senyeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Ho, Shung-Tai] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan	National Defense Medical Center; Taipei City Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; Taipei Veterans General Hospital	Ho, ST (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Ho, ST (corresponding author), Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	stho@vghtpe.gov.tw		CHANG, HSIAO-HUANG/0000-0002-0393-4496; Kao, Senyeong/0000-0002-0209-240X				Chang CH, 2016, CIRCULATION, V133, P2423, DOI 10.1161/CIRCULATIONAHA.115.019143; CHELLURI L, 1993, JAMA-J AM MED ASSOC, V269, P3119, DOI 10.1001/jama.269.24.3119; Chiu LC, 2015, ANN THORAC SURG, V99, P243, DOI 10.1016/j.athoracsur.2014.07.064; Choi MJ, 2017, ANN THORAC SURG, V103, P1246, DOI 10.1016/j.athoracsur.2016.07.069; de Rooij SE, 2005, CRIT CARE, V9, pR307, DOI 10.1186/cc3536; Extracorporeal Life Support Organization, 2013, EXTR LIF SUPP ORG EL; Extracorporeal Life Support Organization, 2010, ELSO GUID ECMO CTR; Extracorporeal Life Support Organization (ELSO), 2014, GUID AD CARD FAIL; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Hemmila MR, 2004, ANN SURG, V240, P595, DOI 10.1097/01.sla.0000141159.90676.2d; Hemmila MR, ANN SURG, V240, P605, DOI 10.1097/01.sla.0000141159.90676.2d; Hood E, 2011, BRIT J ANAESTH, V107, P186, DOI 10.1093/bja/aer105; Hsu CP, 2015, J EPIDEMIOL, V25, P321, DOI 10.2188/jea.JE20140027; Kim KI, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0135-x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee S, 2016, J KOREAN MED SCI, V31, P932, DOI 10.3346/jkms.2016.31.6.932; Lee SH, 2017, HEART LUNG, V46, P137, DOI 10.1016/j.hrtlng.2017.02.003; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leong I. Y. O., 2002, SMJ Singapore Medical Journal, V43, P033; Lewandowski K, 2000, CRIT CARE, V4, P156, DOI 10.1186/cc689; Lin CY, 2007, ANN THORAC SURG, V84, P1256, DOI 10.1016/j.athoracsur.2007.05.045; Liu X, 2016, CHINA PLOS ONE, V11, DOI [10.1371/journal.pone.0158061, DOI 10.1371/JOURNAL.PONE.0158061]; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Saito S, 2007, ANN THORAC SURG, V83, P140, DOI 10.1016/j.athoracsur.2006.08.006; Saxena P, 2015, ANN THORAC SURG, V99, P2053, DOI 10.1016/j.athoracsur.2014.11.075; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	27	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195445	10.1371/journal.pone.0195445	http://dx.doi.org/10.1371/journal.pone.0195445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624620	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600029
J	Nyunt, KKK; Han, WW; Satyanarayana, S; Isaakidis, P; Hone, S; Khaing, AA; Binh, HN; Oo, HN				Nyunt, Kay Khaing Kaung; Han, Wai Wai; Satyanarayana, Srinath; Isaakidis, Petros; Hone, San; Khaing, Aye Aye; Hoa Nguyen Binh; Oo, Htun Nyunt			Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016	PLOS ONE			English	Article								Background Myanmar National AIDS programme's priority is to improve the survival of all people living with HIV by providing anti-retroviral therapy (ART) care. More than 7200 children (aged <15 years) have been enrolled into ART care from 2005 to 2016. A previous study showed that similar to 11% children on ART care had either died or were lost to follow-up by 60 months. Factors associated with death and lost-to follow-up (adverse outcomes) have not been previously studied. Objectives To describe the association between demographic and clinical characteristics at enrollment into ART care with adverse outcomes. Methods Cohort study using records of children enrolled for ART care at Mingalardon Specialist Hospital (main Paediatric ART center in Myanmar) from 2006-2016. We used multivariable Cox proportional hazards regression models for analysis. Results 1,159 children were enrolled for ART care and they contributed a total of 1.45 million person-days of follow-up period. 112 (10%) had an adverse outcome during the follow-up time period (55 deaths, 57 lost to follow-up). Enrollment into the ART care through in-patient care department of the hospital, CD4 Cell count <50/mm(3), enrollment during changing ART guidelines (different ART eligibility criteria and preferred ART regimen) were independently associated with higher hazards of adverse outcome. Receiving protease inhibitor-based ART regimen at enrollment was independently associated with lower hazards of adverse outcome. Age, sex, residing in urban or rural areas, WHO clinical stage, having TB at the time of enrollment, receiving cotrimoxazole prophylaxis were not statistically associated with adverse outcomes. Conclusion Our analysis reconfirms good survival of children on ART care (including those with TB). The characteristics associated with adverse outcomes (other than CD4 cell count<50) are surrogates of some unmeasured underlying health system/patient related factors that needs further exploration to improve the survival of children on ART care.	[Nyunt, Kay Khaing Kaung; Hone, San; Oo, Htun Nyunt] Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar; [Han, Wai Wai] Minist Hlth & Sports, Dept Med Res, Yangon, Myanmar; [Satyanarayana, Srinath; Hoa Nguyen Binh] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Isaakidis, Petros] Med Sans Frontieres MSF Doctors Borders, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres MSF Doctors Borders, Operat Res Unit, Luxembourg, Luxembourg; [Khaing, Aye Aye] Mingaladon Specialist Hosp, Dept Med Care, Minist Hlth & Sports, Yangon, Myanmar; [Hoa Nguyen Binh] Natl TB Program Vietnam, Hanoi, Vietnam		Nyunt, KKK (corresponding author), Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar.	kaykhaingoo132@gmail.com	B, Hoa/AAF-4933-2020	Satyanarayana, Srinath/0000-0002-5420-2551; Isaakidis, Petros/0000-0002-7881-1554				Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Mon KL, 2016, MYANMAR HLTH SCI RES, V28, P1; Myanmar Government, 2015, 2014 MYANM POP HOUS; National AIDS Program, 2011, GUID CLIN MAN HIV IN; National AIDS Program, 2005, GUID CLIN MAN HIV IN; National AIDS Program, 2014, GUID CLIN MAN HIV IN; National AIDS Program, 2016, MYANM NAT STRAT PLAN; National AIDS Program, 2007, GUID CLIN MAN HIV IN; Ph D, 2010, EARLY ANTIRETROVIR T, V359, P2233; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Survey PB, 2014, GARPR ONLINE REPORTI; UNAIDS, 2016, HIV AIDS FACT SHEET	13	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195435	10.1371/journal.pone.0195435	http://dx.doi.org/10.1371/journal.pone.0195435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621302	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800080
J	Peoples, LM; Donaldson, S; Osuntokun, O; Xia, Q; Nelson, A; Blanton, J; Allen, EE; Church, MJ; Bartlett, DH				Peoples, Logan M.; Donaldson, Sierra; Osuntokun, Oladayo; Xia, Qing; Nelson, Alex; Blanton, Jessica; Allen, Eric E.; Church, Matthew J.; Bartlett, Douglas H.			Vertically distinct microbial communities in the Mariana and Kermadec trenches	PLOS ONE			English	Article							DEEP-SEA; HYDROSTATIC-PRESSURE; SP-NOV.; CHALLENGER DEEP; HADAL TRENCHES; JAPAN TRENCH; BACTERIOPLANKTON DISTRIBUTION; PHYLOGENETIC ANALYSIS; BAROPHILIC BACTERIUM; BATHYPELAGIC OCEAN	Hadal trenches, oceanic locations deeper than 6,000 m, are thought to have distinct microbial communities compared to those at shallower depths due to high hydrostatic pressures, topographical funneling of organic matter, and biogeographical isolation. Here we evaluate the hypothesis that hadal trenches contain unique microbial biodiversity through analyses of the communities present in the bottom waters of the Kermadec and Mariana trenches. Estimates of microbial protein production indicate active populations under in situ hydrostatic pressures and increasing adaptation to pressure with depth. Depth, trench of collection, and size fraction are important drivers of microbial community structure. Many putative hadal bathytypes, such as members related to the Marinimicrobia, Rhodobacteraceae, Rhodospirilliceae, and Aquibacter, are similar to members identified in other trenches. Most of the differences between the two trench microbiomes consists of taxa belonging to the Gammaproteobacteria whose distributions extend throughout the water column. Growth and survival estimates of representative isolates of these taxa under deep-sea conditions suggest that some members may descend from shallower depths and exist as a potentially inactive fraction of the hadal zone. We conclude that the distinct pelagic communities residing in these two trenches, and perhaps by extension other trenches, reflect both cosmopolitan hadal bathytypes and ubiquitous genera found throughout the water column.	[Peoples, Logan M.; Donaldson, Sierra; Osuntokun, Oladayo; Xia, Qing; Blanton, Jessica; Allen, Eric E.; Bartlett, Douglas H.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Xia, Qing] North Carolina State Univ, Dept Soil Sci, Raleigh, NC 27695 USA; [Nelson, Alex; Church, Matthew J.] Univ Hawaii Manoa, Ctr Microbial Oceanog Res & Educ, CMORE Hale, Honolulu, HI 96822 USA; [Church, Matthew J.] Univ Montana, Flathead Lake Biol Stn, Poison, MT USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; North Carolina State University; University of Hawaii System; University of Hawaii Manoa; University of Montana System; University of Montana	Bartlett, DH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu		Xia, Qing/0000-0002-6316-9941	National Science Foundation [0801973, 0827051, 1536776]; National Aeronautics and Space Administration [NNX11AG10G, NNX14AP13H]; Prince Albert II Foundation [1265]; Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE) [329108]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Prince Albert II Foundation; Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE)	LMP and DHB were supported by the National Science Foundation (0801973, 0827051, 1536776), National Aeronautics and Space Administration (NNX11AG10G, NNX14AP13H), the Prince Albert II Foundation (Project 1265), and a gift from Earthship Productions. MJC and AN were supported by the Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE; grant ID 329108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8608; Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Angel M.V., 1982, ENVIRONMENTALIST, V2, P1, DOI DOI 10.1007/BF02340472; Belyaev GM, 1989, DEEP SEA OCEAN TRENC; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Cao Y, 2014, APPL ENVIRON MICROB, V80, P54, DOI 10.1128/AEM.02288-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Danovaro R, 2003, DEEP-SEA RES PT I, V50, P1411, DOI 10.1016/j.dsr.2003.07.001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eloe EA, 2011, APPL ENVIRON MICROB, V77, P8145, DOI 10.1128/AEM.05204-11; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Fletcher B, 2009, MAR TECHNOL SOC J, V43, P65, DOI 10.4031/MTSJ.43.5.26; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Fryer P, 2003, EARTH PLANET SC LETT, V211, P259, DOI 10.1016/S0012-821X(03)00202-4; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gardner JV, 2014, MAR GEOD, V37, P1, DOI 10.1080/01490419.2013.837849; Glud RN, 2013, NAT GEOSCI, V6, P284, DOI [10.1038/NGEO1773, 10.1038/ngeo1773]; Hansell DA, 2003, LIMNOL OCEANOGR, V48, P150, DOI 10.4319/lo.2003.48.1.0150; Hatzenpichler R, 2016, P NATL ACAD SCI USA, V113, pE4069, DOI 10.1073/pnas.1603757113; Herndl GJ, 2013, NAT GEOSCI, V6, P718, DOI [10.1038/ngeo1921, 10.1038/NGEO1921]; Hwang CY, 2009, INT J SYST EVOL MICR, V59, P3019, DOI 10.1099/ijs.0.008102-0; Ichino MC, 2015, DEEP-SEA RES PT I, V100, P21, DOI 10.1016/j.dsr.2015.01.010; Ivanova EP, 2015, ANTON LEEUW INT J G, V107, P119, DOI 10.1007/s10482-014-0309-y; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jamieson A, 2015, HADAL ZONE: LIFE IN THE DEEPEST OCEANS, P1, DOI 10.1017/CBO9781139061384; Jamieson AJ, 2013, DEEP-SEA RES PT II, V92, P107, DOI 10.1016/j.dsr2.2012.12.002; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kaneko H, 2000, BIOSCI BIOTECH BIOCH, V64, P72, DOI 10.1271/bbb.64.72; Kato C, 1997, EXTREMOPHILES, V1, P117, DOI 10.1007/s007920050024; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; Kawagucci S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00270; Kaye JZ, 2011, FEMS MICROBIOL ECOL, V75, P123, DOI 10.1111/j.1574-6941.2010.00984.x; Kaye JZ, 2004, APPL ENVIRON MICROB, V70, P6220, DOI 10.1128/AEM.70.10.6220-6229.2004; Kusube M, 2017, INT J SYST EVOL MICR, V67, P824, DOI 10.1099/ijsem.0.001671; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li L, 1999, MAR BIOTECHNOL, V1, P391, DOI 10.1007/PL00011793; Linley TD, 2017, DEEP-SEA RES PT I, V121, P38, DOI 10.1016/j.dsr.2016.12.009; Linley TD, 2016, DEEP-SEA RES PT I, V114, P99, DOI 10.1016/j.dsr.2016.05.003; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maruyama A, 2000, INT J SYST EVOL MICR, V50, P835, DOI 10.1099/00207713-50-2-835; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Nakayama A, 2005, J GEN APPL MICROBIOL, V51, P385, DOI 10.2323/jgam.51.385; Nogi Y, 2004, INT J SYST EVOL MICR, V54, P1627, DOI 10.1099/ijs.0.03049-0; Nogi Y, 1998, ARCH MICROBIOL, V170, P331, DOI 10.1007/s002030050650; Nogi Y, 2002, INT J SYST EVOL MICR, V52, P1527, DOI 10.1099/00207713-52-5-1527; Nunnally CC, 2016, DEEP-SEA RES PT I, V118, P30, DOI 10.1016/j.dsr.2016.10.009; Nunoura T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01261; Nunoura T, 2015, P NATL ACAD SCI USA, V112, pE1230, DOI 10.1073/pnas.1421816112; Nunoura T, 2013, ENVIRON MICROBIOL, V15, P3087, DOI 10.1111/1462-2920.12152; Oksanen J., 2022, R PACKAGE VERSION; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ritchie H, 2017, DEEP-SEA RES PT I, V119, P50, DOI 10.1016/j.dsr.2016.11.006; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Salazar G, 2015, MOL ECOL, V24, P5692, DOI 10.1111/mec.13419; Samo TJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00048; SCHWARZ JR, 1976, APPL ENVIRON MICROB, V31, P46, DOI 10.1128/AEM.31.1.46-48.1976; Seki H, 1976, J OCEANOGR SOC JAPAN, V23, P182; Siedler G, 2004, J PHYS OCEANOGR, V34, P566, DOI 10.1175/2511.1; Sintes E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00077; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Smedile F, 2013, ENVIRON MICROBIOL, V15, P167, DOI 10.1111/j.1462-2920.2012.02827.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamburini C, 2013, ENVIRON MICROBIOL, V15, P1262, DOI 10.1111/1462-2920.12084; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P1533, DOI 10.1016/j.dsr2.2008.12.035; Tamegai H, 1997, EXTREMOPHILES, V1, P207, DOI 10.1007/s007920050035; Tamegai H, 2006, EXTREMOPHILES, V5, P27; Tarn J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00665; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325; Wenzhofer F, 2016, DEEP-SEA RES PT I, V116, P276, DOI 10.1016/j.dsr.2016.08.013; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yanagibayashi M, 1999, FEMS MICROBIOL LETT, V170, P271, DOI 10.1016/S0378-1097(98)00556-4; Yayanos AA, 2001, METHOD MICROBIOL, V30, P615; YAYANOS AA, 1982, APPL ENVIRON MICROB, V43, P1481, DOI 10.1128/AEM.43.6.1481-1489.1982; YAYANOS AA, 1981, P NATL ACAD SCI-BIOL, V78, P5212, DOI 10.1073/pnas.78.8.5212; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P1007, DOI 10.1099/ijs.0.63464-0; Yoshida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057271	98	45	47	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195102	10.1371/journal.pone.0195102	http://dx.doi.org/10.1371/journal.pone.0195102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621268	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800038
J	Thishya, K; Vattam, KK; Naushad, SM; Raju, SB; Kutalal, VK				Thishya, Kalluri; Vattam, Kiran Kumar; Naushad, Shaik Mohammad; Raju, Shree Bhushan; Kutalal, Vijay Kumar			Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MDR1 ABCB1 POLYMORPHISMS; DOSE REQUIREMENTS; ACUTE REJECTION; CLINICAL FACTORS; CYP3A5 GENOTYPE; CALCINEURIN INHIBITORS; ORGAN-TRANSPLANTATION; BLOOD-CONCENTRATIONS; GENE POLYMORPHISMS	The objective of the current study was to explore the role of ABCB1 and CYP3A5 genetic polymorphisms in predicting the bioavailability of tacrolimus and the risk for post-transplant diabetes. Artificial neural network (ANN) and logistic regression (LR) models were used to predict the bioavailability of tacrolimus and risk for post-transplant diabetes, respectively. The five-fold cross-validation of ANN model showed good correlation with the experimental data of bioavailability (r(2) = 0.93-0.96). Younger age, male gender, optimal body mass index were shown to exhibit lower bioavailability of tacrolimus. ABCB1 1236 C>T and 2677G>T/A showed inverse association while CYP3A5*3 showed a positive association with the bioavailability of tacrolimus. Gender bias was observed in the association with ABCB1 3435 C>T polymorphism. CYP3A5*3 was shown to interact synergistically in increasing the bioavailability in combination with ABCB1 1236 TT or 2677GG genotypes. LR model showed an independent association of ABCB1 2677 G>T/A with post transplant diabetes (OR: 4.83, 95% CI: 1.22-19.03). Multifactor dimensionality reduction analysis (MDR) revealed that synergistic interactions between CYP3A5*3 and ABCB1 2677 G>T/A as the determinants of risk for post-transplant diabetes. To conclude, the ANN and MDR models explore both individual and synergistic effects of variables in modulating the bioavailability of tacrolimus and risk for post-transplant diabetes.	[Thishya, Kalluri; Kutalal, Vijay Kumar] Nizams Inst Med Sci, Dept Clin Pharmacol, Hyderabad, Telangana, India; [Thishya, Kalluri; Kutalal, Vijay Kumar] Nizams Inst Med Sci, Dept Therapeut, Hyderabad, Telangana, India; [Vattam, Kiran Kumar; Naushad, Shaik Mohammad] Sandor Lifesci Pvt Ltd, Hyderabad, Telangana, India; [Raju, Shree Bhushan] Nizams Inst Med Sci, Dept Nephrol, Hyderabad, Telanagana, India	Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences	Kutalal, VK (corresponding author), Nizams Inst Med Sci, Dept Clin Pharmacol, Hyderabad, Telangana, India.; Kutalal, VK (corresponding author), Nizams Inst Med Sci, Dept Therapeut, Hyderabad, Telangana, India.	vijaykutala@gmail.com	Naushad, Mohammad/C-3094-2012; Shanmugam, Raju/N-8120-2013; Raju, Sree Bhushan/ABD-1880-2020	Naushad, Mohammad/0000-0001-8952-9581; Shanmugam, Raju/0000-0002-8613-9518; Raju, Sree Bhushan/0000-0001-9409-3874; Kutala, Vijay Kumar/0000-0002-7253-8999	Department of Biotechnology, Government of India [BT/PR7964/MED/12/606/2013]; Sandor Lifesciences Pvt Ltd	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Sandor Lifesciences Pvt Ltd	This work was supported by a grant from Department of Biotechnology, Government of India No. BT/PR7964/MED/12/606/2013 to VKK. Sandor Lifesciences Pvt Ltd only provided salary support to KKV and SMN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Anglicheau D, 2003, J AM SOC NEPHROL, V14, P1889, DOI 10.1097/01.ASN.0000073901.94759.36; Aouam K, 2015, PHARMACOGENOMICS, V16, P2045, DOI 10.2217/pgs.15.138; Borobia AM, 2009, THER DRUG MONIT, V31, P436, DOI 10.1097/FTD.0b013e3181a8f02a; Chandel N, 2009, PHARMACOGENET GENOM, V19, P458, DOI 10.1097/FPC.0b013e32832bd085; Chitnis SD, 2013, XENOBIOTICA, V43, P641, DOI 10.3109/00498254.2012.752118; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; Cusinato DAC, 2014, BRIT J CLIN PHARMACO, V78, P364, DOI 10.1111/bcp.12345; de Jonge H, 2012, CLIN PHARMACOL THER, V92, P366, DOI 10.1038/clpt.2012.109; Fukudo M, 2008, PHARMACOGENET GENOM, V18, P413, DOI 10.1097/FPC.0b013e3282f9ac01; Gerard C, 2014, AAPS J, V16, P379, DOI 10.1208/s12248-014-9577-8; Goto M, 2004, PHARMACOGENETICS, V14, P471, DOI 10.1097/01.fpc.0000114747.08559.49; Haufroid V, 2004, PHARMACOGENETICS, V14, P147, DOI 10.1097/00008571-200403000-00002; Hesselink DA, 2008, PHARMACOGENET GENOM, V18, P339, DOI 10.1097/FPC.0b013e3282f75f88; Kidokoro K, 2012, KIDNEY BLOOD PRESS R, V35, P549, DOI 10.1159/000339494; Kim I-W, 2011, EUROPEAN J CLIN PHAR, V68, P657; Kim IW, 2012, BASIC CLIN PHARMACOL, V111, P217, DOI 10.1111/j.1742-7843.2012.00892.x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Li JL, 2011, PHARMACOGENOMICS J, V11, P300, DOI 10.1038/tpj.2010.42; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; Soria MALM, 2010, TRANSPL P, V42, P3031, DOI 10.1016/j.transproceed.2010.08.001; MacPhee IAM, 2005, TRANSPLANTATION, V79, P499, DOI 10.1097/01.TP.0000151766.73249.12; Omar MS., 2013, INT J PHARM PHARM SC, V5, P470; Passey C, 2012, PHARMACOGENOMICS, V13, P1141, DOI [10.2217/PGS.12.98, 10.2217/pgs.12.98]; Passey C, 2011, BRIT J CLIN PHARMACO, V72, P948, DOI 10.1111/j.1365-2125.2011.04039.x; Pavani A, 2012, PHARMACOGENOMICS J, V12, P306, DOI 10.1038/tpj.2011.4; Pavani A, 2016, PHARMACOGENOMICS, V17, P121, DOI 10.2217/pgs.15.161; Plosker GL, 2000, DRUGS, V59, P323, DOI 10.2165/00003495-200059020-00021; Provenzani A, 2011, INT J MOL MED, V28, P1093, DOI 10.3892/ijmm.2011.794; Provenzani A, 2009, ANN TRANSPL, V14, P23; Renders L, 2007, CLIN PHARMACOL THER, V81, P228, DOI 10.1038/sj.clpt.6100039; Rodriguez-Peralvarez M, 2012, Am J Transplant, V12, P2797; Shi YY, 2013, GENE, V512, P226, DOI 10.1016/j.gene.2012.10.048; Singh R, 2011, J CLIN PHARMACOL, V51, P603, DOI 10.1177/0091270010370704; Singh R, 2009, N-S ARCH PHARMACOL, V380, P169, DOI 10.1007/s00210-009-0415-y; Staatz C, 2001, NEPHROL DIAL TRANSPL, V16, P1905, DOI 10.1093/ndt/16.9.1905; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Tahara T, 2011, DIGEST DIS SCI, V56, P103, DOI 10.1007/s10620-010-1251-0; Tang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42192; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Thervet E, 2010, CLIN PHARMACOL THER, V87, P721, DOI 10.1038/clpt.2010.17; Tsuchiya N, 2004, TRANSPLANTATION, V78, P1182, DOI 10.1097/01.TP.0000137789.58694.B4; Undre NA, 1999, TRANSPLANT P, V31, P296, DOI 10.1016/S0041-1345(98)01633-9; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Wang P, 2010, PHARMACOGENOMICS, V11, P1389, DOI 10.2217/PGS.10.105; Zuo XC, 2013, PHARMACOGENET GENOM, V23, P251, DOI 10.1097/FPC.0b013e32835fcbb6	46	27	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191921	10.1371/journal.pone.0191921	http://dx.doi.org/10.1371/journal.pone.0191921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621269	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800003
J	Cirillo, E; Kutmon, M; Hernandez, MG; Hooimeijer, T; Adriaens, ME; Eijssen, LMT; Parnell, LD; Coort, SL; Evelo, CT				Cirillo, Elisa; Kutmon, Martina; Hernandez, Manuel Gonzalez; Hooimeijer, Tom; Adriaens, Michiel E.; Eijssen, Lars M. T.; Parnell, Laurence D.; Coort, Susan L.; Evelo, Chris T.			From SNPs to pathways: Biological interpretation of type 2 diabetes (T2DM) genome wide association study (GWAS) results	PLOS ONE			English	Article							RISK LOCI; COMPLEX TRAITS; IDENTIFICATION; VARIANTS; ONTOLOGY; DISEASE; GENES; TOOL; UNIFICATION; NETWORKS	Genome-wide association studies (GWAS) have become a common method for discovery of gene-disease relationships, in particular for complex diseases like Type 2 Diabetes Mellitus (T2DM). The experience with GWAS analysis has revealed that the genetic risk for complex diseases involves cumulative, small effects of many genes and only some genes with a moderate effect. In order to explore the complexity of the relationships between T2DM genes and their potential function at the process level as effected by polymorphism effects, a secondary analysis of a GWAS meta-analysis is presented. Network analysis, pathway information and integration of different types of biological information such as eQTLs and gene-environment interactions are used to elucidate the biological context of the genetic variants and to perform an analysis based on data visualization. We selected a T2DM data set from a GWAS meta-analysis, and extracted 1,971 SNPs associated with T2DM. We mapped 580 SNPs to 360 genes, and then selected 460 pathways containing these genes from the curated collection of WikiPathways. We then created and analyzed SNP-gene and SNP-gene-pathway network modules in Cytoscape. A focus on genes with robust connections to pathways permitted identification of many T2DM pertinent pathways. However, numerous genes lack literature evidence of association with T2DM. We also speculate on the genes in specific network structures obtained in the SNP-gene network, such as gene SNP-gene modules. Finally, we selected genes relevant to T2DM from our SNP-gene-pathway network, using different sources that reveal gene-environment interactions and eQTLs. We confirmed functions relevant to T2DM for many genes and have identified some LPL and APOB that require further validation to clarify their involvement in T2DM.	[Cirillo, Elisa; Kutmon, Martina; Hernandez, Manuel Gonzalez; Hooimeijer, Tom; Eijssen, Lars M. T.; Coort, Susan L.; Evelo, Chris T.] Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Kutmon, Martina; Adriaens, Michiel E.; Evelo, Chris T.] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [Parnell, Laurence D.] Tufts Univ, USDA, Human Nutr Res Ctr Aging, ARS,Jean Mayer USDA, Boston, MA 02111 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Tufts University; United States Department of Agriculture (USDA)	Cirillo, E (corresponding author), Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	elisa.cirillo@maastrichtuniversity.nl	Coort, Susan/ABF-1021-2021; Kutmon, Martina/AAT-2718-2021	Kutmon, Martina/0000-0002-7699-8191; Eijssen, Lars/0000-0002-6473-2839; Coort, Susan/0000-0003-1224-9690; Evelo, Chris/0000-0002-5301-3142; Cirillo, Elisa/0000-0002-0241-7833; Adriaens, Michiel/0000-0002-4472-7119	Dutch Province of Limburg	Dutch Province of Limburg	This project/research has been made possible with support of the Dutch Province of Limburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2016, BIORXIV, V1; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Cho YS, 2008, EXP MOL MED, V40, P523, DOI 10.3858/emm.2008.40.5.523; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Erdos MR, 2015, THESIS; FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418; Flannick J, 2016, NAT REV GENET, V17, P535, DOI 10.1038/nrg.2016.56; Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451; Garcia-Campos MA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00383; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462; Hara K, 2016, EXPERT OPIN THER TAR, V20, P255, DOI 10.1517/14728222.2016.1098618; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Jo B, 2016, BIORXIV, V1; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kao PYP, 2017, BBA-GEN SUBJECTS, V1861, P335, DOI 10.1016/j.bbagen.2016.11.030; Kimchi-Sarfaty C, 2007, SCIENCE, V318, P1382; KOBAYASHI J, 1992, BIOCHEM BIOPH RES CO, V182, P70, DOI 10.1016/S0006-291X(05)80113-5; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Niel C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00280; Oliveros J. C., INTERACTIVE TOOL COM; Parnell LD, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-21; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Pinero J, 2016, NUCLEIC ACIDS RES, V19; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddiqa A, 2017, GENOMICS; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Thomas PPM, 2016, PERS MED, V13, P381, DOI 10.2217/pme-2016-0029; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yazdanpanah M, 2013, ANN HUM GENET, V77, P472, DOI 10.1111/ahg.12035; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zambonelli P, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-99; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082	51	25	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193515	10.1371/journal.pone.0193515	http://dx.doi.org/10.1371/journal.pone.0193515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617380	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800008
J	Gertz, H; Fiehler, K; Voudouris, D				Gertz, Hanna; Fiehler, Katja; Voudouris, Dimitris			The role of visual processing on tactile suppression	PLOS ONE			English	Article							REACHING MOVEMENTS; TIME-COURSE; SIGNALS; ENHANCEMENT; ATTENUATION; VISION; HUMANS; LIMB	It has been suggested that tactile signals are suppressed on a moving limb to free capacities for processing other relevant sensory signals. In line with this notion, we recently showed that tactile suppression is indeed stronger in the presence of reach-relevant somatosensory signals. Here we examined whether this effect also generalizes to the processing of additional visual signals during reaching. Brief vibrotactile stimuli were presented on the participants' right index finger either during right-hand reaching to a previously illuminated target LED, or during rest. Participants had to indicate whether they detected the vibrotactile stimulus or not. The target LED remained off (tactile), or was briefly illuminated (tactile & vis) during reaching, providing additional reach-relevant visual information about the target position. If tactile suppression frees capacities for reach-relevantvisual information, suppression should be stronger in the tactile & vis compared to the tactile condition. In an additional visual-discrimination condition (tactile & visDis), the target LED flashed once or twice during reaching and participants had to also report the number of flashes. If tactile suppression occurs to free additional capacities for perception-relevant visual signals, tactile suppression should be even stronger in the tactile & visDis compared to the tactile & vis condition. We found that additional visual signals improved reach endpoint accuracy and precision. In all conditions, reaching led to tactile suppression as indicated by higher detection thresholds compared to rest, confirming previous findings. However, tactile suppression was comparable between conditions arguing against the hypothesis that it frees capacities for processing other relevant visual signals.	[Gertz, Hanna; Fiehler, Katja; Voudouris, Dimitris] Justus Liebig Univ Giessen, Expt Psychol, Giessen, Germany	Justus Liebig University Giessen	Voudouris, D (corresponding author), Justus Liebig Univ Giessen, Expt Psychol, Giessen, Germany.	dimitris.voudouris@psychol.uni-giessen.de	Voudouris, Dimitris/H-7704-2018	Voudouris, Dimitris/0000-0001-9110-0928	German Research Foundation (DFG) [TRR 135]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) TRR 135. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Research Foundation (DFG) TRR 135. Additional materials related to this manuscript (kinematic data and participants' responses from the detection tasks) may be found at http://dx.doi.org/10.5281/zenodo.1207321	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Berkinblit MB, 1995, EXP BRAIN RES, V107, P326; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Buckingham G, 2010, EXP BRAIN RES, V201, P411, DOI 10.1007/s00221-009-2050-8; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; Colino FL, 2016, J MOTOR BEHAV, V48, P390, DOI 10.1080/00222895.2015.1113917; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Gertz H, 2017, J NEUROPHYSIOL, V117, P2262, DOI 10.1152/jn.00052.2017; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Gold JI, 2010, J NEUROPHYSIOL, V103, P140, DOI 10.1152/jn.00744.2009; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Jackson SR, 2011, Q J EXP PSYCHOL, V64, P839, DOI 10.1080/17470218.2010.529580; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Jones SAH, 2012, J NEUROPHYSIOL, V107, P3316, DOI 10.1152/jn.00901.2011; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Manson G., 2012, SEEING PERCEIVING, V25, P106, DOI [10.1163/187847612X647388, DOI 10.1163/187847612X647388]; McIsaac TL, 2015, EXP BRAIN RES, V233, P2607, DOI 10.1007/s00221-015-4333-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkinson A, 2011, COGN NEUROSCI-UK, V2, P47, DOI 10.1080/17588928.2010.525627; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Sarlegna FR, 2006, BRAIN RES BULL, V69, P404, DOI 10.1016/j.brainresbull.2006.02.005; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shergill SS, 2013, NEUROIMAGE, V70, P356, DOI 10.1016/j.neuroimage.2012.12.043; Soto-Faraco S., 2004, HDB MULTISENSORY PRO, P49; Tremblay L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008952; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Voudouris D, 2012, J MOTOR BEHAV, V44, P295, DOI 10.1080/00222895.2012.703975; Voudouris D, 2017, ATTEN PERCEPT PSYCHO, V79, P2424, DOI 10.3758/s13414-017-1385-7; Voudouris D, 2017, J EXP PSYCHOL HUMAN, V43, P1238, DOI 10.1037/xhp0000373; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195396	10.1371/journal.pone.0195396	http://dx.doi.org/10.1371/journal.pone.0195396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617416	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800082
J	Martin-Torrijos, L; Kawai, T; Makkonen, J; Jussila, J; Kokko, H; Dieguez-Uribeondo, J				Martin-Torrijos, Laura; Kawai, Tadashi; Makkonen, Jenny; Jussila, Japo; Kokko, Harri; Dieguez-Uribeondo, Javier			Crayfish plague in Japan: A real threat to the endemic Cambaroides japonicus	PLOS ONE			English	Article							SPECIES PACIFASTACUS-LENIUSCULUS; PATHOGEN APHANOMYCES-ASTACI; FRESH-WATER CRAYFISH; GENETIC DIVERSITY; ALIEN CRAYFISH; FUNGUS; BIODIVERSITY; IMPACT	Global introductions of aquatic species and their associated pathogens are threatening worldwide biodiversity. The introduction of two North American crayfish species, Procambarus clarkiiand Pacifastacus leniusculus, into Japan in 1927 seems to have negatively affected native Japanese crayfish populations of Cambaroides japonicus. Several studies have shown the decline of these native populations due to competition, predation and habitat colonization by the two invasive North American crayfish species. Here, we identify an additional factor contributing to this decline. We report the first crayfish plague outbreaks in C. japonicus populations in Japan, which were diagnosed using both histological and molecular approaches (analyses of the internal transcribed spacer region). Subsequent analyses of the mitochondrial ribosomal rnnS and rnnL regions of diseased specimens indicate that these outbreaks originated from a P. clarkii population and identify a novel haplotype of Aphanomyces astaci, d3-haplotype, hosted by P. clarkii. Overall, our findings demonstrate the first two cases of crayfish plague in Japan, and the first case in a non-European native crayfish species, which originated from the red swamp crayfish P. clarkii. This finding is a matter of concern for the conservation of the native freshwater species of Japan and also highlights the risk of introducing crayfish carrier species into biogeographic regions harboring species susceptible to the crayfish plague.	[Martin-Torrijos, Laura; Dieguez-Uribeondo, Javier] CSIC, Dept Mycol, RJB, Madrid, Spain; [Kawai, Tadashi] Wakanai Fisheries Res Inst, Wakkanai, Hokkaido, Japan; [Makkonen, Jenny; Jussila, Japo; Kokko, Harri] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Eastern Finland	Dieguez-Uribeondo, J (corresponding author), CSIC, Dept Mycol, RJB, Madrid, Spain.	dieguez@rjb.csic.es	MARTIN-TORRIJOS, LAURA/AAH-8654-2019; Diéguez-Uribeondo, Javier/ABF-1130-2021; dieguez-uribeondo, javier/I-2178-2015	MARTIN-TORRIJOS, LAURA/0000-0002-2850-2737; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; dieguez-uribeondo, javier/0000-0002-4488-0658; Kokko, Hanna/0000-0002-5772-4881	Spanish Ministry of Economy and Competitiveness [CGL2016-80526-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). There was no additional external funding received for this study. We also like to thank Emilio Cano and Marta Higuera, RJB-CSIC, for the technical assistance.r This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). There was no additional external funding received for this study.	Alderman D.J., 1993, Freshwater Crayfish, V9, P266; Alderman DJ, 1997, SCI TECHNICAL REV, V15, P15; Almerao MP, 2015, AQUAT CONSERV, V25, P288, DOI 10.1002/aqc.2488; Aquiloni L, 2011, BIOL INVASIONS, V13, P359, DOI 10.1007/s10530-010-9828-2; BARAN I, 1989, J FISH DIS, V12, P193, DOI 10.1111/j.1365-2761.1989.tb00292.x; Bentley AI, 2010, FRESHWATER BIOL, V55, P1861, DOI 10.1111/j.1365-2427.2010.02420.x; Cerenius L., 1988, P131; Cornalia E., 1960, ATTI SOC ITAL SCI NA, V2, P334; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; Dieguez-Uribeondo J, 2003, PHYTOPATHOLOGY, V93, P923, DOI 10.1094/PHYTO.2003.93.8.923; Dieguez-Uribeondo J., 1993, Aquaculture and Fisheries Management, V24, P761, DOI 10.1111/j.1365-2109.1993.tb00655.x; Dieguez-Uribeondo J, 1997, B FR PECHE PISCIC, P753, DOI 10.1051/kmae/1997051; Dieguez-Uribeondo J, 2010, B FRANC E AIS PISCIC, P625; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Faulkes Zen, 2012, Aquat Biosyst, V8, P13; Filipova L, 2011, J N AM BENTHOL SOC, V30, P871, DOI 10.1899/10-130.1; Grandjean F, 2014, VET MICROBIOL, V170, P317, DOI 10.1016/j.vetmic.2014.02.020; Hsieh CY, 2016, J INVERTEBR PATHOL, V136, P117, DOI 10.1016/j.jip.2016.03.015; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Kawai T, 2005, CRUSTACEANA, V78, P1143, DOI 10.1163/156854005775361034; Kawai T, 2004, CRUSTACEANA, V77, P861, DOI 10.1163/156854004774248735; Kawai T, 2004, P BIOL SOC WASH, V117, P23; Kawai T, 2003, J NAT HIST AOMORI, V8, P1; Kawai T, 2011, ORIGIN RED SWAMP CRA; Kawai Tadashi, 2002, Freshwater Crayfish, V13, P198; Kawai T, 2009, J CRUSTACEAN BIOL, V29, P562, DOI 10.1651/08-3125.1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Lodge DM, 2012, ANNU REV ECOL EVOL S, V43, P449, DOI 10.1146/annurev-ecolsys-111511-103919; Lowe S., 100 WORLDS WORST INV; Makkonen J, 2018, PARASITOLOGY; Makkonen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36089; MATTHEWS M, 1992, HYDROBIOLOGIA, V234, P1, DOI 10.1007/BF00010773; Mrugala A, 2017, AQUAT CONSERV, V27, P103, DOI 10.1002/aqc.2674; Nakata K, 2005, CRUSTACEANA, V78, P1389, DOI 10.1163/156854005776759771; Nakata K, 2003, J CRUSTACEAN BIOL, V23, P897, DOI 10.1651/C-2411; Nakata K, 2002, FISHERIES SCI, V68, P763, DOI 10.1046/j.1444-2906.2002.00491.x; Nakata K, 2006, J CRUSTACEAN BIOL, V26, P134, DOI 10.1651/S-2652.1; Ohtaka A, 2005, BIOL INVASIONS, V7, P149, DOI 10.1007/s10530-004-8146-y; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Rocha SCO, 2016, PHYTOTAXA, V270, P286, DOI 10.11646/phytotaxa.270.4.5; Patoka J, 2016, BIOL INVASIONS, V18, P457, DOI 10.1007/s10530-015-1018-9; Peiro DF, 2016, HYDROBIOLOGIA, V781, P181, DOI 10.1007/s10750-016-2841-4; Rezinciuc S., 2015, Freshwater crayfish: a global overview, P182; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P612, DOI 10.1016/j.funbio.2013.10.007; SODERHALL K, 1979, J INVERTEBR PATHOL, V34, P285, DOI 10.1016/0022-2011(79)90075-2; Unestam T., 1972, Report lnst Freshwat Res Drottningholm, VNo. 52, P192; UNESTAM T, 1970, J GEN MICROBIOL, V60, P77, DOI 10.1099/00221287-60-1-77; Unestam T., 1969, RESISTANCE CRAYFISH; Usio Nisikawa, 2001, Biological Invasions, V3, P179, DOI 10.1023/A:1014573915464; Viljamaa-Dirks S., 2008, CRAYFISH DIS DIAGNOS, P32; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022	56	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195353	10.1371/journal.pone.0195353	http://dx.doi.org/10.1371/journal.pone.0195353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617418	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800078
J	Tannus, RK; Almeida-Carvalho, SR; Loureiro-Matos, CA; Miziara-Gonzalez, A; Salzedas-Netto, AA; Szejnfeld, D; D'Ippolito, G; Pereira-Lanzoni, V; Souza-Silva, I				Tannus, R. K.; Almeida-Carvalho, S. R.; Loureiro-Matos, C. A.; Miziara-Gonzalez, A.; Salzedas-Netto, A. A.; Szejnfeld, D.; D'Ippolito, G.; Pereira-Lanzoni, V.; Souza-Silva, I.			Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems	PLOS ONE			English	Article							STAGING SYSTEMS; PROSPECTIVE VALIDATION; LIVER-TRANSPLANTATION; CLIP SCORE; CLASSIFICATION; CANCER; EPIDEMIOLOGY; MANAGEMENT; CIRRHOSIS; OKUDA	Background and aim There are several prognostic systems that address different aspects of the patient and the tumour and can guide the management of patients with hepatocellular carcinoma (HCC). This study aimed to evaluate and compare the eight staging systems for a group of patients in a public service in Brazil. Methods Patients with HCC were retrospectively analysed between 2000 and 2012. The prognostic systems Okuda, The Cancer of the Liver Italian Program (CLIP), the Chinese University Prognostic Index (CUPI), Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (GRETCH), the modified TNM-based Japan Integrated Score (JIS) combined with alpha-fetoprotein and Child-Turcotte-Pugh (CTP), the TNM system, and the Barcelona Clinic Liver Cancer Classification (BCLC) were applied to these patients and compared through model fit measurements, likelihood scores, and the Akaike Information Criterion (AIC). Results A total of 247 patients were studied. The average survival time was 60 months. The TNM, Okuda, CLIP, GRETCH, modified JIS, and BCLC systems were well correlated with one another and individually important to the prediction of survival among the patients studied. However, in the statistical analysis, the CUPI delivered the best predictive performance (AIC = 566; log-likelihood =-281,240). Conclusion Although the CUPI system was demonstrated to be the most appropriate HCC staging system for the studied population, the choice of an ideal system is a controversial subject, andfuture studies with larger numbers of patients are necessary for the validation of the CUPI system as the method of choice for other populations.	[Tannus, R. K.; Almeida-Carvalho, S. R.; Loureiro-Matos, C. A.; Souza-Silva, I.] Fed Univ Sao Paulo Unifesp, Hepatol Unit, Dept Gastroenterol, Sao Paulo, SP, Brazil; [Miziara-Gonzalez, A.] Fed Univ Sao Paulo Unifesp, Liver Transplant Unit, Dept Surg, Sao Paulo, SP, Brazil; [Salzedas-Netto, A. A.] Fed Univ Sao Paulo Unifesp, Dept Pediat Surg, Sao Paulo, SP, Brazil; [Szejnfeld, D.; D'Ippolito, G.] Fed Univ Sao Paulo Unifesp, Dept Diagnost Radiol, Sao Paulo, SP, Brazil; [Pereira-Lanzoni, V.] Fed Univ Sao Paulo Unifesp, Dept Diagnost Pathol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Tannus, RK (corresponding author), Fed Univ Sao Paulo Unifesp, Hepatol Unit, Dept Gastroenterol, Sao Paulo, SP, Brazil.	robertakazan@yahoo.com.br	gonzalez, adriano m/P-4751-2014; Salzedas-Netto, Alcides/H-9175-2017	gonzalez, adriano m/0000-0002-0554-7238; Kazan Tannus, Roberta/0000-0003-1779-6167; Salzedas-Netto, Alcides/0000-0002-6545-9352				Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Chan SL, 2014, CHIN J CANCER, V33, P481, DOI 10.5732/cjc.014.10133; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Cillo U, 2004, J HEPATOL, V40, P124, DOI 10.1016/j.jhep.2003.09.027; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Georgiades CS, 2006, J VASC INTERV RADIOL, V17, P1619, DOI 10.1097/01.RVI.0000236608.91960.34; Guglielmi A, 2014, WORLD J GASTROENTERO, V20, P7525, DOI 10.3748/wjg.v20.i24.7525; IZUMI R, 1994, GASTROENTEROLOGY, V106, P720, DOI 10.1016/0016-5085(94)90707-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kinoshita A, 2015, WORLD J HEPATOL, V7, P406, DOI 10.4254/wjh.v7.i3.406; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Levy I, 2002, GUT, V50, P881, DOI 10.1136/gut.50.6.881; Li X, 2013, ASIA-PAC J CLIN ONCO, V9, P86, DOI 10.1111/ajco.12050; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 1998, HEPATOLOGY, V27, P1572, DOI 10.1002/hep.510270616; Llovet JM, 2000, HEPATOLOGY, V32, P679, DOI 10.1053/jhep.2000.16475; Maida M, 2014, WORLD J GASTROENTERO, V20, P4141, DOI 10.3748/wjg.v20.i15.4141; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; OKUDA K, 1984, HEPATOLOGY, V4, pS3, DOI 10.1002/hep.1840040703; Perrone F, 2000, HEPATOLOGY, V31, P840; Raoul JL, 2016, WORLD J HEPATOL, V8, P1541, DOI [10.4254/wjh.v8.i35.1541, 10.4254/wjh.v8.i17.703]; Shao YY, 2012, BRIT J CANCER, V107, P1672, DOI 10.1038/bjc.2012.466; Subramaniam S, 2013, CHIN CLIN ONCOL, V2, DOI 10.3978/j.issn.2304-3865.2013.07.05; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Trinchet JC, 2010, J HEPATOL, V53, P23, DOI 10.1016/j.jhep.2010.04.002; Vauthey JN, 2007, J AM COLL SURGEONS, V204, P1016, DOI 10.1016/j.jamcollsurg.2006.12.043; VAUTHEY JN, 1995, GASTROENTEROLOGY, V108, P617, DOI 10.1016/0016-5085(95)90109-4; Yang T, 2015, WORLD J GASTROENTERO, V21, P8256, DOI 10.3748/wjg.v21.i27.8256; Yang TA, 2011, J CANCER RES CLIN, V137, P739, DOI 10.1007/s00432-010-0935-3; Yen YH, 2009, DIGEST LIVER DIS, V41, P431, DOI 10.1016/j.dld.2008.11.008; Zhang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088182; Zhao JJ, 2015, CHINESE MED J-PEKING, V128, P316, DOI 10.4103/0366-6999.150095	42	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194922	10.1371/journal.pone.0194922	http://dx.doi.org/10.1371/journal.pone.0194922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617435	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800056
J	Ko, FC; Pan, WL; Cheng, JO; Chen, TH; Kuo, FW; Kao, SJ; Chang, CW; Ho, HC; Wang, WH; Fang, LS				Ko, Fung-Chi; Pan, Wei-Ling; Cheng, Jing-O; Chen, Te-Hao; Kuo, Fu-Wen; Kao, Shu-Ji; Chang, Chih-Wei; Ho, Hsuan-Ching; Wang, Wei-Hsien; Fang, Li -Sing			Persistent organic pollutants in Antarctic notothenioid fish and invertebrates associated with trophic levels	PLOS ONE			English	Article							MARINE FOOD-WEB; DIPHENYL ETHERS PBDES; ORGANOCHLORINE PESTICIDES; BALTIC SEA; BIOACCUMULATION; CONTAMINANTS; PATTERNS; P,P'-DDE; TISSUES; TAIWAN	Notothenioid fish and invertebrate samples from Antarctica were collected in the austral summer of 2009, and analyzed for persistent organic pollutants (POPs), including polycyclic aromatic hydrocarbons (PAHs), organochlorine pesticides (OCPs), and polybrominated diphenylethers (PBDEs), as well as delta C-13 and delta N-15 stable isotopes for trophic level determination. In this study, the POP levels in the Antarctic biota samples were found to be ranked in the following order: OCPs > PAHs >> PBDEs. The POP levels in notothenioid fish and krill correlate to trophic levels; however, the POP concentrations in intertidal benthic invertebrates are higher than in notothenioid fish implying that specific biogeochemical factors may affect bioaccumulation in the Antarctica ecosystem. Biomagnification of POPs may have a smaller role than bioconcentration in Antarctica environment. In addition to the source, transport, exposure, and absorption for each group of POPs in the short food chain in Antarctica, the biological variation among species, interaction habitats, diet and metabolism are also factors for future studies on contaminant bioaccumulation.	[Ko, Fung-Chi; Cheng, Jing-O; Chen, Te-Hao; Kuo, Fu-Wen; Chang, Chih-Wei; Ho, Hsuan-Ching] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Ko, Fung-Chi; Pan, Wei-Ling; Chen, Te-Hao; Chang, Chih-Wei; Ho, Hsuan-Ching] Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan; [Kao, Shu-Ji] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Fang, Li -Sing] Cheng Shiu Univ, Dept Leisure & Sport Management, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Xiamen University; National Sun Yat Sen University; Cheng Shiu University	Ko, FC (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Ko, FC (corresponding author), Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan.	ko@nmmba.gov.tw		Ko, Fung-Chi/0000-0002-8276-2353	National Museum Marine Biology and Aquarium [NMMBA981014]; National Dong-Hwa University; National Museum Marine Biology and Aquarium	National Museum Marine Biology and Aquarium; National Dong-Hwa University; National Museum Marine Biology and Aquarium	This work was funded by the National Museum Marine Biology and Aquarium (Grant No. NMMBA981014 to FCK) (URL: http://www.nmmba.gov.tw/En/cp.aspx?n=77EE24DA4467A777&s=CAD4BFFA9CD4C5C7), and the National Dong-Hwa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Museum Marine Biology and Aquarium, and the National Dong-Hwa University. Special thanks are extended to the crew of the Snow Dragon (Xue Long icebreaker and research vessel) on its 26th cruise to the Antarctic in November 2009. Their cordial and valuable assistance and support in sampling were vital to the success of the study. We also highly appreciate Professor Jiang-Shiou Hwang, the Academic Editor, and three anonymous reviewers who gave constructive comments to improve the quality of this manuscript.	Alegria HA, 2000, ENVIRON SCI TECHNOL, V34, P1953, DOI 10.1021/es990982b; Bargagli R, 2005, ANTARCTIC ECOSYSTEMS; Barrera-Oro E, 2002, ANTARCT SCI, V14, P293, DOI 10.1017/S0954102002000111; Borga K, 2004, ENVIRON TOXICOL CHEM, V23, P2367, DOI 10.1897/03-518; Borghesi N, 2008, CHEMOSPHERE, V73, P155, DOI 10.1016/j.chemosphere.2008.06.031; Cipro CVZ, 2010, CHEMOSPHERE, V78, P767, DOI 10.1016/j.chemosphere.2009.10.006; Corsolini S, 2006, ENVIRON POLLUT, V140, P371, DOI 10.1016/j.envpol.2005.04.039; Corsolini S, 2009, J CHROMATOGR A, V1216, P598, DOI 10.1016/j.chroma.2008.08.012; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; Eastman JT, 2000, ARCH FISH MAR RES, V48, P11; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; GEORGE J. L., 1966, Pesticides in the Antarctic., P155, DOI 10.2307/2401454; Goutte A, 2013, MAR POLLUT BULL, V77, P82, DOI 10.1016/j.marpolbul.2013.10.027; Ko FC, 2014, J HAZARD MATER, V277, P127, DOI 10.1016/j.jhazmat.2013.12.057; Ko FC, 2014, ENVIRON POLLUT, V185, P35, DOI 10.1016/j.envpol.2013.10.025; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; Mormede S, 2003, CHEMOSPHERE, V50, P563, DOI 10.1016/S0045-6535(02)00493-9; Nash SB, 2011, J ENVIRON MONITOR, V13, P497, DOI 10.1039/c0em00230e; Nfon E, 2008, SCI TOTAL ENVIRON, V397, P190, DOI 10.1016/j.scitotenv.2008.02.029; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulsen AH, 2013, ENVIRON POLLUT, V175, P92, DOI 10.1016/j.envpol.2012.12.026; Poulsen AH, 2012, ENVIRON POLLUT, V160, P185, DOI 10.1016/j.envpol.2011.09.022; RISEBROUGH RW, 1968, NATURE, V220, P1098, DOI 10.1038/2201098a0; Schiavone A, 2009, CHEMOSPHERE, V76, P264, DOI 10.1016/j.chemosphere.2009.03.007; SIMONICH SL, 1995, SCIENCE, V269, P1851, DOI 10.1126/science.7569923; SLADEN WJL, 1966, NATURE, V210, P670, DOI 10.1038/210670a0; Sobek A, 2010, SCI TOTAL ENVIRON, V408, P2753, DOI 10.1016/j.scitotenv.2010.03.013; Stephansen DA, 2012, MAR ENVIRON RES, V73, P17, DOI 10.1016/j.marenvres.2011.10.006; Storelli MM, 2009, ENVIRON RES, V109, P851, DOI 10.1016/j.envres.2009.07.008; Storm EG, 2006, ENV TXICOL CHEM, V25, P2502; Strobel A, 2016, CHEMOSPHERE, V161, P555, DOI 10.1016/j.chemosphere.2016.01.089; Tartu S, 2015, SCI TOTAL ENVIRON, V505, P180, DOI 10.1016/j.scitotenv.2014.10.008; TATTON JO, 1967, NATURE, V215, P346, DOI 10.1038/215346a0; Tomy GT, 2008, ENVIRON SCI TECHNOL, V42, P3634, DOI 10.1021/es703083z; WANIA F, 1993, AMBIO, V22, P10; Weber K, 2003, CHEMOSPHERE, V53, P667, DOI 10.1016/S0045-6535(03)00551-4	36	9	10	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194147	10.1371/journal.pone.0194147	http://dx.doi.org/10.1371/journal.pone.0194147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641526	gold, Green Submitted, Green Published			2022-12-27	WOS:000429742900026
J	Pritchard, AL; Johansson, PA; Nathan, V; Howlie, M; Symmons, J; Palmer, JM; Hayward, NK				Pritchard, Antonia L.; Johansson, Peter A.; Nathan, Vaishnavi; Howlie, Madeleine; Symmons, Judith; Palmer, Jane M.; Hayward, Nicholas K.			Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers	PLOS ONE			English	Article							BREAST-CANCER; PHENOTYPIC SPECTRUM; SOMATIC MUTATIONS; VARIANTS; BRCA2; IDENTIFICATION; FAMILIES; DATABASE; MSH6; QUEENSLAND	Background While a number of autosomal dominant and autosomal recessive cancer syndromes have an associated spectrum of cancers, the prevalence and variety of cancer predisposition mutations in patients with multiple primary cancers have not been extensively investigated. An understanding of the variants predisposing to more than one cancer type could improve patient care, including screening and genetic counselling, as well as advancing the understanding of tumour development. Methods A cohort of 57 patients ascertained due to their cutaneous melanoma (CM) diagnosis and with a history of two or more additional non-cutaneous independent primary cancer types were recruited for this study. Patient blood samples were assessed by whole exome or whole genome sequencing. We focussed on variants in 525 pre-selected genes, including 65 autosomal dominant and 31 autosomal recessive cancer predisposition genes, 116 genes involved in the DNA repair pathway, and 313 commonly somatically mutated in cancer. The same genes were analysed in exome sequence data from 1358 control individuals collected as part of non-cancer studies (UK10K). The identified variants were classified for pathogenicity using online databases, literature and in silico prediction tools. Results No known pathogenic autosomal dominant or previously described compound heterozygous mutations in autosomal recessive genes were observed in the multiple cancer cohort. Variants typically found somatically in haematological malignancies (in JAK1, JAK2, SF3B1, SRSF2, TET2 and TYK2) were present in lymphocyte DNA of patients with multiple primary cancers, all of whom had a history of haematological malignancy and cutaneous melanoma, as well as colorectal cancer and/or prostate cancer. Other potentially pathogenic variants were discovered in BUB1B, POLE2, ROS1 and DNMT3A. Compared to controls, multiple cancer cases had significantly more likely damaging mutations (nonsense, frameshift ins/del) in tumour suppressor and tyrosine kinase genes and higher overall burden of mutations in all cancer genes. Conclusions We identified several pathogenic variants that likely predispose to at least one of the tumours in patients with multiple cancers. We additionally present evidence that there may be a higher burden of variants of unknown significance in 'cancer genes' in patients with multiple cancer types. Further screens of this nature need to be carried out to build evidence to show if the cancers observed in these patients form part of a cancer spectrum associated with single germline variants in these genes, whether multiple layers of susceptibility exist (oligogenic or polygenic), or if the occurrence of multiple different cancers is due to random chance.	[Pritchard, Antonia L.; Johansson, Peter A.; Nathan, Vaishnavi; Howlie, Madeleine; Symmons, Judith; Palmer, Jane M.; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Oncogenom Grp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute	Pritchard, AL (corresponding author), QIMR Berghofer Med Res Inst, Oncogenom Grp, Brisbane, Qld, Australia.	antonia.pritchard@qimrberghofer.edu.au	hayward, nick/AAV-8802-2020; Pritchard, Antonia/F-4288-2010; hayward, nicholas/C-1367-2015	Pritchard, Antonia/0000-0001-5336-0454; Nathan, Vaishnavi/0000-0001-7201-6819; hayward, nicholas/0000-0003-4760-1033	National Health and Medical Research Council [APP1093017, APP1026112]; Townsville Central Rotary Club	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Townsville Central Rotary Club	This work was supported by the National Health and Medical Research Council: APP1093017 and APP1026112 to Nicholas K Hayward. Additional funding was provided to Nicholas K Hayward from Jack and Rae Cowie and the Townsville Central Rotary Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Aoude LG, 2015, FAM CANCER, V14, P621, DOI 10.1007/s10689-015-9826-8; Aoude LG, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju408; Aoude LG, 2015, PIGM CELL MELANOMA R, V28, P148, DOI 10.1111/pcmr.12333; Aoude LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072144; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Balmana J, 2011, ANN ONCOL, V22, pvi31, DOI 10.1093/annonc/mdr373; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Couts KL, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00013; Curiel-Lewandrowski C, 2011, ARCH DERMATOL, V147, P248, DOI 10.1001/archdermatol.2010.428; Demeester R, 2001, Hum Mutat, V17, P354, DOI 10.1002/humu.42; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hearle N, 2003, INVEST OPHTH VIS SCI, V44, P458, DOI 10.1167/iovs.02-0026; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Law MH, 2015, NAT GENET, V47, P987, DOI 10.1038/ng.3373; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margraf RL, 2009, HUM MUTAT, V30, P548, DOI 10.1002/humu.20928; Martinelli S, 2015, HUM MUTAT, V36, P787, DOI 10.1002/humu.22809; Masica DL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004725; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; McKusick-Nathans Institute of Genetic Medicine JHUB MD), 2016, ONL MEND INH MAN OMI; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Monnerat C, 2007, FAM CANCER, V6, P453, DOI 10.1007/s10689-007-9143-y; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Myrie KA, 2000, CANCER LETT, V152, P193, DOI 10.1016/S0304-3835(00)00340-2; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Roe OD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006554; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Spier I, 2015, INT J CANCER, V137, P320, DOI 10.1002/ijc.29396; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wadt KAW, 2015, CLIN GENET, V88, P267, DOI 10.1111/cge.12501; Wadt K, 2012, PIGM CELL MELANOMA R, V25, P815, DOI 10.1111/pcmr.12006; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiesner T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4116; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	61	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194098	10.1371/journal.pone.0194098	http://dx.doi.org/10.1371/journal.pone.0194098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641532	Green Published, gold			2022-12-27	WOS:000429742900025
J	Hudson, M; Rutherford, GW; Weiser, S; Fair, E				Hudson, Mollie; Rutherford, George W.; Weiser, Sheri; Fair, Elizabeth			Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review	PLOS ONE			English	Review							TB-HIV; INCOME COUNTRIES; INDIA; CARE; MIX; HIV/AIDS; THAILAND; LESSONS; KENYA	Background Tuberculosis (TB) is the leading cause of infectious disease deaths worldwide and is the leading cause of death among people with HIV. The World Health Organization (WHO) has called for collaboration between public and private healthcare providers to maximize integration of TB/HIV services and minimize costs. We systematically reviewed published models of public-private sector diagnostic and referral services for TB/HIV co-infected patients. Methods We searched PubMed, the Cochrane Central Register of Controlled Trials, Google Scholar, Science Direct, CINAHL and Web of Science. We included studies that discussed programs that linked private and public providers for TB/HIV concurrent diagnostic and referral services and used Review Manager (Version 5.3, 2015) for meta-analysis. Results We found 1,218 unduplicated potentially relevant articles and abstracts; three met our eligibility criteria. All three described public-private TB/HIV diagnostic/referral services with varying degrees of integration. In Kenya private practitioners were able to test for both TB and HIV and offer state-subsidized TB medication, but they could not provide state-subsidized antiretroviral therapy (ART) to co-infected patients. In India private practitioners not contractually engaged with the public sector offered TB/HIV services inconsistently and on a subjective basis. Those partnered with the state, however, could test for both TB and HIV and offer state-subsidized medications. In Nigeria some private providers had access to both state-subsidized medications and diagnostic tests; others required patients to pay out-of-pocket for testing and/or treatment. In a meta-analysis of the two quantitative reports, TB patients who sought care in the public sector were almost twice as likely to have been tested for HIV than TB patients who sought care in the private sector (risk ratio [RR] 1.98, 95% confidence interval [CI] 1.88-2.08). However, HIV-infected TB patients who sought care in the public sector were marginally less likely to initiate ART than TB patients who sought care from private providers (RR 0.89, 95% CI 0.78-1.03). Conclusion These three studies are examples of public-private TB/HIV service delivery and can potentially serve as models for integrated TB/HIV care systems. Successful public-private diagnostic and treatment services can both improve outcomes and decrease costs for patients co-infected with HIV and TB.	[Hudson, Mollie; Rutherford, George W.] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Weiser, Sheri; Fair, Elizabeth] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hudson, M (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	molliehudson47@gmail.com		Hudson, Mollie/0000-0001-8220-2834	NIAID NIH HHS [K24 AI134326] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI134326] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arora VK, 2003, INT J TUBERC LUNG D, V7, P1131; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Center for Disease Control and Prevention, 2017, FIND MISS 4 MILL ROL; Chakaya J, 2008, INT J TUBERC LUNG D, V12, P1274; Daniel OJ, 2013, INT J TUBERC LUNG D, V17, P1195, DOI 10.5588/ijtld.12.0759; Daniels C., 2013, TB HIV DEADLY DUAL E; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Dholakia Yatin N, 2013, Indian J Tuberc, V60, P23; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; International Union Against Tuberculosis and Lung Disease, C ABSTR; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Miller R, 2012, INT J HEALTH PLAN M, V27, P180, DOI 10.1002/hpm.2105; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; PRISMA, TRANSP REP SYST SYST; Rao P, 2011, JAIDS-J ACQ IMM DEF, V57, pS116, DOI 10.1097/QAI.0b013e31821ed719; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Sheikh K, 2006, T ROY SOC TROP MED H, V100, P312, DOI 10.1016/j.trstmh.2005.04.023; Smith E, 2001, WORKING PRIVATE SECT; van't Hoog AH, 2008, INT J TUBERC LUNG D, V12, pS32; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; WHO, 2004, INT POL COLL TB HIV; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2008, PROM IMPL COLL TB HI; World Health Organization, PUBL PRIV MIX PPM TB; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; 2012, GLOB TUB REP 2013, P1	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194960	10.1371/journal.pone.0194960	http://dx.doi.org/10.1371/journal.pone.0194960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634772	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200019
J	Joelsson, K; Hjalten, J; Gibb, H				Joelsson, Klara; Hjaelten, Joakim; Gibb, Heloise			Forest management strategy affects saproxylic beetle assemblages: A comparison of even and uneven-aged silviculture using direct and indirect sampling	PLOS ONE			English	Article							BOREAL SPRUCE FORESTS; DEAD WOOD; FUNCTIONAL-GROUPS; SPECIES RICHNESS; SWEDISH FORESTS; HIGH STUMPS; OLD-GROWTH; LOGS; HETEROGENEITY; DECOMPOSITION	Management of forest for wood production has altered ecosystem structures and processes and led to habitat loss and species extinctions, worldwide. Deadwood is a key resource supporting forest biodiversity, and commonly declines following forest management. However, different forest management methods affect dead wood differently. For example, uneven aged silviculture maintains an age-stratified forest with ongoing dead wood production, while even-aged silviculture breaks forest continuity, leading to long periods without large trees. We asked how deadwood-dependent beetles respond to different silvicultural practices and if their responses depend on deadwood volume, and beetles preference for decay stages of deadwood. We compared beetle assemblages in five boreal forest types with different management strategies: clearcutting and thinning (both representing even-aged silviculture), selective felling (representing uneven-aged silviculture), reference and old growth forest (both uneven-aged controls without a recent history [similar to 50 years] of management, but the latter with high conservation values). We collected beetles using window traps and by sieving the bark from experimental logs (bolts). Beetle assemblages on clear-cuts differed from all other stand types, regardless of trapping method or decay stage preference. Thinning differed from reference stands, indicating incomplete recovery after clear-cutting, while selective felling differed only from clear-cuts. In contrast to our predictions, early and late successional species responded similarly to different silvicultural practices. However, there were indications of marginal assemblage differences both between thinned stands and selective felling and between thinned and old growth stands (p = 0.10). The stand volume of early decay stage wood influenced assemblage composition of early, but not late successional species. Uneven-aged silviculture maintained species assemblages similar to those of the reference and old growth stands and might therefore be a better management option when considering biodiversity conservation.	[Joelsson, Klara; Hjaelten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Gibb, Heloise] La Trobe Univ, Dept Ecol Evolut & Environm, Melbourne, Vic, Australia	Swedish University of Agricultural Sciences; La Trobe University	Joelsson, K (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden.	klara.joelsson@slu.se	Gibb, Heloise/B-8338-2013	Hjalten, Joakim/0000-0002-8279-6633; Gibb, Heloise/0000-0001-7194-0620	Formas [215 - 2012-748]; Stiftelsen Oscar och Lili Lamms Minne [D02012-0056]	Formas(Swedish Research Council Formas); Stiftelsen Oscar och Lili Lamms Minne	This work was funded by Formas [grant number 215 - 2012-748] and Stiftelsen Oscar och Lili Lamms Minne [grant number D02012-0056] to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinvi O, 2007, J INSECT CONSERV, V11, P99, DOI 10.1007/s10841-006-9012-2; Aussenac G, 2000, ANN FOR SCI, V57, P287; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Bernes C., 2011, BIODIVERSITY SWEDEN; Birkemoe T, 2015, J INSECT CONSERV, V19, P163, DOI 10.1007/s10841-015-9757-6; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Drever CR, 2006, CAN J FOREST RES, V36, P2285, DOI 10.1139/X06-132; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fridman J, 2001, SCAND J FOREST RES, V16, P455, DOI 10.1080/02827580152632856; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gibb H, 2006, BIOL CONSERV, V132, P250, DOI 10.1016/j.biocon.2006.04.017; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; Hautala H, 2004, BIODIVERS CONSERV, V13, P1541, DOI 10.1023/B:BIOC.0000021327.43783.a9; Heikkala O, 2016, FOREST ECOL MANAG, V359, P51, DOI 10.1016/j.foreco.2015.09.043; Hjalten J, 2017, FOREST ECOL MANAG, V402, P37, DOI 10.1016/j.foreco.2017.06.064; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Hjalten J, 2010, FOREST ECOL MANAG, V260, P1149, DOI 10.1016/j.foreco.2010.07.003; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Joelsson K, 2018, J ENVIRON MANAGE, V205, P1, DOI 10.1016/j.jenvman.2017.09.054; Joelsson K, 2017, FOREST ECOL MANAG, V391, P436, DOI 10.1016/j.foreco.2017.02.006; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsson BG, 2016, FOREST ECOL MANAG, V376, P174, DOI 10.1016/j.foreco.2016.06.017; Kassambara A., 2016, FACTOEXTRA EXTRACT V, V1; Kebli H, 2012, FOREST ECOL MANAG, V279, P45, DOI 10.1016/j.foreco.2012.05.028; Koch K., 1989, KAFER MITTELEUROPAS; Kouki J, 2012, DIVERS DISTRIB, V18, P348, DOI 10.1111/j.1472-4642.2011.00839.x; Kuuluvainen T, 2002, SILVA FENN, V36, P97, DOI 10.14214/sf.552; Kuuluvainen T, 2012, AMBIO, V41, P720, DOI 10.1007/s13280-012-0289-y; Kuuluvainen T, 2012, CAN J FOREST RES, V42, P1185, DOI [10.1139/X2012-064, 10.1139/x2012-064]; Kuuluvainen T, 2011, SILVA FENN, V45, P823, DOI 10.14214/sf.73; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Lee SI, 2014, AGR FOREST ENTOMOL, V16, P391, DOI 10.1111/afe.12069; Martikainen P, 2003, BIODIVERS CONSERV, V12, P1815, DOI 10.1023/A:1024132829581; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Nilsson SG, 1997, ECOGRAPHY, V20, P491, DOI 10.1111/j.1600-0587.1997.tb00417.x; Oksanen J, 2007, THE VEGAN PACKAGE, P10; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Palm T., 1959, OPUSC ENT S, VXVI, P269; Puettmann KJ, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0031-x; Saint-Germain M, 2007, ECOGRAPHY, V30, P737, DOI 10.1111/j.2007.0906-7590.05080.x; Schall P, 2017, J APPL ECOL, DOI [10.1111/1365-2664.12950, DOI 10.1111/1365-2664.12950]; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; SIITONEN J, 1994, SCAND J FOREST RES, V9, P185, DOI 10.1080/02827589409382830; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SLU, FOR STAT 2016 OFF ST; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Storaunet K, 2002, CAN J FOREST RES, V32, P1801, DOI 10.1139/X02-105; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Thorn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101757; Tikkanen O- P, 2006, ANN ZOOLOGICI FENNIC; Tikkanen OP, 2006, ANN ZOOL FENN, V43, P373; Ulyshen MD, 2016, APPL SOIL ECOL, V105, P25, DOI 10.1016/j.apsoil.2016.03.017; Vanderwel MC, 2006, FOREST ECOL MANAG, V225, P190, DOI 10.1016/j.foreco.2005.12.051; Wang Y, 2016, PACKAGE MVABUND; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wikars LO, 2005, CAN ENTOMOL, V137, P304, DOI 10.4039/N04-104; ZACKRISSON O, 1977, OIKOS, V29, P22, DOI 10.2307/3543289	68	11	11	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194905	10.1371/journal.pone.0194905	http://dx.doi.org/10.1371/journal.pone.0194905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634728	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200014
J	Shin, J; Park, JY; Choi, J				Shin, Jinyoung; Park, Jin Young; Choi, Jaekyung			Long-term exposure to ambient air pollutants and mental health status: A nationwide population-based cross-sectional study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; DEPRESSIVE SYMPTOMS; RISK-FACTOR; POLLUTION; ASSOCIATION	There is a suspected but unproven association between long-term exposure to ambient air pollution and mental health. The aim of this study is to investigate the association between long-term exposure to ambient air pollution and subjective stress, depressive disorders, health-related quality of life (QoL) and suicide. We selected 124,205 adults from the Korean Community Health Survey in 2013 who were at least 19 years old and who had lived in their current domiciles for > five years. Based on the computer-assisted personal interviews to measure subjective stress in daily life, EuroQoL-5 dimensions, depression diagnosis by a doctor, suicidal ideation, and suicidal attempts, we evaluated the risk of mental disorders using multiple logistic regression analysis according to the quartiles of air pollutants, such as particulate matter <10 mu m (PM10), nitrogen dioxide (NO2), carbon monoxide (CO), and sulfur dioxide, using yearly average concentration between August 2012 and July 2013. The prevalence of high stress, poor QoL, depressiveness, diagnosis of depression, and suicide ideation was positively associated with high concentrations of PM10, NO2, and CO after adjusting for confounding factors. Men were at increased risk of stress, poor QoL, and depressiveness from air pollution exposure than were women. The risk of higher stress or poor QoL in subjects < age 65 increased with air pollution more than did that in subjects >= age 65. Long-term exposure to ambient air pollution may be an independent risk factor for mental health disorders ranging from subjective stress to suicide ideation.	[Shin, Jinyoung; Choi, Jaekyung] Konkuk Univ, Sch Med, Res Inst Med Sci, Dept Family Med,Med Ctr, Seoul, South Korea; [Park, Jin Young] Yonsei Univ, Gangnam Severance Hosp, Dept Psychiat, Coll Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System	Choi, J (corresponding author), Konkuk Univ, Sch Med, Res Inst Med Sci, Dept Family Med,Med Ctr, Seoul, South Korea.	cjk@kuh.ac.kr		Shin, Jinyoung/0000-0001-9558-1853; Choi, Jaekyung/0000-0002-0875-7505				Ayanlade A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3553-y; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Cho J, 2014, J AFFECT DISORDERS, V157, P45, DOI 10.1016/j.jad.2014.01.002; Choi Y, 2017, J ENVIRON SCI, V53, P151, DOI 10.1016/j.jes.2016.02.020; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Greenberg N, 2017, J TOXICOL ENV HEAL A, V80, P326, DOI 10.1080/15287394.2017.1313800; Hong JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23858; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; Kim J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040431; Kim KN, 2016, ENVIRON HEALTH PERSP, V124, P1547, DOI 10.1289/EHP192; Kim Sun Taek, 2015, QUALITY CONTROL AIR; Kim YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137044; Kioumourtzoglou MA, 2017, AM J EPIDEMIOL, V185, P801, DOI 10.1093/aje/kww163; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Mannucci Pier Mannuccio, 2017, Int J Environ Res Public Health, V14, DOI 10.3390/ijerph14091048; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Oudin A, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-017-0348-8; Patten SB, 2015, CAN J PSYCHIAT, V60, P23, DOI 10.1177/070674371506000106; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Seo J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4798-2; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Szyszkowicz M, 2010, ENVIRON HEALTH INSIG, V4, P79, DOI 10.4137/EHI.S5662; Szyszkowicz M, 2009, INT J OCCUP MED ENV, V22, P355, DOI 10.2478/v10001-009-0031-6; Wang Y, 2014, ENVIRON HEALTH PERSP, V122, P553, DOI 10.1289/ehp.1205909; Zijlema WL, 2016, INT J HYG ENVIR HEAL, V219, P212, DOI 10.1016/j.ijheh.2015.11.006	28	54	54	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195607	10.1371/journal.pone.0195607	http://dx.doi.org/10.1371/journal.pone.0195607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630645	gold, Green Submitted, Green Published			2022-12-27	WOS:000429505000064
J	Uutela, TI; Kautiainen, HJ; Hakkinen, AH				Uutela, Toini I.; Kautiainen, Hannu J.; Hakkinen, Arja H.			Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; STRENGTH; WOMEN; INACTIVITY; INDEX; ONSET; MASS	Objectives Increasing evidence suggests that inflammation has a detrimental effect on muscle strength. Our objective was to analyse the association between muscle performance and different disease activity levels in patients with rheumatoid arthritis (RA). Method A total of 199 consecutive outpatients were subject to cross-sectional assessment. Measurements of grip strength, endurance of the upper and lower limbs and trunk strength were combined as a muscle performance composite score (MPCS), using a standardised method. The disease activity for 28 joints (DAS28), radiographs of small joints (Larsen score), rheumatoid factor, body mass index (BMI), comorbidities and anti-rheumatic drugs were verified. Patients questionnaires included sociodemographic information, pain level, global disease activity, the Beck Depression Inventory, the mental and physical component scores of Short Form-36 and physical activity level. Results Of the 199 patients, 36%, 17% and 47% patients had remission, low/moderate and high DAS28, respectively. The patients in remission had significantly shorter disease duration, better parameters in terms of pain, physicians assessment, Larsen, Beck or physical component score of Short Form-36, and they were more physically active than other patients. After adjustments for age, sex, RA duration, radiographs and BMI, the decreasing MPCS associated linearly with the increasing DAS28 activity levels (linearity, P <0.001). Conclusion Poorer MPCS is clearly associated with higher disease activity in patients with RA. Muscle performance is a modifiable risk factor. The findings suggest evaluating muscle performance in clinical practice as a part of patient care.	[Uutela, Toini I.] Cent Hosp Lapland, Dept Med, Rovaniemi, Finland; [Uutela, Toini I.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kautiainen, Hannu J.] Helsinki Univ Hosp, Unit Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu J.] Kuopio Univ Hosp, Unit Primary Hlth Care, Kuopio, Finland; [Hakkinen, Arja H.] Cent Hosp Jyvaskyla, Dept Phys & Rehabil Med, Jyvaskyla, Finland; [Hakkinen, Arja H.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland	University of Oulu; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; University of Jyvaskyla	Uutela, TI (corresponding author), Cent Hosp Lapland, Dept Med, Rovaniemi, Finland.; Uutela, TI (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.	toini.uutela@fimnet.fi			EVO-funding from central Hospital of Lapland; Oulu University Hospital	EVO-funding from central Hospital of Lapland; Oulu University Hospital	This work was supported by the EVO-funding from central Hospital of Lapland and Oulu University Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARANTA H, 1994, SCAND J REHABIL MED, V26, P211; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baker JF, 2014, ARTHRIT CARE RES, V66, P1612, DOI 10.1002/acr.22328; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Bruunsgard H, 2005, J LEUKOCYTE BIOL, V78, P19; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen L, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-74; Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Fransen J, 2003, ARTHRIT RHEUM-ARTHR, V49, pS214, DOI [DOI 10.1002/ART.11407, 10.1002/art.11407]; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hakala Markku, 2009, Duodecim, V125, P2131; Hakkinen A, 2006, ANN RHEUM DIS, V65, P30, DOI 10.1136/ard.2004.034769; Hakkinen A, 2005, CLIN EXP RHEUMATOL, V23, P505; Hakkinen A, 2004, ANN RHEUM DIS, V63, P910, DOI 10.1136/ard.2003.013003; Hakkinen A, 1999, SCAND J RHEUMATOL, V28, P145; Henchoz Y, 2012, RHEUMATOLOGY, V51, P1500, DOI 10.1093/rheumatology/kes067; Heyward VH, 1996, APPL BODY COMPOSITIO, P112; Hueber AJ, 2009, RHEUMATOID ARTHRITIS, P200; International Physical Activity Questionnaires (IPAQ), 2015, GUID DAT PROC AN INT; Iversen Maura D, 2012, Int J Clin Rheumtol, V7, P489; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Matschke V, 2010, MED SCI SPORTS EXERC; Metsios GS, 2009, EUR J CARDIOV PREV R, V16, P188, DOI 10.1097/HJR.0b013e3283271ceb; Rall LC, 1996, ARTHRITIS RHEUM, V39, P1115, DOI 10.1002/art.1780390707; Roubenoff R, 2002, AM J CLIN NUTR, V76, P774, DOI 10.1093/ajcn/76.4.774; Sandberg MEC, 2014, ANN RHEUM DIS, V73, P1541, DOI 10.1136/annrheumdis-2014-205180; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Sharif S, 2011, CASE REP MED, V2011, DOI 10.1155/2011/205691; Sheehy C, 2013, SCAND J RHEUMATOL, V42, P289, DOI 10.3109/03009742.2012.747624; Sherbourne CD, 1992, MED CARE, V30; Sokka T, 2008, ARTHRIT RHEUM-ARTHR, V59, P42, DOI 10.1002/art.23255; Sternang O, 2015, AGE AGEING, V44, P269, DOI 10.1093/ageing/afu170; STUCKI G, 1994, J RHEUMATOL, V21, P2200; Summers GD, 2010, NAT REV RHEUMATOL, V6, P445, DOI 10.1038/nrrheum.2010.105; van den Ende CHM, 2000, ANN RHEUM DIS, V59, P615, DOI 10.1136/ard.59.8.615	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194917	10.1371/journal.pone.0194917	http://dx.doi.org/10.1371/journal.pone.0194917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630626	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000019
J	Zhou, N; Katz, M; Knecht, W; Compagno, C; Piskur, J				Zhou, Nerve; Katz, Michael; Knecht, Wolfgang; Compagno, Concetta; Piskur, Jure			Genome dynamics and evolution in yeasts: A long-term yeast-bacteria competition experiment	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SACCHAROMYCES-CEREVISIAE; CLONAL INTERFERENCE; POPULATIONS; INHIBITION; STRAINS; ECOLOGY; DEATH	There is an enormous genetic diversity evident in modern yeasts, but our understanding of the ecological basis of such diversifications in nature remains at best fragmented so far. Here we report a long-term experiment mimicking a primordial competitive environment, in which yeast and bacteria co-exist and compete against each other. Eighteen yeasts covering a wide phylogenetic background spanning approximately 250 million years of evolutionary history were used to establish independent evolution lines for at most 130 passages. Our collection of hundreds of modified strains generated through such a rare two-species cross-kingdom competition experiment re-created the appearance of large-scale genomic rearrangements and altered phenotypes important in the diversification history of yeasts. At the same time, the methodology employed in this evolutionary study would also be a non gene-technological method of reprogramming yeast genomes and then selecting yeast strains with desired traits. Cross-kingdom competition may therefore be a method of significant value to generate industrially useful yeast strains with new metabolic traits.	[Zhou, Nerve; Katz, Michael; Knecht, Wolfgang; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden; [Zhou, Nerve] Botswana Int Univ Sci & Technol, Dept Biol Sci & Biotechnol, Private Bag 16, Palapye, Botswana; [Katz, Michael] Carlsberg Labs, Gamle Carlsberg Vej 10, Copenhagen V, Denmark; [Knecht, Wolfgang] Lund Univ, Lund Prot Prod Platform, Lund, Sweden; [Compagno, Concetta] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	Lund University; Lund University; University of Milan	Zhou, N (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Zhou, N (corresponding author), Botswana Int Univ Sci & Technol, Dept Biol Sci & Biotechnol, Private Bag 16, Palapye, Botswana.	zhoun@biust.ac.bw		Zhou, Nerve/0000-0002-8822-1347	Marie Curie, Cornucopia Project [264717]; Fysiografen Foundation; Lindstrom Foundation; Carlsberg Laboratories, Copenhagen, Denmark under Cornucopia Project [264717]	Marie Curie, Cornucopia Project; Fysiografen Foundation; Lindstrom Foundation; Carlsberg Laboratories, Copenhagen, Denmark under Cornucopia Project	This work was funded by the Marie Curie, Cornucopia Project (264717) to JP, Fysiografen and Lindstrom Foundations to NZ. Part of this work involving use of a Bioscreen C was done at Carlsberg Laboratories, Copenhagen, Denmark as a consortium partner under the same Cornucopia Project (264717). The funder provided support in the form of salaries for authors [MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1985, GENETICS, V110, P173; Ahmad KM, 2013, ANTON LEEUW INT J G, V104, P111, DOI 10.1007/s10482-013-9931-3; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arneborg N, 2000, ARCH MICROBIOL, V174, P125, DOI 10.1007/s002030000185; Bae S, 2006, J APPL MICROBIOL, V100, P712, DOI 10.1111/j.1365-2672.2006.02890.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Batista M, 2011, BIOCONTROL SCI TECHN, V21, P797, DOI 10.1080/09583157.2011.580837; Beckner M, 2011, LETT APPL MICROBIOL, V53, P387, DOI 10.1111/j.1472-765X.2011.03124.x; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Charton C, 2004, BIOCHEM BIOPH RES CO, V318, P67, DOI 10.1016/j.bbrc.2004.03.185; Chernin LS, 1997, APPL ENVIRON MICROB, V63, P834, DOI 10.1128/AEM.63.3.834-839.1997; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; Cray JA, 2013, MICROB BIOTECHNOL, V6, P453, DOI 10.1111/1751-7915.12027; Crowley S, 2013, TRENDS FOOD SCI TECH, V33, P93, DOI 10.1016/j.tifs.2013.07.004; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dunham MJ, 2010, METHOD ENZYMOL, V470, P487, DOI 10.1016/S0076-6879(10)70019-7; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gleeson O, 2010, ANTON LEEUW INT J G, V97, P261, DOI 10.1007/s10482-009-9407-7; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Hallsworth JE, 1998, J FERMENT BIOENG, V86, P451, DOI 10.1016/S0922-338X(98)80150-5; Hellborg L, 2009, EUKARYOT CELL, V8, P1739, DOI 10.1128/EC.00115-09; Humphry DR, 2003, INT J SYST EVOL MICR, V53, P393, DOI 10.1099/ijs.0.02271-0; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Moktaduzzaman M, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fou009; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Mustonen V, 2010, P NATL ACAD SCI USA, V107, P4248, DOI 10.1073/pnas.0907953107; Paquin CE, 1983, RELATIVE FITNESS CAN; Passoth V, 2006, FEMS YEAST RES, V6, P3, DOI 10.1111/j.1567-1364.2005.00004.x; Petersen RF, 1999, INT J SYST BACTERIOL, V49, P1925, DOI 10.1099/00207713-49-4-1925; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; RICHARDS M, 1966, NATURE, V209, P536, DOI 10.1038/209536a0; Roach DR, 2015, MICROB BIOTECHNOL, V8, P510, DOI 10.1111/1751-7915.12253; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Steensels J, 2014, APPL ENVIRON MICROB, V80, P6965, DOI 10.1128/AEM.02235-14; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Ueda KI, 1952, J AGR CHEM SOC JAPAN, V26, P35, DOI DOI 10.1271/NOGEIKAGAKU1924.26.35; Verstrepen KJ, 2006, YEAST HANDB, V2, P399; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Zeyl C, 2006, FEMS YEAST RES, V6, P685, DOI 10.1111/j.1567-1364.2006.00061.x; Zhou N, 2015, THESIS; Zhou N, 2017, COEVOLUTION BACTERIA, V12, DOI [10.1371/journal.pone.0173318, DOI 10.1371/JOURNAL.PONE.0173318]; Zhou N, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox060	61	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194911	10.1371/journal.pone.0194911	http://dx.doi.org/10.1371/journal.pone.0194911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624585	gold, Green Published, Green Submitted			2022-12-27	WOS:000429379600010
J	Adamovicz, L; Allender, MC; Archer, G; Rzadkowska, M; Boers, K; Phillips, C; Driskell, E; Kinsel, MJ; Chu, C				Adamovicz, Laura; Allender, Matthew C.; Archer, Grace; Rzadkowska, Marta; Boers, Kayla; Phillips, Chris; Driskell, Elizabeth; Kinsel, Michael J.; Chu, Caroline			Investigation of multiple mortality events in eastern box turtles (Terrapene carolina carolina)	PLOS ONE			English	Article							VIRUS 3-LIKE VIRUS; RANAVIRUS INFECTION; QUANTITATIVE PCR; DISEASE; MYCOPLASMA; MANAGEMENT; TORTOISES; CHYTRIDIOMYCOSIS; HERPESVIRUS-1; SURVEILLANCE	Wildlife mortality investigations are important for conservation, food safety, and public health; but they are infrequently reported for cryptic chelonian species. Eastern box turtles (Terrapene carolina carolina) are declining due to anthropogenic factors and disease, and while mortality investigations have been reported for captive and translocated individuals, few descriptions exist for free-living populations. We report the results of four natural mortality event investigations conducted during routine health surveillance of three Illinois box turtle populations in 2011, 2013, 2014, and 2015. In April 2011, over 50 box turtles were found dead and a polymicrobial necrotizing bacterial infection was diagnosed in five survivors using histopathology and aerobic/anaerobic culture. This represents the first reported occurrence of necrotizing bacterial infection in box turtles. In August 2013, paired histopathology and qPCR ranavirus detection in nine turtles was significantly associated with occupation of moist microhabitats, identification of oral plaques and nasal discharge on physical exam, and increases in the heterophil count and heterophil to lymphocyte ratio (p < 0.05). In July 2014 and 2015, ranavirus outbreaks reoccurred within a 0.2km radius of highly-disturbed habitat containing ephemeral ponds used by amphibians for breeding. qPCR ranavirus detection in five individuals each year was significantly associated with use of moist microhabitats (p < 0.05). Detection of single and co-pathogens (Terrapene herpesvirus 1, adenovirus, and Mycoplasma sp.) was common before, during, and after mortality events, but improved sample size would be necessary to determine the impacts of these pathogens on the occurrence and outcome of mortality events. This study provides novel information about the causes and predictors of natural box turtle mortality events. Continued investigation of health, disease, and death in free-living box turtles will improve baseline knowledge of morbidity and mortality, identify threats to survival, and promote the formation of effective conservation strategies.	[Adamovicz, Laura; Allender, Matthew C.; Archer, Grace; Rzadkowska, Marta; Boers, Kayla] Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA; [Phillips, Chris] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Driskell, Elizabeth; Kinsel, Michael J.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Chu, Caroline] Univ Illinois, Coll Vet Med, Zool Pathol Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Allender, MC (corresponding author), Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	mcallend@illinois.edu		Adamovicz, Laura/0000-0002-5696-2327				Agha M, 2017, DIS AQUAT ORGAN, V124, P91, DOI 10.3354/dao03122; Allender MC, 2006, J WILDLIFE DIS, V42, P677, DOI 10.7589/0090-3558-42.3.677; Allender Matthew C., 2013, Journal of Herpetological Medicine and Surgery, V23, P25, DOI 10.5818/1529-9651-23.1.25; Allender MC, 2013, J VIROL METHODS, V188, P121, DOI 10.1016/j.jviromet.2012.12.012; Artois Marc, 2009, P187, DOI 10.1007/978-4-431-77134-0_10; Belzer William R., 2011, Turtle and Tortoise Newsletter, V15, P18; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop EJ, 2007, EPIDEMIOL INFECT, V135, P1248, DOI 10.1017/S0950268807008515; Black Y, 2017, J WILDLIFE DIS, V53, P509, DOI 10.7589/2016-08-176; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Blum SA, 2014, P ASREPTILIAN AMPH, P17; Boers K, 2017, HERPETOL REV, V48, P300; Brand CJ, 2013, ECOHEALTH, V10, P446, DOI 10.1007/s10393-013-0897-4; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; BROWN MB, 1994, INFECT IMMUN, V62, P4580, DOI 10.1128/IAI.62.10.4580-4586.1994; Brunner J.L., 2015, RANAVIRUSES LETHAL P, P71, DOI [10.1007/978-3-319-13755-1_4, DOI 10.1007/978-3-319-13755-1_4]; Butkus CE, 2017, J ZOO WILDLIFE MED, V48, P1210, DOI 10.1638/2017-0098.1; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; Clark RW, 2011, BIOL CONSERV, V144, P886, DOI 10.1016/j.biocon.2010.12.001; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Currylow AF, 2014, J HERPETOL, V48, P117, DOI 10.1670/12-235; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; De Voe R, 2004, J ZOO WILDLIFE MED, V35, P534, DOI 10.1638/03-037; DODD CK, 2001, N AM BOX TURTLES NAT; Doszpoly A, 2013, INFECT GENET EVOL, V17, P106, DOI 10.1016/j.meegid.2013.03.049; Edlich RF, 2010, J EMERG MED, V39, P261, DOI 10.1016/j.jemermed.2008.06.024; Farkas SL, 2009, VET MICROBIOL, V138, P169, DOI 10.1016/j.vetmic.2009.03.016; Farnsworth SD, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2362-01; Feldman SH, 2006, J WILDLIFE DIS, V42, P279, DOI 10.7589/0090-3558-42.2.279; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Homan HJ, 2001, WILDLIFE SOC B, V29, P292; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Johnson AJ, 2007, VET PATHOL, V44, P285, DOI 10.1354/vp.44-3-285; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Johnson AJ, 2010, VET MICROBIOL, V142, P160, DOI 10.1016/j.vetmic.2009.09.059; Jousimies-Somer H., 2003, WADSWORTH KTL ANAERO, V6th ed; Kane LP, 2017, J WILDLIFE DIS, V53, P285, DOI 10.7589/2016-06-138; Kane LP, 2016, J VIROL METHODS, V232, P57, DOI 10.1016/j.jviromet.2016.02.002; Kimble SJA, 2017, ECOHEALTH; Kimble SJA, 2015, ECOHEALTH, V12, P334, DOI 10.1007/s10393-014-0974-3; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; Ossiboff RJ, 2015, J WILDLIFE DIS, V51, P466, DOI 10.7589/2014-04-086; Phan HH, 2010, CRIT CARE MED, V38, pS460, DOI 10.1097/CCM.0b013e3181ec667f; R Development Core Team, 2009, R LANG ENV STAT COMP; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Ruder MG, 2010, JAVMA-J AM VET MED A, V237, P783, DOI 10.2460/javma.237.7.783; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Sarani B, 2009, J AM COLL SURGEONS, V208, P279, DOI 10.1016/j.jamcollsurg.2008.10.032; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-57; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; SCHUMACHER IM, 1993, J CLIN MICROBIOL, V31, P1454, DOI 10.1128/JCM.31.6.1454-1460.1993; Sim RR, 2016, J ZOO WILDLIFE MED, V47, P256, DOI 10.1638/2015-0048.1; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; Sleeman J., 2012, NEW DIRECTIONS CONSE, P539; Stacy BA, 2014, J WILDLIFE DIS, V50, P906, DOI 10.7589/2013-10-271; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Wuerthner VP, 2017, J ANIM ECOL, V86, P921, DOI 10.1111/1365-2656.12665	64	23	23	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195617	10.1371/journal.pone.0195617	http://dx.doi.org/10.1371/journal.pone.0195617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621347	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800107
J	Cogoni, C; Carnaghi, A; Mitrovic, A; Leder, H; Fantoni, C; Silani, G				Cogoni, Carlotta; Carnaghi, Andrea; Mitrovic, Aleksandra; Leder, Helmut; Fantoni, Carlo; Silani, Giorgia			Understanding the mechanisms behind the sexualized-body inversion hypothesis: The role of asymmetry and attention biases	PLOS ONE			English	Article							FACE RECOGNITION; PERSON RECOGNITION; OBJECTIFIED WOMEN; PERCEPTION; BODIES; PARTS; ORIENTATION; INFORMATION; LOOKING; GENDER	A controversial hypothesis, named the Sexualized Body Inversion Hypothesis (SBIH), claims similar visual processing of sexually objectified women (i.e., with a focus on the sexual body parts) and inanimate objects as indicated by an absence of the inversion effect for both type of stimuli. The current study aims at shedding light into the mechanisms behind the SBIH in a series of 4 experiments. Using a modified version of Bernard et al.'s (2012) visual-matching task, first we tested the core assumption of the SBIH, namely that a similar processing style occurs for sexualized human bodies and objects. In Experiments 1 and 2 a non-sexualized (personalized) condition plus two object-control conditions (mannequins, and houses) were included in the experimental design. Results showed an inversion effect for images of personalized women and mannequins, but not for sexualized women and houses. Second, we explored whether this effect was driven by differences in stimulus asymmetry, by testing the mediating and moderating role of this visual feature. In Experiment 3, we provided the first evidence that not only the sexual attributes of the images but also additional perceptual features of the stimuli, such as their asymmetry, played a moderating role in shaping the inversion effect. Lastly, we investigated the strategy adopted in the visual-matching task by tracking eye movements of the participants. Results of Experiment 4 suggest an association between a specific pattern of visual exploration of the images and the presence of the inversion effect. Findings are discussed with respect to the literature on sexual objectification.	[Cogoni, Carlotta] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy; [Cogoni, Carlotta] Scuola Int Super Avanzati, Neurosci Sect, Trieste, Italy; [Carnaghi, Andrea; Fantoni, Carlo] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Mitrovic, Aleksandra; Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Silani, Giorgia] Univ Vienna, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria	University of Trento; International School for Advanced Studies (SISSA); University of Trieste; University of Vienna; University of Vienna	Cogoni, C (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy.; Cogoni, C (corresponding author), Scuola Int Super Avanzati, Neurosci Sect, Trieste, Italy.; Silani, G (corresponding author), Univ Vienna, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria.	carlottacogoni.ca@gmail.com; giorgia.silani@univie.ac.at		Mitrovic, Aleksandra/0000-0003-2980-3379; , carlotta/0000-0001-9029-0096; silani, giorgia/0000-0002-4284-3618	PRIN [(2012)-20123X2PXT]; Austrian Science Fund (FWF) [P27355]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is supported by PRIN (2012)-20123X2PXT grant to AC and GS and the Austrian Science Fund (FWF; project P27355) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartky Sandra, 2015, FEMININITY DOMINATIO; Bernard P, 2017, SOCIAL PSYCHOL PERSO; Bernard P, 2015, PSYCHOL WOMEN QUART, V39, P432, DOI 10.1177/0361684315580125; Bernard P, 2013, PSYCHOL SCI, V24, P1071, DOI 10.1177/0956797612474672; Bernard P, 2012, PSYCHOL SCI, V23, P469, DOI 10.1177/0956797611434748; Brandman T, 2012, COGNITION, V125, P365, DOI 10.1016/j.cognition.2012.08.001; Bruyer R, 2011, PERCEPTION, V40, P1478, DOI 10.1068/p6928; Cikara M, 2011, J COGNITIVE NEUROSCI, V23, P540, DOI 10.1162/jocn.2010.21497; Civile C, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016646150; Civile C, 2016, PSYCHOL WOMEN QUART, V40, P199, DOI 10.1177/0361684315604820; Cogoni C, 2018, CORTEX, V99, P258, DOI 10.1016/j.cortex.2017.11.020; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; DALLETT K, 1968, J EXP PSYCHOL, V76, P312, DOI 10.1037/h0025383; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; European Union Agency for Fundamental Rights, 2014, VIOL WOM EU WID SURV; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gervais SJ, 2013, SEX ROLES, V69, P557, DOI 10.1007/s11199-013-0316-x; Gervais SJ, 2012, EUR J SOC PSYCHOL, V42, P743, DOI 10.1002/ejsp.1890; Gray K, 2011, J PERS SOC PSYCHOL, V101, P1207, DOI 10.1037/a0025883; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Knoblauch K., 2012, MODELING PSYCHOPHYSI; Kohler W, 1940, DYNAMICS PSYCHOL VIT; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Monro F, 2005, INT J EAT DISORDER, V38, P85, DOI 10.1002/eat.20153; Neri P, 2009, J VISION, V9, DOI 10.1167/9.12.1; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Papeo L, 2017, PSYCHOL SCI, V28, P369, DOI 10.1177/0956797616685769; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; Ramm BJ, 2010, VIS COGN, V18, P898, DOI 10.1080/13506280903412153; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Robbins RA, 2012, Q J EXP PSYCHOL, V65, P1962, DOI 10.1080/17470218.2012.674145; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; SCAPINELLO KF, 1970, PSYCHON SCI, V21, P329, DOI 10.3758/BF03335807; Schmidt AF, 2015, COGNITION, V134, P77, DOI 10.1016/j.cognition.2014.09.003; Seitz K, 2002, J EXP CHILD PSYCHOL, V82, P367, DOI 10.1016/S0022-0965(02)00106-6; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2013, PSYCHOL SCI, V24, P1069, DOI 10.1177/0956797612474669; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; Urgesi C, 2007, J NEUROSCI, V27, P8023, DOI 10.1523/JNEUROSCI.0789-07.2007; Vaes J, 2011, EUR J SOC PSYCHOL, V41, P774, DOI 10.1002/ejsp.824; Walby S, 2016, BRIT J CRIMINOL, V56, P1203, DOI 10.1093/bjc/azv131; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451	56	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193944	10.1371/journal.pone.0193944	http://dx.doi.org/10.1371/journal.pone.0193944			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621249	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800010
J	Mobley, CB; Haun, CT; Roberson, PA; Mumford, PW; Kephart, WC; Romero, MA; Osburn, SC; Vann, CG; Young, KC; Beck, DT; Martin, JS; Lockwood, CM; Roberts, MD				Mobley, Christopher B.; Haun, Cody T.; Roberson, Paul A.; Mumford, Petey W.; Kephart, Wesley C.; Romero, Matthew A.; Osburn, Shelby C.; Vann, Christopher G.; Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Lockwood, Christopher M.; Roberts, Michael D.			Biomarkers associated with low, moderate, and high vastus lateralis muscle hypertrophy following 12 weeks of resistance training	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOFIBER HYPERTROPHY; RIBOSOME BIOGENESIS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MYONUCLEAR ADDITION; EXERCISE; MYOSTATIN; TESTOSTERONE; HUMANS	We sought to identify biomarkers which delineated individual hypertrophic responses to resistance training. Untrained, college-aged males engaged in full-body resistance training (3 d/wk) for 12 weeks. Body composition via dual x-ray absorptiometry (DXA), vastus lateralis (VL) thickness via ultrasound, blood, VL muscle biopsies, and three-repetition maximum (3-RM) squat strength were obtained prior to (PRE) and following (POST) 12 weeks of training. K-means cluster analysis based on VL thickness changes identified LOW [n = 17; change (mean +/- SD) = +0.11 +/- 0.14 cm], modest (MOD; n = 29, +0.40 +/- 0.06 cm), and high (HI; n = 21, +0.69 +/- 0.14 cm) responders. Biomarkers related to histology, ribosome biogenesis, proteolysis, inflammation, and androgen signaling were analyzed between clusters. There were main effects of time (POST>PRE, p<0.05) but no cluster x time interactions for increases in DXA lean body mass, type I and II muscle fiber cross sectional area and myonuclear number, satellite cell number, and macronutrients consumed. Interestingly, PRE VL thickness was similar to 12% greater in LOW versus HI (p = 0.021), despite POST values being similar to 12% greater in HI versus LOW (p = 0.006). However there was only a weak correlation between PRE VL thickness scores and change in VL thickness (r(2) = 0.114, p = 0.005). Forced post hoc analysis indicated that muscle total RNA levels (i.e., ribosome density) did not significantly increase in the LOW cluster (351 +/- 70 ng/mg to 380 +/- 62, p = 0.253), but increased in the MOD (369 +/- 115 to 429 +/- 92, p = 0.009) and HI clusters (356 +/- 77 to 470 +/- 134, p<0.001; POST HI>POST LOW, p = 0.013). Nonetheless, there was only a weak association between change in muscle total RNA and VL thickness (r(2) = 0.079, p = 0.026). IL-1 beta mRNA levels decreased in the MOD and HI clusters following training (p<0.05), although associations between this marker and VL thickness changes were not significant (r(2) = 0.0002, p = 0.919). In conclusion, individuals with lower pre-training VL thickness values and greater increases muscle total RNA levels following 12 weeks of resistance training experienced greater VL muscle growth, although these biomarkers individually explained only similar to 8-11% of the variance in hypertrophy.	[Mobley, Christopher B.; Haun, Cody T.; Roberson, Paul A.; Mumford, Petey W.; Kephart, Wesley C.; Romero, Matthew A.; Osburn, Shelby C.; Vann, Christopher G.; Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Roberts, Michael D.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA; [Lockwood, Christopher M.] Lockwood LLC, Draper, UT USA	Auburn University System; Auburn University	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA.	mdr0024@auburn.edu	Mobley, Christopher/AAC-2123-2020; Lockwood, Chris/A-8136-2018; Mumford, Petey/GLS-9565-2022	Lockwood, Chris/0000-0002-4002-4301; Mumford, Petey/0000-0002-4946-9702; Mobley, C. Brooks/0000-0002-4045-9962				Ahmed M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030200; Antonio J, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0100-0; Antonio J, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-19; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Dalbo VJ, 2013, EUR J NUTR, V52, P477, DOI 10.1007/s00394-012-0349-x; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Ferrando AA, 1998, AM J PHYSIOL-ENDOC M, V275, pE864; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M, V309, pE72, DOI 10.1152/ajpendo.00050.2015; Greiwe JS, 2001, FASEB J, V15, P475, DOI 10.1096/fj.00-0274com; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Haff G., 2016, ESSENTIALS STRENGTH; HAMMOND HK, 1992, AM J PHYSIOL, V263, pH1675, DOI 10.1152/ajpheart.1992.263.6.H1675; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Hulmi JJ, 2009, AMINO ACIDS, V37, P297, DOI 10.1007/s00726-008-0150-6; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Lambert CP, 2008, J APPL PHYSIOL, V105, P473, DOI 10.1152/japplphysiol.00006.2008; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McGlory C, 2017, J APPL PHYSIOL, V122, P541, DOI 10.1152/japplphysiol.00613.2016; Menon MK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-119; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murton AJ, 2013, INT J BIOCHEM CELL B, V45, P2209, DOI 10.1016/j.biocel.2013.07.005; Nader GA, 2014, J PHYSIOL-LONDON, V592, P5143, DOI 10.1113/jphysiol.2014.284828; Pasiakos SM, 2014, IUBMB LIFE, V66, P478, DOI 10.1002/iub.1291; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Raj DSC, 2008, KIDNEY INT, V73, P1054, DOI 10.1038/ki.2008.21; Rhea MR, 2002, J STRENGTH COND RES, V16, P250, DOI 10.1519/00124278-200205000-00013; Schoenfeld BJ, 2013, J STRENGTH COND RES, V27, P1720, DOI 10.1519/JSC.0b013e31828ddd53; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Stec MJ, 2016, AM J PHYSIOL-ENDOC M, V310, pE652, DOI 10.1152/ajpendo.00486.2015; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Wang DT, 2014, INT IMMUNOPHARMACOL, V19, P206, DOI 10.1016/j.intimp.2014.02.002; Wen Y, 2016, EXERC SPORT SCI REV, V44, P110, DOI 10.1249/JES.0000000000000082; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; Yang LX, 2013, MOL CELL BIOL, V33, P3835, DOI 10.1128/MCB.00476-13; Zamir O, 1992, Mediators Inflamm, V1, P247, DOI 10.1155/S0962935192000371	50	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195203	10.1371/journal.pone.0195203	http://dx.doi.org/10.1371/journal.pone.0195203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621305	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800049
J	Ogunrin, O; Woolfall, K; Gabbay, M; Frith, L				Ogunrin, Olubunmi; Woolfall, Kerry; Gabbay, Mark; Frith, Lucy			Relative solidarity: Conceptualising communal participation in genomic research among potential research participants in a developing Sub-Saharan African setting	PLOS ONE			English	Article							COMMUNITARIANISM; AUTHORITARIAN; AUTONOMY; SAMPLES	Objective As genomic research gathers momentum in sub-Saharan Africa, it has become increasingly important to understand the reasons why individuals wish to participate in this kind of medical research. Against the background of communitarianism conceived as typical of African communities, it is often suggested that individuals consent to participate on the grounds of solidarity and to further the common good. In this paper, we seek to explore this contention by presenting data from focus groups with potential research participants about what would influence their decisions to participate in genomic research. Methods and results These focus groups were conducted as part of a larger qualitative study with a purposively selected group of participants from a community situated in south west Nigeria. We conducted fifteen focus group sessions comprising 50 participants organized by age and sex, namely: 1) adult (>30 years) males, 2) adult females, 3) youth (18-30 years) males, and 4) youth females. A mixed age-group was conducted to probe different views between the age groups. There was discordance and clear division between the adults and youths regarding the decision to participate in genomic research based on commitment to communal values. Adults based their decision to participate on altruism and furthering the common good while youths based their decisions on personal benefits and preferences and also took into account the views and welfare of family members and neighbours. Conclusions This discordance suggests a 'generational shift' and we advance a model of 'relative solidarity' among the youths, which is different from the communal solidarity model typical of African communitarianism. Our findings suggest the need for a closer look at strategies for implementation of community engagement and informed consent in genomic research in this region, and we recommend further studies to explore this emerging trend.	[Ogunrin, Olubunmi] Univ Benin, Dept Med, PMB, Benin, Nigeria; [Ogunrin, Olubunmi; Gabbay, Mark; Frith, Lucy] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Hlth Serv Res, Biomed Eth Res Grp, Liverpool, Merseyside, England; [Woolfall, Kerry] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool, Merseyside, England	University of Benin; University of Liverpool; University of Liverpool	Ogunrin, O (corresponding author), Univ Benin, Dept Med, PMB, Benin, Nigeria.; Ogunrin, O (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Hlth Serv Res, Biomed Eth Res Grp, Liverpool, Merseyside, England.	bunmifunmi@hotmail.com	Olubunmi, Ogunrin A/AAC-9774-2021	Olubunmi, Ogunrin A/0000-0002-0006-291X; Frith, Lucy/0000-0002-8506-0699				Andoh Cletus T., 2011, OPEN J PHILOS, V1, P67, DOI DOI 10.4236/OJPP.2011.12012; [Anonymous], 2014, J EMERGING TRENDS ED; [Anonymous], 2013, ACT CONSORTIUM GUIDA; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Buseh AG, 2013, NURS OUTLOOK, V61, P196, DOI 10.1016/j.outlook.2012.10.004; Callahan D, 2012, INDIVIDUAL GOOD COMM; Chima SC, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S3; Darawsheh W., 2014, INT J THER REHABIL; de Vries J, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-5; Ephraim PE, 2013, ETHICS INF TECHNOL, V15, P275, DOI 10.1007/s10676-013-9333-2; Etzioni A, 2011, J MED ETHICS, V37, P17, DOI 10.1136/jme.2010.037846; Fagbemiro L, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-34; Gauthier CC, 2000, KENNEDY INST ETHIC J, V10, P337, DOI 10.1353/ken.2000.0025; Glaser B.G., 1965, AWARENESS DYING; Gross ML, 2014, SOCIETY, V51, P354, DOI 10.1007/s12115-014-9792-z; H3 Africa Working Group, 2011, HARN GEN TECHN IMPR; Halyal P., 1986, J INDIAN ACADEMY APP, V12, P6; Heberer T, 2009, J CONTEMP CHINA, V18, P491, DOI 10.1080/10670560903033786; Hens K, 2011, PUBLIC HEALTH GENOM, V14, P68, DOI 10.1159/000294185; Igbe MA, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-27; Jegede S, 2009, J ASIAN AFR STUD, V44, P239; Jiang H, 2009, P 4 INT C COMM TECHN, P51, DOI DOI 10.1145/1556460; Kamuya D, 2011, AM J BIOETHICS, V11, P31, DOI 10.1080/15265161.2011.583328; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; Kin RK, 2011, QUALITATIVE RES STAR; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Marshall PA, 2006, AM J PUBLIC HEALTH, P96; Marshall PA, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-38; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mduluza T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S7; Moodley K, 2014, IT S MY BLOOD ETHICA; Ogunbanjo GA, 2005, S AFR FAM PRACT, V47, P51, DOI 10.1080/20786204.2005.10873305; Patil S. K., 2014, J INNOVATIVE RES DEV, V3, P312; Prainsack B, 2011, SOLIDARITY REFLECTIO; Prainsack B, 2013, MED LAW REV, V21, P71, DOI 10.1093/medlaw/fws040; Ramsay M, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0015-x; Steinfield C., 2009, P 4 INT C COMMUNITIE, P245, DOI [DOI 10.1145/1556460.1556496, 10.1145/1556460.1556496]; Stewart DW, 1990, FOCUS GROUP THEORY P; Tangwa GB, 1996, BIOETHICS, V10, P183, DOI 10.1111/j.1467-8519.1996.tb00118.x; Tangwa GB, 2000, HASTINGS CENT REP, V30, P39, DOI 10.2307/3527887; Tindana P, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-76; Tindana P, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-15; Tulgan B., 2016, GREAT GENERATIONAL S; Udokang E. J., 2014, CROSS CULTURAL COMMU, V10, P266; Utz S, 2015, SOCIETIES, V5, P420, DOI 10.3390/soc5020420; van Schalkwyk G, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-19; Walter JK, 2014, PEDIATRICS, V133, pS16, DOI 10.1542/peds.2013-3608D	47	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195171	10.1371/journal.pone.0195171	http://dx.doi.org/10.1371/journal.pone.0195171			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621313	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800045
J	Fick, SE; Evett, RR				Fick, Stephen E.; Evett, Rand R.			Distribution modelling of pre-Columbian California grasslands with soil phytoliths: New insights for prehistoric grassland ecology and restoration	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; COMPETITION; VEGETATION	Historical reconstructions of plant community distributions are useful for biogeographic studies and restoration planning, but the quality of insights gained depends on the depth and reliability of historical information available. For the Central Valley of California, one of the most altered terrestrial ecosystems on the planet, this task is particularly difficult given poor historical documentation and sparse relict assemblages of pre-invasion plant species. Coastal and interior prairies were long assumed to have been dominated by perennial bunchgrasses, but this hypothesis has recently been challenged. We evaluated this hypothesis by creating species distribution models (SDMs) using a novel approach based on the abundance of soil phytoliths (microscopic particles of biogenic silica used as a proxy for long-term grass presence) extracted from soil samples at locations statewide. Modeled historical grass abundance was consistently high along the coast and to a lesser extent in higher elevation foothills surrounding the Central Valley. SDMs found strong associations with mean temperature, temperature variability, and precipitation variability, with higher predicted abundance in regions with cooler, equable temperatures and moderated rainfall, mirroring the pattern for modern perennial grass distribution across the state. The results of this study strongly suggest that the pre-Columbian Central Valley of California was not dominated by grasses. Using soil phytolith data as input for SDMs is a promising new method for predicting the extent of prehistoric grass distributions where alternative historical datasets are lacking.	[Fick, Stephen E.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Evett, Rand R.] Univ Calif Berkeley, Dept ESPM, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Fick, SE (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	sfick@ucdavis.edu		Fick, Stephen/0000-0002-3548-6966	UC Davis Ecology Fellowship; Ben A. Madson scholarship	UC Davis Ecology Fellowship; Ben A. Madson scholarship	This work was supported by internal funding from the UC Davis Ecology Fellowship and the Ben A. Madson scholarship, http://ecology.ucdavis.edu/funding/, http://financialaid.ucdavis.edu/scholarships/campus/awards/caes.html.	Aleman JC, 2013, QUATERNARY RES, V80, P341, DOI 10.1016/j.yqres.2013.05.008; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bartolome JW, THE ECOLOGICAL STATU; Bivand R, 2015, COMPARING IMPLEMENTA; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burcham L. T., 1957, CALIFORNIA RANGE LAN; Cabanes D, 2011, J ARCHAEOL SCI, V38, P2480, DOI 10.1016/j.jas.2011.05.020; Clary J, 2008, PLANT ECOL, V195, P13, DOI 10.1007/s11258-007-9294-9; Clary J, 2012, PLANT ECOL, V213, P1203, DOI 10.1007/s11258-012-0076-7; Clements FE, 1934, J ECOL, V22, P39, DOI 10.2307/2256095; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Dyer AR, 1999, ECOLOGY, V80, P2697, DOI 10.1890/0012-9658(1999)080[2697:EOCORA]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Evett Rand R., 2006, Madrono, V53, P351, DOI 10.3120/0024-9637(2006)53[351:PEFTLO]2.0.CO;2; Evett RR, 2013, HOLOCENE, V23, P1644, DOI 10.1177/0959683613499056; Evett RR, 2013, RESTOR ECOL, V21, P464, DOI 10.1111/j.1526-100X.2012.00912.x; Fishkis O, 2010, GEODERMA, V157, P27, DOI 10.1016/j.geoderma.2010.03.012; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Geology Holstein G., 2011, FREMONTIA, V39, P22; Hamilton JG, 1997, CHANGING PERCEPTIONS, P311; Heady H.F., 1977, TERRESTRIAL VEGETATI, P491; Hengl T, 2014, SOILGRIDS1KM D GLOBA; Higgs E, 2014, FRONT ECOL ENVIRON, V12, P499, DOI 10.1890/110267; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holland V. I., 1995, CALIFORNIA VEGETATIO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hyland E, 2013, PALAEOGEOGR PALAEOCL, V374, P338, DOI 10.1016/j.palaeo.2013.01.026; JACKSON LE, 1990, AGR ECOSYST ENVIRON, V32, P89, DOI 10.1016/0167-8809(90)90126-X; Kuchler AW, 1977, THE MAP OF THE NATUR; Lulow ME, 2011, FREMONTIA, V39, P6; Minnich RA, 2008, CALIFORNIA S FADING; Nevada California, 2006, MADRONO, V53, P351; San Francisco Estuary Institute (SFEI), 2015, CALIFORNIA AQUATIC R; Seabloom EW, 2003, ECOL APPL, V13, P575, DOI 10.1890/1051-0761(2003)013[0575:CSLDAR]2.0.CO;2; White AF, 2012, GEOCHIM COSMOCHIM AC, V94, P72, DOI 10.1016/j.gca.2012.06.009; Wigand PE., 2007, CALIFORNIA GRASSLAND, P37; Young DJN, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00303.1	43	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194315	10.1371/journal.pone.0194315	http://dx.doi.org/10.1371/journal.pone.0194315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617400	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800026
J	Linares, I; Farrokhi, K; Echeverri, J; Kaths, JM; Kollmann, D; Hamar, M; Urbanellis, P; Ganesh, S; Adeyi, OA; Yip, P; Seizner, M; Seizner, N				Linares, Ivan; Farrokhi, Kaveh; Echeverri, Juan; Kaths, Johan Moritz; Kollmann, Dagmar; Hamar, Matyas; Urbanellis, Peter; Ganesh, Sujani; Adeyi, Oyedele A.; Yip, Paul; Seizner, Markus; Seizner, Nazia			PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; RECEPTOR-GAMMA; INFLAMMATORY RESPONSE; GENE-EXPRESSION; AGONIST; CELLS; MICE; APOPTOSIS; PIOGLITAZONE; HOMEOSTASIS	Background PPAR-gamma (gamma) is highly expressed in macrophages and its activation affects their polarization. The effect of PPAR-gamma activation on Kupffer cells (KCs) and liver ischemia-reperfusion injury (IRI) has not yet been evaluated. We investigated the effect of PPAR-gamma activation on KC-polarization and IRI. Materials and methods Seventy percent (70%) liver ischemia was induced for 60mins. PPAR-gamma-agonist or vehicle was administrated before reperfusion. PPAR-gamma-antagonist was used to block PPAR-gamma activation. Liver injury, necrosis, and apoptosis were assessed post-reperfusion. Flow-cytometry determined KC-phenotypes (pro-inflammatory Nitric Oxide +, anti-inflammatory CD206+ and anti-inflammatory IL-10+). Results Liver injury assessed by serum AST was significantly decreased in PPAR-gamma-agonist versus control group at all time points post reperfusion (1hr: 3092 +/- 105 vs 4469 +/- 551; p = 0.042; 6hr: 7041 +/- 1160 vs 12193 +/- 1143; p = 0.015; 12hr: 5746 +/- 328 vs 8608 +/- 1259; p = 0.049). Furthermore, liver apoptosis measured by TUNEL-staining was significantly reduced in PPAR-gamma-agonist versus control group post reperfusion (1hr:2.46 +/- 0.49 vs 6.90 +/- 0.85%;p = 0.001; 6hr:26.40 +/- 2.93 vs 50.13 +/- 8.29%; p = 0.048). H&E staining demonstrated less necrosis in PPAR-gamma-agonist versus control group (24hr:26.66 +/- 4.78 vs 45.62 +/- 4.57%; p = 0.032). The percentage of pro-inflammatory NO+KCs was significantly lower at all post reperfusion time points in the PPAR-gamma-agonist versus control group (1hr:28.49 +/- 4.99 vs 53.54 +/- 9.15%; p = 0.040; 6hr5.51 +/- 0.54 vs 31.12 +/- 9.58%; p = 0.009; 24hr4.15 +/- 1.50 vs 17.10 +/- 4.77%; p = 0.043). In contrast, percentage of anti-inflammatory CD206+ KCs was significantly higher in PPAR-gamma-agonist versus control group prior to IRI (8.62 +/- 0.96 vs 4.88 +/- 0.50%; p = 0.04). Administration of PPAR-gamma-antagonist reversed the beneficial effects on AST, apoptosis, and pro-inflammatory NO+KCs. Conclusion PPAR-gamma activation reduces IRI and decreases the pro-inflammatory NO+ Kupffer cells. PPAR-gamma activation can become an important tool to improve outcomes in liver surgery through decreasing the pro-inflammatory phenotype of KCs and IRI.	[Linares, Ivan; Farrokhi, Kaveh; Echeverri, Juan; Kaths, Johan Moritz; Kollmann, Dagmar; Hamar, Matyas; Urbanellis, Peter; Ganesh, Sujani; Seizner, Markus; Seizner, Nazia] Toronto Gen Hosp, Multi Organ Transplant Program, Toronto, ON, Canada; [Linares, Ivan] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico; [Linares, Ivan; Kaths, Johan Moritz; Urbanellis, Peter] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Farrokhi, Kaveh] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Adeyi, Oyedele A.] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Yip, Paul] Toronto Gen Hosp, Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Seizner, N (corresponding author), Toronto Gen Hosp, Multi Organ Transplant Program, Toronto, ON, Canada.	nseizner@gmail.com	Linares-Cervantes, Ivan/AAA-1484-2021; Selzner, Nazia/AAI-1469-2020	Linares-Cervantes, Ivan/0000-0001-5124-9883; Selzner, Nazia/0000-0002-9435-2597; Selzner, Markus/0000-0002-4326-0887; Adeyi, Oyedele/0000-0003-4272-1095	Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico)	Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico)	IL expresses his gratitude to the Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico) for its support for the Graduate program at University of Toronto.	Agrawal YO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111212; Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Bendinelli P, 1996, FEBS LETT, V398, P193, DOI 10.1016/S0014-5793(96)01228-8; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cheng F, 2008, TRANSPL P, V40, P2163, DOI 10.1016/j.transproceed.2008.07.082; Clavien PA, 2001, HEPATOLOGY, V33, P1555, DOI 10.1053/jhep.2001.25448; DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Fouraschen SMG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/202975; Ghose R, 2007, J HEPATOL, V46, P115, DOI 10.1016/j.jhep.2006.09.008; Giaginis C, 2008, CURR MOL MED, V8, P562, DOI 10.2174/156652408785748022; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hochhauser E, 2015, CELL PHYSIOL BIOCHEM, V36, P1971, DOI 10.1159/000430165; Hu Q, 2014, ASIAN PAC J TROP MED, V7, P271, DOI 10.1016/S1995-7645(14)60036-5; Huang LH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/864509; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Kakiuchi-Kiyota S, 2011, TOXICOL PATHOL, V39, P1032, DOI 10.1177/0192623311422080; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Lee VG, 2001, SHOCK, V16, P355, DOI 10.1097/00024382-200116050-00006; Lim JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09639-7; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Liu HX, 2014, BIOCHEM PHARMACOL, V91, P256, DOI 10.1016/j.bcp.2014.07.003; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Palumbo T, 2017, TRANSPLANTATION, V101, P322, DOI 10.1097/TP.0000000000001552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Reel B, 2013, J SURG RES, V182, P176, DOI 10.1016/j.jss.2012.08.020; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rong YP, 2017, TRANSPL P, V49, P1455, DOI 10.1016/j.transproceed.2017.02.063; Sahu SK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006410; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Stewart RK, 2014, J HEPATOL, V60, P298, DOI 10.1016/j.jhep.2013.09.013; Sun CK, 2017, AM J TRANSL RES, V9, P1543; Sun L, 2016, CELL PHYSIOL BIOCHEM, V38, P1831, DOI 10.1159/000443121; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Wang Q, 2017, MOL MED REP, V15, P798, DOI 10.3892/mmr.2016.6074; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Yanagida H, 2006, SHOCK, V26, P162, DOI 10.1097/01.shk.0000223130.87382.73; Yang Y, 2014, TRANSPL P, V46, P1573, DOI 10.1016/j.transproceed.2014.01.018; Yao L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176106; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115	52	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195212	10.1371/journal.pone.0195212	http://dx.doi.org/10.1371/journal.pone.0195212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617419	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800069
J	Sharma, S; Chunduri, V; Kumar, A; Kumar, R; Khare, P; Kondepudi, KK; Bishnoi, M; Garg, M				Sharma, Saloni; Chunduri, Venkatesh; Kumar, Aman; Kumar, Rohit; Khare, Pragyanshu; Kondepudi, Kanthi Kiran; Bishnoi, Mahendra; Garg, Monika			Anthocyanin bio-fortified colored wheat: Nutritional and functional characterization	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BLUE ALEURONE; PURPLE; BREAD; GRAIN; CORN	Colored wheat, rich in anthocyanins, has created interest among the breeders and baking industry. This study was aimed at understanding the nutritional and product making potential of our advanced, high yielding and regionally adapted colored wheat lines. Our results indicated that our advanced colored wheat lines exhibited higher anthocyanin content and antioxidant activity than donor wheat lines and it varied in the order of white<purple<blue<black wheat. UPLC chromatogram revealed that anthocyanin composition and peak pattern is not only dependent on donor genotype but also background of recipient genotype. Interestingly, the purple wheat extract showed highest anti-inflammatory effect and followed the trend of white<blue<black<purple. Nutritional (carbohydrates, sugar, protein, ash, dietary fibre and vitamins) and processing parameters in relation to end-use quality (SDS sedimentation, gluten content, alveograph) of advanced colored lines were similar to high yielding white wheat cultivar. Colored wheat lines showed high iron and zinc content compared to white wheat indicating double bio-fortification. Therefore, our advanced colored wheat lines with high anthocyanin, iron and zinc contents showed antioxidant and anti-inflammatory activity and possessed desirable features for product making and commercial utilization.	[Sharma, Saloni; Chunduri, Venkatesh; Kumar, Aman; Kumar, Rohit; Khare, Pragyanshu; Kondepudi, Kanthi Kiran; Bishnoi, Mahendra; Garg, Monika] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Garg, M (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	mgarg100@yahoo.com	Kondepudi, Kanthi Kiran/P-8336-2014; Bishnoi, Mahendra/CAG-3229-2022; Khare, Pragyanshu/T-6469-2019; Kumar, Aman/AAY-3202-2020	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Bishnoi, Mahendra/0000-0002-7785-1204	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat"	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat"	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat" was utilized for this study.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 2008, J AGR FOOD CHEM, V56, P11171, DOI 10.1021/jf802168c; Abdel-Aal ESM, 1999, CEREAL CHEM, V76, P350, DOI 10.1094/CCHEM.1999.76.3.350; American Association of Cereal Chemists [AACC], 1990, APPR METH AM ASS CER; AOAC, 1990, INT OFF METH AN, Vfifteenth; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Boeing JS, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0048-1; Boligon A. A., 2014, MED CHEM, V4, P517, DOI [10.4172/2161-0444.1000188, DOI 10.4172/2161-0444.1000188]; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Ficco DBM, 2014, J AGR FOOD CHEM, V62, P8686, DOI 10.1021/jf5003683; Garg M, 2016, J CEREAL SCI, V71, P138, DOI 10.1016/j.jcs.2016.08.004; Garg M, 2009, J CEREAL SCI, V50, P358, DOI 10.1016/j.jcs.2009.06.012; Hosseinian FS, 2008, FOOD CHEM, V109, P916, DOI 10.1016/j.foodchem.2007.12.083; Hu C, 2000, J AGR FOOD CHEM, V48, P1466, DOI 10.1021/jf990677+; Jaafar SNS, 2013, PLANT BREEDING, V132, P546, DOI 10.1111/pbr.12090; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; Kris-Etherton PM, 2004, ANNU REV NUTR, V24, P511, DOI 10.1146/annurev.nutr.23.011702.073237; Lachman J, 2017, J CEREAL SCI, V74, P145, DOI 10.1016/j.jcs.2017.02.007; Li YG, 2015, CROP J, V3, P328, DOI 10.1016/j.cj.2015.04.004; Liu Q, 2010, J AGR FOOD CHEM, V58, P9235, DOI 10.1021/jf101700s; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martinek P, 2013, TAG 64 JAHR VER PFLA, V1, P75; Montilla EC, 2011, J AGR FOOD CHEM, V59, P3385, DOI 10.1021/jf104724k; Mota FL, 2008, IND ENG CHEM RES, V47, P5182, DOI 10.1021/ie071452o; Patel K, 2013, J ACUTE DIS, V2, P169, DOI 10.1016/S2221-6189(13)60123-7; Petroni K, 2014, PLANTA, V240, P901, DOI 10.1007/s00425-014-2131-1; Prasanna BM, 2011, CURR SCI, V81, P1308; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Shipp J., 2010, Open Food Science Journal, V4, P7, DOI 10.2174/1874256401004010007; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125	31	31	31	10	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194367	10.1371/journal.pone.0194367	http://dx.doi.org/10.1371/journal.pone.0194367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617385	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800029
J	Santana, NB; Dias, JCT; Rezende, RP; Franco, M; Oliveira, LKS; Souza, LO				Santana, Nivio Batista; Teixeira Dias, Joao Carlos; Rezende, Rachel Passos; Franco, Marcelo; Silva Oliveira, Larissa Karen; Souza, Lucas Oliveira			Production of xylitol and bio-detoxification of cocoa pod husk hemicellulose hydrolysate by Candida boidinii XM02G	PLOS ONE			English	Article							ETHANOL-PRODUCTION; ATHENSENSIS SB18; BY-PRODUCTS; PRETREATMENT; ACID; XYLOSE; GUILLIERMONDII; FERMENTATION; TROPICALIS; BAGASSE	The use of cocoa pod husk hemicellulose hydrolysate (CPHHH) was evaluated for the production of xylitol by Candida boidinii XM02G yeast isolated from soil of cocoa-growing areas and decaying bark, as an alternative means of reusing this type of waste. Xylitol was obtained in concentrations of 11.34 g.L-1, corresponding to a yield (Y-p/s) of 0.52 g.g(-1) with a fermentation efficiency (epsilon) of 56.6%. The yeast was tolerant to inhibitor compounds present in CPHHH without detoxification in different concentration factors, and was able to tolerate phenolic compounds at approximately 6 g.L-1. The yeast was also able to metabolize more than 99% (p/v) of furfural and hydroxymethylfurfural present in the non-detoxified CPHHH without extension of the cell-growth lag phase, showing the potential of this microorganism for the production of xylitol. The fermentation of cocoa pod husk hydrolysates appears to provide an alternative use which may reduce the impact generated by incorrect disposal of this waste.	[Santana, Nivio Batista] State Univ Southwest Bahia UESB, Dept Anim & Rural Technol, Itapetinga, BA, Brazil; [Teixeira Dias, Joao Carlos; Rezende, Rachel Passos] State Univ Santa Cruz UESC, Dept Exact & Technol Sci, Ilheus, BA, Brazil; [Franco, Marcelo] State Univ Santa Cruz UESC, Dept Biol Sci, Ilheus, BA, Brazil; [Silva Oliveira, Larissa Karen] Univ Estadual Santa Cruz, Biomed, Ilheus, BA, Brazil; [Souza, Lucas Oliveira] State Univ Southwest Bahia UESB, Postgrad Program Food Sci & Engn, Itapetinga, BA, Brazil	Universidade Estadual do Sudoeste da Bahia; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia	Dias, JCT (corresponding author), State Univ Santa Cruz UESC, Dept Exact & Technol Sci, Ilheus, BA, Brazil.	jctdias@uesc.br	Franco, Marcelo/U-4532-2019; Santana, Nívio Batista/AAD-8385-2019	Franco, Marcelo/0000-0002-7827-789X; Dias, Joao/0000-0002-4938-2666				Alemawor F, 2009, SCI RES ESSAYS, V4, P555; [Anonymous], 1995, OFFICIAL METHODS ANA; Aregheore EM, 2002, TROP ANIM HEALTH PRO, V34, P339, DOI 10.1023/A:1015638903740; Caes BR, 2015, ACS SUSTAIN CHEM ENG, V3, P2591, DOI 10.1021/acssuschemeng.5b00473; Canilha L, 2004, PROCESS BIOCHEM, V39, P1909, DOI 10.1016/j.procbio.2003.09.009; Canilha L, 2010, APPL BIOCHEM BIOTECH, V161, P84, DOI 10.1007/s12010-009-8792-8; Cortez DV, 2010, BIORESOURCE TECHNOL, V101, P1858, DOI 10.1016/j.biortech.2009.09.072; da Silva EA, 2005, J IND MICROBIOL BIOT, V32, P481, DOI 10.1007/s10295-005-0027-6; Daud Z, 2013, AUST J BASIC APPL SC, V7; El-Shekeil YA, 2014, MATER DESIGN, V64, P330, DOI 10.1016/j.matdes.2014.07.034; Felipe MGA, 1996, BIORESOURCE TECHNOL, V56, P281, DOI 10.1016/0960-8524(96)00031-4; Ge JP, 2011, AFR J MICROBIOL RES, V5, P1163; Goncalves DB, 2013, BIORESOURCE TECHNOL, V146, P261, DOI 10.1016/j.biortech.2013.07.075; Huang CF, 2011, BIORESOURCE TECHNOL, V102, P3322, DOI 10.1016/j.biortech.2010.10.111; Igbinadolor R. O., 2013, African Journal of Biotechnology, V12, P5375; Jonsson LJ, 2016, BIORESOURCE TECHNOL, V199, P103, DOI 10.1016/j.biortech.2015.10.009; Li HL, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0314-z; Salgado JM, 2012, NEW BIOTECHNOL, V29, P421, DOI 10.1016/j.nbt.2011.07.003; Misra S, 2013, CARBOHYD POLYM, V92, P1596, DOI 10.1016/j.carbpol.2012.11.033; Network Commodity, 2016, GLOB COC PROD 2015 2; Njoku VO, 2014, J ENVIRON CHEM ENG, V2, P881, DOI 10.1016/j.jece.2014.03.003; Oddoye EOK, 2010, SCI RES ESSAYS, V5, P1141; Ofori-Boateng C, 2013, CHEM ENG J, V220, P395, DOI 10.1016/j.cej.2013.01.046; Parajo JC, 1997, ENZYME MICROB TECH, V21, P18, DOI 10.1016/S0141-0229(96)00210-4; Ping Y, 2013, BIOCHEM ENG J, V75, P86, DOI 10.1016/j.bej.2013.03.022; Rocha MVP, 2014, CHEM ENG J, V243, P234, DOI 10.1016/j.cej.2013.12.099; PreziosiBelloy L, 1997, ENZYME MICROB TECH, V21, P124, DOI 10.1016/S0141-0229(96)00247-5; Pua FL, 2013, J ENVIRON CHEM ENG, V1, P460, DOI 10.1016/j.jece.2013.06.012; Rao LV, 2016, BIORESOURCE TECHNOL, V213, P299, DOI 10.1016/j.biortech.2016.04.092; Ravindran R, 2016, BIORESOURCE TECHNOL, V199, P92, DOI 10.1016/j.biortech.2015.07.106; Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004; Sindhu R, 2016, BIORESOURCE TECHNOL, V199, P76, DOI 10.1016/j.biortech.2015.08.030; Syamsiro M, 2012, ENERGY SUSTAIN DEV, V16, P74, DOI 10.1016/j.esd.2011.10.005; Tamanini C., 2004, SEMIN-CIENC AGRAR, V25, P315, DOI DOI 10.5433/1679-0359.2004v25n4p315; Uwagboe E. O., 2010, INT J SCI NAT, V1, P272; Vandeska E, 1996, PROCESS BIOCHEM, V31, P265, DOI 10.1016/0032-9592(95)00058-5; Villarreal MLM, 2006, ENZYME MICROB TECH, V40, P17, DOI 10.1016/j.enzmictec.2005.10.032; Vriesmann LC, 2012, LWT-FOOD SCI TECHNOL, V49, P108, DOI 10.1016/j.lwt.2012.04.018; Wang L., 2013, J APPL MATH, V2013, P12, DOI DOI 10.1186/1476-4598-12-173; Wang SZ, 2015, FUNGAL GENET BIOL, V82, P1, DOI 10.1016/j.fgb.2015.04.022; Wang W, 2015, PROCESS BIOCHEM, DOI [10.1016/j.procbio.2015.03.020, DOI 10.1016/J.PROCBIO.2015.03.020]; Zhang DX, 2012, CHEM ENG J, V181, P636, DOI 10.1016/j.cej.2011.12.030; Zhang JM, 2012, BIORESOURCE TECHNOL, V121, P369, DOI 10.1016/j.biortech.2012.07.020; Zhang JM, 2012, BIORESOURCE TECHNOL, V105, P134, DOI 10.1016/j.biortech.2011.11.119	44	22	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195206	10.1371/journal.pone.0195206	http://dx.doi.org/10.1371/journal.pone.0195206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641547	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900061
J	Weijers, D; Hemerik, L; Heitkonig, IMA				Weijers, Debby; Hemerik, Lia; Heitkonig, Ignas M. A.			An experimental approach in revisiting the magnetic orientation of cattle	PLOS ONE			English	Article							COMPASS ORIENTATION; ONCORHYNCHUS-KETA; CHUM SALMON; ALIGNMENT; FIELD; NAVIGATION; PIGEONS; SALAMANDRIDAE; PREFERENCE; DIRECTION	In response to the increasing number of observational studies on an apparent south-north orientation in non-homing, non-migrating terrestrial mammals, we experimentally tested the alignment hypothesis using strong neodymium magnets on the resting orientation of individual cattle in Portugal. Contrary to the hypothesis, the 34 cows in the experiment showed no directional preference, neither with, nor without a strong neodymium magnet fixed to their collar. The concurrently performed 2,428 daytime observations +/- excluding the hottest part of the day +/- of 659 resting individual cattle did not show a south-north alignment when at rest either. The preferred compass orientation of these cows was on average 130 degrees from the magnetic north (i.e., south east). Cow compass orientation correlated significantly with sun direction, but not with wind direction. In as far as we can determine, this is the first experimental test on magnetic orientation in larger, non-homing, non-migrating mammals. These experimental and observational findings do not support previously published suggestions on the magnetic south-north alignment in these mammals.	[Weijers, Debby; Heitkonig, Ignas M. A.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Hemerik, Lia] Wageningen Univ & Res, Biometris, Dept Math & Stat Methods, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Heitkonig, IMA (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.	ignas.heitkonig@wur.nl		Hemerik, Lia/0000-0002-6892-2840; Heitkonig, Ignas/0000-0001-7771-3111				[Anonymous], 2010, R LANG ENV STAT COMP; Batschelet E., 1981, CIRCULAR STAT BIOL; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Cerveny J, 2016, MAMMAL REV, DOI [10.1111/mam., DOI 10.1111/MAM]; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Deutschlander ME, 2003, ANIM BEHAV, V65, P779, DOI 10.1006/anbe.2003.2111; Edelman NB, 2015, P NATL ACAD SCI USA, V112, P262, DOI 10.1073/pnas.1407915112; Guerra PA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5164; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-38; Hert J, 2011, J COMP PHYSIOL A, V197, P1135, DOI 10.1007/s00359-011-0688-8; Hert J, 2011, J COMP PHYSIOL A, V197, P677, DOI 10.1007/s00359-011-0628-7; HOFMEYR MD, 1987, J ARID ENVIRON, V13, P137; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Horton TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114557; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Kimchi T, 2001, J EXP BIOL, V204, P751; Landler L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124728; Lease HM, 2014, J THERM BIOL, V45, P150, DOI 10.1016/j.jtherbio.2014.08.008; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; Malkemper EP, 2016, J THEOR BIOL, V399, P141, DOI 10.1016/j.jtbi.2016.03.040; Mora CV, 2012, ANIM BEHAV, V84, P377, DOI 10.1016/j.anbehav.2012.05.005; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Papi F, 2000, J EXP BIOL, V203, P3435; Perez SM, 1999, NATURWISSENSCHAFTEN, V86, P140, DOI 10.1007/s001140050587; Phillips JB, 2002, J EXP BIOL, V205, P3903; QUINN TP, 1983, CAN J FISH AQUAT SCI, V40, P1598, DOI 10.1139/f83-185; Rao JS., 2001, TOPICS CIRCULAR STAT; Schlegel PA, 2007, J ETHOL, V25, P177, DOI 10.1007/s10164-006-0016-x; Schlegel PA, 2007, J ETHOL, V25, P185, DOI 10.1007/s10164-006-0017-9; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Slaby P, 2013, J COMP PHYSIOL A, V199, P695, DOI 10.1007/s00359-013-0827-5; Tian LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123205; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Vacha M, 2010, BEHAVIOUR, V147, P425, DOI 10.1163/000579509X12580965484148; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; Walker MM, 2002, CURR OPIN NEUROBIOL, V12, P735, DOI 10.1016/S0959-4388(02)00389-6; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; Wegner RE, 2006, J EXP BIOL, V209, P4747, DOI 10.1242/jeb.02573; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2013, J COMP PHYSIOL A, V199, P89, DOI 10.1007/s00359-012-0769-3; Yano A, 1997, MAR BIOL, V129, P523, DOI 10.1007/s002270050193	50	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0187848	10.1371/journal.pone.0187848	http://dx.doi.org/10.1371/journal.pone.0187848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641517	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900003
J	Guardo, AC; Gomez, CE; Diaz-Brito, V; Pich, J; Arnaiz, JA; Perdiguero, B; Garcia-Arriaza, J; Gonzalez, N; Sorzano, COS; Jimenez, L; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; Alcami, J; Esteban, M; de Quireos, JCLB; Garcia, F; Plana, M				Guardo, Alberto C.; Gomez, Carmen Elena; Diaz-Brito, Vicens; Pich, Judit; Arnaiz, Joan Albert; Perdiguero, Beatriz; Garcia-Arriaza, Juan; Gonzalez, Nuria; Sorzano, Carlos O. S.; Jimenez, Laura; Jimenez, Jose Luis; Munoz-Fernandez, Maria Angeles; Gatell, Jose M.; Alcami, Jose; Esteban, Mariano; de Quireos, Juan Carlos Lopez Bernaldo; Garcia, Felipe; Plana, Montserrat		RISVAC02boost Study	Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization (vol 12, e0186602, 2017)	PLOS ONE			English	Correction													Esteban, Mariano/ABG-5375-2020; Perdiguero, Beatriz/K-6587-2017; Gatell, Jose M/ABC-3607-2020; Jiménez, José Luis/AAK-6193-2020; Alcami, Pepe/T-2242-2018; Plana, Montserrat/AAA-5124-2020; , Felipe/F-4242-2014; Gomez, Carmen Elena/K-1940-2014; Sorzano, Carlos Oscar S S./F-2639-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021	Esteban, Mariano/0000-0003-0846-2827; Perdiguero, Beatriz/0000-0001-6276-7766; Jiménez, José Luis/0000-0001-6187-6223; Alcami, Pepe/0000-0003-0023-7377; , Felipe/0000-0001-7658-5832; Gomez, Carmen Elena/0000-0002-5414-7935; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gonzalez, Nuria/0000-0002-0087-5144				Guardo AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186602	1	1	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195915	10.1371/journal.pone.0195915	http://dx.doi.org/10.1371/journal.pone.0195915			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634751	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200061
J	Andersson, O; Radell, P; Ringo, V; Mulungu, M; Baker, T				Andersson, Oskar; Radell, Peter; Ringo, Victor; Mulungu, Moses; Baker, Tim			Quality of pediatric anesthesia: A crosssectional study of a university hospital in a low-income country	PLOS ONE			English	Article							CHILDREN	Objective To evaluate the quality of pediatric anesthesia in a university hospital in Dar es Salaam, Tanzania. Method A cross-sectional study conducted using a new tool that was developed from the literature and WHO recommendations including 28 parameters as standards for pediatric anesthesia. These 28 parameters consisted of 17 structure parameters of the equipment and medicines that should be present in theatre before any surgery starts, and 11 process parameters of actions taken by staff. Adverse events occurring during the anesthesia were recorded. Results 30 patients were included, aged between 1.5 months to 5 years with a mean of 2.4 years. 26 of the patients underwent elective surgery and 4 patients emergency surgery. Nine parameters were always present and one parameter (bag and mask) was not available for any of the patients. The structure index ranged from 71% to 94% with a mean of 84%. The process index had a mean score of 71% with a range from 50% to 90%: lower than the structure index (p<0.001). With the structure and process index combined the average score was 79% with a low of 67% and high of 89%. 70 adverse events were observed with a range from 0 to 7 adverse events per patient. The most common adverse event was hypoxia at extubation in 20 (69%) patients. Nine patients had an episode of severe hypoxia at extubation. Conclusion Pediatric anesthesia in low resource settings suffers from deficiencies in the structures and processes of providing good quality care. Improvement efforts may be best focused on improving the consistency and quality of the process of care and a reduction in adverse events rather than the structures available. Use of the assessment tool developed for this research could be useful for systematic quality-improvement efforts and to assess the needs in different settings.	[Andersson, Oskar; Radell, Peter] Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden; [Andersson, Oskar; Radell, Peter] Karolinska Univ Hosp, Sect Anesthesia & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Ringo, Victor] Emmilio Mzena Mem Hosp, Dar Es Salaam, Tanzania; [Mulungu, Moses] Muhimbili Natl Hosp, Dar Es Salaam, Tanzania; [Baker, Tim] Karolinska Inst, Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Baker, Tim] Karolinska Univ Hosp, Dept Perioperat Med & Intens Care, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Andersson, O (corresponding author), Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden.; Andersson, O (corresponding author), Karolinska Univ Hosp, Sect Anesthesia & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden.	n.oskar.andersson@gmail.com		Baker, Tim/0000-0001-8727-7018	Swedish Society of Nursing-Mimmie Dahlbecks Fond; Swedish International Development Cooperation Agency-Minor Field Studies (MFS) scholarship	Swedish Society of Nursing-Mimmie Dahlbecks Fond; Swedish International Development Cooperation Agency-Minor Field Studies (MFS) scholarship	This study was supported by Swedish Society of Nursing-Mimmie Dahlbecks Fond, received by OA (https://www.swenurse.se/Fonder-och-stipendier/Projektmedel/Stiftelsen-Mimmie-Dahlbecks-fond/) (Swedish only). For information about the Swedish Society of Nursing please see (https://www.swenurse.se/in-english/). This study was also supported by Swedish International Development Cooperation Agency-Minor Field Studies (MFS) scholarship (http://www.sida.se/English/get-involved/Sida-sponsored-scholarships/), received by OA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, PEDIATR ANESTH, V19, P581, DOI 10.1111/j.1460-9592.2009.02992.x; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Eriksson J, 2015, TROP MED INT HEALTH, V20, P1329, DOI 10.1111/tmi.12553; Gonzalez LP, 2012, CLINICS, V67, P381, DOI 10.6061/clinics/2012(04)12; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Ivani G, 2012, PEDIATR ANESTH, V22, P947, DOI 10.1111/pan.12009; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Schwartz KR, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0113-8; TIRET L, 1988, BRIT J ANAESTH, V61, P263, DOI 10.1093/bja/61.3.263; Weiss M, 2015, CURR OPIN ANESTHESIO, V28, P302, DOI 10.1097/ACO.0000000000000186; World Bank, 2017, WORLD BANK OP DAT; World Health Organization, 2015, PUBLIC HLTH IMPLICAT; World Health Organization, 2009, GUID SAF SURG; Zoumenou E, 2010, PEDIATR ANESTH, V20, P741, DOI 10.1111/j.1460-9592.2010.03348.x	14	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194622	10.1371/journal.pone.0194622	http://dx.doi.org/10.1371/journal.pone.0194622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630656	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000014
J	Ikeda, A; Kobayashi, T; Itakura, S				Ikeda, Ayaka; Kobayashi, Tessei; Itakura, Shoji			Sensitivity to linguistic register in 20-month olds: Understanding the register-listener relationship and its abstract rules	PLOS ONE			English	Article							INFANT-DIRECTED SPEECH; OTHER-RACE FACES; NATIVE LANGUAGE; YOUNG-CHILDREN; PREFERENCE; ACQUISITION; COMMUNICATION; 2-YEAR-OLDS; MOTHERESE; MODELS	Linguistic register reflects changes in speech that depend on the situation, especially the status of listeners and listener-speaker relationships. Following the sociolinguistic rules of register is essential in establishing and maintaining social interactions. Recent research suggests that children over 3 years of age can understand appropriate register-listener relationships as well as the fact that people change register depending on their listeners. However, given previous findings that infants under 2 years of age have already formed both social and speech categories, it may be possible that even younger children can also understand appropriate register-listener relationships. The present study used Infant-Directed Speech (IDS) and formal Adult-Directed Speech (ADS) to examine whether 20-month-old toddlers can understand register-listener relationships. In Experiment 1, we used a violation -of-expectation method to examine whether 20-month-olds understand the individual associations between linguistic registers and listeners. Results showed that the toddlers looked significantly longer at a scene in which the adult was talked to in IDS than when the infant was talked to in IDS. In contrast, there was no difference when the adult and the infant were talked to in formal ADS. In Experiments 2 and 3, we used a habituation switch paradigm to examine whether 20-month-olds understand the abstract rule that a change of register depends on listeners rather than on speakers. Results showed that the toddlers looked significantly longer at the scene where the register rule was violated. The present findings provide new evidence that even 20-month-olds already understand that people change their way of speaking based on listeners, although their understanding of individual register-listener relationships is immature.	[Ikeda, Ayaka; Itakura, Shoji] Kyoto Univ, Grad Sch Letters, Kyoto, Japan; [Ikeda, Ayaka] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Ikeda, Ayaka; Kobayashi, Tessei] NTT Corp, NTT Commun Sci Labs, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Nippon Telegraph & Telephone Corporation	Ikeda, A (corresponding author), Kyoto Univ, Grad Sch Letters, Kyoto, Japan.; Ikeda, A (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan.; Ikeda, A (corresponding author), NTT Corp, NTT Commun Sci Labs, Kyoto, Japan.	ikeda.ayaka.57x@kyoto-u.jp		Ikeda, Ayaka/0000-0002-9198-5735	Japan Society for the Promotion of Science Research Fellowships for Young Scientists [264073]; JSPS [25245067]; Nippon Telegraph and Telephone Corporation	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Telegraph and Telephone Corporation	This research was supported by a grant to AI from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (264073) and by a grant to SI from JSPS (25245067) (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Nippon Telegraph and Telephone Corporation provided support in the form of salaries for authors [TK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agency of Cultural Affairs Government of Japan, 1974, KOT SHIR 1 KEIG LANG; Andersen Elaine, 1984, W J SPEECH COMMUNICA, V48, P125, DOI [10.1080/10570318409374149, DOI 10.1080/10570318409374149]; Andersen ES, 1999, J PRAGMATICS, V31, P1339, DOI 10.1016/S0378-2166(98)00108-8; Andersen ES, 1986, LANGUAGE SOCIALIZATI, P153; Brey E, 2015, CHILD DEV, V86, P276, DOI 10.1111/cdev.12334; Brown P, 2011, POLITENESS SOME UNIV; Canale M., 1980, APPL LINGUIS, V1, P1, DOI [10.1093/applin/1.1.1, DOI 10.1093/APPLIN/1.1.1]; Casasola M, 2000, DEV PSYCHOL, V36, P155, DOI 10.1037//0012-1649.36.2.155; Cohen L.B., 2004, HABIT X NEW PROGRAM; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; COOPER RP, 1994, CHILD DEV, V65, P1663, DOI 10.2307/1131286; DUNN J, 1982, J CHILD LANG, V9, P579, DOI 10.1017/S030500090000492X; Ferguson C. A., 1977, TALKING CHILDREN LAN, P209, DOI DOI 10.1017/S0305000900002130; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Floor P, 2006, INFANCY, V9, P327, DOI 10.1207/s15327078in0903_4; Hudson R. A, 1988, SOCIOLINGUISTICS; HYMES D, 1967, J SOC ISSUES, V23, P8, DOI 10.1111/j.1540-4560.1967.tb00572.x; Ikeda A., 2016, COGNIT STUD, V23, P8; Inui T, 2003, COGNITIVE STUDIES, V10, P304; Katerelos M, 2011, INFANCY, V16, P508, DOI 10.1111/j.1532-7078.2010.00064.x; Kedar Y, 2006, CHILD DEV, V77, P325, DOI 10.1111/j.1467-8624.2006.00873.x; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kidd C, 2011, DEVELOPMENTAL SCI, V14, P925, DOI 10.1111/j.1467-7687.2011.01049.x; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Mast MS, 2004, J NONVERBAL BEHAV, V28, P145, DOI 10.1023/B:JONB.0000039647.94190.21; Matsuo A, 2012, J CHILD LANG, V39, P637, DOI 10.1017/S0305000911000213; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Murase T, 2012, P 76 ANN CONV JAP PS, P967; Nakamura K, 2001, CHILD LANG, V10, P93; Narayan CR, 2016, J ACOUST SOC AM, V139, P1272, DOI 10.1121/1.4944634; National Institute for Japanese Language and Linguistics, 2008, SHIN KOT SHIR 12 WAT; NELSON K, 1973, MONOGR SOC RES CHILD, V149, P1; Oshima-Takane Y, 2011, J CHILD LANG, V38, P455, DOI 10.1017/S0305000910000127; PEGG JE, 1992, INFANT BEHAV DEV, V15, P325, DOI 10.1016/0163-6383(92)80003-D; Pitts CE, 2015, COGNITION, V134, P185, DOI 10.1016/j.cognition.2014.10.003; Quinn PC, 2008, J NEUROPSYCHOL, V2, P15, DOI 10.1348/174866407X231029; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Rispoli M., 1991, FIRST LANG, V11, P41, DOI [DOI 10.1177/014272379101103103, 10.1177/014272379101103103]; Rivera-Gaxiola M, 2005, DEVELOPMENTAL SCI, V8, P162, DOI 10.1111/j.1467-7687.2005.00403.x; SACHS J, 1976, J CHILD LANG, V3, P81, DOI 10.1017/S030500090000132X; Saint-Georges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078103; Seehagen S, 2011, INFANCY, V16, P113, DOI 10.1111/j.1532-7078.2010.00045.x; Shariff AF, 2012, PERS SOC PSYCHOL B, V38, P1178, DOI 10.1177/0146167212446834; SHATZ M, 1973, MONOGR SOC RES CHILD, V38, P1, DOI 10.2307/1165783; Uttley L, 2013, INT J BEHAV DEV, V37, P84, DOI 10.1177/0165025412467583; Wagner L, 2014, FIRST LANG, V34, P299, DOI 10.1177/0142723714544413; Wagner L, 2010, CHILD DEV, V81, P1678, DOI 10.1111/j.1467-8624.2010.01502.x; WEEKS TE, 1971, CHILD DEV, V42, P1119, DOI 10.1111/j.1467-8624.1971.tb02007.x; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Zmyj N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00252	52	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195214	10.1371/journal.pone.0195214	http://dx.doi.org/10.1371/journal.pone.0195214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630608	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000032
J	Mejias-Martin, Y; Marti-Garcia, C; Rodriguez-Mejias, C; Valencia-Quintero, JP; Garcia-Caro, MP; Luna, JD				Mejias-Martin, Yolanda; Marti-Garcia, Celia; Rodriguez-Mejias, Candela; Pablo Valencia-Quintero, Juan; Paz Garcia-Caro, M.; de Dios Luna, Juan			Suicide attempts in Spain according to prehospital healthcare emergency records	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; RISK-FACTORS; IDEATION; PREVALENCE; BEHAVIOR; PLANS	Objective To analyze the number and characteristics of suicide attempts by reviewing records of the public emergency healthcare service information system. Method A retrospective observational study was conducted of emergency telephone calls received between January 1 2007 and December 31 2013 throughout the Andalusia region (Southern Spain). Cases were selected based on phone operator or healthcare team labeling. Data were analyzed on the characteristics of the individuals, the timing and severity of attempts, their prioritization, and their outcome. Results Between January 1 2007 and December 31 2013, 20.942 calls related to suicide attempts were recorded, a rate of 34.7 attempts per 100,000 inhabitants. Most cases were classified by the public emergency healthcare service (Empresa Publica de Emergencias Sanitarias, EPES) as code X84 (The International Statistical Classification of Diseases, tenth revision, ICD-10) or 305(The International Statistical Classification of Diseases, ninth revision, ICD-9). Attempts were more frequent in the 35-49-year age group and there were similar proportions of males and females. The lowest number of calls for suicide attempts were in 2007 and the highest in 2013. Calls were more frequent during the summer months, at weekends, and between 16:00 and 23:00 h. The likelihood of evacuation to the hospital emergency department was almost two-fold lower in over 65-yr-olds than in younger individuals. Significant (p = 0.001) gender differences were found in call outcome and prioritization. The most influential factor for evacuation to a hospital emergency department was the code assigned by the attending healthcare team. Conclusions Information obtained from extra-hospital emergency services provides valuable data on the characteristics and timing of calls related to suicide attempts, complementing information from hospital emergency departments or population surveys. There is a need to standardize the definition and recording of a suicide attempt.	[Mejias-Martin, Yolanda] Univ Hosp Complex Granada, Dept Mental Hlth, Granada, Spain; [Marti-Garcia, Celia] Univ Malaga, Dept Nursing, Fac Hlth Sci, Malaga, Spain; [Rodriguez-Mejias, Candela; Pablo Valencia-Quintero, Juan] Univ Hosp Complex Granada, Dept Intens Care, Granada, Spain; [Paz Garcia-Caro, M.] Univ Granada, Dept Nursing, Fac Hlth Sci, Granada, Spain; [de Dios Luna, Juan] Univ Granada, Biostat Unit, Fac Med, Granada, Spain	Universidad de Malaga; University of Granada; University of Granada	Marti-Garcia, C (corresponding author), Univ Malaga, Dept Nursing, Fac Hlth Sci, Malaga, Spain.	celiamarti@uma.es	Garcia-Caro, Maria Paz/L-2176-2018; Garcia-Caro, Maria Paz/AAC-7578-2019; Martí, Celia/I-4502-2017	Garcia-Caro, Maria Paz/0000-0002-2763-2572; Garcia-Caro, Maria Paz/0000-0002-2763-2572; Martí, Celia/0000-0003-2656-8473				American Association of Suicidology. National Suicide Statistics, OFF FIN DAT; [Anonymous], 2015, IR NAT SUIC PREV STR; [Anonymous], 2015, EST DEF SEG CAUS MUE; [Anonymous], 2011, GUIA PRACT CLIN PR 1; Cordoba-Dona JA, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-55; Ayuso Mateos JL, 2012, ESTUDIO CONDUCTA SUI; Barroeta Urquiza J, 2011, SERVICIOS EMERGENCIA; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Bertolote JM, 2005, PSYCHOL MED, V35, P1457, DOI 10.1017/S0033291705005404; Blanco-Sanchez I, 2015, 8 C INT 13 NAC PSIC, P429; Bobes J, 2011, SUICIDIO PSIQUIATRIA; Boenisch S, 2010, EUR PSYCHIAT, V25, P414, DOI 10.1016/j.eurpsy.2009.11.007; Borges G, 2017, PSYCHOL MED, V47, P949, DOI 10.1017/S0033291716002841; Calafat A, 2005, ADICCIONES, V17, P193, DOI DOI 10.20882/adicciones.368; Canner JK, 2018, EPIDEMIOL PSYCH SCI, V27, P94, DOI 10.1017/S2045796016000871; Clements C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009749; Darvishi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126870; Deisenhammer EA, 2003, ACTA PSYCHIAT SCAND, V108, P402, DOI 10.1046/j.0001-690X.2003.00209.x; DeLeo D, 2003, INFORME MUNDIAL VIOL, P199; Dominguez N, 2012, METAS ENFERM, V15, P66; Empresa Publica de Emergencias Sanitarias, 2016, CART DE SERV; Gabilondo A, 2007, MED CLIN-BARCELONA, V129, P494, DOI 10.1157/13111370; GONZALEZ-FERNANDEZ D, 2009, REV TOXICOL, V26, P122; Gonzalez-Navarro M D, 2012, Semergen, V38, P439, DOI 10.1016/j.semerg.2012.02.004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Kapur N, 2015, LANCET PSYCHIAT, V2, P809, DOI 10.1016/S2215-0366(15)00169-8; Martinez-Martinez S, 2015, 8 C INT 13 NAC PSIC, P430; Mejias Y, 2011, AN SIST SANIT NAVAR, V34, P431, DOI 10.4321/s1137-66272011000300009; Mergl R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129062; Miret M, 2014, J AFFECT DISORDERS, V163, P1, DOI 10.1016/j.jad.2014.03.045; Miret M, 2010, REV PSIQUIATR SALUD, V3, P13, DOI 10.1016/S1888-9891(10)70003-3; OMS, 2012, GUIA INT MHGAP TRAST; Pajonk FG, 2008, GEN HOSP PSYCHIAT, V30, P360, DOI 10.1016/j.genhosppsych.2008.03.005; Pasto L, 2007, REV TOXICOL, V24, P36; Ribeiro JD, 2009, J CLIN PSYCHOL, V65, P1291, DOI 10.1002/jclp.20621; Romo-Aviles N, 2016, INT J DRUG POLICY, V31, P138, DOI 10.1016/j.drugpo.2016.01.014; Sanchez-Teruel D, 2014, GAC SANIT, V28, P256, DOI 10.1016/j.gaceta.2013.10.007; Secretaria de Estado de Telecomunicaciones y para la Sociedad de la Informacion, 2015, COB BAND ANCH ESP PR; Servicio Andaluz de Salud, 2006, PROT COORD AS EXTR U; StataCorp, 2015, STAT STAT SOFTW REL; Lima MJV, 2012, EMERGENCIAS, V24, P121; World Health Organization, 2014, PREV SUIC PREV SUIC	42	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195370	10.1371/journal.pone.0195370	http://dx.doi.org/10.1371/journal.pone.0195370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630660	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000043
J	Weinberg, DB; Kapelner, A				Weinberg, Dana B.; Kapelner, Adam			Comparing gender discrimination and inequality in indie and traditional publishing	PLOS ONE			English	Article							CULTURAL CONSECRATION; QUANTILE REGRESSION; UNITED-STATES; SEGREGATION; EARNINGS; ECONOMY; SCIENCE; WOMEN; LABOR; WORK	In traditional publishing, female authors' titles command nearly half (45%) the price of male authors' and are underrepresented in more prestigious genres, and books are published by publishing houses, which determined whose books get published, subject classification, and retail price. In the last decade, the growth of digital technologies and sales platforms have enabled unprecedented numbers of authors to bypass publishers to publish and sell books. The rise of indie publishing (aka self-publishing) reflects the growth of the "gig" economy, where the influence of firms has diminished and workers are exposed more directly to external markets. Encompassing the traditional and the gig economy, the book industry illuminates how the gig economy may disrupt, replicate, or transform the gender discrimination mechanisms and inequality found in the traditional economy. In a natural experiment spanning from 2002 to 2012 and including over two million book titles, we compare discrimination mechanisms and inequality in indie and traditional publishing. We find that indie publishing, though more egalitarian, largely replicates traditional publishing's gender discrimination patterns, showing an unequal distribution of male and female authors by genre (allocative discrimination), devaluation of genres written predominantly by female authors (valuative discrimination), and lower prices within genres for books by female authors (within-job discrimination). However, these discrimination mechanisms are associated with far less price inequality in indie, only 7%, in large part due to the smaller and lower range of prices in indie publishing compared to traditional publishing. We conclude that, with greater freedom, workers in the gig economy may be inclined to greater equality but will largely replicate existing labor market segmentation and the lower valuation of female-typical work and of female workers. Nonetheless, price setting for work may be more similar for workers in the gig economy due to market competition that will compress prices ranges.	[Weinberg, Dana B.] CUNY, Queens Coll, Dept Sociol, Flushing, NY 11367 USA; [Kapelner, Adam] CUNY, Queens Coll, Dept Math, Queens, NY USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Weinberg, DB (corresponding author), CUNY, Queens Coll, Dept Sociol, Flushing, NY 11367 USA.	dana.weinberg@qc.cuny.edu		Weinberg, Dana/0000-0001-6106-951X	Queens College, CUNY	Queens College, CUNY	This project was funded in part by research enhancement funds from Queens College, CUNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 2004, SOC FORCES, V82, P871, DOI 10.1353/sof.2004.0030; Baumann S, 2001, AM SOCIOL REV, V66, P404, DOI 10.2307/3088886; BECKER HS, 1978, AM J SOCIOL, V83, P862, DOI 10.1086/226635; BELLAS ML, 1994, AM SOCIOL REV, V59, P807, DOI 10.2307/2096369; BERNHARDT A, 1995, AM J SOCIOL, V101, P302, DOI 10.1086/230726; Borgen NT, 2016, STATA J, V16, P403, DOI 10.1177/1536867X1601600208; Cohen PN, 2003, SOC FORCES, V81, P881, DOI 10.1353/sof.2003.0027; Correll J, 2004, J EXP SOC PSYCHOL, V40, P350, DOI 10.1016/j.jesp.2003.07.001; ENGLAND P, 1988, AM SOCIOL REV, V53, P544, DOI 10.2307/2095848; Fernandez-Mateo I, 2009, AM J SOCIOL, V114, P871, DOI 10.1086/595941; JACOBS JA, 1989, AM J SOCIOL, V95, P160, DOI 10.1086/229217; Kalleberg AL, 2016, LERA FOR LIB, V20; KILBOURNE BS, 1994, AM J SOCIOL, V100, P689, DOI 10.1086/230578; Killewald A, 2014, AM SOCIOL REV, V79, P350, DOI 10.1177/0003122414524574; Kim C, 2008, AM SOCIOL REV, V73, P129, DOI 10.1177/000312240807300107; Leicht KT, 2008, ANNU REV SOCIOL, V34, P237, DOI 10.1146/annurev.soc.34.040507.134627; Leuze Kathrin, 2016, WORK EMPLOY SOC, V30, P1; Lieberson S, 2000, AM J SOCIOL, V105, P1249, DOI 10.1086/210431; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Perrin A, 2016, BOOK READING 2016; Petersen T, 2004, AM J SOCIOL, V109, P852, DOI 10.1086/378536; PETERSEN T, 1992, AM J SOCIOL, V98, P67, DOI 10.1086/229969; Radway Janice A., 2009, READING ROMANCE WOME; RESKIN B, 1993, ANNU REV SOCIOL, V19, P241, DOI 10.1146/annurev.so.19.080193.001325; Ridgeway CL, 2004, GENDER SOC, V18, P510, DOI 10.1177/0891243204265269; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Schmutz V, 2010, SOC FORCES, V89, P685, DOI 10.1353/sof.2010.0098; Smith A, 2016, GIG WORK ONLINE SELL; van den Brink M, 2012, ORGANIZATION, V19, P507, DOI 10.1177/1350508411414293; van Doorn N, 2017, INFORM COMMUN SOC, V20, P898, DOI 10.1080/1369118X.2017.1294194; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Williams CL, 2012, GENDER SOC, V26, P549, DOI 10.1177/0891243212445466; Zukin S, 2004, ANNU REV SOCIOL, V30, P173, DOI 10.1146/annurev.soc.30.012703.110553	33	4	4	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195298	10.1371/journal.pone.0195298	http://dx.doi.org/10.1371/journal.pone.0195298			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630619	gold, Green Published			2022-12-27	WOS:000429505000036
J	Tandon, D; Haque, MM; Saravanan, R; Shaikh, S; Sriram, P; Dubey, AK; Mandel, SS				Tandon, Disha; Haque, Mohammed Monzoorul; R., Saravanan; Shaikh, Shafiq; Sriram, P.; Dubey, Ashok Kumar; Mandel, Sharmila S.			A snapshot of gut microbiota of an adult urban population from Western region of India	PLOS ONE			English	Article							DIETARY PATTERNS; DIVERSITY; BUTYRATE; INTERVENTION; DISEASE; OBESITY; HEALTH	The human gut microbiome contributes to a broad range of biochemical and metabolic functions that directly or indirectly affect human physiology. Several recent studies have indicated that factors like age, geographical location, genetic makeup, and individual health status significantly influence the diversity, stability, and resilience of the gut microbiome. Of the mentioned factors, geographical location (and related dietary/socio-economic context) appears to explain a significant portion of microbiome variation observed in various previously conducted base-line studies on human gut microbiome. Given this context, we have undertaken a microbiome study with the objective of cataloguing the taxonomic diversity of gut microbiomes sampled from an urban cohort from Ahmedabad city in Western India. Computational analysis of microbiome sequence data corresponding to 160 stool samples (collected from 80 healthy individuals at two time-points, 60 days apart) has indicated a Prevotella-dominated microbial community. Given that the typical diet of participants included carbohydrate and fibre-rich components (predominantly whole grains and legume based preparations), results appear to validate the proposed correlation between diet/geography and microbiome composition. Comparative analysis of obtained gut microbiome profiles with previously published microbiome profiles from US, China, Finland, and Japan additionally reveals a distinct taxonomic and (inferred) functional niche for the sampled microbiomes.	[Tandon, Disha; Haque, Mohammed Monzoorul; Mandel, Sharmila S.] Tata Consultancy Serv Ltd, Biosci R&D Div, TCS Res, Hadapsar Ind Estate, Pune, Maharashtra, India; [R., Saravanan; Dubey, Ashok Kumar] Tata Chem Ltd, Innovat Ctr, Pune, Maharashtra, India; [Shaikh, Shafiq] Veeda Clin Res Pvt Ltd, Ahmadabad, Gujarat, India; [Sriram, P.] Genotyp Technol P Ltd, Bangalore, Karnataka, India	Tata Sons; Tata Consultancy Services Limited (TCS); Tata Sons; Tata Chemicals Limited	Mandel, SS (corresponding author), Tata Consultancy Serv Ltd, Biosci R&D Div, TCS Res, Hadapsar Ind Estate, Pune, Maharashtra, India.; Dubey, AK (corresponding author), Tata Chem Ltd, Innovat Ctr, Pune, Maharashtra, India.	adubey@tatachemicals.com; sharmila.mande@tcs.com						Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Agrawal S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-89; Anand S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01945; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bhattacharya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142038; Bhute S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00660; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Das A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163099; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dinan TG, 2014, MOL PSYCHIATR, V19, P1252, DOI 10.1038/mp.2014.93; Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Ganju P, 2016, SCI REP-UK, V6, DOI 10.1038/srep18761; Green R, 2016, BRIT J NUTR, V116, P142, DOI 10.1017/S0007114516001598; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartmann M, 2010, J MICROBIOL METH, V83, P250, DOI 10.1016/j.mimet.2010.08.008; Hartstra AV, 2015, DIABETES CARE, V38, P159, DOI 10.2337/dc14-0769; Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706; Kane AV, 2015, PEDIATR RES, V77, P256, DOI 10.1038/pr.2014.179; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McKenney PT, 2015, CELL, V163, P1326, DOI 10.1016/j.cell.2015.11.032; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076; Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nagpal S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148347; Oyri SF, 2015, COMP IMMUNOL MICROB, V43, P36, DOI 10.1016/j.cimid.2015.10.005; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Sarkar A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184515; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Singh P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0109-2; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	49	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195643	10.1371/journal.pone.0195643	http://dx.doi.org/10.1371/journal.pone.0195643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624599	Green Submitted, gold, Green Published			2022-12-27	WOS:000429379600042
J	Vandepitte, L; Vanhoorne, B; Decock, W; Vranken, S; Lanssens, T; Dekeyzer, S; Verfaille, K; Horton, T; Kroh, A; Hernandez, F; Mees, J				Vandepitte, Leen; Vanhoorne, Bart; Decock, Wim; Vranken, Sofie; Lanssens, Thomas; Dekeyzer, Stefanie; Verfaille, Kevin; Horton, Tammy; Kroh, Andreas; Hernandez, Francisco; Mees, Jan			A decade of the World Register of Marine Species - General insights and experiences from the Data Management Team: Where are we, what have we learned and how can we continue?	PLOS ONE			English	Review								The World Register of Marine Species (WoRMS) celebrated its 10th anniversary in 2017. WoRMS is a unique database: there is no comparable global database for marine species, which is driven by a large, global expert community, is supported by a Data Management Team and can rely on a permanent host institute, dedicated to keeping WoRMS online. Over the past ten years, the content of WoRMS has grown steadily, and the system currently contains more than 242,000 accepted marine species. WoRMS has not yet reached completeness: approximately 2,000 newly described species per year are added, and editors also enter the remaining missing older names both accepted and unaccepted an effort amounting to approximately 20,000 taxon name additions per year. WoRMS is used extensively, through different channels, indicating that it is recognized as a high-quality database on marine species information. It is updated on a daily basis by its Editorial Board, which currently consists of 490 taxonomic and thematic experts located around the world. Owing to its unique qualities, WoRMS has become a partner in many large-scale initiatives including OBIS, LifeWatch and the Catalogue of Life, where it is recognized as a high-quality and reliable source of information for marine taxonomy.	[Vandepitte, Leen; Vanhoorne, Bart; Decock, Wim; Lanssens, Thomas; Dekeyzer, Stefanie; Verfaille, Kevin; Hernandez, Francisco; Mees, Jan] Flanders Marine Inst VLIZ, Wandelaarkaai 7, Oostende, Belgium; [Vranken, Sofie] UWA Oceans Inst, Sch Biol Sci, Perth, WA, Australia; [Horton, Tammy] Natl Oceanog Ctr, Southampton, Hants, England; [Kroh, Andreas] Nat Hist Museum, Vienna, Austria; [Mees, Jan] Univ Ghent, Ghent, Belgium	NERC National Oceanography Centre; Ghent University	Vandepitte, L (corresponding author), Flanders Marine Inst VLIZ, Wandelaarkaai 7, Oostende, Belgium.	leen.vandepitte@vliz.be	Kroh, Andreas/AAI-3650-2020; Vandepitte, Leen/N-9764-2014; Horton, Tammy/G-3590-2010; Mees, Jan/HDN-5048-2022	Kroh, Andreas/0000-0002-8566-8848; Vandepitte, Leen/0000-0002-8160-7941; Horton, Tammy/0000-0003-4250-1068; Vranken, Sofie/0000-0002-8459-041X	Flanders Marine Institute; MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6) [GOCE-CT-2003-505446]; Pan European Species directories Infrastructure (PESI, EU-FP7) [RI-223806]; EMODnet Biology I [MARE/2008/03-Lot 4 Biology, SI2.531562]; 4D4Life [INFRA-2008-1.2.2, 238988]; EMODnet Biology 11 [MARE/2012/10 - Lot 5 Biology, SI2.657705]; EMODnet Biology III [EASME/EMFF/2016/1.3.1.2 - Lot 5/S121750022]; AquaRES [BR/132/A6/AQUARES]; LifeWatch; Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada); Global Biodiversity Information Facility (GBIF); Department of Fisheries and Oceans (DFO, Canada); Marine Environmental Data and Information Network (MEDIN, UK); CORONA project of the National Science Foundation (NSF, USA); Natural Environment Research Council [noc010009] Funding Source: researchfish; NERC [noc010009] Funding Source: UKRI	Flanders Marine Institute; MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6); Pan European Species directories Infrastructure (PESI, EU-FP7); EMODnet Biology I; 4D4Life; EMODnet Biology 11; EMODnet Biology III; AquaRES; LifeWatch; Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada)(Alfred P. Sloan Foundation); Global Biodiversity Information Facility (GBIF); Department of Fisheries and Oceans (DFO, Canada); Marine Environmental Data and Information Network (MEDIN, UK); CORONA project of the National Science Foundation (NSF, USA)(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The continuous work on WoRMS is currently made possible through LifeWatch Belgium, part of the E-Science European LifeWatch Infrastructure for Biodiversity and Ecosystem Research. In addition, funding is available through the Flanders Marine Institute. Over the last 10 years, WoRMS and many of its sub-registers have been able to grow by funding received through several projects: MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6, GOCE-CT-2003-505446; 2004-2009), Pan European Species directories Infrastructure (PESI, EU-FP7, RI-223806; 2009-2011), EMODnet Biology I (MARE/2008/03-Lot 4 Biology Contract nr SI2.531562; 2009-2011), 4D4Life (INFRA-2008-1.2.2 Scientific Data Infrastructures Grant Agreement 238988; 2009-2012), EMODnet Biology 11 (MARE/2012/10 - Lot 5 Biology - Contract nr SI2.657705; 2012-2016), EMODnet Biology III (EASME/EMFF/2016/1.3.1.2 - Lot 5/S121750022), AquaRES (BR/132/A6/AQUARES; 2014-2016) and LifeWatch (2012-2017). Next to structured project funding, a number of ad-hoc funds have also contributed to the further development of WoRMS: Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada), the Global Biodiversity Information Facility (GBIF), the Department of Fisheries and Oceans (DFO, Canada), the Marine Environmental Data and Information Network (MEDIN, UK), and the CORONA project of the National Science Foundation (NSF, USA).	[Anonymous], 2017, MYS; [Anonymous], 2010, MANY FISH OTHER SPEC; [Anonymous], 2012, ALC ECH; ASHWORTH JH, 1912, CATALOGUE CHAETOPO 1; Barber A.D., 2014, Bulletin of the British Myriapod and Isopod Group, V27, P43; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Costello MJ, 2008, MAR BEF NEWSLETTER, V8, P36; De Broyer C., 2017, REGISTER ANTARCTIC M; Ellis J, 1786, NATURAL HIST MANY CU; Esper EJC, 1788, PFLANZENTHIERE ABBIL; Fleming J., 1828, HIST BRIT ANIMALS EX; Gerovasileiou V, 2017, WORLD REGISTER MARIN; Guiry MD, 2017, ALGAEBASE; Hartmeyer R., 1916, Mitteilungen aus dem Zoologischen Museum in Berlin, V8; Horton T, 2017, EUR J TAXON, V389, P1, DOI 10.5852/ejt.2017.389; Lamarck JBP, 1815, MEMOIRES MUSEUM HIST, V1, p[69, 162, 331]; Leveque C, 2005, HYDROBIOLOGIA, V542, P39, DOI 10.1007/s10750-004-5522-7; Linnaeus C, 1766, SYSTEMA NATURAE REGN; O'Dor R, 2004, BIOSCIENCE, V54, P92, DOI 10.1641/0006-3568(2004)054[0092:ACOML]2.0.CO;2; Pagad S, 2017, WORLD REGISTER INTRO; Parr Cynthia S, 2014, Biodivers Data J, pe1079, DOI 10.3897/BDJ.2.e1079; Read G., 2017, SCOLOPENDRA LINNAEUS; Read G., 2017, COLOPENDRA MARINA LI; Rees T., 2008, P TDWG, P72; Rees T., 2008, P C OC BIOD INF 2 4, P11; Rees T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107510; Roskov Y., 2017, SPECIES 2000 ITIS CA; Sanamyan K., 2007, ASCIDIACEA WORLD DAT; Sanamyan K., 2007, ASCIDIACEA WORLD DAT; Schlosser JA, 1755, FRS PHILOS T, V49, P449; Slabber M., 1781, PHYS BELUSTIGUNGEN M; Thompson DA, 1910, WORKS ARISTOTLE HIST; Turton W., 1807, BRIT FAUNA CONTAININ; van Soest R, 1758, ALCYONIUM LINNAEUS; Van Soest RWM, 2016, WORLD PORIFERA DATAB; Vandepitte L, 2015, J MAR SCI ENG, V3, P1448, DOI 10.3390/jmse3041448; Vanhoorne B, 2008, INT MARINE DATA INFO, P145; Xu K, 2017, CHINESE REGISTER MAR	39	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194599	10.1371/journal.pone.0194599	http://dx.doi.org/10.1371/journal.pone.0194599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624577	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600008
J	Churchward, CP; Calder, A; Snyder, LAS				Churchward, Colin P.; Calder, Alan; Snyder, Lori A. S.			Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance	PLOS ONE			English	Article							ENCODED EFFLUX PUMP; FACTOR DKSA; STRAINS; REGIONS; GENE; PARC; GYRA	Neisseria gonorrhoeae, due to its short lipooligosaccharide structure, is generally more sensitive to the antimicrobial effects of some fatty acids than most other Gram negative bacteria. This supports recent development of a fatty acid-based potential treatment for gonococcal infections, particularly ophthalmia neonatorum. The N. gonorrhoeae genome contains genes for fatty acid resistance. In this study, the potential for genomic mutations that could lead to resistance to this potential new treatment were investigated. N. gonorrhoeae strain NCCP11945 was repeatedly passaged on growth media containing a sub-lethal concentration of fatty acid myristic acid and monoglyceride monocaprin. Cultures were re-sequenced and assessed for changes in minimum inhibitory concentration. Of note, monocaprin grown cultures developed a mutation in transcription factor gene dksA, which suppresses molecular chaperone DnaK and may be involved in the stress response. The minimum inhibitory concentration after exposure to monocaprin showed a modest two-fold change. The results of this study suggest that N. gonorrhoeae cannot readily evolve resistance that will impact treatment of ophthalmia neonatorum with monocaprin.	[Churchward, Colin P.; Calder, Alan; Snyder, Lori A. S.] Kingston Univ, Sch Life Sci Pharm & Chem, Kingston Upon Thames, Surrey, England; [Churchward, Colin P.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Kingston University; Imperial College London	Snyder, LAS (corresponding author), Kingston Univ, Sch Life Sci Pharm & Chem, Kingston Upon Thames, Surrey, England.	Lsnyder@kingston.ac.uk	Churchward, Colin/AAB-2736-2020	Snyder, Lori/0000-0003-3172-3984; Calder, Alan/0000-0001-5012-048X; Churchward, Colin/0000-0002-7590-5504	Sparks Children's Medical Research charity [11KIN01, 13KIN01]	Sparks Children's Medical Research charity	This work was supported by the Sparks Children's Medical Research charity (www.sparks.org.uk), which has provided for this work with Project Grants 11KIN01 and 13KIN01 to support Colin Churchward and this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x; Bergsson G, 1999, ANTIMICROB AGENTS CH, V43, P2790, DOI 10.1128/AAC.43.11.2790; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Chen PL, 2010, J FORMOS MED ASSOC, V109, P120, DOI 10.1016/S0929-6646(10)60032-0; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Churchward CP, 2017, MBIO, V8, DOI 10.1128/mBio.00534-17; Deguchi T, 1996, ANTIMICROB AGENTS CH, V40, P1020, DOI 10.1128/AAC.40.4.1020; Furman R, 2012, NUCLEIC ACIDS RES, V40, P3392, DOI 10.1093/nar/gkr1273; Golosova O, 2014, PEERJ, V2, DOI 10.7717/peerj.644; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Johnson PJT, 2011, ANTIMICROB AGENTS CH, V55, P2559, DOI 10.1128/AAC.00010-11; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee EH, 2003, J BACTERIOL, V185, P7145, DOI 10.1128/JB.185.24.7145-7152.2003; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lee EH, 2006, MOL MICROBIOL, V60, P1381, DOI 10.1111/j.1365-2958.2006.05185.x; Lee JH, 2012, J MOL BIOL, V416, P503, DOI 10.1016/j.jmb.2011.12.028; Long A, 2015, NAT REV GENET, V16, P567, DOI 10.1038/nrg3937; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; MORSE SA, 1982, INFECT IMMUN, V37, P432, DOI 10.1128/IAI.37.2.432-438.1982; Mueller EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120280; Ohneck EA, 2011, MBIO, V2, DOI 10.1128/mBio.00187-11; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Schielke S, 2011, INT J MED MICROBIOL, V301, P325, DOI 10.1016/j.ijmm.2010.11.007; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; Schlotterer C, 2015, HEREDITY, V114, P431, DOI 10.1038/hdy.2014.86; Su XH, 2001, ANTIMICROB AGENTS CH, V45, P117, DOI 10.1128/AAC.45.1.117-123.2001	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195453	10.1371/journal.pone.0195453	http://dx.doi.org/10.1371/journal.pone.0195453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621310	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000429206800086
J	Jella, KK; Moriarty, R; McClean, B; Byrne, HJ; Lyng, FM				Jella, Kishore Kumar; Moriarty, Roisin; McClean, Brendan; Byrne, Hugh J.; Lyng, Fiona M.			Reactive oxygen species and nitric oxide signaling in bystander cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEDIATED INTERCELLULAR COMMUNICATION; TARGETED CYTOPLASMIC IRRADIATION; SISTER-CHROMATID EXCHANGES; ALPHA-PARTICLE IRRADIATION; VERY-LOW FLUENCES; IONIZING-RADIATION; GLIOMA-CELLS; NONIRRADIATED CELLS; HUMAN FIBROBLASTS	It is now well accepted that radiation induced bystander effects can occur in cells exposed to media from irradiated cells. The aim of this study was to follow the bystander cells in real time following addition of media from irradiated cells and to determine the effect of inhibiting these signals. A human keratinocyte cell line, HaCaT cells, was irradiated (0.005, 0.05 and 0.5 Gy) with Y irradiation, conditioned medium was harvested after one hour and added to recipient bystander cells. Reactive oxygen species, nitric oxide, Glutathione levels, caspase activation, cytotoxicity and cell viability was measured after the addition of irradiated cell conditioned media to bystander cells. Reactive oxygen species and nitric oxide levels in bystander cells treated with 0.5Gy ICCM were analysed in real time using time lapse fluorescence microscopy. The levels of reactive oxygen species were also measured in real time after the addition of extracellular signal-regulated kinase and c-Jun amino-terminal kinase pathway inhibitors. ROS and glutathione levels were observed to increase after the addition of irradiated cell conditioned media (0.005, 0.05 and 0.5 Gy ICCM). Caspase activation was found to increase 4 hours after irradiated cell conditioned media treatment (0.005, 0.05 and 0.5 Gy ICCM) and this increase was observed up to 8 hours and there after a reduction in caspase activation was observed. A decrease in cell viability was observed but no major change in cytotoxicity was found in HaCaT cells after treatment with irradiated cell conditioned media (0.005, 0.05 and 0.5 Gy ICCM). This study involved the identification of key signaling molecules such as reactive oxygen species, nitric oxide, glutathione and caspases generated in bystander cells. These results suggest a clear connection between reactive oxygen species and cell survival pathways with persistent production of reactive oxygen species and nitric oxide in bystander cells following exposure to irradiated cell conditioned media.	[Jella, Kishore Kumar] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Moriarty, Roisin; Lyng, Fiona M.] Dublin Inst Technol, Radiat & Environm Sci Ctr, Focas Inst, Dublin, Ireland; [McClean, Brendan] St Lukes Hosp, Dublin, Ireland; [Byrne, Hugh J.] Dublin Inst Technol, Focas Inst, Dublin, Ireland; [Lyng, Fiona M.] Dublin Inst Technol, Sch Phys, Dublin, Ireland	Emory University; Technological University Dublin; Trinity College Dublin; Technological University Dublin; Technological University Dublin	Jella, KK (corresponding author), Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA.	kjella@emory.edu	Lyng, Fiona/AAD-2842-2020; Byrne, Hugh James/AAD-9713-2020; Jella, Kishore Kumar/N-9875-2018	Lyng, Fiona/0000-0002-9876-963X; Byrne, Hugh James/0000-0002-1735-8610; Jella, Kishore Kumar/0000-0001-9707-795X; Moriarty, Roisin/0000-0001-9167-2328	Irish Government's Programme for Research in Third Level Institutions, Cycle 4	Irish Government's Programme for Research in Third Level Institutions, Cycle 4	The work was conducted as part of the National Biophotonics and Imaging Platform of Ireland (NBIPI), funded by the Irish Governments Programme for Research in Third Level Institutions, Cycle 4 (2007-2013).	Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Aloy MT, 2008, INT J RADIAT ONCOL, V70, P543, DOI 10.1016/j.ijrobp.2007.08.061; Azzam EI, 2002, CANCER RES, V62, P5436; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2015, CANCER LETT, V356, P454, DOI 10.1016/j.canlet.2014.09.043; Chen S, 2008, BRIT J CANCER, V98, P1839, DOI 10.1038/sj.bjc.6604358; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Facoetti A, 2006, RADIAT PROT DOSIM, V122, P271, DOI 10.1093/rpd/ncl431; Facoetti A, 2009, INT J RADIAT BIOL, V85, P690, DOI 10.1080/09553000903020016; Furlong H, 2013, MUTAT RES-FUND MOL M, V741, P35, DOI 10.1016/j.mrfmmm.2013.02.001; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Han W, 2007, ONCOGENE, V26, P2330, DOI 10.1038/sj.onc.1210024; Hanot M, 2009, INT J RADIAT ONCOL, V75, P1247, DOI 10.1016/j.ijrobp.2009.07.014; Harada T, 2008, INT J RADIAT BIOL, V84, P809, DOI 10.1080/09553000802360844; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Huo LH, 2001, RADIAT RES, V156, P521, DOI 10.1667/0033-7587(2001)156[0521:HMIIBC]2.0.CO;2; Iyer R, 2000, CANCER RES, V60, P1290; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jella KK, 2013, INT J RADIAT BIOL, V89, P182, DOI 10.3109/09553002.2013.734942; Jiang Y, 2014, BRIT J CANCER, V111, P772, DOI 10.1038/bjc.2014.368; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Le M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173685; Leach JK, 2001, CANCER RES, V61, P3894; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Lehnert BE, 1997, CANCER RES, V57, P2164; Lewis DA, 2001, RADIAT RES, V156, P251, DOI 10.1667/0033-7587(2001)156[0251:PODDAN]2.0.CO;2; Li ZT, 2015, RADIAT RES, V184, P249, DOI 10.1667/RR14092.1; Li ZT, 2014, RADIAT RES, V182, P573, DOI 10.1667/RR13723.1; Li ZT, 2013, RADIAT RES, V180, P17, DOI 10.1667/RR3332.1; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Lopez-Sanchez N, 2007, MOL CANCER RES, V5, P47, DOI 10.1158/1541-7786.MCR-06-0233; Lorimore SA, 1998, P NATL ACAD SCI USA, V95, P5730, DOI 10.1073/pnas.95.10.5730; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Lyng FM, 2012, INT J RADIAT BIOL, V88, P770, DOI 10.3109/09553002.2012.705222; Lyng FM, 2011, INT J RADIAT BIOL, V87, P683, DOI 10.3109/09553002.2010.549533; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Lyng FM, 2002, RADIAT PROT DOSIM, V99, P169, DOI 10.1093/oxfordjournals.rpd.a006753; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Lyng FM, 2011, INT J RAD BIOL; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2006, MUTAT RES-FUND MOL M, V597, P5, DOI 10.1016/j.mrfmmm.2005.10.011; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Nagasawa H, 2002, CANCER RES, V62, P2531; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1997, CANCER RES, V57, P3963; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Osterreicher J, 2003, ACTA HISTOCHEM, V105, P223, DOI 10.1078/0065-1281-00710; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 1998, INT J RADIAT BIOL, V74, P793, DOI 10.1080/095530098141087; Seymour CB, 2000, RADIAT RES, V153, P508, DOI 10.1667/0033-7587(2000)153[0508:RCOBAT]2.0.CO;2; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2003, CANCER RES, V63, P8437; Shao C, 2002, INT J RADIAT BIOL, V78, P837, DOI 10.1080/09553000210149786; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Shao CL, 2006, RADIAT RES, V166, P479, DOI 10.1667/RR3600.1; Shao CL, 2004, P NATL ACAD SCI USA, V101, P13495, DOI 10.1073/pnas.0404930101; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Temme J, 2013, RADIAT RES, V179, P422, DOI 10.1667/RR3161.2; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Wang XD, 2015, INT J RADIAT BIOL, V91, P452, DOI 10.3109/09553002.2015.1012308; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Xie YX, 2015, MUTAT RES-FUND MOL M, V772, P23, DOI 10.1016/j.mrfmmm.2014.12.010; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhuang SG, 2008, J PHARMACOL EXP THER, V325, P732, DOI 10.1124/jpet.108.136358	80	20	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195371	10.1371/journal.pone.0195371	http://dx.doi.org/10.1371/journal.pone.0195371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621312	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800072
J	Kleven, MD; Gomes, MM; Wortham, AM; Enns, CA; Kahl, CA				Kleven, Mark D.; Gomes, Michelle M.; Wortham, Aaron M.; Enns, Caroline A.; Kahl, Christoph A.			Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; GENE-TRANSFER; HEPCIDIN EXPRESSION; VIRUS; PURIFICATION; SEROTYPE; STOCKS; CONTAMINANTS; TROPISM; MUSCLE	Viral vectors are extensively purified for use in biomedical research, in order to separate biologically active virus particles and to eliminate production related impurities that are assumed to be detrimental to the host. For recombinant adeno-associated virus (rAAV) vectors this is typically accomplished using density gradient-based methods, which are tedious and require specialized ultracentrifugation equipment. In order to streamline the preparation of rAAV vectors for pilot and small animal studies, we recently devised a simple ultrafiltration approach that permits rapid virus concentration and partial removal of production-related impurities. Here we show that systemic administration of such rapidly prepared (RP) rAAV8 vectors in mice is safe and efficiently transduces the liver. Across a range of doses, delivery of RP rAAV8-CMV-eGFP vector induced enhanced green fluorescent protein (eGFP) expression in liver that was comparable to that obtained from a conventional iodixanol gradient-purified (IP) vector. Surprisingly, no liver inflammation or systemic cytokine induction was detected in RP rAAV injected animals, revealing that residual impurities in the viral vector preparation are not deleterious to the host. Together, these data demonstrate that partially purified rAAV vector can be safely and effectively administered in vivo. The speed and versatility of the RP method and lack of need for cumbersome density gradients or expensive ultracentrifuge equipment will enable more widespread use of RP prepared rAAV vectors, such as for pilot liver gene transfer studies.	[Kleven, Mark D.; Wortham, Aaron M.; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Gomes, Michelle M.; Kahl, Christoph A.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Kahl, CA (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.	kahl@ohsu.edu		Gomes, Michelle/0000-0003-4809-2664	National Institutes of Health [P510D011092]; National Institute of Diabetes and Digestive and Kidney Diseases [R0172166, R37054488, T32 A1007472]; NIH NIDDK [R0172166, R37054488, T32 A1007472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All rAAV productions and neutralizing assays were supported in part by National Institutes of Health grant P510D011092 (support for the Oregon National Primate Research Center). Research support for the mouse liver studies came from National Institute of Diabetes and Digestive and Kidney Diseases R0172166 and R37054488 (to C.A.E.) and T32 A1007472 (to M.D.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All rAAV productions and neutralizing assays were supported in part by National Institutes of Health grant P510D011092 (support for the Oregon National Primate Research Center). Research support for the mouse liver studies came from NIH NIDDK R0172166 and R37054488 (to C.A.E.) and T32 A1007472 (to M.D.K.). We are thankful to Jim Wilson and the University of Pennsylvania Vector Core for providing AAV plasmids, to Byung Park and Lina Gao for biostatistics advice, to Barbra Mason (ONPRC Histopathology-Morphology Core) and Sathya Srinivasan (ONPRC Imaging and Morphology Support Core) for help with preparation and imaging of liver immunofluorescence slides, and to Anupriya Agarwal at OHSU for the cytokine panel studies.	Ai JZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40336; Alexander IE, 1997, HUM GENE THER, V8, P1911, DOI 10.1089/hum.1997.8.16-1911; [Anonymous], 2015, PUB THERMOFISHER SCI, VMAN0004015; Arden Erik, 2016, J Biol Methods, V3; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Ayuso E, 2010, CURR GENE THER, V10, P423, DOI 10.2174/156652310793797685; Burova E, 2005, GENE THER, V12, pS5, DOI 10.1038/sj.gt.3302611; Clement N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.2; D'Costa S, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.19; Doria M, 2013, HUM GENE THER METHOD, V24, P392, DOI 10.1089/hgtb.2013.155; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gao K, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2013.9; Geering B, 2011, J IMMUNOL METHODS, V373, P209, DOI 10.1016/j.jim.2011.08.024; Gomes MM, 2016, METHODS MOL BIOL, V1427, P43, DOI 10.1007/978-1-4939-3615-1_3; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Li LN, 2005, J GENE MED, V7, P420, DOI 10.1002/jgm.681; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Miyake K, 2012, J NIPPON MED SCH, V79, P394, DOI 10.1272/jnms.79.394; Moss B, 2013, FIELDS VIROLOGY, V2, P2129; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Strobel B, 2015, HUM GENE THER METHOD, V26, P147, DOI 10.1089/hgtb.2015.051; Tenenbaum L, 1999, GENE THER, V6, P1045, DOI 10.1038/sj.gt.3300904; Urabe M, 2006, MOL THER, V13, P823, DOI 10.1016/j.ymthe.2005.11.024; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179; Wright JF, 2014, BIOMEDICINES, V2, P80, DOI 10.3390/biomedicines2010080; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194728	10.1371/journal.pone.0194728	http://dx.doi.org/10.1371/journal.pone.0194728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621273	gold, Green Published			2022-12-27	WOS:000429206800025
J	Reddy, KG; Khan, MGM; Khan, S				Reddy, Karuna Garan; Khan, Mohammad G. M.; Khan, Sabiha			Optimum strata boundaries and sample sizes in health surveys using auxiliary variables	PLOS ONE			English	Article							STRATIFICATION; POPULATIONS	Using convenient stratification criteria such as geographical regions or other natural conditions like age, gender, etc., is not beneficial in order to maximize the precision of the estimates of variables of interest. Thus, one has to look for an efficient stratification design to divide the whole population into homogeneous strata that achieves higher precision in the estimation. In this paper, a procedure for determining Optimum Stratum Boundaries (OSB) and Optimum Sample Sizes (OSS) for each stratum of a variable of interest in health surveys is developed. The determination of OSB and OSS based on the study variable is not feasible in practice since the study variable is not available prior to the survey. Since many variables in health surveys are generally skewed, the proposed technique considers the readily-available auxiliary variables to determine the OSB and OSS. This stratification problem is formulated into a Mathematical Programming Problem (MPP) that seeks minimization of the variance of the estimated population parameter under Neyman allocation. It is then solved for the OSB by using a dynamic programming (DP) technique. A numerical example with a real data set of a population, aiming to estimate the Haemoglobin content in women in a national Iron Deficiency Anaemia survey, is presented to illustrate the procedure developed in this paper. Upon comparisons with other methods available in literature, results reveal that the proposed approach yields a substantial gain in efficiency over the other methods. A simulation study also reveals similar results.	[Reddy, Karuna Garan] Univ South Pacific, Res Off, Off Deputy Vice Chancellor Res Innovat & Int, Suva, Fiji; [Khan, Mohammad G. M.] Univ South Pacific, Sch Comp Informat & Math Sci, Suva, Fiji; [Khan, Sabiha] Fiji Natl Univ, Sch Publ Hlth & Primary Care, Suva, Fiji	University of the South Pacific; University of the South Pacific; Fiji National University (FNU)	Reddy, KG (corresponding author), Univ South Pacific, Res Off, Off Deputy Vice Chancellor Res Innovat & Int, Suva, Fiji.	reddy_k@usp.ac.fj	Khan, Mohammad G. M./K-2623-2019	Khan, Mohammad G. M./0000-0001-5400-9703; Reddy, Karuna Garan/0000-0002-9467-4668				[Anonymous], 2009, SAMPLING DESIGN ANAL; Aoyama H., 1954, ANN I STAT MATH, V6, P1, DOI DOI 10.1007/BF02960514; Baillargeon S, 2011, SURV METHODOL, V37, P53; Bellman R., 1957, DYNAMIC PROGRAMMING; Buhler W., 1975, Metrika, V22, P161, DOI 10.1007/BF01899725; Cochran W.G., 1977, SAMPLING TECHNIQUES, V98, P259; COCHRAN WG, 1961, B INT STATIST INST, V38, P345; Dalenius T, 1951, SKAND AKTUARIETIDSKR, V34, P133; DALENIUS T, 1959, J AM STAT ASSOC, V54, P88, DOI 10.2307/2282141; Dalenius T., 1957, SKAND AKTUARIETIDSK, V1957, P198; Dalenius T., 1957, SAMPLING SWEDEN CONT; Dalenius T, 1950, SKAND AKTUARIETIDSKR, V33, P203; EKMAN G, 1959, ANN MATH STAT, V30, P219, DOI 10.1214/aoms/1177706377; Gunning P., 2004, SURV METHODOL, V30, P159; Gupta R. K., 2005, ALIGARH J STAT, V25, P49; Hansen MH, 1943, ANN MATH STAT, V14, P333, DOI 10.1214/aoms/1177731356; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Hedlin D., 1998, STRATIFICATION HIGHL; HIDIROGLOU MA, 1993, J BUS ECON STAT, V11, P397, DOI 10.2307/1391630; Horgan JM, 2006, INT STAT REV, V74, P67, DOI 10.1111/j.1751-5823.2006.tb00161.x; Khan A., 2002, CALCUTTA STAT ASS B, V52, P323, DOI DOI 10.1177/0008068320020518; Khan M. G. M., 2005, J INDIAN SOC AGR STA, V59, P146; Khan M. G. M., 2009, J APPL STAT SCI, V16, P453; Khan MGM, 2009, J MATH MODELLING ALG, V8, P1; Khan MI, 2015, J BRAZ SOC MECH SCI, P1; Khan MGM, 2008, SURV METHODOL, V34, P205; Kozak M., 2004, STAT TRANSITION, V6, P797; Kozak M.R., 2006, SURV METHODOL, V32, P157; Lavallee P., 1988, SURV METHODOL, V14, P33; Lavallee P., 1988, P SECT SURV RES METH; Lednicki B., 2003, STAT TRANSITION, V6, P287; Mahalanobis PC, 1952, SANKHYA, V12, P1; Mehta S., 1996, J INDIAN STAT ASS, V34, P9; Nand N., 2003, SURV METHODOL, V34, P1; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neyman J, 1934, J R STAT SOC, V97, P558, DOI 10.2307/2342192; Niemiro W., 1999, WIADOMOSCI STATYSTYC, V10, P1; Niu G, 2011, MICROELECTRON RELIAB, V51, P279, DOI 10.1016/j.microrel.2010.09.009; Patten Scott B, 2006, Clin Pract Epidemiol Ment Health, V2, P13, DOI 10.1186/1745-0179-2-13; Rivest L-P., 2002, SURV METHODOL, V28, P191; Rizvi S. E. H., 2002, METRON, V28, P201; SERFLING RJ, 1968, J AM STAT ASSOC, V63, P1298; SETHI VK, 1963, AUST J STAT, V5, P20, DOI 10.1111/j.1467-842X.1963.tb00134.x; SINGH R, 1969, ANN I STAT MATH, V21, P515, DOI 10.1007/BF02532275; SINGH R, 1975, ANN I STAT MATH, V27, P273, DOI 10.1007/BF02504646; SINGH R, 1973, ANN I STAT MATH, V25, P627, DOI 10.1007/BF02479404; SINGH R, 1972, ANN I STAT MATH, V24, P485, DOI 10.1007/BF02479777; Sweet E.M., 1995, P SECT SURV RES METH, P491; TAGA Y, 1967, ANN I STAT MATH, V19, P101, DOI 10.1007/BF02911670; Taha H.A., 2007, OPERATIONS RES INTRO, VEighth; Thomsen I., 1976, Metrika, V23, P15, DOI 10.1007/BF01902846; Unnithan V. K. G., 1978, SANKHYA, V40, P60; Wahed AS, 2009, STAT MED, V28, P2077, DOI 10.1002/sim.3598; Wang HK, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-14; Zielinski A., 2007, STAT TRANSITION, V8, P223	56	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194787	10.1371/journal.pone.0194787	http://dx.doi.org/10.1371/journal.pone.0194787			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621265	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800027
J	Rill, RA; Farago, KB; Lorincz, A				Rill, Robert Adrian; Farago, Kinga Bettina; Lorincz, Andras			Strategic predictors of performance in a divided attention task	PLOS ONE			English	Article							CALCULATING CORRELATION-COEFFICIENTS; LONGITUDINAL DATA-ANALYSIS; GENERALIZED LINEAR-MODELS; MULTITASKING PERFORMANCE; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; VISUAL-ATTENTION; COGNITIVE LOAD; POLYCHRONICITY; INTERRUPTIONS	In this study we investigate the strategies of subjects in a complex divided attention task. We conducted a series of experiments with ten participants and evaluated their performance. After an extensive analysis, we identified four strategic measures that justify the achievement of the participants, by highlighting the individual differences and predicting performance in a regression analysis using generalized estimating equations. Selecting the more urgent task and user action between multiple simultaneous possibilities form two of the strategic decisions, respectively. The third one refers to choosing a response within the same task when the opportunity is present. The fourth and most important measure of strategy involves thinking ahead and executing an action before a situation would become critical. This latter one has the effect of reducing later cognitive load or timing constraints and it is shown to explain almost as much variance in performance as the other three, more straightforward predictors together. In addition to determining these strategic predictors, we also show how manipulating task difficulty induces a shift in strategy, thus impairing human performance in the rehearsed task. The results of this study indicate that considerable differences in the divided attention ability of normal subjects can be identified early and with simple measurements. The importance of describing and analyzing strategies is also emphasized, which can substantially influence performance in complex tasks and may serve training needs.	[Rill, Robert Adrian; Farago, Kinga Bettina; Lorincz, Andras] Eotvos Lorand Univ, Fac Informat, Budapest, Hungary; [Rill, Robert Adrian] Babes Bolyai Univ, Fac Math & Comp Sci, Cluj Napoca, Romania	Eotvos Lorand University; Babes Bolyai University from Cluj	Rill, RA; Lorincz, A (corresponding author), Eotvos Lorand Univ, Fac Informat, Budapest, Hungary.; Rill, RA (corresponding author), Babes Bolyai Univ, Fac Math & Comp Sci, Cluj Napoca, Romania.	rillroberto88@yahoo.com; lorincz@inf.elte.hu	Rill, Róbert A/I-4603-2017	Rill, Róbert A/0000-0002-3004-7294	Hungarian Government - Research and Technology Innovation Fund [EITKIC 12-1-2012-0001]	Hungarian Government - Research and Technology Innovation Fund	The research was carried out as part of the EITKIC 12-1-2012-0001 project, which is supported by the Hungarian Government, managed by the National Development Agency, financed by the Research and Technology Innovation Fund and was performed in cooperation with the EIT Digital Budapest Associate partner Group (www.ictlabs.elte.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2015, INTERACT COMPUT, V27, P430, DOI 10.1093/iwc/iwu005; Adler RF, 2013, COMPUT HUM BEHAV, V29, P1441, DOI 10.1016/j.chb.2013.01.040; ARTHUR W, 1995, ACTA PSYCHOL, V88, P3, DOI 10.1016/0001-6918(94)E0055-K; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Buhner M, 2006, HUM PERFORM, V19, P253, DOI 10.1207/s15327043hup1903_4; Colom R, 2010, INTELLIGENCE, V38, P543, DOI 10.1016/j.intell.2010.08.002; Delbridge K. A., 2000, THESIS; Duggan GB, 2013, INT J HUM-COMPUT ST, V71, P533, DOI 10.1016/j.ijhcs.2013.01.001; Gonzalez C, 2004, HUM FACTORS, V46, P449, DOI 10.1518/hfes.46.3.449.50395; Goonetilleke RS, 2010, BEHAV INFORM TECHNOL, V29, P187, DOI 10.1080/01449290903222697; Gray BE, 2014, SCHIZOPHRENIA BULL, V40, P1462, DOI 10.1093/schbul/sbu015; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hardy J, 2013, SCI LUMOSITY VERSION; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Hobbes Thomas., 1651, LEVIATHAN MATTER FOR; Hoffmann JA, 2013, PSYCHOL SCI, V24, P869, DOI 10.1177/0956797612463581; Ishizaka K, 2001, HUM PERFORM, V14, P339, DOI 10.1207/S15327043HUP1404_4; Janssen CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130009; Janssen CP, 2010, COGNITIVE SCI, V34, P1548, DOI 10.1111/j.1551-6709.2010.01124.x; Judd T, 2013, COMPUT EDUC, V63, P358, DOI 10.1016/j.compedu.2012.12.017; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Konig CJ, 2005, HUM PERFORM, V18, P243, DOI 10.1207/s15327043hup1803_3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin L., 2015, HDB RES SCHOLARLY PU, P329; Lin L, 2016, TECHNOL KNOWL LEARN, V21, P307, DOI 10.1007/s10758-015-9266-4; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Luck SJ, 2014, J ABNORM PSYCHOL, V123, P783, DOI 10.1037/abn0000003; Moon J, 2013, COGNITIVE PSYCHOL, V67, P26, DOI 10.1016/j.cogpsych.2013.06.001; Morgan B, 2013, P HUM FACT ERG SOC A, V57, P843; Morgan B, 2013, HUM FACTORS, V55, P776, DOI 10.1177/0018720812470842; Oberlander EM, 2007, NPRSTTN079; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Oswald F. L., 2007, LEARNING SOLVE COMPL, P77, DOI DOI 10.4324/9781315091938-4; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pena D, 2008, ACTA PSYCHOL, V128, P1, DOI 10.1016/j.actpsy.2007.09.005; Poposki EM, 2010, HUM PERFORM, V23, P247, DOI 10.1080/08959285.2010.487843; Poposki EM, 2009, NEUROTICISM NEGATIVE; Rubinstein JS, 2001, EXECUTIVE CONTROL CO; Sanbonmatsu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054402; Sanderson KR, 2013, J OCCUP ORGAN PSYCH, V86, P556, DOI 10.1111/joop.12025; Schneps MH., 2015, SCI AM MIND, V26, P24; Schumacher EH, 2001, PSYCHOL SCI, V12, P101, DOI 10.1111/1467-9280.00318; Schunn CD, 2001, J EXP PSYCHOL GEN, V130, P59, DOI 10.1037//0096-3445.130.1.59; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Song K.S., 2013, INT J MULTIMEDIA UBI, V8, P191; Szumowska E, 2017, PERS INDIV DIFFER, V106, P81, DOI 10.1016/j.paid.2016.10.040; Szumowska E, 2016, PERS INDIV DIFFER, V96, P12, DOI 10.1016/j.paid.2016.02.055; Szymura B, 1998, PERS INDIV DIFFER, V24, P713, DOI 10.1016/S0191-8869(97)00198-0; Wang DYD, 2007, HUM FACTORS, V49, P995, DOI 10.1518/001872007X249866; West RL, 2007, J COGN ENG DECIS MAK, V1, P186, DOI 10.1518/155534307X232848; WILLIAMS LJ, 1982, HUM FACTORS, V24, P683, DOI 10.1177/001872088202400605; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang Y, 2005, INT J HUM-COMPUT ST, V62, P425, DOI 10.1016/j.ijhcs.2005.01.002; Zheng BY, 2000, STAT MED, V19, P1265, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1265::AID-SIM486>3.3.CO;2-L	58	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195131	10.1371/journal.pone.0195131	http://dx.doi.org/10.1371/journal.pone.0195131			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621292	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800041
J	Wang, JN; Sun, W; Wells, GA; Li, ZB; Li, TY; Wu, JD; Zhang, YY; Liu, YY; Li, LB; Yu, YP; Liu, YH; Qi, C; Lu, Y; Liu, N; Yan, YY; Liu, LL; Hui, G; Liu, B				Wang, Junnan; Sun, Wei; Wells, George A.; Li, Zhibo; Li, Tianyi; Wu, Junduo; Zhang, Yangyu; Liu, Yingyu; Li, Longbo; Yu, Yunpeng; Liu, Yihang; Qi, Chao; Lu, Yang; Liu, Ning; Yan, Youyou; Liu, Lulu; Hui, Gang; Liu, Bin			Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People's Republic of China: A cross-sectional study	PLOS ONE			English	Article							BLOOD-PRESSURE; AWARENESS; MANAGEMENT; ADULTS; GUIDELINES; DIETARY; OBESITY; TRENDS	Background Hypertension is a significant global public health problem and recognized as an important risk factor for cardiovascular diseases. This study was designed to assess the current prevalence of hypertension and to explore risk factors associated with hypertension by urban and rural status to guide the prevention and control of hypertension in Jilin province. Methods A multi-stage stratified random cluster sampling method was used to obtain data on hypertension, which was investigated by physical examination and face-to-face questionnaire in July 2014-December 2015. Sample data were analyzed by complex weighted statistical analysis to estimate blood pressure levels and prevalence of hypertension in the province. Multivariable logistic regression analysis was used to identify factors influencing hypertension rates. Results The prevalence of hypertension was significantly higher in rural areas than urban areas (25.93% versus 22.73%, respectively). The rates of hypertension known (46.7% versus 38.1%, respectively), control (13.7% versus 5.0%, respectively), and controlled among treated subjects (38.3% versus 17.5%, respectively) were higher in urban areas than in rural areas (all p < 0.001), while the treatment rate was not statistically significantly different between urban and rural areas (35.9% versus 28.4%, respectively). After adjusting for demographic covariates, hypertension prevalence in rural areas was still significantly greater than in urban areas (adjusted OR = 1.22; 95%Cl: 1.10, 1.36; p < 0.001). Common risk factors for hypertension among urban and rural residents included older age; male; married; employed; less education; overweight/obese; greater abdominal waist circumference; family history of hypertension, stroke, or coronary heart disease; current smoker; alcohol consumption; higher visceral adiposity index; and higher body fat percentage. Conclusions This study identified an increased risk for hypertension in rural regions of Jilin province, suggesting that rural hypertension screening and treatment guidelines should receive greater attention.	[Wang, Junnan; Sun, Wei; Li, Zhibo; Li, Tianyi; Wu, Junduo; Li, Longbo; Yu, Yunpeng; Liu, Yihang; Qi, Chao; Lu, Yang; Liu, Ning; Yan, Youyou; Liu, Lulu; Hui, Gang; Liu, Bin] Jilin Univ, Hosp 2, Dept Cardiol, Changchun, Jilin, Peoples R China; [Wells, George A.] Univ Ottawa, Heart Inst, Dept Cardiovasc, Res Methods Ctr, Ottawa, ON, Canada; [Zhang, Yangyu; Liu, Yingyu] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China	Jilin University; University of Ottawa; University of Ottawa Heart Institute; Jilin University	Liu, B (corresponding author), Jilin Univ, Hosp 2, Dept Cardiol, Changchun, Jilin, Peoples R China.	liubin3333@vip.sina.com			National Key RAMP;D Program from the Chinese Ministry of Science and Technology [2011BA111601]; National Clinical Key Specialty Project	National Key RAMP;D Program from the Chinese Ministry of Science and Technology; National Clinical Key Specialty Project	This study was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BA111601) from the Chinese Ministry of Science and Technology and the National Clinical Key Specialty Project.	Abdul-Razak S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3008-y; Abu-Saad K, 2014, AM J HYPERTENS, V27, P1511, DOI 10.1093/ajh/hpu081; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2011, CHIN J HYPERTENS; Bi ZQ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130423; Booth JN, 2017, HYPERTENSION, V70, P275, DOI 10.1161/HYPERTENSIONAHA.116.09004; Bursztyn M, 2014, J HYPERTENS, V32, P1351, DOI [10.1097/HJH.0000000000000171, 10.1097/HJH.0000000000000170]; Chang G, 2006, CHINESE J PREVENTION, V14, P101; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dastan I, 2017, ANATOL J CARDIOL, V18, P39, DOI 10.14744/AnatolJCardiol.2017.7452; De Buyzere M, 2015, J HYPERTENS, V33, P2200, DOI 10.1097/HJH.0000000000000718; Diederichs C, 2014, J HYPERTENS, V32, P1405, DOI 10.1097/HJH.0000000000000211; Gao KY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04552-5; Guan X, 2008, CHIN PREV MED, V9, P197; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Halanych JH, 2010, AM J EPIDEMIOL, V171, P532, DOI 10.1093/aje/kwp417; Hay SI, 2017, LANCET, V389, pE1; Hu LH, 2017, PLOS ONE, V12; Hu MQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004709; Huang JS, 1960, NAT S HEART VASC DIS; Kogure M, 2016, HYPERTENS RES, V39, P670, DOI 10.1038/hr.2016.46; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Lei XY, 2012, CHINA ECON REV, V23, P105, DOI 10.1016/j.chieco.2011.08.004; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Li J, 2014, J ZHENGZHOU U, V49, P744; Li JJ, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0545-7; Lim SS, 2013, LANCET, V381, P1276; Lv SR, 2011, CHINESE J HLTH ED, V27, P52; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Markovic BB, 2011, CROAT MED J, V52, P566, DOI [10.3325/cmj.2011.52.566, 10.3325/cmj.2011.52.556]; Meng XY, 2009, J APPL PREVENTIVE ME, V15, P207; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Nagai M, 2015, HYPERTENS RES, V38, P790, DOI 10.1038/hr.2015.81; National Health Commission for Disease Control and Prevention, 2015, CHIN RES NUTR CHRON; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Ratovoson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137408; Rumball-Smith J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-536; Su M, 2017, LANCET, V390, P2559, DOI 10.1016/S0140-6736(17)32476-5; Suliburska J, 2012, ANN AGR ENV MED, V19, P339; The sixth census leading group office of Jilin Province Jilin Provincial Bureau of Statistics, 2012, JIL PROV 2010 CENS D; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; [王诗镔 Wang Shibin], 2014, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V40, P183; Wei Q, 2015, J HUM HYPERTENS, V29, P64, DOI 10.1038/jhh.2014.32; Wu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132814; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Yang G, 2016, INT J ENV RES PUB HE, V13; Yang L, 2016, PLOS ONE, V11; Zhang G, 2013, CHIN J HLTH ED, V29, P499; [章蓉 Zhang Rong], 2014, [南京医科大学学报. 自然科学版, Journal of Nanjing Medical University. Natural Sciences Edition], V34, P84; 陈伟伟, 2017, [中国循环杂志, Chinese Circulation Journal], V32, P521	55	42	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195340	10.1371/journal.pone.0195340	http://dx.doi.org/10.1371/journal.pone.0195340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621328	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800067
J	Yordanov, Y; Dechartres, A; Ravaud, P				Yordanov, Youri; Dechartres, Agnes; Ravaud, Philippe			Patient-important outcomes in systematic reviews: Poor quality of evidence	PLOS ONE			English	Review							INCREASING VALUE; REDUCING WASTE; TRIALS; INTERVENTIONS; STRENGTH; GRADE	Background Cochrane reviewers are strongly encouraged to evaluate the quality of evidence for the most important outcomes by using the GRADE approach and to report these results in a Summary of Findings (SoF) table. We aimed to assess whether outcomes reported in the SoF table of Cochrane reviews could be considered patient-important outcomes (PlOs) and the quality of the available evidence for these outcomes. Methods We performed a methodological review of Cochrane reviews published between March 2011 and September 2014. For a random sample of Cochrane reviews reporting a SoF table, we extracted all outcomes reported in this table and evaluated whether they could be considered PlOs (i.e., mortality, other clinical events, adverse events, function, pain, quality of life and therapeutic decisions). Then, we collected the quality of evidence for every outcome in these SoF tables. Results We included 290 reviews issued by 47 of the 53 Cochrane Review Groups. Every SoF table included a median of 5 outcomes, for a total of 1414 outcomes; 1089 (77%) could be considered PlOs. Almost all reviews (n = 278, 96%) included at least one PIO in their SoF table. The quality of evidence for the outcomes was high for 12% (n = 168), moderate for 28% (n = 402) and low or very low for 45% (n = 640). Less than one quarter of reviews (n = 63) included at least one PIO with high-quality evidence that favoured a benefit of the experimental intervention evaluated in half of them (n = 34 reviews). Conclusions Many outcomes reported in the SoF table of recent Cochrane reviews can be considered PlOs. However, the quality of available evidence remains limited for these outcomes.	[Yordanov, Youri; Dechartres, Agnes; Ravaud, Philippe] INSERM, U1153, Paris, France; [Yordanov, Youri] UPMC Paris Univ 06, Sorbonne Univ, Paris, France; [Yordanov, Youri] Hop St Antoine, AP HP, Serv Urgences, Paris, France; [Yordanov, Youri; Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epiderniol Clin, Paris, France; [Dechartres, Agnes; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Dechartres, Agnes; Ravaud, Philippe] Cochrane France, Paris, France; [Ravaud, Philippe] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Yordanov, Y (corresponding author), INSERM, U1153, Paris, France.; Yordanov, Y (corresponding author), UPMC Paris Univ 06, Sorbonne Univ, Paris, France.; Yordanov, Y (corresponding author), Hop St Antoine, AP HP, Serv Urgences, Paris, France.; Yordanov, Y (corresponding author), Hop Hotel Dieu, AP HP, Ctr Epiderniol Clin, Paris, France.	youri.yordanov@aphp.fr	ravaud, philippe/C-1694-2009	Yordanov, Youri/0000-0003-0671-6547; Ravaud, Philippe/0000-0001-8264-9206				Agarwal A, 2016, J CLIN EPIDEMIOL; Alonso-Coello P, 2017, J CLIN EPIDEMIOL, V81, P140, DOI 10.1016/j.jclinepi.2017.01.001; Alonso-Coello P, 2016, J CLIN EPIDEMIOL, V72, P16, DOI 10.1016/j.jclinepi.2015.11.002; Ameur H, 2017, J CLIN EPIDEMIOL, V84, P70, DOI 10.1016/j.jclinepi.2017.01.006; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Clarke M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0188-6; Cochrane Collaboration, 2017, COCHR REV GROUPS; Dechartres A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0639-x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Gaudry S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0243-z; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Gorst SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146444; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ioannidis JPA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h72; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Khan KS, 2003, J ROY SOC MED, V96, P118, DOI 10.1258/jrsm.96.3.118; Kirkham JJ, 2013, TRIALS, V14; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Montori VM, 2007, LANCET, V370, P1104, DOI 10.1016/S0140-6736(07)61489-5; O'Connor D, 2011, COCHRANE HDB SYSTEMA; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Rahimi K, 2010, BMJ-BRIT MED J, V341, pC5707, DOI DOI 10.1136/bmj.c5707; Richards T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2614; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI 10.1016/j.jclinepi.2009.12.014; Saldanha IJ, 2017, J CLIN EPIDEMIOL, V84, P85, DOI 10.1016/j.jclinepi.2017.02.005; Schunemann HJ, 2017, COCHRANE HDB SYSTEMA; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Williamson P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000041; Williamson P, 2012, J HEALTH SERV RES PO, V17, P1, DOI 10.1258/jhsrp.2011.011131; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Yordanov Y, 2017, BMC MED IN PRESS	37	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195460	10.1371/journal.pone.0195460	http://dx.doi.org/10.1371/journal.pone.0195460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621329	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800087
J	Crego, RD; Jimenez, JE; Rozzi, R				Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo			Potential niche expansion of the American mink invading a remote island free of native-predatory mammals	PLOS ONE			English	Article							HORN BIOSPHERE RESERVE; ACTIVITY PATTERNS; NEOVISON-VISON; MUSTELA-VISON; HABITAT SELECTION; NAVARINO ISLAND; RELEASE; IMPACT; CONSERVATION; COEXISTENCE	The success of an invasive species depends in part on its niche and the new niche opportunities that such species may find in the invaded habitat. Niche opportunities can be understood as the potential provided by a community to an invasive species to expand its niche by changes in habitat use, behavior, or diet, that favors population growth, reflected in the species occupying more habitat. This may occur under a favorable combination of access to resources that can be further favored by a lack of competitors and a release from natural enemies. The American mink (Neovison vison) is a crepuscular/nocturnal and semi-aquatic mustelid native to North America that generally concentrates activities at <100 m from the water. It has recently established an invasive population on Navarino Island in southern Chile. Here, the mink is now the top terrestrial predator free of predators or competitors. We hypothesized that this lack of potential predators and competitors, together with a more diurnal and terrestrial prey, have resulted in the mink expanding its spatial and temporal niche on Navarino Island as compared to that in its native habitats, expressed in occupancy of sites away from water and diurnal activity. We evaluated this by using 93 randomly-chosen camera-trap stations, occupancy models and mink daily activity patterns. Models showed a dynamic occupancy with the area occupied by mink being highest during summers and lowest in spring with seasonal changes in occupancy related to distance to water sources. Mink occupied and were active at sites up to 880 m from water sources during summers. Occupancy decreased at shorter distances from water during spring, but mink were still active at up to 300 m from water. Mink were active daylong during summers, and nocturnal and crepuscular during winter and spring. These results show that compared to the native and other invaded habitats, on Navarino Island mink use more terrestrial habitats and are more diurnal during summers, suggesting a niche expansion under new niche opportunities that may enhance the negative impacts of this predator on a myriad of small native vertebrates.	[Crego, Ramiro D.; Jimenez, Jaime E.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo] Univ Magallanes, Inst Ecol & Biodivers, Puerto Williams, Chile; [Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo] Univ North Texas, Subantarctic Biocultural Conservat Program, Denton, TX 76203 USA; [Jimenez, Jaime E.; Rozzi, Ricardo] Univ North Texas, Dept Philosophy & Relig, Denton, TX USA	University of North Texas System; University of North Texas Denton; Universidad de Magallanes; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Crego, RD (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Crego, RD (corresponding author), Univ Magallanes, Inst Ecol & Biodivers, Puerto Williams, Chile.; Crego, RD (corresponding author), Univ North Texas, Subantarctic Biocultural Conservat Program, Denton, TX 76203 USA.	ramirocrego84@gmail.com	Crego, Ramiro Daniel/I-3964-2019; Jimenez, Jaime E./AAO-7531-2020; Rozzi, Ricardo/G-1047-2012	Crego, Ramiro Daniel/0000-0001-8583-5936; Rozzi, Ricardo/0000-0001-5265-8726	Rufford Foundation [14986-1]; Conservation Research and Education Opportunities International (CREOi); Institute of Ecology and Biodiversity of Chile (IEB) [ICM P05-002]; Institute of Ecology and Biodiversity of Chile (Basal-CONICYT) [PFB-23]	Rufford Foundation; Conservation Research and Education Opportunities International (CREOi); Institute of Ecology and Biodiversity of Chile (IEB); Institute of Ecology and Biodiversity of Chile (Basal-CONICYT)	This study was funded by the Rufford Foundation (https://www.rufford.org/proiects/ramiro_daniel_crego) (14986-1 to RDC), the Conservation Research and Education Opportunities International (CREOi; http://creoi.org/predatory-impacts-and-variables-deterrnining-the-spatiotemporal-occupancy-of-the-invasive-american-mink-neovison-vison-on-a-pristine-island-ecosystem-in-southern-chile-2/) (RDC), and the Institute of Ecology and Biodiversity of Chile (IEB; grants ICM P05-002 and Basal-CONICYT PFB-23 to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135036; Anderson CB, 2006, BIODIVERS CONSERV, V15, P3295, DOI 10.1007/s10531-005-0605-y; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Bodey TW, 2010, J APPL ECOL, V47, P114, DOI 10.1111/j.1365-2664.2009.01739.x; Bonesi L, 2004, OIKOS, V106, P509, DOI 10.1111/j.0030-1299.2004.13034.x; Brzezinski M, 2010, FOLIA ZOOL, V59, P183; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Costa GC, 2008, AM NAT, V172, P868, DOI 10.1086/592998; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crego RD, 2016, BIOL INVASIONS, V18, P1923, DOI 10.1007/s10530-016-1135-0; Dunstone N, 1983, ACTA ZOO FENN, V174, P189; Dunstone N., 1993, MINK; Fasola L, 2018, BIOL CONSERV, V218, P217, DOI 10.1016/j.biocon.2017.12.031; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fuller AK, 2016, ECOL APPL, V26, P1125, DOI 10.1890/15-0315; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Harrington LA, 2008, J MAMMAL, V89, P991, DOI 10.1644/07-MAMM-A-292.1; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Ibarra JT, 2009, ORYX, V43, P87, DOI 10.1017/S0030605308099997; Ippi S, 2009, ORNITOL NEOTROP, V20, P231; Jaksic Fabian M., 2002, Biological Invasions, V4, P157, DOI 10.1023/A:1020576709964; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manly B.F.J., 2002, RESOURCE SELECTION A; Medina-Vogel G, 2013, J ZOOL, V290, P27, DOI 10.1111/jzo.12010; Melero Y, 2011, FOLIA ZOOL, V60, P47; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moorman MC, 2009, T AM FISH SOC, V138, P306, DOI 10.1577/T08-081.1; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Plummer M, 2016, JAGS PROGRAM ANAL BA; Previtali A, 1998, J ZOOL, V246, P482, DOI 10.1111/j.1469-7998.1998.tb00187.x; R Development Core Team, 2016, R LANG ENV STAT COMP; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Rogers HS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14557; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Royle J. A., 2008, HIERARCHICAL MODELIN; Rozzi R., 2006, CAPE HORN BIOSPHERE; Rozzi R., 2014, SUBANTARCTIC MAGELLA; Rozzi R, 2006, ECOL SOC, V11; Rozzi Ricardo, 2003, Anales del Instituto de la Patagonia Serie Ciencias Naturales, V31, P97; Ruete A, 2016, ECOL APPL, V26, P1475, DOI 10.1890/15-1271; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schuttler E, 2018, PEERJ, V6, DOI 10.7717/peerj.4124; Schuttler E, 2010, BIODIVERS CONSERV, V19, P725, DOI 10.1007/s10531-009-9730-3; Schuttler E, 2009, BIOL CONSERV, V142, P1450, DOI 10.1016/j.biocon.2009.02.013; Schuttler E, 2008, REV CHIL HIST NAT, V81, P585; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Valenzuela AEJ, 2013, BIOL INVASIONS, V15, P645, DOI 10.1007/s10530-012-0315-9; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wellman ST, 2009, CAN FIELD NAT, V123, P368, DOI 10.22621/cfn.v123i4.1005; Yamaguchi N, 2003, J MAMMAL, V84, P1356, DOI 10.1644/1545-1542(2003)084<1356:HPOFAM>2.0.CO;2; Zuberogoitia I, 2006, MAMMALIA, V70, P310, DOI 10.1515/MAMM.2006.046	64	10	12	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194745	10.1371/journal.pone.0194745	http://dx.doi.org/10.1371/journal.pone.0194745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617392	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800047
J	Xu, MQ; Jiang, H; Zhang, LQ; Sun, XL; Luo, D; Fu, Y; Gao, Y; Yuan, B; Zhang, JB				Xu, Ming-Qiang; Jiang, Hao; Zhang, Li-Qun; Sun, Xu-Lei; Luo, Dan; Fu, Yao; Gao, Yan; Yuan, Bao; Zhang, Jia-Bao			MiR-29b affects the secretion of PROG and promotes the proliferation of bovine corpus luteum cells	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE 2; PROGESTERONE; EXPRESSION; OXYTOCIN; METASTASIS; EVOLUTION; PREGNANCY; SURVIVAL; LEUKEMIA; PROTEIN	The regulatory role of miRNAs has been explored in ovarian cells, and their effects on gonadal development, apoptosis, ovulation, steroid production and corpus luteum (CL) development have been revealed. In this study, we analyzed the expression of miR-29b at different stages of bovine CL development and predicted the target genes of miR-29b. We confirmed that miR-29b reduces the expression of the oxytocin receptor (OXTR), affects progesterone (PROG) secretion and regulates the function of the CL. RT-PCR showed that the expression of miR-29b was significantly higher in functional CL phases than in the regressed CL phase. Immunohistochemistry showed that OXTR was expressed in both large and small CL cells and was mainly located in the cell membrane and cytoplasm of these cells. We analyzed the expression levels of OXTR and found that transfection with a miR-29b mimic decreased OXTR expression, but transfection with the inhibitor had a limited effect on the expression of the OXTR protein. At the same time, the secretion of PROG was significantly increased in the miR-29b mimic-transfected group. We also analyzed the effect of miR-29b on the apoptosis of CL cells. Finally, we found that miR-29b could promote the proliferation of bovine CL cells. In conclusion, we found that miR-29b reduces the expression of OXTR and can promote PROG secretion and the proliferation of CL cells via OXTR.	[Xu, Ming-Qiang; Jiang, Hao; Sun, Xu-Lei; Luo, Dan; Fu, Yao; Gao, Yan; Yuan, Bao; Zhang, Jia-Bao] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China; [Zhang, Li-Qun] Jilin Univ, Hosp 1, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Yuan, B; Zhang, JB (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China.	yuan_bao@jlu.edu.cn; zhangjiabaojlu@163.com		Jiang, Hao/0000-0003-2008-6166	National Natural Science Foundation of China [31572400, 31601940]; Modern Agricultural Industry Technology System [CARS-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agricultural Industry Technology System	This work was supported by the National Natural Science Foundation of China (31572400 to JZ and 31601940 to HJ) and the Modern Agricultural Industry Technology System (CARS-37) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chouhan VS, 2014, ANIM REPROD SCI, V148, P251, DOI 10.1016/j.anireprosci.2014.06.009; Daya S, 2009, MATURITAS, V65, pS29, DOI 10.1016/j.maturitas.2009.09.012; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Duong HT, 2012, J REPROD DEVELOP, V58, P223, DOI 10.1262/jrd.11-122T; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Huang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070023; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; KHANDAWOOD FS, 1988, AM J OBSTET GYNECOL, V158, P882, DOI 10.1016/0002-9378(88)90089-0; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; LIU Y, 2017, ONCOTARGET; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Mesen TB, 2015, OBSTET GYN CLIN N AM, V42, P135, DOI 10.1016/j.ogc.2014.10.003; Miyado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14705; Mohammed BT, 2017, J CLIN ENDOCR METAB, V102, P2188, DOI 10.1210/jc.2017-00259; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sakumoto R, 2011, J ANIM SCI, V89, P3040, DOI 10.2527/jas.2010-3479; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Stormshak Fredrick, 2003, Reprod Biol Endocrinol, V1, P92, DOI 10.1186/1477-7827-1-92; Vecchio D, 2012, THERIOGENOLOGY, V77, P1811, DOI 10.1016/j.theriogenology.2011.12.025; Wang HY, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0169-y; Wiltbank MC, 2014, ANIMAL, V8, P70, DOI 10.1017/S1751731114000585; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhao XM, 2016, PEERJ, V4, DOI 10.7717/peerj.1635; Zhou KS, 2014, LEUKEMIA LYMPHOMA, V55, P1544, DOI 10.3109/10428194.2013.855308	41	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195562	10.1371/journal.pone.0195562	http://dx.doi.org/10.1371/journal.pone.0195562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617446	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800094
J	Lee, HS; Thiem, VD; Anh, DD; Duong, TN; Lee, M; Grace, D; Nguyen-Viet, H				Lee, Hu Suk; Vu Dinh Thiem; Dang Duc Anh; Tran Nhu Duong; Lee, Mihye; Grace, Delia; Hung Nguyen-Viet			Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NORTHERN VIETNAM; UNITED-STATES; BAT; VIRUS; ENCEPHALITIS; CHINA; ASIA	Background In Vietnam, rabies has been a notifiable disease for more than 40 years. Over the last five years, on average, more than 350,000 people per year have been bitten by dogs and cats while more than 80 human deaths have been reported yearly. No studies have been conducted to evaluate the geographical and temporal patterns of rabies in humans in Vietnam. Therefore, the main objective of this study was to assess the geographical and temporal distributions of rabies post exposure prophylaxis (PEP) incidence in humans in Vietnam from 2005 to 2015. Methods Average incidence rabies (AIR) PEP rates for every 3 or 4 years (2005-2008, 2009-2012 and 2013-2015) were calculated to describe the spatial distribution of rabies PEP. Hotspot analysis was implemented to identify patterns of spatial significance using the Getis-Ord Gi statistic. For temporal pattern analysis, two regions [Mekong River Delta (MRD) and Southeast Central Coast (SCC)], with the highest incidence rates, and the seasonal-decomposition procedure based on loess (STL), were compared to assess their temporal patterns of rabies PEP. Findings We found hotspots in southern Vietnam and coldspots in northern Vietnam during the study period. Rabies cases were limited to specific areas. In addition, the hotspot analysis showed that new risk areas were identified in each period which were not observed in incidence rate maps. The seasonal plots showed seasonal patterns with a strong peak in February/July and a minor peak in October/December in the MRD region. However, in the SCC, a small peak was detected at the early part of each year and a strong peak in the middle of each year. Conclusion Our findings provide insight into understanding the geographical and seasonal patterns of rabies PEP in Vietnam. This study provides evidence to aid policy makers when making decisions and investing resources. Such information may also be utilized to raise public awareness to prevent rabies exposures and reduce unnecessary PEP.	[Lee, Hu Suk; Hung Nguyen-Viet] Int Livestock Res Inst, Hanoi, Vietnam; [Vu Dinh Thiem; Dang Duc Anh; Tran Nhu Duong] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Lee, Mihye] Royal Bournemouth Hosp, Med Microbiol Dept, Bournemouth, Dorset, England; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya	National Institute of Hygiene & Epidemiology (NIHE); CGIAR; International Livestock Research Institute (ILRI)	Lee, HS (corresponding author), Int Livestock Res Inst, Hanoi, Vietnam.	h.s.Iee@cgiar.org	Nguyen-Viet, Hung/F-6498-2012; Nguyen-Viet, Hung/AHH-2981-2022	Nguyen-Viet, Hung/0000-0001-9877-0596; Nguyen-Viet, Hung/0000-0003-1549-2733; Vu, Thiem/0000-0001-6168-4555; Grace, Delia/0000-0002-0195-9489; Lee, Hu Suk/0000-0002-8731-9836	CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP; Climate Change, Agriculture and Food Security (CCAFS)	CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP; Climate Change, Agriculture and Food Security (CCAFS)	This study was funded through the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP and Climate Change, Agriculture and Food Security (CCAFS) to Hu Suk Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received support from the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), led by the International Food Policy Research Institute (IFPRI). We also acknowledge the CGIAR Fund Donors (https://www.cgianorg/funders/). The authors thank the National Institute of Hygiene and Epidemiology (NIHE) under the Ministry of Health for providing information on human rabies PEP cases. We thank Ms. Minh for data management.	Nguyen ATK, 2014, EMERG INFECT DIS, V20, P161, DOI 10.3201/eid2001.130813; ASEAN, ASEAN RAB EL STRAT 2; Bixler A, 2000, J ZOOL, V251, P525, DOI 10.1111/j.1469-7998.2000.tb00808.x; Cleveland R.B., 1990, J OFF STAT, V6, P3; Courtin F, 2000, PREV VET MED, V43, P13, DOI 10.1016/S0167-5877(99)00083-5; FAO, DEV STEPW APPR RAB P; Feldhamer G.A., 2003, WILD MAMMALS N AM BI; Fooks AR, 2003, J MED VIROL, V71, P281, DOI 10.1002/jmv.10481; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gongal G, 2011, ADV PREV MED; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Lee HS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2326-8; Hung DM, 2008, BMC P, P1; Kim CH, 2006, J VET MED B, V53, P111, DOI 10.1111/j.1439-0450.2006.00928.x; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lee HS, 2014, J VET INTERN MED, V28, P779, DOI 10.1111/jvim.12335; LUMIO J, 1986, LANCET, V1, P378; MALAGA H, 1979, INT J EPIDEMIOL, V8, P243, DOI 10.1093/ije/8.3.243; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Mitmoonpitak C, 1998, EPIDEMIOL INFECT, V120, P165, DOI 10.1017/S0950268897008601; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nadin-Davis SA, 2012, VIRUS RES, V163, P352, DOI 10.1016/j.virusres.2011.10.026; Nguyen AKT, 2015, PUBLIC HEALTH, V129, P1591, DOI 10.1016/j.puhe.2015.07.019; Nguyen AKT, 2011, JPN J INFECT DIS, V64, P391; Nguyen TTH, 2013, J PREV MED WILMINGTO, V7, P29; Piyaphanee W, 2010, AM J TROP MED HYG, V82, P1168, DOI 10.4269/ajtmh.2010.09-0699; Samaratunga H, 1998, NEUROPATH APPL NEURO, V24, P331, DOI 10.1046/j.1365-2990.1998.00129.x; Tao XY, 2009, EMERG INFECT DIS, V15, P1192, DOI 10.3201/eid1508.081551; Tenzin, 2011, ZOONOSES PUBLIC HLTH, V58, P463, DOI 10.1111/j.1863-2378.2011.01393.x; Thao T Dinh, 2004, MAIZE VIETNAM PRODUC; WARRELL DA, 1995, SCHWEIZ MED WSCHR, V125, P879; Wertheim HFL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000044; WHO Expert Consultation on rabies, 2015, WHO TECH REP SER, V931, P1; World Health Organization, HUM RAB 2017; Yamagata J, 2007, MICROBIOL IMMUNOL, V51, P833, DOI 10.1111/j.1348-0421.2007.tb03979.x; Yin Cui-ping, 2012, Virologica Sinica, V27, P132, DOI 10.1007/s12250-012-3244-y; Zienius Dainius, 2007, Ekologija, V53, P59	38	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194943	10.1371/journal.pone.0194943	http://dx.doi.org/10.1371/journal.pone.0194943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634746	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200018
J	Wei, LS; Yan, TJ; Wu, YF; Chen, H; Zhang, BS				Wei, Lusha; Yan, Tongjing; Wu, Yifei; Chen, Hui; Zhang, Baoshan			Optimization of alkaline extraction of hemicellulose from sweet sorghum bagasse and its direct application for the production of acidic xylooligosaccharides by Bacillus subtilis strain MR44	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; GLUCURONOXYLAN XYLANOHYDROLASE; STRUCTURAL-CHARACTERIZATION; ETHANOL-PRODUCTION; OLIGOSACCHARIDES; DEPOLYMERIZATION; POLYSACCHARIDES; XYLANASE	As predominant components of hemicelluloses in grasses, methylglucuroarabinoxylans (MeGAX(n)) are sources for the production of acidic xylooligosaccharides (U-XOS). Bacillus subtilis MR44, an engineered biocatalyst to secrete only the XynC xylanase and Axh43 arabinoxylan hydrolase is capable of processing MeGAX(n) to exclusively U-XOS. The present studies are directed at the explosion on direct alkaline extraction serving for production of U-XOS. Response Surface Methodology was used to optimize xylan extraction conditions on the sweet sorghum bagasse to achieve maximum hemicelluloses yield. The optimized condition was as follows: extraction time of 3.91 h, extraction temperature of 86.1 degrees C, and NaOH concentration (w/w) of 12.33%. Crude xylan extracted with NaOH revealed a compositional analysis of xylose (79.0%), arabinose (5.3%), glucose (1.7%), lignin and ash (5.6%). After neutralization this xylan preparation supported growth of MR44, processing MeGAX(n) from sweet sorghum and accumulating U-XOS. The quality of U-XOS produ ced by MR44 using alkaline-treated sweet sorghum bagasse was comparable to that obtained from purified MeGAX(n). Overall, the present study demonstrates that direct alkaline treatment of sweet sorghum bagasse is useful to improve the bioavailability of MeGAX(n) for MR44-mediated conversion to U-XOS with average degrees of polymerization of 11-12, providing alternative resources with applications in nutrition and human and veterinary medicine.	[Wei, Lusha; Yan, Tongjing; Zhang, Baoshan] Shaanxi Normal Univ, Coll Food Engn & Nutrit Sci, Xian, Shaanxi, Peoples R China; [Wu, Yifei] Northwest Univ, Dept Life Sci, Xian, Shaanxi, Peoples R China; [Chen, Hui] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Shaanxi Normal University; Northwest University Xi'an; Northwest A&F University - China	Zhang, BS (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutrit Sci, Xian, Shaanxi, Peoples R China.	baoshan2@snnu.edu.cn			Shaanxi Normal University [GK 201601007, GK 20170306]; Science and Technology Co-ordination Innovation Project from Shaanxi province [2016KTCL02-33]; Science and Technology Project from Xi'an city [NC1504(4)]; Agricultural Science and Technology Innovation Project from Shaanxi province [2015NY009]	Shaanxi Normal University; Science and Technology Co-ordination Innovation Project from Shaanxi province; Science and Technology Project from Xi'an city; Agricultural Science and Technology Innovation Project from Shaanxi province	This project was supported by the Shaanxi Normal University with funding from central universities No. GK 201601007 and GK 20170306, Science and Technology Co-ordination Innovation Project from Shaanxi province No. 2016KTCL02-33, Science and Technology Project from Xi'an city No. NC1504(4) and Agricultural Science and Technology Innovation Project from Shaanxi province No. 2015NY009.	Avci A, 2013, BIORESOURCE TECHNOL, V130, P603, DOI 10.1016/j.biortech.2012.12.104; Balint S, 2009, APPL BIOCHEM BIOTECH, V153, P151, DOI 10.1007/s12010-008-8423-9; Cai WR, 2008, CARBOHYD POLYM, V71, P403, DOI 10.1016/j.carbpol.2007.06.008; Cunningham R. L., 1986, BIOTECHNOL BIOENG S, V17, P159, DOI DOI 10.1385/ABAB:124:1-3:1119; Don TM, 2006, CARBOHYD POLYM, V63, P331, DOI 10.1016/j.carbpol.2005.08.023; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Gokhale DV, 1998, BIORESOURCE TECHNOL, V63, P187, DOI 10.1016/S0960-8524(97)00062-X; Gomez B, 2016, J CHEM TECHNOL BIOT, V91, P234, DOI 10.1002/jctb.4569; John FJS, 2006, J BACTERIOL, V188, P8617, DOI 10.1128/JB.01283-06; Kardosova A, 1998, CARBOHYD RES, V308, P99, DOI 10.1016/S0008-6215(98)00072-X; Lawther JM, 1996, J APPL POLYM SCI, V60, P1827, DOI 10.1002/(SICI)1097-4628(19960613)60:11<1827::AID-APP6>3.0.CO;2-N; Lu P, 2006, FEMS MICROBIOL LETT, V261, P224, DOI 10.1111/j.1574-6968.2006.00367.x; Preston JF, 2003, ACS SYM SER, V855, P191, DOI 10.1021/bk-2003-0855.ch012; Ravikumar K, 2006, DYES PIGMENTS, V70, P18, DOI 10.1016/j.dyepig.2005.02.004; Reis A, 2003, CARBOHYD POLYM, V53, P101, DOI 10.1016/S0144-8617(03)00007-9; Rhee MS, 2016, APPL MICROBIOL BIOT, V100, P1501, DOI 10.1007/s00253-015-7124-x; Rhee MS, 2014, APPL ENVIRON MICROB, V80, P917, DOI 10.1128/AEM.03246-13; Shi ZJ, 2011, BIORESOURCES, V6, P5151; Sluiter A., 2006, DETERMINATION SUGARS; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; St John FJ, 2011, J MOL BIOL, V407, P92, DOI 10.1016/j.jmb.2011.01.010; Sun SL, 2013, CARBOHYD POLYM, V92, P2224, DOI 10.1016/j.carbpol.2012.11.098; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Wei LS, 2016, J CHEM TECHNOL BIOT, V91, P2056, DOI 10.1002/jctb.4800; Yat SC, 2008, BIORESOURCE TECHNOL, V99, P3855, DOI 10.1016/j.biortech.2007.06.046; Yu Q, 2012, BIORESOURCE TECHNOL, V116, P220, DOI 10.1016/j.biortech.2012.04.031	26	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195616	10.1371/journal.pone.0195616	http://dx.doi.org/10.1371/journal.pone.0195616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634785	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200041
J	Benson, FG; Levin, J; Rispel, LC				Benson, Frew Gerald; Levin, Jonathan; Rispel, Laetitia Charmaine			Health care providers' compliance with the notifiable diseases surveillance system in South Africa	PLOS ONE			English	Article							CAPTURE-RECAPTURE ANALYSIS; INFECTIOUS-DISEASES; COMPLETENESS; NOTIFICATION; HOSPITALIZATIONS; TUBERCULOSIS; NETHERLANDS; PERFORMANCE; PHYSICIANS; COUNTRIES	Background The optimal performance of a notifiable disease surveillance system (NDSS) is dependent on health care provider (HCP) compliance with communicable disease notification. HCP compliance ensures appropriate investigation and control measures by relevant health care authorities. This study examines the compliance of HCPs with the NDSS in South Africa and factors associated with their compliance. Methods A cross-sectional survey was carried out in three randomly selected provinces. We stratified by type of facility, and recruited clusters of HCPs on survey day to participate. All consenting HCPs in the randomly selected health care facilities on the day of the survey, completed a questionnaire that elicited information on socio-demographic characteristics and notification practices. The data were analysed using STATA (R) 14, using the identifiers for stratum and cluster as well as the calculated sampling weights. Results The study found that 58% of 919 HCPs diagnosed a notifiable disease in the year preceding the survey. The majority of these professionals (92%) indicated that they had reported the disease, but only 51% of those notified the disease/s correctly to the Department of Health. Paediatricians were less likely to notify correctly (OR 0.01, 95% CI 0.00-0.12, p = 0.001). The factors that influenced notification were HCPs perceptions of workload (OR 0.84, 95% CI 0.70-0.99, p = 0.043) and that notification data are not useful (OR 0.84, 95% CI 0.71-0.99, p = 0.040). The study found no association between correct notification and HCPs willingness to notify, experience or training on the NDSS, understanding of the purpose of the NDSS, knowledge of what to notify, or perception of feedback given. Conclusions The compliance of HCPs in South Africa with the NDSS is suboptimal. In light of the important role of HCPs in the effective functioning of the NDSS, information on NDSS usefulness and guidelines on correct notification procedures are needed to increase their compliance.	[Benson, Frew Gerald] Rahima Moosa Hosp, Gauteng Dept Hlth, Johannesburg, South Africa; [Benson, Frew Gerald; Levin, Jonathan] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Rispel, Laetitia Charmaine] Univ Witwatersrand, Sch Publ Hlth, Dept Sci & Technol,Fac Hlth Sci, Ctr Hlth Policy,Natl Res Fdn,SARChI Chair Hlth Wo, Johannesburg, South Africa	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand	Benson, FG (corresponding author), Rahima Moosa Hosp, Gauteng Dept Hlth, Johannesburg, South Africa.; Benson, FG (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	frewbenson@gmail.com			Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America [5U19 GH000571-05]; National Health Laboratory Services, South Africa	Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America; National Health Laboratory Services, South Africa	This and the overall research study were funded by the Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America, through co-operative agreement no. 5U19 GH000571-05 with the National Health Laboratory Services, South Africa. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, Department of Health and Human Services, or the US government.	Ahmadi A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.172545; Al-Laham H, 2001, East Mediterr Health J, V7, P590; Allen CJ, 2000, MED J AUSTRALIA, V172, P325; Bawa S B, 2003, Afr J Med Med Sci, V32, P49; Benson FG, 2017, INT J INFECT DIS, V59, P141, DOI 10.1016/j.ijid.2017.03.007; Benson FG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3781-7; Brabazon ED, 2008, EPIDEMIOL INFECT, V136, P241, DOI 10.1017/S0950268807008230; Brabazon ED, 2015, EPIDEMIOL INFECT, V143, P1166, DOI 10.1017/S0950268814001733; Chorba T L, 1990, MMWR Recomm Rep, V39, P1; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Dinis J, 2000, Acta Med Port, V13, P33; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Esler D, 2007, AUST FAM PHYSICIAN, V36, P337; Figueiras A, 2004, PUBLIC HEALTH, V118, P521, DOI 10.1016/j.puhe.2003.12.015; Gauci C, 2007, Euro Surveill, V12, pE5; Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ibarz-Pavon AB, 2016, INT J TUBERC LUNG D, V20, P920, DOI 10.5588/ijtld.15.0907; Isere Elvis E, 2015, Niger Med J, V56, P161, DOI 10.4103/0300-1652.160347; Jansson A, 2005, EPIDEMIOL INFECT, V133, P401, DOI 10.1017/S0950268804003632; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Karim SSA, 1996, S AFR MED J, V86, P834; KARIM SSA, 1991, S AFR MED J, V79, P242; Lafond KE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0568-3; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; National Department of Health (South Africa), 2017, NOT MED COND REP S A; Nkgudi B, 2006, SAMJ S AFR MED J, V96, pA206; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Parneix P, 2015, J HOSP INFECT, V89, P328, DOI 10.1016/j.jhin.2014.12.009; Parrella A, 2009, AUST FAM PHYSICIAN, V38, P932; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Prato R, 2004, Ann Ig, V16, P449; Quan V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-151; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Robinson P, 1999, Commun Dis Intell, V23, P97; Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164; Sahal N, 2009, SCAND J PUBLIC HEALT, V37, P187, DOI 10.1177/1403494808101179; Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015; Sekimoto M, 2009, AM J INFECT CONTROL, V37, P136, DOI 10.1016/j.ajic.2008.03.005; South Africa. National Department of Health, 2011, HUM RES HLTH S AFR H; Tan HF, 2007, VACCINE, V25, P2630, DOI 10.1016/j.vaccine.2006.12.016; Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147579; United Nations, 2016, WORK HLTH GROWTH INV; van Hest N A, 2001, Ned Tijdschr Geneeskd, V145, P175; van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540; Weber IB, 2007, EVALUATION NOTIFIABL; 2016, LANCET, V387, P1348, DOI DOI 10.1016/S0140-6736(16)30116-7	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195194	10.1371/journal.pone.0195194	http://dx.doi.org/10.1371/journal.pone.0195194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630627	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000030
J	Lee, N; Khalenkov, AM; Lugovtsev, VY; Ireland, DD; Samsonova, AP; Bovin, NV; Donnelly, RP; Ilyushina, NA				Lee, Nicolette; Khalenkov, Alexey M.; Lugovtsev, Vladimir Y.; Ireland, Derek D.; Samsonova, Anastasia P.; Bovin, Nicolai V.; Donnelly, Raymond P.; Ilyushina, Natalia A.			The use of plant lectins to regulate H1 N1 influenza A virus receptor binding activity	PLOS ONE			English	Article							NEURAMINIDASE ACTIVITIES; FUNCTIONAL BALANCE; HEMAGGLUTININ; MICE; HA; ACID; COMBINATIONS; REASSORTANTS; REPLICATION; INFECTIONS	We applied an in vitro selection approach using two different plant lectins that bind to alpha 2,3- or alpha 2,6-linked sialic acids to determine which genetic changes of the A/California/04/09 (H1 N1) virus alter hemagglutinin (HA) receptor binding toward alpha 2,3- or alpha 2,6-linked glycans. Consecutive passages of the A/California/04/09 virus with or without lectins in human lung epithelial Calu-3 cells led to development of three HA1 amino acid substitutions, N129D, G155E, and S183P, and one mutation in the neuraminidase (NA), G201E. The S183P mutation significantly increased binding to several a2,6 SA-linked glycans, including YDS, 6'SL(N), and 6-Su-6'SLN, compared to the wild-type virus (up arrow 3.6-fold, P < 0.05). Two other HA1 mutations, N129D and G155E, were sufficient to significantly increase binding to a2,6 linked glycans, 6'SLN and 6-Su-6'SLN, compared to S183P (up arrow 4.1-fold, P < 0.05). These HA1 mutations also increased binding affinity for 3'SLN glycan compared to the wild-type virus as measured by Biacore surface plasmon resonance method. In addition, the HA1 N129D and HA1 G155E substitutions were identified as antigenic mutations. Furthermore, the G201E mutation in NA reduced the NA enzyme activity (down arrow 2.3-fold). These findings demonstrate that the A/California/04/09 (H1N1) virus can acquire enhanced receptor affinity for both alpha 2,3- and alpha 2,6-linked sialic receptors under lectin-induced selective pressure. Such changes in binding affinity are conferred by selection of beneficial HA1 mutations that affect receptor specificity, antigenicity, and/or functional compatibility with the NA protein.	[Lee, Nicolette; Ireland, Derek D.; Donnelly, Raymond P.; Ilyushina, Natalia A.] US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Khalenkov, Alexey M.] US FDA, Div Plasma Prot Therapeut, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Lugovtsev, Vladimir Y.; Samsonova, Anastasia P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Inst Bioorgan Chem, Carbohydrate Chem Lab, Moscow, Russia	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Donnelly, RP; Ilyushina, NA (corresponding author), US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA.	Raymond.Donnelly@fda.hhs.gov; Natalia.llyushina@fda.hhs.gov	Bovin, Nicolai/P-2948-2017; Donnelly, Raymond P./AFT-8600-2022	Bovin, Nicolai/0000-0001-8669-4477; Donnelly, Raymond P./0000-0002-0695-5276; Ireland, Derek/0000-0001-5829-4206; Lugovtsev, Vladimir/0000-0003-0573-1497	intramural funds from the FDA Center for Drug Evaluation and Research; FDA Medical Countermeasures (MCM) Program [2011094]; Russian Science Foundation [14-50-00131]	intramural funds from the FDA Center for Drug Evaluation and Research; FDA Medical Countermeasures (MCM) Program; Russian Science Foundation(Russian Science Foundation (RSF))	This research project was supported in part by intramural funds from the FDA Center for Drug Evaluation and Research and by Grant No. 2011094 from the FDA Medical Countermeasures (MCM) Program to Dr. Raymond P. Donnelly. Dr. N.V. Bovin was supported by the Russian Science Foundation grant # 14-50-00131.	Al Hajjar S, 2010, ANN SAUDI MED, V30, P1, DOI 10.4103/0256-4947.59365; Chan RWY, 2013, VIRUS RES, V178, P133, DOI 10.1016/j.virusres.2013.03.003; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Connaris H, 2014, P NATL ACAD SCI USA, V111, P6401, DOI 10.1073/pnas.1404205111; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Govorkova EA, 2015, ANTIMICROB AGENTS CH, V59, P1495, DOI 10.1128/AAC.04431-14; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Ilyushina N, 2004, VIROLOGY, V329, P33, DOI 10.1016/j.virol.2004.08.002; Ilyushina NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181999; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Lyon JB, 2010, PEDIATR RADIOL, V40, P200, DOI 10.1007/s00247-009-1487-z; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marathe BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071401; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Palmer DF, 1975, IMMUNOLOGY SERIES, V6; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudneva IA, 1996, ARCH VIROL, V141, P1091, DOI 10.1007/BF01718612; RUDNEVA IA, 1993, ARCH VIROL, V133, P437, DOI 10.1007/BF01313781; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wang X, 2017, J VIROL, V91; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zanin M, 2015, J VIROL, V89, P5935, DOI 10.1128/JVI.02537-14	33	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195525	10.1371/journal.pone.0195525	http://dx.doi.org/10.1371/journal.pone.0195525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630683	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000056
J	Pawlat, J; Starek, A; Sujak, A; Terebun, P; Kwiatkowski, M; Budzen, M; Andrejko, D				Pawlat, Joanna; Starek, Agnieszka; Sujak, Agnieszka; Terebun, Piotr; Kwiatkowski, Michal; Budzen, Malgorzata; Andrejko, Dariusz			Effects of atmospheric pressure plasma jet operating with DBD on Lavatera thuringiaca L. seeds' germination	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; PLANT-GROWTH; SURFACE MODIFICATION; DEGRADATION; WATER; MICROORGANISMS; STERILIZATION; POSTDISCHARGE; INACTIVATION; COATINGS	The paper presents the results of an experiment on the effect of pre-sowing stimulation of seeds with atmospheric pressure plasma jet operating with dielectric barrier discharge (DBD plasma jet) on the process of germination of Thuringian Mallow (Lavatera thuringiaca L.). Five groups of seeds characterized by a different exposure times (1, 2, 5, 10 and 15 minutes) as well as untreated seeds control were used. Pre-sowing plasma stimulation of seeds improved germination parameters such as: germination capacity and germination energy for all tested groups relative to control. The highest germination parameters were obtained for seeds stimulated with plasma for the exposure times of 2 and 5 min. The analysis of the contact surface angle indicated the decrease of its' mean values upon seed stimulation while no statistical effects were observed. Analysis of the SEM scans revealed the increase in seed pattern intensity which could be attributed to removing of the surface parts of cuticle possibly covered with wax upon short time-2 and 5 min plasma treatment. Such a phenomenon can act similarly to mechanical scarification of seeds. Longer exposure of seeds to plasma resulted in affecting the deeper zone of cuticle and damage or fracture of some parts of the cuticle. Lower germination parameters of seeds upon longer exposure times to plasma may indicate mechanical damage of the seeds.	[Pawlat, Joanna; Terebun, Piotr; Kwiatkowski, Michal] Lublin Univ Technol, Inst Elect Engn & Electrotechnol, Lublin, Poland; [Starek, Agnieszka; Andrejko, Dariusz] Univ Life Sci Lublin, Dept Biol Bases Food & Feed Technol, Lublin, Poland; [Sujak, Agnieszka; Budzen, Malgorzata] Univ Life Sci Lublin, Dept Biophys, Lublin, Poland	Lublin University of Technology; University of Life Sciences in Lublin; University of Life Sciences in Lublin	Pawlat, J (corresponding author), Lublin Univ Technol, Inst Elect Engn & Electrotechnol, Lublin, Poland.; Starek, A (corresponding author), Univ Life Sci Lublin, Dept Biol Bases Food & Feed Technol, Lublin, Poland.	askmik@hotmail.com; agnieszka.starek@up.lublin.pl	Starek, Agnieszka/V-5985-2018; Kwiatkowski, Michał/D-4855-2017; Pawlat, Joanna/B-3998-2013; Sujak, Sujak/U-5538-2018; Terebun, Piotr/D-4825-2017	Starek, Agnieszka/0000-0002-9387-5900; Kwiatkowski, Michał/0000-0001-5697-3176; Pawlat, Joanna/0000-0001-8224-0355; Sujak, Sujak/0000-0001-5616-3827; Terebun, Piotr/0000-0002-3947-9552; Budzen, Malgorzata/0000-0001-7872-3362; Andrejko, Dariusz/0000-0001-9345-7795	LUT research found; Inkubator Innowacyjnosci+ found; networking actions: KONNECT project; COST Action [TD1208]; CEEPUS [CIII-AT-0063]	LUT research found; Inkubator Innowacyjnosci+ found; networking actions: KONNECT project; COST Action(European Cooperation in Science and Technology (COST)); CEEPUS	This study has been supported by LUT research found, Inkubator Innowacyjnosci+ found, networking actions: KONNECT project, COST TD1208 Action and CEEPUS CIII-AT-0063.; This study has been supported by LUT research found, Inkubator Innowacyjnoki+found, networking actions: KONNECT project, COST TD1208 Action and CEEPUS CIII-AT-0063.	Adamovich I, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa76f5; Bayliss DL, 2012, PLASMA PROCESS POLYM, V9, P597, DOI 10.1002/ppap.201100104; Brisset JL, 2016, PLASMA CHEM PLASMA P, V36, P355, DOI 10.1007/s11090-015-9653-6; Bruggeman PJ, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/5/053002; Canal C, 2009, INT J PHARM, V367, P155, DOI 10.1016/j.ijpharm.2008.09.038; Connor M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41814; Dobrin D, 2015, INNOV FOOD SCI EMERG, V29, P255, DOI 10.1016/j.ifset.2015.02.006; Dvorakova H., 2015, COMPOSITES, V2, P3; Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4; Favia P, 2012, SURF COAT TECH, V211, P50, DOI 10.1016/j.surfcoat.2012.01.032; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hensel K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919559; Henselova M, 2012, BIOLOGIA, V67, P490, DOI 10.2478/s11756-012-0046-5; Iriondo JM, 1996, SOMACLONAL VARIATION, P280, DOI [10.1007/978-3-642-61081-3_19, DOI 10.1007/978-3-642-61081-3_19]; ISTA, 2012, INT RUL SEED TEST; Janca J, 1998, SURF COAT TECH, V98, P1112, DOI 10.1016/S0257-8972(97)00213-2; Janda M, 2016, J PHYS CONF SER, V768, DOI 10.1088/1742-6596/768/1/012009; Janda M, 2016, PLASMA CHEM PLASMA P, V36, P767, DOI 10.1007/s11090-016-9694-5; Ji SH, 2016, ARCH BIOCHEM BIOPHYS, V605, P117, DOI 10.1016/j.abb.2016.02.028; KITAZAKI S, 2012, JPN J APPL PHYS 2, V51; Kitazaki S, 2014, CURR APPL PHYS, V14, pS149, DOI 10.1016/j.cap.2013.11.056; Kolacinski Z, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120393; Kornarzynski K, 2015, ACTA SCI POL TECH AG, V14, P23; Kovalova Z, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/22/224014; Krcma F, 2014, J PHYS CONF SER, V565, DOI 10.1088/1742-6596/565/1/012012; Krishna S, 2016, CHEM ENG J, V292, P35, DOI 10.1016/j.cej.2016.01.108; Krumpolec R, 2012, CHEM LISTY, V106, pS1450; Kubota Y, 2009, J PLASMA FUSION RES, V8, P740; Kutasi K, 2008, PLASMA PROCESS POLYM, V5, P840, DOI 10.1002/ppap.200800085; Laghetti G, 1998, ECON BOT, V52, P107, DOI 10.1007/BF02861301; Liguori A, 2016, PLASMA PROCESS POLYM, V13, P623, DOI 10.1002/ppap.201500143; Liguori A, 2015, PLASMA PROCESS POLYM, V12, P1195, DOI 10.1002/ppap.201500054; Lukes P, 2005, IND ENG CHEM RES, V44, P2921, DOI 10.1021/ie0491342; Lukes P, 2014, PLASMA SOURCES SCI T, P23; Machala Z, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/22/222001; Mizeraczyk J, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120405; Mozetic M, 2010, MATER TEHNOL, V44, P165; Ono R, 2017, VACUUM, V136, P214, DOI 10.1016/j.vacuum.2016.07.017; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; Pawlat J, 2004, J ADV OXID TECHNOL, V7, P59; PAWLAT J, 2013, EUR PHYS J D APPL, V61; Pawlat J, 2007, PLASMA PROCESS POLYM, V4, P753, DOI 10.1002/ppap.200700028; Pawlat J, 2018, PLASMA PROCESS POLYM, V15, DOI 10.1002/ppap.201700064; Pawlat J, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/37/374001; Pawlat J, 2016, IEEE T PLASMA SCI, V44, P314, DOI 10.1109/TPS.2015.2436061; Prysiazhnyi V, 2012, APPL SURF SCI, V258, P5467, DOI 10.1016/j.apsusc.2012.02.040; Puac N, 2006, J PHYS D APPL PHYS, V39, P3514, DOI 10.1088/0022-3727/39/16/S09; Puac N, 2005, MATER SCI FORUM, V494, P291, DOI 10.4028/www.scientific.net/MSF.494.291; Puac N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880360; Puligundla P, 2017, FOOD CONTROL, V71, P376, DOI 10.1016/j.foodcont.2016.07.021; Reuter S, 2015, IEEE T PLASMA SCI, V43, P3185, DOI 10.1109/TPS.2014.2361921; Rognli O.A., 1994, BREED FODD CROP MARG, P93; Sahni M, 2005, J ADV OXID TECHNOL, V8, P105; Schmidt-Bleker A, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/035022; Sera B, 2010, IEEE T PLASMA SCI, V38, P2963, DOI 10.1109/TPS.2010.2060728; Shiratani M, 2016, MRS ADV, V1, P1265, DOI 10.1557/adv.2016.37; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Skoro N, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/47/475206; Sulborska A, 2017, APICULTURAL VALUE TH, P76; Terebun P, 2014, EUR J MED TECHNOL, P38; Vesel A, 2008, SURF INTERFACE ANAL, V40, P1444, DOI 10.1002/sia.2923; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Young T, 2013, J ADV OXID TECHNOL, V16, P89; Zahoranova A, 2016, PLASMA CHEM PLASMA P, V36, P397, DOI 10.1007/s11090-015-9684-z; Zivkovic S, 2004, SEED SCI TECHNOL, V32, P693	66	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194349	10.1371/journal.pone.0194349	http://dx.doi.org/10.1371/journal.pone.0194349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630623	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000010
J	Hebberecht, L; Vancoillie, L; Schauvliege, M; Staelens, D; Dauwe, K; Mortier, V; Verhofstede, C				Hebberecht, Laura; Vancoillie, Leen; Schauvliege, Marlies; Staelens, Delfien; Dauwe, Kenny; Mortier, Virginie; Verhofstede, Chris			Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DISEASE PROGRESSION; SEX WORKERS; SUPERINFECTION; SUBTYPE; MEN; RECOMBINATION; SEROCONVERTERS; DIVERSITY; REGION	Introduction HIV-1 dual infection is a condition that results from infection with at least two HIV-1 variants from different sources. The scarceness of information on this condition is partly due to the fact that its detection is technically challenging. Using next-generation sequencing we defined the extent of HIV-1 dual infection in a cohort of men who have sex with men (MSM). Material & methods Eighty-six MSM, diagnosed with HIV-1 subtype B infection between 2008 and 2013 were selected for next-generation sequencing of the HIV-1 envelope V3. Sequencing was performed on 2 plasma samples collected with an interval of > 6 months before the initiation of antiretroviral therapy. Maximum likelihood phylogenetic trees were inspected for dual infection, defined as the presence of two or more monophyletic clusters with >= 90% bootstrap support and a mean between-cluster genetic distance of >= 10%. To confirm dual infection, deep V3 sequencing of intermediate samples was performed as well as clonal sequencing of the HIV-1 protease-reverse transcriptase gene. Results Five of the 74 patients (6.8%) for whom deep sequencing was successful, showed clear evidence of dual infection. In 4 of them, the second strain was absent in the first sample but occurred in subsequent samples. This was highly suggestive for superinfection. In 3 patients both virus variants were of subtype B, in 2 patients at least one of the variants was a subtype B/non-B recombinant virus. Conclusions Dual infection was confirmed in 6.8% of MSM diagnosed with HIV-1 in Belgium. This prevalence is probably an underestimation, because stringent criteria were used to classify viral variants as originating from a new infection event.	[Hebberecht, Laura; Vancoillie, Leen; Schauvliege, Marlies; Staelens, Delfien; Dauwe, Kenny; Mortier, Virginie; Verhofstede, Chris] Univ Ghent, Aids Reference Lab, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium	Ghent University	Verhofstede, C (corresponding author), Univ Ghent, Aids Reference Lab, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium.	chris.verhofstede@ugent.be			Belgian Ministery of Social Affairs through Health Insurance System	Belgian Ministery of Social Affairs through Health Insurance System	The AIDS Reference Laboratory of Ghent is supported by the Belgian Ministery of Social Affairs through a fund within the Health Insurance System. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Berghe W Vanden, 2011, EURO SURVEILL, V16; Chaillon A, 2013, J VIROL, V87, P12737, DOI 10.1128/JVI.02260-13; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chohan B, 2005, J VIROL, V79, P10701, DOI 10.1128/JVI.79.16.10701-10708.2005; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luan H, 2017, JAIDS-J ACQ IMM DEF, V75, P480, DOI 10.1097/QAI.0000000000001420; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Novitsky V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166746; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Piantadosi A, 2008, AIDS RES HUM RETROV, V24, P1221, DOI 10.1089/aid.2008.0100; Rachinger A, 2010, J VIROL METHODS, V165, P311, DOI 10.1016/j.jviromet.2010.02.016; Redd AD, 2014, AIDS, V28, P2147, DOI 10.1097/QAD.0000000000000365; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Ronen K, 2014, AIDS, V28, P2281, DOI 10.1097/QAD.0000000000000422; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; Vancoillie L, 2015, ANTIVIR THER, V20, P789, DOI 10.3851/IMP2966; Verhofstede C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2850-6; Vidal N, 2013, INFECT GENET EVOL, V14, P73, DOI 10.1016/j.meegid.2012.11.017; Wagner GA, 2017, J VIROL, V91, DOI 10.1128/JVI.00475-17; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195679	10.1371/journal.pone.0195679	http://dx.doi.org/10.1371/journal.pone.0195679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624605	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600043
J	Kim, CR; Jeon, YJ; Kim, MC; Jeong, T; Koo, WR				Kim, Chung Reen; Jeon, Young-Jee; Kim, Moon Chan; Jeong, Taeheum; Koo, Woo Ram			Reference values for hand grip strength in the South Korean population	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; LEAN MASS; SARCOPENIA; WOMEN; HEALTH; ADULTS; ASSOCIATION; MORTALITY; MEN; INTERVENTIONS	Objective To establish reference values for hand grip strength (HGS) in a healthy Korean population and to identify the dependent anthropometric variables that affect HGS. Methods Based on the sixth Korea National Health and Nutrition Examination Survey from 2014 to 2015, we analyzed the HGS data of 7,969 South Koreans. Individuals with specific chronic diseases and who reported poor subjective health status were excluded to ensure a healthy population sample. Means with standard deviations (SDs) and 95% confidence intervals were calculated for each 5-year interval starting from 10 years of age. To determine the relationship between HGS and anthropometric variables, we performed correlation analyses between HGS and height, weight, and body mass index (BMI). Additionally, based on these findings, the cut-off value for low HGS was presented by deriving-2SD values of healthy young adults as recommended by the European Working Group on Sarcopenia in Older People. Results The mean age and BMI of men and women were 38.3 and 38.2 years and 23.8 and 22.4 kg/m(2), respectively. Mean HGS of the dominant hand in men and women was 39.5 and 24.2 kg, respectively. The peak in HGS was at 35-39 years of age, after which HGS decreased in both sexes. HGS was significantly correlated with height, weight, and BMI. The cut-off values for weak HGS were < 28.9 and < 16.8 kg in men and women, respectively. Conclusion These results provide useful reference values to assess HGS in patients who undergo hand surgery or who have various diseases that affect HGS. Moreover, a cut-off value for low HGS may help in defining sarcopenia among the Korean population.	[Kim, Chung Reen; Koo, Woo Ram] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Phys Med & Rehabil, Ulsan, South Korea; [Jeon, Young-Jee; Kim, Moon Chan; Jeong, Taeheum] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Family Med, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jeon, YJ (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Family Med, Ulsan, South Korea.	yjjeon@uuh.ulsan.kr						Barreto SM, 2009, REV SAUDE PUBL, V43, P38, DOI 10.1590/S0034-89102009000900006; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cheung CL, 2013, AGE, V35, P929, DOI 10.1007/s11357-012-9385-y; Chong Choon-Khim, 1994, Journal of the Formosan Medical Association, V93, P616; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Denison HJ, 2015, CLIN INTERV AGING, V10, P859, DOI 10.2147/CIA.S55842; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Doherty TJ, 2001, CURR OPIN CLIN NUTR, V4, P503, DOI 10.1097/00075197-200111000-00007; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Han DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19457; Heimburger O, 2000, AM J KIDNEY DIS, V36, P1213, DOI 10.1053/ajkd.2000.19837; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Karkkainen M, 2009, BONE, V44, P660, DOI 10.1016/j.bone.2008.12.010; Kim KM, 2016, KOREAN J INTERN MED, V31, P643, DOI 10.3904/kjim.2016.015; Kim YS, 2007, J KOREAN SOC PEDIAT, V12, P142; Koley S, 2009, ANTHROPOL ANZ, V67, P21, DOI 10.1127/0003-5548/2009/0003; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lawman HG, 2016, AM J PREV MED, V50, P677, DOI 10.1016/j.amepre.2015.10.022; Lee WJ, 2013, J AM MED DIR ASSOC, V14, P528, DOI 10.1016/j.jamda.2013.03.019; Little MA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22922; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Mathiowetz Virgil, 2002, Occup Ther Int, V9, P201, DOI 10.1002/oti.165; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014; Nascimento DD, 2015, AGING CLIN EXP RES, V27, P791, DOI 10.1007/s40520-015-0349-9; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2005, AM J CLIN NUTR, V82, P915, DOI DOI 10.1093/AJCN/82.4.872; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rosen B, 1996, J Hand Ther, V9, P315; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Schlussel MM, 2008, CLIN NUTR, V27, P601, DOI 10.1016/j.clnu.2008.04.004; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Shim JH, 2013, ARCH PLAST SURG-APS, V40, P52, DOI 10.5999/aps.2013.40.1.52; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Steiber N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163917; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; United Nations Economic and Social Affairs Population Division, 2015, WORLD POP AG 2015; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Wong SL, 2016, HEALTH REP, V27, P3; Wu SW, 2009, APPL ERGON, V40, P811, DOI 10.1016/j.apergo.2008.08.006; Yoo JI, 2017, J KOREAN MED SCI, V32, P868, DOI 10.3346/jkms.2017.32.5.868; Yoshida D, 2014, GERIATR GERONTOL INT, V14, P46, DOI 10.1111/ggi.12210; Yu RB, 2014, GERIATR GERONTOL INT, V14, P15, DOI 10.1111/ggi.12220	53	36	36	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195485	10.1371/journal.pone.0195485	http://dx.doi.org/10.1371/journal.pone.0195485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624617	gold, Green Published, Green Submitted			2022-12-27	WOS:000429379600033
J	Schuelke, J; Meyers, N; Reitmaier, S; Klose, S; Ignatius, A; Claes, L				Schuelke, Julian; Meyers, Nicholaus; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita; Claes, Lutz			Intramembranous bone formation after callus distraction is augmented by increasing axial compressive strain	PLOS ONE			English	Article							EXPERIMENTAL TIBIAL FRACTURES; SEGMENTAL TRANSPORT; EXTERNAL FIXATORS; GENE-EXPRESSION; OSTEOGENESIS; FIXATION; REGENERATION; MICROMOVEMENT; MATURATION; STABILITY	The mechanical environment is a primary factor in the success of distraction osteogenesis. It is known that the interfragmentary movement during the distraction and maturation phase effects the callus formation. In addition to cyclic compression, other movements like shear and bending influence the bone formation process as shown in previous callus distraction studies. Reports of cartilage presence and endochondral ossification in the regenerative zone have been associated with a lack of fixation stability and delayed healing. So far the effects of the direction of interfragmentary movements could not be studied separately. By means of a unique lateral callus distraction model, we investigated the effects of small (0.1 mm) and moderate (0.6 mm), purely axial compression on ossification during callus maturation in sheep. A distraction device incorporating a mobile titanium plate was mounted on the tibia. Following lateral callus distraction, electromechanically controlled movements allowed purely axial cyclic compression of the tissue regenerate. Seven weeks post-operatively, the tissue regenerates were investigated using pCT, histology and immunohistochemistry. The larger amplitude significantly increased bone formation (Fractional bone volume: 19.4% vs. 5.2%, p = 0.03; trabecular thickness: 0.1 mm vs. 0.06 mm, p = 0.006; mean spicule height: 2.6 mm vs. 1.1 mm, p = 0.02) however, no endochondral ossification occurred. The elimination of shear movement, unimpaired neovascularization as well as the tensile strain stimuli during the distraction phase suppressing chondrogenic differentiation may all contribute to the absence of cartilage. In clinical application of distraction osteogenesis, moderate axial interfragmentary movement augments intramembranous ossification provided shear strain is minimized.	[Schuelke, Julian; Meyers, Nicholaus; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita; Claes, Lutz] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden Wurttemberg, Germany	Ulm University	Claes, L (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden Wurttemberg, Germany.	lutz.claes@uni-ulm.de	Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Schuelke, Julian/0000-0002-9532-4205	German Research Foundation [DFG 77/22-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG 77/22-1). All authors state that they have no conflict of interests.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amir LR, 2007, J HISTOCHEM CYTOCHEM, V55, P1095, DOI 10.1369/jhc.6A7162.2007; Amir LR, 2009, ODONTOLOGY, V97, P63, DOI 10.1007/s10266-009-0101-z; ARONSON J, 1989, CLIN ORTHOP RELAT R, P106; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Augat P, 2001, J ORTHOP TRAUMA, V15, P54, DOI 10.1097/00005131-200101000-00010; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Claes L, 2000, J BONE JOINT SURG BR, V82B, P142, DOI 10.1302/0301-620X.82B1.9332; Claes L, 2005, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000150456.39608.bc; Claes L, 2010, BONE, V47, P712, DOI 10.1016/j.bone.2010.07.010; CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8; Claes L, 2008, J ORTHOP RES, V26, P772, DOI 10.1002/jor.20588; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Duda GN, 2002, CLIN ORTHOP RELAT R, P163; FRIERSON M, 1994, CLIN ORTHOP RELAT R, P19; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Haudenschild AK, 2009, ANN BIOMED ENG, V37, P492, DOI 10.1007/s10439-008-9629-2; Hente R, 2004, J ORTHOP RES, V22, P709, DOI 10.1016/j.orthres.2003.11.007; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008; Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1; Kassis B, 1996, J PEDIATR ORTHOPED, V16, P480, DOI 10.1097/01241398-199607000-00011; Leung KS, 2004, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000111889.64238.6a; Lopez-Pliego EM, 2016, INJURY, V47, pS7, DOI 10.1016/S0020-1383(16)30600-3; Meyers N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189432; Morgan EF, 2010, J BIOMECH, V43, P2418, DOI 10.1016/j.jbiomech.2010.04.019; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; Schell H, 2005, J ORTHOP RES, V23, P1022, DOI 10.1016/j.orthres.2005.03.005; Tuohy JL, 2014, VET SURG, V43, P903, DOI 10.1111/j.1532-950X.2014.12189.x; WEIBEL ER, 1963, LAB INVEST, V12, P131; Yang L, 2003, CLIN BIOMECH, V18, P166, DOI 10.1016/S0268-0033(02)00175-4	32	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195466	10.1371/journal.pone.0195466	http://dx.doi.org/10.1371/journal.pone.0195466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624608	Green Submitted, gold, Green Published			2022-12-27	WOS:000429379600031
J	Skowron, PM; Kropinski, AM; Zebrowska, J; Janus, L; Szemiako, K; Czajkowska, E; Maciejewska, N; Skowron, M; Los, J; Los, M; Zylicz-Stachula, A				Skowron, Piotr M.; Kropinski, Andrew M.; Zebrowska, Joanna; Janus, Lukasz; Szemiako, Kasjan; Czajkowska, Edyta; Maciejewska, Natalia; Skowron, Malgorzata; Los, Joanna; Los, Marcin; Zylicz-Stachula, Agnieszka			Sequence, genome organization, annotation and proteomics of the thermophilic, 47.7-kb Geobacillus stearothermophilus bacteriophage TP-84 and its classification in the new Tp84virus genus	PLOS ONE			English	Article							DATABASE; PREDICTION; VIRUSES	Bacteriophage TP-84 is a well-characterized bacteriophage of historical interest. It is a member of the Siphoviridae, and infects a number of thermophilic Geobacillus (Bacillus) stearothermophilus strains. Its' 47.7-kbp double-stranded DNA genome revealed the presence of 81 coding sequences (CDSs) coding for polypeptides of 4 kDa or larger. Interestingly, all CDSs are oriented in the same direction, pointing to a dominant transcription direction of one DNA strand. Based on a homology search, a hypothetical function could be assigned to 31 CDSs. No RNA or DNA polymerase-coding genes were found on the bacteriophage genome indicating that TP-84 relies on the host's transcriptional and replication enzymes. The TP84 genome is tightly packed with CDSs, typically spaced by several-to tens of bp or often overlapping. The genome contains five putative promoter-like sequences showing similarity to the host promoter consensus sequence and allowing for a 2-bp mismatch. In addition, ten putative rho-independent terminators were detected. Because the genome sequence shows essentially no similarity to any previously characterised bacteriophage, TP-84 should be considered a new species in an undefined genus within the Siphoviridae family. Thus a taxonomic proposal of a new Tp84virus genus has been accepted by the International Committee on Taxonomy of Viruses. The bioinformatics genome analysis was verified by confirmation of 33 TP-84 proteins, which included: a) cloning of a selected CDS in Escherichia coli, coding for a DNA single-stranded binding protein (SSB; gene TP84_63), b) purification and functional assays of the recombinant TP-84 SSB, which has been shown to improve PCR reactions, c) mass spectrometric (MS) analysis of TP-84 bacteriophage capsid proteins, d) purification of TP-84 endolysin activity, e) MS analysis of the host cells from infection time course.	[Skowron, Piotr M.; Zebrowska, Joanna; Janus, Lukasz; Czajkowska, Edyta; Maciejewska, Natalia; Zylicz-Stachula, Agnieszka] Univ Gdansk, Dept Mol Biotechnol, Fac Chem, Gdansk, Poland; [Skowron, Piotr M.; Janus, Lukasz; Maciejewska, Natalia; Skowron, Malgorzata; Zylicz-Stachula, Agnieszka] BioVentures Inst Ltd, Poznan, Poland; [Kropinski, Andrew M.] Univ Guelph, Dept Food Sci Mol & Cellular Biol, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Szemiako, Kasjan] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Fac Chem, Gdansk, Poland; [Los, Joanna; Los, Marcin] Phage Consultants, Gdansk, Poland; [Los, Joanna; Los, Marcin] Univ Gdansk, Fac Biol, Dept Bacterial Mol Genet, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; University of Guelph; University of Guelph; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; University of Gdansk	Skowron, PM (corresponding author), Univ Gdansk, Dept Mol Biotechnol, Fac Chem, Gdansk, Poland.; Skowron, PM (corresponding author), BioVentures Inst Ltd, Poznan, Poland.	piotr.skowron@ug.edu.plp	Kropinski, Andrew M/H-7130-2016; Zylicz-Stachula, Agnieszka/G-8000-2011	Kropinski, Andrew M/0000-0002-6871-6799; Zylicz-Stachula, Agnieszka/0000-0003-2479-3634; Zebrowska, Joanna/0000-0003-2637-6439; Szemiako, Kasjan/0000-0002-3265-4717; Skowron, Piotr/0000-0003-1345-3271; Los, Marcin/0000-0001-9732-8376; Maciejewska, Natalia/0000-0001-7728-0598; Czajkowska, Edyta/0000-0002-1571-2356	National Center for Development (Poland) [POIG.01.04.00-22-140/12]; BioVentures Institute Ltd.	National Center for Development (Poland); BioVentures Institute Ltd.	The project has been sponsored in part by the National Center for Development (Poland) grant no POIG.01.04.00-22-140/12 issued to BioVentures Institute Ltd., in which the University of Gdansk has been a scientific partner. The BioVentures Institute Ltd. provided support in the form of salaries for the following authors: Piotr M. Skowron, Joanna Zebrowska, Lukasz Janus, Kasjan Szemiako, Edyta Czajkowska, Natalia Maciejewska, Malgorzata Skowron and Agnieszka Zylicz-Stachula. These authors are (or have been) also University of Gdansk employees or students. The specific roles of these authors are articulated in the 'author contributions' section. During the grant realisation, BioVentures Institute Ltd. also provided materials, reagents and equipment. BioVentures Institute Ltd. has played a predominant role in this study during all of its stages: the concept development, experiments design and realisation, as well as the decision to publish and the manuscript preparation.	Adriaenssens EM, 2018, ARCH VIROL, V163, P1125, DOI 10.1007/s00705-018-3723-z; BASSEL A, 1971, J VIROL, V7, P663, DOI 10.1128/JVI.7.5.663-672.1971; Black LW, 2012, ADV EXP MED BIOL, V726, P469, DOI 10.1007/978-1-4614-0980-9_21; Blanc M, 1997, INT J SYST BACTERIOL, V47, P1246, DOI 10.1099/00207713-47-4-1246; Chaudhry WN, 2014, J BASIC MICROB, V54, P531, DOI 10.1002/jobm.201200710; Chen X, 2016, J DAIRY SCI, V99, P6995, DOI 10.3168/jds.2016-11332; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; EGBERT LARRE N., 1967, J VIROL, V1, P610; EPSTEIN I, 1975, APPL MICROBIOL, V29, P219, DOI 10.1128/AEM.29.2.219-223.1975; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HOLMES D, 1981, J GEN VIROL, V52, P141, DOI 10.1099/0022-1317-52-1-141; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KIZER PE, 1972, BIOCHEMISTRY-US, V11, P1562, DOI 10.1021/bi00759a003; Liu B, 2009, RES MICROBIOL, V160, P166, DOI 10.1016/j.resmic.2008.12.005; Liu B, 2006, CURR MICROBIOL, V53, P163, DOI 10.1007/s00284-005-0509-9; Madden T, 2002, NCBI HDB; MARK KK, 1970, ANAL BIOCHEM, V37, P447, DOI 10.1016/0003-2697(70)90071-0; Marks TJ, 2014, ARCH VIROL, V159, P2771, DOI 10.1007/s00705-014-2101-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nowak M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-91; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012; SAUNDERS GF, 1966, J BACTERIOL, V91, P340, DOI 10.1128/JB.91.1.340-348.1966; SAUNDERS GF, 1965, BIOCHEMISTRY-US, V4, P2836, DOI 10.1021/bi00888a039; Saunders GF, 1964, 148 M AM CHEM SOC C, p36C; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SHARP RJ, 1986, J GEN MICROBIOL, V132, P1709; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skowron P, 2016, METHOD USE NUCLEOTID; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Wang YQ, 2010, APPL ENVIRON MICROB, V76, P7861, DOI 10.1128/AEM.01270-10; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033	38	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195449	10.1371/journal.pone.0195449	http://dx.doi.org/10.1371/journal.pone.0195449			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624616	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600030
J	Gombos, RB; Gonzalez, A; Manrique, M; Chand, D; Savitsky, D; Morin, B; Breous-Nystrom, E; Dupont, C; Ward, RA; Mande, C; Duckless, B; Tango, H; Findeis, MA; Schuster, A; Weight, JD; Underwood, D; Clarke, C; Ritter, G; Merghoub, T; Scheer, D; Wolchok, JD; van Dijk, M; Buell, JS; Cuillerot, JM; Stein, R; Drouin, EE; Wilson, NS				Gombos, Randi B.; Gonzalez, Ana; Manrique, Mariana; Chand, Dhan; Savitsky, David; Morin, Benjamin; Breous-Nystrom, Ekaterina; Dupont, Christopher; Ward, Rebecca A.; Mande, Cornelia; Duckless, Benjamin; Tango, Hao; Findeis, Mark A.; Schuster, Andrea; Weight, Jeremy D.; Underwood, Dennis; Clarke, Christopher; Ritter, Gerd; Merghoub, Taha; Scheer, David; Wolchok, Jedd D.; van Dijk, Marc; Buell, Jennifer S.; Cuillerot, Jean-Marie; Stein, Robert; Drouin, Elise E.; Wilson, Nicholas S.			Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody	PLOS ONE			English	Article							REGULATORY T-CELLS; NIVOLUMAB PLUS IPILIMUMAB; CYTOKINE RELEASE ASSAYS; IN-VITRO; MEDIATED CYTOTOXICITY; ANTITUMOR ACTIVITIES; UNTREATED MELANOMA; CRYSTAL-STRUCTURE; LUNG-CANCER; CTLA-4	CTLA-4 and CD28 exemplify a co-inhibitory and co-stimulatory signaling axis that dynamically sculpts the interaction of antigen-specific T cells with antigen-presenting cells. Anti-CTLA-4 antibodies enhance tumor-specific immunity through a variety of mechanisms including: blockade of CD80 or CD86 binding to CTLA-4, repressing regulatory T cell function and selective elimination of intratumoral regulatory T cells via an Fcy receptor-dependent mechanism. AGEN1884 is a novel IgG1 antibody targeting CTLA-4. It potently enhanced antigen-specific T cell responsiveness that could be potentiated in combination with other immunomodulatory antibodies. AGEN1884 was well-tolerated in non-human primates and enhanced vaccine-mediated antigen-specific immunity. AGEN1884 combined effectively with PD-1 blockade to elicit a T cell proliferative response in the periphery. Interestingly, an IgG2 variant of AGEN1884 revealed distinct functional differences that may have implications for optimal dosing regimens in patients. Taken together, the pharmacological properties of AGEN1884 support its clinical investigation as a single therapeutic and combination agent.	[Gombos, Randi B.; Gonzalez, Ana; Manrique, Mariana; Chand, Dhan; Savitsky, David; Ward, Rebecca A.; Weight, Jeremy D.; Wilson, Nicholas S.] Agenus Inc, Immunomodulatory Drug Discovery, Lexington, MA 02421 USA; [Morin, Benjamin; Findeis, Mark A.] Agenus Inc, Res Biochem, Lexington, MA USA; [Breous-Nystrom, Ekaterina; Mande, Cornelia; Schuster, Andrea] Agenus Switzerland Inc, Basel, Switzerland; [Dupont, Christopher; Duckless, Benjamin; Tango, Hao] Agenus Inc, Translat Biomarkers, Lexington, MA USA; [Clarke, Christopher] Agenus Inc, Safety Pharmacol & Toxicol, Lexington, MA USA; [Ritter, Gerd] Ludwig Inst Canc Res, New York, NY USA; [Merghoub, Taha; Scheer, David; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [van Dijk, Marc] Agenus United Kingdom Ltd, Cambridge, England; [Buell, Jennifer S.; Cuillerot, Jean-Marie] Agenus Inc, Res & Dev Management, Lexington, MA USA; [Stein, Robert] Agenus Inc, Res & Dev Consultant, Lexington, MA USA	Agenus Inc; Agenus Inc; Agenus Inc; Agenus Inc; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Agenus Inc; Agenus Inc	Wilson, NS (corresponding author), Agenus Inc, Immunomodulatory Drug Discovery, Lexington, MA 02421 USA.	nwnicholas@gmail.com	Merghoub, Taha/ABD-8362-2021		Agenus Inc.; Agenus Switzerland Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Agenus Inc.; Agenus Switzerland Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The licensed antibodies, AGEN1884, AGEN2041 and AGEN2034, were developed under a Collaborative Research and Development Agreement between Ludwig Cancer Research, 4 Antibody AG (now Agenus Switzerland Inc.) and Recepta Biopharma S.A. Funding of this work was provided by Agenus Inc. or Agenus Switzerland Inc. The funder provided support in the form of salaries for authors RBG, AG, MM, DC, DS, BM, EB-N, CD, RAW, CM, BD, HT, MAF, AS, JDW, DU, CC, MvD, JSB, JC, RS, EED and NSW, and was also involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Antonia S, 2016, LANCET ONCOL, V17, P299, DOI 10.1016/S1470-2045(15)00544-6; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Breous-Nystrom E, 2014, METHODS, V65, P57, DOI 10.1016/j.ymeth.2013.09.003; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Callahan MK, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00385; Chung S, 2014, J IMMUNOL METHODS, V407, P63, DOI 10.1016/j.jim.2014.03.021; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; Funt SA, 2014, ONCOLOGY-NY, V28, P6; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; Grawunder U, 2016, United States Patent, Patent No. 9346874; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Jure-Kunkel M, 2007, US patent, Patent No. [US7288638B2, 7288638]; Kim JM, 2013, J EXP MED, V210, P1647, DOI 10.1084/jem.20131625; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le Mercier I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00418; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Levy R, 2016, P NATL ACAD SCI USA, V113, pE6437, DOI 10.1073/pnas.1603321113; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Montler R, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.16; Moreau T, 1996, BRAIN, V119, P225, DOI 10.1093/brain/119.1.225; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Piccotti Joseph R, 2005, J Immunotoxicol, V2, P191, DOI 10.1080/15476910500362838; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robert L, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29244; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Schadendorf D, 2014, J CLIN ONCOL, V56, P2736, DOI DOI 10.1200/JC0.2014.56.2736; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spindler N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004377; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sznol M, 2008, J CLIN ONCOL, V26; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Thudium K. B., 2011, US Patent Application Publication No, Patent No. [US 2011/0150892 Al, 20110150892]; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trist HM, 2014, J IMMUNOL, V192, P792, DOI 10.4049/jimmunol.1301554; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Van Dijk MA, 2016, Anti-ctla-4 antibodies and methods of use thereof. United States Patent Application Publication No. 20160368989, Patent No. 20160368989; Van Dijk MA, 2017, Anti-pd-1 antibodies and methods of use thereof. United States Patent Application Publication No. 20170081409, Patent No. 20170081409; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Vessillier S, 2015, J IMMUNOL METHODS, V424, P43, DOI 10.1016/j.jim.2015.04.020; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xu ZH, 2012, J IMMUNOL, V189, P4470, DOI 10.4049/jimmunol.1201813	71	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0191926	10.1371/journal.pone.0191926	http://dx.doi.org/10.1371/journal.pone.0191926			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617360	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800002
J	Shaheen, AA; Kaplan, GG; Almishri, W; Vallerand, I; Frolkis, AD; Patten, S; Swain, MG				Shaheen, Abdel-Aziz; Kaplan, Gilaad G.; Almishri, Wagdi; Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott; Swain, Mark G.			The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes	PLOS ONE			English	Article							PLATELET-DERIVED SEROTONIN; PRIMARY SCLEROSING CHOLANGITIS; QUALITY-OF-LIFE; LIVER-TRANSPLANTATION; MAJOR DEPRESSION; CIRRHOSIS; FATIGUE; DISEASE; POPULATION; PREVALENCE	Background Depression is prevalent in primary biliary cholangitis (PBC) patients. Our aims were to examine the effects of depression and antidepressants on hepatic outcomes of PBC patients. Methods We used the UK Health Improvement Network database to identify PBC patients between 1974 and 2007. Our primary outcome was one of three clinical events: decompensated cirrhosis, liver transplantation and death. We assessed depression and each class of antidepressant medication in adjusted multivariate Cox proportional hazards models to identify independent predictors of outcomes. In a sensitivity analysis, the study population was restricted to PBC patients using ursodeoxycholic acid (UDCA). Results We identified 1,177 PBC patients during our study period. In our cohort, 86 patients (7.3%) had a depression diagnosis prior to PBC diagnosis, while 79 patients (6.7%) had a depression diagnosis after PBC diagnosis. Ten-year incidence of mortality, decompensated cirrhosis, and liver transplantation were 13.4%, 6.6%, and 2.0%, respectively. In our adjusted models, depression status was not a predictor of poor outcomes. After studying all classes of antidepressants, using the atypical antidepressant mirtazapine after PBC diagnosis was significantly protective (Adjusted HR 0.23: 95% CI 0.07-0.72) against poor liver outcomes (decompensation, liver transplant, mortality), which remained statistically significant in patients using UCDA (HR 0.21: 95% CI 0.05-0.83). Conclusions In our study, depression was not associated with poor clinical outcomes. However, using the antidepressant mirtazapine was associated with decreased mortality, decompensated cirrhosis and liver transplantation in PBC patients. These findings support further assessment of mirtazapine as a potential treatment for PBC patients.	[Shaheen, Abdel-Aziz; Kaplan, Gilaad G.; Frolkis, Alexandra D.; Swain, Mark G.] Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Almishri, Wagdi; Swain, Mark G.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott] Univ Calgary, Dept Psychiat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Shaheen, AA (corresponding author), Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada.	az.shaheen@ucalgary.ca	Patten, Scott/B-4434-2011; Shaheen, Abdel Aziz/AAX-3773-2021; Kaplan, Gil/AAH-2335-2021	Patten, Scott/0000-0001-9871-4041; Shaheen, Abdel Aziz/0000-0002-2940-897X; Kaplan, Gil/0000-0003-2719-0556	Canadian Institutes of Health Research Team Grant [THC - 135231]; Alberta Innovates [201300174] Funding Source: researchfish	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded through a Canadian Institutes of Health Research Team Grant (M. Swain as PI). Grant title: Health Challenges in Chronic Inflammation Initiative. Grant ID: THC - 135231.	Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Alam A, 2013, PRIMARY CARE COMPANI, V15; Andersson NW, 2015, PSYCHOL MED, V45, P3559, DOI 10.1017/S0033291715001488; [Anonymous], 2010, THIN DATA GUIDE RES, P106; Bhayat F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-252; Biagini MR, 2008, EUR J GASTROEN HEPAT, V20, P122, DOI 10.1097/MEG.0b013e3282f1cbda; Blak BT, 2009, VALUE HEALTH, V12, pA253, DOI 10.1016/S1098-3015(10)74240-6; BRADLEY P, 1995, BRIT MED J, V311, P951; Carta MG, 2002, J PSYCHOSOM RES, V53, P789, DOI 10.1016/S0022-3999(02)00328-8; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Eyre HA, 2016, PHARMACOPSYCHIATRY, V49, P85, DOI 10.1055/s-0042-103159; Hohenester S, 2009, SEMIN IMMUNOPATHOL, V31, P283, DOI 10.1007/s00281-009-0164-5; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Josephson CB, 2017, JAMA NEUROL, V74, P533, DOI 10.1001/jamaneurol.2016.5042; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Lalor PF, 2013, AM J PHYSIOL-GASTR L, V304, pG469, DOI 10.1152/ajpgi.00407.2012; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lesurtel M, 2012, CLIN RES HEPATOL GAS, V36, P319, DOI 10.1016/j.clinre.2012.05.005; Lewinson RT, 2017, J INVEST DERMATOL, V137, P828, DOI 10.1016/j.jid.2016.11.032; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Mells GF, 2013, HEPATOLOGY, V58, P273, DOI 10.1002/hep.26365; Mojtabai R, 2004, PSYCHOL MED, V34, P623, DOI 10.1017/S0033291703001764; Mullish BH, 2014, ALIMENT PHARM THER, V40, P880, DOI 10.1111/apt.12925; Myers RP, 2009, HEPATOLOGY, V50, P1884, DOI 10.1002/hep.23210; Nery FG, 2007, COMPR PSYCHIAT, V48, P14, DOI 10.1016/j.comppsych.2006.04.002; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; PAYNE C, 1995, BRIT MED J, V311, P951; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Rogal SS, 2011, LIVER TRANSPLANT, V17, P251, DOI 10.1002/lt.22231; Frick LR, 2013, LIFE SCI, V92, P525, DOI 10.1016/j.lfs.2013.01.020; Ruddell RG, 2008, J HEPATOL, V48, P666, DOI 10.1016/j.jhep.2008.01.006; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Singh N, 1997, DIGEST DIS SCI, V42, P1421, DOI 10.1023/A:1018898106656; ter Borg PCJ, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-13; Valtysdottir ST, 2000, CLIN EXP RHEUMATOL, V18, P597; van Os E, 2007, J HEPATOL, V46, P1099, DOI 10.1016/j.jhep.2007.01.036; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Zyrianova Y, 2006, IRISH J MED SCI, V175, P32, DOI 10.1007/BF03167946	46	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194839	10.1371/journal.pone.0194839	http://dx.doi.org/10.1371/journal.pone.0194839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617396	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800051
J	Huang, S; Jaffe, PR				Huang, Shan; Jaffe, Peter R.			Isolation and characterization of an ammonium-oxidizing iron reducer: Acidimicrobiaceae sp A6	PLOS ONE			English	Article							SP NOV.; HUMIC SUBSTANCES; WETLAND SOILS; FE(III) OXIDE; NITROGEN LOSS; GEN. NOV.; REDUCTION; OXIDATION; MICROORGANISMS; HETEROGENEITY	Acidimicrobiaceae sp. A6 (ATCC, PTA-122488), a strain that has been previously reported to play a key role in the oxidation of ammonium (NH4+) under iron reducing conditions, has now been isolated from riparian wetland soils in New Jersey, USA. Incubations of this strain in a medium containing ferrihydrite as the ferric iron [Fe(III)] source, CO2 as the carbon source, under room temperature, and a pH of 4.5, resulted in 52% of NH4+ removal over a 20-day incubation period, while reducing Fe(III) in the expected stoichiometric ratio when NH4+ was oxidized to nitrite with Fe(III) as the electron acceptor. This study demonstrates that this new isolated strain is capable of oxidizing NH4+ while reducing iron under anaerobic conditions.	[Huang, Shan; Jaffe, Peter R.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	Princeton University	Jaffe, PR (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	jaffe@princeton.edu		Jaffe, Peter/0000-0002-8531-8549	Princeton University; NSF [CBET-1433101]	Princeton University(Princeton University); NSF(National Science Foundation (NSF))	Funding for this work was provided by Project X from Princeton University, and NSF Project No. CBET-1433101. (PRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blothe M, 2008, APPL ENVIRON MICROB, V74, P1019, DOI 10.1128/AEM.01194-07; Bridge TAM, 1998, APPL ENVIRON MICROB, V64, P2181; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Clark DA, 1996, MICROBIOL-UK, V142, P785, DOI 10.1099/00221287-142-4-785; Cleaver AA, 2007, APPL ENVIRON MICROB, V73, P4294, DOI 10.1128/AEM.02658-06; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Ding LJ, 2014, ENVIRON SCI TECHNOL, V48, P10641, DOI 10.1021/es503113s; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Hacherl EL, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001312; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Huang S, 2015, BIOGEOSCIENCES, V12, P769, DOI 10.5194/bg-12-769-2015; Huang S, 2016, SOIL BIOL BIOCHEM, V98, P148, DOI 10.1016/j.soilbio.2016.04.012; Itoh T, 2011, INT J SYST EVOL MICR, V61, P1281, DOI 10.1099/ijs.0.023044-0; Johnson DB, 2008, EXTREMOPHILES, V12, P789, DOI 10.1007/s00792-008-0184-4; Johnson DB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00096; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li M, 2011, APPL MICROBIOL BIOT, V89, P1243, DOI 10.1007/s00253-010-2929-0; Lloyd JR, 1999, J BACTERIOL, V181, P7647, DOI 10.1128/JB.181.24.7647-7649.1999; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; MacDonald LH, 2011, WATER RES, V45, P1049, DOI 10.1016/j.watres.2010.10.017; Nevin KP, 2002, APPL ENVIRON MICROB, V68, P2294, DOI 10.1128/AEM.68.5.2294-2299.2002; Sawayama S, 2006, J BIOSCI BIOENG, V101, P70, DOI 10.1263/jbb.101.70; Scott DT, 1998, ENVIRON SCI TECHNOL, V32, P2984, DOI 10.1021/es980272q; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Ward BB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00553; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wolf M, 2009, ENVIRON SCI TECHNOL, V43, P5679, DOI 10.1021/es803647r; Yang WH, 2012, NAT GEOSCI, V5, P538, DOI [10.1038/ngeo1530, 10.1038/NGEO1530]	32	55	59	27	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194007	10.1371/journal.pone.0194007	http://dx.doi.org/10.1371/journal.pone.0194007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641534	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900021
J	Bongomin, F; Harris, C; Hayes, G; Kosmidis, C; Denning, DW				Bongomin, Felix; Harris, Chris; Hayes, Gemma; Kosmidis, Chris; Denning, David W.			Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis	PLOS ONE			English	Article							GEORGES RESPIRATORY QUESTIONNAIRE; QUALITY-OF-LIFE; AZOLE RESISTANCE; HEALTH-STATUS; MULTICENTER TRIAL; CHRONIC CAVITARY; GUIDELINES; MICAFUNGIN; FUMIGATUS; DIAGNOSIS	There is a paucity of evidence surrounding the optimal antifungal therapy for use in chronic pulmonary aspergillosis (CPA) and the duration of therapy remains unclear. We retrospectively evaluated treatment outcomes, including change in quality of life scores (St George's Respiratory Questionnaire (QoL)), weight and Aspergillus IgG at 6 and 12 months following initiation of therapy in a cohort of 206 CPA patients referred to the UK National Aspergillosis Centre (NAC), Manchester between April 2013 and March 2015. One hundred and forty-two patients (69%) were azole naive at presentation and 105 (74%) (Group A) were commenced on itraconazole, 27 (19%) on voriconazole, and 10 (7%) were not treated medically. The remainder (64 patients, 31%) had previously trialled, or remained on, azole therapy at inclusion (Group B) of whom 46 (72%) received itraconazole, 16 (25%) voriconazole, and 2 (3%) posaconazole. Initial therapy was continued for 12 months in 78 patients (48%) of those treated; the azole was changed in 62 (32%) patients and discontinued in 56 (29%) patients for adverse reactions (32, 57%), azole resistance (11, 20%), clinical failure (8, 14%) or clinical stability (5, 9%). Azole discontinuation rates were higher in Group B than in Group A (42% vs. 22%, p = 0.003). For all patients who survived, weight increased (median of 62.2Kg at baseline, to 64.8 at 12 months), mean Aspergillus IgG declined from 260 (baseline) to 154 (12 months) and QoL improved from 62.2/100 (baseline) to 57.2/100 (12 months). At 12 months, there was no difference in median survival between Groups A and B (95% vs. 91%, p = 0.173). The rate of emergence of resistance during therapy was 13% for itraconazole compared to 5% for voriconazole. Bronchial artery embolization was done in 9 (4.4%) patients and lobectomy in 7 (3.2%). The optimal duration of azole therapy in CPA is undetermined due to the absence of evidenced based endpoints allowing clinical trials to be undertaken. However we have demonstrated itraconazole and voriconazole are modestly effective for CPA, especially if given for 12 months, but fewer than 50% of patients manage this duration. This suggests extended therapy may be required for demonstrable clinical improvement.	[Bongomin, Felix; Harris, Chris; Hayes, Gemma; Kosmidis, Chris; Denning, David W.] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; [Bongomin, Felix; Hayes, Gemma; Kosmidis, Chris; Denning, David W.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Kosmidis, Chris; Denning, David W.] Manchester Acad Hlth Serv Ctr, Manchester, Lancs, England; [Hayes, Gemma] Northern Devon Healthcare Trust, North Devon Dist Hosp, Raleigh Pk, Barnstaple, Devon, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England.; Denning, DW (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England.; Denning, DW (corresponding author), Manchester Acad Hlth Serv Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019; Kosmidis, Chris/AAS-8700-2020; Bongomin, Felix/I-4626-2019	Denning, David/0000-0001-5626-2251; Kosmidis, Chris/0000-0003-0662-1265; Bongomin, Felix/0000-0003-4515-8517	UK National Health Service Highly Specialised Commissioning team; Cidara Therapeutics; Global Action Fund for Fungal Disease	UK National Health Service Highly Specialised Commissioning team; Cidara Therapeutics; Global Action Fund for Fungal Disease	This work was primarily funded by the UK National Health Service Highly Specialised Commissioning team and also supported by an educational grant from Cidara Therapeutics to the University Hospital of South Manchester and by a grant from the Global Action Fund for Fungal Disease to the University of Manchester on behalf of Dr. Felix Bongomin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by an educational grant from Cidara Therapeutics. We would like to thank Mr. Philip Foden of the department of medical statistics and Mr. Paul Somerset of the department of medical illustrations both of the Manchester University NHS Foundation Trust (Wythenshawe Hospital) for sacrificing their to time to help with statistics and illustrations respectively. This work was presented in part as an abstract at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, 2017) held in Vienna, Austria.	Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Al-shair K, 2013, CLIN INFECT DIS, V57, P828, DOI 10.1093/cid/cit411; Al-Shair K, 2013, CHEST, V144, P623, DOI 10.1378/chest.12-0014; Albarrag AM, 2011, ANTIMICROB AGENTS CH, V55, P5113, DOI 10.1128/AAC.00517-11; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; CAMPBELL JH, 1991, THORAX, V46, P839, DOI 10.1136/thx.46.11.839; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Felton TW, 2010, CLIN INFECT DIS, V51, P1383, DOI 10.1086/657306; Godet C, 2016, CHEST, V150, P139, DOI 10.1016/j.chest.2016.02.640; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Howard SJ, 2011, ANTIMICROB AGENTS CH, V55, P4802, DOI 10.1128/AAC.00304-11; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Izumikawa K, 2007, MED MYCOL, V45, P273, DOI 10.1080/13693780701278386; Jain Lakshmi R, 2006, J Infect, V52, pe133, DOI 10.1016/j.jinf.2005.08.022; Jewkes J., 1983, ANN THORAC SURG, V53, P621; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; JONES PW, 1994, EUR RESPIR J, V7, P55, DOI 10.1183/09031936.94.07010055; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Jones PW, 2008, STRUCTURE, V44, P1; Kawamura S, 2000, INTERNAL MED, V39, P209, DOI 10.2169/internalmedicine.39.209; Kohno S, 2004, SCAND J INFECT DIS, V36, P372, DOI 10.1080/00365540410020406; Kohno S, 2013, EUR J CLIN MICROBIOL, V32, P387, DOI 10.1007/s10096-012-1754-z; Kohno S, 2011, MED MYCOL, V49, P688, DOI 10.3109/13693786.2011.561369; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Lowes D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01062-2016; Muldoon EG, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0276-3; Newton PJ, 2016, J INFECTION, V73, P485, DOI 10.1016/j.jinf.2016.06.001; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Page ID, 2016, J INFECTION, V72, P240, DOI 10.1016/j.jinf.2015.11.003; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Sambatakou H, 2006, AM J MED, V119; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; TOMLINSON JR, 1987, CHEST, V92, P505, DOI 10.1378/chest.92.3.505; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Yoshida K, 2012, J INFECT CHEMOTHER, V18, P378, DOI 10.1007/s10156-012-0414-7	40	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193732	10.1371/journal.pone.0193732	http://dx.doi.org/10.1371/journal.pone.0193732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634721	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200002
J	Koziarska, D; Krol, J; Nocon, D; Kubaszewski, P; Rzepa, T; Nowacki, P				Koziarska, Dorota; Krol, Joanna; Nocon, Danuta; Kubaszewski, Przemyslaw; Rzepa, Teresa; Nowacki, Przemyslaw			Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland	PLOS ONE			English	Article							QUALITY-OF-LIFE; EMPLOYMENT STATUS; DISABILITY; PERSONALITY; FATIGUE; DISEASE; PEOPLE; SCALE; WORK; HOPE	Multiple Sclerosis (MS) is the most common, primary neurogenic cause of disability among young adults. We investigated demographic and clinical factors associated with unemployment on the example of 150 MS patients receiving immunomodulatory treatment in Poland. This study was based on clinical evaluation and collection of self-reported questionnaires, with an attention to self-motivation, severe fatigue and moderate disability. Patients who were unemployed (40% of all patients) had a mean disease duration of almost 5 years. Older (p<0.001), less educated (p = 0.007) and more severely disabled patients (p<0,001) were most likely to be unemployed. Moderate disability (OR = 11.089 95% CI: 4.11-34.201, p<0,001), severe fatigue (OR = 2.625 95% CI: 1.02-6.901, p = 0,046) and lower level of self-motivation (KNS) (OR = 0.947, 95% CI: 0.896-0.006, p = 0.042) were independently associated with unemployment.	[Koziarska, Dorota; Nocon, Danuta; Nowacki, Przemyslaw] Pomeranian Med Univ, Dept Neurol, Szczecin, Poland; [Krol, Joanna] Univ Szczecin, Inst Psychol, Szczecin, Poland; [Kubaszewski, Przemyslaw; Rzepa, Teresa] Univ Social Sci & Humanities Poznan, Poznan, Poland	Pomeranian Medical University; University of Szczecin	Koziarska, D (corresponding author), Pomeranian Med Univ, Dept Neurol, Szczecin, Poland.	dorkoz@pum.edu.pl		Nowacki, Przemyslaw/0000-0002-6536-2905; Rzepa, Teresa/0000-0002-2128-8416				Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; Amato MP, 2010, NEUROL SCI, V31, P211, DOI 10.1007/s10072-010-0376-4; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; [Anonymous], MSQL MULT SCLER QUAL; Barnum DD, 1998, CHILD HEALTH CARE, V27, P15, DOI 10.1207/s15326888chc2701_2; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Bevan S, 2011, M EMPL CAR ASP PEOPL; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Carrieri L, 2014, WORK, V47, P509, DOI 10.3233/WOR-131623; Edan G, 2014, J NEUROL NEUROSUR PS, V85, P1183, DOI 10.1136/jnnp-2013-306222; Edan G, 2015, 67 AAN 18 25 APR; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; GRONNING M, 1990, J NEUROL NEUROSUR PS, V53, P388, DOI 10.1136/jnnp.53.5.388; Kappos L, 2015, J NEUROL NEUROSUR PS, V86, P1202, DOI 10.1136/jnnp-2014-310024; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laguna M., 2005, KWESTIONARIUSZ NADZI; LINN MW, 1985, AM J PUBLIC HEALTH, V75, P502, DOI 10.2105/AJPH.75.5.502; Miller A, 2006, QUAL LIFE RES, V15, P259, DOI 10.1007/s11136-005-0891-6; Moore P, 2013, MULT SCLER J, V19, P1647, DOI 10.1177/1352458513481396; Multiple Sclerosis International Federation, MSIF SURV EMPL MS; O'Connor R, 2005, J NEUROL, V252, P892, DOI 10.1007/s00415-005-0765-4; Orlewska E, 2005, EUR J NEUROL, V12, P31, DOI 10.1111/j.1468-1331.2004.00950.x; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Pfleger CCH, 2010, EUR J NEUROL, V17, P1346, DOI 10.1111/j.1468-1331.2010.03020.x; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; Pompeii LA, 2005, J OCCUP REHABIL, V15, P69, DOI 10.1007/s10926-005-0875-y; Ratsep T, 2000, MULT SCLER, V6, P397, DOI 10.1177/135245850000600607; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Snyder C.R., 1997, GROUP DYN-THEOR RES, V1, P107, DOI [DOI 10.1037/1089-2699.1.2.107, 10.1037/1089-2699.1.2.107]; Snyder CR, 1997, J PEDIATR PSYCHOL, V22, P399, DOI 10.1093/jpepsy/22.3.399; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Snyder CR, 2001, COPING STRESS, P3, DOI [DOI 10.1093/MED:PSYCH/9780195130447.001.0001, DOI 10.1093/MED:PSYCH/9780195130447.003.0001]; Strober LB, 2012, MULT SCLER J, V18, P647, DOI 10.1177/1352458511426735; Trisolini M, 2010, MULT SCLER INT FED, P1, DOI [10.18632/oncotarget.21284, DOI 10.18632/ONCOTARGET.21284]; Uccelli MM, 2009, J NEUROL, V256, P1989, DOI 10.1007/s00415-009-5225-0; Wickstrom A, MULT SCLER	40	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194117	10.1371/journal.pone.0194117	http://dx.doi.org/10.1371/journal.pone.0194117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634737	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200007
J	Song, Y; Liu, Y; Pan, Y; Yuan, XF; Chang, PY; Tian, Y; Cui, WW; Li, D				Song, Yuan; Liu, Ya; Pan, Yun; Yuan, Xiaofeng; Chang, Pengyu; Tian, Yuan; Cui, Weiwei; Li, Dong			The effect of long chain polyunsaturated fatty acid supplementation on intelligence in low birth weight infant during lactation: A meta-analysis	PLOS ONE			English	Article							PRETERM INFANTS; DOCOSAHEXAENOIC ACID; CHILDRENS IQ; DOUBLE-BLIND; AGE; COGNITION; TRIAL; MILK	Background Low birth weight infant (LBWIs) are prone to mental and behavioural problems. As an important constituent of the brain and retina, long chain polyunsaturated fatty acids are essential for foetal infant mental and visual development. The effect of lactation supplemented with long chain polyunsaturated fatty acids (LCPUFA) on the improvement of intelligence in low birth weight children requires further validation. Methods In this study, a comprehensive search of multiple databases was performed to identify studies focused the association between intelligence and long chain polyunsaturated fatty acid supplementation in LBWIs. Studies that compared the Bayley Scales of Infant Development (BSID) or the Wechsler Abbreviated Scale of Intelligence for Children (WISC) scores between LBWIs who were supplemented and controls that were not supplemented with LCPUFA during lactation were selected for inclusion in the meta-analysis. Results The main outcome was the mean difference in the mental development index (MDI) and psychomotor development index (PDI) of the BSID and the full scale intelligence quotient (FSIQ), verbal intelligence quotient (VIQ) and performance intelligence quotient (PIQ) of the WISC between LBWIs and controls. Our findings indicated that the mean BSID or WISC scores in LBWIs did not differ between the supplemented groups and controls. Conclusion This meta-analysis does not reveal that LCPUFA supplementation has a significant impact on the level of intelligence in LBWIs.	[Song, Yuan; Liu, Ya; Cui, Weiwei] Jilin Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Changchun, Jilin, Peoples R China; [Song, Yuan] Jilin Prov Peoples Hosp, Dept Gastroenterol, Changchun, Jilin, Peoples R China; [Pan, Yun] Tianqiao Dist Jinan Food & Drug Adm, Jinan, Shandong, Peoples R China; [Yuan, Xiaofeng] Changchun Univ Chinese Med, Affiliated Hosp, Dept Pediat, Changchun, Jilin, Peoples R China; [Chang, Pengyu] Jilin Univ, Hosp 1, Dept Radiotherapy, Changchun, Jilin, Peoples R China; [Tian, Yuan] Jilin Univ, Coll Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun, Jilin, Peoples R China; [Li, Dong] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Jilin, Peoples R China; [Li, Dong] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin, Peoples R China	Jilin University; Changchun University of Chinese Medicine; Jilin University; Jilin University; Jilin University; Jilin University	Cui, WW (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Changchun, Jilin, Peoples R China.; Li, D (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Jilin, Peoples R China.; Li, D (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin, Peoples R China.	cuiweiwei@jlu.edu.cn; lidong1@jlu.edu.cn	Chang, Peng/GSE-0357-2022; Li, Dong/D-5419-2016	Li, Dong/0000-0002-2508-3282	National Natural Science Foundation of China [81773412, 81501423]; Norman Bethune Program of Jilin University [2015223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Norman Bethune Program of Jilin University	This work was supported by the National Natural Science Foundation of China (No. 81773412; 81501423) and the Norman Bethune Program of Jilin University (No. 2015223). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Almaas AN, 2015, PEDIATRICS, V135, P972, DOI 10.1542/peds.2014-4094; [Anonymous], 2009, LANCET, V373, P353, DOI 10.1016/S0140-6736(09)60114-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Collins CT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007314; Coutsoudis A, 2009, LANCET, V374, P423, DOI 10.1016/S0140-6736(09)60661-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang Po-Chiung, 2005, Chang Gung Med J, V28, P708; Fewtrell MS, 2004, J PEDIATR-US, V144, P471, DOI 10.1016/j.jpeds.2004.01.034; Fewtrell MS, 2002, PEDIATRICS, V110, P73, DOI 10.1542/peds.110.1.73; Gong Q, 2018, EUR J CULT STUD, V21, P223, DOI 10.1177/1367549416656859; Harris WS, 2015, J PERINATOL, V35, P1, DOI 10.1038/jp.2014.195; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Helland IB, 2008, PEDIATRICS, V122, pE472, DOI 10.1542/peds.2007-2762; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Isaacs EB, 2011, PEDIATRICS, V128, pE890, DOI 10.1542/peds.2010-3153; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kilbride HW, 2017, J PERINATOL, V37, P475, DOI 10.1038/jp.2017.12; Kitamura T, 2016, ANN NUTR METAB, V68, P103, DOI 10.1159/000443024; Kitsantas P, 2006, ARTIF INTELL MED, V38, P275, DOI 10.1016/j.artmed.2006.03.008; Kormos CE, 2014, J PUBLIC HEALTH-UK, V36, P213, DOI 10.1093/pubmed/fdt071; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Matinolli HM, 2015, J NUTR, V145, P2084, DOI 10.3945/jn.115.212415; MAUER AM, 1985, PEDIATRICS, V75, P976; Moon K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub5; O'Connor DL, 2001, PEDIATRICS, V108, P359, DOI 10.1542/peds.108.2.359; Organization WH, 1975, PREGN AB AD WHO M GE; Schulzke SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub4; Senn SJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-10; Singer LT, 2003, J DEV BEHAV PEDIATR, V24, P233, DOI 10.1097/00004703-200308000-00003; Smithers LG, 2010, AM J CLIN NUTR, V91, P628, DOI 10.3945/ajcn.2009.28603; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Taylor HG, 2000, DEV NEUROPSYCHOL, V17, P289, DOI 10.1207/S15326942DN1703_2; Uauy R, 2003, J PEDIATR-US, V143, pS17, DOI 10.1067/S0022-3476(03)00398-6; van Wezel-Meijler G, 2002, ACTA PAEDIATR, V91, P942, DOI 10.1080/080352502760272632; Westerberg AC, 2011, ACTA PAEDIATR, V100, P47, DOI 10.1111/j.1651-2227.2010.01946.x; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; Woltil HA, 1999, PROSTAG LEUKOTR ESS, V61, P235, DOI 10.1054/plef.1999.0095	39	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195662	10.1371/journal.pone.0195662	http://dx.doi.org/10.1371/journal.pone.0195662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634752	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200046
J	Ding, JF; Huang, ZJ; Zhu, M; Li, CY; Zhu, XK; Guo, WS				Ding, Jinfeng; Huang, Zhengjin; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan			Does cyclic water stress damage wheat yield more than a single stress?	PLOS ONE			English	Article							WINTER-WHEAT; WATERLOGGING TOLERANCE; DRY-MATTER; DROUGHT STRESS; SPRING WHEAT; GRAIN-YIELD; GROWTH; SOIL; MECHANISMS; BARLEY	The occurrence of water stress during wheat growth is more frequent due to climate change. Three experiments (cyclic drought, cyclic waterlogging, and cyclic drought plus waterlogging) were conducted to investigate the effects of mild and severe cyclic/single water stress at elongation and heading stages on winter wheat (Triticum aestivum L.) yield. The effect of either mild drought at elongation or mild waterlogging at heading on wheat yield was not significant; however, significance did occur under other single water stresses. As the stress becomes more severe, the yield loss significantly increases. Extreme drought/waterlogging treatment at elongation caused a greater yield penalty than stress at heading stage. Except the combination of mild drought and mild waterlogging treatment, cyclic water stress significantly decreased wheat yields. The decrease in wheat yield under cyclic severe drought and waterlogging was significantly higher than any other treatment, with percentage decreases of 71.52 and 73.51%, respectively. In general, a yield reduction from mild cyclic water stress did not indicate more severe damage than single treatments; in contrast, grain yield suffered more when water stress occurred again after severe drought and waterlogging. Drought during elongation significantly decreased kernel number, whereas drought at heading/waterlogging during elongation and heading decreased the spike weight, which might be the main reason for the yield penalty. Furthermore, water stress caused variation in the decrease of total biomass and/or harvest index. The present study indicates comprehensive understanding of the types, degree, and stages of water stress are essential for assessing the impact of multiple water stresses on wheat yield.	[Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China; [Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou, Jiangsu, Peoples R China; [Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China; [Huang, Zhengjin] Jiangsu Prov & Chinese Acad Sci, Nanjing Bot Garden Mem Sun Yat Sen, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Inst Agr Sci, Yangzhou, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Inst Technol Dev, Yangzhou, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Minist Educ China, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Chinese Academy of Sciences; Yangzhou University; Yangzhou University; Ministry of Education, China; Yangzhou University	Guo, WS (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Inst Agr Sci, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Inst Technol Dev, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Minist Educ China, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China.	guows@yu.edu.cn		Ding, Jinfeng/0000-0002-3845-9429	National Natural Science Foundation of China [31401317]; National Key Research and Development Program of China [2016YFD0300405]; Special Scientific Research Fund of the Ministry of Agriculture [201503130]; Jiangsu Agricultural Industry Technology System [SXGC[2017]295]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science and Technology Innovation Team of Yangzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Special Scientific Research Fund of the Ministry of Agriculture; Jiangsu Agricultural Industry Technology System; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science and Technology Innovation Team of Yangzhou University	This work was supported by the grants from the National Natural Science Foundation of China (31401317), the National Key Research and Development Program of China (2016YFD0300405), the Special Scientific Research Fund of the Ministry of Agriculture (201503130), Jiangsu Agricultural Industry Technology System (SXGC[2017]295), the Priority Academic Program Development of Jiangsu Higher Education Institutions and Science and Technology Innovation Team of Yangzhou University.	Ali M, 1999, FIELD CROP RES, V62, P35, DOI 10.1016/S0378-4290(99)00003-9; Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Cheng S., 2012, WHEAT S CHINA; de San Celedonio RP, 2014, PLANT SOIL, V378, P265, DOI 10.1007/s11104-014-2028-6; Dickin E, 2009, J AGR SCI-CAMBRIDGE, V147, P127, DOI 10.1017/S0021859608008289; Dickin E, 2008, EUR J AGRON, V28, P234, DOI 10.1016/j.eja.2007.07.010; Eck HV, 1998, AGRON J, V80, P902; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Foulkes MJ, 2007, FIELD CROP RES, V103, P11, DOI 10.1016/j.fcr.2007.04.007; GALES K, 1984, PLANT SOIL, V80, P67, DOI 10.1007/BF02232940; Hague ME, 2012, PLANT PROD SCI, V15, P164, DOI 10.1626/pps.15.164; Herzog M, 2016, PLANT CELL ENVIRON, V39, P1068, DOI 10.1111/pce.12676; Hossain MA, 2011, AUST J CROP SCI, V5, P1094; Izanloo A, 2008, J EXP BOT, V59, P3327, DOI 10.1093/jxb/ern199; Jager K, 2014, J PLANT PHYSIOL, V171, P1256, DOI 10.1016/j.jplph.2014.04.013; Li P, 2011, AGRON J, V103, P1619, DOI 10.2134/agronj2011.0013; Liu CL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034002; Liu EK, 2016, AGR WATER MANAGE, V167, P75, DOI 10.1016/j.agwat.2015.12.026; Ma J, 2014, CROP SCI, V54, P331, DOI 10.2135/cropsci2013.03.0141; Nezhadahmadi A, 2013, SCI WORLD J, DOI 10.1155/2013/610721; Sayre K., 1994, ANN WHEAT NEWSL, V40, P165; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Setter TL, 2000, DAW292 GRDC, P68; Shao GC, 2013, PHOTOSYNTHETICA, V51, P429, DOI 10.1007/s11099-013-0039-9; SOJKA RE, 1975, AGRON J, V67, P591, DOI 10.2134/agronj1975.00021962006700050001x; Tan W, 2008, PHOTOSYNTHETICA, V46, P21, DOI 10.1007/s11099-008-0005-0; Vicente-Serrano SM, 2010, AGR FOREST METEOROL, V150, P614, DOI 10.1016/j.agrformet.2010.02.002; WATSON ER, 1976, AUST J EXP AGR, V16, P114, DOI 10.1071/EA9760114; Wollenweber B, 2003, J AGRON CROP SCI, V189, P142, DOI 10.1046/j.1439-037X.2003.00025.x; Wu JD, 2014, ACTA PHYSIOL PLANT, V36, P207, DOI 10.1007/s11738-013-1401-z; Yang JC, 2000, CROP SCI, V40, P1645, DOI 10.2135/cropsci2000.4061645x; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069	34	25	25	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195535	10.1371/journal.pone.0195535	http://dx.doi.org/10.1371/journal.pone.0195535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630647	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000057
J	Lee, SE; Sung, JM; Cho, IJ; Kim, HC; Chang, HJ				Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Kim, Hyeon Chang; Chang, Hyuk-Jae			Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort	PLOS ONE			English	Article							PRIMARY PREVENTION; THERAPY; INTERVENTION; METAANALYSIS; MORTALITY; MELLITUS; JUPITER; TRIAL; WOMEN	Background Statins have been known to increase the risk of incident type 2 diabetes mellitus (DM); however, other factors, especially hypertension, are also associated with DM development. Objective We investigated whether statin use increases the risk of DM and further analyzed whether the relation between statin use and incident DM differs according to the presence of hypertension and gender. Methods From a nationwide health-screening cohort, 40,164 participants with total cholesterol levels >= eve mg/dL and without pre-diagnosed DM, cardiovascular disease, or cancer, who underwent a series of regular health check-ups, were enrolled. Statin users were defined as participants who were prescribed statins more than twice during 6 months. Results There were 17,798 statin non-users and 22,366 statin users. During 7.66 +/- 3.21 years of follow-up, incident DM developed in 5.68% of statin non-users and 7.64% of statin users. Among the entire study population, statin use was associated with new-onset DM after adjusting for clinical risk factors. In sub-analysis according to hypertension, statin use significantly increased the risk of incident DM only in normotensive patients [hazard ratio (HR) 1.31, 95% confidence interval (CI) 1.09 to 1.58, p = 0.004], and not in hypertensive patients (p>0.05). Furthermore, continuous statin use was strongly associated with new-onset DM in women, regardless of hypertension presence (all p<0.05). However, in men, statin was associated with new-onset DM only in normotensive males (HR 1.61, 95% CI 1.35 to 1.92, p<0.001) and not in hypertensive males (p>0.05). Conclusions Statin use increased the risk of new-onset DM only in normotensive patients and hypertensive women, suggesting that these groups should be more carefully monitored for the development of DM during the course of follow-up.	[Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Kim, Hyeon Chang; Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Chang, Hyuk-Jae] Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Cardiovasc Imaging Res Ctr, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Yonsei Univ Hlth Syst, Dept Prevent Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Cardiovasc Imaging Res Ctr, Coll Med, Seoul, South Korea.	hjchang@yuhs.ac	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Sang-Eun/0000-0001-6645-4038; Chang, Hyuk-Jae/0000-0002-6139-7545	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [2012027176]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT)	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (MSIT), (No. 2012027176) (HJC). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. HJC had full access to all of the data in the study and had final responsibility for the decision to submit for publication.	Baker WL, 2010, DIABETES RES CLIN PR, V87, P98, DOI 10.1016/j.diabres.2009.10.008; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Food U Administration D, 2015, FDA EXP ADV STAT RIS; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Ha KH, 2015, ENDOCRINOL METAB, V30, P142, DOI 10.3803/EnM.2015.30.2.142; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Koh KK, 2012, INT J CARDIOL, V154, P97, DOI 10.1016/j.ijcard.2011.09.002; Koo BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110650; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Mancia G, 2003, HYPERTENSION, V41, P431, DOI 10.1161/01.HYP.0000057420.27692.AD; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mancia G, 2009, J HYPERTENS, V27, P1672, DOI 10.1097/HJH.0b013e32832be5f9; Mason JM, 2005, J HYPERTENS, V23, P1777, DOI 10.1097/01.hjh.0000177537.91527.09; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sowers JR, 2000, NEW ENGL J MED, V342, P969, DOI 10.1056/NEJM200003303421310; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884	28	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195459	10.1371/journal.pone.0195459	http://dx.doi.org/10.1371/journal.pone.0195459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630642	Green Published, gold			2022-12-27	WOS:000429505000050
J	Orysiak, J; Mazur-Rozycka, J; Fitzgerald, J; Starczewski, M; Malczewska-Lenczowska, J; Busko, K				Orysiak, Joanna; Mazur-Rozycka, Joanna; Fitzgerald, John; Starczewski, Michal; Malczewska-Lenczowska, Jadwiga; Busko, Krzysztof			Vitamin D status and its relation to exercise performance and iron status in young ice hockey players	PLOS ONE			English	Article							PROFESSIONAL FOOTBALL PLAYERS; ATHLETIC PERFORMANCE; COMPETITIVE SEASON; D SUPPLEMENTATION; D INSUFFICIENCY; HIGH PREVALENCE; MUSCLE FUNCTION; WINTER MONTHS; STRENGTH; ASSOCIATION	Objectives The aim was to examine the association between serum vitamin D concentration and isometric strength of various muscle groups, vertical jump performance, and repeated sprint ability in young ice hockey players. The secondary aim was to determine the association between vitamin D deficiency and indices of iron status. Methods Fifty male ice hockey players (17.2 +/- 0.9 years) participated in this cross-sectional study. Exercise performance was evaluated using isometric strength measures of upper and lower extremities, vertical jump performance and repeated sprint ability (RSA). Blood samples were collected for the determination of serum 25-hydroxyvitamin D (25(OH)D) and multiple indicies of iron status. Results The mean serum 25(OH)D concentration was 30.4 ng.ml(-1) and ranged from 12.5 to 91.4 ng.ml(-1). Eleven participants (22%) had vitamin D deficiency and 20 athletes (40%) had vitamin D insufficiency. Serum 25(OH)D concentration was not positively correlated with isometric muscle strength, vertical jump performance, or RSA after adjusting for age, training experience, fat mass, fat free mass and height. Serum 25(OH)D concentration was not associated with indices of iron status. Conclusion Vitamin D insufficiency is highly prevalent in ice hockey players, but 25(OH)D concentration but it is not associated with exercise performance or indices of iron status.	[Orysiak, Joanna; Malczewska-Lenczowska, Jadwiga] Natl Res Inst, Dept Nutr Physiol & Dietet, Inst Sport, Warsaw, Poland; [Mazur-Rozycka, Joanna] Natl Res Inst CIOP PIB, Cent Inst Labour Protect, Dept Ergon, Warsaw, Poland; [Fitzgerald, John] Univ North Dakota, Dept Kinesiol & Publ Hlth Educ, Grand Forks, ND USA; [Starczewski, Michal] Natl Res Inst, Dept Physiol, Inst Sport, Warsaw, Poland; [Busko, Krzysztof] Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland	Institute of Sport - National Research Institute; Central Institute for Labour Protection - National Research Institute; University of North Dakota Grand Forks; Institute of Sport - National Research Institute; Kazimierz Wielki University	Busko, K (corresponding author), Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland.	krzysztof.busko@ukw.edu.pl	Starczewski, Michal/AAS-9392-2021; Malczewska-Lenczowska, Jadwiga/O-4417-2018; Starczewski, Michal/ABH-1873-2021; Buśko, Krzysztof/ABE-7456-2020	Starczewski, Michal/0000-0001-7419-8943; Malczewska-Lenczowska, Jadwiga/0000-0001-9574-8158; Starczewski, Michal/0000-0001-7419-8943; Buśko, Krzysztof/0000-0002-6456-3502; Mazur-Rozycka, Joanna/0000-0002-3905-9291; Orysiak, Joanna/0000-0002-4998-2274	Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland [2016/0005/0223/SubB/DSW]; Institute of Sport National Research Institute [102.05]	Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland; Institute of Sport National Research Institute	This work was co-supported by the Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland (grant number 2016/0005/0223/SubB/DSW) and Institute of Sport National Research Institute (grant number 102.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bacchetta J, 2014, J AM SOC NEPHROL, V25, P564, DOI 10.1681/ASN.2013040355; Biesalski HK, 2011, NUTRITION, V27, pS1, DOI 10.1016/j.nut.2011.04.002; Bishop D, 2003, J SCI MED SPORT, V6, P199, DOI 10.1016/S1440-2440(03)80255-4; Brocherie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144446; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; Close GL, 2013, J SPORT SCI, V31, P344, DOI 10.1080/02640414.2012.733822; Close GL, 2013, BRIT J SPORT MED, V47, P692, DOI 10.1136/bjsports-2012-091735; Constantini NW, 2010, CLIN J SPORT MED, V20, P368, DOI 10.1097/JSM.0b013e3181f207f2; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Deakin V, 2010, CLIN SPORTS NUTR, P222; Dellavalle DM, 2014, MED SCI SPORT EXER, V46, P1204, DOI 10.1249/MSS.0000000000000208; DeLuca HF, 2016, VITAM HORM, V100, P1, DOI 10.1016/bs.vh.2015.11.001; Dubnov-Raz G, 2015, PEDIATR EXERC SCI, V27, P113, DOI 10.1123/pes.2014-0030; Dzedzej A, 2016, BIOL SPORT, V33, P223, DOI 10.5604/20831862.1201811; Fallon KE, 2008, J SCI MED SPORT, V11, P329, DOI 10.1016/j.jsams.2007.02.017; Farlinger CM, 2007, J STRENGTH COND RES, V21, P915; Farrokhyar F, 2015, SPORTS MED, V45, P365, DOI 10.1007/s40279-014-0267-6; Fitzgerald JS, 2015, J STRENGTH COND RES, V29, P2513, DOI 10.1519/JSC.0000000000000887; Fitzgerald JS, 2014, J STRENGTH COND RES, V28, P3200, DOI 10.1519/JSC.0000000000000523; Gajewski J, 2011, BIOL SPORT, V28, P239, DOI 10.5604/965479; Gajewski J, 2018, ACTA BIOENGINEERING, V20; Gibson R.S., 2005, PRINCIPLES NUTR ASSE, V2nd ed., P443; Hamilton B, 2014, J SCI MED SPORT, V17, P139, DOI 10.1016/j.jsams.2013.03.006; Heaney RP, 2011, J BONE MINER RES, V26, P455, DOI 10.1002/jbmr.328; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Jastrzebska M, 2016, J STRENGTH COND RES, V30, P2648, DOI 10.1519/JSC.0000000000001337; Koundourakis NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101659; Malczewska-Lenczowska J, 2009, BIOMED HUM KINET, V1, P36, DOI 10.2478/v10101-009-0010-1; Mielgo-Ayuso J, 2015, APPL PHYSIOL NUTR ME, V40, P615, DOI 10.1139/apnm-2014-0500; Monlezun DJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001799; Orysiak J, 2015, J STRENGTH COND RES, V29, P2333, DOI 10.1519/JSC.0000000000000880; Owens DJ, 2018, SPORTS MED, V48, pS3, DOI 10.1007/s40279-017-0841-9; Peeling P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093002; Peterson BJ, 2015, J STRENGTH COND RES, V29, P1465, DOI 10.1519/JSC.0000000000000786; Pludowski P, 2013, ENDOKRYNOL POL, V64, P319, DOI 10.5603/EP.2013.0012; Sghaier-Ayadi A, 2015, BIOL SPORT, V32, P281, DOI 10.5604/20831862.1163690; Solarz K, 2014, PHYSIOL RES, V63, P237, DOI 10.33549/physiolres.932586; Valtuena J, 2014, NUTR HOSP, V30, P124, DOI 10.3305/nh.2014.30.1.7539; Weaver CM, 2004, AM J CLIN NUTR, V80, p1735S, DOI 10.1093/ajcn/80.6.1735S; Wyon MA, 2016, CLIN J SPORT MED, V26, P279, DOI 10.1097/JSM.0000000000000264; Wyon MA, 2014, J SCI MED SPORT, V17, P8, DOI 10.1016/j.jsams.2013.03.007	43	9	10	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195284	10.1371/journal.pone.0195284	http://dx.doi.org/10.1371/journal.pone.0195284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630669	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000035
J	Wozniak-Knopp, G; Stadlmayr, G; Perthold, JW; Stadlbauer, K; Gotsmy, M; Becker, S; Ruker, F				Wozniak-Knopp, Gordana; Stadlmayr, Gerhard; Perthold, Jan Walther; Stadlbauer, Katharina; Gotsmy, Mathias; Becker, Stefan; Rueker, Florian			An antibody with Fab-constant domains exchanged for a pair of C(H)3 domains	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; HUMAN IGG1; EFFECTOR FUNCTION; STRUCTURAL CLASSIFICATION; DIRECTED EVOLUTION; VARIABLE DOMAINS; IMMUNOGLOBULIN-G; BISPECIFIC IGG; DISULFIDE BOND; STABILITY	We have designed a complete antibody-like construct where the C(H)1 and C-K domains are exchanged for a pair of the C(H)3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immunoglobulin sequences without artificial linkers, expressed at a high level in mammalian cells, however exhibited low solubility. Rational mutagenesis aimed at the amino acid residues located at the interface of the variable domains and the exchanged CH3 domains was applied to improve the biophysical properties of the molecule. The domain -exchanged construct, including variable domains of the HER2/neu specific antibody trastuzumab, was able to bind to the surface of the strongly HER2/neu positive cell line SKBR3 4-fold weaker than trastuzumab, but could nevertheless incite a more potent response in an antibody-dependent cell cytotoxicity (ADCC) reporter assay with Fc gamma RIlla-overexpressing T-cells. This could be explained with a stronger binding to the Fc gamma RIlla. Importantly, the novel construct could mediate a specific ADCC effect with natural killer cells similar to the parental antibody.	[Wozniak-Knopp, Gordana; Stadlmayr, Gerhard; Stadlbauer, Katharina; Gotsmy, Mathias; Rueker, Florian] Univ Nat Resources & Life Sci BOKU, Dept Biotechnol, Christian Doppler Lab Innovat Immunotherapeut, Vienna, Austria; [Perthold, Jan Walther] Univ Nat Resources & Life Sci BOKU, Inst Mol Modeling & Simulat, Dept Mat Sci, Vienna, Austria; [Becker, Stefan] Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Merck KGaA	Wozniak-Knopp, G (corresponding author), Univ Nat Resources & Life Sci BOKU, Dept Biotechnol, Christian Doppler Lab Innovat Immunotherapeut, Vienna, Austria.	gordana.wozniak@boku.ac.at	Wozniak-Knopp, Gordana/AAL-5148-2021; Perthold, Jan Walther/I-3359-2019	Wozniak-Knopp, Gordana/0000-0002-4069-070X; Perthold, Jan Walther/0000-0002-8575-0278; Stadlbauer, Katharina/0000-0002-0724-5874; Gotsmy, Mathias/0000-0003-1333-4870; Rueker, Florian/0000-0001-7639-2686	Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria); F-star; Merck KGaA	Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria); F-star; Merck KGaA(Merck & Company)	This study was funded by Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria) to GWK, (CD Laboratory for Innovative Immunotherapeutics) and F-star (www.f-star.com). These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck KGaA provided support in the form of salary for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Grevys A, 2015, J IMMUNOL, V194, P5497, DOI 10.4049/jimmunol.1401218; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hu SZ, 1996, CANCER RES, V56, P3055; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Krah S, 2017, PROTEIN ENG DES SEL, V30, P291, DOI 10.1093/protein/gzw077; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lefranc MP, 2009, IMGT INT IMMUNOGENET; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Leung KM, 2015, MOL THER, V23, P1722, DOI 10.1038/mt.2015.127; Liu Z, 2015, J BIOL CHEM, V290, P7535, DOI 10.1074/jbc.M114.620260; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moore PA, 2011, BLOOD, V117, P4542, DOI 10.1182/blood-2010-09-306449; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Saxena A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00580; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen Y, 2013, MABS-AUSTIN, V5, P418, DOI 10.4161/mabs.24291; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Skegro D, 2017, J BIOL CHEM; Teerinen T, 2006, J MOL BIOL, V361, P687, DOI 10.1016/j.jmb.2006.06.073; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; TISCHENKO VM, 1982, EUR J BIOCHEM, V126, P517, DOI 10.1111/j.1432-1033.1982.tb06811.x; Tischenko VM, 1998, BIOCHEMISTRY-US, V37, P5576, DOI 10.1021/bi972647a; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; Traxlmayr MW, 2012, BBA-PROTEINS PROTEOM, V1824, P542, DOI 10.1016/j.bbapap.2012.01.006; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Wozniak-Knopp G, 2012, ARCH BIOCHEM BIOPHYS, V526, P181, DOI 10.1016/j.abb.2012.03.024; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Yan BX, 2012, J BIOL CHEM, V287, P5891, DOI 10.1074/jbc.M111.311811	43	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195442	10.1371/journal.pone.0195442	http://dx.doi.org/10.1371/journal.pone.0195442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630643	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000049
J	Heinrichs, V; Dieluweit, S; Stellbrink, J; Pyckhout-Hintzen, W; Hersch, N; Richter, D; Merkel, R				Heinrichs, Viktor; Dieluweit, Sabine; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Hersch, Nils; Richter, Dieter; Merkel, Rudolf			Chemically defined, ultrasoft PDMS elastomers with selectable elasticity for mechanobiology	PLOS ONE			English	Article							LINEAR VISCOELASTICITY; MECHANICAL-PROPERTIES; CURE KINETICS; CELL; STIFFNESS; RIGIDITY; SIZE; POLYMER	Living animal cells are strongly influenced by the mechanical properties of their environment. To model physiological conditions ultrasoft cell culture substrates, in some instances with elasticity (Young's modulus) of only 1 kPa, are mandatory. Due to their long shelf life PDMS-based elastomers are a popular choice. However, uncertainty about additives in commercial formulations and difficulties to reach very soft materials limit their use. Here, we produced silicone elastomers from few, chemically defined and commercially available substances. Elastomers exhibited elasticities in the range from 1 kPa to 55 kPa. In detail, a high molecular weight (155 kg/mol), vinyl-terminated linear silicone was crosslinked with a multifunctional (f = 51) crosslinker (a copolymer of dimethyl siloxane and hydrosilane) by a platinum catalyst. The following different strategies towards ultrasoft materials were explored: sparse crosslinking, swelling with inert silicone polymers, and, finally, deliberate introduction of dangling ends into the network (inhibition). Rheological experiments with very low frequencies led to precise viscoelastic characterizations. All strategies enabled tuning of stiffness with the lowest stiffness of-1 kPa reached by inhibition. This system was also most practical to use. Biocompatibility of materials was tested using primary cortical neurons from rats. Even after several days of cultivation no adverse effects were found.	[Heinrichs, Viktor; Dieluweit, Sabine; Hersch, Nils; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany; [Heinrichs, Viktor; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Richter, Dieter] Forschungszentrum Julich, Juelich Ctr Neutron Sci 1, Julich, Germany; [Heinrichs, Viktor; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Richter, Dieter] Forschungszentrum Julich, Inst Complex Syst 1, Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Merkel, R (corresponding author), Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany.	r.merkel@fz-juelich.de	pyckhout-hintzen, wim/J-9461-2013; Stellbrink, Jorg/K-3351-2013; Richter, Dieter/H-3701-2013; Merkel, Rudolf/G-3647-2013	pyckhout-hintzen, wim/0000-0002-1142-359X; Stellbrink, Jorg/0000-0001-6183-3901; Richter, Dieter/0000-0003-0719-8470; Merkel, Rudolf/0000-0003-3178-3282; Hersch, Nils/0000-0003-4717-8984				[Anonymous], 1980, VISCOELASTIC PROPERT; Bejenariu A.G., 2009, COMP STUDY INFLUENCE, V17, P269; Brands D W, 2000, Stapp Car Crash J, V44, P249; Cai LH, 2015, ADV MATER, V27, P5132, DOI 10.1002/adma.201502771; Carraher CE, 2000, APPL POLYM SCI 21 CE; CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Colby R.H., 2003, POLYM PHYS; DAVIDSON DW, 1950, J CHEM PHYS, V18, P1417, DOI 10.1063/1.1747496; DAVIDSON DW, 1951, J CHEM PHYS, V19, P1484, DOI 10.1063/1.1748105; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doi M., 1988, THEORY POLYM DYNAMIC; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061; Frankr SMG, 2012, RHEOL ACTA, V51, P559, DOI 10.1007/s00397-012-0624-z; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Guan DB, 2016, CHINESE J POLYM SCI, V34, P1290, DOI 10.1007/s10118-016-1847-8; HAVRILIAK S, 1966, J POLYM SCI POL SYM, P99; Hong IK, 2013, J IND ENG CHEM, V19, P42, DOI 10.1016/j.jiec.2012.05.006; Jensen MK, 2009, INT J ADHES ADHES, V29, P687, DOI 10.1016/j.ijadhadh.2008.10.005; Larsen AL, 2004, E-POLYMERS; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Moreira R, 2014, TISSUE ENG PART C-ME, V20, P741, DOI 10.1089/ten.tec.2013.0426; Mrozek RA, 2011, POLYMER, V52, P3422, DOI 10.1016/j.polymer.2011.05.021; Nejad SP, 2016, ADV DRUG DELIVER REV, V96, P161, DOI 10.1016/j.addr.2015.11.003; PATEL SK, 1992, MACROMOLECULES, V25, P5241, DOI 10.1021/ma00046a021; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Santoro F, 2014, NANO LETT, V14, P6906, DOI 10.1021/nl502922b; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; STAUFFER D, 1994, INTRO PERCOLATION TH; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; TOLL JS, 1956, PHYS REV, V104, P1760, DOI 10.1103/PhysRev.104.1760; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vlahos C, 2003, POLYMER, V44, P503, DOI 10.1016/S0032-3861(02)00511-6; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zorn R, 2002, J CHEM PHYS, V116, P3204, DOI 10.1063/1.1446035	45	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195180	10.1371/journal.pone.0195180	http://dx.doi.org/10.1371/journal.pone.0195180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624610	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600017
J	Nogueira, BMF; Rolla, VC; Akrami, KM; Kiene, SM				Nogueira, Betania M. F.; Rolla, Valeria C.; Akrami, Kevan M.; Kiene, Susan M.			Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; DIAGNOSIS	Background Worldwide, about 11% of Tuberculosis (TB) cases occur in people living with HIV (PLHIV) and it is the leading cause of death in this population. An important step towards reducing the incidence and mortality of TB in PLHIV is to reduce the time from onset of symptoms to treatment. Factors related to TB treatment delay therefore need to be understood. Methods Using data from a prospective cohort study of patients diagnosed with TB at the National Institute of Infectious Disease, at the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil we conducted a survival analysis to identify factors associated with patient and health care treatment delay. In our analysis we included patients who were co-infected with TB and HIV (n = 201). Patients were followed during the course of their TB treatment and information regarding duration of symptoms, sociodemographics and clinical characteristics were collected at the baseline visit. Results The median time from onset of initial symptoms to prescription of TB treatment (total delay) was 82 days. From initiation of symptoms to first visit at INI clinic (patient delay), the median was 51 days. From first visit to initiation of treatment (health care delay) the median was 16 days. Illiteracy was associated with greater patient delay [Hazard Ratio (HR) = 2.25, CI 95% 1.29-3.94]. Having had a previous episode of TB (HR = 0.53, CI 95% 0.37-0.74) and being married (HR = 0.71, CI 95% 0.54-0.94) were inversely related to patient delay. Illiteracy was also associated with greater health care delay (HR = 2.83, CI 95% 1.25-5.47) in contrast to high viral load (HR = 0.37, CI 95% 0.24-0.54) and weight loss greater than 10% (HR = 0.54, CI 95% 0.37-0.8), both of which were inversely related to health care delay. Conclusions This study highlights the existence of factors that lead to greater risk of delayed treatment of TB among patients co-infected with HIV and TB. These include factors that can be assessed through targeted interventions which have implications for improving treatment outcomes and, through reduced duration of infectiousness, reduce the incidence of TB in Brazil.	[Nogueira, Betania M. F.; Kiene, Susan M.] San Diego State Univ, Div Epidemiol & Biostat, San Diego, CA 92182 USA; [Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Akrami, Kevan M.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA	California State University System; San Diego State University; Fundacao Oswaldo Cruz; University of California System; University of California San Diego	Nogueira, BMF (corresponding author), San Diego State Univ, Div Epidemiol & Biostat, San Diego, CA 92182 USA.	betaniafnogueira@gmail.com	Rolla, Valeria Cavalcanti/AAI-6078-2021	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Kiene, Susan/0000-0001-8922-5289	Rotary Foundation [GG1745722]; J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil; UNODC; Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ [01/2013]	Rotary Foundation; J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil; UNODC; Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ	This work was supported by the Rotary Foundation grant GG1745722 and J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil to BMFN and the Brazilian Program of STD-AIDS and Viral Hepatitis, in partnership with the UNODC and the Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ, edital modalidade pesquisas no 01/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coimbra I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-208; dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; [Institut Brasileiro de Geogratia e Estatistica (IBGE) Pesquisa Nacional por Amostra de Domicilios (PNAD)], 2009, PESQ NAC AM DOM; Instituto Brasileiro de Geografia e Estatistica ( IBGE), 2016, 36 IBGE; Instituto Paulo Montenegro, 2011, IND ALF FUNC BRAS 20; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Madebo T., 1999, MED GEN MED, pE6; Ministerio da Saude, 2015, B EP TUB, V46; Ministerio da Saude do Brasil, 2015, B EP HIV AIDS; Saldana L, 2013, PUBLIC HEALTH, V127, P171, DOI 10.1016/j.puhe.2012.11.010; Saraceni V, 2008, INT J TUBERC LUNG D, V12, P769; Saraceni V, 2014, JAIDS-J ACQ IMM DEF, V67, P98, DOI 10.1097/QAI.0000000000000247; Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI 10.1590/S0034-89102009005000022; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Schmaltz CAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045704; Statistics Canada OECD, 2013, OECD SKILLS OUTL 201; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sunnetcioglu A, 2015, ANN CLIN MICROB ANTI; Sunnetcioglu A, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0092-2; UNAIDS, 2016, PREV GAP REP; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Whitehorn J, 2010, INT J TUBERC LUNG D, V14, P741; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, THE END TB STRAT; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, TUB PROF 2016; Wysocki AD, 2013, REV ESC ENFERM USP, V47, P434; Ponce MAZ, 2016, EPIDEMIOL SERV SAUDE, V25, P553, DOI [10.5123/s1679-49742016000300011, 10.5123/S1679-49742016000300011]	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195409	10.1371/journal.pone.0195409	http://dx.doi.org/10.1371/journal.pone.0195409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624603	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600027
J	Balakrishnan, S; Mironov, SL				Balakrishnan, Saju; Mironov, Sergej L.			Rescue of hyperexcitability in hippocampal CA1 neurons from Mecp2 ((-/y)) mouse through surface potential neutralization	PLOS ONE			English	Article							HCN1 CHANNELS; RETT-SYNDROME; BRAIN-STEM; CALCIUM-CHANNELS; EXTRACELLULAR PH; I-H; MODEL; HYPERVENTILATION; DYSFUNCTION; MAGNESIUM	Hyperventilation is a known feature of Rett syndrome (RTT). However, how hyperventilation is related to other RTT symptoms such as hyperexcitability is unknown. Intense breathing during hyperventilation induces hypocapnia and culminates in respiratory alkalosis. Alkalinization of extracellular milieu can trigger epilepsy in patients who already have neuronal hyperexcitability. By combining patch-clamp electrophysiology and quantitative glutamate imaging, we compared excitability of CA1 neurons of WT and Mecp2 ((-/y)) mice, and analyzed the biophysical properties of subthreshold membrane channels. The results show that Mecp2 ((-/y)) CA1 neurons are hyperexcitable in normal pH (7.4) and are increasingly vulnerable to alkaline extracellular pH (8.4), during which their excitability increased further. Under normal pH conditions, an abnormal negative shift in the voltage-dependencies of HCN (hyperpolarization-activated cyclic nucleotide-gated) and calcium channels in the CA1 neurons of Mecp2 ((-/y)) mice was observed. Alkaline pH also enhanced excitability in wild-type (WT) CA1 neurons through modulation of the voltage dependencies of HCN- and calcium channels. Additionally alkaline pH augmented spontaneous glutamate release and burst firing in WT CA1 neurons. Conversely, acidic pH (6.4) and 8 mM Mg2+ exerted the opposite effect, and diminished hyperexcitability in Mecp2 ((-/y)) CA1 neurons. We propose that the observed effects of pH and Mg2+ are mediated by changes in the neuronal membrane surface potential, which consecutively modulates the gating of HCN and calcium channels. The results provide insight to pivotal cellular mechanisms that can regulate neuronal excitability and help to devise treatment strategies for hyperexcitability induced symptoms of Rett syndrome.	[Balakrishnan, Saju; Mironov, Sergej L.] Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol, DFG Res Ctr 103,Cluster Excellence 171, Gottingen, Germany	University of Gottingen	Balakrishnan, S (corresponding author), Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol, DFG Res Ctr 103,Cluster Excellence 171, Gottingen, Germany.	saju.balakrishnan@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence [171]; Cluster of Excellence; DFG Research Centre for Nano scale Microscopy and Molecular Physiology of the Brain [EXC 171, FZT 103]	Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence; Cluster of Excellence; DFG Research Centre for Nano scale Microscopy and Molecular Physiology of the Brain	This project was funded by The Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence 171.	Avery RB, 1996, J NEUROSCI, V16, P5567; Balakrishnan S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00015; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bodda C, 2013, AM J PATHOL, V183, P195, DOI 10.1016/j.ajpath.2013.03.019; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cichy A, 2015, J NEUROSCI, V35, P4025, DOI 10.1523/JNEUROSCI.2593-14.2015; CIRIGNOTTA F, 1986, AM J MED GENET, V24, P167; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; EGGER J, 1992, LANCET, V340, P621, DOI 10.1016/0140-6736(92)92166-D; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Fedorovich SV, 2003, NEUROCHEM RES, V28, P715, DOI 10.1023/A:1022809716834; Galland L, 1991, Magnes Trace Elem, V10, P287; Gantz SC, 2011, J NEUROSCI, V31, P12629, DOI 10.1523/JNEUROSCI.0684-11.2011; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Herrmann S, 2015, INT J MOL SCI, V16, P1429, DOI 10.3390/ijms16011429; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmes MD, 2004, EPILEPSIA, V45, P618, DOI 10.1111/j.0013-9580.2004.63803.x; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Isaev D, 2012, J NEUROPHYSIOL, V107, P417, DOI 10.1152/jn.00574.2011; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Janc OA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00056; Jin XR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00316; Julu POO, 2001, ARCH DIS CHILD, V85, P29, DOI 10.1136/adc.85.1.29; Kalmbach BE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0114-15.2015; Kase D, 2012, J SIGNAL TRANSDUCT; KERR A, 1990, BRAIN DEV-JPN, V12, P61, DOI 10.1016/S0387-7604(12)80179-3; Khurana I, 2015, TXB MED PHYSL; KOSTYUK PG, 1982, J MEMBRANE BIOL, V70, P171, DOI 10.1007/BF01870560; Kumandas S, 2001, BRAIN DEV-JPN, V23, P240, DOI 10.1016/S0387-7604(01)00191-7; Kuwana S, 1998, BRAIN RES, V786, P194, DOI 10.1016/S0006-8993(97)01476-5; Lei SB, 2001, J NEUROPHYSIOL, V85, P2030, DOI 10.1152/jn.2001.85.5.2030; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; Mackay J, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9196-7; Makani S, 2007, J NEUROSCI, V27, P7438, DOI 10.1523/JNEUROSCI.2304-07.2007; Malcolm AT, 2003, BBA-BIOMEMBRANES, V1609, P183, DOI 10.1016/S0005-2736(02)00687-9; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Mironov SL, 2011, NEUROPHARMACOLOGY, V60, P869, DOI 10.1016/j.neuropharm.2011.01.002; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Mironov SL, 2000, EUR J NEUROSCI, V12, P520, DOI 10.1046/j.1460-9568.2000.00928.x; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Oginsky MF, 2017, J CELL PHYSIOL, V232, P1151, DOI 10.1002/jcp.25589; Okamoto K, 2014, J PHYSIOL SCI, V64, P421, DOI 10.1007/s12576-014-0337-4; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Ren J, 2012, J NEUROSCI, V32, P17230, DOI 10.1523/JNEUROSCI.2951-12.2012; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Schneider D, 2009, NEUROLOGICAL B, V1, P11; Shah MJ, 2001, J NEUROPHYSIOL, V85, P1051, DOI 10.1152/jn.2001.85.3.1051; Sinning A, 2013, FEBS LETT, V587, P1923, DOI 10.1016/j.febslet.2013.04.045; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; SOUTHALL DP, 1988, ARCH DIS CHILD, V63, P1039, DOI 10.1136/adc.63.9.1039; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toloe J, 2014, MOL CELL NEUROSCI, V59, P47, DOI 10.1016/j.mcn.2013.12.008; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang W, 2014, J NEUROSCI, V34, P2754, DOI 10.1523/JNEUROSCI.4900-12.2014	71	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195094	10.1371/journal.pone.0195094	http://dx.doi.org/10.1371/journal.pone.0195094			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621262	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800037
J	Schanzer, D; Antoniou, T; Kwong, J; Timmerman, K; Yan, P				Schanzer, Dena; Antoniou, Tony; Kwong, Jeffrey; Timmerman, Karen; Yan, Ping			Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; SURVIVAL; CANADA; TRENDS; STATES	Background While combination antiretroviral therapy (cART) has significantly improved survival times for persons diagnosed with HIV, estimation of life expectancy (LE) for this cohort remains a challenge, as mortality rates are a function of both time since diagnosis and age, and mortality rates for the oldest age groups may not be available. Methods A validated case-finding algorithm for HIV was used to update the cohort of HIV-positive adults who had entered care in Ontario, Canada as of 2012. The Chiang II abridged life table algorithm was modified to use mortality rates stratified by time since entering the cohort and to include various methods for extrapolation of the excess HIV mortality rates to older age groups. Results As of 2012, there were approximately 15,000 adults in care for HIV in Ontario. The crude all-cause mortality rate declined from 2.6% (95%CI 2.3, 2.9) per year in 2000 to 1.3% (1.2, 1.5) in 2012. Mortality rates were elevated for the first year of care compared to subsequent years (rate ratio of 2.6 (95% CI 2.3, 3.1)). LE for a 20-year old living in Ontario was 62 years (expected age at death is 82), while LE for a 20-year old with HIV was estimated to be reduced to 47 years, for a loss of 15 years of life. Ignoring the higher mortality rates among new cases introduced a modest bias of 1.5 additional years of life lost. In comparison, using 55+ as the open-ended age group was a major source of bias, adding 11 years to the calculated LE. Conclusions Use of age limits less than the expected age at death for the open-ended age group significantly overstates the estimated LE and is not recommended. The Chiang II method easily accommodated input of stratified mortality rates and extrapolation of excess mortality rates.	[Schanzer, Dena; Timmerman, Karen; Yan, Ping] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada; [Antoniou, Tony; Kwong, Jeffrey] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Antoniou, Tony; Kwong, Jeffrey] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Kwong, Jeffrey] Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey] Univ Hlth Network, Toronto, ON, Canada	Public Health Agency of Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Schanzer, D (corresponding author), Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada.	dena.schanzer@canada.ca	Schanzer, Dena/G-1593-2011; Yan, Ping/AAD-2758-2019	Schanzer, Dena/0000-0001-7093-4309; Yan, Ping/0000-0001-6765-0735	Institute for Clinical Evaluative Sciences (ICES); Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health Research (CIHR); Government of Ontario	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Government of Ontario	The authors acknowledge the support provided by the Institute for Clinical Evaluative Sciences (ICES). This study made use of de-identified data from the ICES Data Repository, which is managed by ICES with support from its partners: Canada's Strategy for Patient-Oriented Research (SPOR), the Ontario SPOR Support Unit, the Canadian Institutes of Health Research (CIHR) and the Government of Ontario. The opinions, results and conclusions reported are those of the authors. No endorsement by ICES or any of its partners is intended or should be inferred.	[Anonymous], 2016, SUMM MEAS CAN PROGR; [Anonymous], 2002, SAS 2 SAS STAT 9 US, V3; [Anonymous], 2002, SAS 2 SAS STAT 9 US, V1; [Anonymous], 2002, SAS 2 SAS STAT 9 US, V2; Antoniou Tony, 2013, Open Med, V7, pe98; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; Eayres D, 2004, J EPIDEMIOL COMMUN H, V58, P243, DOI 10.1136/jech.2003.009654; Elandt-Johnson R.C., 1999, SURVIVAL MODELS DATA; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; ICES, ACC ICES DAT; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P39, DOI 10.1097/QAI.0000000000001014; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2011, SEX HEALTH, V8, P526, DOI 10.1071/SH11046; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Office of National Statistics UK, 2015, LIF EXP BIRTH AG 65; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Peters PA, 2010, INT J CIRCUMPOL HEAL, V69, P38, DOI 10.3402/ijch.v69i1.17429; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sergerie F., 2016, REP DEM SIT CAN INT; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Statistics Canada, 2016, TABL 102 0552 DEATHS; Statistics Canada, 2016, TABL 051 0001 EST PO; Strauss David J, 2005, J Insur Med, V37, P20; Toson B., 2003, NATL STAT METHODOL S, V33; Trickey A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160460; Wainberg MA, 2016, LANCET INFECT DIS, V16, P1215, DOI 10.1016/S1473-3099(16)30383-8; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Yang QY, 2010, CAN J PUBLIC HEALTH, V101, P486, DOI 10.1007/BF03403969	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195031	10.1371/journal.pone.0195031	http://dx.doi.org/10.1371/journal.pone.0195031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621255	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800033
J	Stansfeld, SA; Carr, E; Smuk, M; Clark, C; Murray, E; Shelton, N; Head, J				Stansfeld, Stephen A.; Carr, Ewan; Smuk, Melanie; Clark, Charlotte; Murray, Emily; Shelton, Nicola; Head, Jenny			Mid-life psychosocial work environment as a predictor of work exit by age 50	PLOS ONE			English	Article							BRITISH CIVIL-SERVANTS; TERM SICKNESS ABSENCE; EARLY RETIREMENT; OLDER WORKERS; PAID EMPLOYMENT; WHITEHALL-II; HEALTH INEQUALITIES; DISABILITY PENSION; ILL HEALTH; FOLLOW-UP	Objectives To examine whether psychosocial work characteristics at age 45 years predict exit from the labour market by the age of 50 years in data from the 1958 British Birth Cohort. Methods Psychosocial work characteristics (decision latitude, job demands, job strain and work social support at 45 years and job insecurity at 42 years) measured by questionnaire were linked to employment outcomes (unemployment, retirement, permanent sickness, homemaking) at 50 years in 6510 male and female participants. Results Low decision latitude (RR = 2.01, 95%CI 1.06,3.79), low work social support (RR = 1.96, 95%CI 1.12,3.44), and high job insecurity (RR = 2.27, 95%CI 1.41, 3.67) predicted unemployment at 50, adjusting for sex, housing tenure, socioeconomic status, marital status, and education. High demands were associated with lower risk of unemployment (RR = 0.50, 95%CI 0.29,0.88) but higher risk of permanent sickness (RR = 2.14, 95%CI 1.09,4.21). Conclusions Keeping people in the workforce beyond 50 years may contribute to both personal and national prosperity. Employers may wish to improve working conditions for older workers, in particular, increase control over work, increase support and reduce demands to retain older employees in the workforce.	[Stansfeld, Stephen A.; Smuk, Melanie; Clark, Charlotte] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, Ctr Psychiat, London, England; [Carr, Ewan; Murray, Emily; Shelton, Nicola; Head, Jenny] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; Queen Mary University London; University of London; University College London	Stansfeld, SA (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, Ctr Psychiat, London, England.	s.a.stansfeld@qmul.ac.uk	Head, Jenny/GYA-2625-2022	Clark, Charlotte/0000-0003-3031-4986; Stansfeld, Stephen/0000-0001-8716-3897; Murray, Emily/0000-0001-6297-6920; Head, Jennifer/0000-0002-6054-0872	Economic and Social Research Council; United Kingdom's Medical Research Council under the Lifelong Health and Wellbeing Cross-Council Programme initiative [ES/L002892/1]; Uncertain Futures: Managing Late Career Transitions and Extended Working Life project from the ESRC [ES/L002949/1]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC [ES/L002892/1, ES/L002949/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); United Kingdom's Medical Research Council under the Lifelong Health and Wellbeing Cross-Council Programme initiative; Uncertain Futures: Managing Late Career Transitions and Extended Working Life project from the ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was jointly funded by the Economic and Social Research Council and the United Kingdom's Medical Research Council, under the Lifelong Health and Wellbeing Cross-Council Programme initiative [ES/L002892/1]. Charlotte Clark is also funded by the Uncertain Futures: Managing Late Career Transitions and Extended Working Life project from the ESRC [ES/L002949/1]. SAS was (in part) supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Albertsen K, 2007, SCAND J PUBLIC HEALT, V35, P78, DOI 10.1080/14034940600858474; Blekesaune M, 2005, RES AGING, V27, P3, DOI 10.1177/0164027504271438; Christensen KB, 2008, EUR J PUBLIC HEALTH, V18, P235, DOI 10.1093/eurpub/ckm130; Clausen T, 2014, J NURS MANAGE, V22, P583, DOI 10.1111/j.1365-2834.2012.01484.x; Clausen T, 2014, SCAND J PUBLIC HEALT, V42, P377, DOI 10.1177/1403494814527187; Claussen B, 2009, SCAND J PUBLIC HEALT, V37, P590, DOI 10.1177/1403494809105795; Crimmins EM, 2004, SOZ PRAVENTIV MED, V49, P122, DOI 10.1007/S00038-004-3105-z; de Wind A, 2014, SCAND J WORK ENV HEA, V40, P186, DOI 10.5271/sjweh.3393; Ferrie JE, 2005, SOC SCI MED, V60, P1593, DOI 10.1016/j.socscimed.2004.08.006; Ferrie JE, 2001, BMJ-BRIT MED J, V322, P647, DOI 10.1136/bmj.322.7287.647; Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136/jech.2005.038752; Henderson M, 2009, BRIT J PSYCHIAT, V194, P220, DOI 10.1192/bjp.bp.107.044271; Hengel KMO, 2012, INT ARCH OCC ENV HEA, V85, P783, DOI 10.1007/s00420-011-0719-3; Henkens K, 1997, RES AGING, V19, P139, DOI 10.1177/0164027597192001; Henkens K, 1996, AGEING SOC, V16, P561, DOI 10.1017/S0144686X00020237; HENSING G, 1995, SOC PSYCH PSYCH EPID, V30, P39, DOI 10.1007/BF00784433; Hintsa T, 2015, J EPIDEMIOL COMMUN H, V69, P543, DOI 10.1136/jech-2014-205148; Jensen LD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000991; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kubicek B, 2010, RES AGING, V32, P467, DOI 10.1177/0164027510364120; Lahelma E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-309; Leijten FRM, 2015, J EPIDEMIOL COMMUN H, V69, P1058, DOI 10.1136/jech-2015-205719; Liira J, 1999, SCAND J WORK ENV HEA, V25, P42, DOI 10.5271/sjweh.382; Lund T, 2005, J OCCUP ENVIRON MED, V47, P1141, DOI 10.1097/01.jom.0000174301.80318.f2; Lund Thomas, 2005, Eur J Ageing, V2, P275, DOI 10.1007/s10433-005-0013-x; Mein G, 2000, AGE AGEING, V29, P529, DOI 10.1093/ageing/29.6.529; MENG XL, 1994, STAT SCI, V9, P538, DOI 10.1214/ss/1177010269; Michie S, 2003, OCCUP ENVIRON MED, V60, P3, DOI 10.1136/oem.60.1.3; Muntaner C, 2010, INT J HEALTH SERV, V40, P281, DOI 10.2190/HS.40.2.h; North FM, 1996, AM J PUBLIC HEALTH, V86, P332, DOI 10.2105/AJPH.86.3.332; Podsakoff NP, 2007, J APPL PSYCHOL, V92, P438, DOI 10.1037/0021-9010.92.2.438; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Prime, 2014, MISS MILL ILL EMPL C; Robroek SJW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134867; Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P125, DOI 10.5271/sjweh.3319; Roelen CAM, 2011, OCCUP MED-OXFORD, V61, P96, DOI 10.1093/occmed/kqq181; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Samuelsson A, 2013, SCAND J WORK ENV HEA, V39, P351, DOI 10.5271/sjweh.3338; Stansfeld SA, 2008, OCCUP ENVIRON MED, V65, P634, DOI 10.1136/oem.2007.036640; Thielen K, 2014, EUR J PUBLIC HEALTH, V24, P34, DOI 10.1093/eurpub/ckt011; Vaez M, 2007, SOC PSYCH PSYCH EPID, V42, P381, DOI 10.1007/s00127-007-0189-9; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; Van Solinge H, 2014, AGEING SOC, V34, P1551, DOI 10.1017/S0144686X13000330; Virtanen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088695	46	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195495	10.1371/journal.pone.0195495	http://dx.doi.org/10.1371/journal.pone.0195495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621353	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000429206800093
J	Yoon, JS; So, CH; Lee, HS; Lim, JS; Hwang, JS				Yoon, Jong Seo; So, Cheol Hwan; Lee, Hae Sang; Lim, Jung Sub; Hwang, Jin Soon			The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated	PLOS ONE			English	Article							CLEFT CYSTS; CHILDREN; ETIOLOGY; GIRLS	Brain magnetic resonance imaging (MRI) is routinely performed to identify brain lesions in boys with central precocious puberty (CPP). We investigated the prevalence of CPP in Korean boys and the necessity for routine brain MRI examinations. This retrospective cross-sectional study was conducted from April 2003 to December 2016 at a Korean university hospital. Among 151 boys who were diagnosed with CPP, the data of 138 boys who underwent sellar MRI were evaluated. The mean age of the study subjects was 9.51 +/- 0.56 years (<8 years [n = 4] and >= 8 years [n = 134]). We excluded patients who had been previously diagnosed with brain tumors and those who did not undergo a sellar MRI because of refusal or the decision of the pediatric endocrinologist. The main outcome measure was the prevalence of intracranial lesions among boys with CPP. Normal sellar MRI findings were observed in 128 of the 138 boys (93%). Mild brain abnormalities were found in 10 boys (7%), while none of the patients had pathological brain lesions. The prevalence (7%) of intracranial lesions among boys who were healthy, did not have neurological symptoms, and were diagnosed with CPP was different from that previously reported. None of the identified lesions necessitated treatment. Although this was a single country study, we found that the previously reported prevalence of brain lesions in boys with CPP is much higher than the prevalence observed in Korea. This study suggests the need to globally reevaluate the prevalence of pathological brain lesions among male pediatric patients with CPP.	[Yoon, Jong Seo; Lee, Hae Sang; Hwang, Jin Soon] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea; [So, Cheol Hwan] Wonkwang Univ, Wonkwang Univ Hosp, Sch Med, Dept Pediat, Jeonbuk, South Korea; [Lim, Jung Sub] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea	Ajou University; Ajou University Hospital; Wonkwang University; National Cancer Center - Korea (NCC)	Hwang, JS (corresponding author), Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea.	pedhwang@ajou.ac.kr	LIM, JUNG SUB/GLU-0130-2022; lee, Hae Sang/AFL-6833-2022; lee, haesang/AAG-6951-2022	lee, Hae Sang/0000-0002-9684-4042; Yoon, Jong Seo/0000-0003-2331-1680; So, Cheol Hwan/0000-0003-1759-0003				Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Al-Gahtany Mubarak, 2003, Hormones (Athens), V2, P149; Al-Holou WN, 2009, J NEUROSURG-PEDIATR, V4, P230, DOI 10.3171/2009.4.PEDS0951; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; BRIDGES NA, 1994, ARCH DIS CHILD, V70, P116, DOI 10.1136/adc.70.2.116; Carel JC, 2004, HUM REPROD UPDATE, V10, P135, DOI 10.1093/humupd/dmh012; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Choi Keun Hee, 2013, Ann Pediatr Endocrinol Metab, V18, P183, DOI 10.6065/apem.2013.18.4.183; De Sanctis V, 2000, J PEDIATR ENDOCR MET, V13, P687; ELSTER AD, 1990, RADIOLOGY, V174, P681, DOI 10.1148/radiology.174.3.2305049; Greulich W.W., 1971, RADIOGRAPHIC ATLAS S; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141844; Kliegman RM, NELSON TXB PEDIAT, P2656; Lim Han Hyuk, 2010, Korean J Pediatr, V53, P759, DOI 10.3345/kjp.2010.53.7.759; NEELY EK, 1995, J PEDIATR-US, V127, P47, DOI 10.1016/S0022-3476(95)70255-5; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; Trifanescu R, 2012, CLIN ENDOCRINOL, V76, P151, DOI 10.1111/j.1365-2265.2011.04235.x; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; XhrouetHeinrichs D, 1997, ACTA PAEDIATR, V86, P808; Zada G, 2009, NEUROSURGERY, V64; Zada G, 2009, NEUROSURGERY, V64, P1132, DOI 10.1227/01.NEU.0000341873.20737.56; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	24	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195209	10.1371/journal.pone.0195209	http://dx.doi.org/10.1371/journal.pone.0195209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614125	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600036
J	He, Q; Hao, YP; Liu, H; Liu, WY				He, Qing; Hao, Yinping; Liu, Hui; Liu, Wenyi			Analysis of exergy efficiency of a super-critical compressed carbon dioxide energy-storage system based on the orthogonal method	PLOS ONE			English	Article							THERMODYNAMIC ANALYSIS; CYCLES	Super-critical carbon dioxide energy-storage (SC-CCES) technology is a new type of gas energy-storage technology. This paper used orthogonal method and variance analysis to make significant analysis on the factors which would affect the thermodynamics characteristics of the SC-CCES system and obtained the significant factors and interactions in the energy-storage process, the energy-release process and the whole energy-storage system. Results have shown that the interactions in the components have little influence on the energy-storage process, the energy-release process and the whole energy-storage process of the SC-CCES system, the significant factors are mainly on the characteristics of the system component itself, which will provide reference for the optimization of the thermal properties of the energy-storage system.	[He, Qing; Hao, Yinping; Liu, Wenyi] North China Elect Power Univ, Sch Energy Power & Mech Engn, Beijing, Peoples R China; [Liu, Hui] Elect Power Res Inst CO LTD, Shenhua Guohua Beijing, Beijing, Peoples R China	North China Electric Power University	Hao, YP (corresponding author), North China Elect Power Univ, Sch Energy Power & Mech Engn, Beijing, Peoples R China.	lbabo0824@163.com			National Key Research and Development Program of China [2017YFB0903601]	National Key Research and Development Program of China	This paper is supported by the National Key Research and Development Program of China (No. 2017YFB0903601).	Ahmadi P, 2011, ENERGY, V36, P5886, DOI 10.1016/j.energy.2011.08.034; Bai Z, 2010, APPL ORTHOGONAL EXPT, P142; Cayer E, 2009, APPL ENERG, V86, P1055, DOI 10.1016/j.apenergy.2008.09.018; Gordon Rogers, 1992, ENG THERMODYNAMICS W; [何青 He Qing], 2016, [动力工程学报, Journal of Chinese Society of Power Engineering], V36, P313; Kim YM, 2011, ENERGY, V36, P6220, DOI 10.1016/j.energy.2011.07.040; Liu H, 2016, ENERG CONVERS MANAGE, V127, P149, DOI 10.1016/j.enconman.2016.08.096; Moran M.J., 2006, FUNDAMENTALS ENG THE; Morandin M, 2012, ENERGY, V45, P375, DOI 10.1016/j.energy.2012.03.031; Padilla RV, 2015, APPL ENERG, V148, P348, DOI 10.1016/j.apenergy.2015.03.090; Peking University Mathematics Department, 1976, MATH METH SCHED MULT; Reistad GM, 1980, ACS SYM SER, V122, P143; Tian HL, APPL ORTHOGONAL EXPT, P917; Wang MK, 2015, APPL THERM ENG, V91, P812, DOI 10.1016/j.applthermaleng.2015.08.081; Wang ZW, 2016, APPL ENERG, V180, P810, DOI 10.1016/j.apenergy.2016.08.014; Weng J, 2014, OPTIMAL DESIGN PACKA, P409; [杨俊兰 Yang Junlan], 2013, [流体机械, Fluid Machinery], V41, P66; Zhang XR, 2017, INT J ENERGY RES, V41; Zhang Y., 2014, STUDY SYSTEM INTEGTA; Zhang Y, 2016, RENEW ENERG, V99, P682, DOI 10.1016/j.renene.2016.07.048	20	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195614	10.1371/journal.pone.0195614	http://dx.doi.org/10.1371/journal.pone.0195614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634742	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200040
J	Pike, A; Dimopoulos, G				Pike, Andrew; Dimopoulos, George			Genetic modification of Anopheles stephensi for resistance to multiple Plasmodium falciparum strains does not influence susceptibility to o'nyong'nyong virus or insecticides, or Wolbachia-mediated resistance to the malaria parasite	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; POPULATIONS; MOSQUITOS; DENSITY	Mosquitoes that have been genetically engineered for resistance to human pathogens are a potential new tool for controlling vector-borne disease. However, genetic modification may have unintended off-target effects that could affect the mosquitoes' utility for disease control. We measured the resistance of five genetically modified Plasmodium-suppressing Anopheles stephensi lines to o'nyong'nyong virus, four classes of insecticides, and diverse Plasmodium falciparum field isolates and characterized the interactions between our genetic modifications and infection with the bacterium Wolbachia. The genetic modifications did not alter the mosquitoes' resistance to either o'nyong'nyong virus or insecticides, and the mosquitoes were equally resistant to all tested P. falciparum strains, regardless of Wolbachia infection status. These results indicate that mosquitoes can be genetically modified for resistance to malaria parasite infection and remain compatible with other vector-control measures without becoming better vectors for other pathogens.	[Pike, Andrew; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	gdimopo1@jhu.edu		Pike, Andrew/0000-0003-3155-9969	National Institutes of Health / National Institute of Allergy and Infectious Disease [RO1A1061576]; Bloomberg Philanthropies	National Institutes of Health / National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Philanthropies	This work was supported by National Institutes of Health / National Institute of Allergy and Infectious Disease RO1A1061576 (to George Dimopoulos) and Bloomberg Philanthropies (to Andrew Pike).	[Anonymous], 1998, WHOCDCMAL98; Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Duron O, 2007, HEREDITY, V98, P368, DOI 10.1038/sj.hdy.6800948; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Molina-Cruz A, 2014, MEM I OSWALDO CRUZ, V109, P662, DOI 10.1590/0074-0276130553; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691; Pike A, 2014, INSECT BIOCHEM MOLEC, V52, P82, DOI 10.1016/j.ibmb.2014.06.005; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; van Schalkwyk DA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-320; WHO, 2016, WORLD MAL REP 2016; WHO, 2013, TEST PROC INREMO, V2	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195720	10.1371/journal.pone.0195720	http://dx.doi.org/10.1371/journal.pone.0195720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634777	gold, Green Submitted, Green Published			2022-12-27	WOS:000429522200051
J	Wu, DF; Yu, F; Nie, W				Wu, Dengfeng; Yu, Fang; Nie, Wei			Improvement of the reduction in catastrophic health expenditure in China's public health insurance	PLOS ONE			English	Article							CARE; HOUSEHOLDS; INCOME	This study aimed to locate the contributing factors of Catastrophic Health Expenditure (CHE), evaluate their impacts, and try to propose strategies for reducing the possibilities of CHE in the context of China's current public health insurance system. The financial data of all hospitalization cases from a sample hospital in 2013 were gathered and used to determine the pattern of household medical costs. A simulation model was constructed based on China's current public health insurance system to evaluate the financial burden for medical service on Chinese patients, as well as to calculate the possibilities of CHE. Then, by adjusting several parameters, suggestions were made for China's health insurance system in order to reduce CHE. It's found with China's current public health insurance system, the financial aid that a patient may receive depends on whether he is from an urban or rural area and whether he is employed. Due to the different insurance policies and the wide income gap between urban and rural areas, rural residents are much more financially vulnerable during health crisis. The possibility of CHE can be more than 50% for low-income rural families. The CHE ratio can be dramatically lowered by applying different policies for different household income groups. It's concluded the financial burden for medical services of Chinese patients is quite large currently, especially for those from rural areas. By referencing different healthcare policies in the world, applying different health insurance policies for different income groups can dramatically reduce the possibility of CHE in China.	[Wu, Dengfeng; Yu, Fang] Jiujiang Univ, Econ & Management Sch, Jiujiang City, Peoples R China; [Nie, Wei] Jiujiang Univ Hosp, Jiujiang City, Peoples R China	Jiujiang University; Jiujiang University	Wu, DF (corresponding author), Jiujiang Univ, Econ & Management Sch, Jiujiang City, Peoples R China.	wudengfeng1105@hotmail.com			National Natural Foundation of China [71661018, 71663034, CMB16-261]; Project of Science and Technology Department of Jiangxi Province [20161BBA100]; Project of Education Department of Jiangxi Province [JC1562]; University of Arkansas; Jiujiang University Hospital	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology Department of Jiangxi Province; Project of Education Department of Jiangxi Province; University of Arkansas; Jiujiang University Hospital	This research is funded by the National Natural Foundation of China 71661018, 71663034, CMB16-261, Project of Science and Technology Department 20161BBA100, and Project of Education Department JC1562 of Jiangxi Province. It is also supported by the University of Arkansas and Jiujiang University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded by the National Natural Foundation of China 71661018, 71663034, CMB16-261, Project of Science and Technology Department 20161BBA100, and Project of Education Department JC1562 of Jiangxi Province. It is also supported by the University of Arkansas and Jiujiang University Hospital.	Aji B, 2017, ASIA-PAC J PUBLIC HE, V29, P506, DOI 10.1177/1010539517729778; Akazili J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1289735; Anderson GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187293; Aregbeshola BS, 2017, EUROPEAN J HLTH EC H, P5; Carrin G., 2002, INT SOC SECUR REV, V55, P57, DOI [10.1111/1468-246x.00124, DOI 10.1111/1468-246X.00124]; Diaz-Gonzalez E, 2017, PAPELES POBLAC, V23, P65, DOI 10.22185/24487147.2017.91.004; DING H., 1993, J QUANTITATIVE TECHN, V02, P55; Edoka I, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0661-4; Gu H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4713-x; Guessous I, 2012, PREV MED, V55, P521, DOI 10.1016/j.ypmed.2012.08.005; Gwatidzo SD, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0408-x; Homaie R, 2016, INT J AGING HUM DEV, V48, P313; Hu Liu YN, 2012, J AESTHETICS VISUAL, V4, P1; Jan S, 2016, B WORLD HEALTH ORGAN, V94, P193, DOI 10.2471/BLT.15.158303; Kmictowicz ZW, 1975, E AFRICA EC REV, V7; Kockaya G, 2017, VALUE HEALTH, V20, pA669, DOI 10.1016/j.jval.2017.08.1633; Lee JE, 2016, J KOREAN MED SCI, V31, P336, DOI 10.3346/jkms.2016.31.3.336; Amaya-Lara JL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0472-z; Liu K, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0638-3; Lv H, 2012, THESIS HUAZHONG U SC, P5; MAJUMDER A, 1990, J APPL ECONOM, V5, P189, DOI 10.1002/jae.3950050206; Mao HY, 2016, INT J INFORM MANAGE, V36, P1062, DOI 10.1016/j.ijinfomgt.2016.07.001; Mao WH, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0675-y; MCDONALD JB, 1995, J ECONOMETRICS, V66, P133, DOI 10.1016/0304-4076(94)01612-4; Mchenga M, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0515-0; Meng Q, 2012, LANCET, V6, P160; Mohanty SK, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-016-0514-6; Ngcamphalala C, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1428473; Pandey A, 2018, B WORLD HEALTH ORGAN, V96, P18, DOI 10.2471/BLT.17.191759; Pradhan J, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0177-z; Qin XJ, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0669-9; Rahman MS, 2018, LANCET GLOB HEALTH, V6, pE84, DOI 10.1016/s2214-109x(17)30413-8; Rajaraman I., 1975, J DEV STUDIES; Rezapour A, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/ijpvm.IJPVM_104_17; Rickard J L, 2017, WORLD J SURG, P11; Sahu Kirti Sundar, 2017, Indian J Public Health, V61, P67, DOI 10.4103/ijph.IJPH_168_15; Scott JW, 2017, J AM COLL SURGEONS, V225, pS118, DOI 10.1016/j.jamcollsurg.2017.07.262; Scott John W, 2017, ANN SURG, P4; Si Y, 2017, INT J EQUITY HLTH, V7; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; Sulakshana Nandi, 2017, PLOS ONE, V12, P11; Vilcu I, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0436-3; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/s2214-109x(17)30486-2, 10.1016/S2214-109X(17)30429-1]; Wang C. R., 2018, ISSUES AGR EC, V2, P131; Wang K., 2006, THESIS SE U, P4; Wu DF, 2015, APPL MATH MODEL, V39, P7277, DOI 10.1016/j.apm.2015.02.042; Yang T, 2017, BMJ OPEN, V6; ZENG Y, 2011, THESIS FUDAN U CHINA, P4; Zhang YC, 2015, ACSR ADV COMPUT, P220	49	16	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194915	10.1371/journal.pone.0194915	http://dx.doi.org/10.1371/journal.pone.0194915			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634779	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200016
J	Zhang, X; Xiao, WX; Hu, XH				Zhang, Xue; Xiao, Wangxin; Hu, Xihao			Predicting essential proteins by integrating orthology, gene expressions, and PPI networks	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CENTRALITY; GENOMICS; DATABASE	Identifying essential proteins is very important for understanding the minimal requirements of cellular life and finding human disease genes as well as potential drug targets. Experimental methods for identifying essential proteins are often costly, time-consuming, and laborious. Many computational methods for such task have been proposed based on the topological properties of protein-protein interaction networks (PINs). However, most of these methods have limited prediction accuracy due to the noisy and incomplete natures of PINs and the fact that protein essentiality may relate to multiple biological factors. In this work, we proposed a new centrality measure, OGN, by integrating orthologous information, gene expressions, and PINs together. OGN determines a protein's essentiality by capturing its co-clustering and co-expression properties, as well as its conservation in the evolution process. The performance of OGN was tested on the species of Saccharomyces cerevisiae. Compared with several published centrality measures, OGN achieves higher prediction accuracy in both working alone and ensemble.	[Zhang, Xue] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Xiao, Wangxin] Huaiyin Inst Technol, Sch Comp & Software Engn, Huaian, Jiangsu, Peoples R China; [Hu, Xihao] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Hu, Xihao] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Tufts University; Huaiyin Institute of Technology; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, X (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.; Xiao, WX (corresponding author), Huaiyin Inst Technol, Sch Comp & Software Engn, Huaian, Jiangsu, Peoples R China.	lindajja03@gmail.com; wangxinxiao19750329@gmail.com			National Natural Science Foundation of China [61402423, 51678282, 51378243]; Guizhou Provincial Science and Technology Fund [[2015]2135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Provincial Science and Technology Fund	This work was funded by National Natural Science Foundation of China, No. 61402423, XZ; National Natural Science Foundation of China, No. 51678282, WX; National Natural Science Foundation of China, No. 51378243, WX; Guizhou Provincial Science and Technology Fund with grant No. [2015]2135, XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li GS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1115-5; Li M, 2016, TSINGHUA SCI TECHNOL, V21, P668, DOI 10.1109/TST.2016.7787009; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Qin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang JX, 2013, PROTEOM CLIN APPL, V7, P181, DOI 10.1002/prca.201200068; Wei W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072343; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang X, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1166-7; Zhang X, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00075; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058763; Zhang X, 2012, COMPUT SCI INF SYST, V9, P1627, DOI 10.2298/CSIS120130044Z; Zhang X, 2012, COMPUT SCI INF SYST, V9, P1513, DOI 10.2298/CSIS120202045Z; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	30	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195410	10.1371/journal.pone.0195410	http://dx.doi.org/10.1371/journal.pone.0195410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634727	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200029
J	Kisler, LB; Gurion, I; Granovsky, Y; Sinai, A; Sprecher, E; Shamay-Tsoory, S; Weissman-Fogel, I				Kisler, Lee-Bareket; Gurion, Ilan; Granovsky, Yelena; Sinai, Alon; Sprecher, Elliot; Shamay-Tsoory, Simone; Weissman-Fogel, Irit			Can a single pulse transcranial magnetic stimulation targeted to the motor cortex interrupt pain processing?	PLOS ONE			English	Article							EVOKED-POTENTIALS; NEUROPATHIC PAIN; SENSORIMOTOR CORTEX; BRAIN; TMS; PERCEPTION; SUPPRESSION; ACTIVATION; RTMS; REPRESENTATIONS	The modulatory role of the primary motor cortex (M1), reflected by an inhibitory effect of Ml-stimulation on clinical pain, motivated us to deepen our understanding of M1's role in pain modulation. We used Transcranial Magnetic Stimulation (TMS)-induced virtual lesion (VL) to interrupt with M1 activity during noxious heat pain. We hypothesized that TMS-VL will effect experimental pain ratings. Three VL protocols were applied consisting of single-pulse TMS to transiently interfere with right M1 activity: (1) VLM1-TMS applied to 11 subjects, 20 msec before the individual's first pain-related M1 peak activation, as determined by source analysis (sLORETA), (2) VL-50 (N = 16; TMS applied 50 ms prior to noxious stimulus onset), and (3) VL+150 (N = 16; TMS applied 150 ms after noxious stimulus onset). Each protocol included 3 conditions ('pain -alone', ' TMS-VL', and `SHAM-VL'), each consisted of 30 noxious heat stimuli. Pain ratings were compared, in each protocol, for TMS-VL vs. SHAM-VL and vs. pain-alone conditions. Repeated measures analysis of variance, corrected for multiple comparisons revealed no significant differences in the pain ratings between the different conditions within each protocol. Therefore, our results from this exploratory study suggest that a single pulse TMS-induced VL that is targeted to M1 failed to interrupt experimental pain processing in the specific three stimulation timing examined here.	[Kisler, Lee-Bareket; Gurion, Ilan; Shamay-Tsoory, Simone] Univ Haifa, Dept Psychol, Haifa, Israel; [Kisler, Lee-Bareket; Granovsky, Yelena] Technion Fac Med, Lab Clin Neurophysiol, Haifa, Israel; [Granovsky, Yelena; Sinai, Alon; Sprecher, Elliot] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Sinai, Alon] Rambam Hlth Care Campus, Dept Neurosurg, Haifa, Israel; [Weissman-Fogel, Irit] Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel	University of Haifa; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus; University of Haifa	Weissman-Fogel, I (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel.	ifogel@univ.haifa.ac.il			Israel Science Foundation [518/12]; IWF	Israel Science Foundation(Israel Science Foundation); IWF	This work was supported by the Israel Science Foundation grant #518/12 (https://www.isf.org.il/#/) to AS, YG and IWF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Borckardt JJ, 2011, CLIN J PAIN, V27, P486, DOI 10.1097/AJP.0b013e31820d2733; Bradley C, 2016, BRAIN STIMUL, V9, P48, DOI 10.1016/j.brs.2015.08.015; BRASILNETO JP, 1992, ELECTROEN CLIN NEURO, V85, P9, DOI 10.1016/0168-5597(92)90095-S; Burns E, 2016, EUR J PAIN, V20, P1203, DOI 10.1002/ejp.859; Cohen NR, 2009, EXP BRAIN RES, V196, P303, DOI 10.1007/s00221-009-1838-x; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Dambeck N, 2006, BRAIN RES, V1072, P194, DOI 10.1016/j.brainres.2005.05.075; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; DosSantos MF, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00018; Epstein CM, 1999, CLIN NEUROPHYSIOL, V110, P1073, DOI 10.1016/S1388-2457(99)00047-4; Franca NRM, 2013, BEHAV BRAIN RES, V250, P211, DOI 10.1016/j.bbr.2013.05.019; Frot M, 2013, HUM BRAIN MAPP, V34, P2655, DOI 10.1002/hbm.22097; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gelnar PA, 1999, NEUROIMAGE, V10, P460, DOI 10.1006/nimg.1999.0482; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Granovsky Y, 2005, PAIN, V115, P238, DOI 10.1016/j.pain.2005.02.017; Granovsky Y, 2016, EUR J PAIN, V20, P241, DOI 10.1002/ejp.715; Granovsky Y, 2008, J PAIN, V9, P53, DOI 10.1016/j.jpain.2007.08.010; Hamilton RH, 1998, TRENDS COGN SCI, V2, P168, DOI 10.1016/S1364-6613(98)01172-3; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Jahanshahi M, 2000, EXP BRAIN RES, V131, P1, DOI 10.1007/s002219900224; Kanda M, 2003, CLIN NEUROPHYSIOL, V114, P860, DOI 10.1016/S1388-2457(03)00034-8; Kisler LB, 2017, BEHAV BRAIN RES, V328, P209, DOI 10.1016/j.bbr.2017.04.006; Kisler LB, 2016, EXP BRAIN RES, V234, P3119, DOI 10.1007/s00221-016-4710-9; Kramer JLK, 2012, CLIN NEUROPHYSIOL, V123, P582, DOI 10.1016/j.clinph.2011.08.013; Kramer JLK, 2013, PAIN, V154, P235, DOI 10.1016/j.pain.2012.10.027; Lee MC, 2009, J NEUROSCI, V29, P7909, DOI 10.1523/JNEUROSCI.0014-09.2009; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lin KP, 2012, CHINESE J PHYSIOL, V55, P163, DOI 10.4077/CJP.2012.AMM117; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; Lockwood PL, 2013, CORTEX, V49, P2201, DOI 10.1016/j.cortex.2012.10.006; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; Meister IG, 2006, NEUROSCIENCE, V142, P119, DOI 10.1016/j.neuroscience.2006.06.023; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Mylius V, 2007, NEUROSCI LETT, V415, P49, DOI 10.1016/j.neulet.2006.12.042; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nizard J, 2012, DISCOV MED, V14, P237; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007/s00018-004-4283-9; Osaka N, 2007, NEUROSCI LETT, V418, P232, DOI 10.1016/j.neulet.2007.01.087; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Marqui R.D., 2007, ARXIV07103341; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; Porro CA, 2007, BEHAV BRAIN RES, V178, P183, DOI 10.1016/j.bbr.2006.11.011; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Reichenbach A, 2011, NEUROIMAGE, V54, P1375, DOI 10.1016/j.neuroimage.2010.08.047; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; ROTHWELL JC, 1987, BRAIN, V110, P1173, DOI 10.1093/brain/110.5.1173; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Shitara H, 2011, NEUROIMAGE, V56, P1469, DOI 10.1016/j.neuroimage.2011.03.011; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Siebner HR, 2001, HUM BRAIN MAPP, V12, P157, DOI 10.1002/1097-0193(200103)12:3<157::AID-HBM1012>3.0.CO;2-V; Soto D, 2009, NEUROSCI LETT, V451, P261, DOI 10.1016/j.neulet.2008.12.052; Thut G, 2003, CLIN NEUROPHYSIOL, V114, P2071, DOI 10.1016/S1388-2457(03)00205-0; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Valeriani M, 2007, CLIN NEUROPHYSIOL, V118, P1097, DOI 10.1016/j.clinph.2007.01.015; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Ziemann U, 2010, CORTEX, V46, P124, DOI 10.1016/j.cortex.2009.02.020	73	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195739	10.1371/journal.pone.0195739	http://dx.doi.org/10.1371/journal.pone.0195739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630681	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000069
J	Konietzke, P; Weinheimer, O; Wielputz, MO; Savages, D; Ziyeh, T; Tu, C; Newmann, B; Galban, CJ; Mall, MA; Kauczor, HU; Robinson, TE				Konietzke, Philip; Weinheimer, Oliver; Wielpuetz, Mark O.; Savages, Dasha; Ziyeh, Tiglath; Tu, Christin; Newmann, Beverly; Galban, Craig J.; Mall, Marcus A.; Kauczor, Hans-Ulrich; Robinson, Terry E.			Validation of automated lobe segmentation on paired inspiratory-expiratory chest CT in 8-14 year-old children with cystic fibrosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STRUCTURAL LUNG-DISEASE; COMPUTED-TOMOGRAPHY; YOUNG-CHILDREN; QUANTITATIVE ASSESSMENT; TRAPPED AIR; INFANTS; COPD; PROGRESSION; EMPHYSEMA	Objectives Densitometry on paired inspiratory and expiratory multidetector computed tomography (MDCT) for the quantification of air trapping is an important approach to assess functional changes in airways diseases such as cystic fibrosis (CF). For a regional analysis of functional deficits, an accurate lobe segmentation algorithm applicable to inspiratory and expiratory scans is beneficial. Materials and methods We developed a fully automated lobe segmentation algorithm, and subsequently validated automatically generated lobe masks (ALM) against manually corrected lobe masks (MLM). Paired inspiratory and expiratory CTs from 16 children with CF (mean age 11.1 +/- 2.4) acquired at 4 time-points (baseline, 3mon, 12mon, 24mon) with 2 kernels (B30f, B60f) were segmented, resulting in 256 ALM. After manual correction spatial overlap (Dice index) and mean differences in lung volume and air trapping were calculated for ALM vs. MLM. Results The mean overlap calculated with Dice index between ALM and MLM was 0.98 +/- 0.02 on inspiratory, and 0.86 +/- 0.07 on expiratory CT. If 6 lobes were segmented (lingula treated as separate lobe), the mean overlap was 0.97 +/- 0.02 on inspiratory, and 0.83 +/- 0.08 on expiratory CT. The mean differences in lobar volumes calculated in accordance with the approach of Bland and Altman were generally low, ranging on inspiratory CT from 5.7 +/- 52.23cm(3) for the right upper lobe to 17.41 +/- 14.92cm(3) for the right lower lobe. Higher differences were noted on expiratory CT. The mean differences for air trapping were even lower, ranging from 0 +/- 0.01 for the right upper lobe to 0.03 +/- 0.03 for the left lower lobe. Conclusions Automatic lobe segmentation delivers excellent results for inspiratory and good results for expiratory CT. It may become an important component for lobe-based quantification of functional deficits in cystic fibrosis lung disease, reducing necessity for user-interaction in CT post-processing.	[Konietzke, Philip; Weinheimer, Oliver; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Baden Wurttembe, Germany; [Konietzke, Philip; Weinheimer, Oliver; Wielpuetz, Mark O.; Mall, Marcus A.; Kauczor, Hans-Ulrich] Heidelberg Univ, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Baden Wurttembe, Germany; [Konietzke, Philip; Weinheimer, Oliver; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Baden Wurttembe, Germany; [Wielpuetz, Mark O.] Univ Hosp Kobe, Dept Radiol, Kobe, Hyogo, Japan; [Savages, Dasha; Ziyeh, Tiglath; Tu, Christin; Robinson, Terry E.] Stanford Univ, Med Ctr, Dept Pediat, Ctr Excellence Pediat Cyst Fibrosis & Pulm Dis, Stanford, CA 94305 USA; [Newmann, Beverly] Stanford Univ, Med Ctr, Pediat Radiol, Stanford, CA 94305 USA; [Galban, Craig J.] Univ Michigan, Dept Radiol, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Mall, Marcus A.] Heidelberg Univ, Dept Pediat, Div Pediat Pulmonol & Allergy, Heidelberg, Baden Wurttembe, Germany; [Mall, Marcus A.] Heidelberg Univ, Dept Pediat, Cyst Fibrosis Ctr, Heidelberg, Baden Wurttembe, Germany; [Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, Heidelberg, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Kobe University; Stanford University; Stanford University; University of Michigan System; University of Michigan; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Konietzke, P (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Baden Wurttembe, Germany.; Konietzke, P (corresponding author), Heidelberg Univ, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Baden Wurttembe, Germany.; Konietzke, P (corresponding author), Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Baden Wurttembe, Germany.	philip.konietzke@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Mall, Marcus A./AAA-1498-2022; Weinheimer, Oliver/AAN-3652-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020	Mall, Marcus A./0000-0002-4057-2199; Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Konietzke, Philip/0000-0001-8580-6721	Bundesministerium fur Bildung and Forschung (BMBF) [82DZL00401, 82DZL004A1]; Novartis Institutes for Biomedical Research, Cambridge, MA, USA; Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Novartis Institutes for Biomedical Research, Cambridge, MA, USA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	This study was supported by grants from the Bundesministerium fur Bildung and Forschung (BMBF) to the German Center for Lung Research (DZL) (82DZL00401 and 82DZL004A1), and Novartis Institutes for Biomedical Research, Cambridge, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Achenbach T, 2012, EUR J RADIOL, V81, P183, DOI 10.1016/j.ejrad.2010.09.012; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Development Core Team R, R LANG ENV STAT COMP; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Goris ML, 2003, CHEST, V123, P1655, DOI 10.1378/chest.123.5.1655; Gu SC, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/382806; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; Hersh CP, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-42; Heussel CP, 2010, EUR J RADIOL, V74, P473, DOI 10.1016/j.ejrad.2009.03.023; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Kauczor HU, 2013, LANCET RESP MED, V1, P95, DOI 10.1016/S2213-2600(13)70011-0; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kongstad T, 2013, J CYST FIBROS, V12, P559, DOI 10.1016/j.jcf.2013.05.012; Kuo WY, 2017, EUR RADIOL, V27, P4680, DOI 10.1007/s00330-017-4819-7; Kuo W, 2017, J CYST FIBROS, V16, P116, DOI 10.1016/j.jcf.2016.05.015; Lassen B, 2013, IEEE T MED IMAGING, V32, P210, DOI 10.1109/TMI.2012.2219881; Lim HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151498; Loeve M, 2015, EUR J RADIOL, V84, P1184, DOI 10.1016/j.ejrad.2015.02.011; Loeve M, 2012, RADIOLOGY, V262, P969, DOI 10.1148/radiol.11110966; Long FR, 2005, PEDIATR RADIOL, V35, P677, DOI 10.1007/s00247-005-1450-6; Long FR, 2004, J PEDIATR-US, V144, P154, DOI 10.1016/j.jpeds.2003.09.026; Mall Marcus, 2006, V34, P116; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Martinez TM, 2005, AM J RESP CRIT CARE, V172, P1133, DOI 10.1164/rccm.200412-1665OC; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Matsuoka S, 2007, J COMPUT ASSIST TOMO, V31, P384, DOI 10.1097/01.rct.0000243457.00437.10; Mott LS, 2013, J PEDIATR-US, V163, P243, DOI 10.1016/j.jpeds.2012.12.042; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Robinson TE, 2017, J CYST FIBROS, V16, pS44, DOI [10.1016/S1569-1993(17)30304-1, DOI 10.1016/S1569-1993(17)30304-1]; Rosenfeld M, 2012, JAMA-J AM MED ASSOC, V307, P2269, DOI 10.1001/jama.2012.5214; Rosenow T, 2015, AM J RESP CRIT CARE, V191, P1158, DOI 10.1164/rccm.201501-0061OC; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Tustison N., 2009, INSIGHT J, V9; Weinheimer O., 2017, FULLY AUTOMATED LOBE; Weinheimer O, 2011, 4 INT WORKSH PULM IM; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Well DS, 2007, SEMIN NUCL MED, V37, P103, DOI 10.1053/j.semnuclmed.2006.10.004; Wielputz MO, 2015, CURR OPIN PULM MED, V21, P609, DOI 10.1097/MCP.0000000000000213; Wielputz MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112898; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Wiemker R, 2005, BRIT J RADIOL, V78, pS46, DOI 10.1259/bjr/30281702	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194557	10.1371/journal.pone.0194557	http://dx.doi.org/10.1371/journal.pone.0194557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630630	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000012
J	Thanel, K; Garfinkel, D; Riley, C; Esch, K; Girma, W; Kebede, T; Kasongo, G; Afolabi, K; Kalamar, A; Thurston, S; Longfield, K; Bertrand, J; Shaw, B				Thanel, Katherine; Garfinkel, Danielle; Riley, Christina; Esch, Keith; Girma, Woldemariam; Kebede, Tadele; Kasongo, Gaby; Afolabi, Kayode; Kalamar, Amanda; Thurston, Sarah; Longfield, Kim; Bertrand, Jane; Shaw, Bryan		FPwatch Grp	Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants	PLOS ONE			English	Article								Background In developing regions, an estimated 214 million women have an unmet need for family planning. Reaching Family Planning 2020 (FP2020) commitments will require a shift in modern contraceptive promotion, including improved access to long-acting reversible contraceptives (LARCs). Until now, a lack of market data limited understanding of the potential of LARCs to increase contraceptive access and choice. Methods From 2015, the FPwatch Project conducted representative surveys in Ethiopia, Nigeria, and Democratic Republic of Congo (DRC) using a full census approach in selected administrative areas. In these areas, every public and private sector outlet with the potential to sell or distribute modern contraceptives was approached. In outlets with modern contraceptives, product audits and provider interviews assessed contraceptive market composition, market share, availability, price, and outlet readiness to perform services. Results Fifty-four percent of outlets in Ethiopia had LARC commodities or services available at the time of the survey, versus 7% and 8% of outlets in Nigeria and DRC, respectively. When present, LARCs were usually available with at least two other methods (99%, 39%, and 84% of public health facilities in Ethiopia, Nigeria and DRC, respectively). Many public facilities had both implants and IUDs in stock (76%, 47%, and 53%, respectively). Lack of readiness to provide LARCs was mostly due to a lack of equipment, private room, or the commodity itself. Market share for implants in the public sector was 60%, 53%, and 37% of Couple Years of Protection (CYP) in Ethiopia, Nigeria, and DRC. Discussion Limited availability of LARCs in Nigeria and DRC restricts contraceptive choice and makes it difficult for women to adopt and use modern contraception consistently. Brand-specific subsidies, task shifting, and promotion of methods that require less equipment and training are promising strategies for increasing uptake. Substantial government investment is required to improve availability and affordability. Investment in implants should be prioritized to make progress towards FP2020 commitments.	[Thanel, Katherine; Garfinkel, Danielle; Riley, Christina; Esch, Keith; Kalamar, Amanda; Thurston, Sarah; FPwatch Grp] Populat Serv Int, Washington, DC 20036 USA; [Girma, Woldemariam] Populat Serv Int Ethiopia, Addis Ababa, Ethiopia; [Kebede, Tadele] Fed Minist Hlth, Addis Ababa, Ethiopia; [Kasongo, Gaby] Assoc Sante Familiale, Kinshasa, DEM REP CONGO; [Afolabi, Kayode] Fed Minist Hlth, Ibadan, Nigeria; [Bertrand, Jane] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Shaw, Bryan] Georgetown Univ, Inst Reprod Hlth, Washington, DC USA	Federal Ministry of Health - Ethiopia (FMOH); Tulane University; Georgetown University	Thanel, K (corresponding author), Populat Serv Int, Washington, DC 20036 USA.	kthanel@gmail.com			Bill and Melinda Gates Foundation [OPP1112709]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	FPwatch was funded by the Bill and Melinda Gates Foundation, https://www.gatesfoundation.org/, through grant number OPP1112709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB HEALTH-SCI PRAC, V4, pS1, DOI 10.9745/GHSP-D-16-00241; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Bertrand J, COMMUNICATION; Charyeva Z, 2015, GLOB HEALTH-SCI PRAC, V3, P382, DOI 10.9745/GHSP-D-15-00129; Christofield M, 2016, LACOSTE ACCESSIBLE C; Contraceptive Security, 2011, FACTC 3 UND DEM SUPP; Duvall S, 2014, GLOB HEALTH-SCI PRAC, V2, P72, DOI 10.9745/GHSP-D-13-00116; FP2020, 2016, FP2020 MOM MIDP; High Impact Practices in Family Planning (HIP), SOC MARK LEV PRIV SE; Jacobstein R, 2013, GLOB HEALTH-SCI PRAC, V1, P11, DOI 10.9745/GHSP-D-12-00003; Migiro K., 2013, FACTBOX WOMEN KENYAN; Ministry of Health, 2016, COST IMPL PLAN FAM P; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; World Health Organization (WHO), 2012, EV POL EXP ACC FAM P	15	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195228	10.1371/journal.pone.0195228	http://dx.doi.org/10.1371/journal.pone.0195228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630607	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000033
J	Evans, SM; Griffin, KJ; Blick, RAJ; Poore, AGB; Verges, A				Evans, Suzanna M.; Griffin, Kingsley J.; Blick, Ray A. J.; Poore, Alistair G. B.; Verges, Adriana			Seagrass on the brink: Decline of threatened seagrass Posidonia australis continues following protection	PLOS ONE			English	Article							ZOSTERA-CAPRICORNI; WESTERN-AUSTRALIA; COCKBURN SOUND; IMAGE-ANALYSIS; WATER-QUALITY; BOTANY-BAY; RECOVERY; DEGRADATION; MEADOWS; IMPACT	Seagrasses are in decline globally due to sustained pressure from coastal development, water quality declines and the ongoing threat from climate change. The result of this decline has been a change in coastal productivity, a reduction in critical fisheries habitat and increased erosion. Attempts to slow this decline have included legislative protection of habitat and direct restoration efforts. Monitoring the success of these approaches requires tracking changes in the abundance of seagrasses, but such monitoring is frequently conducted at either too coarse a spatial scale, or too infrequently to adequately detect changes within individual meadows. Here, we used high resolution aerial imagery to quantify the change in meadows dominated by Posidonia australis over five years at 14 sites in five estuaries in south-eastern Australia. Australia has some of the world's most diverse and extensive sea grass meadows, but the widely distributed P. australis has a slow growth rate, recovers poorly after disturbance, and suffers runaway attrition if the conditions for recovery are not met. In 2010, after declines of 12-57% between the 1940s and 1980s, P. australis was listed as a threatened ecological community in New South Wales. We quantified changes in area at fine spatial scales and, where loss was observed, describe the general patterns of temporal decline within each meadow. Our results demonstrate that seagrass meadows dominated by P. australis underwent declines of similar to 2-40% total area at 11 out of 14 study sites between 2009 and 2014. In the iconic Sydney Harbour, our analyses suggest that P. australis meadows are declining at an average rate greater than 10% yr(-1), exceeding the global rate of seagrass decline. Highlighting these alarming declines across the study region should serve as means to prioritise management action and review the effectiveness of legislative listing as a method to limit impacts at an ecosystem level.	[Evans, Suzanna M.; Griffin, Kingsley J.; Blick, Ray A. J.; Poore, Alistair G. B.; Verges, Adriana] Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Evans, Suzanna M.; Verges, Adriana] UNSW Australia, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Evans, Suzanna M.; Poore, Alistair G. B.; Verges, Adriana] Sydney Inst Marine Sci, Mosman, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science	Griffin, KJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	k.griffin@unsw.edu.au	Poore, Alistair/C-2934-2008; Blick, Ray/AAB-5604-2020; Verges, Adriana/B-8288-2013	Poore, Alistair/0000-0002-3560-3659; Verges, Adriana/0000-0002-3507-1234	Australian Postgraduate Awards; Australian Research Council [LP160100836]; Sea Life Trust Conservation Fund; Evolution & Ecology Research Centre (UNSW)	Australian Postgraduate Awards(Australian Government); Australian Research Council(Australian Research Council); Sea Life Trust Conservation Fund; Evolution & Ecology Research Centre (UNSW)	SE, RB and KG were supported by Australian Postgraduate Awards. This project was partly funded by project LP160100836 from the Australian Research Council, by the Sea Life Trust Conservation Fund (http//www.sealifetrustorg.au/) and the Evolution & Ecology Research Centre (UNSW) (http://www.eerc.unsw.edu.au/). The research was made possible by Nearmap Australia Photomaps (http:/www.nearmap.com.au/) accessed through the University of Queensland, St. Lucia.	Albani AD., 2013, PORT HACKING PRESENT; [Anonymous], [No title captured]; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Blandon A, 2014, ESTUAR COAST SHELF S, V141, P1, DOI 10.1016/j.ecss.2014.01.009; CAMBRIDGE ML, 1986, AQUAT BOT, V24, P269, DOI 10.1016/0304-3770(86)90062-8; Creese RG, 2009, MAPPING HABITATS NSW; Cullen-Unsworth LC, 2016, J APPL ECOL, V53, P967, DOI 10.1111/1365-2664.12637; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Demers MCA, 2013, MAR ENVIRON RES, V83, P54, DOI 10.1016/j.marenvres.2012.10.010; DPI N, 2012, END POP NSW POS AUST; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; ESRI, 2014, ARCGIS VERS 10 2 2; Evans SM, 2017, RESTORATION ECOLOGY; Glasby TM., 2015, FISHERIES FINAL REPO, V147; Greening H, 2006, ENVIRON MANAGE, V38, P163, DOI 10.1007/s00267-005-0079-4; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamada Y, 2013, ENVIRON MONIT ASSESS, V185, P3173, DOI 10.1007/s10661-012-2781-z; Heenkenda MK, 2014, REMOTE SENS-BASEL, V6, P6064, DOI 10.3390/rs6076064; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; KIRKMAN H, 1978, AQUAT BOT, V5, P63, DOI 10.1016/0304-3770(78)90047-5; Kirkman H., 1997, SEAGRASSES AUSTR; Larkum A, 1976, MARINE FRESHWATER RE, V27, P117, DOI DOI 10.1071/MF9760117; LARKUM AWD, 1990, AQUAT BOT, V37, P55, DOI 10.1016/0304-3770(90)90064-R; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lukatelich R, 1987, ENV PROTECTION AUTHO, V16; Manly, 2009, MANL COV COAST ZON M; Marion SR, 2010, RESTOR ECOL, V18, P549, DOI 10.1111/j.1526-100X.2010.00695.x; Meehan AJ, 2000, AQUAT BOT, V67, P161, DOI 10.1016/S0304-3770(99)00097-2; Meehan AJ, 2004, AQUAT BOT, V79, P1, DOI 10.1016/j.aquabot.2003.11.009; MIDDLETON MJ, 1984, AQUAT BOT, V18, P89, DOI 10.1016/0304-3770(84)90082-2; Mumby PJ, 1999, J ENVIRON MANAGE, V55, P157, DOI 10.1006/jema.1998.0255; Nearmap, 2009, NEARM PHOT AER IM; NSW D, 2011, BOT BAY CABL PROJ SE; Orth RJ, 2017, ESTUAR COAST, P1; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Owers CJ, 2016, INT J REMOTE SENS, V37, P4296, DOI 10.1080/01431161.2016.1211349; Preen A, 1993, WIDESPREAD LOSS SEAG; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; Rasheed MA, 1999, J EXP MAR BIOL ECOL, V235, P183, DOI 10.1016/S0022-0981(98)00158-0; Roca G, 2015, ECOL INDIC, V54, P161, DOI 10.1016/j.ecolind.2015.02.031; Roelfsema CM, 2014, REMOTE SENS ENVIRON, V150, P172, DOI 10.1016/j.rse.2014.05.001; Shepherd S, 1989, DECLINE SEAGRASSES; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Spalding M, 2003, DISTRIBUTION STATUS, P5; Thomas M, 1999, SEAGRASS AUSTR STRAT, V98, P223; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Walker DI, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P551; Watford FA, 1998, INVENTORY ESTUARINE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; West R, 1989, REGIONAL STUDIES SEA, P230; West RJ, 2012, WETLANDS AUSTR J, V26, P3; Wood SN, 2017, MGCV MIXED GAM COMPU; Wright A, 2013, POSIDONIA AUSTRALIS	55	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0190370	10.1371/journal.pone.0190370	http://dx.doi.org/10.1371/journal.pone.0190370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624579	gold, Green Submitted, Green Published			2022-12-27	WOS:000429379600001
J	Alvarez-Ponce, D; Torres-Sanchez, M; Feyertag, F; Kulkarni, A; Nappi, T				Alvarez-Ponce, David; Torres-Sanchez, Maria; Feyertag, Felix; Kulkarni, Asmita; Nappi, Taylen			Molecular evolution of DNMT1 in vertebrates: Duplications in marsupials followed by positive selection	PLOS ONE			English	Article							CPG-RICH ISLANDS; DNA METHYLTRANSFERASE; NUCLEOTIDE SUBSTITUTIONS; MONODELPHIS-DOMESTICA; SEQUENCE SPECIFICITY; X-CHROMOSOMES; GC-CONTENT; METHYLATION; GENOME; EXPRESSION	DNA methylation is mediated by a conserved family of DNA methyltransferases (Dnmts). The human genome encodes three active Dnmts (Dnmt1, Dnmt3a and Dnmt3b), the tRNA methyltransferase Dnmt2, and the regulatory protein Dnmt3L. Despite their high degree of conservation among different species, genes encoding Dnmts have been duplicated and/or lost in multiple lineages throughout evolution, indicating that the DNA methylation machinery has some potential to undergo evolutionary change. However, little is known about the extent to which this machinery, or the methylome, varies among vertebrates. Here, we study the molecular evolution of Dnmt1, the enzyme responsible for maintenance of DNA methylation patterns after replication, in 79 vertebrate species. Our analyses show that all studied species exhibit a single copy of the DNMT1 gene, with the exception of tilapia and marsupials (tammar wallaby, koala, Tasmanian devil and opossum), each of which displays two apparently functional DNMT1 copies. Our phylogenetic analyses indicate that DNMT1 duplicated before the radiation of major marsupial groups (i.e., at least similar to 75 million years ago), thus giving rise to two DNMT1 copies in marsupials (copy 1 and copy 2). In the opossum lineage, copy 2 was lost, and copy 1 recently duplicated again, generating three DNMT1 copies: two putatively functional genes (copy la and 1b) and one pseudogene (copy 1 Psi). Both marsupial copies (DNMT1 copies 1 and 2) are under purifying selection, and copy 2 exhibits elevated rates of evolution and signatures of positive selection, suggesting a scenario of neofunctionalization. This gene duplication might have resulted in modifications in marsupial methylomes and their dynamics.	[Alvarez-Ponce, David; Torres-Sanchez, Maria; Feyertag, Felix; Kulkarni, Asmita; Nappi, Taylen] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Torres-Sanchez, Maria] Univ Complutense Madrid, Dept Biodivers Ecol & Evolut, Madrid, Spain	Nevada System of Higher Education (NSHE); University of Nevada Reno; Complutense University of Madrid	Alvarez-Ponce, D (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	dap@unr.edu	Torres-Sánchez, María/AAC-9387-2019	Torres-Sánchez, María/0000-0001-8484-9279; Alvarez-Ponce, David/0000-0002-8729-1036; Nappi, Taylen/0000-0002-1145-8362	Smooth Muscle Plasticity COBRE of the University of Nevada, Reno - National Institutes of Health [5P30GM110767-04]; FPI predoctoral fellowship [BES-2013- 062723]; Ministry of Economy and Competitiveness of Spain [EEBB-I-16-11395]	Smooth Muscle Plasticity COBRE of the University of Nevada, Reno - National Institutes of Health; FPI predoctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by a Pilot Grant from the Smooth Muscle Plasticity COBRE of the University of Nevada, Reno, funded by the National Institutes of Health (grant 5P30GM110767-04). MTS was supported by a FPI predoctoral fellowship (BES-2013- 062723) and a travel grant (EEBB-I-16-11395) from the Ministry of Economy and Competitiveness of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Campos C, 2012, GENE, V500, P93, DOI 10.1016/j.gene.2012.03.041; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Ding F, 2003, GENESIS, V36, P209, DOI 10.1002/gene.10215; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Duchene DA, 2017, SYST BIOL; Dunwell TL, 2014, EPIGENOMICS-UK, V6, P459, DOI [10.2217/EPI.14.46, 10.2217/epi.14.46]; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jeltsch A, 2010, SCIENCE, V328, P837, DOI 10.1126/science.1190738; Johnson Rebecca N., 2014, Technical Reports of the Australian Museum Online, V24, DOI 10.3853/j.1835-4211.24.2014.1624; JUKES T H, 1969, P21; Jurkowski TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028104; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mugal CF, 2015, G3-GENES GENOM GENET, V5, P441, DOI 10.1534/g3.114.015545; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; NEI M, 1986, MOL BIOL EVOL, V3, P418; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peat Julian R, 2017, F1000Res, V6, P526, DOI 10.12688/f1000research.11281.1; Ponger L, 2005, MOL BIOL EVOL, V22, P1119, DOI 10.1093/molbev/msi098; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waters SA, 2018, MOL BIOL EVOL, V35, P431, DOI 10.1093/molbev/msx297; Whelan S, 1999, MOL BIOL EVOL, V16, P1292, DOI 10.1093/oxfordjournals.molbev.a026219; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Z, 2015, BIORXIV	65	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195162	10.1371/journal.pone.0195162	http://dx.doi.org/10.1371/journal.pone.0195162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621315	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800044
J	Dharanipragada, P; Vogeti, S; Parekh, N				Dharanipragada, Prashanthi; Vogeti, Sriharsha; Parekh, Nita			iCopyDAV: Integrated platform for copy number variations-Detection, annotation and visualization	PLOS ONE			English	Article							READ-DEPTH; STRUCTURAL VARIATION; VARIANT ANNOTATION; GENETIC-VARIATION; CANCER; IDENTIFICATION; DELETION; DATABASE; TOOL; ORGANIZATION	Discovery of copy number variations (CNVs), a major category of structural variations, have dramatically changed our understanding of differences between individuals and provide an alternate paradigm for the genetic basis of human diseases. CNVs include both copy gain and copy loss events and their detection genome-wide is now possible using high-throughput, low-cost next generation sequencing (NGS) methods. However, accurate detection of CNVs from NGS data is not straightforward due to non-uniform coverage of reads resulting from various systemic biases. We have developed an integrated platform, iCopyDAV, to handle some of these issues in CNV detection in whole genome NGS data. It has a modular framework comprising five major modules: data pre-treatment, segmentation, variant calling, annotation and visualization. An important feature of iCopyDAV is the functional annotation module that enables the user to identify and prioritize CNVs encompassing various functional elements, genomic features and disease-associations. Parallelization of the segmentation algorithms makes the iCopyDAV platform even accessible on a desktop. Here we show the effect of sequencing coverage, read length, bin size, data pre-treatment and segmentation approaches on accurate detection of the complete spectrum of CNVs. Performance of iCopyDAV is evaluated on both simulated data and real data for different sequencing depths. It is an open-source integrated pipeline available at https://github.com/ vogetihrsh/icopydav and as Docker's image at http://bioint.iiitac.iniicopydavi.	[Dharanipragada, Prashanthi; Vogeti, Sriharsha; Parekh, Nita] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India	International Institute of Information Technology Hyderabad	Parekh, N (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India.	nita@iiit.ac.in	Parekh, Nita/T-6880-2018; Parekh, Nita/P-6156-2019	Parekh, Nita/0000-0002-8737-0260	University Grants Commission (UGC), India	University Grants Commission (UGC), India(University Grants Commission, India)	PD acknowledges University Grants Commission (UGC), India, for Research assistantship.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Andries V, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1408-5; Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BELLOS E, 2012, GENOME BIOL, V13; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Chen K, 2014, GENOME RES, V24, P310, DOI 10.1101/gr.162883.113; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; Collins RL., 2016, CNVIEW VISUALIZATION, P49536; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Duan JB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-150; Dumas LJ, 2012, AM J HUM GENET, V91, P444, DOI 10.1016/j.ajhg.2012.07.016; Erikson GA, 2015, GENET MED, V17, P714, DOI 10.1038/gim.2014.180; Fan XP, 2014, J GEOPHYS RES-ATMOS, V119, P2050, DOI 10.1002/2013JD020402; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Graham RL, 2007, PARALLEL PROCESS LET, V17, P79, DOI 10.1142/S0129626407002880; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Jung SH, 2014, ARTHRITIS RHEUMATOL, V66, P2103, DOI 10.1002/art.38650; Keeney JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00427; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Krasnitz A, 2014, PARDNACOPY PARALLEL; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; L angmead B., 2010, CURR PROTOC BIOINFOR; Lai D, HMMCOPY; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Ma LN, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0766-y; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Magi A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr068; Malekpour SA, 2016, MATH BIOSCI, V279, P53, DOI 10.1016/j.mbs.2016.07.006; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mohiyuddin M, 2015, BIOINFORMATICS, V31, P2741, DOI 10.1093/bioinformatics/btv204; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Nguyen HT, 2014, FRONT GENET, V5; O'Bleness MS, 2012, G3-GENES GENOM GENET, V2, P977, DOI 10.1534/g3.112.003061; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Olshen A, DNACOPY; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Samarakoon PS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2374-2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Sinha R, 2015, PLOS ONE, V10; Smith SD, 2015, PEERJ, V3, DOI 10.7717/peerj.836; Szatkiewicz JP, 2013, NUCLEIC ACIDS RES, V41, P1519, DOI 10.1093/nar/gks1363; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang ZH, 2016, GENOME RES, V26, P844, DOI 10.1101/gr.201491.115; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Xi RB, 2016, NUCLEIC ACIDS RES, V44, P6274, DOI 10.1093/nar/gkw491; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yau C, 2013, BIOINFORMATICS, V29, P2482, DOI 10.1093/bioinformatics/btt416; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang YW, 2015, NUCLEIC ACIDS RES, V43, pW289, DOI 10.1093/nar/gkv556; Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080170; Zhao YX, 2016, AM J ALZHEIMERS DIS, V31, P163, DOI 10.1177/1533317515588181; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	87	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195334	10.1371/journal.pone.0195334	http://dx.doi.org/10.1371/journal.pone.0195334			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621297	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800064
J	Du, ZQ; Dong, J; Bi, JB; Bai, RH; Zhang, J; Wu, Z; Lv, Y; Zhang, XF; Wu, RQ				Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Bai, Ruhai; Zhang, Jia; Wu, Zheng; Lv, Yi; Zhang, Xufeng; Wu, Rongqian			Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; NEUTROPHIL/LYMPHOCYTE RATIO; LIVER-TRANSPLANTATION; PROGNOSTIC-FACTOR; SURVIVAL; RISK; CHEMOTHERAPY; RECURRENCE; DISEASE; MARKER	The neutrophil to lymphocyte ratio (NLR), a simple marker of inflammation, has recently been showed to predict tumor recurrence in hepatocellular carcinoma (HCC) patients after hepatic resection or liver transplantation. However, whether it can be used to predict HCC development in cirrhotic patients remained unknown. The aim of this study was to evaluate the predictive value of the preoperative NLR for the development of HCC in cirrhotic patients who underwent splenectomy. A total of 230 HBV-associated cirrhotic patients who underwent splenectomy in our hospital from January 2000 to December 2012 were included in this study. Detailed clinical data included patients' general characteristics, laboratory tests and imaging studies, surgical procedures and complications. Information on patients' follow-up data was also obtained. We found that 38 (16.52%) patients developed HCC after splenectomy during the follow-up period. An elevated preoperative NLR was associated with increased risk of developing HCC in cirrhotic patients after splenectomy. The optimal cutoff value of NLR for HCC development was 2.27. In patients who developed HCC during the follow-up period, NLR scores showed no predictive value in overall survival after splenectomy. However, NLR scores appeared to have a much better predictive value in overall survival in patients who did not develop HCC. In conclusion, cirrhotic patients who underwent splenectomy remain at a relatively high risk of developing HCC, and an elevated preoperative NLR is associated with HCC development in cirrhotic patients who underwent splenectomy for hypersplenism.	[Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Lv, Yi; Zhang, Xufeng; Wu, Rongqian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaanxi Prov Ctr Regenerat Med & Surg Engn, Xian, Shaanxi, Peoples R China; [Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Lv, Yi; Zhang, Xufeng; Wu, Rongqian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Xian, Shaanxi, Peoples R China; [Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Wu, Zheng; Lv, Yi; Zhang, Xufeng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Bai, Ruhai] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, XF; Wu, RQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaanxi Prov Ctr Regenerat Med & Surg Engn, Xian, Shaanxi, Peoples R China.; Zhang, XF; Wu, RQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Xian, Shaanxi, Peoples R China.; Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.	xfzhang125@126.com; rwu001_@mail.xjtu.edu.cn	Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Bai, Ruhai/AAV-2762-2020; Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531; ruhai, bai/0000-0001-5426-6291	Ministry of Education Innovation Team Development Program of China [IRT16R57]; Young Talent Recruiting Plans of Xi'an Jiaotong University	Ministry of Education Innovation Team Development Program of China; Young Talent Recruiting Plans of Xi'an Jiaotong University	This work was supported by a grant from the Ministry of Education Innovation Team Development Program of China (No. IRT16R57, YL) and a research fund for Young Talent Recruiting Plans of Xi'an Jiaotong University (RW).	Aino H, 2016, MOL CLIN ONCOL, V5, P83, DOI 10.3892/mco.2016.879; Aizawa M, 2011, WORLD J SURG, V35, P2717, DOI 10.1007/s00268-011-1269-2; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Basyigit S, 2015, EUR J GASTROEN HEPAT, V27, P1230, DOI 10.1097/MEG.0000000000000426; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Coffin CS, 2014, ALIMENT PHARM THER, V40, P1262, DOI 10.1111/apt.12990; Do AL, 2014, J CLIN GASTROENTEROL, V48, P644, DOI 10.1097/MCG.0000000000000015; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Harimoto N, 2013, TRANSPLANTATION, V96, P1008, DOI 10.1097/TP.0b013e3182a53f2b; Hiramatsu N, 2016, J GASTROEN HEPATOL, V31, P546, DOI 10.1111/jgh.13229; Ho MC, 2016, LIVER CANCER, V5, P245, DOI 10.1159/000449336; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Liao WJ, 2014, TRANSL ONCOL, V7, P248, DOI 10.1016/j.tranon.2014.02.011; LIAW YF, 1989, LIVER, V9, P235; Lv X, 2016, TUMOR BIOL, V37, P8889, DOI 10.1007/s13277-015-4764-5; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Seretis C, 2013, AM J SURG, V205, P691, DOI 10.1016/j.amjsurg.2012.08.006; Triolo M, 2014, LIVER INT, V34, P139, DOI 10.1111/liv.12394; van Kessel KEM, 2016, BLADDER CANCER, V2, P351, DOI 10.3233/BLC-160055; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yang H.D, 2016, ONCOTARGET; Yang T, 2017, J SURG ONCOL; Yavuzcan A, 2013, J TURK-GER GYNECOL A, V14, P210, DOI 10.5152/jtgga.2013.55452	33	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195336	10.1371/journal.pone.0195336	http://dx.doi.org/10.1371/journal.pone.0195336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621282	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800065
J	Imai, Y; Kariya, T; Iwakiri, M; Yamada, Y; Takimoto, E				Imai, Yousuke; Kariya, Taro; Iwakiri, Masaki; Yamada, Yoshitsugu; Takimoto, Eiki			Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload	PLOS ONE			English	Article							SYSTOLIC HEART-FAILURE; CHRONIC INHIBITION; PHOSPHODIESTERASE 5; EJECTION FRACTION; PDE5 INHIBITION; DYSFUNCTION; MECHANISMS; EXPRESSION; HYPERTENSION; HYPERTROPHY	Right ventricular (RV) dysfunction following left ventricular (LV) failure is associated with poor prognosis. RV remodeling is thought initiated by the increase in the afterload of RV due to secondary pulmonary hypertension (PH) to impaired LV function; however, RV molecular changes might occur in earlier stages of the disease. cGMP (cyclic guanosine monophosphate)-phosphodiesterase 5 (PDE5) inhibitors, widely used to treat PH through their pulmonary vasorelaxation properties, have shown direct cardiac benefits, but their impacts on the RV in LV diseases are not fully determined. Here we show that RV molecular alterations occur early in the absence of RV hemodynamic changes during LV pressure-overload and are ameliorated by PDE5 inhibition. Two-day moderate LV pressure-overload (transverse aortic constriction) neither altered RV pressure/function nor RV weight in mice, while it induced only mild LV hypertrophy. Importantly, pathological molecular features were already induced in the RV free wall myocardium, including up-regulation of gene markers for hypertrophy and inflammation, and activation of extracellular signal-regulated kinase (ERK) and calcineurin. Concomitant PDE5 inhibition (sildenafil) prevented induction of such pathological genes and activation of ERK and calcineurin in the RV as well as in the LV. Importantly, dexamethasone also prevented these RV molecular changes, similarly to sildenafil treatment. These results suggest the contributory role of inflammation to the early pathological interventricular interaction between RV and LV. The current study provides the first evidence for the novel early molecular cross-talk between RV and LV, preceding RV hemodynamic changes in LV disease, and supports the therapeutic strategy of enhancing cGMP signaling pathway to treat heart diseases.	[Imai, Yousuke; Kariya, Taro; Iwakiri, Masaki; Yamada, Yoshitsugu] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan; [Takimoto, Eiki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Takimoto, Eiki] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	University of Tokyo; University of Tokyo; Johns Hopkins University	Takimoto, E (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan.; Takimoto, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	etakimo1@jhmi.edu	Kariya, Taro/AAF-4551-2021; Takimoto, Eiki/AAC-5100-2021	Kariya, Taro/0000-0001-7678-3652; Takimoto, Eiki/0000-0001-7767-0094	National Institute of Health [R01 HL-093432]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health Grants R01 HL-093432 (ET).	Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; De Vecchis Renato, 2017, J Clin Med Res, V9, P488, DOI 10.14740/jocmr3008w; Di Luigi L, 2016, INFLAMMATION, V39, P1238, DOI 10.1007/s10753-016-0359-6; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fiore D, 2016, J CLIN ENDOCR METAB, V101, P1525, DOI 10.1210/jc.2015-4252; Giannetta E, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0185-3; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Guimaraes FD, 2017, MOL CELL BIOCHEM, V424, P87, DOI 10.1007/s11010-016-2846-3; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jang HS, 2014, BBA-MOL BASIS DIS, V1842, P1733, DOI 10.1016/j.bbadis.2014.06.022; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koka S, 2014, AM J PHYSIOL-HEART C, V306, pH1558, DOI 10.1152/ajpheart.00865.2013; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mandosi E, 2015, EXPERT OPIN THER TAR, V19, P1617, DOI 10.1517/14728222.2015.1066337; Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Poels EM, 2015, AM J PHYSIOL-HEART C, V308, pH803, DOI 10.1152/ajpheart.00573.2014; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975; Sachan N, 2011, CIRC RES, V108, P437, DOI 10.1161/CIRCRESAHA.110.235309; Nunes AKS, 2015, BRAIN RES, V1627, P119, DOI 10.1016/j.brainres.2015.09.008; Santi D, 2015, EUR J ENDOCRINOL, V172, pR103, DOI 10.1530/EJE-14-0700; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Venneri MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126580; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687; Wang RC, 2014, RESP MED, V108, P531, DOI 10.1016/j.rmed.2014.01.003; Williams JW, 2013, AM J PHYSIOL-LUNG C, V305, pL693, DOI 10.1152/ajplung.00214.2013; WILSON DW, 1989, MICROVASC RES, V38, P57; Wu XJ, 2014, EUR J HEART FAIL, V16, P444, DOI 10.1002/ejhf.47; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhao SG, 2015, INT J CARDIOL, V198, P178, DOI 10.1016/j.ijcard.2015.06.183	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195528	10.1371/journal.pone.0195528	http://dx.doi.org/10.1371/journal.pone.0195528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621314	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800097
J	Moreau, J; Khalil, T; Dupic, G; Chautard, E; Lemaire, JJ; Magnier, F; Dedieu, V; Lapeyre, M; Verrelle, P; Biau, J				Moreau, Juliette; Khalil, Toufic; Dupic, Guillaume; Chautard, Emmanuel; Lemaire, Jean-Jacques; Magnier, Florian; Dedieu, Veronique; Lapeyre, Michel; Verrelle, Pierre; Biau, Julian			Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; SURGICAL RESECTION; SALVAGE THERAPY; BREAST-CANCER; SURVIVAL; MANAGEMENT; RADIONECROSIS; RADIOTHERAPY; TUMORS; SRS	In the present study, we have evaluated the efficacy and toxicity of repeated brain metastases (BM) stereotactic radiosurgery (SRS2) following local failure of a prior radiosurgical procedure (SRS1). Between December 1996 and August 2015, 30 patients with 36 BM underwent SRS2 with a median dose of 18Gy. All BM were located outside critical structures. Following SRS2, local control at 6 months and one year were respectively 82.9% (IC 95%: 67.6-91.9) and 67.8% (IC 95%: 51-81). On multivariate analysis, planning target volume (PTV) < 3cc (HR: 0.19 (0.1-0.52)) and whole brain radiotherapy (WBRT) prior to SRS2 (HR: 0.25 (0.1-0.64)) were significantly associated with a better local control. One- and two-year overall survival rates after SRS2 were respectively 65.5% (IC 95%: 47.3-80%) and 27.6% (IC 95%: 14.7-45.7). Median overall survival following SRS2 was 14.2 months (range 1-106). Nineteen (63%) patients died from progressive systemic disease. Three (10%) patients died from out-field progressive brain disease and 8 (27%) in-field. Concerning toxicities, edema, radionecrosis, and hemorrhages were identified in 5 (12.8%), 4 (10.2%), and 5 (12.8%) patients respectively. No toxicity resulted in a neurological deficit. On univariate analysis, toxicities were significantly associated with PTV > 7cc (p = 0.02) and all patients had a WBRT before SRS2. A second course of SRS for locally recurrent brain metastases showed encouraging rates of local control. This treatment led to acceptable toxicities, especially for brain metastases smaller than 7cc, in our selected cohort of patients with BM located outside critical structures. Further studies are needed.	[Moreau, Juliette; Dupic, Guillaume; Chautard, Emmanuel; Lapeyre, Michel; Verrelle, Pierre; Biau, Julian] Univ Clermont Auvergne, Radiotherapy Dept, Ctr Jean Perrin, Clermont Ferrand, France; [Khalil, Toufic; Lemaire, Jean-Jacques] Clermont Ferrand Hosp, Neurosurg Dept, Clermont Ferrand, France; [Chautard, Emmanuel; Dedieu, Veronique; Biau, Julian] Univ Clermont Auvergne, INSERM, U1240 IMoST, Clermont Ferrand, France; [Lemaire, Jean-Jacques] Univ Clermont Auvergne, CNRS, Inst Pascal, UMR 6602, Clermont Ferrand, France; [Magnier, Florian; Dedieu, Veronique] Ctr Jean Perrin, Med Phys Dept, Clermont Ferrand, France; [Verrelle, Pierre] Inst Curie, Radiat Oncol Dept, Paris, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); UNICANCER; Centre Jean Perrin; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Biau, J (corresponding author), Univ Clermont Auvergne, Radiotherapy Dept, Ctr Jean Perrin, Clermont Ferrand, France.; Biau, J (corresponding author), Univ Clermont Auvergne, INSERM, U1240 IMoST, Clermont Ferrand, France.	Julian.biau@clermont.unicancer.fr	CHAUTARD, Emmanuel/X-8946-2019; Biau, Julian/X-9035-2019; dedieu, veronique/X-8551-2019	CHAUTARD, Emmanuel/0000-0003-2655-7803; Biau, Julian/0000-0002-1570-4487; MAGNIER, Florian/0000-0001-9403-9923; Lemaire, Jean-Jacques/0000-0003-4395-5328				Ahmed KA, 2015, ANN ONCOL; Ammirati M, 2010, J NEURO-ONCOL, V96, P85, DOI 10.1007/s11060-009-0055-6; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bartsch R, 2007, J NEURO-ONCOL, V85, P311, DOI 10.1007/s11060-007-9420-5; Blonigen BJ, 2010, INT J RADIAT ONCOL, V77, P996, DOI 10.1016/j.ijrobp.2009.06.006; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chen JCT, 2000, NEUROSURGERY, V46, P860, DOI 10.1097/00006123-200004000-00017; Cicone F, 2015, EUR J NUCL MED MOL I, V42, P103, DOI 10.1007/s00259-014-2886-4; Hanna A, 2016, J NEURO-ONCOL, V127, P303, DOI 10.1007/s11060-015-2034-4; Holt DE, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00084; Jayachandran P, 2014, INT J RADIAT ONCOL, V90, pS320, DOI 10.1016/j.ijrobp.2014.05.1063; Kim DH, 2012, INT J RADIAT ONCOL, V84, pS286, DOI 10.1016/j.ijrobp.2012.07.746; Kirsch DG, 2005, J CLIN ONCOL, V23, P2114, DOI 10.1200/JCO.2005.05.249; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Kohutek ZA, 2015, J NEURO-ONCOL, V125, P149, DOI 10.1007/s11060-015-1881-3; Kwon KY, 2007, CLIN NEUROL NEUROSUR, V109, P132, DOI 10.1016/j.clineuro.2006.06.007; Lin NU, 2015, LANCET ONCOL, V16, pE270, DOI 10.1016/S1470-2045(15)70057-4; Lin XL, 2015, J CLIN ONCOL, V33, P3475, DOI 10.1200/JCO.2015.60.9503; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Mckay WH, 2017, J NEUROSURG, V127, P148, DOI 10.3171/2016.5.JNS153051; Milano MT, 2009, INT J RADIAT ONCOL, V73, P832, DOI 10.1016/j.ijrobp.2008.04.073; Minniti G, 2016, J NEURO-ONCOL, V126, P91, DOI 10.1007/s11060-015-1937-4; Minniti G, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-48; Miyakawa A, 2016, INT J CLIN ONCOL, P1; Noel G, 2001, RADIOTHER ONCOL, V60, P61, DOI 10.1016/S0167-8140(01)00359-0; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Redmond AJ, 2008, J NEUROSURG, V109, P99, DOI 10.3171/JNS/2008/109/12/S16; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Song CW, 2014, INT J CLIN ONCOL, V19, P570, DOI 10.1007/s10147-014-0717-z; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Trifiletti DM, 2015, INT J RADIAT ONCOL, V93, pE73, DOI 10.1016/j.ijrobp.2015.07.729; Truong MT, 2006, NEUROSURGERY, V59, P86, DOI 10.1227/01.NEU.0000219858.80351.38; Vecil GG, 2005, J NEUROSURG, V102, P209, DOI 10.3171/jns.2005.102.2.0209	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195608	10.1371/journal.pone.0195608	http://dx.doi.org/10.1371/journal.pone.0195608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621341	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800106
J	Bogoni, JA; Graipel, ME; Peroni, N				Bogoni, Juliano Andre; Graipel, Mauricio Eduardo; Peroni, Nivaldo			The ecological footprint of Acca sellowiana domestication maintains the residual vertebrate diversity in threatened highlands of Atlantic Forest	PLOS ONE			English	Article							LARGE-BODIED MAMMALS; SEED-DISPERSAL; COMMUNITY STRUCTURE; ARAUCARIA-ANGUSTIFOLIA; DIDELPHIS-ALBIVENTRIS; TROPICAL FOREST; FOOD WEBS; TOP-DOWN; PLANT; PATTERNS	Past and contemporary human actions are causing numerous changes in patterns and processes at various ecosystem scales and trophic levels, including unintended downstream changes, such as species interactions. In its native range Acca sellowiana (Feijoa) combines some characteristics of human interactions: incipient domestication, restricted to subtropical Atlantic Forest highlands, associated with the threatened conifer Araucaria angustifolia (Araucaria), within a domesticated landscape with anthropogenic forest patches, and provides fruit at a time of resource shortage (Araucaria seeds-pinhao). We quantify the trophic relationships between Feijoa and vertebrates, and evaluate the influences on interactions caused by environmental variations, Feijoa domestication evidences, spatial distance and fruit availability. In four sites within protected areas, we selected 28 focal individuals of Feijoa (seven/site) and collected three temporal replicas between 2015 and 2016, when we measured productivity and frugivory via 45-second videos taken with camera traps. Using ecological network, rarefaction curves and variation partitioning analyses, we evaluate the frugivory network topology, the spatiotemporal structure of communities in relation to fruit availability and the influence of predictive variables on frugivory. We found a large spatiotemporal variation in productivity of Feijoa and that 20 species consumed Feijoa fruits, with a species degree of 2.8 (+/- 5.7) and average Feijoa degree of 14.4 (+/- 10.1), in a modular network with intermediary connectance. Rarefaction curves showed that richness and the independent records are congruent with the fruit amount. Variation partitioning showed that, for the focal individuals, canopy area, green coverage, patch size and distance to water influenced frugivory, and the Feijoa domestication influenced significantly the mammalian frugivory. Feijoa is an important resource that provides food during the time of year when Pinhao is absent, and attracts frugivores, maintain the residual diversity of vertebrates contributing to the structure of communities in highlands. Our insights allowed us to evaluate the magnitude of the interactions between vertebrates and an incipient domesticated tree, in a cultural landscape and highly threatened environment, under a basal foodweb approach with implications for bottom-up and top-down forces. The results contribute to understanding animal-plant relationships, including concepts that can be replicated for other sessile prey and mobile predators in any region or habitat under different gradients of management. Thus, this work shows how human actions can change not only patterns of distribution and abundance but also the diversity and direction of interspecific interactions among species.	[Bogoni, Juliano Andre; Peroni, Nivaldo] Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Graipel, Mauricio Eduardo] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Bogoni, JA (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil.	bogoni.ja@gmail.com	Peroni, Nivaldo/ABA-2663-2021; Graipel, Maurício/T-3443-2019; Peroni, Nivaldo/AAU-4701-2020	Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Bogoni, Juliano Andre/0000-0002-8541-0556	Brazilian Ministry of Education (CAPES); CNPq; Brazilian Ministry of Education (MEC-CAPES)	Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Education (MEC-CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian Ministry of Education (CAPES), Ph.D. scholarship (JAB) and (CNPq) productivity fellowship (NP).; JAB thanks the Brazilian Ministry of Education (MEC-CAPES) for a Ph.D. scholarship. NP thanks CNPq for a productivity fellowship. We thank Patricia Puechagut and Rafael B. Suhs for field support and for the photography contained in S2 Fig., and Laboratorio de Ecologia Terrestre Animal (LECOTA-UFSC) for loaned camera-traps. We thank the PPBio and ICM-Bio for field support. We thank Mauricio Sedrez dos Reis, Tania T. Castellani, Luiz Gustavo R. Oliveira-Santos, Mauricio Cantor, Fabio Daura-Jorge, and Adriano Paglia for comments on the manuscript. We thank Fernanda Michalski and other two anonymous reviewers for their important contribution to this manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2008, GLOBAL ECOL BIOGEOGR, V17, P503, DOI 10.1111/j.1466-8238.2008.00386.x; Amarante CVT, 2011, REV BRAS FRUTIC, V33, P1; [Anonymous], 1912, POMONA COLL J BOT; [Anonymous], THESIS; [Anonymous], THESIS; [Anonymous], 2013, PACKFOR FORWARD SELE; [Anonymous], RODRIGUESIA; [Anonymous], 2008, QUANT GIS VERS 3 4 4; Bartuszevige AM, 2008, J ARID ENVIRON, V72, P904, DOI 10.1016/j.jaridenv.2007.11.007; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bitencourt Ana Luisa Vietti, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P109; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bogoni JA, 2016, MAMMALIA; Bogoni JA, 2017, BIOL CONSERV, V211, P85, DOI 10.1016/j.biocon.2017.05.012; Bogoni JA, 2016, BIODIVERS CONSERV, V25, P1661, DOI 10.1007/s10531-016-1147-1; Bogoni JA, 2016, J MAMMAL, V97, P713, DOI 10.1093/jmammal/gyv215; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brocardo CR, 2013, BIOL CONSERV, V163, P107, DOI 10.1016/j.biocon.2013.04.024; Brower J.E., 1998, FIELD LAB METHODS GE; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Caceres NC, 2002, STUD NEOTROP FAUNA E, V37, P97, DOI 10.1076/snfe.37.2.97.8582; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cantor M, 2010, BIOTA NEOTROP, V10, P45, DOI 10.1590/S1676-06032010000200004; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Ceotto P, 2009, DIET VARIATION MARSU; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Neto EMDL, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-33; de Jesus Costa Elizabete Marques, 2008, Neotropical Biology and Conservation, V3, P66; de Lima RAF, 2015, BIODIVERS CONSERV, V24, P2135, DOI 10.1007/s10531-015-0953-1; de Souza JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158127; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dormann C.F., 2008, INTERACTIONS, V8, P8; dos Reis MS, 2014, ECOL SOC, V19, DOI 10.5751/ES-06163-190243; dos Santos KL, 2009, ECON BOT, V63, P204, DOI 10.1007/s12231-009-9076-5; Ducroquet JPHJ, 1997, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.1997.452.5; Dupont YL, 2011, OIKOS, V120, P170, DOI 10.1111/j.1600-0706.2010.18699.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Galetti M, 2015, GLOB ECOL CONSERV, V3, P824, DOI 10.1016/j.gecco.2015.04.008; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gressler Eliana, 2006, Braz. J. Bot., V29, P509, DOI 10.1590/S0100-84042006000400002; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hickel E. R., 2000, Revista Brasileira de Fruticultura, V22, P96; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Instituto Brasileiro de Geografia e Estatistica (IBGE), 1992, MAN TECN VEG TAM REC; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Karubian J, 2011, WILSON J ORNITHOL, V123, P137, DOI 10.1676/10-029.1; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Lacerda AEB, 2016, BIOTROPICA, P1; Landrum LR, 1997, BRITTONIA, V49, P508, DOI 10.2307/2807742; Lessa LG, 2013, ACTA BOT BRAS, V27, P519, DOI 10.1590/S0102-33062013000300009; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Mello AJM, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0039-x; Magurran A.E., 2004, MEASURING BIOL DIVER; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; May RM, 1976, NATURE, V260, P471, DOI DOI 10.1038/260471A0; Mckey D, 2010, P NATL ACAD SCI USA, V107, P7823, DOI 10.1073/pnas.0908925107; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Nogales M, 2005, FUNCT ECOL, V19, P429, DOI 10.1111/j.0269-8463.2005.00975.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Oliveira-Santos LGR, 2008, J TROP ECOL, V24, P563, DOI 10.1017/S0266467408005324; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; PAINE RT, 1980, J ANIM ECOL, V49, P667; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pires MM, 2014, OECOLOGIA, V175, P1247, DOI 10.1007/s00442-014-2971-1; Pizo Marco Aurelio, 1996, Ornitologia Neotropical, V6, P87; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Purves DW, 2005, J ECOL, V93, P658, DOI 10.1111/j.1365-2745.2005.00988.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Rambo B., 1951, ANAIS BOT HERBARIO B, V3, P7; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Redondo B, 2012, BRENESIA, V77, P357; Rocha LEC, 2005, THESIS; Santos K. L. dos, 2011, Biotemas, V24, P75; Santos KL, 2017, AGROECOLOGY SUSTAINA; Souza AF, 2007, AUSTRAL ECOL, V32, P524, DOI 10.1111/j.1442-9993.2007.01724.x; Sunquist M.E., 1989, P197; Tabarelli M., 1999, Revista Brasileira de Biologia, V59, P239, DOI 10.1590/S0034-71081999000200008; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Uowolo AL, 2008, PAC SCI, V62, P129, DOI 10.2984/1534-6188(2008)62[129:COTPCM]2.0.CO;2; van der Pijl L., 1992, PRINCIPLES DISPERSAL; Vasconcellos-Neto J, 2009, ACTA BOT BRAS, V23, P1171, DOI 10.1590/S0102-33062009000400027; Vidal MM, 2014, ECOLOGY, V95, P3440, DOI 10.1890/13-1584.1; Vidal MM, 2013, BIOL CONSERV, V163, P42, DOI 10.1016/j.biocon.2013.03.025; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Will H, 2008, J ECOL, V96, P1011, DOI 10.1111/j.1365-2745.2007.01341.x; Yumoto T, 1999, BIOTROPICA, V31, P654, DOI 10.1111/j.1744-7429.1999.tb00414.x; Zhang XueYong, 2013, African Journal of Agricultural Research, V8, P3967	109	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195199	10.1371/journal.pone.0195199	http://dx.doi.org/10.1371/journal.pone.0195199			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617455	gold, Green Published			2022-12-27	WOS:000429203800068
J	Stojanova, B; Surinova, M; Klapste, J; Kolarikova, V; Hadincova, V; Munzbergova, Z				Stojanova, Bojana; Surinova, Maria; Klapste, Jaroslav; Kolarikova, Veronika; Hadincova, Veroslava; Munzbergova, Zuzana			Adaptive differentiation of Festuca rubra along a climate gradient revealed by molecular markers and quantitative traits	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; CO-INERTIA ANALYSIS; PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; Q(ST)-F-ST COMPARISONS; POPULATION DIVERGENCE; ALTITUDINAL GRADIENT; NATURAL-SELECTION; STOMATAL DENSITY; EVOLUTIONARY	Species response to climate change is influenced by predictable (selective) and unpredictable (random) evolutionary processes. To understand how climate change will affect present-day species, it is necessary to assess their adaptive potential and distinguish it from the effects of random processes. This will allow predicting how different genotypes will respond to forecasted environmental change. Space for time substitution experiments are an elegant way to test the response of present day populations to climate variation in real time. Here we assess neutral and putatively adaptive variation in 11 populations of Festuca rubra situated along crossed gradients of temperature and moisture using molecular markers and phenotypic measurements, respectively. By comparing population differentiation in putatively neutral molecular markers and phenotypic traits (Q(ST)-F(ST)comparisons), we show the existence of adaptive differentiation in phenotypic traits and their plasticity across the climatic gradient. The observed patterns of differentiation are due to the high genotypic and phenotypic differentiation of the populations from the coldest (and wettest) environment. Finally, we observe statistically significant covariation between markers and phenotypic traits, which is likely caused by isolation by adaptation. These results contribute to a better understanding of the current adaptation and evolutionary potential to face climate change of a widespread species. They can also be extrapolated to understand how the studied populations will adjust to upcoming climate change without going through the lengthy process of phenotyping.	[Stojanova, Bojana] Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic; [Stojanova, Bojana; Surinova, Maria; Kolarikova, Veronika; Munzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Surinova, Maria; Hadincova, Veroslava; Munzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, Pruhonice, Czech Republic; [Klapste, Jaroslav] Scion New Zealand Forest Res Inst Ltd, Rotorua, New Zealand	University of Ostrava; Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Scion	Stojanova, B (corresponding author), Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic.; Stojanova, B (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	bojana.stojanova@gmail.com	Šurinová, Mária/F-5239-2015; Klapste, Jaroslav/B-6668-2016; Stojanova, Bojana/AAL-9784-2021; Hadincova, Veroslava/D-4572-2013; Münzbergová, Zuzana/F-6321-2013	Klapste, Jaroslav/0000-0001-5504-3735; Hadincova, Veroslava/0000-0002-3825-1919; Münzbergová, Zuzana/0000-0002-4026-6220; Stojanova, Bojana/0000-0002-6761-7756	Czech Grant Agency [GACR 15-07795S]; Academy of Sciences of the Czech Republic; Charles University of Prague; Scion (New Zealand Forest Research Institute Ltd.), a commerial company; University of Ostrava; Norwegian Research Council [NORKLIMA 184912, KLIMAFORSK 244525];  [RVO 67985939]	Czech Grant Agency(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Charles University of Prague; Scion (New Zealand Forest Research Institute Ltd.), a commerial company; University of Ostrava; Norwegian Research Council(Research Council of NorwayEuropean Commission); 	The study was supported by project GACR 15-07795S of the Czech Grant Agency, which provided funding for field trips and all experimental work, and parts of the salaries of ZM, VH, and BS, through the Academy of Sciences of the Czech Republic and Charles University of Prague. JK salary was funded by Scion (New Zealand Forest Research Institute Ltd.), a commerial company. BS salary was partly funded by the University of Ostrava. The study was also partly supported institutional research projects RVO 67985939 and MSMT. The plant material upon which this research was based was collected from within the SEEDCLIM Climate Grid field sites in western Norway, PI Vigdis Vandvik, funded by the Norwegian Research Council projects NORKLIMA 184912 and KLIMAFORSK 244525. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; The study was supported by project GACR 15-07795S and partly by institutional research projects RVO 67985939 and MSMT. The plant material upon which this research was based was collected from within the SEEDCLIM Climate Grid field sites in western Norway, PI Vigdis Vandvik, funded by the Norwegian Research Council projects NORKLIMA 184912 and KLIMAFORSK 244525. The SEEDCLIM project team granted access to the field sites and provided the associated climatic and environmental data.	[Anonymous], 2014, R LANG ENV STAT COMP; Aykanat T, 2015, MOL ECOL, V24, P5158, DOI 10.1111/mec.13383; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; BEERLING DJ, 1993, P ROY SOC B-BIOL SCI, V251, P133, DOI 10.1098/rspb.1993.0019; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Brommer JE, 2005, EVOLUTION, V59, P1362; Butler D.G., 2017, ASREML R REFERENCE M; Castro S, 2011, EVOL ECOL, V25, P795, DOI 10.1007/s10682-010-9439-5; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; de Jong G, 2005, NEW PHYTOL, V166, P101, DOI 10.1111/j.1469-8137.2005.01322.x; De Kort H, 2016, J EVOLUTION BIOL, V29, P253, DOI 10.1111/jeb.12777; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Fu YB, 2006, MOL ECOL NOTES, V6, P894, DOI 10.1111/j.1471-8286.2006.01390.x; Garcia-Navas V, 2014, J EVOLUTION BIOL, V27, P1590, DOI 10.1111/jeb.12412; Gomory D, 2015, EUR J FOREST RES, V134, P1075, DOI 10.1007/s10342-015-0910-2; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Govindjee SA, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI DOI 10.1016/J.JPH0T0BI0L.2010.12.010; Hanssen-Bauer I, 2005, CLIM RES, V29, P255, DOI 10.3354/cr029255; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henderson C. R, 1984, APPL LINEAR MODELS A; Herben T, 2001, OIKOS, V95, P43, DOI 10.1034/j.1600-0706.2001.950105.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karhunen M, 2014, EVOLUTION, V68, P559, DOI 10.1111/evo.12268; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim Y, 2000, GENETICS, V155, P1415; Klanderud K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130205; KORNER C, 1989, FLORA, V182, P353; Lauvergeat V, 2005, MOL ECOL NOTES, V5, P401, DOI 10.1111/j.1471-8286.2005.00941.x; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Lester RE, 2014, GLOBAL CHANGE BIOL, V20, P3471, DOI 10.1111/gcb.12634; LEWONTIN RC, 1973, GENETICS, V74, P175; Li S-L, 2015, ANN BOT; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Luo Y, 2015, HEREDITY, V114, P220, DOI 10.1038/hdy.2014.89; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Meerhoff M., 2012, ENV WARMING SHALLOW; Meineri E, 2014, J VEG SCI, V25, P275, DOI 10.1111/jvs.12062; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Michalakis Y, 1996, GENETICS, V142, P1061; Michalski SG, 2015, ECOL EVOL, V5, P2172, DOI 10.1002/ece3.1481; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Munzbergova A Z, 2017, J ECOL; Munzbergova A Z, 2017, ECOL EVOL; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nicotra AB, 2015, ECOL EVOL, V5, P634, DOI 10.1002/ece3.1329; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; PICKETT S T A, 1989, P110; Pons O, 1996, GENETICS, V144, P1237; Porth I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142864; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Rogell B, 2012, MOL ECOL, V21, P2963, DOI 10.1111/j.1365-294X.2012.05590.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Skalova H, 1997, J EVOLUTION BIOL, V10, P383, DOI 10.1007/s000360050031; Springate DA, 2011, J EVOLUTION BIOL, V24, P2280, DOI 10.1111/j.1420-9101.2011.02360.x; Stenstrom A, 2002, AM J BOT, V89, P1410, DOI 10.3732/ajb.89.9.1410; Sultan SE, 1995, ACTA BOT NEERL, V44, P363; Valladares F, 2000, NEW PHYTOL, V148, P79, DOI 10.1046/j.1469-8137.2000.00737.x; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; VIA S, 1993, AM NAT, V142, P352, DOI 10.1086/285542; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Zhang LR, 2012, ECOL EVOL, V2, P1065, DOI 10.1002/ece3.233	88	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194670	10.1371/journal.pone.0194670	http://dx.doi.org/10.1371/journal.pone.0194670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617461	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800043
J	Nowicki, JP; O'Connell, LA; Cowman, PF; Walker, SPW; Coker, DJ; Pratchett, MS				Nowicki, Jessica P.; O'Connell, Lauren A.; Cowman, Peter F.; Walker, Stefan P. W.; Coker, Darren J.; Pratchett, Morgan S.			Variation in social systems within Chaetodon butterflyfishes, with special reference to pair bonding	PLOS ONE			English	Article							CORAL-REEF FISHES; GROWTH-RATE ADVANTAGE; PRAIRIE VOLE; MATING SYSTEM; SEX-CHANGE; CORALLIVOROUS BUTTERFLYFISH; MONOGAMOUS BUTTERFLYFISH; MICROTUS-OCHROGASTER; GENE-EXPRESSION; BEHAVIOR	For many animals, affiliative relationships such as pair bonds form the foundation of society and are highly adaptive. Animal systems amenable for comparatively studying pair bonding are important for identifying underlying biological mechanisms, but mostly exist in mammals. Better establishing fish systems will enable comparison of pair bonding mechanisms across taxonomically distant lineages that may reveal general underlying mechanistic principles. We examined the utility of wild butterflyfishes (f: Chaetodontidae; g: Chaetodon) for comparatively studying pair bonding. Using stochastic character mapping, we provide the first analysis of the evolutionary history of butterflyfish sociality, revealing that pairing is ancestral, with at least seven independent transitions to gregarious grouping and solitary behavior since the late Miocene. We then formally verified social systems in six sympatric and widespread species representing a clade with one ancestrally reconstructed transition from paired to solitary grouping at Lizard Island, Australia. In situ observations of the size, selective affiliation and aggression, fidelity, and sex composition of social groups confirmed that Chaetodon baronessa, C. lunulatus, and C. vagabundus are predominantly pair bonding, whereas C. rainfordi, C. plebeius, and C. trifascialis are predominantly solitary. Even in the predominantly pair bonding species, C. lunulatus, a proportion of adults (15%) are solitary. Importantly, inter-and intra-specific differences in social systems do not co-vary with other previously established attributes, including parental care. Hence, the proposed butterflyfish populations are promising for inter-and intra-species comparative analyses of pair bonding and its mechanistic underpinnings. Avenues for further developing the system are proposed, including determining whether the aforementioned utility of these species applies across their geographic disruptions.	[Nowicki, Jessica P.; Cowman, Peter F.; Walker, Stefan P. W.; Coker, Darren J.; Pratchett, Morgan S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Nowicki, Jessica P.; O'Connell, Lauren A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Coker, Darren J.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	James Cook University; Stanford University; King Abdullah University of Science & Technology	Nowicki, JP; Pratchett, MS (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.; Nowicki, JP (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jnowicki@stanford.edu; Morgan.pratchett@jcu.edu.au	Cowman, Peter Francis/G-9998-2017; Pratchett, Morgan/AAW-5179-2020; Nowicki, Jessica Ploetz/AAY-2349-2021	Cowman, Peter Francis/0000-0001-5977-5327; Pratchett, Morgan/0000-0002-1862-8459; Nowicki, Jessica Ploetz/0000-0002-6373-8761; O'Connell, Lauren/0000-0002-2706-4077	Australian Research Centre; James Cook University Postgraduate Research Grant	Australian Research Centre; James Cook University Postgraduate Research Grant	This work was supported by an Australian Research Centre grant to SPWW and MSP, as well as a James Cook University Postgraduate Research Grant to JPN. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155877; Allen G.R., 1998, GUIDE ANGELFISHES BU; Aragona BJ, 2004, ILAR J, V45, P35, DOI 10.1093/ilar.45.1.35; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bellwood DR, 2014, Biology of Butterflyfishes, P1; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berumen ML, 2009, ENVIRON BIOL FISH, V86, P447, DOI 10.1007/s10641-009-9545-9; Berumen ML, 2005, ENVIRON BIOL FISH, V72, P409, DOI 10.1007/s10641-004-2595-0; Berumen ML, 2005, MAR ECOL PROG SER, V287, P217, DOI 10.3354/meps287217; Berumen ML, 10 INT COR REEF S 20; Blowes SA, 2013, AM NAT, V182, P157, DOI 10.1086/670821; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bonaldo R. M., 2005, Braz. J. Biol., V65, P211, DOI 10.1590/S1519-69842005000200004; BOUCHONNAVARO Y, 1981, J EXP MAR BIOL ECOL, V55, P145, DOI 10.1016/0022-0981(81)90108-8; BRADLEY JS, 1990, J ANIM ECOL, V59, P487, DOI 10.2307/4876; Brandl SJ, 2014, OCEANOGR MAR BIOL, V52, P1; Bull CM, 2000, BEHAV PROCESS, V51, P7, DOI 10.1016/S0376-6357(00)00115-7; Buxton CD, 1990, ALTERNATIVE LIFE HIS, P113; Caldwell JP, 1997, NATURE, V385, P211, DOI 10.1038/385211a0; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Choat J, 1991, ECOLOGY FISHES CORAL, V39; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cole A.J., 2014, BIOL BUTTERFLYFISHES; Cole KS, 2001, ENVIRON BIOL FISH, V61, P161, DOI 10.1023/A:1011032228716; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cowman PF, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00394; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cowman PF, 2013, P R SOC B; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; Delbeek J, 2006, ADVANCEMENTS MARINE, P2; Delbeek JC, 2014, BIOL BUTTERFLYFISHES; DeVries AC, 1997, CAN J ZOOL, V75, P295, DOI 10.1139/z97-037; Dewan AK, 2011, HORM BEHAV, V59, P56, DOI 10.1016/j.yhbeh.2010.10.002; DRISCOLL JW, 1988, ENVIRON BIOL FISH, V22, P29, DOI 10.1007/BF00000542; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EHRLICH PR, 1977, J ZOOL, V183, P213; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; Freeman SM, 2013, OXYTOCIN, VASOPRESSIN AND RELATED PEPTIDES IN THE REGULATION OF BEHAVIOR, P128; FRICKE HW, 1986, ETHOLOGY, V73, P307; FROESE R., 2012, FISHBASE; Fuentes A, 2000, YEARB PHYS ANTHROPOL, V43, P33; GETZ LL, 1986, BEHAV ECOL SOCIOBIOL, V18, P275, DOI 10.1007/BF00300004; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gobrogge K, 2016, CURR OPIN NEUROBIOL, V38, P80, DOI 10.1016/j.conb.2016.04.011; Godin, 1997, BEHAV ECOLOGY TELEOS; Goodson JL, 2006, HORM BEHAV, V50, P223, DOI 10.1016/j.yhbeh.2006.03.005; Goodson JL, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00013; Gregson MA, 2008, CORAL REEFS, V27, P583, DOI 10.1007/s00338-008-0366-7; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gubernick David J., 1994, Ettore Majorana International Life Sciences Series, V13, P427; Harding JA, 2003, ANIM BEHAV, V65, P865, DOI 10.1006/anbe.2003.2144; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hinde RA, 1982, ETHOLOGY ITS NATURE; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V25, P61, DOI 10.1007/BF00002201; Hourigan TF, 1987, THESIS; Hourigan TF, 1987, BEHAV ECOLOGY 3 SPEC; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Johnson ZV, 2015, CURR OPIN BEHAV SCI, V3, P38, DOI 10.1016/j.cobeha.2015.01.009; KREBS JR, 1990, PHILOS T ROY SOC B, V329, P153, DOI 10.1098/rstb.1990.0160; Kuiter R. H., 2002, BUTTERFLYFISHES BANN; KUWAMURA T, 1994, BEHAV ECOL, V5, P434, DOI 10.1093/beheco/5.4.434; Lawton RJ, 2012, ECOGRAPHY, V35, P566, DOI 10.1111/j.1600-0587.2011.07326.x; LOBEL PS, 1978, PAC SCI, V32, P193; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; MCGRAW L, 2010, SOCIAL BEHAV GENES E; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Munday PL, 2002, BEHAV ECOL SOCIOBIOL, V52, P247, DOI 10.1007/s00265-002-0517-8; NEUDECKER S, 1982, Z TIERPSYCHOL, V59, P299; Nowicki JP, 2017, BIORXIV, DOI [10.1101/214627, DOI 10.1101/214627]; O'Connor CM, 2016, HORM BEHAV, V80, P30, DOI 10.1016/j.yhbeh.2015.10.015; Oldfield RG, 2013, HORM BEHAV, V64, P44, DOI 10.1016/j.yhbeh.2013.04.006; Oliveira RF, 2012, J FISH BIOL, V81, P2127, DOI 10.1111/j.1095-8649.2012.03477.x; Ondrasek NR, 2016, ETHOLOGY, V122, P443, DOI 10.1111/eth.12493; Phelps SM, 2010, NEUROPHARMACOLOGY, V58, P17, DOI 10.1016/j.neuropharm.2009.06.043; Pratchett MS, 2015, CORAL REEFS, V34, P665, DOI 10.1007/s00338-014-1254-y; Pratchett MS, 2014, ECOL EVOL, V4, P3612, DOI 10.1002/ece3.1208; Pratchett MS, 2006, CORAL REEFS, V25, P85, DOI 10.1007/s00338-005-0081-6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Pratchett MS, 2014, Biology of Butterflyfishes, P1; Proges S., 2005, ATTACHMENT BONDING N; Pyle RL, 2016, ZOOKEYS, P137, DOI 10.3897/zookeys.614.10200; Quinlan RJ, 2007, CROSS-CULT RES, V41, P149, DOI 10.1177/1069397106298893; REESE E S, 1975, Zeitschrift fuer Tierpsychologie, V37, P37; REESE ES, 1973, COPEIA, P145, DOI 10.2307/1442375; REESE ES, 1991, ECOL INT B, V0019, P00029; Reese ES, 1978, CONTRASTS BEHAV, V347; Reichard U. H., 2003, MONOGAMY MATING STRA; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; Sale PF, 1978, REEF FISHES OTHER VE, P313; SHAPIRO DY, 1987, BIOSCIENCE, V37, P490, DOI 10.2307/1310421; Smith CM, 2000, CONDOR, V102, P201, DOI 10.1650/0010-5422(2000)102[0201:LTPBIH]2.0.CO;2; Summers K, 2013, SEXUAL SELECTION PER, P289; SUTTON M, 1985, ANIM BEHAV, V33, P1332, DOI 10.1016/S0003-3472(85)80194-9; Taborsky M, 2015, TRENDS NEUROSCI, V38, P189, DOI 10.1016/j.tins.2015.01.004; Tanaka N., 1992, GALAXEA, V11, P66; Thresher RE, 1984, REPROD REEF FISHES; Tricas T. C., 1985, P 5 INT COR REEF C, V5, P409; TRICAS TC, 1989, ANIM BEHAV, V37, P830, DOI 10.1016/0003-3472(89)90067-5; Tricas TC, 1986, LIFE HIST FORAGING E; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; Volkmar FR, 2001, J CLIN CHILD PSYCHOL, V30, P80, DOI 10.1207/S15374424JCCP3001_9; Wang ZX, 2004, PHYSIOL BEHAV, V83, P319, DOI 10.1016/j.physbeh.2004.08.024; Weitekamp CA, 2017, EVOLUTION NERVOUS SY, P327, DOI DOI 10.1016/B978-0-12-804042-3.00025-7; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Whiteman EA, 2004, BIOL REV, V79, P351, DOI 10.1017/S1464793103006304; Wilson, 2000, SOCIOBIOLOGY; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; Yabuta S, 1997, ICHTHYOL RES, V44, P183, DOI 10.1007/BF02678696; Yabuta S, 2000, J ETHOL, V18, P11, DOI 10.1007/s101640070018; Yabuta S, 1997, ICHTHYOL RES, V44, P177, DOI 10.1007/BF02678695; Yabuta S, 2002, ANIM BEHAV, V63, P165, DOI 10.1006/anbe.2001.1869; Yabuta S, 2014, BIOL BUTTERFLYFISHES; Yabuta S, 2007, ICHTHYOL RES, V54, P207, DOI 10.1007/s10228-006-0391-x; Yabuta S, 2014, BIOLOGY OF BUTTERFLYFISHES, P200; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599; Zwickl DJ, 2006, GARLI GENETIC ALGORI	121	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194465	10.1371/journal.pone.0194465	http://dx.doi.org/10.1371/journal.pone.0194465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641529	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900031
J	Klaus, A; Strube, C; Roper, KM; Radespiel, U; Schaarschmidt, F; Nathan, S; Goossens, B; Zimmermann, E				Klaus, Annette; Strube, Christina; Roeper, Kathrin Monika; Radespiel, Ute; Schaarschmidt, Frank; Nathan, Senthilvel; Goossens, Benoit; Zimmermann, Elke			Fecal parasite risk in the endangered proboscis monkey is higher in an anthropogenically managed forest environment compared to a riparian rain forest in Sabah, Borneo	PLOS ONE			English	Article							NASALIS-LARVATUS; INTESTINAL MICROBIOME; INFECTIOUS-DISEASES; SEX-DIFFERENCES; HELMINTH EGGS; RICHNESS; PATTERNS; PRIMATES; CONSERVATION; FRAGMENTATION	Understanding determinants shaping infection risk of endangered wildlife is a major topic in conservation medicine. The proboscis monkey, Nasalis larvatus, an endemic primate flagship species for conservation in Borneo, is endangered through habitat loss, but can still be found in riparian lowland and mangrove forests, and in some protected areas. To assess socioecological and anthropogenic influence on intestinal helminth infections in N. larvatus, 724 fecal samples of harem and bachelor groups, varying in size and the number of juveniles, were collected between June and October 2012 from two study sites in Malaysian Borneo: 634 samples were obtained from groups inhabiting the Lower Kinabatangan Wildlife Sanctuary (LKWS), 90 samples were collected from groups of the Labuk Bay Proboscis Monkey Sanctuary (LBPMS), where monkeys are fed on stationary feeding platforms. Parasite risk was quantified by intestinal helminth prevalence, host parasite species richness (PSR), and eggs per gram feces (epg). Generalized linear mixed effect models were applied to explore whether study site, group type, group size, the number of juveniles per group, and sampling month predict parasite risk. At the LBPMS, prevalence and epg of Trichuris spp., strongylids, and Strongyloides spp. but not Ascaris spp., as well as host PSR were significantly elevated. Only for Strongyloides spp., prevalence showed significant changes between months; at both sites, the beginning rainy season with increased precipitation was linked to higher prevalence, suggesting the external life cycle of Strongyloides spp. to benefit from humidity. Higher prevalence, epgs, and PSR within the LBPMS suggest that anthropogenic factors shape host infection risk more than socioecological factors, most likely via higher re-infection rates and chronic stress. Noninvasive measurement of fecal parasite stages is an important tool for assessing transmission dynamics and infection risks for endangered tropical wildlife. Findings will contribute to healthcare management in nature and in anthropogenically managed environments.	[Klaus, Annette; Roeper, Kathrin Monika; Radespiel, Ute; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Lower Saxony, Germany; [Klaus, Annette; Strube, Christina] Univ Vet Med Hannover, Inst Parasitol, Ctr Infect Med, Hannover, Lower Saxony, Germany; [Schaarschmidt, Frank] Leibniz Univ Hannover, Inst Biostat, Hannover, Lower Saxony, Germany; [Nathan, Senthilvel; Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales; [Klaus, Annette] Springer Heidelberg, Vet Med & Parasitol Dept, Heidelberg, Baden Wuerttemb, Germany; [Roeper, Kathrin Monika] Zoo Hannover, Zool Dept, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Leibniz University Hannover; Cardiff University; Cardiff University	Zimmermann, E (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Lower Saxony, Germany.	elke.Zimmermann@tiho-hannover.de	Zimmermann, Elke/D-2281-2015	Strube, Christina/0000-0002-9093-1006; Zimmermann, Elke/0000-0002-3714-4281	German Academic Exchange Service (DAAD) [D/12/40192, 332 4 04 106]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work received support from German Academic Exchange Service (DAAD) (D/12/40192, grant number 332 4 04 106, Annette Klaus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G, 2005, CURR SCI INDIA, V89, P454; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Azmi R., 1998, NATURAL VEGETATION 1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker DJ, 2015, ECOL LETT, V18, P483, DOI 10.1111/ele.12428; Benavides JA, 2012, AM J PHYS ANTHROPOL, V147, P52, DOI 10.1002/ajpa.21627; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bidin K, 2006, HYDROL PROCESS, V20, P3835, DOI 10.1002/hyp.6160; Boonratana R., PRIMATES FRAGMENTS C; Brack M., 1995, P25; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2005, AM J PRIMATOL, V67, P259, DOI 10.1002/ajp.20181; Chapman CA, PRIMATE PARASITE ECO, V80, DOI [10.1002/ajp.20601, DOI 10.1002/AJP.20601]; Clough D, 2010, AM J PHYS ANTHROPOL, V142, P441, DOI 10.1002/ajpa.21243; Cogswell F., 2007, Flynn's parasites of laboratory animals, P693, DOI 10.1002/9780470344552.ch21; Crestian J., 1975, Recueil de Medecine Veterinaire de l'Ecole d'Alfort, V151, P13; Dunn J., 2009, THESIS U BARCELONA B; Eckert KA, 2006, INT J PRIMATOL, V27, P227, DOI 10.1007/s10764-005-9010-3; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Fuxjager MJ, 2011, FUNCT ECOL, V25, P132, DOI 10.1111/j.1365-2435.2010.01784.x; Ganesh Swaytha, 2011, Gastroenterol Hepatol (N Y), V7, P194; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Gillespie TR, 2008, AM J PRIMATOL, V70, P222, DOI 10.1002/ajp.20475; Gillespie TR, 2006, INT J PRIMATOL, V27, P1129, DOI 10.1007/s10764-006-9064-x; Gillespie TR, 2010, AM J PHYS ANTHROPOL, V143, P534, DOI 10.1002/ajpa.21348; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Goossens B., 2012, Journal of Oil Palm & the Environment, V3, P38, DOI 10.5366/jope.2012.05; Gotoh S, 2000, PRIMATES, V41, P291, DOI 10.1007/BF02557598; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JESSEE MT, 1970, LAB ANIM CARE, V20, P83; King N, 2013, P INT C TOUR DEV 201; Klaus A, 2017, INT J PARASITOL-PAR, V6, P320, DOI 10.1016/j.ijppaw.2017.09.005; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Lawson B, 2012, PHILOS T R SOC B, V367, P2852, DOI 10.1098/rstb.2012.0130; LBPMS. Labuk Bay Proboscis Monkey Sanctuary, 2013, JAL LAB JUNCT SPS 3; MacIntosh AJJ, 2010, PRIMATES, V51, P353, DOI 10.1007/s10329-010-0211-9; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Matsuda I, 2008, AM J PRIMATOL, V70, P1097, DOI 10.1002/ajp.20604; Matsuda I, 2010, AM J PHYS ANTHROPOL, V142, P235, DOI 10.1002/ajpa.21218; Matsuda I, 2010, ECOL RES, V25, P475, DOI 10.1007/s11284-009-0677-3; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; Meijaard E, 2000, BIOL CONSERV, V92, P15, DOI 10.1016/S0006-3207(99)00066-X; MullerGraf CDM, 1996, PARASITOLOGY, V112, P489, DOI 10.1017/S0031182000076952; Navarro-Gonzalez N, 2013, VET PARASITOL, V196, P114, DOI 10.1016/j.vetpar.2013.02.019; Nguyen N, 2015, AM J PRIMATOL, V77, P579, DOI 10.1002/ajp.22379; Nunn CL, 2003, AM NAT, V162, P597, DOI 10.1086/378721; Nunn CL, 2006, INFECT DIS PRIMATES; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Radespiel U, 2015, PARASITOL RES, V114, P941, DOI 10.1007/s00436-014-4259-0; Roper KM, 2014, AM J PRIMATOL, V76, P192, DOI 10.1002/ajp.22221; Semire FA, 2012, ADV SPACE RES, V50, P1241, DOI 10.1016/j.asr.2012.06.031; Sha John C.M., 2008, Primate Conservation, V23, P107, DOI 10.1896/052.023.0112; Snaith TV, 2008, AM J PRIMATOL, V70, P1072, DOI 10.1002/ajp.20601; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Stark D. J., 2012, Endangered Species Research, V16, P31, DOI 10.3354/esr00385; Stark DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174891; Strait K, 2012, AM COLL LAB, P197, DOI 10.1016/B978-0-12-381366-4.00004-3; STUART MD, 1995, INT J PRIMATOL, V16, P577, DOI 10.1007/BF02735282; Turner WC, 2012, J ANIM ECOL, V81, P58, DOI 10.1111/j.1365-2656.2011.01892.x; Warren K.S., 2001, THESIS MURDOCH U; Wenz-Mucke A, 2013, PARASITOLOGY, V140, P709, DOI 10.1017/S003118201200203X; YEAGER CP, 1989, INT J PRIMATOL, V10, P497, DOI 10.1007/BF02739363; Zaiss MM, 2016, PARASITE IMMUNOL, V38, P5, DOI 10.1111/pim.12274; Zerbe P., 2009, International Zoo Yearbook, V43, P149, DOI 10.1111/j.1748-1090.2008.00062.x; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	68	9	10	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195584	10.1371/journal.pone.0195584	http://dx.doi.org/10.1371/journal.pone.0195584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630671	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000429505000061
J	Regev, E; Asher, E; Fefer, P; Beigel, R; Mazin, I; Matetzky, S				Regev, Ehud; Asher, Elad; Fefer, Paul; Beigel, Roy; Mazin, Israel; Matetzky, Shlomi		Platelets Thrombosis Sheba PLATIS	Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; ST-SEGMENT ELEVATION; TREATMENT PLATELET REACTIVITY; DRUG-ELUTING STENTS; INCREASED RISK; RESISTANCE; TERM; METAANALYSIS; TICAGRELOR	Objectives The clinical significance of the laboratory-based phenomenon of clopidogrel hypo-responsiveness and platelet reactivity associated with acute myocardial infarction, despite chronic clopidogrel therapy, is largely unknown. We aimed to determine platelet reactivity and clinical and angiographic features in 29 consecutive patients sustaining an acute myocardial infarction despite chronic (>1 month) clopidogrel therapy. Methods Platelet reactivity was determined on admission using conventional aggregometry. All patients underwent coronary angiography within 24 hours of admission. Patients were matched with clopidogrel-naive acute myocardial infarction patients. Clopidogrel-naive patients received a 600 mg clopidogrel loading dose and 75 mg/day thereafter. Results Of the 29 study patients, 19 (66%) presented with ST-elevation myocardial infarction, and in 25% the infarction was related to angiographically-proved definite stent thrombosis. Two-thirds of these patients were poor responders to clopidogrel (adenosine diphosphate-induced platelet aggregation >50%) and dual antiplatelet poor responsiveness was found in 57% in the chronic clopidogrel therapy group. Compared with clopidogrel-naive patients, chronic clopidogrel therapy patients were more likely to demonstrate clopidogrel poor responsiveness (66% versus 38%, p = 0.02), to be diabetic (52% versus 33%, p = 0.1) and to have multi-vessel coronary disease (79% versus 55%, p = 0.03). Conclusions Patients sustaining acute coronary syndrome despite chronic clopidogrel therapy are more likely to exhibit inadequate platelet inhibition with clopidogrel.	[Matetzky, Shlomi] Leviev Heart Ctr, Sheba Med Ctr, Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Matetzky, S (corresponding author), Leviev Heart Ctr, Sheba Med Ctr, Tel Hashomer, Israel.	shlomixnatetzky@sheba.health.gov.il	Asher, Elad/I-3544-2019	Asher, Elad/0000-0003-3381-605X; Regev, Ehud/0000-0001-5504-2820				Ajzenberg N, 2005, J AM COLL CARDIOL, V45, P1753, DOI 10.1016/j.jacc.2004.10.079; Alexopoulos D, 2012, J AM COLL CARDIOL, V60, P193, DOI 10.1016/j.jacc.2012.03.050; Angiolillo DJ, 2014, J AM COLL CARDIOL, V64, P1005, DOI 10.1016/j.jacc.2014.06.1170; Asher E, 2014, THROMB HAEMOSTASIS, V112, P137, DOI 10.1160/TH13-10-0845; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Budaj A, 2002, CIRCULATION, V106, P1622, DOI 10.1161/01.CIR.0000029926.71825.E2; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cuisset T, 2006, J THROMB HAEMOST, V4, P542, DOI 10.1111/j.1538-7836.2005.01751.x; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eikelboom John, 2005, MedGenMed, V7, P76; El-Hayek G, 2014, AM J CARDIOL, V114, P236, DOI 10.1016/j.amjcard.2014.04.035; Fefer P, 2007, PLATELETS, V18, P175, DOI 10.1080/09537100601039747; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Keating FK, 2004, AM J CARDIOL, V94, P725, DOI 10.1016/j.amjcard.2004.05.054; Kereiakes DJ, 2015, JAMA-J AM MED ASSOC, V313, P1113, DOI 10.1001/jama.2015.1671; Mallouk N, 2012, THROMB HAEMOSTASIS, V107, P494, DOI 10.1160/TH11-03-0202; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2014, CIRCULATION, V129, P2136, DOI 10.1161/CIRCULATIONAHA.113.007524; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Park SH, 2009, AM J CARDIOL, V104, P1292, DOI 10.1016/j.amjcard.2009.06.049; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Reny JL, 2016, THROMB HAEMOSTASIS, V115, P844, DOI 10.1160/TH15-09-0742; Serebruany VL, 2014, THROMB HAEMOSTASIS, V112, P4, DOI 10.1160/TH13-10-0862; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steinhubl SR, 2005, J AM COLL CARDIOL, V45, P1757, DOI 10.1016/j.jacc.2005.03.017; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Tisminetzky M, 2014, AM J CARDIOL, V113, P1137, DOI 10.1016/j.amjcard.2013.12.020; TSCHOEPE D, 1995, DIABETES, V44, P890, DOI 10.2337/diabetes.44.8.890; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Yusuf S, 2001, NEW ENGL J MED, V345, P494	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195504	10.1371/journal.pone.0195504	http://dx.doi.org/10.1371/journal.pone.0195504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624604	Green Submitted, gold, Green Published			2022-12-27	WOS:000429379600035
J	Alonso-Diaz, S; Cantlon, JF; Piantadosi, ST				Alonso-Diaz, Santiago; Cantlon, Jessica F.; Piantadosi, Steven T.			A threshold-free model of numerosity comparisons	PLOS ONE			English	Article							DECISION-MAKING; RESPONSE-TIME; NUMBER SENSE; REPRESENTATION; VARIABILITY; COMPETITION; MECHANISMS; PRINCIPLE; NEURONS; MONKEYS	A dominant mechanism in the Judgment and Decision Making literature states that information is accumulated about each choice option until a decision threshold is met. Only after that threshold does a subject start to execute a motor response to indicate their choice. However, recent research has revealed spatial gradients in motor responses as a function of comparison difficulty as well as changes-of-mind in the middle of an action, both suggesting continued accumulation and processing of decision-related signals after the decision boundary. Here we present a formal model and supporting data from a number comparison task that a continuous motor planner, combined with a simple statistical inference scheme, can model detailed behavioral effects without assuming a threshold. This threshold-free model reproduces subjects' sensitivity to numerical distance in reaching, accuracy, reaction time, and changes of mind. We argue that the motor system positions the effectors using an optimal biomechanical feedback controller, and continuous statistical inference on outputs from cognitive processes.	[Alonso-Diaz, Santiago; Cantlon, Jessica F.; Piantadosi, Steven T.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Alonso-Diaz, Santiago] Univ Javeriana, Dept Econ, Bogota, Colombia	University of Rochester; Pontificia Universidad Javeriana	Alonso-Diaz, S (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.; Alonso-Diaz, S (corresponding author), Univ Javeriana, Dept Econ, Bogota, Colombia.	santiagoalonsadiaz@gmail.com		Alonso Diaz, Santiago/0000-0002-1623-2274	James S. McDonnell Foundation [220020300]; National Science Foundation [DRL-1459625]; NIH [R01 HD085996-01]	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the James S. McDonnell Foundation (220020300) and the National Science Foundation (Education Core Research Grant DRL-1459625) to JC. We thank Goker Erdogan for comments on the manuscript.; This work was supported by James S. McDonnell Foundation (220020300, JC) https://www.jsmf.org, and National Science Foundation (Education Core Research Grant DRL-1459625, JC) https://www.nsf.gov, and NIH R01 HD085996-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2017, ADV NEURAL INF PROCE, V30, P1834; Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Alonso-Diaz S, J NUMERICAL IN PRESS; Anobile G, 2014, PSYCHOL SCI, V25, P265, DOI 10.1177/0956797613501520; Arrighi R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1791; Ben-Itzhak S, 2008, NEURAL COMPUT, V20, P779, DOI 10.1162/neco.2007.12-05-077; Brockwell P., 2006, INTRO TIME SERIES FO; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Cantlon JF, 2012, P NATL ACAD SCI USA, V109, P10725, DOI 10.1073/pnas.1201893109; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Chapman CS, 2014, J VISION, V14, DOI 10.1167/14.3.30; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0479; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 2007, ATTENTION PERFORM, P527, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0024; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Dotan D, 2013, COGNITION, V129, P512, DOI 10.1016/j.cognition.2013.07.007; Faulkenberry TJ, 2016, J COGN PSYCHOL, V28, P825, DOI 10.1080/20445911.2016.1191504; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Gablonsky JM, 2001, J GLOBAL OPTIM, V21, P27, DOI 10.1023/A:1017930332101; GALLISTEL CR, 1989, ANNU REV PSYCHOL, V40, P155, DOI 10.1146/annurev.ps.40.020189.001103; Gelman A., 2004, BAYESIAN DATA ANAL; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Haith AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004171; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; HENIS EA, 1995, BIOL CYBERN, V72, P407, DOI 10.1007/BF00201416; HOFF B, 1994, BIOL CYBERN, V71, P481, DOI 10.1007/BF00198466; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; HOGAN N, 1984, J NEUROSCI, V4, P2745; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Nieder A, 2016, NATURE REV NEUROSCIE, V17; Park J, 2014, COGNITION, V133, P188, DOI 10.1016/j.cognition.2014.06.011; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; R Core Team, 2014, R LANG ENV STAT COMP; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2014, J EXP PSYCHOL HUMAN, V40, P870, DOI 10.1037/a0034954; Ratclifff R, 2015, COGNITION, V137, P115, DOI 10.1016/j.cognition.2014.12.004; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rucci M, 2015, TRENDS NEUROSCI, V38, P195, DOI 10.1016/j.tins.2015.01.005; Santens S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025429, 10.1371/journal.pone.0025383]; Shadlen MN, 2016, NEURON, V90, P927, DOI 10.1016/j.neuron.2016.04.036; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shteingart H, 2013, J EXP PSYCHOL GEN, V142, P476, DOI 10.1037/a0029550; Simon H, 1997, MODELS BOUNDED RATIO; Song JH, 2008, COGNITION, V106, P994, DOI 10.1016/j.cognition.2007.03.014; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Verguts T, 2005, PSYCHON B REV, V12, P66, DOI 10.3758/BF03196349; Vo VA, 2014, PSYCHOL SCI, V25, P1712, DOI 10.1177/0956797614538458; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wijdenes LO, 2016, J NEUROPHYSIOL, V116, P1295, DOI 10.1152/jn.00113.2016	67	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195188	10.1371/journal.pone.0195188	http://dx.doi.org/10.1371/journal.pone.0195188			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621275	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800046
J	Lawrence, JP; Mahony, M; Noonan, BP				Lawrence, J. P.; Mahony, Michael; Noonan, Brice P.			Differential responses of avian and mammalian predators to phenotypic variation in Australian Brood Frogs	PLOS ONE			English	Article							POISON FROG; WARNING SIGNALS; EVOLUTION; MIMICRY; APOSEMATISM; DIVERSITY; SELECTION; TOXICITY; COLORS	Anti-predator signaling is highly variable with numerous examples of species employing cryptic coloration to avoid detection or conspicuous coloration (often coupled with a secondary defense) to ensure detection and recollection. While the ends of this spectrum are clear in their function, how species use intermediate signals is less clear. Australian Brood Frogs (Pseudophryne) display conspicuous coloration on both their dorsum and venter. Coupled with the alkaloid toxins these frogs possess, this coloration may be aposematic, providing a protective warning signal to predators. We assessed predation rates of known and novel color patterns and found no difference for avian or mammalian predators. However, when Pseudophryne dorsal phenotypes were collectively compared to the high-contrast ventral phenotype of this genus, we found birds, but not mammals, attacked dorsal phenotypes significantly less frequently than the ventral phenotype. This study, importantly, shows a differential predator response to ventral coloration in this genus which has implications for the evolution of conspicuous signaling in Pseudophryne.	[Lawrence, J. P.; Noonan, Brice P.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Mahony, Michael] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia	University of Mississippi; University of Newcastle	Lawrence, JP (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	JPLarry@gmail.com		Lawrence, Justin/0000-0001-8577-4870	East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation [OISE-1515149]	East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation	This work was funded by the East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation grant no. OISE-1515149 to JPL (https://www.nsf.gov/pubs/2013/nsf13593/nsf13593.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2013, BEHAV ECOL, V24, P1237, DOI 10.1093/beheco/art058; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bowmaker JK, 1998, EYE, V12, P541, DOI 10.1038/eye.1998.143; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Hegna RH, 2012, EVOL ECOL; Hegna RH, 2011, ANN ZOOL FENN, V48, P29, DOI 10.5735/086.048.0103; Kikuchi DW, 2013, Q REV BIOL, V88, P297, DOI 10.1086/673758; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Maan ME, 2009, P NATL ACAD SCI USA, V106, P19072, DOI 10.1073/pnas.0903327106; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OSBORNE WS, 1989, AUST WILDLIFE RES, V16, P537; Paluh DJ, 2014, J HERPETOL, V48, P249, DOI 10.1670/13-027; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Rojas B, 2014, BEHAV PROCESS, V109, P164, DOI 10.1016/j.beproc.2014.08.014; Rojas B, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0193; Roper TJ, 1997, ODOUR COLOUR CUES TA, P1241; Ruxton GD, 2005, AVOIDING ATTACK EVOL; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; SCHWARZKOPF L, 1992, BEHAV ECOL SOCIOBIOL, V31, P17, DOI 10.1007/BF00167812; Smith BP, 2002, J NAT PROD, V65, P439, DOI 10.1021/np010506a; Valkonen J, 2011, EVOL ECOL, V25, P1047, DOI 10.1007/s10682-011-9463-0; Wang IJ, 2011, EVOLUTION, V65, P1637, DOI 10.1111/j.1558-5646.2011.01257.x; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Yeager Justin, 2011, Herpetological Review, V42, P357	34	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195446	10.1371/journal.pone.0195446	http://dx.doi.org/10.1371/journal.pone.0195446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621321	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800085
J	Low, LL; Yan, S; Kwan, YH; Tan, CS; Thumboo, J				Low, Lian Leng; Yan, Shi; Kwan, Yu Heng; Tan, Chuen Seng; Thumboo, Julian			Assessing the validity of a data driven segmentation approach: A 4 year longitudinal study of healthcare utilization and mortality	PLOS ONE			English	Article							CLUSTER-ANALYSIS; POPULATION SEGMENTATION; RISK	Background Segmentation of heterogeneous patient populations into parsimonious and relatively homogenous groups with similar healthcare needs can facilitate healthcare resource planning and development of effective integrated healthcare interventions for each segment. We aimed to apply a data-driven, healthcare utilization-based clustering analysis to segment a regional health system patient population and validate its discriminative ability on 4-year longitudinal healthcare utilization and mortality data. Methods We extracted data from the Singapore Health Services Electronic Health Intelligence System, an electronic medical record database that included healthcare utilization (inpatient admissions, specialist outpatient clinic visits, emergency department visits, and primary care clinic visits), mortality, diseases, and demographics for all adult Singapore residents who resided in and had a healthcare encounter with our regional health system in 2012. Hierarchical clustering analysis (Ward's linkage) and K-means cluster analysis using age and healthcare utilization data in 2012 were applied to segment the selected population. These segments were compared using their demographics (other than age) and morbidities in 2012, and longitudinal healthcare utilization and mortality from 2013-2016. Results Among 146,999 subjects, five distinct patient segments "Young, healthy"; "Middle age, healthy"; "Stable, chronic disease"; "Complicated chronic disease" and "Frequent admitters" were identified. Healthcare utilization patterns in 2012, morbidity patterns and demographics differed significantly across all segments. The "Frequent admitters" segment had the smallest number of patients (1.79% of the population) but consumed 69% of inpatient admissions, 77% of specialist outpatient visits, 54% of emergency department visits, and 23% of primary care clinic visits in 2012. 11.5% and 31.2% of this segment has end stage renal failure and malignancy respectively. The validity of cluster-analysis derived segments is supported by discriminative ability for longitudinal healthcare utilization and mortality from 2013-2016. Incident rate ratios for healthcare utilization and Cox hazards ratio for mortality increased as patient segments increased in complexity. Patients in the "Frequent admitters" segment accounted for a disproportionate healthcare utilization and 8.16 times higher mortality rate. Conclusion Our data-driven clustering analysis on a general patient population in Singapore identified five patient segments with distinct longitudinal healthcare utilization patterns and mortality risk to provide an evidence-based segmentation of a regional health system's healthcare needs.	[Low, Lian Leng] Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore; [Low, Lian Leng] Duke NUS Med Sch, Family Med, Singapore, Singapore; [Low, Lian Leng; Thumboo, Julian] Singapore Hlth Serv, SingHlth Reg Hlth Syst, Singapore, Singapore; [Yan, Shi; Kwan, Yu Heng] Duke NUS Med Sch, Singapore, Singapore; [Kwan, Yu Heng] Singapore Heart Fdn, Singapore, Singapore; [Tan, Chuen Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Thumboo, Julian] SingHealth, Off Insights & Analyt, Singapore, Singapore; [Thumboo, Julian] Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore; [Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital	Low, LL (corresponding author), Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore.; Low, LL (corresponding author), Duke NUS Med Sch, Family Med, Singapore, Singapore.; Low, LL (corresponding author), Singapore Hlth Serv, SingHlth Reg Hlth Syst, Singapore, Singapore.	low.lian.leng@singhealth.com.sg	Tan, Chuen Seng/K-1078-2013; Low, Lian Leng/M-2853-2016	Tan, Chuen Seng/0000-0002-6513-2309; Kwan, Yu Heng/0000-0001-7802-9696; Low, Lian Leng/0000-0003-4228-2862	SingHealth Foundation Health Services Research (Aging) Startup Grant [SHF/HSRAg004/2015]; SingHealth Nurturing Clinician Scientist Award Academic Clinical Programme Funding; SingHealth Regional Health System	SingHealth Foundation Health Services Research (Aging) Startup Grant(SingHealth); SingHealth Nurturing Clinician Scientist Award Academic Clinical Programme Funding; SingHealth Regional Health System	This research received grant funding from SingHealth Foundation Health Services Research (Aging) Startup Grant SHF/HSRAg004/2015 and SingHealth Nurturing Clinician Scientist Award Academic Clinical Programme Funding FY 2016 Cycle 2. URL: https://research.singhealth.com.sg/Pages/ResearchGrants.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the SingHealth Regional Health System and Mr. Tan Wee Boon from the Medicine Academic Clinical Program SingHealth for supporting our study.	3M Health Information Systems, 2016, 3M TM CLIN RISK GROU; Alderwick H., 2014, POPULATION HLTH SYST; Bauman AE, 2003, MED J AUSTRALIA, V179, P253, DOI 10.5694/j.1326-5377.2003.tb05532.x; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Blashfield RK., 1988, HDB MULTIVARIATE EXP, P447, DOI [10.1007/978-1-4613-0893-5_14, DOI 10.1007/978-1-4613-0893-5_14]; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Carr D, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx012; Chong JL, 2017, ANN ACAD MED SINGAP, V46, P287; Choose Health Delaware, 2013, DEL STAT HLTH CAR IN; Chung RJ, 2015, CURRENT TREATMENT OP; Everitt BS, 2011, QUALITY QUANTITY; Forma L, 2009, EUR J PUBLIC HEALTH, V19, P313, DOI 10.1093/eurpub/ckp028; Fuller RL, 2016, POPUL HEALTH MANAG, V19, P136, DOI 10.1089/pop.2015.0043; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Han J, 2012, DATA MINING CONCEPTS; Hewner S, 2014, ONLINE J NURSING INF, P1; Hewner S, 2016, RES NURS HEALTH, V39, P215, DOI 10.1002/nur.21731; Horn SR, 2016, J PSYCHIATR RES, V83, P151, DOI 10.1016/j.jpsychires.2016.08.018; Johns Hopkins University, 2014, J HOPK ACG SYST EXC; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Lafortune Louise, 2009, BMC Geriatr, V9, P6, DOI 10.1186/1471-2318-9-6; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Liu LT, 2013, SCI WORLD J, DOI 10.1155/2013/589675; Lo Siou G, 2011, AM J EPIDEMIOL, V173, P956, DOI 10.1093/aje/kwq458; Lynn J, 2007, MILBANK Q, V85, P185, DOI 10.1111/j.1468-0009.2007.00483.x; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Noble DJ, 2013, JAMA-J AM MED ASSOC, V309, P1119, DOI 10.1001/jama.2013.592; North West London Whole Systems Integrated Care, WHAT APPR SHOULD WE; Porter M., 2010, NEW ENGL J MED, V363, P1, DOI [10.1056/NEJMp1002530., DOI 10.1056/NEJMP1002530]; Porter ME, 2013, HEALTH AFFAIR, V32, P516, DOI 10.1377/hlthaff.2012.0961; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Remington PL, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0044-2; Rijckmans M, 2007, SCAND J CARING SCI, V21, P406, DOI 10.1111/j.1471-6712.2007.00476.x; Sayer Caroline, 2017, NEW ENGLAND J MED; Sheets Lincoln, 2016, AMIA Annu Symp Proc, V2016, P1129; Singapore Department of Statistics, 2017, POP TRENDS DEP STAT; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Stine NW, 2013, JAMA-J AM MED ASSOC, V309, P449, DOI 10.1001/jama.2012.154302; Suzman R, 2011, NIH PUBL, V1, P273; Tsai JS, 2010, J PAIN SYMPTOM MANAG, V39, P655, DOI 10.1016/j.jpainsymman.2009.09.005; Tsiptsis K., 2010, DATA MINING TECHNIQU; van der Laan MRE, 2014, SOC SCI MED, V113, P68, DOI 10.1016/j.socscimed.2014.05.012; Vuik SI, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0115-z; Zayas Cilia E, 2016, Proc Int Fla AI Res Soc Conf, V2016, P361; Zhou Yi Yvonne, 2014, Perm J, V18, P18, DOI 10.7812/TPP/14-005	46	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195243	10.1371/journal.pone.0195243	http://dx.doi.org/10.1371/journal.pone.0195243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621280	Green Submitted, gold, Green Published			2022-12-27	WOS:000429206800051
J	Cyriac, D; Hofmann, RW; Stewart, A; Sathish, P; Winefield, CS; Moot, DJ				Cyriac, Daliya; Hofmann, Rainer W.; Stewart, Alan; Sathish, P.; Winefield, Christopher S.; Moot, Derrick J.			Intraspecific differences in long-term drought tolerance in perennial ryegrass	PLOS ONE			English	Article							LOLIUM-PERENNE; OSMOTIC ADJUSTMENT; WATER RELATIONS; ABIOTIC STRESS; PHYSIOLOGICAL-RESPONSES; ABSCISIC-ACID; GROWTH; RECOVERY; GRASS; ACCUMULATION	Lolium perenne L. (perennial ryegrass) is the most important pasture grass species in temperate regions of the world. However, its growth is restricted in summer dry environments. Germplasm screening can be used to identify accessions or individual plants for incorporation into breeding programs for drought tolerance. We selected nine perennial ryegrass accessions from different global origins and from a range of climatic and environmental conditions. In addition, the perennial ryegrass cultivar 'Grasslands Impact' was chosen as a reference. The accessions were grown for 360 days in a controlled environment through six consecutive drought stress and recovery cycles. We observed intraspecific differences in drought stress responsiveness for shoot biomass and survival from the third stress cycle. An accession from Norway had 50% more shoot dry matter than the next best-performing accession after six drought cycles. Compared with the reference cultivar 'Grasslands Impact', shoot dry matter of the accession from Norway was more than seven times higher after six drought cycles, indicating superior performance of this ecotype under drought stress. Drought tolerance was characterized by osmotic adjustment and higher relative leaf water content at low soil moisture levels. Furthermore, the findings of this study identify solute potential as an early predictor of drought stress tolerance. These intraspecific differences can be used in breeding programs for the development of drought-tolerant perennial ryegrass cultivars.	[Cyriac, Daliya; Hofmann, Rainer W.; Winefield, Christopher S.; Moot, Derrick J.] Lincoln Univ, Agr & Life Sci Div, Canterbury, New Zealand; [Stewart, Alan] PGG Wrightson, Canterbury, New Zealand; [Sathish, P.] Indigenz Ltd, Auckland, New Zealand	Lincoln University - New Zealand	Cyriac, D; Hofmann, RW (corresponding author), Lincoln Univ, Agr & Life Sci Div, Canterbury, New Zealand.	Daliya.Cyriac@lincolnuni.ac.nz; Rainer.Hofmann@lincoln.ac.nz	Winefield, Chris/P-7696-2018	Winefield, Chris/0000-0002-6262-6370	Pastoral Genomics Ltd.; Callaghan Innovation	Pastoral Genomics Ltd.; Callaghan Innovation	The funding bodies, Pastoral Genomics Ltd. and Callaghan Innovation, provided financial support for the PhD study of the first author (DC). The funders did not have any role in the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; BACON CW, 1993, AGR ECOSYST ENVIRON, V44, P123, DOI 10.1016/0167-8809(93)90042-N; Ballizany WL, 2012, FUNCT PLANT BIOL, V39, P167, DOI 10.1071/FP11193; BLUM A, 1989, CROP SCI, V29, P230, DOI 10.2135/cropsci1989.0011183X002900010052x; Blum A, 2017, PLANT CELL ENVIRON, V40, P4, DOI 10.1111/pce.12800; Bouma E., 2005, Bulletin OEPP, V35, P233; Brummer EC, 2009, GRASSLAND QUIETNESS, P157; Chappel PR, NIWA SCI TECHNOLOGY, V61, P1; Charlton J. F. L., 1999, Proceedings of the New Zealand Grassland Association, V61, P147; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Cheplick GP, 2004, AM J BOT, V91, P1960, DOI 10.3732/ajb.91.12.1960; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Cox JE, 1978, SOIL BUREAU B, P34; Cui Y, 2015, HORTSCIENCE, V50, P1148, DOI 10.21273/HORTSCI.50.8.1148; Easton HS, 2011, GRASSLAND RES PRACTI, V15, P139; ELMI AA, 1995, NEW PHYTOL, V131, P61, DOI 10.1111/j.1469-8137.1995.tb03055.x; Esperon-Rodriguez M, 2018, AUSTRAL ECOL, V43, P397, DOI 10.1111/aec.12577; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; GARWOOD EA, 1967, J AGR SCI-CAMBRIDGE, V68, P281, DOI 10.1017/S002185960001635X; GARWOOD EA, 1967, J AGR SCI-CAMBRIDGE, V69, P125, DOI 10.1017/S002185960001652X; Guy CL, 2003, CAN J BOT, V81, P1216, DOI [10.1139/b03-130, 10.1139/B03-130]; Han LB, 2008, ACTA HORTIC, P273; He L, 2017, CROP PASTURE SCI, V68, P176, DOI [10.1071/CP16208, 10.1071/cp16208]; He L, 2017, NZ J AGR RES, P1; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hulke BS, 2007, CROP SCI, V47, P1596, DOI 10.2135/cropsci2006.10.0671; Humphreys M, 1997, P 18 INT GRASSL C AS; Hunt W. F., 1989, Proceedings of the New Zealand Grassland Association, V50, P11; JONES MB, 1980, ANN APPL BIOL, V96, P87, DOI 10.1111/j.1744-7348.1980.tb04772.x; Jongdee B, 2002, FIELD CROP RES, V76, P153, DOI 10.1016/S0378-4290(02)00036-9; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Korte C, 1983, P NZ GRASSLAND ASS; Kosgey J, 2011, THESIS; Lelievre F, 2009, CROP SCI, V49, P2371, DOI 10.2135/cropsci2009.06.0324; Liu JR, 2008, SCI HORTIC-AMSTERDAM, V115, P190, DOI 10.1016/j.scienta.2007.08.003; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Matthew C, 2012, PR N Z GRASSL ASSOC, V74, P195; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mohammadi MHS, 2017, PLANT PHYSIOL BIOCH, V111, P129, DOI 10.1016/j.plaphy.2016.11.014; Moot DJ, 2000, NEW ZEAL J AGR RES, V43, P15, DOI 10.1080/00288233.2000.9513404; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; NORRIS IB, 1982, J AGR SCI-CAMBRIDGE, V99, P547, DOI 10.1017/S0021859600031221; Patel M, 2015, PLANT BIOTECHNOL J, V13, P689, DOI 10.1111/pbi.12291; Salinger J, 2003, LEGUMES DRYLAND PAST; SHEPHERD W, 1977, J BRIT GRASSLAND SOC, V32, P225; Simpson WR, 2012, FUNGAL BIOL-UK, V116, P234, DOI 10.1016/j.funbio.2011.11.006; THOMAS H, 1990, ANN BOT-LONDON, V66, P521, DOI 10.1093/oxfordjournals.aob.a088061; THOMAS H, 1987, J EXP BOT, V38, P115, DOI 10.1093/jxb/38.1.115; THOMAS H, 1990, ANN APPL BIOL, V116, P371, DOI 10.1111/j.1744-7348.1990.tb06619.x; THOMAS H, 1989, ANN BOT-LONDON, V64, P581, DOI 10.1093/oxfordjournals.aob.a087879; THOMAS H, 1991, NEW PHYTOL, V118, P35, DOI 10.1111/j.1469-8137.1991.tb00563.x; Tveito OE, 2005, METEOROL APPL, V12, P57, DOI 10.1017/S1350482705001490; Verkerk G, 2003, THERIOGENOLOGY, V59, P553, DOI 10.1016/S0093-691X(02)01239-6; Volaire F, 1998, NEW PHYTOL, V140, P451, DOI [10.1046/j.1469-8137.1998.00287.x, 10.1111/j.1469-8137.1998.00287.x]; Westermeier P, 2016, P 26 GEN M EUR GRASS; WILSON D, 1975, ANN APPL BIOL, V79, P83, DOI 10.1111/j.1744-7348.1975.tb01524.x; WILSON JR, 1979, OECOLOGIA, V41, P77, DOI 10.1007/BF00344838; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Zhang ZX, 2008, BIOTECHNOL BIOTEC EQ, V22, P938, DOI 10.1080/13102818.2008.10817583	65	21	22	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194977	10.1371/journal.pone.0194977	http://dx.doi.org/10.1371/journal.pone.0194977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617413	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800059
J	Czigany, Z; Bleilevens, C; Beckers, C; Stoppe, C; Mohring, M; Fulop, A; Szijarto, A; Lurje, G; Neumann, UP; Tolba, RH				Czigany, Zoltan; Bleilevens, Christian; Beckers, Christian; Stoppe, Christian; Moehring, Michaela; Fueloep, Andras; Szijarto, Attila; Lurje, Georg; Neumann, Ulf P.; Tolba, Rene H.			Limb remote ischemic conditioning of the recipient protects the liver in a rat model of arterialized orthotopic liver transplantation	PLOS ONE			English	Article							REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; MICROCIRCULATION; PRESERVATION; MECHANISMS; GRAFTS; CARDIOPROTECTION; PRETREATMENT; PROTOCOLS; APOPTOSIS	Background Ischemic-reperfusion (IR) injury still represents a major concern in clinical transplantation, especially in the era of extreme organ shortage and extended criteria donor organs. In the present study we aimed to investigate the hepatoprotective effects of remote ischemic conditioning (RIC) in a rat model of arterialized orthotopic liver transplantation (OLT). Methods Male Lewis rats were used (n = 144 / 72 OLT cases; 240-340g) as donors and recipients. Livers were flushed and stored in 4 degrees C HTK-solution for 8h before implantation. Recipients were randomly allocated into three experimental groups: RIC 1, RIC 2, Control. In RIC 1, RIC 2 groups, RIC was applied in the recipient before hepatectomy or after reperfusion (4x5-5min IR via clamping the infrarenal aorta), respectively. Animals were sacrificed at 1, 3,24,168h post-reperfusion (n = 6 recipient/group/time point). Hepatocellular injury, graft circulation, serum cytokines, tissue redox-stress and adenosine-triphosphate (ATP) levels have been assessed. Additional markers were analyzed, using Western blotting and reverse-transcription polymerase chain reaction. Results RIC 1 group showed significantly (p<0.05) improved portal venous and microcirculation flow as well as velocity. RIC has significantly reduced tissue injury according to the serum levels of transaminases and results of histopathological evaluation. Reduced TUNEL-staining (p<0.01 RIC 1-2 vs. Control) and elevated pBAD/BAD ratio was detected in the RIC groups (p<0.01 RIC 1 vs. Control). Supporting findings were obtained from measurements of serum IL-10 as well as tissue malondialdehyde and ATP levels. Hemoxygenase-1 (HO-1) mRNA-expression was significantly higher in RIC 1 compared to Control (p<0.05 RIC 1 vs. Control). Conclusion These results suggest that RIC might confer potent protection against the detrimental effects of IR injury including tissue damage, apoptosis, graft circulation, inflammation, tissue energetic status in OLT. HO-1 overexpression might play an orchestrating role in RIC mediated organ protection. An earlier intervention (RIC 1 protocol) was more effective than remote conditioning after graft reperfusion.	[Czigany, Zoltan; Moehring, Michaela; Tolba, Rene H.] Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany; [Czigany, Zoltan; Lurje, Georg; Neumann, Ulf P.] Rhein Westfal TH Aachen, Dept Surg & Transplantat, Aachen, Germany; [Bleilevens, Christian; Beckers, Christian; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Intens Care Med, Aachen, Germany; [Fueloep, Andras; Szijarto, Attila] Semmelweis Univ, HPB Res Ctr, Dept Surg 1, Budapest, Hungary	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Semmelweis University	Czigany, Z (corresponding author), Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany.; Czigany, Z (corresponding author), Rhein Westfal TH Aachen, Dept Surg & Transplantat, Aachen, Germany.	zczigany@ukaachen.de	Bleilevens, Christian/AAG-8034-2020	Bleilevens, Christian/0000-0002-2104-1843; Lurje, Georg/0000-0001-9674-0756; Czigany, Zoltan/0000-0003-0373-3210	German Academic Exchange Program (DAAD); European Society for Surgical Research (ESSR)	German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Society for Surgical Research (ESSR)	During the course of the project, ZC was supported by the German Academic Exchange Program (DAAD-https://www.daad.de/de/) and the Fellowship Award of the European Society for Surgical Research (ESSR-http://essr.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; An MY, 2017, BIOCHEM BIOPH RES CO, V488, P278, DOI 10.1016/j.bbrc.2017.05.014; Atanda AC, 2017, CARDIOVASC REVASCULA, V18, P549, DOI 10.1016/j.carrev.2017.06.001; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Correa F, 2008, CELL PHYSIOL BIOCHEM, V22, P635, DOI 10.1159/000185547; Cotterell AH, 2015, DIGEST DIS SCI, V60, P2579, DOI 10.1007/s10620-015-3729-2; Czigany Z, 2014, J SURG RES; Czigany Z, 2015, EUR SURG RES, V55, P119, DOI 10.1159/000437095; Czigany Z, 2015, J SURG RES, V193, P642, DOI 10.1016/j.jss.2014.08.046; Czigany Z, 2013, J SURG RES, V185, P605, DOI 10.1016/j.jss.2013.07.018; Czigany Zoltan, 2012, Orvosi Hetilap, V153, P1579, DOI 10.1556/OH.2012.29469; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Eitel I, 2015, EUR HEART J, V36, P3049, DOI 10.1093/eurheartj/ehv463; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Friedman BH, 2012, LIVER TRANSPLANT, V18, P166, DOI 10.1002/lt.22451; Fukai M, 2005, FREE RADICAL BIO MED, V38, P1372, DOI 10.1016/j.freeradbiomed.2005.02.004; Hata K, 2007, LIVER TRANSPLANT, V13, P114, DOI 10.1002/lt.20957; Hausenloy DJ, 2012, CARDIOVASC DRUG THER, V26, P87, DOI 10.1007/s10557-011-6364-y; Hess DC, 2013, STROKE, V44, P1191, DOI 10.1161/STROKEAHA.112.678482; Hess DC, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.223; Ho PWL, 2016, NEPHROLOGY, V21, P274, DOI 10.1111/nep.12614; Howells CC, 2011, J THEOR BIOL, V271, P114, DOI 10.1016/j.jtbi.2010.11.040; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jia JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121972; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Kono Y, 2014, DRUG DES DEV THER, V8, P1175, DOI 10.2147/DDDT.S68715; Kraemer R, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-32; Kume M, 2006, J SURG RES, V136, P209, DOI 10.1016/j.jss.2006.05.038; Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x; Liang RP, 2017, WORLD J GASTROENTERO, V23, P6995, DOI 10.3748/wjg.v23.i38.6995; McLeod SL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005522; Minor T, 2000, CRYOBIOLOGY, V40, P182, DOI 10.1006/cryo.2000.2231; Nagai K, 2013, JOVE-J VIS EXP, DOI 10.3791/4376; Nagai K, 2013, TRANSPLANTATION, V95, P78, DOI 10.1097/TP.0b013e318277e2d1; Pickard JMJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0568-z; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Puhl G, 2005, LIVER TRANSPLANT, V11, P555, DOI 10.1002/lt.20394; Robertson FP, 2017, HPB, V19, P757, DOI 10.1016/j.hpb.2017.05.005; Saat TC, 2015, J SURG RES, V198, P217, DOI 10.1016/j.jss.2015.04.057; Shi W, 2012, CARDIOVASCULAR RES; Starzl TE, 2010, HEPATOLOGY, V51, P1869, DOI 10.1002/hep.23595; Sutter AG, 2014, EUR CYTOKINE NETW, V25, P69, DOI 10.1684/ecn.2015.0359; Szijarto A, 2012, J SURG RES, V178, P797, DOI 10.1016/j.jss.2012.06.067; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wang CF, 2011, WORLD J GASTROENTERO, V17, P3101, DOI 10.3748/wjg.v17.i26.3101; Wang M, 2012, J SURG RES; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098834; Xie H, 2014, ACTA PHARMACOL SIN, V35, P1504, DOI 10.1038/aps.2014.78; Yagi S, 2011, J SURG RES, V167, pE375, DOI 10.1016/j.jss.2010.12.040; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195507	10.1371/journal.pone.0195507	http://dx.doi.org/10.1371/journal.pone.0195507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617450	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800089
J	Hahne, J; Kloster, T; Rathmann, S; Weber, M; Lipski, A				Hahne, Julia; Kloster, Tabea; Rathmann, Sandra; Weber, Mareike; Lipski, Andre			Isolation and characterization of Corynebacterium spp. from bulk tank raw cow's milk of different dairy farms in Germany	PLOS ONE			English	Article							SP-NOV.; CORYNEFORM BACTERIA; IDENTIFICATION; STRAINS; TELLURITE; SURFACE; CLASSIFICATION; DIVERSITY; ALIGNMENT; SYSTEM	We detected Corynebacterium spp. in raw milk samples of three farms by means of a selective, tellurite-containing medium. The isolated strains were identified based on full 16S rRNA gene sequences and partial rpoB gene sequences as C. xerosis, C. variabile, C. lactis, C. callunae, C. confusum, C. glutamicum and C. crudilactis. The identification based on 16S rRNA and rpoB sequences was not reliable for isolates of C. xerosis. Chemotaxonomic markers of the isolates, fatty acids, acyl type of peptidoglycan, presence and length of mycolic acids, quinone patterns, and polar lipids, were in accord with the known characteristics of these species. Biochemical profiles, analyzed with the API Coryne system, were able to differentiate all groups, but were unable to identify the strains due to an inappropriate database for raw-milk associated corynebacteria. Most of the tested isolates showed a single-substance resistance against oxacillin, but three single isolates were classified as multidrug resistant.	[Hahne, Julia; Kloster, Tabea; Rathmann, Sandra; Weber, Mareike; Lipski, Andre] Rhein Friedrich Wilhelms Univ Bonn, Inst Nutr & Food Sci, Dept Food Microbiol & Hyg, Bonn, North Rhine Wes, Germany	University of Bonn	Lipski, A (corresponding author), Rhein Friedrich Wilhelms Univ Bonn, Inst Nutr & Food Sci, Dept Food Microbiol & Hyg, Bonn, North Rhine Wes, Germany.	lipski@uni-bonn.de						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIRDPARKER AC, 1962, J APPL BACTERIOL, V25, P12, DOI 10.1111/j.1365-2672.1962.tb01113.x; BENDINGER B, 1992, INT J SYST BACTERIOL, V42, P474, DOI 10.1099/00207713-42-3-474; Bernard KA, 2002, J CLIN MICROBIOL, V40, P4375, DOI 10.1128/JCM.40.11.4375-4381.2002; Bernard KA, 1896, CORYNEBACTERIUM, P350; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Bernard Wiebe, 2010, BERGEYS MANUAL SYSTE, V877, P245; Bockelmann W, 2001, INT DAIRY J, V11, P307, DOI 10.1016/S0958-6946(01)00060-7; Brennan NM, 2001, INT J SYST EVOL MICR, V51, P843, DOI 10.1099/00207713-51-3-843; BRENNAN PJ, 1971, LIPIDS, V6, P401, DOI 10.1007/BF02531377; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; COYLE MB, 1990, CLIN MICROBIOL REV, V3, P227, DOI 10.1128/CMR.3.3.227-246.1990; deMiguelMartinez I, 1996, EUR J CLIN MICROBIOL, V15, P617; Dolci P, 2009, J APPL MICROBIOL, V106, P278, DOI 10.1111/j.1365-2672.2008.04001.x; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; Funke G, 1996, J CLIN MICROBIOL, V34, P1124, DOI 10.1128/JCM.34.5.1124-1128.1996; Funke G, 1998, INT J SYST BACTERIOL, V48, P1291, DOI 10.1099/00207713-48-4-1291; Funke G, 2008, J CLIN MICROBIOL, V46, P638, DOI 10.1128/JCM.01491-07; Goncalves JL, 2014, VET MICROBIOL, V173, P147, DOI 10.1016/j.vetmic.2014.06.028; Goncalves JL, 2016, VET J, V209, P87, DOI 10.1016/j.tvjl.2015.08.009; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Haltia L, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-22; Harrigan W.F., 1998, LAB METHODS FOOD MIC; HOISCHEN C, 1990, J BACTERIOL, V172, P3409, DOI 10.1128/jb.172.6.3409-3416.1990; Hommez J, 1999, J CLIN MICROBIOL, V37, P954, DOI 10.1128/JCM.37.4.954-957.1999; Khamis A, 2005, J CLIN MICROBIOL, V43, P1934, DOI 10.1128/JCM.43.4.1934-1936.2005; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Konig C, 2014, J CLIN MICROBIOL, V52, P4318, DOI 10.1128/JCM.02291-14; Konrad R, 2010, EUROSURVEILLANCE, V15, P43, DOI DOI 10.2807/ESE.15.43.19699-EN.PII; LECHEVALIER MP, 1973, CAN J MICROBIOL, V19, P965, DOI 10.1139/m73-154; MINNIKIN DE, 1977, INT J SYST BACTERIOL, V27, P104, DOI 10.1099/00207713-27-2-104; Otsuka Y, 2005, J CLIN MICROBIOL, V43, P3713, DOI 10.1128/JCM.43.8.3713-3717.2005; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Raats D, 2011, FOOD MICROBIOL, V28, P465, DOI 10.1016/j.fm.2010.10.009; Renaud FNR, 1998, J CLIN MICROBIOL, V36, P3698, DOI 10.1128/JCM.36.12.3698-3702.1998; Renaud FNR, 2001, INT J SYST EVOL MICR, V51, P1723, DOI 10.1099/00207713-51-5-1723; Renaud FNR, 2007, INT J SYST EVOL MICR, V57, P1113, DOI 10.1099/ijs.0.64665-0; RIEGEL P, 1994, J CLIN MICROBIOL, V32, P1860, DOI 10.1128/JCM.32.8.1860-1865.1994; Schukken YH, 2009, VET MICROBIOL, V134, P9, DOI 10.1016/j.vetmic.2008.09.014; SEGAL E, 1973, MED MICROBIOL IMMUN, V158, P165, DOI 10.1007/BF02120551; SOTO A, 1994, J CLIN PATHOL, V47, P756, DOI 10.1136/jcp.47.8.756; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TINSDALE GFW, 1947, J PATHOL BACTERIOL, V59, P461, DOI 10.1002/path.1700590313; Vacheyrou M, 2011, INT J FOOD MICROBIOL, V146, P253, DOI 10.1016/j.ijfoodmicro.2011.02.033; von Graevenitz A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P819, DOI 10.1007/0-387-30743-5_31; WALTER EG, 1992, PLASMID, V27, P52, DOI 10.1016/0147-619X(92)90006-V; Watts JL, 2000, ANTIMICROB AGENTS CH, V44, P3476, DOI 10.1128/AAC.44.12.3476-3477.2000; Watts JL, 2000, J DAIRY SCI, V83, P2373, DOI 10.3168/jds.S0022-0302(00)75126-5; Weber M, 2014, J DAIRY SCI, V97, P6761, DOI 10.3168/jds.2014-8340; Wiertz R, 2013, INT J SYST EVOL MICR, V63, P4495, DOI 10.1099/ijs.0.050757-0; WILKINSO.SG, 1970, J BACTERIOL, V104, P1035, DOI 10.1128/JB.104.3.1035-1044.1970; YAMADA Y, 1976, J GEN APPL MICROBIOL, V22, P203, DOI 10.2323/jgam.22.203; ZEBOVITZ E, 1955, J BACTERIOL, V70, P686, DOI 10.1128/JB.70.6.686-690.1955; Zimmermann J, 2016, INT J SYST EVOL MICR, V66, P5288, DOI 10.1099/ijsem.0.001509	57	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194365	10.1371/journal.pone.0194365	http://dx.doi.org/10.1371/journal.pone.0194365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617406	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800028
J	Liu, B; Arakawa, Y; Yokogawa, R; Tokunaga, S; Terada, Y; Murata, D; Matsui, Y; Fujimoto, K; Fukui, N; Tanji, M; Mineharu, Y; Minamiguchi, S; Miyamoto, S				Liu, Bin; Arakawa, Yoshiki; Yokogawa, Ryuta; Tokunaga, Shinya; Terada, Yukinori; Murata, Daiki; Matsui, Yasuzumi; Fujimoto, Ko-ichi; Fukui, Nobuyuki; Tanji, Masahiro; Mineharu, Yohei; Minamiguchi, Sachiko; Miyamoto, Susumu			PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+and CD8+infiltrating lymphocytes	PLOS ONE			English	Article							GERM-CELL TUMORS; LIGAND 1 EXPRESSION; NERVOUS-SYSTEM GERMINOMA; INFILTRATING LYMPHOCYTES; RADIATION-THERAPY; PD-L1 EXPRESSION; IMMUNE CHECKPOINTS; COLORECTAL-CANCER; BRAIN-TUMORS; LUNG-CANCER	One histopathological characteristic of intracranial germinoma is abundant tumor-infiltrating lymphocytes (TILs) showing a two-cell pattern with large undifferentiated tumor cells. The programmed cell death 1 (PD-1)/programmed cell death 1 ligand (PD-L) axis has recently been recognized as an anti-tumor immune system. To evaluate intratumor immune status in intracranial germinoma, we examined expressions of PD-1 and PD-L1 (clone 28-8) and subtypes of TILs. Expressions of PD-1 and PD-L1 were detected immunohistochemically in 25 formalin-fixed, paraffin-embedded tumor specimens from 24 patients with intracranial germinoma consisting of 22 primary and 3 recurrent tumors. To evaluate subtypes of TILs, quantification of lymphocytes with CD3, CD8, CD4, and Foxp3 was performed. Statistical analyses were performed among PD-1, PD-L1 and subtypes of TILs. In 25 tumor tissue, expressions of PD-1 in TILs and PD-L1 in tumor cells were identified in 96% (24/25) and 92% (23/25), respectively. Expression of PD-1 was associated with CD3+ TIL density. Expression of PD-1 correlated with Foxp3+ TIL density and CD8+ TIL density, but not with CD4+ TIL density. Furthermore, expression of PD-1 correlated strongly with Foxp3+/CD4+ ratio. Taken together, increase of PD-1+ expression is associated with accumulation of Foxp3+ and CD8+ TILs. These findings intimate that PD-1/PD-L1 axis might shape the immune infiltration suggesting a modulation of the immune response and subsequent tumor growth in intracranial germinoma. Anti-PD-1 and anti-PD-L1 are potential immune therapeutic strategies in intracranial germinoma.	[Liu, Bin; Arakawa, Yoshiki; Yokogawa, Ryuta; Tokunaga, Shinya; Terada, Yukinori; Murata, Daiki; Matsui, Yasuzumi; Fujimoto, Ko-ichi; Fukui, Nobuyuki; Tanji, Masahiro; Mineharu, Yohei; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Minamiguchi, Sachiko] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan	Kyoto University; Kyoto University	Arakawa, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan.	yarakawa@kuhp.kyoto-u.ac.jp		Mineharu, Yohei/0000-0002-6346-3999	JSPS KAKENHI [JP25462254, JP16K10754]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank the members in the Department of Neurosurgery for constructive comments on the manuscript and throughout the project. This work was supported by JSPS KAKENHI Grant Number JP25462254 and JP16K10754.; This work was supported by JSPS KAKENHI Grant Number JP25462254 and JP16K10754 to YA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapetite C, 2010, NEURO-ONCOLOGY, V12, P1318, DOI 10.1093/neuonc/noq093; Aoki T, 2016, PEDIATR BLOOD CANCER, V63, P1461, DOI 10.1002/pbc.26018; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Balmaceda C, 1996, J CLIN ONCOL, V14, P2908, DOI 10.1200/JCO.1996.14.11.2908; Bamberg M, 1999, J CLIN ONCOL, V17, P2585, DOI 10.1200/JCO.1999.17.8.2585; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Callea M, 2015, CANCER IMMUNOL RES, V3, P1158, DOI 10.1158/2326-6066.CIR-15-0043; Chemaitilly W, 2010, ENDOCR-RELAT CANCER, V17, pR141, DOI 10.1677/ERC-10-0002; Cheng S, 2016, J NEURO-ONCOL, V127, P173, DOI 10.1007/s11060-015-2029-1; Cho KT, 2002, CHILD NERV SYST, V18, P30, DOI 10.1007/s00381-001-0547-y; Cierna Z, 2016, ANN ONCOL, V27, P300, DOI 10.1093/annonc/mdv574; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dahlin AM, 2011, MODERN PATHOL, V24, P671, DOI 10.1038/modpathol.2010.234; Darb-Esfahani S, 2016, ONCOTARGET, V7, P1486, DOI 10.18632/oncotarget.6429; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Fangusaro J, 2008, PEDIATR BLOOD CANCER, V50, P312, DOI [10.1002/pbc.21307, 10.1002/pbc.21555]; Fankhauser CD, 2015, BRIT J CANCER, V113, P411, DOI 10.1038/bjc.2015.244; Fu H, 2017, J CLIN NEUROSCIENCE; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Harter PN, 2015, ONCOTARGET, V6, P40836, DOI 10.18632/oncotarget.5696; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Janssen-Heijnen MLG, 2010, J CLIN ONCOL, V28, P2520, DOI 10.1200/JCO.2009.25.9697; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; Kenjo M, 2015, JPN J RADIOL, V33, P336, DOI 10.1007/s11604-015-0424-3; Kim JW, 2014, ONCOLOGY-NY, V28, P15; Louis D.N., 2016, WHO CLASSIFICATION G, V4th ed.; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; Matsutani M, 2001, J NEURO-ONCOL, V54, P311, DOI 10.1023/A:1012743707883; Merchant TE, 2011, J CLIN ONCOL, V29, P4776, DOI 10.1200/JCO.2011.37.9453; Murata D, 2018, J NEUROSURG, V128, P710, DOI 10.3171/2016.11.JNS16991; NEUWELT EA, 1979, ANN NEUROL, V6, P133, DOI 10.1002/ana.410060211; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Osorio Diana S, 2015, CNS Oncol, V4, P273, DOI 10.2217/cns.15.13; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Roth P, 2013, EXPERT REV ANTICANC, V13, P1319, DOI 10.1586/14737140.2013.852473; SAITO T, 1989, J NEUROSURG, V70, P81, DOI 10.3171/jns.1989.70.1.0081; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Utsuki S, 2006, NEUROL MED-CHIR, V46, P429, DOI 10.2176/nmc.46.429; van Vulpen M, 2002, ONCOL REP, V9, P683; Vasiljevic A, 2015, NEUROCHIRURGIE, V61, P130, DOI 10.1016/j.neuchi.2013.06.006; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Wilmotte R, 2005, NEUROREPORT, V16, P1081, DOI 10.1097/00001756-200507130-00010; Zschabitz S, 2017, EUR J CANCER, V76, P1, DOI 10.1016/j.ejca.2017.01.033	49	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194594	10.1371/journal.pone.0194594	http://dx.doi.org/10.1371/journal.pone.0194594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617441	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800039
J	Ratnayeke, S; van Manen, FT; Clements, GR; Kulaimi, NAM; Sharp, SP				Ratnayeke, Shyamala; van Manen, Frank T.; Clements, Gopalasamy Reuben; Kulaimi, Noor Azleen Mohd; Sharp, Stuart P.			Carnivore hotspots in Peninsular Malaysia and their landscape attributes	PLOS ONE			English	Article							OIL PALM AGRICULTURE; POPULATION-DENSITY; BIODIVERSITY LOSS; EXTINCTION RISK; CONSERVATION; CONFLICT; PATTERNS; LEOPARDS; MAMMALS; FOREST	Mammalian carnivores play a vital role in ecosystem functioning. However, they are prone to extinction because of low population densities and growth rates, and high levels of persecution or exploitation. In tropical biodiversity hotspots such as Peninsular Malaysia, rapid conversion of natural habitats threatens the persistence of this vulnerable group of animals. Here, we carried out the first comprehensive literature review on 31 carnivore species reported to occur in Peninsular Malaysia and updated their probable distribution. We georeferenced 375 observations of 28 species of carnivore from 89 unique geographic locations using records spanning 1948 to 2014. Using the Getis-Ord Gi*statistic and weighted survey records by IUCN Red List status, we identified hotspots of species that were of conservation concern and built regression models to identify environmental and anthropogenic landscape factors associated with Getis-Ord Gi* zscores. Our analyses identified two carnivore hot spots that were spatially concordant with two of the peninsula's largest and most contiguous forest complexes, associated with Taman Negara National Park and Royal Belum State Park. A cold spot overlapped with the southwestern region of the Peninsula, reflecting the disappearance of carnivores with higher conservation rankings from increasingly fragmented natural habitats. Getis-Ord Gi* zscores were negatively associated with elevation, and positively associated with the proportion of natural land cover and distance from the capital city. Malaysia contains some of the world's most diverse carnivore assemblages, but recent rates of forest loss are some of the highest in the world. Reducing poaching and maintaining large, contiguous tracts of lowland forests will be crucial, not only for the persistence of threatened carnivores, but for many mammalian species in general.	[Ratnayeke, Shyamala; Clements, Gopalasamy Reuben] Sunway Univ, Dept Biol Sci, Bandar Sunway, Malaysia; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA; [Clements, Gopalasamy Reuben] Rimba, Kuala Lumpur, Malaysia; [Kulaimi, Noor Azleen Mohd] Dept Wildlife & Natl Pk, Ex Situ Conservat Div, Kuala Lumpur, Malaysia; [Sharp, Stuart P.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Sunway University; United States Department of the Interior; United States Geological Survey; Lancaster University	Ratnayeke, S (corresponding author), Sunway Univ, Dept Biol Sci, Bandar Sunway, Malaysia.	shyamalar@sunway.edu.my	Sharp, Stuart P/F-8246-2014; Ratnayeke, Shyamala/AAB-9412-2019; kulaimi, noor azleen mohd/AAF-6330-2021	Sharp, Stuart P/0000-0002-3059-2532; noor azleen, kulaimi/0000-0002-1224-7735; Clements, Gopalasamy Reuben/0000-0002-9715-4385; T. van Manen, Frank/0000-0001-5340-8489				Abdullah SA, 2008, LANDSCAPE URBAN PLAN, V87, P147, DOI 10.1016/j.landurbplan.2008.05.008; Abdullah SA, 2006, LANDSCAPE URBAN PLAN, V77, P263, DOI 10.1016/j.landurbplan.2005.03.003; Adyla MNN, 2016, AIP CONF PROC, V1784, DOI 10.1063/1.4966876; Agus F., 2013, REPORTS TECH PANELS, P65; [Anonymous], 2008, J SCI TECHNOL TROPIC; Azad MAJBA, 2006, BIODIVERS CONSERV, V15, P1013, DOI 10.1007/s10531-004-3953-0; Azhar B, 2014, BIODIVERS CONSERV, V23, P1175, DOI 10.1007/s10531-014-0656-z; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Boitani L, 2012, TECH ECOL CONSERVAT, P8; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Choudhury A, 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T41710A45220632.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T41710A45220632.EN]; Chye L. K, 2010, LANDSCAPE, V14, P15; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Corlett RT, 2014, Ecology of Tropical East Asia, 2nd Edition, P1, DOI 10.1093/acprof:oso/9780199681341.001.0001; Crook KR, 2002, CONSERV BIOL; Department of Statistics Malaysia, 2015, MAL POP STAT ETHN GR; Department of Statistics Malaysia, 2015, MAL A GLANC; Department of Wildlife and National Parks (DWNP), 2008, NAT TIG ACT PLAN MAL; Department of Wildlife and National Parks (DWNP) Peninsular Malaysia, 2009, RED LIST MAMM PEN MA, V1st; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Ellis Richard, 2005, TIGER BONE RHINO HOR; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2009, ECOL SOC, V14; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Gumal Melvin, 2014, Cat News, P10; Haines AM, 2012, WILDLIFE SOC B, V36, P685, DOI 10.1002/wsb.194; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hedges L., 2013, Small Carnivore Conservation, V49, P9; Hedges L, 2015, J WILDLIFE MANAGE, V79, P846, DOI 10.1002/jwmg.901; Hock S.S., 2007, POPULATION PENINSULA; Ikanda Dennis, 2008, Endangered Species Research, V6, P67, DOI 10.3354/esr00120; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; International Union for Conservation of Nature, 2001, 2001 IUCN RED LIST C; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Kawanishi Kae, 2003, Cat News, V39, P3; Kiviat E, 2002, URBAN HABITATS, V2, P28; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2013, ENCY BIODIVERSITY, V1, P509, DOI DOI 10.1016/B978-0-12-384719-5.00357-9; Laidlaw RK, 2000, CONSERV BIOL, V14, P1639, DOI 10.1046/j.1523-1739.2000.99073.x; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lynam AJ, 2007, ORYX, V41, P454, DOI 10.1017/S0030605307001019; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Medway L., 1969, WILD MAMMALS MALAYA; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Phua MH, 2008, J ENVIRON MANAGE, V88, P784, DOI 10.1016/j.jenvman.2007.04.011; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rao M, 2001, SCIENCE, V294, P1923; Ratnayeke S, 2012, URSUS, V23, P206, DOI 10.2192/URSUS-D-11-00029.1; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Rayan DM, 2007, TIGER MONITORI UNPUB; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rostro-Garcia S, 2016, BIOL CONSERV, V201, P293, DOI 10.1016/j.biocon.2016.07.001; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Sasidhran S, 2016, FOREST ECOL MANAG, V363, P140, DOI 10.1016/j.foreco.2015.12.037; Schwabe KA, 2015, J ENVIRON DEV, V24, P54, DOI 10.1177/1070496514551173; Scott L. M., 2010, HDB APPL SPATIAL ANA, P2741, DOI DOI 10.1007/978-3-642-03647-7_2; Sen YH, 1990, J WILDL PARKS MALAYS, VX, P1; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shekhar S, 2011, WIRES DATA MIN KNOWL, V1, P193, DOI 10.1002/widm.25; Shepherd Chris R., 2010, Traffic Bulletin, V23, P49; Shevade VS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070747; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Sollmann R, 2017, DIVERS DISTRIB, V23, P317, DOI 10.1111/ddi.12530; Swihart RK, 2009, DIVERS DISTRIB, V9, P1; Tan CKW, 2017, BIOL CONSERV, V206, P65, DOI 10.1016/j.biocon.2016.12.012; Thayne JB, 2012, ANN ASSOC AM GEOGR; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; van Langevelde F, 2009, J ENVIRON MANAGE, V90, P660, DOI 10.1016/j.jenvman.2007.09.003; VANBREE PJH, 1992, Z SAUGETIERKD, V57, P179; Wadey J, 2014, TROP CONSERV SCI, V7, P181; Webb Richard, 1998, Arboricultural Journal, V22, P287; Wei CTK, 2015, TROP CONSERV SCI, V8, P732, DOI 10.1177/194008291500800310; WELLS DR, 1989, NATURAL HIST B SIAM, V37, P87; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Yusof E, 2000, J WILDL PARKS, V18, P3	94	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194217	10.1371/journal.pone.0194217	http://dx.doi.org/10.1371/journal.pone.0194217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617402	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000429203800024
J	Rachas, A; Tuppin, P; Meyer, L; Falissard, B; Faye, A; Mahlaoui, N; de la Rochebrochard, E; Frank, M; Durieux, P; Warszawski, J				Rachas, Antoine; Tuppin, Philippe; Meyer, Laurence; Falissard, Bruno; Faye, Albert; Mahlaoui, Nizar; de la Rochebrochard, Elise; Frank, Marie; Durieux, Pierre; Warszawski, Josiane			Excess mortality and hospitalizations in transitional-age youths with a long-term disease: A national population-based cohort study (vol 13, e0193729, 2018)	PLOS ONE			English	Correction													de La Rochebrochard, Elise/O-5802-2015; MAHLAOUI, Nizar/AAH-6103-2020	de La Rochebrochard, Elise/0000-0002-1639-7335; MAHLAOUI, Nizar/0000-0002-0030-8094				Rachas A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193729	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195926	10.1371/journal.pone.0195926	http://dx.doi.org/10.1371/journal.pone.0195926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634765	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200063
J	Backhaus, T; von Cranach, M; Brich, J				Backhaus, Tilo; von Cranach, Moritz; Brich, Jochen			Ultrasound-guided lumbar puncture with a needle-guidance system: A prospective and controlled study to evaluate the learnability and feasibility of a newly developed approach	PLOS ONE			English	Article							SPINAL-ANESTHESIA; EPIDURAL-ANESTHESIA; REGIONAL ANESTHESIA; VASCULAR ACCESS; PHANTOM; COMPLICATIONS; CANNULATION; HEADACHE; SKILLS; SPACE	Objective To evaluate the learnability and feasibility of a new technique comprising a needle-guidance-system (NGS) for ultrasound-assisted lumbar puncture. Method Using a randomized crossover study design, 24 medical students were asked to perform an ultrasound-assisted lumbar puncture on a gel phantom using two different techniques that each included a paramedian insertion site. Procedure 1 (P1) used a pre-procedural ultrasound scan to predetermine the ideal insertion point. Procedure 2 (P2) applied a new technique comprising an NGS for performing real-time ultrasound-guided lumbar puncture. Success rates and performance times for both procedures were compared. Participants were also asked to complete a post-study questionnaire, both to quantitatively assess the workload involved and state their personal preferences. Results In comparison to the pre-procedural scan (P1), the NGS (P2) was associated with a significant increase in the number of successful punctures per participant (5 (P2) [interquartile range: 3.3-5.0] vs. 3 (P1) [interquartile range: 1.3-4.0], p = 0.005), and led to a significant reduction in performance time (118 seconds vs. 80.6 seconds, p < 0.001). In terms of workload perception, NGS use was associated with significantly better performances and lower frustration levels, as rated by students in the post-study questionnaire. Finally, 23/24 participants stated their preference for P2. Conclusion Our newly-developed technique for real-time ultrasound-guided lumbar puncture proved to be learnable and feasible for novices, and only required a small amount of training. The use of an NGS therefore has the potential to serve as a key feature of the ultrasound-assisted lumbar puncture.	[Backhaus, Tilo; von Cranach, Moritz; Brich, Jochen] Univ Freiburg, Med Ctr, Dept Neurol & Neurosci, Freiburg, Germany	University of Freiburg	Backhaus, T (corresponding author), Univ Freiburg, Med Ctr, Dept Neurol & Neurosci, Freiburg, Germany.	tilo.backhaus@uniklinik-freiburg.de						Auroy Y, 1997, ANESTHESIOLOGY, V87, P479, DOI 10.1097/00000542-199709000-00005; Auyong DB, 2015, ANESTHESIOLOGY, V123, P535, DOI 10.1097/ALN.0000000000000759; Barsuk JH, 2012, NEUROLOGY, V79, P132, DOI 10.1212/WNL.0b013e31825dd39d; Boon JM, 2004, CLIN ANAT, V17, P544, DOI 10.1002/ca.10250; Brinkmann S, 2013, CAN J ANESTH, V60, P896, DOI 10.1007/s12630-013-9984-9; Chin KJ, 2010, ACTA ANAESTH SCAND, V54, P252, DOI 10.1111/j.1399-6576.2009.02112.x; Conroy PH, 2013, ANESTHESIOL RES PRAC, V2013, DOI 10.1155/2013/525818; de Oliveira GR, 2002, EUR J ANAESTH, V19, P447, DOI 10.1017/S0265021502000716; de Seze MP, 2007, ANESTH ANALG, V104, P975, DOI 10.1213/01.ane.0000253485.75797.e7; Edwards C, 2015, NEUROLOGY, V84, pE69, DOI 10.1212/WNL.0000000000001335; Flaatten H, 1998, ACTA ANAESTH SCAND, V42, P759, DOI 10.1111/j.1399-6576.1998.tb05318.x; Grau T, 2001, J CLIN ANESTH, V13, P213, DOI 10.1016/S0952-8180(01)00245-8; HARRISON DA, 1992, ANAESTHESIA, V47, P902, DOI 10.1111/j.1365-2044.1992.tb03161.x; Hart SG., 2006, PROC HUM FACTORS ERG, V50, P904, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Keri Z, 2015, CAN J ANESTH, V62, P777, DOI 10.1007/s12630-015-0367-2; Kim EJ, 2016, KOREAN J ANESTHESIOL, V69, P15, DOI 10.4097/kjae.2016.69.1.15; Kopac DS, 2013, J VASC SURG, V58, P735, DOI 10.1016/j.jvs.2013.03.007; Kopacz DJ, 1996, REGION ANESTH, V21, P182; Margarido CB, 2010, CAN J ANAESTH, V57, P120, DOI 10.1007/s12630-009-9219-2; McVicar J, 2015, REGION ANESTH PAIN M, V40, P150, DOI 10.1097/AAP.0000000000000209; Meiser VC, 2016, EUR ARCH OTO-RHINO-L, V273, P2697, DOI 10.1007/s00405-015-3806-3; Morrow DS, 2016, J ULTRAS MED, V35, P831, DOI 10.7863/ultra.15.04085; Niazi AU, 2014, ACTA ANAESTH SCAND, V58, P875, DOI 10.1111/aas.12353; Paech MJ, 2012, INT J OBSTET ANESTH, V21, P101, DOI 10.1016/j.ijoa.2011.09.003; Peterson MA, 2014, ACAD EMERG MED, V21, P130, DOI 10.1111/acem.12305; Puolakka R, 2000, REGION ANESTH PAIN M, V25, P488, DOI 10.1053/rapm.2000.7607; Rabinowitz A, 2007, ANESTH ANALG, V105, P1855, DOI 10.1213/01.ane.0000287655.95619.fa; Rafiqul Islam Md, 2006, J BSA, V19; Sander D, 2015, J CARDIOTHOR VASC AN, V29, P1261, DOI 10.1053/j.jvca.2015.03.014; Shaikh F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1720; Soni NJ, 2016, NEUROL-CLIN PRACT, V6, P358, DOI 10.1212/CPJ.0000000000000265; Srinivasan KK, 2015, ANESTH ANALG, V121, P1089, DOI 10.1213/ANE.0000000000000911; Swenson JD, 2016, REGION ANESTH PAIN M, V41, P356, DOI 10.1097/AAP.0000000000000390; Tielens LKP, 2014, ANAESTHESIA, V69, P24, DOI 10.1111/anae.12461; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Uppal V, 2011, ANAESTHESIA, V66, P493, DOI 10.1111/j.1365-2044.2011.06710.x; White ML, 2012, PEDIATR EMERG CARE, V28, P1009, DOI 10.1097/PEC.0b013e31826ca96b; Wong SW, 2013, CAN J ANESTH, V60, P50, DOI 10.1007/s12630-012-9809-2; Wulf H, 1996, CAN J ANAESTH, V43, P1260, DOI 10.1007/BF03013437	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195317	10.1371/journal.pone.0195317	http://dx.doi.org/10.1371/journal.pone.0195317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630646	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000040
J	Zhu, YS; Sun, HJ; He, SD; Lou, QY; Yu, M; Tang, MM; Tu, LJ				Zhu, Yongsheng; Sun, Hanju; He, Shudong; Lou, Qiuyan; Yu, Min; Tang, Mingming; Tu, Lijun			Metabolism and prebiotics activity of anthocyanins from black rice (Oryza sativa L.) in vitro	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; VANILLIC ACID; IDENTIFICATION; BIOTRANSFORMATION; QUANTIFICATION; BIFIDOBACTERIA; POLYPHENOLS; PIGMENTS	Anthocyanins are naturally active substances. In this study, anthocyanins from black rice were obtained by membrane filtration and column chromatography separation. Five anthocyanin monomers in black rice extract were identified by HPLC-MS/MS, and the major anthocyanin monomer (cyanidin-3-glucoside, C3G) was purified by preparative HPLC (Pre-HPLC). The proliferative effects of the anthocyanins on Bifidobacteria and Lactobacillus were investigated by determining the media pH, bacterial populations and metabolic products. After anaerobic incubation at 37 degrees C for 48 h, not only the pH of the media containing C3G was lower than that of the extract of black rice anthocyanin (BRAE), but the numbers of both Bifidobacteria and Lactobacillus were also significantly increased. Furthermore, hydroxyphenylpropionic, hydroxyphenylacetic, and hydroxybenzoic acids and other metabolites were detected by GC-MS in vitro. Our results revealed that the anthocyanins and anthocyanin monomers from black rice had prebiotic activity and they were metabolized into several small molecules by Bifidobacteria and Lactobacillus.	[Zhu, Yongsheng; Sun, Hanju; He, Shudong; Lou, Qiuyan; Yu, Min; Tang, Mingming; Tu, Lijun] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [He, Shudong] Dalian Polytech Univ, Sch Food Sci & Technol, Natl Engn Res Ctr Seafood, Dalian, Liaoning, Peoples R China	Hefei University of Technology; Dalian Polytechnic University	Sun, HJ (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China.	sunhanjv@163.com	He, Shudong/ABF-4582-2021; He, Shudong/H-4396-2014	He, Shudong/0000-0002-1155-4928; Sun, Hanju/0000-0002-3886-4088	National Natural Science Foundation of China [31771974, 31701524]; Anhui Provincial Natural Science Foundation [1708085MC70]; Autumn Project of Hefei University of Technology [JZ2015QSJH0217]; China Postdoctoral Science Foundation [2017M611208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Autumn Project of Hefei University of Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors are grateful for the financial support from the National Natural Science Foundation of China (No. 31771974, No. 31701524), the Anhui Provincial Natural Science Foundation (No. 1708085MC70), the Autumn Project of Hefei University of Technology (No. JZ2015QSJH0217), and the 61th Financial Grant from China Postdoctoral Science Foundation (No. 2017M611208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila M, 2009, FOOD RES INT, V42, P1453, DOI 10.1016/j.foodres.2009.07.026; Bowen-Forbes CS, 2010, J FOOD COMPOS ANAL, V23, P554, DOI 10.1016/j.jfca.2009.08.012; Cao YG, 2009, BIOCHEM PHARMACOL, V77, P1096, DOI 10.1016/j.bcp.2008.11.029; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Chen XQ, 2012, FOOD CHEM, V135, P2783, DOI 10.1016/j.foodchem.2012.06.098; Chen Y, 2017, FOOD CHEM, V237, P887, DOI 10.1016/j.foodchem.2017.06.054; Cheng JR, 2016, FOOD CHEM, V213, P721, DOI 10.1016/j.foodchem.2016.07.032; Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006; Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016; Hao J, 2015, J CEREAL SCI, V64, P92, DOI 10.1016/j.jcs.2015.05.003; He SD, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13091; Hou ZH, 2013, FOOD RES INT, V50, P691, DOI 10.1016/j.foodres.2011.07.037; Ichikawa Haruyo, 2001, J Med Food, V4, P211, DOI 10.1089/10966200152744481; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Keppler K, 2005, BIOORGAN MED CHEM, V13, P5195, DOI 10.1016/j.bmc.2005.05.003; Kim HJ, 2009, J AGR FOOD CHEM, V57, P7529, DOI 10.1021/jf900788c; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kumar S, 2014, EUR J PHARMACOL, V743, P117, DOI 10.1016/j.ejphar.2014.09.010; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee JH, 2010, FOOD SCI BIOTECHNOL, V19, P391, DOI 10.1007/s10068-010-0055-5; Mapari SAS, 2005, CURR OPIN BIOTECH, V16, P231, DOI 10.1016/j.copbio.2005.03.004; Pitija K, 2013, INT J FOOD SCI TECH, V48, P300, DOI 10.1111/j.1365-2621.2012.03187.x; Sanchez-Patan F, 2012, FOOD CHEM, V131, P337, DOI 10.1016/j.foodchem.2011.08.011; Serra A, 2011, FOOD CHEM, V126, P1127, DOI 10.1016/j.foodchem.2010.11.145; Sghir A, 1998, J APPL MICROBIOL, V85, P769, DOI 10.1111/j.1365-2672.1998.00590.x; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Wang JP, 2010, POULTRY SCI, V89, P1549, DOI 10.3382/ps.2009-00235; Zhang X, 2016, J AGR FOOD CHEM, V64, P2582, DOI 10.1021/acs.jafc.6b00586	29	52	53	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195754	10.1371/journal.pone.0195754	http://dx.doi.org/10.1371/journal.pone.0195754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630662	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000073
J	Ghaderi, AH; Moradkhani, S; Haghighattard, A; Akrami, F; Khayyer, Z; Balci, F				Ghaderi, Amir Hossein; Moradkhani, Shadi; Haghighattard, Arvin; Akrami, Fatemeh; Khayyer, Zahra; Balci, Fuat			Time estimation and beta segregation: An EEG study and graph theoretical approach	PLOS ONE			English	Article							MULTI CHANNEL EEG; INTERNAL CLOCK; FUNCTIONAL SEGREGATION; PARKINSONS-DISEASE; PERCEPTION; OSCILLATIONS; FREQUENCY; COHERENCE; SYNCHRONIZATION; CONNECTIVITY	Elucidation of the neural correlates of time perception constitutes an important research topic in cognitive neuroscience. The focus to date has been on durations in the millisecond to seconds range, but here we used electroencephalography (EEG) to examine brain functional connectivity during much longer durations (i.e., 15 min). For this purpose, we conducted an initial exploratory experiment followed by a confirmatory experiment. Our results showed that those participants who overestimated time exhibited lower activity of beta (1830 Hz) at several electrode sites. Furthermore, graph theoretical analysis indicated significant differences in the beta range (15-30 Hz) between those that overestimated and underestimated time. Participants who underestimated time showed higher clustering coefficient compared to those that overestimated time. We discuss our results in terms of two aspects. FFT results, as a linear approach, are discussed within localized/dedicated models (i.e., scalar timing model). Second, non-localized properties of psychological interval timing (as emphasized by intrinsic models) are addressed and discussed based on results derived from graph theory. Results suggested that although beta amplitude in central regions (related to activity of BG-thalamocortical pathway as a dedicated module) is important in relation to timing mechanisms, the properties of functional activity of brain networks; such as the segregation of beta network, are also crucial for time perception. These results may suggest subjective time may be created by vector units instead of scalar ticks.	[Ghaderi, Amir Hossein] Univ Tabriz, Dept Psychol, Cognit Neurosci Lab, Tabriz, Iran; [Ghaderi, Amir Hossein; Moradkhani, Shadi; Haghighattard, Arvin; Akrami, Fatemeh] Iranian Neurowave Lab, Esfahan, Iran; [Moradkhani, Shadi] Amirkabir Univ Technol, Dept Phys, Tehran, Iran; [Haghighattard, Arvin] Islamic Azad Univ, North Tehran Branch, Dept Biol, Tehran, Iran; [Haghighattard, Arvin] Islamic Azad Univ, Tehran Med Sci Branch, Dept Genet, Tehran, Iran; [Akrami, Fatemeh] Iran Univ Med Sci, Fac Hlth Management & Informat, Tehran, Iran; [Khayyer, Zahra] Univ Isfahan, Dept Psychol, Esfahan, Iran; [Balci, Fuat] Koc Univ, Dept Psychol, Istanbul, Turkey	University of Tabriz; Amirkabir University of Technology; Islamic Azad University; Islamic Azad University; Iran University of Medical Sciences; University of Isfahan; Koc University	Ghaderi, AH (corresponding author), Univ Tabriz, Dept Psychol, Cognit Neurosci Lab, Tabriz, Iran.; Ghaderi, AH (corresponding author), Iranian Neurowave Lab, Esfahan, Iran.	a_ghaderi@tabrizu.ac.ir	Balci, Fuat/Y-9061-2018; Haghighatfard, Arvin/ACF-6171-2022; Ghaderi, Amirhossein/AAB-9680-2021	Balci, Fuat/0000-0003-3390-9352; Ghaderi, Amirhossein/0000-0001-5497-3025; Haghighatfard, Arvin/0000-0002-2179-9822; Moradkhani, Shadi/0000-0002-7093-7646				Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Babiloni C, 2011, INT J PSYCHOPHYSIOL, V82, P260, DOI 10.1016/j.ijpsycho.2011.09.008; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Berlin HA, 2004, J PERS DISORD, V18, P358, DOI 10.1521/pedi.18.4.358.40349; Boccara N, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-1-4419-6562-2; Brown P, 1999, MOVEMENT DISORD, V14, P423, DOI 10.1002/1531-8257(199905)14:3<423::AID-MDS1006>3.0.CO;2-V; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cha M, P 18 INT C WORLD WID, P721, DOI DOI 10.1145/1526709.1526806; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Cravo AM, 2011, J NEUROPHYSIOL, V106, P2964, DOI 10.1152/jn.00157.2011; Droit-Volet S, 2013, J PHYSIOL-PARIS, V107, P255, DOI 10.1016/j.jphysparis.2013.03.005; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Eddington A, 1927, NATURE PHYS WORLD GI; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Einstein A., 1950, MEANING RELATIVITY; Etchell AC, 2016, NEUROIMAGE, V125, P953, DOI 10.1016/j.neuroimage.2015.10.086; Etchell AC, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01036; Fraschini M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036015; Ghaderi A, 2016, INTERVAL TIMING ADUL, P6173; Ghaderi AH, 2017, BASIC CLIN NEUROSCI, V8, P267, DOI 10.18869/nirp.bcn.8.4.267; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Goel A, 2016, NEURON, V91, P320, DOI 10.1016/j.neuron.2016.05.042; Graber S, 2002, BRAIN LANG, V82, P65, DOI 10.1016/S0093-934X(02)00002-0; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Kononowicz TW, 2015, NEUROPSYCHOLOGIA, V75, P381, DOI 10.1016/j.neuropsychologia.2015.06.014; Kramer RSS, 2013, CONSCIOUS COGN, V22, P846, DOI 10.1016/j.concog.2013.05.008; Krause D, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01993; Kulashekhar S, 2016, HUM BRAIN MAPP, V37, P3262, DOI 10.1002/hbm.23239; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Merchant H, 2015, PHIL T R SOC B, V370, DOI 10.1098/rstb.2014.0093; Merchant H, 2018, J NEURAL TRANSM, V125, P461, DOI 10.1007/s00702-017-1716-9; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Moazami-Goudarzi M, 2008, NEUROIMAGE, V41, P985, DOI 10.1016/j.neuroimage.2008.03.032; Ng KK, 2014, ADV EXP MED BIOL, V829, P187, DOI 10.1007/978-1-4939-1782-2_11; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; Reichert JL, 2015, CLIN NEUROPHYSIOL, V126, P2068, DOI 10.1016/j.clinph.2014.09.032; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanei S., 2013, EEG SIGNAL PROCESSIN; Schank T., 2005, J GRAPH ALGORITHMS A, V9, P265, DOI DOI 10.7155/JGAA.00108; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Thatcher R.W., 2003, J NEUROTHER, V7, P87, DOI [10.1300/j184v07n03_05, DOI 10.1300/J184V07N03_05]; Thatcher RW, 2012, DEV NEUROPSYCHOL, V37, P476, DOI 10.1080/87565641.2011.619241; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Utianski RL, 2016, CLIN NEUROPHYSIOL, V127, P2228, DOI 10.1016/j.clinph.2016.02.017; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; WEARDEN JH, 1991, LEARN MOTIV, V22, P59, DOI 10.1016/0023-9690(91)90017-3; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006	66	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195380	10.1371/journal.pone.0195380	http://dx.doi.org/10.1371/journal.pone.0195380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624619	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600025
J	Nay-Htoon, B; Xue, W; Lindner, S; Cuntz, M; Ko, J; Tenhunen, J; Werner, C; Dubbert, M				Nay-Htoon, Bhone; Xue, Wei; Lindner, Steve; Cuntz, Matthias; Ko, Jonghan; Tenhunen, John; Werner, Christiane; Dubbert, Maren			Quantifying differences in water and carbon cycling between paddy and rainfed rice (Oryza sativa L.) by flux partitioning	PLOS ONE			English	Article							SUBSTRATE WEIGHT-LOSS; DRY-SEEDED RICE; MICROBIAL RESPIRATION; HERBACEOUS VEGETATION; OXYGEN-ISOTOPE; CLIMATE-CHANGE; ECOSYSTEM CO2; AEROBIC RICE; EVAPOTRANSPIRATION; EXCHANGE	Agricultural crops play an important role in the global carbon and water cycle. Global climate change scenarios predict enhanced water scarcity and altered precipitation pattern in many parts of the world. Hence, a mechanistic understanding of water fluxes, productivity and water use efficiency of cultivated crops is of major importance, i.e. to adapt management practices. We compared water and carbon fluxes of paddy and rainfed rice by canopy scale gas exchange measurements, crop growth, daily evapotranspiration, transpiration and carbon flux modeling. Throughout a monsoon rice growing season, soil evaporation in paddy rice contributed strongly to evapotranspiration (96.6% to 43.3% from initial growth to fully developed canopy and amounted to 57.9% of total water losses over the growing seasons. Evaporation of rainfed rice was significantly lower (by 65% on average) particularly before canopy closure. Water use efficiency (WUE) was significantly higher in rainfed rice both from an agronomic (WUEagro, i.e. grain yield per evapotranspiration) and ecosystem (WUEeco, i.e. gross primary production per evapotranspiration) perspective. However, our results also show that higher WUE in rainfed rice comes at the expense of higher respiration losses compared to paddy rice (26% higher on average). Hence, suggestions on water management depend on the regional water availability (i.e. Mediterranean vs. Monsoon climate) and the balance between higher respiratory losses versus a potential reduction in CH4 and other greenhouse gas emissions. Our results suggest that a shift from rainfed/unsaturated soil to waterlogged paddy conditions after closure of the rice canopy might be a good compromise towards a sustainable use of water while preserving grain yield, particularly for water-limited production areas.	[Nay-Htoon, Bhone] Minist Agr Livestock & Irrigat, Dept Rural Dev, LIFT UNOPS Tech Assistant Team, Nay Pyi Taw, Myanmar; [Xue, Wei; Lindner, Steve; Tenhunen, John] Univ Bayreuth, Dept Plant Ecol, Bayreuth, Germany; [Cuntz, Matthias] INRA, Tree & Ecosyst Level Integrat Ecol & Ecophysiol, Nantes, France; [Ko, Jonghan] Chonnam Natl Univ, Dept Appl Plant Sci, Gwangju, South Korea; [Werner, Christiane; Dubbert, Maren] Univ Freiburg, Dept Ecosyst Physiol, Freiburg, Germany	University of Bayreuth; INRAE; Chonnam National University; University of Freiburg	Dubbert, M (corresponding author), Univ Freiburg, Dept Ecosyst Physiol, Freiburg, Germany.	maren.dubbert@cep.uni-freiburg.de	Dubbert, Maren/K-4204-2019; Werner, Christiane/B-2948-2009; Ko, Jonghan/AAP-5709-2021; Xue, Wei/K-2455-2017	Werner, Christiane/0000-0002-7676-9057; Dubbert, Maren/0000-0002-2352-8516; Xue, Wei/0000-0003-3257-7755	Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO at the University of Bayreuth, Germany [GRK 1565/1]; Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea; German Research Foundation (DFG); University of Freiburg	Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO at the University of Bayreuth, Germany(German Research Foundation (DFG)); Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO (GRK 1565/1) at the University of Bayreuth, Germany and Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Adekoya M. A., 2014, Journal of Agricultural Science (Toronto), V6, P110; Alberto MCR, 2014, AGR WATER MANAGE, V136, P1, DOI 10.1016/j.agwat.2014.01.005; Alberto MCR, 2013, FIELD CROP RES, V146, P51, DOI 10.1016/j.fcr.2013.03.006; Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Alberto MCR, 2009, AGR FOREST METEOROL, V149, P1737, DOI 10.1016/j.agrformet.2009.06.003; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2012, 1203 ESA; [Anonymous], 2012, CROPS FEED WORLD 7 R; Arnell NW, 2014, CLIMATIC CHANGE, V122, P127, DOI 10.1007/s10584-013-0948-4; Balwinder-Singh, 2014, AGR WATER MANAGE, V135, P19, DOI 10.1016/j.agwat.2013.12.008; Beer C, 2009, GLOBAL BIGEOCHEMICAL; Berger S, 2013, BIOGEOCHEMISTRY, V115, P317, DOI 10.1007/s10533-013-9837-1; Bhattacharyya P, 2014, AGR ECOSYST ENVIRON, V189, P127, DOI 10.1016/j.agee.2014.03.013; Bouman B.A.M, 2002, P INT WORKSHOP WATER, P356; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; BUNNELL FL, 1977, SOIL BIOL BIOCHEM, V9, P41, DOI 10.1016/0038-0717(77)90059-1; BUNNELL FL, 1977, SOIL BIOL BIOCHEM, V9, P33, DOI 10.1016/0038-0717(77)90058-X; Dubbert M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00530; Dubbert M, 2013, J HYDROL, V496, P142, DOI 10.1016/j.jhydrol.2013.05.033; Duchemin B, 2006, AGR WATER MANAGE, V79, P1, DOI 10.1016/j.agwat.2005.02.013; Fitzjarrald DR, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000596; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gavilan P, 2007, AGR WATER MANAGE, V89, P275, DOI 10.1016/j.agwat.2007.01.014; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Hejazi MI, 2014, HYDROL EARTH SYST SC, V18, P2859, DOI 10.5194/hess-18-2859-2014; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Istanbulluoglu E, 2012, ECOHYDROLOGY, V5, P121, DOI 10.1002/eco.211; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kudo Y, 2014, AGR ECOSYST ENVIRON, V186, P77, DOI 10.1016/j.agee.2014.01.015; LEUNING R, 1994, AGR FOREST METEOROL, V67, P221, DOI 10.1016/0168-1923(94)90004-3; Li YL, 2008, AGR FOREST METEOROL, V148, P1318, DOI 10.1016/j.agrformet.2008.03.013; Lindner S, 2016, AGR FOREST METEOROL, V228, P229, DOI 10.1016/j.agrformet.2016.07.014; Lindner S, 2015, AGR ECOSYST ENVIRON, V199, P132, DOI 10.1016/j.agee.2014.09.005; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Miyata A, 2000, AGR FOREST METEOROL, V102, P287, DOI 10.1016/S0168-1923(00)00092-7; Mo XG, 2004, J HYDROL, V285, P125, DOI 10.1016/j.jhydrol.2003.08.013; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; Multsch S, 2015, GEOSCI MODEL DEV, V8, P1233, DOI 10.5194/gmd-8-1233-2015; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, DOI 10.1080/00750770109555783]; Nay-Htoon B, 2013, J NATURAL RES DEV, V03, P58, DOI 10.5027/jnrd.v3i0.05; NIE LX, 2012, REV CITE THIS VERSIO, V32, P411, DOI DOI 10.1007/S13593-011-0055-8; Nishimura S, 2015, J GEOPHYS RES-BIOGEO, V120, P63, DOI 10.1002/2014JG002746; Otieno D, 2012, WETLANDS, V32, P895, DOI 10.1007/s13157-012-0322-8; Pape L, 2009, BIOGEOSCIENCES, V6, P405, DOI 10.5194/bg-6-405-2009; Payero JO, 2013, AGR WATER MANAGE, V129, P31, DOI 10.1016/j.agwat.2013.06.018; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Sakai RK, 2004, GLOBAL CHANGE BIOL, V10, P895, DOI 10.1111/j.1529-8817.2003.00773.x; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Seo J, 2014, WETLANDS, V34, P213, DOI 10.1007/s13157-013-0477-y; Smith P, 2007, CLIMATE CHANGE 2007; Team RC, 2014, R LANG ENV STAT COMP; Thanawong K, 2014, J CLEAN PROD, V73, P204, DOI 10.1016/j.jclepro.2013.12.067; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P1, DOI 10.1023/A:1009848813994; Weller S, 2014, NUTR CYCLING AGROECO, DOI 10.1007/s10705-014-9658-1; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Yan XY, 2003, GLOBAL CHANGE BIOL, V9, P237, DOI 10.1046/j.1365-2486.2003.00564.x; Zhao XS, 2008, J HYDROL, V355, P181, DOI 10.1016/j.jhydrol.2008.03.019; Zhou MC, 2006, J HYDROL, V327, P151, DOI 10.1016/j.jhydrol.2005.11.013	64	12	12	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195238	10.1371/journal.pone.0195238	http://dx.doi.org/10.1371/journal.pone.0195238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624613	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600019
J	Fu, M; Travier, N; Martin-Sanchez, JC; Martinez-Sanchez, JM; Vidal, C; Garcia, M				Fu, Marcela; Travier, Noemie; Martin-Sanchez, Juan Carlos; Martinez-Sanchez, Jose M.; Vidal, Carmen; Garcia, Montse		LUCAPREV Res Grp	Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria	PLOS ONE			English	Article							LOW-DOSE CT; SELECTION CRITERIA; POPULATION; TRIAL; SURVIVAL	Background There are two main types of strategies to identify target population for lung cancer screening: 1) strategies based on age and cumulative smoking criteria, 2) risk prediction models allowing the calculation of an individual risk. The objective of this study was to compare different strategies to identify the proportion of the Spanish population at high risk of developing lung cancer, susceptible to be included in a lung cancer screening programme. Methods Cross-sectional study. We used the data of the Spanish National Interview Health Survey (ENSE) of 2011-2012 (21,006 individuals) to estimate the proportion of participants at high risk of developing lung cancer. This estimation was performed using the U.S. national lung screening trial (NLST) criteria and a 6-year prediction model (PLCOm2012), both independently and in combination. Results The prevalence of individuals at high risk of developing lung cancer according to the NLST criteria was 4.9% (7.9% for men, 2.4% for women). Among the 1,034 subjects who met the NLST criteria, 533 (427 men and 106 women) had a 6-year lung cancer risk >= 2.0%. The combination of these two selection strategies showed that 2.5% of the Spanish population had a high risk of developing lung cancer. However, this selection process did not take into account different groups of subjects <75 years old having an individual risk of lung cancer >= 2%, such as heavy smokers <55 years old who were long-time former smokers, and ever smokers having smoked <30 pack-years with other risk factors. Conclusions Further research is needed to determine which selection strategy achieves a higher benefit/harm ratio and to assess other prevention strategies for individuals with elevated risk for lung cancer but who do not meet the screening eligibility criteria.	[Fu, Marcela; Martinez-Sanchez, Jose M.] Catalan Inst Oncol IDIBELL, Tobacco Control Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain; [Travier, Noemie; Vidal, Carmen; Garcia, Montse] Catalan Inst Oncol IDIBELL, Canc Screening Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain; [Martin-Sanchez, Juan Carlos; Martinez-Sanchez, Jose M.] Univ Int Catalunya, Grp Evaluat Hlth Determinants & Hlth Policies, Sant Cugat Del Valles, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Internacional de Catalunya (UIC)	Vidal, C; Garcia, M (corresponding author), Catalan Inst Oncol IDIBELL, Canc Screening Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain.	cvidal@iconcologia.net; moarcia@iconcologia.net	Díaz-Sanchis, Mireia/H-1593-2015; Garcia, Montse/B-8832-2014; Martín, JuanCarlos/AAB-5440-2019; Martínez-Sánchez, Jose/AAA-6343-2019; Martínez-Sánchez, Jose M/ABH-3093-2020; Sanchez, Juan Carlos Martin/G-5650-2019; Vidal, Carmen/H-4029-2016; Trapero-Bertran, Marta/D-7437-2014	Díaz-Sanchis, Mireia/0000-0001-9360-4548; Garcia, Montse/0000-0002-3437-3185; Martín, JuanCarlos/0000-0002-1045-4802; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Sanchez, Juan Carlos Martin/0000-0002-1045-4802; Vidal, Carmen/0000-0003-2768-2710; Trapero-Bertran, Marta/0000-0002-9233-1776; Travier, Noemie/0000-0001-5228-7769	Asociacion Espanola Contra el Cancer de Barcelona [PROYBAR16909FU]	Asociacion Espanola Contra el Cancer de Barcelona	This study has been funded by the Asociacion Espanola Contra el Cancer de Barcelona in the Call for proposals of Research in Oncology of 2016 (grant PROYBAR16909FU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Berto J, 2016, GAC SANIT, V30, P386, DOI 10.1016/j.gaceta.2016.07.001; Callol L, 2007, LUNG CANCER, V56, P217, DOI 10.1016/j.lungcan.2007.01.010; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Ferlay J, 2014, IARC CANCERBASE; Garrido P, 2017, ARCH BRONCONEUMOL; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Marcus MW, 2015, J THORAC DIS, V7, pS156, DOI 10.3978/j.issn.2072-1439.2015.04.19; McRonald FE, 2014, CANCER PREV RES, V7, P362, DOI 10.1158/1940-6207.CAPR-13-0206; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ruano-Ravina A, 2016, GAC SANIT, V30, P383, DOI 10.1016/j.gaceta.2016.03.003; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Sanchez-Salcedo P, 2015, AM J RESP CRIT CARE, V191, P924, DOI 10.1164/rccm.201410-1848OC; Spanish Statistical Office, 2017, CIFR POBL 1 EN 2017 CIFR POBL 1 EN 2017; Tammemagi MC, 2015, J THORAC IMAG, V30, P88, DOI 10.1097/RTI.0000000000000142; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; ten Haaf K, 2015, J THORAC ONCOL, V10, P1285, DOI 10.1097/JTO.0000000000000593; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Viguier J, 2015, EUR J CANCER PREV, V24, pS87, DOI 10.1097/CEJ.0000000000000142; Weber M, 2017, INT J CANCER, V141, P242, DOI 10.1002/ijc.30673	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195441	10.1371/journal.pone.0195441	http://dx.doi.org/10.1371/journal.pone.0195441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621354	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800084
J	Charifi, M; Miserazzi, A; Sow, M; Perrigault, M; Gonzalez, P; Ciret, P; Benomar, S; Massabuau, JC				Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Benomar, Soumaya; Massabuau, Jean-Charles			Noise pollution limits metal bioaccumulation and growth rate in a filter feeder, the Pacific oyster Magallana gigas	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; GENE-EXPRESSION; CORBICULA-FLUMINEA; CADMIUM; ACCUMULATION; TOXICITY; EXPOSURE; BEHAVIOR; STRESS; SOUND	Shipping has increased dramatically in recent decades and oysters can hear them. We studied the interaction between noise pollution and trace metal contamination in the oyster Magallana gigas. Four oyster-groups were studied during a 14-day exposure period. Two were exposed to cadmium in the presence of cargo ship-noise ([Cd++]w approximate to 0.5 mu g-L-1; maximum sound pressure level 150 dBrms re 1 mu Pa), and 2 were exposed only to cadmium. The Cd concentration in the gills ([Cd]g) and the digestive gland ([Cd]dg), the valve closure duration, number of valve closures and circadian distribution of opening and closure, the daily shell growth-rate and the expression of 19 genes in the gills were studied. Oysters exposed to Cd in the presence of cargo ship-noise accumulated 2.5 times less Cd in their gills than did the controls without ship noise and their growth rate was 2.6 times slower. In the presence of ship noise, oysters were closed more during the daytime, and their daily valve activity was reduced. Changes in gene activity in the gills were observed in 7 genes when the Cd was associated with the ship noise. In the absence of ship noise, a change in expression was measured in 4 genes. We conclude that chronic exposure to cargo ship noise has a depressant effect on the activity in oysters, including on the volume of the water flowing over their gills (Vw). In turn, a decrease in the Vw and valve-opening duration limited metal exposure and uptake by the gills but also limited food uptake. This latter conclusion would explain the slowing observed in the fat metabolism and growth rate. Thus, we propose that cargo ship noise exposure could protect against metal bioaccumulation and affect the growth rate. This latter conclusion points towards a potential risk in terms of ecosystem productivity.	[Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Massabuau, Jean-Charles] Univ Bordeaux, EPOC, Arcachon, France; [Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Massabuau, Jean-Charles] CNRS, EPOC, Talence, France; [Charifi, Mohcine; Benomar, Soumaya] Mohammed V Agdal Univ, Fac Sci, Unit Res Biol Rhythms Neurosci & Environm, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Mohammed V University in Rabat	Massabuau, JC (corresponding author), Univ Bordeaux, EPOC, Arcachon, France.; Massabuau, JC (corresponding author), CNRS, EPOC, Talence, France.	jean-charles.massabuau@u-bordeaux.fr	Perrigault, Mickael/P-2887-2017	Perrigault, Mickael/0000-0002-7271-100X; Gonzalez, Patrice/0000-0003-2628-2993; Massabuau, Jean-Charles/0000-0003-1302-1719	Campus France; ANR [ANR-15-CE04-0002-02]; NEUROMED; Institut National de la Sante et de la Recherche Medical (INSERM); GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco; MoIIuSCAN Eye Project; Centre National pour la Recherche Scientifique et Technique (CNRST); TOTAL RD [FR00008208]	Campus France; ANR(French National Research Agency (ANR)); NEUROMED; Institut National de la Sante et de la Recherche Medical (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco; MoIIuSCAN Eye Project; Centre National pour la Recherche Scientifique et Technique (CNRST); TOTAL RD	This study was supported by grants from Campus France, ANR (ANR-15-CE04-0002-02 WAQMOS), NEUROMED, the Institut National de la Sante et de la Recherche Medical (INSERM), the GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco, the MoIIuSCAN Eye Project, and the Centre National pour la Recherche Scientifique et Technique (CNRST) to M.C.. TOTAL R&D provided a grant (no. FR00008208) to A.M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W, 2002, COMP BIOCHEM PHYS C, V133, P1, DOI 10.1016/S1532-0456(02)00113-8; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2008, BEHAVIOUR, V145, P1065, DOI 10.1163/156853908784474498; Andrade H, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00187; Andre M, 2011, FRONT ECOL ENVIRON, V9, P489, DOI 10.1890/100124; [Anonymous], R LANG ENV STAT COMP; [Anonymous], [No title captured]; Bijoux H., 2014, THESIS; Bruintjes R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150686; Burtin B., 1986, THESIS; Campbell P., 2003, P 7 INT S FISH PHYS, P125; CAMPBELL PGC, 1985, CAN J FISH AQUAT SCI, V42, P2034, DOI 10.1139/f85-251; Charifi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185353; Cheng L, 2011, PHYSIOL BEHAV, V104, P981, DOI 10.1016/j.physbeh.2011.06.018; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; ELLERS O, 1995, BIOL BULL-US, V189, P128, DOI 10.2307/1542463; Espinosa EP, 2016, J PROTEOMICS, V132, P63, DOI 10.1016/j.jprot.2015.11.018; Fewtrell JL, 2012, MAR POLLUT BULL, V64, P984, DOI 10.1016/j.marpolbul.2012.02.009; Fournier E, 2006, ENVIRON TOXICOL CHEM, V25, P2692, DOI 10.1897/05-386R1.1; Frisk GV, 2012, SCI REP-UK, V2, DOI 10.1038/srep00437; Gamain P., 2016, THESIS; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Gonzalez P, 2006, BIOMETALS, V19, P225, DOI 10.1007/s10534-005-5670-x; Guerra A, 2011, BIOL CONSERV, V144, P1989, DOI 10.1016/j.biocon.2011.04.021; Haberkorn H, 2011, MAR POLLUT BULL, V62, P1191, DOI 10.1016/j.marpolbul.2011.03.034; Hawkins AD, 2015, REV FISH BIOL FISHER, V25, P39, DOI 10.1007/s11160-014-9369-3; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Fernandez-Reiriz MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148245; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; LAGARDERE JP, 1982, MAR BIOL, V71, P177, DOI 10.1007/BF00394627; Lassus P, 2007, AQUAT LIVING RESOUR, V20, P59, DOI 10.1051/alr:2007016; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD R, 1961, J EXP BIOL, V38, P447; Lloyd R, 1962, I PUBL HLTH ENGRS J, V61, P132; Mai H, 2014, AQUAT TOXICOL, V147, P48, DOI 10.1016/j.aquatox.2013.11.024; Marie V, 2006, ENVIRON TOXICOL CHEM, V25, P412, DOI 10.1897/05-114R.1; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; MOSHER J I, 1972, Proceedings of the Malacological Society of London, V40, P125; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; PALACE VP, 1993, CAN J FISH AQUAT SCI, V50, P156, DOI 10.1139/f93-018; Pan K, 2008, AQUAT TOXICOL, V90, P253, DOI 10.1016/j.aquatox.2008.09.010; Payton L, 2017, MAR BIOTECHNOL, V19, P361, DOI 10.1007/s10126-017-9761-9; Peng C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24266; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Pierron F, 2007, ENVIRON TOXICOL CHEM, V26, P1010, DOI 10.1897/06-490R.1; Radford AN, 2016, GLOBAL CHANGE BIOL, V22, P3349, DOI 10.1111/gcb.13352; RANDALL D, 1991, PHYSIOL ZOOL, V64, P26; Roberts L, 2015, MAR ECOL PROG SER, V538, P185, DOI 10.3354/meps11468; Rogers P.H., 1988, P131; Rogers PH, 2016, ADV EXP MED BIOL, V875, P933, DOI 10.1007/978-1-4939-2981-8_115; Romeo M, 2000, AQUAT TOXICOL, V48, P185, DOI 10.1016/S0166-445X(99)00039-9; Ross D, 2005, IEEE J OCEANIC ENG, V30, P257, DOI 10.1109/JOE.2005.850879; Ross D., 1993, Acoustics Bulletin, V18, P5; Samson J, 2005, ENVIRON TOXICOL PHAR, V20, P142, DOI 10.1016/j.etap.2004.12.059; Schwartzmann C, 2011, LIMNOL OCEANOGR, V56, P1940, DOI 10.4319/lo.2011.56.5.1940; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Solan M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20540; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tran D, 2002, ENVIRON TOXICOL CHEM, V21, P327, DOI 10.1897/1551-5028(2002)021<0327:RBFIVA>2.0.CO;2; Tran D, 2001, ENVIRON TOXICOL CHEM, V20, P2073, DOI 10.1002/etc.5620200929; Wale MA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1194	64	8	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194174	10.1371/journal.pone.0194174	http://dx.doi.org/10.1371/journal.pone.0194174			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617387	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800022
J	Jajou, R; de Neeling, A; van Hunen, R; de Vries, G; Schimmel, H; Mulder, A; Anthony, R; van der Hoek, W; van Soolingen, D				Jajou, Rana; de Neeling, Albert; van Hunen, Rianne; de Vries, Gerard; Schimmel, Henrieke; Mulder, Arnout; Anthony, Richard; van der Hoek, Wim; van Soolingen, Dick			Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RECENT TRANSMISSION; OUTBREAKS	Background Patients with Mycobacterium tuberculosis isolates sharing identical DNA fingerprint patterns can be epidemiologically linked. However, municipal health services in the Netherlands are able to confirm an epidemiological link in only around 23% of the patients with isolates clustered by the conventional variable number of tandem repeat (VNTR) genotyping. This research aims to investigate whether whole genome sequencing (WGS) is a more reliable predictor of epidemiological links between tuberculosis patients than VNTR genotyping. Methods VNTR genotyping and WGS were performed in parallel on all Mycobacterium tuberculosis complex isolates received at the Netherlands National Institute for Public Health and the Environment in 2016. Isolates were clustered by VNTR when they shared identical 24-loci VNTR patterns; isolates were assigned to a WGS cluster when the pair-wise genetic distance was <= 12 single nucleotide polymorphisms (SNPs). Cluster investigation was performed by municipal health services on all isolates clustered by VNTR in 2016. The proportion of epidemiological links identified among patients clustered by either method was calculated. Results In total, 535 isolates were genotyped, of which 25% (134/535) were clustered by VNTR and 14% (76/535) by WGS; the concordance between both typing methods was 86%. The proportion of epidemiological links among WGS clustered cases (57%) was twice as common than among VNTR clustered cases (31%). Conclusion When WGS was applied, the number of clustered isolates was halved, while all epidemiologically linked cases remained clustered. WGS is therefore a more reliable tool to predict epidemiological links between tuberculosis cases than VNTR genotyping and will allow more efficient transmission tracing, as epidemiological investigations based on false clustering can be avoided.	[Jajou, Rana; de Neeling, Albert; van Hunen, Rianne; de Vries, Gerard; Schimmel, Henrieke; Mulder, Arnout; Anthony, Richard; van der Hoek, Wim; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van Hunen, Rianne; de Vries, Gerard] KNCV TB Fdn, The Hague, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; KNCV Tuberculosis Foundation; Radboud University Nijmegen	Jajou, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	rana.jajou@rivm.nl	Anthony, Richard/AAP-3406-2020	Anthony, Richard/0000-0002-0550-5273; de Vries, Gerard/0000-0003-1278-4503; de Neeling, Albert Johannes/0000-0001-8578-1990				Ayabina D, 2017, GENOME BASED TRANSMI; Bjorn-Mortensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33180; de Beer JL, 2014, J CLIN MICROBIOL, V52, P1338, DOI 10.1128/JCM.03436-13; de Vries G, 2018, LANCET RESP MED; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Gurjav U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163612; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Jajou R, 2017, J CLIN MICROBIOL; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Lee RS, 2015, J INFECT DIS, V211, P1905, DOI 10.1093/infdis/jiv011; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; National Institute for Public Health and the Environment, TUB KEYP; National Institute for Public Health and the Environment. National Tuberculosis Control Plan, NAT TUB CONTR PLAN 2; Nikolayevskyy V, 2016, TUBERCULOSIS, V98, P77, DOI 10.1016/j.tube.2016.02.009; R Core Team, R LANG ENV STAT COMP; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; Slump E, TUBERCULOSE NEDERLAN; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; World Health Organization, END TB STRAT; Yang CG, 2017, LANCET INFECT DIS, V17, P275, DOI [10.1016/S1473-3099(16)30418-2, 10.1016/s1473-3099(16)30418-2]	30	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195413	10.1371/journal.pone.0195413	http://dx.doi.org/10.1371/journal.pone.0195413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617456	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800084
J	Rahman, F; Guanl, J; Glazier, RH; Brown, A; Bierman, AS; Croxford, R; Stukel, TA				Rahman, Farah; Guanl, Jun; Glazier, Richard H.; Brown, Adalsteinn; Bierman, Arlene S.; Croxford, Ruth; Stukel, Therese A.			Association between quality domains and health care spending across physician networks	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; 30-DAY MORTALITY-RATES; EMERGENCY-DEPARTMENT; REGIONAL-VARIATIONS; READMISSION RATES; CHRONIC ILLNESS; HEART-FAILURE; UNITED-STATES; OF-CARE; PART 2	One of the more fundamental health policy questions is the relationship between health care quality and spending. A better understanding of these relationships is needed to inform health systems interventions aimed at increasing quality and efficiency of care. We measured 65 validated quality indicators (01) across Ontario physician networks. QIs were aggregated into domains representing six dimensions of care: screening and prevention, evidence-based medications, hospital-community transitions (7-day post-discharge visit with a primary care physician; 30-day post-discharge visit with a primary care physician and specialist), potentially avoidable hospitalizations and emergency department (ED) visits, potentially avoidable readmissions and unplanned returns to the ED, and poor cancer end of life care. Each domain rate was computed as a weighted average of 01 rates, weighting by network population at risk. We also measured overall and sector-specific per capita healthcare network spending. We evaluated the associations between domain rates, and between domain rates and spending using weighted correlations, weighting by network population at risk, using an ecological design. All indicators were measured using Ontario health administrative databases. Large variations were seen in timely hospital-community transitions and potentially avoidable hospitalizations. Networks with timely hospital-community transitions had lower rates of avoidable admissions and readmissions (r=-0.89, -0.58, respectively). Higher physician spending, especially outpatient primary care spending, was associated with lower rates of avoidable hospitalizations (r=-0.83) and higher rates of timely hospital-community transitions (r=0.81) and moderately associated with lower readmission rates (r=-0.46). Investment in effective primary care services may help reduce burden on the acute care sector and associated expenditures.	[Rahman, Farah; Guanl, Jun; Glazier, Richard H.; Bierman, Arlene S.; Croxford, Ruth; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.; Brown, Adalsteinn] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Glazier, Richard H.] Univ Toronto, Dept Family & Community Med, Fac Med, Toronto, ON, Canada; [Glazier, Richard H.; Brown, Adalsteinn; Stukel, Therese A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Glazier, Richard H.; Brown, Adalsteinn] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Bierman, Arlene S.] Agcy Healthcare Res & Qual, Ctr Evidence & Practice Improvement, Rockville, MD USA; [Bierman, Arlene S.] Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Bierman, Arlene S.] Dept Med, Toronto, ON, Canada; [Stukel, Therese A.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Stukel, Therese A.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Agency for Healthcare Research & Quality; Dartmouth College; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Stukel, TA (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Stukel, TA (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.; Stukel, TA (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada.	stukel@ices.on.ca		, Farah/0000-0002-0569-1467	Canadian Institutes of Health Research (CIHR) [FDN 143303]; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was supported by funding provided by a Foundation Grant (FDN 143303) from the Canadian Institutes of Health Research (CIHR). The funding agency had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the report for publication. RG is supported as a Clinician Scientist in the Department of Family and Community Medicine at St. Michael's Hospital and at the University of Toronto. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Agency for Healthcare Research and Quality, 2015, CHARTB CAR COORD MEA; Agency for Healthcare Research and Quality, 2016, CAR COORD; Albright BB, 2016, MED CARE, V54, P326, DOI 10.1097/MLR.0000000000000477; Austin PC, 2012, PSYCHIAT RES, V196, P32, DOI 10.1016/j.psychres.2011.09.023; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Bierman AS, 2016, LANCET, V388, P2721, DOI 10.1016/S0140-6736(16)32232-2; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Chang CH, 2011, JAMA-J AM MED ASSOC, V305, P2096, DOI 10.1001/jama.2011.665; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gao J, 2014, MED CARE, V52, P164, DOI 10.1097/MLR.0000000000000041; Giacomazzo A., 2012, RAPID LIT REV INCENT; Giacomazzo A., 2012, RAPID LIT REV EVIDEN; Hakkinen U, 2015, HEALTH ECON, V24, P116, DOI 10.1002/hec.3270; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; Hussey PS, 2013, ANN INTERN MED, V158, P27, DOI 10.7326/0003-4819-158-1-201301010-00006; Huynh TM., 2014, EXPLORING ACCOUNTABL; James J, 2015, PATIENT ENGAGEMENT; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Joynt KE, 2012, JAMA-J AM MED ASSOC, V307, P1082, DOI 10.1001/jama.2012.287; Kaplan RS, 2016, NEW ENGL J MED, V375, P1918, DOI 10.1056/NEJMp1607079; Kittelsen SAC, 2015, HEALTH ECON, V24, P140, DOI 10.1002/hec.3260; Kralj B., 2009, MEASURING RURALITY D; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Levine DM, 2016, JAMA INTERN MED, V176, P1778, DOI 10.1001/jamainternmed.2016.6217; Li P, 2012, J PEDIATR-US, V161, P208, DOI 10.1016/j.jpeds.2012.02.038; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; McKillop I., 2013, GUIDELINES PERSON LE, V1; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Ovretveit J, 2009, REV EVIDENCE WHICH I, P95; Phillips R., 2017, HLTH AFFAIRS BLOG; Radley D, 2012, RISING CHALLENGE RES; Radley DC, 2012, NEW ENGL J MED, V367, P3, DOI 10.1056/NEJMp1204516; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Schultz Susan E, 2017, CMAJ Open, V5, pE856, DOI 10.9778/cmajo.20170083; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stukel TA., 2016, VARIATIONS QUALITY I; Stukel Therese A, 2013, Open Med, V7, pe40; Stukel TA, 2012, JAMA-J AM MED ASSOC, V307, P1037, DOI 10.1001/jama.2012.265; Vigod SN, 2015, J PSYCHIATR RES, V61, P205, DOI 10.1016/j.jpsychires.2014.12.003; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Young RA, 2017, ANN FAM MED, V15, P175, DOI 10.1370/afm.2014	60	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195222	10.1371/journal.pone.0195222	http://dx.doi.org/10.1371/journal.pone.0195222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614131	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600037
J	Hsu, SH; Hsiao, CF; Tsai, SB				Hsu, Sheng-Hsun; Hsiao, Cheng-Fu; Tsai, Sang-Bing			Constructing a consumption model of fine dining from the perspective of behavioral economics	PLOS ONE			English	Article							CUSTOMER SATISFACTION; RESTAURANTS; QUALITY; CHOICE; SCALES; INTENTIONS; ATTRIBUTES; PERCEPTION; SAFETY; PRICE	Numerous factors affect how people choose a fine dining restaurant, including food quality, service quality, food safety, and hedonic value. A conceptual framework for evaluating restaurant selection behavior has not yet been developed. This study surveyed 150 individuals with fine dining experience and proposed the use of mental accounting and axiomatic design to construct a consumer economic behavior model. Linear and logistic regressions were employed to determine model correlations and the probability of each factor affecting behavior. The most crucial factor was food quality, followed by service and dining motivation, particularly regarding family dining. Safe ingredients, high cooking standards, and menu innovation all increased the likelihood of consumers choosing fine dining restaurants.	[Hsu, Sheng-Hsun] Chung Hua Univ, Dept Business Adm, Hsinchu, Taiwan; [Hsiao, Cheng-Fu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan; [Hsiao, Cheng-Fu] Hsing Wu Univ, Dept Hospitality Management, New Taipei, Taiwan; [Tsai, Sang-Bing] Univ Elect Sci & Technol China, Zhongshan Inst, Chengdu, Guangdong, Peoples R China	Chung Hua University; Chung Hua University; University of Electronic Science & Technology of China	Hsiao, CF (corresponding author), Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan.; Hsiao, CF (corresponding author), Hsing Wu Univ, Dept Hospitality Management, New Taipei, Taiwan.	haiso085009@yahoo.com.tw	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829				Akaichi F, 2013, AM J AGR ECON, V95, P949, DOI 10.1093/ajae/aat013; Alonso AD, 2013, J HOSP MARKET MANAG, V22, P547, DOI 10.1080/19368623.2012.671562; ARNOULD EJ, 1994, J MARKETING RES, V31, P484, DOI 10.2307/3151878; Arora R., 2006, Services Marketing Quarterly, V28, P89, DOI 10.1300/J396v28n01_05; Auty S., 1992, Service Industries Journal, V12, P324, DOI 10.1080/02642069200000042; Back KJ, 2012, INT J HOSP MANAG, V31, P535, DOI 10.1016/j.ijhm.2011.07.013; Barbas S, 2003, J POP CULT, V36, P669, DOI 10.1111/1540-5931.00040; Brandt RD., 1987, ADD VALUE YOUR SERVI, P61; Carnevalli JA, 2010, INT J PROD ECON, V125, P1, DOI 10.1016/j.ijpe.2010.01.002; Chen A, 2015, INT J CONTEMP HOSP M, V27, P236, DOI 10.1108/IJCHM-07-2013-0280; Cheng CC, 2012, INT J HOSP MANAG, V31, P1155, DOI 10.1016/j.ijhm.2012.02.003; Chin JB, 2013, TOTAL QUAL MANAG BUS, V24, P1160, DOI 10.1080/14783363.2012.661132; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; FLAMER S, 1983, MULTIVAR BEHAV RES, V18, P275, DOI 10.1207/s15327906mbr1803_3; Glaser B.G., 1965, AWARENESS DYING; Gourville JT, 1998, J CONSUM RES, V25, P160, DOI 10.1086/209533; Ha J, 2013, INT J HOSP MANAG, V32, P155, DOI 10.1016/j.ijhm.2012.05.007; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Harrington R. J., 2013, Journal of Foodservice Business Research, V16, P219, DOI 10.1080/15378020.2013.782240; Harrington R. J., 2011, Journal of Foodservice Business Research, V14, P272, DOI 10.1080/15378020.2011.594388; HAUSER JR, 1988, HARVARD BUS REV, V66, P63; HENDERSON PW, 1992, ORGAN BEHAV HUM DEC, V51, P92, DOI 10.1016/0749-5978(92)90006-S; Henson S, 2006, J FOOD SAFETY, V26, P275, DOI 10.1111/j.1745-4565.2006.00049.x; Hsee CK, 2009, J MARKETING RES, V46, P396, DOI 10.1509/jmkr.46.3.396; Johnson C., 2005, Cornell Hotel and Restaurant Administration Quarterly, V46, P170, DOI 10.1177/0010880405275115; Jung HS, 2012, INT J HOSP MANAG, V31, P875, DOI 10.1016/j.ijhm.2011.10.006; Jung JM, 2015, INT J HOSP MANAG, V45, P88, DOI 10.1016/j.ijhm.2014.11.007; KAHNEMAN D, 1993, MANAGE SCI, V39, P17, DOI 10.1287/mnsc.39.1.17; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim I, 2012, INT J CONTEMP HOSP M, V24, P402, DOI 10.1108/09596111211217888; Kim WG, 2009, INT J HOSP MANAG, V28, P144, DOI 10.1016/j.ijhm.2008.06.010; Koo L. C., 1999, International Journal of Contemporary Hospitality Management, V11, P242, DOI 10.1108/09596119910272784; Kozinets RV, 2002, J MARKETING RES, V39, P61, DOI 10.1509/jmkr.39.1.61.18935; Lane C, 2013, POETICS, V41, P342, DOI 10.1016/j.poetic.2013.05.003; Lee JH, 2011, INT J HOSP MANAG, V30, P658, DOI 10.1016/j.ijhm.2010.12.001; LEWIS RC, 1981, J ADVERTISING RES, V21, P69; LOKEN B, 1987, J MARKET RES SOC, V29, P353; MASLOW AH, 1954, J PERS, V22, P326, DOI 10.1111/j.1467-6494.1954.tb01136.x; Matzler K, 2004, IND MARKET MANAG, V33, P271, DOI 10.1016/S0019-8501(03)00055-5; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Netzer O, 2008, MARKET LETT, V19, P337, DOI 10.1007/s11002-008-9046-1; Njite D., 2008, Journal of Foodservice Business Research, V11, P237, DOI 10.1080/15378020801995523; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Ottenbacher M., 2007, INT J CONTEMP HOSP M, V19, P444, DOI DOI 10.1108/09596110710775110; Ponnam A, 2014, INT J HOSP MANAG, V37, P47, DOI 10.1016/j.ijhm.2013.10.004; Prelec D, 1998, MARKET SCI, V17, P4, DOI 10.1287/mksc.17.1.4; Rick SI, 2008, J CONSUM RES, V34, P767, DOI 10.1086/523285; Riviere P, 2006, FOOD QUAL PREFER, V17, P572, DOI 10.1016/j.foodqual.2006.04.002; Rohr A, 2005, FOOD CONTROL, V16, P649, DOI 10.1016/j.foodcont.2004.06.001; Scheidl R, 2010, MECHATRONICS, V20, P842, DOI 10.1016/j.mechatronics.2010.04.008; SPIGGLE S, 1994, J CONSUM RES, V21, P491, DOI 10.1086/209413; Stevens P., 1995, CORNELL HOTEL REST A, V36, P556; Suh NP, 1998, CIRP ANNALS 1998 - MANUFACTURING TECHNOLOGY, VOL 47/2/1998, P627; Suh NP., 2001, AXIOMATIC DESIGN ADV; Suh NP, 1990, PRINCIPLES DESIGN; Thaler RH, 1999, J BEHAV DECIS MAKING, V12, P183, DOI 10.1002/(SICI)1099-0771(199909)12:3<183::AID-BDM318>3.0.CO;2-F; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Thrane C, 2007, J REVENUE PRICING MA, V5, P315, DOI 10.1057/palgrave.rpm.5160055; Tikkanen I, 2007, BRIT FOOD J, V109, P721, DOI 10.1108/00070700710780698; Tontini G, 2013, TOTAL QUAL MANAG BUS, V24, P1253, DOI 10.1080/14783363.2013.836790; Voon BH, 2012, PROCD SOC BEHV, V38, P388, DOI 10.1016/j.sbspro.2012.03.361; Wiedmann KP, 2009, PSYCHOL MARKET, V26, P625, DOI 10.1002/mar.20292; Yim ES, 2014, INT J HOSP MANAG, V39, P11, DOI 10.1016/j.ijhm.2014.01.010; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446	65	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194886	10.1371/journal.pone.0194886	http://dx.doi.org/10.1371/journal.pone.0194886			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641554	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900053
J	Yaguchi, C; Itoh, H; Tsuchiya, KJ; Furuta-Isomura, N; Horikoshi, Y; Matsumoto, M; Jeenat, FU; Keiko, MK; Kohmura-Kobatashi, Y; Tamura, N; Sugihara, K; Kanayama, N				Yaguchi, Chizuko; Itoh, Hiroaki; Tsuchiya, Kenji J.; Furuta-Isomura, Naomi; Horikoshi, Yoshimasa; Matsumoto, Masako; Jeenat, Ferdous U.; Keiko, Muramatsu-Kato; Kohmura-Kobatashi, Yukiko; Tamura, Naoaki; Sugihara, Kazuhiro; Kanayama, Naohiro			Placental pathology predicts infantile physical development during first 18 months in Japanese population: Hamamatsu birth cohort for mothers and children (HBC Study)	PLOS ONE			English	Article							HISTOLOGIC CHORIOAMNIONITIS; NONCOMMUNICABLE DISEASES; GESTATIONAL-AGE; HEALTH; TERM; PERSPECTIVE; PREGNANCIES; MEDICINE; FEATURES; LESIONS	The present study aimed to investigate the relationship between placental pathological findings and physiological development during the neonate and infantile periods. Study participants were 258 infants from singleton pregnancies enrolled in the Hamamatsu Birth Cohort for Mothers and Children (HBC Study) whose placentas were stored in our pathological division. They were followed up from birth to 18 months of age. Physiological development (body weight and the ponderal index [PI]) was assessed at 0, 1, 4, 6, 10, 14, and 18 months. Placental blocks were prepared by random sampling and eleven pathological findings were assessed, as follows: 'Accelerated villous maturation', Decidual vasculopathy', 'Thrombosis or Intramural fibrin deposition', Avascular villi', Delayed villous maturation', 'Maternal inflammatory response', 'Fetal inflammatory response', of unknown etiology (VUE)', Deciduitis', 'Maternal vascular malperfusion', and 'Fetal vascular malperfusion'. Mixed model analysis with the use of the xtmixedcommand by the generic statistical software, Stata version 13.1., identified 'Accelerated villous maturation' and 'Maternal vascular malperfusion' as significant predictors of a lower body weight and Deciduitis' as a significant predictor of a small PI, throughout the first 18 months of life. In conclusion, the present study is the first to demonstrate that some pathological findings of the placenta are associated with changes in infantile physical development during the initial 18 months of life in the Japanese population.	[Yaguchi, Chizuko; Itoh, Hiroaki; Furuta-Isomura, Naomi; Horikoshi, Yoshimasa; Matsumoto, Masako; Jeenat, Ferdous U.; Keiko, Muramatsu-Kato; Kohmura-Kobatashi, Yukiko; Tamura, Naoaki; Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan; [Tsuchiya, Kenji J.] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Itoh, H (corresponding author), Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan.	hitou-endo@umin.ac.jp	Tsuchiya, Kenji J./I-9123-2019	Tsuchiya, Kenji J./0000-0002-1314-4199; Yaguchi, Chizuko/0000-0002-7166-423X; Itoh, Hiroaki/0000-0001-8577-3878	Ministry of Education, Science, Culture and Sports, Japan [15H04882, 16K15703]; Grants-in-Aid for Scientific Research [15H04882] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (Nos. 15H04882 and 16K15703) to HI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (Nos. 15H04882 and 16K15703).	Agboola SO, 2013, QJM-INT J MED, V106, P791, DOI 10.1093/qjmed/hct088; Arizawa M., 2013, CLIN PLACENTOLOGY, V1; Baergen RN, 2011, MANUAL OF PATHOLOGY OF THE HUMAN PLACENTA, SECOND EDITION, P1, DOI 10.1007/978-1-4419-7494-5; Beebe LA, 1996, OBSTET GYNECOL, V87, P771, DOI 10.1016/0029-7844(95)00483-1; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Catov JM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.022; Chisholm KM, 2016, PEDIATR DEVEL PATHOL, V19, P37, DOI 10.2350/15-04-1621-OA.1; Conti N, 2015, EUR J OBSTET GYN R B, V188, P34, DOI 10.1016/j.ejogrb.2015.02.034; de Onis M, 2015, WORLD REV NUTR DIET, V113, P278, DOI 10.1159/000360352; DESA DJ, 1973, J PATHOL, V110, P347, DOI 10.1002/path.1711100409; Elimian A, 2000, OBSTET GYNECOL, V96, P333, DOI 10.1016/S0029-7844(00)00928-5; Fogarty NME, 2013, AM J PATHOL, V183, P144, DOI 10.1016/j.ajpath.2013.03.016; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Gupta S, 2014, BBA-PROTEINS PROTEOM, V1844, P899, DOI 10.1016/j.bbapap.2013.12.020; Hanson MA, 2015, BEST PRACT RES CL OB, V29, P24, DOI 10.1016/j.bpobgyn.2014.06.007; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Imura H, 2013, P JPN ACAD B-PHYS, V89, P462, DOI 10.2183/pjab.89.462; Itoh H, 2017, DEV ORIGINS HLTH DIS; Itoh H, 2015, HYPERTENS RES PREGNA, V3, P1, DOI 10.14390/jsshp.3.1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Khalife N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040534; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kim Y.-S., 2014, J MAT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083901; Kingdom JC, 1997, PLACENTA, V18, P23; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kraus F.T., 2004, PLACENTAL PATHOLOGY; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Nakamura Y, 2015, HUM PATHOL, V46, P1171, DOI 10.1016/j.humpath.2015.04.007; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Seidmann L, 2014, PLACENTA, V35, P925, DOI 10.1016/j.placenta.2014.07.018; Takagai S, 2016, INT J EPIDEMIOL, V45, P333, DOI 10.1093/ije/dyv290; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tsuchiya KJ, 2010, J DEV ORIG HLTH DIS, V1, P158, DOI 10.1017/S2040174410000140; Williams MC, 2000, AM J OBSTET GYNECOL, V183, P1094, DOI 10.1067/mob.2000.108866; Yamazaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142609	43	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194988	10.1371/journal.pone.0194988	http://dx.doi.org/10.1371/journal.pone.0194988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634735	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200020
J	Bourdon, M; Santulli, P; Maignien, C; Gayet, V; Pocate-Cheriet, K; Marcellin, L; Chapron, C				Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Gayet, Vanessa; Pocate-Cheriet, Khaled; Marcellin, Louis; Chapron, Charles			The deferred embryo transfer strategy improves cumulative pregnancy rates in endometriosis-related infertility: A retrospective matched cohort study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; DEEPLY INFILTRATING ENDOMETRIOSIS; MAGNETIC-RESONANCE; FREEZE-ALL; ASSISTED REPRODUCTION; OVARIAN STIMULATION; LIVE BIRTH; FRESH; IVF; DIAGNOSIS	Background Controlled ovarian stimulation in assisted reproduction technology (ART) may alters endometrial receptivity by an advancement of endometrial development. Recently, technical improvements in vitrification make deferred frozen-thawed embryo transfer (Def-ET) a feasible alternative to fresh embryo transfer (ET). In endometriosis-related infertility the eutopic endometrium is abnormal and its functional alterations are seen as likely to alter the quality of endometrial receptivity. One question in the endometriosis ART-management is to know whether Def-ET could restore optimal receptivity in endometriosis-affected women leading to increase in pregnancy rates. Objective To compare cumulative ART-outcomes between fresh versus Def-ET in endometriosis-infertile women. Materials and methods This matched cohort study compared def-ET strategy to fresh ET strategy between 01/10/2012 and 31/12/2014. One hundred and thirty-five endometriosis-affected women with a scheduled def-ET cycle and 424 endometriosis-affected women with a scheduled fresh ET cycle were eligible for matching. Matching criteria were: age, number of prior ART cycles, and endometriosis phenotype. Statistical analyses were conducted using univariable and multivariable logistic regression models. Results 135 in the fresh ET group and 135 in the def-ET group were included in the analysis. The cumulative clinical pregnancy rate was significantly increased in the def-ET group compared to the fresh ET group [58 (43%) vs. 40 (29.6%), p = 0.047]. The cumulative ongoing pregnancy rate was 34.8% (n = 47) and 17.8% (n = 24) respectively in the Def-ET and the fresh-ET groups (p = 0.005). After multivariable conditional logistic regression analysis, Def-ET was associated with a significant increase in the cumulative ongoing pregnancy rate as compared to fresh ET (OR = 1.76, CI95% 1.06-2.92, p = 0.028). Conclusion Def-ET in endometriosis-affected women was associated with significantly higher cumulative ongoing pregnancy rates. Our preliminary results suggest that Def-ET for endometriosis-affected women is an attractive option that could increase their ART success rates. Future studies, with a randomized design, should be conducted to further confirm those results.	[Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Gayet, Vanessa; Marcellin, Louis; Chapron, Charles] Ctr Hosp Univ CHU Cochin, Dept Gynecol Obstet & Reprod Med 2, Paris, France; [Bourdon, Mathilde; Santulli, Pietro; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Dept Stress Oxydant Proliferat Cellulaire & Infla, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France; [Santulli, Pietro; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Dept Dev Reprod & Canc, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France; [Pocate-Cheriet, Khaled] Ctr Hosp Univ CHU Cochin, Dept Histol Embryol & Reprod Biol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Santulli, P (corresponding author), Ctr Hosp Univ CHU Cochin, Dept Gynecol Obstet & Reprod Med 2, Paris, France.; Santulli, P (corresponding author), Univ Paris 05, Dept Stress Oxydant Proliferat Cellulaire & Infla, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France.; Santulli, P (corresponding author), Univ Paris 05, Dept Dev Reprod & Canc, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France.	pietro.santulli@cch.aphp.fr	Santulli, Pietro/T-5201-2019; louis, marcellin/V-4728-2019	louis, marcellin/0000-0003-4482-9710; Santulli, Pietro/0000-0002-4985-7326	Finox Forward Research Grant	Finox Forward Research Grant	This study was partially supported by a Finox Forward Research Grant to CC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abrao MS, 2007, HUM REPROD, V22, P3092, DOI 10.1093/humrep/dem187; Ahn SH, 2016, FERTIL STERIL, V106, P1420, DOI 10.1016/j.fertnstert.2016.07.005; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366; Benaglia L, 2011, HUM REPROD, V26, P2368, DOI 10.1093/humrep/der208; Blockeel C, 2016, HUM REPROD, V31, P491, DOI 10.1093/humrep/dev339; Bourdon M, 2017, J ENDOMETR PELVIC PA, V9, P87, DOI 10.5301/jeppd.5000281; Bourdon M, 2017, REPROD SCI, V24, P1325, DOI 10.1177/1933719116687659; Bourdon M, 2017, REPROD BIOMED ONLINE, V34, P248, DOI 10.1016/j.rbmo.2016.11.015; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brandes M, 2010, HUM REPROD, V25, P118, DOI 10.1093/humrep/dep341; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 2014, HUM REPROD, V29, P1688, DOI 10.1093/humrep/deu090; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2004, ULTRASOUND OBST GYN, V24, P175, DOI 10.1002/uog.1107; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Check JH, 1999, J ASSIST REPROD GEN, V16, P416, DOI 10.1023/A:1020565408018; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Corwin MT, 2014, RADIOLOGY, V271, P126, DOI 10.1148/radiol.13131394; de Ziegler D, 2010, FERTIL STERIL, V94, P2796, DOI 10.1016/j.fertnstert.2010.05.056; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Dueholm M, 2007, CURR OPIN OBSTET GYN, V19, P505, DOI 10.1097/GCO.0b013e3282f1bf00; Evans J, 2014, HUM REPROD UPDATE, V20, P808, DOI 10.1093/humupd/dmu027; Fauque P, 2007, J ASSIST REPROD GEN, V24, P159, DOI 10.1007/s10815-007-9115-z; Ferrero S, 2015, FERTIL STERIL, V104, P771, DOI 10.1016/j.fertnstert.2015.08.031; Gardner DK, 2002, J REPROD IMMUNOL, V55, P85, DOI 10.1016/S0165-0378(01)00136-X; Germond M, 2004, HUM REPROD, V19, P2442, DOI 10.1093/humrep/deh501; Guerriero S, 2015, ULTRASOUND OBSTET GY; Hamdan M, 2015, OBSTET GYNECOL, V125, P79, DOI 10.1097/AOG.0000000000000592; Houshdaran S, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140434; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kinkel K, 2006, EUR RADIOL, V16, P285, DOI 10.1007/s00330-005-2882-y; Maheshwari A, 2015, HUM REPROD, V30, P2703, DOI 10.1093/humrep/dev263; Maignien C, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.11.1042; Manzanares MA, 2010, FERTIL STERIL, V93, P1215, DOI 10.1016/j.fertnstert.2008.12.019; Marcellin L, 2015, HUM REPROD, V30, P392, DOI 10.1093/humrep/deu321; Medeiros LR, 2015, ARCH GYNECOL OBSTET, V291, P611, DOI 10.1007/s00404-014-3470-7; Millischer AE, 2015, ULTRASOUND OBST GYN, V46, P109, DOI 10.1002/uog.14712; Nikas G, 1999, HUM REPROD, V14, P787, DOI 10.1093/humrep/14.3.787; Opoien HK, 2012, FERTIL STERIL, V97, P912, DOI 10.1016/j.fertnstert.2012.01.112; Piketty M, 2009, HUM REPROD, V24, P602, DOI 10.1093/humrep/den405; Roque M, 2015, FERTIL STERIL, V103, P1190, DOI 10.1016/j.fertnstert.2015.01.045; Sampson JA, 1927, AM J PATHOL, V3, P93; Santulli P, 2016, HUM REPROD, V31, P1014, DOI 10.1093/humrep/dew035; Santulli P, 2016, FERTIL STERIL, V105, P978, DOI 10.1016/j.fertnstert.2015.12.006; Santulli P, 2014, J CLIN ENDOCR METAB, V99, P881, DOI 10.1210/jc.2013-2950; Santulli P, 2011, FERTIL STERIL, V95, P507, DOI 10.1016/j.fertnstert.2010.09.018; Shapiro BS, 2014, REPROD BIOMED ONLINE, V29, P286, DOI 10.1016/j.rbmo.2014.04.009; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Somigliana E, 2008, HUM REPROD, V23, P1526, DOI 10.1093/humrep/den133; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	53	27	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194800	10.1371/journal.pone.0194800	http://dx.doi.org/10.1371/journal.pone.0194800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630610	gold, Green Submitted, Green Published			2022-12-27	WOS:000429505000017
J	Hesen, NA; Riksen, NP; Aalders, B; Brouwer, MAE; Ritskes-Hoitinga, M; El Messaoudi, S; Weyer, KE				Hesen, Nienke A.; Riksen, Niels P.; Aalders, Bart; Brouwer, Michelle A. E.; Ritskes-Hoitinga, Merel; El Messaoudi, Saloua; Weyer, Kimberley E.			A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction (vol 12, e0183664, 2017)	PLOS ONE			English	Correction									[Brouwer, Michelle A. E.] Radboud Univ Nijmegen, Med Ctr, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, Dept Hlth Evidence,Nijmegen Inst Hlth Sci, Nijmegen, Netherlands	Radboud University Nijmegen	Brouwer, MAE (corresponding author), Radboud Univ Nijmegen, Med Ctr, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, Dept Hlth Evidence,Nijmegen Inst Hlth Sci, Nijmegen, Netherlands.		Ritskes-Hoitinga, Merel/GLT-8517-2022; Riksen, Niels P/G-8260-2015; Brouwer, Michelle A.E./O-4866-2017; Wever, Kimberley E./D-9705-2016	Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Riksen, Niels P/0000-0001-9197-8124; Wever, Kimberley E./0000-0003-3635-3660				Hesen NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183664	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195858	10.1371/journal.pone.0195858	http://dx.doi.org/10.1371/journal.pone.0195858			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630663	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000077
J	Kamps-Hughes, N; McUsic, A; Kurihara, L; Harkins, TT; Pal, P; Ray, C; Ionescu-Zanetti, C				Kamps-Hughes, Nick; McUsic, Andrew; Kurihara, Laurie; Harkins, Timothy T.; Pal, Prithwish; Ray, Claire; Ionescu-Zanetti, Cristian			ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data	PLOS ONE			English	Article							DRIVER MUTATIONS; RARE MUTATIONS; DISCOVERY; CANCER; DNA	The accurate detection of ultralow allele frequency variants in DNA samples is of interest in both research and medical settings, particularly in liquid biopsies where cancer mutational status is monitored from circulating DNA. Next-generation sequencing (NGS) technologies employing molecular barcoding have shown promise but significant sensitivity and specificity improvements are still needed to detect mutations in a majority of patients before the metastatic stage. To address this we present analytical validation data for ERASE-Seq (Elimination of Recurrent Artifacts and Stochastic Errors), a method for accurate and sensitive detection of ultralow frequency DNA variants in NGS data. ERASE-Seq differs from previous methods by creating a robust statistical framework to utilize technical replicates in conjunction with background error modeling, providing a 10 to 100-fold reduction in false positive rates compared to published molecular barcoding methods. ERASE-Seq was tested using spiked human DNA mixtures with clinically realistic DNA input quantities to detect SNVs and indels between 0.05% and 1% allele frequency, the range commonly found in liquid biopsy samples. Variants were detected with greater than 90% sensitivity and a false positive rate below 0.1 calls per 10,000 possible variants. The approach represents a significant performance improvement compared to molecular barcoding methods and does not require changing molecular reagents.	[Kamps-Hughes, Nick; Ionescu-Zanetti, Cristian] Fluxion Biosci Inc, San Francisco, CA 94080 USA; [McUsic, Andrew; Kurihara, Laurie; Harkins, Timothy T.] Swift Biosci Inc, Ann Arbor, MI USA; [Pal, Prithwish; Ray, Claire] Illumine Inc, San Diego, CA USA		Ionescu-Zanetti, C (corresponding author), Fluxion Biosci Inc, San Francisco, CA 94080 USA.	cristian@fluxionbio.com	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Ionescu-Zanetti, Cristian/0000-0002-3123-0699	Fluxion Biosciences; Swift Biosciences; Illumina	Fluxion Biosciences; Swift Biosciences; Illumina	The studies were funded by Fluxion Biosciences, Swift Biosciences and Illumina. No individual authors received specific funding for this work. The affiliated companies provided support in the form of salaries for authors NKH, CIZ (Fluxion Biosciences), AM, LH, TH (Swift Biosciences), PP and CR (Illumina). The respective companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Chae YK, 2016, ONCOTARGET, V7, P65364, DOI 10.18632/oncotarget.11692; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fang LT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0758-2; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kuderer NM, 2017, JAMA ONCOL, V3, P996, DOI 10.1001/jamaoncol.2016.4983; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., EBMNET, V17; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Peng Q, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1806-8; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Pishvaian MJ, 2017, ONCOTARGET, V8, P83446, DOI 10.18632/oncotarget.13225; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Stadler ZK, 2014, J CLIN ONCOL, V32, P687, DOI 10.1200/JCO.2013.49.7271; Torga G, 2018, JAMA ONCOL, V4, P868, DOI 10.1001/jamaoncol.2017.4027; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918	37	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195272	10.1371/journal.pone.0195272	http://dx.doi.org/10.1371/journal.pone.0195272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630678	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000034
J	Khan, Z; Ahmad, S; Al-Sweih, N; Joseph, L; Alfouzan, W; Asadzadeh, M				Khan, Ziauddin; Ahmad, Suhail; Al-Sweih, Noura; Joseph, Leena; Alfouzan, Wadha; Asadzadeh, Mohammad			Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait	PLOS ONE			English	Article							AMPHOTERICIN-B; COMBINATION THERAPY; SP NOV.; RESISTANT; FUNGEMIA; IDENTIFICATION; EMERGENCE; PATHOGEN; STATES	Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. This study investigated occurrence of C. auris in clinical specimens in Kuwait and its susceptibility to antifungal agents. Clinical yeast strains isolated during 3.5 year period and forming pink-colored colonies on CHROMagar Candida were studied by wet mount examination for microscopic morphology and Vitek 2 yeast identification system. A simple species-specific PCR assay was developed for molecular identification and results were confirmed by PCR-sequencing of rDNA. Antifungal susceptibility testing of one isolate from each patient was determined by Etest. The 280 isolates forming pink-colored colonies on CHROMagar Candida, were identified by Vitek 2 as Candida haemulonii (n = 166), Candida utilis (n = 49), Candida kefyr(n = 45), Candida guilliermondii (n = 9), Candida famata (n = 6) and Candida conglobata (n = 5). Species-specific PCR and PCR-sequencing of rDNA identified 166 C. haemulonii isolates as C. auris (n = 158), C. haemulonii (n = 6) and Candida duobushaemulonii (n = 2). C. auris isolates originated from diverse clinical specimens from 56 patients. Of 56 C. auris isolates tested, all were resistant to fluconazole, 41/ 56 (73%) and 13/56 (23%) were additionally resistant to voriconazole and amphotericin B, respectively. Eleven (20%) isolates were resistant to fluconazole, voriconazole and amphotericin B. One isolate was resistant to caspofungin and micafungin. Increasing isolation of C. auris in recent years from diverse clinical specimens including bloodstream shows that C. auris is an emerging non-albicans Candida species in Kuwait causing a variety of infections. Inability of conventional identification methods to accurately identify this pathogen and multidrug-resistant nature of many strains calls for a greater understanding of its epidemiology, risk factors for acquiring C. auris infection and management strategies in high-risk patients. This is the first comprehensive study on the emergence of this multidrug-resistant yeast from Kuwait and the Middle East.	[Khan, Ziauddin; Ahmad, Suhail; Al-Sweih, Noura; Joseph, Leena; Alfouzan, Wadha; Asadzadeh, Mohammad] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021; Alfouzan, Wadha/AAR-8290-2021; Alfouzan, Wadha A/GRA-2552-2022	Alfouzan, Wadha/0000-0002-4501-5316; asadzadeh, Mohammad/0000-0002-9151-1505	Kuwait University [MI01/15]	Kuwait University	This work was supported by Kuwait University Research Sector Grant No. MI01/15.	Abdolrasouli A, 2017, MYCOSES, V60, P758, DOI 10.1111/myc.12699; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2003, MED MYCOL, V41, P487, DOI 10.1080/1369378031000147458; Al-Sweih N, 2017, J MYCOL MED, V27, P271, DOI 10.1016/j.mycmed.2017.01.010; Al-Sweih N, 2015, J CLIN MICROBIOL, V53, P1038, DOI 10.1128/JCM.03351-14; Al-Sweih N, 2014, MED MYCOL CASE REP, V5, P9, DOI 10.1016/j.mmcr.2014.04.004; Al-Sweih N, 2011, MED MYCOL, V49, P766, DOI 10.3109/13693786.2011.572300; Arendrup MC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00485-17, 10.1128/AAC.00485-17]; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142880; Ben-Ami R, 2017, EMERG INFECT DIS, V23, P195, DOI 10.3201/eid2302.161486; Cadnum JL, 2017, INFECT CONT HOSP EP, V38, P1240, DOI 10.1017/ice.2017.162; Calvo B, 2016, J INFECTION, V73, P369, DOI 10.1016/j.jinf.2016.07.008; Castanheira M, 2016, DIAGN MICR INFEC DIS, V85, P200, DOI 10.1016/j.diagmicrobio.2016.02.009; CDC, 2017, REC ID CAND AUR; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2018, J ANTIMICROB CHEMOTH, V73, P891, DOI 10.1093/jac/dkx480; Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; Emara M, 2015, EMERG INFECT DIS, V21, P1091, DOI 10.3201/eid2106.150270; Jeffery-Smith A, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00029-17; Kathuria S, 2015, J CLIN MICROBIOL, V53, P1823, DOI 10.1128/JCM.00367-15; Kean R, 2018, J HOSP INFECT, V98, P433, DOI 10.1016/j.jhin.2017.11.015; Khan Z., 2017, CLIN MED RES PRACT, V7, P240, DOI [10.1016/j.cmrp.2017.11.004, DOI 10.1016/J.CMRP.2017.11.004]; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2007, J CLIN MICROBIOL, V45, P2025, DOI 10.1128/JCM.00222-07; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Kordalewska M, 2017, J CLIN MICROBIOL, V55, P2445, DOI 10.1128/JCM.00630-17; Kumar A, 2017, REV IBEROAM MICOL, V34, P109, DOI 10.1016/j.riam.2016.11.004; Lass-Florl C, 2011, CLIN MICROBIOL INFEC, V17, pE27, DOI 10.1111/j.1469-0691.2011.03644.x; Lepak AJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00791-17, 10.1128/aac.00791-17]; Lesho EP, 2018, INFECT CONT HOSP EP, V39, P53, DOI 10.1017/ice.2017.231; Lockhart SR, 2017, J CLIN MICROBIOL, V55, P3324, DOI 10.1128/JCM.01355-17; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Magobo RE, 2014, EMERG INFECT DIS, V20, P1250, DOI 10.3201/eid2007.131765; Mizusawa M, 2017, J CLIN MICROBIOL, V55, P638, DOI 10.1128/JCM.02202-16; Morales-Lopez SE, 2017, EMERG INFECT DIS, V23, P162, DOI 10.3201/eid2301.161497; Rudramurthy SM, 2017, J ANTIMICROB CHEMOTH, V72, P1794, DOI 10.1093/jac/dkx034; Gaitan ACR, 2017, REV IBEROAM MICOL, V34, P23, DOI 10.1016/j.riam.2016.11.002; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Schelenz S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0132-5; Sears D, 2017, INT J INFECT DIS, V63, P95, DOI 10.1016/j.ijid.2017.08.017; Sipavak ES, 2017, J CLIN MICROBIO 1122; Tsay S, 2018, CLIN INFECT DIS, V66, P306, DOI 10.1093/cid/cix744; Vallabhaneni S, 2017, AM J TRANSPLANT, V17, P296, DOI 10.1111/ajt.14121; Vallabhaneni S, 2016, MMWR-MORBID MORTAL W, V65, P1234, DOI 10.15585/mmwr.mm6544e1; Welsh RM, 2017, J CLIN MICROBIOL, V55, P2996, DOI [10.1128/jcm.00921-17, 10.1128/JCM.00921-17]	47	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195743	10.1371/journal.pone.0195743	http://dx.doi.org/10.1371/journal.pone.0195743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630658	Green Submitted, gold, Green Published			2022-12-27	WOS:000429505000070
J	Wang, SM; Lu, DY; Zhang, ZY; Jia, XY; Yang, L				Wang, Sumei; Lu, Dongyuan; Zhang, Zhenyu; Jia, Xingyuan; Yang, Lei			Effects of mechanical stretching on the morphology of extracellular polymers and the mRNA expression of collagens and small leucine-rich repeat proteoglycans in vaginal fibroblasts from women with pelvic organ prolapse	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; GENE-EXPRESSION; BIOMECHANICAL PROPERTIES; CANCER BIOLOGY; DECORIN; FIBROMODULIN; LUMICAN; FIBRILLOGENESIS; BIGLYCAN; BINDING	To determine the effect of mechanical stretching load and the efficacy of postmenopausal estrogen therapy (ET) on pelvic organ prolapse (POP), vaginal fibroblasts isolated from postmenopausal women with or without POP were subjected to 0.1-Hz uniaxial cyclic mechanical stretching (CS) with 10% elongation and 10-8 M 17-I3-estradiol (E-2) treatment. We investigated the morphological characteristics of extracellular polymers using scanning electron microscopy (SEM) and monitored the mRNA expression of type I collagen (COL I) and type III collagen (COL III) as well as the small leucine-rich proteoglycan (SLRP) family members decorin (DCN), biglycan (BGN), fibromodulin (FMO), and lumican (LUM), using real-time quantitative polymerase chain reaction (RT-PCR). Using SEM, certain viscoelastic polymers were found to be randomly distributed among fibroblasts, which for normal fibroblasts formed clusters of plum flower-like patterns under static-culture conditions and resembled stretched strips when stretched in culture, whereas polymers among POP fibroblasts resembled stretched strips under static-cultured conditions and presented broken networks when stretched in culture. RT-PCR revealed that COL I, DCN, BGN, FMO, and LUM mRNA expression was significantly higher in POP than in normal fibroblasts under static-culture condition. Following CS, COL I and BGN mRNA expression was significantly up-regulated in normal fibroblasts, and DCN and FMO mRNA expression was down-regulated in POP fibroblasts. Following concomitant CS and E2 treatment, significantly elevated COL I and DCN mRNA expression was observed in normal fibroblasts, and significantly elevated COL I and BGN mRNA expression was observed in POP fibroblasts. COL III mRNA expression was not significantly different between the POP and normal group, and CS did not significantly affect expression in either group, though COL III was down-regulated in normal fibroblasts concomitantly treated with E-2 and CS. We conclude that the morphological distribution of extracellular polymers in POP fibroblasts exhibited higher sensitivity and lower tolerance to stretching loads than do normal fibroblasts. These mechanical properties were further reflected in the transcription of COL I. Defects in the compensatory function of BGN for DCN and LUM for FMO exist in POP fibroblasts, which further affect the structure and function of COL I in response to stretching load, ultimately resulting in abnormal reconstruction of pelvic supportive connective tissues and the occurrence of POP. ET can maintain stretching-induced elevations in COL I and DCN transcription in healthy women and improve stretching-induced COL I, DCN, BGN, and FMO transcriptional changes in POP women to prevent and improve POP. Only down-regulated COL III transcription was observed upon concomitant CS and E2 treatment in normal fibroblasts, which suggests that the tensile strength, not the elasticity, of the supportive connective tissues is damaged in POP and that the higher tensile strength induced by ET in healthy fibroblasts prevents POP. These findings confirm the role of higher sensitivity and lower tolerance to mechanical stretching in the pathogenesis of POP and further provide evidence supporting the use of ET to prevent and inhibit POP in postmenopausal women.	[Wang, Sumei; Zhang, Zhenyu] Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Lu, Dongyuan] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Key Lab Micrograv,Natl Micrograv Lab, Beijing, Peoples R China; [Lu, Dongyuan] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Jia, Xingyuan; Yang, Lei] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Capital Medical University	Wang, SM; Zhang, ZY (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.; Jia, XY (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China.	sumeiwang@ccmu.edu.cn; Zhenyuzhang@ccmu.edu.cn; jiaxy@hotmail.com	YANG, LEI/GQH-4271-2022		National Key Technology Research and Development Program during the 11th Five-Year Plan Period [2007BAI04B05]	National Key Technology Research and Development Program during the 11th Five-Year Plan Period	This work was supported by the National Key Technology Research and Development Program during the 11th Five-Year Plan Period (2007BAI04B05)(ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Alimohamad H, 2005, J PERIODONTAL RES, V40, P73, DOI 10.1111/j.1600-0765.2004.00776.x; Bildircin D, 2014, Minerva Ginecol, V66, P201; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Cowman Mary K, 2015, F1000Res, V4, P622, DOI 10.12688/f1000research.6885.1; DELANCEY JOL, 1993, CLIN OBSTET GYNECOL, V36, P897, DOI 10.1097/00003081-199312000-00015; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2; Ewies AAA, 2008, MOL HUM REPROD, V14, P127, DOI 10.1093/molehr/gam090; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fuermetz A, 2015, EUR J OBSTET GYN R B, V187, P45, DOI 10.1016/j.ejogrb.2015.02.021; Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Ghodsi H, 2015, J MECH BEHAV BIOMED, V51, P194, DOI 10.1016/j.jmbbm.2015.07.015; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jia XY, 2013, EXP MOL PATHOL, V95, P68, DOI 10.1016/j.yexmp.2013.05.007; Jin Ling, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P18; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Karamanou K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45138; Kim CM, 2007, INT J GYNECOL OBSTET, V98, P248, DOI 10.1016/j.ijgo.2007.02.019; Kim SG, 2002, CELL STRUCT FUNCT, V27, P139, DOI 10.1247/csf.27.139; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; Lelievre SA, 2009, BBA-GEN SUBJECTS, V1790, P925, DOI 10.1016/j.bbagen.2009.03.013; Liu YM, 2006, HUM REPROD, V21, P303, DOI 10.1093/humrep/dei296; Markiewicz M, 2013, J INVEST DERMATOL, V133, P120, DOI 10.1038/jid.2012.264; Martins P, 2013, GYNECOL OBSTET INVES, V75, P85, DOI 10.1159/000343230; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; O'Dell KK, 2007, INT UROGYNECOL J, V18, P1481, DOI 10.1007/s00192-007-0387-8; Phillips CH, 2006, BJOG-INT J OBSTET GY, V113, P39, DOI 10.1111/j.1471-0528.2005.00773.x; Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004; Ruiz-Zapata AM, 2013, INT UROGYNECOL J, V24, P1567, DOI 10.1007/s00192-013-2069-z; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang SM, 2015, INT J MOL SCI, V16, P9406, DOI 10.3390/ijms16059406; Wen Y, 2007, HUM REPROD, V22, P1718, DOI 10.1093/humrep/dem039; Word RA, 2009, OBSTET GYN CLIN N AM, V36, P521, DOI 10.1016/j.ogc.2009.09.001; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	56	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0193456	10.1371/journal.pone.0193456	http://dx.doi.org/10.1371/journal.pone.0193456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630675	gold, Green Published			2022-12-27	WOS:000429505000002
J	Yu, N; Wei, YL; Zhu, Y; Zhu, N; Wang, YL; Zhang, HP; Sun, AD				Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong			Integrated approach for identifying and evaluating the quality of Marsdenia tenacissima in the medicine market	PLOS ONE			English	Article							POLYOXYPREGNANE GLYCOSIDES; IDENTIFICATION; AUTHENTICATION; HERBS; LEAVES; PLANTS; ITS2	The accurate identification and quality evaluation of herbal medical plants is highly necessary to ensure their safety and efficacy. In present study, a new strategy combining DNA barcoding techniques with thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) was proposed to facilitate the identification and quality control of M. tenacissima. In present work, the internal transcribed spacer 2 (ITS2) barcode was successfully used to identify 58 M. tenacissima samples and its adulterants. TLC successfully identified the other three M. tenacissima samples that failed to produce ITS2 regions. An adulterant was found in all the 62 samples. Moreover, the content of active medicinal ingredients is important for herbal plants quality. The content of tenacissoside H (TS-H) of M. tenacissima samples was determined by HPLC to range from 0.39% to 1.09%, which meets the criterion of the Chinese Pharmacopoeia. Thus, DNA barcoding coupled with TLC and HPLC is very promising to identify and evaluate the quality of M. tenacissima in the medicine market.	[Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong] Beijing Forestry Univ, Beijing Key Lab Forest Food Proc & Safety, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, AD (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Sun, AD (corresponding author), Beijing Forestry Univ, Beijing Key Lab Forest Food Proc & Safety, Beijing, Peoples R China.	adsun@bjfu.edu.cn			Forestry public welfare industry research special funds [201504606]	Forestry public welfare industry research special funds	This research work was supported by Forestry public welfare industry research special funds (No. 201504606).	Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Chen JJ, 2008, TALANTA, V77, P152, DOI 10.1016/j.talanta.2008.05.054; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Deng J, 2005, PHYTOCHEMISTRY, V66, P1040, DOI 10.1016/j.phytochem.2005.03.018; Deng J, 2006, J CHROMATOGR A, V1116, P83, DOI 10.1016/j.chroma.2006.03.021; Donno D, 2015, J FUNCT FOODS, V18, P1070, DOI 10.1016/j.jff.2014.05.020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Han JP, 2016, SCI REP, P6; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jiang LL, 2016, J PHARMACEUT BIOMED, V129, P398, DOI 10.1016/j.jpba.2016.07.030; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kim HJ, 2010, ARCH PHARM RES, V33, P1355, DOI 10.1007/s12272-010-0909-7; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035146; Lo YT, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0029-x; LUO SQ, 1993, PHYTOCHEMISTRY, V34, P1615, DOI 10.1016/S0031-9422(00)90856-2; Marichamy K., 2014, SCI PARK, V1, P23218045, DOI [DOI 10.9780/23218045/1202013/49, 10.9780/23218045/1202013/49]; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Poornima B., 2010, IJRAP, V1, P8; Sasidharan S, 2011, AFR J TRADIT COMPLEM, V8, P1; State Pharmacopoeia Committee, 2015, MARSD TEN ROXB, P296; Sun ZY, 2013, J NAT MED-TOKYO, V67, P296, DOI 10.1007/s11418-012-0681-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Beek TA, 2009, J CHROMATOGR A, V1216, P2002, DOI 10.1016/j.chroma.2009.01.013; Xin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08337; Xin TY, 2013, FOOD RES INT, V54, P1699, DOI 10.1016/j.foodres.2013.10.007; Xu CJ, 2015, FOOD CHEM, V186, P83, DOI 10.1016/j.foodchem.2014.11.042; Yu N, 2016, MOLECULES, V21, DOI 10.3390/molecules21091221; Zhang Hailing, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.09.2008.1016	37	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195240	10.1371/journal.pone.0195240	http://dx.doi.org/10.1371/journal.pone.0195240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624609	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600020
J	Zhao, PW; Xu, CY; Zhou, M; Zhang, B; Ge, P; Zeng, N; Liu, HY				Zhao, Pengwu; Xu, Chongyang; Zhou, Mei; Zhang, Bo; Ge, Peng; Zeng, Nan; Liu, Hongyan			Rapid regeneration offsets losses from warming-induced tree mortality in an aspen dominated broad-leaved forest in northern China	PLOS ONE			English	Article							POPULUS-TREMULOIDES; CANOPY OPENNESS; BOREAL FOREST; DROUGHT; GROWTH; DYNAMICS; COMPETITION; RESILIENCE; SEEDLINGS; DECLINE	Worldwide tree mortality as induced by climate change presents a challenge to forest managers. To successfully manage vulnerable forests requires the capacity of regeneration to compensate for losses from tree mortality. We observed rapid regeneration and the growth release of young trees after warming-induced mortality in a David aspen-dominated (Populus davidiana) broad-leaved forest in Inner Mongolia, China, as based on individual tree measurements taken in 2012 and 2015 from a 6-ha permanent plot. Warming and drought stress killed large trees 10-15 m tall with a total number of 2881 trees during 2011-2012, and also thinned the upper crowns. David aspen recruitment increased 2 times during 2012-2015 and resulted in a high transition probability of David aspen replacing the same or other species, whereas the recruitment of Mongolian oak (Quercus mongolica) was much lower: it decreased from 2012 to 2015, indicating that rapid regeneration represented a regrowth phase for David aspen, and not succession to Mongolian oak. Further, we found that the recruitment density increased with canopy openness, thus implying that warming induced mortality enhanced regeneration. Our results suggest that David aspen has a high regrowth ability to offset individual losses from warming-induced mortality. This important insight has implications for managing this vulnerable forest in the semi-arid region of northern China.	[Zhao, Pengwu; Zhou, Mei; Ge, Peng; Zeng, Nan] Inner Mongolia Agr Univ, Acad Forestry, Hohhot, Inner Mongolia, Peoples R China; [Xu, Chongyang; Zhang, Bo; Liu, Hongyan] Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China; [Xu, Chongyang; Zhang, Bo; Liu, Hongyan] Peking Univ, MOE Lab Earth Surface Proc, Beijing, Peoples R China	Inner Mongolia Agricultural University; Peking University; Peking University	Zhou, M (corresponding author), Inner Mongolia Agr Univ, Acad Forestry, Hohhot, Inner Mongolia, Peoples R China.; Liu, HY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China.; Liu, HY (corresponding author), Peking Univ, MOE Lab Earth Surface Proc, Beijing, Peoples R China.	daxl528@aliyun.com; lhy@urban.pku.edu.cn			National Natural Science of China [41325002, 41530747]	National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was granted by National Natural Science of China to Hongyan Liu with grant No. 41325002 and 41530747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL://www.nsfc.gov.cn/.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Baker WL, 1989, LANDSCAPE ECOL, V2, P112; Bose AK, 2014, FOREST ECOL MANAG, V329, P37, DOI 10.1016/j.foreco.2014.06.004; Brais S, 2004, CAN J FOREST RES, V34, P431, DOI [10.1139/x03-144, 10.1139/X03-144]; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Brandt JP, 2003, FOREST ECOL MANAG, V178, P287, DOI 10.1016/S0378-1127(02)00479-6; Bretfeld M, 2015, FOREST ECOL MANAG, V347, P96, DOI 10.1016/j.foreco.2015.03.006; BROWN JK, 1987, CAN J FOREST RES, V17, P1100, DOI 10.1139/x87-168; DeByle NV, 1985, RM119 FORT COLL; Dudley MM, 2015, FOREST ECOL MANAG, V353, P240, DOI 10.1016/j.foreco.2015.06.002; Dulamsuren C, 2013, ECOSYSTEMS, V16, P1536, DOI 10.1007/s10021-013-9700-1; Enoki T, 2004, PLANT ECOL, V173, P283, DOI 10.1023/B:VEGE.0000029336.80225.f0; ENRIGHT N, 1979, AUST J ECOL, V4, P3, DOI 10.1111/j.1442-9993.1979.tb01195.x; Feng HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18018; Frey BR, 2004, CAN J FOREST RES, V34, P1379, DOI 10.1139/X04-062; Gerhardt K, 1996, FOREST ECOL MANAG, V82, P33, DOI 10.1016/0378-1127(95)03700-4; Gradowski T, 2010, FOREST ECOL MANAG, V259, P383, DOI 10.1016/j.foreco.2009.10.033; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/NCLIMATE2837, 10.1038/nclimate2837]; Kaufmann J, 2014, CAN J FOREST RES, V44, P777, DOI 10.1139/cjfr-2014-0131; Kharuk VI, 2013, FOREST ECOL MANAG, V310, P312, DOI 10.1016/j.foreco.2013.08.042; Kharuk VI, 2013, FOREST ECOL MANAG, V289, P385, DOI 10.1016/j.foreco.2012.10.024; Kneeshaw DD, 1998, ECOLOGY, V79, P783, DOI 10.1890/0012-9658(1998)079[0783:CGCATR]2.0.CO;2; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Landhausser SM, 2015, CAN J FOREST RES, V45, P1056, DOI 10.1139/cjfr-2015-0062; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu HY, 2000, J VEG SCI, V11, P525, DOI 10.2307/3246582; Machado JL, 1999, CAN J FOREST RES, V29, P1438, DOI 10.1139/cjfr-29-9-1438; McDowell NG, 2013, NEW PHYTOL, V200, P289, DOI 10.1111/nph.12502; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; O'Brien MJ, 2014, NAT CLIM CHANGE, V4, P710, DOI [10.1038/NCLIMATE2281, 10.1038/nclimate2281]; Qi ZH, 2015, GLOBAL CHANGE BIOL, V21, P816, DOI 10.1111/gcb.12703; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rogers PC, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1661; Rogers PC, 2014, J VEG SCI, V25, P457, DOI 10.1111/jvs.12099; Romme WH, 2005, ECOLOGY, V86, P404, DOI 10.1890/03-4093; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Shepperd WD, 2015, FOREST SCI, V61, P932, DOI 10.5849/forsci.14-101; Shepperd WD, 2001, CAN J FOREST RES, V31, P739, DOI 10.1139/cjfr-31-5-739; Strand EK, 2009, FOREST ECOL MANAG, V257, P1705, DOI 10.1016/j.foreco.2009.01.026; Hogg EH, 2015, GLOBAL CHANGE BIOL, V21, P1968, DOI 10.1111/gcb.12805; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Wang GG, 2003, CAN J FOREST RES, V33, P1998, DOI [10.1139/x03-123, 10.1139/X03-123]; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2015, CAN J FOREST RES, V45, P1768, DOI 10.1139/cjfr-2015-0225; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Worrall JJ, 2010, FOREST ECOL MANAG, V260, P638, DOI 10.1016/j.foreco.2010.05.020; Xu CY, 2018, FOREST ECOL MANAG, V409, P298, DOI 10.1016/j.foreco.2017.11.035; Xu CY, 2017, GLOBAL CHANGE BIOL, V23, P2370, DOI 10.1111/gcb.13582; Yamanaka N., 2014, RESTORATION DEV DEGR, P49, DOI DOI 10.1007/978-4-431-54481-4_4; Zeng N, 2016, FOREST CHRON, V92, P336, DOI 10.5558/tfc2016-060; Zhang J, 2015, P NATL ACAD SCI USA, V112, P4009, DOI 10.1073/pnas.1420844112; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128; Zou Hou-yuan, 2002, Xibei Zhiwu Xuebao, V22, P1	53	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195630	10.1371/journal.pone.0195630	http://dx.doi.org/10.1371/journal.pone.0195630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624614	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600041
J	Cheng, X; Li, K; Xu, SS; Li, PZ; Yan, Y; Wang, G; Berman, Z; Guo, R; Liang, JX; Traore, S; Yang, XS				Cheng, Xin; Li, Ke; Xu, Shengsong; Li, Peizhi; Yan, Yu; Wang, Guang; Berman, Zachary; Guo, Rui; Liang, Jianxin; Traore, Sira; Yang, Xuesong			Applying chlorogenic acid in an alginate scaffold of chondrocytes can improve the repair of damaged articular cartilage	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED CARTILAGE; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; IN-VIVO; MICE; OSTEOARTHRITIS; DEFECTS; MODEL; TRANSPLANTATION	Damaged cartilage has very low regenerative potential which has led to the search for novel tissue-engineering approaches to help treat cartilage defects. While various approaches have been reported, there is no perfect treatment currently. In this study we evaluated the effects of a plant extract, chlorogenic acid (CGA), as part of chondrocyte transplantation on a model of knee joint injury in chicks. First, primary cultured chondrocytes used to evaluate the effects of CGA on chondrogenesis. Then using an articular cartilage injury model of chick knee we assessed the functional recovery after transplantation of the complexes containing chondrocytes and CGA in an alginate scaffold. Histological analysis, PCR, and western blot were further used to understand the underlying mechanisms. We showed that 60 mu M CGA in alginate exhibited notable effects on stimulating chondrogenesis in vitro. Secondly, it was shown that the application of these complexes accelerated the recovery of injury-induced dysfunction by gait analysis when followed for 21 days. Histochemical analysis demonstrated that there was less abnormal vasculature formation, more chondrocyte proliferation and cartilage matrix synthesis in the presence of the complexes containing CGA. We discovered CGA treated transplantation up-regulated the expressions of Sox9 and Col2a1 which were responsible for the stimulation of chondrogenesis. Furthermore, the application of these complexes could suppress the abnormal angiogenesis and fibrosis at the injury site. Lastly, the elevated levels of inflammatory cytokines IL-1 beta, TNF-alpha, p-p65, and MMPs expression were decreased in the presence of CGA. This may be caused through adjusting cellular redox homeostasis associated with Nrf2. This study suggests that combining chondrocytes and CGA on an alginate scaffold can improve the recovery of damaged articular cartilage.	[Cheng, Xin; Li, Ke; Xu, Shengsong; Li, Peizhi; Yan, Yu; Wang, Guang; Guo, Rui; Liang, Jianxin; Traore, Sira; Yang, Xuesong] Jinan Univ, Med Coll, Joint Lab Embryon Dev & Prenatal Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Berman, Zachary] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Yang, Xuesong] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China	Jinan University; University of California System; University of California San Diego; Jinan University	Yang, XS (corresponding author), Jinan Univ, Med Coll, Joint Lab Embryon Dev & Prenatal Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China.; Yang, XS (corresponding author), Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.	yang_xuesong@126.com	Xu, Shengsong/HHD-0354-2022; Wang, Guang/AAC-4624-2019	Xu, Shengsong/0000-0002-4349-6507; LIANG, Jianxin/0000-0002-6636-0872; Berman, Zachary/0000-0002-8651-9772	NSFC; Science and Technology Planning Project of Guangdong Province; Science and Technology Program of Guangzhou; Guangdong Natural Science Foundation; Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Science and Technology Program of Guangzhou; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University	This study was supported by NSFC, Science and Technology Planning Project of Guangdong Province, Science and Technology Program of Guangzhou, Guangdong Natural Science Foundation, and Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University.	Adamzyk C, 2016, J CRANIO MAXILL SURG, V44, P985, DOI 10.1016/j.jcms.2016.04.012; Ben Shoham A, 2016, DEVELOPMENT, V143, P3933, DOI 10.1242/dev.139253; Bishi DK, 2016, ADV HEALTHC MATER, V5, P1058, DOI 10.1002/adhm.201500897; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Chen WP, 2014, INT J CLIN EXP PATHO, V7, P8797; Chen WP, 2011, INT IMMUNOPHARMACOL, V11, P23, DOI 10.1016/j.intimp.2010.09.021; Ching SH, 2017, CRIT REV FOOD SCI, V57, P1133, DOI 10.1080/10408398.2014.965773; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Gentile P, 2017, BIOMATER SCI-UK, V5, P1922, DOI 10.1039/c7bm00525c; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hattori K, 2005, ARTHRITIS RES THER, V7, pR552, DOI 10.1186/ar1710; Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742, DOI 10.1152/ajpcell.1996.271.3.C742; HELBING G, 1982, FORTSCHR MED, V100, P83; HEMBRY RM, 1994, VIRCHOWS ARCH, V425, P413; Kazemnejad S, 2016, CELL TISSUE RES, V364, P559, DOI 10.1007/s00441-015-2355-9; Klennert BJ, 2017, J BIOMECH, V52, P31, DOI 10.1016/j.jbiomech.2016.11.056; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2; Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5; Markarian Gregory G, 2016, J Surg Orthop Adv, V25, P18; Qin L, 2015, BIOMATERIALS, V59, P125, DOI 10.1016/j.biomaterials.2015.04.038; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; VANBEUNINGEN HM, 1991, ARTHRITIS RHEUM, V34, P606, DOI 10.1002/art.1780340513; Wang G, 2016, J AGR FOOD CHEM, V64, P1610, DOI 10.1021/acs.jafc.5b05897; Wang PZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148372; Westacott CI, 1996, SEMIN ARTHRITIS RHEU, V25, P254, DOI 10.1016/S0049-0172(96)80036-9; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455	40	15	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195326	10.1371/journal.pone.0195326	http://dx.doi.org/10.1371/journal.pone.0195326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621359	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800062
J	do Nascimento, SV; Magalhaes, MM; Cunha, RL; Costa, PHD; Alves, RCD; de Oliveira, GC; Valadares, RBD				do Nascimento, Sidney Vasconcelos; Magalhaes, Marcelo Murad; Cunha, Roberto Lisboa; de Oliveira Costa, Paulo Henrique; de Oliveira Alves, Ronnie Cley; de Oliveira, Guilherme Correa; da Silva Valadares, Rafael Borges			Differential accumulation of proteins in oil palms affected by fatal yellowing disease	PLOS ONE			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; COMPARATIVE PROTEOMIC ANALYSIS; PHYTOPHTHORA-PALMIVORA; WATERLOGGING STRESS; METABOLISM; EXPRESSION; ARABIDOPSIS; PHLOEM; ROOTS; MAIZE	There is still no consensus on the true origin of fatal yellowing, one of the most important diseases affecting oil palm (Elaeis guineensis Jacq.) plantations. This study involved two-dimensional liquid chromatography coupled with tandem mass spectrometry (2D-UPLC-MSE) analyses to identify changes in protein profiles of oil palms affected by FY disease. Oil palm roots were sampled from two growing areas. Differential accumulation of proteins was assessed by comparing plants with and without symptoms and between plants at different stages of FY development. Most of the proteins identified with differential accumulation were those related to stress response and energy metabolism. The latter proteins include the enzymes alcohol dehydrogenase and aldehyde dehydrogenase, related to alcohol fermentation, which were identified in plants with and without symptoms. The presence of these enzymes suggests an anaerobic condition before or during FY. Transketolase, isoflavone reductase, cinnamyl alcohol dehydrogenase, caffeic acid 3-O-methyltransferase, S-adenosylmethionine synthase, aldehyde dehydrogenase and ferritin, among others, were identified as potential marker proteins and could be used to guide selection of FY-tolerant oil palm genotypes or to understand the source of this anomaly. When comparing different stages of FY, we observed high accumulation of alcohol dehydrogenase and other abiotic stress related-proteins at all disease stages. On the other hand, biological stress-related proteins were more accumulated at later stages of the disease. These results suggest that changes in abiotic factors can trigger FY development, creating conditions for the establishment of opportunistic pathogens.	[do Nascimento, Sidney Vasconcelos; de Oliveira Costa, Paulo Henrique; de Oliveira Alves, Ronnie Cley; de Oliveira, Guilherme Correa; da Silva Valadares, Rafael Borges] Inst Tecnol Vale, Belem, Para, Brazil; [do Nascimento, Sidney Vasconcelos; Cunha, Roberto Lisboa; da Silva Valadares, Rafael Borges] Univ Fed Rural Amazonia, Programa Posgrad Biotecnol Aplicada Agr, Belem, Para, Brazil; [Magalhaes, Marcelo Murad; Cunha, Roberto Lisboa] Embrapa Amazonia Oriental, Anal Sustainable Syst Lab, Belem, Para, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal Rural da Amazonia (UFRA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Valadares, RBD (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Valadares, RBD (corresponding author), Univ Fed Rural Amazonia, Programa Posgrad Biotecnol Aplicada Agr, Belem, Para, Brazil.	rafael.borges.valadares@itv.org	Alves, Ronnie/U-9893-2019; Cunha, Roberto Lisboa/S-9909-2019; cunha, roberto L/B-9346-2016	Alves, Ronnie/0000-0003-4139-0562; Cunha, Roberto Lisboa/0000-0002-2964-7938; cunha, roberto L/0000-0002-2964-7938; Valadares, Rafael/0000-0003-4481-982X	Institute Tecnologico Vale	Institute Tecnologico Vale	This work was supported by Institute Tecnologico Vale. The funder provided support in the form of salaries for authors RBSV, GO and ROA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta A., 2003, Better Crops International, V17, P22; Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; Bernardes MSR, 2001, PESQUISA AMARELECIME; Bertolde FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108705; Boari AJ, 2009, S BRASILEIRO SENSORI, P523; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Botcher A, 2012, FERRITIN FUNCTIONS B, P65; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Campos Ndia Alves, 2016, Plant Omics, V9, P19; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cheng Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01024; Chinchilla C, 2005, ASD OIL PALM PAP, V28, P21; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Costa MR, 2014, REV SODEBRAS, V9, P40; Cristancho JA, 2012, ROLE SOIL PLANT NUTR, V33; de Llanos R, 2016, APPL ENVIRON MICROB, V82, P3052, DOI 10.1128/AEM.00305-16; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Ernst AM, 2012, P NATL ACAD SCI USA, V109, pE1980, DOI 10.1073/pnas.1202999109; Fan R, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-16; Freeg HA, 2016, CERCET AGRON MOLD, V49; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Vargas LHG, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1100-z; Govindaraj M, 2015, GENETICS RES INT, V2015, DOI [10.1155/2015/431487, DOI 10.1155/2015/431487]; Haque ME, 2011, PROTEIN PEPTIDE LETT, V18, P912; HENDRY GAF, 1985, NEW PHYTOL, V101, P199, DOI 10.1111/j.1469-8137.1985.tb02826.x; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Ismail AM, 2009, ANN BOT-LONDON, V103, P197, DOI 10.1093/aob/mcn211; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jiang GL, 2016, ADV PLANT BREEDING S, V1, P431; Kamal AHM, 2015, J PROTEOMICS, V112, P1, DOI 10.1016/j.jprot.2014.08.014; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Laing D, 2012, INFORM AGRONOMICAS, P137; Less H, 2011, PLANT CELL, V23, P1264, DOI 10.1105/tpc.110.082867; Louise C, 1993, AN 14 C BRAS ENT JAN, P194; Majerus V, 2009, PLANT SOIL, V324, P253, DOI 10.1007/s11104-009-9952-x; Martinez G, 2014, PALMAS, V35, P11; Martinez G., 2010, PALMAS, V31, P43; Meguro N, 2006, ABIOTIC STRESS TOLERANCE IN PLANTS: TOWARD THE IMPROVEMENT OF GLOBAL ENVIRONMENT AND FOOD, P111, DOI 10.1007/1-4020-4389-9_7; Mekhilef S, 2011, RENEW SUST ENERG REV, V15, P1937, DOI 10.1016/j.rser.2010.12.012; Metwali EMR, 2016, ARCH BIOL SCI, V68, P427, DOI 10.2298/ABS150629126M; Miro B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00269; Morales-Olmedo M, 2015, CHIL J AGR RES, V75, P45, DOI 10.4067/S0718-58392015000300006; MUNEVAR MF, 2001, PALMAS, V22, P9; Nadeem MZ, 2017, BIOTECHNOLOGY BIOTEC, P1314; Nakazono M, 2000, PLANT PHYSIOL, V124, P587, DOI 10.1104/pp.124.2.587; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neutelings G, 2011, PLANT SCI, V181, P379, DOI 10.1016/j.plantsci.2011.06.012; Pradhan SK, 2016, PLOS ONE, V11; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sarria GA, 2016, EUR J PLANT PATHOL, V145, P39, DOI 10.1007/s10658-015-0810-9; Sarria G.A., 2008, PALMAS, V29, P31; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Silva HM, 1996, WORKSH CULT DEND, P87; Silveira RI, 2000, EVOLUCAO SINTOMATOLO; SINGH D, 2016, PLOS ONE, V11; Souza RLR, 2000, DENPASA AMARELECIMEN; Srivastava VK, 2016, PLANT CELL REP, V35, P1021, DOI 10.1007/s00299-016-1935-9; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Teixeira, 2010, ZONEAMENTO AGROECOLO, P153; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Torres GA, 2016, PHYTOPATHOLOGY; Trindade DR, 2005, PRAGAS DOENCAS CULTI, P439; Tsuji H, 2003, FEBS LETT, V546, P369, DOI 10.1016/S0014-5793(03)00631-8; Villon M., 2007, DRENAJE; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang JP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01557; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Yu F, 2015, PROTEOMICS, V15, P135, DOI 10.1002/pmic.201400156	70	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195538	10.1371/journal.pone.0195538	http://dx.doi.org/10.1371/journal.pone.0195538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621343	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800099
J	Ogren, J; Irewall, AL; Soderstrom, L; Mooe, T				Ogren, Joachim; Irewall, Anna-Lotta; Soderstrom, Lars; Mooe, Thomas			Serious hemorrhages after ischemic stroke or TIA - Incidence, mortality, and predictors	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; NATIONWIDE COHORT; SUBGROUP ANALYSIS; VASCULAR-DISEASE; WARFARIN; ASPIRIN; ATTACK; PREVENTION	Background Data are lacking on the risk and impact of a serious hemorrhage on the prognosis after ischemic stroke (IS) or transient ischemic attack (TIA). We aimed to estimate the incidence of serious hemorrhage, analyze the impact on mortality, and identify predictors of hemorrhage after discharge from IS or TIA. Methods and findings All patients admitted to Ostersund Hospital for an IS or TIA in 2010-2013 were included (n = 1528, mean age: 75.1 years). Serious hemorrhages were identified until 31st December 2015. Incidence rates were calculated. The impact on mortality (stratified by functional level) was determined with Kaplan-Meier analysis. Non-parametric estimation under the assumption of competing risk was performed to assess the cumulative incidence and predictors of serious hemorrhages. The incidence rates of serious (n = 113) and intracranial hemorrhages (n = 45) after discharge from IS and TIA were 2.48% and 0.96% per year at risk, respectively. Patients with modified Rankin Scale (mRS) scores of 3-5 exhibited 58.9% mortality during follow-up and those with mRS scores of 0-2 exhibited 18.4% mortality. A serious hemorrhage did not affect mortality in patients with impaired functional status, but it increased the risk of death in patients with mRS scores of 0-2. Hypertension was associated with increased risk of serious hemorrhage. Conclusions We found that, after discharge from an IS or TIA, serious hemorrhages were fairly common. Impairments in function were associated with high mortality, but serious hemorrhages only increased the risk of mortality in patients with no or slight disability. Improved hypertension treatment may decrease the risk of serious hemorrhage, but in patients with low functional status, poor survival makes secondary prevention challenging.	[Ogren, Joachim; Irewall, Anna-Lotta; Mooe, Thomas] Umea Univ, Dept Publ Hlth & Clin Med, Ostersund, Sweden; [Soderstrom, Lars] Unit Res Dev & Educ, Ostersund, Sweden; [Ogren, Joachim] Ostersunds Sjukhus, Medicinmottagningen, Ostersund, Sweden	Umea University	Ogren, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Ostersund, Sweden.; Ogren, J (corresponding author), Ostersunds Sjukhus, Medicinmottagningen, Ostersund, Sweden.	joachim.ogren@regionjh.se		Ogren, Joachim/0000-0002-3542-7966	Research Development and Education Unit, Region Jamtland Harjedalen [JLL-640691]	Research Development and Education Unit, Region Jamtland Harjedalen	Fundings recieved from Research Development and Education Unit, Region Jamtland Harjedalen (Grant number: JLL-640691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Asberg S, 2013, INT J STROKE, V8, P80, DOI 10.1111/j.1747-4949.2011.00718.x; Atar S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.013; Badillo R, 2015, PHARMACOEPIDEM DR S, V24, P849, DOI 10.1002/pds.3817; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; CHIMOWITZ MI, 1995, NEUROLOGY, V45, P1488, DOI 10.1212/WNL.45.8.1488; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Collins R, 2004, LANCET, V363, P757; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Schryver ELLM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001342.pub3; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Douketis JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.008; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Eriksson M, 2008, CEREBROVASC DIS, V25, P423, DOI 10.1159/000121343; Evans A, 2000, STROKE, V31, P2106, DOI 10.1161/01.STR.31.9.2106; Feng WW, 2010, NEUROLOGY, V74, P588, DOI 10.1212/WNL.0b013e3181cff776; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gulmez SE, 2009, BRIT J CLIN PHARMACO, V67, P460, DOI 10.1111/j.1365-2125.2009.03362.x; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Irewall AL, 2014, CEREBROVASC DIS EXTR, V4, P28, DOI 10.1159/000358121; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Ogren J, 2015, CIRC-CARDIOVASC QUAL, V8, P413, DOI 10.1161/CIRCOUTCOMES.114.001606; Petty GW, 1999, ANN INTERN MED, V130, P14, DOI 10.7326/0003-4819-130-1-199901050-00004; Saxena R, 2004, COCHRANE DB SYST REV; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Usman MHU, 2009, AM J CARDIOL, V103, P1107, DOI 10.1016/j.amjcard.2009.01.003; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195324	10.1371/journal.pone.0195324	http://dx.doi.org/10.1371/journal.pone.0195324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621285	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800061
J	Sakamoto, M; Kwon, J; Tamada, H; Hirahara, Y				Sakamoto, Maki; Kwon, Jinhwan; Tamada, Hikaru; Hirahara, Yumi			Optimal linguistic expression in negotiations depends on visual appearance	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; HIRING DECISIONS; GENDER; SEX; PREFERENCES; BEAUTIFUL; DISCRIMINATION; HYPOTHESIS; SELECTION; ACCURACY	We investigate the influence of the visual appearance of a negotiator on persuasiveness within the context of negotiations. Psychological experiments were conducted to quantitatively analyze the relationship between visual appearance and the use of language. Male and female participants were shown three female and male photographs, respectively. They were asked to report how they felt about each photograph using a seven-point semantic differential (SD) scale for six affective factors (positive impression, extraversion, intelligence, conscientiousness, emotional stability, and agreeableness). Participants then answered how they felt about each negotiation scenario (they were presented with pictures and a situation combined with negotiation sentences) using a seven-point SD scale for seven affective factors (positive impression, extraversion, intelligence, conscientiousness, emotional stability, agreeableness, and degree of persuasion). Two experiments were conducted using different participant groups depending on the negotiation situations. Photographs with good or bad appearances were found to show high or low degrees of persuasion, respectively. A multiple regression equation was obtained, indicating the importance of the three language factors (euphemistic, honorific, and sympathy expressions) to impressions made during negotiation. The result shows that there are optimal negotiation sentences based on various negotiation factors, such as visual appearance and use of language. For example, persons with good appearance might worsen their impression during negotiations by using certain language, although their initial impression was positive, and persons with bad appearance could effectively improve their impressions in negotiations through their use of language, although the final impressions of their negotiation counterpart might still be more negative than those for persons with good appearance. In contrast, the impressions made by persons of normal appearance were not easily affected by their use of language. The results of the present study have significant implications for future studies of effective negotiation strategies considering visual appearance as well as gender.	[Sakamoto, Maki; Kwon, Jinhwan; Tamada, Hikaru] Univ Electrocommun, Dept Informat, Tokyo, Japan; [Hirahara, Yumi] Pallas Global Enterprise, Tokyo, Japan	University of Electro-Communications - Japan	Sakamoto, M (corresponding author), Univ Electrocommun, Dept Informat, Tokyo, Japan.	maki.sakamoto@uec.ac.jp			JSPS [15K12127]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Challenging Exploratory Research (No. 15K12127). One of the authors, Yumi Hirahara, is employed by a commercial company, Pallas Global Enterprise. This company provided support in the form of salaries for Yumi Hirahra, This company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'Author contributions' section.	Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; AYRES I, 1995, MICH LAW REV, V94, P109, DOI 10.2307/1289861; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; BARDACK NR, 1985, J SOC PSYCHOL, V125, P777, DOI 10.1080/00224545.1985.9713553; Barry B, 1996, ORGAN BEHAV HUM DEC, V67, P127, DOI 10.1006/obhd.1996.0069; BEM SL, 1981, PSYCHOL REV, V88, P354, DOI 10.1037/0033-295X.88.4.354; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BERRY DS, 1990, SOC COGNITION, V8, P343, DOI 10.1521/soco.1990.8.4.343; BORKENAU P, 1992, J PERS SOC PSYCHOL, V62, P645, DOI 10.1037/0022-3514.62.4.645; Brothers L., 1997, FRIDAYS FOOTPRINT SO; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1986, J PERS SOC PSYCHOL, V50, P559, DOI 10.1037/0022-3514.50.3.559; DERMER M, 1975, J PERS SOC PSYCHOL, V31, P1168, DOI 10.1037/h0077085; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Eagly A.H., 1987, SEX DIFFERENCES SEXU; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Erickson AJ, 1977, COMPONENT PARTS WORL; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; FISCHER JL, 1958, WORD, V14, P47, DOI 10.1080/00437956.1958.11659655; Forgas J. P., 2001, HDB AFFECT SOCIAL CO; FUNDER DC, 1987, PSYCHOL BULL, V101, P75, DOI 10.1037/0033-2909.101.1.75; Giles H., 1977, ITL REV APPL LINGUIS, V33, P27; Haas MR, 1944, LANGUAGE, V20, P142, DOI 10.2307/410153; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Hatfield E, 2000, CORSINI ENCY PSYCHOL, V3, P1203; JACKSON LA, 1983, J APPL SOC PSYCHOL, V13, P443, DOI 10.1111/j.1559-1816.1983.tb01751.x; KING WC, 1994, J MANAGE, V20, P605, DOI 10.1177/014920639402000305; Labov W., 1972, SOCIOLINGUISTICS PAT; Lakoff R., 1978, WOMENS LANGUAGE WOME, P139; Lakoff Robin, 1975, LANGUAGE WOMANS PLAC; LAMBERT WE, 1960, J ABNORM SOC PSYCH, V60, P44, DOI 10.1037/h0044430; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Leaper C, 2011, PSYCHOL WOMEN QUART, V35, P129, DOI 10.1177/0361684310392728; Little AC, 2006, PERS INDIV DIFFER, V41, P1107, DOI 10.1016/j.paid.2006.04.015; Makino Seiichi., 1986, DICT BASIC JAPANESE; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; MORROW PC, 1990, J MANAGE, V16, P45, DOI 10.1177/014920639001600104; Okamoto S., 2004, JAPANESE LANGUAGE GE; Pettey RE, HDB AFFECTIVE SCI; Petty RE, 2015, COGNITION EMOTION, V29, P1, DOI 10.1080/02699931.2014.967183; Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066; PRUITT DG, 1986, J EXP SOC PSYCHOL, V22, P264, DOI 10.1016/0022-1031(86)90029-6; RAZA SM, 1987, J APPL PSYCHOL, V72, P596, DOI 10.1037/0021-9010.72.4.596; ROSS J, 1981, ADMIN SCI QUART, V26, P617, DOI 10.2307/2392343; RYNES S, 1990, PERS PSYCHOL, V43, P13, DOI 10.1111/j.1744-6570.1990.tb02004.x; Suzuki K, 2014, ADV AFFECTIVE PLEASU, V483, P221; Williams J.E., 1990, SEX PSYCHE GENDER SE; Williams John E., 1982, MEASURING SEX STEREO; Wolffhechel K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107721; WOOD RG, 1993, J LABOR ECON, V11, P417, DOI 10.1086/298302; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	52	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195496	10.1371/journal.pone.0195496	http://dx.doi.org/10.1371/journal.pone.0195496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621361	Green Submitted, gold, Green Published			2022-12-27	WOS:000429206800094
J	Toger, J; Arvidsson, PM; Bock, J; Kanski, M; Pedrizzetti, G; Carlsson, M; Arheden, H; Heiberg, E				Toger, Johannes; Arvidsson, Per M.; Bock, Jelena; Kanski, Mikael; Pedrizzetti, Gianni; Carlsson, Marcus; Arheden, Hakan; Heiberg, Einar			Hemodynamic forces in the left and right ventricles of the human heart using 4D flow magnetic resonance imaging: Phantom validation, reproducibility, sensitivity to respiratory gating and free analysis software	PLOS ONE			English	Article							RELATIVE PRESSURE FIELDS; BLOOD-FLOW; DIASTOLIC FUNCTION; KINETIC-ENERGY; 4-DIMENSIONAL FLOW; HEALTHY-VOLUNTEERS; COMPUTATION; VELOCITIES; VOLUME	Purpose To investigate the accuracy, reproducibility and sensitivity to respiratory gating, field strength and ventricle segmentation of hemodynamic force quantification in the left and right ventricles of the heart (LV and RV) using 4D-flow magnetic resonance imaging (MRI), and to provide free hemodynamic force analysis software. Materials and methods A pulsatile flow phantom was imaged using 4D flow MRI and laser-based particle image velocimetry (PIV). Cardiac 4D flow MRI was performed in healthy volunteers at 1.5T (n = 23). Reproducibility was investigated using MR scanners from two different vendors on the same day (n = 8). Subsets of volunteers were also imaged without respiratory gating (n = 17), at 3T on the same day (n = 6), and 1-12 days later on the same scanner (n = 9, median 6 days). Agreement was measured using the intraclass correlation coefficient (ICC). Results Phantom validation showed good accuracy for both scanners (Scanner 1: bias -14 +/- 9%, y = 0.82x+0.08, R-2 = 0.96, Scanner 2: bias -12 +/- 8%, y = 0.99x-0.08, R-2 = 1.00). Force reproducibility was strong in the LV (0.09 +/- 0.07 vs 0.09 +/- 0.07 N, bias 0.00 +/- 0.04 N, ICC = 0.87) and RV (0.09 +/- 0.06 vs 0.09 +/- 0.05 N, bias 0.00 +/- 0.03, ICC = 0.83). Strong to very strong agreement was found for scans with and without respiratory gating (LV/RV: ICC = 0.94/0.95), scans on different days (ICC = 0.92/0.87), and 1.5T and 3T scans (ICC = 0.93/0.94). Conclusion Software for quantification of hemodynamic forces in 4D-flow MRI was developed, and results show high accuracy and strong to very strong reproducibility for both the LV and RV, supporting its use for research and clinical investigations. The software including source code is released freely for research.	[Toger, Johannes; Arvidsson, Per M.; Bock, Jelena; Kanski, Mikael; Carlsson, Marcus; Arheden, Hakan; Heiberg, Einar] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Clin Physiol, Lund, Sweden; [Pedrizzetti, Gianni] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Heiberg, Einar] Lund Univ, Dept Biomed Engn, Fac Engn, Lund, Sweden	Lund University; Skane University Hospital; University of Trieste; Lund University	Heiberg, E (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Clin Physiol, Lund, Sweden.; Heiberg, E (corresponding author), Lund Univ, Dept Biomed Engn, Fac Engn, Lund, Sweden.	einar.heiberg@med.lu.se	Töger, Johannes/F-1927-2014; Arvidsson, Per M/E-2560-2014; Carlsson, Marcus/AAR-4318-2021	Töger, Johannes/0000-0002-3365-7282; Arvidsson, Per M/0000-0002-2262-3562; Carlsson, Marcus/0000-0002-9480-5250; Pedrizzetti, Gianni/0000-0003-2886-7653	Research Council, Sweden (Vetenskapsradet) [2012-4944, 2016-01617]; National Visualization Programme (Kunskap- och Kompetensstiftelsen) [2009-0080]; Knowledge Foundation; Region of Scania, Sweden (Region Skane); Medical Faculty at Lund University, Sweden (Medicinska Fakulteten vid Lunds Universitet); Heart-Lung Foundation, Sweden (Hjart-Lungfonden)	Research Council, Sweden (Vetenskapsradet); National Visualization Programme (Kunskap- och Kompetensstiftelsen); Knowledge Foundation; Region of Scania, Sweden (Region Skane); Medical Faculty at Lund University, Sweden (Medicinska Fakulteten vid Lunds Universitet); Heart-Lung Foundation, Sweden (Hjart-Lungfonden)	This study was funded by the Research Council, Sweden (Vetenskapsradet, grants 2012-4944 and 2016-01617), the Knowledge Foundation and the National Visualization Programme (Kunskap- och Kompetensstiftelsen, grant 2009-0080), The Region of Scania, Sweden (Region Skane), The Medical Faculty at Lund University, Sweden (Medicinska Fakulteten vid Lunds Universitet), and The Heart-Lung Foundation, Sweden (Hjart-Lungfonden). While Dr. Einar Heiberg is the owner of the company Medviso AB, the company did not fund or influence the design, analysis or presentation of data in the present study.	Arvidsson PM, 2017, AM J PHYSIOL-HEART C, V312, pH314, DOI 10.1152/ajpheart.00583.2016; Arvidsson PM, 2013, J APPL PHYSIOL, V114, P1472, DOI 10.1152/japplphysiol.00932.2012; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Busch J, 2017, J MAGN RESON IMAGING, V46, P1516, DOI 10.1002/jmri.25668; Cain Peter A, 2009, BMC Med Imaging, V9, P2, DOI 10.1186/1471-2342-9-2; Carlsson M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-55; COURTOIS M, 1990, CIRCULATION, V81, P1688, DOI 10.1161/01.CIR.81.5.1688; COURTOIS M, 1988, CIRCULATION, V78, P661, DOI 10.1161/01.CIR.78.3.661; Doost SN, 2016, COMPUT METH PROG BIO, V127, P232, DOI 10.1016/j.cmpb.2015.12.020; Dyverfeldt P, 2008, J MAGN RESON IMAGING, V28, P655, DOI 10.1002/jmri.21475; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Dyverfeldt P, 2013, JACC-CARDIOVASC IMAG, V6, P64, DOI 10.1016/j.jcmg.2012.07.017; Ebbers T, 2002, J BIOMECH ENG-T ASME, V124, P288, DOI 10.1115/1.1468866; Ebbers T, 2001, MAGNET RESON MED, V45, P872, DOI 10.1002/mrm.1116; Ebbers T, 2009, J MAGN RESON IMAGING, V30, P54, DOI 10.1002/jmri.21775; Eriksson J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03089-x; Eriksson J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12685; Eriksson J, 2015, MAGN RESON MED, V74, P1716, DOI 10.1002/mrm.25539; Farneback G, 2007, P IEEE INT C COMP VI; Ghosh E, 2013, ANN BIOMED ENG, V41, P1269, DOI 10.1007/s10439-013-0756-z; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Kanski M, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0061-4; Kessler LG, 2015, STAT METHODS MED RES, V24, P9, DOI 10.1177/0962280214537333; Khalafvand SS, 2017, J BIOMECH, V50, P71, DOI 10.1016/j.jbiomech.2016.11.032; Kovacs SJ, 1987, AM J PHYSIOL-HEART C, V252; LeBreton JM, 2008, ORGAN RES METHODS, V11, P815, DOI 10.1177/1094428106296642; LIMA JAC, 1986, CIRCULATION, V74, P463, DOI 10.1161/01.CIR.74.3.463; Lorenz CH, 2000, J CARDIOV MAGN RESON, V2, P97, DOI 10.3109/10976640009148678; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Pedrizzetti G, 2015, J BIOMECH, V48, P388, DOI 10.1016/j.jbiomech.2014.11.049; Pettigrew JB., 1864, PHILOS T R SOC LOND, V154, P445, DOI DOI 10.1098/RSTL.1864.0014; R Development Core Team, 2009, R LANG ENV STAT COMP; SALLIN EA, 1969, BIOPHYS J, V9, P954, DOI 10.1016/S0006-3495(69)86429-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steding-Ehrenborg K, 2016, Am J Physiol Heart Circ Physiol, V310, pH113, DOI 10.1152/ajpheart.00544.2015; Stephensen S, 2014, AM J PHYSIOL-HEART C, V306, pH895, DOI 10.1152/ajpheart.00483.2013; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Toger J, 2016, J MAGN RESON IMAGING, V43, P1386, DOI 10.1002/jmri.25111; Toger J, 2016, MAGN RESON MED, V75, P1064, DOI 10.1002/mrm.25683; Trudnowski RJ, 1974, CLIN CHEM; Tufvesson J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/970357; Tyszka J M, 2000, J Magn Reson Imaging, V12, P321, DOI 10.1002/1522-2586(200008)12:2<321::AID-JMRI15>3.0.CO;2-2; Yang GZ, 1996, MAGN RESON MED, V36, P520, DOI 10.1002/mrm.1910360404	44	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195597	10.1371/journal.pone.0195597	http://dx.doi.org/10.1371/journal.pone.0195597			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621344	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800105
J	Vavrycuk, V				Vavrycuk, Vaclav			Fair ranking of researchers and research teams	PLOS ONE			English	Article							MULTI-AUTHORED PAPERS; H-INDEX; COUNTING METHODS; CO-AUTHORS; CREDIT; PUBLICATION; ORDER	The main drawback of ranking of researchers by the number of papers, citations or by the Hirsch index is ignoring the problem of distributing authorship among authors in multi-author publications. So far, the single-author or multi-author publications contribute to the publication record of a researcher equally. This full counting scheme is apparently unfair and causes unjust disproportions, in particular, if ranked researchers have distinctly different collaboration profiles. These disproportions are removed by less common fractional or authorship-weighted counting schemes, which can distribute the authorship credit more properly and suppress a tendency to unjustified inflation of co-authors. The urgent need of widely adopting a fair ranking scheme in practise is exemplified by analysing citation profiles of several highly-cited astronomers and astrophysicists. While the full counting scheme often leads to completely incorrect and misleading ranking, the fractional or authorship-weighted schemes are more accurate and applicable to ranking of researchers as well as research teams. In addition, they suppress differences in ranking among scientific disciplines. These more appropriate schemes should urgently be adopted by scientific publication databases as the Web of Science (Thomson Reuters) or the Scopus (Elsevier).	[Vavrycuk, Vaclav] Czech Acad Sci, Inst Geophys, Prague, Czech Republic	Czech Academy of Sciences; Institute of Geophysics of the Czech Academy of Sciences	Vavrycuk, V (corresponding author), Czech Acad Sci, Inst Geophys, Prague, Czech Republic.	vv@ig.cas.cz	Vavrycuk, Vaclav/E-4188-2013; Vavrycuk, Vaclav/ABF-3755-2020	Vavrycuk, Vaclav/0000-0003-3962-2678; Vavrycuk, Vaclav/0000-0003-3962-2678				Aad G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.191803; Abramo G, 2013, J INFORMETR, V7, P198, DOI 10.1016/j.joi.2012.11.003; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 2015, ARXIV150702099; Ausloos M, 2013, SCIENTOMETRICS, V95, P895, DOI 10.1007/s11192-012-0936-x; Aziz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059814; Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4; Du J, 2013, SCIENTOMETRICS, V96, P277, DOI 10.1007/s11192-012-0905-4; Egghe L, 2000, J AM SOC INFORM SCI, V51, P145, DOI 10.1002/(SICI)1097-4571(2000)51:2<145::AID-ASI6>3.0.CO;2-9; Egghe L, 2008, J AM SOC INF SCI TEC, V59, P1608, DOI 10.1002/asi.20845; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Galam S, 2011, SCIENTOMETRICS, V89, P365, DOI 10.1007/s11192-011-0447-1; Hagen NT, 2010, SCIENTOMETRICS, V84, P785, DOI 10.1007/s11192-009-0129-4; Hagen NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004021; Herteliu C, 2017, PUBLICATIONS, V5, DOI 10.3390/publications5020015; Hirsch JE, 2010, SCIENTOMETRICS, V85, P741, DOI 10.1007/s11192-010-0193-9; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HODGE SE, 1981, SCIENCE, V213, P950; Hu XJ, 2010, J INF SCI, V36, P73, DOI 10.1177/0165551509348133; Hu XJ, 2009, J AM SOC INF SCI TEC, V60, P2378, DOI 10.1002/asi.21164; Huang MH, 2011, J AM SOC INF SCI TEC, V62, P2427, DOI 10.1002/asi.21625; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Kennedy D, 2003, SCIENCE, V301, P733, DOI 10.1126/science.301.5634.733; Kosmulski M, 2012, J INFORMETR, V6, P639, DOI 10.1016/j.joi.2012.06.006; Kwok LS, 2005, J MED ETHICS, V31, P554, DOI 10.1136/jme.2004.010553; Lange LL, 2001, SCIENTOMETRICS, V52, P457, DOI 10.1023/A:1014299917063; Lin CS, 2013, J INFORMETR, V7, P611, DOI 10.1016/j.joi.2013.03.007; LINDSEY D, 1980, SOC STUD SCI, V10, P145, DOI 10.1177/030631278001000202; LINDSEY D, 1982, SCIENTOMETRICS, V4, P389, DOI 10.1007/BF02135124; Liu XZ, 2012, J INFORMETR, V6, P557, DOI 10.1016/j.joi.2012.05.002; Liu XZ, 2012, SCIENTOMETRICS, V91, P37, DOI 10.1007/s11192-011-0571-y; Miskiewicz J, 2013, PHYSICA A, V392, P5119, DOI 10.1016/j.physa.2013.06.027; Papatheodorou SI, 2008, J CLIN EPIDEMIOL, V61, P546, DOI 10.1016/j.jclinepi.2007.07.017; Romanovsky AA, 2012, CELL CYCLE, V11, P4118, DOI 10.4161/cc.22179; Rousseau R, 2014, ASLIB J INFORM MANAG, V66, P2, DOI 10.1108/AJIM-01-2013-0001; Schreiber M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/040201; Schreiber M, 2008, J INFORMETR, V2, P211, DOI 10.1016/j.joi.2008.05.001; Schreiber M, 2009, J AM SOC INF SCI TEC, V60, P1274, DOI 10.1002/asi.21057; Sekercioglu CH, 2008, SCIENCE, V322, P371, DOI 10.1126/science.322.5900.371a; Stallings J, 2013, P NATL ACAD SCI USA, V110, P9680, DOI 10.1073/pnas.1220184110; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; van Eck NJ, 2008, J INFORMETR, V2, P263, DOI 10.1016/j.joi.2008.09.004; Waltman L, 2015, J INFORMETR, V9, P872, DOI 10.1016/j.joi.2015.08.001; Waltman L, 2012, J INFORMETR, V6, P700, DOI 10.1016/j.joi.2012.07.008; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yong A., 2014, NOT AM MATH SOC, V61, P1040, DOI DOI 10.1090/N0TI1164; Zhang CT, 2009, EMBO REP, V10, P416, DOI 10.1038/embor.2009.74	47	37	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195509	10.1371/journal.pone.0195509	http://dx.doi.org/10.1371/journal.pone.0195509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621316	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800096
J	Choi, B; Lee, HW; Mo, S; Kim, JY; Kim, HW; Rhyu, IJ; Hong, E; Lee, YK; Choi, JS; Kim, CH; Kim, H				Choi, Byungil; Lee, Hyun Woo; Mo, Seojung; Kim, Jin Yong; Kim, Hyun Wook; Rhyu, Im Joo; Hong, Eunhwa; Lee, Yeon Kyung; Choi, June-Seek; Kim, Chong-Hyun; Kim, Hyun			Inositol 1,4,5-trisphosphate 3-kinase A overexpressed in mouse forebrain modulates synaptic transmission and mGluR-LTD of CA1 pyramidal neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; PROTEIN-KINASE-C; DHPG-INDUCED LTD; GYRUS IN-VITRO; SIGNAL-TRANSDUCTION; RAT HIPPOCAMPUS; BEHAVIORAL FLEXIBILITY; ENDOPLASMIC-RETICULUM; DENDRITIC SPINES	Inositol 1,4,5-trisphosphate 3-kinase A (IP3K-A) regulates the level of the inositol polyphosphates, inositol trisphosphate (IP3) and inositol tetrakisphosphate to modulate cellular signaling and intracellular calcium homeostasis in the central nervous system. IP3K-A binds to F-actin in an activity-dependent manner and accumulates in dendritic spines, where it is involved in the regulation of synaptic plasticity. IP3K-A knockout mice exhibit deficits in some forms of hippocampus-dependent learning and synaptic plasticity, such as long-term potentiation in the dentate gyrus synapses of the hippocampus. In the present study, to further elucidate the role of IP3K-A in the brain, we developed a transgenic (Tg) mouse line in which IP3K-A is conditionally overexpressed approximately 3-fold in the excitatory neurons of forebrain regions, including the hippocampus. The Tg mice showed an increase in both presynaptic release probability of evoked responses, along with bigger synaptic vesicle pools, and miniature excitatory postsynaptic current amplitude, although the spine density or the expression levels of the postsynaptic density-related proteins NR2B, synaptotagmin 1, and PSD-95 were not affected. Hippocampal-dependent learning and memory tasks, including novel object recognition and radial arm maze tasks, were partially impaired in Tg mice. Furthermore, (R,S)-3,5-dihydroxyphenylglycine-induced metabotropic glutamate receptor long-term depression was inhibited in Tg mice and this inhibition was dependent on protein kinase C but not on the IP3 receptor. Long-term potentiation and depression dependent on N-methyl-d-aspartate receptor were marginally affected in Tg mice. In summary, this study shows that overexpressed IP3K-A plays a role in some forms of hippocampus-dependent learning and memory tasks as well as in synaptic transmission and plasticity by regulating both presynaptic and postsynaptic functions.	[Choi, Byungil; Lee, Hyun Woo; Mo, Seojung; Kim, Jin Yong; Kim, Hyun Wook; Rhyu, Im Joo; Kim, Hyun] Korea Univ, Dept Anat, Coll Med, Brain Korea, Seoul, South Korea; [Hong, Eunhwa; Lee, Yeon Kyung; Choi, June-Seek] Korea Univ, Dept Psychol, Seoul, South Korea; [Kim, Chong-Hyun] Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea; [Kim, Chong-Hyun] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST)	Kim, H (corresponding author), Korea Univ, Dept Anat, Coll Med, Brain Korea, Seoul, South Korea.; Kim, CH (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea.; Kim, CH (corresponding author), Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul, South Korea.	ckimya@kist.re.kr; kimhyun@korea.ac.kr		Kim, Hyun/0000-0002-7210-5798; Kim, Jin Yong/0000-0001-8080-3206; Rhyu, Im Joo/0000-0002-5558-6278	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017M3C7A1048566, NRF-2012M3A9B6055378, NRF-2017M3C7A1079692, NRF-2016M3C7A1905119]; KIST Institutional Program [2E28412]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; KIST Institutional Program(Korea Institute of Science & Technology (KIST))	This work was supported by National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3C7A1048566, NRF-2012M3A9B6055378, NRF-2017M3C7A1079692 to H. Kim; NRF-2016M3C7A1905119 to C-H. Kim) and KIST Institutional Program (2E28412 to C-H. Kim).; This work was supported by National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3C7A1048566, NRF-2017M3C7A1079692 to H. Kim; NRF-2016M3C7A1905119 to C-H. Kim) and KIST Institutional Program (2E28412 to C-H. Kim)	ABE T, 1992, J BIOL CHEM, V267, P13361; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Ashour DJ, 2015, CYTOSKELETON, V72, P93, DOI 10.1002/cm.21208; Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhardwaj SK, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00072; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Chen A, 2017, PSYCHOPHARMACOLOGY, V234, P681, DOI 10.1007/s00213-016-4503-7; Chung S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23757; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; ERNEUX C, 1989, EUR J BIOCHEM, V181, P317, DOI 10.1111/j.1432-1033.1989.tb14726.x; ERNEUX C, 1995, EUR J BIOCHEM, V234, P598, DOI 10.1111/j.1432-1033.1995.598_b.x; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heinke B, 2005, PAIN, V118, P145, DOI 10.1016/j.pain.2005.08.004; Jin I, 2012, P NATL ACAD SCI USA, V109, P9137, DOI 10.1073/pnas.1206846109; Jolas T, 2002, NEUROBIOL DIS, V11, P394, DOI 10.1006/nbdi.2002.0557; Jun KS, 1998, LEARN MEMORY, V5, P317; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lee DM, 2012, J BIOL CHEM, V287, P15981, DOI 10.1074/jbc.M112.344101; Lu W, 2014, J BIOL CHEM, V289, P19218, DOI 10.1074/jbc.M113.511246; LUO JH, 1993, J BIOL CHEM, V268, P23580; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mihalas S, 2011, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00158; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicoll RA, 1998, NEUROBIOL LEARN MEM, V70, P62, DOI 10.1006/nlme.1998.3838; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pick JE, 2017, EMBO J, V36, P232, DOI 10.15252/embj.201694526; Rammes G, 2003, J PHYSIOL-LONDON, V546, P455, DOI 10.1113/jphysiol.2002.033514; Rush AM, 2002, J NEUROSCI, V22, P6121; Sanderson TM, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-30; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Schnabel R, 2001, BRIT J PHARMACOL, V132, P1095, DOI 10.1038/sj.bjp.0703905; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Sun W, 2006, NEUROSCI LETT, V392, P181, DOI 10.1016/j.neulet.2005.09.048; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Windhorst S, 2012, CELL SIGNAL, V24, P750, DOI 10.1016/j.cellsig.2011.11.010; YAMADA M, 1992, BRAIN RES, V578, P41, DOI 10.1016/0006-8993(92)90227-Z; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Zheng C, 2015, NEUROPHARMACOLOGY, V93, P80, DOI 10.1016/j.neuropharm.2015.01.016	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193859	10.1371/journal.pone.0193859	http://dx.doi.org/10.1371/journal.pone.0193859			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617377	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800015
J	Cubaka, VK; Schriver, M; Cotton, P; Nyirazinyoye, L; Kallestrup, P				Cubaka, Vincent Kalumire; Schriver, Michael; Cotton, Philip; Nyirazinyoye, Laetitia; Kallestrup, Per			Providers' perceptions of communication with patients in primary healthcare in Rwanda	PLOS ONE			English	Article							OF-THE-LITERATURE; PHYSICIAN COMMUNICATION; DECISION-MAKING; DOCTOR; PARTNERSHIP; OUTCOMES; SKILLS; TIME	Background Delivery of effective healthcare is contingent on the quality of communication between the patient and the healthcare provider. Little is known about primary healthcare providers' perceptions of communication with patients in Rwanda. Aim To explore providers' perceptions of patient-provider communication (PPC) and analyse the ways in which providers present and reflect on communication practice and problems. Methods Qualitative, in-depth, semi structured interviews with nine primary health care providers. An abductive analysis supplemented by the framework method was applied. A narrative approach allowed the emergence of archetypical narratives on PPC. Results Providers shared rich reflections on the importance of proper communication with patients and appeared committed to making their interaction work optimally. Still, providers had difficulty critically analysing limitations of their communication in practice. Reported communication issues included lack of communication training as well as time and workload issues. Two archetypes of narratives on PPC issues and practice emerged and are discussed. Conclusion While providers' narratives put patients at the centre of care, there were indications that patient-provider communication training and practice need further development. In-depth exploration of highlighted issues and adapted strategies to tackle communication drawbacks are prerequisites to improvement. This study contributes to the advancement of knowledge related to communication between the patient and the provider in a resource-limited setting.	[Cubaka, Vincent Kalumire; Cotton, Philip] Univ Rwanda, Sch Med & Pharm, Kigali, Rwanda; [Cubaka, Vincent Kalumire; Schriver, Michael; Kallestrup, Per] Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark; [Nyirazinyoye, Laetitia] Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda	University of Rwanda; Aarhus University; University of Rwanda	Cubaka, VK (corresponding author), Univ Rwanda, Sch Med & Pharm, Kigali, Rwanda.; Cubaka, VK (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Global Hlth, Aarhus, Denmark.	cukalvin@icloud.com	Cubaka, Vincent Kalumire/K-4630-2019; Kallestrup, Per/AAA-8313-2022	Cubaka, Vincent Kalumire/0000-0001-7449-2421; Kallestrup, Per/0000-0001-6041-4510	Karen Elise Jansen foundation, Denmark	Karen Elise Jansen foundation, Denmark	This work was supported by the Karen Elise Jansen foundation, Denmark (http://www.kejfond.dk) to PK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; BUCHANAN A, 1978, PHILOS PUBLIC AFF, V7, P370; Bylund CL, 2012, PATIENT EDUC COUNS, V87, P261, DOI 10.1016/j.pec.2011.10.006; Carcone AI, 2013, J DEV BEHAV PEDIATR, V34, P599, DOI 10.1097/DBP.0b013e3182a67daf; Cheng Brenda S S, 2015, Dent Update, V42, P185; Courtney R, 1997, Nurse Pract, V22, P46; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Dutta MJ, 2011, ROUTL COMMUN SER, P320; FLINDERS DJ, 1986, CURRICULUM INQ, V16, P33, DOI 10.2307/1179551; Franzosi R, 1998, ANNU REV SOCIOL, V24, P517, DOI 10.1146/annurev.soc.24.1.517; Ha JF, 2010, OCHSNER J, V10, P38; Hain D, 2011, J AM ACAD NURSE PRAC, V23, P351, DOI 10.1111/j.1745-7599.2011.00619.x; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Kapiriri L, 2006, INT J MED INFORM, V75, P714, DOI 10.1016/j.ijmedinf.2005.10.003; King Ann, 2013, J Grad Med Educ, V5, P385, DOI 10.4300/JGME-D-13-00072.1; Kitson A, 2013, J ADV NURS, V69, P4, DOI 10.1111/j.1365-2648.2012.06064.x; Lewis J, 2003, QUALITATIVE RES PRAC; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Manojlovich M, 2007, AM J CRIT CARE, V16, P536; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Matusitz J, 2014, SOC WORK PUBLIC HLTH, V29, P252, DOI 10.1080/19371918.2013.776416; McWhinney I R, 1993, Scand J Prim Health Care, V11, P3, DOI 10.3109/02813439308994894; Ogden J, 2004, FAM PRACT, V21, P479, DOI 10.1093/fampra/cmh502; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Rodin G, 2009, SUPPORT CARE CANCER, V17, P627, DOI 10.1007/s00520-009-0601-y; Sandman L, 2010, HEALTH CARE ANAL, V18, P60, DOI 10.1007/s10728-008-0108-6; Schiavo R., 2007, HLTH COMMUNICATION T, P436; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Scott J, 2016, MED EDUC, V50, P441, DOI 10.1111/medu.12939; Snowden A, 2013, J CLIN NURS, V22, P1353, DOI 10.1111/j.1365-2702.2012.04337.x; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stott N C, 1979, J R Coll Gen Pract, V29, P201; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Timmermans S, 2012, SOCIOL THEOR, V30, P167, DOI 10.1177/0735275112457914; van Dalen J, 2013, PATIENT EDUC COUNS, V92, P292, DOI 10.1016/j.pec.2013.05.020; Williams MV, 2002, FAM MED, V34, P383; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	40	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195269	10.1371/journal.pone.0195269	http://dx.doi.org/10.1371/journal.pone.0195269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617429	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800072
J	Innes, S; Harvey, J; Collins, IJ; Cotton, MF; Judd, A				Innes, Steve; Harvey, Justin; Collins, Intira Jeannie; Cotton, Mark Fredric; Judd, Ali			Lipoatrophy/Iipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; BODY-FAT CHANGES; LIPODYSTROPHY; INHIBITOR; LIPOATROPHY; PREVALENCE; STAVUDINE; SUBSTITUTION; ADOLESCENTS; DEFINITION	Background Following widespread use of stavudine, a thymidine analogue, in antiretroviral therapy (ART) over the past three decades, up to a third of children developed lipoatrophy (LA) and/or lipohypertrophy (LH). Following phasing-out of stavudine, incidence of newly-diagnosed LA and LH declined dramatically. However, the natural history of existing cases should be explored, particularly with prolonged protease inhibitor exposure. Methods The Collaborative HIV Paediatric Study (CHIPS) is a multicentre cohort study of most HIV-infected children in the United Kingdom and Ireland. Those on ART with a LA/LH assessment recorded in 2003-2011 were included. Assessments were completed annually by consultant physicians. Using the 0-3 grading system, LA or LH was defined as grade 2 or 3. Resolution was defined as return to grade 1 or 0 in all body regions. Results Of 1345 children followed for median (IQR) 5.5 (2.9, 8.2) years after ART initiation, 30 developed LA and 27 developed LH, all at least 2 years after ART initiation. Median age at LA diagnosis was 11 (10, 13) years and at LH diagnosis was 13 (11, 15) years. Children with LA were more likely white (p<0.0001); lower height-for-age z-score at ART initiation (p = 0.02); initiated ART earlier (p = 0.04), with longer ART exposure (p = 0.04). Children with LH were similar to those without. Analysis of individual drugs revealed that LA was associated with greater duration of exposure to stavudine and didanosine; while LH was associated with greater duration of exposure to stavudine and ritonavir (given alone or in combination with another protease inhibitor). Median time in follow-up following ART switch was 2.8 (1.9, 4.9) and 2.5 (1.6, 4.7) years respectively. Resolution occurred in 10 (30%) of LA cases (median time to resolution 2.3 [1.8, 3.6] years) and 3 (11%) of LH cases (median time to resolution 2.0 [1.7, 2.1] years). Conclusions Prevalence of LA and LH were low, with some resolution noted, especially for LA. More long-term data are needed.	[Innes, Steve; Cotton, Mark Fredric] Stellenbosch Univ, Family Infect Dis Clin Res Unit FAMCRU, Cape Town, South Africa; [Innes, Steve; Cotton, Mark Fredric] Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Innes, Steve; Cotton, Mark Fredric] Stellenbosch Univ, Cape Town, South Africa; [Harvey, Justin] Stellenbosch Univ, Ctr Stat Consultat, Cape Town, South Africa; [Collins, Intira Jeannie; Judd, Ali] UCL, Med Res Council Clin Trials Unit, London, England	Stellenbosch University; Stellenbosch University; Stellenbosch University; Medical Research Council Clinical Trials Unit; University of London; University College London	Innes, S (corresponding author), Stellenbosch Univ, Family Infect Dis Clin Res Unit FAMCRU, Cape Town, South Africa.; Innes, S (corresponding author), Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa.; Innes, S (corresponding author), Stellenbosch Univ, Cape Town, South Africa.	innes@sun.ac.za	Cotton, Mark/AAQ-9936-2020; Collins, Intira Jeannie/I-5048-2019	Cotton, Mark/0000-0003-2559-6034; Collins, Intira Jeannie/0000-0003-2132-6037; Harvey, Justin/0000-0002-8101-373X; Innes, Steve/0000-0003-3969-8680	NHS (London Specialised Commissioning Group); Bristol-Myers Squibb; Boehringer Ingelheim; GlaxoSmithKline; Roche; Abbott; Gilead Sciences; Medical Research Council programme [MC_UU_12023/26]; GSK Foundation [COL116446]; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) [158-INN]; Bill & Melinda Gates Foundation [OPP1065257]; South African Medical Research Council; Eunice Kennedy Shriver National Institute Of Child Health & Human Development [1R01HD083042]; MRC [MC_UU_12023/26, MC_UU_12023/17] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	NHS (London Specialised Commissioning Group); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Abbott(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Medical Research Council programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GSK Foundation; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CHIPS is funded by the NHS (London Specialised Commissioning Group) and has received additional support from Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Roche, Abbott, and Gilead Sciences. This work was supported by the Medical Research Council programme (MC_UU_12023/26). SI received support from the GSK Foundation (grant # COL116446); a research grant from Collaborative Initiative for Paediatric HIV Education and Research (CIPHER; 158-INN); a research grant from Bill & Melinda Gates Foundation (grant # OPP1065257); a self-initiated research grant from the South African Medical Research Council; and a research grant from Eunice Kennedy Shriver National Institute Of Child Health & Human Development (1R01HD083042). The views expressed in this publication do not necessarily reflect the official policies of the South African Medical Research Council or the US Department of Health and Human Services; nor does mention of trade names, commercial practices, or organisations imply endorsement by the South African or US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2012, JAIDS-J ACQ IMM DEF, V59, P314, DOI 10.1097/QAI.0b013e31824330cb; Aurpibul L, 2007, ANTIVIR THER, V12, P1247; Aurpibul L, 2012, PEDIATR INFECT DIS J, V31, P384, DOI 10.1097/INF.0b013e31823f0e11; Belloso WH, 2003, JAIDS-J ACQ IMM DEF, V32, P104, DOI 10.1097/00126334-200301010-00015; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Childs T, 2015, LANCET HIV, V2, pE151, DOI 10.1016/S2352-3018(15)00021-1; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; DeLaMora Patricia, 2006, Curr HIV/AIDS Rep, V3, P74, DOI 10.1007/s11904-006-0021-2; Dzwonek AB, 2006, JAIDS-J ACQ IMM DEF, V43, P121, DOI 10.1097/01.qai.0000230523.94588.85; Greeff M, 2008, QUAL HEALTH RES, V18, P311, DOI 10.1177/1049732307311118; Grunfeld C., 2002, 14 INT AIDS C BARC S; Hartman K, 2006, PEDIATR INFECT DIS J, V25, P427, DOI 10.1097/01.inf.0000215003.32256.aa; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Innes S, 2013, PEDIAT INFECT DIS J; Innes S, 2009, S AFR J HIV MED; Innes S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-183; Jacobson DL, 2005, CLIN INFECT DIS, V40, P1837, DOI 10.1086/430379; Kinabo GD, 2013, PEDIATR INFECT DIS J, V32, P39, DOI 10.1097/INF.0b013e3182755a34; La Rovere, 2004, AIDS, V18, P1443, DOI 10.1097/01.aids.0000131334.38172.01; Nyblade L, 2003, DISENTANGLING HIV AI; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; Plankey M, 2009, AIDS BEHAV, V13, P53, DOI 10.1007/s10461-008-9444-7; Sawawiboon N, 2012, INT J STD AIDS, V23, P497, DOI 10.1258/ijsa.2011.011348; South African National Department of Health, 2010, GUID MAN HIV CHILDR; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Vigano A, 2007, ANTIVIR THER, V12, P297; Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2010, ANT THER HIV INF INF	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194132	10.1371/journal.pone.0194132	http://dx.doi.org/10.1371/journal.pone.0194132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617438	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800020
J	Kath, C; Goni-Oliver, P; Muller, R; Schultz, C; Haucke, V; Eickholt, B; Schmoranzer, J				Kath, Christina; Goni-Oliver, Paloma; Mueller, Rainer; Schultz, Carsten; Haucke, Volker; Eickholt, Britta; Schmoranzer, Jan			PTEN suppresses axon outgrowth by down-regulating the level of detyrosinated microtubules	PLOS ONE			English	Article							LHERMITTE-DUCLOS-DISEASE; TUMOR-SUPPRESSOR; CELL MOTILITY; POSTTRANSLATIONAL MODIFICATIONS; SELECTIVE STABILIZATION; DYNAMIC INSTABILITY; NEGATIVE REGULATION; SOMA SIZE; TUBULIN; MECHANISMS	Inhibition of the phospholipid phosphatase and tumor suppressor PTEN leads to excessive polarized cell growth during directed cell migration and neurite outgrowth. These processes require the precise regulation of both the actin and microtubule cytoskeleton. While PTEN is known to regulate actin dynamics through phospholipid modulation, whether and how PTEN regulates microtubule dynamics is unknown. Here, we show that depletion of PTEN leads to elevated levels of stable and post-translationally modified (detyrosinated) microtubules in fibroblasts and developing neurons. Further, PTEN depletion enhanced axon outgrowth, which was rescued by reducing the level of detyrosinated microtubules. These data demonstrate a novel role of PTEN in regulating the microtubule cytoskeleton. They further show a novel function of detyrosinated microtubules in axon outgrowth. Specifically, PTEN suppresses axon outgrowth by down-regulating the level of detyrosinated microtubules. Our results suggest that PTEN's role in preventing excessive cell growth in cancerous and neuro-developmental phenotypes is partially exerted by stabilization and detyrosination of the microtubule cytoskeleton.	[Kath, Christina; Goni-Oliver, Paloma; Eickholt, Britta; Schmoranzer, Jan] Charite, Virchowweg 6, Berlin, Germany; [Kath, Christina; Haucke, Volker; Schmoranzer, Jan] Leibniz Inst Mol Pharmacol, Robert Roessle Str 10, Berlin, Germany; [Mueller, Rainer; Schultz, Carsten] European Mol Biol Lab, Meyerhofstr 1, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); European Molecular Biology Laboratory (EMBL)	Schmoranzer, J (corresponding author), Charite, Virchowweg 6, Berlin, Germany.; Schmoranzer, J (corresponding author), Leibniz Inst Mol Pharmacol, Robert Roessle Str 10, Berlin, Germany.	jan.schmoranzer@charite.de		Eickholt, Britta/0000-0001-7873-8687; Mueller, Rainer/0000-0003-3464-494X; Schmoranzer, Jan/0000-0002-4482-7080	Deutsche Forschungsgemeinschaft (DFG) [SFB958/Z02, SFB958/A16, TRR186/A08]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG) to J.S. (SFB958/Z02), to B.E. (SFB958/A16), to V.H. and C.S. (TRR186/A08).; This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG) to J.S. (SFB958/Z02), to B.E. (SFB958/A16), to V.H. and C.S. (TRR186/A08). We like to thank the Advanced Medical Bioimaging Core Facility (AMBIO) of the Charite-Universitatsmedizin for support in acquisition and analysis of imaging data.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Aillaud C, 2017, SCIENCE, V358, P1448, DOI 10.1126/science.aao4165; ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; Baas PW, 2016, CYTOSKELETON, V73, P442, DOI 10.1002/cm.21286; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gordon-Weeks PR, 2016, BRAIN RES BULL, V126, P293, DOI 10.1016/j.brainresbull.2016.06.015; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kaul N, 2014, BIOPHYS J, V106, P2636, DOI 10.1016/j.bpj.2014.05.008; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Knafo S, 2017, TRENDS NEUROSCI, V40, P83, DOI 10.1016/j.tins.2016.11.008; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Kreis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071957; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Leibinger M, 2017, P NATL ACAD SCI USA, V114, pE5454, DOI 10.1073/pnas.1621225114; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marcos S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005405; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mester J, 2013, AM J MED GENET C, V163C, P114, DOI 10.1002/ajmg.c.31364; Mester JL, 2011, EUR J HUM GENET, V19, P763, DOI 10.1038/ejhg.2011.20; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; Pacheco A, 2016, BRAIN RES BULL, V126, P300, DOI 10.1016/j.brainresbull.2016.07.013; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tsujita K, 2015, BBA-MOL CELL BIOL L, V1851, P824, DOI 10.1016/j.bbalip.2014.10.011; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zink S, 2012, J CELL SCI, V125, P5998, DOI 10.1242/jcs.109470	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193257	10.1371/journal.pone.0193257	http://dx.doi.org/10.1371/journal.pone.0193257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617365	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800006
J	Lutter, SH; Dayer, AA; Heggenstaller, E; Larkin, JL				Lutter, Seth H.; Dayer, Ashley A.; Heggenstaller, Emily; Larkin, Jeffery L.			Effects of biological monitoring and results outreach on private landowner conservation management	PLOS ONE			English	Article							SUCCESSIONAL FOREST HABITAT; UNITED-STATES; PROGRAMS; LANDS; EXPERIENCES; EDUCATION; IMPROVE	Sustained management efforts by private landowners are crucial for the long-term success of private land natural resource conservation and related environmental benefits. Landowner outreach is a primary means of recruiting private landowners into voluntary conservation incentive programs, and could also help sustain conservation behaviors through time. However, evaluation of outreach targeting landowners during or after participation in natural resource conservation incentive programs is lacking. We assessed two methods of landowner outreach associated with a Natural Resources Conservation Service incentive program targeting effective management of early successional forest habitat on private land in the Appalachians and Upper Great Lakes regions of the United States. While early successional forest habitat benefits many wildlife species, the program target species were the Golden-winged Warbler (Vermivora chrysoptera) and American Woodcock (Scolopax minor). After habitat management through the program occurred, biological technicians monitored wildlife and vegetation on enrolled properties and results were communicated to landowners in mailed packets. Our research focused on whether landowner interactions with technicians or receipt of result mailings could influence landowner post-program management intentions and management-related cognitions (e.g., agency trust, perceptions of outcomes). We conducted a telephone survey with landowners from January to May 2017, and analyzed survey data using quantitative group comparisons and qualitative coding methods. Landowners that accompanied biological technicians on monitoring site visits had higher agency trust and more positive perceptions of program outcomes. Result mailings did not improve landowner perceptions of program outcomes or agency trust, but did provide benefits such as increased landowner knowledge about birds. Neither outreach method was associated with more positive landowner post-program management intentions. Our findings underline the importance and potential of direct interactions between conservation biologists and landowners. These two forms of non-traditional outreach administered by biologists could be a worthwhile component of future conservation program evaluations on private lands.	[Lutter, Seth H.; Dayer, Ashley A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Heggenstaller, Emily] Indiana Univ Penn, Res Inst, Indiana, PA USA; [Larkin, Jeffery L.] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Larkin, Jeffery L.] Amer Bird Conservancy, The Plains, VA USA	Virginia Polytechnic Institute & State University; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Lutter, SH (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	lutter@vt.edu		Dayer, Ashley/0000-0002-8105-0776	United States Department of Agriculture's Natural Resources Conservation Service Conservation Effects Assessment Project [68-7482-15-501]; Virginia Tech Open Access Subvention Fund	United States Department of Agriculture's Natural Resources Conservation Service Conservation Effects Assessment Project; Virginia Tech Open Access Subvention Fund	This project was funded by the United States Department of Agriculture's Natural Resources Conservation Service Conservation Effects Assessment Project [https://www.nrcs.usda.gov/wps/portal/nrcs/main/national/technical/nra/ceap/] (Award #68-7482-15-501 awarded to JL and AD). Publishing costs were provided by the Virginia Tech Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EVID BASE, DOI DOI 10.21307/eb-2016-003; Ardoin N., 2013, INFLUENCING CONSERVA; Bakermans MH, 2015, NORTHEAST NAT, V22, P690, DOI 10.1656/045.022.0405; Bakermans MH, 2011, GOLDEN WINGED WARBLE, P68; Baumgart-Getz A, 2012, J ENVIRON MANAGE, V96, P17, DOI 10.1016/j.jenvman.2011.10.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Bogart RE, 2008, P 4 INT PARTN FLIGHT, P441; Butler B.J., 2016, NRS157 USDA FOR SERV; Case DJ, 2009, INVESTIGATING COMMUN; Ciuzio E, 2013, WILDLIFE SOC B, V37, P267, DOI 10.1002/wsb.266; Dayer A. A., 2014, Human Dimensions of Wildlife, V19, P355, DOI 10.1080/10871209.2014.918678; Dayer A. A., 2017, CONSERV LETT; Dayer AA, 2016, WILDLIFE SOC B, V40, P59, DOI 10.1002/wsb.613; Farmer JR, 2017, CONSERV LETT, V10, P58, DOI 10.1111/conl.12241; Ferranto S, 2012, J ENVIRON MANAGE, V97, P131, DOI 10.1016/j.jenvman.2011.10.017; Fishbein M, 2000, PREDICTING CHANGING; Frey Erin, 2014, BRAIN SCI, V1, P172, DOI DOI 10.1177/2372732214550405; Hansson A, 2012, J ENVIRON MANAGE, V113, P271, DOI 10.1016/j.jenvman.2012.09.008; Hilty J, 2003, CONSERV BIOL, V17, P132, DOI 10.1046/j.1523-1739.2003.01361.x; Jackson-Smith DB, 2011, J AGRIC EDUC EXT, V17, P341, DOI 10.1080/1389224X.2011.576823; Jacobson S.K., 2006, CONSERVATION ED OUTR; Kamal S, 2015, J ENVIRON PLANN MAN, V58, P576, DOI 10.1080/09640568.2013.875463; Kammin LA, 2009, J WILDLIFE MANAGE, V73, P973, DOI 10.2193/2007-074; King DI, 2014, FOREST ECOL MANAG, V324, P186, DOI 10.1016/j.foreco.2013.12.001; Kuhfuss L, 2015, DISCUSSION PAPERS EN, V2015; McKenzie-Mohr D, 2000, J SOC ISSUES, V56, P543, DOI 10.1111/0022-4537.00183; McNeil DJ, 2017, GLOB ECOL CONSERV, V9, P90, DOI 10.1016/j.gecco.2016.12.006; Newton B, 2001, BIOSCIENCE, V51, P297, DOI 10.1641/0006-3568(2001)051[0297:EEAOEO]2.0.CO;2; North American Bird Conservation Initiative, 2016, STAT N AM BIRDS 2016; North American Bird Conservation Initiative, 2017, STAT BIRDS 2017 BEN; Pennsylvania Game Commission, 2015, 2015 2025 STAT WILDL; Race D, 2013, SOC NATUR RESOUR, V26, P1050, DOI 10.1080/08941920.2013.779338; Reimer AP, 2014, ENVIRON MANAGE, V53, P318, DOI 10.1007/s00267-013-0184-8; Selinske MJ, 2015, CONSERV LETT, V8, P282, DOI 10.1111/conl.12154; Sharp RL, 2013, J INTERPRETATION RES, V17, P23; Shrublands Litvaitis J., 2003, FOREST ECOL MANAG, V185, P1; Stern MJ, 2008, SOC NATUR RESOUR, V21, P859, DOI 10.1080/08941920801973763; Stern MJ, 2014, SOC NATUR RESOUR, P117; Wright DR, 2015, SOC NATUR RESOUR, V28, P1013, DOI 10.1080/08941920.2015.1054976	40	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194740	10.1371/journal.pone.0194740	http://dx.doi.org/10.1371/journal.pone.0194740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617388	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800046
J	Ramongolalaina, C; Teraishi, M; Okumoto, Y				Ramongolalaina, Clarissien; Teraishi, Masayoshi; Okumoto, Yutaka			QTLs underlying the genetic interrelationship between efficient compatibility of Bradyrhizobium strains with soybean and genistein secretion by soybean roots	PLOS ONE			English	Article							FROGEYE LEAF-SPOT; GEOGRAPHICAL-DISTRIBUTION; NODULATING BRADYRHIZOBIA; ANTIBACTERIAL ACTIVITY; ISOFLAVONE CONTENTS; GLYCINE-MAX; JAPONICUM; RESISTANCE; SEED; RHIZOBIUM	Soybean plants establish symbiotic relationships with soil rhizobia which form nodules on the plant roots. Nodule formation starts when the plant roots exudate isoflavonoids that induce nod gene expression of a specific Bradyrhizobium. We examined the specific indigenous rhizobia that form nodules with the soybean cultivars Peking and Tamahomare in different soils. PCR-RFLP analysis targeted to the 16S-23S rRNA gene internal transcribed spacer (ITS) region of the bacterial type of each root nodule showed that Bradyrhizobium japonicum (USDA110-type) and Bradyrhizobium elkanii (USDA94-type) had high compatibility with the Tamahomare and Peking cultivars, respectively. We grew 93 recombinant inbred lines (RIL) of soybean seeds derived from the cross between Peking and Tamahomare in three different field soils and identified the indigenous rhizobia nodulating each line using the same PCR-RFLP analysis. QTL analysis identified one QTL region in chromosome-18 with a highly significant additive effect that controls compatibility with both B. japonicum USDA110 and B. elkanii USDA94. We also measured the amount of daidzein and genistein secretion from roots of the 93 RILs by HPLC analysis. QTL analysis showed one QTL region in chromosome-18 controlling genistein secretion from roots and coinciding with that regulating compatibility of specific indigenous rhizobia with soybean. The amount of genistein may be a major regulatory factor in soybean-rhizobium compatibility.	[Ramongolalaina, Clarissien; Teraishi, Masayoshi; Okumoto, Yutaka] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan	Kyoto University	Teraishi, M (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	temple@kais.kyoto-u.ac.jp	Teraishi, Masayoshi/AAC-1055-2021; Teraishi, Masayoshi/D-8602-2018	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052				Akao S., 2004, SOIL SCI PLANT NUTR, V50, P517; Baker WA, 1999, CROP SCI, V39, P1021, DOI 10.2135/cropsci1999.0011183X003900040010x; BANFALVI Z, 1988, MOL GEN GENET, V214, P420, DOI 10.1007/BF00330475; Chianu JN, 2011, SUSTAINABLE AGR, V2; Chueire LMD, 1997, PLANT SOIL, V196, P1, DOI 10.1023/A:1004222218007; CHURCHILL GA, 1994, GENETICS, V138, P963; Concibido VC, 1997, CROP SCI, V37, P258, DOI 10.2135/cropsci1997.0011183X003700010046x; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; DEMSKI JW, 1975, PHYTOPATHOLOGY, V65, P95, DOI 10.1094/Phyto-65-95; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; Dolatabadian A, 2012, S AFR J BOT, V79, P9, DOI 10.1016/j.sajb.2011.11.001; DUNN MF, 1992, FEMS MICROBIOL LETT, V97, P107; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GRAHAM TL, 1991, PLANT PHYSIOL, V95, P594, DOI 10.1104/pp.95.2.594; Guo B, 2005, THEOR APPL GENET, V111, P965, DOI 10.1007/s00122-005-0031-2; Hayashi M, 2011, BREEDING SCI, V61, P544, DOI 10.1270/jsbbs.61.544; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; KEELING BL, 1982, PHYTOPATHOLOGY, V72, P807, DOI 10.1094/Phyto-72-807; KOSSLAK RM, 1990, APPL ENVIRON MICROB, V56, P1333, DOI 10.1128/AEM.56.5.1333-1341.1990; KOSSLAK RM, 1987, P NATL ACAD SCI USA, V84, P7428, DOI 10.1073/pnas.84.21.7428; Kouchi H, 2010, PLANT CELL PHYSIOL, V51, P1381, DOI 10.1093/pcp/pcq107; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lozovaya VV, 2005, CROP SCI, V45, P1934, DOI 10.2135/cropsci2004.0567; Miransari M, 2009, EUR J SOIL BIOL, V45, P146, DOI 10.1016/j.ejsobi.2008.11.002; Munoz N, 2014, BIOL FERT SOILS, V50, P207, DOI 10.1007/s00374-013-0843-1; Murphy SE, 2009, CROP SCI, V49, P1313, DOI 10.2135/cropsci2008.09.0533; Napoles MC, 2009, SPAN J AGRIC RES, V7, P665; Pradhan A, 2011, T ASABE, V54, P1031, DOI 10.13031/2013.37088; Pradhan A, 2009, AGR EC REP; Sadowsky MJ, 1991, RHIZOSPHERE PLANT GR, P173; Saeki Y, 2004, SOIL SCI PLANT NUTR, V50, P517, DOI 10.1080/00380768.2004.10408508; Saeki Y, 2006, SOIL SCI PLANT NUTR, V52, P418, DOI 10.1111/j.1747-0765.2006.00050.x; Saeki Y, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P163; Sayama T, 2009, PLANT SCI, V176, P514, DOI 10.1016/j.plantsci.2009.01.007; Shiro S, 2013, APPL ENVIRON MICROB, V79, P3610, DOI 10.1128/AEM.00236-13; Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x; Suss C, 2006, J BIOTECHNOL, V126, P69, DOI [10.1016/j.jbiotec.20063.03.037, 10.1016/j.jbiotec.2006.03.037]; Sugiyama A, 2016, BIOSCI BIOTECH BIOCH, V80, P89, DOI 10.1080/09168451.2015.1062714; Sugiyama A, 2008, PLANT SIGNAL BEHAV, V3, P38, DOI 10.4161/psb.3.1.4819; Tang F, 2016, PLANT PHYSIOL, V170, P26, DOI 10.1104/pp.15.01661; TJEPKEMA JD, 1980, SCIENCE, V209, P279, DOI 10.1126/science.7384801; Ulanowska K, 2006, ARCH MICROBIOL, V184, P271, DOI 10.1007/s00203-005-0063-7; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118447; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yang W, 2001, PLANT BREEDING, V120, P73, DOI 10.1046/j.1439-0523.2001.00563.x; Yoshikawa T, 2010, BREEDING SCI, V60, P243, DOI 10.1270/jsbbs.60.243; Zhang S, 2004, PLANT SOIL, V262, P277, DOI 10.1023/B:PLSO.0000037048.26437.fa; Zhao X, 2014, PLANT PROD SCI, V17, P103, DOI 10.1626/pps.17.103	51	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194671	10.1371/journal.pone.0194671	http://dx.doi.org/10.1371/journal.pone.0194671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617389	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800044
J	Swe, KT; Rahman, MM; Rahman, MS; Saito, E; Abe, SK; Gilmour, S; Shibuya, K				Swe, Khin Thet; Rahman, Md. Mizanur; Rahman, Md. Shafiur; Saito, Eiko; Abe, Sarah K.; Gilmour, Stuart; Shibuya, Kenji			Cost and economic burden of illness over 15 years in Nepal: A comparative analysis	PLOS ONE			English	Article							HEALTH	Background With an increasing burden of non-communicable disease in Nepal and limited progress towards universal health coverage, country- and disease-specific estimates of financial hardship related to healthcare costs need to be evaluated to protect the population effectively from healthcare-related financial burden. Objectives To estimate the cost and economic burden of illness and to assess the inequality in the financial burden due to catastrophic health expenditure from 1995 to 2010 in Nepal. Methods This study used nationally representative Nepal Living Standards Surveys conducted in 1995 and 2010. A Bayesian two-stage hurdle model was used to estimate average cost of illness and Bayesian logistic regression models were used to estimate the disease-specific incidence of catastrophic health payment and impoverishment. The concentration curve and index were estimated by disease category to examine inequality in healthcare-related financial hardship. Findings Inflation-adjusted mean out-of-pocket (OOP) payments for chronic illness and injury increased by 4.6% and 7.3%, respectively, while the cost of recent acute illness declined by 1.5% between 1995 and 2010. Injury showed the highest incidence of catastrophic expenditure (30.7% in 1995 and 22.4% in 2010) followed by chronic illness (12.0% in 1995 and 9.6% in 2010) and recent acute illness (21.1% in 1995 and 7.8% in 2010). Asthma, diabetes, heart conditions, malaria, jaundice and parasitic illnesses showed increased catastrophic health expenditure over time. Impoverishment due to injury declined most (by 12% change in average annual rate) followed by recent acute illness (9.7%) and chronic illness (9.6%) in 15 years. Inequality analysis indicated that poorer populations with recent acute illness suffered more catastrophic health expenditure in both sample years, while wealthier households with injury and chronic illnesses suffered more catastrophic health expenditure in 2010. Conclusion To minimize the economic burden of illness, several approaches need to be adopted, including social health insurance complemented with an upgraded community-based health insurance system, subsidy program expansion for diseases with high economic burden and third party liability motor insurance to reduce the economic burden of injury.	[Swe, Khin Thet; Rahman, Md. Mizanur; Rahman, Md. Shafiur; Abe, Sarah K.; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Sch Int Hlth, Grad Sch Med, Tokyo, Japan; [Saito, Eiko] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan	University of Tokyo; University of Tokyo	Swe, KT (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Sch Int Hlth, Grad Sch Med, Tokyo, Japan.	kinthetswe1989@gmail.com	Abe, Sarah/ABF-2941-2020; Rahman, Shafiur/R-2964-2019	Abe, Sarah/0000-0003-3991-2739; Rahman, Shafiur/0000-0003-1911-6807; Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour, and Welfare Health and Labour Science Research Grants [H26-Chikyukibo-Ippan-001, H28-Chikyukibo-Shitei-002]	Ministry of Health, Labour, and Welfare Health and Labour Science Research Grants	This work was supported by Ministry of Health, Labour, and Welfare Health and Labour Science Research Grants (grant no: H26-Chikyukibo-Ippan-001, and H28-Chikyukibo-Shitei-002).	[Anonymous], 2010, NEP CROSS SETT STAG; Asante A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152866; Belay T, 2011, ASSESSING FISCAL SPA; Cooper NJ, 2007, HEALTH ECON, V16, P37, DOI 10.1002/hec.1141; Dieleman JL, 2016, LANCET, V387, P2521, DOI 10.1016/S0140-6736(16)30167-2; Engelgau MM, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8724-5; Gelman A., 2021, BAYESIAN DATA ANAL; Gonulal S. O., 2009, MOTOR 3 PARTY LIABIL; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Mishra SR, 2015, GLOB HLTH ACTION, P8; O'Donnell O, 2008, ANALYZING HLTH EQUIT; Prakongsai P, 2008, B WORLD HEALTH ORGAN, V86, P898, DOI 10.2471/BLT.07.049593; Prasai DP, 2013, REV STUDIES NEPALS N; Saito E, 2014, B WORLD HEALTH ORGAN, V92, P760, DOI 10.2471/BLT.13.126615; Stoermer M, 2012, REV COMMUNITY BASED; The World Bank, GDP DEFL NEP; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wang H, 2012, LIFE SCI, V6; WHO, GLOB HLTH EXP DAT; World Health Organization, 2015, TRACK UN HLTH COV 1; Xu K., 2005, DISTRIBUTION HLTH PA; Zaidi S., 2002, GUIDELINES CONSTRUCT; 2010, WORLD HLTH REP HLTH, P1	24	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194564	10.1371/journal.pone.0194564	http://dx.doi.org/10.1371/journal.pone.0194564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617393	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800037
J	Walles, JK; Tesfaye, F; Jansson, M; Balcha, TT; Winqvist, N; Kefeni, M; Abeya, SG; Belachew, F; Sturegard, E; Bjorkman, P				Walles, John Konig; Tesfaye, Fregenet; Jansson, Marianne; Balcha, Taye Tolera; Winqvist, Niclas; Kefeni, Mestawet; Abeya, Sileshi Garoma; Belachew, Feleke; Sturegard, Erik; Bjorkman, Per			Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting	PLOS ONE			English	Article							HEALTH-CARE WORKERS; ANTIGEN-SPECIFIC CD4; INTERFERON-GAMMA; IFN-GAMMA; ASSAYS; RISK; SENSITIVITY; DIAGNOSIS	We evaluated the performance of QuantiFERON-TB Gold Plus (OFT-Plus), which includes two Mycobacterium tuberculosis antigen formulations (TB1 and TB2), for detection of latent tuberculosis infection during pregnancy. Eight-hundred-twenty-nine Ethiopian pregnant women (5.9% HIV-positive) were tested with QFT-Plus, with bacteriological sputum analysis performed for women with clinically suspected tuberculosis and HIV-positive women irrespective of clinical presentation. QFT-Plus read-out was categorized according to the conventional cut-off (0.35 IU/ml) for both antigen formulations. In addition, we analysed the distribution of QFT-Plus results within a borderline zone (0.20-0.70 IU/ml), and interferon-gamma response in relation to HIV infection and gestational age. Two-hundred-seventy-seven women (33%) were QFT-Plus-positive (HIV-positive 16/49 [33%]; HIV-negative 261/780 [33%]). There was a strong agreement between the two antigen formulations (kappa = 0.92), with discordant results in 29 cases (3.5%). Whereas discordant QFT-Plus results were rare in pregnancy, several results with both TB1 and TB2 within the borderline range were observed (11/49 [22%] vs. 43/780 [5.5%] in HIV-positive and HIV-negative women, respectively; p<0.0001). HIV-positive women had lower absolute interferon-gamma levels (TB1: 0.47 vs. 2.16 IU/ml; p<0.001, TB2: 0.49 vs. 2.24 IU/ml, p<0.001, considering results >= 0.20 IU/ml) compared to HIV-negative women. QFT-Plus-positive women who submitted samples at later stages of pregnancy had lower mitogen- (p<0.001) but higher TB-antigen-specific (p = 0.031 for TB1, p = 0.061 for TB2) interferon-gamma response. Considering their lower capacity to produce TB-specific interferon-y, a lower cut-off level for defining QFT-Plus-positivity may be considered in HIV-positive pregnant women.	[Walles, John Konig; Tesfaye, Fregenet; Balcha, Taye Tolera; Winqvist, Niclas; Sturegard, Erik; Bjorkman, Per] Lund Univ, Dept Translat Med, Clin Infect Med, Malmo, Sweden; [Walles, John Konig] Cent Hosp Kristianstad, Dept Infect Dis, Kristianstad, Sweden; [Jansson, Marianne] Lund Univ, Dept Lab Med, Med Microbiol, Lund, Sweden; [Balcha, Taye Tolera] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Winqvist, Niclas; Sturegard, Erik] Skane Reg Off Infect Dis Control & Prevent, Malmo, Sweden; [Kefeni, Mestawet; Belachew, Feleke] Adama Reg Lab, Adama, Ethiopia; [Abeya, Sileshi Garoma] Adama Hosp Med Coll, Adama, Ethiopia	Lund University; Lund University	Walles, JK (corresponding author), Lund Univ, Dept Translat Med, Clin Infect Med, Malmo, Sweden.; Walles, JK (corresponding author), Cent Hosp Kristianstad, Dept Infect Dis, Kristianstad, Sweden.	John.Konig_Walles@med.lu.se	Walles, John/AAE-9202-2019	Konig Walles, John/0000-0002-3445-7741; Jansson, Marianne/0000-0001-6536-8146				Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Aris A, 2008, J OBSTET GYNAECOL RE, V34, P7, DOI 10.1111/j.1447-0756.2007.00676.x; Asuquo B, 2012, J OBSTET GYNAECOL, V32, P635, DOI 10.3109/01443615.2012.704436; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates M, 2015, INT J INFECT DIS, V32, P124, DOI 10.1016/j.ijid.2014.12.014; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Esmail H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1875-6; Ethiopia Federal Ministry of Health Implementation, 2007, GUID TB HIV COLL ACT; Gebreegziabiher D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364137; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Jonsson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187313; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; LaCourse SM, 2016, INFECT DIS OBSTET GY, P21; LaCourse SM, 2017, JAIDS-J ACQ IMM DEF, V75, P128, DOI 10.1097/qai.0000000000001298; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Lin WC, 2016, J MICROBIOL IMMUNOL, V49, P729, DOI 10.1016/j.jmii.2014.08.010; Mathad JS, 2016, AM J RESP CRIT CARE, V193, P1421, DOI 10.1164/rccm.201508-1595OC; Mathad JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092308; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Moon HW, 2017, J CLIN MICROBIOL, V55, P1650, DOI 10.1128/JCM.02498-16; Nemes E, 2017, AM J RESP CRIT CARE, V196, P638, DOI 10.1164/rccm.201704-0817OC; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; Nikolova M, 2013, DIAGN MICR INFEC DIS, V75, P277, DOI 10.1016/j.diagmicrobio.2012.11.023; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Petruccioli E, 2017, TUBERCULOSIS, V106, P38, DOI 10.1016/j.tube.2017.06.002; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Rendell NL, 2016, INT J TUBERC LUNG D, V20, P1615, DOI 10.5588/ijtld.16.0314; Sharma T, 2013, INDIAN J HEMATOL BLO, V29, P278; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; Telisinghe L, 2017, INT J TUBERC LUNG D, V21, P690, DOI 10.5588/ijtld.16.0764; Thanassi W, 2012, PULM MED, V2012, DOI 10.1155/2012/291294; Towers CV, 2010, J MATERN-FETAL NEO M, V23, P1091, DOI 10.3109/14767050903580359; Ufelle SA, 2017, BIOMED RES-INDIA, V28, P6282; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193589	10.1371/journal.pone.0193589	http://dx.doi.org/10.1371/journal.pone.0193589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617458	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800010
J	Bodmer, NK; Havranek, JJ				Bodmer, Nicholas K.; Havranek, James J.			Efficient minimization of multipole electrostatic potentials in torsion space	PLOS ONE			English	Article							POLARIZABLE FORCE-FIELD; ANALYTICAL MOLECULAR-SURFACE; SEQUENCE CULLING SERVER; PROTEIN-PROTEIN DOCKING; DRUDE OSCILLATOR MODEL; ATOMIC MULTIPOLE; LIGAND-BINDING; BIOMOLECULAR STRUCTURE; CONFORMATIONAL ENERGY; STRUCTURE PREDICTION	The development of models of macromolecular electrostatics capable of delivering improved fidelity to quantum mechanical calculations is an active field of research in computational chemistry. Most molecular force field development takes place in the context of models with full Cartesian coordinate degrees of freedom. Nevertheless, a number of macromolecular modeling programs use a reduced set of conformational variables limited to rotatable bonds. Efficient algorithms for minimizing the energies of macromolecular systems with torsional degrees of freedom have been developed with the assumption that all atom-atom interaction potentials are isotropic. We describe novel modifications to address the anisotropy of higher order multipole terms while retaining the efficiency of these approaches. In addition, we present a treatment for obtaining derivatives of atom-centered tensors with respect to torsional degrees of freedom. We apply these results to enable minimization of the Amoeba multipole electrostatics potential in a system with torsional degrees of freedom, and validate the correctness of the gradients by comparison to finite difference approximations. In the interest of enabling a complete model of electrostatics with implicit treatment of solvent-mediated effects, we also derive expressions for the derivative of solvent accessible surface area with respect to torsional degrees of freedom.	[Bodmer, Nicholas K.; Havranek, James J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Havranek, JJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	jjhavranek@wustl.edu		Havranek, James/0000-0001-8241-5928	National Institute Of General Medical Sciences of the National Institutes of Health [R01GM101602]; Rosetta Commons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101602] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rosetta Commons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R01GM101602 to JJH. Grant from the Rosetta Commons. www.rosettacommons.org. The sponsors and funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ABAGYAN RA, 1989, J BIOMOL STRUCT DYN, V6, P833, DOI 10.1080/07391102.1989.10507740; ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Anandakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067715; Antila HS, 2015, J COMPUT CHEM, V36, P739, DOI 10.1002/jcc.23850; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bryant R, 2004, DISCRETE COMPUT GEOM, V32, P293, DOI 10.1007/s00454-004-1099-1; Chen JH, 2005, J COMPUT CHEM, V26, P1565, DOI 10.1002/jcc.20293; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; FAERMAN CH, 1990, J AM CHEM SOC, V112, P4915, DOI 10.1021/ja00168a043; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GIBSON KD, 1990, J COMPUT CHEM, V11, P468, DOI 10.1002/jcc.540110406; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gresh N, 2004, J COMPUT CHEM, V25, P823, DOI 10.1002/jcc.20012; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harder E, 2009, J AM CHEM SOC, V131, P2760, DOI 10.1021/ja806825g; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Izadi S, 2014, J PHYS CHEM LETT, V5, P3863, DOI 10.1021/jz501780a; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jiang N, 2010, J PHYS CHEM B, V114, P11241, DOI 10.1021/jp102844h; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; Jiao D, 2009, J COMPUT CHEM, V30, P1701, DOI 10.1002/jcc.21268; Klenin KV, 2011, J COMPUT CHEM, V32, P2647, DOI 10.1002/jcc.21844; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemkul JA, 2016, J PHYS CHEM B, V120, P11436, DOI 10.1021/acs.jpcb.6b09262; Lemkul JA, 2014, J PHYS CHEM LETT, V5, P2077, DOI 10.1021/jz5009517; MAZUR AK, 1989, J BIOMOL STRUCT DYN, V6, P815, DOI 10.1080/07391102.1989.10507739; NOGUTI T, 1983, J PHYS SOC JPN, V52, P3685, DOI 10.1143/JPSJ.52.3685; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; PEAR MR, 1979, J CHEM PHYS, V71, P212, DOI 10.1063/1.438119; PERROT G, 1992, J COMPUT CHEM, V13, P1, DOI 10.1002/jcc.540130102; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Savelyev A, 2014, J PHYS CHEM B, V118, P6742, DOI 10.1021/jp503469s; Savelyev A, 2014, J COMPUT CHEM, V35, P1219, DOI 10.1002/jcc.23611; Schnieders MJ, 2007, J CHEM THEORY COMPUT, V3, P2083, DOI 10.1021/ct7001336; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Shi Y, 2013, J CHEM THEORY COMPUT, V9, P4046, DOI 10.1021/ct4003702; Shi Y, 2012, J PHYS CHEM B, V116, P1716, DOI 10.1021/jp210265d; Stone A. J, 2013, THEORY INTERMOLECULA, pxi; Totrov M, 1996, J STRUCT BIOL, V116, P138, DOI 10.1006/jsbi.1996.0022; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wedemeyer WJ, 2003, PROTEINS, V53, P262, DOI 10.1002/prot.10525; WILLIAMS DE, 1988, J COMPUT CHEM, V9, P745, DOI 10.1002/jcc.540090705; Wu JC, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1138-6; Zhang CS, 2017, J CHEM THEORY COMPUT, V13, P666, DOI 10.1021/acs.jctc.6b00918	49	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195578	10.1371/journal.pone.0195578	http://dx.doi.org/10.1371/journal.pone.0195578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641557	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900075
J	He, C; Tian, CC; Li, G; Mei, YH; Zhang, QG; Jiao, YZ				He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou			Experimental study on the relationship between the mineral production capability and the physiochemical properties in the coproduction of Q phase-3CaO.3Al(2)O(3).CaSO4 cement clinker	PLOS ONE			English	Article							COAL	A coproduction tests of quaternary (Q) phase(6CaO.4Al2O3.MgO.SiO2)-3CaO-3Al(2)O(3).CaSO4 cement clinker and an experimental study on the relationship between the mineral production capability and the physiochemical properties are conducted in a two-stage multi-phase reaction test bed with Changguang coal. X-ray diffractometer (XRD) analyses are performed on the coproduction clinker samples. The results demonstrate that, with the reduction in particle sizes of the coal powder and the additives and expanded screening level differences between them, both the proportion of Q phase and the mass of 3CaO.3Al(2)O(3).CaSO4 in the clinker increase accordingly. When mixed coal powder particles are prepared through reducing particle sizes and expanding screening level differences between coal powder and additives, the additives CaO and MgO are more likely to be enclosed by coal powder to form globular polymerized particles. In addition, this preparation aids in polymerization and promotes even distribution of CaO, MgO and coal minerals, thus facilitating clinker mineral formation reactions of inorganic substances in the mixed coal powder. Target minerals, such as 2CaO.SiO2 and Q phase, are found in both industrial high-calcium limestone and low-calcium limestone coproduction clinker samples. A diffraction peak of free CaO is also evident in both samples. Compared with a coproduction clinker sample of high-calcium limestone, that of low-calcium limestone exhibits higher diffraction peaks for 2CaO.SiO2 and Q phase. With the current state of the art, it is not yet the optimum choice to substitute CaCO3 for CaO in Q-phase cement clinker coproduction. Before the technology matures and gains practical application, further study on the form and the mixing process of calcium-based additives for cement clinker coproduction will be required.	[He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou] Henan Agr Univ, Coll Mech & Elect Engn, Minist Agr, Key Lab New Mat & Facil Rural Renewable Energy, Zhengzhou, Henan, Peoples R China; [He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou] Collaborat Innovat Ctr Biomass Energy, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Jiao, YZ (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Minist Agr, Key Lab New Mat & Facil Rural Renewable Energy, Zhengzhou, Henan, Peoples R China.; Jiao, YZ (corresponding author), Collaborat Innovat Ctr Biomass Energy, Zhengzhou, Henan, Peoples R China.	jiaoyouzhou@126.com		He, Chao/0000-0003-4280-1802; He, Chao/0000-0002-6426-6858	Natural Science Foundation of China [51706063]; Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China [201403019-1]; Natural Science Foundation of Henan Province [162300410156]; Science and Technology Innovation Talents Program of Henan Province [164100510014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China; Natural Science Foundation of Henan Province; Science and Technology Innovation Talents Program of Henan Province	This work was supported by Natural Science Foundation of China (No.51706063), Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China (No. 201403019-1), Natural Science Foundation of Henan Province (No.162300410156), and Science and Technology Innovation Talents Program of Henan Province (No.164100510014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmaruzzaman M, 2010, PROG ENERG COMBUST, V36, P327, DOI 10.1016/j.pecs.2009.11.003; Jiao YZ, 2012, ADV MATER RES-SWITZ, V354-355, P240, DOI 10.4028/www.scientific.net/AMR.354-355.240; Jiao You-zhou, 2008, Journal of Zhejiang University, V42, P977; [焦有宙 Jiao Youzhou], 2010, [动力工程学报, Journal of Power Engineering], V30, P633; Kirgiz M. S., 2014, EUROPEAN J ENV CIVIL, V20, P38; Kirgiz M. S., 2016, EUROPEAN J ENV CIVIL, V20, P64; Kirgiz MS, 2015, ZKG INT, V68, P60; Kirgiz MS, 2014, ZKG INT, V67, P42; Liu Hao, 2005, Proceedings of the CSEE, V25, P72; Luo YJ, 2008, THESIS; Sharonova OM, 2010, FUEL PROCESS TECHNOL, V91, P573, DOI 10.1016/j.fuproc.2010.01.003; [王春梅 Wang Chunmei], 2004, [工程热物理学报, Journal of Engineering Thermophysics], V25, P1053; Wang W. L., 2004, J ZHEJIANG U, V37, P225; Wang Wen-long, 2005, Proceedings of the CSEE, V25, P96; Wang Wen-long, 2005, Proceedings of the CSEE, V25, P116; Wang WL, 2003, WASTE MANAGE RES, V21, P243, DOI 10.1177/0734242X0302100308; Zhao Yong-chun, 2007, Proceedings of the CSEE, V27, P12	17	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195505	10.1371/journal.pone.0195505	http://dx.doi.org/10.1371/journal.pone.0195505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634732	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200035
J	Romero, V; Fitzpatrick, P; Roulier, S; Duncan, A; Richardson, MJ; Schmidt, RC				Romero, Veronica; Fitzpatrick, Paula; Roulier, Stephanie; Duncan, Amie; Richardson, Michael J.; Schmidt, R. C.			Evidence of embodied social competence during conversation in high functioning children with autism spectrum disorder (vol 13, e0193906, 2018)	PLOS ONE			English	Correction													Romero, Veronica/ABI-1513-2020		National Institute of Mental Health [R01GM105045]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The following information is missing from the Funding section: National Institute of Mental Health also provided funding under award number R01GM105045 (MJR, RCS).	Romero V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193906	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195888	10.1371/journal.pone.0195888	http://dx.doi.org/10.1371/journal.pone.0195888			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634762	Green Published, gold			2022-12-27	WOS:000429522200060
J	Wu, MY; Lee, YC; Lin, CL; Huang, MC; Sun, MF; Yen, HR				Wu, Mei-Yao; Lee, Yu-Chen; Lin, Cheng-Li; Huang, Ming-Cheng; Sun, Mao-Feng; Yen, Hung-Rong			Trends in use of acupuncture among adults in Taiwan from 2002 to 2011: A nationwide population-based study	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; ALTERNATIVE MEDICINE; PRESCRIPTION PATTERNS; GENERAL-POPULATION; DIABETES-MELLITUS; HERBAL PRODUCTS; BREAST-CANCER; COMPLEMENTARY	In recent years, acupuncture has gained in popularity worldwide. However, recent epidemiological studies are lacking. We conducted this study to investigate the trends in acupuncture utilization among adults in Taiwan from 2002 to 2011. We analyzed data from the Longitudinal Health Insurance Database 2000 (LHID 2000), which contains all original claims data for 1 million beneficiaries randomly sampled from the registry of all beneficiaries enrolled in the National Health Insurance (NHI) program in 2000. The one-year prevalence of acupuncture use among adults increased from 7.98% in 2002 to 10.9% in 2011. Acupuncture use significantly increased yearly (incidence rate ratio = 1.04, 95% CI = 1.03-1.05, p<0.001). Patients who were female, were middle-aged, resided in highly urbanized areas and suffered from injury or disorders of the musculoskeletal system were prone to more frequent acupuncture use. Our study revealed that the utilization of acupuncture became increasingly popular in Taiwan from 2002 to 2011. Our findings may provide useful information for clinical practice and research as well as for health policy decision making.	[Wu, Mei-Yao; Lee, Yu-Chen; Huang, Ming-Cheng; Sun, Mao-Feng; Yen, Hung-Rong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Lee, Yu-Chen] China Med Univ, Grad Inst Acupuncture Sci, Coll Chinese Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Huang, Ming-Cheng; Sun, Mao-Feng; Yen, Hung-Rong] China Med Univ, Grad Inst Chinese Med, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong] China Med Univ Hosp, Dept Med Res, Res Ctr Tradit Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong] China Med Univ, Res Ctr Chinese Herbal Med, Taichung, Taiwan; [Yen, Hung-Rong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Yen, Hung-Rong] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Yen, HR (corresponding author), China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan.; Yen, HR (corresponding author), China Med Univ, Grad Inst Chinese Med, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.; Yen, HR (corresponding author), China Med Univ Hosp, Dept Med Res, Res Ctr Tradit Chinese Med, Taichung, Taiwan.; Yen, HR (corresponding author), China Med Univ, Res Ctr Chinese Herbal Med, Taichung, Taiwan.; Yen, HR (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.; Yen, HR (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.	hungrongyen@gmail.com	Huang, Ming-Cheng/GRY-5937-2022; Yen, Hung-Rong/M-1373-2013	Huang, Ming-Cheng/0000-0003-0830-7093; Yen, Hung-Rong/0000-0002-0131-1658	China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW107-TDU-B-212-123004]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence [MOHW107-TDU-B-212-114-24]	China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence	This study was supported in part by China Medical University under the Higher Education Sprout Project, Ministry of Education, Taiwan (http://www.cmu.edu.tw) (HRY), the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW107-TDU-B-212-123004) (http://www.mohw.gov.tw/EN/Ministry/Index.aspx) (HRY), and the Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW107-TDU-B-212-114-24) (http://www.cmuh.cmu.edu.tw) (HRY). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011; CHANG B, 1974, J AM DIET ASSOC, V65, P436; Chang LC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-170; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chen FP, 2006, J ALTERN COMPLEM MED, V12, P379, DOI 10.1089/acm.2006.12.379; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cramer H, 2015, COMPLEMENT THER MED, V23, P423, DOI 10.1016/j.ctim.2015.04.009; Crew KD, 2010, J CLIN ONCOL, V28, P1154, DOI 10.1200/JCO.2009.23.4708; Fleischer T, 2017, INTEGR CANCER THER, V16, P156, DOI 10.1177/1534735416664171; Harris PE, 2012, INT J CLIN PRACT, V66, P924, DOI 10.1111/j.1742-1241.2012.02945.x; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Huang MC, 2015, J ETHNOPHARMACOL, V176, P9, DOI 10.1016/j.jep.2015.10.024; Huang TP, 2013, ALLERGY, V68, P1610, DOI 10.1111/all.12273; Huang TP, 2014, COMPLEMENT THER MED, V22, P500, DOI 10.1016/j.ctim.2014.04.002; Hwang JH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-103; Ishizaki N, 2010, EVID-BASED COMPL ALT, V7, P493, DOI 10.1093/ecam/nen037; Lai CY, 2017, EUR J NEUROL, V24, P1166, DOI 10.1111/ene.13361; Lee AL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002536; Liao HH, 2015, J ETHNOPHARMACOL, V173, P11, DOI 10.1016/j.jep.2015.07.014; Lien ASY, 2016, J ETHNOPHARMACOL, V191, P324, DOI 10.1016/j.jep.2016.06.051; Lisi AJ, 2015, PAIN MED, V16, P1282, DOI 10.1111/pme.12821; Liu CY, 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lu WD, 2008, HEMATOL ONCOL CLIN N, V22, P631, DOI 10.1016/j.hoc.2008.04.005; MacPherson H, 2006, COMPLEMENT THER MED, V14, P20, DOI 10.1016/j.ctim.2005.07.006; Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2; Mao JJ, 2014, CANCER-AM CANCER SOC, V120, P3744, DOI 10.1002/cncr.28917; Martin DP, 2006, MAYO CLIN PROC, V81, P749, DOI 10.4065/81.6.749; Patil S, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0552-1; Ratmansky M, 2016, J ALTERN COMPLEM MED, V22, P33, DOI 10.1089/acm.2015.0066; Redd Doug, 2014, AMIA Annu Symp Proc, V2014, P1002; Sanders Steven H, 2005, Pain Pract, V5, P303, DOI 10.1111/j.1533-2500.2005.00033.x; Shih CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001572; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Thomas K, 2004, J PUBLIC HEALTH, V26, P152, DOI 10.1093/pubmed/fdh139; Upchurch DM, 2014, J ALTERN COMPLEM MED, V20, P32, DOI 10.1089/acm.2012.0120; Vincent A, 2010, ACUPUNCT MED, V28, P189, DOI 10.1136/aim.2010.002568; Wardle JL, 2013, ACUPUNCT MED, V31, P45, DOI 10.1136/acupmed-2012-010244; Wei YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/689813; Weng SW, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1272-0; Wu MY, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1239-7; Xue CCL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-105; Yeh YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004115; Yen HR, 2017, INTEGR CANCER THER, V16, P147, DOI 10.1177/1534735416659357; Yen HR, 2015, J ETHNOPHARMACOL, V171, P223, DOI 10.1016/j.jep.2015.05.038; Yen HR, 2015, INT J PEDIATR OTORHI, V79, P591, DOI 10.1016/j.ijporl.2015.02.002	45	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195490	10.1371/journal.pone.0195490	http://dx.doi.org/10.1371/journal.pone.0195490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634741	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200034
J	Klishko, OK; Lopes-Lima, M; Bogan, AE; Matafonov, DV; Froufe, E				Klishko, Olga K.; Lopes-Lima, Manuel; Bogan, Arthur E.; Matafonov, Dmitry V.; Froufe, Elsa			Morphological and molecular analyses of Anodontinae species (Bivalvia, Unionidae) of Lake Baikal and Transbaikalia	PLOS ONE			English	Article							WATER; DIVERSITY; MOLLUSKS; MUSSELS; ANATINA; RUSSIA; SHELL; TCS	The diversity and taxonomy of anodontine species in Lake Baikal and Transbaikalia region has been contentious since it is based on a typological species concept, the so called "Comparatory Method". Using this method, six Comparatory anodontine species have been described for the study area as belonging to the genus Colletopterum. This genus was separated from Anodonta based on shell characteristics and further split into two subgenera, i.e. Colletopterum sensu stricto and Colletopterum (Piscinaliana). However, many authors do not recognize this separation maintaining all Colletopterum forms within Anodonta. The current study clarifies the taxonomy and systematics of Anodontinae in this region, using a combination of molecular, morphological and anatomical data. All previously recognized Comparatory forms are here recognized as a single species, i.e. Anodonta anatina.	[Klishko, Olga K.] Russian Acad Sci, Inst Nat Resources Ecol & Cryol, Siberian Branch, Chita, Russia; [Lopes-Lima, Manuel] Univ Porto, CIBIO InBIO Res Ctr Biodivers & Genet Resources, Vairao, Portugal; [Lopes-Lima, Manuel; Froufe, Elsa] Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, Matosinhos, Portugal; [Lopes-Lima, Manuel; Bogan, Arthur E.] Int Union Conservat Nat, Species Survival Commiss, SSC IUCN Mollusc Specialist Grp, Cambridge, England; [Bogan, Arthur E.] North Carolina State Museum Nat Sci, Res Lab, Raleigh, NC USA; [Matafonov, Dmitry V.] Russian Acad Sci, Inst Gen & Expt Biol, Siberian Branch, Ulan Ude, Russia	Russian Academy of Sciences; Universidade do Porto; Universidade do Porto; Russian Academy of Sciences	Lopes-Lima, M (corresponding author), Univ Porto, CIBIO InBIO Res Ctr Biodivers & Genet Resources, Vairao, Portugal.; Lopes-Lima, M (corresponding author), Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, Matosinhos, Portugal.; Lopes-Lima, M (corresponding author), Int Union Conservat Nat, Species Survival Commiss, SSC IUCN Mollusc Specialist Grp, Cambridge, England.	manuelpmlopeslima@gmail.com	Froufe, Elsa/F-2286-2013; Lopes-Lima, Manuel/N-1222-2014	Froufe, Elsa/0000-0003-0262-0791; Lopes-Lima, Manuel/0000-0002-2761-7962; Matafonov, Dmitry/0000-0001-9931-4816	Fundacao para a Ciencia e tecnologia (FCT [PTDC/AGRFOR/1627/2014];  [SFRH/BD/115728/2016];  [SFRH/BPD/108445/2015]	Fundacao para a Ciencia e tecnologia (FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	Fundacao para a Ciencia e tecnologia (FCT) funded the genetics work under project PTDC/AGRFOR/1627/2014. Research grants from the same institution were awarded to MLL (SFRH/BD/115728/2016) and EF (SFRH/BPD/108445/2015).	[Anonymous], 1870, SYNOPSIS FAMILY UNIO; Bogatov VV, 2012, ZOOL ZH, V91, P393; BOGATOV VV, 1992, ZOOL ZH, V71, P132; Bogatov VV, 2005, ZOOL ZH, V84, P1050; Bogatov VV, 2016, IDENTIFICATION GUIDE, V2, P285; Bolotov IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122408; Bourguignat J, 1880, MATERIAUX SERVIR HIS; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; dos Santos AM, 2016, BIOINFORMATICS, V32, P627, DOI 10.1093/bioinformatics/btv636; Froufe E, 2014, AQUAT CONSERV, V24, P561, DOI 10.1002/aqc.2456; Galaziy GI, 1987, BAIKAL LAKE QUESTION; Graf DL, 2007, P ACAD NAT SCI PHILA, V156, P71, DOI 10.1635/0097-3157(2007)156[71:PFMMBU]2.0.CO;2; Graf DL, 2018, MUSSEL PROJECT WEB S; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Israel W, 1910, BEIL NACHR BL DT MAL, V4, P49; Kauffmann E.G, 1969, TREATISE INVERTEBRAT, P129; Klishko O, 2017, ZOOTAXA, V4286, P93, DOI 10.11646/zootaxa.4286.1.4; Klishko OK, 2018, SYST BIODIVERS, V16, P287, DOI 10.1080/14772000.2017.1383527; Klishko OK, 2016, ZOOKEYS, P13, DOI 10.3897/zookeys.580.7588; Klishko OK, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.438.7493; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuster NC, 1854, SYSTEMATISCHES CONCH, P89; Kuster NC, 1842, SYSTEMATISCHES CONCH, P41; LOCARD A, 1890, ANN SOC LINNEENNE LY, V36, P50; Lopes-Lima M, 2017, MOL PHYLOGENET EVOL, V106, P174, DOI 10.1016/j.ympev.2016.08.021; Lopes-Lima M, 2017, BIOL REV, V92, P572, DOI 10.1111/brv.12244; Martens R, 1969, SUPERFAMILIA UNIONAC, P88; Modell H., 1945, JENA Z NATUR, V78, P58; Prozorova LA, 2006, HYDROBIOLOGIA, V568, P201, DOI 10.1007/s10750-006-0314-x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; ROPER DS, 1994, HYDROBIOLOGIA, V284, P205, DOI 10.1007/BF00006690; Sayenko E.M., 2014, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V18, P79; Seed R., 1980, Topics in Geobiology, V1, P23; Slugina ZV, 1999, GUIDE KEY BIVALVIA L; Stanley S.M., 1970, GEOLOGICAL SOC AM, V125, P1, DOI 10.1130/MEM125-p1; Starobogatov Ya.I., 1984, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V89, P74; Starobogatov YI, 2004, NAUKA, V6; Starobogatov YI, 1977, FAMILY UNIONIDAE IDE, P126; Tevesz M., 1980, SKELETAL GROWTH AQUA, P295; Vinarski MV, 2016, ANAL CATALOGUE FRESH; ZATRAVKIN MN, 1983, MOLLYUSKI SISTEMATIK, V7, P40; Zhadin VI, 1938, FAUNA USSR MOLLUSCA, V4; Zhadin VI, 1952, IDENTIFICATION GUIDE, V46; Zieritz A, 2015, J ZOOL SYST EVOL RES, V53, P76, DOI 10.1111/jzs.12077; Zieritz A, 2011, J MORPHOL, V272, P1365, DOI 10.1002/jmor.10990; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x	46	18	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194944	10.1371/journal.pone.0194944	http://dx.doi.org/10.1371/journal.pone.0194944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630628	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000021
J	Tavousi, P				Tavousi, Pouya			Approximating net interactions among rigid domains	PLOS ONE			English	Article							SIMULATIONS; ALGORITHM; SUMS	Many physical simulations aim at evaluating the net interaction between two rigid bodies, resulting from the cumulative effect of pairwise interactions between their constituents. This is manifested particularly in biomolecular applications such as hierarchical protein folding instances where the interaction between almost rigid domains directly influences the folding pathway, the interaction between macromolecules for drug design purposes, self-assembly of nanoparticles for drug design and drug delivery, and design of smart materials and biosensors. In general, the brute force approach requires quadratic (in terms of the number of particles) number of pairwise evaluation operations for any relative pose of the two bodies, unless simplifying assumptions lead to a collapse of the computational complexity. We propose to approximate the pairwise interaction function using a linear predictor function, in which the basis functions have separated forms, i.e. the variables that describe local geometries of the two rigid bodies and the ones that reflect the relative pose between them are split in each basis function. Doing so replaces the quadratic number of interaction evaluations for each relative pose with a one-time quadratic computation of a set of characteristic parameters at a preprocessing step, plus constant number of pose function evaluations at each pose, where this constant is determined by the required accuracy of approximation as well as the efficiency of the used approximation method. We will show that the standard deviation of the error for the net interaction is linearly (in terms of number of particles) proportional to the regression error, if the regression errors are from a normal distribution. Our results show that proper balance of the tradeoff between accuracy and speed-up yields an approximation which is computationally superior to other existing methods while maintaining reasonable precision.	[Tavousi, Pouya] Univ Connecticut, Sch Engn, Dept Mech Engn, Storrs, CT 06269 USA; [Tavousi, Pouya] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Tavousi, P (corresponding author), Univ Connecticut, Sch Engn, Dept Mech Engn, Storrs, CT 06269 USA.; Tavousi, P (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	pouya.tavousi@uconn.edu						An ZW, 2013, WAVE MOTION, V50, P295, DOI 10.1016/j.wavemoti.2012.09.004; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Behandish M, 2013, ASME 2013 INT DES EN; Beylkin G, 2009, SIAM J SCI COMPUT, V31, P1840, DOI 10.1137/070710524; Brennick CA, 2017, IMMUNOTHERAPY-UK, V9, P361, DOI 10.2217/imt-2016-0146; Cadek M., 1990, AEQUATIONES MATH, V40, P8, DOI DOI 10.1007/BF02112277; Corwin WL, 2017, J IMMUNOL METHODS, V445, P71, DOI 10.1016/j.jim.2017.03.013; Dubbeldam D, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3429610; Eastman P, 2010, J CHEM THEORY COMPUT, V6, P434, DOI 10.1021/ct900463w; Ebrahimi-Nik H, 2017, CD11C MHCII INT BONE; Ebrahimi-Nik H, 2017, TUMOR CONTROL INDEX; Ebrahimi-Nik H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194888; ELMEGREEN DM, 1995, ASTROPHYS J, V453, P100, DOI 10.1086/176374; Gandhi M. V., 1992, SMART MAT STRUCTURES; Gonzalez D, 2010, INT J NUMER METH ENG, V81, P637, DOI 10.1002/nme.2710; GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9; Hockney R. W., 1988, COMPUTER SIMULATION, DOI [10.1201/9780367806934, DOI 10.1201/9781439822050.CH8]; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Kazerounian K, 2005, J MECH DESIGN, V127, P712, DOI 10.1115/1.1867502; Kuriyan J., 2012, MOL LIFE PHYS CHEM P; Lotan I, 2004, J COMPUT BIOL, V11, P902, DOI 10.1089/1066527042432279; Luo TZ, 2013, NAT MATER, V12, P1063, DOI [10.1038/nmat3772, 10.1038/NMAT3772]; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; NEUMAN F, 1990, LINEAR ALGEBRA APPL, V134, P153, DOI 10.1016/0024-3795(90)90014-4; Oshino S, 2011, PUBL ASTRON SOC JPN, V63, P881, DOI 10.1093/pasj/63.4.881; Poursina M, 2012, J COMPUT PHYS, V231, P7237, DOI 10.1016/j.jcp.2012.06.041; Rassias T.M., 1995, FINITE SUMS DECOMPOS; Tavousi P., 2015, ASME J NANOTECHNOL E, V6, DOI DOI 10.1115/1.4032759; Tavousi P, 2013, ASME 2013 INT DES EN; Tavousi P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18151-x; Tavousi P, 2016, J MECH DESIGN, V138, DOI 10.1115/1.4033394; Trueblood KN, 1996, ACTA CRYSTALLOGR A, V52, P770, DOI 10.1107/S0108767396005697; Nguyen TD, 2011, COMPUT PHYS COMMUN, V182, P2307, DOI 10.1016/j.cpc.2011.06.005; WODAK SJ, 1987, PROG BIOPHYS MOL BIO, V49, P29, DOI 10.1016/0079-6107(87)90008-3; Zahra Shahbazi HIKKPB, 2010, ADV ROBOT KINEMATICS	35	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195618	10.1371/journal.pone.0195618	http://dx.doi.org/10.1371/journal.pone.0195618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630635	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000065
J	Xiao, C; Ma, TF; Dieng, AB; Blei, DM; Wang, F				Xiao, Cao; Ma, Tengfei; Dieng, Adji B.; Blei, David M.; Wang, Fei			Readmission prediction via deep contextual embedding of clinical concepts	PLOS ONE			English	Article								Objective Hospital readmission costs a lot of money every year. Many hospital readmissions are avoidable, and excessive hospital readmissions could also be harmful to the patients. Accurate prediction of hospital readmission can effectively help reduce the readmission risk. However, the complex relationship between readmission and potential risk factors makes readmission prediction a difficult task. The main goal of this paper is to explore deep learning models to distill such complex relationships and make accurate predictions. Materials and methods We propose CONTENT, a deep model that predicts hospital readmissions via learning interpretable patient representations by capturing both local and global contexts from patient Electronic Health Records (EHR) through a hybrid Topic Recurrent Neural Network (TopicRNN) model. The experiment was conducted using the EHR of a real world Congestive Heart Failure (CHF) cohort of 5,393 patients. Results The proposed model outperforms state-of-the-art methods in readmission prediction (e.g. 0.6103 +/- 0.0130 vs. second best 0.5998 +/- 0.0124 in terms of ROC-AUC). The derived patient representations were further utilized for patient phenotyping. The learned phenotypes provide more precise understanding of readmission risks. Discussion Embedding both local and global context in patient representation not only improves prediction performance, but also brings interpretable insights of understanding readmission risks for heterogeneous chronic clinical conditions. Conclusion This is the first of its kind model that integrates the power of both conventional deep neural network and the probabilistic generative models for highly interpretable deep patient representation learning. Experimental results and case studies demonstrate the improved performance and interpretability of the model.	[Xiao, Cao] IBM Res, AI Healthcare, Cambridge, MA USA; [Ma, Tengfei] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Dieng, Adji B.; Blei, David M.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Wang, Fei] Cornell Univ, Weill Cornell Med Sch, New York, NY 10021 USA	International Business Machines (IBM); International Business Machines (IBM); Columbia University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Wang, F (corresponding author), Cornell Univ, Weill Cornell Med Sch, New York, NY 10021 USA.	few2001@med.cornell.edu		Ma, Tengfei/0000-0002-1086-529X	National Science Foundation [IIS-1650723, IIS-1716432]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation IIS-1650723 and IIS-1716432 to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, IEEE T BIG DATA; Arisoy E, 2012, IEEE T AUDIO SPEECH, V20, P540, DOI 10.1109/TASL.2011.2162323; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Baytas IM, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P65, DOI 10.1145/3097983.3097997; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Blei DM, 2017, J AM STAT ASSOC, V112, P859, DOI 10.1080/01621459.2017.1285773; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Che C, 2017, SIAM INT C DAT MIN; Cheng Y., 2016, 2016 SIAM INT C DATA, P432, DOI DOI 10.1137/1.9781611974348.49; Cho K., 2014, EMNLP 2014 2014 C EM, P1724, DOI DOI 10.3115/V1/D14-1179; Choi E, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1495, DOI 10.1145/2939672.2939823; Choi E, 2017, J AM MED INFORM ASSN, V24, P361, DOI 10.1093/jamia/ocw112; Dieng AB, 2017, INT C LEARN REPR; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Katz Stuart D, 2004, Congest Heart Fail, V10, P243, DOI 10.1111/j.1527-5299.2004.03298.x; Kingma D, 2013, AUTOENCODING VARIATI; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Lang CC, 2007, HEART, V93, P665, DOI 10.1136/hrt.2005.068296; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Little R. J. A., 1987, STAT ANAL MISSING DA; Ma T, 2018, SIAM INT C DAT MIN; Mathias JS, 2013, J AM MED INFORM ASSN, V20, pE118, DOI 10.1136/amiajnl-2012-001360; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Mikolov T., 2012, CONTEXT DEPENDENT RE; Pascanu T., 2013, INT C MACH LEARN, P1310; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Nguyen P, 2017, IEEE J BIOMED HEALTH, V21, P22, DOI 10.1109/JBHI.2016.2633963; Pivovarov R, 2014, J BIOMED INFORM, V51, P24, DOI 10.1016/j.jbi.2014.03.016; Robert I, 2014, INT J BREAST CANC; Roy SB, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1691, DOI 10.1145/2783258.2788585; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Theano Development Team, 2016, ARXIV160502688; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tran T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0425-8; Wu J, 2010, MED CARE, V48	43	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195024	10.1371/journal.pone.0195024	http://dx.doi.org/10.1371/journal.pone.0195024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630604	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000022
J	Kishi, F; Nagai, K; Takamatsu, N; Tominaga, T; Tamaki, M; Shibata, E; Murakami, T; Kishi, S; Abe, H; Koezuka, Y; Minagawa, N; Ichien, G; Doi, T				Kishi, Fumi; Nagai, Kojiro; Takamatsu, Norimichi; Tominaga, Tatsuya; Tamaki, Masanori; Shibata, Eriko; Murakami, Taichi; Kishi, Seiji; Abe, Hideharu; Koezuka, Yasuhiko; Minagawa, Naoto; Ichien, Go; Doi, Toshio			Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study	PLOS ONE			English	Article							RENAL-FUNCTION; GFR DECLINE; ASSOCIATION; MARKER; PROTEINURIA; FORMULA; ALBUMIN; RISK; CKD	Urinary type IV collagen (U-Co14) and albumin excretion is evaluated to monitor the development of diabetic kidney disease. However, U-Co14 excretion in the general population without diabetes has not yet been fully elucidated. In this study, 1067 participants without diabetes and with urinary albumin-creatinine ratio <300 mg/gCr (normo- or microalbuminuria) who underwent an annual health examination in 2004 were enrolled and observed for 5 years. They were divided according to the amount of U-Co14 or urinary albumin excreted. The decline in estimated glomerular filtration rate (eGFR) was calculated. In participants with eGFR >= 80 mUmin, abnormal U-Co14 excretion was indicated as a significant independent risk factor for 10% eGFR change per year, which is one of the prognostic factors for the development of end stage kidney disease. Moreover, in contrast to urinary albumin excretion, U-Co14 excretion was not related to age or kidney function, suggesting that some individuals with abnormal U-Co14 excretion can have an independent hidden risk for the development of kidney dysfunction. In conclusion, it is important to measure U-Co14 excretion in the general population without diabetes to determine changes in renal features in every individual and help detect future complications such as diabetic kidney disease. If U-Co14 excretion is abnormal, kidney manifestation should be carefully followed up, even if the kidney function and urinalysis findings are normal.	[Kishi, Fumi; Nagai, Kojiro; Tamaki, Masanori; Shibata, Eriko; Murakami, Taichi; Kishi, Seiji; Abe, Hideharu; Doi, Toshio] Tokushima Univ, Dept Nephrol, Grad Sch, Tokushima, Japan; [Takamatsu, Norimichi] Kawashima Hosp, Dept Kidney Dis Dialysis & Transplantat, Tokushima, Japan; [Tominaga, Tatsuya] Tokushima Univ, Grad Sch, Dept Chronomed, Inst Biomed Sci, Tokushima, Japan; [Koezuka, Yasuhiko; Minagawa, Naoto; Ichien, Go] HuBit Genomix Inc, Tokyo, Japan	Tokushima University; Tokushima University	Nagai, K (corresponding author), Tokushima Univ, Dept Nephrol, Grad Sch, Tokushima, Japan.	knagai@tokushimasu.ac.jp			HuBit Genomix Inc.	HuBit Genomix Inc.	The authors received no specific funding for this work. HuBit Genomix Inc. provided support in the form of salaries for authors YK, NM and GI but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ando Y, 1997, BRIT J CANCER, V76, P1067, DOI 10.1038/bjc.1997.509; [Anonymous], 2001, Diabetes Care, V24 Suppl 1, pS1; Araki S, 2010, DIABETES CARE, V33, P1805, DOI 10.2337/dc10-0199; BANU N, 1995, DIABETES RES CLIN PR, V29, P57, DOI 10.1016/0168-8227(95)01119-X; Chang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132927; Cohen MP, 2001, DIABETES CARE, V24, P914, DOI 10.2337/diacare.24.5.914; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Enomoto D, 2012, CLIN EXP HYPERTENS, V34, P612, DOI 10.3109/10641963.2012.683911; Furumatsu Y, 2011, NEPHRON CLIN PRACT, V117, pC160, DOI 10.1159/000319794; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Hanevold CD, 2008, HYPERTENSION, V51, P334, DOI 10.1161/HYPERTENSIONAHA.107.098095; Hirayama A, 2015, AM J HYPERTENS, V28, P1150, DOI 10.1093/ajh/hpv003; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Ishimitsu T, 2000, HYPERTENS RES, V23, P459, DOI 10.1291/hypres.23.459; Kado S, 1996, DIABETES RES CLIN PR, V31, P103, DOI 10.1016/0168-8227(96)01210-7; Kanda E, 2017, CLIN EXP NEPHROL, DOI 10.1007/s10157-017-1463-0; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Katavetin Pisut, 2010, Diabetes Res Clin Pract, V89, pe33, DOI 10.1016/j.diabres.2010.05.007; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Locatelli F, 2006, J AM SOC NEPHROL, V17, pS81, DOI 10.1681/ASN.2005121332; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Matsumoto A, 2017, HYPERTENS RES, V40, P771, DOI 10.1038/hr.2017.25; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2016, KIDNEY INT, V90, P1109, DOI 10.1016/j.kint.2016.08.003; Morita M, 2011, AM J KIDNEY DIS, V58, P915, DOI 10.1053/j.ajkd.2011.04.019; Mule G, 2017, ADV EXP MED BIOL, V956, P279, DOI 10.1007/5584_2016_85; OBATA K, 1989, CLIN CHIM ACTA, V181, P293, DOI 10.1016/0009-8981(89)90235-0; Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109; Takamatsu N, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-34; Tian XF, 2016, NEPHROL DIAL TRANSPL, V31, P1577, DOI 10.1093/ndt/gfw021; Trachtenberg F, 2007, AM J KIDNEY DIS, V50, P938, DOI 10.1053/j.ajkd.2007.08.014	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195523	10.1371/journal.pone.0195523	http://dx.doi.org/10.1371/journal.pone.0195523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624611	gold, Green Published			2022-12-27	WOS:000429379600036
J	Ren, FJ; Liu, N				Ren, Fuji; Liu, Ning			Emotion computing using Word Mover's Distance features based on Ren_CECps	PLOS ONE			English	Article							SENTIMENT; VISUALIZATION; CORPUS; MODEL; BLOG	In this paper, we propose an emotion separated method(SeTEIDF) to assign the emotion labels of sentences with different values, which has a better visual effect compared with the values represented by TF.IDF in the visualization of a multi-label Chinese emotional corpus Ren_CECps. Inspired by the enormous improvement of the visualization map propelled by the changed distances among the sentences, we being the first group utilizes the Word Mover's Distance(WMD) algorithm as a way of feature representation in Chinese text emotion classification. Our experiments show that both in 80% for training, 20% for testing and 50% for training, 50% for testing experiments of Ren_CECps, WMD features get the best f1 scores and have a greater increase compared with the same dimension feature vectors obtained by dimension reduction TF.IDF method. Compared experiments in English corpus also show the efficiency of WMD features in the cross-language field.	[Ren, Fuji; Liu, Ning] Tokushima Univ, Fac Engn, Tokushima, Japan	Tokushima University	Ren, FJ (corresponding author), Tokushima Univ, Fac Engn, Tokushima, Japan.	ren@is.tokushima-u.ac.jp			Japan Society For The Promotion of Science, KAKENHI [15H01712]	Japan Society For The Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society For The Promotion of Science, KAKENHI Grant Number 15H01712 to FR, https://www.jsps.go.jp/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreevskaia A., 2006, P 11 C EUROPEAN CHAP, P209; Arleo A, 2017, INFORM SCIENCES, V381, P124, DOI 10.1016/j.ins.2016.11.012; Baccianella S., 2010, P 7 INT C LANG RES O, V10, P2200; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Buja A, 2008, J COMPUT GRAPH STAT, V17, P444, DOI 10.1198/106186008X318440; Cachopo AMdJC, 2007, IMPROVING METHODS SI, P124; Cambria E., 2016, P COLING 2016 26 INT, P2666, DOI DOI 10.1007/978-3-319-55209-5_5; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Cao N, 2016, IEEE T VIS COMPUT GR, V22, P1149, DOI 10.1109/TVCG.2015.2424878; Cheng XY, 2017, ACM T ASIAN LOW-RESO, V17, DOI 10.1145/3132684; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Friendly M, 2005, J HIST BEHAV SCI, V41, P103, DOI 10.1002/jhbs.20078; Fu AY, 2006, IEEE T DEPEND SECURE, V3, P301, DOI 10.1109/TDSC.2006.50; Heimerl F, 2012, IEEE T VIS COMPUT GR, V18, P2839, DOI 10.1109/TVCG.2012.277; Huang XD, 2007, INFORM SCIENCES, V177, P2821, DOI 10.1016/j.ins.2007.02.016; Inselberg A, 1985, VISUAL COMPUT, V1, P69, DOI 10.1007/BF01898350; Kusner MJ, 2015, PR MACH LEARN RES, V37, P957; Li Ji, 2012, IEEJ T ELECT INFORM, V132, P1362; Li TMH, 2014, CRISIS, V35, P168, DOI 10.1027/0227-5910/a000248; Liao Jian, 2016, Chinese Computational Linguistics and Natural Language Processing Based on Naturally Annotated Big Data. 15th China National Conference, CCL 2016, and 4th International Symposium, NLP-NABD 2016. Proceedings: LNAI 10035, P227, DOI 10.1007/978-3-319-47674-2_20; Liu, 2014, NATURAL LANGUAGE PRO, P457, DOI [DOI 10.1007/978-3-662-45924-9_42, DOI 10.1007/978-3-662-45924-9_]; Lu Y, 2017, J NATURAL LANGUAGE P, V24, P205; Ma YX, 2017, INFORM SCIENCES, V390, P54, DOI 10.1016/j.ins.2016.03.021; Matsumoto K., 2011, 2011 7th International Conference on Natural Language Processing and Knowledge Engineering (NLPKE), P214, DOI 10.1109/NLPKE.2011.6138197; Mikolov T., 2013, ADV NEURAL INFORM PR, V26, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Minato J, 2006, LECT NOTES ARTIF INT, V4114, P924; Minsky M., 1985, SOC MIND, V16, P163; Mukherjee Subhabrata, 2012, Computational Linguistics and Intelligent Text Processing. Proceedings 13th International Conference (CICLing 2012), P475, DOI 10.1007/978-3-642-28604-9_39; Najim SA, 2014, INFORM SCIENCES, V278, P206, DOI 10.1016/j.ins.2014.03.048; Pagliardini M., 2017, UNSUPERVISED LEARNIN; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pele O, 2009, IEEE I CONF COMP VIS, P460, DOI 10.1109/ICCV.2009.5459199; Petropoulos A, 2017, INFORM SCIENCES, V412, P50, DOI 10.1016/j.ins.2017.05.038; Picard RW, 1997, AFFECTIVE COMPUTING, V1, P35; Quan C., 2010, INT J ADV INTELLIGEN, V2, P105; Quan CQ, 2016, INFORM SCIENCES, V329, P581, DOI 10.1016/j.ins.2015.09.050; Quan CQ, 2010, COMPUT SPEECH LANG, V24, P726, DOI 10.1016/j.csl.2010.02.002; Le Q, 2014, PR MACH LEARN RES, V32, P1188; Rehurek R., 2010, P LREC 2010 WORKSH N; Ren FJ, 2016, IEEE J BIOMED HEALTH, V20, P1384, DOI 10.1109/JBHI.2015.2459683; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; STEWART GW, 1993, SIAM REV, V35, P551, DOI 10.1137/1035134; Su Q., 2008, P 17 INT C WORLD WID, P959, DOI DOI 10.1145/1367497.1367627; Tan SB, 2008, EXPERT SYST APPL, V34, P2622, DOI 10.1016/j.eswa.2007.05.028; Tang DY, 2016, IEEE T KNOWL DATA EN, V28, P496, DOI 10.1109/TKDE.2015.2489653; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wan XJ, 2007, INFORM SCIENCES, V177, P3718, DOI 10.1016/j.ins.2007.02.045; Wang Canhui, 2008, P 17 WWW, P457, DOI [10.1145/1367497.1367560, DOI 10.1145/1367497.1367560]; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Wang L, 2015, LECT NOTES ARTIF INT, V9332, P197, DOI 10.1007/978-3-319-27194-1_20; Wang L, 2016, IEEJ T ELECTR ELECTR, V11, P178, DOI 10.1002/tee.22204; Xiao KC, 2016, INT CONF SOFTW ENG, P922, DOI 10.1109/ICSESS.2016.7883216; Yang M, 2017, AAAI CONF ARTIF INTE, P5013; Zhang YS, 2016, CHINESE J ELECTRON, V25, P601, DOI 10.1049/cje.2016.07.002; Zhang YW, 2015, LECT NOTES ARTIF INT, V9078, P52, DOI 10.1007/978-3-319-18032-8_5; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194136	10.1371/journal.pone.0194136	http://dx.doi.org/10.1371/journal.pone.0194136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624573	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600004
J	Perrier, L; Rascle, P; Morelle, M; Toulmonde, M; Vince, DR; Le Cesne, A; Terrier, P; Neuville, A; Meeus, P; Farsi, F; Ducimetiere, F; Blay, JY; Coquard, IR; Coindre, JM				Perrier, Lionel; Rascle, Pauline; Morelle, Magali; Toulmonde, Maud; Vince, Dominique Ranchere; Le Cesne, Axel; Terrier, Philippe; Neuville, Agnes; Meeus, Pierre; Farsi, Fadila; Ducimetiere, Francoise; Blay, Jean-Yves; Coquard, Isabelle Ray; Coindre, Jean-Michel			The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group	PLOS ONE			English	Review							MANDATORY 2ND OPINION; 2ND-OPINION PATHOLOGY; SURGICAL PATHOLOGY; DIAGNOSIS; EXPERT; IMPACT; MANAGEMENT; PROGRAMS; HEALTH	Objective This study examined the types of discordance occurring in the diagnosis of soft tissue and visceral sarcomas, gastrointestinal stromal tumors (GIST), and desmoid tumors, as well as the economic impact of diagnostic discrepancies. Methods We carried out a retrospective, multicenter analysis using prospectively implemented databases performed on a cohort of patients within the French RRePS network in 2010. Diagnoses were deemed to be discordant based on the 2013 World Health Organization (WHO) classification. Predictive factors of discordant diagnoses were explored. A decision tree was used to assess the expected costs of two strategies of disease management: one based on revised diagnoses after centralized histological review (option 1), the other on diagnoses without centralized review (option 2). Both were defined based on the patient and the disease characteristics, according to national or international guidelines. The time horizon was 12 months and the perspective of the French National Health Insurance (NHI) was retained. Costs were expressed in Euros for 2013. Sensitivity analyses were performed using low and high scenarios that included 20% estimates for cost. Results A total of 2,425 patients were included. Three hundred forty-one patients (14%) had received discordant diagnoses. These discordances were determined to mainly be benign tumors diagnosed as sarcomas (n = 124), or non -sarcoma malignant tumors diagnosed as sarcomas (n = 77). The probability of discordance was higher for a final diagnosis of desmoid tumors when compared to liposarcomas (odds ratio = 5.1; 95%CI [2.6-10.4]). The expected costs per patient for the base-case analysis (low- and high-case scenarios) amounted to 8,791 ( 7,033 and 10,549, respectively) for option 1 and 8,904 ( 7,057 and 10,750, respectively) for option 2. Conclusions Our findings highlight misdiagnoses of sarcomas, which were found to most often be confused with benign tumors. Centralized histological reviews are likely to provide cost-savings for the French NHI.	[Perrier, Lionel; Morelle, Magali] Univ Lyon, Leon Berard Canc Ctr, GATE L SE UMR 5824, Lyon, France; [Perrier, Lionel; Rascle, Pauline; Morelle, Magali] Leon Berard Canc Ctr, DRCI, Direct Clin Res & Innovat, Lyon, France; [Toulmonde, Maud] Inst Bergonie, Dept Med, Bordeaux, France; [Vince, Dominique Ranchere] Canc Ctr Leon Berard, Dept Anatomopathol, Lyon, France; [Le Cesne, Axel] Inst Gustave Roussy, Dept Med, Villejuif, France; [Terrier, Philippe] Gustave Roussy, Dept Pathol, Villejuif, France; [Neuville, Agnes; Coindre, Jean-Michel] Inst Bergonie, Dept Anatomopathol, Bordeaux, France; [Meeus, Pierre] Canc Ctr Leon Berard, Dept Surg, Lyon, France; [Farsi, Fadila] Reseau Espace Sante Canc Rhone Alpes, Lyon, France; [Ducimetiere, Francoise; Coquard, Isabelle Ray] Sante Individu Soc EA INSERM 4129, Canc Ctr Leon Beard, Lyon, France; [Blay, Jean-Yves; Coquard, Isabelle Ray] Canc Ctr Leon Berard, Dept Med, Lyon, France; [Coindre, Jean-Michel] Univ Victor Segalen, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Institut Bergonie; UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Institut Bergonie; UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); UDICE-French Research Universities; Universite de Bordeaux	Perrier, L (corresponding author), Univ Lyon, Leon Berard Canc Ctr, GATE L SE UMR 5824, Lyon, France.; Perrier, L (corresponding author), Leon Berard Canc Ctr, DRCI, Direct Clin Res & Innovat, Lyon, France.	lionel.perrier@lyon.unicancer.fr	Blay, Jean-Yves/N-3966-2016; Perrier, Lionel/AAC-8048-2021	Blay, Jean-Yves/0000-0001-7190-120X; Perrier, Lionel/0000-0003-4487-8723	French National Cancer Institute (INCa) [2012-010/V0-HS]	French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France)	This work was supported by The French National Cancer Institute (http://www.e-cancer.fr/) (INCa), Convention INCa no 2012-010/V0-HS.	Arbiser ZK, 2001, AM J CLIN PATHOL, V116, P473; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P954, DOI 10.1002/pds.4233; Bleiweiss IJ, 2012, J CLIN ONCOL, V30, P2175, DOI 10.1200/JCO.2012.42.1255; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Coblentz TR, 2001, CANCER-AM CANCER SOC, V91, P1284, DOI 10.1002/1097-0142(20010401)91:7<1284::AID-CNCR1130>3.3.CO;2-5; Coindre JM, 2012, MODERN PATHOL, V25, p10A; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Epstein JI, 1996, AM J SURG PATHOL, V20, P851, DOI 10.1097/00000478-199607000-00008; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Hahm GK, 2001, ARCH PATHOL LAB MED, V125, P736; Institut National du Cancer (INCa), SYNTH ACT 2010 DOUBL; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kennecke HF, 2012, J CLIN ONCOL, V30, P2227, DOI 10.1200/JCO.2011.38.9247; Kronz JD, 1999, CANCER, V86, P2426, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3; Lapeyrere N, 2008, ANN PATHOL, V28, P478, DOI 10.1016/j.annpat.2008.09.044; Lehnhardt M, 2009, CHIRURG, V80, P341, DOI 10.1007/s00104-008-1562-2; Lehnhardt M, 2008, J SURG ONCOL, V97, P40, DOI 10.1002/jso.20897; LINDSEY PA, 1990, J HEALTH POLIT POLIC, V15, P543, DOI 10.1215/03616878-15-3-543; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Manion E, 2008, AM J SURG PATHOL, V32, P732, DOI 10.1097/PAS.0b013e31815a04f5; Mastrangelo G, 2012, CANCER-AM CANCER SOC, V118, P5339, DOI 10.1002/cncr.27555; Matasar MJ, 2012, ANN ONCOL, V23, P159, DOI 10.1093/annonc/mdr029; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; MCCARTHY EG, 1981, LANCET, V1, P1352; Raab SS, 2005, ARCH PATHOL LAB MED, V129, P459; Ray-Coquard I, 2004, ANN ONCOL, V15, P307, DOI 10.1093/annonc/mdh058; Ray-Coquard I, 2012, ANN ONCOL, V23, P2442, DOI 10.1093/annonc/mdr610; RUCHLIN HS, 1982, MED CARE, V20, P3, DOI 10.1097/00005650-198201000-00002; Sirota RL, 2006, ARCH PATHOL LAB MED, V130, P604; Thway Khin, 2009, Sarcoma, V2009, P741975, DOI 10.1155/2009/741975; Tomaszewski JE, 2000, AM J CLIN PATHOL, V114, P329, DOI 10.1093/ajcp/114.3.329; Zhang HY, 2010, AM J SURG PATHOL, V34, P1304, DOI 10.1097/PAS.0b013e3181e92d0b	32	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193330	10.1371/journal.pone.0193330	http://dx.doi.org/10.1371/journal.pone.0193330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621244	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800005
J	Seppanen, E; Tan, D; Corscadden, KJ; Currie, AJ; Richmond, PC; Thornton, RB; Kirkham, LAS				Seppanen, Elke; Tan, Dino; Corscadden, Karli J.; Currie, Andrew J.; Richmond, Peter C.; Thornton, Ruth B.; Kirkham, Lea-Ann S.			Evidence of functional cell-mediated immune responses to nontypeable Haemophilus influenzae in otitis-prone children	PLOS ONE			English	Article							NK CELLS; ADAPTIVE IMMUNITY; YOUNG-CHILDREN; MOUSE LUNG; MEMORY; LYMPHOCYTE; GENERATION; SUBSETS	Otitis media (OM) remains a common paediatric disease, despite advances in vaccinology. Susceptibility to recurrent acute OM (rAOM) has been postulated to involve defective cell-mediated immune responses to common otopathogenic bacteria. We compared the composition of peripheral blood mononuclear cells (PBMC) from 20 children with a history of rAOM (otitis-prone) and 20 healthy non-otitis-prone controls, and assessed innate and cell-mediated immune responses to the major otopathogen nontypeable Haemophilus influenzae (NTHi). NTHi was a potent stimulator of inflammatory cytokine secretion from PBMC within 4 hours, with no difference in cytokine levels produced between PBMC from cases or controls. In the absence of antigen stimulation, otitis-prone children had more circulating Natural Killer (NK) cells (p<0.01), particularly NKdim (CD56(lo)) cells (p<0.01), but fewer CD4(+) T cells (p<0.01) than healthy controls. NTHi challenge significantly increased the proportion of activated (CD107a(+)) NK cells in otitis-prone and non-otitis-prone children (p<0.01), suggesting that NK cells from otitis-prone children are functional and respond to NTHi. CD8(+) T cells and NK cells from both cases and controls produced IFN gamma in response to polyclonal stimulus (Staphylococcal enterotoxin B; SEB), with more IFN gamma(+) CD8(+) T cells present in cases than controls (p<0.05) but similar proportions of IFN gamma(+) NK cells. Otitis prone children had more circulating IFN gamma-producing NK cells (p<0.05) and more IFN gamma-producing CD4(+) (p<0.01) or CD8(+) T-cells (p<0.05) than healthy controls. In response to SEB, more CD107a-expressing CD8(+) T cells were present in cases than controls (p<0.01). Despite differences in PBMC composition, PBMC from otitis-prone children mounted innate and T cell-mediated responses to NTHi challenge that were comparable to healthy children. These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity.	[Seppanen, Elke; Corscadden, Karli J.; Richmond, Peter C.; Thornton, Ruth B.; Kirkham, Lea-Ann S.] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Tan, Dino] Univ Western Australia, Sch Med & Pharmacol, Ctr Resp Hlth, Perth, WA, Australia; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Currie, Andrew J.; Richmond, Peter C.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Richmond, Peter C.] Perth Childrens Hosp, Perth, WA, Australia; [Thornton, Ruth B.] Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia	Telethon Kids Institute; Wesfarmers Limited; University of Western Australia; Murdoch University; University of Western Australia; University of Western Australia	Kirkham, LAS (corresponding author), Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.	lea-ann.kirkham@uwa.edu.au	Tan, Dino BA/A-5876-2013; Kirkham, Lea-Ann S/A-5847-2013; Seppanen, Elke/AHD-5402-2022; Richmond, Peter C/G-3379-2012; Currie, Andrew/C-2778-2015; Tan, Dino/R-1423-2019; Thornton, Ruth/GOP-2314-2022	Kirkham, Lea-Ann S/0000-0001-5421-8126; Richmond, Peter C/0000-0001-7562-7228; Currie, Andrew/0000-0002-5193-3404; Seppanen, Elke/0000-0003-1673-4167; Thornton, Ruth/0000-0001-9852-8310	Australian National Health and Medical Research Council [1011306, 1061428]; Perth Children's Hospital Foundation [9420]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Perth Children's Hospital Foundation	This work was supported by the Australian National Health and Medical Research Council, https://www.nhmrc.gov.au/, (App#1011306 (LK) and 1061428 (LK)) and the Perth Children's Hospital Foundation, https://pchf.org.au/, formerly the Princess Margaret Hospital for Children Foundation (App#9420 (LK, AC, RT, PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Batoni G, 2005, SCAND J IMMUNOL, V62, P498, DOI 10.1111/j.1365-3083.2005.01692.x; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foxwell AR, 1998, IMMUNOL CELL BIOL, V76, P323, DOI 10.1046/j.1440-1711.1998.00740.x; Habib S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153223; Kaur R, 2011, VACCINE, V29, P1023, DOI 10.1016/j.vaccine.2010.11.055; Kendirli T, 2008, TURKISH J PEDIATR, V50, P63; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; King PT, 2008, CLIN EXP IMMUNOL, V153, P376, DOI 10.1111/j.1365-2249.2008.03697.x; King PT, 2008, CLIN EXP IMMUNOL, V152, P542, DOI 10.1111/j.1365-2249.2008.03667.x; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Kirkham Lea-Ann S, 2013, BMC Res Notes, V6, P522, DOI 10.1186/1756-0500-6-522; Kodama H, 1999, ACTA OTO-LARYNGOL, V119, P377, DOI 10.1080/00016489950181422; Ngo CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150949; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Pizzutto SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104236; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Sharma SK, 2013, CURR ALLERGY ASTHM R, V13, P495, DOI 10.1007/s11882-013-0370-z; Sharma SK, 2012, J INFECT DIS, V205, P1225, DOI 10.1093/infdis/jis179; Sharma SK, 2011, J INFECT DIS, V204, P645, DOI 10.1093/infdis/jir340; Strunk T, 2011, INNATE IMMUN-LONDON, V17, P508, DOI 10.1177/1753425910379840; Thornton RB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00556-16; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Wiertsema SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049061; Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193962	10.1371/journal.pone.0193962	http://dx.doi.org/10.1371/journal.pone.0193962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621281	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800012
J	Shimada, T; Ohori, M; Inagaki, Y; Shimooka, Y; Sugimura, N; Ishihara, I; Yoshida, T; Kobayashi, M				Shimada, Takeshi; Ohori, Manami; Inagaki, Yusuke; Shimooka, Yoko; Sugimura, Naoya; Ishihara, Ikuyo; Yoshida, Tomotaka; Kobayashi, Masayoshi			A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan	PLOS ONE			English	Article							INTRINSIC MOTIVATION; PREDICTIVE-VALIDITY; SOCIAL FUNCTION; COGNITION; NEUROCOGNITION; INPATIENTS; DEFICITS; SCALE; METACOGNITION; METAANALYSIS	The individualized occupational therapy (IOT) program is a psychosocial program that we developed to facilitate proactive participation in treatment and improve cognitive functioning and other outcomes for inpatients with acute schizophrenia. The program consists of motivational interviewing, self-monitoring, individualized visits, handicraft activities, individualized psychoeducation, and discharge planning. This multicenter, open-labeled, blinded-endpoint, randomized controlled trial evaluated the impact of adding IOT to a group OT (GOT) program as usual for outcomes in recently hospitalized patients with schizophrenia in Japanese psychiatric hospitals setting compared with GOT alone. Patients with schizophrenia were randomly assigned to the GOT+IOT group or the GOT alone group. Among 136 randomized patients, 129 were included in the intent-to-treat population: 66 in the GOT+IOT and 63 in the GOT alone groups. Outcomes were administered at baseline and discharge or 3 months following hospitalization including the Brief Assessment of Cognition in Schizophrenia Japanese version (BACS-J), the Schizophrenia Cognition Rating Scale Japanese version, the Social Functioning Scale Japanese version, the Global Assessment of Functioning scale, the Intrinsic Motivation Inventory Japanese version (IMI-J), the Morisky Medication Adherence Scale-8 (MMAS-8), the Positive and Negative Syndrome Scale (PANSS), and the Japanese version of Client Satisfaction Questionnaire-8 (CSQ-8J). Results of linear mixed effects models indicated that the IOT+GOT showed significant improvements in verbal memory (p <0.01), working memory (p = 0.02), verbal fluency (p < 0.01), attention (p < 0.01), and composite score (p < 0.01) on the BACS-J; interest/enjoyment (p < 0.01), value/usefulness (p < 0.01), perceived choice (p < 0.01), and IMI-J total (p < 0.01) on the IMI-J; MMAS-8 score (p < 0.01) compared with the GOT alone. Patients in the GOT+IOT demonstrated significant improvements on the CSQ-8J compared with the GOT alone (p < 0.01). The present findings provide support for the feasibility in implementing an IOT program and its effectiveness for improving cognitive impairment and other outcomes in patients with schizophrenia.	[Shimada, Takeshi; Yoshida, Tomotaka] Mental Support Soyokaze Hosp, Med Corp Seitaikai, Dept Occupat Therapy, Nagano, Japan; [Shimada, Takeshi; Kobayashi, Masayoshi] Shinshu Univ, Grad Sch Med, Dept Hlth Sci, Nagano, Japan; [Ohori, Manami] Azumi Hosp, North Alps Med Ctr, Dept Occupat Therapy, Nagano, Japan; [Inagaki, Yusuke] Nagano Prefectural Mental Wellness Ctr Komagane, Dept Occupat Therapy, Nagano, Japan; [Shimooka, Yoko] Iida Hosp, Social Med Corp Ritsuzankai, Dept Occupat Therapy, Nagano, Japan; [Sugimura, Naoya] Nanshin Hosp, Med Corp Akitsukai, Dept Occupat Therapy, Nagano, Japan; [Ishihara, Ikuyo] Matsuoka Hosp, Med Corp Aiseikai, Dept Occupat Therapy, Nagano, Japan	Shinshu University	Kobayashi, M (corresponding author), Shinshu Univ, Grad Sch Med, Dept Hlth Sci, Nagano, Japan.	mkobaya@shinshu-u.ac.jp			Japanese Association of Occupational Therapists [2016-01]	Japanese Association of Occupational Therapists	This study received a research grant from the Japanese Association of Occupational Therapists (http://www jaot.or.jp/). The grant was obtained by TS, and the grant number was 2016-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2010, CURR DIR PSYCHOL SCI, V19, P260, DOI 10.1177/0963721410377743; Allen CK., 1985, OCCUPATIONAL THERAPY; Almerie MQ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009006.pub2; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Barch DM, 2008, J ABNORM PSYCHOL, V117, P776, DOI 10.1037/a0013944; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Chan KKS, 2012, CLIN PSYCHOL REV, V32, P535, DOI 10.1016/j.cpr.2012.06.001; Choi J, 2010, SCHIZOPHR RES, V118, P12, DOI 10.1016/j.schres.2009.08.001; Choi J, 2010, SCHIZOPHRENIA BULL, V36, P966, DOI 10.1093/schbul/sbp030; Dickey B, 2003, ARCH GEN PSYCHIAT, V60, P340, DOI 10.1001/archpsyc.60.4.340; Duncombe LW, 2004, AM J OCCUP THER, V58, P272, DOI 10.5014/ajot.58.3.272; Emsley R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-50; Ferri F, 2012, CONSCIOUS COGN, V21, P1365, DOI 10.1016/j.concog.2012.05.001; Fervaha G, 2014, JAMA PSYCHIAT, V71, P1058, DOI 10.1001/jamapsychiatry.2014.1105; FIDLER GS, 1981, AM J OCCUP THER, V35, P566, DOI 10.5014/ajot.35.9.567; Flavell J.H., 1976, NATURE INTELLIGENCE, P231, DOI DOI 10.1038/HDY.1976.85; Foruzandeh N, 2013, JPN J NURS SCI, V10, P136, DOI 10.1111/j.1742-7924.2012.00211.x; Foussias G, 2015, SCHIZOPHR RES, V166, P276, DOI 10.1016/j.schres.2015.05.019; Goncalves-Bradley DC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub5; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green Michael F, 2014, Schizophr Res Cogn, V1, pe1; Haddock G, 2005, SCHIZOPHRENIA BULL, V31, P697, DOI 10.1093/schbul/sbi029; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Horghagen S, 2014, SCAND J OCCUP THER, V21, P145, DOI 10.3109/11038128.2013.866691; Hoshii J, 2013, CLIN REHABIL, V27, P638, DOI 10.1177/0269215512473136; Johnstone P, 1999, BRIT MED J, V318, P1387, DOI 10.1136/bmj.318.7195.1387; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; Kaneda Y., 2010, CLIN PSYCHIATR, V52, P1027; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kayama A, 2014, OCCUPATIONAL THERAPY; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Keefe RSE, 2015, EUR NEUROPSYCHOPHARM, V25, P176, DOI 10.1016/j.euroneuro.2014.06.009; Keefe RSE, 2014, JAMA PSYCHIAT, V71, P987, DOI 10.1001/jamapsychiatry.2014.1281; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Keefe RSE, 2006, AM J PSYCHIAT, V163, P426, DOI 10.1176/appi.ajp.163.3.426; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; Kreyenbuhl Julie, 2010, Schizophr Bull, V36, P94, DOI 10.1093/schbul/sbp130; Kurtz MM, 2011, CLIN PSYCHOL REV, V31, P663, DOI 10.1016/j.cpr.2011.02.008; Lepage M, 2014, CAN J PSYCHIAT, V59, P5, DOI 10.1177/070674371405900103; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; Lysaker PH, 2010, ACTA PSYCHIAT SCAND, V122, P405, DOI 10.1111/j.1600-0447.2010.01554.x; Lysaker PH, 2015, J NERV MENT DIS, V203, P530, DOI 10.1097/NMD.0000000000000323; Lysaker PH, 2011, SCHIZOPHR RES, V131, P214, DOI 10.1016/j.schres.2011.06.011; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Medalia A, 2002, REMEDIATION COGNITIV; Medalia A, 2011, SCHIZOPHRENIA BULL, V37, pS122, DOI 10.1093/schbul/sbr063; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Ministry of Health Labour and Welfare, 2015, PAT SURV 2014; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Moritz S, 2011, PSYCHOL MED, V41, P1823, DOI 10.1017/S0033291710002618; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; Morriss R, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; Murphy SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001087.pub5; Nakagami E, 2010, SCHIZOPHRENIA BULL, V36, P935, DOI 10.1093/schbul/sbq043; Nelson TO, 1990, PSYCHOL LEARNING MOT; Nemoto T., 2008, JPN B SOC PSYCHIATR, V17, P188; Nuechterlein KH, 2014, AM J PSYCHIATR REHAB, V17, P225, DOI 10.1080/15487768.2014.935674; Nurjannah I, 2014, J CLIN NURS, V23, P1175, DOI 10.1111/jocn.12297; Odes H, 2011, AM J OCCUP THER, V65, P314, DOI 10.5014/ajot.2011.001362; Pekkala ET., 2002, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD002831, 10.1002/14651858.CD002831]; Shimada T, 2016, HONG KONG J OCCUP TH, V28, P7, DOI 10.1016/j.hkjot.2016.10.002; Shimada T, 2016, OCCUP THER INT, V23, P425, DOI 10.1002/oti.1445; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; TACHIMORI H, 1999, CLIN PSYCHIATR, V41, P711; Tanaka C, 2014, CLIN REHABIL, V28, P740, DOI 10.1177/0269215514521440; Uchiyama N, 2012, CLIN PSYCHIATR, V54, P1201; Velligan DI, 2000, AM J PSYCHIAT, V157, P1317, DOI 10.1176/appi.ajp.157.8.1317; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P741, DOI 10.1093/schbul/sbq144; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855	75	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193869	10.1371/journal.pone.0193869	http://dx.doi.org/10.1371/journal.pone.0193869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621261	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800009
J	Howell, DA; Hart, RI; Smith, AG; Macleod, U; Patmore, R; Cook, G; Roman, E				Howell, Debra A.; Hart, Ruth I.; Smith, Alexandra G.; Macleod, Una; Patmore, Russell; Cook, Gordon; Roman, Eve			Myeloma: Patient accounts of their pathways to diagnosis	PLOS ONE			English	Article							HEMATOLOGICAL MALIGNANCY RESEARCH; MULTIPLE-MYELOMA; CANCER-DIAGNOSIS; RESEARCH NETWORK; PRIMARY-CARE; QUALITATIVE DESCRIPTION; SUB-TYPE; SURVIVAL; DELAY; ROUTES	Background Pathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP consultations and emergency presentation. This is the first qualitative study to examine events leading to diagnosis by asking patients about their experiences during this time. Methods Set within a UK population-based cohort, semi-structured interviews were conducted with 20 myeloma patients with varying characteristics and pathways, 12 of whom invited their relatives to take part. Interviews were audio-recorded and qualitative analysis undertaken. Results Pre-diagnostic awareness of myeloma was minimal. Disease onset was typically described as gradual, and health changes vague but progressive, with increasing loss of function. A wide range of symptoms was reported, with the similarity of these to self-limiting conditions failing to raise suspicion of myeloma among patients and GPs. Patients tended to normalise symptoms at first, although all eventually sought GP advice. GPs often initially suggested benign diagnoses, which were sometimes only revised after multiple consultations with persistent/worsening symptoms. Referrals were made to various hospital specialities, and haematology if associated with abnormal blood tests suggestive of myeloma. Once in secondary care, progress towards diagnosis was generally rapid. Conclusions Accounts confirmed that pathways to diagnosis could be difficult, largely due to the way myeloma presents, and how symptoms are interpreted and managed by patients and GPs. Recognition of 'normal' health and consultation patterns for the individual could promote appropriate help-seeking and timely referral when changes occur, and may be more effective than raising awareness about the myriad of potential symptoms associated with this disease.	[Howell, Debra A.; Hart, Ruth I.; Smith, Alexandra G.; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York, N Yorkshire, England; [Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Patmore, Russell] Castle Hill Hosp, Queens Ctr Oncol & Haematol, Dept Haematol, Kingston Upon Hull, N Humberside, England; [Cook, Gordon] St James Univ Hosp, St Jamess Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England; [Hart, Ruth I.] Univ Edinburgh, Old Med Sch, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of York - UK; University of Hull; University of York - UK; University of Hull; Saint James's University Hospital; University of Edinburgh	Howell, DA (corresponding author), Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York, N Yorkshire, England.	debra.howell@york.ac.uk	Howell, Debra/P-3742-2018	Howell, Debra/0000-0002-7521-7402; Roman, Eve/0000-0001-7603-3704	Cancer Research UK (CRUK) [C38860/A13509]; Bloodwise [15037]	Cancer Research UK (CRUK)(Cancer Research UK); Bloodwise	This study was funded by Cancer Research UK (CRUK): Grant reference C38860/A13509. The Haematological Malignancy Research Network (HMRN) is funded by Bloodwise: Grant reference 15037. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We are grateful to the patients and relatives who took part in this study and shared their experiences with us. This study was funded by Cancer Research UK (National Awareness and Early Diagnosis Initiative): grant reference C38860/A13509; HMRN is funded by Bloodwise: grant reference 15037.	ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Black G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135027; Burt R.S., 2005, BROKERAGE CLOSURE IN; Department of Health, 2000, NHS CANC PLAN PLAN I; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Glaser B.G., 1965, AWARENESS DYING; Howell D, 2017, BRIT J HAEMATOL, V177, P67, DOI 10.1111/bjh.14513; Howell Debra A, 2013, BMC Hematol, V13, P9, DOI 10.1186/2052-1839-13-9; Kariyawasan CC, 2007, QJM-INT J MED, V100, P635, DOI 10.1093/qjmed/hcm077; Keeble S, 2014, INT J CANCER, V135, P1220, DOI 10.1002/ijc.28763; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Mitchell ED, 2015, BRIT J CANCER, V112, pS50, DOI 10.1038/bjc.2015.42; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Neal RD, 2013, BRIT J CANCER, V110, P584; NICE, 2015, SUSP CANC REC REF; *NICE, 2005, REF GUID SUSP CANC; Pope C, 2006, QUALITATIVE RES HLTH; Roman E, 2016, CANCER EPIDEMIOL, V42, P186, DOI 10.1016/j.canep.2016.03.011; Rubin GP, 2015, BRIT J CANCER, V112, P676, DOI 10.1038/bjc.2014.634; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE106, DOI 10.3399/bjgp15X683545; Smith A, 2015, BRIT J CANCER, V112, P1575, DOI 10.1038/bjc.2015.94; Smith A, 2011, BRIT J CANCER, V105, P1684, DOI 10.1038/bjc.2011.450; Smith A, 2010, BRIT J HAEMATOL, V148, P739, DOI 10.1111/j.1365-2141.2009.08010.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194788	10.1371/journal.pone.0194788	http://dx.doi.org/10.1371/journal.pone.0194788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617390	Green Published, gold, Green Accepted			2022-12-27	WOS:000429203800049
J	Kenyon, CR				Kenyon, Chris R.			HIV prevalence by ethnic group covaries with prevalence of herpes simplex virus-2 and high-risk sex in Uganda: An ecological study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNITED-STATES; PARTNER-CONCURRENCY; AIDS MORTALITY; SOUTH-AFRICA; INFECTION; BEHAVIOR; TYPE-2; ASSOCIATION; SEROPREVALENCE	Background HIV prevalence varies from 1.7% to 14.8% between ethnic groups in Uganda. Understanding the factors responsible for this heterogeneity in HIV spread may guide prevention efforts. Methods We evaluated the relationship between HIV prevalence by ethnic group and a range of risk factors as well as the prevalence of herpes simplex virus-2 (HSV-2), syphilis and symptomatic STIs in the 2004/2005 Uganda HIV/AIDS Sero-Behavioural Survey a two stage, nationally representative, population based survey of 15-59-year-olds. Spearman's correlation was used to assess the relationship between HIV prevalence and each variable. Results There was a positive association between HIV prevalence and HSV-2, symptomatic STIs and high-risk sex (sex with a non-cohabiting, non-marital partner) for women. Non-significant positive associations were present between HIV and high-risk sex for men and lifetime number of partners for men and women. Conclusion Variation in sexual behavior may contribute to the variations in HIV, HSV-2 and other STI prevalence by ethnic group in Uganda. Further work is necessary to delineate which combinations of risk factors determine differential STI spread in Uganda.	[Kenyon, Chris R.] Inst Trop Med, HIV STI Unit, Antwerp, Belgium; [Kenyon, Chris R.] Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa	Institute of Tropical Medicine (ITM); University of Cape Town	Kenyon, CR (corresponding author), Inst Trop Med, HIV STI Unit, Antwerp, Belgium.; Kenyon, CR (corresponding author), Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa.	ckenyon@itg.be		Kenyon, Chris/0000-0002-2557-8998				Aral SO, 2005, J INFECT DIS, V191, pS1, DOI 10.1086/425290; Aral SO, 1996, J INFECT DIS, V174, pS127, DOI 10.1093/infdis/174.Supplement_2.S127; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Chesson HW, 2003, SEX TRANSM DIS, V30, P419, DOI 10.1097/00007435-200305000-00008; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Dingemanse M., ETHNOLINGUISTIC MAP; Fabiani Massimo, 2007, Confl Health, V1, P3, DOI 10.1186/1752-1505-1-3; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Glynn JR, 2008, SEX TRANSM INFECT, V84, P356, DOI 10.1136/sti.2008.030056; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; HACKETT C J, 1953, Bull World Health Organ, V8, P129; HACKETT CJ, 1947, BRIT MED J, V1, P88, DOI 10.1136/bmj.1.4489.88; HOGLE JA, 2002, WHAT HAPPENED UGANDA; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, 2014, INTERDISCIPLINARY PE; Kenyon C, 2016, JOURNAL OF SEXUALLY; Kenyon CR, 2016, EPIDEMIOL INFECT, V144, P556, DOI 10.1017/S095026881500165X; Kenyon C, 2013, INT J STD AIDS, V24, P804, DOI 10.1177/0956462413482810; Kenyon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064080; Kenyon C, 2012, INT J INFECT DIS, V16, pE826, DOI 10.1016/j.ijid.2012.05.008; Kenyon CR, 2016, EPIDEMICS-NETH, V15, P56, DOI 10.1016/j.epidem.2016.02.002; Kenyon CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140835; Kenyon CR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004711; Kenyon CR, 2014, INT J INFECT DIS, V29, P54, DOI 10.1016/j.ijid.2014.05.014; Kenyon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106230; Knopf A, 2014, SOC SCI MED, V108, P175, DOI 10.1016/j.socscimed.2014.01.039; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Mishra V., 2009, LEVELS SPREAD HIV SE; Morris M, 2008, SEXUALLY TRANSMITTED, pxxv; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Oluoch T, 2011, OPEN AIDJ, V5; Osbak K, SEX TRANSM IN PRESS; Rubaihayo J, 2010, INFECT DIS REP, V2, P40, DOI [10.4081/idr.2010.e13, 10.4081/idr.2010.1585]; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; South African Department of Health, 2013, 2012 NAT ANT SENT HI; Uganda Ministry of Health, 2012, UG AIDS IND SURV 201; van Rooijen MS, 2016, SEX TRANSM INFECT, V92, P257, DOI 10.1136/sextrans-2015-052213; WAWER MJ, 1994, BRIT MED J, V308, P171, DOI 10.1136/bmj.308.6922.171; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195431	10.1371/journal.pone.0195431	http://dx.doi.org/10.1371/journal.pone.0195431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617423	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800085
J	Lee, EH; Park, CH; Choi, HJ; Kawala, RA; Bai, HW; Chung, BY				Lee, Eun-Hee; Park, Chul Hong; Choi, Hyo Jin; Kawala, Remigius Ambrose; Bai, Hyoung-Woo; Chung, Byung Yeoup			Dexamethasone modified by gamma irradiation as a novel anticancer drug in human non-small cell lung cancer	PLOS ONE			English	Article							PROSTATE-CANCER; GLUCOCORTICOIDS; CYTOTOXICITY; DOXORUBICIN; ROTENONE; CYCLE	Dexamethasone (Dex) is widely used in the management of leukemia and lymphoma. While Dex is commonly used for hematological malignancies, the effects of Dex in solid cancer cells remain controversial. To develop a more effective anticancer drug for solid cancers, Dex was modified by ionizing radiation and the anticancer activity of ionizing-radiation-irradiated Dex (Dex-IR) was investigated in human lung cancer cells. Using the MTT assay, the proliferation of non-small cell lung cancer cells was significantly inhibited after treatment with Dex-IR compared with Dex. Furthermore, Dex-IR induced apoptotic cell death and cell cycle arrest of H1650 human lung cancer cells. The invasiveness of H1650 cells was significantly reduced and the matrix metalloproteinase activity was strongly suppressed. These results indicate that Dex-IR acts as a tumor suppressor by both inducing apoptosis and arresting the cell cycle. Although the structure of Dex-IR remains to be determined, our results suggest it may be useful as a novel anticancer agent for the treatment of solid cancers.	[Lee, Eun-Hee; Park, Chul Hong; Choi, Hyo Jin; Kawala, Remigius Ambrose; Bai, Hyoung-Woo; Chung, Byung Yeoup] Korea Atom Energy Inst KAERI, Res Div Biotechnol, Adv Radiat Technol Inst ARTI, 29 Geumgu Gil, Jeongeup Si, Jeollabuk Do, South Korea; [Lee, Eun-Hee] Daegu Gyeongbuk Med Innovat Fdn, Med Device Dev Ctr, Daegu, South Korea; [Kawala, Remigius Ambrose; Bai, Hyoung-Woo] Univ Sci & Technol UST, Radiat Biotechnol & Appl Radioisotope Sci, Daejeon, South Korea	University of Science & Technology (UST)	Bai, HW; Chung, BY (corresponding author), Korea Atom Energy Inst KAERI, Res Div Biotechnol, Adv Radiat Technol Inst ARTI, 29 Geumgu Gil, Jeongeup Si, Jeollabuk Do, South Korea.; Bai, HW (corresponding author), Univ Sci & Technol UST, Radiat Biotechnol & Appl Radioisotope Sci, Daejeon, South Korea.	hbai@kaeri.re.kr; bychung@kaeri.re.kr		Kawala, Remigius Ambrose/0000-0001-9566-2151	Ministry of Science, ICT & Future Planning; Basic Science Research Program; Original Technology Research Program for Brain Science through the National Research Foundation - Korean government, MSIT [NRF-2016M3C7A1913933]	Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program; Original Technology Research Program for Brain Science through the National Research Foundation - Korean government, MSIT(Ministry of Science & ICT (MSIT), Republic of Korea)	This research was funded by the Ministry of Science, ICT & Future Planning and by the Basic Science Research Program and also the Original Technology Research Program for Brain Science through the National Research Foundation funded by the Korean government, MSIT(NRF-2016M3C7A1913933).The funders had a role in study design, data collection and analysis, and preparation of the manuscript.	Badaboina S, 2015, INT J MOL SCI, V16, P16806, DOI 10.3390/ijms160816806; Di Carlo A, 2006, ONCOL REP, V15, P1321; Fakih M, 2002, UROLOGY, V60, P553, DOI 10.1016/S0090-4295(02)01741-7; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Geng Y, 2014, GENET MOL RES, V13, P6827, DOI 10.4238/2014.August.29.4; Gennari A, 1996, ANN ONCOL, V7, P978, DOI 10.1093/oxfordjournals.annonc.a010806; Gundisch S, 2012, ANTICANCER RES, V32, P4251; Herr I, 2006, LANCET ONCOL, V7, P425, DOI 10.1016/S1470-2045(06)70694-5; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Jung HJ, 2009, RADIAT PHYS CHEM, V78, P386, DOI 10.1016/j.radphyschem.2009.03.004; Kim TH, 2011, BIOORG MED CHEM LETT, V21, P1512, DOI 10.1016/j.bmcl.2010.12.122; Komiya A, 2010, ONCOL LETT, V1, P73, DOI 10.3892/ol_00000013; Lee EH, 2017, ONCOTARGET, V8, P20645, DOI 10.18632/oncotarget.15830; Ling YH, 1996, MOL PHARMACOL, V49, P832; Lupertz R, 2010, TOXICOLOGY, V271, P115, DOI 10.1016/j.tox.2010.03.012; Park CH, 2013, BIOORG MED CHEM LETT, V23, P1099, DOI 10.1016/j.bmcl.2012.12.003; Paul-Clark MJ, 2002, P NATL ACAD SCI USA, V99, P1677, DOI 10.1073/pnas.022641099; Strehl C, 2011, CLIN EXP RHEUMATOL, V29, pS13; Wang H, 2007, INT J ONCOL, V30, P947; Wang LJ, 2016, ACTA PHARMACOL SIN, V37, P845, DOI 10.1038/aps.2016.39; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	21	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194341	10.1371/journal.pone.0194341	http://dx.doi.org/10.1371/journal.pone.0194341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617386	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800027
J	Tramuto, F; Maida, CM; Pojero, F; Colomba, GME; Casucciol, A; Restivo, V; Vitale, F				Tramuto, Fabio; Maida, Carmelo Massimo; Pojero, Fanny; Colomba, Giuseppina Maria Elena; Casucciol, Alessandra; Restivo, Vincenzo; Vitale, Francesco			Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies	PLOS ONE			English	Article							WILD-TYPE; VIRUS; ELIMINATION; INFECTION; EPITOPES; PROGRESS	Following the indication of the World Health Organization, a national plan for the elimination of measles was approved in Italy and this included the improvement of the molecular surveillance of measles viruses and the interruption of indigenous transmission of the disease. Nevertheless, large outbreaks continue to occur in almost all regions of the country, including Sicily. Here we describe the epidemiology and molecular dynamics of measles viruses as a result of the measles surveillance activity carried out by the "Reference Laboratory for Measles and Rubella" in Sicily over a 5-year period. Biological samples of 259 suspected measles cases were tested for viral RNA detection and a total of 223 (86.1%) were classified as laboratory confirmed. The median age of confirmed measles cases was 21.0 years and about half of them were adults aged 19 years and older. Overall, one-third of the patients showed clinical complications and these latter were more common among adults than children (44.9% vs. 25.7%). The vast majority of measles cases were unvaccinated (94.2%, n = 210). The phylogenetic analysis of 221 measles virus nucleotide sequences revealed sporadic detections of genotypes D4 and H1, while endemic circulation of genotypes D8 and B3 was documented. Genotype D8 was associated with epidemics occurred between 2013 and 2016, whereas genotype B3 was more recently introduced into Sicily characterizing the current measles outbreak. The results of this study confirm the autochthonous co-circulation of viral variants belonging to different genotypes during the study period, and emphasizes the need of measles surveillance programmes in order to investigate the viral dynamics, the pathways of disease transmission, and to eventually adapt the development of successfull vaccine formulations.	[Tramuto, Fabio; Maida, Carmelo Massimo; Pojero, Fanny; Colomba, Giuseppina Maria Elena; Casucciol, Alessandra; Restivo, Vincenzo; Vitale, Francesco] Univ Palermo, Dept Hlth Promot Sci & Mother Child Care G DAless, Hyg Sect, Palermo, Italy; [Tramuto, Fabio; Maida, Carmelo Massimo; Vitale, Francesco] Univ Hosp Paolo Giaccone, Clin Epidemiol Unit, Palermo, Italy	University of Palermo; University of Palermo; Policlinico Paolo Giaccone	Tramuto, F (corresponding author), Univ Palermo, Dept Hlth Promot Sci & Mother Child Care G DAless, Hyg Sect, Palermo, Italy.; Tramuto, F (corresponding author), Univ Hosp Paolo Giaccone, Clin Epidemiol Unit, Palermo, Italy.	fabio.tramuto@unipa.it	maida, carmelo massimo/AAH-1838-2021; Vitale, Francesco/AAC-6013-2022; Colomba, Giuseppina Maria Elena/AAI-6138-2021; Tramuto, Fabio/AAM-3478-2021	maida, carmelo massimo/0000-0002-6989-9259; Vitale, Francesco/0000-0002-6354-8060; Tramuto, Fabio/0000-0003-0108-4608; casuccio, alessandra/0000-0002-5676-9535	Regional Plan for Prevention Assessorato Regionale della Salute; Regione Siciliana	Regional Plan for Prevention Assessorato Regionale della Salute; Regione Siciliana(Regione Sicilia)	This research was funded by the Regional Plan for Prevention Assessorato Regionale della Salute, Regione Siciliana approved through the resolution no. 351 of 8 March 2016, to implement the understanding between State and Regions of 30 July 2015, Progetti Obiettivo di Piano Sanitario Nazionale 2015. Linea progettuale 2.9.15.3 Implementazione della rete di sorveglianza epidemiologico-molecolare per il morbillo e la rosolia del Piano Regionale della Prevenzione 2016-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley SF, 2017, GENOTYPE SPECIFIC ME; Amendola A, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.33.30596; Amendola A, 2017, INFECT GENET EVOL, V48, P120, DOI 10.1016/j.meegid.2016.12.013; Munoz-Alia MA, 2017, VIRUS RES, V236, P30, DOI 10.1016/j.virusres.2017.04.018; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; [Anonymous], GLOB MEASL RUB STRAT; Aquino F, 2017, VACCINE, V35, P4494, DOI 10.1016/j.vaccine.2017.07.029; Bankamp B, 2013, J CLIN VIROL, V58, P176, DOI 10.1016/j.jcv.2013.05.018; Berti E, 2016, EPIDEMIOL INFECT, V144, P2605, DOI 10.1017/S0950268816001023; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; Chibo D, 2000, J GEN VIROL, V81, P2511, DOI 10.1099/0022-1317-81-10-2511; degli Atti MC, 2017, PEDIATR INFECT DIS J, V36, P844, DOI 10.1097/INF.0000000000001609; El Mubarak HS, 2007, J GEN VIROL, V88, P2028, DOI 10.1099/vir.0.82804-0; European Centre for Disease Prevention and Control (ECDC), MEASL CAS DEF; European Centre for Disease Prevention and Control (ECDC), MONTHL MEASL EP UPD; Filia A, 2016, EUROSURVEILLANCE, V21; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Grammens T, 2016, EUROSURVEILLANCE, V21, P17, DOI 10.2807/1560-7917.ES.2016.21.32.30313; Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032; Hukic M, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.9.21047; Istituto Superiore di (National Institute of Health Rome), 2017, EP WEEKL B MEASL IT, V35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Magurano F, 2015, J CLIN VIROL, V64, P34, DOI 10.1016/j.jcv.2014.12.019; Ministero della Salute, PIAN NAZ EL MORB ROS; Munoz-Alfa MA, 2017, J VIROL, V91, DOI 10.1128/JVI.00209-17; Nasab GSF, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw089; Nic Lochlainn L, 2016, EUROSURVEILLANCE, V21; O'Connor P, 2017, CLIN MICROBIOL INFEC, V23, P504, DOI 10.1016/j.cmi.2017.01.003; Pan American Health Organization and World Health Organization (PAHO/ WHO), 2016, REG AM DECL MEASL; Piccirilli G, 2016, J CLIN VIROL, V81, P34, DOI 10.1016/j.jcv.2016.05.018; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tramuto F, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES2015.20.20.21134; Trentini F, 2017, LANCET INFECT DIS, V17, P1089, DOI 10.1016/S1473-3099(17)30421-8; Tu B, 2016, EPIDEMIOL INFECT, V144, P2613, DOI 10.1017/S0950268816001114; van Boven M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003061; World Health Organization (WHO), 2016, INF STAT MEASL RUB E; World Health Organization (WHO) D Dept. of Immunization Vaccines and Biologicals, MAN LAB DIAGN MEASL; Woudenberg T, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.3.30443	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195256	10.1371/journal.pone.0195256	http://dx.doi.org/10.1371/journal.pone.0195256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617454	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800071
J	Zhang, MS; Kelso, JAS; Tognoli, E				Zhang, Mengsen; Kelso, J. A. Scott; Tognoli, Emmanuelle			Critical diversity: Divided or united states of social coordination	PLOS ONE			English	Article							PHASE-TRANSITIONS; MULTIFREQUENCY COORDINATION; DYNAMICS; SYNCHRONIZATION; COMPLEXITY; OSCILLATORS; SEGREGATION; INTEGRATION; MECHANISM; NETWORKS	Much of our knowledge of coordination comes from studies of simple, dyadic systems or systems containing large numbers of components. The huge gap 'in between' is seldom addressed, empirically or theoretically. We introduce a new paradigm to study the coordination dynamics of such intermediate-sized ensembles with the goal of identifying key mechanisms of interaction. Rhythmic coordination was studied in ensembles of eight people, with differences in movement frequency ('diversity) manipulated within the ensemble. Quantitative change in diversity led to qualitative changes in coordination, a critical value separating regimes of integration and segregation between groups. Metastable and multifrequency coordination between participants enabled communication across segregated groups within the ensemble, without destroying overall order. These novel findings reveal key factors underlying coordination in ensemble sizes previously considered too complicated or 'messy' for systematic study and supply future theoretical/computational models with new empirical checkpoints.	[Zhang, Mengsen; Kelso, J. A. Scott; Tognoli, Emmanuelle] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Kelso, J. A. Scott] Ulster Univ, Intelligent Syst Res Ctr, Derry Londonderry, North Ireland	State University System of Florida; Florida Atlantic University; Ulster University	Zhang, MS (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	zhang@ccs.fau.edu		Zhang, Mengsen/0000-0003-3085-152X	National Institute of Mental Health [MH080838, EB025819]; Chaire d'Excellence Pierre de Fermat; Davimos Family Endowment for Excellence in Science; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB025819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Chaire d'Excellence Pierre de Fermat(Region Occitanie); Davimos Family Endowment for Excellence in Science; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH080838 and EB025819), the Chaire dExcellence Pierre de Fermat, and the Davimos Family Endowment for Excellence in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of Mental Health (MH080838), the Chaire d'Excellence Pierre de Fermat, and the Davimos Family Endowment for Excellence in Science. The paper is dedicated to Dr. Thomas C. Schelling, who passed away on December 13, 2016 and is best known to complex system scientists for his seminal paper "Dynamic models of segregation" (1971, The Journal of Mathematical Sociology). We thank Dr. Roxana Stefanescu for assisting in data collection.	Alderisio F, 2016, BIOL CYBERN, V110, P151, DOI 10.1007/s00422-016-0685-7; [Anonymous], 2009, COMPLEX ADAPTIVE SYS; Arnold V. I., 2009, COLLECTED WORKS REPR, P152; Ash J, 2007, PHYSICA A, V380, P673, DOI 10.1016/j.physa.2006.12.058; Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Blau P.M., 1977, INEQUALITY HETEROGEN; Boiger M, 2012, EMOT REV, V4, P221, DOI 10.1177/1754073912439765; BROWN FA, 1959, SCIENCE, V130, P1535, DOI 10.1126/science.130.3388.1535; BUCK J, 1976, SCI AM, V234, P74; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G., 2006, RHYTHMS BRAIN; Camazine S., 2003, SELF ORG BIOL SYSTEM; CARNEIRO RL, 1967, SOUTHWEST J ANTHROP, V23, P234, DOI 10.1086/soutjanth.23.3.3629251; Changizi MA, 2005, COMPLEXITY, V10, P13, DOI 10.1002/cplx.20085; DEGUZMAN GC, 1991, BIOL CYBERN, V64, P485, DOI 10.1007/BF00202613; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Edelman GM, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P139; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fogel A., 1992, SOC DEV, V1, P122, DOI [10.1111/j.1467-9507.1992.tb00116.x, DOI 10.1111/J.1467-9507.1992.TB00116.X, https://doi.org/10.1111/j.1467-9507.1992.tb00116.x]; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; Fuchs A, 2013, NONLINEAR DYNAMICS C; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; Haken H, 1996, PHYSICA D, V90, P179, DOI 10.1016/0167-2789(95)00235-9; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HAKEN H, 2004, SYNERGETICS INTRO AD; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JEKA JJ, 1995, J EXP PSYCHOL HUMAN, V21, P360, DOI 10.1037/0096-1523.21.2.360; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso J. A. S., 1988, Neural and Synergetic Computers. Proceedings of the International Symposium, P180; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kelso JAS, 2008, ECOL PSYCHOL, V20, P180, DOI 10.1080/10407410801949297; Kelso JAS, 2014, CRITICALITY IN NEURAL SYSTEMS, P67; Kelso JAS, 2013, NEURAL NETWORKS, V37, P120, DOI 10.1016/j.neunet.2012.09.003; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kelso JAS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00023; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KELSO JAS, 1992, J EXP PSYCHOL HUMAN, V18, P645, DOI 10.1037/0096-1523.18.3.645; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kostrubiec V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142029; Kuramoto Y., 2002, Nonlinear Phenomena in Complex Systems, V5, P380; Kuramoto Y., 1983, CHEM OSCILLATIONS WA; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lemke J.L., 2000, MIND CULTURE ACTIVIT, V7, P273, DOI [10.1207/S15327884MCA0704_03, DOI 10.1207/S15327884MCA0704_03]; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Nishikawa T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.114101; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O., 2009, ENCY COMPLEXITY SYST, V19, P8198, DOI DOI 10.1007/978-0-387-30440-3_486; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Parra J, 2003, BRAIN, V126, P1164, DOI 10.1093/brain/awg109; PEPER CE, 1995, J EXP PSYCHOL HUMAN, V21, P1117, DOI 10.1037/0096-1523.21.5.1117; Pfau T, 2009, SCIENCE, V325, P289, DOI 10.1126/science.1174605; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00405; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schelling T., 1978, MICROMOTIVES MACROBE; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; SCHONER G, 1988, J THEOR BIOL, V135, P501, DOI 10.1016/S0022-5193(88)80273-X; SCHONER G, 1990, J THEOR BIOL, V142, P359, DOI 10.1016/S0022-5193(05)80558-2; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Sekara V, 2016, P NATL ACAD SCI USA, V113, P9977, DOI 10.1073/pnas.1602803113; Simon HA., 1977, MODELS OF DISCOVERY, P245, DOI [10.1007/978-94-010-9521-1_14, DOI 10.1007/978-94-010-9521-1_14]; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stark TH, 2012, SOCIOL EDUC, V85, P179, DOI 10.1177/0038040711427314; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Strogatz S., 2003, HYPERION, DOI [DOI 10.1063/1.1784276, 10.1063/1.1784276]; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; STROGATZ SH, 1993, SCI AM, V269, P102, DOI 10.1038/scientificamerican1293-102; Takamatsu A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228102; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tognoli E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00122; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Von Holst E., 1973, COLLECTED PAPERS E V, V1, P3; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; Winfree AT., 1980, GEOMETRY BIOL TIME; Wunderlich F., 2008, STUDIES ENV AESTHETI, V6, P91; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	105	19	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193843	10.1371/journal.pone.0193843	http://dx.doi.org/10.1371/journal.pone.0193843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617371	Green Published, Green Submitted, gold			2022-12-27	WOS:000429203800014
J	Abramowitz, MK; Hall, CB; Amodu, A; Sharma, D; Androga, L; Hawkins, M				Abramowitz, Matthew K.; Hall, Charles B.; Amodu, Afolarin; Sharma, Deep; Androga, Lagu; Hawkins, Meredith			Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study	PLOS ONE			English	Article							LEAN MASS; INDEX; SARCOPENIA; OBESITY; HEALTH; ASSOCIATION; OUTCOMES; WHITE; MODEL; RISK	Background The level of body-mass index (BMI) associated with the lowest risk of death remains unclear. Although differences in muscle mass limit the utility of BMI as a measure of adiposity, no study has directly examined the effect of muscle mass on the BMI-mortality relationship. Methods Body composition was measured by dual-energy x-ray absorptiometry in 11,687 participants of the National Health and Nutrition Examination Survey 1999-2004. Low muscle mass was defined using sex-specific thresholds of the appendicular skeletal muscle mass index (ASMI). Proportional hazards models were created to model associations with all-cause mortality. Results At any level of BMI >= 22, participants with low muscle mass had higher body fat percentage (%TBF), an increased likelihood of diabetes, and higher adjusted mortality than other participants. Increases in %TBF manifested as 30-40% smaller changes in BMI than were observed in participants with preserved muscle mass. Excluding participants with low muscle mass or adjustment for ASMI attenuated the risk associated with low BMI, magnified the risk associated with high BMI, and shifted downward the level of BMI associated with the lowest risk of death. Higher ASMI was independently associated with lower mortality. Effects were similar in never-smokers and ever-smokers. Additional adjustment for waist circumference eliminated the risk associated with higher BMI. Results were unchanged after excluding unintentional weight loss, chronic illness, early mortality, and participants performing muscle-strengthening exercises or recommended levels of physical activity. Conclusions Muscle mass mediates associations of BMI with adiposity and mortality and is inversely associated with the risk of death. After accounting for muscle mass, the BMI associated with the greatest survival shifts downward toward the normal range. These results provide a concrete explanation for the obesity paradox.	[Abramowitz, Matthew K.; Sharma, Deep; Androga, Lagu; Hawkins, Meredith] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Abramowitz, Matthew K.; Hall, Charles B.; Hawkins, Meredith] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hall, Charles B.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA; [Amodu, Afolarin] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Amodu, Afolarin] Massachusetts Gen Hosp, Boston, MA 02114 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Abramowitz, MK (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.; Abramowitz, MK (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	matthew.abramowitz@einstein.yu.edu	Hall, Charles B./AAX-8216-2020; Androga, Lagu/HCH-8463-2022	Hall, Charles/0000-0001-9982-8120	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [K23 DK099438]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK099438, R01DK079974, R01DK069861, P30DK020541] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by K23 DK099438 to MKA from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (https://www.niddk.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2016, CTR DIS CONTR PREV, pX; [Anonymous], 2010, COMP AN NHANES 1999; [Anonymous], 2015, COMP AN NHIS PUBL US; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Beavers KM, 2011, AM J CLIN NUTR, V94, P767, DOI 10.3945/ajcn.110.004895; Bowman K, 2017, J GERONTOL A-BIOL, V72, P203, DOI 10.1093/gerona/glw147; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Collamati A, 2016, J GERIATR CARDIOL, V13, P615, DOI 10.11909/j.issn.1671-5411.2016.07.004; Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Feliciano EMC, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2319; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heymsfield SB, 2011, AM J CLIN NUTR, V93, P736, DOI 10.3945/ajcn.110.007161; Karter AJ, 2013, DIABETES CARE, V36, P574, DOI 10.2337/dc12-0722; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li CY, 2009, AM J CLIN NUTR, V90, P1457, DOI 10.3945/ajcn.2009.28141; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Muntner P, 2010, HYPERTENSION, V55, P1339, DOI 10.1161/HYPERTENSIONAHA.109.149609; National Center for Health Statistics, 2015, PUBL US LINK MORT FI; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Peter RS, 2017, J EPIDEMIOL, V27, P294, DOI 10.1016/j.je.2016.06.007; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; Rom O, 2012, ANN NY ACAD SCI, V1259, P47, DOI 10.1111/j.1749-6632.2012.06532.x; Schenker N, 2011, STAT MED, V30, P260, DOI 10.1002/sim.4080; Sharma A, 2015, AM J CARDIOL, V115, P1428, DOI 10.1016/j.amjcard.2015.02.024; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; van den Borst B, 2011, THORAX, V66, P961, DOI 10.1136/thoraxjnl-2011-200010; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	47	88	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194697	10.1371/journal.pone.0194697	http://dx.doi.org/10.1371/journal.pone.0194697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641540	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900040
J	Caramenti, M; Lafortuna, CL; Mugellini, E; Abou Khaled, O; Bresciani, JP; Dubois, A				Caramenti, Martina; Lafortuna, Claudio L.; Mugellini, Elena; Abou Khaled, Omar; Bresciani, Jean-Pierre; Dubois, Amandine			Matching optical flow to motor speed in virtual reality while running on a treadmill	PLOS ONE			English	Article							HUMAN WALKING; ENERGY-COST; PERCEPTION; GAIT; LOCOMOTION; PATTERN; MOTION; EXHAUSTION; KINEMATICS; ENERGETICS	We investigated how visual and kinaesthetic/efferent information is integrated for speed perception in running. Twelve moderately trained to trained subjects ran on a treadmill at three different speeds (8, 10, 12 km/h) in front of a moving virtual scene. They were asked to match the visual speed of the scene to their running speed-i.e., treadmill's speed. For each trial, participants indicated whether the scene was moving slower or faster than they were running. Visual speed was adjusted according to their response using a staircase until the Point of Subjective Equality (PSE) was reached, i.e., until visual and running speed were perceived as equivalent. For all three running speeds, participants systematically underestimated the visual speed relative to their actual running speed. Indeed, the speed of the visual scene had to exceed the actual running speed in order to be perceived as equivalent to the treadmill speed. The underestimation of visual speed was speed-dependent, and percentage of underestimation relative to running speed ranged from 15% at 8km/h to 31% at 12km/h. We suggest that this fact should be taken into consideration to improve the design of attractive treadmill-mediated virtual environments enhancing engagement into physical activity for healthier lifestyles and disease prevention and care.	[Caramenti, Martina; Bresciani, Jean-Pierre; Dubois, Amandine] Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland; [Caramenti, Martina; Lafortuna, Claudio L.] CNR, Ist Bioimmagini & Fisiol Mol, Milan, Italy; [Caramenti, Martina; Mugellini, Elena; Abou Khaled, Omar] Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland	University of Fribourg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Caramenti, M (corresponding author), Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland.; Caramenti, M (corresponding author), CNR, Ist Bioimmagini & Fisiol Mol, Milan, Italy.; Caramenti, M (corresponding author), Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland.	martina.caramenti@unifr.ch	Caramenti, Martina/N-4755-2019; KHALED, Omar ABOU/O-6389-2019; Caramenti, Martina/H-7426-2018; Bresciani, Jean-Pierre/H-4340-2012	Caramenti, Martina/0000-0002-3345-0994; KHALED, Omar ABOU/0000-0002-0178-9037; Caramenti, Martina/0000-0002-3345-0994; Lafortuna, Claudio/0000-0002-8625-7653; Bresciani, Jean-Pierre/0000-0002-7242-5433				Abernethy B, 2002, GAIT POSTURE, V15, P256, DOI 10.1016/S0966-6362(01)00195-3; Alexander RM, 2002, AM J HUM BIOL, V14, P641, DOI 10.1002/ajhb.10067; Banton T, 2005, PRESENCE-TELEOP VIRT, V14, P394, DOI 10.1162/105474605774785262; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Brandt T, 2000, CURR OPIN NEUROL, V13, P3, DOI 10.1097/00019052-200002000-00002; Burgess N, 2002, ADV NEURAL INFORM PR; Candau R, 1998, EUR J APPL PHYSIOL, V77, P479, DOI 10.1007/s004210050363; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; Dal Monte A, 1973, BIOMECHANICS, P359; Dal U, 2010, GAIT POSTURE, V31, P366, DOI 10.1016/j.gaitpost.2010.01.006; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; Durgin FH, 2005, PERCEPTION LINEAR SE; Durgin FH, 2007, ACM T APPL PERCEPT, V4, DOI [10.1145/1227134.1227139, 10.1145/1227134/1227139]; Dutto DJ, 2002, MED SCI SPORT EXER, V34, P1324, DOI 10.1097/00005768-200208000-00014; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; ELLIOTT BC, 1976, MED SCI SPORT EXER, V8, P84; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Graff C, 2014, J MATH PSYCHOL, V60, P82, DOI 10.1016/j.jmp.2014.02.001; GRIEVE DW, 1966, ERGONOMICS, V9, P379, DOI 10.1080/00140136608964399; Hunter I, 2007, EUR J APPL PHYSIOL, V100, P653, DOI 10.1007/s00421-007-0456-1; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2001, EXP BRAIN RES, V141, P370, DOI 10.1007/s002210100884; Kassler L., 2010, P 7 S APPL PERC GRAP; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Knapp JM, 1999, VISUAL PERCEPTION EG; Kong PW, 2012, GAIT POSTURE, V36, P46, DOI 10.1016/j.gaitpost.2012.01.001; Kong PW, 2009, SPORT BIOMECH, V8, P52, DOI 10.1080/14763140802629990; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Loomis JM, 1999, WAYFINDING BEHAVIOR, P125; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Margaria R., 1976, BIOMECHANICS ENERGET; Marsh AP, 2006, MED SCI SPORT EXER, V38, P1157, DOI 10.1249/01.mss.0000222844.81638.35; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Mohler BJ, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134/1227138; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; PAILHOUS J, 1990, BEHAV BRAIN RES, V38, P275, DOI 10.1016/0166-4328(90)90181-D; Powell W., 2011, 3 IEEE VR 2011 WORKS; Pretto P, 2009, COMPUT GRAPH-UK, V33, P139, DOI 10.1016/j.cag.2009.01.003; Pretto P, 2012, ELIFE, V1, DOI 10.7554/eLife.00031; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Sekiya N, 1996, J HUM MOVEMENT STUD, V30, P241; Siegel ZD, 2015, IMPROVING DISTANCE P; SILER WL, 1991, INT J SPORT BIOMECH, V7, P12, DOI 10.1123/ijsb.7.1.12; Snowden RJ, 1998, NATURE, V392, P450, DOI 10.1038/33049; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; SPARROW WA, 1983, J MOTOR BEHAV, V15, P237; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; Thompson WB, 2004, PRESENCE-TELEOP VIRT, V13, P560, DOI 10.1162/1054746042545292; Thurrell AEI, 1998, PERCEPTION, V27, P147; Turano KA, 2005, VISION RES, V45, P3117, DOI 10.1016/j.visres.2005.06.017; Varraine E, 2002, EXP BRAIN RES, V142, P374, DOI 10.1007/s00221-001-0934-3; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; Waller D, 2008, J EXP PSYCHOL-APPL, V14, P61, DOI 10.1037/1076-898X.14.1.61; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011	68	17	17	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195781	10.1371/journal.pone.0195781	http://dx.doi.org/10.1371/journal.pone.0195781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641564	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900092
J	Tanaka, H; Watanabe, Y; Nakamura, H; Takahashi, H; Arisawa, A; Fujiwara, T; Matsuo, C; Tomiyama, N				Tanaka, Hisashi; Watanabe, Yoshiyuki; Nakamura, Hajime; Takahashi, Hiroto; Arisawa, Atsuko; Fujiwara, Takuya; Matsuo, Chisato; Tomiyama, Noriyuki			Multiple blood flow measurements before and after carotid artery stenting via phase-contrast magnetic resonance imaging: An observational study	PLOS ONE			English	Article							DYNAMIC CEREBRAL AUTOREGULATION; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; CT PERFUSION; HYPERPERFUSION SYNDROME; QUANTITATIVE-ANALYSIS; ASYMPTOMATIC PATIENTS; FOLLOW-UP; STENOSIS; ENDARTERECTOMY	After carotid artery stenting, the procurement of information about blood flow redistribution among brain-feeding arteries and its time trend is essential to understanding a patient's physiological background and to determine their care regimen. Cerebral blood flow has been measured twice following carotid artery stenting in few previous studies, with some discrepancies in the results. The purpose of this study was to measure cerebral blood flow at multiple time points after carotid artery stenting, and to elucidate the time trend of cerebral blood flow and redistribution among arteries. Blood flow rates in 11 subjects were measured preoperatively, at one day, one week, and about three months, respectively after carotid artery stenting by using phase-contrast magnetic resonance imaging. The target vessels were the bilateral internal carotid arteries, the basilar artery, and the bilateral middle cerebral arteries. Lumen was semi-automatically defined using an algorithm utilizing pulsatility. The results showed that blood flow rates in the stented internal carotid artery and the ipsilateral middle cerebral artery increased following carotid artery stenting. Blood flow rates in the contralateral internal carotid artery and the basilar artery gradually declined, and they were lower than the preoperative values at three months after stenting. The sum of blood flow rates of the bilateral internal carotid arteries and the basilar artery increased after carotid artery stenting, and then decreased over the next three months. There was no significant change in the blood flow rate in the contralateral middle cerebral artery. From these results, it was concluded that redistribution among the bilateral internal carotid arteries and the basilar artery occurs after carotid artery stenting, and that it takes months thereafter to reach another equilibrium.	[Tanaka, Hisashi; Watanabe, Yoshiyuki; Takahashi, Hiroto; Arisawa, Atsuko; Fujiwara, Takuya; Matsuo, Chisato; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Nakamura, Hajime] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka, Japan	Osaka University; Osaka University	Tanaka, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan.	tanaka@radiol.med.osaka.u.ac.jp	Nakamura, Hajime/GPK-0454-2022	Tanaka, Hisashi/0000-0002-6148-0672	Japan society for the promotion of science KAKENHI [JP25461821]	Japan society for the promotion of science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan society for the promotion of science (http://www.isps.go.jp/english/) KAKENHI Grant Number JP25461821. H. Tanaka received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2010, INTERV NEURORADIOL, V16, P420, DOI 10.1177/159101991001600408; Alperin N, 2003, MAGNET RESON MED, V49, P934, DOI 10.1002/mrm.10455; Aralasmak A, 2015, J COMPUT ASSIST TOMO, V39, P313, DOI 10.1097/RCT.0000000000000211; Bonati LH, 2015, LANCET, V385, P529, DOI 10.1016/S0140-6736(14)61184-3; Calderon-Arnulphi M, 2011, AM J NEURORADIOL, V32, P1552, DOI 10.3174/ajnr.A2546; Chahwan S, 2007, J VASC SURG, V45, P523, DOI 10.1016/j.jvs.2006.11.044; Chin SC, 2012, J VASC SURG, V56, P1281, DOI 10.1016/j.jvs.2012.04.038; Duan YX, 2012, EUR J RADIOL, V81, P744, DOI 10.1016/j.ejrad.2011.01.042; Gaudiello F, 2008, AM J NEURORADIOL, V29, P919, DOI 10.3174/ajnr.A0945; Hosoda K, 2001, STROKE, V32, P1567, DOI 10.1161/01.STR.32.7.1567; Huang L, 2017, WORLD NEUROSURG, V104, P863, DOI 10.1016/j.wneu.2017.04.144; Iwata T, 2011, NEUROSURGERY, V68, P649, DOI 10.1227/NEU.0b013e3182077ed8; Jones CE, 2006, NMR BIOMED, V19, P198, DOI 10.1002/nbm.1017; Kataoka T, 2006, INTERV NEURORADIOL, V12, P201, DOI 10.1177/15910199060120S136; Kawai N, 2014, J STROKE CEREBROVASC, V23, pE55, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.012; Khan MA, 2017, J CEREBR BLOOD F MET, V37, P541, DOI 10.1177/0271678X16631149; Machalinska A, 2017, POL ARCH INTERN MED, V127, P722, DOI 10.20452/pamw.4064; Malowidzka-Serwinska M, 2015, NEUROL NEUROCHIR POL, V49, P412, DOI 10.1016/j.pjnns.2015.10.005; Mas JL, 2014, STROKE, V45, P2750, DOI 10.1161/STROKEAHA.114.005671; Matsubara S, 2009, J NEUROSURG, V111, P28, DOI 10.3171/2008.09.17663; Merckel LG, 2012, AM J NEURORADIOL, V33, P280, DOI 10.3174/ajnr.A2757; Musialek P, 2017, POL ARCH INTERN MED, V127, P718, DOI 10.20452/pamw.4157; Nakagawa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180684; Oka F, 2013, AM J NEURORADIOL, V34, P616, DOI 10.3174/ajnr.A3250; PELC LR, 1992, RADIOLOGY, V185, P809, DOI 10.1148/radiology.185.3.1438767; Pinero P, 2014, J NEUROINTERV SURG, V6, P527, DOI 10.1136/neurintsurg-2013-010859; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; Ringer AJ, 2002, NEUROSURGERY, V51, P639, DOI 10.1227/01.NEU.0000023712.24510.D7; Shakur SF, 2015, NEUROSURGERY, V76, P330, DOI 10.1227/NEU.0000000000000618; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Szarmach A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051008; Szarmach A, 2011, POL J RADIOL, V76, P7; Tang SC, 2008, J VASC SURG, V48, P88, DOI 10.1016/j.jvs.2008.02.025; Tavares A, 2010, INTERV NEURORADIOL, V16, P161, DOI 10.1177/159101991001600207; Trojanowska A, 2006, J NEURORADIOLOGY, V33, P169, DOI 10.1016/S0150-9861(06)77255-8; Van Laar PJ, 2007, J VASC SURG, V45, P1155, DOI 10.1016/j.jvs.2006.11.067; White CJ, 2014, J AM COLL CARDIOL, V64, P723, DOI 10.1016/j.jacc.2014.04.069; Wilkinson ID, 2003, AM J NEURORADIOL, V24, P1501; WOLF RL, 1993, MAGN RESON MED, V30, P82, DOI 10.1002/mrm.1910300113; Wu TH, 2013, COMPUT METH PROG BIO, V111, P693, DOI 10.1016/j.cmpb.2013.06.012; Yoshie T, 2016, NEURORADIOLOGY, V58, P253, DOI 10.1007/s00234-015-1623-4; Youn SW, 2013, EUR RADIOL, V23, P2880, DOI 10.1007/s00330-013-2899-6; Yun TJ, 2013, NEURORADIOLOGY, V55, P271, DOI 10.1007/s00234-012-1104-y	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195099	10.1371/journal.pone.0195099	http://dx.doi.org/10.1371/journal.pone.0195099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641548	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900060
J	Zhou, JJ; Wang, YM; Lee, VWS; Zhang, GY; Medbury, H; Williams, H; Wang, Y; Tan, TK; Harris, DCH; Alexander, SI; Durkan, AM				Zhou, Jimmy Jianheng; Wang, Yuan Min; Lee, Vincent W. S.; Zhang, Geoff Yu; Medbury, Heather; Williams, Helen; Wang, Ya; Tan, Thian Kui; Harris, David C. H.; Alexander, Stephen I.; Durkan, Anne M.			DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice	PLOS ONE			English	Article							ATHEROSCLEROTIC LESION FORMATION; FRACTALKINE RECEPTOR CX(3)CR1; SMOOTH-MUSCLE-CELLS; DENDRITIC CELLS; MACROPHAGE-MIGRATION; CHEMOKINE-RECEPTOR; HEYMANN NEPHRITIS; RENAL INJURY; IN-VIVO; CCL2	Studies disrupting the chemokine pathway CX3CL1 (fractalkine)/CX3CR1 have shown decreased atherosclerosis in animal models but the techniques used to interrupt the pathway have not been easily translatable into human trials. DNA vaccination potentially overcomes the translational difficulties. We evaluated the effect of a DNA vaccine, targeted to CX3CR1, on atherosclerosis in a murine model and examined possible mechanisms of action. DNA vaccination against CX3CR1, enhanced by dendritic cell targeting using DEC205 single chain variable region fragment (scFv), was performed in 8 week old ApoE-/mice, fed a normal chow diet. High levels of anti- CX3CR1 antibodies were induced in vaccinated mice. There were no apparent adverse reactions to the vaccine. Arterial vessels of 34 week old mice were examined histologically for atherosclerotic plaque size, macrophage infiltration, smooth muscle cell infiltration and lipid deposition. Vaccinated mice had significantly reduced atherosclerotic plaque in the brachiocephalic artery. There was less macrophage infiltration but no significant change to the macrophage phenotype in the plaques. There was less lipid deposition in the lesions, but there was no effect on smooth muscle cell migration. Targeted DNA vaccination to CX3CR1 was well tolerated, induced a strong immune response and resulted in attenuated atherosclerotic lesions with reduced macrophage infiltration. DNA vaccination against chemokine pathways potentially offers a potential therapeutic option for the treatment of atherosclerosis.	[Zhou, Jimmy Jianheng; Wang, Yuan Min; Zhang, Geoff Yu; Alexander, Stephen I.; Durkan, Anne M.] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia; [Zhou, Jimmy Jianheng; Lee, Vincent W. S.; Harris, David C. H.; Alexander, Stephen I.; Durkan, Anne M.] Univ Sydney, Sydney, NSW, Australia; [Lee, Vincent W. S.; Wang, Ya; Tan, Thian Kui; Harris, David C. H.] Univ Sydney, Westmead Inst Med Res, Ctr Transplantat & Renal Res, Westmead, NSW, Australia; [Medbury, Heather; Williams, Helen] Univ Sydney, Westmead Hosp, Vasc Biol Res Ctr, Surg, Westmead, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Durkan, AM (corresponding author), Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia.; Durkan, AM (corresponding author), Univ Sydney, Sydney, NSW, Australia.	anne.durkan@health.nsw.gov.au	Williams, Helen/AAW-9632-2021; wangwangwang, yuanyaun/HHN-6432-2022; Durkan, Anne/AAP-4205-2020; Lee, Vincent/H-6468-2019; Harris, David/W-4786-2019	Williams, Helen/0000-0001-8221-5766; Durkan, Anne/0000-0003-3739-2290; Lee, Vincent/0000-0002-9400-3696; 	Jacquot award from the Royal Australasian College of Physicians; National Health and Medical Research Council of Australia (NHMRC) [571343]	Jacquot award from the Royal Australasian College of Physicians; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Jacquot award from the Royal Australasian College of Physicians and a research grant from the National Health and Medical Research Council of Australia (NHMRC grant 571343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; Ada Gordon, 2003, Expert Opin Emerg Drugs, V8, P27, DOI 10.1517/14728214.8.1.27; Ali MT, 2015, BIOMATERIALS, V69, P22, DOI 10.1016/j.biomaterials.2015.07.059; Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cho HI, 2012, CANCER IMMUNOL IMMUN, V61, P343, DOI 10.1007/s00262-011-1110-7; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Demangel C, 2005, MOL IMMUNOL, V42, P979, DOI 10.1016/j.molimm.2004.09.034; Fissolo N, 2012, CLIN IMMUNOL, V142, P76, DOI 10.1016/j.clim.2010.11.011; Flierl U, 2012, THROMB HAEMOSTASIS, V108, P457, DOI 10.1160/TH12-04-0271; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kumar AHS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057230, 10.1371/journal.pone.0064972]; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee VWS, 2008, AM J PHYSIOL-RENAL, V295, pF335, DOI 10.1152/ajprenal.00077.2008; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu H, 2010, CARDIOVASC DRUG THER, V24, P17, DOI 10.1007/s10557-009-6210-7; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Monie A, 2009, EXPERT REV VACCINES, V8, P1221, DOI 10.1586/ERV.09.76; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nchinda G, 2010, P NATL ACAD SCI USA, V107, P4281, DOI 10.1073/pnas.1000621107; Opriessnig T, 2011, MICROBIOL IMMUNOL, V55, P863, DOI 10.1111/j.1348-0421.2011.00385.x; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Quintar A, 2017, CIRC RES, V120, P1789, DOI 10.1161/CIRCRESAHA.117.310739; Riek AE, 2013, J STEROID BIOCHEM, V136, P309, DOI 10.1016/j.jsbmb.2012.12.019; Rowinska Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170644; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sallberg M, 2009, EXPERT OPIN BIOL TH, V9, P805, DOI 10.1517/14712590902988444; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Stolla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043572; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; van Wanrooij EJA, 2008, CARDIOVASC RES, V78, P590, DOI 10.1093/cvr/cvn025; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Wang Y, 2013, KIDNEY INT, V83, P223, DOI 10.1038/ki.2012.374; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wu HL, 2005, KIDNEY INT, V67, P2178, DOI 10.1111/j.1523-1755.2005.00323.x; Wu HL, 2003, J IMMUNOL, V171, P4824, DOI 10.4049/jimmunol.171.9.4824; Youssef S, 2000, J CLIN INVEST, V106, P361, DOI 10.1172/JCI9109; Zheng GP, 2006, J AM SOC NEPHROL, V17, P465, DOI 10.1681/ASN.2005020164; Zhou JJ, 2012, INT J CLIN EXP MED, V5, P24	51	7	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195657	10.1371/journal.pone.0195657	http://dx.doi.org/10.1371/journal.pone.0195657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641559	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900080
J	Lu, Y; Jin, XZ; Duan, CAX; Chang, F				Lu, Yun; Jin, Xiuze; Duan, Cheng-a-xin; Chang, Feng			Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; GLOBAL EPIDEMIOLOGY; ECONOMIC-EVALUATION; ANTIVIRAL THERAPY; INTERFERON-ALPHA; RIBAVIRIN; METAANALYSIS; DISEASE; TRIAL	Background Hepatitis C is the second fastest growing infectious disease in China. The standard-of-care for chronic hepatitis C in China is Pegylated interferon plus ribavirin (PR), which is associated with tolerability and efficacy issues. An interferon- and ribavirin-free, all-oral regimen comprising daclatasvir (DCV) and asunaprevir (ASV), which displays higher efficacy and tolerability, has recently been approved in China. Objectives This study is to estimate the cost-effectiveness of DCV+ASV (24 weeks) for chronic hepatitis C genotype 1b treatment-naive patients compared with PR regimen (48 weeks) in China. Methods A cohort-based Markov model was developed from Chinese payer perspective to project the lifetime outcomes of treating 10,000 patients with an average age of 44.5 with two hypothetical regimens, DCV+ASV and PR. Chinese-specific health state costs and efficacy data were used. The annual discount rate was 5%. Base-case analysis and sensitivity analysis were conducted. Results For HCV Genotype 1b treatment-naive patients, DCV+ASV proved to be dominant over PR, with a cost saving of (sic)33,480(5,096 USD) and gains in QALYs and life years of 1.29 and 0.85, respectively. The lifetime risk of compensated cirrhosis, decompensated cirrhosis, hepatocellular carcinoma and liver-related death was greatly reduced with DCV+ASV. Univariate sensitivity analysis demonstrated that key influencers were the discount rate, time horizon, initial disease severity and sustained virological response rate of DCV+ASV, with all scenarios resulting in additional benefit. Probabilistic sensitivity analysis demonstrated that DCV+ASV has a high likelihood (100%) of being cost-effective. Conclusion DCV+ASV is not only an effective and well-tolerated regimen to treat chronic HCV genotype 1b infection treatment-naive patients, but also is more cost-effective than PR regimen. DCV+ASV can benefit both the public health and reimbursement system in China.	[Lu, Yun; Jin, Xiuze; Duan, Cheng-a-xin; Chang, Feng] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Chang, F (corresponding author), China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China.	cpucf@163.com		Chang, Feng/0000-0003-2689-4041; Chang, Feng/0000-0002-5089-9275	National Natural Science Foundation of China [71673298]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17_0738]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by National Natural Science Foundation of China. Grant number: 71673298 (http://www.nsfc.gov.cn/) and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX17_0738) to XJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CANC TODAY; Chen GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155934; Chen H, 2017, CHINA PLOS ONE, V12, DOI [10.1371/journal.pone.0175189, DOI 10.1371/JOURNAL.PONE.0175189]; Chen YD, 2002, HEPATOBILIARY PANCR, V1; Wei L, 2015, CHINESE J LIVER DISE, P19; Duan ZP, 2014, VALUE HEALTH, V17, pA805, DOI 10.1016/j.jval.2014.08.515; Duan ZP, 2014, J CLIN GASTROENTEROL, V48, P679, DOI 10.1097/MCG.0000000000000109; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hartwell D, 2009, INT J TECHNOL ASSESS, V25, P56, DOI 10.1017/S0266462309090084; Ishida H, 2004, HEPATOL RES, V28, P125, DOI 10.1016/j.hepres.2003.11.002; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; McEwan Philip, 2014, Value Health Reg Issues, V3, P5, DOI 10.1016/j.vhri.2013.08.001; Ministry of Health Labour & Welfare, 2013, STUD MED EC ASS MEAS; OrganizationWH, 2014, GUID SCREEN CAR TREA, P343; Parikh ND, 2017, DIGEST DIS SCI, V62, P3243, DOI 10.1007/s10620-017-4776-7; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Qin QQ, 2015, J VIRAL HEPATITIS, V22, P238, DOI 10.1111/jvh.12295; Rao HY, 2017, J GASTROEN HEPATOL, V32, P244, DOI 10.1111/jgh.13467; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Torrance GW, 1989, INT J TECHNOLOGY ASS, V5; Wei L, 26 C AS PAC ASS STUD; World Health Orgnisation, CHIN LIF TABL 2015; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	28	10	12	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195117	10.1371/journal.pone.0195117	http://dx.doi.org/10.1371/journal.pone.0195117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634736	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200024
J	Lu, J; Hu, XM; Meng, YT; Zhao, HY; Cao, Q; Jin, ML				Lu, Jun; Hu, Xiumei; Meng, Yutong; Zhao, Hongying; Cao, Qing; Jin, Mulan			The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer	PLOS ONE			English	Article							COLORECTAL-CARCINOMA; SEROSAL INVOLVEMENT; STAGING SYSTEM; CLASSIFICATION	Objectives The aims of this study were to evaluate the associations between peritoneal elastic lamina invasion (ELI) and the clinicopathological prognostic factors of colon cancer, to evaluate the feasibility of ELI with use of an elastic stain to help diagnose serosal invasion of colon cancer in routine practice, so as to help us to provide a more accurate estimate for prognosis and stage of patients and a marker for postoperative treatment. Methods 254 cases with colon cancer were included in the study. According to the presence of elastic lamina (EL) and elastic lamina invasion (ELI), all cases were divided into four groups: pT3 EL negative (pT3 EL (-)), pT3 ELI positive (pT3 ELI (+)), pT3 ELI negative (pT3 ELI (-)) and pT4a. Statistical analysis was used to analyze the relationship between elastic lamina invasion and other established adverse histologic features. Results The EL and ELI positive rates were 81.5% and 42.1% respectively. There were significant differences in mph node metastasis, venous invasion and tumor buds between pT3 ELI (-) and pT3 ELI (+), pT3 ELI (-) and pT4a. There was no significant difference in same factors between pT3 ELI (+) and pT4a. In pT3 stage, there were significant differences in lymph node metastasis, perineural invasion and tumor buds between EL (-) and ELI (+). There were no significant differences in same factors between EL (-) and ELI (-). EL was detected less frequently in right-sided tumors compared with left-sided tumors. Conclusions ELI might be the prognostic factors of colon cancer with II stage and might be the marker of postoperative adjuvant chemotherapy. Patients with pT3 ELI (+) might have similar prognosis to patients with pT4a. For patients with pT3 colon cancer, EL(-) might have similar prognosis as ELI (-) and might take the same therapy. In addition, the right half colon EL positive rate was lower than the left colon. Elastic staining might be a useful tool to help determine the invasive depth and stage of colon cancer.	[Lu, Jun; Hu, Xiumei; Meng, Yutong; Zhao, Hongying; Cao, Qing; Jin, Mulan] Capital Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China		Jin, ML (corresponding author), Capital Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China.	kinmokuran@163.com		Lu, Jun/0000-0003-0363-7288				DAVIS NC, 1983, AUST NZ J SURG, V53, P211, DOI 10.1111/j.1445-2197.1983.tb02430.x; Grin A, 2013, HUM PATHOL, V44, P2696, DOI 10.1016/j.humpath.2013.07.013; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; KNUDSEN PJT, 1991, J ANAT, V177, P41; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Liang WY, 2013, AM J SURG PATHOL, V37, P1565, DOI 10.1097/PAS.0b013e31828ea2de; Ludeman L, 2005, HISTOPATHOLOGY, V47, P123, DOI 10.1111/j.1365-2559.2005.02189.x; Merkel S, 2001, CANCER, V92, P1435, DOI 10.1002/1097-0142(20010915)92:6<1435::AID-CNCR1467>3.0.CO;2-N; Morris M, 2006, BRIT J SURG, V93, P866, DOI 10.1002/bjs.5345; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; NEWLAND RC, 1995, CANCER, V76, P564, DOI 10.1002/1097-0142(19950815)76:4<564::AID-CNCR2820760405>3.0.CO;2-Z; Petersen VC, 2002, GUT, V51, P65, DOI 10.1136/gut.51.1.65; Puppa G, 2010, ARCH PATHOL LAB MED, V134, P837, DOI 10.1043/1543-2165-134.6.837; Shepherd NA, 1997, GASTROENTEROLOGY, V112, P1096, DOI 10.1016/S0016-5085(97)70119-7; Shinto E, 2004, DIS COLON RECTUM, V47, P467, DOI 10.1007/s10350-003-0083-9; Stewart C, 2006, HISTOPATHOLOGY, V49, P435, DOI 10.1111/j.1365-2559.2006.02498.x; Stewart Colin J R, 2011, Cancers (Basel), V3, P164, DOI 10.3390/cancers3010164; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194804	10.1371/journal.pone.0194804	http://dx.doi.org/10.1371/journal.pone.0194804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630617	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000018
J	Macgregor, LJ; Hunter, AM				Macgregor, Lewis J.; Hunter, Angus M.			High-threshold motor unit firing reflects force recovery following a bout of damaging eccentric exercise	PLOS ONE			English	Article							SURFACE EMG; BICEPS-BRACHII; MUSCLE DAMAGE; COMMON DRIVE; DECOMPOSITION; RECRUITMENT; SYNCHRONIZATION; PREVENTION; DISCHARGE; RESPONSES	Exercise-induced muscle damage (EIMD) is associated with impaired muscle function and reduced neuromuscular recruitment. However, motor unit firing behaviour throughout the recovery period is unclear. EIMD impairment of maximal voluntary force (MVC) will, in part, be caused by reduced high-threshold motor unit firing, which will subsequently increase to recover MVC. Fourteen healthy active males completed a bout of eccentric exercise on the knee extensors, with measurements of MVC, rate of torque development and surface electromyography performed pre-exercise and 2, 3, 7 and 14 days post-exercise, on both damaged and control limb. EIMD was associated with decreased MVC (235.2 +/- 49.3 Nm vs. 161.3 +/- 52.5 Nm; p <0.001) and rate of torque development (495.7 +/- 136.9 Nm.s-1 vs. 163.4 +/- 163.7 Nm.s-1; p <0.001) 48h post-exercise. Mean motor unit firing rate was reduced (16.4 +/- 2.2 Hz vs. 12.6 +/- 1.7 Hz; p <0.01) in high-threshold motor units only, 48h post-exercise, and common drive was elevated (0.36 +/- 0.027 vs. 0.56 +/- 0.032; p< 0.001) 48h post-exercise. The firing rate of high-threshold motor units was reduced in parallel with impaired muscle function, whilst early recruited motor units remained unaltered. Common drive of motor units increased in offset to the firing rate impairment. These alterations correlated with the recovery of force decrement, but not of pain elevation. This study provides fresh insight into the central mechanisms associated with EIMD recovery, relative to muscle function. These findings may in turn lead to development of novel management and preventative procedures.	[Macgregor, Lewis J.; Hunter, Angus M.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland	University of Stirling	Hunter, AM (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	a.m.hunter1@stir.ac.uk	Macgregor, Lewis/N-2052-2019	Macgregor, Lewis/0000-0003-2310-6468; Hunter, Angus/0000-0001-7562-6145				Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; Amann M, 2012, CLIN EXP PHARMACOL P, V39, P831, DOI 10.1111/j.1440-1681.2012.05681.x; Aminian-Far A, 2011, J ATHL TRAINING, V46, P43, DOI 10.4085/1062-6050-46.1.43; Balshaw G, 2012, J ELECTROMYOGR KINES, V22, P308, DOI 10.1016/j.jelekin.2011.11.009; Balshaw TG, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13111; Beck TW, 2012, MUSCLE NERVE, V46, P759, DOI 10.1002/mus.23386; Blanc Y., 2010, TOREHJ, V3, P110, DOI [10.2174/1874943701003010110, DOI 10.2174/1874943701003010110]; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Clarkson PM, 1997, INT J SPORTS MED, V18, pS314, DOI 10.1055/s-2007-972741; CLARKSON PM, 1986, INT J SPORTS MED, V7, P152, DOI 10.1055/s-2008-1025753; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Contessa P, 2013, J NEUROPHYSIOL, V109, P1548, DOI 10.1152/jn.00237.2012; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; Dartnall TJ, 2008, J NEUROPHYSIOL, V99, P1008, DOI 10.1152/jn.00686.2007; Dartnall TJ, 2011, J NEUROPHYSIOL, V105, P1225, DOI 10.1152/jn.00854.2010; Dartnall TJ, 2009, J NEUROPHYSIOL, V102, P413, DOI 10.1152/jn.91285.2008; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2015, J APPL PHYSIOL, V118, P1084, DOI 10.1152/japplphysiol.00061.2015; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; De Luca CJ, 2009, J NEUROPHYSIOL, V101, P1620, DOI 10.1152/jn.90245.2008; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Defreitas JM, 2014, MUSCLE NERVE, V49, P575, DOI 10.1002/mus.23978; Evans RK, 2002, MED SCI SPORT EXER, V34, P1892, DOI 10.1097/00005768-200212000-00006; Fell J, 2008, J AGING PHYS ACTIV, V16, P97, DOI 10.1123/japa.16.1.97; Fling BW, 2009, J ELECTROMYOGR KINES, V19, P800, DOI 10.1016/j.jelekin.2008.06.003; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gauche E, 2009, J ELECTROMYOGR KINES, V19, pE481, DOI 10.1016/j.jelekin.2009.01.006; Gleeson NP, 1996, SPORTS MED, V21, P18, DOI 10.2165/00007256-199621010-00003; Gregory JE, 2004, EXP BRAIN RES, V157, P234, DOI 10.1007/s00221-004-1838-9; Gregory JE, 2002, J PHYSIOL-LONDON, V538, P209, DOI 10.1113/jphysiol.2001.012785; HENNEMAN E, 1985, J EXP BIOL, V115, P105; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Holobar A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016008; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Howatson G, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-20; Hu XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066001; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026007; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2012, IEEE ENG MED BIO, P4116, DOI 10.1109/EMBC.2012.6346872; Hunter AM, 2012, J ELECTROMYOGR KINES, V22, P334, DOI 10.1016/j.jelekin.2012.01.009; Jackman SR, 2010, MED SCI SPORT EXER, V42, P962, DOI 10.1249/MSS.0b013e3181c1b798; Kennedy DS, 2015, J APPL PHYSIOL, V118, P408, DOI 10.1152/japplphysiol.00375.2014; Kline JC, 2014, J NEUROPHYSIOL, V112, P2718, DOI 10.1152/jn.00724.2013; Knapik J J, 1983, J Orthop Sports Phys Ther, V5, P58; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Macaluso F, 2012, J ATHL TRAINING, V47, P414, DOI 10.4085/1062-6050-47.4.13; MacIntyre DL, 2001, EUR J APPL PHYSIOL, V84, P180, DOI 10.1007/s004210170002; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Martin V, 2004, MED SCI SPORT EXER, V36, P1907, DOI 10.1249/01.MSS.0000145526.43208.08; Minett GM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00024; Molina R, 2012, CLIN PHYSIOL FUNCT I, V32, P179, DOI 10.1111/j.1475-097X.2011.01074.x; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Paschalis V, 2005, CLIN BIOMECH, V20, P617, DOI 10.1016/j.clinbiomech.2005.02.011; Peake JM, 2017, J APPL PHYSIOL, V122, P531, DOI 10.1152/japplphysiol.00086.2017; Penailillo L, 2015, SCAND J MED SCI SPOR, V25, P417, DOI 10.1111/sms.12241; Piitulainen H, 2010, J ELECTROMYOGR KINES, V20, P879, DOI 10.1016/j.jelekin.2009.10.001; Pope ZK, 2016, J NEUROPHYSIOL, V115, P2608, DOI 10.1152/jn.00039.2016; Racinais S, 2008, EUR J APPL PHYSIOL, V102, P439, DOI 10.1007/s00421-007-0604-7; Rattray B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00079; Semmler JG, 1998, EXP BRAIN RES, V119, P27, DOI 10.1007/s002210050316; Suresh N, 2011, IEEE ENG MED BIO, P8243, DOI 10.1109/IEMBS.2011.6092032; Toft AD, 2002, AM J PHYSIOL-CELL PH, V283, pC289, DOI 10.1152/ajpcell.00583.2001; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Trevino Michael A, 2014, BMC Res Notes, V7, P611, DOI 10.1186/1756-0500-7-611; Vijayan K, 2001, J APPL PHYSIOL, V90, P770, DOI 10.1152/jappl.2001.90.3.770; Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053; Ye X, 2014, J MUSCULOSKEL NEURON, V14, P377; Ye X, 2015, HUM MOVEMENT SCI, V40, P24, DOI 10.1016/j.humov.2014.11.011; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	75	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195051	10.1371/journal.pone.0195051	http://dx.doi.org/10.1371/journal.pone.0195051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630622	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000023
J	Gomez-Rial, J; Curras-Tuala, MJ; Rivero-Calle, I; Rodriguez-Tenreiro, C; Redondo-Collazo, L; Gomez-Carballa, A; Pardo-Seco, J; Salas, A; Martinon-Torres, F				Gomez-Rial, Jose; Jose Curras-Tuala, Maria; Rivero-Calle, Irene; Rodriguez-Tenreiro, Carmen; Redondo-Collazo, Lorenzo; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio; Martinon-Torres, Federico			Rotavirus intestinal infection induces an oral mucosa cytokine response	PLOS ONE			English	Article							EPITHELIAL-CELLS; IL-22; EXPRESSION; IGA; INTERLEUKIN-22	Introduction Salivary glands are known immune effector sites and considered to be part of the whole mucosal immune system. The aim of the present study was to assess the salivary immune response to rotavirus (RV) infection through the analysis of the cytokine immune profile in saliva. Material and methods A prospective comparative study of serial saliva samples from 27 RV-infected patients (sampled upon admission to the hospital during acute phase and at convalescence-i.e. at least three months after recovery) and 36 healthy controls was performed. Concentrations of 11 salivary cytokines (IFN-gamma, IFN-alpha(2), IL-1 beta, IL-6, IL-8, IL-10, IL-15,IL12(p70), INF-alpha, IFN lambda(1), IL-22) were determined. Cytokine levels were compared between healthy controls acute infection and convalescence. The correlation between clinical data and salivary cytokine profile in infected children was assessed. Results The salivary cytokine profile changes significantly in response to acute RV infection. In RV infected patients, IL-22 levels were increased in the acute phase with respect to convalescence (P-value < 0.001). Comparisons between infected and control group showed significant differences in salivary IFN-alpha(2), IL-1 beta, IL-6, IL-8, IL-10 and IL-22. Although acute-phase levels of IL-12, IL-10, IL-6 and IFN-gamma showed nominal association with Vesikari's severity, this trend did not reach statistical significance after multiple test adjustment. Conclusions RV infection induces a host salivary immune response, indicating that immune mucosal response to RV infection is not confined to the intestinal mucosa. Our data point to a whole mucosal implication in the RV infection as a result of the integrative mucosal immune response, and suggest the salivary gland as effector site for RV infection.	[Gomez-Rial, Jose; Jose Curras-Tuala, Maria; Rivero-Calle, Irene; Rodriguez-Tenreiro, Carmen; Redondo-Collazo, Lorenzo; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio; Martinon-Torres, Federico] Hosp Clin Univ Santiago de Compostela, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Rial, Jose] Hosp Clin Univ Santiago de Compostela, Serv Anal Clin, Lab Inmunol, Galicia, Spain; [Rivero-Calle, Irene; Redondo-Collazo, Lorenzo; Martinon-Torres, Federico] Hosp Clin Univ Santiago de Compostela, Dept Pediat, Translat Pediat & Infect Dis, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Hosp Clin Univ Santiago de Compostela, Inst Invest Sanitarias IDIS, GenPoB Res Grp, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Dept Anat Patolox & Ciencias Forenses,Unidade Xen, Galicia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gomez-Rial, J (corresponding author), Hosp Clin Univ Santiago de Compostela, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain.; Gomez-Rial, J (corresponding author), Hosp Clin Univ Santiago de Compostela, Serv Anal Clin, Lab Inmunol, Galicia, Spain.	jose.gomez.rial@sergas.es	Tuala, María José Currás/AAD-7498-2020; rivero, irene/ABC-9006-2020; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Pardo-Seco, Jacobo J/G-3752-2016; Martinon-Torres, Federico/E-4982-2016; Gómez-Carballa, Alberto/I-4610-2014	Tuala, María José Currás/0000-0002-6390-8505; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Martinon-Torres, Federico/0000-0002-9023-581X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Redondo Collazo, Lorenzo/0000-0002-3521-678X; Gomez Rial, Jose/0000-0002-3173-8484; Rivero Calle, Irene/0000-0002-3678-9264	Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud) [GePEM ISCIII/PI16/01478, ReSVinext ISCIII/PI16/01569]; FEDER; Conselleria de Sanidade, Xunta de Galicia [RHI07/2, PI16/01569]; Fondo de Investigacion Sanitaria (FIS) del Plan Nacional de I + D + I [PI070069/PI1000540]; fondos FEDER; Consolidation e Estructuracion REDES (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) [2016-PG071, 2016GI-1344]; G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria) [ED341D R2016/021]; Merck Sharp; Dohme	Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud); FEDER(European Commission); Conselleria de Sanidade, Xunta de Galicia(Xunta de Galicia); Fondo de Investigacion Sanitaria (FIS) del Plan Nacional de I + D + I; fondos FEDER(European Commission); Consolidation e Estructuracion REDES (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia); G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria); Merck Sharp; Dohme	This study received support from the Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud): project GePEM ISCIII/PI16/01478/Cofinanciado FEDER (AS.) and project ReSVinext ISCIII/PI16/01569/Cofinanciado FEDER (F.M.T.); Conselleria de Sanidade, Xunta de Galicia (RHI07/2-intensificacion de la actividad investigadora, PS09749 and 10PXIB918184PR), Institute de Salud Carlos III (Intensificacion de la actividad investigadora 2007-2012, PI16/01569), Fondo de Investigacion Sanitaria (FIS; PI070069/PI1000540) del Plan Nacional de I + D + I and 'fondos FEDER' (F.M.T.), and 2016-PG071 Consolidation e Estructuracion REDES 2016GI-1344 (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria, ED341D R2016/021) (A.S. and F.M.T) and funding from Merck Sharp and Dohme. Funding sources had no involvement in the design of the study, collection, analysis and interpretation of data, and in writing the manuscript. There was no additional external funding received for this study.	Aase A., 2015, MUCOSAL IMMUNOL; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Bielenberg DR, 1998, CANCER BIOTHER RADIO, V13, P375, DOI 10.1089/cbr.1998.13.375; Brandtzaeg P, 2004, J PEDIATR GASTR NUTR, V39, pS725, DOI 10.1097/00005176-200406003-00004; Candy DCA, 2007, PLOS MED, V4, P614, DOI 10.1371/journal.pmed.0040117; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Deo Vikas, 2010, Dent Today, V29, P60; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Ganz T, 2002, P NATL ACAD SCI USA, V99, P3357, DOI 10.1073/pnas.072073199; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Katlinskaya YV, 2016, MOL CELL BIOL, V36, P1124, DOI 10.1128/MCB.00988-15; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Lavoie TN, 2011, SCAND J IMMUNOL, V74, P377, DOI 10.1111/j.1365-3083.2011.02583.x; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; McGhee JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001397; OSBORNE MP, 1988, J PEDIATR GASTR NUTR, V7, P236, DOI 10.1097/00005176-198803000-00014; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; PIERCE NF, 1975, J EXP MED, V142, P1550, DOI 10.1084/jem.142.6.1550; Rivero-Calle I, 2016, J INFECTION, V72, pS98, DOI 10.1016/j.jinf.2016.04.029; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Sack U, 1998, CLIN DIAGN LAB IMMUN, V5, P28, DOI 10.1128/CDLI.5.1.28-32.1998; Salas A, 2016, INFECT GENET EVOL, V44, P403, DOI 10.1016/j.meegid.2016.07.044; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Silva N, 2015, J APPL ORAL SCI, V23, P329, DOI 10.1590/1678-775720140259; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Sugawara S, 2002, J ENDOTOXIN RES, V8, P465, DOI 10.1179/096805102125001082; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Team R. D. C, 2011, R LANG ENV STAT COMP; Waterhouse CCM, 1999, CELL IMMUNOL, V193, P1, DOI 10.1006/cimm.1999.1468; Yin L, 2007, J MED MICROBIOL, V56, P976, DOI 10.1099/jmm.0.47198-0; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	37	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195314	10.1371/journal.pone.0195314	http://dx.doi.org/10.1371/journal.pone.0195314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621276	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800058
J	Morris, JK; Springett, AL; Greenlees, R; Loane, M; Addor, MC; Arriola, L; Barisic, I; Bergmann, JEH; Csaky-Szunyogh, M; Dias, C; Draper, ES; Garne, E; Gatt, M; Khoshnood, B; Klungsoyr, K; Lynch, C; McDonnell, R; Nelen, V; Neville, AJ; O'Mahony, M; Pierini, A; Queisser-Luft, A; Randrianaivo, H; Rankin, J; Rissmann, A; Kurinczuk, J; Tucker, D; Verellen-Dumoulin, C; Wellesley, D; Dolk, H				Morris, Joan K.; Springett, Anna L.; Greenlees, Ruth; Loane, Maria; Addor, Marie-Claude; Arriola, Larraitz; Barisic, Ingeborg; Bergmann, Jorieke E. H.; Csaky-Szunyogh, Melinda; Dias, Carlos; Draper, Elizabeth S.; Garne, Ester; Gatt, Miriam; Khoshnood, Babak; Klungsoyr, Kari; Lynch, Catherine; McDonnell, Robert; Nelen, Vera; Neville, Amanda J.; O'Mahony, Mary; Pierini, Anna; Queisser-Luft, Annette; Randrianaivo, Hanitra; Rankin, Judith; Rissmann, Anke; Kurinczuk, Jennifer; Tucker, David; Verellen-Dumoulin, Christine; Wellesley, Diana; Dolk, Helen			Trends in congenital anomalies in Europe from 1980 to 2012	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID FORTIFICATION; ZIKA VIRUS-INFECTION; HEART-DEFECTS; PREVALENCE; RISK; ASSOCIATION; REDUCTION; EUROCAT; DISEASE	Background Surveillance of congenital anomalies is important to identify potential teratogens. Methods This study analysed the prevalence of 61 congenital anomaly subgroups (excluding chromosomal) in 25 population-based EUROCAT registries (1980-2012). Live births, fetal deaths and terminations of pregnancy for fetal anomaly were analysed with multilevel random-effects Poisson regression models. Results Seventeen anomaly subgroups had statistically significant trends from 2003-2012; 12 increasing and 5 decreasing. Conclusions The annual increasing prevalence of severe congenital heart defects, single ventricle, atrioventricular septal defects and tetralogy of Fallot of 1.4% (95% CI: 0.7% to 2.0%), 4.6% (1.0% to 8.2%), 3.4% (1.3% to 5.5%) and 4.1% (2.4% to 5.7%) respectively may reflect increases in maternal obesity and diabetes (known risk factors). The increased prevalence of cystic adenomatous malformation of the lung [6.5% (3.5% to 9.4%)] and decreased prevalence of limb reduction defects [-2.8% (-4.2% to -1.5%)] are unexplained. For renal dysplasia and maternal infections, increasing trends may be explained by increased screening, and deceases in patent ductus arteriosus at term and increases in craniosynostosis, by improved follow up period after birth and improved diagnosis. For oesophageal atresia, duodenal atresia/stenosis and ano-rectal atresia/stenosis recent changes in prevalence appeared incidental when compared with larger long term fluctuations. For microcephaly and congenital hydronephrosis trends could not be interpreted due to discrepancies in diagnostic criteria. The trends for club foot and syndactyly disappeared once registries with disparate results were excluded. No decrease in neural tube defects was detected, despite efforts at prevention through folic acid supplementation.	[Morris, Joan K.; Springett, Anna L.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Greenlees, Ruth; Loane, Maria; Dolk, Helen] Univ Ulster, Fac Life & Hlth Sci, Newtownabbey, North Ireland; [Addor, Marie-Claude] Univ Hosp Ctr CHUV, Dept Woman Mother Child, Lausanne, Switzerland; [Arriola, Larraitz] Biodonostia Res Inst, Publ Hlth Div, San Sebastian, Spain; [Barisic, Ingeborg] Univ Zagreb, Med Sch, Childrens Hosp Zagreb, Dept Med Genet & Reprod Hlth, Zagreb, Croatia; [Bergmann, Jorieke E. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Csaky-Szunyogh, Melinda] Hungarian Congenital Abnormal Registry, Natl Publ Hlth & Med Officer Serv, Budapest, Hungary; [Dias, Carlos] Ctr Estudos & Registo AC, Lisbon, Portugal; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Garne, Ester] Hosp Lillebaelt, Paediat Dept, Kolding, Denmark; [Gatt, Miriam] Directorate Hlth Informat & Res, Guardamangia, Malta; [Khoshnood, Babak] Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Sorbonne Paris Cite,INSERM,UMR 1153, Ctr Epidemiol & Stat,Paris Registry Congenital An, Paris, France; [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Div Mental & Phys Hlth, Bergen, Norway; [Lynch, Catherine] Hlth Serv Execut, Dept Publ Hlth, Kilkenny, Ireland; [McDonnell, Robert] Hlth Serv Execut, Dept Publ Hlth, Dublin, Ireland; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Neville, Amanda J.] Univ Ferrara, Ctr Clin & Epidemiol Res, IMER Registry, Ferrara, Italy; [Neville, Amanda J.] Azienda Osped Univ Ferrara, Ferrara, Italy; [O'Mahony, Mary] Hlth Serv Execut, Dept Publ Hlth, Cork, Ireland; [Pierini, Anna] CNR, Inst Clin Physiol, Pisa, Italy; [Queisser-Luft, Annette] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Child & Adolescence Med, Mainz, Germany; [Randrianaivo, Hanitra] Registre Malformat Congenit Reun, St Pierre, Reunion, France; [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Rissmann, Anke] Otto von Guericke Univ, Malformat Monitoring Ctr Saxony Anhalt, Magdeburg, Germany; [Kurinczuk, Jennifer] Univ Oxford, Natl Perinatal & Epidemiol Unit, Oxford, England; [Tucker, David] Publ Hlth Wales, Swansea, W Glam, Wales; [Verellen-Dumoulin, Christine] Ctr Human Genet, Inst Pathol Genet, Charleroi, Belgium; [Wellesley, Diana] Univ Southampton, Southampton, Hants, England; [Wellesley, Diana] Wessex Clin Genet Serv, Southampton, Hants, England	University of London; Queen Mary University London; Ulster University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zagreb; University of Groningen; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Johannes Gutenberg University of Mainz; Newcastle University - UK; Otto von Guericke University; University of Oxford; University of Southampton	Morris, JK (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.	j.k.morris@qmul.ac.uk	Klungsøyr, Kari/ABC-6147-2020; Draper, Elizabeth/S-6874-2019; Khoshnood, Babak/N-9096-2017; Draper, Elizabeth S/I-6304-2018; Pierini, Anna/A-9622-2013; Barisic, Ingeborg/HDN-8784-2022; Morris, Joan/AAT-9211-2020; Matias Dias, Carlos/I-6335-2012	Klungsøyr, Kari/0000-0003-2482-1690; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Pierini, Anna/0000-0003-3321-9343; Morris, Joan/0000-0002-7164-612X; Loane, Maria/0000-0002-1206-3637; Matias Dias, Carlos/0000-0002-0206-5874; Rankin, Judith/0000-0001-5355-454X	European Union	European Union(European Commission)	This work was supported by the European Union in the framework of the Health Programme (2008-2013) to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the many people throughout Europe involved in providing and processing information, including affected families, clinicians, health professionals, medical records clerks and registry staff. This work was supported by funding from the European Union in the framework of the Health Programme (2008-2013)	Bell R, 2012, DIABETOLOGIA, V55, P936, DOI 10.1007/s00125-012-2455-y; Botting J, 2002, DRUG NEWS PERSPECT, V15, P604, DOI 10.1358/dnp.2002.15.9.840066; Boyd PA, 2011, BIRTH DEFECTS RES A, V91, pS2, DOI 10.1002/bdra.20780; Collins JS, 2001, J PEDIAT, V159, P143; COOPER LZ, 1985, REV INFECT DIS, V7, pS2; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Dolk H, 2005, ARCH DIS CHILD-FETAL, V90, pF355, DOI 10.1136/adc.2004.062810; Dolk H, 2015, EUR J EPIDEMIOL, V30, P1153, DOI 10.1007/s10654-015-0012-y; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; EUROCAT, 2015, EUROCAT STAT MON REP; EUROCAT, 2009, EUROCAT SPEC REP PRE; EUROCAT, 2014, EUROCAT STAT MON PRO; FIRTH HV, 1991, LANCET, V337, P762, DOI 10.1016/0140-6736(91)91374-4; Greenlees R, 2011, BIRTH DEFECTS RES A, V91, pS51, DOI 10.1002/bdra.20775; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; INPI, 2018, NORMATIVE INSTRUCTIO; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Khoshnood B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5949; Khoshnood B, 2013, J PEDIATR-US, V162, P108, DOI 10.1016/j.jpeds.2012.06.035; Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651; MASTROIACOVO P, 1991, LANCET, V337, P1091, DOI 10.1016/0140-6736(91)91735-D; Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721; Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Tararbit K, 2013, HUM REPROD, V28, P367, DOI 10.1093/humrep/des400; Tararbit K, 2011, EUR HEART J, V32, P500, DOI 10.1093/eurheartj/ehq440; Taruscio D, 2014, PUBLIC HEALTH GENOM, V17, P115, DOI 10.1159/000360602; WHO, 2011, DIAB EP EUR	35	56	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194986	10.1371/journal.pone.0194986	http://dx.doi.org/10.1371/journal.pone.0194986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621304	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000429206800031
J	Shebanits, K; Andersson-Assarsson, JC; Larsson, I; Carlsson, LMS; Feuk, L; Larhammar, D				Shebanits, Kateryna; Andersson-Assarsson, Johanna C.; Larsson, Ingrid; Carlsson, Lena M. S.; Feuk, Lars; Larhammar, Dan			Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference	PLOS ONE			English	Article							DROPLET-DIGITAL PCR; FOOD-INTAKE; EXTREME OBESITY; HUMAN GENOME; LIFE-STYLE; PREDISPOSES; DISCOVERY; APPETITE; CHINESE; SEX	Multiple genetic studies have linked copy number variation (CNV) in different genes to body mass index (BMI) and obesity. A CNV on chromosome 10q11.22 has been associated with body weight. This CNV region spans NPY4R, the gene encoding the pancreatic polypeptide receptor Y4, which has been described as a satiety-stimulating receptor. We have investigated CNV of the NPY4R gene and analysed its relationship to BMI, waist circumference and self-reported dietary intake from 558 individuals (216 men and 342 women) representing a wide BMI range. The copy number for NPY4R ranged from 2 to 8 copies (average 4.6 +/- 0.8). Rather than the expected negative correlation, we observed a positive correlation between NPY4R copy number and BMI as well as waist circumference (r = 0.267, p = 2.65x 10(-7) and r = 0.256, p = 8x10(-7), respectively). Each additional copy of NPY4R correlated with 2.6 kg/m(2) increase in BMI and 5.67 cm increase in waist circumference (p = 3.3x10(-7) and p = 1x10(-6), respectively) for women. For men, there was no statistically significant correlation between CNV and BMI. Our results suggest that NPY4R genetic variation influences body weight in women, but the exact role of this receptor appears to be more complex than previously proposed.	[Shebanits, Kateryna; Larhammar, Dan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Andersson-Assarsson, Johanna C.; Carlsson, Lena M. S.] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Larsson, Ingrid] Sahlgrens Univ Hosp, Dept Gastroenterol & Hepatol, Gothenburg, Sweden; [Feuk, Lars] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; Uppsala University	Larhammar, D (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	dan.larhammar@neuro.uu.se	Andersson-Assarsson, Johanna/M-2524-2019; Carlsson, Lena/F-7570-2018	Andersson-Assarsson, Johanna/0000-0001-9082-8589; Carlsson, Lena/0000-0003-4145-6242	Swedish Research Council [K2013-54X-11285-19, K2013-55X-22189-01-2]; Swedish Brain Foundation [F02016-0217]; Sahlgrenska University Hospital Regional Agreement on Medical Education and Research; Swedish Research Council; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Sahlgrenska University Hospital Regional Agreement on Medical Education and Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This study was supported by the grants from the Swedish Research Council (https://www.vr.se/) K2013-54X-11285-19 (LC) and K2013-55X-22189-01-2 (DL), the Swedish Brain Foundation (http://www.hjarnfonden.se/) F02016-0217 (DL), and the Sahlgrenska University Hospital Regional Agreement on Medical Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge all the participants of our study for making this work possible. Our study was funded by the Swedish Research Council, the Swedish Brain Foundation, and the Sahlgrenska University Hospital Regional Agreement on Medical Education and Research. We thank Leif Andersson for access to the droplet digital PCR facility and Jennifer Meadows for input and guidance during the initial setup of the method.	Abou Tayoun AN, 2016, HUM MUTAT, V37, P119, DOI 10.1002/humu.22912; Aerts E, 2016, OBESITY, V24, P970, DOI 10.1002/oby.21435; Aronne LJ, 2002, OBES RES, V10, p14S, DOI 10.1038/oby.2002.184; Artuso R, 2011, J HUM GENET, V56, P508, DOI 10.1038/jhg.2011.50; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; Campbell RE, 2003, J NEUROSCI, V23, P1487, DOI 10.1523/JNEUROSCI.23-04-01487.2003; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Chu JH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-157; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fetissov SO, 2004, NEUROPEPTIDES, V38, P175, DOI 10.1016/j.npep.2004.05.009; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kojima S, 2007, PEPTIDES, V28, P459, DOI 10.1016/j.peptides.2006.09.024; Larsson I, 2004, INT J OBESITY, V28, P1317, DOI 10.1038/sj.ijo.0802732; Lin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008488; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388; Lissner L, 1998, EUR J CLIN NUTR, V52, P316, DOI 10.1038/sj.ejcn.1600567; LUNDELL I, 1995, J BIOL CHEM, V270, P29123, DOI 10.1074/jbc.270.49.29123; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Mazaika E, 2014, CURR PROTOC HUM GENE, V82, p[7, 241], DOI DOI 10.1002/0471142905.HG0724S82; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Reinehr T, 2006, INT J OBESITY, V30, P1476, DOI 10.1038/sj.ijo.0803393; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Sillence KA, 2015, CLIN CHEM, V61, P1399, DOI 10.1373/clinchem.2015.239137; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Sun C, 2013, GENE, V516, P198, DOI 10.1016/j.gene.2012.12.081; Svobodova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142572; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Wang K, 2010, DIABETES, V59, P2690, DOI 10.2337/db10-0192; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	47	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194668	10.1371/journal.pone.0194668	http://dx.doi.org/10.1371/journal.pone.0194668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621259	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800023
J	Bossi, F; Gallucci, M; Ricciardelli, P				Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola			How social exclusion modulates social information processing: A behavioural dissociation between facial expressions and gaze direction	PLOS ONE			English	Article							EYE GAZE; OSTRACISM; PERCEPTION; NEED; ATTENTION; BELONG; BRAIN; SEX; SENSITIVITY; VALIDATION	Social exclusion is a painful experience that is felt as a threat to the human need to belong and can lead to increased aggressive and anti-social behaviours, and results in emotional and cognitive numbness. Excluded individuals also seem to show an automatic tuning to positivity: they tend to increase their selective attention towards social acceptance signals. Despite these effects known in the literature, the consequences of social exclusion on social information processing still need to be explored in depth. The aim of this study was to investigate the effects of social exclusion on processing two features that are strictly bound in the appraisal of the meaning of facial expressions: gaze direction and emotional expression. In two experiments (N = 60, N = 45), participants were asked to identify gaze direction or emotional expressions from facial stimuli, in which both these features were manipulated. They performed these tasks in a four-block crossed design after being socially included or excluded using the Cyberball game. Participants' empathy and self-reported emotions were recorded using the Empathy Quotient (EQ) and PANAS questionnaires. The Need Threat Scale and three additional questions were also used as manipulation checks in the second experiment. In both experiments, excluded participants showed to be less accurate than included participants in gaze direction discrimination. Modulatory effects of direct gaze (Experiment 1) and sad expression (Experiment 2) on the effects of social exclusion were found on response times (RTs) in the emotion recognition task. Specific differences in the reaction to social exclusion between males and females were also found in Experiment 2: excluded male participants tended to be less accurate and faster than included male participants, while excluded females showed a more accurate and slower performance than included female participants. No influence of social exclusion on PANAS or EQ scores was found. Results are discussed in the context of the importance of identifying gaze direction in appraisal theories.	[Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola] NeuroMl Milan Ctr Neurosci, Milan, Italy	University of Milano-Bicocca	Bossi, F (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.; Bossi, F (corresponding author), NeuroMl Milan Ctr Neurosci, Milan, Italy.	tbossi3@campus.unimib.it	Gallucci, Marcello/AAC-5495-2019; Gallucci, Marcello/H-3989-2012; Bossi, Francesco/AGU-0358-2022	Gallucci, Marcello/0000-0003-3546-0093; Gallucci, Marcello/0000-0003-3546-0093; Bossi, Francesco/0000-0003-3359-8187	Fondazione Cariplo and Regione Lombardia [2016-0925]; University of Milano-Bicocca	Fondazione Cariplo and Regione Lombardia(Regione Lombardia); University of Milano-Bicocca	This research was funded by a grant from Fondazione Cariplo and Regione Lombardia (pratica # 2016-0925) to Paola Ricciardelli and a scholarship from the University of Milano-Bicocca to Francesco Bossi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by Fondazione Cariplo and Regione Lombardia (grant n. 2016-0925) to PR and a scholarship from the University of Milano-Bicocca to FB. The authors would like to thank Laura Caccia for her help with data collection. The authors have declared no conflicts of interest for this article.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Artuso C, 2015, SOC COGNITION, V33, P543, DOI 10.1521/soco.2015.33.6.543; Artuso C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00362; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P506, DOI 10.1111/j.1751-9004.2007.00020.x; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Bernstein MJ, 2008, PSYCHOL SCI, V19, P981, DOI 10.1111/j.1467-9280.2008.02187.x; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Bockler A, 2014, SOC PSYCHOL PERS SCI, V5, P140, DOI 10.1177/1948550613488951; Carraro L, 2017, COGN PROCESS, V18, P97, DOI 10.1007/s10339-016-0785-2; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Cohen J., 2003, APPL MULTIPLE REGRES, V3rd ed., DOI DOI 10.4324/9780203774441; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; DeWall CN, 2011, EMOTION, V11, P623, DOI 10.1037/a0023534; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P729, DOI 10.1037/a0014634; Draine S., 2014, INQUISIT 4; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Hartgerink CHJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127002; Jamieson JP, 2010, PERS SOC PSYCHOL B, V36, P690, DOI 10.1177/0146167209358882; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Lipp OV, 2009, MOTIV EMOTION, V33, P249, DOI 10.1007/s11031-009-9136-2; Lyyra P, 2017, Q J EXP PSYCHOL, V70, P1713, DOI 10.1080/17470218.2016.1204327; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Otten M, 2013, SOC COGN AFFECT NEUR, V8, P789, DOI 10.1093/scan/nss071; Pavlova MA, 2017, J NEUROSCI RES, V95, P235, DOI 10.1002/jnr.23871; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; R Development Core Team, 2009, R LANG ENV STAT COMP; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Riva P, 2016, J SOCIAL PERSONAL RE, V34, P1; RStudio Inc, 2016, RSTUDIO INT DEV ENV; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Scherer K. R., 1992, INT REV STUDIES EMOT, V2, P139; Scherer Klaus, 1984, NATURE FUNCTION EMOT; Scherer Klaus R., 2001, APPRAISAL PROCESSES; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Twenge JM, 2003, J PERS SOC PSYCHOL, V85, P409, DOI 10.1037/0022-3514.85.3.409; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilkowski BM, 2009, PSYCHOL SCI, V20, P495, DOI 10.1111/j.1467-9280.2009.02321.x; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 1997, PERS SOC PSYCHOL B, V23, P693, DOI 10.1177/0146167297237003; Williams KD, 2009, ADV EXPT SOCIAL PSYC, V41; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Wirth JH, 2010, PERS SOC PSYCHOL B, V36, P869, DOI 10.1177/0146167210370032; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	62	4	5	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195100	10.1371/journal.pone.0195100	http://dx.doi.org/10.1371/journal.pone.0195100			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617410	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800064
J	Doubell, TP; Alsetrawi, A; Bastawrous, DAS; Bastawrous, MAS; Daibes, A; Jadalla, A; Schnupp, JWH				Doubell, T. P.; Alsetrawi, A.; Bastawrous, D. A. S.; Bastawrous, M. A. S.; Daibes, A.; Jadalla, A.; Schnupp, J. W. H.			The effect of interaural timing on the posterior auricular muscle reflex in normal adult volunteers	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; BINAURAL INTERACTION COMPONENT; DELAY-DEPENDENT CHANGES; EVOKED-POTENTIALS; PROCESSING DISORDERS; SOUND LOCALIZATION; PINNA MOVEMENTS; RESPONSES; CHILDREN; TIME	The posterior auricular muscle (PAM) reflex to sounds has been used clinically to determine hearing threshold as an alternative to other audiological diagnostic measures such as the auditory brainstem response. We have shown that the PAM response is also sensitive to interaural timing differences in normally hearing adults. PAM responses were evoked by both ipsilateral/contralateral monaural stimulation and by binaural stimulation. Introducing sound delays ipsilaterally or contralaterally decreased the PAM response amplitude and increased its latency. The PAM response in this study shows a qualitatively similar pattern to that seen by the binaural interaction component (BIC) of the auditory brainstem potential to binaural clicks described in previous studies, in that both: have their shortest latency and maximal amplitudes centred around zero interaural timing differences, have response latencies increase with increasing interaural delays up to 1.2 ms and have response amplitudes decrease with increasing interaural delays of up to 1.2 ms. Our data show that the PAM response may be useful in measuring binaural integration in humans non-invasively for diagnostic or research studies.	[Doubell, T. P.; Alsetrawi, A.; Bastawrous, D. A. S.; Bastawrous, M. A. S.; Daibes, A.; Jadalla, A.] Med Univ Bahrain, Royal Coll Surg Ireland, Sch Med, Busaiteen, Bahrain; [Schnupp, J. W. H.] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Schnupp, J. W. H.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Royal College of Surgeons - Ireland; City University of Hong Kong; University of Oxford	Doubell, TP (corresponding author), Med Univ Bahrain, Royal Coll Surg Ireland, Sch Med, Busaiteen, Bahrain.	tdoubell@rcsi-mub.com		schnupp, jan w h/0000-0002-2604-0057	Royal College of Surgeons of Ireland:Medical University of Bahrain research committee	Royal College of Surgeons of Ireland:Medical University of Bahrain research committee	The equipment used in this study was purchased by a grant from the Royal College of Surgeons of Ireland:Medical University of Bahrain research committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agung K, 2005, INT J AUDIOL, V44, P631, DOI 10.1080/14992020500266613; Akeroyd MA, 2006, INT J AUDIOL, V45, pS25, DOI 10.1080/14992020600782626; Benning SD, 2004, PSYCHOPHYSIOLOGY, V41, P426, DOI 10.1111/j.1469-8986.00160.x; Benning SD, 2011, PSYCHOPHYSIOLOGY, V48, P410, DOI 10.1111/j.1469-8986.2010.01071.x; Brantberg K, 1999, SCAND AUDIOL, V28, P15, DOI 10.1080/010503999424879; CODY DTR, 1969, LARYNGOSCOPE, V79, P400, DOI 10.1288/00005537-196903000-00007; Cook A, 2014, EAR HEARING, V35, P230, DOI 10.1097/AUD.0b013e3182a4efdf; Dau T, 2000, J ACOUST SOC AM, V107, P1530, DOI 10.1121/1.428438; Delb W, 2003, INT J AUDIOL, V42, P401, DOI 10.3109/14992020309080049; Delb WF, 2004, INT J AUDIOL, V43, P69, DOI 10.1080/14992020400050012; DOBIE RA, 1980, ELECTROEN CLIN NEURO, V49, P303, DOI 10.1016/0013-4694(80)90224-2; DOBIE RA, 1979, ARCH OTOLARYNGOL, V105, P391; DUS V, 1975, ELECTROEN CLIN NEURO, V39, P523, DOI 10.1016/0013-4694(75)90055-3; Emanuel DC, 2011, AM J AUDIOL, V20, P48, DOI 10.1044/1059-0889(2011/10-0019); FRIAUF E, 1985, J COMP NEUROL, V240, P161, DOI 10.1002/cne.902400206; Furst M, 2004, HEARING RES, V187, P63, DOI 10.1016/S0378-5955(03)00331-9; FURST M, 1985, J ACOUST SOC AM, V78, P1644, DOI 10.1121/1.392802; Gibson WPR, 1975, THESIS; Goksoy C, 2005, BRAIN RES, V1054, P183, DOI 10.1016/j.brainres.2005.06.083; Gopal KV, 1999, SCAND AUDIOL, V28, P77, DOI 10.1080/010503999424798; Gordon KA, 2007, NEUROREPORT, V18, P613, DOI 10.1097/WNR.0b013e3280b10c15; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; GUNNARSON AD, 1991, J SPEECH HEAR RES, V34, P1207, DOI 10.1044/jshr.3405.1207; Hackley SA, 2015, PSYCHOPHYSIOLOGY, V52, P1263, DOI 10.1111/psyp.12501; HENKEL CK, 1978, J COMP NEUROL, V182, P763, DOI 10.1002/cne.901820502; Horta-Junior JAC, 2008, J COMP NEUROL, V507, P1763, DOI 10.1002/cne.21625; Jaganathan R, 2002, OPTIMISING POST AURI; JERGER S, 1988, AM J OTOL, V9, P63; JEWETT DL, 1970, SCIENCE, V167, P1517, DOI 10.1126/science.167.3924.1517; Jiang ZD, 1996, PEDIATR RES, V39, P708, DOI 10.1203/00006450-199604000-00024; JONES SJ, 1990, ELECTROEN CLIN NEURO, V77, P214, DOI 10.1016/0168-5597(90)90040-K; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; Laumen G, 2016, EAR HEARING, V37, pE276, DOI 10.1097/AUD.0000000000000301; Laumen G, 2016, HEARING RES, V337, P46, DOI 10.1016/j.heares.2016.04.009; LEVINE RA, 1981, ANN NEUROL, V9, P384, DOI 10.1002/ana.410090412; MCPHERSON DL, 1995, HEARING RES, V89, P162, DOI 10.1016/0378-5955(95)00134-1; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Mukerji S, 2010, TRENDS AMPLIF, V14, P170, DOI 10.1177/1084713810381771; O'Beirne GA, 1999, HEARING RES, V138, P115, DOI 10.1016/S0378-5955(99)00159-8; Patuzzi RB, 2000, AUDIOL NEURO-OTOL, V5, P322, DOI 10.1159/000013898; Populin LC, 1998, J NEUROSCI, V18, P4233; Pratt H, 1998, EVOKED POTENTIAL, V108, P511, DOI 10.1016/S0168-5597(98)00029-X; Purdy SC, 2005, INT J AUDIOL, V44, P625, DOI 10.1080/14992020500266639; Riedel H, 2006, HEARING RES, V218, P5, DOI 10.1016/j.heares.2006.03.018; Stollman MHP, 1996, BRIT J AUDIOL, V30, P227, DOI 10.3109/03005369609079043; THORNTON ARD, 1975, J LARYNGOL OTOL, V89, P997, DOI 10.1017/S0022215100081317; TOTSUKA G, 1954, ANN OTO RHINOL LARYN, V63, P939, DOI 10.1177/000348945406300406; Ungan P, 1997, HEARING RES, V106, P66, DOI 10.1016/S0378-5955(97)00003-8; WREGE KS, 1981, ARCH NEUROL-CHICAGO, V38, P572, DOI 10.1001/archneur.1981.00510090066008; YOSHIE N, 1969, ACTA OTO-LARYNGOL, VS, P89	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194965	10.1371/journal.pone.0194965	http://dx.doi.org/10.1371/journal.pone.0194965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617426	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800058
J	Spitsyn, VM; Kondakov, AV; Bolotov, NI; Pham, NT; Gofarov, MY; Bolotov, IN				Spitsyn, Vitaly M.; Kondakov, Alexander V.; Bolotov, Nikita I.; Nhi Thi Pham; Gofarov, Mikhail Y.; Bolotov, Ivan N.			DNA barcoding unravels contrasting evolutionary history of two widespread Asian tiger moth species during the Late Pleistocene	PLOS ONE			English	Article							POPULATION-GENETICS; CREATONOTOS-TRANSIENS; GLOBAL PHYLOGEOGRAPHY; NEW-GUINEA; LEPIDOPTERA; ARCTIIDAE; COMMUNITIES; INFERENCES; SOFTWARE; SEQUENCE	Populations of widespread pest insects in tropical areas are characterized by a complex evolutionary history, with overlapping natural and human-mediated dispersal events, sudden expansions, and bottlenecks. Here, we provide biogeographic reconstructions for two widespread pest species in the tiger moth genus Creatonotos (Lepidoptera: Erebidae: Arctiinae) based on the mitochondrial cytochrome c oxidase subunit I (COI) gene. The Asian Creatonotos transiens reveals shallow genetic divergence between distant populations that does not support its current intraspecific systematics with several local subspecies. In contrast, the more widespread Creatonotos gangis comprises at least three divergent subclades corresponding to certain geographic areas, i.e. Australia, Arabia + South Asia and Southeast Asia. With respect to our approximate Bayesian computation (ABC) model, the expansion of Creatonotos gangis into Australia is placed in the Late Pleistocene (similar to 65-63 ka). This dating coincide with an approximate time of the earliest human migration into the continent (similar to 65-54 ka) and the period of intervisibility between Timor and Australia (similar to 65-62 ka). Our findings highlight that the drying Sunda and Sahul shelf areas likely support successful migrations of Asian taxa into Australia during the Pleistocene. The phylogeographic patterns discovered in this study can be used to improve the effectiveness of integrated pest control programs that is a task of substantial practical importance to a broad range of agricultural stakeholders.	[Spitsyn, Vitaly M.; Kondakov, Alexander V.; Gofarov, Mikhail Y.; Bolotov, Ivan N.] Northern Arctic Fed Univ, Lab Mol Ecol & Phylogenet, Arkhangelsk, Russia; [Spitsyn, Vitaly M.; Kondakov, Alexander V.; Bolotov, Nikita I.; Gofarov, Mikhail Y.; Bolotov, Ivan N.] Russian Acad Sci, Fed Ctr Integrated Arctic Res, Inst Biogeog & Genet Resources, Arkhangelsk, Russia; [Nhi Thi Pham] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Nhi Thi Pham] Vietnam Acad Sci & Technol, Grad Univ Sci & Technol, Hanoi, Vietnam	Northern Arctic Federal University; N. Laverov Federal Center for Integrated Arctic Research; Russian Academy of Sciences; Vietnam Academy of Science & Technology (VAST); Vietnam Academy of Science & Technology (VAST)	Spitsyn, VM (corresponding author), Northern Arctic Fed Univ, Lab Mol Ecol & Phylogenet, Arkhangelsk, Russia.; Spitsyn, VM (corresponding author), Russian Acad Sci, Fed Ctr Integrated Arctic Res, Inst Biogeog & Genet Resources, Arkhangelsk, Russia.	vitalik91993@yandex.ru	Gofarov, Mikhail Y/U-9024-2017; Kondakov, Alexander V/C-9202-2018; Bolotov, Ivan N/P-2892-2015	Gofarov, Mikhail Y/0000-0002-8532-0307; Kondakov, Alexander V/0000-0002-6305-6496; Spitsyn, Vitaly M./0000-0003-2955-3795	National Geographic Society (USA) [9821-15]; Federal Agency for Scientific Organizations (Russia) [0409-20150143]	National Geographic Society (USA)(National Geographic Society); Federal Agency for Scientific Organizations (Russia)	The field works and sampling were supported by the National Geographic Society (USA, grant no. 9821-15) (http llama natonalgeographic corn). The molecular analyses were supported by the Federal Agency for Scientific Organizations (Russia, project no. 0409-20150143) (http//fano.gov.ru/en/).	ALLSOPP PG, 1980, B ENTOMOL RES, V70, P343, DOI 10.1017/S0007485300007628; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergstrom A, 2016, CURR BIOL, V26, P809, DOI 10.1016/j.cub.2016.01.028; Biswas Olive, 2016, Journal of Entomology and Zoology Studies, V4, P13; Bito D, 2007, J BIOGEOGR, V34, P769, DOI 10.1111/j.1365-2699.2006.01652.x; Bolotov IN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02312-z; Bolotov IN, 2015, POLAR BIOL, V38, P905, DOI 10.1007/s00300-014-1643-2; BOPPRE M, 1986, NATURWISSENSCHAFTEN, V73, P17, DOI 10.1007/BF01168801; BOPPRE M, 1989, ZOOL J LINN SOC-LOND, V96, P339, DOI 10.1111/j.1096-3642.1989.tb02518.x; Braby MF, 2015, SYST BIODIVERS, V13, P386, DOI 10.1080/14772000.2014.992378; Catindig J. L. A., 1993, International Rice Research Notes, V18, P34; Catling D, 2013, BANGLADESH RICE J, V17, P75; Cerny Karel, 2011, Entomofauna, V32, P29; Condamine FL, 2015, SCI REPORTS, P5; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; De Freina Josef J., 2007, Nota Lepidopterologica, V30, P375; Dubatolov V. V., 2010, Evraziatskii entomologicheskii Zhurnal, V9, P727; Dubatolov Vladimir V., 2010, Neue Entomologische Nachrichten, V65, P1; Dubatolov Vladimir V., 2007, Bonner Zoologische Beitraege, V55, P113; Epperson BK, 2003, GEOGRAPHICAL GENETIC, V356; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feller Z, 2013, ORG DIVERS EVOL, V13, P569; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freina JJ, 2010, ESPERIANA BUCHREIHE, V15, P423; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Gurule S. A., 2010, Flora and Fauna (Jhansi), V16, P295; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hegna RH, 2015, J BIOGEOGR, V42, P1469, DOI 10.1111/jbi.12513; Holland D., 2009, Horticultural Reviews, V35, P127; Johnson CN, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2399; Kealy S, 2017, ARCHAEOL PROSPECT, P1570; Kumar Manoj, 2006, Indian Journal of Agricultural Research, V40, P42; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paul Monalisa, 2016, Journal of Entomology and Zoology Studies, V4, P435; Rambaut A., 2014, TRACER V16; Ronka K, 2016, SYST ENTOMOL, V41, P844, DOI 10.1111/syen.12194; Rougerie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101108; Saltre A F, 2016, NAT COMM, P7; Sambrook J., 1989, MOL CLONING LAB MANU; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; SCHNEIDER D, 1982, SCIENCE, V215, P1264, DOI 10.1126/science.215.4537.1264; Shah S. Kr., 2015, Journal of Zoology Studies, V2, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Van Eecke R., 1927, 4 ZOOLOGISCHE MEDEDE, V10, P90; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Voda R, 2016, SCI REPORTS, P6; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; WINK M, 1990, J COMP PHYSIOL B, V160, P389, DOI 10.1007/BF01075670; Wink M, 1997, J CHEM ECOL, V23, P1549, DOI 10.1023/B:JOEC.0000006421.49263.ae; WUNDERER H, 1989, J INSECT PHYSIOL, V35, P87, DOI 10.1016/0022-1910(89)90041-3; WUNDERER H, 1986, EXP BIOL, V46, P11; Yago M, 2008, ZOOTAXA, P15; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou CL, 2012, PAN-PAC ENTOMOL, V88, P381, DOI 10.3956/2011-33.1; Zhou LH, 2016, J APPL ENTOMOL, P12371	68	2	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194200	10.1371/journal.pone.0194200	http://dx.doi.org/10.1371/journal.pone.0194200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617397	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800023
J	Zhang, CL; Sun, M; Zhang, XQ; Chen, SY; Nie, G; Peng, Y; Huang, LK; Ma, X				Zhang, Chenglin; Sun, Ming; Zhang, Xinquan; Chen, Shiyong; Nie, Gang; Peng, Yan; Huang, Linkai; Ma, Xiao			AFLP-based genetic diversity of wild orchardgrass germplasm collections from Central Asia and Western China, and the relation to environmental factors	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L.; GALICIA NORTHWEST SPAIN; POPULATION-STRUCTURE; TALL FESCUE; MOLECULAR MARKERS; TIBETAN PLATEAU; ISSR MARKERS; SSR MARKERS; EVOLUTION; PLANTS	Dactylis glomerata L. (orchardgrass) is an important perennial forage species in temperate areas of the world. It is usually used for silage, grazing and hay because of its high nutritional value and reproducibility. Central Asia, Xinjiang and Tibetan Plateau in China possess various special micro-environments that harbor many valuable resources, while different degrees of degradation of the grassland ecosystem occurred due to climatic changing and human activities. Investigating the genetic diversity of wild D. glomerat could provide basis for collection, protection, and utilization of some excellent germplasm resources. Totally 210 individuals from 14 populations D five from Xinjiang, two from Kangding (Tibetan Plateau), and seven from Central Asia were identified using AFLP technology. The average values of Nei's genetic diversity (H-j) and Shannon information index (H-o) were 0.383 and 0.394 respectively. UPGMA tree, STRUCTURE analysis and principal coordinate analysis (PCoA) showed populations from same region clustered together. AMOVA revealed 35.10% of the genetic differentiation (F-st) occurred among populations. Gene flow (N-m) was limited among all populations. Genetic diversity of D. glomerata was high but limited under isolation-by-distance pattern, resulting in high genetic differentiation and low gene flow among populations. Adjacent regions also exhibited similar results because of the barriers of high mountains. The environmental factors, such as precipitation, elevation, latitude and longitude also had some impacts on genetic diversity and structure pattern of populations.	[Zhang, Chenglin; Sun, Ming; Zhang, Xinquan; Nie, Gang; Peng, Yan; Huang, Linkai; Ma, Xiao] Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China; [Chen, Shiyong] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Southwest Minzu University	Ma, X (corresponding author), Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China.	maroar@126.com	Zhang, Cheng/GRS-8698-2022; sun, ming/GRE-6915-2022		National Basic S&T Resources Survey Project of China [2017FY100602]; Earmarked Fund for the Modern Agro-Industry Technology Research System [CARS-34]; National Key Basic Research Program of China (973 Program) [2014CB138705]	National Basic S&T Resources Survey Project of China; Earmarked Fund for the Modern Agro-Industry Technology Research System; National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic S&T Resources Survey Project of China (#2017FY100602), the Earmarked Fund for the Modern Agro-Industry Technology Research System (#CARS-34) to XZ and the National Key Basic Research Program of China (973 Program) (#2014CB138705) to XM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Arthur AD, 2008, BIOL CONSERV, V141, P1972, DOI 10.1016/j.biocon.2008.05.010; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; BORRILL M, 1962, GENETICA, V32, P94, DOI 10.1007/BF01816089; Brekke P, 2011, MOL ECOL, V20, P29, DOI 10.1111/j.1365-294X.2010.04923.x; Chen YY, 2010, PLANT SYST EVOL, V290, P127, DOI 10.1007/s00606-010-0355-5; Christensen S, 2011, GENET RESOUR CROP EV, V58, P657, DOI 10.1007/s10722-010-9607-z; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Feng XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13758; Fox Joseph L., 2005, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V33, P49; Fu KX, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0013-1; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; HANCOCK JF, 1981, AM J BOT, V68, P1, DOI 10.2307/2442984; Hijmans RJ, 2004, HUMAN SCI RES, V19, P49; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; Hu YP, 2016, AQUAT BOT, V134, P54, DOI 10.1016/j.aquabot.2016.06.011; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jafari A, 2007, J AGR SCI-CAMBRIDGE, V145, P599, DOI 10.1017/S0021859607007332; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Kong P, 2009, QUATERNARY RES, V72, P229, DOI 10.1016/j.yqres.2009.06.002; Langridge P, 2005, BIOTECHNOL AGRIC FOR, V55, P3; Last L, 2014, ECOL INDIC, V38, P181, DOI 10.1016/j.ecolind.2013.11.004; Last L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-102; Ligges U., 2003, J STAT SOFTW, V08, P11, DOI DOI 10.18637/JSS.V008.I11; Lindner R, 1997, GENET RESOUR CROP EV, V44, P499, DOI 10.1023/A:1008690831828; Lindner R, 2004, GENET RESOUR CROP EV, V51, P437, DOI 10.1023/B:GRES.0000023457.30193.63; [刘长娥 Liu Change], 2006, [中国草地学报, Chinese Journal of Grassland], V28, P18; LUMARET R, 1987, OECOLOGIA, V73, P436, DOI 10.1007/BF00385262; Ma X, 2008, BIOCHEM SYST ECOL, V36, P514, DOI 10.1016/j.bse.2008.03.003; Madesis P, 2014, GENET MOL RES, V13, P4226, DOI 10.4238/2014.June.9.8; McEwen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068889; McVean GAT, 2002, GENETICS, V162, P987; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Mian MAR, 2002, CROP SCI, V42, P944, DOI 10.2135/cropsci2002.0944; Mki PC, 2010, PLANT BREEDING, V127, P510; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Niazkhani S. M., 2013, International Journal of Agronomy and Plant Production, V4, P3022; Null RCTR, 2013, COMPUTING, V14, P12; Oksanen J, 2016, J STAT SOFTW, V48, P21; Ortego J, 2015, PLANT BIOLOGY, V17, P676, DOI 10.1111/plb.12272; Palsboll PJ, 2013, MOL ECOL, V22, P22, DOI 10.1111/mec.12094; Parisod C, 2008, BOT HELV, V118, P1, DOI 10.1007/s00035-008-0825-3; Peng Yan, 2006, Yichuan, V28, P845; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Richard CE, 2003, CONSERVING BIODIVERSITY IN ARID REGIONS: BEST PRACTICES IN DEVELOPING NATIONS, P249; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Santiago M, 2016, AOB PLANTS, V8, P34; Schlick K., 2011, THESIS; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shahidul I, 2013, METHODS MOL BIOL, V1069, P179, DOI 10.1007/978-1-62703-613-9_13; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Stewart AV, 2014, CROP PASTURE SCI, V65, P780, DOI 10.1071/CP13407; Stewart AV, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P73, DOI 10.1007/978-3-642-14255-0_5; Storz JF, 2010, SCIENCE, V329, P40, DOI 10.1126/science.1192481; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Sui XQ, 2009, AFR J BIOTECHNOL, V8, P3431; Sun M, 2017, CR BIOL, V340, P145, DOI 10.1016/j.crvi.2016.12.003; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Team R.C., 2012, COMPUTING, V1, P12; Tuna M, 2004, EUPHYTICA, V135, P39, DOI 10.1023/B:EUPH.0000009537.08697.4e; Turner LR, 2012, GRASS FORAGE SCI, V67, P507, DOI 10.1111/j.1365-2494.2012.00866.x; Vitalis Renaud, 2012, Methods Mol Biol, V888, P277, DOI 10.1007/978-1-61779-870-2_16; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wright S., 2001, GENETICS, V28, P1054; Wu JB, 2010, BIOCHEM SYST ECOL, V38, P471, DOI 10.1016/j.bse.2010.04.008; Xie WG, 2010, CAN J PLANT SCI, V90, P13, DOI 10.4141/CJPS08192; Xu JH, 2016, THEOR APPL CLIMATOL, V123, P321, DOI 10.1007/s00704-014-1364-z; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zeng B, 2008, CAN J PLANT SCI, V88, P53, DOI 10.4141/CJPS07017; Zhang CL, 2017, MOLECULES, V22, P13; Zhang XQ, 2002, GENET RESOUR CROP EV, V49, P397	77	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195273	10.1371/journal.pone.0195273	http://dx.doi.org/10.1371/journal.pone.0195273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641553	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900063
J	Gabilondo, H; Rubio-Ferrera, I; Losada-Perez, M; del Saz, D; Leon, Y; Molina, I; Torroja, L; Allan, DW; Benito-Sipos, J				Gabilondo, Hugo; Rubio-Ferrera, Irene; Losada-Perez, Maria; del Saz, Delia; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Allan, Douglas W.; Benito-Sipos, Jonathan			Segmentally homologous neurons acquire two different terminal neuropeptidergic fates in the Drosophila nervous system	PLOS ONE			English	Article							EMBRYONIC CNS; CELL FATE; MELANOGASTER; NEUROBLASTS; LINEAGES; PATTERN; GENES	In this study, we identify the means by which segmentally homologous neurons acquire different neuropeptide fates in Drosophila. Ventral abdominal (Va)-neurons in the A1 segment of the ventral nerve cord express DH31 and AstA neuropeptides (neuropeptidergic fate I) by virtue of Ubxactivity, whereas the A2-A4 Va-neurons express the Capa neuropeptide (neuropeptidergic fate II) under the influence of abdA. These different fates are attained through segment-specific programs of neural subtype specification undergone by segmentally homologous neurons. This is an attractive alternative by which Hox genes can shape Drosophila segmental neural architecture (more sophisticated than the previously identified binary "to live" or "not to live" mechanism). These data refine our knowledge of the mechanisms involved in diversifying neuronal identity within the central nervous system.	[Gabilondo, Hugo; Rubio-Ferrera, Irene; Losada-Perez, Maria; del Saz, Delia; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Benito-Sipos, Jonathan] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Allan, Douglas W.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada	Autonomous University of Madrid; University of British Columbia	Benito-Sipos, J (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	jonathan.benito@uam.es	Torroja, Laura/L-2449-2013; Molina, Isabel/L-2432-2013; Leon, Yolanda/ABG-6797-2020; Torroja, Laura/AAU-7896-2021; Losada Perez, Maria/E-8779-2013	Torroja, Laura/0000-0001-6939-6259; Molina, Isabel/0000-0003-1687-2447; Torroja, Laura/0000-0001-6939-6259; , Irene/0000-0001-6372-440X; Benito-Sipos, Jonathan/0000-0002-1159-3644; Losada Perez, Maria/0000-0002-6717-7762	 [BFU2013-43858-P]		This study was supported by grant number: BFU2013-43858-P, URL: http://www.mineco.gob.es.	Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Birkholz O, 2013, DEVELOPMENT, V140, P1830, DOI 10.1242/dev.090043; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Gabilondo H, 2011, MECH DEVELOP, V128, P208, DOI 10.1016/j.mod.2011.01.002; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; Moris-Sanz M, 2014, DEVELOPMENT, V141, P4366, DOI 10.1242/dev.113381; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Rogulja-Ortmann A, 2008, FLY, V2, P316, DOI 10.4161/fly.7464; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Suska A, 2011, DEV BIOL, V353, P72, DOI 10.1016/j.ydbio.2011.02.015; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; UDOLPH G, 1993, DEVELOPMENT, V118, P765; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Veverytsa L, 2012, P NATL ACAD SCI USA, V109, pE748, DOI 10.1073/pnas.1114710109	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194281	10.1371/journal.pone.0194281	http://dx.doi.org/10.1371/journal.pone.0194281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634720	Green Submitted, gold, Green Published			2022-12-27	WOS:000429522200008
J	Romijn, EI; Finnoy, A; Kumar, R; Lilledahl, MB				Romijn, Elisabeth I.; Finnoy, Andreas; Kumar, Rajesh; Lilledahl, Magnus B.			Automated calibration and control for polarization-resolved second harmonic generation on commercial microscopes	PLOS ONE			English	Article							COLLAGEN	Polarization-resolved second harmonic generation (P-SHG) microscopy has evolved as a promising technique to reveal subresolution information about the structure and orientation of ordered biological macromolecules. To extend the adoption of the technique, it should be easily integrated onto commercial laser scanning microscopes. Furthermore, procedures for easy calibration and assessment of measurement accuracy are essential, and measurements should be fully automated to allow for analysis of large quantities of samples. In this paper we present a setup for P-SHG which is readily incorporated on commercial multiphoton microscopes. The entire system is completely automated which allows for rapid calibration through the freely available software and for automated imaging for different polarization measurements, including linear and circular polarization of the excitation beam. The results show that calibration settings are highly system dependent. We also show that the accuracy of the polarization control is easily quantified and that it varies between systems. The accuracy can be tuned by iterative alignment of optics or a more fine-grained calibration procedure. Images of real samples show that the red accuracy of the results is easily visualized with the automated setup. Through this system we believe that P-SHG could develop a wider adoption in biomedical applications.	[Romijn, Elisabeth I.; Finnoy, Andreas; Kumar, Rajesh; Lilledahl, Magnus B.] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Lilledahl, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway.	rnagnus.lilledahl@ntnu.no			Norwegian University of Science and Technology (NTNU)	Norwegian University of Science and Technology (NTNU)	Our research was funded by the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambekar R, 2012, BIOMED OPT EXPRESS, V3, P2021, DOI 10.1364/BOE.3.002021; Brideau C, 2012, PROC SPIE, V8226, DOI 10.1117/12.908995; Chen WL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3132062; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Chou CK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2824379; Doras C, 2011, OPT EXPRESS, V19, P15062, DOI 10.1364/OE.19.015062; Gusachenko I, 2010, OPT EXPRESS, V18, P19339, DOI 10.1364/OE.18.019339; Hompland T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983664; Kumar R, 2015, J BIOPHOTONICS, V8, P730, DOI 10.1002/jbio.201400086; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Lin J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826516; Psilodimitrakopoulos S, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084007; Romijn EI, 2017, MATLAB CODE AUTOMATE, DOI [10.5281/zenodo.883081, DOI 10.5281/ZENODO.883081]; ROTH S, 1979, J CHEM PHYS, V70, P1637, DOI 10.1063/1.437677; Rouede D, 2015, OPT EXPRESS, V23, P13309, DOI 10.1364/OE.23.013309; Schon P, 2008, OPT EXPRESS, V16, P20891, DOI 10.1364/OE.16.020891; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Su PJ, 2010, BIOMATERIALS, V31, P9415, DOI 10.1016/j.biomaterials.2010.08.055; Tiaho F, 2007, OPT EXPRESS, V15, P12286, DOI 10.1364/OE.15.012286	19	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195027	10.1371/journal.pone.0195027	http://dx.doi.org/10.1371/journal.pone.0195027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634729	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200022
J	Sasaki, Y; Kawamoto, A; Tahara, H; Kasuga, K; Sato, R; Ohnishi, M; Nakamura, S; Koizumi, N				Sasaki, Yuya; Kawamoto, Akihiro; Tahara, Hajime; Kasuga, Kie; Sato, Ryoichi; Ohnishi, Makoto; Nakamura, Shuichi; Koizumi, Nobuo			Leptospiral flagellar sheath protein FcpA interacts with FIaA2 and FIaB1 in Leptospira biflexa	PLOS ONE			English	Article							PERIPLASMIC FLAGELLA; BORRELIA-BURGDORFERI; PSEUDOMONAS-AERUGINOSA; MOTILITY; SPIROCHETE; INTERROGANS; VIRULENCE; INVOLVEMENT; CHEMOTAXIS; MORPHOLOGY	Leptospira spp. are spirochete bacteria that possess periplasmic flagella (PFs) underneath the outer membrane; each flagellum is attached to each end of the protoplasmic cylinder. PFs of Leptospira have a coiled shape that bends the end of the cell body. However, the molecular mechanism by which multiple flagellar proteins organize to form the distinctively curled PF of Leptospira remains unclear. Here we obtained a slow-motility mutant of L. biflexa MD4-3 by random insertion mutagenesis using a Himarl transposon. In MD4-3, the gene encoding the flagellar sheath protein, flagellar-coiling protein A (FcpA), which was recently identified in L. interrogans, was inactivated. As with L. interrogans triangle fcpA strains, the L. biflexa triangle fcpA strain lacked a distinct curvature at both ends of the cell body, and its motility was significantly reduced as compared with that of the wild-type strain. PFs isolated from the AfcpA strain were straight and were thinner than those isolated from the wild-type strain. Western blot analysis revealed that flagellar proteins FlaAl, FIaA2, FIaB1, and FIaB2 were expressed in the triangle fcpA strain but the flagellar proteins, except for FIaB2 were not incorporated in its PFs. Immunoprecipitation assay using anti-FcpA antiserum demonstrated that FcpA associates with FIaA2 and FIaB1. The association between FcpA and FIaA2 was also verified using pull-down assay. The regions of FIaA2 and FIaB1 interacting with FcpA were determined using a bacterial two-hybrid assay. These results suggest that FcpA together with FIaA2, produces coiling of PF of the Leptospira, and the interaction between the sheath and core filament may be mediated by FcpA and FIaB1.	[Sasaki, Yuya; Sato, Ryoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo, Japan; [Sasaki, Yuya; Ohnishi, Makoto; Koizumi, Nobuo] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Kawamoto, Akihiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tahara, Hajime; Nakamura, Shuichi] Tohoku Univ, Grad Sch Engn, Dept Appl Phys, Sendai, Miyagi, Japan; [Kasuga, Kie] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata, Niigata, Japan; [Kasuga, Kie] Kanazawa Univ, Div Med Sci, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Kawamoto, Akihiro] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan	Tokyo University of Agriculture & Technology; National Institute of Infectious Diseases (NIID); Osaka University; Tohoku University; Niigata University; Kanazawa University; Osaka University	Koizumi, N (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	nkoizumi@niid.go.jp	Kasuga, Kie/D-2308-2013; Sato, Ryoichi/G-1074-2013	Kasuga, Kie/0000-0003-0489-194X; Koizumi, Nobuo/0000-0002-5733-535X; Nakamura, Shuichi/0000-0003-3972-7779	JSPS KAKENHI [25460557, 16K08797];  [15H01307]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by JSPS KAKENHI Grant Numbers 25460557 and 16K08797 to NK and the Grant-in-Aid for Scientific Research on Innovative Areas "Harmonized Supramolecular Motility Machinery and Its Diversity" to SN (15H01307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berg HC, 1978, S SOC GEN MICROBIOL, P285; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; CHARON NW, 1991, J BACTERIOL, V173, P4820, DOI 10.1128/jb.173.15.4820-4826.1991; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1992, RES MICROBIOL, V143, P597, DOI 10.1016/0923-2508(92)90117-7; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Ge YG, 1997, J BACTERIOL, V179, P552, DOI 10.1128/jb.179.2.552-556.1997; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; KELLYWINTENBERG K, 1993, J BACTERIOL, V175, P2458, DOI 10.1128/JB.175.8.2458-2461.1993; KELLYWINTENBERG K, 1990, J BACTERIOL, V172, P5135, DOI 10.1128/jb.172.9.5135-5139.1990; KOOPMAN MBH, 1992, INFECT IMMUN, V60, P2920, DOI 10.1128/IAI.60.7.2920-2925.1992; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2000, J BACTERIOL, V182, P6698, DOI 10.1128/JB.182.23.6698-6706.2000; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martin FS, 2017, ACTA CRYSTALLOGR F, V73, P123, DOI 10.1107/S2053230X17002096; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Nakamura S, 2017, METHODS MOL BIOL, V1593, P243, DOI 10.1007/978-1-4939-6927-2_19; Nakamura S, 2014, BIOPHYS J, V106, P47, DOI 10.1016/j.bpj.2013.11.1118; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Slamti Leyla, 2012, Methods Mol Biol, V859, P169, DOI 10.1007/978-1-61779-603-6_9; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Toma C, 2014, CELL MICROBIOL, V16, P1366, DOI 10.1111/cmi.12296; Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e019492	10.1371/journal.pone.0194923	http://dx.doi.org/10.1371/journal.pone.0194923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634754	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200017
J	Godai, K; Hasegawa-Moriyama, M; Matsunaga, A; Kanmura, Y				Godai, Kohei; Hasegawa-Moriyama, Maiko; Matsunaga, Akira; Kanmura, Yuichi			Phenylephrine does not improve oxygenation during one-lung ventilation: A randomized, double-blind, cross-over study	PLOS ONE			English	Article							PULSE PRESSURE VARIATION; FLUID RESPONSIVENESS; MANAGEMENT; ANESTHESIA; HYPOXEMIA	Background Phenylephrine is an alpha(1) adrenergic receptor agonist that causes pulmonary vasoconstriction, and so may effectively enhance hypoxic pulmonary vasoconstriction (HPV). However, there is little evidence that phenylephrine augments HPV in clinical situations. This study aimed to evaluate the clinical effects of phenylephrine infusion on oxygenation during one-lung ventilation (OLV) in patients undergoing thoracic surgery. Methods This was a prospective, randomized, double-blind, cross-over study. Included patients were those undergoing elective thoracic surgery in the lateral decubitus position with OLV. Patients were randomly allocated to two groups. The N-P group initially had OLV with normal saline infusion for 30 minutes; after a 10 minute interval, OLV was then maintained with phenylephrine infusion for 30 minutes. The P-N group had the drug-infusion in the reverse order. The primary outcome was arterial partial pressure of oxygen. Secondary outcomes were mean arterial pressure, heart rate, pulse pressure variation, perfusion index, and difference between bladder and skin temperature. Statistical analysis was performed using the student t-test, Fisher's exact test, and ANOVA for Cross-over design. P < 0.05 was considered statistically significant. Results Twenty-nine patients were analyzed. Although phenylephrine infusion significantly increased mean arterial pressure (P < 0.001), arterial partial pressure of oxygen did not differ between the two timepoints (P = 0.19). There was no carryover effect in arterial partial pressure of oxygen (P = 0.14). Phenylephrine infusion significantly decreased heart rate (P = 0.02) and pulse pressure variation (P < 0.001). Conclusions Phenylephrine infusion did not improve oxygenation during OLV. The present results indicate that phenylephrine does not have clinically meaningful effects on HPV.	[Godai, Kohei; Hasegawa-Moriyama, Maiko; Matsunaga, Akira; Kanmura, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, Kagoshima, Japan	Kagoshima University	Godai, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, Kagoshima, Japan.	kxg179@icloud.com	Godai, Kohei/T-4675-2018	Godai, Kohei/0000-0002-5333-9417				Allen TK, 2010, ANESTH ANALG, V111, P1221, DOI 10.1213/ANE.0b013e3181e1db21; APPLETON C, 1985, J PHARMACOL EXP THER, V233, P729; Biais M, 2012, ANESTHESIOLOGY, V116, P1354, DOI 10.1097/ALN.0b013e318256ee28; Brassard CL, 2014, CAN J ANESTH, V61, P1103, DOI 10.1007/s12630-014-0246-2; Unzueta MC, 2007, ANESTH ANALG, V104, P1029, DOI 10.1213/01.ane.0000260313.63893.2f; Doering EB, 1997, ANESTHESIOLOGY, V87, P18, DOI 10.1097/00000542-199707000-00004; Fu Q, 2015, DRUG DISCOV THER, V9, P296, DOI 10.5582/ddt.2015.01046; Karzai W, 2009, ANESTHESIOLOGY, V110, P1402, DOI 10.1097/ALN.0b013e31819fb15d; Lee JH, 2011, EUR J ANAESTH, V28, P39, DOI 10.1097/EJA.0b013e32834089cf; Li T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004327; Lumb AB, 2015, ANESTHESIOLOGY, V122, P932, DOI 10.1097/ALN.0000000000000569; Montes FR, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-99; Raphael J, 2017, CURR OPIN ANESTHESIO, V30, P7, DOI 10.1097/ACO.0000000000000408; Rebet O, 2016, EUR J ANAESTH, V33, P638, DOI 10.1097/EJA.0000000000000470; Sato K, 2001, Masui, V50, P1118; Schloss B, 2013, THORAC CARD SURG REP, V2, P16, DOI 10.1055/s-0033-1343734; Tanaka M, 1994, Masui, V43, P1124; Xia JY, 2016, EXP THER MED, V12, P1141, DOI 10.3892/etm.2016.3432	18	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195576	10.1371/journal.pone.0195576	http://dx.doi.org/10.1371/journal.pone.0195576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630639	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000059
J	Nilson, F; Borjesson, M				Nilson, Finn; Borjesson, Mats			Mortality in long-distance running races in Sweden-2007-2016	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; UNITED-STATES; MARATHON; EXERCISE; RUNNERS; ARREST; HEALTH	Background During the last decade, an increasing popularity of marathons has been seen. Although running has been shown to have considerable positive health effects, the risk of sudden death, most often due to sudden cardiac arrests, is also a risk runners expose themselves to. Whilst there are some studies on the mortality amongst long-distance runners, much of the evidence is dated. Given the increased popularity in running during the 21(st) century as well as the improvements in medical care at marathons, more knowledge is required on the mortality risk. Materials and method Publicly available racing and news databases were used to identify the number of entrants and finishers in half to full marathons in Sweden between 2007 and 2016 and the number of deaths that occurred in conjunction with the races. Results A total of 1,156,271 runners entered a long distance (21-42km) running race in Sweden between 2007 and 2016, and 834,412 runners finished the races (72.2%). A large majority of the finishers (677,050 (81%)) competed in distances under a full marathon. Two deaths occurred during the time period, meaning that the death rate was 0.24 (95% confidence interval 0.04-0.79) per 100,000 finishers. Conclusions This study can show that death rates in long distance running races between 2007 and 2016 in Sweden are very low, compared to previous studies. When added to the existing literature, the combined picture suggests a general downward trend in the risk of death during marathons since the 1980s.	[Nilson, Finn] Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden; [Borjesson, Mats] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Gothenburg, Sweden; [Borjesson, Mats] Sahlgrens Univ Hosp, Dept Food Nutr & Sport Sci, Gothenburg, Sweden	Karlstad University; University of Gothenburg; Sahlgrenska University Hospital	Nilson, F (corresponding author), Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden.	finn.nilson@kau.se	Nilson, Finn/H-2383-2017	Nilson, Finn/0000-0002-6928-0683				[Anonymous], 2016, 2016 STAT SPORT US R; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Borjesson M, 2009, BRIT J SPORT MED, V43, P644, DOI 10.1136/bjsm.2008.054718; Borjesson M, 2011, EUR HEART J, V32, P2119, DOI 10.1093/eurheartj/ehr178; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Davis MF., 2005, EXPERT GUIDE SPORTS; Drezner JA, 2011, BRIT J SPORT MED, V45, P947, DOI 10.1136/bjsports-2011-090077; Harmon KG, 2014, BRIT J SPORT MED; Hart Lawrence, 2013, Clin J Sport Med, V23, P409, DOI 10.1097/01.jsm.0000433155.97054.c8; Jones BR W., ACSMS GUIDELINES TEA; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Lee D., 2017, PROGR CARDIOVASCULAR; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Mathews SC, 2012, AM J SPORT MED, V40, P1495, DOI 10.1177/0363546512444555; Ots M, 2009, J COMMUN INQ, V33, P376, DOI 10.1177/0196859909340581; Pedoe DST, 2007, SPORTS MED, V37, P448, DOI 10.2165/00007256-200737040-00046; Pyne SW., 2016, 34 MASS PARTICIPATIO, P339; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Roberts WO, 2000, MED SCI SPORT EXER, V32, P1549; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Roberts WO, 2012, BRIT J SPORT MED; Schwabe K, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093470; Shirakawa T., 2017, INT J CLIN MED, V08, P472, DOI [10.4236/ijcm.2017.87044, DOI 10.4236/IJCM.2017.87044]; Torell MF, 2017, EUR J PREV CARDIOL, V24, P1673, DOI 10.1177/2047487317729251; Waite O, 2016, PHYSICIAN SPORTSMED, V44, P79, DOI 10.1080/00913847.2016.1135036; Webner D, 2012, MED SCI SPORT EXER, V44, P1843, DOI 10.1249/MSS.0b013e318258b59a; Williams PT, 2009, MED SCI SPORT EXER, V41, P523, DOI 10.1249/MSS.0b013e31818c1752	28	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195626	10.1371/journal.pone.0195626	http://dx.doi.org/10.1371/journal.pone.0195626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630680	Green Submitted, Green Published, gold			2022-12-27	WOS:000429505000067
J	Barbieri, F; Dichtl, W; Heidbreder, A; Brandauer, E; Stefani, A; Adukauskaite, A; Senoner, T; Schgor, W; Hintringer, F; Hogl, B				Barbieri, Fabian; Dichtl, Wolfgang; Heidbreder, Anna; Brandauer, Elisabeth; Stefani, Ambra; Adukauskaite, Agne; Senoner, Thomas; Schgoer, Wilfried; Hintringer, Florian; Hoegl, Birgit			Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor: A validation study against the gold standard polysomnography	PLOS ONE			English	Article							HEART-FAILURE; VENTILATION; PACEMAKERS; DIAGNOSIS	Background Sleep disordered breathing is a common but often undiagnosed comorbidity in heart failure patients. Cardiac implantable electronic devices used for cardiac resynchronization therapy (CRT) may detect sleep apnea by use of a transthoracic impedance sensor. Validation of the AP scan algorithm (Boston Scientific) was performed by using the diagnostic gold standard polysomnography (PSG). Methods Forty-one patients with impaired left ventricular ejection fraction, frequent right ventricular pacing due to atrioventricular block and heart failure symptoms despite optimal medical therapy underwent upgrading to biventricular pacing. Within one month after left ventricular lead implantation, sleep apnea was assessed by single-night PSG and AP scan measurements. Results AP scan measurements were valid in only 21 of 41 (51.2%) patients in the index night of the PSG. The PSG determined apnea-hypopnea index did not correlate statistically significant with the AP scan measurements (r = 0.41, 95% confidence interval-0.05-0.72, p = 0.07). The degree of overestimation is displayed by using the Bland-Altman method: mean difference-12.4, standard deviation 15.8, 95% confidence interval-43.3-18.6. Conclusions In heart failure patients receiving CRT upgrading, the AP scan algorithm may need further improvement before it can be recommended for sleep apnea detection.	[Barbieri, Fabian; Dichtl, Wolfgang; Adukauskaite, Agne; Senoner, Thomas; Schgoer, Wilfried; Hintringer, Florian] Med Univ Innsbruck, Univ Hosp Internal Med Cardiol & Angiol 3, Innsbruck, Austria; [Heidbreder, Anna; Brandauer, Elisabeth; Stefani, Ambra; Hoegl, Birgit] Med Univ Innsbruck, Univ Hosp Neurol, Innsbruck, Austria; [Heidbreder, Anna] Univ Hosp Munster, Div Sleep Med & Neuromuscular Disorders, Dept Neurol, Munster, Germany	Medical University of Innsbruck; Medical University of Innsbruck; University of Munster	Dichtl, W (corresponding author), Med Univ Innsbruck, Univ Hosp Internal Med Cardiol & Angiol 3, Innsbruck, Austria.	wolfgang.dichtl@tirol-kliniken.at	Heidbreder, Anna/GLR-3355-2022; Stefani, Ambra/AAK-2172-2020; Barbieri, Fabian/AAY-2105-2020; Senoner, Thomas/AAA-7368-2019; Dichtl, Wolfgang/H-7128-2017	Heidbreder, Anna/0000-0002-9552-7619; Stefani, Ambra/0000-0003-4259-8824; Barbieri, Fabian/0000-0003-4456-1822; Senoner, Thomas/0000-0001-5711-244X; Dichtl, Wolfgang/0000-0002-0421-2110; Hogl, Birgit/0000-0003-1894-7641	Jubilaumsfond der Osterreichischen Nationalbank [15974]; Boston Scientific(R)	Jubilaumsfond der Osterreichischen Nationalbank; Boston Scientific(R)	This work has been supported by the "Jubilaumsfond der Osterreichischen Nationalbank" Nr. 15974; (https://www.oenb.at/Ueber-Uns/Forschungsfoerderung/Jubilaeumsfonds.html) and by an unrestricted "Investigator Sponsored Research" grant by Boston Scientific (R) (http://www.bostonscientific.com/en-US/investigator-sponsored-research.html), both awarded to Wolfgang Dichtl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S, V3; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356; Defaye P, 2004, J CARDIOVASC ELECTR, V15, P1034, DOI 10.1046/j.1540-8167.2004.04030.x; Defaye P, 2014, HEART RHYTHM, V11, P842, DOI 10.1016/j.hrthm.2014.02.011; Dias M, 2017, SLEEP MED, V37, P27, DOI 10.1016/j.sleep.2017.06.006; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426; Herrscher TE, 2011, J CARD FAIL, V17, P420, DOI 10.1016/j.cardfail.2011.01.013; Jilek C, 2011, EUR J HEART FAIL, V13, P68, DOI 10.1093/eurjhf/hfq183; Mazza A, 2017, PACEMAKER DETECTED S, Vpii, DOI 10.1093/europace/euw371; Moubarak G, 2017, HEART RHYTHM, V14, P359, DOI 10.1016/j.hrthm.2016.11.033; Rowley JA, 2017, SLEEP MED CLIN, V12, P221, DOI 10.1016/j.jsmc.2017.03.001; Scharf C, 2004, CIRCULATION, V110, P2562, DOI 10.1161/01.CIR.0000145540.36097.EB; Shalaby A, 2006, PACE, V29, P1036, DOI 10.1111/j.1540-8159.2006.00496.x	16	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195573	10.1371/journal.pone.0195573	http://dx.doi.org/10.1371/journal.pone.0195573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624601	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600039
J	Feijo, A; Patterson, BD; Cordeiro-Estrela, P				Feijo, Anderson; Patterson, Bruce D.; Cordeiro-Estrela, Pedro			Taxonomic revision of the long-nosed armadillos, Genus Dasypus Linnaeus, 1758 (Mammalia, Cingulata)	PLOS ONE			English	Article							9-BANDED ARMADILLO; DISTRIBUTIONAL LIMITS; RANGE EXPANSION; XENARTHRA; DASYPODIDAE; INVERTEBRATES; NOVEMCINCTUS; POLYEMBRYONY; COLLECTION; PHYLOGENY	Dasypus is the most speciose genus of the order Cingulata, including approximately 40% of known living armadillos. Nine species are currently recognized, although comprehensive analyses of the entire genus have never been done. Our aim is to revise the taxonomy of the long-nosed armadillos and properly define the taxa. We examined 2126 specimens of Dasypus preserved in 39 different museum collections, including 17 type specimens. Three complementary methods were applied to explore morphological datasets both qualitatively and quantitatively. Qualitative morphological variation in discrete characters was assessed by direct observations of specimens. Linear morphometric variation was based on external data and cranial measurements of 887 adult skulls. The shape and size of the skull was abstracted through two-dimensional geometric morphometric analyses of dorsal, lateral and ventral views of respectively 421, 211, and 220 adult specimens. Our results converge on the recognition of eight living species (D. beniensis, D. kappleri, D. mazzai, D. novemcinctus, D. pastasae, D. pilosus, D. sabanicola, and D. septemcinctus), and three subspecies of D. septemcinctus (D. s. septemcinctus, D. s. hybridus, and a new subspecies from Cordoba described here). Information on type material, diagnosis, distribution, and taxonomic comments for each taxon are provided. We designate a lectotype for D. novemcinctus; and a neotype for Loricatus hybridus (= D. septemcinctus hybridus).	[Feijo, Anderson; Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Lab Mamiferos, Dept Sisternat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil; [Feijo, Anderson; Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Programa Posgrad Ciencias Biol Zool, Dept Sistemat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil; [Feijo, Anderson; Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Feijo, Anderson] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Field Museum of Natural History (Chicago); Chinese Academy of Sciences; Institute of Zoology, CAS	Feijo, A (corresponding author), Univ Fed Paraiba, Lab Mamiferos, Dept Sisternat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil.; Feijo, A (corresponding author), Univ Fed Paraiba, Programa Posgrad Ciencias Biol Zool, Dept Sistemat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil.; Feijo, A (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA.; Feijo, A (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	andefeijo@gmail.com	Feijó, Anderson/F-4287-2018; Patterson, Bruce D/O-5068-2019	Patterson, Bruce D/0000-0002-2249-7260; Feijo, Anderson/0000-0002-4643-2293; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); AMNH Grants Program; Field Museum of Natural History's Brown Fund for Mammal Research; Chinese Academy of Sciences President's International Fellowship Initiative [2018PB0040]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); AMNH Grants Program; Field Museum of Natural History's Brown Fund for Mammal Research; Chinese Academy of Sciences President's International Fellowship Initiative	Funded by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) (AF), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (AF), AMNH Grants Program (Collection Study) (AF), Field Museum of Natural History's Brown Fund for Mammal Research, and Chinese Academy of Sciences President's International Fellowship Initiative (Grant number 2018PB0040).	Abba AM, 2015, J MAMMAL, V96, P673, DOI 10.1093/jmammal/gyv082; Abba Agustín M., 2011, Mastozool. neotrop., V18, P185; Abba AM, 2012, MAMMALIA, V76, P123, DOI 10.1515/mammalia-2011-0089; Abba AM, 2016, MAMM SPECIES, V48, P931; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anderson Sydney, 1997, Bulletin of the American Museum of Natural History, V231, P1; ATKIN L, 1988, J TROP ECOL, V4, P307, DOI 10.1017/S026646740000287X; Avila-Pires F. D. de., 1965, American Museum Novitates, VNo. 2209, P1; Azara F., 1802, APUNTAMIENTOS HIST N; Azara F., 1801, ESSAIS HIST NATURELL; BAILEY V., 1905, N AMER FAUNA, V25, P1; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Balete DS, 2007, J MAMMAL, V88, P287, DOI 10.1644/06-MAMM-A-090R.1; Balk L, 1749, AMOENITATES ACAD, V1, P277; Billet G, 2017, PEERJ, V5, DOI 10.7717/peerj.3593; Blanford W.T., 1879, SCI RESULTS 2 YARKAN, P1; Blumenbach J.F., 1779, HDB NATURGESCHICHTE; Boily Patrice, 2008, P126; Braun Janet K., 1995, Mastozoologia Neotropical, V2, P173; Burmeister H., 1854, WELCHE WAHREND REISE; Burmeister H., 1848, ZOOTOMIE PALAEOZOOLO, V1, P199; Burmeister H., 1862, ABH NATURF GES HALLE, V6, P145; CABANIS J, 1848, REISEN BRIT GUIANA J, P766; Cabrera A., 1958, Revista del Museo Argentino de Ciencias Naturales Bernardino Rivadavia (Zool), V4, P1; Castro M.C., 2015, Revista del Museo de La Plata Seccion Paleontologia, V15, P1; Castro MC, 2015, ZOOTAXA, V3947, P30, DOI 10.11646/zootaxa.3947.1.2; Castro MC, 2014, NATURWISSENSCHAFTEN, V101, P77, DOI 10.1007/s00114-013-1131-5; Castro MC, 2013, QUATERN INT, V317, P80, DOI 10.1016/j.quaint.2013.04.032; Ciancio MR, 2012, J MAMM EVOL, V19, P1, DOI 10.1007/s10914-011-9177-7; Costa FR, 2010, ZOOTAXA, P61; Cracraft J., 1983, Current Ornithology, V1, P159; CUVIER F, 1825, DENTS MAMMIFERES CON; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; Desmarest AG., 1803, PAIRS DETEVILLE, V21, P428; Desmarest AG, 1822, ENCY METHODIQUE, P277; Desmarest AG., 1804, PAIRS DETERVILLE, V24, P5; Diaz M. Monica, 2000, Occasional Papers of the Oklahoma Museum of Natural History, V10, P1; NASCIMENTO FABIO OLIVEIRA DO, 2017, Pap. Avulsos Zool., V57, P231, DOI 10.11606/0031-1049.2017.57.19; Du Rietz G. E., 1930, SVENSK BOT TIDSKRIFT, V24, P333; Erxleben J.C.P., 1777, SYSTEMA REGNI ANIMAL; Esselstyn JA, 2012, BIOL LETTERS, V8, P990, DOI 10.1098/rsbl.2012.0574; Feijo A, 2017, THESIS; Feijo A., 2013, REV NORDESTINA BIOL, V22, P3, DOI DOI 10.11606/D.41.2006.TDE-16082007-065514; Feijo A, 2016, ZOOTAXA, V4170, P271, DOI 10.11646/zootaxa.4170.2.3; Feijo A, 2014, ZOOTAXA, V3887, P88, DOI 10.11646/zootaxa.3887.1.6; Fermin P., 1769, RIVIERES FORTERESSES; Fitzinger, 1856, TAGEBLATT, V32, P123; Fitzinger LJ, 1871, SITZUNGSBERICHTE MN, V64, P329; Flower W. H., 1886, Proceedings of the Zoological Society, P420; Flower WH, 1894, P ZOOL SOC LOND, P655; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH DEP STAT; Frechkop S, 1949, B I ROYAL SCI NATURE, V25, P1; Frisch J.L., 1775, NATUR SYSTEM VIERFUS; Galbreath G.J., 1985, P243; Gardner A.L., 2005, MAMMAL SPECIES WORLD, P94; Gardner A. L., 2008, MAMMALS S AM, V1, DOI DOI 10.1644/08-MAMM-R-296.1; Gibb GC, 2016, MOL BIOL EVOL, V33, P621, DOI 10.1093/molbev/msv250; GOLDMAN EA, 1920, SMITHSONIAN MISCELLA, V69, P1; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Gray, 1865, P ZOOL SOC LOND, V1865, P359, DOI DOI 10.1111/J.1469-7998.1865.TB02351.X; Gray J. E., 1869, P398; Gray JE., 1873, HAND LIST EDENTATE T; Gray JE, 1874, P ZOOL SOC LOND, P244; Hall E. R., 1981, MAMMALS N AM, V1; HAMLETT G. W. D., 1939, JOUR MAMMAL, V20, P328, DOI 10.2307/1374259; Harbers A, 2014, COLLECTING NATURE, P137; HARDY ICW, 1995, TRENDS ECOL EVOL, V10, P179, DOI 10.1016/S0169-5347(00)89045-X; HAUTIER L, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3650; Helgen KM, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.324.5827; HERSHKOVITZ P, 1987, Fieldiana Zoology, P11; Hollister N., 1925, Journal of Mammalogy, V6, P60; Honaker J, 2011, J STAT SOFTW, V45, P1; HUMPHREY SR, 1974, BIOSCIENCE, V24, P457, DOI 10.2307/1296853; Husson AM, 1978, LEIDEN ZOOLOGISCHE M, V2; ICZN, 1954, OP 258 REJ NOM PURP, V5, P245; ICZN, 1963, B ZOOL NOMENCLATURE, V20, P187; ICZN, 1999, INT CODE ZOOLOGICAL; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Krauss F., 1862, ARCH NATURGESCH, V28, P19; Lacepede BG de la V, 1801, HIST NATURELLE BUFFO; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P239, DOI 10.1016/0035-9203(79)90225-6; Lesson R-P, 1827, MANUEL MAMMALOGIE HI; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1; Linnaeus C, 1748, SECUNDUM SEXTAM STOC; Linnaeus C, 1758, SYSTEMA NATURAE REGN, V1, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Linnaeus C, 1754, MUSEUM SAE RAE MITIS; Linnaeus C, 1749, AMOEN ACAD HOLM, V1, P27; Lonnberg E., 1928, Arkiv for Zoologi Stockholm, V20A, P1; Lonnberg E, 1913, ARK ZOOL, V8, P1, DOI DOI 10.5962/BHL.PART.1065; Lonnberg Einar, 1942, ARKIV ZOOL [STOCKHOLM], V34A, P1; Loughry WJ, 2015, J MAMMAL, V96, P635, DOI 10.1093/jmammal/gyv005; Loughry W.J., 2013, 9 BANDED ARMADILLO N; Loughry WJ, 1998, AM SCI, V86, P274; Abba AM, 2008, CONTRIB MACN, P5; Marcgrave G., 1648, HIST NATURALIS BRASI; Mayr E., 1942, P1; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; MCBEE K, 1982, Mammalian Species, P1, DOI 10.2307/3503864; Moeller W., 1968, Zoologische Jahrbuecher (Anatomie), V85, P411; Mondolfi E, 1968, MEMORIA SOC CIENCIAS, V27, P149; Nunez D, 2004, SMITHSON HERPETOL IN, V134, P1; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Outomuro D, 2017, J ANIM ECOL, P1; Palin OF, 2011, BIOTROPICA, V43, P100, DOI 10.1111/j.1744-7429.2010.00650.x; Patton James L., 2015, P733; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; Paynter Jr RA, 1997, ORNITHOLOGICAL GAZET; Paynter Jr RA, 1994, ORNITHOLOGICAL GAZET; Paynter R. A., 1995, ORNITHOLOGICAL GAZET; Peters W., 1864, GEOMYS HAPLODON DASY, V1865, P177; Prodohl PA, 1996, P ROY SOC B-BIOL SCI, V263, P1643, DOI 10.1098/rspb.1996.0240; R Development Core Team, 2009, R LANG ENV STAT COMP; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Rhoads SN, 1894, P ACAD NAT SCI PHILA, V1894, P111; Rincon AD, 2008, J VERT PALEONTOL, V28, P197; Rohlf, 2013, TPSDIG VERSION 2 17; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; RUSSELL ROBERT J., 1953, PROC BIOL SOC WASHINGTON, V66, P21; Sanborn CC., 1929, FIELD MUS NAT HIST Z, V17, P47, DOI 10.5962/bhl.title.3241; Schlager S., 2020, MORPHO CALCULATIONS; Schreber J, 1774, SAUGTHIERE ABBILDUNG, P1774; Shapiro B, 2015, BOREAS, V44, P14, DOI 10.1111/bor.12094; SIMPSON GEORGE GAYLORD, 1961; Soibelzon E, 2013, QUATERN INT, V299, P72, DOI 10.1016/j.quaint.2012.09.009; Stangl FB, 1995, TEX J SCI, V47, P39; Superina M, 2014, MAMMAL REV, V44, P69, DOI 10.1111/mam.12010; TABER FW, 1945, J MAMMAL, V26, P211, DOI 10.2307/1374817; Talmage RV, 1954, ARMADILLO DASYPUS NO, V41; Taulman JF, 2014, J BIOGEOGR, V41, P1626, DOI 10.1111/jbi.12319; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; Garbino GST, 2015, INT J PRIMATOL, V36, P1049, DOI 10.1007/s10764-015-9882-9; Thomas O., 1901, Annals of Natural History, V(7), P366; Thomas O, 1911, P ZOOL SOC LOND, V1911, P687; Thomas O., 1880, Proceedings of the Zoological Society, P393; Truman R, 2005, LEPROSY REV, V76, P198; Truman Richard W., 2008, P111; Turner Jr HN, 1853, P ZOOL SOC LOND, V1851, P205; Vaccaro Olga B., 1998, Iheringia Serie Zoologia, V85, P67; Vizcaino Sergio F., 1997, Edentata, V3, P7; Vizcaino Sergio F., 1995, Mastozoologia Neotropical, V2, P5; Voss RS, 2009, B AM MUS NAT HIST, V331, P406, DOI 10.1206/582-11.1; Wagler JG, 1830, NATURLICHES SYSTEM A; Wetzel R.M., 1979, P43; Wetzel R.M., 1985, P23; Wetzel RM, 2008, MAMMALS S AM, V1, P128, DOI [10.7208/chicago/9780226282428.001.0001, DOI 10.7208/CHICAGO/9780226282428.001.0001]; WHEELER A, 1991, ZOOL J LINN SOC-LOND, V103, P145, DOI 10.1111/j.1096-3642.1991.tb00901.x; Wible JR, 2004, ANN CARNEGIE MUS, V73, P117; Yepes J., 1928, Revista de la Universidad de Buenos Aires, V24, P461; Yepes J., 1933, Physis Buenos Aires, V11, P225; Zachos FE, 2016, MAMM BIOL, V81, P185, DOI 10.1016/j.mambio.2015.10.002; Zamorano Martin, 2008, BioScriba, V1, P17; Zuur AF, 2007, STAT BIOL HEALTH, P163	159	18	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195084	10.1371/journal.pone.0195084	http://dx.doi.org/10.1371/journal.pone.0195084			69	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624590	Green Submitted, Green Published, gold			2022-12-27	WOS:000429379600015
J	Gibbs, A; Dunkle, K; Washington, L; Willan, S; Shai, N; Jewkes, R				Gibbs, Andrew; Dunkle, Kristin; Washington, Laura; Willan, Samantha; Shai, Nwabisa; Jewkes, Rachel			Childhood traumas as a risk factor for HIV-risk behaviours amongst young women and men living in urban informal settlements in South Africa: A cross-sectional study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SEXUAL-ABUSE; PREVALENCE; CHILDREN; MULTICOUNTRY; ADOLESCENTS; INFECTIONS; DEPRESSION; THERAPY; SOWETO	Childhood traumas, in the form of physical, sexual, and emotional abuse and neglect, are globally widespread and highly prevalent, and associated with a range of subsequent poor health outcomes. This study sought to understand the relationship between physical, sexual and emotional childhood abuse and subsequent HIV-risk behaviours amongst young people (18-30) living in urban informal settlements in Durban, South Africa. Data came from self completed questionnaires amongst 680 women and 677 men comprising the baseline of the Stepping Stones and Creating Futures intervention trial. Men and women were analysed separately. Logistic regression models assessed the relationship between six HIV-risk behaviours and four measures of trauma: the form of trauma, the severity of each trauma, the range of traumas, and overall severity of childhood trauma. Childhood traumas were incredibly prevalent in this population. All childhood traumas were associated with a range of HIV-risk behaviours. This was for the ever/never trauma, as well as the severity of each type of trauma, the range of trauma, and overall severity of childhood trauma. Despite the wider harsh contexts of urban informal settlements, childhood traumas still play a significant role in shaping subsequent HIV-risk behaviours amongst young people. Interventions to reduce childhood traumas for populations in informal settlements need to be developed. In addition, trauma focused therapies need to be considered as part of wider HIV-prevention interventions for young adults.	[Gibbs, Andrew; Dunkle, Kristin; Willan, Samantha; Shai, Nwabisa; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Washington, Laura] Project Empower, Durban, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Kwazulu Natal; University of Witwatersrand	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	Andrew.gibbs@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Gibbs, Andrew/0000-0003-2812-5377; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council (SAMRC)	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council (SAMRC)	This trial is funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies and the funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication. Funding was managed by the South African Medical Research Council (SAMRC), who also supported the project team.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 2015, 22 UN HAB; Arriola KRJ, 2005, CHILD ABUSE NEGLECT, V29, P725, DOI 10.1016/j.chiabu.2004.10.014; Artz L., 2016, OPTIMUS STUDY S AFRI; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Closson K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3832-0; Cushman LF, 1998, FAM PLANN PERSPECT, V30, P240, DOI 10.2307/2991611; de Arellano MAR, 2014, PSYCHIAT SERV, V65, P591, DOI 10.1176/appi.ps.201300255; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Fonseka RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136321; Fulu E, 2017, LANCET GLOB HEALTH, V5, pE512, DOI 10.1016/s2214-109x(17)30103-1; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, GLOBAL PUBL IN PRESS, P1; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2016, AJAR-AFR J AIDS RES, V15, P141, DOI 10.2989/16085906.2016.1204331; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Irish L, 2009, J PEDIATR PSYCHOL; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Jewkes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038210; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Knerr W, 2013, PREV SCI, V14, P352, DOI 10.1007/s11121-012-0314-1; Maharaj P, 2005, INT FAMILY PLANNING, P24; Meinck F, 2016, J EPIDEMIOL COMMUN H, V70, P910, DOI 10.1136/jech-2015-205860; Meinck F, 2015, TRAUMA VIOLENCE ABUS, V16, P81, DOI 10.1177/1524838014523336; Murray LK, 2015, JAMA PEDIATR, V169, P761, DOI 10.1001/jamapediatrics.2015.0580; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sikweyiya Y, 2009, CULT HEALTH SEX, V11, P529, DOI 10.1080/13691050902912783; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; UNAIDS & Habitat, 2015, END AIDS EP ADV CIT; United Nations Children's Fund, 2014, HIDD PLAIN SIGHT STA; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343; World Health Organisation, 2010, HIDD CIT UNM OV HLTH	39	28	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195369	10.1371/journal.pone.0195369	http://dx.doi.org/10.1371/journal.pone.0195369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624612	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600024
J	Berlow, NE; Svalina, MN; Quist, MJ; Settelmeyer, TP; Zherebitskiy, V; Kogiso, M; Qi, L; Du, YC; Hawkins, CE; Hulleman, E; Li, XN; Gultekin, SH; Keller, C				Berlow, Noah E.; Svalina, Matthew N.; Quist, Michael J.; Settelmeyer, Teagan P.; Zherebitskiy, Viktor; Kogiso, Mari; Qi, Lin; Du, Yuchen; Hawkins, Cynthia E.; Hulleman, Esther; Li, Xiao-Nan; Gultekin, Sakir H.; Keller, Charles			IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; PANCREATIC DUCTAL ADENOCARCINOMA; PEDIATRIC BRAIN-TUMORS; HIGH-DOSE-CHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; BISPECIFIC ANTIBODY; PSEUDOMONAS EXOTOXIN; MALIGNANT GLIOMA; STEM GLIOMAS; CELLS	Diffuse intrinsic pontine glioma (DIPG) is a universally fatal childhood cancer of the brain. Despite the introduction of conventional chemotherapy and radiotherapy, improvements in survival have been marginal and long-term survivorship is uncommon. Thus, new targets for therapeutics are critically needed. Early phase clinical trials exploring molecularly-targeted therapies against the epidermal growth factor receptor (EGFR) and novel immunotherapies targeting interleukin receptor-13 alpha 2 (IL-13R alpha 2) have demonstrated activity in this disease. To identify additional therapeutic markers for cell surface receptors, we performed exome sequencing (16 new samples, 22 previously published samples, total 38 with 26 matched normal DNA samples), RNA deep sequencing (17 new samples, 11 previously published samples, total 28 with 18 matched normal RNA samples), and immunohistochemistry (17 DIPG tissue samples) to examine the expression of the interleukin-4 (IL-4) signaling axis components (IL-4, interleukin 13 (IL-13), and their respective receptors IL-4R alpha, IL-13R alpha 1, and IL-13R alpha 2). In addition, we correlated cytokine and receptor expression with expression of the oncogenes EGFR and c-MET. In DIPG tissues, transcript-level analysis found significant expression of IL-4, IL-13, and IL-13R alpha 1/2, with strong differential expression of IL-13R alpha 1/2 in tumor versus normal brain. At the protein level, immunohistochemical studies revealed high content of IL-4 and IL-13R alpha 1/2 but notably low expression of IL-13. Additionally, a strong positive correlation was observed between c-Met and IL-4R alpha. The genomic and transcriptional landscape across all samples was also summarized. These data create a foundation for the design of potential new immunotherapies targeting IL-13 cell surface receptors in DIPG.	[Berlow, Noah E.; Svalina, Matthew N.; Quist, Michael J.; Settelmeyer, Teagan P.; Keller, Charles] Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA; [Zherebitskiy, Viktor; Gultekin, Sakir H.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Kogiso, Mari; Qi, Lin; Du, Yuchen; Li, Xiao-Nan] Texas Childrens Canc Ctr, Dept Pediat, Houston, TX USA; [Hawkins, Cynthia E.] Hosp Sick Children, Div Pathol, Toronto, ON, Canada; [Hulleman, Esther] Vrije Univ Univ, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp, Amsterdam, Netherlands; [Keller, Charles] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Oregon Health & Science University; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oregon Health & Science University	Keller, C (corresponding author), Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA.; Keller, C (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	charles@cc-tdi.org	Hulleman, Esther/AAD-7073-2021; Hawkins, Cynthia/M-2571-2019	Keller, Charles/0000-0003-2505-7487; Hulleman, Esther/0000-0001-9256-947X	Lyla Nsouli Foundation	Lyla Nsouli Foundation	Funded by Lyla Nsouli Foundation: http://www.lylansoulifoundation.org (CK). With Purpose: http://www.with-purpose.org/ (CK).	Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bouffet E, 2000, CANCER, V88, P685, DOI 10.1002/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K; Brehmer D, 2005, CANCER RES, V65, P379; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P410, DOI 10.1093/neuonc/noq205; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Debinski W, 1998, CRIT REV ONCOGENESIS, V9, P255; Debinski W, 1999, CLIN CANCER RES, V5, P985; Debinski W, 1995, CLIN CANCER RES, V1, P1253; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dunkel IJ, 1996, PEDIATR NEUROSURG, V24, P263, DOI 10.1159/000121049; FINLAY JL, 1990, J NEURO-ONCOL, V9, P239, DOI 10.1007/BF02341155; Finlay JL, 2005, J NEURO-ONCOL, V75, P253, DOI 10.1007/s11060-005-6747-7; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hamasuna R, 2001, INT J CANCER, V93, P339, DOI 10.1002/ijc.1349; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; He QZ, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-70; Jalali R, 2010, INT J RADIAT ONCOL, V77, P113, DOI 10.1016/j.ijrobp.2009.04.031; Jennings MT, 2002, J CLIN ONCOL, V20, P3431, DOI 10.1200/JCO.2002.04.109; Joshi BH, 2000, CANCER RES, V60, P1168; Karajannis M, 2008, J CELL PHYSIOL, V217, P584, DOI 10.1002/jcp.21544; Kawakami M, 2004, CANCER-AM CANCER SOC, V101, P1036, DOI 10.1002/cncr.20470; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LANGMOEN IA, 1991, CHILD NERV SYST, V7, P13, DOI 10.1007/BF00263825; Li G, 2012, J NEURO-ONCOL, V108, P395, DOI 10.1007/s11060-012-0842-3; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Mardor Y, 2009, J PHARMACOL EXP THER, V330, P520, DOI 10.1124/jpet.109.154401; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PACKER RJ, 1990, ANN NEUROL, V27, P167, DOI 10.1002/ana.410270212; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pollack IF, 2014, J CLIN ONCOL, V32, P2050, DOI 10.1200/JCO.2013.54.0526; Rahaman SO, 2005, CANCER RES, V65, P2956, DOI 10.1158/0008-5472.CAN-04-3592; Shimamura T, 2007, CANCER RES, V67, P9903, DOI 10.1158/0008-5472.CAN-06-4558; Smith SE, 2014, PEDIATR BLOOD CANCER, V61, P765, DOI 10.1002/pbc.24923; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Thaci B, 2014, NEURO-ONCOLOGY, V16, P1304, DOI 10.1093/neuonc/nou045; Van Mieghem E, 2013, EUR J NEUROL, V20, P1335, DOI 10.1111/ene.12192; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yano H, 2001, Brain Tumor Pathol, V18, P7, DOI 10.1007/BF02478919	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193565	10.1371/journal.pone.0193565	http://dx.doi.org/10.1371/journal.pone.0193565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621254	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800008
J	Bam, W; Hooper-Bui, LM; Strecker, RM; Adhikari, PL; Overton, EB				Bam, Wokil; Hooper-Bui, Linda M.; Strecker, Rachel M.; Adhikari, Puspa L.; Overton, Edward B.			Coupled effects of oil spill and hurricane on saltmarsh terrestrial arthropods	PLOS ONE			English	Article							WATER-HORIZON OIL; POLYCYCLIC AROMATIC-HYDROCARBONS; GRASSHOPPER ORTHOPTERA; TROPHIC DIVERSITY; IMPACTS; PLANT; CONSERVATION; DISTURBANCE; PREDATION; ABUNDANCE	Terrestrial arthropods play an important role in saltmarsh ecosystems, mainly affecting the saltmarsh's primary production as the main consumers of terrestrial primary production and decomposition. Some of these arthropods, including selected insects and spiders, can be used as ecological indicators of overall marsh environmental health, as they are differentially sensitive to ecological stressors, such as land loss, erosion, oil spills, and tropical storms. In the present study, we used terrestrial arthropods collected from seven (three lightly-oiled, four heavily-oiled) sites in Barataria Bay and from three unoiled reference sites in Delacroix, Louisiana, to determine the impacts of the distribution and re-distribution of Deepwater Horizon (DWH) oil on these saltmarsh ecosystems. A total of 9,476 and 12,256 insects were collected in 2013 and 2014, respectively. The results show that the terrestrial arthropods were negatively affected by the re-distribution of DWH oil by Hurricane Isaac in 2012, although the level of impacts varied among the arthropod groups. Moreover, the mean diversity index was higher (>1.5) in 2014 than in 2013 (<1.5) for all sites, suggesting a recovery trajectory of the saltmarsh arthropod population. The higher taxonomic richness observed in the reference sites compared to the oiled sites for both years also indicated long-term impacts of DWH oil to the saltmarsh arthropod community. Whereas a slow recovery of certain terrestrial arthropods was observed, long-term monitoring of arthropod communities would help better understand the recovery and succession of the marsh ecosystems.	[Bam, Wokil] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Hooper-Bui, Linda M.; Strecker, Rachel M.; Adhikari, Puspa L.; Overton, Edward B.] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Bam, W (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	wbam1@lsu.edu	Bui, Dr. Linda/AAW-7252-2021; Bam, Wokil/H-3162-2018	Bam, Wokil/0000-0002-7320-3496; Adhikari, Puspa/0000-0003-0170-685X	Gulf of Mexico Research Initiative [940264100]	Gulf of Mexico Research Initiative	This work was supported by Gulf of Mexico Research Initiative - 940264100 to LMHB through the Coastal Waters Consortium (CWC). http://research.gulfresearchinitiative.org/gomri-funded-researchers/person/?pid=841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2017, FLA ENTOMOL, V100, P366, DOI 10.1653/024.100.0236; Adhikari PL, 2016, ENVIRON POLLUT, V212, P413, DOI 10.1016/j.envpol.2016.01.064; Adhikari PL, 2015, MAR CHEM, V168, P60, DOI 10.1016/j.marchem.2014.11.001; Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Bacosa HP, 2016, MAR POLLUT BULL, V109, P236, DOI 10.1016/j.marpolbul.2016.05.076; Bejarano AC, 2016, ENVIRON POLLUT, V218, P709, DOI 10.1016/j.envpol.2016.07.065; Bergqvist R, 2013, TRANSP SOC, P1; Boufadel MC, 2014, ENVIRON SCI TECHNOL, V48, P9496, DOI 10.1021/es5012862; Burns CMB, 2014, BIOSCIENCE, V64, P820, DOI 10.1093/biosci/biu124; CAMERON GN, 1972, ECOLOGY, V53, P58, DOI 10.2307/1935710; Chen X, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2049; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Day RH, 1997, ECOL APPL, V7, P593; Desender K, 1999, BIOL CONSERV, V87, P221, DOI 10.1016/S0006-3207(98)00058-5; Doxon ED, 2011, J FIELD ORNITHOL, V82, P60, DOI 10.1111/j.1557-9263.2010.00308.x; Evans M, 2017, MAR POLLUT BULL, V115, P47, DOI 10.1016/j.marpolbul.2016.11.022; Gros J, 2017, P NATL ACAD SCI USA, V114, P10065, DOI 10.1073/pnas.1612518114; Husseneder C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18968; Jennings VH, 2006, ENVIRON ENTOMOL, V35, P1550, DOI 10.1603/0046-225X(2006)35[1550:CAAOGC]2.0.CO;2; Karr JR, 2003, NORTHWEST SCI, V77, P202; KEMP WP, 1991, ENVIRON ENTOMOL, V20, P1504, DOI 10.1093/ee/20.6.1504; KEMP WP, 1990, OECOLOGIA, V83, P299, DOI 10.1007/BF00317552; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Larson DP, 1999, J AGR URBAN ENTOMOL, V16, P207; LARSSON S, 1989, OIKOS, V56, P277, DOI 10.2307/3565348; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; Mcgeogh MA, 2007, BIOL REV, V73, P181, DOI [DOI 10.1111/J.1469-185X.1997.TB00029.X, 10.1111/j.1469-185x.1997.tb00029.x]; McPhee JJ, 2015, ESTUAR COAST SHELF S, V167, P67, DOI 10.1016/j.ecss.2015.07.008; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nixon Z, 2016, MAR POLLUT BULL, V107, P170, DOI 10.1016/j.marpolbul.2016.04.003; Olin JA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1878; Pearson CV, 2006, J INSECT SCI, V6; Pennings SC, 2011, BASIC GUIDE IDENTIFY; Pennings SC, 2014, BIOSCIENCE, V64, P789, DOI 10.1093/biosci/biu118; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Pfeiffer W.J., 1981, ECOLOGY SALT MARSH, P87, DOI DOI 10.1007/978-1-4612-5893-3_5; Preisser EL, 2004, AM NAT, V163, P754, DOI 10.1086/383620; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rabalais NN, 2016, OCEANOGRAPHY, V29, P150, DOI 10.5670/oceanog.2016.79; Ramsey E, 2014, MAR POLLUT BULL, V89, P85, DOI 10.1016/j.marpolbul.2014.10.032; Reed JT, 2010, J ENTOMOL SCI, V45, P111, DOI 10.18474/0749-8004-45.2.111; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; SAS Institute Inc, 2013, SAS9 4 SOFTW; Sasser C. E., 2014, VEGETATION TYPES COA; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; SCHMITZ OJ, 1992, THEOR POPUL BIOL, V41, P161, DOI 10.1016/0040-5809(92)90042-R; SCHOWALTER TD, 1981, OIKOS, V37, P126, DOI 10.2307/3544083; Sokolov IM, 2018, PSYCHE J ENTOMOLOGY, V2018, P1, DOI [10.1155/2018/1808370, DOI 10.1155/2018/1808370]; Speight M. R., 2009, ECOLOGY INSECTS CONC; Spiller DA, 2007, ECOLOGY, V88, P37, DOI 10.1890/0012-9658(2007)88[37:AOIFDF]2.0.CO;2; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Stout SA, 2016, MAR POLLUT BULL, V108, P186, DOI 10.1016/j.marpolbul.2016.04.031; Tarr MA, 2016, OCEANOGRAPHY, V29, P126, DOI 10.5670/oceanog.2016.77; Triplehorn CA, 2006, BORROR DELONGS INTRO; Turner RE, 2014, MAR POLLUT BULL, V86, P291, DOI 10.1016/j.marpolbul.2014.07.003; Turner RE, 2014, MAR POLLUT BULL, V87, P57, DOI 10.1016/j.marpolbul.2014.08.011; Turney S, 2016, OIKOS, V125, P1224, DOI 10.1111/oik.03404; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Wheeler Alfred G., 2001, BIOL PLANT BUGS HEMI; Whipple Sean D., 2010, Journal of Orthoptera Research, V19, P75, DOI 10.1665/034.019.0113; Wimp GM, 2010, ECOLOGY, V91, P3303, DOI 10.1890/09-1291.1; Zengel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132324	68	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194941	10.1371/journal.pone.0194941	http://dx.doi.org/10.1371/journal.pone.0194941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641552	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900055
J	Mijderwijk, HJ; Stolker, RJ; Duivenvoorden, HJ; Klimek, M; Steyerberg, EW				Mijderwijk, Hendrik-Jan; Stolker, Robert Jan; Duivenvoorden, Hugo J.; Klimek, Markus; Steyerberg, Ewout W.			Prognostic model for psychological outcomes in ambulatory surgery patients: A prospective study using a structural equation modeling framework	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; FATIGUE; CONVALESCENCE; VALIDATION; ANESTHESIA; UNIVERSAL; RECOVERY; QUALITY; RETURN	Introduction Surgical procedures are increasingly carried out in a day-case setting. Along with this increase, psychological outcomes have become prominent. The objective was to evaluate prospectively the prognostic effects of sociodemographic, medical, and psychological variables assessed before day-case surgery on psychological outcomes after surgery. Methods The study was carried out between October 2010 and September 2011. We analyzed 398 mixed patients, from a randomized controlled trial, undergoing day-case surgery at a university medical center. Structural equation modeling was used to jointly study presurgical prognostic variables relating to sociodemographics (age, sex, nationality, marital status, having children, religion, educational level, employment), medical status (BMI, heart rate), and psychological status associated with anxiety (State-Trait Anxiety Inventory (STAI), Hospital Anxiety and Depression Scale (HADS-A)), fatigue (Multidimensional Fatigue Inventory (MFI)), aggression (State-Trait Anger Scale (STAS)), depressive moods (HADS-D), self-esteem, and self-efficacy. We studied psychological outcomes on day 7 after surgery, including anxiety, fatigue, depressive moods, and aggression regulation. Results The final prognostic model comprised the following variables: anxiety (STAI, HADS-A), fatigue (MFI), depression (HADS-D), aggression (STAS), self-efficacy, sex, and having children. The corresponding psychological variables as assessed at baseline were prominent (i.e. standardized regression coefficients >= 0.20), with STAI-Trait score being the strongest predictor overall. STAI-State (adjusted R-2 = 0.44), STAI-Trait (0.66), HADS-A (0.45) and STAS-Trait (0.54) were best predicted. Conclusion We provide a prognostic model that adequately predicts multiple postoperative outcomes in day-case surgery. Consequently, this enables timely identification of vulnerable patients who may require additional medical or psychological preventive treatment or-in a worst-case scenario-could be unselected for day-case surgery.	[Mijderwijk, Hendrik-Jan; Stolker, Robert Jan; Duivenvoorden, Hugo J.; Klimek, Markus] Erasmus Univ, Dept Anesthesiol, Med Ctr, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mijderwijk, HJ (corresponding author), Erasmus Univ, Dept Anesthesiol, Med Ctr, Rotterdam, Netherlands.	h.mijderwijk@erasmusmc.nl	Klimek, Markus/N-7047-2019	Klimek, Markus/0000-0002-0122-9929; Mijderwijk, Hendrik-Jan/0000-0002-9516-8257				[Anonymous], 1980, HANDLEIDING BIJ ZELF; Au K, 2016, J NEUROSURG, V4, P1; Aylin P, 2005, BRIT MED J, V331, P803, DOI 10.1136/bmj.331.7520.803; Bellani Marco L, 2008, Int J Surg, V6 Suppl 1, pS44, DOI 10.1016/j.ijsu.2008.12.019; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berg CA, 2008, PSYCHOL AGING, V23, P505, DOI 10.1037/a0012687; Bergua V, 2012, INT PSYCHOGERIATR, V24, P1163, DOI 10.1017/S1041610212000300; Bisgaard T, 2002, SURGERY, V132, P817, DOI 10.1067/msy.2002.127682; Bisgaard T, 2001, ARCH SURG-CHICAGO, V136, P917, DOI 10.1001/archsurg.136.8.917; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bowley DMG, 2003, SURGERY, V133, P141, DOI 10.1067/msy.2003.34; Browne MW, 1992, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Carli Francesco, 2015, Anesthesiol Clin, V33, P17, DOI 10.1016/j.anclin.2014.11.002; CHRISTENSEN T, 1986, ACTA PSYCHIAT SCAND, V73, P76, DOI 10.1111/j.1600-0447.1986.tb02670.x; DeCherney AH, 2002, OBSTET GYNECOL, V99, P51, DOI 10.1016/S0029-7844(01)01622-2; Efron B., 1994, MONOGRAPHS STAT APPL; Garcia-Miguel FJ, 2003, LANCET, V362, P1749, DOI 10.1016/S0140-6736(03)14857-X; George D., 2016, SPSS WINDOWS STEP ST; Glass PSA, 2014, SOUTH AFR J ANAESTH, V20, P59, DOI 10.1080/22201173.2014.10844568; Hall GM, 2002, ANESTH ANALG, V95, P1446, DOI 10.1097/00000539-200211000-00064; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jarrett PEM, 2001, EUR J ANAESTH, V18, P32, DOI 10.1046/j.1365-2346.2001.00007.x; Jones KR, 2001, SURGERY, V129, P128, DOI 10.1067/msy.2001.111696; Kerkhof GF, 2011, HYPERTENSION, V57, P255, DOI 10.1161/HYPERTENSIONAHA.110.163600; Kline R.B., 2011, PRINCIPLES PRACTICE; Meier C, 2011, INT J CHRONIC OBSTR, V6, P583, DOI 10.2147/COPD.S24508; Mijderwijk H, 2013, EUR J ANAESTH, V30, P743, DOI 10.1097/EJA.0b013e328361d395; Mitchell M, 2010, J ADV NURS, V66, P1059, DOI 10.1111/j.1365-2648.2010.05266.x; Purzner T, 2011, NEUROSURGERY, V69, P119, DOI 10.1227/NEU.0b013e318215a270; Puts M, 2015, J GERIATR ONCOL, V6, P341, DOI 10.1016/j.jgo.2015.07.004; Reuter M, 2004, EUR J ANAESTH, V21, P434, DOI 10.1017/S0265021504006040; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Van der Ploeg H.M., 1982, HANDLEIDING BIJ ZELF; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193441	10.1371/journal.pone.0193441	http://dx.doi.org/10.1371/journal.pone.0193441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641522	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900014
J	Neergaard, JS; Dragsbaek, K; Christiansen, C; Karsdal, MA; Brix, S; Henriksen, K				Neergaard, Jesper Skov; Dragsbaek, Katrine; Christiansen, Claus; Karsdal, Morten Asser; Brix, Susanne; Henriksen, Kim			Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PLASMA TAU; CASPASE-CLEAVAGE; A-BETA; PROTEIN; SERUM; DIAGNOSIS; PROGRESSION; FRAGMENTS	Background Truncated tau appears to be specifically related to disease pathology and recent studies have shown the presence and elevation of several truncated tau species in Cerebrospinal fluid (CSF) of subjects with Alzheimer's disease (AD); however, the relevance of truncated Tau measurements in blood is still being studied. Objective The aim of the current study was to assess the longitudinal associations between baseline levels of two novel blood biomarker candidates measuring truncated tau, Tau-A and Tau-C, and the risk of incident dementia and AD in elderly women. Methods Using solid phase competitive ELISA, two tau fragments were detected in serum of 5,309 women from the Prospective Epidemiological Risk Factor study. The study was an observational, prospective study of Danish postmenopausal women. Subjects were followed with registry-linkage for up to 15 years (median follow-up time 13.7 years). Cox regression was used to assess the utility of the biomarker candidates in relation to dementia and AD. Results High levels of Tau-A and Tau-C (above the median) in blood were associated with lower risk of dementia and AD (Tau-A: Dementia HR[95% CI] = 0.85[0.70 +/- 1.04]; AD 0.71[0.52 +/- 0.98] and Tau-C: Dementia 0.84[0.70 +/- 1.00]; AD 0.78[0.60 +/- 1.03]). Tau-C gave a very modest increase in the AUC in a 5-year prediction horizon as compared to a reference model with age and education, while a combination of the two did not improve their predictive capacity. Conclusions Measurement of tau in serum is feasible. The serological tau turnover profile may be related to the diagnosis and development of dementia and AD. The exact processing and profile in serum in relation to cognitive disorders remains to be further assessed to provide simple non-invasive tests to identify subjects with progressive cognitive disorders.	[Neergaard, Jesper Skov; Dragsbaek, Katrine; Christiansen, Claus; Karsdal, Morten Asser; Henriksen, Kim] Nord Biosci AS, Herlev, Denmark; [Neergaard, Jesper Skov; Dragsbaek, Katrine; Brix, Susanne] Tech Univ Denmark, DTU Bioengn, Lyngby, Denmark	Nordic Bioscience; Technical University of Denmark	Neergaard, JS (corresponding author), Nord Biosci AS, Herlev, Denmark.; Neergaard, JS (corresponding author), Tech Univ Denmark, DTU Bioengn, Lyngby, Denmark.	jesper.neergaard@gmail.com	Pedersen, Susanne Brix/B-3484-2009	Pedersen, Susanne Brix/0000-0001-8951-6705; Karsdal, Morten/0000-0001-5026-8740	Danish Research Foundation (Den Danske Forskningsfond)	Danish Research Foundation (Den Danske Forskningsfond)	This work was supported by The Danish Research Foundation (Den Danske Forskningsfond), who is acknowledged for funding the PERF study. The Foundation had no role in the study design, data interpretation or preparation and submission of this manuscript. CC, MAK and KH are employed by Nordic Bioscience and hold stocks in the company. Nordic Bioscience provided support in the form of salaries for authors CC, MAK and KH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen P. K., 2012, STAT MODELS BASED CO; ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; BEER J, 1995, NEURODEGENERATION, V4, P51, DOI 10.1006/neur.1995.0006; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1602/neurorx.1.2.213; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Caroli A, 2010, NEUROBIOL AGING, V31, P1263, DOI 10.1016/j.neurobiolaging.2010.04.024; Chiu MJ, 2014, HUM BRAIN MAPP, V35, P3132, DOI 10.1002/hbm.22390; Dage JL, 2016, ALZHEIMERS DEMENT, V12, P1226, DOI 10.1016/j.jalz.2016.06.001; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Frautschy SA, 1998, AM J PATHOL, V152, P307; Galasko D, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt164; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Henriksen K, 2015, J ALZHEIMERS DIS, V43, P1331, DOI 10.3233/JAD-140984; Henriksen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064990; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Krishnan S, 2014, BIOL TRACE ELEM RES, V158, P158, DOI 10.1007/s12011-014-9930-x; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lonskaya I, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-46; Luo WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11161; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Mouiha A, 2012, J ALZHEIMERS DIS, V30, P91, DOI 10.3233/JAD-2012-111367; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Murray ME, 2015, BRAIN, V138, P1370, DOI 10.1093/brain/awv050; Neergaard JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003112; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Prince M, 2015, WORLD ALZHEIMERS REP; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shanthi KB, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115598250; Solomon A, 2014, ALZHEIMERS DEMENT, V10, P303, DOI 10.1016/j.jalz.2013.03.004; Sparks D Larry, 2012, Am J Neurodegener Dis, V1, P99; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; Tzen KY, 2014, ACS CHEM NEUROSCI, V5, P830, DOI 10.1021/cn500101j; Wang T, 2014, INT J GERIATR PSYCH, V29, P713, DOI 10.1002/gps.4053; Weinstein G, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt235; Zetterberg H, 2018, HAND CLINIC, V146, P85, DOI 10.1016/B978-0-12-804279-3.00006-X; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194802	10.1371/journal.pone.0194802	http://dx.doi.org/10.1371/journal.pone.0194802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641555	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900047
J	Smith, MP; Standl, M; Berdel, D; von Berg, A; Bauer, CP; Schikowski, T; Koletzko, S; Lehmann, I; Kramer, U; Heinrich, J; Schulz, H				Smith, Maia Phillips; Standl, Marie; Berdel, Dietrich; von Berg, Andrea; Bauer, Carl-Peter; Schikowski, Tamara; Koletzko, Sibylle; Lehmann, Irina; Kraemer, Ursula; Heinrich, Joachim; Schulz, Holger			Handgrip strength is associated with improved spirometry in adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MUSCLE STRENGTH; PULMONARY REHABILITATION; CLINICAL-PRACTICE; PROGNOSTIC VALUE; PUBERTAL CHANGES; GRIP STRENGTH; LUNG-FUNCTION; EXERCISE; NUTRITION	Introduction Pulmonary rehabilitation, including aerobic exercise and strength training, improves function, such as spirometric indices, in lung disease. However, we found spirometry did not correlate with physical activity (PA) in healthy adolescents (Smith ERJ: 42(4), 2016). To address whether muscle strength did, we measured these adolescents' handgrip strength and correlated it with spirometry. Methods In 1846 non-smoking, non-asthmatic Germans (age 15.2 years, 47% male), we modeled spirometric indices as functions of handgrip strength by linear regression in each sex, corrected for factors including age, height, and lean body mass. Results Handgrip averaged 35.4 (SD 7.3) kg in boys, 26.6 (4.2) in girls. Spirometric volumes and flows increased linearly with handgrip. In boys each kg handgrip was associated with about 28 mL greater FEV1 and FVC; 60 mL/sec faster PEF; and 38 mL/sec faster FEF2575. Effects were 10-30% smaller in girls (all p<0.0001) and stable when Z-scores for spirometry and grip were modeled, after further correction for environment and/or other exposures, and consistent across stages of puberty. Conclusions Grip strength was associated with spirometry in a cohort of healthy adolescents whose PA was not. Thus, research into PA's relationship with lung function should consider strength as well as total PA. Strength training may benefit healthy lungs; interventions are needed to prove causality.	[Smith, Maia Phillips; Standl, Marie; Heinrich, Joachim; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Smith, Maia Phillips] St Georges Univ, Dept Publ Hlth & Prevent Med, True Blue Point, Grenada; [Berdel, Dietrich; von Berg, Andrea] Marien Hosp Wesel, Res Inst, Dept Pediat, Wesel, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, Munich, Germany; [Schikowski, Tamara; Kraemer, Ursula] Heinrich Heine Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Schikowski, Tamara; Kraemer, Ursula] Heinrich Heine Univ Dusseldorf, Med Fac, Dusseldorf, Germany; [Koletzko, Sibylle] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [Lehmann, Irina] UFZ Leipzig, Helmholtz Zentrum Umweltforsch, Core Facil Studien, Dept Umweltimmunol, Leipzig, Germany; [Schulz, Holger] German Ctr Lung Res, Comprehens Pneumol Ctr Munich CPC M, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; Technical University of Munich; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Smith, MP (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany.; Smith, MP (corresponding author), St Georges Univ, Dept Publ Hlth & Prevent Med, True Blue Point, Grenada.	maia.phillips.smith@gmail.com	Heinrich, Joachim/N-1720-2013	Heinrich, Joachim/0000-0002-9620-1629; Standl, Marie/0000-0002-5345-2049; Lehmann, Irina/0000-0001-8875-5587; Smith, Maia Phillips/0000-0002-1154-1158	Federal Ministry for Environment (IUF Dusseldorf) [FKZ 20462296]; company Mead Johnson; company Nestle; European Studies; Nestle; Mead Johnson; Numico; Pharmacia; Stiftung Kindergesundheit; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef; Comprehensive Pneumology Center Munich (CPC-M); Federal Ministry for Education, Science, Research and Technology (interventional arm)	Federal Ministry for Environment (IUF Dusseldorf); company Mead Johnson; company Nestle(Nestle SA); European Studies; Nestle(Nestle SA); Mead Johnson; Numico(Danone NutriciaRoyal Numico N.V.); Pharmacia; Stiftung Kindergesundheit; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef; Comprehensive Pneumology Center Munich (CPC-M); Federal Ministry for Education, Science, Research and Technology (interventional arm)	This study was part of the 15-year followup of two German birth cohorts, GINIplus (German Infant Study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development) and LISAplus (Influence of lifestyle factors on the development of the immune system and allergies Plus the influence of traffic emissions and genetics). We thank the GINIplus and LISAplus Study Groups for all their excellent work. The GINIplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg (J. Heinrich, I. Bruske, H. Schulz, C. Flexeder, C. Zeller, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler); Research Institute, Department of Pediatrics, Marien-Hospital, Wesel (D. Berdel, A. von Berg, B. Filipiak-Pittroff); Ludwig-Maximilians-University of Munich, Dr von Hauner Children's Hospital (S. Koletzko, K. Werkstetter); Department of Pediatrics, Technische Universitat Munchen and Deutsche Rentenversicherung Bayern (C.P. Bauer, U. Hoffmann); and IUF-Leibniz Institute for Environmental Research, Dusseldorf (B. Hoffmann, E. Link, C. Klumper, U. Kramer). The LISAplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen, German Research Center for Environmental Health (J. Heinrich, I. Bruske, H. Schulz, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler, C. Flexeder, C. Zeller); Department of Pediatrics, Marien Hospital Wesel, Wesel (A. von Berg); Pediatric Practice, Bad Honnef (B. Schaaf); Technical University, Munich (C.P. Bauer, U. Hoffmann); Helmholtz Centre for Environmental Research - UFZ, Department of Environmental Immunology/Core Facility Studies, Leipzig (I. Lehmann, M. Bauer, G. Herberth, J. Muller, S. Roder and M. Schilde); Department of Pediatrics, Municipal Hospital 'St. Georg', Leipzig (M. Borte, U. Diez, C. Dorn, E. Braun); and ZAUM - Center for Allergy and Environment, Technical University Munich (M. Ollert, J. Grosch). The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, and 10 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 4 study centres: Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, Ludwig-Maximilians-University Munich, Technical University Munich, and from 6 years onwards also from IUF-Leibniz Research-Institute for Environmental Medicine at the University of Dusseldorf, and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The 15-year follow-up of the GINI study was supported by the companies Mead Johnson and Nestle and in cooperation with European Studies (e.g. MeDALL, ESCAPE). Some projects not directly related to the intervention effect of the hydrolyzates (e.g. effect of cesarean section, effect of solid food introduction) were partly supported by Nestle, Mead Johnson, Numico, Pharmacia and Stiftung Kindergesundheit, and in cooperation with European studies (e.g. MeDALL). The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years.; The 4 year, 6 year, and 10 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF - Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). This work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, and 10 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 4 study centres: Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, Ludwig-Maximilians-University Munich, Technical University Munich, and from 6 years onwards also from IUF-Leibniz Research-Institute for Environmental Medicine at the University of Dusseldorf, and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The 15-year follow-up of the GINIplus study was supported by the companies Mead Johnson and Nestle and in cooperation with European Studies (e.g. MeDALL, ESCAPE). Some projects not directly related to the intervention effect of the hydrolyzates (e.g. effect of cesarean section, effect of solid food introduction) were partly supported by Nestle, Mead Johnson, Numico, Pharmacia and Stiftung Kindergesundheit, and in cooperation with European studies (e.g. MeDALL).; The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years. The 4 year, 6 year, and 10 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF-Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296).; This work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research.	Latorre-Roman PA, 2014, IRAN J ALLERGY ASTHM, V13, P396; [Anonymous], 2012, GLI2012; [Anonymous], 2013, NATL J PHYSL PAHRM P, DOI DOI 10.5455/NJPPP.2013.3.109-114; Bae JY, 2015, J PHYS THER SCI, V27, P2687, DOI 10.1589/jpts.27.2687; Balas J, 2009, ISOKINET EXERC SCI, V17, P173, DOI 10.3233/IES-2009-0350; Berntsen S, 2008, PEDIATR EXERC SCI, V20, P402, DOI 10.1123/pes.20.4.402; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Courteix D, 1997, EUR J APPL PHYSIOL O, V76, P264, DOI 10.1007/s004210050246; COUSER JI, 1993, CHEST, V103, P37, DOI 10.1378/chest.103.1.37; CRAIG BW, 1989, MECH AGEING DEV, V49, P159, DOI 10.1016/0047-6374(89)90099-7; Cussler EC, 2005, MED SCI SPORTS EXERC, V35, P10; De Cocker K, 2011, PUBLIC HEALTH NUTR, V14, P246, DOI 10.1017/S1368980010000558; Greutmann M, 2011, HEART, V97, P1164, DOI 10.1136/hrt.2010.213579; Harms CA, 1997, J APPL PHYSIOL, V82, P1573, DOI 10.1152/jappl.1997.82.5.1573; Illi SK, 2012, SPORTS MED, V42, P707, DOI 10.2165/11631670-000000000-00000; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Ji J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066098; KEENS TG, 1977, AM REV RESPIR DIS, V116, P853; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mazic S, 2015, REV PORT PNEUMOL, V21, P192, DOI 10.1016/j.rppnen.2014.12.003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nici L, 2006, AM J RESP CRITICAL C, V173; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; Quist M, BMC CANC; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007; Rozek-Piechura K, 2014, ANN AGR ENV MED, V21, P369, DOI 10.5604/1232-1966.1108607; Sahin G, 2004, SOUTH MED J, V97, P25; Shah S, 2013, INDIAN J MED RES, V138, P492; Skloot GS, 2010, RESP CARE, V55; Smith M. P., 2016, EUROPEAN RESP J, V47; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152217; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Troosters, ELF FACT SHEET YOUR; World Health Organization, 2011, GLOB REC PHYS ACT HL; Yadav Raj Kumar, 2001, Indian Journal of Physiology and Pharmacology, V45, P493	47	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194560	10.1371/journal.pone.0194560	http://dx.doi.org/10.1371/journal.pone.0194560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641533	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900035
J	Enane, LA; Mokete, K; Joel, D; Daimari, R; Tshume, O; Anabwani, G; Mazhani, L; Steenhoff, AP; Lowenthal, ED				Enane, Leslie A.; Mokete, Keboletse; Joel, Dipesalema; Daimari, Rahul; Tshume, Ontibile; Anabwani, Gabriel; Mazhani, Loeto; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.			"We did not know what was wrong" Barriers along the care cascade among hospitalized adolescents with HIV in Gaborone, Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; INFECTION; CHILDREN; AFRICA; YOUTH; AGE	High mortality among adolescents with HIV reflects delays and failures in the care cascade. We sought to elucidate critical missed opportunities and barriers to care among adolescents hospitalized with HIV at Botswana's tertiary referral hospital. We enrolled all HIV-infected adolescents (aged 10-19 years) hospitalized with any diagnosis other than pregnancy from July 2015 to January 2016. Medical records were reviewed for clinical variables and past engagement in care. Semi-structured interviews of the adolescents (when feasible) and their caregivers explored delays and barriers to care. Twenty-one eligible adolescents were identified and 15 were enrolled. All but one were WHO Clinical Stage 3 or 4. Barriers to diagnosis included lack of awareness about perinatal HIV infection, illness or death of the mother, and fear of discrimination. Barriers to adherence to antiretroviral therapy included nondisclosure, isolation, and mental health concerns. The number of hospitalized HIV infected adolescents was lower than expected. However, among those hospitalized, the lack of timely diagnosis and subsequent gaps in the care cascade elucidated opportunities to improve outcomes and quality of life for this vulnerable group.	[Enane, Leslie A.; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Enane, Leslie A.; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Enane, Leslie A.] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Enane, Leslie A.; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Botswana UPenn Partnership, Gaborone, Botswana; [Mokete, Keboletse; Joel, Dipesalema; Tshume, Ontibile; Anabwani, Gabriel] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Joel, Dipesalema; Daimari, Rahul; Mazhani, Loeto] Univ Botswana, Fac Med, Gaborone, Botswana; [Anabwani, Gabriel] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Childrens Hosp Philadelphia, Ctr Global Hlth, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; University of Botswana; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Enane, LA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.; Enane, LA (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; Enane, LA (corresponding author), Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA.; Enane, LA (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	lenane@iu.edu		Enane, Leslie A./0000-0001-8390-5881	National Institute of Mental Health [NIH K23 MH095669]; Penn Center for AIDS Research (CFAR), an NIH [P30 AI45008]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Penn Center for AIDS Research (CFAR), an NIH	This work was supported by the National Institute of Mental Health under Grant NIH K23 MH095669 (EDL); and by the Penn Center for AIDS Research (CFAR), an NIH-funded program, under Grant P30 AI45008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Botswana Ministry of Health, 2012, BOTSW NAT HIV AIDS T, P1; Buzdugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053213; Cohn J, 2016, LANCET HIV, V3, pE473, DOI 10.1016/S2352-3018(16)30050-9; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Hall BJ, 2017, AIDS BEHAV, V21, P1755, DOI 10.1007/s10461-016-1537-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Livingston Julie, 2005, DEBILITY MORAL IMAGI; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Machine EM, 2016, AIDS CARE, V28, P1402, DOI 10.1080/09540121.2016.1179714; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Muir-Cochrane E., 2006, INT J QUAL METH, V5, P15, DOI DOI 10.1177/160940690600500107; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ojwang' VO, 2016, AIDS CARE, V28, P500, DOI 10.1080/09540121.2015.1110234; Reif LK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20859; Shaw S, 2016, JAIDS-J ACQ IMM DEF, V72, P387, DOI 10.1097/QAI.0000000000000977; Statistics Botswana, 2013, BOTS AIDS IMP SURV 4; Teasdale CA, 2016, JAIDS-J ACQ IMM DEF, V71, pE56, DOI [10.1097/QAI.0000000000000877, 10.1097/QAI.0000000000000902]; UNAIDS, 2015, ALL ENDADOLESCENTAID; UNAIDS, UNAIDS EST 2017; UNAIDS, 2016, EST; UNICEF World Bank World Food Program USAID ENGINE, 2016, EV CHILD END AIDS 7, P1; United Nations Children's Fund UNICEF, 2013, AIDS FREE GEN CHILDR, P1; Vreeman RC, 2015, AIDS BEHAV, V19, P626, DOI 10.1007/s10461-015-0998-x; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; Williams S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21922; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; Wood SM, 2015, JAMA PEDIATR, V169, P619, DOI 10.1001/jamapediatrics.2015.58; Yang E, 2018, AIDS CARE, V30, P224, DOI 10.1080/09540121.2017.1344767	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195372	10.1371/journal.pone.0195372	http://dx.doi.org/10.1371/journal.pone.0195372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630654	Green Published, gold			2022-12-27	WOS:000429505000044
J	Sedighi, A; Ulman, SM; Nussbaum, MA				Sedighi, Alireza; Ulman, Sophia M.; Nussbaum, Maury A.			Information presentation through a head worn display ("smart glasses") has a smaller influence on the temporal structure of gait variability during dual-task gait compared to handheld displays (paper-based system and smartphone)	PLOS ONE			English	Article							MOVEMENT VARIABILITY; APPROXIMATE ENTROPY; AUGMENTED REALITY; MENTAL WORKLOAD; MUSCLE-ACTIVITY; WALKING SPEED; PERFORMANCE; STABILITY; PRECISION; TREADMILL	The need to complete multiple tasks concurrently is a common occurrence both daily life and in occupational activities, which can often include simultaneous cognitive and physical demands. As one example, there is increasing availability of head-worn display technologies that can be employed when a user is mobile (e.g., while walking). This new method of information presentation may, however, introduce risks of adverse outcomes such as a decrement to gait performance. The goal of this study was thus to quantify the effects of a head worn display (i.e., smart glasses) on motor variability during gait and to compare these effects with those of other common information displays (i.e., smartphone and paper-based system). Twenty participants completed four walking conditions, as a single task and in three dual-task conditions (three information displays). In the dual-task conditions, the information display was used to present several cognitive tasks. Three different measures were used to quantify variability in gait parameters for each walking condition (using the cycle-to cycle standard deviation, sample entropy, and the "goal-equivalent manifold" approach). Our results indicated that participants used less adaptable gait strategies in dual-task walking using the paper-based system and smartphone conditions compared with single-task walking. Gait performance, however, was less affected during dual-task walking with the smart glasses. We conclude that the risk of an adverse gait event (e.g., a fall) in head-down walking conditions (i.e., the paper-based system and smartphone conditions) were higher than in single-task walking, and that head-worn displays might help reduce the risk of such events during dual-task gait conditions.	[Sedighi, Alireza; Ulman, Sophia M.; Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nussbaum, MA (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.; Nussbaum, MA (corresponding author), Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	nussbaum@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431; Sedighi, Alireza/0000-0001-5283-4523	NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T03OH008613] Funding Source: NIH RePORTER	NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Asai T, 2013, GAIT POSTURE, V38, P830, DOI 10.1016/j.gaitpost.2013.04.005; Barnette JJ, 1998, ANN M MIDS ED RES AS; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Beauchet O, 2005, J NEUROENG REHABIL, V2, P2, DOI [10.1186/1743-0003-2-2, DOI 10.1186/1743-0003-2-2]; Bernstein N, 1967, COORDINATION REGULAT; Birch L, 2000, SCAND J WORK ENV HEA, V26, P299, DOI 10.5271/sjweh.546; Blangsted AK, 2004, EUR J APPL PHYSIOL, V91, P253, DOI 10.1007/s00421-003-0979-z; Bohnsack-McLagan NK, 2016, J BIOMECH, V49, P229, DOI 10.1016/j.jbiomech.2015.12.010; Brodeur MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106953; Brusie T, 2015, SYST INF ENG DES S C; Chehrehrazi M, 2017, HUM MOVEMENT SCI, V51, P72, DOI 10.1016/j.humov.2016.11.005; Cirulis A, 2013, PROCEDIA COMPUT SCI, V26, P14, DOI 10.1016/j.procs.2013.12.003; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Crowley P, 2016, EFFECTS MOBILE PHONE, V28, P101; Cusumano JP, 2013, HUM MOVEMENT SCI, V32, P899, DOI 10.1016/j.humov.2013.07.019; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; DiDomenico A, 2008, INT J IND ERGONOM, V38, P977, DOI 10.1016/j.ergon.2008.01.012; DiDomenico A, 2011, INT J IND ERGONOM, V41, P255, DOI 10.1016/j.ergon.2011.01.008; Dingwell JB, 2013, J NEUROPHYSIOL, V109, P225, DOI 10.1152/jn.00951.2011; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Fallavollita P, 2016, L N COMPUT VIS BIOME, P251, DOI 10.1007/978-3-319-23482-3_13; Finsen L, 2001, J ELECTROMYOGR KINES, V11, P373, DOI 10.1016/S1050-6411(01)00015-3; Fiorentino M, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P86, DOI 10.1109/ISMAR.2002.1115077; Gaudez C, 2016, APPL ERGON, V53, P71, DOI 10.1016/j.apergo.2015.08.014; HART S G, 1988, P139; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; He JB, 2015, ACCIDENT ANAL PREV, V81, P218, DOI 10.1016/j.aap.2015.03.033; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Hou L, 2015, J COMPUT CIVIL ENG, V29, DOI 10.1061/(ASCE)CP.1943-5487.0000344; Iben H., 2009, P 2009 INT C MULTIMO, P281, DOI DOI 10.1145/1647314.1647374, Patent No. 1647374; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kaplan E., 2001, BOSTON NAMING TEST P; Kennedy R.S., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kopper M, 2016, ERGONOMICS, V59, P615, DOI 10.1080/00140139.2015.1100757; Lewis JR, 2009, LECT NOTES COMPUT SC, V5619, P94, DOI 10.1007/978-3-642-02806-9_12; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Liu YC, 2004, INT J HUM-COMPUT ST, V61, P679, DOI 10.1016/j.ijhcs.2004.06.002; Magnani RM, 2017, GAIT POSTURE, V55, P105, DOI 10.1016/j.gaitpost.2017.04.019; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Malcolm BR, 2015, NEUROIMAGE, V117, P230, DOI 10.1016/j.neuroimage.2015.05.028; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Muller H, 2009, ADV EXP MED BIOL, V629, P439, DOI 10.1007/978-0-387-77064-2_23; Mustonen T, 2013, J EXP PSYCHOL-APPL, V19, P333, DOI 10.1037/a0034635; Newell KM, 1998, MOTOR BEHAVIOR AND HUMAN SKILL, P143; Newell KM, 1993, ISSUES VARIABILITY M; Orlosky J, 2014, MOB COMPUT COMMUN RE, V18, P20, DOI 10.1145/2636242.2636246; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Roffey DM, 2010, SPINE J, V10, P262, DOI 10.1016/j.spinee.2009.12.023; Salinas MM, 2017, GAIT POSTURE, V57, P15, DOI 10.1016/j.gaitpost.2017.05.002; Sawyer BD, 2014, HUM FACTORS, V56, P1307, DOI 10.1177/0018720814555723; Schaefer S, 2015, GAIT POSTURE, V41, P258, DOI 10.1016/j.gaitpost.2014.10.013; Schaefer S, 2010, EUR J DEV PSYCHOL, V7, P371, DOI 10.1080/17405620802535666; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Scholz JP, 2001, EXP BRAIN RES, V141, P485, DOI 10.1007/s002210100878; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Sedighi A, 2017, J ELECTROMYOGR KINES, V37, P61, DOI 10.1016/j.jelekin.2017.09.001; Srinivasan D, 2016, EUR J APPL PHYSIOL, V116, P227, DOI 10.1007/s00421-015-3268-8; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trebuchon-Da Fonseca A, 2009, BRAIN, V132, P2772, DOI 10.1093/brain/awp083; Van Krevelen D., 2010, INT J VIRT REAL, V9, P1, DOI DOI 10.20870/IJVR.2010.9.2.2767; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright P., 1983, Behaviour and Information Technology, V2, P227, DOI 10.1080/01449298308914479; Yang T, 2015, LECT NOTES COMPUT SC, V9179, P535, DOI 10.1007/978-3-319-21067-4_54; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	75	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195106	10.1371/journal.pone.0195106	http://dx.doi.org/10.1371/journal.pone.0195106			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630614	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000025
J	Petrovic, T; Sekler, M; Petric, D; Lazic, S; Debeljak, Z; Vidanovic, D; Cupina, AI; Lazic, G; Lupulovic, D; Kolarevic, M; Plavsic, B				Petrovic, Tamas; Sekler, Milanko; Petric, Dusan; Lazic, Sava; Debeljak, Zoran; Vidanovic, Dejan; Cupina, Aleksandra Ignjatovic; Lazic, Gospava; Lupulovic, Diana; Kolarevic, Migo; Plavsic, Budimir			Methodology and results of integrated WNV surveillance programmes in Serbia	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEROLOGICAL EVIDENCE; INFECTION; VOJVODINA; MOSQUITO; TRANSMISSION; CIRCULATION; HORSES; BIRDS	Studies conducted during the past few years have confirmed active West Nile virus (WNV) circulation in Serbia. Based on these studies and the epidemiological situation, the Veterinary Directorate of the Ministry of Agriculture and Environmental Protection launched national WNV surveillance programmes in 2014 and 2015. The programmes encompassed the territory of Serbia and were conducted by the veterinary service in collaboration with entomologists and ornithologists. The objective of the programmes was early detection of WNV and timely reporting to the public health service and local authorities to increase both clinical and mosquito control preparedness. The WNV surveillance programmes were based on direct and indirect surveillance of the presence of WNV by the serological testing of initially seronegative sentinel horses and chickens as well as through viral detection in pooled mosquito and wild bird samples. The most intense WNV circulation was observed in all seven districts of Vojvodina Province (northern Serbia) and Belgrade City, where most of the positive samples were detected among sentinel animals, mosquitoes and wild birds. The West Nile virus surveillance programmes in 2014 and 2015 showed satisfactory results in their capacity to indicate the spatial distribution of the risk for humans and their sensitivity to early detect viral circulation at the enzootic level. Most of the human cases were preceded by the detection of WNV circulation as part of the surveillance programmes. According to the existing data, it can be reasonably assumed that WNV infection, now an endemic infection in Serbia, will continue to present a significant problem for the veterinary service and public health.	[Petrovic, Tamas; Lazic, Sava; Lazic, Gospava; Lupulovic, Diana] Sci Vet Inst Novi Sad, Dept Virol, Novi Sad, Serbia; [Sekler, Milanko; Debeljak, Zoran; Vidanovic, Dejan; Kolarevic, Migo] Specialized Vet Inst Kraljevo, Kraljevo, Serbia; [Petric, Dusan; Cupina, Aleksandra Ignjatovic] Univ Novi Sad, Fac Agr, Lab Med & Vet Entomol, Novi Sad, Serbia; [Plavsic, Budimir] Minist Agr & Environm Protect, Vet Directorate, Belgrade, Serbia	University of Novi Sad; University of Novi Sad	Petrovic, T (corresponding author), Sci Vet Inst Novi Sad, Dept Virol, Novi Sad, Serbia.	tomy@niv.ns.ac.rs	Vidanovic, Dejan/AAH-8241-2020; Petrovic, Tamas/H-3764-2019	Vidanovic, Dejan/0000-0003-0192-5120; Petrovic, Tamas/0000-0002-9164-3356; Lazic, Sava/0000-0001-8480-1283	Ministry of Education, Science and Technological Development of the Republic of Serbia [TR31084, III43007]; Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia	Ministry of Education, Science and Technological Development of the Republic of Serbia; Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia	This work was supported by project grants TR31084 and III43007 of the Ministry of Education, Science and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs/). The implementation of WNV surveillance programs was funded by the Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia (http://www.vet.minpoli.gov.rs/sr/pocetna). Also, part of the work of TP, DP, AIC and GL was done under the frame of EurNegVec COST Action TD1303 (http://www.cost.eu/COST_Actions/bmbs/TD1303). BP is employed in the Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia, and has an active role in designing of the WNV surveillance programs and the review of the final work. The funders had no other role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelini P, 2010, EURO SURVEILL, V15; [Anonymous], 2012, EPISOUTH WEEKLY EPI; [Anonymous], 2014, PROGRAM NADZIRANJA G; [Anonymous], 2013, PENNSYLVANIA W NILE; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Barbic L, 2012, VET MICROBIOL, V159, P504, DOI 10.1016/j.vetmic.2012.04.038; Barker C.M., 2012, P MOSQ CONTR ASS CAL, V80, P17; Blackmore CGM, 2003, AM J TROP MED HYG, V69, P141, DOI 10.4269/ajtmh.2003.69.141; Bordoski M, 1972, Vojnosanit Pregl, V29, P173; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Castillo-Olivares J, 2004, VET RES, V35, P467, DOI 10.1051/vetres:2004022; CDC [Centers for Disease Control and Prevention], 2013, W NIL VIR US GUID SU; Chaintoutis SC, 2016, ACTA TROP, V163, P26, DOI 10.1016/j.actatropica.2016.07.018; ECDC (European Centre for Disease Prevention and Control), 2014, REP CAS W NIL FEV EU; ECDC (European Centre for Disease Prevention and Control), CUM NUMB W NIL FEV C; ECDC (European Centre for Disease Prevention and Control), 2012, REP CAS W NIL FEV EU; Erdelyi K, 2007, VECTOR-BORNE ZOONOT, V7, P181, DOI 10.1089/vbz.2006.0586; Groen TA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2484-y; Hrnjakovic-Cvjetkovic I., 2017, ARCH VET MED, V10, P77, DOI [10.46784/e-avm.v10i1.79, DOI 10.46784/E-AVM.V10I1.79]; Institute of Public Health of Serbia (Serbian CDC), 2014, INF AKT EP SIT GROZN; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Linke S, 2007, AM J TROP MED HYG, V77, P358, DOI 10.4269/ajtmh.2007.77.358; Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249; Medic S, 2014, J INFECT DEV COUNTR, V8, P914, DOI 10.3855/jidc.3885; Nemeth N, 2007, EMERG INFECT DIS, V13, P305, DOI 10.3201/eid1302.051626; Nemeth NM, 2007, AM J TROP MED HYG, V76, P431, DOI 10.4269/ajtmh.2007.76.431; Petric D, 2017, MOL CELL PROBE, V31, P28, DOI 10.1016/j.mcp.2016.10.011; Petric D, 2012, HEALTHMED, V6, P462; Petrovic T, 2014, ARCH BIOL SCI, V66, P473, DOI 10.2298/ABS1402473P; Petrovic T, 2013, EURO SURVEILL, V18, P20622; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Popovic N., 2013, EURO SURVEILL, V18; Rizzo C, 2012, EUROSURVEILLANCE, V17, P7; Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Vesenjak-Hirjan J, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P129; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012; Ziegler U, 2012, ZOONOSES PUBLIC HLTH, V59, P95, DOI 10.1111/zph.12015	40	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195439	10.1371/journal.pone.0195439	http://dx.doi.org/10.1371/journal.pone.0195439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624622	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600028
J	Cunningham, DJ; Shearer, DA; Carter, N; Drawer, S; Pollard, B; Bennett, M; Eager, R; Cook, CJ; Farrell, J; Russell, M; Kilduff, LP				Cunningham, Daniel J.; Shearer, David A.; Carter, Neil; Drawer, Scott; Pollard, Ben; Bennett, Mark; Eager, Robin; Cook, Christian J.; Farrell, John; Russell, Mark; Kilduff, Liam P.			Assessing worst case scenarios in movement demands derived from global positioning systems during international rugby union matches: Rolling averages versus fixed length epochs	PLOS ONE			English	Article							TEAM SOCCER MATCH; PHYSICAL DEMANDS; PLAY; FLUCTUATIONS; RELIABILITY; PERFORMANCE; RESPONSES; VELOCITY; INJURY; GAMES	The assessment of competitive movement demands in team sports has traditionally relied upon global positioning system (GPS) analyses presented as fixed-time epochs (e.g., 5-40 min). More recently, presenting game data as a rolling average has become prevalent due to concerns over a loss of sampling resolution associated with the windowing of data over fixed periods. Accordingly, this study compared rolling average (ROLL) and fixed-time (FIXED) epochs for quantifying the peak movement demands of international rugby union match-play as a function of playing position. Elite players from three different squads (n = 119) were monitored using 10 Hz GPS during 36 matches played in the 2014-2017 seasons. Players categorised broadly as forwards and backs, and then by positional sub-group (FR: front row, SR: second row, BR: back row, HB: half back, MF: midfield, B3: back three) were monitored during match-play for peak values of high-speed running (>5 m.s(-1); HSR) and relative distance covered (m.min(-1)) over 60-300 s using two types of sample-epoch (ROLL, FIXED). Irrespective of the method used, as the epoch length increased, values for the intensity of running actions decreased (e.g., For the backs using the ROLL method, distance covered decreased from 177.4 +/- 20.6 m.min(-1) in the 60 s epoch to 107.5 +/- 13.3 m.min(-1) for the 300 s epoch). For the team as a whole, and irrespective of position, estimates of fixed effects indicated significant between-method differences across all time-points for both relative distance covered and HSR. Movement demands were underestimated consistently by FIXED versus ROLL with differences being most pronounced using 60 s epochs (95% CI HSR: -6.05 to -4.70 m.min(-1), 95% CI distance: -18.45 to -16.43 m.min(-1)). For all HSR time epochs except one, all backs groups increased more (p < 0.01) from FIXED to ROLL than the forward groups. Linear mixed modelling of ROLL data highlighted that for HSR (except 60 s epoch), SR was the only group not significantly different to FR. For relative distance covered all other position groups were greater than the FR (p < 0.05). The FIXED method underestimated both relative distance (similar to 11%) and HSR values (up to similar to 20%) compared to the ROLL method. These differences were exaggerated for the HSR variable in the backs position who covered the greatest HSR distance; highlighting important consideration for those implementing the FIXED method of analysis. The data provides coaches with a worst-case scenario reference on the running demands required for periods of 60-300 s in length. This information offers novel insight into game demands and can be used to inform the design of training games to increase specificity of preparation for the most demanding phases of matches.	[Cunningham, Daniel J.; Cook, Christian J.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Sch Psychol & Therapeut Studies, Pontypridd, Wales; [Shearer, David A.; Kilduff, Liam P.] Swansea Univ, Welsh Inst Performance Sci, Coll Engn, Swansea, W Glam, Wales; [Carter, Neil] Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Drawer, Scott] Team Sky, Sky Performance Hub, London, England; [Pollard, Ben] Saracens RFC, North London, England; [Bennett, Mark; Eager, Robin] Rugby Football Union, Greater London, England; [Cook, Christian J.] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Farrell, John] Georgian Rugby Union, Tbilisi, Georgia; [Russell, Mark] Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England	Swansea University; University of South Wales; Swansea University; Swansea University; University of Canberra	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.; Kilduff, LP (corresponding author), Swansea Univ, Welsh Inst Performance Sci, Coll Engn, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019; Russell, Mark/M-1652-2019	Shearer, David/0000-0002-5877-8160; Russell, Mark/0000-0002-7305-1090; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union; Team Sky; Georgia Rugby	Rugby Football Union; Team Sky; Georgia Rugby	The author(s) received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors Scott Drawer, Mark Bennett, Robin Eager and Ben Pollard, Team Sky provided support in the form of a salary to Scott Drawer and Georgia Rugby provided support in the form of a salary for John Farrell but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2016, INT J SPORTS PHYSL P; Anderson L, 2016, J SPORT SCI, V34, P1250, DOI 10.1080/02640414.2015.1106574; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beato M, 2016, J HUM KINET, V54, P15, DOI 10.1515/hukin-2016-0031; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Cunningham DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164990; Delaney JA, 2016, INT J SPORT PHYSIOL, V11, P802, DOI 10.1123/ijspp.2015-0424; Delaney JA, 2015, INT J SPORT PHYSIOL, V10, P725, DOI 10.1123/ijspp.2015-0092; Furlan N, 2015, INT J SPORT PHYSIOL, V10, P802, DOI 10.1123/ijspp.2014-0315; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2006, J STRENGTH COND RES, V20, P309, DOI 10.1519/R-17655.1; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; James N, 2005, J SPORT SCI, V23, P63, DOI 10.1080/02640410410001730106; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P568, DOI 10.1123/ijspp.2017-0214; Lacome M, 2017, EUR J SPORT SCI, V17, P132, DOI 10.1080/17461391.2016.1220986; Laserna Jose de, 1916, IMPARCIAL 18 ENE, P1; Lindsay A, 2015, EUR J SPORT SCI, P1; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Reardon C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177072; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Russell M, 2016, HUM MOVEMENT SCI, V45, P96, DOI 10.1016/j.humov.2015.11.011; Russell M, 2015, J SPORT SCI, V33, P2133, DOI 10.1080/02640414.2015.1064153; Russell M, 2016, J STRENGTH COND RES, V30, P2839, DOI 10.1519/JSC.0000000000000805; Tierney P, 2016, SCAND J MED SCI SPOR; Tierney PJ, 2016, HUM MOVEMENT SCI, V49, P1, DOI 10.1016/j.humov.2016.05.007; Varley MC, 2012, INT J SPORT PHYSIOL, V7, P183, DOI 10.1123/ijspp.7.2.183; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941	37	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195197	10.1371/journal.pone.0195197	http://dx.doi.org/10.1371/journal.pone.0195197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621279	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800048
J	Hong, EH; Shin, YU; Kang, MH; Cho, H; Seong, M				Hong, Eun Hee; Shin, Yong Un; Kang, Min Ho; Cho, Heeyoon; Seong, Mincheol			Wide scan imaging with swept-source optical coherent tomography for glaucoma diagnosis	PLOS ONE			English	Article							CHOROIDAL THICKNESS; PROGRESSION; ABILITY; VOLUME; DAMAGE	Purpose To determine glaucoma-discriminating abilities of macular and circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurements of wide scan (12X9mm) using swept-source optical coherence tomography (SS-OCT) compared to measurements of standard macula and disc scans (6 X 6 mm). Methods This retrospective chart review study included 60 glaucomatous and 62 healthy eyes of total 122 subjects who visited a glaucoma clinic and were examined with wide, standard macula, and standard disc scans of SS-OCT (DRI-OCT-1 Atlantis; Topcon Inc., Tokyo, Japan) on the same day. Thickness measurements of the ganglion cell layer plus inner plexiform layer (mGCIPL), mGCIPL plus nerve fiber layer (mGCC), and total retinal layer (TRL) were assessed in wide and standard macula scans. Thickness measurements of cpRNFL were assessed in wide and standard disc scans. The repeatability and agreement of measurements taken in each scan were evaluated using intraclass correlation coefficients (ICCs). The abilities of parameters to discriminate between glaucoma and normal groups were assessed using areas under receiver operating characteristic curves (AUCs). Results The repeatability and agreement of all parameters showed high ICC values (all >= 0.800). AUCs for mGCIPL thickness were 0.710-0.847 and 0.701-0.836 in standard macula and wide scans, respectively. AUCs for cpRNFL thickness were 0.749-0.902 and 0.726-0.897 in standard disc and wide scans, respectively. There were no significant differences in AUCs between wide and standard scans. Conclusions The agreement between SS-OCT wide and standard scans for mGCIPL, mGCC and cpRNFL measurements were excellent. As the glaucoma-discriminating ability of wide scans was comparable to that of standard macula/disc scans, a single wide scan can replace separate standard macula/disc scans for evaluating glaucoma.	[Hong, Eun Hee; Shin, Yong Un; Kang, Min Ho; Cho, Heeyoon; Seong, Mincheol] Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Hanyang University	Seong, M (corresponding author), Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	goddns76@hanmail.net	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985; Seong, Mincheol/0000-0001-7912-0096	National Research Foundation of Korea [NRF-2017R1D1A1B03030905, NRF-2017R1D1A1803031934]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea NRF-2017R1D1A1B03030905 to YUS and NRF-2017R1D1A1803031934 to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareef RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155319; Bagga H, 2005, J GLAUCOMA, V14, P358, DOI 10.1097/01.ijg.0000176930.21853.04; Bussel II, 2013, BR J OPHTHALMOL; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Griffith JF, 2015, CLIN OPHTHALMOL, V9, P1275, DOI 10.2147/OPTH.S85851; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kim KE, 2014, INVEST OPHTH VIS SCI, V55, P3501, DOI 10.1167/iovs.14-13925; Lee KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147964; Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]; Lee WJ, 2017, J GLAUCOMA, V26, P577, DOI 10.1097/IJG.0000000000000662; Leung CKS, 2014, CURR OPIN OPHTHALMOL, V25, P104, DOI 10.1097/ICU.0000000000000024; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125957; Yang ZY, 2015, AM J OPHTHALMOL, V159, P193, DOI 10.1016/j.ajo.2014.10.019	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195040	10.1371/journal.pone.0195040	http://dx.doi.org/10.1371/journal.pone.0195040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621263	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800034
J	Nakayama, N; Arakawa, N; Ejiri, H; Matsuda, R; Makino, T				Nakayama, Natsuki; Arakawa, Naoko; Ejiri, Harumi; Matsuda, Reiko; Makino, Tsuneko			Heart rate variability can clarify students' level of stress during nursing simulation	PLOS ONE			English	Article							CLINICAL LEARNING-ENVIRONMENT; CRITICAL-CARE; SCALE	Simulation is regarded as an effective educational method for the delivery of clinical scenarios. However, exposure to unfamiliar environments during simulation can cause excessive stress among students, possibly leading to unnatural speech/behavior and poor skill learning (Yerkes-Dodson's law). Thus, assessing students' stress in a simulation can provide educators with a better understanding of their mental state. This study sought to clarify stress changes throughout the progression of the simulation by measuring heart rate variability and students' subjective reactions in 74 nursing students. Heart rate variability was calculated in terms of its high-frequency(HF) and low-frequency/high-frequency (LF/HF) components during 4 phases the break, patient care, reporting, and debriefing. Students were interviewed about stress experienced during the simulation. The results showed that HF decreased significantly from the break to the patient care and reporting phases. Furthermore, LF/HF increased significantly from the break to the reporting phases. Approximately 55 students felt stressed during the simulation, 24 of whom felt most stressed during the reporting phase. Therefore, the reporting phase involved high objective and subjective stress. It may be possible that the educator's evaluative attitude increased students' stress. Therefore, a stress intervention during the reporting phase might further improve students' performance during that phase. The debriefing phase did not significantly differ from the break phase for objective stress, and students did not report feeling stressed. Thus, in this phase, they were released from the stress of the reporting phase and the unfamiliar environment. During this phase, they might be able to learn what they could not understand owing to high stress in the patient care and reporting phases. This study provides objective and subjective evidence of students' stress during simulation, and indicates the necessity of providing support during the reporting phase and the importance of debriefing when using clinical scenarios for teaching clinical skills.	[Nakayama, Natsuki] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan; [Arakawa, Naoko; Ejiri, Harumi; Matsuda, Reiko; Makino, Tsuneko] Chubu Univ, Coll Life & Hlth Sci, Dept Nursing, Kasugai, Aichi, Japan	Nagoya University; Chubu University	Nakayama, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan.	nakayama@met.nagoya-u.ac.jp	Arakawa, Naoko/R-1031-2019					Abe Y, 2013, AM J CRIT CARE, V22, P33, DOI 10.4037/ajcc2013229; Biernacki M, 2012, MED PR, V63, P377; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Bolesta S, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe78594; Camm AJ, 1996, EUR HEART J, V17, P354; Castaldo R, 2016, IEEE ENG MED BIO, P3805, DOI 10.1109/EMBC.2016.7591557; Chan DSK, 2003, WESTERN J NURS RES, V25, P519, DOI 10.1177/0193945903253161; Decker S, 2013, CLIN SIMUL NURS, V9, pS26, DOI 10.1016/j.ecns.2013.04.008; Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Hamaideh SH, 2017, J MENT HEALTH, V26, P197, DOI 10.3109/09638237.2016.1139067; Hinchey Paul R, 2011, Air Med J, V30, P86, DOI 10.1016/j.amj.2010.11.002; Javorka M, 2018, AM J PHYSIOL-REG I, V14; Labrague Leodoro J, 2017, J Ment Health, V26, P471, DOI 10.1080/09638237.2016.1244721; Li H, 2016, INT J PSYCHIAT MED, V51, P47, DOI 10.1177/0091217415621265; Lusk JM, 2013, NURS EDUC, V38, P16, DOI 10.1097/NNE.0b013e318276df8b; McCraty Rollin, 2015, Glob Adv Health Med, V4, P46, DOI 10.7453/gahmj.2014.073; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McNiesh SG, 2011, J NURS EDUC, V50, P197, DOI 10.3928/01484834-20101029-03; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Morrison A L, 2001, Aust Crit Care, V14, P116, DOI 10.1016/S1036-7314(01)80028-X; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pinna GD, 2006, AM J PHYSIOL-HEART C, V290, pH424, DOI 10.1152/ajpheart.00438.2005; Roh YS, 2016, NURS HEALTH SCI, V18, P238, DOI 10.1111/nhs.12259; Shreeve MW, 2008, J CHIPROPR EDUC, V22, P23, DOI 10.7899/1042-5055-22.1.23; Skaalvik MW, 2011, J CLIN NURS, V20, P2294, DOI 10.1111/j.1365-2702.2011.03727.x; Springer R, 2013, SURGERY, V154, P345, DOI 10.1016/j.surg.2013.04.038; van der Zwan JE, 2015, APPL PSYCHOPHYS BIOF, V40, P257, DOI 10.1007/s10484-015-9293-x; Wu M, 2015, IEEE ENG MED BIO, P1625, DOI 10.1109/EMBC.2015.7318686; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195280	10.1371/journal.pone.0195280	http://dx.doi.org/10.1371/journal.pone.0195280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621278	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800054
J	Semeraro, R; Orlandini, V; Magi, A				Semeraro, Roberto; Orlandini, Valerio; Magi, Alberto			Xome-Blender: A novel cancer genome simulator	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; MYELOID-LEUKEMIA GENOME; COPY-NUMBER ALTERATION; ACCURATE; MUTATIONS; DISCOVERY; IDENTIFICATION; LANDSCAPE; FRAMEWORK	The adoption of next generation sequencing based methods in cancer research allowed for the investigation of the complex genetic structure of tumor samples. In the last few years, considerable importance was given to the research of somatic variants and several computational approaches were developed for this purpose. Despite continuous improvements to these programs, the validation of their results it's a hard challenge due to multiple sources of error. To overcome this drawback different simulation approaches are used to generate synthetic samples but they are often based on the addition of artificial mutations that mimic the complexity of genomic variations. For these reasons, we developed a novel software, Xome-Blender, that generates synthetic cancer genomes with user defined features such as the number of subclones, the number of somatic variants and the presence of copy number alterations (CNAs), without the addition of any synthetic element. The singularity of our method is the "morphological approach" used to generate mutation events. To demonstrate the power of our tool we used it to address the hard challenge of evaluating the performance of nine state-of-the-art somatic variant calling methods for small and large variants (VarScan2, MuTect, Shimmer, BCFtools, Strelka, EXCAVATOR2, Control-FREEC and CopywriteR). Through these analyses we observed that by using Xome-Blender data it is possible to appraise small differences between their performance and we have designated VarScan2 and EXCAVATOR2 as best tool for this kind of applications. Xome-Blender is unix-based, licensed under the GPLv3 and freely available at https://github.com/rsemeraro/XomeBlender.	[Semeraro, Roberto; Magi, Alberto] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Orlandini, Valerio] Meyer Childrens Univ Hosp, Med Genet Unit, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Semeraro, R (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.	roberto.semeraro@unifi.it	Semeraro, Roberto/AAB-2193-2019; MAGI, Alberto/M-6773-2015	Semeraro, Roberto/0000-0003-0601-6903; MAGI, Alberto/0000-0001-7393-4283; Orlandini, Valerio/0000-0002-6857-5471	Italian Ministry of Health, Young Investigators Award [GR-2011-02352026]	Italian Ministry of Health, Young Investigators Award	AM and RS were supported by Italian Ministry of Health, Young Investigators Award, Project GR-2011-02352026 Detecting copy number variants from whole-exome sequencing data applied to acute myeloid leukemias.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; [Anonymous], 2012, PILEUP2BASE; [Anonymous], 2010, PICARD TYPE; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bodini M, 2015, BLOOD, V125, P600, DOI 10.1182/blood-2014-05-576157; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boutros PC, 2014, NAT GENET, V46, P318, DOI 10.1038/ng.2932; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Consortium GP, 1000 GEN PROJ REP; D'Aurizio R, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw695; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Holtgrewe M, 2010, MASON READ SIMULATOR; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Janin L, 2014, EAGLE ENHANCED ARTIF; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pattnaik S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-40; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194472	10.1371/journal.pone.0194472	http://dx.doi.org/10.1371/journal.pone.0194472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621252	Green Published, gold			2022-12-27	WOS:000429206800019
J	Betancor, PK; Hildebrand, A; Bohringer, D; Emmerich, F; Schlunck, G; Reinhard, T; Lapp, T				Betancor, Paola Kammrath; Hildebrand, Antonia; Bohringer, Daniel; Emmerich, Florian; Schlunck, Gunther; Reinhard, Thomas; Lapp, Thabo			Activation of human macrophages by human corneal allogen in vitro	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; PENETRATING KERATOPLASTY; LYMPH-NODES; IMMUNE PRIVILEGE; ANTERIOR-CHAMBER; CELL PHENOTYPES; DENDRITIC CELLS; AQUEOUS-HUMOR; MECHANISMS; MONOCYTES	Purpose To study distinct aspects of human monocyte-derived macrophage (MDM) activation by human corneal tissue as a possible initial stage in human corneal allograft rejection. Methods Human monocytes were isolated from peripheral blood mononuclear cells (PBMC) and differentiated into MDM. Human corneas with or without endothelium were fragmented using a standardized protocol. MDM were stimulated with human corneal fragments, corneal fragment supernatant, lipopolysaccharide (LPS) or interferon-gamma (IFN gamma), and expression profiles for 34 cytokines were determined in MDM-conditioned media using a Luminex bead-based multiplex assay. Data from clinical aqueous humour samples served for comparison and validation. To assess cell recruitment, immunogenicity of corneal endothelial cells (CEC), monocyte survival and differentiation, we applied transwell migration assays, cell viability assays and fluorescence-activated cell sorting, respectively. Results Corneal fragments induced MDM to release distinct cytokines into the medium. Media thus conditioned in vitro by stimulated MDM shared cytokine patterns, namely MCP-1, MIP-1 alpha and MIP-1 beta, with human aqueous humor samples obtained in human corneal allograft rejection. The presence of CEC in tissue fragments used for MDM stimulation attenuated the upregulation of distinct pro-inflammatory chemokines, like MCP-3 and IL-8, reduced the monocyte survival time, and diminished monocyte-to-macrophage differentiation induced by conditioned media. Distinct anti-inflammatory cytokines, like IL-4 and IL-13, were upregulated in the presence of corneal endothelium. Cornea fragment-stimulated MDMs induced recruitment of monocytes from a PBMC pool in a transwell migration model, modulated immune cell viability and promoted further immune cell recruitment and differentiation. Conclusions Human macrophages respond to allogenic corneal tissue and generate an inflammatory milieu. This can drive further recruitment of immunocompetent cells and modulate cell survival and differentiation of the cells recruited. These observations are consistent with the hypothesis that macrophages play a significant role in the initiation of corneal transplant rejection. Our data also indicate that distinct aspects of early human corneal transplant rejection can be modelled in vitro.	[Betancor, Paola Kammrath; Hildebrand, Antonia; Bohringer, Daniel; Schlunck, Gunther; Reinhard, Thomas; Lapp, Thabo] Univ Freiburg, Fac Med, Ctr Eye, Med Ctr, Freiburg, Germany; [Emmerich, Florian] Univ Freiburg, Fac Med, Inst Transfus Med & Gene Therapy, Med Ctr, Freiburg, Germany	University of Freiburg; University of Freiburg	Lapp, T (corresponding author), Univ Freiburg, Fac Med, Ctr Eye, Med Ctr, Freiburg, Germany.	Thabo.Lapp@uniklinik-freiburg.de		Lapp, Thabo/0000-0001-7097-7587; Kammrath Betancor, Paola/0000-0001-7654-6032	"Ernst-und-Berta-Grimmke-Stiftung" (Germany); "Gertrud Kusen Stiftung (Germany); "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany)	"Ernst-und-Berta-Grimmke-Stiftung" (Germany); "Gertrud Kusen Stiftung (Germany); "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany)	This research was supported by a grant from: 1) the "Ernst-und-Berta-Grimmke-Stiftung" (Germany), research grant (to TL); 2) the "Gertrud Kusen Stiftung (Germany), research grant (to TL); and 3) the "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany), Doctoral scholarship (to PKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzegar A, 2016, J IMMUNOL, V196, P3983, DOI 10.4049/jimmunol.1600251; Boyette LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176460; Camelo S, 2004, J IMMUNOL, V172, P5388, DOI 10.4049/jimmunol.172.9.5388; Coster DJ, 2009, EYE, V23, P1894, DOI 10.1038/eye.2009.17; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cunnusamy K, 2010, INVEST OPHTH VIS SCI, V51, P6566, DOI 10.1167/iovs.10-6161; Flynn TH, 2008, AM J TRANSPLANT, V8, P1537, DOI 10.1111/j.1600-6143.2008.02285.x; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gasser L, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0068-1; HOLLAND EJ, 1994, CORNEA, V13, P317, DOI 10.1097/00003226-199407000-00006; Hori J, 2010, INVEST OPHTH VIS SCI, V51, P6556, DOI 10.1167/iovs.09-4959; Kuffova L, 2001, TRANSPLANTATION, V72, P1292, DOI 10.1097/00007890-200110150-00019; Lapp T, 2015, INVEST OPHTH VIS SCI, V56, P7250, DOI 10.1167/iovs.15-16941; Larkin DFP, 1997, EYE, V11, P68, DOI 10.1038/eye.1997.13; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; NAIR S, 1995, INT IMMUNOL, V7, P679, DOI 10.1093/intimm/7.4.679; Niederkorn JY, 2007, CURR EYE RES, V32, P1005, DOI 10.1080/02713680701767884; Niederkorn JY, 2010, OCUL IMMUNOL INFLAMM, V18, P162, DOI 10.3109/09273948.2010.486100; Niederkorn JY, 2015, J CLIN EXP OPHTHALMO, V6; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Reinhard T, 2002, ARCH OPHTHALMOL-CHIC, V120, P1630; Reinhard T, 2002, CORNEA, V21, P56, DOI 10.1097/00003226-200201000-00013; Slegers TPAM, 2004, TRANSPLANTATION, V77, P1641, DOI 10.1097/01.TP.0000129410.89410.F2; Slegers TPAM, 2000, INVEST OPHTH VIS SCI, V41, P2239; Tsukamoto M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1216-6; VANDERVEEN G, 1994, INVEST OPHTH VIS SCI, V35, P3505; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Williams KA, 2008, TRANSPLANTATION, V86, P1720, DOI 10.1097/TP.0b013e3181903b0a; Yamagami S, 2003, CORNEA, V22, pS61, DOI 10.1097/00003226-200310001-00009; Yamagami S, 2001, INVEST OPHTH VIS SCI, V42, P1293; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	34	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194855	10.1371/journal.pone.0194855	http://dx.doi.org/10.1371/journal.pone.0194855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617399	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800053
J	English, WR; Ireland-Zecchini, H; Baker, AH; Littlewood, TD; Bennett, MR; Murphy, G				English, William R.; Ireland-Zecchini, Heather; Baker, Andrew H.; Littlewood, Trevor D.; Bennett, Martin R.; Murphy, Gillian			Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DEATH DOMAIN; LEUKEMIC-CELLS; LIPID RAFTS; CD95; OVEREXPRESSION; REDISTRIBUTION; MECHANISM; INVASION; PROLIFERATION	Over expression of Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) in vascular smooth muscle cells (VSMCs) induces apoptosis and reduces neointima formation occurring after saphenous vein interposition grafting or coronary stenting. In studies to address the mechanism of TIMP-3-driven apoptosis in human VSMCs we find that TIMP-3 increased activation of caspase-8 and apoptosis was inhibited by expression of Cytokine response modifier A (CrmA) and dominant negative FAS-Associated protein with Death Domain (FADD). TIMP-3 induced apoptosis did not cause mitochondrial depolarisation, increase activation of caspase-9 and was not inhibited by over-expression of B-cell Lymphoma 2 (BcI2), indicating a mitochondrial independent/type-I death receptor pathway. TIMP-3 increased levels of the First Apoptosis Signal receptor (FAS) and depletion of FAS with shRNA showed TIMP-3-induced apoptosis was FAS dependent. TIMP-3 induced formation of the Death-Inducing Signalling Complex (DISC), as detected by immunoprecipitation and by immunofluorescence. Cellular-FADD-like IL-1 converting enzyme-Like Inhibitory Protein (c-FLIP) localised with FAS at the cell periphery in the absence of TIMP-3 and this localisation was lost on TIMP-3 expression with c-FLIP adopting a perinuclear localisation. Although TIMP-3 inhibited FAS shedding, this did not increase total surface levels of FAS but instead increased FAS levels within localised regions at the cell surface. A Disintegrin And Metalloproteinase 17 (ADAM17) is inhibited by TIMP-3 and depletion of ADAM17 with shRNA significantly decreased FAS shedding. However ADAM17 depletion did not induce apoptosis or replicate the effects of TIMP-3 by increasing localised clustering of cell surface FAS. ADAM17-depleted cells could activate caspase-3 when expressing levels of TIMP-3 that were otherwise sub-apoptotic, suggesting a partial role for ADAM17 mediated ectodomain shedding in TIMP-3 mediated apoptosis. We conclude that TIMP-3 induced apoptosis in VSMCs is highly dependent on FAS and is associated with changes in FAS and c-FLIP localisation, but is not solely dependent on shedding of the FAS ectodomain.	[English, William R.; Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [English, William R.] Univ Sheffield, Sch Med, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Ireland-Zecchini, Heather] Univ Cambridge, Microscopy Core Facil, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Baker, Andrew H.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Littlewood, Trevor D.] Univ Cambridge, Dept Biochem, Cambridge, England; [Bennett, Martin R.] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Sheffield; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Glasgow; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	English, WR (corresponding author), Univ Cambridge, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.; English, WR (corresponding author), Univ Sheffield, Sch Med, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	w.english@sheffield.ac.uk	Baker, Andy/AAO-5250-2021	Baker, Andy/0000-0003-1441-5576; Bennett, Martin/0000-0002-2565-1825; English, William/0000-0003-3024-2441	Cancer Research UK; Hutchison Whampoa Limited; European Union [LSHC-CT-2003-503297]; British Heart Foundation; British Heart Foundation Intermediate Research Fellowship [FS/03/055/15910]; British Heart Foundation [RG/13/14/30314]; flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research; Cancer Research UK Cambridge Institute, University of Cambridge UK	Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; European Union(European Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation Intermediate Research Fellowship; British Heart Foundation(British Heart Foundation); flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research; Cancer Research UK Cambridge Institute, University of Cambridge UK	This work was supported by Cancer Research UK and Hutchison Whampoa Limited (WRE, HIZ, GM), European Union Framework Programme 6 LSHC-CT-2003-503297 (GM), and the British Heart Foundation (AHB, TDL, MRB). WRE was supported by a British Heart Foundation Intermediate Research Fellowship (FS/03/055/15910). MRB is supported by a British Heart Foundation Grant RG/13/14/30314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support of the flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research and the Cancer Research UK Cambridge Institute, University of Cambridge UK. We would also like to acknowledge the support of colleagues within the Tumour Microcirculation Group and Dr. Allan Lawrie for their assistance at the University of Sheffield, UK.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 2002, MOL THER, V5, P705, DOI 10.1006/mthe.2002.0606; Ahonen M, 1998, CANCER RES, V58, P2310; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Charlier E, 2010, LEUKEMIA, V24, P821, DOI 10.1038/leu.2010.9; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Dorrie J, 2002, CYTOKINE, V18, P98, DOI 10.1006/cyto.2002.1030; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; Ireland Zecchini H, 2012, CURR PROT CYT, V59; Johnson TW, 2005, ARTERIOSCL THROM VAS, V25, P754, DOI 10.1161/01.ATV.0000157582.33180.a9; Kallio JP, 2011, INT J CANCER, V128, P991, DOI 10.1002/ijc.25404; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; Lam P, 2005, MOL THER, V12, P144, DOI 10.1016/j.ymthe.2005.02.028; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Nicklin S A, 1999, Methods Mol Med, V30, P271, DOI 10.1385/1-59259-247-3:271; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Sata M, 2000, ARTERIOSCL THROM VAS, V20, P309, DOI 10.1161/01.ATV.20.2.309; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; Woessner J.F., 2000, PROTEIN PROFILE SER; Zhang L, 2009, CANC GENE THER; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033	41	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195116	10.1371/journal.pone.0195116	http://dx.doi.org/10.1371/journal.pone.0195116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617412	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000429203800066
J	Hamiehli, A; Tayyarli, R; Tabajal, H; Zein, SEL; Khalil, PB; Karat, N; Kanafanil, ZA; Kanj, N; Aki, IB; Araj, G; Berjaoui, G; Kanj, SS				Hamiehli, Amal; Tayyarli, Ralph; Tabajal, Houssam; Zein, Saeed E. L.; Khalil, Pierre Bou; Karat, Nathalie; Kanafanil, Zeina A.; Kanj, Nadim; Aki, Imad Bou; Araj, George; Berjaoui, Ghina; Kanj, Souha S.			Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon	PLOS ONE			English	Article							INFECTION; PULMONARY; COMPLEX; DISEASE; PARAENSE	Objective The objective of this study is to describe the clinical significance of Mycobacterium simiae at a major tertiary care center in Lebanon. Methods This is a retrospective study of patients with positive cultures for M. simiae isolated between 2004 and 2016 at the American University of Beirut Medical Center. Results This study included 103 M. simiae isolates recovered from 51 patients. Their mean age was 62.7 years. The majority were males and smokers. Specimens were mostly from respiratory sources (97%). Common comorbidities included chronic lung disease (such as chronic obstructive pulmonary disease), solid tumor, systemic disease, and diabetes mellitus. Productive cough and dyspnea were the most common symptoms. Frequent radiographic findings were infiltrates and nodules on chest X-ray and nodules, infiltrates, and bronchiectasis on chest computed tomography scan. Among 18 tested isolates, 5.8% were resistant to clarithromycin, 11.7% to amikacin, and 70-100% to other antimicrobials. Out of 13 patients receiving early treatment, 5 noted improvement, one had recurrence of symptoms, two received alternative diagnosis, and five died. Two of those deaths were related to M. simiae. Common treatment regimens included clarithromycin in different combinations with trimethoprim-sulfamethoxazole, moxifloxacin, and amikacin. Moreover, clofazimine was used in only two patients whose isolates were resistant to all but one agent. Duration of treatment ranged from 6-24 months. Conclusion In Lebanon, M. simiae is increasingly encountered with true infection rates of at least 47%. Furthermore, the prevalence of multidrug resistance among the Lebanese M. simiae isolates is very high limiting the treatment options.	[Hamiehli, Amal; Tayyarli, Ralph; Tabajal, Houssam; Zein, Saeed E. L.; Kanafanil, Zeina A.; Kanj, Souha S.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis, Beirut, Lebanon; [Khalil, Pierre Bou; Karat, Nathalie; Kanj, Nadim; Aki, Imad Bou] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Beirut, Lebanon; [Araj, George] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon; [Berjaoui, Ghina] Amer Univ Beirut, Med Ctr, Dept Radiol, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Kanj, SS (corresponding author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis, Beirut, Lebanon.	sk11@aub.edu.lb	Tayyar, Ralph/GRR-3590-2022	Tayyar, Ralph/0000-0002-5354-0209; Bou Akl, Imad/0000-0001-8984-6683; Tabaja, Hussam/0000-0002-5650-4852; Kanj, Souha/0000-0001-6413-3396; Kanafani, Zeina/0000-0001-8814-1286				Aksamit TR, 2014, RESP MED, V108, P417, DOI 10.1016/j.rmed.2013.09.014; Al-Abdely HM, 2000, J INFECTION, V41, P143, DOI 10.1053/jinf.2000.0700; Araj George F, 2016, J Med Liban, V64, P1; Baghaei P, 2012, J INFECT DEV COUNTR, V6, P23, DOI 10.3855/jidc.1297; Baghizadeh A, 2017, CAN RESPIR J, V2017, P5; Balkis MM, 2009, INT J INFECT DIS, V13, pE286, DOI [10.1016/j.ijid.2008.10.015, 10.1016/j.ijid.2008.06.036]; Cruz AT, 2007, J CLIN MICROBIOL, V45, P2745, DOI 10.1128/JCM.00359-07; da Costa ARF, 2015, INT J SYST EVOL MICR, V65, P656, DOI 10.1099/ijs.0.068395-0; da Costa ARF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002340; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hankins D, 2013, J PEDIATR INFECT DIS, V2, P394, DOI 10.1093/jpids/pis098; Hashemi-Shahraki A, 2013, JPN J INFECT DIS, V66, P475, DOI 10.7883/yoken.66.475; Maoz C, 2008, EUR J CLIN MICROBIOL, V27, P945, DOI 10.1007/s10096-008-0522-6; MARCHEVSKY A, 1982, AM J CLIN PATHOL, V78, P695, DOI 10.1093/ajcp/78.5.695; Narang R, 2010, CLIN MICROBIOL INFEC, V16, P912, DOI 10.1111/j.1469-0691.2009.03021.x; Nasser M., 2014, J MED MICROB DIAGN, V4, P175; Onen ZP, 2010, TUBERK TORAK, V58, P306; Panagiotou M, 2014, PULM MED, V2014, DOI 10.1155/2014/894976; Piersimoni C, 2009, EMERG INFECT DIS, V15, P1351, DOI 10.3201/eid1509.081259; Poonawala H, 2017, J CLIN MICROBIOL, V55, P2283, DOI 10.1128/JCM.00663-17; ROSE HD, 1982, AM REV RESPIR DIS, V126, P1110; Shitrit D, 2008, RESP MED, V102, P1598, DOI 10.1016/j.rmed.2008.05.004; Tortoli E, 2011, INT J SYST EVOL MICR, V61, P1606, DOI 10.1099/ijs.0.025601-0; van Ingen J, 2008, EUR RESPIR J, V31, P106, DOI 10.1183/09031936.00076107; van Ingen J, 2012, ANTIMICROB AGENTS CH, V56, P6324, DOI 10.1128/AAC.01505-12; van Ingen J, 2012, INT J ANTIMICROB AG, V39, P173, DOI 10.1016/j.ijantimicag.2011.09.019	26	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195390	10.1371/journal.pone.0195390	http://dx.doi.org/10.1371/journal.pone.0195390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617415	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800081
J	Pellikaan, P; Giarmatzis, G; Vander Sloten, J; Verschueren, S; Jonkers, I				Pellikaan, Pim; Giarmatzis, Georgios; Vander Sloten, Jos; Verschueren, Sabine; Jonkers, Ilse			Ranking of osteogenic potential of physical exercises in postmenopausal women based on femoral neck strains	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIGH-IMPACT EXERCISE; TRABECULAR BONE; CORTICAL BONE; HIP FRACTURE; PROXIMAL FEMUR; OLDER MEN; WALKING; PRESERVATION; OSTEOPOROSIS	The current study aimed to assess the potential of different exercises triggering an osteogenic response at the femoral neck in a group of postmenopausal women. The osteogenic potential was determined by ranking the peak hip contact forces (HCFs) and consequent peak tensile and compressive strains at the superior and inferior part of the femoral neck during activities such as (fast) walking, running and resistance training exercises. Results indicate that fast walking (5-6 km/h) running and hopping induced significantly higher strains at the femoral neck than walking at 4 km/h which is considered a baseline exercise for bone preservation. Exercises with a high fracture risk such as hopping, need to be considered carefully especially in a frail elderly population and may therefore not be suitable as a training exercise. Since superior femoral neck frailness is related to elevated hip fracture risk, exercises such as fast walking (above 5 km/h) and running can be highly recommended to stimulate this particular area. Our results suggest that a training program including fast walking (above 5 km/h) and running exercises may increase or preserve the bone mineral density (BMD) at the femoral neck.	[Pellikaan, Pim; Vander Sloten, Jos] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium; [Giarmatzis, Georgios; Verschueren, Sabine] Katholieke Univ Leuven, Dept Rehabil Sci, Res Grp Musculoskeletal Rehabil, Leuven, Belgium; [Jonkers, Ilse] Katholieke Univ Leuven, Dept Movement Sci, Human Movement Biomech Res Grp, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Pellikaan, P (corresponding author), Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium.	pim.pellikaan@kuleuven.be	Giarmatzis, Georgios/AAC-1725-2022; Verschueren, Sabine/K-4213-2015	Giarmatzis, Georgios/0000-0003-1387-2134; Verschueren, Sabine/0000-0003-2592-494X	Fund for Scientific Research (FWO-Vlaanderen) [G0526512]; Materialise NV through the Materialise chair for patient-specific biomechanics	Fund for Scientific Research (FWO-Vlaanderen)(FWO); Materialise NV through the Materialise chair for patient-specific biomechanics	This study was supported by grant G0526512 from the Fund for Scientific Research (FWO-Vlaanderen www.fwo.be) to S. Verschueren and by the funding of Materialise NV through the Materialise chair for patient-specific biomechanics (www.materialise.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2015, J BONE MINER RES, V30, P1709, DOI 10.1002/jbmr.2499; Allison SJ, 2013, BONE, V53, P321, DOI 10.1016/j.bone.2012.12.045; Anderson DE, 2013, J APPL BIOMECH, V29, P505, DOI 10.1123/jab.29.5.505; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Bailey CA, 2010, BONE, V46, P1043, DOI 10.1016/j.bone.2009.12.001; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063; Bell KL, 1999, J BONE MINER RES, V14, P111, DOI 10.1359/jbmr.1999.14.1.111; BIEWENER AA, 1993, CALCIFIED TISSUE INT, V53, pS68, DOI 10.1007/BF01673406; Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005; Boonen S, 2008, BEST PRACT RES CL EN, V22, P765, DOI 10.1016/j.beem.2008.07.002; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318; COWIN SC, 1984, CALCIFIED TISSUE INT, V36, pS98, DOI 10.1007/BF02406141; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Edwards WB, 2016, J BIOMECH, V49, P1206, DOI 10.1016/j.jbiomech.2016.03.007; Engelke K, 2016, CLIN REV BONE MINER, V14, P26, DOI 10.1007/s12018-015-9201-1; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Garcia J M, 2001, Comput Methods Biomech Biomed Engin, V4, P355, DOI 10.1080/10255840108908014; Giarmatzis G, 2017, GAIT POSTURE, V53, P155, DOI 10.1016/j.gaitpost.2017.01.020; Giarmatzis G, 2015, J BONE MINER RES, V30, P1431, DOI 10.1002/jbmr.2483; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Howe TE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000333.pub2; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; Johannesdottir F, 2011, BONE, V48, P1268, DOI 10.1016/j.bone.2011.03.776; Kelley GA, 2001, AM J PHYS MED REHAB, V80, P65, DOI 10.1097/00002060-200101000-00017; Kemmler W, 2011, PHYSICIAN SPORTSMED, V39, P142, DOI 10.3810/psm.2011.02.1872; Kerr D, 2001, J BONE MINER RES, V16, P175, DOI 10.1359/jbmr.2001.16.1.175; Kim WS, 2014, ANN REHABIL MED-ARM, V38, P101, DOI 10.5535/arm.2014.38.1.101; Loveridge N, 2004, BONE, V35, P929, DOI 10.1016/j.bone.2004.05.025; Ma D, 2013, MENOPAUSE, V20, P1216, DOI [10.1097/GME.0000000000000100, 10.1097/gme.0000000000000100]; Martelli S, 2014, J BIOMECH, V47, P1784, DOI 10.1016/j.jbiomech.2014.03.036; Martyn-St James M, 2006, OSTEOPOROSIS INT, V17, P1225, DOI 10.1007/s00198-006-0083-4; Martyn-St James M, 2009, BRIT J SPORT MED, V43, P898, DOI 10.1136/bjsm.2008.052704; Martyn-St James M, 2008, BONE, V43, P521, DOI 10.1016/j.bone.2008.05.012; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; Milovanovic P, 2012, BONE, V50, P63, DOI 10.1016/j.bone.2011.09.044; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Mokhtarzadeh H, 2014, J BIOMECH, P1; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Speirs AD, 2007, J BIOMECH, V40, P2318, DOI 10.1016/j.jbiomech.2006.10.038; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Taylor ME, 1996, MED ENG PHYS, V18, P122, DOI 10.1016/1350-4533(95)00031-3; Thomas CDL, 2009, J BONE MINER RES, V24, P1808, DOI [10.1359/jbmr.090504, 10.1359/JBMR.090504]; Vahdati A, 2014, J MECH BEHAV BIOMED, V30, P244, DOI 10.1016/j.jmbbm.2013.11.015; van Arkel RJ, 2013, J ORTHOP RES, V31, P1172, DOI 10.1002/jor.22364	52	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195463	10.1371/journal.pone.0195463	http://dx.doi.org/10.1371/journal.pone.0195463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617448	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800087
J	Imasaki, T; Wenzel, S; Yamada, K; Bryant, ML; Takagi, Y				Imasaki, Tsuyoshi; Wenzel, Sabine; Yamada, Kentaro; Bryant, Megan L.; Takagi, Yuichiro			Titer estimation for quality control (TEQC) method: A practical approach for optimal production of protein complexes using the baculovirus expression vector system	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GENERAL TRANSCRIPTION FACTOR; MEDIATOR HEAD MODULE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INSECT CELLS; RECOMBINANT BACULOVIRUS; MULTIPROTEIN COMPLEXES; ESCHERICHIA-COLI; IN-VITRO	The baculovirus expression vector system (BEVS) is becoming the method of choice for expression of many eukaryotic proteins and protein complexes for biochemical, structural and pharmaceutical studies. Significant technological advancement has made generation of recombinant baculoviruses easy, efficient and user-friendly. However, there is a tremendous variability in the amount of proteins made using the BEVS, including different batches of virus made to express the same proteins. Yet, what influences the overall production of proteins or protein complexes remains largely unclear. Many downstream applications, particularly protein structure determination, require purification of large quantities of proteins in a repetitive manner, calling for a reliable experimental set-up to obtain proteins or protein complexes of interest consistently. During our investigation of optimizing the expression of the Mediator Head module, we discovered that the 'initial infectivity' was an excellent indicator of overall production of protein complexes. Further, we show that this initial infectivity can be mathematically described as a function of multiplicity of infection (M01), correlating recombinant protein yield and virus titer. All these findings led us to develop the Titer Estimation for Quality Control (TEQC) method, which enables researchers to estimate initial infectivity, titer/MOI values in a simple and affordable way, and to use these values to quantitatively optimize protein expressions utilizing BEVS in a highly reproducible fashion.	[Imasaki, Tsuyoshi; Wenzel, Sabine; Yamada, Kentaro; Bryant, Megan L.; Takagi, Yuichiro] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Imasaki, Tsuyoshi] RIKEN, Ctr Life Sci Technol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yamada, Kentaro] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; RIKEN; Indiana University System; Indiana University Bloomington	Takagi, Y (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	ytakagi@iu.edu		Takagi, Yuichiro/0000-0002-0988-6798; Imasaki, Tsuyoshi/0000-0001-5462-1820	US National Science Foundation [MCB-1157688]; National Institutes of Health/General Medical Sciences [R01 GM111695]; Showalter Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111695] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Showalter Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by US National Science Foundation grant MCB-1157688, the National Institutes of Health/General Medical Sciences (R01 GM111695), and Showalter Trust Fund to (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008; Barford D, 2013, CURR OPIN STRUC BIOL, V23, P357, DOI 10.1016/j.sbi.2013.03.009; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Janakiraman V, 2006, NAT PROTOC, V1, P2271, DOI 10.1038/nprot.2006.387; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kwon MS, 2002, BIOTECHNOL PROGR, V18, P647, DOI 10.1021/bp020298s; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LICARI P, 1991, BIOTECHNOL BIOENG, V37, P238, DOI 10.1002/bit.260370306; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; Massotte D, 2003, BBA-BIOMEMBRANES, V1610, P77, DOI 10.1016/S0005-2736(02)00720-4; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; MULVANIA T, 2004, BIOPROCESS J, V3, P47, DOI DOI 10.12665/J33.MULVANIA; MURHAMMER DW, 1988, BIO-TECHNOL, V6, P1411, DOI 10.1038/nbt1288-1411; NEUTRA R, 1992, APPL MICROBIOL BIOT, V37, P74, DOI 10.1007/BF00174206; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POWER JF, 1994, BIOTECHNOL BIOENG, V44, P710, DOI 10.1002/bit.260440607; Radford KM, 1997, CYTOTECHNOLOGY, V24, P73, DOI 10.1023/A:1007962903435; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOPF B, 1990, J BIOTECHNOL, V15, P169, DOI 10.1016/0168-1656(90)90059-K; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; SMITH GE, 1983, J VIROL, V46, P584, DOI 10.1128/JVI.46.2.584-593.1983; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; van Oers MM, 2015, J GEN VIROL, V96, P6, DOI 10.1099/vir.0.067108-0; VOLKMAN LE, 1976, J VIROL, V19, P820, DOI 10.1128/JVI.19.3.820-832.1976; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Wong KTK, 1996, BIOTECHNOL BIOENG, V49, P659, DOI 10.1002/(SICI)1097-0290(19960320)49:6&lt;659::AID-BIT7&gt;3.0.CO;2-N; Yang C, 2010, PROTEIN EXPRES PURIF, V70, P172, DOI 10.1016/j.pep.2009.09.021	53	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195356	10.1371/journal.pone.0195356	http://dx.doi.org/10.1371/journal.pone.0195356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614134	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600053
J	Hannan, NJ; Binder, NK; Beard, S; Nguyen, TV; Kaitu'u-Lino, TJ; Tong, S				Hannan, Natalie J.; Binder, Natalie K.; Beard, Sally; Tuong-Vi Nguyen; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen			Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIANGIOGENIC FACTORS; MITOCHONDRIAL DAMAGE; SERUM MELATONIN; PREGNANCY; ENDOGLIN; RATS; WOMEN; HYPERTENSION; PATHOGENESIS	Preeclampsia is one of the most serious complications of pregnancy. Currently there are no medical treatments. Given placental oxidative stress may be an early trigger in the pathogenesis of preeclampsia, therapies that enhance antioxidant pathways have been proposed as treatments. Melatonin is a direct free-radical scavenger and indirect antioxidant. We performed in vitro assays to assess whether melatonin 1) enhances the antioxidant response element genes (heme-oxygenase 1, (HO-1), glutamate-cysteine ligase (GCLC), NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1), thioredoxin (TXN)) or 2) alters secretion of the anti-angiogenic factors soluble fms-like tyrosine kinase-1 (sFLT) or soluble endoglin (sENG) from human primary trophoblasts, placental explants and human umbilical vein endothelial cells (HUVECs) and 3) can rescue TNF-alpha induced endothelial dysfunction. In primary trophoblast melatonin treatment increased expression of the antioxidant enzyme TXN. Expression of TXN, GCLC and NQO1 was upregulated in placental tissue with melatonin treatment. HUVECs treated with melatonin showed an increase in both TXN and GCLC. Melatonin did not increase HO-1 expression in any of the tissues examined. Melatonin reduced sFLT secretion from primary trophoblasts, but had no effect on sFLT or sENG secretion from placental explants or HUVECs. Melatonin did not rescue TNF-alpha induced VCAM-1 and ET-1 expression in endothelial cells. Our findings suggest that melatonin induces antioxidant pathways in placenta and endothelial cells. Furthermore, it may have effects in reducing sFLT secretion from trophoblast, but does not reduce endothelial dysfunction. Given it is likely to be safe in pregnancy, it may have potential as a therapeutic agent to treat or prevent preeclampsia.	[Hannan, Natalie J.; Binder, Natalie K.; Beard, Sally; Tuong-Vi Nguyen; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp,Mercy Perinatal, Heidelberg, Vic, Australia	University of Melbourne	Hannan, NJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp,Mercy Perinatal, Heidelberg, Vic, Australia.	nhannan@unimelb.edu.au		Hannan, Natalie/0000-0001-8446-2250; Tong, Stephen/0000-0002-2319-0586; Binder, Natalie K/0000-0002-8943-2269; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737	National Health and Medical Research Council of Australia (NHMRC) [1050765, 1062418]; University of Melbourne CR Roper Fellowship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne CR Roper Fellowship(University of Melbourne)	The National Health and Medical Research Council of Australia (NHMRC) provided salary support (#1050765 to ST; #1062418 to TKL). NJH salary was supported by a University of Melbourne CR Roper Fellowship. The funders had no role in study design, data collection, analysis or decision to publish.	Agarwal I, 2011, PREGNANCY HYPERTENS, V1, P17, DOI 10.1016/j.preghy.2010.10.007; Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; Atamer Y, 2005, EUR J OBSTET GYN R B, V119, P60, DOI 10.1016/j.ejogrb.2004.06.033; Brownfoot FC, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.019; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Cagnacci A, 1998, AM J PHYSIOL-REG I, V274, pR335, DOI 10.1152/ajpregu.1998.274.2.R335; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hannan NJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01993-w; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Hastie R, 2017, REPROD SCI, V24, P1245, DOI 10.1177/1933719116681516; Hobson SR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003788; Hung MW, 2013, J PINEAL RES, V55, P247, DOI 10.1111/jpi.12067; Jahnke G, 1999, TOXICOL SCI, V50, P271, DOI 10.1093/toxsci/50.2.271; JANES SL, 1995, THROMB HAEMOSTASIS, V74, P1059; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; KIVELA A, 1991, ACTA ENDOCRINOL-COP, V124, P233, DOI 10.1530/acta.0.1240233; Laflamme AK, 1998, AM J HYPERTENS, V11, P219, DOI 10.1016/S0895-7061(97)00401-9; Lanoix D, 2008, J PINEAL RES, V45, P50, DOI 10.1111/j.1600-079X.2008.00555.x; Lanoix D, 2013, MOL CELL ENDOCRINOL, V381, P35, DOI 10.1016/j.mce.2013.07.010; Lanoix D, 2012, J PINEAL RES, V53, P417, DOI 10.1111/j.1600-079X.2012.01012.x; Lanoix D, 2012, MOL CELL ENDOCRINOL, V348, P1, DOI 10.1016/j.mce.2011.08.025; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Miller SL, 2012, NEUROENDOCRINOLOGY, V96, P13, DOI 10.1159/000336378; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Nakamura Y, 2001, J PINEAL RES, V30, P29, DOI 10.1034/j.1600-079X.2001.300104.x; Okatani Y, 2001, J PINEAL RES, V31, P173, DOI 10.1034/j.1600-079x.2001.310212.x; Onda K TS, 2017, HYPERTENSION; Onda K, 2015, HYPERTENSION, V65, P855, DOI 10.1161/HYPERTENSIONAHA.114.04781; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rahman R, 2016, PREGNANCY HYPERTENS, V6, P259, DOI 10.1016/j.preghy.2016.09.001; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1978, BRIT MED J, V1, P467, DOI 10.1136/bmj.1.6111.467; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Simko F, 2007, J PINEAL RES, V42, P319, DOI 10.1111/j.1600-079X.2007.00436.x; Soliman A, 2015, J PINEAL RES, V59, P38, DOI 10.1111/jpi.12236; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tong S, 2015, HYPERTENSION, V66, P1073, DOI 10.1161/HYPERTENSIONAHA.115.05847; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Voiculescu S E, 2014, J Med Life, V7, P488; Wang ZQ, 2016, J PINEAL RES, V60, P217, DOI 10.1111/jpi.12305; Wiktor H, 2004, VIRCHOWS ARCH, V445, P74, DOI 10.1007/s00428-004-1024-2; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	50	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0187082	10.1371/journal.pone.0187082	http://dx.doi.org/10.1371/journal.pone.0187082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641523	gold, Green Published			2022-12-27	WOS:000429742900002
J	Hemminger, J; Arole, V; Ayoub, I; Brodsky, SV; Nadasdy, T; Satoskar, AA				Hemminger, Jessica; Arole, Vidya; Ayoub, Isabelle; Brodsky, Sergey V.; Nadasdy, Tibor; Satoskar, Anjali A.			Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis	PLOS ONE			English	Article							IMMUNE-COMPLEXES; KUPFFER CELLS; DISEASE; RECEPTOR; MICE; GN	Background Small glomerular IgA deposits have been reported in patients with liver cirrhosis, mainly as an incidental finding in autopsy studies. We recently encountered nine cirrhotic patients who presented with acute proliferative glomerulonephritis with unusually large, exuberant glomerular immune complex deposits, in the absence of systemic lupus erythematosus (SLE) or monoclonal gammopathy-related kidney disease. Deposits were typically IgA dominant/codominant. Our aim was to further elucidate the etiology, diagnostic pitfalls, and clinical outcomes. Methods We present clinical features and kidney biopsy findings of nine cirrhotic patients with an unusual acute immune complex glomerulonephritis. We also identified native kidney biopsies from all patients with liver cirrhosis at our institution over a 13-year period (January 2004 to December 2016) to evaluate presence of glomerular IgA deposits in them (n = 118). Results Six of nine cirrhotic patients with the large immune deposits had a recent/concurrent acute bacterial infection, prompting a diagnosis of infection-associated glomerulonephritis and treatment with antibiotics. In the remaining three patients, no infection was identified and corticosteroids were initiated. Three of nine patients recovered kidney function (one recovered kidney function after liver transplant); three patients developed chronic kidney disease but remained off dialysis; two patients became dialysis-dependent and one patient developed sepsis and expired shortly after biopsy. Within the total cohort of 118 patients with cirrhosis, 67 others also showed IgA deposits, albeit small; and 42 patients had no IgA deposits. Conclusions These cases provide support to the theory that liver dysfunction may compromise clearance of circulating immune complexes, enabling deposition in the kidney. At least in a subset of cirrhotic patients, a superimposed bacterial infection may serve as a "second-hit" and lead to acute glomerulonephritis with exuberant immune complex deposits. Therefore, a trial of antibiotics is recommended and caution is advised before immunosuppressive treatment is offered. Unfortunately, most of these patients have advanced liver failure; therefore both diagnosis and management remain a challenge.	[Hemminger, Jessica; Arole, Vidya; Brodsky, Sergey V.; Nadasdy, Tibor; Satoskar, Anjali A.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Div Renal & Transplant Pathol, Columbus, OH 43210 USA; [Ayoub, Isabelle] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Div Nephrol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Satoskar, AA (corresponding author), Ohio State Univ, Dept Pathol, Wexner Med Ctr, Div Renal & Transplant Pathol, Columbus, OH 43210 USA.	Anjaii.Satoskar@osumn.edu	brodsky, sergey/AAU-3507-2021; Satoska, Anjali/U-6053-2019	Satoskar, Anjali/0000-0002-3332-0161				AREND WP, 1972, J EXP MED, V136, P514, DOI 10.1084/jem.136.3.514; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Berger J, 1977, Adv Nephrol Necker Hosp, V7, P3; Boils CL, 2015, KIDNEY INT, V87, P1241, DOI 10.1038/ki.2014.424; Bu R, 2015, AM J NEPHROL, V41, P98, DOI 10.1159/000377684; BURGESS JB, 1992, HEPATOLOGY, V15, P702, DOI 10.1002/hep.1840150425; D'Agati V, 2014, RENAL DIS SYSTEMIC L; ENDO Y, 1983, ACTA PATHOL JAPON, V33, P333; FUKUDA Y, 1982, ACTA PATHOL JAPON, V32, P561; GHABRA N, 1991, CLIN NEPHROL, V35, P6; HAAKENSTAD AO, 1974, J IMMUNOL, V112, P1939; Haas M., 2014, IGA NEPHROPATHY IGA; KAWAGUCHI K, 1986, HUM PATHOL, V17, P1137, DOI 10.1016/S0046-8177(86)80419-1; MONTOLIU J, 1986, AM J NEPHROL, V6, P199, DOI 10.1159/000167116; NAKAMOTO Y, 1981, VIRCHOWS ARCH A, V392, P45, DOI 10.1007/BF00430547; Nasr SH, 2013, KIDNEY INT, V83, P792, DOI 10.1038/ki.2012.407; NEWELL GC, 1987, AM J KIDNEY DIS, V9, P183, DOI 10.1016/S0272-6386(87)80053-7; Nochy D, 1976, Clin Nephrol, V6, P422; Pouria S, 1999, NEPHROL DIAL TRANSPL, V14, P2279, DOI 10.1093/ndt/14.10.2279; RIFAI A, 1984, J EXP MED, V160, P125, DOI 10.1084/jem.160.1.125; SANCHO J, 1984, IMMUNOLOGY, V53, P283; SANCHO J, 1982, CLIN EXP IMMUNOL, V47, P327; Satoskar A, 2014, POSTINFECTIOUS INFEC, V7th; Satoskar AA, 2006, CLIN J AM SOC NEPHRO, V1, P1179, DOI 10.2215/CJN.01030306; Satoskar AA, 2017, CLIN J AM SOC NEPHRO, V12, P39, DOI 10.2215/CJN.05070516; Sethi S, 2016, J AM SOC NEPHROL, V27, P1278, DOI 10.1681/ASN.2015060612; SILVAIN C, 1995, J IMMUNOL, V155, P1606; Sise ME, 2016, KIDNEY INT REP, V1, P135, DOI 10.1016/j.ekir.2016.06.006; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Takada D, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0769-1	30	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193274	10.1371/journal.pone.0193274	http://dx.doi.org/10.1371/journal.pone.0193274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634718	gold, Green Submitted, Green Published			2022-12-27	WOS:000429522200001
J	Madsen, JK; Pilditch, TD				Madsen, Jens Koed; Pilditch, Toby D.			A method for evaluating cognitively informed micro-targeted campaign strategies: An agent-based model proof of principle	PLOS ONE			English	Article							SOURCE CREDIBILITY; DYNAMICS; WARMTH	In political campaigns, perceived candidate credibility influences the persuasiveness of messages. In campaigns aiming to influence people's beliefs, micro-targeted campaigns (MTCs) that target specific voters using their psychological profile have become increasingly prevalent. It remains open how effective MTCs are, notably in comparison to population-targeted campaign strategies. Using an agent-based model, the paper applies recent insights from cognitive models of persuasion, extending them to the societal level in a novel framework for exploring political campaigning. The paper provides an initial treatment of the complex dynamics of population level political campaigning in a psychologically informed manner. Model simulations show that MTCs can take advantage of the psychology of the electorate by targeting voters favourable disposed towards the candidate. Relative to broad campaigning, MTCs allow for efficient and adaptive management of complex campaigns. Findings show that disliked MTC candidates can beat liked population-targeting candidates, pointing to societal questions concerning campaign regulations.	[Madsen, Jens Koed] Univ Oxford, Sch Geog & Environm, Oxford, England; [Pilditch, Toby D.] UCL, Dept Expt Psychol, London, England	University of Oxford; University of London; University College London	Madsen, JK (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford, England.	jens.madsen@ouce.ox.ac.uk		Madsen, Jens Koed/0000-0003-2405-8496				Acemoglu D, 2011, DYN GAMES APPL, V1, P3, DOI 10.1007/s13235-010-0004-1; [Anonymous], 2007, INFLUENCE PSYCHOL PE; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; Ayres I, 1992, RESPONSIVE REGULATIO, P21; Bandini S, 2009, JASSS-J ARTIF SOC S, V12, pA51; Bimber B, 2014, J INF TECHNOL POLITI, V11, P130, DOI 10.1080/19331681.2014.895691; Bloom PB, 2011, POLIT PSYCHOL, V32, P643, DOI 10.1111/j.1467-9221.2011.00826.x; Bovens L, 2003, BAYESIAN EPISTEMOLOG; Brinol P, 2009, EUR REV SOC PSYCHOL, V20, P49, DOI 10.1080/10463280802643640; CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037/0022-3514.66.3.460; Citrin Jack., 1999, MEASURES POLITICAL A, P465, DOI DOI 10.1016/J.TOURMAN.2010.08.016; Cook J, 2016, TOP COGN SCI, V8, P160, DOI 10.1111/tops.12186; Corner A. J., 2009, INFORMAL LOG, V29, P337, DOI [10.22329/il. v29i4.2903, DOI 10.22329/IL.V29I4.2903]; Cuddy AJC, 2011, RES ORGAN BEHAV, V31, P73, DOI 10.1016/j.riob.2011.10.004; Dermody J, 2010, EUR J MARKETING, V44, P421, DOI 10.1108/03090561011020507; Duggins PA, 2017, 14067770 ARXIV; Epstein J.M., 1996, GROWING ARTIFICIAL S; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fukuyama F., 1995, TRUST; Gilbert N., 2008, AGENT BASED MODELS; Hahn U., 2008, INFORMAL LOG, V26, P1, DOI [https://doi.org/10.22329/il.v26i1.428, DOI 10.22329/IL.V26I1.428]; Hahn U., 2012, BAYESIAN ARGUMENTATI, P15; Hahn U, 2007, PSYCHOL REV, V114, P704, DOI 10.1037/0033-295X.114.3.704; Haidt J., 2012, RIGHTEOUS MIND WHY G; Harris AJL, 2016, COGNITIVE SCI, V40, P1496, DOI 10.1111/cogs.12276; Housholder EE, 2014, J INF TECHNOL POLITI, V11, P368, DOI 10.1080/19331681.2014.951753; Issenberg S, 2012, VICTORY LAB SECRET S; Jager W., 2004, COMPUTATIONAL MATH O, V10, P295, DOI DOI 10.1007/S10588-005-6282-2; Jern A., 2009, ADV NEURAL INFORM PR, V22; Lagnado D. A., 2012, ARGUMENT COMPUTATION, V4, P1; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Lupton RN, 2015, POLIT PSYCHOL, V36, P399, DOI 10.1111/pops.12102; Madsen J.K., 2017, P 39 ANN C COGN SCI, P2657; Madsen J. K., 2016, P 38 ANN C COGN SCI, P165; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Oaksford M., 2007, BAYESIAN RATIONALITY; Parunak HV, 1998, LECT NOTES ARTIF INT, V1534, P10; Petty R. E., 1981, ATTITUDES PERSUASION; PETTY RE, 1984, J PERS SOC PSYCHOL, V46, P69, DOI 10.1037/0022-3514.46.1.69; Pilditch T., 2017, P 39 ANN C COGN SCI, P943	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193909	10.1371/journal.pone.0193909	http://dx.doi.org/10.1371/journal.pone.0193909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634722	Green Published, gold			2022-12-27	WOS:000429522200005
J	Nualnoi, T; Kirosingh, A; Basallo, K; Hau, D; Gates-Hollingsworth, MA; Thorkildson, P; Crump, RB; Reed, DE; Pandit, S; AuCoin, DP				Nualnoi, Teerapat; Kirosingh, Adam; Basallo, Kaitlin; Hau, Derrick; Gates-Hollingsworth, Marcellene A.; Thorkildson, Peter; Crump, Reva B.; Reed, Dana E.; Pandit, Sujata; AuCoin, David P.			Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis Iipopolysaccharide	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; POTENTIAL AGENT; O-ANTIGEN; TULAREMIA; IGG; LIPOPOLYSACCHARIDE; BIOTERRORISM; EPIDEMIOLOGY; DIAGNOSIS; EVOLUTION	The CDC Tier 1 select agent Francisella tularensis is a small, Gram-negative bacterium and the causative agent of tularemia, a potentially life-threatening infection endemic in the United States, Europe and Asia. Currently, there is no licensed vaccine or rapid point-of care diagnostic test for tularemia. The purpose of this research was to develop monoclonal antibodies (mAbs) specific to the F. tularensis surface-expressed lipopolysaccharide (LPS) for a potential use in a rapid diagnostic test. Our initial antigen capture ELISA was developed using murine IgG3 mAb 1A4. Due to the low sensitivity of the initial assay, IgG subclass switching, which is known to have an effect on the functional affinity of a mAb, was exploited for the purpose of enhancing assay sensitivity. The ELISA developed using the IgG1 or IgG2b mAbs from the subclass-switch family of 1A4 IgG3 yielded improved assay sensitivity. However, surface plasmon resonance (SPR) demonstrated that the functional affinity was decreased as a result of subclass switching. Further investigation using direct ELISA revealed the potential self-association of 1A4 IgG3, which could explain the higher functional affinity and higher assay background seen with this mAb. Additionally, the higher assay background was found to negatively affect assay sensitivity. Thus, enhancement of the assay sensitivity by subclass switching is likely due to the decrease in assay background, simply by avoiding the self-association of IgG3.	[Nualnoi, Teerapat; Kirosingh, Adam; Basallo, Kaitlin; Hau, Derrick; Gates-Hollingsworth, Marcellene A.; Thorkildson, Peter; Crump, Reva B.; Reed, Dana E.; Pandit, Sujata; AuCoin, David P.] Univ Nevada, Dept Microbiol & Immunol, Reno Sch Med, Reno, NV 89557 USA; [Nualnoi, Teerapat] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Hat Yai, Thailand; [Basallo, Kaitlin] InBios Int Inc, Seattle, WA USA; [Crump, Reva B.] Univ Nevada, Dept Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Prince of Songkla University; Nevada System of Higher Education (NSHE); University of Nevada Reno	AuCoin, DP (corresponding author), Univ Nevada, Dept Microbiol & Immunol, Reno Sch Med, Reno, NV 89557 USA.	daucoin@med.unr.edu	; Nualnoi, Teerapat/G-9819-2017	Kirosingh, Adam/0000-0003-0500-9269; Hau, Derrick/0000-0002-4301-6403; Nualnoi, Teerapat/0000-0003-3294-1975	National Institute of Allergy and Infectious Diseases [U54AI065359]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (U54AI065359) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) to DPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti PE, 2003, BIOTECHNIQUES, V35, P850, DOI 10.2144/03354ss02; Barker JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157842; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chaignat V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-234; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1991, J IMMUNOL, V146, P2659; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dillon MJ, 2016, VIRULENCE, V7, P691, DOI 10.1080/21505594.2016.1176655; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Dulay SB, 2014, ANAL BIOANAL CHEM, V406, P4685, DOI 10.1007/s00216-014-7860-2; Franek M, 2001, ANAL CHIM ACTA, V444, P131, DOI 10.1016/S0003-2670(01)01162-X; Fukui T, 2004, LAB INVEST, V84, P485, DOI 10.1038/labinvest.3700056; GREENSPAN NS, 1992, IMMUNOL TODAY, V13, P164, DOI 10.1016/0167-5699(92)90120-V; Grunow R, 2000, CLIN DIAGN LAB IMMUN, V7, P86, DOI 10.1128/CDLI.7.1.86-90.2000; Gunnell MK, 2016, CURR ISSUES MOL BIOL, V18, P79; Harik NS, 2013, PEDIATR ANN, V42, P288, DOI 10.3928/00904481-20130619-13; Houghton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002727; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Maurin M, 2015, EXPERT REV ANTI-INFE, V13, P141, DOI 10.1586/14787210.2015.986463; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Nuti DE, 2011, MBIO, V2, DOI 10.1128/mBio.00136-11; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PERLMUTTER RM, 1978, J IMMUNOL, V121, P566; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rowe HM, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00094; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Splettstoesser WD, 2005, J VET MED B, V52, P249, DOI 10.1111/j.1439-0450.2005.00863.x; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Ulu-Kilic A, 2014, TRAVEL MED INFECT DI, V12, P609, DOI 10.1016/j.tmaid.2014.10.007; Wagar E, 2016, CLIN MICROBIOL REV, V29, P175, DOI 10.1128/CMR.00033-15; World Health Organization, 2007, WHO GUIDELINES TULAR; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195308	10.1371/journal.pone.0195308	http://dx.doi.org/10.1371/journal.pone.0195308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630613	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000039
J	van der Star, BJ; van Dijk, CE; Zock, JP; Smit, LAM; Baliatsas, C; Heederik, DJJ; Yzermans, CJ				van der Star, Baukje J.; van Dijk, Christel E.; Zock, Jan-Paul; Smit, Lidwien A. M.; Baliatsas, Christos; Heederik, Dick J. J.; Yzermans, C. Joris			Healthcare utilisation prior to the diagnosis of inflammatory bowel diseases and the influence of livestock exposure: A longitudinal case-control study	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; FARMS; PREVALENCE; RESIDENTS; SYMPTOMS; EUROPE; COHORT; DELAY; COPD	An increased prevalence of the inflammatory bowel diseases, ulcerative colitis and Crohn's disease, was found amongst residents in a livestock dense area. We hypothesised that exposure to livestock farms might be a substantial environmental factor that contributes to the development of these diseases and that in the lead up to inflammatory bowel diseases potential risk factors can be identified. This study aimed to investigate the contribution of livestock exposure to the development of these diseases and the clinical events prior to the diagnosis. Electronic health records from 2006-2013 of general practices were used. The study population consisted of patients with a new diagnosis of inflammatory bowel diseases resident in areas with a high (n = 141) or lower (n = 109) livestock density. Patients with low back pain (n = 10,469) were used as controls. For those in a livestock dense area, distance to livestock farms was determined. Associations between morbidities and drug prescriptions in the reporting year and three years previous to the diagnosis, and the residential proximity to livestock exposure were investigated with multivariable logistic regression analyses. Acute and chronic morbidity of the gastrointestinal tract and associated drug prescriptions were predictive for the development of inflammatory bowel diseases. In addition, a positive association was found between infections and living within 500 meter of poultry farms and the development of inflammatory bowel diseases [OR: 3.3 (1.1-9.9)]. Nonetheless, overall livestock exposure contributed little to the development of these diseases. These results suggest that exposure to livestock farms on its own contributes minimal to the development of inflammatory bowel diseases. Nonetheless, having infections appeared to be a risk factor for neighbouring residents of poultry farms. More research is warranted to explain the increased prevalence of inflammatory bowel diseases amongst residents in areas with a high density of livestock.	[van der Star, Baukje J.; van Dijk, Christel E.; Zock, Jan-Paul; Baliatsas, Christos; Yzermans, C. Joris] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Smit, Lidwien A. M.; Heederik, Dick J. J.] Univ Utrecht, IRAS, Utrecht, Netherlands; [van der Star, Baukje J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Star, BJ (corresponding author), NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.; van der Star, BJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	b.vanderstar@vumc.nl	Smit, Lidwien AM/AFC-8689-2022; Zock, Jan-Paul/P-5034-2018	Smit, Lidwien AM/0000-0003-0292-0946; Zock, Jan-Paul/0000-0002-2941-6259; Heederik, Dick/0000-0002-4550-1437	Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"); Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health)	Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"); Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health)	This work was supported by the Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"), and the Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health) to CEVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar T, 2014, CLIN IMMUNOL, V153, P199, DOI 10.1016/j.clim.2014.04.012; Bamias G, 2005, ANN INTERN MED, V143, P895, DOI 10.7326/0003-4819-143-12-200512200-00007; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Boneberger A, 2011, J CROHNS COLITIS, V5, P525, DOI 10.1016/j.crohns.2011.04.012; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Brassard P, 2015, EUR RESPIR J, V45, P962, DOI 10.1183/09031936.00079414; Burisch J, 2014, J CROHNS COLITIS, V8, P607, DOI 10.1016/j.crohns.2013.11.021; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Cohen AD, 2009, J EUR ACAD DERMATOL, V23, P561, DOI 10.1111/j.1468-3083.2008.03031.x; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Haapamaki J, 2011, J CROHNS COLITIS, V5, P41, DOI 10.1016/j.crohns.2010.09.008; Heederik D., 2011, MOGELIJKE EFFECTEN I; Hooiveld M, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0123-2; Hutfless S, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/690581; Jeziorska M, 2001, J PATHOL, V194, P484, DOI 10.1002/path.904; Kariyawasam VC, 2014, INFLAMM BOWEL DIS, V20, P1382, DOI 10.1097/MIB.0000000000000119; Lamberts H., 1987, ICPC INT CLASSIFICAT; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3458; Prins M, 2015, ZORG HUISARTS JAARCI; Radon K, 2007, PEDIATRICS, V120, P354, DOI 10.1542/peds.2006-3624; Raj AA, 2008, RESP MED, V102, P780, DOI 10.1016/j.rmed.2007.08.014; Schoepfer AM, 2013, AM J GASTROENTEROL, V108, P1744, DOI 10.1038/ajg.2013.248; Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230; Timm S, 2014, EUR J EPIDEMIOL, V29, P429, DOI 10.1007/s10654-014-9922-3; van Dijk CE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0421-3; van Dooren C., 2016, 10 INT C LIF CYCL AS; van Gils-van Rooij ESJ, 2015, J AM BOARD FAM MED, V28, P807, DOI 10.3122/jabfm.2015.06.140261; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; WHOCC, 2014, GUID ATC CLASS DDD A	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195305	10.1371/journal.pone.0195305	http://dx.doi.org/10.1371/journal.pone.0195305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630633	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000038
J	Abdollahi, S; Davis, A; Miller, JH; Feinberg, AW				Abdollahi, Sara; Davis, Alexander; Miller, John H.; Feinberg, Adam W.			Expert-guided optimization for 3D printing of soft and liquid materials	PLOS ONE			English	Article							TOPOLOGY OPTIMIZATION; ORIENTATION; DESIGN	Additive manufacturing (AM) has rapidly emerged as a disruptive technology to build mechanical parts, enabling increased design complexity, low-cost customization and an ever-increasing range of materials. Yet these capabilities have also created an immense challenge in optimizing the large number of process parameters in order achieve a high-performance part. This is especially true for AM of soft, deformable materials and for liquid-like resins that require experimental printing methods. Here, we developed an expert-guided optimization (EGO) strategy to provide structure in exploring and improving the 3D printing of liquid polydimethylsiloxane (PDMS) elastomer resin. EGO uses three steps, starting first with expert screening to select the parameter space, factors, and factor levels. Second is a hill-climbing algorithm to search the parameter space defined by the expert for the best set of parameters. Third is expert decision making to try new factors or a new parameter space to improve on the best current solution. We applied the algorithm to two calibration objects, a hollow cylinder and a five-sided hollow cube that were evaluated based on a multi-factor scoring system. The optimum print settings were then used to print complex PDMS and epoxy 3D objects, including a twisted vase, water drop, toe, and ear, at a level of detail and fidelity previously not obtained.	[Abdollahi, Sara; Feinberg, Adam W.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Abdollahi, Sara; Davis, Alexander] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Miller, John H.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Miller, John H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Feinberg, Adam W.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; The Santa Fe Institute; Carnegie Mellon University	Feinberg, AW (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.; Feinberg, AW (corresponding author), Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.	feinberg@andrew.cmu.edu	Hudson, Andrew/ABC-1122-2021; Feinberg, Adam W/AAM-8547-2020; Feinberg, Adam W/A-7103-2009; Miller, John J/GZG-5663-2022	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; 	Disruptive Health Technology Institute, Carnegie Mellon University [A017261-HIGHMARK-Feinberg]	Disruptive Health Technology Institute, Carnegie Mellon University	This work was funded by the Disruptive Health Technology Institute, Carnegie Mellon University (A017261-HIGHMARK-Feinberg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadi-Eydivand M, 2016, APPL SOFT COMPUT, V39, P36, DOI 10.1016/j.asoc.2015.11.011; Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655; Compton BG, 2014, ADV MATER, V26, P5930, DOI 10.1002/adma.201401804; Dawes RM., 1993, HDB DATA ANAL BEHAV, P351; Ghorpade A, 2007, P I MECH ENG B-J ENG, V221, P1209, DOI 10.1243/09544054JEM771; Hinton TJ, 2016, ACS BIOMATER SCI ENG, V2, P1781, DOI 10.1021/acsbiomaterials.6b00170; Hinton TJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500758; Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017; Langelaar M, 2016, ADDIT MANUF, V12, P60, DOI 10.1016/j.addma.2016.06.010; Li WD, 2007, INT J COMPUT INTEG M, V20, P80, DOI 10.1080/09511920600667366; Lind JU, 2017, NAT MATER, V16, P303, DOI [10.1038/NMAT4782, 10.1038/nmat4782]; Majewski C, 2011, EVOLUTIONARY COMPUTI, P197; Mohamed OA, 2015, ADV MANUF, V3, P42, DOI 10.1007/s40436-014-0097-7; O'Bryan CS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602800; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Saadlaoui Y, 2017, J MANUF SYST, V43, P178, DOI 10.1016/j.jmsy.2017.03.006; Sood AK, 2009, MATER DESIGN, V30, P4243, DOI 10.1016/j.matdes.2009.04.030; Thrimurthulu K, 2004, INT J MACH TOOL MANU, V44, P585, DOI 10.1016/j.ijmachtools.2003.12.004; Torrado AR, 2016, J FAIL ANAL PREV, V16, P154, DOI 10.1007/s11668-016-0067-4; Torres CMS, 2003, NAN SCI TEC, P1; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; Wang CC, 2007, RAPID PROTOTYPING J, V13, P304, DOI 10.1108/13552540710824814; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937	24	39	39	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194890	10.1371/journal.pone.0194890	http://dx.doi.org/10.1371/journal.pone.0194890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621286	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800028
J	Chanani, S; Waingankar, A; More, NS; Pantvaidya, S; Fernandez, A; Jayaraman, A				Chanani, Sheila; Waingankar, Anagha; More, Neena Shah; Pantvaidya, Shanti; Fernandez, Armida; Jayaraman, Anuja			Participation of pregnant women in a community-based nutrition program in Mumbai's informal settlements: Effect on exclusive breastfeeding practices	PLOS ONE			English	Article							PROMOTION INTERVENTIONS; PEER COUNSELORS; DETERMINANTS; EFFICACY; GROWTH; INDIA; BIRTH	Background In urban Maharashtra, India, approximately half of mothers exclusively breastfeed. For children residing in informal settlements of Mumbai, this study examines factors associated with exclusive breastfeeding, and whether exclusive breastfeeding, in a community-based nutrition program to prevent and treat wasting among children under age three, is associated with enrolment during the mother's pregnancy. Methods The nutrition program conducted a cross-sectional endline survey (October-December 2015) of caregivers in intervention areas. Factors associated with exclusive breastfeeding for infants under six months of age were explored using multi-level logistic regressions. Additionally, program surveillance data collected during home-based counselling visits documented breastfeeding practices for children under six months of age. Using the surveillance data (January 2014-March 2016), exclusive breastfeeding status was regressed adjusting for child, maternal and socioeconomic characteristics, and whether the child was enrolled in the program in utero or after birth. Results The community-based endline survey included 888 mothers of infants. Mothers who received the nutrition program home visits or attended group counselling sessions were more likely to exclusively breastfeed (adjusted odds ratio 1.67, 95% CI 1.16, 2.41). Having a normal weight-for-height z-score (adjusted odds ratio 1.57, 95% CI 1.00, 2.45) was associated positively with exclusive breastfeeding. As expected, being an older infant aged three to five months (adjusted odds ratio 0.34, 95% CI 0.25, 0.48) and receiving a prelacteal feed after birth (adjusted odds ratio 0.57, 95% CI 0.41, 0.80) were associated with lower odds of exclusively breastfeeding. Surveillance data (N = 3420) indicate that infants enrolled in utero have significantly higher odds of being exclusively breastfed (adjusted odds ratio 1.55, 95% CI 1.30, 1.84) than infants enrolled after birth. Conclusions Prenatal enrolment in community-based programs working on child nutrition in urban informal settlements of India can improve exclusive breastfeeding practices.	[Chanani, Sheila; Waingankar, Anagha; More, Neena Shah; Pantvaidya, Shanti; Fernandez, Armida; Jayaraman, Anuja] Soc Nutr Educ & Hlth Act, Bombay, Maharashtra, India		Chanani, S (corresponding author), Soc Nutr Educ & Hlth Act, Bombay, Maharashtra, India.	sheila.chanani@gmail.com		Chanani, Sheila/0000-0001-8518-3114	Forbes Marshall Foundation; Quadrivium Foundation	Forbes Marshall Foundation; Quadrivium Foundation	Funding for analysis, interpretation of data, and dissemination of program findings came from Forbes Marshall Foundation and Quadrivium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts C, 2000, INT J EPIDEMIOL, V29, P1041, DOI 10.1093/ije/29.6.1041; Achadi E, 2016, GLOBAL NUTR REPORT 2; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Chandhiok N, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0059-0; Commissioner C Road M., 2011, CENS IND 2011 PROV P; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dyson P, 2012, TOURISM GEOGR, V14, P254, DOI 10.1080/14616688.2011.609900; Ezeh A, 2016, LANCET, V6736, P1, DOI DOI 10.1016/50140-6736(16)31650-6; Giugliani ERJ, 2015, ACTA PAEDIATR, V104, P20, DOI 10.1111/apa.13160; Gupta A, 2010, INDIAN J PEDIATR, V77, P413, DOI 10.1007/s12098-010-0049-6; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Heikens GT, 2008, LANCET, V371, P181, DOI 10.1016/S0140-6736(07)61691-2; Hunegnaw MT, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0121-1; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; International Institute for Population Sciences, 2016, NAT FAM HLTH SURV 4; Johns Hopkins Bloomberg School of Public Health, 2016, 2016 PNEUM DIARRH PR; Kerac M, 2015, FOOD NUTR BULL, V36, pS30, DOI 10.1177/15648265150361S105; Kronborg H, 2007, ACTA PAEDIATR, V96, P1064, DOI 10.1111/j.1651-2227.2007.00341.x; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Leroy JL, 2008, J NUTR, V138, P628, DOI 10.1093/jn/138.3.628; Malhotra R, 2008, MATERN CHILD NUTR, V4, P181, DOI 10.1111/j.1740-8709.2007.00130.x; McKenna KM, 2009, J MIDWIFERY WOM HEAL, V54, P78, DOI 10.1016/j.jmwh.2008.07.012; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; More NS, 2018, GLOB HEALTH-SCI PRAC, V6, P103, DOI 10.9745/GHSP-D-17-00182; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Pagel C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-151; Patel A, 2010, FOOD NUTR BULL, V31, P314, DOI 10.1177/156482651003100221; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sachdev H P, 1995, Indian Pediatr, V32, P1287; Setegn T, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-17; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Thakur SK, 2012, EUR J CLIN NUTR, V66, P376, DOI 10.1038/ejcn.2011.182; Tiwari R, 2009, J TROP PEDIATRICS, V55, P49, DOI 10.1093/tropej/fmn037; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; UN-Habitat, 2016, INT J, DOI [10.1016/S0264-2751(03)00010-6, DOI 10.1016/S0264-2751(03)00010-6]; UNICEF, 2016, STATE WORLDS CHILDRE; USAID, 2017, COM BAS MAN AC MALN; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organisation WHO: Maternal I Health C, 2013, ESS NUTR ACT IMPR MA, P144; World Health Organization, 1998, EV 10 STEPS SUCC BRE, V23, P1; World Health Organization; United Nations Children's Fund (UNICEF), 2017, 1000 DAYS A T NURT H; 2013, Lancet, V13, P1	47	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195619	10.1371/journal.pone.0195619	http://dx.doi.org/10.1371/journal.pone.0195619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621355	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800108
J	Dalum, HS; Waldemar, AK; Korsbek, L; Hjorthoj, C; Mikkelsen, JH; Thomsen, K; Kistrup, K; Olander, M; Lindschou, J; Nordentoft, M; Eplov, LF				Dalum, Helle Stentoft; Waldemar, Anna Kristine; Korsbek, Lisa; Hjorthoj, Carsten; Mikkelsen, John Hegel; Thomsen, Karin; Kistrup, Kristen; Olander, Mette; Lindschou, Jane; Nordentoft, Merete; Eplov, Lene Falgaard			Illness management and recovery: Clinical outcomes of a randomized clinical trial in community mental health centers	PLOS ONE			English	Article							GLOBAL ASSESSMENT; RATING-SCALE; INTERVENTION; RELIABILITY; PROGRAM; SAMPLE; GAF	Objective Illness Management and Recovery (IMR) is a psychosocial intervention with a recovery-oriented approach. The program has been evaluated in different settings; however evidence for the effects of IMR is still deficient. The aim of this trial was to investigate the benefits and harms of the IMR program compared with treatment as usual in Danish patients with schizophrenia or bipolar disorder. Method The trial was designed as a randomized, assessor-blinded, multi-center, clinical trial investigating the IMR program compared with usual treatment. 198 people diagnosed with schizophrenia or bipolar disorder participated. The primary outcome was the Global Assessment of Functioning (GAF-F) at the end of intervention and the secondary and explorative outcomes included severity of symptoms and service utilization. Results IMR had no significant effect on functioning, symptoms, substance use or service utilization. Conclusion This randomized trial contributes to the evidence base of IMR by providing a methodological solid base for its conclusions; however the trial has some important limitations. More research is needed to get a firm answer on the effectiveness of the IMR.	[Dalum, Helle Stentoft; Mikkelsen, John Hegel; Kistrup, Kristen] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Frederiksberg, Copenhagen, Denmark; [Dalum, Helle Stentoft] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Ballerup, Copenhagen, Denmark; [Waldemar, Anna Kristine; Korsbek, Lisa] Mental Hlth Serv Capital Reg Denmark, Competence Ctr Recovery & Rehabil, Mental Hlth Ctr Ballerup, Copenhagen, Denmark; [Hjorthoj, Carsten; Nordentoft, Merete; Eplov, Lene Falgaard] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Copenhagen, Res Unit, Copenhagen, Denmark; [Thomsen, Karin] Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Hvidovre, Copenhagen, Denmark; [Olander, Mette] Municipal Roskilde, Roskilde, Denmark; [Lindschou, Jane] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Eplov, LF (corresponding author), Mental Hlth Serv Capital Reg Denmark, Mental Hlth Ctr Copenhagen, Res Unit, Copenhagen, Denmark.	Lena.Falgaard.Eplov@regionh.dk	Nordentoft, Merete/AAH-3253-2019; Waldemar, Anna Kristine/AAV-5058-2021	Waldemar, Anna Kristine/0000-0003-2581-1662; Eplov, Lene/0000-0002-9334-8692; Nordentoft, Merete/0000-0003-4895-7023	Mental Health Centre Frederiksberg; Mental Health Centre Ballerup; HSD in pH.d; Danish Health Fund	Mental Health Centre Frederiksberg; Mental Health Centre Ballerup; HSD in pH.d; Danish Health Fund	This RTC was founded by the Danish Health Fund who supported the research team (the Ph.d.-project), Mental Health Centre Frederiksberg and Mental Health Centre Ballerup who supported the interventions and the research. And finally Capital Region of Denmark supported HSD in pH.d.; This trial was founded by the Danish Health Fund, Mental Health Center Ballerup, Mental Health Center Frederiksberg and the Capital Region of Denmark. We are grateful for the participation of the patients and the assistance of the clinical staff in each community mental health centers, and for the help from Ann-Lis Gregersen for text revision.	Amri I, 2014, VALUE HEALTH, V17, pA765, DOI 10.1016/j.jval.2014.08.285; Bero L, 2013, JAMA INTERN MED, V173, P580, DOI 10.1001/jamainternmed.2013.4190; Burns T, 2007, ACTA PSYCHIAT SCAND, V116, P403, DOI 10.1111/j.1600-0447.2007.01108.x; COOPER JE, 1977, PSYCHOL MED, V7, P517, DOI 10.1017/S0033291700004499; Dalum HS, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-195; Dalum HS, 2016, J MENT HEALTH, P1; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fardig R, 2011, PSYCHIAT SERV, V62, P606, DOI 10.1176/ps.62.6.pss6206_0606; Gingerich S., 2005, EVIDENCE BASED MENTA, P395; Haddock G, 2003, BRIT J PSYCHIAT, V183, P418, DOI 10.1192/bjp.183.5.418; Hasson-Ohayon I, 2007, PSYCHIAT SERV, V58, P1461, DOI 10.1176/appi.ps.58.11.1461; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hooper CL, 2000, J PSYCHIATR NEUROSCI, V25, P178; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Korsbek L, 2014, COCHRANE DATABASE SY; Lecrubier Y, 2007, EUR PSYCHIAT, V22, P252, DOI 10.1016/j.eurpsy.2007.01.1218; Levitt AJ, 2009, PSYCHIAT SERV, V60, P1629, DOI 10.1176/ps.2009.60.12.1629; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; McGuire AB, 2013, PSYCHIAT RES, V210, P684, DOI 10.1016/j.psychres.2013.08.008; Merinder LB, 1999, SOC PSYCH PSYCH EPID, V34, P287, DOI 10.1007/s001270050146; Mueser KT, 2006, SCHIZOPHRENIA BULL, V32, pS32, DOI 10.1093/schbul/sbl022; Mueser KT, 2002, PSYCHIAT SERV, V53, P1272, DOI 10.1176/appi.ps.53.10.1272; Pedersen G, 2007, COMPR PSYCHIAT, V48, P88, DOI 10.1016/j.comppsych.2006.03.008; Pedersen G, 2012, COMPR PSYCHIAT, V53, P292, DOI 10.1016/j.comppsych.2011.04.007; Piersma HL, 1997, COMMUNITY MENT HLT J, V33, P35, DOI 10.1023/A:1022413110345; Salyers MP, 2014, PSYCHIAT SERV, V65, P1005, DOI 10.1176/appi.ps.201300354; Salyers MP, 2010, COMMUNITY MENT HLT J, V46, P319, DOI 10.1007/s10597-009-9284-6; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	30	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194027	10.1371/journal.pone.0194027	http://dx.doi.org/10.1371/journal.pone.0194027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621284	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800013
J	de la Rubia, E; Diaz-Estrella, A; Reyes-Lecuona, A; Langley, A; Brown, M; Sharples, S				de la Rubia, Ernesto; Diaz-Estrella, Antonio; Reyes-Lecuona, Arcadio; Langley, Alyson; Brown, Michael; Sharples, Sarah			Natural locomotion based on a reduced set of inertial sensors: Decoupling body and head directions indoors	PLOS ONE			English	Article							REALITY	Inertial sensors offer the potential for integration into wireless virtual reality systems that allow the users to walk freely through virtual environments. However, owing to drift errors, inertial sensors cannot accurately estimate head and body orientations in the long run, and when walking indoors, this error cannot be corrected by magnetometers, due to the magnetic field distortion created by ferromagnetic materials present in buildings. This paper proposes a technique, called EHBD (Equalization of Head and Body Directions), to address this problem using two head- and shoulder-located magnetometers. Due to their proximity, their distortions are assumed to be similar and the magnetometer measurements are used to detect when the user is looking straight forward. Then, the system corrects the discrepancies between the estimated directions of the head and the shoulder, which are provided by gyroscopes and consequently are affected by drift errors. An experiment is conducted to evaluate the performance of this technique in two tasks (navigation and navigation plus exploration) and using two different locomotion techniques: (1) gaze-directed mode (GD) in which the walking direction is forced to be the same as the head direction, and (2) decoupled direction mode (DD) in which the walking direction can be different from the viewing direction. The obtained results show that both locomotion modes show similar matching of the target path during the navigation task, while DD's path matches the target path more closely than GD in the navigation plus exploration task. These results validate the EHBD technique especially when allowing different walking and viewing directions in the navigation plus exploration tasks, as expected. While the proposed method does not reach the accuracy of optical tracking (ideal case), it is an acceptable and satisfactory solution for users and is much more compact, portable and economical.	[de la Rubia, Ernesto; Diaz-Estrella, Antonio; Reyes-Lecuona, Arcadio] Univ Malaga, Dept Tecnol Elect, Escuela Tecn Super Ingn Telecomunicac, Campus Teatinos, Malaga, Spain; [Langley, Alyson; Brown, Michael; Sharples, Sarah] Univ Nottingham, Human Factors Res Grp, Fac Engn, Nottingham, England	Universidad de Malaga; University of Nottingham	de la Rubia, E (corresponding author), Univ Malaga, Dept Tecnol Elect, Escuela Tecn Super Ingn Telecomunicac, Campus Teatinos, Malaga, Spain.	e@uma.es	Reyes-Lecuona, Arcadio/M-7022-2014	Reyes-Lecuona, Arcadio/0000-0002-3699-4065; Diaz Estrella, Antonio/0000-0002-2773-0113	Junta de Andalucia; project CENIT Espana Virtual, within the Ingenio program - Elecnor Deimos	Junta de Andalucia(Junta de Andalucia); project CENIT Espana Virtual, within the Ingenio program - Elecnor Deimos	This research has been supported by the Junta de Andalucia and the project CENIT Espana Virtual, within the Ingenio 2010 program, subcontracted by Elecnor Deimos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bachmann ER, 2012, 2012 17TH INTERNATIONAL CONFERENCE ON COMPUTER GAMES (CGAMES), P108, DOI 10.1109/CGames.2012.6314560; Barrie P., 2009, P 6 INT C MOB TECHN, DOI [10.1145/1710035.1710096, DOI 10.1145/1710035.1710096]; Bruder G, 2009, 3DUI : IEEE SYMPOSIUM ON 3D USER INTERFACES 2009, PROCEEDINGS, P75, DOI 10.1109/3DUI.2009.4811208; Cirio G., 2009, P 16 ACM S VIRT REAL, P155, DOI DOI 10.1145/1643928.1643965; Colosio C, 2008, FP6IST5034525 SATIN; Darken RP, 1997, ACM S US INT SOFTW T, P213; de la Rubia E., 2013, ELECTRON LETT, V49, P488; de la Rubia E, 2015, PRESENCE-VIRTUAL AUG, V24, P298, DOI 10.1162/PRES_a_00236; De Luca A, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5051, DOI 10.1109/IROS.2009.5354610; Fischer C, 2013, IEEE PERVAS COMPUT, V12, P17, DOI 10.1109/MPRV.2012.16; Fourati H, 2013, 2013 EUROPEAN CONTROL CONFERENCE (ECC), P4208; Freitag S, 2014, 2014 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P119, DOI 10.1109/3DUI.2014.6798852; Gozick B, IEEE T INSTRUMENTATI, V60, P3883; Inertial Labs, 2014, 3DSUIT MOT CAPT SYST; Intersense, 2012, 072000940D05 INT; Iwata H, 2005, IEEE COMPUT GRAPH, V25, P64, DOI 10.1109/MCG.2005.5; Iwata H, 2001, P IEEE VIRT REAL ANN, P131, DOI 10.1109/VR.2001.913779; Iwata H, ACM SIGGRAPH 2006 EM; Jiung-yao H, 2000, J COMPUTER GRAPHICS, V8, P1; Kennedy R.S., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; La Valle SM, 2017, VIRTUAL REALITY TRAC; Medina Eliana, 2008, Proceedings of the Human Factors and Ergonomics Society. 52nd Annual Meeting, P2102, DOI 10.1518/107118108X352490; Metamotion, 2014, METAMOTION IGS 190; Nabiyouni Mahdi, 2015, 2015 IEEE Symposium on 3D User Interfaces (3DUI), P3, DOI 10.1109/3DUI.2015.7131717; Neth CT, 2011, P IEEE VIRT REAL ANN, P151, DOI 10.1109/VR.2011.5759454; Nitzsche N, 2003, PROC SPIE, V5079, P265, DOI 10.1117/12.488379; Peck TC, 2011, P IEEE VIRT REAL ANN, P55, DOI 10.1109/VR.2011.5759437; Razzaque S., 2005, REDIRECTED WALKING; Roetenberg Daniel, 2009, 1 XSENS MOT TECHN BV, V1, P1; Ruddle RA, 2009, ACM T COMPUT-HUM INT, V16, DOI 10.1145/1502800.1502805; Sharples S, 2008, DISPLAYS, V29, P58, DOI 10.1016/j.displa.2007.09.005; Smit P, 2011, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-0-85729-433-3_4; Souman JL, 2011, ACM T APPL PERCEPT, V8, DOI 10.1145/2043603.2043607; Steinice F, 2008, IEEE VIRTUAL REALITY 2008, PROCEEDINGS, P291; Steinicke F, 2010, IEEE T VIS COMPUT GR, V16, P17, DOI 10.1109/TVCG.2009.62; Steinicke Frank, 2008, P ACM S VIRTUAL REAL, P149, DOI [10.1145/1450579.1450611, DOI 10.1145/1450579.1450611]; Suma EA, 2010, P IEEE VIRT REAL ANN, P305, DOI 10.1109/VR.2010.5444752; Suma EA, 2009, IEEE VIRTUAL REALITY 2009, PROCEEDINGS, P245, DOI 10.1109/VR.2009.4811037; Suryajaya M., 2009, P 16 ACM S VIRT REAL, P31; Sutherland I.E., 1965, PROC IFIP C, P506, DOI DOI 10.1109/MC.2005.274; Swapp D, 2010, IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI 2010), P71, DOI 10.1109/3DUI.2010.5444717; Vasylevska K, 2013, P IEEE VIRT REAL ANN, P109, DOI 10.1109/VR.2013.6549386; Vasylevska K, 2013, 2013 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P39, DOI 10.1109/3DUI.2013.6550194; Vincent D. E, 2012, PORTABLE INDOOR MULT; Waller D, 2007, BEHAV RES METHODS, V39, P835, DOI 10.3758/BF03192976; Williams B, 2007, APGV 2007: SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, PROCEEDINGS, P41; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Xie X., 2010, P 7 S APPL PERCEPTIO, P65, DOI [10.1145/1836248.1836260, DOI 10.1145/1836248.1836260]; XSens, 2014, MULT FULL BOD IMM VR; YEI Technology, PRIOVR 2016; Yoon J, 2006, INT J ROBOT RES, V25, P687, DOI 10.1177/0278364906067373; Zhu R, 2009, IEEE SENS J, V9, P223, DOI 10.1109/JSEN.2008.2012196	53	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195191	10.1371/journal.pone.0195191	http://dx.doi.org/10.1371/journal.pone.0195191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621298	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800047
J	Feng, QZ; Liu, ZL; Weber, SA; Li, SZ				Feng, Quanzhou; Liu, Z. Lewis; Weber, Scott A.; Li, Shizhong			Signature pathway expression of xylose utilization in the genetically engineered industrial yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; BIOMASS CONVERSION INHIBITORS; EXTERNAL RNA CONTROLS; ETHANOLOGENIC YEAST; ETHANOLIC FERMENTATION; ALCOHOLIC FERMENTATION; FUNCTIONAL EXPRESSION; HEXOSE TRANSPORTERS; PICHIA-STIPITIS; GENE-EXPRESSION	Haploid laboratory strains of Saccharomyces cerevisiae are commonly used for genetic engineering to enable their xylose utilization but little is known about the industrial yeast which is often recognized as diploid and as well as haploid and tetraploid. Here we report three unique signature pathway expression patterns and gene interactions in the centre metabolic pathways that signify xylose utilization of genetically engineered industrial yeast S. cerevisiae NRRL Y-50463, a diploid yeast. Quantitative expression analysis revealed outstanding high levels of constitutive expression of YXI, a synthesized yeast codon-optimized xylose isomerase gene integrated into chromosome XV of strain Y-50463. Comparative expression analysis indicated that the YX/was necessary to initiate the xylose metabolic pathway along with a set of heterologous xylose transporter and utilization facilitating genes including XUT4, XUT6, XKS1 and XYL2. The highly activated transketolase and transaldolase genes TKL1, TKL2, TAL1 and NQM1 as well as their complex interactions in the non oxidative pentose phosphate pathway branch were critical for the serial of sugar transformation to drive the metabolic flow into glycolysis for increased ethanol production. The significantly increased expression of the entire PRS gene family facilitates functions of the life cycle and biosynthesis superpathway for the yeast. The outstanding higher levels of constitutive expression of YXI and the first insight into the signature pathway expression and the gene interactions in the closely related centre metabolic pathways from the industrial yeast aid continued efforts for development of the next-generation biocatalyst. Our results further suggest the industrial yeast is a desirable delivery vehicle for new strain development for efficient lignocellulose-to-advanced biofuels production.	[Feng, Quanzhou; Liu, Z. Lewis; Weber, Scott A.] ARS, Bioenergy Res Unit, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; [Feng, Quanzhou; Li, Shizhong] Tsinghua Univ, Inst New Energy Technol, Beijing, Peoples R China; [Liu, Z. Lewis; Li, Shizhong] USDA MOST Joint Res Ctr Biofuels, Peoria, IL USA	United States Department of Agriculture (USDA); Tsinghua University	Liu, ZL (corresponding author), ARS, Bioenergy Res Unit, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.; Li, SZ (corresponding author), Tsinghua Univ, Inst New Energy Technol, Beijing, Peoples R China.; Liu, ZL; Li, SZ (corresponding author), USDA MOST Joint Res Ctr Biofuels, Peoria, IL USA.	ZLewis.Liu@ars.usda.gov; szli@mail.tsinghua.edu.cn						Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Applied Biosystem, 2006, USITC PUBL, V127AP05-03; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CARTER AT, 1994, YEAST, V10, P1031, DOI 10.1002/yea.320100805; Eliasson A, 2001, ENZYME MICROB TECH, V29, P288, DOI 10.1016/S0141-0229(01)00386-6; FLETCHER TS, 1992, BIOCHEMISTRY-US, V31, P1892, DOI 10.1021/bi00121a044; Fonseca C, 2011, ENZYME MICROB TECH, V48, P518, DOI 10.1016/j.enzmictec.2011.02.010; GONG CS, 1981, APPL ENVIRON MICROB, V41, P430, DOI 10.1128/AEM.41.2.430-436.1981; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hernando Y, 1999, J BIOL CHEM, V274, P12480, DOI 10.1074/jbc.274.18.12480; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Huang H, 2008, PROTEINS, V73, P1076, DOI 10.1002/prot.22237; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jin YS, 2000, J MICROBIOL BIOTECHN, V10, P564; Jin YS, 2004, APPL ENVIRON MICROB, V70, P6816, DOI 10.1128/AEM.70.11.6816-6825.2004; Johansson B, 2002, FEMS YEAST RES, V2, P277, DOI 10.1016/S1567-1356(02)00114-9; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karhumaa K, 2005, YEAST, V22, P359, DOI 10.1002/yea.1216; Karhumaa K, 2007, APPL MICROBIOL BIOT, V73, P1039, DOI 10.1007/s00253-006-0575-3; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Liu Z. L., 2011, COMPLETE CODONS OF S; Liu ZL, 2007, J MICROBIOL METH, V68, P486, DOI 10.1016/j.mimet.2006.10.014; Liu ZL, 2006, APPL MICROBIOL BIOT, V73, P27, DOI 10.1007/s00253-006-0567-3; Liu ZL, 2015, BIOENERG RES, V8, P1203, DOI 10.1007/s12155-014-9575-9; Liu ZL, 2008, BIOENERGY, P17; Liu ZL, 2009, MOL GENET GENOMICS, V282, P233, DOI 10.1007/s00438-009-0461-7; Liu ZL, 2009, J BIOTECHNOL, V143, P10, DOI 10.1016/j.jbiotec.2009.06.006; Liu ZL, 2005, APPL BIOCHEM BIOTECH, V121, P451, DOI 10.1385/ABAB:121:1-3:0451; Ma M, 2012, BIOENERG RES, V5, P459, DOI 10.1007/s12155-011-9176-9; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Mannazzu I, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P19; Matsushika A, 2012, MICROBIAL STRESS TOL, V22, P137; Matsushika A, 2009, BIORESOURCE TECHNOL, V100, P2392, DOI 10.1016/j.biortech.2008.11.047; Matsushika A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-16; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Moon JW, 2013, BIOCATAL AGRIC BIOTE, V2, P247, DOI 10.1016/j.bcab.2013.03.005; Moyses DN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030207; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Salusjarvi L, 2006, APPL BIOCHEM BIOTECH, V128, P237, DOI 10.1385/ABAB:128:3:237; Salusjarvi L, 2003, YEAST, V20, P295, DOI 10.1002/yea.960; Salusjarvi L, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-18; SCHAAFF I, 1990, EUR J BIOCHEM, V188, P597, DOI 10.1111/j.1432-1033.1990.tb15440.x; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Toivari MH, 2001, METAB ENG, V3, P236, DOI 10.1006/mben.2000.0191; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; VANZYL C, 1989, J GEN MICROBIOL, V135, P2791; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Walfridsson M, 1996, APPL ENVIRON MICROB, V62, P4648, DOI 10.1128/AEM.62.12.4648-4651.1996; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Zeng WY, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0223-y; Zhou Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06556	64	21	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195633	10.1371/journal.pone.0195633	http://dx.doi.org/10.1371/journal.pone.0195633			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621349	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800111
J	Huang, WY; Wang, PL; Wu, Q				Huang, Wenya; Wang, Peiling; Wu, Qiang			A correlation comparison between Altmetric Attention Scores and citations for six PLOS journals	PLOS ONE			English	Article							IMPACT; INDICATORS; METRICS; TWEETS	This study considered all articles published in six Public Library of Science (PLOS) journals in 2012 and Web of Science citations for these articles as of May 2015. A total of 2,406 articles were analyzed to examine the relationships between Altmetric Attention Scores (AAS) and Web of Science citations. The AAS for an article, provided by Altmetric aggregates activities surrounding research outputs in social media (news outlet mentions, tweets, blogs, Wikipedia, etc.). Spearman correlation testing was done on all articles and articles with AAS. Further analysis compared the stratified datasets based on percentile ranks of AAS: top 50%, top 25%, top 10%, and top 1%. Comparisons across the six journals provided additional insights. The results show significant positive correlations between AAS and citations with varied strength for all articles and articles with AAS (or social media mentions), as well as for normalized AAS in the top 50%, top 25%, top 10%, and top 1% data sets. Four of the six PLOS journals, Genetics, Pathogens, Computational Biology, and Neglected Tropical Diseases, show significant positive correlations across all datasets. However, for the two journals with high impact factors, PLOS Biology and Medicine, the results are unexpected: the Medicine articles showed no significant correlations but the Biology articles tested positive for correlations with the whole dataset and the set with AAS. Both journals published substantially fewer articles than the other four journals. Further research to validate the AAS algorithm, adjust the weighting scheme, and include appropriate social media sources is needed to understand the potential uses and meaning of AAS in different contexts and its relationship to other metrics.	[Huang, Wenya; Wu, Qiang] Univ Sci & Technol China, Sch Management, Hefei, Anhui, Peoples R China; [Wang, Peiling] Univ Tennessee, Sch Informat Sci, Knoxville, TN USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Tennessee System; University of Tennessee Knoxville	Wu, Q (corresponding author), Univ Sci & Technol China, Sch Management, Hefei, Anhui, Peoples R China.	qiangwu@ustc.edu.cn		Wu, Qiang/0000-0002-1308-1669; Wang, Peiling/0000-0003-4202-7570	National Natural Science Foundation of China [71273250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	One of the authors of this paper (QW) is partly funded by National Natural Science Foundation of China grant #71273250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adie E, 2013, LEARN PUBL, V26, P11, DOI 10.1087/20130103; Bar-Ilan J., 2012, P 17 INT C SCI TECHN, V52900, P98; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2016, J ASSOC INF SCI TECH, V67, P1016, DOI 10.1002/asi.23633; Bornmann L, 2014, J INFORMETR, V8, P935, DOI 10.1016/j.joi.2014.09.007; Costas R, 2015, ASLIB J INFORM MANAG, V67, P260, DOI 10.1108/AJIM-12-2014-0173; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; de Winter JCF, 2015, SCIENTOMETRICS, V102, P1773, DOI 10.1007/s11192-014-1445-x; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Garfield E, 1979, CITATION INDEXING IT; Groth P, 2011, ISSI NEWSLETTER, P70; Haustein S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120495; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Holmberg Kim, 2014, Scientometrics, V101, P1027, DOI 10.1007/s11192-014-1229-3; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P424, DOI 10.1002/asi.21232; Li XM, 2012, SCIENTOMETRICS, V91, P461, DOI 10.1007/s11192-011-0580-x; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Peoples BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166570; Perianes-Rodriguez A, 2016, SCIENTOMETRICS, V106, P539, DOI 10.1007/s11192-015-1801-5; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Priem J., 2010, ALTMETRICS MANIFESTO; Priem J., 2010, 1 MONDAY, V15, DOI DOI 10.5210/FM.V15I7.2874; Priem J., 2011, DATACITES SUMM M DAT; Priem J., 2012, PREPRINT; Robinson-Garcia N, 2014, PROF INFORM, V23, P359, DOI 10.3145/epi.2014.jul.03; Shema H, 2014, J ASSOC INF SCI TECH, V65, P1018, DOI 10.1002/asi.23037; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Sud P, 2014, SCIENTOMETRICS, V98, P1131, DOI 10.1007/s11192-013-1117-2; Thelwall M., 2016, J DATA INF SCI, V1, P7, DOI DOI 10.20309/JDIS.201610; Thelwall M, 2016, ASLIB J INFORM MANAG, V68, P2, DOI 10.1108/AJIM-09-2015-0146; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Torres-Salinas D, 2013, COMUNICAR, V21, P53, DOI 10.3916/C41-2013-05; Waltman L, 2013, J INFORMETR, V7, P833, DOI 10.1016/j.joi.2013.08.002; Wang J, 2014, J INFORMETR, V8, P329, DOI 10.1016/j.joi.2014.01.006; WANG PL, 1995, P ASIS ANNU MEET, V32, P181; Wang X., 2014, PREPRINT; Wu Q, 2011, SCIENTOMETRICS, V89, P245, DOI 10.1007/s11192-011-0456-0; You Q, 2014, LIB INFORM SERVICE, V58, P79; Zahedi Z, 2014, ALTM 14 WORKSH WEB S; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0	40	63	64	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194962	10.1371/journal.pone.0194962	http://dx.doi.org/10.1371/journal.pone.0194962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621253	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800029
J	Khan, T; Zaman, G; Alshomrani, AS				Khan, Tahir; Zaman, Gui; Alshomrani, Ali Saleh			Spreading dynamic of acute and carrier hepatitis B with nonlinear incidence	PLOS ONE			English	Article							MODEL	Hepatitis B infection caused by the hepatitis B virus. It is one of the serious viral infection and a global health problem. In the transmission of hepatitis B infection different phases, i.e., acute and chronic carrier stages play an important role. The chronic carries individuals do not exhibit any symptoms and are able to transmit the infection. Here we assessed the transmissibility associated with different infection stages of hepatitis B and generated an epidemic model with nonlinear incidence rate. In order to do this, first we formulate the model by splitting the infectious class into two subclasses, namely acutely infected and chronic carries with both horizontal and vertical transmission. The basic properties of the proposed model are presented. The basic reproductive number is obtained by using the next generation matrix approach. Biological sense of the threshold condition is investigated and discussed in detail. We also find the conditions to investigate all possible equilibria of the model in terms of the basic reproduction number. Finally, we perform numerical simulations to support our analytical work.	[Khan, Tahir; Zaman, Gui] Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunkhawa, Pakistan; [Alshomrani, Ali Saleh] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	King Abdulaziz University	Zaman, G (corresponding author), Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunkhawa, Pakistan.	gzaman@uom.edu.pk	ALSHOMRANI, ALI SALEH/Q-4236-2017	ALSHOMRANI, ALI SALEH/0000-0001-9222-8915	Higher Education Commission (HEC) of Pakistan [20-1983/R, D/HEC/11]; Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	This work has been partially supported by Higher Education Commission (HEC) of Pakistan under the project No. 20-1983/R and D/HEC/11 and the Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia.	Allen L., 2008, LECT NOTES MATH EPID; Fan M, 2001, MATH BIOSCI, V170, P199, DOI 10.1016/S0025-5564(00)00067-5; Kamien M.I., 2012, DYNAMIC OPTIMIZATION, VSecond; Khan T, 2017, J BIOL DYNAM, V11, P172, DOI 10.1080/17513758.2016.1256441; Khan T, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2706-3; Lashari AA, 2013, APPL MATH INFORM SCI, V7, P301, DOI 10.12785/amis/070138; Li JQ, 2002, MATH COMPUT MODEL, V35, P1235, DOI 10.1016/S0895-7177(02)00082-1; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li L, 2015, APPL MATH COMPUT, V252, P397, DOI 10.1016/j.amc.2014.11.107; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Mann J, 2011, J THEOR BIOL, V269, P266, DOI 10.1016/j.jtbi.2010.10.028; Mukherjee A, 2015, CHAOS SOLITON FRACT, V78, P16, DOI 10.1016/j.chaos.2015.06.020; Pang LY, 2015, APPL MATH COMPUT, V256, P131, DOI 10.1016/j.amc.2014.12.096; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Thornley S, 2008, J THEOR BIOL, V254, P599, DOI 10.1016/j.jtbi.2008.06.022; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Zaman G, 2008, BIOSYSTEMS, V93, P240, DOI 10.1016/j.biosystems.2008.05.004; Zaman G, 2009, BIOSYSTEMS, V98, P43, DOI 10.1016/j.biosystems.2009.05.006; Zeb A, 2013, APPL MATH MODEL, V37, P5326, DOI 10.1016/j.apm.2012.10.005; Zou L, 2015, J THEOR BIOL, V369, P1, DOI 10.1016/j.jtbi.2015.01.005; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191914	10.1371/journal.pone.0191914	http://dx.doi.org/10.1371/journal.pone.0191914			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621241	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800002
J	McHorney, CA; Crivera, C; Laliberte, F; Germain, G; Wynant, W; Lefebvre, P				McHorney, Colleen A.; Crivera, Concetta; Laliberte, Francois; Germain, Guillaume; Wynant, Willy; Lefebvre, Patrick			Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users	PLOS ONE			English	Article							STROKE PREVENTION; MEDICATION ADHERENCE; THERAPY; DABIGATRAN; REGIMENS; INSIGHTS; BURDEN; IMPACT	Background Medication non-adherence can result in poor health outcomes. Understanding differences in adherence rates to non-vitamin K oral anticoagulants (NOACs) could guide treatment decisions and improve clinical outcomes among patients with non-valvular atrial fibrillation (NVAF). Objective To compare adherence to rivaroxaban and apixaban among the overall NVAF population and subgroups of prior oral anticoagulant (OAC) users (e.g., multiple comorbidities, non-adherence risk factors). Methods Using healthcare claims from the Truven Health Analytics MarketScan (7/2012-7/2015), adult patients with >= 2 dispensings of rivaroxaban or apixaban >= 180 days apart with > 60 days of supply, >= 6 months of pre- and post-index eligibility, >= 1 atrial fibrillation diagnosis pre- or on the index date, and without valvular involvement were identified. Propensity-score methods adjusting for potential baseline confounders were used to create matched cohorts of rivaroxaban and apixaban patients. Adherence was assessed during the implementation phase using the percentage of patients with proportion of days covered (PDC) >= 0.8 at 6 months. Subgroups of patients with prior OAC use were evaluated; additional subgroups were identified and evaluated by Quan-Charlson Comorbidity index >= 2 and presence of non-adherence risk factors (i.e., mental disorders, stress, isolation, and rheumatoid arthritis). Results A total of 13,890 NVAF subjects were included in each of the 2 matched cohorts. All baseline characteristics were balanced between cohorts. At 6 months, significantly more rivaroxaban users were adherent to treatment compared to apixaban users (81.8% vs. 78.0%; absolute difference of 3.8%; p<.001). Rivaroxaban users had significantly higher adherence rates in all subgroups examined. Conclusion Rivaroxaban users had consistently higher adherence rates than apixaban users overall and among all NVAF subgroups examined.	[McHorney, Colleen A.] Evidera, Bethesda, MD USA; [Crivera, Concetta] Janssen Sci Affairs LLC, Raritan, NJ USA; [Laliberte, Francois; Germain, Guillaume; Wynant, Willy; Lefebvre, Patrick] Grp Anal Ltee, Montreal, PQ, Canada	Evidera; Johnson & Johnson; Janssen Pharmaceuticals	Germain, G (corresponding author), Grp Anal Ltee, Montreal, PQ, Canada.	Guillaume.Germain@analysisgroup.com			Janssen Scientific Affairs, LLC, Raritan, NJ, United States; Janssen Scientific Affairs	Janssen Scientific Affairs, LLC, Raritan, NJ, United States; Janssen Scientific Affairs	This research was funded by Janssen Scientific Affairs, LLC, Raritan, NJ, United States (https://www.janssenime.com/). The funders were involved in the study design, data collection, analysis, decision to publish, and preparation of the manuscript. CC is an employee of Janssen Scientific Affairs. FL, GG, WW, and PL are employees of Groupe danalyse, Ltee, a consulting company that has received research grants from Janssen Scientific Affairs. CM is an employee of Evidera, a consultancy company that has received consultancy fees from Janssen Scientific Affairs, LLC.	Al-Khalili F., 2016, CLIN TRIALS REGUL SC, V18, P1, DOI [10.1016/j.ctrsc.2016.03.003, DOI 10.1016/J.CTRSC.2016.03.003]; Andrade JG, 2016, CAN J CARDIOL, V32, P747, DOI 10.1016/j.cjca.2015.09.023; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Brown JD, 2017, J MANAG CARE SPEC PH, V23, P958, DOI 10.18553/jmcp.2017.23.9.958; Choudhry NK, 2014, HEALTH AFFAIR, V33, P493, DOI 10.1377/hlthaff.2013.0060; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Clemens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099276; Coleman CI, 2017, STROKE, V48, P2142, DOI 10.1161/STROKEAHA.117.017474; Crivera C, 2015, IRC ARDIOVASC QUA S2, V8, pA366; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dunbar-Jacob Jacqueline, 2003, J Cardiovasc Nurs, V18, P209; Farrell Barbara, 2013, Can Pharm J (Ott), V146, P262, DOI 10.1177/1715163513500208; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Gutierrez C, 2011, ATRIAL FIBRILLATION, V83; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Laliberte F, 2012, ADV THER, V29, P675, DOI 10.1007/s12325-012-0040-x; Leslie RS, 2014, AM J PHARM BENEFIST, V6, P183; McHorney CA, 2015, CURR MED RES OPIN, V31, P2167, DOI 10.1185/03007995.2015.1096242; Nau DP, PROPORTION DAYS COVE; Pharmacy Quality Alliance (PQA), 2014, TECHN SPEC PQA APPR, P56; Rodriguez RA, 2013, J THROMB HAEMOST, V11, P390, DOI 10.1111/jth.12086; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Staerk L, 2017, J INTERN MED; Vrijens B, 2015, EUROPACE, V17, P514, DOI 10.1093/europace/euu311; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Weeda ER, 2016, INT J CARDIOL, V216, P104, DOI 10.1016/j.ijcard.2016.04.082; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003074	30	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194099	10.1371/journal.pone.0194099	http://dx.doi.org/10.1371/journal.pone.0194099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621248	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800014
J	Zhu, B; Fu, Y; Liu, JL; Mao, Y				Zhu, Bin; Fu, Yang; Liu, Jinlin; Mao, Ying			Spatial distribution of 12 class B notifiable infectious diseases in China: A retrospective study	PLOS ONE			English	Article							ECONOMETRIC-ANALYSIS; TEMPORAL ANALYSIS; YUNNAN PROVINCE; TUBERCULOSIS; EMISSIONS	Background China is the largest developing country with a relatively developed public health system. To further prevent and eliminate the spread of infectious diseases, China has listed 39 notifiable infectious diseases characterized by wide prevalence or great harm, and classified them into classes A, B, and C, with severity decreasing across classes. Class A diseases have been almost eradicated in China, thus making class B diseases a priority in infectious disease prevention and control. In this retrospective study, we analyze the spatial distribution patterns of 12 class B notifiable infectious diseases that remain active all over China. Methods Global and local Moran's I and corresponding graphic tools are adopted to explore and visualize the global and local spatial distribution of the incidence of the selected epidemics, respectively. Inter-correlations of clustering patterns of each pair of diseases and a cumulative summary of the high/low cluster frequency of the provincial units are also provided by means of figures and maps. Results Of the 12 most commonly notifiable class B infectious diseases, viral hepatitis and tuberculosis show high incidence rates and account for more than half of the reported cases. Almost all the diseases, except pertussis, exhibit positive spatial autocorrelation at the provincial level. All diseases feature varying spatial concentrations. Nevertheless, associations exist between spatial distribution patterns, with some provincial units displaying the same type of cluster features for two or more infectious diseases. Overall, high low (unit with high incidence surrounded by units with high incidence, the same below) and high high spatial cluster areas tend to be prevalent in the provincial units located in western and southwest China, whereas low low and low high spatial cluster areas abound in provincial units in north and east China. Conclusion Despite the various distribution patterns of 12 class B notifiable infectious diseases, certain similarities between their spatial distributions are present. Substantial evidence is available to support disease-specific, location-specific, and disease-combined interventions. Regarding provinces that show high high/high low patterns of multiple diseases, comprehensive interventions targeting different diseases should be established. As to the adjacent provincial units revealing similar patterns, coordinated actions need to be taken across borders.	[Zhu, Bin; Liu, Jinlin; Mao, Ying] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China; [Zhu, Bin; Fu, Yang] City Univ Hong Kong, Dept Publ Policy, Hong Kong, Hong Kong, Peoples R China	Xi'an Jiaotong University; City University of Hong Kong	Mao, Y (corresponding author), Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China.	mao_ying@mail.xjtu.edu.cn	Liu, Jinlin/J-3794-2018	Liu, Jinlin/0000-0002-7655-8532; Fu, Yang/0000-0002-6915-2972; Zhu, Bin/0000-0002-0091-6356; Mao, Ying/0000-0002-8271-2524				Allen R. G., 1998, FAO Irrigation and Drainage Paper; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2006, INTRO SPATIAL DATA A, V38, P5; Aristegui J, 2003, INT J INFECT DIS; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Chen J, 2013, INT ARCH PHOTOGRAMM, V40-4-W3, P47, DOI 10.5194/isprsarchives-XL-4-W3-47-2013; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118362; Chuai XW, 2012, J GEOGR SCI, V22, P630, DOI 10.1007/s11442-012-0952-z; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Fischer MM, 2008, J REGIONAL SCI, V48, P969, DOI 10.1111/j.1467-9787.2008.00572.x; Fung C. H., 2015, PLOS ONE, V10, P1; Ge EJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0104-2; Gibney KB, 2016, LANCET INFECT DIS, V3099, P86; Hao Y, 2016, J CLEAN PROD, V112, P1443, DOI 10.1016/j.jclepro.2015.05.005; Hu Y, 2014, INT J ENV RES PUB HE, V11, P701, DOI 10.3390/ijerph110100701; Huang L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0268-4; Khabbaz RF, 2014, LANCET, V384, P53, DOI 10.1016/S0140-6736(14)60890-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li Q, 2014, STOCH ENV RES RISK A, V28, P429, DOI 10.1007/s00477-013-0762-6; Lim SS, 2012, LANCET, V379, P1080, DOI 10.1016/S0140-6736(12)60151-2; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Long RY, 2016, APPL ENERG, V166, P210, DOI 10.1016/j.apenergy.2015.09.100; McCloskey B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1; Moraga P, 2011, STAT MED, V30, P1057, DOI 10.1002/sim.4160; Nakatani H, 2016, J EPIDEMIOL, V26, P171, DOI 10.2188/jea.JE20160010; National Health and Family Planning Commission, 2016, CHIN HLTH FAM PLANN; Parra-Amaya Mayra Elizabeth, 2016, Diseases, V4, DOI 10.3390/diseases4020016; Peng ZH, 2011, GEOSPATIAL HEALTH, V5, P177, DOI 10.4081/gh.2011.169; Rao HX, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0139-4; Spellberg B, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-3; Travnikar T, 2015, WINDING ROAD INVESTM, V21, P16; UN, 2015, 2030 AG SUST DEV; Wang XY, 2006, B WORLD HEALTH ORGAN, P84; World Bank, 2004, MILLENNIUM DEV GOALS; World Health Organization, 2015, HLTH 2015 MDGS SDGS; Wu X, 2017, BMC INFECT DIS, V17, P1; Xia J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0650-2; Zhang JH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004470; Zhang L, 2012, PLOS ONE, P7; Zhang XY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011038; Zhang YQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006669; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	44	6	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195568	10.1371/journal.pone.0195568	http://dx.doi.org/10.1371/journal.pone.0195568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621351	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800103
J	Leitner, JB; Ayduk, O; Boykin, CM; Mendoza-Denton, R				Leitner, Jordan B.; Ayduk, Oezlem; Boykin, C. Malik; Mendoza-Denton, Rodolfo			Reducing negative affect and increasing rapport improve interracial mentorship outcomes	PLOS ONE			English	Article							CROSS-GROUP FRIENDSHIP; STEREOTYPE THREAT; SELF-DISCLOSURE; INTERPERSONAL CLOSENESS; AFRICAN-AMERICANS; OUTGROUP MEMBERS; PERFORMANCE; SENSITIVITY; ANXIETY; METAANALYSIS	Research suggests that interracial mentoring relationships are strained by negative affect and low rapport. As such, it stands to reason that strategies that decrease negative affect and increase rapport should improve these relationships. However, previous research has not tested this possibility. In video-chats (Studies 1 and 2) and face-to-face meetings (Study 3), we manipulated the degree of mutual self-disclosure between mentees and mentors, a strategy that has been shown to reduce negative affect and increase rapport. We then measured negative affect and rapport as mediators, and mentee performance (quality of speech delivered; Studies 1 and 3) and mentor performance (warmth and helpfulness; Studies 2 and 3) as key outcomes. Results revealed that increased self-disclosure decreased negative affect and increased rapport for both mentees and mentors. Among mentees, decreased negative affect predicted better performance (Studies 1 and 3). Among mentors, increased rapport predicted warmer feedback (Studies 2 and 3). These effects remained significant when we meta-analyzed data across studies (Study 4), and also revealed the relationship of rapport to more helpful feedback. Findings suggest that affect and rapport are key features in facilitating positive outcomes in interracial mentoring relationships.	[Leitner, Jordan B.; Ayduk, Oezlem; Boykin, C. Malik; Mendoza-Denton, Rodolfo] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Leitner, JB (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	jleitner@gmail.com		Ayduk, Ozlem/0000-0003-4779-2909	National Science Foundation [1306709]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation (nsf.gov) under Award Numbers 1306709 (to R.M. and O.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2004, J APPL PSYCHOL, V89, P127, DOI 10.1037/0021-9010.89.1.127; Allport G.W., 1954, NATURE PREJUDICE; Aron A, 1997, PERS SOC PSYCHOL B, V23, P363, DOI 10.1177/0146167297234003; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Blascovich J, 2001, PSYCHOL SCI, V12, P225, DOI 10.1111/1467-9280.00340; Butz DA, 2006, J PERS SOC PSYCHOL, V91, P1066, DOI 10.1037/0022-3514.91.6.1066; Chandler DE, 2011, ACAD MANAG ANN, V5, P519, DOI 10.1080/19416520.2011.576087; COLLINS NL, 1994, PSYCHOL BULL, V116, P457, DOI 10.1037/0033-2909.116.3.457; COZBY PC, 1973, PSYCHOL BULL, V79, P73, DOI 10.1037/h0033950; Cranford JA, 2006, PERS SOC PSYCHOL B, V32, P917, DOI 10.1177/0146167206287721; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Crosby JR, 2007, J EXP SOC PSYCHOL, V43, P663, DOI 10.1016/j.jesp.2006.06.007; de Janasz SC, 2003, ACAD MANAGE EXEC, V17, P78, DOI 10.5465/AME.2003.11851850; Dutton J. E., 2003, POSITIVE ORG SCHOLAR, V3, P263; Gaertner S. L., 2014, REDUCING INTERGROUP; Ghosh R, 2013, J VOCAT BEHAV, V83, P106, DOI 10.1016/j.jvb.2013.03.011; Haveman HA, 2012, ANN AM ACAD POLIT SS, V639, P114, DOI 10.1177/0002716211418443; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hurtado S., 2010, NEW DIRECTIONS I RES, P5, DOI DOI 10.1002/IR.357; John-Henderson NA, 2015, J EXP SOC PSYCHOL, V56, P203, DOI 10.1016/j.jesp.2014.10.002; Jones JM, 2003, J SOC ISSUES, V59, P217, DOI 10.1111/1540-4560.t01-1-00014; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; KRAM KE, 1985, ACAD MANAGE J, V28, P110, DOI 10.2307/256064; Leitner JB, 2016, SOCIAL COGNITIVE AFF, V12, P534; Levin S, 2003, GROUP PROCESS INTERG, V6, P76, DOI 10.1177/1368430203006001013; Logel C, 2009, J PERS SOC PSYCHOL, V96, P1089, DOI 10.1037/a0015703; McDonald ML, 2013, ACAD MANAGE J, V56, P1169, DOI 10.5465/amj.2011.0230; Mendoza-Denton R, 2002, J PERS SOC PSYCHOL, V83, P896, DOI 10.1037//0022-3514.83.4.896; Mendoza-Denton R, 2007, SOC PERSONAL PSYCHOL, V1, P68, DOI 10.1111/j.1751-9004.2007.00010.x; Mendoza-Denton R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174296; Mendoza-Denton R, 2010, SOC PSYCHOL PERS SCI, V1, P127, DOI 10.1177/1948550609357796; Page-Gould E, 2008, J PERS SOC PSYCHOL, V95, P1080, DOI 10.1037/0022-3514.95.5.1080; Page-Gould E, 2014, J SOC ISSUES, V70, P256, DOI 10.1111/josi.12059; Paolini S, 2004, PERS SOC PSYCHOL B, V30, P770, DOI 10.1177/0146167203262848; Ragins BR, 2000, ACAD MANAGE J, V43, P1177, DOI 10.2307/1556344; Rouse ED, 2013, ACAD MANAGEMENT P, P11221; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Shelton JN, 2005, J PERS SOC PSYCHOL, V88, P91, DOI 10.1037/0022-3514.88.1.91; Spencer SJ, 2016, ANNU REV PSYCHOL, V67, P415, DOI 10.1146/annurev-psych-073115-103235; Spreng RN, 2009, J PERS ASSESS, V91, P62, DOI 10.1080/00223890802484381; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stewart MM, 2008, ACAD MANAG LEARN EDU, V7, P42, DOI 10.5465/AMLE.2008.31413861; Toosi NR, 2012, PSYCHOL BULL, V138, P1, DOI 10.1037/a0025767; Underhill CM, 2006, J VOCAT BEHAV, V68, P292, DOI 10.1016/j.jvb.2005.05.003; Vacharkulksemsuk T, 2012, J EXP SOC PSYCHOL, V48, P399, DOI 10.1016/j.jesp.2011.07.015; Vorauer JD, 2006, PSYCHOL REV, V113, P862, DOI 10.1037/0033-295X.113.4.862; Vorauer JD, 2004, J PERS SOC PSYCHOL, V87, P384, DOI 10.1037/0022-3514.87.3.384; Wanberg CR, 2007, J VOCAT BEHAV, V70, P398, DOI 10.1016/j.jvb.2007.01.002; Woolf K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1220	51	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194123	10.1371/journal.pone.0194123	http://dx.doi.org/10.1371/journal.pone.0194123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617368	Green Published, gold			2022-12-27	WOS:000429203800018
J	Massey, AJ				Massey, Andrew J.			A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells	PLOS ONE			English	Article							KINASE 1 CHK1; SHIFT ASSAY; IDENTIFICATION; COMBINATION; INHIBITOR	Determining and understanding drug target engagement is critical for drug discovery. This can be challenging within living cells as selective readouts are often unavailable. Here we describe a novel method for measuring target engagement in living cells based on the principle of altered protein thermal stabilization / destabilization in response to ligand binding. This assay (HCIF-CETSA) utilizes high content, high throughput single cell immunofluorescent detection to determine target protein levels following heating of adherent cells in a 96 well plate format. We have used target engagement of Chk1 by potent small molecule inhibitors to validate the assay. Target engagement measured by this method was subsequently compared to target engagement measured by two alternative methods (autophosphorylation and CETSA). The HCIF-CETSA method appeared robust and a good correlation in target engagement measured by this method and CETSA for the selective Chk1 inhibitor V158411 was observed. However, these EC50 values were 23- and 12-fold greater than the autophosphorylation IC50. The described method is therefore a valuable advance in the CETSA method allowing the high throughput determination of target engagement in adherent cells.	[Massey, Andrew J.] Vernalis Res, Granta Pk, Cambridge, England	Vernalis	Massey, AJ (corresponding author), Vernalis Res, Granta Pk, Cambridge, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573	Vernalis Research	Vernalis Research	This work was funded by Vernalis Research who agreed to the publication of this manuscript. The funder provided support in the form of salaries for author AJM, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific role of the author are articulated in the 'author contributions' section.	Blackwood E, 2013, MOL CANCER THER, V12, P1968, DOI 10.1158/1535-7163.MCT-12-1218; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Geneste CC, 2017, SLAS DISCOV; Han XZ, 2016, J BIOL CHEM, V291, P12951, DOI 10.1074/jbc.M115.713248; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Liu QH, 2000, GENE DEV, V14, P1448; Massey AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40778; Massey AJ, 2016, MOL ONCOL, V10, P101, DOI 10.1016/j.molonc.2015.08.004; Massey AJ, 2015, ONCOTARGET, V6, P35797, DOI 10.18632/oncotarget.5929; McNulty DE, 2017, SLAS DISCOV; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Seashore-Ludlow B, 2016, J BIOMOL SCREEN, V21, P1019, DOI 10.1177/1087057116659256; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wayne J, 2016, ONCOTARGET, V7, P85033, DOI 10.18632/oncotarget.13119; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226	22	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195050	10.1371/journal.pone.0195050	http://dx.doi.org/10.1371/journal.pone.0195050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617433	Green Submitted, gold, Green Published			2022-12-27	WOS:000429203800060
J	Spirrov, D; Van Eeckhoutte, M; Van Deun, L; Francart, T				Spirrov, Dimitar; Van Eeckhoutte, Maaike; Van Deun, Lieselot; Francart, Tom			Real-time loudness normalisation with combined cochlear implant and hearing aid stimulation	PLOS ONE			English	Article							LEVEL; DIFFERENCE; MODEL	Background People who use a cochlear implant together with a contralateral hearing aid so-called bimodal listeners have poor localisation abilities and sounds are often not balanced in loudness across ears. In order to address the latter, a loudness balancing algorithm was created, which equalises the loudness growth functions for the two ears. The algorithm uses loudness models in order to continuously adjust the two signals to loudness targets. Previous tests demonstrated improved binaural balance, improved localisation, and better speech intelligibility in quiet for soft phonemes. In those studies, however, all stimuli were preprocessed so spontaneous head movements and individual head-related transfer functions were not taken into account. Furthermore, the hearing aid processing was linear. Study design In the present study, we simplified the acoustical loudness model and implemented the algorithm in a real-time system. We tested bimodal listeners on speech perception and on sound localisation, both in normal loudness growth configuration and in a configuration with a modified loudness growth function. We also used linear and compressive hearing aids. Results The comparison between the original acoustical loudness model and the new simplified model showed loudness differences below 3% for almost all tested speech-like stimuli and levels. We found no effect of balancing the loudness growth across ears for speech perception ability in quiet and in noise. We found some small improvements in localisation performance. Further investigation with a larger sample size is required.	[Spirrov, Dimitar; Van Eeckhoutte, Maaike; Van Deun, Lieselot; Francart, Tom] Univ Leuven, KU Leuven, ExpORL, Neurosci, Leuven, Belgium; [Van Deun, Lieselot] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven	Spirrov, D (corresponding author), Univ Leuven, KU Leuven, ExpORL, Neurosci, Leuven, Belgium.	dimitar.spirrov@kuleuven.be		Spirrov, Dimitar/0000-0003-2072-4682; Van Eeckhoutte, Maaike/0000-0002-5612-5326	Flanders Innovation; Cochlear Ltd. (IWT R D) [110722]; Cochlear Ltd. (IWT Baekeland) [140748]; Agency for Innovation by Science and Technology in Flanders (IWT) [131106]	Flanders Innovation; Cochlear Ltd. (IWT R D); Cochlear Ltd. (IWT Baekeland); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by Flanders Innovation (https:/www.iwt.be) and Cochlear Ltd. (http://www.cochlear.com/wps/wcm/connect/be/home) (IWT R & D 110722 and IWT Baekeland 140748). Maaike Van Eeckhoutte was supported by a PhD grant for Strategic Basic Research by the Agency for Innovation by Science and Technology in Flanders (IWT, 131106).; This work was supported by Flanders Innovation and Cochlear Ltd. (IWT R & D 110722 and IWT Baekeland 140748). Maaike Van Eeckhoutte was supported by a PhD grant for Strategic Basic Research by the Agency for Innovation by Science and Technology in Flanders (IWT, 131106). Cochlear Ltd. also provided the necessary additional equipment. The authors would like to acknowledge Kato Van Deun who helped with the testing. We are also very grateful to all subjects who participated in this study. Finally, we would like to thank the two reviewers for their constructive and helpful feedback.	Allen JB, 1997, J ACOUST SOC AM, V102, P3628, DOI 10.1121/1.420150; Blamey PJ, 2000, EAR HEARING, V21, P6, DOI 10.1097/00003446-200002000-00004; Bosman AJ, 1995, AUDIOLOGY, V34, P260; Burdiel E, 2012, AUDIO ENGINEERING SO; Buus S, 1997, J ACOUST SOC AM, V101, P669, DOI 10.1121/1.417959; BYRNE D, 1990, EAR HEARING, V11, P40, DOI 10.1097/00003446-199002000-00009; Byrne D, 2001, J Am Acad Audiol, V12, P37; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Ching T Y C, 2007, Trends Amplif, V11, P161, DOI 10.1177/1084713807304357; Ching TYC, 2001, EAR HEARING, V22, P365, DOI 10.1097/00003446-200110000-00002; Dillon H, 1996, EAR HEARING, V17, P287, DOI 10.1097/00003446-199608000-00001; Dillon H, 2011, PHONAK FOCUS, V40, P1; Dorman MF, 2014, AUDIOL NEURO-OTOL, V19, P234, DOI 10.1159/000360070; English R, 2016, INT J AUDIOL, P1; Fitzpatrick EM, 2010, TRENDS AMPLIF, V14, P199, DOI 10.1177/1084713810396511; Francart T, 2012, PLOS ONE, P7; Francart T, 2008, J NEUROSCI METH, V172, P283, DOI 10.1016/j.jneumeth.2008.04.020; Francart T, 2008, AUDIOL NEURO-OTOL, V13, P309, DOI 10.1159/000124279; Francart T, 2013, EAR HEARING, V34, P685, DOI 10.1097/AUD.0b013e31829d14cb; Francart T, 2012, HEARING RES, V294, P114, DOI 10.1016/j.heares.2012.09.002; Francart T, 2011, J ACOUST SOC AM, V130, P2817, DOI 10.1121/1.3641414; Francart T, 2009, JARO-J ASSOC RES OTO, V10, P131, DOI 10.1007/s10162-008-0145-8; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GREENWOOD DD, 1991, HEARING RES, V54, P164, DOI 10.1016/0378-5955(91)90117-R; Holube I, 2010, INT J AUDIOL, V49, P891, DOI 10.3109/14992027.2010.506889; Hoth S, 2007, EUR ARCH OTO-RHINO-L, V264, P129, DOI 10.1007/s00405-006-0159-y; Kates James M, 2005, Trends Amplif, V9, P45, DOI 10.1177/108471380500900202; KATES JM, 2005, EURASIP J APPL SIG P, V18, P3003; Krishnamoorthi H, 2008, INT CONF ACOUST SPEE, P361, DOI 10.1109/ICASSP.2008.4517621; McDermott Hugh J, 2002, J Am Acad Audiol, V13, P14; McKay CM, 2003, J ACOUST SOC AM, V113, P2054, DOI 10.1121/1.1558378; Moore BCJ, 1997, AUDIT NEUROSCI, V3, P289; Moore BCJ, 2004, HEARING RES, V188, P70, DOI 10.1016/S0378-5955(03)00347-2; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Stone MA, 1999, J ACOUST SOC AM, V106, P3603, DOI 10.1121/1.428213; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Theelen-vandenHoek FL, 2016, INT J AUDIOL, V2027, P1; Van den Bogaert T, 2006, J ACOUST SOC AM, V119, P515, DOI 10.1121/1.2139653; van Wieringen A, 2008, INT J AUDIOL, V47, P348, DOI 10.1080/14992020801895144; Veugen LCE, 2015, EAR HEARING; Ward D, 2013, IEEE WORK APPL SIG; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325)	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195412	10.1371/journal.pone.0195412	http://dx.doi.org/10.1371/journal.pone.0195412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617421	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800083
J	Palama, A; Malsert, J; Gentaz, E				Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard			Are 6-month-old human infants able to transfer emotional information (happy or angry) from voices to faces? An eye-tracking study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; 7-MONTH-OLD INFANTS; GENERALIZED DISCRIMINATION; PERCEPTION; RECOGNITION; NEWBORNS; LIFE; ATTENTION; MOTHERS	The present study examined whether 6-month-old infants could transfer amodal information (i.e. independently of sensory modalities) from emotional voices to emotional faces. Thus, sequences of successive emotional stimuli (voice or face from one sensory modality-auditory-to another sensory modality-visual-), corresponding to a cross-modal transfer, were displayed to 24 infants. Each sequence presented an emotional (angry or happy) or neutral voice, uniquely, followed by the simultaneous presentation of two static emotional faces (angry or happy, congruous or incongruous with the emotional voice). Eye movements in response to the visual stimuli were recorded with an eye-tracker. First, results suggested no difference in infants' looking time to happy or angry face after listening to the neutral voice or the angry voice. Nevertheless, after listening to the happy voice, infants looked longer at the incongruent angry face (the mouth area in particular) than the congruent happy face. These results revealed that a cross-modal transfer (from auditory to visual modalities) is possible for 6-month-old infants only after the presentation of a happy voice, suggesting that they recognize this emotion amodally.	[Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, SensoriMotor Affect & Social Dev Lab, Geneva, Switzerland; [Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Swiss Ctr Affect Sci, Campus Biotech, Geneva, Switzerland; [Gentaz, Edouard] CNRS, Grenoble, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS)	Gentaz, E (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, SensoriMotor Affect & Social Dev Lab, Geneva, Switzerland.; Gentaz, E (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Campus Biotech, Geneva, Switzerland.; Gentaz, E (corresponding author), CNRS, Grenoble, France.	edouard.gentaz@unige.ch		Palama, Amaya/0000-0002-9251-0520; Gentaz, Edouard/0000-0003-0574-5557	Swiss National Fund [100019-156073]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This research was supported by the Swiss National Fund for the research grant 100019-156073 awarded to E.G.	Amso D, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00180; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; BARRERA ME, 1981, CHILD DEV, V52, P714, DOI 10.2307/1129196; Bayet L., 2015, THESES U GRENOBLE; Bayet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129812; Bayet L, 2014, ANN PSYCHOL, V114, P469; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bornstein MH, 2011, INFANT BEHAV DEV, V34, P100, DOI 10.1016/j.infbeh.2010.10.002; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; CARON AJ, 1988, CHILD DEV, V59, P604, DOI 10.1111/j.1467-8624.1988.tb03219.x; CARON RF, 1982, CHILD DEV, V53, P1008, DOI 10.1111/j.1467-8624.1982.tb01365.x; CARON RF, 1985, CHILD DEV, V56, P1552, DOI 10.2307/1130474; Dollion N., 2015, J VISION, V15, pe795, DOI [10.1167/15.12.795, DOI 10.1167/15.12.795]; Dollion N, 2015, CHEM SENSES, V40, P241; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Feron J, 2006, COGNITIVE DEV, V21, P81, DOI 10.1016/j.cogdev.2006.01.005; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Geangu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027132; Geangu E, 2010, INFANT BEHAV DEV, V33, P279, DOI 10.1016/j.infbeh.2010.03.004; Gentaz E, 2016, VIE SECRETE ENFANTS; Godard O, 2016, DEVELOPMENTAL SCI, V19, P155, DOI 10.1111/desc.12292; Hoehl S, 2014, EMOTION PROCESSING I, P1; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; Iacobucci D, 2001, J CONSUM PSYCHOL, V10, P1, DOI 10.1207/S15327663JCP1001&2_01; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; KUCHUK A, 1986, CHILD DEV, V57, P1054; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; LARGO RH, 1989, DEV MED CHILD NEUROL, V31, P440, DOI 10.1111/j.1469-8749.1989.tb04022.x; Leppanen J, 2010, INT J BEHAV DEV, V34, P547, DOI 10.1177/0165025410365804; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; LUDEMANN PM, 1991, CHILD DEV, V62, P55, DOI 10.2307/1130704; LUDEMANN PM, 1988, DEV PSYCHOL, V24, P492, DOI 10.1037/0012-1649.24.4.492; Lundqvist D., 1998, KAROLINSKA DIRECTED; Montague DPF, 2002, CHILD DEV, V73, P1339, DOI 10.1111/1467-8624.00475; NELSON CA, 1987, CHILD DEV, V58, P889, DOI 10.2307/1130530; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.2307/1130173; Oster H., 1981, INFANT SOCIAL COGNIT, P85; Peltola MJ, 2011, PSYCHOPHYSIOLOGY, V48, P1291, DOI 10.1111/j.1469-8986.2011.01188.x; Peltola MJ, 2009, EMOTION, V9, P560, DOI 10.1037/a0015806; Rigato S, 2011, EUR J DEV PSYCHOL, V8, P624, DOI 10.1080/17405629.2011.602239; Sander D, 2014, TRAITE PSYCHOL EMOTI; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; SOKEN NH, 1992, CHILD DEV, V63, P787; Soken NH, 1999, CHILD DEV, V70, P1275, DOI 10.1111/1467-8624.00093; Streri A, 2004, Q J EXP PSYCHOL-A, V57, P523, DOI 10.1080/02724980343000378; Striano T, 2002, INFANCY, V3, P115, DOI 10.1207/S15327078IN0301_6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; YOUNGBROWNE G, 1977, CHILD DEV, V48, P555, DOI 10.1111/j.1467-8624.1977.tb01197.x	49	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194579	10.1371/journal.pone.0194579	http://dx.doi.org/10.1371/journal.pone.0194579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641530	gold, Green Published			2022-12-27	WOS:000429742900036
J	Hughes, E; Hopkins, LJ; Parker, R				Hughes, Emily; Hopkins, Laurence J.; Parker, Richard			Survival from alcoholic hepatitis has not improved over time (vol 13, e0192393, 2018)	PLOS ONE			English	Correction																		Hughes E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192393	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195857	10.1371/journal.pone.0195857	http://dx.doi.org/10.1371/journal.pone.0195857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634763	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200059
J	Keren-Aviram, G; Dachet, F; Bagla, S; Balan, K; Loeb, JA; Dratz, EA				Keren-Aviram, Gal; Dachet, Fabien; Bagla, Shruti; Balan, Karina; Loeb, Jeffrey A.; Dratz, Edward A.			Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ALPHA-B-CRYSTALLIN; FIBRILLARY ACIDIC PROTEIN; DYSFUNCTION; GENE; HIPPOCAMPUS; EXPRESSION; TISSUE; GFAP; IDENTIFICATION	Epilepsy is a common neurological disorder, which is not well understood at the molecular level. Exactly why some brain regions produce epileptic discharges and others do not is not known. Patients who fail to respond to antiseizure medication (refractory epilepsy) can benefit from surgical removal of brain regions to reduce seizure frequency. The tissue removed in these surgeries offers an invaluable resource to uncover the molecular and cellular basis of human epilepsy. Here, we report a proteomic study to determine whether there are common proteomic patterns in human brain regions that produce epileptic discharges. We analyzed human brain samples, as part of the Systems Biology of Epilepsy Project (SBEP). These brain pieces are in vivo electrophysiologically characterized human brain samples withdrawn from the neocortex of six patients with refractory epilepsy. This study is unique in that for each of these six patients the comparison of protein expression was made within the same patient: a more epileptic region was compared to a less epileptic brain region. The amount of epileptic activity was defined for each patient as the frequency of their interictal spikes (electric activity between seizures that is a parameter strongly linked to epilepsy). Proteins were resolved from three subcellular fractions, using a 2D differential gel electrophoresis (2D-DIGE), revealing 31 identified protein spots that changed significantly. Interestingly, glial fibrillary acidic protein (GFAP) was found to be consistently down regulated in high spiking brain tissue and showed a strong negative correlation with spike frequency. We also developed a two-step analysis method to select for protein species that changed frequently among the patients and identified these proteins. A total of 397 protein spots of interest (S01) were clustered by protein expression patterns across all samples. These clusters were used as markers and this analysis predicted proteomic changes due to both histological differences and molecular pathways, revealed by examination of gene ontology clusters. Our experimental design and proteomic data analysis predicts novel glial changes, increased angiogenesis, and changes in cytoskeleton and neuronal projections between high and low interictal spiking regions. Quantitative histological staining of these same tissues for both the vascular and glial changes confirmed these findings, which provide new insights into the structural and functional basis of neocortical epilepsy.	[Keren-Aviram, Gal; Dratz, Edward A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Dachet, Fabien; Bagla, Shruti; Balan, Karina; Loeb, Jeffrey A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Dachet, Fabien; Loeb, Jeffrey A.] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA	Montana State University System; Montana State University Bozeman; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Loeb, JA (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.; Loeb, JA (corresponding author), Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA.	jaloeb@uic.edu		Dachet, Fabien/0000-0002-5146-3449	NIH/HINDS [R01NS045207, R01NS058802, R56 NS083527]; NIH [R21RR16240, R42RR021790, P20RR024237, P20GM104935]; NSF [0321267]; Montana Board of Research and Commercialization of Technology [5-14, 6-46, 08-17]; Murdock Charitable Trust	NIH/HINDS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Montana Board of Research and Commercialization of Technology; Murdock Charitable Trust	This work was funded by NIH/HINDS Grants R01NS045207, R01NS058802, and R56 NS083527 (to Jeffrey A. Loeb) and NIH R21RR16240, NSF 0321267, Montana Board of Research and Commercialization of Technology #5-14, #6-46 and #08-17, Murdock Charitable Trust, NIH R42RR021790, NIH P20RR024237, and NIH P20GM104935 (to Edward A. Dratz).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2012, CLUSTER CLUSTER ANAL; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Asano E, 2003, EPILEPSIA, V44, P425, DOI 10.1046/j.1528-1157.2003.38902.x; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Boer K, 2010, EPILEPSY RES, V90, P99, DOI 10.1016/j.eplepsyres.2010.03.014; Boulpaep EL, 2009, MED PHYSL, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Che Y, 2001, J NEUROSCI RES, V65, P425, DOI 10.1002/jnr.1170; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; D'Amici GM, 2012, NAT PROTOC, V7, P36, DOI 10.1038/nprot.2011.427; Dachet F, 2015, BRAIN; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Eun JP, 2004, EXP MOL MED, V36, P185, DOI 10.1038/emm.2004.26; Ezzet F., 2007, PHARMACOMETRICS, P103, DOI [10.1002/9780470087978.ch4, DOI 10.1002/9780470087978.CH4]; Fisher NI, 1984, BIOMETRICS, V40, P567; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo RY, 2007, J CELL PHYSIOL, V211, P327, DOI 10.1002/jcp.20937; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Hashimoto M, 2002, J BIOL CHEM, V277, P11465, DOI 10.1074/jbc.M111428200; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kelemen Halasz P, 2010, NEUROPSYCHIATRIC DIS, V465; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kovacs R, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03703.x; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; Liu X, 2009, MASS SPECTROMETRY RE; Loeb JA, 2010, EPILEPSIA, V51, P171, DOI 10.1111/j.1528-1167.2010.02635.x; Loeb JA, 2011, NEUROSCI LETT, V497, P205, DOI 10.1016/j.neulet.2011.02.041; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Maaty WS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00411; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Martinian L, 2009, NEUROPATH APPL NEURO, V35, P394, DOI [10.1111/j.1365-2990.2008.00996.x, 10.1111/j.1365-2990.2009.00996.x]; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mirza N, 2011, HUM MOL GENET, V20, P4381, DOI 10.1093/hmg/ddr365; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Rakhade SN, 2008, EPILEPSIA, V49, P226, DOI 10.1111/j.1528-1167.2007.01310.x; Rakhade SN, 2005, ANN NEUROL, V58, P736, DOI 10.1002/ana.20633; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Sarnat HB, 2009, CAN J NEUROL SCI, V36, P566, DOI 10.1017/S0317167100008052; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seifert G, 2013, EXP NEUROL, V244, P4, DOI 10.1016/j.expneurol.2011.08.024; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Visanji NP, 2012, EPILEPSIA, V53, pe50, DOI 10.1111/j.1528-1167.2011.03369.x; Walpurgis K, 2012, ELECTROPHORESIS, V33, P2537, DOI 10.1002/elps.201200151; Weissberg Itai, 2011, Epilepsy Res Treat, V2011, P143908, DOI 10.1155/2011/143908; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Witcher MR, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00061; Wu HC, 2017, EPILEPSIA, V58, P1626, DOI 10.1111/epi.13848; Yang JW, 2005, MOL BRAIN RES, V139, P348, DOI 10.1016/j.molbrainres.2005.06.010; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889; Yun CH, 2006, EPILEPSIA, V47, P574, DOI 10.1111/j.1528-1167.2006.00470.x; Zhang Y, 2013, SPRINGER SERIES TRAN, P141; Zhao FH, 2012, SYNAPSE, V66, P781, DOI 10.1002/syn.21567; Ziemba KS, 2011, NEUROLOGIST, V17, P176, DOI 10.1097/NRL.0b013e318217368e	78	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195639	10.1371/journal.pone.0195639	http://dx.doi.org/10.1371/journal.pone.0195639			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634780	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200044
J	Pagliai, FA; Pan, L; Silva, D; Gonzalez, CF; Lorca, GL				Pagliai, Fernando A.; Pan, Lei; Silva, Danilo; Gonzalez, Claudio F.; Lorca, Graciela L.			Zinc is an inhibitor of the LdtR transcriptional activator	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; MULTIPLE-ANTIBIOTIC-RESISTANCE; COMPLETE GENOME SEQUENCE; CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; GENE-EXPRESSION; UPTAKE SYSTEM; MARR FAMILY; REGULATOR; PROTEIN	LdtR is a master regulator of gene expression in Liberibacter asiaticus, one of the causative agents of citrus greening disease. LdtR belongs to the MarR-family of transcriptional regulators and it has been linked to the regulation of more than 180 genes in Liberibacter species, most of them gathered in the following Clusters of Orthologous Groups: cell motility, cell wall envelope, energy production, and transcription. Our previous transcriptomic evidence suggested that LdtR is directly involved in the modulation of the zinc uptake system genes (znu) in the closely related L. crescens. In this report, we show that LdtR is involved in the regulation of one of the two encoded zinc uptake mechanisms in L. asiaticus, named znu(2). We also show that LdtR binds zinc with higher affinity than benzbromarone, a synthetic effector inhibitory molecule, resulting in the disruption of the LdtR:promoter interactions. Using site directed mutagenesis, electrophoretic mobility shift assays (EMSAs), and isothermal titration calorimetry, we identified that residues C28 and T43 in LdtR, located in close proximity to the Benz1 pocket, are involved in the interaction with zinc. These results provided new evidence of a high-affinity effector molecule targeting a key player in L. asiaticus' physiology and complemented our previous findings about the mechanisms of signal transduction in members of the MarR-family.	[Pagliai, Fernando A.; Pan, Lei; Silva, Danilo; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019; Pan, Lei/K-2570-2019	Pan, Lei/0000-0002-7194-0302; Pagliai, Fernando A./0000-0002-0434-4594	Specialty Crop Research Initiative [2015-70016-23029]; Plant Biotic Interactions Program from the USDA National Institute of Food and Agriculture [201703060]	Specialty Crop Research Initiative; Plant Biotic Interactions Program from the USDA National Institute of Food and Agriculture	This work is supported by the Specialty Crop Research Initiative (Award number 2015-70016-23029 to G.L.L. and C.F.G), and the Plant Biotic Interactions Program (Award number 201703060 to C.F.G.) from the USDA National Institute of Food and Agriculture, http://nifa/usda.gov/.	Ahmad K, 2016, PLANT SOIL MICROBES, V1, P225, DOI [10.1007/978-3-319-27455-3_12, DOI 10.1007/978-3-319-27455-3_12]; Ahmad K, 2011, AFR J MICROBIOL RES, V5, P4967, DOI 10.5897/AJMR11.236; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Bassanezi RB, 2009, EUR J PLANT PATHOL, V125, P565, DOI 10.1007/s10658-009-9506-3; Bhubhani S, 2014, MICROBIOL-SGM, V160, P2452, DOI 10.1099/mic.0.082446-0; Bove JM, 2006, J PLANT PATHOL, V88, P7; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Butof L, 2017, COMPONENTS UNIQUE RE, V199, P1, DOI [10.1128/JB, DOI 10.1128/JB]; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chaoprasid P, 2016, APPL ENVIRON MICROB, V82, P3503, DOI 10.1128/AEM.00299-16; Choudhury R, 2001, CURR SCI INDIA, V81, P768; D'Orazio M, 2015, METALLOMICS, V7, P1023, DOI 10.1039/c5mt00017c; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Duval V, 2013, J BACTERIOL, V195, P3341, DOI 10.1128/JB.02224-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075389; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gardner CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01630; Gilston BA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001987; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazai Eszter, 2009, Acta Pharm Hung, V79, P17; Hijaz F, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1183084; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Li JY, 2017, MOL PLANT MICROBE IN, V30, P620, DOI [10.1094/mpmi-12-16-0257-r, 10.1094/MPMI-12-16-0257-R]; Loto F, 2017, MICROB BIOTECHNOL, V10, P642, DOI 10.1111/1751-7915.12706; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; McCauley A., 2009, NUTR MANAG, V9, P1, DOI DOI 10.1109/ISTC.2012.6325235; McFedries A, 2013, CHEM BIOL, V20, P667, DOI 10.1016/j.chembiol.2013.04.008; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Pagliai FA, 2017, MICROB BIOTECHNOL, V10, P896, DOI 10.1111/1751-7915.12728; Pagliai FA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01314; Pagliai FA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004101; Pagliai FA, 2014, MOL MICROBIOL, V92, P853, DOI 10.1111/mmi.12598; Pagliai FA, 2010, J BIOL CHEM, V285, P16921, DOI 10.1074/jbc.M110.111138; Pan L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01591; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Pederick VG, PSEUDOMONAS AERUGINO, P1, DOI [10.1038/srep13139, DOI 10.1038/SREP13139]; Rajasekaran P, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00062; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Sambrook J, 1989, MOL CLONING LAB MANU, P626; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; SCHWARZ R E, 1970, Phytophylactica, V2, P59; Sharma N, 2016, BBA-PROTEINS PROTEOM, V1864, P1649, DOI 10.1016/j.bbapap.2016.08.016; Sharma N, 2015, J STRUCT BIOL, V189, P184, DOI 10.1016/j.jsb.2015.01.012; Spann T.M., 2011, CITRUS IND, V92, P6; Trivedi P, 2010, APPL ENVIRON MICROB, V76, P3427, DOI 10.1128/AEM.02901-09; Trzaskowski B, 2008, J BIOL INORG CHEM, V13, P133, DOI 10.1007/s00775-007-0306-y; Vahling-armstrong CM, 2012, 2 PLANT BACTERIA S M, P7, DOI [10.1371/journal.pone.0037340, DOI 10.1371/JOURNAL.PONE.0037340]; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Yan Q, 2013, MOL PLANT PATHOL, V14, P391, DOI 10.1111/mpp.12015; Yu LL, 2009, BIOCHEMISTRY-US, V48, P2099, DOI 10.1021/bi801662s; Zhang MQ, 2016, J APPL MICROBIOL, V120, P1616, DOI 10.1111/jam.13102	61	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195746	10.1371/journal.pone.0195746	http://dx.doi.org/10.1371/journal.pone.0195746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634775	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200055
J	Eberly, L; Richter, D; Comerci, G; Ocksrider, J; Mercer, D; Mlady, G; Wascher, D; Schenck, R				Eberly, Lauren; Richter, Dustin; Comerci, George; Ocksrider, Justin; Mercer, Deana; Mlady, Gary; Wascher, Daniel; Schenck, Robert			Psychosocial and demographic factors influencing pain scores of patients with knee osteoarthritis	PLOS ONE			English	Article							RHEUMATIC-DISEASES; OSTEO-ARTHRITIS; UNITED-STATES; DISABILITY; VARIABLES; HEALTH; DISCORDANCE; PREDICTORS; COMMUNITY; SEVERITY	Background Pain levels in patients with osteoarthritis (OA) of the knee are commonly assessed by using a numeric scoring system, but results may be influenced by factors other than the patient's actual physical discomfort or disease severity, including psychosocial and demographic variables. We examined the possible relation between knee-pain scores and several psychosocial, sociodemographic, disease, and treatment variables in 355 patients with knee OA. Methods The pain-evaluation instrument was a 0- to 10-point rating scale. Data obtained retrospectively from the patients' medical records were demographic characteristics, body mass index (BMI), concomitant disorders, illicit and prescription drug use, alcohol use, smoking, knee OA treatment, and severity of knee OA indicated by Kellgren-Lawrence (KL) radiographic grade. Univariate and multivariate analyses were performed to determine whether these variables correlated with reported pain scores. Results On univariate analysis, higher pain scores were significantly associated with Native American or Hispanic ethnicity; a higher BMI; current prescription for an opioid, antidepressant, or gabapentinoid medication; depression; diabetes mellitus; fibromyalgia; illicit drug use; lack of health insurance; smoking; previous knee injection; and recommendation by the clinician that the patient undergo knee surgery. Neither the patient's sex nor the KL grade showed a correlation. On multivariate analysis, depression, current opioid prescription, and Native American or Hispanic ethnicity retained a significant association with higher pain scores. Conclusions and implications Our results in a large, ethnically diverse group of patients with knee OA suggest that psycho social and sociodemographic factors may be important determinants of pain levels reported by patients with knee OA.	[Eberly, Lauren; Richter, Dustin; Ocksrider, Justin; Mercer, Deana; Wascher, Daniel; Schenck, Robert] Univ New Mexico, Dept Orthopaed & Rehabil, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Comerci, George] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Mlady, Gary] Univ New Mexico, Dept Radiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Richter, D (corresponding author), Univ New Mexico, Dept Orthopaed & Rehabil, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	DLRichter@salud.unm.edu	Wascher, Daniel/Q-1703-2019	Wascher, Daniel/0000-0002-8766-826X; Richter, Dustin/0000-0001-9935-6493	Orthopaedic Rehabilitation Association	Orthopaedic Rehabilitation Association	We thank William D. Tandberg, MD for performing the statistical analysis and Renee Robillard and Sahar Freedman for editorial assistance. This study received the Vernon L. Nickel Award of 2015 by the Orthopaedic Rehabilitation Association and was presented at the 68th Annual Meeting of the Association of Bone and Joint Surgeons.	BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bernardy K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009796.pub2; Callahan LF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3492; CARMAN WJ, 1989, SEMIN ARTHRITIS RHEU, V18, P10, DOI 10.1016/0049-0172(89)90009-7; Castrejon I, 2014, ARTHRIT CARE RES, V66, P934, DOI 10.1002/acr.22237; Creamer P, 1999, J RHEUMATOL, V26, P1785; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; DEXTER P, 1994, J RHEUMATOL, V21, P279; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P485, DOI 10.1136/ard.16.4.485; Kramer BJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P588, DOI 10.1002/art.10795; Lachance L, 2001, OSTEOARTHR CARTILAGE, V9, P527, DOI 10.1053/joca.2000.0429; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LICHTENBERG PA, 1986, J PSYCHOSOM RES, V30, P327, DOI 10.1016/0022-3999(86)90010-3; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; Parker JC, 1995, ARTHRIT CARE RES, V8, P279, DOI 10.1002/art.1790080412; Pud D, 2006, DRUG ALCOHOL DEPEN, V82, P218, DOI 10.1016/j.drugalcdep.2005.09.007; SALAFFI F, 1991, J RHEUMATOL, V18, P1581; Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x; Sokka T, 2003, BEST PRACT RES CL RH, V17, P427, DOI 10.1016/S1521-6942(03)00020-2; Somers TJ, 2009, J PAIN SYMPTOM MANAG, V37, P863, DOI 10.1016/j.jpainsymman.2008.05.009; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208	27	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195075	10.1371/journal.pone.0195075	http://dx.doi.org/10.1371/journal.pone.0195075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630676	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000024
J	Ikka, T; Yamashita, H; Kurita, I; Tanaka, Y; Taniguchi, F; Ogino, A; Takeda, K; Horie, N; Hojo, H; Nanjo, F; Morita, A				Ikka, Takashi; Yamashita, Hiroto; Kurita, Ikuya; Tanaka, Yasuno; Taniguchi, Fumiya; Ogino, Akiko; Takeda, Kazuya; Horie, Nobuhiro; Hojo, Hiroshi; Nanjo, Fumio; Morita, Akio			Quantitative validation of nicotine production in tea (Camellia sinensis L.)	PLOS ONE			English	Article							WOUND-INDUCED CHANGES; DIETARY NICOTINE; GENE-EXPRESSION; JASMONIC ACID; BIOSYNTHESIS; PLANTS; MS/MS	Endogenous nicotine was confirmed to be present in tea plants (Camellia sinensis L.) by liquid chromatography-tandem mass spectrometry of tea samples from tea-producing regions in six Asian countries. All samples contained nicotine (0.011-0.694 mu g g(-1) dry weight). Nicotine contents remained constant during manufacturing of green, oolong and black teas, implying that nicotine is stable against heating, drying, enzymatic oxidation and mechanical damage during processing. Flower buds and seeds of cultivar Yabukita also contained nicotine (0.030-0.041 mu g g(-1) dry weight). A comparison of two cultivars revealed that higher nicotine contents were found in the black tea cultivar Benifuki. All plant parts of hydroponic Yabukita contained nicotine (0.003-0.013 mu g g(-1) dry weight). Tea cells cultured in B5 medium as well as roots and stems of tea seedlings contained nicotine levels similar to those of new leaves from field-grown plants. Although the levels of endogenous nicotine in tea plants are extremely low and sample contamination cannot be discounted, these levels exceed the maximum acceptable limit in Japan (0.01 mu g g(-1) dry weight).	[Ikka, Takashi; Yamashita, Hiroto; Kurita, Ikuya; Tanaka, Yasuno; Morita, Akio] Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka, Japan; [Taniguchi, Fumiya; Ogino, Akiko] NIFTS, Tea Res Div, Makurazaki, Kagoshima, Japan; [Takeda, Kazuya; Horie, Nobuhiro; Hojo, Hiroshi; Nanjo, Fumio] Mitsui Norin Co Ltd, Fujieda, Shizuoka, Japan	Shizuoka University; Mitsui Norin Co. Ltd.	Morita, A (corresponding author), Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka, Japan.	morita.akio@shizuoka.ac.jp		Ikka, Takashi/0000-0002-1845-5658	Japanese Society for the Promotion of Science [26292010, 17H03756]; public research funds in Japan (JSPS KAKENHI); Mitsui Norin Co. Ltd	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); public research funds in Japan (JSPS KAKENHI); Mitsui Norin Co. Ltd(Mitsui & Co., LTD.)	This work was supported by the Japanese Society for the Promotion of Science Grant-in-Aid for Scientific Research Number 26292010 (AM) and 17H03756 (AM). We carried out this research entirely through public research funds in Japan (JSPS KAKENHI). We did not receive financial assistance for this study from the relevant private company (Mitsui Norin Co. Ltd); Mitsui Norin Co. Ltd provided salaries for authors KT, NH, HH and FN. The specific roles of these authors are articulated in the 'author contributions' section. The funders also did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript.	Andersson C., 2003, NICOTINE ALKALOIDS S, P17; BALDWIN IT, 1994, J CHEM ECOL, V20, P2139, DOI 10.1007/BF02066250; Baldwin IT, 1997, PLANTA, V201, P397, DOI 10.1007/s004250050082; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; CASTRO A, 1986, BIOCHEM ARCH, V2, P91; Cavalieri C, 2010, FOOD ADDIT CONTAM A, V27, P473, DOI 10.1080/19440040903479768; Chou WM, 1998, PLANT J, V15, P289, DOI 10.1046/j.1365-313X.1998.00220.x; DAVIS RA, 1991, FOOD CHEM TOXICOL, V29, P821, DOI 10.1016/0278-6915(91)90109-K; DAWSON RF, 1948, ADV ENZYMOL REL S BI, V8, P203; DOMINO EF, 1993, NEW ENGL J MED, V329, P437, DOI 10.1056/NEJM199308053290619; EFSA, 2009, EFSA J RN 286, P1; El-Ramady H, DBG REPORTS 2015; European Food Safety Authority, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2098; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Alonso SG, 2012, SCI TOTAL ENVIRON, V416, P527, DOI 10.1016/j.scitotenv.2011.11.046; HASHIMOTO T, 1994, ANNU REV PLANT PHYS, V45, P257, DOI 10.1146/annurev.pp.45.060194.001353; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; International Tea Committee (ITC), 2015, INT TEA COMM ANN B S; Jin YF, 2015, CORESTA M AGR PHYT A, V41; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; KONISHI S, 1985, SOIL SCI PLANT NUTR, V31, P361, DOI 10.1080/00380768.1985.10557443; Kuboi T, 1994, TEA RES J JAPAN, V80, P8; Lee KW, 2002, J NUTR, V132, P785, DOI 10.1093/jn/132.4.785; Li F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3623898; Malmberg RL, 1998, CRIT REV PLANT SCI, V17, P199, DOI 10.1016/S0735-2689(98)00358-X; Michael AJ, 2016, J BIOL CHEM; Morita A, 2011, SOIL SCI PLANT NUTR, V57, P796, DOI 10.1080/00380768.2011.629176; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Petterson DS, 1991, TOXIC SUBSTANCES CRO; SHEEN SJ, 1988, J FOOD SCI, V53, P1572, DOI 10.1111/j.1365-2621.1988.tb09328.x; Shi QM, 2006, J EXP BOT, V57, P2899, DOI 10.1093/jxb/erl051; Shoji T, 2000, PLANT CELL PHYSIOL, V41, P1072, DOI 10.1093/pcp/pcd027; Shoji T, 2013, HERBACEOUS PLANTS CU, P37; Siegmund B, 1999, J AGR FOOD CHEM, V47, P3113, DOI 10.1021/jf990089w; Suzuki T, 2003, BIOSCI BIOTECH BIOCH, V67, P2683, DOI 10.1271/bbb.67.2683; Thrane C, 2015, EUR FOOD RES TECHNOL, V241, P227, DOI 10.1007/s00217-015-2447-5; Wang SS, 2008, J INTEGR PLANT BIOL, V50, P958, DOI 10.1111/j.1744-7909.2008.00684.x; Xu BF, 2004, PLANT GROWTH REGUL, V44, P101, DOI 10.1023/B:GROW.0000049419.22779.f5	38	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195422	10.1371/journal.pone.0195422	http://dx.doi.org/10.1371/journal.pone.0195422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630638	Green Published, gold			2022-12-27	WOS:000429505000048
J	Polyzos, AA; Wood, NI; Williams, P; Wipf, P; Morton, AJ; McMurray, CT				Polyzos, Aris A.; Wood, Nigel I.; Williams, Paul; Wipf, Peter; Morton, A. Jennifer; McMurray, Cynthia T.			XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age-and sex-dependent	PLOS ONE			English	Article							CAG REPEAT; CARDIOLIPIN OXIDATION; MOTOR DEFICITS; MICE; PHENOTYPE; LENGTH; PATHOPHYSIOLOGY; ABNORMALITIES; INSTABILITY; NITROXIDE	We have reported that the radical scavenger XJB-5-131 attenuates or reverses progression of the disease phenotype in the HdhQ(150/150) mouse, a slow onset model of HD. Here, we tested whether XJB-5-131 has beneficial effects in R6/2 mice, a severe early onset model of HD. We found that XJB-5-131 has beneficial effects in R6/2 mice, by delaying features of the motor and histological phenotype. The impact was sex-dependent, with a stronger effect in male mice. XJB-5-131 treatment improved some locomotor deficits in female R6/2 mice, but the effects were, in general, greater in male mice. Chronic treatment of male R6/2 mice with XJB-5-1-131 reduced weight loss, and improved the motor and temperature regulation deficits, especially in male mice. Treatment with XJB-5-131 had no effect on the lifespan of R6/2 mice. Nevertheless, it significantly slowed somatic expansion at 90 days, and reduced the density of inclusions. Our data show that while treatment with XJB-5-131 had complex effects on the phenotype of R6/2 mice, it produced a number of significant improvements in this severe model of HD.	[Polyzos, Aris A.; Williams, Paul; McMurray, Cynthia T.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Wood, Nigel I.; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Anat Bldg, Cambridge, England; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McMurray, CT (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	ctmcmurray@lbl.gov	Classen, Scott/AAY-8176-2020; Wipf, Peter/AAG-1771-2021; Morton, Jenny/AAT-8642-2020	Wipf, Peter/0000-0001-7693-5863; Morton, Jenny/0000-0003-0181-6346; Polyzos, Aris/0000-0002-9542-5807	National Institutes of Health [NS060115, CA092584, GM066359, AG04337601]; CHDI Inc.; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants, NS060115 (to CTM), and CA092584 (to CTM), GM066359 (to CTM), AG04337601 (to PW). AJM is funded by CHDI Inc.	Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Budworth H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005267; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chan RB, 2012, NAT NEUROSCI, V15, P1325, DOI 10.1038/nn.3222; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Duzdevich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017119; Epperly MW, 2017, IN VIVO, V31, P39, DOI 10.21873/invivo.11022; Escobales N, 2014, J MOL CELL CARDIOL, V77, P136, DOI 10.1016/j.yjmcc.2014.10.009; Fink MP, 2007, BIOCHEM PHARMACOL, V74, P801, DOI 10.1016/j.bcp.2007.05.019; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Hunt MJ, 2005, EXP BRAIN RES, V166, P220, DOI 10.1007/s00221-005-2357-z; Javadov S, 2015, ONCOTARGET, V6, P39469, DOI 10.18632/oncotarget.5783; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2009, ADV DRUG DELIVER REV, V61, P1375, DOI 10.1016/j.addr.2009.06.008; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Krainz T, 2016, ACS CENTRAL SCI, V2, P653, DOI 10.1021/acscentsci.6b00199; Larson E, 2015, NEUROBIOL DIS, V76, P98, DOI 10.1016/j.nbd.2015.01.004; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; Nasto LA, 2013, J ORTHOP RES, V31, P1150, DOI 10.1002/jor.22320; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Polyzos A, 2016, HUM MOL GENET, V25, P1792, DOI 10.1093/hmg/ddw051; Rasband W.S., 2015, IMAGE J; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Skillings EA, 2016, J HUNTINGTONS DIS, V5, P19, DOI 10.3233/JHD-160189; Trushina E, 2014, HUM MOL GENET, V23, P129, DOI 10.1093/hmg/ddt406; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xun ZY, 2012, CELL REP, V2, P1137, DOI 10.1016/j.celrep.2012.10.001	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194580	10.1371/journal.pone.0194580	http://dx.doi.org/10.1371/journal.pone.0194580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630611	Green Published, gold, Green Submitted			2022-12-27	WOS:000429505000013
J	Olariu, E; Pooley, N; Danel, A; Miret, M; Preiser, JC				Olariu, Elena; Pooley, Nicholas; Danel, Aurelie; Miret, Montserrat; Preiser, Jean-Charles			A systematic scoping review on the consequences of stress-related hyperglycaemia	PLOS ONE			English	Review							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL GLUCOSE CONTROL; TRAUMA PATIENTS; INSULIN THERAPY; ADMISSION HYPERGLYCEMIA; PERSISTENT HYPERGLYCEMIA; HOSPITAL MORTALITY; GLYCEMIC CONTROL	Background Stress-related hyperglycaemia (SHG) is commonly seen in acutely ill patients and has been associated with poor outcomes in many studies performed in different acute care settings. We aimed to review the available evidence describing the associations between SHG and different outcomes in acutely ill patients admitted to an ICU. Study designs, populations, and outcome measures used in observational studies were analysed. Methods We conducted a systematic scoping review of observational studies following the Joanna Briggs methodology. Medline, Embase, and the Cochrane Library were searched for publications between January 2000 and December 2015 that reported on SHG and mortality, infection rate, length of stay, time on ventilation, blood transfusions, renal replacement therapy, or acquired weakness. Results The search yielded 3,063 articles, of which 43 articles were included (totalling 536,476 patients). Overall, the identified studies were heterogeneous in study conduct, SHG definition, blood glucose measurements and monitoring, treatment protocol, and outcome reporting. The most frequently reported outcomes were mortality (38 studies), ICU and hospital length of stay (23 and 18 studies, respectively), and duration of mechanical ventilation (13 studies). The majority of these studies (40 studies) compared the reported outcomes in patients who experienced SHG with those who did not. Fourteen studies (35.9%) identified an association between hyperglycaemia and increased mortality (odds ratios ranging from 1.13 to 2.76). Five studies identified hyperglycaemia as an independent risk factor for increased infection rates, and one identified it as an independent predictor of increased ICU length of stay. Discussion SHG was consistently associated with poor outcomes. However, the wide divergences in the literature mandate standardisation of measuring and monitoring SHG and the creation of a consensus on SHG definition. A better comparability between practices will improve our knowledge on SHG consequences and management.	[Olariu, Elena; Pooley, Nicholas] PHMR Ltd, London, England; [Danel, Aurelie; Miret, Montserrat] Nestle Hlth Sci, Vevey, Switzerland; [Preiser, Jean-Charles] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium	Nestle SA; Universite Libre de Bruxelles	Preiser, JC (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium.	Jean-Charles.Preiser@erasme.ulb.ac.be	Preiser, Jean-Charles/AAL-2355-2021; Olariu, Elena/B-1303-2015	Preiser, Jean-Charles/0000-0003-3163-0390; Olariu, Elena/0000-0002-8718-5516	Nestle (Vevey, Switzerland)	Nestle (Vevey, Switzerland)	PHMR was commissioned by Nestle Health Science to perform this research. In collaboration with Nestle Health Science, PHMR wrote the scoping review's protocol, designed the search strategy and eligibility criteria, performed the study selection, charted the data and summarised the results. A protocol was not registered for this systematic scoping review as PROSPERO currently does not accept systematic scoping review protocols (personal communication). All authors had full access to the data. All authors had final responsibility for the decision to submit for publication. At the time of writing, EO and NP were permanent employees of PHMR; AD and MM are permanent employees of Nestle Health Science; J-CP has received honoraria for speeches and consultancy fees from Nestle (Vevey, Switzerland).	Abdelhamid YA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1471-6; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Bochicchio GV, 2005, AM SURGEON, V71, P171; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Chabok SY, 2009, ACTA MED IRANICA; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc4957; Deckers JW, 2013, AM J CARDIOL, V112, P1306, DOI 10.1016/j.amjcard.2013.06.007; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P506, DOI 10.1177/0148607112458526; Donati A, 2014, CRIT CARE RESUSC, V16, P13; Duane TM, 2008, J TRAUMA, V64, P1184, DOI 10.1097/TA.0b013e31816c5c95; Duane TM, 2006, AM SURGEON, V72, P613; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Eslami S, 2008, CRIT CARE, V12, DOI 10.1186/cc7114; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Gale SC, 2007, AM SURGEON, V73, P454; Gornik I, 2010, CRIT CARE, V14, DOI 10.1186/cc9101; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jones S, 2011, JBI LIB SYST REV, V9, P418; Juneja R, 2009, CRIT CARE, V13, DOI 10.1186/cc8129; Kadri Z, 2006, HEART, V92, P910, DOI 10.1136/hrt.2005.073791; Kalfon P, 2014, INTENS CARE MED, V40, P171, DOI 10.1007/s00134-013-3189-0; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kreutziger J, 2015, INJURY, V46, P15, DOI 10.1016/j.injury.2014.09.018; Krinsley JS, 2017, ENDOCR PRACT, V23, P318, DOI 10.4158/EP161532.OR; Krinsley JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0908-7; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kuppinger D, 2013, NUTRITION, V29, P708, DOI 10.1016/j.nut.2012.11.019; Lacherade JC, 2007, INTENS CARE MED, V33, P814, DOI 10.1007/s00134-007-0543-0; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Leite SAO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-49; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levin PD, 2008, ENDOCRINOLOGIST, V18, P304, DOI 10.1097/TEN.0b013e31818fee7c; Lionel KR, 2014, INDIAN J CRIT CARE M, V18, P21, DOI 10.4103/0972-5229.125431; Lucas Marília Coelho Silva, 2012, Rev. bras. ter. intensiva, V24, P157, DOI 10.1590/S0103-507X2012000200010; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McAllister DA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001708; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Mesotten D, 2015, LANCET DIABETES ENDO, V3, P723, DOI 10.1016/S2213-8587(15)00223-5; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Plummer MP, 2014, INTENS CARE MED, V40, P973, DOI 10.1007/s00134-014-3287-7; Preiser JC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1607-3; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Safavi M, 2009, ULUS TRAVMA ACIL CER, V15, P120; Salim A, 2009, AM SURGEON, V75, P25; Santhanam R, 2007, NEUROL INDIA, V55, P349; Schlussel AT, 2012, J SURG RES, V176, P202, DOI 10.1016/j.jss.2011.07.004; Schlussel Andrew T, 2011, J Diabetes Sci Technol, V5, P731; Shin S, 2007, AM SURGEON, V73, P769; Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc9369; Smith RS, 2012, AM J SURG, V204, P915, DOI 10.1016/j.amjsurg.2012.05.016; Sperry JL, 2009, J TRAUMA, V66, P1076, DOI 10.1097/TA.0b013e31817db0de; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van Ackerbroeck S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1064-9; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Yuan YH, 2009, AM J GASTROENTEROL, V104, P1086, DOI 10.1038/ajg.2009.118	76	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194952	10.1371/journal.pone.0194952	http://dx.doi.org/10.1371/journal.pone.0194952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624594	Green Published, gold, Green Submitted			2022-12-27	WOS:000429379600011
J	Pinto, HA; Goncalves, NQ; Lopez-Hernandez, D; Pulido-Murillo, EA; Melo, AL				Pinto, Hudson A.; Goncalves, Nicole Q.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.			The life cycle of a zoonotic parasite reassessed: Experimental infection of Melanoides tuberculata (Mollusca: Thiaridae) with Centrocestus formosanus (Trematoda: Heterophyidae)	PLOS ONE			English	Article							CRYPTOCOTYLE-LINGUA CREPLIN; FRESH-WATER FISH; DIGENEA-HETEROPHYIDAE; SYSTEMATIC POSITION; INTERMEDIATE HOST; CHIANG-MAI; MORPHOLOGY; HISTORY; METACERCARIAE; PREVALENCE	Centrocestus formosanus is a foodborne intestinal trematode that is native to Asia and has been introduced into the Americas and Europe. Although there are several studies of C. formosanus in definitive vertebrate hosts (birds and mammals, including humans), and in intermediate vertebrate hosts (fish and amphibians), there is little published information regarding interaction with its transmitting mollusc. In this study we studied the miracidial development of C. formosanus using a mouse as a source of eggs. Adult parasites were maintained in water in order to develop miracidia in intrauterine eggs. Miracidia appeared at 12 days of incubation, with no hatching observed for up to 40 days. Subsequently, we placed dead C. formosanus containing eggs with miracidia individually in contact with 48 specimens of Melanoides tuberculata, and observed the absence of the parasites after 1 h of exposure, suggesting that they were ingested by the snails. Of the 33 experimentally-infected snails that were alive after 84-89 days post-infection (DPI), seven (21%) shed cercariae. We detected young C. formosanus rediae in 21/33 (64%) M. tuberculata at 90 DPI. To our knowledge, this report is the first to show that, in the life cycle of C. formosanus, infection of molluscs occurs passively by ingestion of eggs, followed by a long intramolluscan phase. We compare these data with those described for other Heterophyidae, and discuss on the phylogenetic background of the pattern of miracidial development verified in these parasites.	[Pinto, Hudson A.; Goncalves, Nicole Q.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Pinto, HA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.	hudsonalves13@icb.ufmg.br	Pinto, Hudson/AAE-7958-2021	Pinto, Hudson/0000-0002-5519-1348; Pulido Murillo, Eduardo Alberto/0000-0002-9039-3068	Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG) [Edital 02/2018]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG), with grant from the Edital 02/2018, to HAP. NQG received funding from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. DL-H and EAP-M received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL P K, 1981, Rivista di Parassitologia, V42, P185; AMEEL DJ, 1950, J PARASITOL, V36, P427, DOI 10.2307/3273167; AMEEL DONALD J., 1938, JOUR PARASITOL, V24, P219, DOI 10.2307/3272291; Bearup A. J., 1962, Proceedings of the Linnean Society of New South Wales, V86, P251; BURNS WC, 1953, J PARASITOL, V39, P60, DOI 10.2307/3274061; Cable RM, 1937, Q J MED SCI, V76, P573; Cameron T. W. M., 1937, Canadian Journal of Research Ottawa D, V15, P38; Cantu V, 2013, PARASITOLOGY, V140, P814, DOI 10.1017/S0031182013000085; Chai Jong-Yil, 2017, Food Waterborne Parasitol, V8-9, P33, DOI 10.1016/j.fawpar.2017.09.001; Chai JY, 2013, J PARASITOL, V99, P531, DOI 10.1645/12-37.1; CHEN H. T., 1948, LINGNANSCI JOUR, V22, P93; CHEN H. T., 1942, JOUR PARASITOL, V28, P285, DOI 10.2307/3272966; CRIBB TH, 1986, AUST J ZOOL, V34, P279, DOI 10.1071/ZO9860279; DUDGEON D, 1986, J ZOOL, V208, P37; El-Naffar M.K., 1980, Journal of the Egyptian Society of Parasitology, V10, P117; Simoes SBE, 2010, ACTA TROP, V113, P226, DOI 10.1016/j.actatropica.2009.10.020; Simoes SBE, 2009, MEM I OSWALDO CRUZ, V104, P106, DOI 10.1590/S0074-02762009000100016; Faust E. C., 1926, Journal of Parasitology Urbana, V13, P91, DOI 10.2307/3271705; FAUST EC, 1927, AM J HYG, V8, P1; Fleming BP, 2011, J AQUAT ANIM HEALTH, V23, P117, DOI 10.1080/08997659.2011.616840; Frankel VM, 2015, INT J PARASITOL, V45, P703, DOI 10.1016/j.ijpara.2015.03.012; Garcia-Vedrenne AE, 2017, INT J PARASITOL, V47, P41, DOI 10.1016/j.ijpara.2016.10.003; Han ET, 2008, KOREAN J PARASITOL, V46, P49, DOI 10.3347/kjp.2008.46.1.49; Huston DC, 2014, J PARASITOL, V100, P239, DOI 10.1645/13-419.1; Iakovleva NV, 2006, EXP PARASITOL, V113, P24, DOI 10.1016/j.exppara.2005.12.002; IRWIN SWB, 1978, PARASITOLOGY, V76, P193, DOI 10.1017/S0031182000047776; Mendoza-Estrada LJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8272407; Johnson MS, 2012, J PARASITOL, V98, P111, DOI 10.1645/GE-2841.1; Kimura D, 2007, VET PARASITOL, V146, P367, DOI 10.1016/j.vetpar.2007.02.032; KOIE M, 1990, SYST PARASITOL, V15, P141, DOI 10.1007/BF00009992; Krailas D, 2016, ACTA TROP, V156, P79, DOI 10.1016/j.actatropica.2016.01.007; Kudo N, 2014, J VET MED SCI, V76, P1531, DOI 10.1292/jvms.14-0281; KUNTZ RE, 1956, J PARASITOL, V42, P613, DOI 10.2307/3274882; Kvach Y, 2017, PARASITOL RES, V116, P1973, DOI 10.1007/s00436-017-5480-4; Lo CT, 1996, J PARASITOL, V82, P347, DOI 10.2307/3284178; LYSTER L. L., 1940, CANADIAN JOUR RES SECT D ZOOL SCI, V18, P106; MARTIN WE, 1958, J PARASITOL, V44, P305, DOI 10.2307/3274597; Mitchell AJ, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:SOAEFT]2.0.CO;2; Moszczynska A, 2009, MOL ECOL RESOUR, V9, P75, DOI 10.1111/j.1755-0998.2009.02634.x; NIEMI DR, 1974, P HELM SOC WASH, V41, P223; NISHIGORI M., 1924, TAIWAN IGAKKAI ZASSH, V234, P181; NODA K, 1959, J PARASITOL, V45, P635, DOI 10.2307/3274816; dos Santos EGN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-92; ODENING K, 1970, Z PARASITENK, V33, P194; Ostrowski de Nunez M, 2001, ACTA PARASITOL, V46, P119; PERKINS K. W., 1956, AMER MIDLAND NAT, V55, P139, DOI 10.2307/2422329; Pinto Hudson A, 2014, ScientificWorldJournal, V2014, P807492, DOI 10.1155/2014/807492; Pinto HA, 2015, PARASITOL INT, V64, P236, DOI 10.1016/j.parint.2015.02.002; Pinto HA, 2011, ZOOTAXA, P15, DOI 10.11646/zootaxa.2799.1.2; Pinto HA, 2012, REV BRAS PARASITOL V, V21, P334, DOI 10.1590/S1984-29612012000300032; Pinto HA, 2010, REV INST MED TROP SP, V52, P207, DOI 10.1590/S0036-46652010000400008; Scholz T, 2000, AM MIDL NAT, V143, P185, DOI 10.1674/0003-0031(2000)143[0185:TIADOC]2.0.CO;2; SHAMEEM U, 1988, SYST PARASITOL, V11, P73, DOI 10.1007/BF00006979; SHEN W. X., 1959, ACTA ZOOL SINICA, V11, P470; Shimazu T, 2015, KOREAN J PARASITOL, V53, P627, DOI 10.3347/kjp.2015.53.5.627; Stoyanov B, 2015, SYST PARASITOL, V91, P1, DOI 10.1007/s11230-015-9559-y; Stunkard HW, 1930, J MORPHOL, V50, P143, DOI 10.1002/jmor.1050500106; STUNKARD HW, 1955, BIOL BULL, V109, P475, DOI 10.2307/1539177; TARASCHEWSKI H, 1985, Z PARASITENKD, V71, P505, DOI 10.1007/BF00928353; Mati VLT, 2013, REV INST MED TROP SP, V55, P133, DOI 10.1590/S0036-46652013000200013; Thaenkham U, 2012, PARASITOL INT, V61, P90, DOI 10.1016/j.parint.2011.06.004; Thaenkham U, 2011, PARASITOL INT, V60, P521, DOI 10.1016/j.parint.2011.07.015; Le TH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1968-0; Tolley-Jordan LR, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P401; Van KV, 2012, NANFANG NONGYE XUEBA, V43, P520, DOI DOI 10.3969/j:issn.2095-1191.2012.04.520; Wanlop A, 2017, KOREAN J PARASITOL, V55, P445, DOI 10.3347/kjp.2017.55.4.445; Wongsawad C, 2017, KOREAN J PARASITOL, V55, P31, DOI 10.3347/kjp.2017.55.1.31; WOOTTON DM, 1957, J PARASITOL, V43, P271, DOI 10.2307/3274345; YAMAGUTI S, 1975, SYNOPTICAL REV LIFE; Yousif F, 2016, EXP PARASITOL, V168, P56, DOI 10.1016/j.exppara.2016.06.007	70	3	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194161	10.1371/journal.pone.0194161	http://dx.doi.org/10.1371/journal.pone.0194161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624583	Green Submitted, Green Published, gold			2022-12-27	WOS:000429379600005
J	Vano, YA; Oudard, S; By, MA; Tetu, P; Thibault, C; Aboudagga, H; Scotte, F; Elaidi, R				Vano, Yann-Alexandre; Oudard, Stephane; By, Marie-Agnes; Tetu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotte, Florian; Elaidi, Reza			Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; NEUTROPHIL/LYMPHOCYTE RATIO; INDEPENDENT PREDICTOR; PROGNOSTIC-FACTOR; MONOCYTE COUNTS; SURVIVAL; CHEMOTHERAPY; INFLAMMATION; CARCINOMA; INDICATOR	This study assessed the prognostic value of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic solid tumors. Clinical and biological data for patients with metastatic solid tumors treated in an oncology outpatient department and prospectively followed by a call center (PROCHE program) between January 2008 and December 2011 were analyzed. All patients with an NLR value within 28 days before the first cycle of first line of chemotherapy were included (cohort 1). To assess influence of chemotherapy line on NLR prognostic value, data from patients treated with later chemotherapy lines were also analyzed (cohort 2). Adjusted multivariate Cox regressions with or without non-linear and time-dependent effects were performed. Optimal NLR cut-off was investigated by time dependent sensitivity analysis using several indices. There were 317 and 134 patients in cohorts 1 and 2, respectively. Elevated NLR was associated with worse survival (hazard ratio [HR] for death, 1.35 [95% confidence interval 1.19-1.54]; p<0.0001). The optimal NLR cut-off in cohort 1 was dependent on index used and time of assessment: HR values were non-significant at a cut-off of 3.0 (1.34 [0.99-1.32], but significant when the cut-off was 4.0 (1.53 [1.11-2.10]). NLR was linearly related to mortality risk; in subgroup analysis, no significant interaction was found with co-variables or tumor localization overall (cohorts 1+2). Pretreatment NLR is a useful prognostic tool in patients with metastatic solid tumors, irrespective of primary tumor site, chemotherapy line, age, gender and performance status. However, using an NLR cut-off value for clinical decision-making requires extreme caution.	[Vano, Yann-Alexandre; Oudard, Stephane; Tetu, Pauline; Thibault, Constance; Scotte, Florian] Hop Europeen Georges Pompidou, Dept Oncol, Paris, France; [Vano, Yann-Alexandre; Oudard, Stephane; Tetu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotte, Florian] Univ Paris 5 Descartes, Paris, France; [Vano, Yann-Alexandre] Cordeliers Res Ctr, Canc Immune Control & Escape, UMRS1138, Paris, France; [Oudard, Stephane] INSERM U970, Angiogenesis & Immunotherapy Lab, PARCC, Team 10, Paris, France; [By, Marie-Agnes] CHU Bretonneau, Dept Oncol, Tours, France; [Aboudagga, Hail] Hop Europeen Georges Pompidou, Dept Pharm, Paris, France; [Elaidi, Reza] Hop Europeen Georges Pompidou, Dept Oncol, Assoc Rech Therapeut Innovantes Cancerol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Vano, YA (corresponding author), Hop Europeen Georges Pompidou, Dept Oncol, Paris, France.; Vano, YA (corresponding author), Univ Paris 5 Descartes, Paris, France.; Vano, YA (corresponding author), Cordeliers Res Ctr, Canc Immune Control & Escape, UMRS1138, Paris, France.	yann.vano@aphp.fr		Vano, Yann-Alexandre/0000-0002-9410-1368; OUDARD, Stephane/0000-0003-0893-285X				Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beuselinck B, 2014, BJU INT, V114, P81, DOI 10.1111/bju.12494; Botta C, 2011, EUR J CANCER, V47, pS181, DOI 10.1016/S0959-8049(11)70932-7; Cho H, 2009, BIOMARKERS, V14, P161, DOI 10.1080/13547500902777616; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Dirican A, 2015, INT J CLIN ONCOL, V20, P70, DOI 10.1007/s10147-014-0672-8; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Giraldo NA, 2015, VIRCHOWS ARCH, V467, P127, DOI 10.1007/s00428-015-1787-7; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ishizuka M, 2012, ANTICANCER RES, V32, P3291; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Luo Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001670; Ma Jin-ping, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P944; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Miskolci V, 2007, MOL MED, V13, P134, DOI 10.2119/2006-00072.Miskolci; Nakamura Y, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0904-7; Ohki S, 2012, ONCOL REP, V28, P453, DOI 10.3892/or.2012.1812; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Salim DK, 2015, MOL CLIN ONCOL, V3, P839, DOI 10.3892/mco.2015.557; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Scotte F, 2013, EUR J CANCER, V49, P541, DOI 10.1016/j.ejca.2012.08.025; Taguchi S, 2015, INT J UROL, V22, P638, DOI 10.1111/iju.12766; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; van Soest RJ, 2015, ANN ONCOL, V26, P743, DOI 10.1093/annonc/mdu569; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang SY, 2011, ONCOL LETT, V2, P735, DOI 10.3892/ol.2011.304; Wang Y, 2015, CANCER CHEMOTH PHARM, V75, P255, DOI 10.1007/s00280-014-2622-6; Zhang GM, 2015, INT J CLIN ONCOL, DOI 10.1007/s10147-015-0894-4; Zhao QT, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S90875; Zhao WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31394	40	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195042	10.1371/journal.pone.0195042	http://dx.doi.org/10.1371/journal.pone.0195042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624591	Green Submitted, Green Published, gold			2022-12-27	WOS:000429379600012
J	Jehu, DA; Cantu, H; Hill, A; Paquette, C; Cote, JN; Nantel, J				Jehu, Deborah A.; Cantu, Hiram; Hill, Allen; Paquette, Caroline; Cote, Julie N.; Nantel, Julie			Medication and trial duration influence postural and pointing parameters during a standing repetitive pointing task in individuals with Parkinson's disease	PLOS ONE			English	Article							DISCRETE COGNITIVE TASKS; OLDER-ADULTS; LIMB MOVEMENTS; DUAL-TASKING; GAIT; FALLS; BALANCE; PEOPLE; SWAY; STABILITY	We aimed to determine the effects of levodopa medication on the performance of a repetitive pointing task while standing, and to investigate the optimal trial duration in individuals with Parkinson's disease, and older adults. Seventeen individuals with Parkinson's disease (5 freezers) and 9 older adults stood on force platforms for 30 s and 120 s while performing a bilateral repetitive pointing task, tracked by motion capture. Participants with Parkinson's disease were assessed on and off medication and older adults were also assessed on separate days. The main findings were that: 1) on medication, participants with Parkinson's exhibited greater center of pressure root mean square in the medial-lateral direction, greater velocity in the medial-lateral and anterior-posterior directions, and greater range in the medial-lateral direction than off medication; 2) longer trial durations resulted in greater center of pressure range in the medial-lateral and anterior-posterior directions and greater coefficient of variation in finger pointing on the least affected side; 3) Parkinson's participants exhibited larger range in the medial-lateral direction compared to older adults; 4) off medication, freezers presented with less range and root mean square in the anterior-posterior direction than non-freezers; and 5) a correlation emerged between the freezing of gait questionnaire and pointing asymmetry and the coefficient of variation of pointing on the most affected side. Therefore, Parkinson's medication may increase instability during a repetitive pointing task. Longer trials may provide a better depiction of sway by discriminating between those with and without neurological impairment. Individuals with Parkinson's were less stable than older adults, supporting that they are at a greater risk for falls. The greater restrictive postural strategy in freezers compared to non-freezers is likely a factor that augments fall risk. Lastly, the link between freezing of gait and upper-limb movement indicates that freezing may manifest first in the lower-limbs.	[Jehu, Deborah A.; Hill, Allen; Nantel, Julie] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Cantu, Hiram; Paquette, Caroline; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Paquette, Caroline; Cote, Julie N.] Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada	University of Ottawa; McGill University; Universite de Montreal	Nantel, J (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	jnantel@uottawa.ca	Nantel, Julie/AAE-8114-2021; paquette, caroline/U-3793-2019	paquette, caroline/0000-0001-8109-5301; Jehu, Deborah/0000-0002-9084-7445; Hill, Allen/0000-0003-0939-0765; Nantel, Julie/0000-0001-7253-9222	Canada Foundation for Innovation [10131]; Natural Sciences and Engineering Research Council [05111]; National Council on Science and Technology of Mexico (CONACYT); Bloomberg Manulife Fellowship	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Council on Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Bloomberg Manulife Fellowship	This project was supported by grants from: 1. The Canada Foundation for Innovation (#10131), https://www.innovation.ca/fr; 2. The Natural Sciences and Engineering Research Council (#05111), http://www.nserc-crsng.gc.ca; 3. Hiram Cantu was supported by PhD fellowships from the National Council on Science and Technology of Mexico (CONACYT), https://twas.org/partner/national-council-science-and-technology-mexico; and 4. The Bloomberg Manulife Fellowship, https://www.mcgill.ca/bloomberg-manulife/fellowships.	Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; Armand S, 2009, PARKINSONISM RELAT D, V15, P359, DOI 10.1016/j.parkreldis.2008.08.007; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Barbieri FA, 2016, HUM MOVEMENT SCI, V46, P96, DOI 10.1016/j.humov.2015.12.009; Beaulne-Seguin Z, 2016, GAIT POSTURE, V49, P443, DOI 10.1016/j.gaitpost.2016.08.002; Blaszczyk JW, 2011, HUM MOVEMENT SCI, V30, P396, DOI 10.1016/j.humov.2010.07.017; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dona F, 2016, PHYSIOTHERAPY, V102, P272, DOI 10.1016/j.physio.2015.08.009; Frenklach A, 2009, MOVEMENT DISORD, V24, P377, DOI 10.1002/mds.22358; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Hayes HA, 2015, MOTOR CONTROL, V19, P325, DOI 10.1123/mc.2014-0039; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Jacobs JV, 2014, PARKINSONISM RELAT D, V20, P779, DOI 10.1016/j.parkreldis.2014.04.001; Jehu DA, MOTOR CONTR IN PRESS; Jehu DA, 2016, AGING CLIN EXP RES, V28, P1211, DOI 10.1007/s40520-015-0513-2; Johnson L, 2013, MOVEMENT DISORD, V28, P1250, DOI 10.1002/mds.25449; Kahneman D., 1973, ATTENTION EFFORT; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 2017, GAIT POSTURE, V55, P43, DOI 10.1016/j.gaitpost.2017.04.003; Lajoie Y, 2016, J MOTOR BEHAV, V48, P264, DOI 10.1080/00222895.2015.1089833; Lamont RM, 2017, GAIT POSTURE, V55, P62, DOI 10.1016/j.gaitpost.2017.04.005; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mancini M, 2008, CLIN BIOMECH, V23, P450, DOI 10.1016/j.clinbiomech.2007.11.007; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; McNeely ME, 2012, GAIT POSTURE, V36, P144, DOI 10.1016/j.gaitpost.2012.02.009; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Nantel J, 2012, NEUROSCIENCE, V221, P151, DOI 10.1016/j.neuroscience.2012.07.007; Nantel J, 2014, PARKINSONISM RELAT D, V20, P447, DOI 10.1016/j.parkreldis.2014.01.017; Nantel J, 2012, PARKINSONISM RELAT D, V18, P285, DOI 10.1016/j.parkreldis.2011.11.005; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nova IC, 2004, PARKINSONISM RELAT D, V10, P411, DOI 10.1016/j.parkreldis.2004.04.004; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Poizner H, 1998, Motor Control, V2, P251; Sciadas R, 2016, HUM MOVEMENT SCI, V47, P135, DOI 10.1016/j.humov.2016.03.003; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Su KJ, 2014, GAIT POSTURE, V39, P65, DOI 10.1016/j.gaitpost.2013.05.029; Tagliabue M, 2009, NEUROSCIENCE, V158, P1206, DOI 10.1016/j.neuroscience.2008.12.007; Tombu M, 2005, J EXP PSYCHOL HUMAN, V31, P790, DOI 10.1037/0096-1523.31.4.790; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Vossius C, 2010, ACTA NEUROL SCAND, V121, P38, DOI 10.1111/j.1600-0404.2009.01239.x; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Zia S, 2000, ANN NEUROL, V47, P218, DOI 10.1002/1531-8249(200002)47:2<218::AID-ANA12>3.3.CO;2-R; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	57	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195322	10.1371/journal.pone.0195322	http://dx.doi.org/10.1371/journal.pone.0195322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621320	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800060
J	Lavalle, L; Thomas, AS; Beaton, B; Ebrahim, H; Reed, M; Ramaswami, U; Elliott, P; Mehta, AB; Hughes, DA				Lavalle, L.; Thomas, A. S.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Elliott, P.; Mehta, A. B.; Hughes, D. A.			Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE; PLASMA; GLOBOTRIAOSYLSPHINGOSINE; HYPERTROPHY; URINE; GENE	Background Fabry disease (FD) results from X-linked inheritance of a mutation in the GLA gene, encoding for alpha galactosidase A, and is characterized by heterogeneous clinical manifestations. Two phenotypes have been described "Classic" and "late onset" which cannot be predicted exclusively by genotype. The latter has been considered an attenuated form of the disease often affecting a single organ system commonly the heart. Recent studies have demonstrated that cardiac outcomes are similar in patients with classic and late onset mutations. In this study we investigate the relationship between clinical heterogeneity and plasma lyso-Gb3 in a large single centre cohort of N215S patients and compare this to patients with other mutations. Methods In this single-centre, retrospective, cross-sectional study we analysed a cohort of 251 FD patients: 84 N215S mutation (37 males) and 167 non-N215S mutations (58 males). The Mainz severity score index (MSSI) was used as an index of overall disease severity. Cardiac function and morphology were assessed by electrocardiogram and echocardiogram. Left ventricular mass was calculated using the Devereux formula and the left ventricular mass index (LVMI) calculated to adjust for height (g/m(2.7)). The presence of white matter lesions was assessed by cerebral MRI or computed tomography (CT). GFR was measured by radio-isotope (chromium-EDTA) method and adjusted for patient height (ml/min/m(2.7)), and urinary protein quantification was undertaken by 24 hour urine collection. Plasma globotriaosylsphingosine (lyso-Gb3) was analysed prior to ERT in 84 patients. Results N215S patients showed later symptom onset (males: p< 0.0001, females: p<0.03), later development of left ventricular hypertrophy (LVH) (median survival without LVH: 41 (non- N215S) vs. 64 (N215S) years, p< 0.0001), later development of proteinuria (median survival without proteinuria 43 (non-N215S) vs 71 years (N215S), p< 0.0001), later occurrence of cerebrovascular events (stroke/ Transient lschaemic Attacks (TIA); median survival without stroke: 74 years (non-N215S) vs. not reached (N215S), p< 0.02), later decline in renal function to GFR <60 ml/min/1.73m(2) (median survival: 56 (non-N215S) vs. 72 (N215S) years, p< 0.01), and greater overall survival (median survival 81 (N215S) vs. 66 (non-N215S) years, p< 0.0006). Lyso-Gb3 was found to be less elevated in N215S compared to non-N215S male and female patients. However, the N215S population eventually reached an overall severity measured by MSSI comparable to the non-N215S without equivalent elevation of lyso-Gb3 (means: 6.7 vs. 74.3 nmol/L, p < 0.001). In addition, N215S patients showed strong correlations between lyso-Gb3 levels and LVMI, GFR, and MSSI. These associations became stronger when we investigated individuals' life time exposure to lyso-Gb3 (calculated as [lyso-Gb3]*age): MSSI (r(2) = 0.88, p< 0.0001), LVMI (r(2) = 0.59, p< 0.005), and GFR (r(2) = 0.75, p = 0.0001). Conclusion These results demonstrate that the N215S mutation results in a late onset phenotype involving the heart and other organs. Correlations between clinical manifestations and plasma lyso-Gb3 variations in this group suggest a Fabry-relevant disease mechanism for the heterogeneity observed in this group.	[Lavalle, L.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Mehta, A. B.; Hughes, D. A.] Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London, England; [Lavalle, L.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Mehta, A. B.; Hughes, D. A.] UCL, Med Sch, London, England; [Thomas, A. S.] Barts Hlth NHS Trust, Barts Heart Ctr, UCL Inst Cardiovasc Sci, London, England; [Elliott, P.] St Georges Hosp NHS Fdn Trust, Haematol Dept, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Barts Health NHS Trust; University of London; University College London	Hughes, DA (corresponding author), Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London, England.	rmgvdah@ucl.ac.uk	Mehta, Atul/GPC-7364-2022; Elliott, Perry/AAR-3430-2020; Mehta, Atul/AAF-3559-2022; Mehta, Atul/AFI-0044-2022	Elliott, Perry/0000-0003-3383-3984; 	Shire [IIRGBR000297]; MPS Society	Shire; MPS Society	This study was funded by Shire (IIRGBR000297, Dr Derralynn Hughes) and the MPS Society (Dr Derralynn Hughes). The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Arends M, 2017, J AM SOC NEPHROL, V28, P1631, DOI 10.1681/ASN.2016090964; Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Carpio D, 2015, HUM MOL GENET; DAVIES JP, 1993, HUM MOL GENET, V2, P1051, DOI 10.1093/hmg/2.7.1051; Deegan PB, 2006, J MED GENET; Desnick RJ, 2004, J PEDIATR-US, V144, pS20, DOI 10.1016/j.jpeds.2004.01.051; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Eng CM, 1994, HUM MUTAT; Ferreira S, 2015, MOL GENET METAB; Germain DP, 1999, BIOCHEM BIOPH RES CO, V257, P708, DOI 10.1006/bbrc.1999.0310; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Hsu TR, 2016, J AM COLL CARDIOL, V68, P2554, DOI 10.1016/j.jacc.2016.09.943; Hughes DA, 2010, MOL GENET METAB, V101, P219, DOI 10.1016/j.ymgme.2010.06.002; Lang RM, 2006, EUR J ECHOCARDIOGR; Liao HC, 2013, CLIN CHIM ACTA; Liu HC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0111-y; Lukas J, 2015, HUM MUTAT; Mehta A, 2002, GENEREVIEWS; MORGAN SH, 1990, Q J MED, V75, P491; Niemann M, 2014, CIRC CARDIOVASC GENE; Nowak A, 2017, MOL GENET METAB; Oder D, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001691; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Patel V, 2016, HEART; Ranieri M, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0414-5; RedonnetVernhet I, 1996, J MED GENET, V33, P682, DOI 10.1136/jmg.33.8.682; Reuter C, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001918; Ries M., 2006, FABRY DIS PERSPECTIV; Rombach SM, 2010, BIOCH BIOPHYS ACTA; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL; Schiffmann R, 2016, GENET MED; Schiffmann R, 2013, GENET MED, V15, P983, DOI 10.1038/gim.2013.56; Seydelmann N, 2015, BEST PRACT RES CLIN; Smid BE, 2015, J MED GENET, V52, P262, DOI 10.1136/jmedgenet-2014-102872; Sterns JD, 2014, FRONT CELL DEV BIOL; Tondel C, 2013, J AM SOC NEPHROL; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	43	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193550	10.1371/journal.pone.0193550	http://dx.doi.org/10.1371/journal.pone.0193550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621274	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800007
J	Kularatne, RS; Muller, EE; Maseko, DV; Kufa-Chakezha, T; Lewis, DA				Kularatne, Ranmini S.; Muller, Etienne E.; Maseko, Dumisile V.; Kufa-Chakezha, Tendesayi; Lewis, David A.			Trends in the relative prevalence of genital ulcer disease pathogens and association with HIV infection in Johannesburg, South Africa, 2007-2015	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SYPHILIS; UGANDA; ETIOLOGY; RAKAI; CIRCUMCISION; CARCINOMA; STAGE; MEN	Background In South Africa, treatment of genital ulcer disease (GUD) occurs in the context of syndromic management. GUD aetiological studies have been conducted in Johannesburg since 2007. We report on GUD pathogen prevalence, sero-prevalence of STI co-infections and aetiological trends among GUD patients presenting to a community-based primary healthcare facility in Johannesburg over a 9-year period. Methods and findings GUD surveys were conducted from January to April each year. Consecutive genital ulcers were sampled from consenting adults. Swab-extracted DNA was tested by multiplex realtime PCR assays for herpes simplex virus (HSV), Treponema pallidum (TP), Haemophilus ducreyi (HD) and Chlamydia trachomatis (CT). HSV-positive DNA extracts were further sub typed into HSV-1 and HSV-2 using a commercial PCR assay; CT-positive extracts were tested with an in-house PCR assay specific for serovars L1-L3 (lymphogranuloma venereum). Sera were tested for HIV, HSV-2, and syphilis co-infections. Giemsa-stained ulcer smears were screened for Klebsiella granulomatis by microscopy. Data were analysed with STATA (TM) version 14. Of 771 GUD specimens, 503 (65.2%) had a detectable pathogen: HSV 468 (60.7%); TP 30 (3.9%); CT L1-3 7 (0.9%); HD 4 (0.5%). No aetiological agents were detected in 270 (34.8%) ulcer specimens. Seroprevalence rates were as follows: HIV 61.7%; HSV-2 80.2% and syphilis 5.8%. There was a strong association between GUD pathogen detection and HIV seropositivity (p < 0.001); 68% of cases caused by HSV were co-infected with HIV. There was a significant decline in the relative prevalence of ulcer derived HSV over time, predominantly from 2013-2015 (p-value for trend = 0.023); and a trend towards a decrease in the HIV seropositivity rate (p-value for trend = 0.209). Conclusions HSV remains the leading cause of pathogen-detectable GUD in South Africa. The prevalence of HIV co-infection among GUD patients is high, underlining the importance of linkage to universal HIV testing and treatment in primary healthcare settings.	[Kularatne, Ranmini S.; Muller, Etienne E.; Maseko, Dumisile V.; Kufa-Chakezha, Tendesayi] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Kularatne, Ranmini S.] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Lewis, David A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Lewis, David A.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Sydney	Kularatne, RS (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Kularatne, RS (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa.	ranminik@nicd.ac.za		Lewis, David/0000-0002-5534-8392; Kufa, Tendesayi/0000-0002-9797-616X				Bailey GP, 2010, J INFECT DIS, V201, P1811, DOI 10.1086/652785; Ballard RC, 2002, SEX TRANSM INFECT, V78, P274, DOI 10.1136/sti.78.4.274; Brankin AE, 2009, INT J STD AIDS, V20, P650, DOI 10.1258/ijsa.2009.009067; Brunasso AMG, 2012, UROLOGY, V80, pE9, DOI 10.1016/j.urology.2012.04.022; Childs T, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.ES.2015.20.48.30076; Cohen Myron S, 2004, Top HIV Med, V12, P104; Gonzalez-Beiras C, 2016, EMERG INFECT DIS, V22, P1, DOI 10.3201/eid2201.150425; Gratzer B, 2014, SEX TRANSM DIS, V41, P285, DOI 10.1097/OLQ.0000000000000126; Gupta V, 2016, INT J STD AIDS, V27, P323, DOI 10.1177/0956462415584484; Hata H, 2010, ACTA DERM-VENEREOL, V90, P539, DOI 10.2340/00015555-0902; Hope-Rapp E, 2010, SEX TRANSM DIS, V37, P153, DOI 10.1097/OLQ.0b013e3181bf5a98; Karumudi Usha Rani, 2005, Expert Rev Anti Infect Ther, V3, P825, DOI 10.1586/14787210.3.5.825; Keogan MT, 2009, CLIN EXP IMMUNOL, V156, P1, DOI 10.1111/j.1365-2249.2008.03857.x; Kiddugavu MG, 2005, SEX TRANSM DIS, V32, P1, DOI 10.1097/01.olq.0000148297.48590.d8; Knaute DF, 2012, CLIN INFECT DIS, V55, P1615, DOI 10.1093/cid/cis757; Lewis D. A., 2009, Southern African Journal of Epidemiology & Infection, V24, P6; Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90; Mehta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038991; Morre SA, 2005, EMERG INFECT DIS, V11, P1311, DOI 10.3201/eid1108.050535; National Department of Health, 2008, 1 LIN COMPR MAN CONT, P1; National Department of Health, 2015, SEX TRANSM INF MAN G; O'Farrell N, 2001, INT J STD AIDS, V12, P423, DOI 10.1258/0956462011923435; Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115; Phiri S, 2013, SEX TRANSM DIS, V40, P923, DOI 10.1097/OLQ.0000000000000051; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Shamini N., 2001, SMJ Singapore Medical Journal, V42, P292; STIGMA, 2019, GUID MAN SEX TRANSM; Tan DHS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004210; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	32	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194125	10.1371/journal.pone.0194125	http://dx.doi.org/10.1371/journal.pone.0194125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617372	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800019
J	Ojanguren, I; Moullec, G; Hobeika, J; Miravitlles, M; Lemiere, C				Ojanguren, Inigo; Moullec, Gregory; Hobeika, Jad; Miravitlles, Marc; Lemiere, Catherine			Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma (vol 13, e0193144, 2018)	PLOS ONE			English	Correction													Miravitlles, Marc/AAH-5284-2019	Miravitlles, Marc/0000-0002-9850-9520; Ojanguren, Inigo/0000-0003-1270-5772				Ojanguren I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193144	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195648	10.1371/journal.pone.0195648	http://dx.doi.org/10.1371/journal.pone.0195648			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617436	gold, Green Published, Green Submitted			2022-12-27	WOS:000429203800096
J	Sobieski, C; Warikoo, N; Shu, HJ; Mennerick, S				Sobieski, Courtney; Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven			Ambient but not local lactate underlies neuronal tolerance to prolonged glucose deprivation	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; MOUSE WHITE-MATTER; SYNAPTIC FUNCTION; IN-VITRO; OXIDATIVE-METABOLISM; EXTRACELLULAR POTASSIUM; ASTROCYTIC GLYCOLYSIS; CULTURED ASTROCYTES; GLYCOGEN-METABOLISM; ENERGY-METABOLISM	Neurons require a nearly constant supply of ATP. Glucose is the predominant source of brain ATP, but the direct effects of prolonged glucose deprivation on neuronal viability and function remain unclear. In sparse rat hippocampal microcultures, neurons were surprisingly resilient to 16 h glucose removal in the absence of secondary excitotoxicity. Neuronal survival and synaptic transmission were unaffected by prolonged removal of exogenous glucose. Inhibition of lactate transport decreased microculture neuronal survival during concurrent glucose deprivation, suggesting that endogenously released lactate is important for tolerance to glucose deprivation. Tandem depolarization and glucose deprivation also reduced neuronal survival, and trace glucose concentrations afforded neuroprotection. Mass cultures, in contrast to microcultures, were insensitive to depolarizing glucose deprivation, a difference attributable to increased extracellular lactate levels. Removal of local astrocyte support did not reduce survival in response to glucose deprivation or alter evoked excitatory transmission, suggesting that on-demand, local lactate shuttling is not necessary for neuronal tolerance to prolonged glucose removal. Taken together, these data suggest that endogenously produced lactate available globally in the extracellular milieu sustains neurons in the absence of glucose. A better understanding of resilience mechanisms in reduced preparations could lead to therapeutic strategies aimed to bolster these mechanisms in vulnerable neuronal populations.	[Sobieski, Courtney; Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; [Sobieski, Courtney] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO USA; [Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63130 USA; [Mennerick, Steven] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63130 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA.	menneris@wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Warikoo, Natasha/0000-0002-8329-7801	National Institutes of Health (NIH) [MH078823, MH099658, MH104506, MH106198]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants MH078823 (SM), MH099658 (SM), MH104506 (SM), and MH106198 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants MH078823, MH099658, MH104506, and MH106198. We thank Ann Benz for technical help with cultures, Amanda Taylor for help with early survival data collection, and Shannon Macauley-Rambach for help with lactate measurements. We also thank Colin Nichols, Joe Henry Steinbach, Shannon Macauley-Rambach, Joe Dougherty, Andrew Yoo and lab members for discussion and insights.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AUER R, 1985, ACTA NEUROPATHOL, V67, P279, DOI 10.1007/BF00687813; AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Budd SL, 1996, J NEUROCHEM, V67, P2282; CATALDO AM, 1986, J ELECTRON MICR TECH, V3, P413, DOI 10.1002/jemt.1060030406; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; CECCARELLI B, 1979, J CELL BIOL, V81, P178, DOI 10.1083/jcb.81.1.178; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hassel B, 2002, NEUROCHEM RES, V27, P167, DOI 10.1023/A:1014827327690; HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275; Honegger P, 1999, J CEREBR BLOOD F MET, V19, P1051, DOI 10.1097/00004647-199909000-00013; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Izumi Y, 1997, J NEUROSCI, V17, P9448; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kreft M, 2012, ASN NEURO, V4, DOI 10.1042/AN20120007; Li BW, 2015, J NEUROCHEM, V135, P742, DOI 10.1111/jnc.13143; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Llorente-Folch I, 2016, J NEUROSCI, V36, P4443, DOI 10.1523/JNEUROSCI.3691-15.2016; Lujan B, 2016, J NEUROPHYSIOL, V116, P2523, DOI 10.1152/jn.00629.2016; Mattson MP, 2000, J NEUROSCI, V20, P1358; Maus M, 1999, EUR J NEUROSCI, V11, P3215, DOI 10.1046/j.1460-9568.1999.00745.x; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; McKenna MC, 2012, NEUROCHEM RES, V37, P2613, DOI 10.1007/s11064-012-0901-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mennerick S, 1996, J NEUROSCI, V16, P55; Moulder KL, 2007, J NEUROSCI, V27, P9846, DOI 10.1523/JNEUROSCI.2803-07.2007; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Rich L, 2017, NEUROSCIENTIST, V23, P356, DOI 10.1177/1073858416672622; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2001, NEUROSCI LETT, V307, P151, DOI 10.1016/S0304-3940(01)01937-1; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Sobieski C, 2015, J NEUROSCI, V35, P11105, DOI 10.1523/JNEUROSCI.1289-15.2015; Sonnewald U, 1996, NEUROCHEM RES, V21, P987, DOI 10.1007/BF02532408; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Suh SW, 2003, J NEUROSCI, V23, P10681; SWANSON RA, 1990, J NEUROCHEM, V54, P490, DOI 10.1111/j.1471-4159.1990.tb01898.x; Takahashi S, 2014, ASN NEURO, V6, DOI 10.1177/1759091414550997; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Tang F, 2014, NAT COMMUN, V5, pra26; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N; Waagepetersen HS, 2002, NEUROCHEM RES, V27, P1431, DOI 10.1023/A:1021636102735; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; WIELOCH T, 1985, NEUROSCI LETT, V58, P25, DOI 10.1016/0304-3940(85)90323-4; Wijnen JP, 2015, NMR BIOMED, V28, P514, DOI 10.1002/nbm.3278; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011	80	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195520	10.1371/journal.pone.0195520	http://dx.doi.org/10.1371/journal.pone.0195520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617444	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800090
J	Wheelwright, M; Win, Z; Mikkila, JL; Amen, KY; Alford, PW; Metzger, JM				Wheelwright, Matthew; Win, Zaw; Mikkila, Jennifer L.; Amen, Kamilah Y.; Alford, Patrick W.; Metzger, Joseph M.			Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MUSCULAR-DYSTROPHY; HEART-FAILURE; CONTRACTION; CALCIUM; EXPRESSION; HYPERTROPHY; SHAPE	Recent advances have made it possible to readily derive cardiac myocytes from human induced pluripotent stem cells (hiPSC-CMs). HiPSC-CMs represent a valuable new experimental model for studying human cardiac muscle physiology and disease. Many laboratories have devoted substantial effort to examining the functional properties of isolated hiPSC-CMs, but to date, force production has not been adequately characterized. Here, we utilized traction force microscopy (TFM) with micro-patterning cell printing to investigate the maximum force production of isolated single hiPSC-CMs under varied culture and assay conditions. We examined the role of length of differentiation in culture and the effects of varied extracellular calcium concentration in the culture media on the maturation of hiPSC-CMs. Results show that hiPSC-CMs developing in culture for two weeks produced significantly less force than cells cultured from one to three months, with hiPSC-CMs cultured for three months resembling the cell morphology and function of neonatal rat ventricular myocytes in terms of size, dimensions, and force production. Furthermore, hiPSC-CMs cultured long term in conditions of physiologic calcium concentrations were larger and produced more force than hiPSC-CMs cultured in standard media with sub-physiological calcium. We also examined relationships between cell morphology, substrate stiffness and force production. Results showed a significant relationship between cell area and force. Implementing directed modifications of substrate stiffness, by varying stiffness from embryonic-like to adult myocardium-like, hiPSC-CMs produced maximal forces on substrates with a lower modulus and significantly less force when assayed on increasingly stiff adult myocardium like substrates. Calculated strain energy measurements paralleled these findings. Collectively, these findings further establish single cell TFM as a valuable approach to illuminate the quantitative physiological maturation of force in hiPSC-CMs.	[Wheelwright, Matthew; Mikkila, Jennifer L.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Win, Zaw; Amen, Kamilah Y.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu		Wheelwright, Matthew/0000-0001-8883-4453; Win, Zaw/0000-0001-7512-8816	NIH [U01HL100407, R01HL132874]; Summers' Wish Pediatric Cardiology Innovators Fund; Regenerative Medicine Minnesota Award [RMM 2016 GSCH 002R]; Muscular Dystrophy Association; Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summers' Wish Pediatric Cardiology Innovators Fund; Regenerative Medicine Minnesota Award; Muscular Dystrophy Association(Muscular Dystrophy Association); Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NIH (U01HL100407 to JMM; R01HL132874), Summers' Wish Pediatric Cardiology Innovators Fund to JMM, Regenerative Medicine Minnesota Award (RMM 2016 GSCH 002R to MW), the Muscular Dystrophy Association and the Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship to MW. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ND, 2015, J MOL CELL CARDIOL, V80, P1, DOI 10.1016/j.yjmcc.2014.12.016; Bedada FB, 2014, STEM CELL REP, V3, P594, DOI 10.1016/j.stemcr.2014.07.012; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Beussman KM, 2016, METHODS, V94, P43, DOI 10.1016/j.ymeth.2015.09.005; Boheler KR, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/214203; Boothe SD, 2016, CELL BIOCHEM BIOPHYS, V74, P527, DOI 10.1007/s12013-016-0758-1; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chang WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168071; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Desai RA, 2004, METHOD CELL BIOL, V119, P3; Echegaray K, 2017, REV ESP CARDIOL, V16, P30462; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Elustondo PA, 2017, J BIOENERG BIOMEMBR, V49, P113, DOI 10.1007/s10863-016-9676-6; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Hashimoto A, 2016, INT HEART J, V57, P112, DOI 10.1536/ihj.15-376; Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294; Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830; Huebsch N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24726; Ivaschenko CY, 2013, AM J PHYSIOL-HEART C, V305, P913; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jones AR, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00089; JONES HC, 1987, J PHYSIOL-LONDON, V383, P441; Kuo PL, 2012, AM J PATHOL, V181, P2030, DOI 10.1016/j.ajpath.2012.08.045; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Min, 2014, Biomed Res Int, V2014, P375262, DOI 10.1155/2014/375262; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Redondo F, 2016, J PHARMACOL SCI, V131, P141, DOI 10.1016/j.jphs.2016.04.015; Martiel JL, 2015, METHOD CELL BIOL, V125, P269, DOI 10.1016/bs.mcb.2014.10.008; Mattei G, 2016, ACTA BIOMATER, V45, P60, DOI 10.1016/j.actbio.2016.08.055; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; Oakes PW, 2014, BIOPHYS J, V107, P825, DOI 10.1016/j.bpj.2014.06.045; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Pioner JM, 2016, STEM CELL REP, V6, P885, DOI 10.1016/j.stemcr.2016.04.006; Posterino GS, 2011, J APPL PHYSIOL, V111, P236, DOI 10.1152/japplphysiol.00067.2011; Raeker MO, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00014; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Ribeiro MC, 2015, BIOMATERIALS, V51, P138, DOI 10.1016/j.biomaterials.2015.01.067; Robertson C, 2013, STEM CELLS, V31, P829, DOI 10.1002/stem.1331; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Shimizu T., 2016, Reproductive Medicine and Biology, V15, P35, DOI 10.1007/s12522-015-0213-9; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; terKeurs HEDJ, 1996, CAN J CARDIOL, V12, P1047; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Tse JR., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1016s47, DOI 10.1002/0471143030.CB1016S47]; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tyrode MV, 1910, ARCH INT PHARMACOD T, V20, P205; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Wang YanFei, 2013, Journal of Chemistry, V2013, P784543; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Young JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06425; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144	62	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194909	10.1371/journal.pone.0194909	http://dx.doi.org/10.1371/journal.pone.0194909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617427	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800055
J	Figueroa, DB; Tillotson, J; Li, MJ; Piwowar-Manning, E; Hendrix, CW; Holtz, TH; Bokoch, K; Bekker, LG; van Griensven, F; Mannheimer, S; Hughes, JP; Grant, RM; Bumpus, NN				Figueroa, Dominique B.; Tillotson, Joseph; Li, Maoji; Piwowar-Manning, Estelle; Hendrix, Craig W.; Holtz, Timothy H.; Bokoch, Kevin; Bekker, Linda-Gail; van Griensven, Frits; Mannheimer, Sharon; Hughes, James P.; Grant, Robert M.; Bumpus, Namandje N.			Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; BLOOD SPOT SAMPLES; PYRUVATE-KINASE; PREEXPOSURE PROPHYLAXIS; CREATINE-KINASE; MUTATIONS	Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse transcriptase. Adenylate kinase 2 (AK2) has been previously demonstrated to phosphorylate tenofovir to tenofovir-monophosphate, while creatine kinase, muscle (CKM), pyruvate kinase, muscle (PKM) and pyruvate kinase, liver and red blood cell (PKLR) each have been found to phosphorylate tenofovir-monophosphate to the pharmacologically active tenofovir-diphosphate. In the present study, genomic DNA isolated from dried blood spots collected from 505 participants from Bangkok, Thailand; Cape Town, South Africa; and New York City, USA were examined for variants in AK2, CKM, PKM, and PKLR using next-generation sequencing. The bioinformatics tools SIFT and PolyPhen predicted that 19 of the 505 individuals (3.7% frequency) carried variants in at least one kinase that would result in a decrease or loss of enzymatic activity. To functionally test these predictions, AK2 and AK2 variants were expressed in and purified from E. coli, followed by investigation of their activities towards tenofovir. Interestingly, we found that purified AK2 had the ability to phosphorylate tenofovir-monophosphate to tenofovir- diphosphate in addition to phosphorylating tenofovir to tenofovir-monophosphate. Further, four of the six AK2 variants predicted to result in a loss or decrease of enzyme function exhibited a >= 30% decrease in activity towards tenofovir in our in vitro assays. Of note, an AK2 K28R variant resulted in a 72% and 81% decrease in the formation of tenofovir-monophosphate and tenofovir-diphosphate, respectively. These data suggest that there are naturally occurring genetic variants that could potentially impact TFV activation.	[Figueroa, Dominique B.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Tillotson, Joseph; Hendrix, Craig W.; Bumpus, Namandje N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA; [Li, Maoji] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Piwowar-Manning, Estelle] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Holtz, Timothy H.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, HIV STD Res Program, Nonthaburi, Thailand; [Holtz, Timothy H.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Bokoch, Kevin] FHI 360, Res Triangle Pk, NC USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [van Griensven, Frits] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Mannheimer, Sharon] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Mannheimer, Sharon] Columbia Univ, Dept Med, Mailman Sch Publ Hlth, New York, NY USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Fred Hutchinson Cancer Center; Johns Hopkins University; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; FHI 360; University of Cape Town; University of California System; University of California San Francisco; Columbia University; Columbia University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes	Bumpus, NN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA.	nbumpus1@jhmi.edu	Hendrix, Craig W/G-4182-2014; Bekker, Linda-Gail/AAZ-8929-2020	Hendrix, Craig W/0000-0002-5696-8665; BEKKER, LINDA-GAIL/0000-0002-0755-4386	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [UM1AI068613, UM1AI068617, UM1AI068619]; Division of Intramural Research, NIAID;  [R01 AI128781]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, U19AI113127, UM1AI069470, UM1AI068617] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the HIV Prevention Trials Network (HPTN), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [grant numbers UM1AI068613 (HPTN Laboratory Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068619 (HPTN Core and Operations Center). Additional funding was provided by the Division of Intramural Research, NIAID. Support was also provided by R01 AI128781 awarded to NNB. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the United States Centers for Disease Control and Prevention, the National Institutes of Health, or the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amico KR, 2014, JAIDS-J ACQ IMM DEF, V66, P530, DOI 10.1097/QAI.0000000000000216; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hoenig M, 2017, BLOOD, V129, P2928, DOI 10.1182/blood-2016-11-745638; Hollegaard MV, 2009, GENET TEST MOL BIOMA, V13, P173, DOI 10.1089/gtmb.2008.0073; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Jaouani M, 2017, INT J LAB HEMATOL, V39, P223, DOI 10.1111/ijlh.12610; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4351; Kitzenberg D, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0114-5; Lade JM, 2015, EBIOMEDICINE, V2, P1145, DOI 10.1016/j.ebiom.2015.07.008; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu Y, 2014, DRUG METAB DISPOS, V42, P1796, DOI 10.1124/dmd.114.060194; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ning XL, 2017, EUR J MED CHEM, V138, P343, DOI 10.1016/j.ejmech.2017.06.064; Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Saavedra-Matiz CA, 2013, CLIN CHEM, V59, P1045, DOI 10.1373/clinchem.2012.198945; Schooley RT, 2002, AIDS, V16, P1257, DOI 10.1097/00002030-200206140-00008; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; USFDA A, 2012, FDA APPR 1 MED RED H; van Wijk R, 2009, HUM MUTAT, V30, P446, DOI 10.1002/humu.20915; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195764	10.1371/journal.pone.0195764	http://dx.doi.org/10.1371/journal.pone.0195764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641561	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900090
J	Iglesias-Escudero, M; Moro-Garcia, MA; Marcos-Fernandez, R; Garcia-Torre, A; Alvarez-Arguelles, ME; Suarez-Fernandez, ML; Martinez-Camblor, P; Rodriguez, M; Alonso-Arias, R				Iglesias-Escudero, Maria; Antonio Moro-Garcia, Marco; Marcos-Fernandez, Raquel; Garcia-Torre, Alejandra; Elena Alvarez-Arguelles, Marta; Luisa Suarez-Fernandez, Maria; Martinez-Camblor, Pablo; Rodriguez, Minerva; Alonso-Arias, Rebeca			Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; T-CELL SUBSETS; CYTOMEGALOVIRUS-INFECTION; CARDIOVASCULAR-DISEASE; NORFOLK COHORT; IMMUNE-SYSTEM; OLDER WOMEN; FOLLOW-UP; MORTALITY; PEOPLE	Anti-CMV (cytomegalovirus) antibody titers are related to immune alterations and increased risk of mortality. To test whether they represent a marker of infection history, we analyzed the effect of viral reactivations on the production of specific antibodies in kidney transplant patients. We quantified CMV-DNAemia and antibody titers in 58 kidney transplant patients before transplantation and during a follow-up of 315 days (standard deviation, SD: 134.5 days). In order to calculate the intensity of the infection, we plotted the follow-up time of the infection on the x-axis and the number of DNA-CMV copies on the y-axis and calculated the area under the curve (CMV-AUC). The degree of T-lymphocyte differentiation was analyzed with flow cytometry, the cells were labelled with different monoclonal antibodies in order to distinguish their differentiation state, from naive T-cells to senescent T-cells. Peak viremia was significantly higher in patients experiencing a primary infection (VI) compared to patients experiencing viral reactivation (VR). Our data indicate that the overall CMV viral load over the course of a primary infection is significantly higher than in a reactivation of a previously established infection. Whereas patients who experienced an episode of CMV reactivation during the course of our observation showed increased levels of CMV-specific antibodies, patients who did not experience CMV reactivation (WVR) showed a drop in CMV antibody levels that corresponds to an overall drop in antibody levels, probably due to the continuing immunosuppression after the renal transplant. We found a positive correlation between the CMV viremia over the course of the infection or reactivation and the CMV-specific antibody titers in the examined patients. We also observed a positive correlation between anti-CMV titers and T-cell differentiation. In conclusion, our data show that anti-CMV antibody titers are related to the course of CMV infection in kidney transplant patients.	[Iglesias-Escudero, Maria; Antonio Moro-Garcia, Marco; Marcos-Fernandez, Raquel; Garcia-Torre, Alejandra; Alonso-Arias, Rebeca] HUCA, Immunol Dept, Oviedo, Spain; [Elena Alvarez-Arguelles, Marta] HUCA, Dept Microbiol, Oviedo, Spain; [Luisa Suarez-Fernandez, Maria; Rodriguez, Minerva] HUCA, Nephrol Dept, Oviedo, Spain; [Martinez-Camblor, Pablo] HUCA, Stat Dept, Oviedo, Spain	Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias	Alonso-Arias, R (corresponding author), HUCA, Immunol Dept, Oviedo, Spain.	ralonsoarias@hotmail.es	Camblor, Pablo Martinez/Z-4834-2019; García, Marco Antonio Moro/AAK-9701-2020; RG, SMABSS/N-3322-2018	Camblor, Pablo Martinez/0000-0001-7845-3905; García, Marco Antonio Moro/0000-0001-9601-5757; RG, SMABSS/0000-0001-9944-3861; Iglesias Escudero, Maria/0000-0003-1645-4130; Alonso-Arias, Rebeca/0000-0002-9596-3787	Plan Estatal de I+D+i - Instituto de Salud Carlos III [PI14/01566, PI17/00714]; Fondo Europeo de Desarrollo Regional (FEDER)	Plan Estatal de I+D+i - Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by grants PI14/01566 and PI17/00714 from Plan Estatal de I+D+i 2013-2016, co-funded by "Instituto de Salud Carlos III" and by "Fondo Europeo de Desarrollo Regional (FEDER).	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Moro-Garcia MA, 2012, AGE, V34, P479, DOI 10.1007/s11357-011-9240-6; Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x; de la Torre-Cisneros J, 2011, ENFERM INFEC MICR CL, V29, P735, DOI 10.1016/j.eimc.2011.05.022; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Fann M, 2005, IMMUNOL REV, V205, P190, DOI 10.1111/j.0105-2896.2005.00262.x; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Houghtelin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01272; Issa NC, 2009, CLIN INFECT DIS, V48, P772, DOI 10.1086/597089; Kasiske BL, 2013, AM J TRANSPLANT, V13, P199, DOI 10.1111/ajt.12026; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Leng SX, 2011, AGE, V33, P607, DOI 10.1007/s11357-011-9205-9; Li HF, 2014, EXP GERONTOL, V54, P84, DOI 10.1016/j.exger.2014.01.010; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; Meijers RWJ, 2015, AM J TRANSPLANT, V15, P3143, DOI 10.1111/ajt.13396; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Vallejo AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026558; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Weltevrede M, 2016, EXP GERONTOL, V77, P87, DOI 10.1016/j.exger.2016.02.005; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Xu H, 2014, AM J TRANSPLANT, V14, P319, DOI 10.1111/ajt.12574; Yong MK, 2017, J INFECT DIS, V215, P1684, DOI 10.1093/infdis/jix192	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194789	10.1371/journal.pone.0194789	http://dx.doi.org/10.1371/journal.pone.0194789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641536	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900046
J	Griffin, FR; Mode, NA; Ejiogu, N; Zonderman, AB; Evans, MK				Griffin, Felicia R.; Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.			Frailty in a racially and socioeconomically diverse sample of middle-aged Americans in Baltimore	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OLDER AUSTRALIAN WOMEN; ALL-CAUSE MORTALITY; UNITED-STATES; HEALTH SURVEY; ADULTS; SCALE; VALIDITY; RISK; RACE	Frailty is a risk factor for disability and mortality, and is more prevalent among African American (AA) elderly than whites. We examine frailty in middle-aged racially and economically diverse adults, and investigate how race, poverty and frailty are associated with mortality. Data were from 2541 participants in the Healthy Aging in Neighborhoods of Diversity across the Life Span study in Baltimore, Maryland; 35-64 years old at initial assessment (56% women; 58% AA). Frailty was assessed using a modified FRAIL scale of fatigue, resistance, ambulation, illness and weight loss, and compared with difficulties in physical functioning and daily activities. Frailty prevalence was calculated across race and age groups, and associations with survival were assessed by Cox Regression. 278 participants were frail (11%); 924 pre-frail (36%); 1339 not frail (53%). For those aged 45-54, a higher proportion of whites (13%) than AAs (8%) were frail; while the proportions were similar for those 55-64 (14%,16%). Frailty was associated with overall survival with an average follow-up of 6.6 years, independent of race, sex and poverty status (HR = 2.30; 95%Cl 1.67-3.18). In this sample of economically and racially diverse older adults, the known association of frailty prevalence and age differed across race with whites having higher prevalence at younger ages. Frailty was associated with survival beyond the risk factors of race and poverty status in this middle-aged group. Early recognition of frailty at these younger ages may provide an effective method for preventing or delaying disabilities.	[Griffin, Felicia R.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Griffin, Felicia R.] Winston Salem State Univ, Dept Math, Winston Salem, NC USA	State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Winston-Salem State University	Mode, NA (corresponding author), NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA.	nicolle.mode@nih.gov	Evans, Michele Kim/AAE-4776-2019; Ezike, Ngozi/AAL-3075-2021	Mode, Nicolle/0000-0002-8193-0554	National Institute on Aging Intramural Research Program, National Institutes of Health [AG000513]; NATIONAL INSTITUTE ON AGING [ZIAAG000513, ZIAAG000199] Funding Source: NIH RePORTER	National Institute on Aging Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is entirely supported by the National Institute on Aging Intramural Research Program, National Institutes of Health AG000513 (MKE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Bruyere O, 2017, AGING CLIN EXP RES, V29, P905, DOI 10.1007/s40520-017-0806-8; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Evans MK, 2010, ETHNIC DIS, V20, P267; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gardiner PA, 2015, J AM MED DIR ASSOC, V16, P781, DOI 10.1016/j.jamda.2015.05.005; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hahn RA, 1996, INT J HEALTH SERV, V26, P673, DOI 10.2190/967K-LC4F-DU66-W5P9; Hirsch C, 2006, ANN EPIDEMIOL, V16, P545, DOI 10.1016/j.annepidem.2005.10.003; Tarazona-Santabalbina FJ, 2016, J AM MED DIR ASSOC, V17, P426, DOI 10.1016/j.jamda.2016.01.019; Kehler DS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0423-6; Lepkowski J., 2011, HANDLS PRINCIPLE CIT; Lopez D, 2012, J AM GERIATR SOC, V60, P171, DOI 10.1111/j.1532-5415.2011.03746.x; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; National Center for Health Statistics, 2015, HLTH US 2014 SPEC FE; Ng TP, 2015, AM J MED, V128, P1225, DOI 10.1016/j.amjmed.2015.06.017; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rosas-Carrasco O, 2016, J AM MED DIR ASSOC, V17, P1094, DOI 10.1016/j.jamda.2016.07.008; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Susanto M, 2018, J AM MED DIR ASSOC, V19, P65, DOI 10.1016/j.jamda.2017.08.003; Szanton SL, 2010, J EPIDEMIOL COMMUN H, V64, P63, DOI 10.1136/jech.2008.078428; Team RC., 2013, R LANG ENV STAT COMP; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Woo J, 2015, J AM MED DIR ASSOC, V16, P412, DOI 10.1016/j.jamda.2015.01.087; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; World Health Organization, 2018, WORLD REP AG HLTH; Zonderman AB, 2016, JAMA INTERN MED, V176, P1394, DOI 10.1001/jamainternmed.2016.3649	37	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195637	10.1371/journal.pone.0195637	http://dx.doi.org/10.1371/journal.pone.0195637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634767	Green Submitted, gold, Green Published			2022-12-27	WOS:000429522200043
J	Scherer, U; Kuhnhardt, M; Schuett, W				Scherer, Ulrike; Kuhnhardt, Mira; Schuett, Wiebke			Predictability is attractive: Female preference for behaviourally consistent males but no preference for the level of male aggression in a bi-parental cichlid	PLOS ONE			English	Article							MATE CHOICE; INDIVIDUAL-DIFFERENCES; JAPANESE-QUAIL; FIGHTING MALES; PERSONALITY; BOLDNESS; FISH; EAVESDROP; SELECTION; ECOLOGY	Although personality traits can largely affect individual fitness we know little about the evolutionary forces generating and maintaining personality variation. Here, we investigated the hypothesis that personality variation in aggression is sexually selected in the monogamous, bi-parental cichlid Pelvicachromis pulcher. In this species, breeding pairs form territories and they aggressively defend their territory and offspring against con- and heterospecific intruders. In our mate choice study, we followed up two alternative hypotheses. We either expected females to show a directional preference for a high level and high consistency of aggression (potentially indicating mate choice for male parental quality). Alternatively, we expected females to choose males for (dis-)similarity in the level/consistency of aggression (potentially indicating mate choice for compatibility). Individual level and consistency of aggression were assessed for males and females using mirror tests. After eavesdropping on aggressive behaviour of two males (differing in level and consistency of aggression) females were then allowed to choose between the two males. Males, but not females, showed personality variation in aggression. Further, females generally preferred consistent over inconsistent males independent of their level of aggression. We did not detect a general preference for the level of male aggression. However, we found an above average preference for consistent high-aggression males; whereas female preference for inconsistent high-aggression did not deviate from random choice. Our results suggest behavioural consistency of aggression in male rainbow kribs is selected for via female mate choice. Further, our study underlines the importance of considering both the level and the consistency of a behavioural trait in studies of animal behaviour.	[Scherer, Ulrike; Kuhnhardt, Mira; Schuett, Wiebke] Univ Hamburg, Zool Inst, Bioctr Grindel, Hamburg, Germany; [Schuett, Wiebke] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Hamburg; University of Sussex	Scherer, U (corresponding author), Univ Hamburg, Zool Inst, Bioctr Grindel, Hamburg, Germany.	u.k.scherer@gmail.com	Scherer, Ulrike/AAC-8286-2020	Scherer, Ulrike/0000-0003-1086-8527; Schuett, Wiebke/0000-0002-4149-6095	DFG (Deutsche Forschungsgemeinschaft) [SCHU-2927/2-1]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was funded by DFG (Deutsche Forschungsgemeinschaft, http://www.dfg.de/), grant to W.S. (SCHU-2927/2-1).	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Aquiloni L, 2008, CURR BIOL, V18, pR462, DOI 10.1016/j.cub.2008.04.006; Ariyomo TO, 2015, J FISH BIOL, V86, P1852, DOI 10.1111/jfb.12674; Ariyomo TO, 2012, ANIM BEHAV, V83, P41, DOI 10.1016/j.anbehav.2011.10.004; Ballew NG, 2017, AM NAT, V189, P396, DOI 10.1086/690909; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bierbach D, 2013, BEHAV ECOL SOCIOBIOL, V67, P675, DOI 10.1007/s00265-013-1487-8; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Budaev SV, 1999, ANIM BEHAV, V58, P195, DOI 10.1006/anbe.1999.1124; Cain KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077816; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; Chira A, 2014, ANN FOR RES, V57, P347; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dechaume-Moncharmont FX, 2011, CR BIOL, V334, P906, DOI 10.1016/j.crvi.2011.08.004; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; DUFTY AM, 1989, HORM BEHAV, V23, P185, DOI 10.1016/0018-506X(89)90059-7; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Fawcett TW, 2003, P ROY SOC B-BIOL SCI, V270, P1637, DOI 10.1098/rspb.2003.2328; GRANT JWA, 1990, CAN J FISH AQUAT SCI, V47, P915, DOI 10.1139/f90-105; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; Ioannou CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33991; ITZKOWITZ M, 1984, BEHAVIOUR, V89, P251, DOI 10.1163/156853984X00407; Jaeger B, 2016, R2GLMM COMPUTES R SQ; Kralj-Fiser S, 2013, BEHAV ECOL, V24, P824, DOI 10.1093/beheco/art030; Laubu C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501013; LAVERY RJ, 1994, ETHOLOGY, V97, P265; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; McKaye KR, 2008, CARIBB J SCI, V44, P13; Montiglio PO, 2016, J ANIM ECOL, V85, P125, DOI 10.1111/1365-2656.12436; Mutzel A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1019; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nandy B, 2016, ANIM BEHAV, V114, P3, DOI 10.1016/j.anbehav.2016.01.019; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Poschadel JR, 2009, ACTA ETHOL, V12, P55, DOI 10.1007/s10211-009-0055-8; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; R Development Core Team, 2009, R LANG ENV STAT COMP; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Royle NJ, 2010, BEHAV ECOL, V21, P1125, DOI 10.1093/beheco/arq156; Scherer U, 2017, ANIM BEHAV, V128, P117, DOI 10.1016/j.anbehav.2017.04.007; Scherer U, 2016, J FISH BIOL, V89, P1866, DOI 10.1111/jfb.13069; SCHLINGER BA, 1987, PHYSIOL BEHAV, V40, P343, DOI 10.1016/0031-9384(87)90057-6; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp I, 1999, BEHAVIOUR, V136, P519, DOI 10.1163/156853999501450; Schluter A, 1998, ANIM BEHAV, V56, P147, DOI 10.1006/anbe.1998.0762; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuett W, 2011, ETHOLOGY, V117, P908, DOI 10.1111/j.1439-0310.2011.01945.x; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schuett W, 2010, J ETHOL, V28, P273, DOI 10.1007/s10164-009-0181-9; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Spritzer MD, 2005, ANIM BEHAV, V69, P1121, DOI 10.1016/j.anbehav.2004.06.033; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; Stoffel MA, 2017, RPTR REPEATABILITY E, P1639, DOI [10.1111/2041-210X.12797, DOI 10.1111/2041-210X.12797]; Teyssier A, 2014, BEHAV ECOL, V25, P723, DOI 10.1093/beheco/aru049; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Witte K, 2010, BEHAV ECOL, V21, P193, DOI 10.1093/beheco/arp154	62	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195766	10.1371/journal.pone.0195766	http://dx.doi.org/10.1371/journal.pone.0195766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634757	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000429522200056
J	Sharma, A; Benbrook, DM; Woo, S				Sharma, Ankur; Benbrook, Doris Mangiaracina; Woo, Sukyung			Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; FLEXIBLE-HETEROAROTINOIDS; INDUCE APOPTOSIS; ANTITUMOR AGENT; CANCER; PREDICTION; CELLS; SUFFICIENT; METABOLISM; ABSORPTION	SHetA2 is a small molecule drug with promising cancer prevention and therapeutic activity and a high preclinical safety profile. The study objectives were to perform interspecies scaling and pharmacokinetic (PK) modeling of SHetA2 for human PK prediction. The PK data obtained from mice, rats, and dogs after intravenous and oral doses were used for simultaneous fitting to PK models. The disposition of SHetA2 was best described by a two-compartment model. The absorption kinetics was well characterized with a first-order absorption model for mice and rats, and a gastrointestinal transit model for dogs. Oral administration of SHetA2 showed a relatively fast absorption in mice, prolonged absorption (i.e., flip-flop kinetics) toward high doses in rats, and an early peak followed by a secondary peak at high doses in dogs. The oral bioavailability was 17.7-19.5% at 20-60 mg/kg doses in mice, <1.6% at 100-2000 mg/kg in rats, and 11.2% at 100 mg/kg decreasing to 3.45% at 400 mg/kg and 1.11% at 1500 mg/kg in dogs. The disposition parameters were well correlated with the body weight for all species using the allometric equation, which predicted values of CL (17.3 L/h), V-1(36.2 L/h), V-2 (68.5 L/h) and CLD (15.2 L/h) for a 70-kg human. The oral absorption rate and bioavailability of SHetA2 was highly dependent on species, doses, formulations, and possibly other factors. The limited bioavailability at high doses was taken into consideration for the suggested first-in-human dose, which was much lower than the dose estimated based on toxicology studies. In summary, the present study provided the PK model for SHetA2 that depicted the disposition and absorption kinetics in preclinical species, and computational tools for human PK prediction.	[Sharma, Ankur; Woo, Sukyung] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Benbrook, Doris Mangiaracina] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Woo, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	sukyung-woo@ouhsc.edu		Benbrook, Doris/0000-0001-7606-8245; Woo, Sukyung/0000-0003-3932-7185	NCI PREVENT Program [N01-CN-43306]; non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention"; NATIONAL CANCER INSTITUTE [R01CA196200] Funding Source: NIH RePORTER	NCI PREVENT Program; non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The IV and oral PK data of SHetA2 in mice [13] and rats [11], and oral PK data in dogs [11] referenced during the study have been previously published. The IV PK data in dogs was extracted from a NCI PREVENT Program report (N01-CN-43306 Work assignment 21). The data was generated under a non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention" to Dr. Benbrook and transferred to her under a Material Transfer Agreement between the NCI and the University of Oklahoma. The data was provided in a table as part of a final report "Fourteen Day Oral Range-Finding Study of SHetA2 in Dogs" prepared by Kasim K. Kabirov, M.D., Ph.D. Queries regarding this data should be sent to lyublmov@uic.edu. The authors do not have any special access privileges to this data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee AK, 2010, 49 ANN M SOC TOX MAR; Benbrook DM, 2005, INVEST NEW DRUG, V23, P417, DOI 10.1007/s10637-005-2901-5; Benbrook DM, 2014, INVEST NEW DRUG, V32, P412, DOI 10.1007/s10637-013-0041-x; Benbrook DM, 2013, CANCER PREV RES, V6, P908, DOI 10.1158/1940-6207.CAPR-13-0171; BOXENBAUM H, 1983, AM J PHYSIOL, V245, pR768, DOI 10.1152/ajpregu.1983.245.6.R768; BOXENBAUM H, 1982, J PHARMACOKINET BIOP, V10, P201, DOI 10.1007/BF01062336; Darwich AS, 2012, J PHARM PHARMACOL, V64, P1008, DOI 10.1111/j.2042-7158.2012.01538.x; DEDRICK RL, 1973, J PHARMACOKINET BIOP, V1, P435, DOI 10.1007/BF01059667; Doppalapudi RS, 2012, MUTAT RES-GEN TOX EN, V746, P78, DOI 10.1016/j.mrgentox.2012.03.009; FDA, 2005, EST MAX SAF START DO; FDA, 2006, GUID IND INV REV EXP; Feng MR, 2000, PHARM RES-DORDR, V17, P410, DOI 10.1023/A:1007520818956; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Gnanasekaran KK, 2015, EUR J MED CHEM, V96, P209, DOI 10.1016/j.ejmech.2015.03.070; Huang WL, 2009, AAPS J, V11, P217, DOI 10.1208/s12248-009-9098-z; Izumi T, 1996, J PHARMACOL EXP THER, V277, P1630; Kabirov KK, 2013, DRUG CHEM TOXICOL, V36, P284, DOI 10.3109/01480545.2012.710632; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Liu SQ, 2004, J MED CHEM, V47, P999, DOI 10.1021/jm030346v; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Liu TZ, 2009, MOL CANCER THER, V8, P1227, DOI 10.1158/1535-7163.MCT-08-1069; Liu ZF, 2008, RAPID COMMUN MASS SP, V22, P3371, DOI 10.1002/rcm.3744; Mahmood I, 1996, XENOBIOTICA, V26, P887, DOI 10.3109/00498259609052491; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mukai H, 1999, INT J PHARM, V186, P215, DOI 10.1016/S0378-5173(99)00184-2; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Sharma A, 2017, J PHARM TECHNOL DRUG, V6, P1; Vuppugalla R, 2011, J PHARM SCI-US, V100, P4111, DOI 10.1002/jps.22551; Wang YX, 1999, DRUG METAB DISPOS, V27, P855; Yanez JA, 2011, THER DELIV, V2, P643, DOI [10.4155/TDE.11.19, 10.4155/tde.11.19]; Yu LX, 1996, ADV DRUG DELIVER REV, V19, P359, DOI 10.1016/0169-409X(96)00009-9; Zhang YL, 2006, CANCER CHEMOTH PHARM, V58, P561, DOI 10.1007/s00280-006-0211-z	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194046	10.1371/journal.pone.0194046	http://dx.doi.org/10.1371/journal.pone.0194046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634717	gold, Green Submitted, Green Published			2022-12-27	WOS:000429522200006
J	Vasquez-Suarez, A; Lobos-Gonzalez, F; Cronshaw, A; Sepulveda-Ugarte, J; Figueroa, M; Dagnino-Leone, J; Bunster, M; Martinez-Oyanedel, J				Vasquez-Suarez, Aleikar; Lobos-Gonzalez, Francisco; Cronshaw, Andrew; Sepulveda-Ugarte, Jose; Figueroa, Maximiliano; Dagnino-Leone, Jorge; Bunster, Marta; Martinez-Oyanedel, Jose			The gamma(33) subunit of R-phycoerythrin from Gracilaria chilensis has a typical double linked phycourobilin similar to y subunit	PLOS ONE			English	Article							BILIN ATTACHMENT SITES; C-PHYCOCYANIN; BETA-SUBUNITS; RED ALGAE; EVOLUTION; PROTEINS; LIGHT; PHYCOBILIPROTEINS; PHYCOBILISOMES; CYANOBACTERIA	Phycobilisomes (PBS) are accessory light harvesting protein complexes formed mainly by phycobiliproteins (PBPs). The PBPs absorb light that is efficiently transferred to Photosystems due to chromophores covalently bound to specific cysteine residues. Besides phycobiliproteins (PE), the PBS contains linker proteins responsible for assembly and stabilization of the whole complex and the tuning of energy transfer steps between chromophores. The linker (gamma(33)) from Gracilaria chilensis, is a chromophorylated rod linker associated to (alpha beta)(6) hexamers of R-phycoerythrin (R-PE). Its role in the energy transfer process is not clear yet. Structural studies as well as the composition and location of the chromophores are essential to understand their involvement in the energy transfer process in PBS. To achieve this, the coding gene of gamma(33) was cloned and sequenced. The sequence was analyzed by informatics tools, to obtain preliminary information which leaded the next experiments. The protein was purified from R-phycoerythrin, and the sequence confirmed by mass spectrometry. The coding sequence analysis revealed a protein of 318 aminoacid residues containing a chloroplastidial transit peptide (cTP) of 39 aminoacids at the N-terminus. The conservation of cysteines revealed possible chromophorylation sites. Using a and 13 R-PE subunits as spectroscopic probes in denaturation assays, we deduced a double bonded phycourobilin (PUB) on gamma(33) subunit that were confirmed between Cys62 and Cys73 (DL-PUB62/73) by mass spectrometry. The cysteines involved in the double link are located in a helical region, in a conformation that reminds the position of the DL-PUB50/61 in the beta subunit of R-PE. The position of single linked PUB at Cys(95) and a single linked PEB at Cys(172) were also confirmed. Spectroscopic studies show the presence of both types of chromophores and that there are not energy transfer by FRET among them.	[Vasquez-Suarez, Aleikar; Lobos-Gonzalez, Francisco; Sepulveda-Ugarte, Jose; Figueroa, Maximiliano; Dagnino-Leone, Jorge; Bunster, Marta; Martinez-Oyanedel, Jose] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Lab Biofis Mol, Concepcion, Chile; [Cronshaw, Andrew] Univ Edinburgh, Michael Swann Bldg,Kings Bldg, Edinburgh, Midlothian, Scotland	Universidad de Concepcion; University of Edinburgh	Bunster, M; Martinez-Oyanedel, J (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Lab Biofis Mol, Concepcion, Chile.	mbunster@udec.cl; jmartine@udec.cl			FONDECYT [113.0256]; VRID_UDEC [216.037.021-1.0]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [63130071]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); VRID_UDEC; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT #113.0256; VRID_UDEC #216.037.021-1.0; and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) #63130071 Beca Doctoral to AVS.	APT KE, 1993, J BIOL CHEM, V268, P16208; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Barton C, 2010, MICRON, V47, P915; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Braiman MS, 1999, J PHYS CHEM B, V103, P4744, DOI 10.1021/jp983011b; Brawley SH, 2017, P NATL ACAD SCI USA, V114, pE6361, DOI 10.1073/pnas.1703088114; BRYANT DA, 1978, J BIOL CHEM, V253, P220; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bunster M, 1997, BOL SOC CHIL QUIM, V42, P449; Chang WR, 1996, J MOL BIOL, DOI [10.1006/JMBI.1996.0547PMID:8876649, DOI 10.1006/JMBI.1996.0547PMID:8876649]; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; Hu ZN, 2004, J APPL PHYCOL, V16, P161, DOI 10.1023/B:JAPH.0000048456.26639.1a; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Martinez-Oyanedel J, 2004, BIOL RES, V37, P733, DOI 10.4067/S0716-97602004000500003; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; NAGY JO, 1985, J BIOL CHEM, V260, P4864; Pizarro SA, 2001, PHOTOCHEM PHOTOBIOL, V73, P556, DOI 10.1562/0031-8655(2001)073<0556:SSOTLH>2.0.CO;2; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sepulveda-Ugarte J, 2011, J PHOTOCH PHOTOBIO A, V219, P211, DOI 10.1016/j.jphotochem.2011.02.012; van Montfort BA, 2002, J MASS SPECTROM, V37, P322, DOI 10.1002/jms.288; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Wang S, 2004, ACTA BOT SIN, V46, P1135; Yi ZW, 2005, FEBS LETT, V579, P3569, DOI 10.1016/j.febslet.2005.05.033; Zhang J, 2017, NATURE, V551, P57, DOI 10.1038/nature24278	34	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195656	10.1371/journal.pone.0195656	http://dx.doi.org/10.1371/journal.pone.0195656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634783	gold, Green Published, Green Submitted			2022-12-27	WOS:000429522200045
J	Bonnet, E; Moutet, ML; Baulard, C; Bacq-Daian, D; Sandron, F; Mesrob, L; Fin, B; Delepine, M; Palomares, MA; Jubin, C; Blanche, H; Meyer, V; Boland, A; Olaso, R; Deleuze, JF				Bonnet, Eric; Moutet, Marie-Laure; Baulard, Celine; Bacq-Daian, Delphine; Sandron, Florian; Mesrob, Lilia; Fin, Bertrand; Delepine, Marc; Palomares, Marie-Ange; Jubin, Claire; Blanche, Helene; Meyer, Vincent; Boland, Anne; Olaso, Robert; Deleuze, Jean-Francois			Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples	PLOS ONE			English	Article							SEQUENCE ARTIFACTS; GENOME; TISSUE; URACIL; FORMALDEHYDE; DEAMINATION; EXPRESSION; FRAMEWORK; ALIGNMENT; GENES	Next-generation sequencing (NGS) studies are becoming routinely used for the detection of novel and clinically actionable DNA variants at a pangenomic scale. Such analyses are now used in the clinical practice to enable precision medicine. Formalin-fixed paraffin-embedded (FFPE) tissues are still one of the most abundant source of cancer clinical specimen, unfortunately this method of preparation is known to degrade DNA and therefore compromise subsequent analysis. Some studies have reported that variant detection can be performed on FFPE samples sequenced with NGS techniques, but few or none have done an in-depth coverage analysis and compared the influence of different state-of-the-art FFPE DNA extraction kits on the quality of the variant calling. Here, we generated 42 human whole-exome sequencing data sets from fresh-frozen (FF) and FFPE samples. These samples include normal and tumor tissues from two different organs (liver and colon), that we extracted with three different FFPE extraction kits (QlAamp DNA FFPE Tissue kit and GeneRead DNA FFPE kit from Qiagen, Maxwell (TM) RSC DNA FFPE Kit from Promega). We determined the rate of concordance of called variants between matched FF and FFPE samples on all common variants (representing at least 86% of the total number of variants for SNVs). The concordance rate is very high between all matched FF/FFPE pairs, with equivalent values for the three kits we analyzed. On the other hand, when looking at the difference between the total number of variants in FF and FFPE, we find a significant variation for the three different FFPE DNA extraction kits. Coverage analysis shows that FFPE samples have less good indicators than FF samples, yet the coverage quality remains above accepted thresholds. We detect limited but statistically significant variations in coverage indicator values between the three FFPE extraction kits. Globally, the GeneRead and QlAamp kits have better variant calling and coverage indicators than the Maxwell kit on the samples used in this study, although this kit performs better on some indicators and has advantages in terms of practical usage. Taken together, our results confirm the potential of FFPE samples analysis for clinical genomic studies, but also indicate that the choice of a FFPE DNA extraction kit should be done with careful testing and analysis beforehand in order to maximize the accuracy of the results.	[Bonnet, Eric; Moutet, Marie-Laure; Baulard, Celine; Bacq-Daian, Delphine; Sandron, Florian; Mesrob, Lilia; Fin, Bertrand; Delepine, Marc; Palomares, Marie-Ange; Jubin, Claire; Meyer, Vincent; Boland, Anne; Olaso, Robert; Deleuze, Jean-Francois] CEA, Direct Rech Fondamentale, Ctr Natl Rech Genom Humaine, Inst Biol Francois Jacob, Evry, France; [Deleuze, Jean-Francois] LabEx GenMed, Evry, France; [Blanche, Helene; Deleuze, Jean-Francois] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Deleuze, Jean-Francois] Ctr REFerence Innovat EXpertise & Transfert CREFI, Evry, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Deleuze, JF (corresponding author), CEA, Direct Rech Fondamentale, Ctr Natl Rech Genom Humaine, Inst Biol Francois Jacob, Evry, France.; Deleuze, JF (corresponding author), LabEx GenMed, Evry, France.; Deleuze, JF (corresponding author), Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France.; Deleuze, JF (corresponding author), Ctr REFerence Innovat EXpertise & Transfert CREFI, Evry, France.	deleuze@cng.fr	Olaso, Robert/AAC-4162-2019	Sandron, Florian/0000-0001-7491-0283; Bonnet, Eric/0000-0002-8468-2867	LABEX (laboratory of excellence program investment for the future) GENMED (Medical Genomics)	LABEX (laboratory of excellence program investment for the future) GENMED (Medical Genomics)	We would like to thank Florence Jobard, Caroline Horgues, Jeanne-Antide Perrier, Emmanuel Menard, David Derbala, Johan Tassin for excellent technical advice and assistance. Ste A phane Meslage and Ghislain Septier were very helpful for the whole-exome analysis pipeline and for the calculation of the whole-exome coverage statistics. This work has been developed and supported by the LABEX (laboratory of excellence program investment for the future) GENMED (Medical Genomics).	Astolfi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1982-6; AUERBACH C, 1977, MUTAT RES, V39, P317, DOI 10.1016/0165-1110(77)90011-2; Bagnall RD, 2017, GENET MED, V19, P1127, DOI 10.1038/gim.2017.15; BARAK Y, 1995, J BIOL CHEM, V270, P24174, DOI 10.1074/jbc.270.41.24174; Bauche S, 2016, AM J HUM GENET, V99, P753, DOI 10.1016/j.ajhg.2016.06.033; Bonfiglio S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2720-4; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Bruel AL, 2017, J MED GENETICS; Carrick DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127353; Cerino M, 2017, MUSCLE NERVE; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Forbes SA, 2016, NUCLEIC ACIDS RES; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heydt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104566; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Inadome Y, 2003, DIAGN MOL PATHOL, V12, P231, DOI 10.1097/00019606-200312000-00007; Janecka A, 2015, ANAL BIOCHEM, V476, P8, DOI 10.1016/j.ab.2015.01.019; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARLSEN F, 1994, LAB INVEST, V71, P604; Khokhar SK, 2012, CLIN CHEM LAB MED, V50, P267, DOI 10.1515/CCLM.2011.763; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lee CH, 2007, HUM GENE THER, V18, P27, DOI 10.1089/hum.2005.239; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munchel S, 2015, ONCOTARGET, V6, P25943, DOI 10.18632/oncotarget.4671; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nicolas G, 2016, EUR J HUM GENET, V24, P710, DOI 10.1038/ejhg.2015.173; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	49	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195471	10.1371/journal.pone.0195471	http://dx.doi.org/10.1371/journal.pone.0195471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621323	Green Submitted, gold, Green Published			2022-12-27	WOS:000429206800091
J	Hertz, U; Bahrami, B; Keramati, M				Hertz, Uri; Bahrami, Bahador; Keramati, Mehdi			Stochastic satisficing account of confidence in uncertain value-based decisions	PLOS ONE			English	Article							BANDIT PROBLEMS; HUMAN BRAIN; METACOGNITION; RISK; CHOICE; BIASES	Every day we make choices under uncertainty; choosing what route to work or which queue in a supermarket to take, for example. It is unclear how outcome variance, e.g. uncertainty about waiting time in a queue, affects decisions and confidence when outcome is stochastic and continuous. How does one evaluate and choose between an option with unreliable but high expected reward, and an option with more certain but lower expected reward? Here we used an experimental design where two choices' payoffs took continuous values, to examine the effect of outcome variance on decision and confidence. We found that our participants' probability of choosing the good (high expected reward) option decreased when the good or the bad options' payoffs were more variable. Their confidence ratings were affected by outcome variability, but only when choosing the good option. Unlike perceptual detection tasks, confidence ratings correlated only weakly with decisions' time, but correlated with the consistency of trial-by-trial choices. Inspired by the satisficing heuristic, we propose a "stochastic satisficing" (SSAT) model for evaluating options with continuous uncertain outcomes. In this model, options are evaluated by their probability of exceeding an acceptability threshold, and confidence reports scale with the chosen option's thus-defined satisficing probability. Participants' decisions were best explained by an expected reward model, while the SSAT model provided the best prediction of decision confidence. We further tested and verified the predictions of this model in a second experiment. Our model and experimental results generalize the models of metacognition from perceptual detection tasks to continuous-value based decisions. Finally, we discuss how the stochastic satisficing account of decision confidence serves psychological and social purposes associated with the evaluation, communication and justification of decision-making.	[Hertz, Uri] Univ Haifa, Informat Syst Dept, Haifa, Israel; [Hertz, Uri] Univ Haifa, Sch Polit Sci, Haifa, Israel; [Bahrami, Bahador] UCL, Inst Cognit Neurosci, London, England; [Bahrami, Bahador] Ludwig Maximilians Univ Munchen, Fac Psychol & Educ Sci, Munich, Germany; [Keramati, Mehdi] UCL, Gatsby Computat Neurosci Unit, London, England; [Keramati, Mehdi] UCL, Max Planck Ctr Computat Psychiat & Ageing Res, London, England	University of Haifa; University of Haifa; University of London; University College London; University of Munich; University of London; University College London; University of London; University College London	Hertz, U (corresponding author), Univ Haifa, Informat Syst Dept, Haifa, Israel.; Hertz, U (corresponding author), Univ Haifa, Sch Polit Sci, Haifa, Israel.	uhertz@is.haifa.ac.il	Hertz, Uri/AAA-4799-2020	Hertz, Uri/0000-0003-4852-3516	European Research Council [NeuroCoDec 309865]; John Templeton Foundation; Gatsby Charitable Foundation	European Research Council(European Research Council (ERC)European Commission); John Templeton Foundation; Gatsby Charitable Foundation	UH and BB are supported by the European Research Council (NeuroCoDec 309865). UH is also supported by the John Templeton Foundation. MK is supported by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, MACROECONOMIC THEORY; Bang D, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170193; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Camerer Colin F, 2011, ADV BEHAV EC; Carpenter B, 2015, J STAT SOFTW; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Erev I, 2005, PSYCHOL REV, V112, P912, DOI 10.1037/0033-295X.112.4.912; Fleming SM, 2016, PSYCHOL REV, V124, P1; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Meyniel F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004305; Navajas J, 2017, NAT HUM BEHAV, V1, P810, DOI 10.1038/s41562-017-0215-1; Navajas J, 2016, CURR OPIN BEHAV SCI, V11, P55, DOI 10.1016/j.cobeha.2016.05.005; Nicolle A, 2011, J NEUROSCI, V31, P3320, DOI 10.1523/JNEUROSCI.5615-10.2011; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Pouget A, 2016, NAT NEUROSCI, V19, P366, DOI 10.1038/nn.4240; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reverdy P, 2017, IEEE T AUTOMAT CONTR, V62, P3788, DOI 10.1109/TAC.2016.2644380; Reverdy P, 2014, IEEE DECIS CONTR P, P5718, DOI 10.1109/CDC.2014.7040284; Reverdy PB, 2014, P IEEE, V102, P544, DOI 10.1109/JPROC.2014.2307024; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Sanders JI, 2016, NEURON, V90, P499, DOI 10.1016/j.neuron.2016.03.025; Sani A, 2013, NIPS, P1; Shea N, 2014, TRENDS COGN SCI, V18, P186, DOI 10.1016/j.tics.2014.01.006; Simon H. A., 1982, MODELS BOUNDED RATIO; Simon H. A., 1997, ADM BEHAV STUDY DECI, V4th; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Sutton R.S., 2012, REINFORCEMENT LEARNI, V2nd; Symmonds M, 2011, NEUROIMAGE, V58, P1139, DOI 10.1016/j.neuroimage.2011.06.087; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Von Neumann J, 1966, THEORY GAMES EC BEHA; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; WINTER SG, 1971, Q J ECON, V85, P237, DOI 10.2307/1880703; Winter SG, 2000, STRATEGIC MANAGE J, V21, P981, DOI 10.1002/1097-0266(200010/11)21:10/11<981::AID-SMJ125>3.0.CO;2-4; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416	45	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195399	10.1371/journal.pone.0195399	http://dx.doi.org/10.1371/journal.pone.0195399			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621325	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000429206800075
J	Humphries, H; Osman, F; Knight, L; Karim, QA				Humphries, Hilton; Osman, Farzana; Knight, Lucia; Karim, Quarraisha Abdool			Exploratory analysis of the ecological variables associated with sexual health profiles in high-risk, sexually-active female learners in rural KwaZulu-Natal	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIGH-SCHOOL-STUDENTS; REPRODUCTIVE HEALTH; SOUTH-AFRICA; ADOLESCENT HEALTH; YOUNG-PEOPLE; HIV-RISK; PREGNANCY; PREVALENCE; WOMEN	Purpose Young women are at high risk for negative sexual health outcomes. Despite their high risk, many sexually-active women never experience negative sexual health outcomes. This study explored the ecological risk factors associated with the risk profiles of sexually-active female high school-learners in rural KwaZulu-Natal, South Africa. Methods Using baseline data from N = 596 sexually-active school-going women, we explored the ecological factors associated with being sexually-active and managing risk successfully [SARS] or unsuccessfully [SARU]. Generalised estimated equations (GEE) were applied to data collected at multiple levels while adjusting for school and other included variables. GEE were used to calculate probability of being SARU. Results Amongst SARU learners, 21.9% had HIV, 38.6% had HSV-2, 12.5% were pregnant, 28.7% self-reported STI symptoms and 51.9% reported a previous pregnancy. Individual-level factors had the greatest impact on being SARU. Univariate and multivariate analysis highlighted several important partner factors associated with SARU. Age was significantly associated with the risk profiles (p<0.0001), a greater proportion of SARU learners were 18 or older compared to the SARS learners. The odds of being SARU decreased when >= 18 years (aOR = 0.2577, 95% CI 0.1462-0.4542) or if not falling pregnant was important (aOR = 0.6343, 95% CI 0.4218-0.9538). Having >1 HIV test (aOR = 2.2161, 95% CI 1.3964-3.5169) increased the odds a SARU profile. Conclusion Individual and partner level factors are important for the sexual health profile of an adolescent female. While the exploratory findings require further research; managing multiple sexual health outcomes, tailoring responses around a risk profile and including partners is essential for successful interventions.	[Humphries, Hilton; Osman, Farzana; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Knight, Lucia] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Humphries, Hilton] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Congella, South Africa	University of Kwazulu Natal; University of the Western Cape; Columbia University; University of Kwazulu Natal	Humphries, H (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.; Humphries, H (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Congella, South Africa.	Hilton.humphries@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Knight, Lucia/0000-0001-9938-6887; Humphries, Hilton/0000-0001-8503-4127	MIET Africa; National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [1 U19 AI51794]; Columbia University Southern African Fogarty AIDS International Training and Research Programme (AITRP) - Fogarty International Center, National Institutes of Health [D43TW00231]	MIET Africa; National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Health and Human Services (DHHS); Columbia University Southern African Fogarty AIDS International Training and Research Programme (AITRP) - Fogarty International Center, National Institutes of Health	Funding for the study was provided by MIET Africa (QAK). CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA) and is supported by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant# 1 U19 AI51794). The career development of HH was supported by the Columbia University Southern African Fogarty AIDS International Training and Research Programme (AITRP) funded by the Fogarty International Center, National Institutes of Health (grant #D43TW00231).	Bastien S, 2012, INT J STD AIDS, V23, P761, DOI 10.1258/ijsa.2012.011433; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bekker L, 2015, J INT AIDS SOC, V18; Blum R., 2005, WORLD HEAL ORGAN, P155; Blum RW, 2012, LANCET, V379, P1567, DOI 10.1016/S0140-6736(12)60407-3; Brewster KL, 2008, J ADOLESCENT HEALTH, V42, P73, DOI 10.1016/j.jadohealth.2007.08.010; Bronfenbrenner U., 1994, INT ENCY ED, V3, P37; Cederbaum JA, 2014, AFR J REPROD HEALTH, V18, P26; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Cluver LD, 2014, AIDS, V28, pS389, DOI 10.1097/QAD.0000000000000340; Cooper D, 2004, REPROD HEALTH MATTER, V12, P70, DOI 10.1016/S0968-8080(04)24143-X; Cowan F, 2009, CURR OPIN HIV AIDS, V4, P288, DOI 10.1097/COH.0b013e32832c7d10; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Fearon E, 2015, SOC SCI MED, V146, P62, DOI 10.1016/j.socscimed.2015.09.039; Frohlich JA, 2014, SAMJ S AFR MED J, V104, P687, DOI [10.7196/SAMJ.7841, 10.7196/samj.7841]; Frohlich JA, 2015, J ACQ IMMUN DEF SYND, V70, P1; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Harrison A, 2012, SEX HEALTH, V9, P178, DOI 10.1071/SH10150; Hindin MJ, 2013, B WORLD HEALTH ORGAN, V91, P10, DOI 10.2471/BLT.12.107565; Huang GZ, 2013, IET CIRC DEVICE SYST, V7, P1, DOI 10.1049/iet-cds.2012.0253; Humphries, 2017, CAPRISA CLIN TRIALS, P77; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2009, CULT HEALTH SEX, V11, P675, DOI 10.1080/13691050902846452; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Karim QA, 2017, JAIDS-J ACQ IMM DEF, V75, pS17, DOI [10.1097/QAI.0000000000001316, 10.1097/qai.0000000000001316]; Karim QA, 2014, SEX TRANSM INFECT, V90, P620, DOI 10.1136/sextrans-2014-051548; Kaufman CE, 2001, STUD FAMILY PLANN, V32, P147, DOI 10.1111/j.1728-4465.2001.00147.x; Kharsany ABM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-231; Kulzer JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-8; Kuo C, 2016, AIDS CARE, V121, P1; Leask K, 2015, J INT AIDS SOC, V18, P44; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; MacPhail C, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-31; Magnani R, 2005, J ADOLESCENT HEALTH, V36, P289, DOI 10.1016/j.jadohealth.2004.02.025; Mason-Jones AJ, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-49; Michielsen K, 2010, AIDS, V24, P1193, DOI 10.1097/QAD.0b013e3283384791; Mmari K, 2009, GLOB PUBLIC HEALTH, V4, P350, DOI 10.1080/17441690701664418; Montague C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096468; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; O'Sullivan LF, 2006, CULT HEALTH SEX, V8, P99, DOI 10.1080/13691050600665048; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Phillips SJ, 2016, INT J GYNECOL OBSTET, V132, P1, DOI 10.1016/j.ijgo.2015.10.005; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS11, DOI 10.1016/j.jadohealth.2016.05.022; Shisana O, 2012, S AFRICAN NATL HIV P; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UNAIDS, 2016, UNAIDS GAP REP; Volpe EM, 2013, J INTERPERS VIOLENCE, V28, P2068, DOI 10.1177/0886260512471082; Wechsberg W.M., 2010, DRUGS SEX GENDER BAS	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195107	10.1371/journal.pone.0195107	http://dx.doi.org/10.1371/journal.pone.0195107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621283	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800040
J	Hyde, Z; Smith, K; Flicker, L; Atkinson, D; Almeida, OP; Lautenschlager, NT; Dwyer, A; LoGiudice, D				Hyde, Zoe; Smith, Kate; Flicker, Leon; Atkinson, David; Almeida, Osvaldo P.; Lautenschlager, Nicola T.; Dwyer, Anna; LoGiudice, Dina			Mortality in a cohort of remote-living Aboriginal Australians and associated factors	PLOS ONE			English	Article							INDIGENOUS AUSTRALIANS; WESTERN-AUSTRALIA; HEALTH GAP; PREVALENCE; DISEASE; FRAILTY; PEOPLE; POPULATION; LINKAGE; AGE	Objectives We aimed to describe mortality in a cohort of remote-living Aboriginal Australians using electronic record linkage. Methods Between 2004 and 2006, 363 Aboriginal people living in remote Western Australia (WA) completed a questionnaire assessing medical history and behavioural risk factors. We obtained mortality records for the cohort from the WA Data Linkage System and compared them to data for the general population. We used Cox proportional hazards regression to identify predictors of mortality over a 9-year follow-up period. Results The leading causes of mortality were diabetes, renal failure, and ischaemic heart disease. Diabetes and renal failure accounted for 28% of all deaths. This differed from both the Australian population as a whole, and the general Indigenous Australian population. The presence of chronic disease did not predict mortality, nor did behaviours such as smoking. Only age, male sex, poor mobility, and cognitive impairment were risk factors. Conclusions To reduce premature mortality, public health practitioners should prioritise the prevention and treatment of diabetes and renal disease in Aboriginal people in remote WA. This will require a sustained and holistic approach.	[Hyde, Zoe; Smith, Kate; Flicker, Leon; Almeida, Osvaldo P.; Lautenschlager, Nicola T.; Dwyer, Anna; LoGiudice, Dina] Univ Western Australia, Ctr Med Res, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Hyde, Zoe; Smith, Kate; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Atkinson, David] Univ Western Australia, Rural Clin Sch WA, Perth, WA, Australia; [Atkinson, David] Kimberley Aboriginal Med Serv, Broome, Australia; [Atkinson, David] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Lautenschlager, Nicola T.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Lautenschlager, Nicola T.] Melbourne Hlth, NorthWestern Mental Hlth, Melbourne, Vic, Australia; [Dwyer, Anna] Univ Notre Dame, Nulungu Res Inst, Broome, Australia; [LoGiudice, Dina] Melbourne Hlth, Aged Care, Melbourne, Vic, Australia; [LoGiudice, Dina] Univ Melbourne, Melbourne, Vic, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Melbourne; University of Notre Dame Australia; University of Melbourne	LoGiudice, D (corresponding author), Univ Western Australia, Ctr Med Res, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.; LoGiudice, D (corresponding author), Melbourne Hlth, Aged Care, Melbourne, Vic, Australia.; LoGiudice, D (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	dina.logiudice@mh.org.au	Hyde, Zoë/B-6411-2009; LoGiudice, Dina/ABD-2618-2021; Flicker, Leon/AAE-1530-2022; Smith, Kate/ABF-3402-2021; Almeida, Osvaldo P./A-4925-2008	Hyde, Zoë/0000-0002-5985-1729; Flicker, Leon/0000-0002-3650-0475; Smith, Kate/0000-0003-4077-1996; Almeida, Osvaldo P./0000-0002-8689-6199; Atkinson, David/0000-0001-7069-5555; Lautenschlager, Nicola/0000-0003-4850-7794; LoGiudice, Dina/0000-0002-0391-3898	National Health and Medical Research Council [353612]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council, number 353612, to DLG.	Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Anderson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119333; Australian Bureau of Statistics, 2014, CAUS DEATH AUSTR 201; Australian Institute of Health and Welfare, 2021, AUSTR BURD DIS STUD; Australian Institute of Health and Welfare, 2010, CONTR CHRON DIS GAP; Australian Institute of Health and Welfare, 2014, SUPPL DAT LEAD CAUS; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Institute of Health and Welfare and Australian Bureau of Statistics, 2012, NAT BEST PRACT GUID; Azzopardi P, 2012, MED J AUSTRALIA, V197, P32, DOI 10.5694/mja12.10036; Burke V, 2007, PREV MED, V44, P135, DOI 10.1016/j.ypmed.2006.09.008; Cass A, 2004, SOC SCI MED, V58, P767, DOI 10.1016/S0277-9536(03)00243-0; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cotter PR, 2012, AUST HEALTH REV, V36, P68, DOI 10.1071/AH11996; Demaio A, 2012, GLOB HEALTH PROMOT, V19, P58, DOI 10.1177/1757975912441230; Department of Families Community Services and Indigenous Affairs., 2009, CLOS GAP IND DIS CHA; Eades SJ, 2010, MED J AUSTRALIA, V193, P521, DOI 10.5694/j.1326-5377.2010.tb04036.x; Gracey M, 2006, ASIA PAC J CLIN NUTR, V15, P178; Gracey M, 2014, INTERN MED J, V44, P1141, DOI 10.1111/imj.12577; Hill K, 2007, INT J EPIDEMIOL, V36, P580, DOI 10.1093/ije/dym011; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hyde Z, 2016, MATURITAS, V87, P89, DOI 10.1016/j.maturitas.2016.02.013; Jones K, 2008, HLTH HUMAN BEHAV; Kritharides L, 2010, HEART LUNG CIRC, V19, P337, DOI 10.1016/j.hlc.2010.02.017; LoGiudice DC, 2012, INTERN MED J, V42, pE102, DOI 10.1111/j.1445-5994.2010.02332.x; Marley JV, 2010, MED J AUSTRALIA, V193, P516, DOI 10.5694/j.1326-5377.2010.tb04035.x; National Health and Medical Research Council, 2003, VAL ETH GUID ETH CON; Paradies Y, 2002, AUST NZ J PUBL HEAL, V26, P11, DOI 10.1111/j.1467-842X.2002.tb00264.x; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; Smith K, 2015, ALZHEIMERS DEMENTIA; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wakerman J, 2001, Aust Fam Physician, V30, P1141; Wang Z, 2010, BMC EMERG MED, V10, DOI [10.1186/1471-227X-10-1, 10.1186/1471-2458-10-487]; WEERAMANTHRI T, 1992, AUST J PUBLIC HEALTH, V16, P431; Zhao YJ, 2008, AUST NZ J PUBL HEAL, V32, P307, DOI 10.1111/j.1753-6405.2008.00245.x	35	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195030	10.1371/journal.pone.0195030	http://dx.doi.org/10.1371/journal.pone.0195030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621272	Green Published, gold			2022-12-27	WOS:000429206800032
J	Fabris, S; MacLean, DA				Fabris, Sergio; MacLean, David A.			Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; NITRIC-OXIDE; CANCER; CACHEXIA; METABOLISM; MECHANISMS; PATHWAYS; CELLS; CARDIOTOXICITY; ANTHRACYCLINES	Skeletal muscle (SM) health and integrity is dependent on the dynamic balance between protein synthesis and degradation, and central to this process is the availability of amino acids (AA) in the amino pool. While Doxorubicin (DOX) remains one of the most widely used chemotherapeutic agents for the treatment of solid and hematological malignancies, little is known of the effect of the drug on SM, particularly its effect on the availability of amino acids in the tissue. The purpose of this study was to examine the effect of DOX administration on vascular, interstitial and intracellular concentrations of AA in SM of the rat up to 8 days after the administration of a 1.5 or 4.5 mg/kg i.p. dose of DOX. In the plasma, total amino acids (TAA) were significantly increased compared to control where greater (P<0.05) concentrations were observed following the 1.5 mg/kg dose compared to the 4.5 mg/kg dose. Compared to control, the 1.5 mg/kg dose resulted in an increase (P<0.05) in interstitial TAA whereas the 4.5 mg/kg resulted in a sustained decrease (P<0.05). Intracellular TAA, essential amino acids (EAA) and branched-chain amino acids (BCAA) where significantly increased in each muscle group analyzed, following the 1.5 and 4.5 mg/kg doses compared to control. This study provides important insight into the amino acid response following DOX chemotherapy and presents a substantial foundation for future studies focused on reducing SM damage and recovery by targeting amino acid metabolism.	[Fabris, Sergio; MacLean, David A.] Laurentian Univ, Biomol Sci, Sudbury, ON, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Laurentian University; Northern Ontario School of Medicine; Northern Ontario School of Medicine	Fabris, S (corresponding author), Laurentian Univ, Biomol Sci, Sudbury, ON, Canada.	fabris.sergo@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) to DAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Pamela Chenard for her excellent technical assistance. This study was supported by the Natural Sciences and Engineering Research Council.	Ananieva Elitsa, 2015, World J Biol Chem, V6, P281, DOI 10.4331/wjbc.v6.i4.281; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Cole JT, 2015, NUTR HEALTH SER, P13, DOI 10.1007/978-1-4939-1923-9_2; de Lima EA, 2016, J CACHEXIA SARCOPENI, V7, P615, DOI 10.1002/jcsm.12104; DELGADO JMR, 1972, ARCH INT PHARMACOD T, V198, P9; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Fabris S, 2016, CELL BIOL TOXICOL, V32, P121, DOI 10.1007/s10565-016-9325-1; Fabris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139070; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fearon KCH, 2010, HPB, V12, P323, DOI 10.1111/j.1477-2574.2010.00178.x; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; HALL TR, 1993, J BIOL CHEM, V268, P3092; Holecek M, 2011, CURR NUTR FOOD SCI, V7, P50, DOI 10.2174/157340111794941139; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Leuenberger UA, 2008, EUR J APPL PHYSIOL, V102, P457, DOI 10.1007/s00421-007-0601-x; Lu Min, 2011, Genes Cancer, V2, P985, DOI 10.1177/1947601911436199; MacLean D, 1998, J APPL PHYSIOL, V85, P1583, DOI 10.1152/jappl.1998.85.4.1583; MACLEAN DA, 1994, AM J PHYSIOL-ENDOC M, V267, pE1010, DOI 10.1152/ajpendo.1994.267.6.E1010; MacLean DA, 1998, CIRCULATION, V98, P1990, DOI 10.1161/01.CIR.98.19.1990; MacLean DA, 2001, AM J PHYSIOL-HEART C, V280, pH546, DOI 10.1152/ajpheart.2001.280.2.H546; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Narendrula R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2197-1; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; RUDERMAN NB, 1974, J BIOL CHEM, V249, P5500; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Vaughan VC, 2013, J CACHEXIA SARCOPENI, V4, P95, DOI 10.1007/s13539-012-0087-1; Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; WEISS RB, 1992, SEMIN ONCOL, V19, P670; White-Gilbertson S, 2009, MOL ONCOL, V3, P402, DOI 10.1016/j.molonc.2009.05.003; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	45	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195330	10.1371/journal.pone.0195330	http://dx.doi.org/10.1371/journal.pone.0195330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617462	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800075
J	Gerzanich, V; Kwon, MS; Woo, SK; Ivanov, A; Simard, JM				Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Ivanov, Alexander; Simard, J. Marc			SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; NF-KAPPA-B; SULFONYLUREA RECEPTOR 1; OPERATED CA2+ ENTRY; HEMORRHAGIC TRANSFORMATION; TRPC3 CHANNELS; DEPENDENT MODULATION; REACTIVE ASTROCYTES; VASOGENIC EDEMA; ISCHEMIC-STROKE	Background Hemorrhagic transformation is a major complication of ischemic stroke, is linked to matrix metalloproteinase-9 (MMP-9), and is exacerbated by tissue plasminogen activator (tPA). Cerebral ischemia/reperfusion is characterized by SUR1-TRPM4 (sulfonylurea receptor 1 transient receptor potential melastatin 4) channel upregulation in microvascular endothelium. In humans and rodents with cerebral ischemia/reperfusion (I/R), the SUR1 antagonist, glibenclamide, reduces hemorrhagic transformation and plasma MMP-9, but the mechanism is unknown. We hypothesized that tPA induces protease activated receptor 1 (PAR1)mediated, Ca2+-dependent phasic secretion of MMP-9 from activated brain endothelium, and that SUR1-TRPM4 is required for this process. Methods Cerebral I/R, of 2 and 4 hours duration, respectively, was obtained using conventional middle cerebral artery occlusion. Immunolabeling was used to quantify p65 nuclear translocation. Murine and human brain endothelial cells (BEC) were studied in vitro, without and with NF-kappa B activation, using immunoblot, zymography and ELISA, patch clamp electrophysiology, and calcium imaging. Genetic and pharmacological manipulations were used to identify signaling pathways. Results Cerebral I/R caused prominent nuclear translocation of p65 in microvascular endothelium. NF-kappa B-activation of BEC caused de novo expression of SUR1-TRPM4 channels. In NF-kappa B activated BEC: (i) tPA caused opening of SUR1-TRPM4 channels in a plasmin-, PAR1-, TRPC3- and Ca2+-dependent manner; (ii) tPA caused PAR1-dependent secretion of MMP-9; (iii) tonic secretion of MMP-9 by activated BEC was not influenced by SUR1 inhibition; (iv) phasic secretion of MMP-9 induced by tPA or the PAR1-agonist, TFLLR, required functional SUR1-TRPM4 channels, with inhibition of SUR1 decreasing tPA-induced MMP-9 secretion. Conclusions tPA induces PAR1-mediated, SUR1-TRPM4-dependent, phasic secretion of MMP-9 from activated brain endothelium.	[Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Ivanov, Alexander; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu			National Heart, Lung, and Blood Institute [R01HL082517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported National Heart, Lung, and Blood Institute, grant# R01HL082517. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Bartha K, 2000, J CEREBR BLOOD F MET, V20, P175, DOI 10.1097/00004647-200001000-00022; Boulay AC, 2015, JOVE-J VIS EXP, DOI 10.3791/53208; Bouron A, 2015, PFLUG ARCH EUR J PHY, V467, P1143, DOI 10.1007/s00424-014-1590-3; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Cameron M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155468; Carroll JE, 1998, MOL BRAIN RES, V56, P186, DOI 10.1016/S0169-328X(98)00045-X; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V385, P241, DOI 10.1016/j.bbrc.2009.05.049; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; del Zoppo GJ, 2013, SEMIN THROMB HEMOST, V39, P856, DOI 10.1055/s-0033-1357490; Eishingdrelo Haifeng, 2013, Curr Chem Genom Transl Med, V7, P9, DOI 10.2174/2213988501307010009; Feine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041633; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guo SZ, 2010, CEREBROVASC DIS, V30, P290, DOI 10.1159/000319072; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; Harteneck C, 2011, CURR PHARM BIOTECHNO, V12, P35, DOI 10.2174/138920111793937943; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hosomi N, 2005, J CEREBR BLOOD F MET, V25, P959, DOI 10.1038/sj.jcbfm.9600086; Howard EF, 1998, NEUROSCI LETT, V248, P199, DOI 10.1016/S0304-3940(98)00239-0; Jickling GC, 2014, J CEREBR BLOOD F MET, V34, P185, DOI 10.1038/jcbfm.2013.203; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kochukov MY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000913; Kunte H, 2012, ANN NEUROL, V72, P799, DOI 10.1002/ana.23680; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lee M, 2012, STROKE, V43, P3189, DOI 10.1161/STROKEAHA.112.670604; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liu XS, 2006, J CEREBR BLOOD F MET, V26, P787, DOI 10.1038/sj.jcbfm.9600227; Liu XY, 2009, NEURON, V61, P425, DOI 10.1016/j.neuron.2008.12.015; Lopez-Atalaya JP, 2008, J CEREBR BLOOD F MET, V28, P1212, DOI 10.1038/jcbfm.2008.14; Lu HQ, 2009, J BIOL CHEM, V284, P11100, DOI 10.1074/jbc.M806956200; Machida T, 2017, NEUROSCIENCE, V350, P146, DOI 10.1016/j.neuroscience.2017.03.026; Maryanoff Bruce E., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P13, DOI 10.2174/1568016033356724; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; Moshal KS, 2006, AM J PHYSIOL-HEART C, V291, pH2825, DOI 10.1152/ajpheart.00377.2006; Moshal KS, 2006, AM J PHYSIOL-CELL PH, V290, pC883, DOI 10.1152/ajpcell.00359.2005; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Park JY, 2008, BIOCHEM BIOPH RES CO, V368, P677, DOI 10.1016/j.bbrc.2008.01.153; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Rajput PS, 2014, NEUROSCIENCE; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Soto AG, 2015, P NATL ACAD SCI USA, V112, pE3600, DOI 10.1073/pnas.1508838112; Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vennekens R., 2007, V179, P269; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Yang Z, 2017, MOL PHARMACOL, V92, P201, DOI 10.1124/mol.116.107839; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	81	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195526	10.1371/journal.pone.0195526	http://dx.doi.org/10.1371/journal.pone.0195526			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617457	gold, Green Submitted, Green Published			2022-12-27	WOS:000429203800091
J	Spergser, J; Loncaric, I; Tichy, A; Fritz, J; Scope, A				Spergser, Joachim; Loncaric, Igor; Tichy, Alexander; Fritz, Johannes; Scope, Alexandra			The cultivable autochthonous microbiota of the critically endangered Northern bald ibis (Geronticus eremita)	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; ESCHERICHIA-COLI; GASTROINTESTINAL MICROBIOTA; INTERSPECIFIC VARIATIONS; FECAL MICROBIOTA; GUT MICROBIOTA; BIRD AGE; DIVERSITY; WILD; PREVALENCE	The critically endangered Northern bald ibis (Geronticus eremita) is a migratory bird that became extinct in Europe centuries ago. Since 2014, the Northern bald ibis is subject to an intensive rehabilitation and conservation regime aiming to reintroduce the bird in its original distribution range in Central Europe and concurrently to maintain bird health and increase population size. Hitherto, virtually nothing is known about the microbial communities associated with the ibis species; an information pivotal for the veterinary management of these birds. Hence, the present study was conducted to provide a baseline description of the cultivable microbiota residing in the Northern bald ibis. Samples derived from the choana, trachea, crop and cloaca were examined employing a culturomic approach in order to identify microbes at each sampling site and to compare their frequency among age classes, seasonal appearances and rearing types. In total, 94 microbial species including 14 potentially new bacterial taxa were cultivated from the Northern bald ibis with 36, 58 and 59 bacterial species isolated from the choana, crop and cloaca, respectively. The microbiota of the Northern bald ibis was dominated by members of the phylum Firmicutes, followed by Proteobacteria, Actinobacteria, Bacteroidetes and Fusobacteria, altogether phylotypes commonly observed within avian gut environments. Differences in relative abundances of various microbial taxa were evident among sample types indicating mucosa-specific colonisation properties and tissue tropism. Besides, results of the present study indicate that the composition of microbiota was also affected by age, season (environment) and rearing type. While the prevalence of traditional pathogenic microbial species was extremely low, several opportunists including Clostridium perfringens toxotype A were frequently present in samples indicating that the Northern bald ibis may represent an important animal reservoir for these pathogens. In summary, the presented study provides a first inventory of the cultivable microbiota residing in the critically endangered Northern bald ibis and represents a first step in a wider investigation of the ibis microbiome with the ultimate goal to contribute to the management and survival of this critically endangered bird.	[Spergser, Joachim; Loncaric, Igor] Univ Vet Med, Dept Pathobiol, Inst Microbiol, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci, Bioinformat & Biostat Platform, Vienna, Austria; [Fritz, Johannes] Waldrappteam, Mutters, Austria; [Scope, Alexandra] Univ Vet Med, Clin Unit Internal Med Small Anim, Dept Compan Anim & Horses, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Spergser, J (corresponding author), Univ Vet Med, Dept Pathobiol, Inst Microbiol, Vienna, Austria.	Joachim.Spergser@vetmeduni.ac.at		Fritz, Johannes/0000-0003-4691-2892	European Union [LIFE+12-BIO_AT_000143]	European Union(European Commission)	The reintroduction project runs with 50 % contribution of the LIFE financial instrument of the European Union (LIFE+12-BIO_AT_000143, LIFE Northern Bald Ibis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baele M, 2001, J APPL MICROBIOL, V91, P488, DOI 10.1046/j.1365-2672.2001.01407.x; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bennett DC, 2013, VET MICROBIOL, V166, P304, DOI 10.1016/j.vetmic.2013.05.018; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bisgaard M, 2005, 14 WORLD VET POULTR, P110; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Bottacini F, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S4; Braconaro P, 2015, MICROB PATHOGENESIS, V88, P65, DOI 10.1016/j.micpath.2015.08.006; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; Casado E, 2002, COMP BIOCHEM PHYS A, V131, P233, DOI 10.1016/S1095-6433(01)00483-4; Christman J, 2008, ROUT STUD CONTEMP PH, V14, P146; Dec M, 2014, RES MICROBIOL, V165, P190, DOI 10.1016/j.resmic.2014.02.003; Deem S. L., 2007, International Zoo Yearbook, V41, P3, DOI 10.1111/j.1748-1090.2007.00020.x; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dewar ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099996; Dewar ML, 2014, FEMS MICROBIOL ECOL, V89, P47, DOI 10.1111/1574-6941.12332; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; Eisenberg T, 2016, VIRULENCE, V7, P630, DOI 10.1080/21505594.2016.1177694; Fritz J., 2017, International Zoo Yearbook, V51, P107, DOI 10.1111/izy.12163; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2010, ISME J, V4, P611, DOI 10.1038/ismej.2009.147; Gomez G, 2011, J COMP PATHOL, V144, P219, DOI 10.1016/j.jcpa.2010.08.007; Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Goossens E, 2017, VET RES, V48, DOI 10.1186/s13567-017-0413-x; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Hammons S, 2010, SYST APPL MICROBIOL, V33, P275, DOI 10.1016/j.syapm.2010.04.003; Hansen DL, 2009, APPL ENVIRON MICROB, V75, P1546, DOI 10.1128/AEM.00444-08; Jost BH, 2005, INFECT IMMUN, V73, P652, DOI 10.1128/IAI.73.1.652-656.2005; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Keyburn AL, 2010, VET RES, V41, DOI 10.1051/vetres/2009069; Klomp JE, 2008, J AVIAN BIOL, V39, P530, DOI 10.1111/j.0908-8857.2008.04333.x; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; KUMERLOEVE H, 1984, BIOL CONSERV, V30, P363, DOI 10.1016/0006-3207(84)90053-3; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Macfarlane GT, 2009, DIGEST DIS, V27, P90, DOI 10.1159/000268127; Mead Geoffrey C., 1997, P216; Meng XL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.137; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Ryu H, 2012, APPL ENVIRON MICROB, V78, P4338, DOI 10.1128/AEM.07923-11; Saidenberg A. B. S., 2005, Ciencia Veterinaria nos Tropicos, V8, P16; Santos SS, 2012, FEMS MICROBIOL ECOL, V82, P63, DOI 10.1111/j.1574-6941.2012.01407.x; Schmidt-Ukaj S, 2014, VET DERMATOL, V25, P555, DOI 10.1111/vde.12146; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Su HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099826; Taverniti V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00392; Tel OY, 2013, J ZOO WILDLIFE MED, V44, P21, DOI 10.1638/1042-7260-44.1.21; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Waite DW, 2014, APPL ENVIRON MICROB, V80, P4650, DOI 10.1128/AEM.00975-14; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Welchman DD, 2013, AVIAN PATHOL, V42, P171, DOI 10.1080/03079457.2013.778387; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Yoo HS, 1997, J CLIN MICROBIOL, V35, P228, DOI 10.1128/JCM.35.1.228-232.1997; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	73	10	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195255	10.1371/journal.pone.0195255	http://dx.doi.org/10.1371/journal.pone.0195255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617453	gold, Green Published			2022-12-27	WOS:000429203800070
J	Martinez, E; Aira, Z; Buesa, I; Aizpurua, I; Rada, D; Azkue, JJ				Martinez, Endika; Aira, Zigor; Buesa, Itsaso; Aizpurua, Ibane; Rada, Diego; Azkue, Jon Jatsu			Embodied pain in fibromyalgia: Disturbed somatorepresentations and increased plasticity of the body schema	PLOS ONE			English	Article							RUBBER-HAND ILLUSION; REFLEX SYMPATHETIC DYSTROPHY; HEALTH-CARE UTILIZATION; PHANTOM LIMB PAIN; QUALITY-OF-LIFE; ANOREXIA-NERVOSA; BACK-PAIN; MENTAL REPRESENTATIONS; PERCEPTION DISTURBANCE; DIAGNOSTIC-CRITERIA	Fibromyalgia syndrome (FMS) is a highly prevalent, chronic musculoskeletal condition characterized by widespread pain and evoked pain at tender points. This study evaluated various aspects of body awareness in a sample of 14 women with FMS and 13 healthy controls, such as plasticity of the body schema, body esteem, and interoceptive awareness. To this end, the Rubber Hand Illusion (RHI), the Body Esteem Scale (BES), and the Body Perception Questionnaire (BPQ) were used, respectively. Consistent with increased plasticity of the body schema, FMS patients scored higher, with large or very large effect sizes, across all three domains evaluated in the RHI paradigm, namely proprioceptive drift and perceived ownership and motor control over the rubber hand. Scores on all items addressed by the BES were consistently lower among FMS subjects (2.52, SEM.19 vs 3.89, SEM.16, respectively, p < .01, Cohen's d = .38-.66). In the FMS sample, BES scores assigned to most painful regions also were lower than those assigned to the remaining body sites (1.58, SEM.19 vs 2.87, SEM.18, respectively, p < .01). Significantly higher scores (p < .01, Cohen's d.51-.87) were found in the FMS sample across awareness (3.57 SEM.15 vs 1.87 SEM.11), stress response (3.76 SEM.11 vs 1.78 SEM.11), autonomic nervous system reactivity (2.59 SEM.17 vs 1.35 SEM.07), and stress style 2 (2.73 SEM.27 vs 1.13 SEM.04) subscales of the BPQ. Intensity of ongoing clinical pain was found to be strongly correlated with interoceptive awareness (r = .75, p = .002). The results suggest a disturbed embodiment in FMS, characterized by instability of the body schema, negatively biased cognitions regarding one's own body, and increased vigilance to internal bodily cues. These manifestations may be interpreted as related with the inability of incoming sensory inputs to adequately update negatively biased off-line somatorepresentations stored as long-term memory.	[Martinez, Endika; Aira, Zigor; Buesa, Itsaso; Aizpurua, Ibane; Azkue, Jon Jatsu] Univ Basque Country, Dept Neurosci, Sch Med & Nursery, UPV EHU, Barrio Sarriena S-N, Leioa, Bizkaia, Spain; [Rada, Diego] Univ Basque Country, Sch Pharm, Prevent Med & Publ Hlth Dept, UPV EHU Paseo Univ, Vitoria, Araba, Spain	University of Basque Country; University of Basque Country	Buesa, I (corresponding author), Univ Basque Country, Dept Neurosci, Sch Med & Nursery, UPV EHU, Barrio Sarriena S-N, Leioa, Bizkaia, Spain.	itsaso.buesa@ehu.eus	Aira, Zigor/ABG-4661-2020; Buesa, Itsaso/ABF-6852-2020; Azkue, Jon Jatsu/H-2023-2015	Martinez, Endika/0000-0002-1755-2106; Azkue, Jon Jatsu/0000-0002-8609-5500; Aizpurua, Ibane/0000-0001-9190-1864	Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak) [GIC15/25]; University of the Basque Country UPV/EHU [PPG17/06]	Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak); University of the Basque Country UPV/EHU	This work was supported by the Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak, GIC15/25) and the University of the Basque Country UPV/EHU (PPG17/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply indebted to AVAFAS (Asociacion Vasca de Fibromialgia y Astenia Cronica) for participating in this study. Supported by the Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak, GIC15/25) and the University of the Basque Country UPV/EHU (PPG17/06).	Ablin JN, 2012, CLIN EXP RHEUMATOL, V30, pS39; Akkaya N, 2012, CLIN RHEUMATOL, V31, P983, DOI 10.1007/s10067-012-1965-9; Alexander RW, 1998, ARTHRIT CARE RES, V11, P102, DOI 10.1002/art.1790110206; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arendt-Nielsen Lars, 2003, Curr Pain Headache Rep, V7, P355, DOI 10.1007/s11916-003-0034-0; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Bertamini M, 2011, CONSCIOUS COGN, V20, P1108, DOI 10.1016/j.concog.2011.04.006; Borg C, 2015, BRAIN COGNITION, V101, P35, DOI 10.1016/j.bandc.2015.10.002; Borsook D, 2003, ADV DRUG DELIVER REV, V55, P967, DOI 10.1016/S0169-409X(03)00099-1; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boyington Josephine E A, 2015, Open Rheumatol J, V9, P1, DOI 10.2174/1874312901409010001; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Bultitude JH, 2017, BRAIN, V140, P2306, DOI 10.1093/brain/awx152; Bultitude JH, 2010, EXP BRAIN RES, V204, P409, DOI 10.1007/s00221-009-2107-8; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Coslett HB, 2002, NEUROLOGY, V59, P357, DOI 10.1212/WNL.59.3.357; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Ares JD, 2015, PAIN PRACT, V15, P643, DOI 10.1111/papr.12219; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Drossman DA, 2000, PSYCHOSOM MED, V62, P309, DOI 10.1097/00006842-200005000-00004; Dunn BD, 2010, BEHAV RES THER, V48, P1133, DOI 10.1016/j.brat.2010.07.006; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Eubanks JR, 2006, PERCEPT MOTOR SKILL, V102, P485, DOI 10.2166/OMS.102.2.485-497; Fayed N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3072; Filbrich L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10077-8; Finestone HM, 2000, CHILD ABUSE NEGLECT, V24, P547, DOI 10.1016/S0145-2134(00)00112-5; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; GALER BS, 1995, J PAIN SYMPTOM MANAG, V10, P385, DOI 10.1016/0885-3924(95)00061-3; Gaudio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110087; Giudice NA, 2013, EXP BRAIN RES, V224, P141, DOI 10.1007/s00221-012-3295-1; Giummarra MJ, 2007, BRAIN RES REV, V54, P219, DOI 10.1016/j.brainresrev.2007.01.009; Goldberg RT, 1999, DISABIL REHABIL, V21, P23, DOI 10.1080/096382899298061; Golding JM, 2002, J TRAUMA STRESS, V15, P187, DOI 10.1023/A:1015247110020; Green CR, 2001, CLIN J PAIN, V17, P359, DOI 10.1097/00002508-200112000-00011; Guterstam A, 2011, PLOS ONE, V6, P1; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Harlow BL, 2005, AM J EPIDEMIOL, V161, P871, DOI 10.1093/aje/kwi108; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert MS, 2014, ANN BEHAV MED, V48, P50, DOI 10.1007/s12160-013-9563-x; Hollins M, 2016, EXP BRAIN RES, V234, P1377, DOI 10.1007/s00221-015-4541-0; Horwitz EB, 2003, SCAND J CARING SCI, V17, P257, DOI 10.1046/j.1471-6712.2003.00223.x; Imbierowicz K, 2003, EUR J PAIN, V7, P113, DOI 10.1016/S1090-3801(02)00072-1; Jones KD, 2009, JCR-J CLIN RHEUMATOL, V15, P16, DOI 10.1097/RHU.0b013e318190f991; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kallai J, 2015, PSYCHIAT RES, V229, P410, DOI 10.1016/j.psychres.2015.05.109; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Keizer A, 2012, PSYCHIAT RES, V200, P530, DOI 10.1016/j.psychres.2012.05.001; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kendall-Tackett K, 2003, WOMEN THER, V26, P45, DOI 10.1300/J015v26n01_03; Kopec JA, 2004, CAN J PUBLIC HEALTH, V95, P361, DOI 10.1007/BF03405147; Lampe A, 2003, J PSYCHOSOM RES, V54, P361, DOI 10.1016/S0022-3999(02)00399-9; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Lewis JS, 2012, EUR J PAIN, V16, P1320, DOI 10.1002/j.1532-2149.2012.00120.x; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Lotze L., 2007, CURR RHEUMATOL REP, V9, P488; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; MacLachlan M, 2003, J REHABIL RES DEV, V40, P59, DOI 10.1682/JRRD.2003.01.0059; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Martin J, 2014, PAIN PRACT, V14, P721, DOI 10.1111/papr.12134; Martin J, 2014, PAIN MED, V15, P682, DOI 10.1111/pme.12375; Mather M, 2007, PERSPECT PSYCHOL SCI, V2, P33, DOI 10.1111/j.1745-6916.2007.00028.x; McBeth J, 1999, ARTHRITIS RHEUM, V42, P1397, DOI 10.1002/1529-0131(199907)42:7<1397::AID-ANR13>3.0.CO;2-7; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meireles SA, 2014, ACTA ORTOP BRAS, V22, P163, DOI 10.1590/1413-78522014220300386; Monterde S, 2004, REV ESP REUMATOL, V31, P507; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Moseley GL, 2009, PAIN, V144, P314, DOI 10.1016/j.pain.2009.04.030; Moseley GL, 2004, NEUROLOGY, V62, P2182, DOI 10.1212/01.WNL.0000130156.05828.43; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Nishigami T, 2015, MANUAL THER, V20, P63, DOI 10.1016/j.math.2014.06.010; Osborn M, 2006, SCAND J CARING SCI, V20, P216, DOI 10.1111/j.1471-6712.2006.00399.x; Osumi M, 2015, NEUROCASE, V21, P628, DOI 10.1080/13554794.2014.961482; Pain Valenzuela-Moguillansky C., 2013, CONSTRUCTIVIST FDN, V8; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Porges, 1993, BODY PERCEPTION QUES; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Reinersmann A, 2013, PAIN, V154, P1519, DOI 10.1016/j.pain.2013.03.039; Reinersmann A, 2012, PAIN, V153, P2174, DOI 10.1016/j.pain.2012.05.025; Reinersmann A, 2010, NEUROSCI LETT, V486, P240, DOI 10.1016/j.neulet.2010.09.062; Riva G, 2017, CONSCIOUS COGN; Riva G, 2012, MED HYPOTHESES, V79, P113, DOI 10.1016/j.mehy.2012.03.036; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Romano D, 2015, CONSCIOUS COGN, V34, P140, DOI 10.1016/j.concog.2015.04.008; Romano D, 2015, NEUROPSYCHOLOGIA, V70, P414, DOI 10.1016/j.neuropsychologia.2014.10.033; Ryan C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-59; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Schwoebel J, 2002, NEUROLOGY, V59, P775, DOI 10.1212/WNL.59.5.775; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; Schwoebel J, 2000, J COGNITIVE NEUROSCI, P543; Serino S, 2015, PSYCHIAT RES, V230, P732, DOI 10.1016/j.psychres.2015.10.025; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Sorensen J, 1998, J RHEUMATOL, V25, P152; STRAUMAN TJ, 1991, J PERS SOC PSYCHOL, V61, P946, DOI 10.1037/0022-3514.61.6.946; TALLEY NJ, 1995, AM J GASTROENTEROL, V90, P366; Terhaar J, 2012, CLIN NEUROPHYSIOL, V123, P1950, DOI 10.1016/j.clinph.2012.02.086; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Trapp W, 2015, J BACK MUSCULOSKELET, V28, P651, DOI 10.3233/BMR-140561; Treede RD, 2006, EXP NEUROL, V197, P1, DOI 10.1016/j.expneurol.2005.10.009; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tsakiris M, 2008, CONSCIOUS COGN, V17, P1317, DOI 10.1016/j.concog.2008.06.012; Tsay A, 2015, NEUROSCI BIOBEHAV R, V52, P221, DOI 10.1016/j.neubiorev.2015.03.004; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; van den Berg PA, 2010, J ADOLESCENT HEALTH, V47, P290, DOI 10.1016/j.jadohealth.2010.02.004; van Stralen HE, 2013, PERCEPTION, V42, P991, DOI 10.1068/p7583; Vartanian LR., 2012, ENCY BLAND HUMAN APP, V2, P711, DOI DOI 10.1016/B978-0-12-384925-0.00112-7; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wenninger K, 1998, J TRAUMA STRESS, V11, P543, DOI 10.1023/A:1024408830159; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	130	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194534	10.1371/journal.pone.0194534	http://dx.doi.org/10.1371/journal.pone.0194534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624596	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600007
J	Foksinski, M; Zarakowska, E; Gackowski, D; Skonieczna, M; Gajda, K; Hudy, D; Szpila, A; Bialkowski, K; Starczak, M; Labejszo, A; Czyz, J; Rzeszowska-Wolny, J; Olinski, R				Foksinski, Marek; Zarakowska, Ewelina; Gackowski, Daniel; Skonieczna, Magdalena; Gajda, Karolina; Hudy, Dorota; Szpila, Anna; Bialkowski, Karol; Starczak, Marta; Labejszo, Anna; Czyz, Jaroslaw; Rzeszowska-Wolny, Joanna; Olinski, Ryszard			Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2 '-deoxycytidine level in cultured cancerous cell lines (vol 12, e0188856, 2017)	PLOS ONE			English	Correction													Bialkowski, Karol/E-2328-2014; Foksinski, Marek/D-4942-2014; Olinski, Ryszard/E-9607-2014; Gackowski, Daniel/G-5693-2012	Bialkowski, Karol/0000-0002-3836-8076; Foksinski, Marek/0000-0002-1338-8230; Gackowski, Daniel/0000-0002-7259-1511; Gajda, Karolina/0000-0002-0447-3628				Foksinski M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188856	1	1	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195819	10.1371/journal.pone.0195819	http://dx.doi.org/10.1371/journal.pone.0195819			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630664	gold, Green Submitted, Green Published			2022-12-27	WOS:000429505000074
J	Jang, H; Elaish, M; Mahesh, KC; Abundo, MC; Ghorbani, A; Ngunjiri, JM; Lee, CW				Jang, Hyesun; Elaish, Mohamed; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Ngunjiri, John M.; Lee, Chang-Won			Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; AVIAN INFLUENZA; VIRUS; PROTECTION; VACCINATION; H5; INFECTION; REPLICATION; INDUCTION; CHILDREN	Outbreaks of novel highly pathogenic avian influenza viruses have been reported in poultry species in the United States since 2014. These outbreaks have proven the limitations of bio-security control programs, and new tools are needed to reinforce the current avian influenza control arsenal. Some enzootic countries have implemented inactivated influenza vaccine (IIV) in their control programs, but there are serious concerns that a long-term use of IIV without eradication may result in the selection of novel antigenically divergent strains. A broadly protective vaccine is needed, such as live-attenuated influenza vaccine (LAIV). We showed in our previous studies that pc4-LAIV (a variant that encodes a C-terminally truncated NS1 protein) can provide significant protection against heterologous challenge virus in chickens vaccinated at 2-4 weeks of age through upregulation of innate and adaptive immune responses. The current study was conducted to compare the performances of pc4-LAIV and IIV in young chickens vaccinated at 1 day of age. A single dose of pc4-LAIV was able to induce stronger innate and mucosal IgA responses and protect young immunologically immature chickens better than a single dose of IIV. Most importantly, when 1-day-old chickens were intranasally primed with pc4-LAIV and subcutaneously boosted with IIV three weeks later, they showed a rapid, robust, and highly cross-reactive serum antibody response and a high level of mucosal IgA antibody response. This vaccination regimen warrants further optimization to increase its range of protection.	[Jang, Hyesun; Elaish, Mohamed; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Jang, Hyesun; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ngunjiri, JM; Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.; Lee, CW (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	ngunjiri.1@osu.edu; iee.2854@osu.edu	Ngunjiri, John/AAB-3798-2021; Elaish, Mohamed/AAT-4642-2020; Jang, Hyesun/AAG-7814-2021	Ngunjiri, John/0000-0002-2131-1698; Ghorbani, Amir/0000-0001-8511-1727; Elaish, Mohamed/0000-0003-3628-5856; Jang, Hyesun/0000-0002-8142-8222	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Doctoral SEEDS Grant from the Ohio Agricultural Research and Development Center [OHOA1006]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Doctoral SEEDS Grant from the Ohio Agricultural Research and Development Center	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture; Doctoral SEEDS Grant no. OHOA1006 from the Ohio Agricultural Research and Development Center.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Ambrose CS, 2012, VACCINE, V30, P886, DOI 10.1016/j.vaccine.2011.11.104; Apanius V., 1998, AVIAN GROWTH DEV EVO; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Awad F, 2016, AVIAN PATHOL, V45, P169, DOI 10.1080/03079457.2015.1137866; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Basuno E, 2010, TRANSBOUND EMERG DIS, V57, P7, DOI 10.1111/j.1865-1682.2010.01121.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; CDC, AV INFL CURR SIT SUM; Chen GL, 2011, P NATL ACAD SCI USA, V108, P1140, DOI 10.1073/pnas.1009908108; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Elaish M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171174; *FAO, 2007, GLOB STRAT PREV CONT; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; FROMMER A, 1994, AVIAN PATHOL, V23, P425, DOI 10.1080/03079459408419013; Ganapathy K, 2005, AVIAN PATHOL, V34, P248, DOI 10.1080/03079450500112344; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GHENDON Y, 1990, ACTA VIROL, V34, P295; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Hoft DF, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/cvi.00414-16, 10.1128/CVI.00414-16]; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hsu SM, 2010, AVIAN DIS, V54, P1197, DOI 10.1637/9305-031710-Reg.1; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156603; Jang H, 2013, POULTRY SCI, V92, P2290, DOI 10.3382/ps.2013-03116; Jang YH, 2012, J VIROL, V86, P5953, DOI 10.1128/JVI.07149-11; Kapczynski DR, 2014, METHODS MOL BIOL, V1161, P217, DOI 10.1007/978-1-4939-0758-8_18; Lau YF, 2011, J VIROL, V85, P76, DOI 10.1128/JVI.01564-10; Lee Chang-Won, 2005, Animal Health Research Reviews, V6, P1, DOI 10.1079/AHR2005101; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Lorenzo MMG, 2013, CHEST, V143, P502, DOI 10.1378/chest.12-1711; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Ngunjiri JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118934; OIE, 2012, MANUAL DIAGNOSTIC TE; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Pitisuttithum P, 2017, LANCET INFECT DIS, V17, P833, DOI [10.1016/S1473-3099(17)30240-2, 10.1016/s1473-3099(17)30240-2]; RICE JT, 1979, POULTRY SCI, V58, P18, DOI 10.3382/ps.0580018; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sridhar S, 2015, VACCINES, V3, P373, DOI 10.3390/vaccines3020373; Suarez DL, 2017, VET MICROBIOL, V206, P144, DOI 10.1016/j.vetmic.2016.11.025; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Suarez DL, 2006, DEV BIOLOGICALS, V124, P117; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2000, AVIAN DIS, V44, P132, DOI 10.2307/1592516; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; To KKW, 2012, CLIN VACCINE IMMUNOL, V19, P1012, DOI 10.1128/CVI.00081-12; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; Toro H, 2009, POULTRY SCI, V88, P867, DOI 10.3382/ps.2008-00333; Toro H, 2010, AVIAN DIS, V54, P224, DOI 10.1637/8773-033109-Reg.1; USDA, AVIAN INFLUENZA; van Ginkel FW, 2015, VACCINE, V33, P2655, DOI 10.1016/j.vaccine.2015.04.026; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang LY, 2010, AVIAN DIS, V54, P297, DOI 10.1637/8623-012309-ResNote.1; Wu DL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07630; Zhu W, 2017, INT J MOL SCI, V18	68	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195285	10.1371/journal.pone.0195285	http://dx.doi.org/10.1371/journal.pone.0195285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624615	Green Submitted, gold, Green Published			2022-12-27	WOS:000429379600023
J	Baker, AD; Leberg, PL				Baker, Angela Darnell; Leberg, Paul L.			Impacts of human recreation on carnivores in protected areas	PLOS ONE			English	Article							HUMAN DISTURBANCE; MAMMALIAN CARNIVORES; WILDLIFE RESPONSES; EXTINCTION RISK; NORTH-AMERICA; NATIONAL-PARK; TOP PREDATORS; ROADS; CONSERVATION; FOREST	Mammalian carnivores can be particularly sensitive to human disturbance, even within protected areas (PAs). Our objective was to understand how human disturbance affects carnivore communities in southern Arizona, USA by studying habitat occupancy based on data collected using non-invasive methods in three PAs with different levels of human disturbance. Carnivore occupancy varied based on human disturbance variables (i.e., roads, trails, etc.). Common carnivore species (coyotes, gray foxes, and bobcats) had high occupancy probability in highly disturbed sites, while all other carnivore species had a higher probability of occupancy in low disturbance protected areas. Additionally, overall carnivore diversity was higher in PAs with low human disturbance. Edges of PAs appeared to negatively impact occupancy of nearly all carnivore species. We also found the presence of roads and trails, and not necessarily how much they are used, had a significant negative impact on the occupancy of most carnivore species. Furthermore, the overall level of disturbance within a PA influenced how sensitive carnivores were to human disturbance variables. Carnivores were more sensitive in PAs with higher levels of disturbance and were relatively unaffected by disturbance variables in a PA with low base levels of disturbance. Increased visitation to PAs, expected with the region's high level of population growth, is likely to cause shifts in the carnivore communities favoring species that are less sensitive to disturbance.	[Baker, Angela Darnell; Leberg, Paul L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Baker, Angela Darnell] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	University of Louisiana Lafayette; California State University System; California State Polytechnic University, Humboldt	Baker, AD (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.; Baker, AD (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	ange.baker.darnell@gmail.com	Shen, Mason/ABC-9871-2020	Darnell Baker, Ange/0000-0003-1419-3248	Graduate Student Organization at the University of Louisiana at Lafayette	Graduate Student Organization at the University of Louisiana at Lafayette	Funding was provided by the Graduate Student Organization at the University of Louisiana at Lafayette and from generous donors facilitated through InstrumentI Crowdfunding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Bidlack Allison, 2007, THESIS; Blom A, 2005, ORYX, V39, P381, DOI 10.1017/S0030605305001080; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Cahalane VH., 1941, J MAMMAL, V20, P418; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Davies M. L., 2010, ANIMAL CONSERVATION, V14, P56; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Dunstan CE, 1996, J BIOGEOGR, V23, P187, DOI 10.1046/j.1365-2699.1996.d01-220.x; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Floren A, 2001, ECOGRAPHY, V24, P547, DOI 10.1034/j.1600-0587.2001.d01-210.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; FREDDY DJ, 1986, WILDLIFE SOC B, V14, P63; Frid A, 2002, CONSERV ECOL, V6; Gittleman John L., 2005, P370; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Gucinski H., 2001, PNWGTR509 USDA FOR S; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hass CC, 2009, J ZOOL, V278, P174, DOI 10.1111/j.1469-7998.2009.00565.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J.E., 2013, PRESENCE SOFTWARE ES; IUCN, PROT AR AB 2008; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kays R, 2016, J APPL ECOLOGY; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; KING M M, 1986, Transactions of the North American Wildlife and Natural Resources Conference, P74; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Larson CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167259; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Long R.A., 2012, NONINVASIVE SURVEY M; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI, PRESENCE USER MANUAL; MAEHR DS, 1995, CONSERV BIOL, V9, P1008, DOI 10.1111/j.1523-1739.2005.00286.x-i1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Miller SG, 2001, WILDLIFE SOC B, V29, P124; National Park Service [NPS], VIS US STA 2016; National Park Service [NPS], ORG PIP CACT NAT MON; National Park Service [NPS], SAG NAT PARK 2016; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Pirie TJ, 2016, WILDLIFE BIOL, V22, P13, DOI 10.2981/wlb.00129; Prange S, 2004, CAN J ZOOL, V82, P1804, DOI 10.1139/Z04-179; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Ray J. C., 2005, LARGE CARNIVORES CON; Reed SE, 2011, SOUTHWEST NAT, V56, P231, DOI 10.1894/F13-JKF-14.1; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Riley SPD, 2006, J WILDLIFE MANAGE, V70, P1425, DOI 10.2193/0022-541X(2006)70[1425:SEOBAG]2.0.CO;2; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Terborgh J., 1999, CONTINENTAL CONSERVA; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; United States Forest Service [USFS], NAT VIS US MON PROGR; VANDYKE FG, 1986, J WILDLIFE MANAGE, V50, P95; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Western Regional Climate Center [WRCC], AR CLIM SUMM 1981 20; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zielinski W.J., 1995, PSWGTR157 USDA FOR S PSWGTR157 USDA FOR S; [No title captured]	82	18	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195436	10.1371/journal.pone.0195436	http://dx.doi.org/10.1371/journal.pone.0195436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621335	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800081
J	Yamazaki, T; Joshita, S; Umemura, T; Usami, Y; Sugiura, A; Fujimori, N; Kimura, T; Matsumoto, A; Igarashi, K; Ota, M; Tanaka, E				Yamazaki, Tomoo; Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji			Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C	PLOS ONE			English	Article							PLASMA LYSOPHOSPHATIDIC ACID; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; CIRRHOSIS; DACLATASVIR; ASUNAPREVIR; REGRESSION; MARKERS; PREDICT	Sustained virological response (SVR) rates have increased remarkably since the introduction of direct-acting antiviral agents (DAAs) for chronic hepatitis C. Autotaxin (ATX) is a secreted enzyme converting lysophosphatidylcholine to lysophosphatidic acid and a newly established biomarker for liver fibrosis. Interferon-free DAA regimens for chronic hepatitis C could improve liver stiffness in SVR patients according to several non-invasive evaluation methods, but the clinical response and significance of ATX in this context have not yet been defined. We therefore investigated sequential serum ATX levels at baseline, 4 weeks after the start of treatment, and 24 weeks after treatment in 159 hepatitis C virus (HCV)-infected patients who received DAA therapy. Other non-invasive fibrosis markers (aspartate aminotransferase-to-platelet ratio and FIB-4 index) were examined as well. Baseline median ATX levels were comparable between the 144 patients who achieved a SVR and the 15 who did not (1.54 vs. 1.62 mg/L), but median ATX levels became significantly decreased during and after DAA therapy in the SVR group only (from 1.54 to 1.40 and 1.31 mg/L, respectively; P < 0.001). ATX was significantly decreased between baseline and 4 weeks of treatment in overall, male, and female SVR patients (all P < 0.001). In subjects with low necro-inflammatory activity in the liver (i.e., alanine aminotransferase < 30 U/L), ATX levels were significantly reduced from baseline to 4 weeks of treatment and remained low (P < 0.001) in patients with a SVR. Thus, interferon-free DAA therapy was associated with a significant decrease in serum ATX levels in patients achieving a SVR, suggesting early regression of liver fibrosis in addition to inflammation treatment.	[Yamazaki, Tomoo; Joshita, Satoru; Umemura, Takeji; Sugiura, Ayumi; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Ota, Masao; Tanaka, Eiji] Shinshu Univ, Sch Med, Div Hepatol & Gastroenterol, Dept Med, Matsumoto, Nagano, Japan; [Joshita, Satoru; Umemura, Takeji] Shinshu Univ, Res Ctr Next Generat Med, Matsumoto, Nagano, Japan; [Usami, Yoko] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Igarashi, Koji] TOSOH Corp, Biosci Div, Ayase, Kanagawa, Japan	Shinshu University; Shinshu University; Shinshu University; Tosoh Corporation	Umemura, T (corresponding author), Shinshu Univ, Res Ctr Next Generat Med, Matsumoto, Nagano, Japan.	tumemura@shinshu-u.ac.jp	Igarashi, Koji/AAC-5332-2020; Joshita, Satoru/K-5679-2019	Igarashi, Koji/0000-0002-5007-7079; Joshita, Satoru/0000-0002-6364-9654; Umemura, Takeji/0000-0001-7985-919X				Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Chan J, 2017, DIG DIS SCI; Farquhar MJ, 2017, J HEPATOL, V66, P919, DOI 10.1016/j.jhep.2017.01.009; Ichikawa Y, 2016, HEPATOL RES; Ikeda H, 2012, CLIN CHIM ACTA, V413, P1817, DOI 10.1016/j.cca.2012.07.014; Jansen S, 2009, CANCER LETT, V284, P216, DOI 10.1016/j.canlet.2009.04.029; Joshita S, 2017, HEPATOL RES; Kaffe E, 2017, HEPATOLOGY, V65, P1369, DOI 10.1002/hep.28973; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knop V, 2016, J VIRAL HEPATITIS, V23, P994, DOI 10.1111/jvh.12578; Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Masuda A, 2011, CLIN CHIM ACTA, V412, P1944, DOI 10.1016/j.cca.2011.06.039; Miyaki E, 2016, HEPATOL RES, V46, P758, DOI 10.1111/hepr.12621; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2002, J CELL BIOL, V158, P197, DOI 10.1083/jcb.200206094; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Naz S, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02322-2016; Ogasawara N, 2018, J MED VIROL, V90, P313, DOI 10.1002/jmv.24950; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Pleli T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103532; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tada T, 2017, J GASTROEN HEPATOL, V32, P1982, DOI 10.1111/jgh.13788; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Umemura T, 2015, AM J GASTROENTEROL, V110, P857, DOI 10.1038/ajg.2015.118; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yamazaki T, 2017, SCI REP-UK, V7, DOI 10.1038/srep46705	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195632	10.1371/journal.pone.0195632	http://dx.doi.org/10.1371/journal.pone.0195632			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617443	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800095
J	Bafoil, M; Jemmat, A; Martinez, Y; Merbahi, N; Eichwald, O; Dunand, C; Yousfi, M				Bafoil, Maxime; Jemmat, Achraf; Martinez, Yves; Merbahi, Nofel; Eichwald, Olivier; Dunand, Christophe; Yousfi, Mohammed			Effects of low temperature plasmas and plasma activated waters on Arabidopsis thaliana germination and growth	PLOS ONE			English	Article							SEED-GERMINATION; AIR PLASMA	Two plasma devices at atmospheric pressure (air dielectric barrier discharge and helium plasma jet) have been used to study the early germination of Arabidopsis thaliana seeds during the first days. Then, plasma activated waters are used during the later stage of plant development and growth until 42 days. The effects on both testa and endospserm ruptures during the germination stage are significant in the case of air plasma due to its higher energy and efficiency of producing reactive oxygen species than the case of helium plasma. The latter has shown distinct effects only for testa rupture. Analysis of germination stimulations are based on specific stainings for reactive oxygen species production, peroxidase activity and also membrane permeability tests. Furthermore, scanning electron microscopy (SEM) has shown a smoother seed surface for air plasma treated seeds that can explain the plasma induced-germination. During the growth stage, plants were watered using 4 kinds of water (tap and deionized waters activated or not by the low temperature plasma jet). With regards to other water kinds, the characterization of the tap water has shown a larger conductivity, acidity and concentration of reactive nitrogen and oxygen species. Only the tap water activated by the plasma jet has shown a significant effect on the plant growth. This effect could be correlated to reactive nitrogen species such as nitrite/nitrate species present in plasma activated tap water.	[Bafoil, Maxime; Jemmat, Achraf; Merbahi, Nofel; Eichwald, Olivier; Yousfi, Mohammed] Univ Paul Sabatier, UMR CNRS 5213, LAPLACE, Toulouse, France; [Bafoil, Maxime; Jemmat, Achraf; Dunand, Christophe] Univ Toulouse, CNRS, UPS, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Martinez, Yves] Federat Rech 3450, Plateforme Imagerie, Pole Biotechnol Vegetale, Castanet Tolosan, France; [Jemmat, Achraf] Rhein Westfal TH Aachen, Inst Bot & Mol Genet, Bioecon Sci Ctr, Aachen, Germany	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; RWTH Aachen University	Yousfi, M (corresponding author), Univ Paul Sabatier, UMR CNRS 5213, LAPLACE, Toulouse, France.; Dunand, C (corresponding author), Univ Toulouse, CNRS, UPS, Lab Rech Sci Vegetales, Castanet Tolosan, France.	dunand@lrsv.ups-tlse.fr; yousfi@laplace.univ-tlse.fr	Dunand, Christophe/I-6424-2012	Dunand, Christophe/0000-0003-1637-4042	University Paul Sabatier Toulouse CNRS	University Paul Sabatier Toulouse CNRS	University Paul Sabatier Toulouse CNRS	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; De Giorgi J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005708; Dekkers BJW, 2013, PLANT PHYSIOL, V163, P205, DOI 10.1104/pp.113.223511; Dhayal M, 2006, VACUUM, V80, P499, DOI 10.1016/j.vacuum.2005.06.008; Dubinov AE, 2000, IEEE T PLASMA SCI, V28, P180, DOI 10.1109/27.842898; Dubinov AE, 2017, IEEE T PLASMA SCI, V45, P294, DOI 10.1109/TPS.2017.2649604; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Jemmat A, 2015, EFFECTS 3 LOW TEMP P; Jiang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097753; Krapivina S.A., 1994, U.S. Patent, Patent No. [5281315A, 5281315]; Lariguet P, 2013, PLANTA, V238, P381, DOI 10.1007/s00425-013-1901-5; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Mildaziene V, 2016, BIOELECTROMAGNETICS, DOI 10.1002/bem.22003; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Molina I, 2008, PLANT J, V53, P437, DOI 10.1111/j.1365-313X.2007.03348.x; Muller K, 2006, PLANT CELL PHYSIOL, V47, P864, DOI 10.1093/pcp/pcj059; Ogawa Y, 2005, BIOTECHNOL BIOENG, V92, P865, DOI 10.1002/bit.20659; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Puac N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880360; Samouillan V, 2012, IEEE T PLASMA SCI, V40, P1688, DOI 10.1109/TPS.2012.2190303; Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005; Sarin NB., 2014, BIO-PROTOCOL, V4, DOI [10.21769/BioProtoc.1108, DOI 10.21769/BIOPROTOC.1108]; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Stolarik T, 2015, PLASMA CHEM PLASMA P, V35, P659, DOI 10.1007/s11090-015-9627-8; Villeger S, 2005, PLASMA PROCESS POLYM, V2, P709, DOI 10.1002/ppap.200500040; Vishwanath SJ, 2013, PLANT PHYSIOL, V163, P1118, DOI 10.1104/pp.113.224410; Volin JC, 2000, CROP SCI, V40, P1706, DOI 10.2135/cropsci2000.4061706x; Yousfi M, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/045003; Yousfi M, 2014, FUND CLIN PHARMACOL, V28, P123, DOI 10.1111/fcp.12018; Zerrouki A, 2016, PLASMA PROCESS POLYM, V13, P633, DOI 10.1002/ppap.201500144	37	55	56	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195512	10.1371/journal.pone.0195512	http://dx.doi.org/10.1371/journal.pone.0195512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630641	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000053
J	Mohamad, N; Ubaidillah; Mazlan, SA; Imaduddin, F; Choi, SB; Yezid, M				Mohamad, N.; Ubaidillah; Mazlan, S. A.; Imaduddin, F.; Choi, Seung-Bok; Yezid, M.			A comparative work on the magnetic field dependent properties of plate-like and spherical iron particle-based magnetorheological grease	PLOS ONE			English	Article							RHEOLOGICAL PROPERTIES; SHAPE; STABILITY	In this study, a new magnetorheological (MR) grease was made featuring plate-like carbonyl iron (CI) particles, and its magnetic field-dependent rheological properties were experimentally characterized. The plate-like CI particles were prepared through high-energy ball milling of spherical CI particles. Then, three different ratios of the CI particles in the MR grease, varying from 30 to 70 wt% were mixed by dispersing the plate-like CI particles into the grease medium with a mechanical stirrer. The magnetic field-dependent rheological properties of the plate-like CI particle-based MR grease were then investigated using a rheometer by changing the magnetic field intensity from 0 to 0.7 Tat room temperature. The measurement was undertaken at two different modes, namely, a continuous shear mode and oscillation mode. It was shown that both the apparent viscosity and storage modulus of the MR grease were heavily dependent on the magnetic field intensity as well as the CI particle fraction. In addition, the differences in the yield stress and the MR effect between the proposed MR grease featuring the plate-like CI particles and the existing MR grease with the spherical CI particles were investigated and discussed in detail.	[Mohamad, N.; Mazlan, S. A.; Yezid, M.] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, VSE Res Lab, Kuala Lumpur, Malaysia; [Ubaidillah] Univ Sebelas Maret, Fac Engn, Mech Engn Dept, Cetral Java, Surakarta, Indonesia; [Ubaidillah] NCSTT, Bandung, Indonesia; [Imaduddin, F.] Multimedia Univ, Fac Engn & Technol, Melaka, Malaysia; [Choi, Seung-Bok] Inha Univ, Dept Mech Engn, Smart Struct & Syst Lab, Incheon, South Korea	Universiti Teknologi Malaysia; Sebelas Maret University; Institute Technology of Bandung; Multimedia University; Inha University	Mazlan, SA (corresponding author), Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, VSE Res Lab, Kuala Lumpur, Malaysia.	amri.kl@utm.my	Ubaidillah, Ubaidillah/H-4841-2018; Imaduddin, Fitrian/GZA-8216-2022; Mohamad, Norzilawati/AAB-4652-2020; Mazlan, Saiful Amri/AAG-8000-2020; Mazlan, Saiful Amri/AAG-3423-2021	Ubaidillah, Ubaidillah/0000-0002-7190-5849; Mazlan, Saiful Amri/0000-0002-0096-8877; Mohamad, Norzilawati/0000-0002-3113-6598; Imaduddin, Fitrian/0000-0001-6478-018X	Universiti Teknologi Malaysia [04E02]; Sustainable Higher Education Research Alliances (SHERA) Project through Prime Award [AID-497-A-16_00004]; Hibah Kolaborasi Internasional, LPPM, Universitas Sebelas Maret (UNS)	Universiti Teknologi Malaysia; Sustainable Higher Education Research Alliances (SHERA) Project through Prime Award; Hibah Kolaborasi Internasional, LPPM, Universitas Sebelas Maret (UNS)	Funding for this research was provided by the following sources: i) Universiti Teknologi Malaysia 04E02 (Grant Post-Doctoral Research University); ii) Sustainable Higher Education Research Alliances (SHERA) Project through Prime Award: AID-497-A-16_00004, USAID; iii) Hibah Kolaborasi Internasional 2018, LPPM, Universitas Sebelas Maret (UNS).	An HN, 2012, SOFT MATTER, V8, P11995, DOI 10.1039/c2sm26587g; Ashtiani M, 2015, J MAGN MAGN MATER, V374, P716, DOI 10.1016/j.jmmm.2014.09.020; Bell R C, 2006, INT J MOD PHYS B, V21, p4992 ; Chekanova L. A., 2015, Solid State Phenomena, V233-234, P64, DOI 10.4028/www.scientific.net/SSP.233-234.64; de Vicente J, 2002, J MAGN MAGN MATER, V251, P100, DOI 10.1016/S0304-8853(02)00484-5; de Vicente J, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3259358; de Vicente J, 2010, J RHEOL, V54, P1337, DOI 10.1122/1.3479045; Gomez-Ramirez A, 2009, SOFT MATTER, V5, P3888, DOI 10.1039/b906505a; Gong XL, 2012, J RHEOL, V56, P1375, DOI 10.1122/1.4739263; HERMANN A., 2016, Rev. IBRACON Estrut. Mater., V9, P48, DOI 10.1590/S1983-41952016000100004; Hu ZD, 2014, ARAB J SCI ENG, V39, P7355, DOI 10.1007/s13369-014-1358-2; Jones SB, 2000, WATER RESOUR RES, V36, P2821, DOI 10.1029/2000WR900198; Jonkkari I, 2015, J INTEL MAT SYST STR, V26, P2256, DOI 10.1177/1045389X14551436; Ju BX, 2013, IND ENG CHEM RES, V52, P11583, DOI 10.1021/ie4013419; Kavlicoglu BM, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/12/125030; Kim JE, 2012, IEEE T MAGN, V48, P3442, DOI 10.1109/TMAG.2012.2195160; Laherisheth Z, 2017, SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa54a1; Mohamad N, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/9/095043; Park BO, 2011, COLLOID POLYM SCI, V289, P381, DOI 10.1007/s00396-010-2363-y; Park JH, 2001, KOREAN J CHEM ENG, V18, P580, DOI 10.1007/BF02706371; Rankin PJ, 1999, RHEOL ACTA, V38, P471, DOI 10.1007/s003970050198; Rao PV, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/8/085019; Sahin H, 2007, P SPIE INT SOC OPT E; Sahin H, 2009, J INTEL MAT SYST STR, V20, P2215, DOI 10.1177/1045389X09351608; Shah K, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/027001; Shah K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4837660; Shilan ST, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/9/095025; Siebert E, 2015, SMART MATER STRUCT, V24, DOI 10.1088/0964-1726/24/7/075011; Srikala D, 2010, J NANOSCI NANOTECHNO, V10, P8088, DOI 10.1166/jnn.2010.3011; Sugiyama S, 2013, FRONT MECH ENG, V8, P261, DOI 10.1007/s11465-013-0268-4; Ubaidillah, 2015, ADV ENG MATER, V17, P563, DOI 10.1002/adem.201400258; Upadhyay RV, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/1/015002; Wang W, 2015, J ALLOY COMPD, V637, P106, DOI 10.1016/j.jallcom.2015.02.220; Wei Juan, 2013, Applied Mechanics and Materials, V246-247, P1231, DOI 10.4028/www.scientific.net/AMM.246-247.1231; Yang P, 2017, J INTEL MAT SYST STR	35	18	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0191795	10.1371/journal.pone.0191795	http://dx.doi.org/10.1371/journal.pone.0191795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630595	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000001
J	Fan, XZ; Peters, BA; Min, D; Ahn, J; Hayes, RB				Fan, Xiaozhou; Peters, Brandilyn A.; Min, Deborah; Ahn, Jiyoung; Hayes, Richard B.			Comparison of the oral microbiome in mouthwash and whole saliva samples	PLOS ONE			English	Article							HUMAN HEALTH; PLAQUE; CHLORHEXIDINE; MOUTHRINSE; EFFICACY; PROJECT	Population-based epidemiologic studies can provide important insight regarding the role of the microbiome in human health and disease. Buccal cells samples using commercial mouthwash have been obtained in large prospective cohorts for the purpose of studying human genomic DNA. We aimed to better understand if these mouthwash samples are also a valid resource for the study of the oral microbiome. We collected one saliva sample and one Scope mouthwash sample from 10 healthy subjects. Bacterial 16S rRNA genes from both types of samples were amplified, sequenced, and assigned to bacterial taxa. We comprehensively compared these paired samples for bacterial community composition and individual taxonomic abundance. We found that mouthwash samples yielded similar amount of bacterial DNA as saliva samples (p from Student's t-test for paired samples = 0.92). Additionally, the paired samples had similar within sample diversity (p from = 0.33 for richness, and p = 0.51 for Shannon index), and clustered as pairs for diversity when analyzed by unsupervised hierarchical cluster analysis. No significant difference was found in the paired samples with respect to the taxonomic abundance of major bacterial phyla, Bacteroidetes, Firmicutes, Proteobacteria, Fusobacteria, and Actinobacteria (FDR adjusted q values from Wilcoxin signed-rank test = 0.15, 0.15, 0.87, 1.00 and 0.15, respectively), and all identified genera, including genus Streptococcus (q = 0.21), Prevotella (q = 0.25), Neisseria (q = 0.37), Veillonella (q = 0.73), Fusobacterium (q = 0.19), and Porphyromonas (q = 0.60). These results show that mouthwash samples perform similarly to saliva samples for analysis of the oral microbiome. Mouthwash samples collected originally for analysis of human DNA are also a resource suitable for human microbiome research.	[Fan, Xiaozhou; Peters, Brandilyn A.; Min, Deborah; Ahn, Jiyoung; Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Ahn, Jiyoung; Hayes, Richard B.] NYU, NYU Laura & Isaac Perlmutter Canc Inst, New York, NY 10016 USA	New York University; New York University	Hayes, RB (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA.; Hayes, RB (corresponding author), NYU, NYU Laura & Isaac Perlmutter Canc Inst, New York, NY 10016 USA.	Richard.b.hayes@nyumc.org	Fan, Xiaozhou/J-6059-2019	Fan, Xiaozhou/0000-0002-7992-3232; Peters, Brandilyn/0000-0002-1534-2578; Ahn, Jiyoung/0000-0002-2900-2304; Hayes, Richard/0000-0002-0918-661X	National Cancer Institute [R01CA164964]; NATIONAL CANCER INSTITUTE [R01CA164964, R01CA159036] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grant R01CA164964 from the National Cancer Institute (http://www.cancer.gov/researchandfunding) (JA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Araujo MWB, 2015, J AM DENT ASSOC, V146, P610, DOI 10.1016/j.adaj.2015.02.011; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P500, DOI 10.1002/cncr.10197; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fan XZ, 2018, GUT, V67, P120, DOI 10.1136/gutjnl-2016-312580; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Haps S, 2008, Int J Dent Hyg, V6, P290, DOI 10.1111/j.1601-5037.2008.00344.x; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hayes RB, 2018, JAMA ONCOL, V4, P358, DOI 10.1001/jamaoncol.2017.4777; Herrera D, 2003, J CLIN PERIODONTOL, V30, P307, DOI 10.1034/j.1600-051X.2003.00341.x; Kilian M, 2016, BRIT DENT J, V221, P657, DOI 10.1038/sj.bdj.2016.865; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Ohlrich Edward J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5818; Pitten FA, 2001, ARZNEIMITTELFORSCH, V51, P588; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; SCHEIE AA, 1989, J DENT RES, V68, P1609; Shin JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09786-x; Sreenivasan PK, 2013, LETT APPL MICROBIOL, V56, P14, DOI 10.1111/lam.12008; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Yamashita Y, 2017, J ORAL SCI, V59, P201, DOI 10.2334/josnusd.16-0856; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Yu GQ, 2017, CANCER EPIDEM BIOMAR, V26, P249, DOI [10.1158/1055-9965.EPI-16-0538, 10.1158/1055-9965.epi-16-0538]	30	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194729	10.1371/journal.pone.0194729	http://dx.doi.org/10.1371/journal.pone.0194729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641531	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900042
J	Kosuth, M; Mason, SA; Wattenberg, EV				Kosuth, Mary; Mason, Sherri A.; Wattenberg, Elizabeth V.			Anthropogenic contamination of tap water, beer, and sea salt	PLOS ONE			English	Article								Plastic pollution has been well documented in natural environments, including the open waters and sediments within lakes and rivers, the open ocean and even the air, but less attention has been paid to synthetic polymers in human consumables. Since multiple toxicity studies indicate risks to human health when plastic particles are ingested, more needs to be known about the presence and abundance of anthropogenic particles in human foods and beverages. This study investigates the presence of anthropogenic particles in 159 samples of globally sourced tap water, 12 brands of Laurentian Great Lakes beer, and 12 brands of commercial sea salt. Of the tap water samples analyzed, 81% were found to contain anthropogenic particles. The majority of these particles were fibers (98.3%) between 0.1-5 mm in length. The range was 0 to 61 particles/L, with an overall mean of 5.45 particles/L. Anthropogenic debris was found in each brand of beer and salt. Of the extracted particles, over 99% were fibers. After adjusting for particles found in lab blanks for both salt and beer, the average number of particles found in beer was 4.05 particles/L with a range of 0 to 14.3 particles/L and the average number of particles found in each brand of salt was 212 particles/kg with a range of 46.7 to 806 particles/kg. Based on consumer guidelines, our results indicate the average person ingests over 5,800 particles of synthetic debris from these three sources annually, with the largest contribution coming from tap water (88%).	[Kosuth, Mary; Wattenberg, Elizabeth V.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Mason, Sherri A.] SUNY Coll Fredonia, Dept Chem & Biochem, Fredonia, NY 14063 USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; SUNY Fredonia	Kosuth, M (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA.	kosu0003@umn.edu		Kosuth, Mary/0000-0001-8673-9620	University of Minnesota's School of Public Health, Division of Environmental Health Sciences	University of Minnesota's School of Public Health, Division of Environmental Health Sciences	Funding for this study was provided by the James W. Wright Scholarship which was provided by the University of Minnesota's School of Public Health, Division of Environmental Health Sciences. This scholarship was awarded to Mary Kosuth in 2016.	Acosta-Coley I, 2014, ENVIRON MONIT ASSESS, P435; Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304; Atsdr. cdc. gov, 2018, ATSDR TOX SUBST POL; Bakir A, 2013, ENV POLLUT C, V185C, P16; Baldwin AK, 2016, ENVIRON SCI TECHNOL, V50, P10377, DOI 10.1021/acs.est.6b02917; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Buchanan J.B, 1971, MAR POLLUT BULL, V2, P23, DOI [10.1016/0025-326X(71)90136-6, DOI 10.1016/0025-326X(71)90136-6]; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Cousin HR, 2015, FREQUENCY INGESTED P, P6; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Dris R, 2015, ENVIRON CHEM, P2015; Eerkes-Medrano D, 2015, SCI DIRECT, P63, DOI DOI https://doi.org/10.1016/j.watres.2015.02.012; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Europe Plastics, 2016, PLASTICS FACTS 2016, V2016; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Heilongjiang People's Government, 2017, IMPL OP HEIL PROV MU; Iniguez ME, 2017, SCI REPORTS; Karageorge A., 2017, SUPPORT CARE CANCER, P1; Liebezeit G, 2014, FOOD ADDIT CONTAM A, V31, P1574, DOI 10.1080/19440049.2014.945099; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Lyke R., 2012, ALL BEER MAGAZINE; Mason S, 2017, J GREAT LAKES RES, P753; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; Reisser J, 2014, PLOS ONE; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085433; Schirinzi G.F, 2017, ENVIRON RES, V67, P579; Sharma S, 2017, MICROPLASTIC POLLUTI, P21530; Taylor M. L., 2016, SCI REPORTS, P6; Teuten EL, 2009, TRANSPORT RELEASE CH, P2027; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; van Franeker JA, 2015, ENVIRON POLLUT, V203, P89, DOI 10.1016/j.envpol.2015.02.034; Wagner M, 2014, ENV SCI EUROPE; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317; Yang D, 2015, ENVIRON SCI TECHNOL, P13622; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	40	377	395	35	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194970	10.1371/journal.pone.0194970	http://dx.doi.org/10.1371/journal.pone.0194970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641556	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900057
J	Sullivan, J; Moss-Racusin, C; Lopez, M; Williams, K				Sullivan, Jessica; Moss-Racusin, Corinne; Lopez, Michael; Williams, Katherine			Backlash against gender stereotype-violating preschool children	PLOS ONE			English	Article							STATUS INCONGRUITY; MATERNAL-BEHAVIOR; PERCEIVED SEX; SHOULD-NOT; WOMEN; ATTITUDES; BOYS; MEN; BELIEFS; REPLICATION	While there is substantial evidence that adults who violate gender stereotypes often face backlash (i.e. social and economic penalties), less is known about the nature of gender stereotypes for young children, and the penalties that children may face for violating them. We conducted three experiments, with over 2000 adults from the US, to better understand the content and consequences of adults' gender stereotypes for young children. In Experiment 1, we tested which characteristics adults (N=635) believed to be descriptive (i.e. typical), prescriptive (i.e. required), and proscriptive (i.e. forbidden) for preschool-aged boys and girls. Using the characteristics that were rated in Experiment 1, we then constructed vignettes that were either 'masculine' or 'feminine', and manipulated whether the vignettes were said to describe a boy or a girl. Experiment 2 (N=697) revealed that adults rated stereotype-violating children as less likeable than their stereotype-conforming peers, and that this difference was more robust for boys than girls. Experiment 3 (N=731) was a direct replication of Experiment 2, and revealed converging evidence of backlash against stereotype-violating children. In sum, our results suggest that even young children encounter backlash from adults for stereotype violations, and that these effects may be strongest for boys.	[Sullivan, Jessica; Moss-Racusin, Corinne; Williams, Katherine] Skidmore Coll, Dept Psychol, Saratoga Springs, NY 12866 USA; [Lopez, Michael] Skidmore Coll, Dept Math, Saratoga Springs, NY 12866 USA	Skidmore College; Skidmore College	Sullivan, J (corresponding author), Skidmore Coll, Dept Psychol, Saratoga Springs, NY 12866 USA.	jsulliv1@skidmore.edu		Williams, Katherine/0000-0001-8963-7574	start-up funding by Skidmore College	start-up funding by Skidmore College	This work was supported by start-up funding provided by Skidmore College to JS and CMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antill J.K., 1987, REV PERSONALITY SOCI, V7, P294; Bem Sandra, 1998, UNCONVENTIONAL FAMIL; BEM SL, 1981, PSYCHOL REV, V88, P354, DOI 10.1037/0033-295X.88.4.354; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore JEO, 2003, SEX ROLES, V48, P411, DOI 10.1023/A:1023574427720; Bogdan E, 1976, REPLICATION CONDRY C; Brescoll VL, 2008, PSYCHOL SCI, V19, P268, DOI 10.1111/j.1467-9280.2008.02079.x; Brescoll VL, 2005, PSYCHOL WOMEN QUART, V29, P436, DOI 10.1111/j.1471-6402.2005.00244.x; Brewer M., 1988, ADV SOCIAL COGNITION, P1; Brown CS, 2004, DEV PSYCHOL, V40, P714, DOI 10.1037/0012-1649.40.5.714; Burgess D, 1999, PSYCHOL PUBLIC POL L, V5, P665, DOI 10.1037//1076-8971.5.3.665; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; Cahill B, 1997, SEX ROLES, V36, P517, DOI 10.1007/BF02766688; CARTER DB, 1984, SOC COGNITION, V2, P294, DOI 10.1521/soco.1984.2.4.294; COKER DR, 1984, SEX ROLES, V10, P19, DOI 10.1007/BF00287744; CONDRY J, 1976, CHILD DEV, V47, P812; Diekman AB, 2004, SEX ROLES, V50, P373, DOI 10.1023/B:SERS.0000018892.26527.ea; Diekman AB, 2006, PSYCHOL WOMEN QUART, V30, P369, DOI 10.1111/j.1471-6402.2006.00312.x; Eagly A. H., 1994, EUROPEAN REV SOCIAL, V5, P1, DOI [10.1080/14792779543000002, DOI 10.1080/14792779543000002]; EAGLY AH, 1989, PERS SOC PSYCHOL B, V15, P543, DOI 10.1177/0146167289154008; Endendijk JJ, 2014, PARENT-SCI PRACT, V14, P141, DOI 10.1080/15295192.2014.972753; Evans CD, 2009, PSYCHOL WOMEN QUART, V33, P235, DOI 10.1111/j.1471-6402.2009.01493.x; FAGOT BI, 1989, CHILD DEV, V60, P663, DOI 10.1111/j.1467-8624.1989.tb02746.x; FAGOT BI, 1978, CHILD DEV, V49, P459, DOI 10.2307/1128711; FAGOT BI, 1993, DEV REV, V13, P205, DOI 10.1006/drev.1993.1009; FAGOT BI, 1992, DEV PSYCHOL, V28, P225, DOI 10.1037/0012-1649.28.2.225; Fast A, CHILD DEV IN PRESS; FEINMAN S, 1981, SEX ROLES, V7, P289, DOI 10.1007/BF00287543; FEINMAN S, 1974, PSYCHOL REP, V35, P643, DOI 10.2466/pr0.1974.35.1.643; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Friedman MS, 2006, J ADOLESCENT HEALTH, V38, P621, DOI 10.1016/j.jadohealth.2005.04.014; Gelman SA, 2004, MONOGR SOC RES CHILD, V69, P1, DOI 10.1111/j.0037-976X.2004.00274.x; Gill MJ, 2004, J EXP SOC PSYCHOL, V40, P619, DOI 10.1016/j.jesp.2003.12.001; Grace DM, 2008, CHILD DEV, V79, P1928, DOI 10.1111/j.1467-8624.2008.01234.x; HAUGH SS, 1980, CHILD DEV, V51, P598, DOI 10.2307/1129302; Heilman ME, 2004, J APPL PSYCHOL, V89, P416, DOI 10.1037/0021-9010.89.3.416; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Heyman GD, 2001, SOC DEV, V10, P230, DOI 10.1111/1467-9507.00161; Keselman HJ, 2002, BRIT J MATH STAT PSY, V55, P27, DOI 10.1348/000711002159680; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Lancy DF., 2015, ANTHR CHILDHOOD CHER; Leaper C, 2000, DEV PSYCHOL, V36, P381, DOI 10.1037/0012-1649.36.3.381; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; MARTIN CL, 1983, CHILD DEV, V54, P563, DOI 10.2307/1130043; MARTIN CL, 1990, SEX ROLES, V22, P151, DOI 10.1007/BF00288188; McShane BB, 2017, J CONSUM RES, V43, P1048, DOI 10.1093/jcr/ucw085; Moradi B, 2010, COUNS PSYCHOL, V38, P397, DOI 10.1177/0011000009335263; Moss-Racusin CA, 2016, J APPL SOC PSYCHOL, V46, P379, DOI 10.1111/jasp.12366; Moss-Racusin CA, 2014, GENDER IN ORGANIZATIONS: ARE MEN ALLIES OR ADVERSARIES TO WOMEN'S CAREER ADVANCEMENT?, P247; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Moss-Racusin CA, 2010, PSYCHOL MEN MASCULIN, V11, P140, DOI 10.1037/a0018093; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Okimoto TG, 2010, PERS SOC PSYCHOL B, V36, P923, DOI 10.1177/0146167210371949; Parmley M, 2008, SEX ROLES, V58, P358, DOI 10.1007/s11199-007-9335-9; Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066; Rowley SJ, 2007, SOC DEV, V16, P150, DOI 10.1111/j.1467-9507.2007.00376.x; Ruble DN, 2007, CHILD DEV, V78, P1121, DOI 10.1111/j.1467-8624.2007.01056.x; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P157, DOI 10.1037/0022-3514.87.2.157; Rudman LA, 1999, J PERS SOC PSYCHOL, V77, P1004, DOI 10.1037/0022-3514.77.5.1004; Rudman LA, 2001, J SOC ISSUES, V57, P743, DOI 10.1111/0022-4537.00239; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Rudman LA, 2008, RES ORGAN BEHAV, V28, P61, DOI 10.1016/j.riob.2008.04.003; Rudman LA, 2013, J SOC ISSUES, V69, P322, DOI 10.1111/josi.12017; Rudman LA, 2012, ADV EXP SOC PSYCHOL, V45, P167, DOI 10.1016/B978-0-12-394286-9.00004-4; Rudman LA, 2012, J EXP SOC PSYCHOL, V48, P165, DOI 10.1016/j.jesp.2011.10.008; SIGNORELLA ML, 1984, CHILD DEV, V55, P393; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; SLABY RG, 1975, CHILD DEV, V46, P849; SMITH C, 1978, CHILD DEV, V49, P1263; Steinberg L, 2001, J PERS SOC PSYCHOL, V81, P332, DOI 10.1037/0022-3514.81.2.332; STERN M, 1989, SEX ROLES, V20, P501, DOI 10.1007/BF00288198; Steuer FB, 2010, PSYCHOL REP, V107, P139, DOI 10.2466/07.10.17.PR0.107.4.139-144; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Toomey RB, 2010, DEV PSYCHOL, V46, P1580, DOI 10.1037/a0020705; WILL JA, 1976, AM J ORTHOPSYCHIAT, V46, P135, DOI 10.1111/j.1939-0025.1976.tb01234.x; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; Williams VSL, 1999, J EDUC BEHAV STAT, V24, P42, DOI 10.2307/1165261; Yu CY, 2017, J ADOLESCENT HEALTH, V61, pS48, DOI 10.1016/j.jadohealth.2017.07.005	79	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195503	10.1371/journal.pone.0195503	http://dx.doi.org/10.1371/journal.pone.0195503			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630651	Green Published, Green Submitted, gold			2022-12-27	WOS:000429505000052
J	Le Moullec, N; Fianu, A; Maillard, O; Chazelle, E; Naty, N; Schneebeli, C; Gerardin, P; Huiart, L; Charles, MA; Favier, F				Le Moullec, Nathalie; Fianu, Adrian; Maillard, Olivier; Chazelle, Emilie; Naty, Nadege; Schneebeli, Chantal; Gerardin, Patrick; Huiart, Laetitia; Charles, Marie-Aline; Favier, Francois			Sexual dimorphism in the association between gestational diabetes mellitus and overweight in offspring at 5-7 years: The OBEGEST cohort study	PLOS ONE			English	Article							IN-UTERO EXPOSURE; REUNION ISLAND; OBESITY; CHILDHOOD; PREGNANCY; RISK; PREVALENCE; HYPERGLYCEMIA; ENVIRONMENT; GLYCEMIA	Evidence from literature is mixed regarding a possible association of maternal gestational diabetes mellitus (GDM) and overweight in the offspring. Sexual dimorphism, or sex disparities in the pathogenesis linking GDM exposure to overweight, could be at play. The objective of this study was to investigate the association between GDM and child overweight at 5-7 years. Six hundred pairs (1:1) of Reunionese liveborn singletons selected from a hospital based birth registry, matched for sex, gestational age, and birth period, underwent a prospective in-home follow-up and were analyzed with respect to their exposure to GDM. The primary outcome was child overweight at 5-7 years, as defined by the International Obesity Task Force. The association between GDM exposure and child overweight was estimated by the odds ratio (OR) using conditional logistic regression models. For the subset of children exposed to GDM with available maternal glycemic data, we analyzed the relationship between maternal glycemic levels during pregnancy and child body mass index (BMI) at 5-7 years with a linear regression model. In light of the significant interaction between sex and GDM, all statistical analyses were then stratified by sex. After controlling for pre-pregnancy BMI and maternal sociodemographic characteristics, the risk of overweight increased with exposure to GDM for boys (adjusted OR: 2.34; 95% confidence interval = 1.26-4.34, P = 0.007) but not for girls (adjusted OR: 0.56; 95%Cl = 0.28-1.10, P=0.093). Consistent with this, the linear increase of boys' BMI at 5-7 years with maternal blood glucose levels during pregnancy, in the exposed group, displayed a dose-response relationship. Our findings indicate that exposure to GDM is a risk factor for childhood overweight in boys but not in girls, which adds to the growing body of evidence suggesting greater sensitivity of male offspring to intrauterine hyperglycemia.	[Le Moullec, Nathalie] CHU Reunion, Dept Endocrinol Diabetol & Nutr, St Pierre, Reunion, France; [Fianu, Adrian; Maillard, Olivier; Chazelle, Emilie; Naty, Nadege; Schneebeli, Chantal; Gerardin, Patrick; Huiart, Laetitia; Favier, Francois] Univ Reunion, CHU Reunion, INSERM CIC Clin & Epidemiol 1410, St Pierre, Reunion, France; [Fianu, Adrian] Univ Toulouse, UMR1027, UPS, INSERM, Toulouse, France; [Charles, Marie-Aline] Ctr Res Epidemiol & Populat Hlth, Paris, France; [Charles, Marie-Aline] Paris Descartes Univ, Paris, France	CHU Reunion; CHU Reunion; University of La Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Cite	Fianu, A (corresponding author), Univ Reunion, CHU Reunion, INSERM CIC Clin & Epidemiol 1410, St Pierre, Reunion, France.; Fianu, A (corresponding author), Univ Toulouse, UMR1027, UPS, INSERM, Toulouse, France.	adrian.fianu@chu-reunion.fr	Charles, Marie Aline/F-8567-2017; Charles, Marie Aline/S-1866-2019	Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; maillard, olivier/0000-0001-6677-3952	Centre Hospitalier Universitaire (CHU) Reunion; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer	Centre Hospitalier Universitaire (CHU) Reunion; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer	The Centre Hospitalier Universitaire (CHU) Reunion was the study sponsor. The OBEGEST cohort study was carried out with financial support from Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer (2008 PHRC-I grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; Allirot X, 2007, DIABETES METAB, V33, P347, DOI 10.1016/j.diabet.2007.03.006; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Aris IM, 2015, AM J CLIN NUTR, V102, P1104, DOI 10.3945/ajcn.115.117614; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Buchanan TA, 2007, DIABETES CARE, V30, P3154; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; Daraki V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126327; Durnwald C, 2015, SEMIN PERINATOL, V39, P254, DOI 10.1053/j.semperi.2015.05.002; Favier F, 2005, DIABETES RES CLIN PR, V67, P234, DOI 10.1016/j.diabres.2004.07.013; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gupta Y, 2015, INT J WOMENS HEALTH, V7, P539, DOI 10.2147/IJWH.S82046; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Kalisch-Smith JI, 2017, PLACENTA, V54, P10, DOI 10.1016/j.placenta.2016.12.008; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P377; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Li SS, 2017, INT J EPIDEMIOL, V46, P1533, DOI [10.1093/ije/dyx211, 10.1093/ije/dyx151]; Lingwood BE, 2011, DIABETES CARE, V34, P2581, DOI 10.2337/dc11-0728; Mariotti E, 2013, CORPULENCE ENFANTS C; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Monteiro LJ, 2016, PLACENTA, V48, pS54, DOI 10.1016/j.placenta.2015.11.015; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Oken E, 2016, AM J PERINAT, V33, P1273, DOI 10.1055/s-0036-1586509; Pettitt DJ, 2010, DIABETES CARE, V33, P1219, DOI 10.2337/dc09-2384; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Regnault N, 2013, DIABETES CARE, V36, P3045, DOI 10.2337/dc13-0333; Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Silverman BL, 1998, DIABETES CARE, V21, pB142; Tam WH, 2017, DIABETES CARE, V40, P679, DOI 10.2337/dc16-2397; Vivet-Lefebure A, 2007, GYNECOL OBSTET FERTI, V35, P530, DOI 10.1016/j.gyobfe.2007.04.010; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wilkin TJ, 2006, INT J OBESITY, V30, P1056, DOI 10.1038/sj.ijo.0803317; Yang I, 2016, NURS RES, V65, P76, DOI 10.1097/NNR.0000000000000133; Zhao YL, 2015, J DEV ORIG HLTH DIS, V6, P479, DOI 10.1017/S2040174415007205; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	46	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195531	10.1371/journal.pone.0195531	http://dx.doi.org/10.1371/journal.pone.0195531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621322	Green Published, gold, Green Submitted			2022-12-27	WOS:000429206800098
J	Ahmed, AM; Rizaner, A; Ulusoy, AH				Ahmed, Ahmed Mohamed; Rizaner, Ahmet; Ulusoy, Ali Hakan			A novel decision tree classification based on post-pruning with Bayes minimum risk	PLOS ONE			English	Article								Pruning is applied in order to combat over-fitting problem where the tree is pruned back with the goal of identifying decision tree with the lowest error rate on previously unobserved instances, breaking ties in favour of smaller trees with high accuracy. In this paper, pruning with Bayes minimum risk is introduced for estimating the risk-rate. This method proceeds in a bottom-up fashion converting a parent node of a subtree to a leaf node if the estimated risk-rate of the parent node for that subtree is less than the risk rates of its leaf. This paper proposes a post-pruning method that considers various evaluation standards such as attribute selection, accuracy, tree complexity, and time taken to prune the tree, precision/recall scores, TP/FN rates and area under ROC. The experimental results show that the proposed method produces better classification accuracy and its complexity is not much different than the complexities of reduced-error pruning and minimum-error pruning approaches. The experiments also demonstrate that the proposed method shows satisfactory performance in terms of precision score, recall score, TP rate, FP rate and area under ROC.	[Ahmed, Ahmed Mohamed] Univ Bahri, Coll Comp Sci, Khartoum, Sudan; [Ahmed, Ahmed Mohamed] Eastern Mediterranean Univ, Dept Math, Fac Arts & Sci, Gazimagusa, North Cyprus, Turkey; [Rizaner, Ahmet; Ulusoy, Ali Hakan] Eastern Mediterranean Univ, Dept Informat Technol, Sch Comp & Technol, Gazimagusa, North Cyprus, Turkey	Eastern Mediterranean University; Eastern Mediterranean University	Ahmed, AM (corresponding author), Univ Bahri, Coll Comp Sci, Khartoum, Sudan.; Ahmed, AM (corresponding author), Eastern Mediterranean Univ, Dept Math, Fac Arts & Sci, Gazimagusa, North Cyprus, Turkey.	aymansafy76@yahoo.com	Ahmed, Ahmed/HGB-0691-2022; Ulusoy, Ali Hakan/D-4752-2013; Rizaner, Ahmet/H-3568-2016	Ahmed, Ahmed/0000-0003-3019-5462; Ulusoy, Ali Hakan/0000-0002-2992-9265; Rizaner, Ahmet/0000-0001-8419-5308				Ahmed AM, 2016, PROCEDIA COMPUT SCI, V102, P137, DOI 10.1016/j.procs.2016.09.380; Bahnsen AC, 2015, EXPERT SYST APPL, V42, P6609, DOI 10.1016/j.eswa.2015.04.042; Bahnsen AC, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P333, DOI 10.1109/ICMLA.2013.68; Berzal F, 2003, DATA KNOWL ENG, V44, P31, DOI 10.1016/S0169-023X(02)00062-9; Bradford JP, 1998, EUR C MACH LEARN APR, P31; Breiman L., 1984, CLASSIFICATION REGRE; Buntine W., 1992, Statistics and Computing, V2, P63, DOI 10.1007/BF01889584; Elomaa T, 2001, J ARTIF INTELL RES, V15, P163, DOI 10.1613/jair.816; Esposito F, 1995, LECT NOTES ARTIF INT, V912, P287; Frank E, THESIS; Hall L. O., 2003, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V12, P249, DOI 10.1142/S0218213003001228; Han J, 2012, MOR KAUF D, P1; Katz G, 2014, J COMPUT SCI TECH-CH, V29, P392, DOI 10.1007/s11390-014-1438-5; Mansour Y., 1997, P 14 INT C MACH LEAR, P195; Mehta M., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P216; Mehta S, 2015, COMP COMM CONTR IC4, P1; Mohamed WN, CONTR SYST COMP ENG; Oates T, 1997, 14 INT C MACH LEARN; QUINLAN JR, 1989, INFORM COMPUT, V80, P227, DOI 10.1016/0890-5401(89)90010-2; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	22	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194168	10.1371/journal.pone.0194168	http://dx.doi.org/10.1371/journal.pone.0194168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617369	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800021
J	D'Eath, RB; Jack, M; Futro, A; Talbott, D; Zhu, QM; Barclay, D; Baxter, EM				D'Eath, Richard B.; Jack, Mhairi; Futro, Agnieszka; Talbott, Darren; Zhu, Qiming; Barclay, David; Baxter, Emma M.			Automatic early warning of tail biting in pigs: 3D cameras can detect lowered tail posture before an outbreak	PLOS ONE			English	Article							MANAGEMENT; BEHAVIOR; CLASSIFICATION; PREVALENCE; SYSTEMS; DOCKING; LESIONS; DAMAGE	Tail biting is a major welfare and economic problem for indoor pig producers worldwide. Low tail posture is an early warning sign which could reduce tail biting unpredictability. Taking a precision livestock farming approach, we used Time-of-flight 3D cameras, processing data with machine vision algorithms, to automate the measurement of pig tail posture. Validation of the 3D algorithm found an accuracy of 73.9% at detecting low vs. not low tails (Sensitivity 88.4%, Specificity 66.8%). Twenty-three groups of 29 pigs per group were reared with intact (not docked) tails under typical commercial conditions over 8 batches. 15 groups had tail biting outbreaks, following which enrichment was added to pens and biters and/or victims were removed and treated. 3D data from outbreak groups showed the proportion of low tail detections increased pre-outbreak and declined post-outbreak. Pre-outbreak, the increase in low tails occurred at an increasing rate over time, and the proportion of low tails was higher one week pre-outbreak (-1) than 2 weeks pre-outbreak (-2). Within each batch, an outbreak and a non-outbreak control group were identified. Outbreak groups had more 3D low tail detections in weeks-1, +1 and +2 than their matched controls. Comparing 3D tail posture and tail injury scoring data, a greater proportion of low tails was associated with more injured pigs. Low tails might indicate more than just tail biting as tail posture varied between groups and over time and the proportion of low tails increased when pigs were moved to a new pen. Our findings demonstrate the potential for a 3D machine vision system to automate tail posture detection and provide early warning of tail biting on farm.	[D'Eath, Richard B.; Jack, Mhairi; Futro, Agnieszka; Baxter, Emma M.] SRUC, Edinburgh, Midlothian, Scotland; [Talbott, Darren] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Zhu, Qiming; Barclay, David] Innovent Technol Ltd, Turriff, Aberdeen, Scotland	University of Edinburgh	D'Eath, RB (corresponding author), SRUC, Edinburgh, Midlothian, Scotland.	rick.death@sruc.ac.uk	Zixuan, Huang/ABI-3557-2020	Baxter, Emma/0000-0003-3370-7371; D'Eath, Rick/0000-0002-1801-254X	Innovate UK as part of the Agri-Tech Catalyst [132343]; Innovate UK scheme; Biotechnology and Biological Sciences Research Council [TS/P000541/1]; RCUK [BB/P004962/1]; Rural and Environment Science and Analytical Services Division of the Scottish Government; BBSRC [BB/P004962/1] Funding Source: UKRI	Innovate UK as part of the Agri-Tech Catalyst(UK Research & Innovation (UKRI)Innovate UK); Innovate UK scheme(UK Research & Innovation (UKRI)Innovate UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RCUK(UK Research & Innovation (UKRI)); Rural and Environment Science and Analytical Services Division of the Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for a project titled "Early detection of tail biting in pigs using 3D video to measure tail posture (132343)" was awarded by Innovate UK (https//www.gov.uk/government/organisations/innovate-uk) to commercial partners (authors DB and QZ) as part of the Agri-Tech Catalyst. The Innovate UK funding does not cover all of the project costs, as such the commercial partner Innovent Technology (Ltd) contributed further funding by part-supporting the salaries of its employees: authors DB and QZ. As part of the Innovate UK scheme which funds academics and commercial partners to work together, the Biotechnology and Biological Sciences Research Council (https://www.bbsrc.ac.uk) provided funding to the academic partner SRUC (authors RBD, EMB, MJ, AF) BBSRC grant ref TS/P000541/1; RCUK grant ref BB/P004962/1 http://gtr.rcuk.ac.uk/projects?ref=BB%2FP004962%2F1). Additional funding to SRUC (authors RBD, EMB, MJ, AF) was awarded from the Rural and Environment Science and Analytical Services Division of the Scottish Government, http://www.gov.scot/Topcs/Research/Abouti/EBAR/StrategicResearch/strategicresearch2016-21/srp2016-21 Input from a student from the University of Edinburgh MSc Applied Animal Behaviour and Animal Welfare (DT; https://www.ed.ac.uk/vet/studying/postgrnaduate/taught-programmes/applied-animal-behaviourwelfare) was carried out on a voluntary basis. The funders provided support in the form of salaries for authors [RBD, MJ, AF, QZ, DB, EMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banhazi T. M., 2012, International Journal of Agricultural and Biological Engineering, V5, P1, DOI 10.3965/j.ijabe.20120503.001; Berckmans D, 2014, REV SCI TECH OIE, V33, P189, DOI 10.20506/rst.33.1.2273; Bracke MBM, 2013, J AGR ENVIRON ETHIC, V26, P847, DOI 10.1007/s10806-012-9410-2; D'Eath RB, 2016, ANIMAL, V10, P687, DOI 10.1017/S1751731115002098; D'Eath RB, 2014, ANIMAL, V8, P1479, DOI 10.1017/S1751731114001359; Di Giminiani P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05404-y; EFSA, 2007, ANNEX EFSA J, V611, P1; Fournel S, 2017, BIOSYST ENG, V155, P96, DOI 10.1016/j.biosystemseng.2016.12.005; Groffen J., 2012, 393 SLU DEP AN ENV H; Harley S, 2014, ANIM WELFARE, V23, P275, DOI 10.7120/09627286.23.3.275; Harley S, 2012, VET REC, V171, P621, DOI 10.1136/vr.100986; Keeling LJ, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-32; Kritas SK, 2004, J SWINE HEALTH PROD, V12, P17; Lahrmann HP, 2017, ANIMAL, V11, P1825, DOI 10.1017/S1751731117000490; Lahrmann HP, 2017, APPL ANIM BEHAV SCI; Larsen MLV, 2016, VET J, V209, P50, DOI 10.1016/j.tvjl.2015.12.001; Matthews SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17451-6; Matthews SG, 2016, VET J, V217, P43, DOI 10.1016/j.tvjl.2016.09.005; McGlone J.J., 1990, T5283 TEX TECH U AGR, V283, P69; Munsterhjelm C, 2013, ANIM WELFARE, V22, P331, DOI 10.7120/09627286.22.3.331; Nasirahmadi A, 2017, LIVEST SCI, V202, P25, DOI 10.1016/j.livsci.2017.05.014; Paoli MA, 2016, ANIM WELFARE, V25, P287, DOI 10.7120/09627286.25.2.287; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; Schroder-Petersen DL, 2004, ACTA AGR SCAND A-AN, V54, P159, DOI 10.1080/09064700410003835; Scollo A, 2017, PREV VET MED, V146, P114, DOI 10.1016/j.prevetmed.2017.08.001; Sihvo HK, 2012, J COMP PATHOL, V146, P73, DOI 10.1016/j.jcpa.2011.11.112; SKOV A/ S, 2018, PROD MAN SYST CAM WE; Sonoda LT, 2013, BERL MUNCH TIERARZTL, V126, P104, DOI 10.2376/0005-9366-126-104; Statham P, 2009, APPL ANIM BEHAV SCI, V121, P157, DOI 10.1016/j.applanim.2009.09.011; Studnitz M, 2007, APPL ANIM BEHAV SCI, V107, P183, DOI 10.1016/j.applanim.2006.11.013; Sutherland MA, 2011, APPL ANIM BEHAV SCI, V135, P179, DOI 10.1016/j.applanim.2011.10.015; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Ursinus WW, 2014, APPL ANIM BEHAV SCI, V156, P22, DOI 10.1016/j.applanim.2014.04.001; Valros A, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/2055-5660-1-2; Van de Weerd HA, 2003, APPL ANIM BEHAV SCI, V84, P101, DOI 10.1016/S0168-1591(03)00150-3; Viazzi S, 2014, COMPUT ELECTRON AGR, V104, P57, DOI 10.1016/j.compag.2014.03.010; Zonderland JJ, 2011, ANIMAL, V5, P767, DOI 10.1017/S1751731110002326; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zonderland JJ, 2009, APPL ANIM BEHAV SCI, V121, P165, DOI 10.1016/j.applanim.2009.09.002	39	49	50	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194524	10.1371/journal.pone.0194524	http://dx.doi.org/10.1371/journal.pone.0194524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617403	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800033
J	Ghorbani, A; Izadpanah, K; Dietzgen, RG				Ghorbani, Abozar; Izadpanah, Keramatollah; Dietzgen, Ralf G.			Changes in maize transcriptome in response to maize Iranian mosaic virus infection	PLOS ONE			English	Article							PLANT DEFENSE; GENE-EXPRESSION; PROTEIN; RESISTANCE; TOMATO; RHABDOVIRUS; MECHANISMS; IMMUNITY; GENOMICS; BIOLOGY	Background Maize Iranian mosaic virus (MIMV, genus Nucleorhabdovirus, family Rhabdoviridae) causes an economically important disease in maize and other gramineous crops in Iran. MIMV negative-sense RNA genome sequence of 12,426 nucleotides has recently been completed. Maize Genetics and Genomics database shows that 39,498 coding genes and 4,976 non-coding genes of maize have been determined, but still some transcripts could not be annotated. The molecular host cell responses of maize to MIMV infection including differential gene expression have so far not been elucidated. Methodology/Principal findings Complementary DNA libraries were prepared from total RNA of MIMV-infected and mock inoculated maize leaves and sequenced using Illumina HiSeq 2500. Cleaned raw transcript reads from MIMV-infected maize were mapped to reads from uninfected maize and to a maize reference genome. Differentially expressed transcripts were characterized by gene ontology and biochemical pathway analyses. Transcriptome data for selected genes were validated by real-time quantitative PCR. Conclusion/Significance Approximately 42 million clean reads for each treatment were obtained. In MIMV-infected maize compared to uninfected plants, 1689 transcripts were up-regulated and 213 transcripts were down-regulated. In response to MIMV infection, several pathways were activated in maize including immune receptor signaling, metabolic pathways, RNA silencing, hormone-mediated pathways, protein degradation, protein kinase and ATP binding activity, and fatty acid metabolism. Also, several transcripts including those encoding hydrophobic protein RCI2B, adenosylmethionine decarboxylase NAC transcription factor and nucleic acid binding, leucine-rich repeat, heat shock protein, 26S proteasome, oxidoreductases and endonuclease activity protein were up-regulated. These data will contribute to the identification of genes and pathways involved in plant-virus interactions that may serve as future targets for improved disease control.	[Ghorbani, Abozar; Izadpanah, Keramatollah] Shiraz Univ, Coll Agr, Plant Virol Res Ctr, Shiraz, Iran; [Ghorbani, Abozar; Dietzgen, Ralf G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	Shiraz University; University of Queensland	Dietzgen, RG (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	r.dietzgen@uq.edu.au	Ghorbani, Abozar/ABB-5025-2021; Dietzgen, Ralf Georg/A-5565-2010	Ghorbani, Abozar/0000-0002-2183-0033; Dietzgen, Ralf Georg/0000-0002-7772-2250	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation; Plant Virology Research Center, Shiraz University; Shiraz University, Iran	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation; Plant Virology Research Center, Shiraz University; Shiraz University, Iran	The research was jointly supported by the Queensland Department of Agriculture and Fisheries and the University of Queensland through the Queensland Alliance for Agriculture and Food Innovation. Plant Virology Research Center, Shiraz University provided funds for part of this research. AG was supported by a scholarship from Shiraz University, Iran.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Amarasinghe GK, 2017, ARCH VIROL, V162, P2493, DOI 10.1007/s00705-017-3311-7; Asters MC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04815; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Calil IP, 2017, ANN BOT-LONDON, V119, P711, DOI 10.1093/aob/mcw200; Carmo LST, 2017, J PROTEOMICS, V151, P284, DOI 10.1016/j.jprot.2016.07.018; Cassone BJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-133; Chen J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0584-5; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; Choi H, 2015, PLANT MOL BIOL, V88, P233, DOI 10.1007/s11103-015-0317-y; Converse R., 1990, LAB MANUAL, P179; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; de la Torre F, 2013, PLANT CELL, V25, P2748, DOI 10.1105/tpc.113.113530; Dietzgen R. G., 2012, RHABDOVIRUSES MOL TA; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Estakhr A, 2015, ANN RES REV BIOL, V8, P1; Fan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132277; Fan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085284; Gamage SMKW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159085; Goyer A, 2010, PHYTOCHEMISTRY, V71, P1615, DOI 10.1016/j.phytochem.2010.06.022; Hazarika Pranjal, 2011, Physiology and Molecular Biology of Plants, V17, P115, DOI 10.1007/s12298-011-0053-y; IZADPANAH K, 1983, PHYTOPATHOL Z, V107, P283; IZADPANAH K, 1989, J PHYTOPATHOL, V126, P43, DOI 10.1111/j.1439-0434.1989.tb01088.x; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Jeevalatha A, 2017, VIRUS RES, V232, P22, DOI 10.1016/j.virusres.2017.01.015; Jensen PJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-261; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kidd Parris, 2003, Altern Med Rev, V8, P223; Liu J, 2014, J INTEGR PLANT BIOL, V56, P122, DOI 10.1111/jipb.12133; Liu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119858; Liu YJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2780-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Maldonado AFS, 2015, TRENDS FOOD SCI TECH, V46, P49, DOI 10.1016/j.tifs.2015.07.013; Massah A, 2008, ARCH VIROL, V153, P1041, DOI 10.1007/s00705-008-0085-y; Massah A., 2005, Iranian Journal of Plant Pathology, V41, P151; Medina J, 2001, PLANT PHYSIOL, V125, P1655, DOI 10.1104/pp.125.4.1655; Min BE, 2010, MOL PLANT MICROBE IN, V23, P1420, DOI 10.1094/MPMI-04-10-0097; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Plat J, 2015, J AOAC INT, V98, P697, DOI 10.5740/jaoacint.SGEPlat; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Sood A, 2017, BIOENERG RES, V10, P129, DOI 10.1007/s12155-016-9783-6; Stobbe AH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00150; Strable J, 2009, COLD SPRING HARBOR P, V2009; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Tzin V, 2015, PLANT PHYSIOL, V169, P1727, DOI 10.1104/pp.15.01039; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177739; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058274; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Wu WQ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-118; Zhang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121222	61	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194592	10.1371/journal.pone.0194592	http://dx.doi.org/10.1371/journal.pone.0194592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634778	Green Published, Green Submitted, gold			2022-12-27	WOS:000429522200012
J	Yurchenko, KS; Zhou, PP; Kovner, AV; Zavjalov, EL; Shestopalova, LV; Shestopalov, AM				Yurchenko, Kseniya S.; Zhou, Peipei; Kovner, Anna V.; Zavjalov, Evgenii L.; Shestopalova, Lidiya V.; Shestopalov, Alexander M.			Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model	PLOS ONE			English	Article							PANCREATIC ADENOCARCINOMA; INFECTION; APOPTOSIS; REPLICATION; VIROTHERAPY; RESPONSES; MTH-68/H; GLIOMA; DEATH; TRIAL	Oncolyic virotherapy is one of the modern experimental techniques to treat human cancers. Here we studied the antitumor activity of wild-type Newcastle disease virus (NDV) isolates from Russian migratory birds. We showed that NDV could selectively kill malignant cells without affecting healthy cells. We evaluated the oncolytic effect of 44 NDV isolates in 4 histogenetically different human cell lines (HCT116, HeLa, A549, MCF7). The safety of the isolates was also tested in normal peripheral blood mononuclear (PBMC) cells. The viability of tumor cell lines after incubation with NDV isolates was evaluated by MTT. All cell lines, except for normal PBMC primary cells, had different degrees of susceptibility to NDV infection. Seven NDV strains had the highest oncolytic activity, and some NDV strains demonstrated oncolytic selectivity for different cell lines. In vivo, we described the intratumoral activity of NDV/Altai/pigeon/770/2011 against subcutaneous non-small cell lung carcinoma using xenograft SCID mice model. All animals were responsive to therapy. Histology confirmed therapy-induced destructive changes and growing necrotic bulk density in tumor tissue. Our findings indicate that wild-type NDV strains selectively kill tumor cells with no effect on healthy PBMC cells, and intratumoral virotherapy with NDV suppresses the subcutaneous tumor growth in SCID mice.	[Yurchenko, Kseniya S.; Kovner, Anna V.; Shestopalov, Alexander M.] Res Inst Expt & Clin Med, Subdiv FRC FTM, Novosibirsk, Novosibirsk Reg, Russia; [Zhou, Peipei; Shestopalova, Lidiya V.] Novosibirsk State Univ, Novosibirsk, Novosibirsk Reg, Russia; [Zhou, Peipei] Heilongjiang Univ, Harbin, Heilongjiang, Peoples R China; [Zavjalov, Evgenii L.] Russian Acad Sci, Ctr Genet Resources Lab Anim, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Novosibirsk Reg, Russia	Novosibirsk State University; Heilongjiang University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Yurchenko, KS (corresponding author), Res Inst Expt & Clin Med, Subdiv FRC FTM, Novosibirsk, Novosibirsk Reg, Russia.	xenia7yurchenko@gmail.com	Yurchenko, Kseniya/S-2821-2019; Zavjalov, Evgenii/X-2415-2019; Shestopalova, Lidiya V/E-4056-2014; Shestopalov, Alexander/AAO-5569-2020; kovner, anna/L-9133-2015	Shestopalova, Lidiya V/0000-0002-6619-2135; Yurchenko, Kseniya/0000-0002-0679-8493; kovner, anna/0000-0001-9543-9005	Russian Scientific Foundation [17-44-07001]; small grant of the mayoralty of the city of Novosibirsk for young scientists; Ministry of Education and Science of Russia [RFMEFI62117X0015]; Russian Science Foundation [17-44-07001] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); small grant of the mayoralty of the city of Novosibirsk for young scientists; Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported partially by a grant of Russian Scientific Foundation (project No. 17-44-07001) in the part of monitoring and analysis of viral samples isolated from migratory birds in the framework of monitoring of influenza virus. The animal study was financed by a small grant of the mayoralty of the city of Novosibirsk for young scientists. The animal study was carried out in the Center for Genetic Resources of Laboratory Animals at the Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, supported by the Ministry of Education and Science of Russia (RFMEFI62117X0015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 2008, DIS POULTRY, P74; Altomonte J, 2010, MOL THER, V18, P275, DOI 10.1038/mt.2009.231; An Y, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0273-0; Apostolidis L, 2007, INT J ONCOL, V31, P1009; Arifin MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/586363; Bai FL, 2014, CANCER BIOL THER, V15, P1226, DOI 10.4161/cbt.29686; Bian JC, 2011, ARCH VIROL, V156, P1335, DOI 10.1007/s00705-011-0987-y; Buijs PRA, 2014, CANCER GENE THER, V21, P24, DOI 10.1038/cgt.2013.78; Buijs P, 2015, VIRUSES-BASEL, V7, P2980, DOI 10.3390/v7062756; Cox RM, 2017, CURR OPIN VIROL, V24, P105, DOI 10.1016/j.coviro.2017.05.004; Csatary LK, 2004, J NEURO-ONCOL, V67, P83, DOI 10.1023/B:NEON.0000021735.85511.05; Elankumaran S, 2006, J VIROL, V80, P7522, DOI 10.1128/JVI.00241-06; Elankumaran S, 2010, J VIROL, V84, P3835, DOI 10.1128/JVI.01553-09; Fournier P, 2012, METHODS MOL BIOL, V797, P177, DOI 10.1007/978-1-61779-340-0_13; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Ghrici M, 2013, INT J MOL MED, V31, P525, DOI 10.3892/ijmm.2013.1244; Grimes S.E., 2002, BASIC LAB MANUAL SMA; Kabilov M. R., 2016, GENOME ANNOUNC, V4; Koks CA, 2015, INT J CANCER, V136, pE313, DOI 10.1002/ijc.29202; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Lam HY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/718710; Laurie SA, 2006, CLIN CANCER RES, V12, P2555, DOI 10.1158/1078-0432.CCR-05-2038; Lazar I, 2010, J VIROL, V84, P639, DOI 10.1128/JVI.00401-09; Li PD, 2011, HEAD NECK-J SCI SPEC, V33, P1394, DOI 10.1002/hed.21609; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Meng CC, 2012, ARCH VIROL, V157, P1011, DOI 10.1007/s00705-012-1270-6; Miller P., 2013, DIS POULTRY, P89, DOI DOI 10.1002/9781119421481.CH3.(HTTPS://D0I.0RG/); Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Molouki A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-179; Molouki A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-385; MOORE AE, 1952, P SOC EXP BIOL MED, V81, P498; NIH National Cancer Institute, TOP INT ALT COMPL TH; Pecora AL, 2002, J CLIN ONCOL, V20, P2251, DOI 10.1200/JCO.2002.08.042; Puhlmann J, 2010, ONCOGENE, V29, P2205, DOI 10.1038/onc.2009.507; Ravindra PV, 2009, VIRUS RES, V141, P13, DOI 10.1016/j.virusres.2008.12.008; REICHARD KW, 1992, J SURG RES, V52, P448, DOI 10.1016/0022-4804(92)90310-V; Schirrmacher V, 1999, GENE THER, V6, P63, DOI 10.1038/sj.gt.3300787; Schirrmacher V, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030016; Song KY, 2010, J MOL MED, V88, P589, DOI 10.1007/s00109-010-0605-6; Wagner S, 2006, APMIS, V114, P731, DOI 10.1111/j.1600-0463.2006.apm_516.x; Walter RJ, 2012, J PANCREAS, V13, P45; Yaacov B, 2012, J GEN VIROL, V93, P1664, DOI 10.1099/vir.0.043281-0; Yurchenko K. S, 2015, GENOME ANNOUNC, V3, P1514, DOI DOI 10.1128/GEN0MEA.01514-14; Yurchenko KS, 2015, GENOME ANNOUNC, V3; Zamarin D, 2009, MOL THER, V17, P697, DOI 10.1038/mt.2008.286	46	23	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195425	10.1371/journal.pone.0195425	http://dx.doi.org/10.1371/journal.pone.0195425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621357	Green Submitted, Green Published, gold			2022-12-27	WOS:000429206800077
J	Komura, T; Ando, H; Horikoshi, K; Suzuki, H; Isagi, Y				Komura, Taketo; Ando, Haruko; Horikoshi, Kazuo; Suzuki, Hajime; Isagi, Yuji			DNA barcoding reveals seasonal shifts in diet and consumption of deep-sea fishes in wedge-tailed shearwaters	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; SOUTHEASTERN BERING-SEA; WESTERN INDIAN-OCEAN; CALONECTRIS-DIOMEDEA; MARINE ECOSYSTEMS; STABLE-ISOTOPES; FEEDING ECOLOGY; YELLOWFIN TUNA; PREY SELECTION; BULWERS PETREL	The foraging ecology of pelagic seabirds is difficult to characterize because of their large foraging areas. In the face of this difficulty, DNA metabarcoding may be a useful approach to analyze diet compositions and foraging behaviors. Using this approach, we investigated the diet composition and its seasonal variation of a common seabird species on the Ogasawara Islands, Japan: the wedge-tailed shearwater Ardenna pacifica. We collected fecal samples during the prebreeding (N= 73) and rearing (N= 96) periods. The diet composition of wedge-tailed shearwater was analyzed by Ion Torrent sequencing using two universal polymerase chain reaction primers for the 12S and 16S mitochondrial DNA regions that targeted vertebrates and mollusks, respectively. The results of a BLAST search of obtained sequences detected 31 and 1 vertebrate and mollusk taxa, respectively. The results of the diet composition analysis showed that wedge-tailed shearwaters frequently consumed deep-sea fishes throughout the sampling season, indicating the importance of these fishes as a stable food resource. However, there was a marked seasonal shift in diet, which may reflect seasonal changes in food resource availability and wedge-tailed shearwater foraging behavior. The collected data regarding the shearwater diet may be useful for in situ conservation efforts. Future research that combines DNA metabarcoding with other tools, such as data logging, may provide further insight into the foraging ecology of pelagic seabirds.	[Komura, Taketo; Isagi, Yuji] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Ando, Haruko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Horikoshi, Kazuo; Suzuki, Hajime] Inst Boninol, Nishi Machi, Tokyo, Japan	Kyoto University; National Institute for Environmental Studies - Japan	Komura, T (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	little.village.health.man@gmail.com	Isagi, Yuji/ABA-8678-2020	Isagi, Yuji/0000-0002-9777-076X; Komura, Taketo/0000-0001-7491-5594	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4-1402]; Grants-in-Aid for Scientific Research [16K18484] Funding Source: KAKEN	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environment Research and Technology Development Fund (4-1402) of the Ministry of the Environment, Japan (http://www.env.go.jp/policy/kenkyu/suishin/gaiyou/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2014, MOL ECOL, V23, P3719, DOI 10.1111/mec.12785; Ando K., 2004, REP TOKYO METROP FIS, V213, P23; Baduini CL, 2006, MAR ECOL PROG SER, V320, P279, DOI 10.3354/meps320279; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Berry TE, 2017, DNA METABARCODING DI; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; BirdLife International, 2017, IUCN RED LIST THREAT; BLACKBURN M, 1970, MAR BIOL, V7, P14, DOI 10.1007/BF00346804; Bond AL, 2010, WATERBIRDS, V33, P50, DOI 10.1675/063.033.0106; BOST CA, 1993, ACTA OECOL, V14, P463; Bourgeois K, 2011, J ORNITHOL, V152, P947, DOI 10.1007/s10336-011-0677-2; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Brazil M., 2009, BIRDS E AS E CHIN TA; Brodeur RD, 2006, GEOPHYS RES LETT, P33, DOI [10.1029/2006GL027800, DOI 10.1029/2006GL027800]; Brooke M, 2004, ALBATROSSES PETRELS; Buglione M, 2018, MAMM BIOL, V88, P31, DOI 10.1016/j.mambio.2017.10.010; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Catry T, 2009, MAR ECOL PROG SER, V374, P259, DOI 10.3354/meps07713; Cecere JG, 2013, WATERBIRDS, V36, P432, DOI 10.1675/063.036.0414; Chiba Hayato, 2007, Journal of the Yamashina Institute for Ornithology, V39, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connell SC, 2014, NEW ZEAL J MAR FRESH, V48, P416, DOI 10.1080/00288330.2014.914042; Craine JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161511; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dolganova NT, 2004, PROG OCEANOGR, V61, P227, DOI 10.1016/j.pocean.2004.06.008; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Giusti A, 2017, J AGR FOOD CHEM, V65, P2902, DOI 10.1021/acs.jafc.6b05802; Gould P, 1997, EMU, V97, P168, DOI 10.1071/MU97020; GOULD PJ, 1967, CONDOR, V69, P529, DOI 10.2307/1366157; Granadeiro JP, 1998, MAR ECOL PROG SER, V166, P267, DOI 10.3354/meps166267; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hedd A, 1997, IBIS, V139, P452, DOI 10.1111/j.1474-919X.1997.tb04658.x; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P6147, DOI 10.1016/S0967-0645(02)00338-7; Jansen JK, 2002, OECOLOGIA, V131, P306, DOI 10.1007/s00442-002-0880-1; Jarman SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082227; Kato K., 2011, TOKYO METROP RES FIS, V5, P17; Kato K., 2008, TOKYO METROP RES FIS, P1; Kawakami K, 2012, CONDOR, V114, P507, DOI 10.1525/cond.2012.110196; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; Maeda H., 2006, TOKYO METROP RES FIS, V1, P31; Matsumoto K, 2012, ORNITHOL SCI, V11, P9, DOI 10.2326/osj.11.9; MCduie Fiona, 2015, Marine Ornithology, V43, P123; McInnes J. C., 2017, MOL ECOL; McInnes JC, 2017, METHODS ECOL EVOL, V8, P192, DOI 10.1111/2041-210X.12677; Ministry of the Environment, 2015, JAP BIRD RED LIST; Nakabou T., 2013, FISHES JAPAN PICTORI; Nakahara F., 2015, DNA BARCODES, DOI [10.1515/dna-2015-0021, DOI 10.1515/DNA-2015-0021]; Navarro J, 2007, MAR ECOL PROG SER, V351, P261, DOI 10.3354/meps07115; Neves VC, 2011, WATERBIRDS, V34, P357, DOI 10.1675/063.034.0310; Oehm J, 2017, ECOL EVOL, V7, P1984, DOI 10.1002/ece3.2790; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Olson RJ, 2014, MAR ECOL PROG SER, V497, P157, DOI 10.3354/meps10609; Peters KJ, 2015, MAR ECOL-EVOL PERSP, V36, P347, DOI 10.1111/maec.12145; Polovina J. J., 2008, GEOPHYS RES LETT, P35, DOI DOI 10.1029/2008GL035090; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; R_Core_Team, 2015, R LANG ENV STAT COMP; Ramos JA, 2018, CONDOR, V120, P283, DOI 10.1650/CONDOR-17-220.1; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stamoulis KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43819; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; The Ornithological Society of Japan, 2012, CHECK LIST JAPANESE; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Waap S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01312-3; Waap S., 2015, TROPHIC RELATIONSHIP; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Yamamoto T, 2011, MAR ECOL PROG SER, V424, P191, DOI 10.3354/meps08973	80	10	10	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195385	10.1371/journal.pone.0195385	http://dx.doi.org/10.1371/journal.pone.0195385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630670	gold, Green Published, Green Submitted			2022-12-27	WOS:000429505000046
J	Islam, M; Ercumen, A; Ashraf, S; Rahman, M; Shoab, AK; Luby, SP; Unicomb, L				Islam, Mahfuza; Ercumen, Ayse; Ashraf, Sania; Rahman, Mahbubur; Shoab, Abul K.; Luby, Stephen P.; Unicomb, Leanne			Unsafe disposal of feces of children < 3 years among households with latrine access in rural Bangladesh: Association with household characteristics, fly presence and child diarrhea	PLOS ONE			English	Article							YOUNG-CHILDREN; BURKINA-FASO; HYGIENE; BEHAVIOR; RISK; MANAGEMENT; SANITATION; POTTIES	Background Young children frequently defecate in the living environment in low-income countries. Unsafe child feces disposal has been associated with risk of diarrhea. Additionally, reported practices can underestimate socially undesirable unhygienic behaviors. This analysis aimed to assess (1) the sensitivity of reported child feces disposal practices as an indicator for observed presence of human feces in the domestic environment, (2) household characteristics associated with reported unsafe feces disposal and (3) whether unsafe feces disposal is associated with fly presence and diarrhea among children <3 years. Methods We recorded caregiver-reported feces disposal practices for children <3 years; unsafe disposal was defined as feces put/rinsed into a drain, ditch, bush or garbage heap or left on the ground and safe disposal as feces put/rinsed into latrine or specific pit or buried. We conducted spot checks for human feces, counted flies in the compound and recorded caregiver-reported child diarrhea prevalence among 803 rural Bangladeshi households. We assessed associations using generalized estimating equations (GEE) and generalized linear models (GLM) with robust standard errors. Results Unsafe disposal of child feces was reported by 80% of households. Reported disposal practices had high sensitivity (91%) but low positive predictive value (15%) as an indicator of observed feces in the compound. Unsafe disposal was more common among households that reported daily adult open defecation (PR: 1.13, 1.02-1.24) and had children defecating in a nappy or on the ground versus in a potty (PR: 2.92, 1.98-4.32), and less common in households where adults reported always defecating in latrines (PR: 0.91, 0.84-0.98). The presence of observed human feces was similarly associated with these household characteristics. Reported unsafe feces disposal or observed human feces were not associated with fly detection or child diarrhea. Conclusion Despite access to on-site sanitation, unsafe child feces disposal was reported by the majority of households. However, this practices was not associated with diarrhea; suggesting that child feces may not be the most important fecal exposure. Before resources are invested to improve child feces management practices, studies should explore whether these contribute meaningfully to risk of enteric disease.	[Islam, Mahfuza; Rahman, Mahbubur; Shoab, Abul K.; Unicomb, Leanne] Int Ctr Diarrheal Dis Res Bangladesh, Enter & Resp Infect Program, Environm Intervent Unit, Infect Dis Div, Dhaka, Bangladesh; [Ercumen, Ayse] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ashraf, Sania] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Luby, Stephen P.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University	Islam, M (corresponding author), Int Ctr Diarrheal Dis Res Bangladesh, Enter & Resp Infect Program, Environm Intervent Unit, Infect Dis Div, Dhaka, Bangladesh.	mi_sheuli@icddrb.org	Unicomb, Leanne Elizabeth/AAW-4900-2021	Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Ercumen, Ayse/0000-0001-6002-1514; Ashraf, Sania/0000-0001-7305-8922	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors would like to thank the participants for donating their time, field team for collecting the data. We also thank all the collaborators engaged in the WASH Benefits study and Bill and Melinda Gates Foundation for funding.; This research protocol was funded by Bill and Melinda Gates Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2014, BANGLADESH NATL HYGI; ALAM N, 1989, INT J EPIDEMIOL, V18, P242, DOI 10.1093/ije/18.1.242; ALAM N, 1991, J DIARRHOEAL DIS RES, V9, P104; Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476; AULIA H, 1994, J DIARRHOEAL DIS RES, V12, P42; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; AZIZ KMA, 1990, T ROY SOC TROP MED H, V84, P433, DOI 10.1016/0035-9203(90)90353-G; BALTAZAR JC, 1989, INT J EPIDEMIOL, V18, pS16, DOI 10.1093/ije/18.Supplement_2.S16; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Cirillo VJ, 2006, PERSPECT BIOL MED, V49, P52, DOI 10.1353/pbm.2006.0005; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; Ercumen A, 2017, TROP MED INT HEALTH, V22, P2, DOI 10.1111/tmi.12803; Freeman MC, 2016, T ROY SOC TROP MED H, V110, P386, DOI 10.1093/trstmh/trw043; George CM, 2016, J PEDIATR-US, V176, P43, DOI 10.1016/j.jpeds.2016.05.035; Gil A, 2004, 11 BUR GLOB HLTH; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Hussain F, 2017, AM J TROP MED HYG, V97, P469, DOI 10.4269/ajtmh.15-0932; HUTTLY SRA, 1994, J DIARRHOEAL DIS RES, V12, P14; Jinadu MK, 2007, HEALTH EDUC J, V66, P222, DOI 10.1177/0017896907080120; Kwong LH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060563; Majorin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089551; MERTENS TE, 1992, INT J EPIDEMIOL, V21, P1157, DOI 10.1093/ije/21.6.1157; Miller-Petrie MK, 2016, AM J TROP MED HYG, V94, P456, DOI 10.4269/ajtmh.15-0423; Morita T, 2016, TROP MED INT HEALTH, V21, P1403, DOI 10.1111/tmi.12773; Mwambete K D, 2010, Tanzan J Health Res, V12, P47; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Sultana R, 2013, TROP MED INT HEALTH, V18, P854, DOI 10.1111/tmi.12103; TRAORE E, 1994, J EPIDEMIOL COMMUN H, V48, P270, DOI 10.1136/jech.48.3.270; UNICEF/MICS/DHS, LAT AV MICS DHS SURV; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO/UNICEF, COR QUEST DRINK WAT; WHO/UNICEF Joint Water Supply and Sanitation Monitoring Programme, 2014, PROGR DRINK WAT SAN; Wilunda C, 2009, J HEALTH RES, V23, P17; World Health Organization, PROGR SAN DRINK WAT; Yeager BAC, 1999, SOC SCI MED, V49, P531, DOI 10.1016/S0277-9536(99)00119-7	36	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195218	10.1371/journal.pone.0195218	http://dx.doi.org/10.1371/journal.pone.0195218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621289	gold, Green Published, Green Submitted			2022-12-27	WOS:000429206800050
J	Guan, C; Li, XR; Zhang, P; Chen, YL				Guan, Chao; Li, Xinrong; Zhang, Peng; Chen, Yongle			Diel hysteresis between soil respiration and soil temperature in a biological soil crust covered desert ecosystem	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; TENGGER-DESERT; SEASONAL-VARIATION; CO2 EFFLUX; VEGETATION; PHOTOSYNTHESIS; DEPENDENCE; PULSES; FOREST	Soil respiration induced by biological soil crusts (BSCs) is an important process in the carbon (C) cycle in arid and semi-arid ecosystems, where vascular plants are restricted by the harsh environment, particularly the limited soil moisture. However, the interaction between temperature and soil respiration remains uncertain because of the number of factors that control soil respiration, including temperature and soil moisture, especially in BSC-dominated areas. In this study, the soil respiration in moss-dominated crusts and lichen-dominated crusts was continuously measured using an automated soil respiration system over a one-year period from November 2015 to October 2016 in the Shapotou region of the Tengger Desert, northern China. The results indicated that over daily cycles, the half-hourly soil respiration rates in both types of BSC-covered areas were commonly related to the soil temperature. The observed diel hysteresis between the half-hourly soil respiration rates and soil temperature in the BSC-covered areas was limited by nonlinearity loops with semielliptical shapes, and soil temperature often peaked later than the half-hourly soil respiration rates in the BSC-covered areas. The average lag times between the half-hourly soil respiration rates and soil temperature for both types of BSC-covered areas were two hours over the diel cycles, and they were negatively and linearly related to the volumetric soil water content. Our results highlight the diel hysteresis phenomenon that occurs between soil respiration rates and soil temperatures in BSC-covered areas and the negative response of this phenomenon to soil moisture, which may influence total C budget evaluations. Therefore, the interactive effects of soil temperature and moisture on soil respiration in BSC-covered areas should be considered in global carbon cycle models of desert ecosystems.	[Guan, Chao; Li, Xinrong; Zhang, Peng; Chen, Yongle] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, NW Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China; [Guan, Chao; Chen, Yongle] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guan, C (corresponding author), Chinese Acad Sci, Shapotou Desert Res & Expt Stn, NW Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China.; Guan, C (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	guanchao880421@163.com	Li, Xinrong/GNW-6025-2022		National Natural Science Foundation of China [41621001, 41530746]; West Light Program for Talent Cultivation of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Program for Talent Cultivation of Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China (grant No. 41621001, 41530746) and the West Light Program for Talent Cultivation of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap J, 1994, RESTORATION MANAGEME, V12, P85; Belnap J., 2003, BIOL SOIL CRUSTS STR, DOI 10.1007/978-3-642-56475-8_21; Cable JM, 2004, OECOLOGIA, V141, P317, DOI 10.1007/s00442-003-1461-7; Carbone MS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000611; Castillo-Monroy AP, 2011, ECOSYSTEMS, V14, P835, DOI 10.1007/s10021-011-9449-3; Darrouzet-Nardi A, 2015, BIOGEOCHEMISTRY, V126, P363, DOI 10.1007/s10533-015-0163-7; Feng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102954; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Grote EE, 2010, GLOBAL CHANGE BIOL, V16, P2763, DOI 10.1111/j.1365-2486.2010.02201.x; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu R, 2015, CATENA, V127, P9, DOI 10.1016/j.catena.2014.12.012; Jia RL, 2012, SOIL BIOL BIOCHEM, V45, P31, DOI 10.1016/j.soilbio.2011.09.021; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lai Z, 2016, J FOREST RES, V21, P1; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2003, PLANT SOIL, V251, P237, DOI 10.1023/A:1023023702248; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Li XR, 2000, ACTA BOT SIN, V42, P965; Liu Q, 2006, GLOBAL CHANGE BIOL, V12, P2136, DOI 10.1111/j.1365-2486.2006.01245.x; Liu Z, 2017, CATENA, V155, P147, DOI 10.1016/j.catena.2017.03.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Parkin TB, 2003, SOIL SCI SOC AM J, V67, P1763, DOI 10.2136/sssaj2003.1763; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P515, DOI 10.1111/j.1365-2486.2010.02250.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tucker CL, 2017, BIOGEOCHEMISTRY, V135, P239, DOI 10.1007/s10533-017-0372-3; van Asperen H, 2017, AGR FOREST METEOROL, V234, P95, DOI 10.1016/j.agrformet.2016.12.014; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Welsch DL, 2004, BIOGEOCHEMISTRY, V71, P415, DOI 10.1023/B:BIOG.0000049350.24911.e9; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4; Wohlfahrt G, 2008, GLOBAL CHANGE BIOL, V14, P1475, DOI 10.1111/j.1365-2486.2008.01593.x; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Zhang ZS, 2013, PLANT SOIL, V367, P449, DOI 10.1007/s11104-012-1465-3; Zhong YQW, 2016, FIELD CROP RES, V199, P1, DOI 10.1016/j.fcr.2016.09.014	42	5	5	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195606	10.1371/journal.pone.0195606	http://dx.doi.org/10.1371/journal.pone.0195606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624606	Green Published, Green Submitted, gold			2022-12-27	WOS:000429379600040
J	Zheng, TY; Lanahan, AA; Lynd, LR; Olson, DG				Zheng, Tianyong; Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.			The redox-sensing protein Rex modulates ethanol production in Thermoanaerobacterium saccharolyticum	PLOS ONE			English	Article							STRESS-RESPONSE; CLOSTRIDIUM-THERMOCELLUM; REPRESSOR REX; WILD-TYPE; TOLERANCE; BACTERIUM; ALCOHOL	Thermoanaerobacterium saccharolyticum is a thermophilic anaerobe that has been engineered to produce high amounts of ethanol, reaching similar to 90% theoretical yield at a titer of 70 g/L. Here we report the physiological changes that occur upon deleting the redox-sensing transcriptional regulator Rex in wild type T. saccharolyticum: a single deletion of rex resulted in a two-fold increase in ethanol yield (from 40% to 91% theoretical yield), but the resulting strains grew only about a third as fast as the wild type strain. Deletion of the rex gene also had the effect of increasing expression of alcohol dehydrogenase genes, adhE and adhA. After several serial transfers, the ethanol yield decreased from an average of 91% to 55%, and the growth rates had increased. We performed whole-genome resequencing to identify secondary mutations in the Delta rex strains adapted for faster growth. In several cases, secondary mutations had appeared in the adhE gene. Furthermore, in these strains the NADH-linked alcohol dehydrogenase activity was greatly reduced. Complementation studies were done to reintroduce rex into the Delta rex strains: reintroducing rex decreased ethanol yield to below wild type levels in the Delta rex strain without adhE mutations, but did not change the ethanol yield in the Delta rex strain where an adhE mutation occurred.	[Zheng, Tianyong; Lynd, Lee R.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Zheng, Tianyong; Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] Ctr Bioenergy Innovat, Oak Ridge, TN 37831 USA	Dartmouth College; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Dartmouth College	Lynd, LR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.; Lynd, LR; Olson, DG (corresponding author), BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.; Lynd, LR; Olson, DG (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Lynd, LR; Olson, DG (corresponding author), Ctr Bioenergy Innovat, Oak Ridge, TN 37831 USA.	Lee.R.Lynd@Dartmouth.edu; Daniel.G.Olson@darlmouth.edu	Zheng, Tianyong/T-3554-2019; Olson, Daniel/F-2058-2011; Lynd, Lee R/N-1260-2013	Olson, Daniel/0000-0001-5393-6302; Lynd, Lee R/0000-0002-5642-668X; Zheng, Tianyong/0000-0001-6127-4492	Office of Biological and Environmental Research in the DOE Office of Science;  [DE-AC05-00OR22725]	Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 	The BioEnergy Science Center and Center for Bioenergy Innovation are U.S. Department of Energy Bioenergy Research Centers supported by the Office of Biological and Environmental Research in the DOE Office of Science. Grant number DE-AC05-00OR22725 was awarded to LL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bitoun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044766; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CARTWRIGHT CP, 1986, J GEN MICROBIOL, V132, P369; Chandler M, 2004, ANN MICROBIOL, V54, P427; Christensen GA, 2015, J BACTERIOL, V197, P29, DOI 10.1128/JB.02083-14; Currie DH, 2014, APPL ENVIRON MICROB, V80, P5001, DOI 10.1128/AEM.00998-14; Currie DH, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0159-x; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Herring CD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0536-8; Hon S, 2017, METAB ENG, V42, P175, DOI 10.1016/j.ymben.2017.06.011; Hu LJ, 2016, J BIOTECHNOL, V233, P17, DOI 10.1016/j.jbiotec.2016.06.024; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305; Kuehl J V, 2014, DESULFOVIBRIO ALASKE, V5, P1; LEAO C, 1984, BIOTECHNOL BIOENG, V26, P403, DOI 10.1002/bit.260260422; Lo J, 2015, J BACTERIOL, V197, P2920, DOI 10.1128/JB.00347-15; Madden T., 2002, NCBI HDB, V2002; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; McLaughlin KJ, 2010, MOL CELL, V38, P563, DOI 10.1016/j.molcel.2010.05.006; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Olson D.G., 2012, METHODS ENZYMOLOGY; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pei JJ, 2011, METAB ENG, V13, P186, DOI 10.1016/j.ymben.2010.12.006; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2008, ENZYME MICROB TECH, V42, P453, DOI 10.1016/j.enzmictec.2009.01.005; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tian L, 2016, APPL ENV MICROBIOL, V82; Timmons MD, 2009, APPL MICROBIOL BIOT, V82, P929, DOI 10.1007/s00253-009-1891-1; Vesic D, 2013, J BACTERIOL, V195, P1815, DOI 10.1128/JB.02135-12; Wietzke M, 2012, APPL MICROBIOL BIOT, V96, P749, DOI 10.1007/s00253-012-4112-2; Zhang L, 2014, J BACTERIOL, V196, P3949, DOI 10.1128/JB.02037-14; Zheng TY, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00542-16; Zheng TY, 2015, J BACTERIOL, V197, P2610, DOI 10.1128/JB.00232-15; Zhou JL, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0304-1	40	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195143	10.1371/journal.pone.0195143	http://dx.doi.org/10.1371/journal.pone.0195143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621294	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800043
J	Hefti, MM; Farrell, K; Kim, S; Bowles, KR; Fowkes, ME; Raj, T; Crary, JF				Hefti, Marco M.; Farrell, Kurt; Kim, SoongHo; Bowles, Kathryn R.; Fowkes, Mary E.; Raj, Towfique; Crary, John F.			High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development	PLOS ONE			English	Article							GENE-EXPRESSION; FETAL-TAU; PROTEIN; ISOFORMS; PHOSPHORYLATION; MUTATIONS; 3-REPEAT; DISTINCT	The microtubule associated protein tau plays a critical role in the pathogenesis of neurode-generative disease. Recent studies suggest that tau also plays a role in disorders of neuronal connectivity, including epilepsy and post-traumatic stress disorder. Animal studies have shown that the MAPT gene, which codes for the tau protein, undergoes complex pre-mRNA alternative splicing to produce multiple isoforms during brain development. Human data, particularly on temporal and regional variation in tau splicing during development are however lacking. In this study, we present the first detailed examination of the temporal and regional sequence of MAPT alternative splicing in the developing human brain. We used a novel computational analysis of large transcriptomic datasets (total n = 502 patients), quantitative polymerase chain reaction (qPCR) and western blotting to examine tau expression and splicing in post-mortem human fetal, pediatric and adult brains. We found that MAPT exons 2 and 10 undergo abrupt shifts in expression during the perinatal period that are unique in the canonical human microtubule-associated protein family, while exon 3 showed small but significant temporal variation. Tau isoform expression may be a marker of neuronal maturation, temporally correlated with the onset of axonal growth. Immature brain regions such as the ganglionic eminence and rhombic lip had very low tau expression, but within more mature regions, there was little variation in tau expression or splicing. We thus demonstrate an abrupt, evolutionarily conserved shift in tau isoform expression during the human perinatal period that may be due to tau expression in maturing neurons. Alternative splicing of the MAPT pre-mRNA may play a vital role in normal brain development across multiple species and provides a basis for future investigations into the developmental and pathological functions of the tau protein.	[Hefti, Marco M.; Kim, SoongHo; Fowkes, Mary E.; Crary, John F.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Hefti, Marco M.; Farrell, Kurt; Bowles, Kathryn R.; Raj, Towfique; Crary, John F.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Hefti, Marco M.; Bowles, Kathryn R.; Crary, John F.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hefti, Marco M.; Farrell, Kurt; Kim, SoongHo; Bowles, Kathryn R.; Raj, Towfique; Crary, John F.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Bowles, Kathryn R.; Raj, Towfique] Icahn Sch Med Mt Sinai, Dept Genet & Genome Sci, New York, NY 10029 USA; [Hefti, Marco M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Iowa	Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.; Hefti, MM (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	marco-hefti@uiowa.edu; john.crary@mountsinai.org	Raj, Towfique/ABD-7620-2021	Hefti, Marco/0000-0002-3127-4528; Farrell, Kurt/0000-0001-6955-7278	National Institutes of Health [National Institute on Aging] [F32AG056098, R01AG054008]; National Institutes of Health [National Institute of Neurological Disorders and Stroke] [R01NS095252]; Alzheimer's Association [NIRG-15-363188]; United States Department of Defense [13267017]; Tau Consortium; Alexander Saint-Amand Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, F32AG056098, R01AG054008] Funding Source: NIH RePORTER	National Institutes of Health [National Institute on Aging](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health [National Institute of Neurological Disorders and Stroke](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); United States Department of Defense(United States Department of Defense); Tau Consortium; Alexander Saint-Amand Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (http://www.nih.gov) [National Institute on Aging grant numbers F32AG056098 to K.F. and R01AG054008 to J.F.C.] and [National Institute of Neurological Disorders and Stroke grant no. R01NS095252 to J.F.C.], the Alzheimer's Association (http://www.alz.org) [NIRG-15-363188 to J.F.C.], the United States Department of Defense (http://www.defense.gov) [13267017 to J.F.C.], the Tau Consortium (http://www.tauconsortium.org) [to J.F.C.], and an Alexander Saint-Amand Scholarship (https://glg.it) [to J.F.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Arendt T, 2016, BRAIN RES B; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bearce EA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00241; BrainSpan, 2011, BRAINSPAN ATL DEV HU; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Gumucio A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-148; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Ingelsson M, 2007, ACTA NEUROPATHOL, V114, P471, DOI 10.1007/s00401-007-0280-z; IOVINO M, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV222; Jovanov-Milosevic N, 2012, INT J BIOCHEM CELL B, V44, P1290, DOI 10.1016/j.biocel.2012.05.001; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lacovich V, 2017, J NEUROSCI, V37, P58, DOI 10.1523/JNEUROSCI.2305-16.2016; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Luciani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071716; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Mattsson N, 2010, NEUROSCI RES, V66, P330, DOI 10.1016/j.neures.2009.11.012; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Perfetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093983; Pierce MJ, 2012, AM J MED GENET A, V158A, P606, DOI 10.1002/ajmg.a.33958; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Sealey MA, 2017, NEUROBIOL DIS, V105, P74, DOI 10.1016/j.nbd.2017.05.003; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Suh J, 2010, J NEUROCHEM, V114, P160, DOI 10.1111/j.1471-4159.2010.06732.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Verheyen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146127; Vuong CK, 2016, NAT REV NEUROSCI, V17, P265, DOI 10.1038/nrn.2016.27; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	47	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195771	10.1371/journal.pone.0195771	http://dx.doi.org/10.1371/journal.pone.0195771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634760	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200057
J	Babii, C; Mihalache, G; Bahrin, LG; Neagu, AN; Gostin, I; Mihai, CT; Sarbu, LG; Birsa, LM; Stefan, M				Babii, Cornelia; Mihalache, Gabriela; Bahrin, Lucian Gabriel; Neagu, Anca-Narcisa; Gostin, Irina; Mihai, Cosmin Teodor; Sarbu, Laura-Gabriela; Birsa, Lucian Mihail; Stefan, Marius			A novel synthetic flavonoid with potent antibacterial properties: In vitro activity and proposed mode of action	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITIES; GENISTEIN; MECHANISM; DAMAGE; TWIGS; COLI; OIL	The emergence of pathogenic multidrug-resistant bacteria demands new approaches in finding effective antibacterial agents. Synthetic flavonoids could be a reliable solution due to their important antimicrobial activity. We report here the potent in vitro antibacterial activity of CICI-flav-a novel synthetic tricyclic flavonoid. The antimicrobial effects were tested using the minimum inhibitory concentration (MIC), time kill and biofilm formation assays. Fluorescence microscopy and scanning electron microscopy were employed to study the mechanism of action. MTT test was used to assess the cytotoxicity of CICI-flay. Our results showed that Gram positive bacteria were more sensitive (MIC = 0.24 mu g/mL) to CICI-flav compared to the Gram negative ones (MIC = 3.9 mu g/mL). We found that our compound showed significantly enhanced antibacterial activities, 32 to 72-fold more active than other synthetic flavonoids. CICI-flav showed bactericidal activity at concentrations ranging from 0.48 to 15.62 mu g/mL. At twice the MIC, all Escherichia coli and Klebsiella pneumoniae cells were killed within 1 h. Also CICI-flav presented good anti-biofilm activity. The mechanism of action is related to the impairment of the cell membrane integrity. No or very low cytotoxicity was evidenced at effective concentrations against Vero cells. Based on the strong antibacterial activity and cytotoxicity assessment, CICI-flav has a good potential for the design of new antimicrobial agents.	[Babii, Cornelia; Mihalache, Gabriela; Neagu, Anca-Narcisa; Gostin, Irina; Stefan, Marius] Alexandru Ioan Cuza Univ, Dept Biol, Fac Biol, Iasi, Romania; [Babii, Cornelia] Alexandru Ioan Cuza Univ, CERNESIM, Integrated Ctr Environm Sci Studies North Eastern, Iasi, Romania; [Bahrin, Lucian Gabriel; Sarbu, Laura-Gabriela; Birsa, Lucian Mihail] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Mihai, Cosmin Teodor] Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept Sci, Iasi, Romania; [Mihai, Cosmin Teodor] Univ Med & Pharm Grigore T Popa Iasi, Adv Res & Dev Ctr Expt Med CEMEX, Iasi, Romania	Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Grigore T Popa University of Medicine & Pharmacy	Stefan, M (corresponding author), Alexandru Ioan Cuza Univ, Dept Biol, Fac Biol, Iasi, Romania.; Birsa, LM (corresponding author), Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania.	lbirsa@uaic.ro; stefanm@uaic.ro	Gostin, Irina Neta N/H-5555-2013; 孙, 琦/K-9357-2018; Sarbu, Laura/AAR-2110-2021; Birsa, Lucian Mihail/C-1568-2012; Stefan, Marius/P-3261-2014; Mihai, Cosmin-Teodor/F-7815-2011	Sarbu, Laura/0000-0003-1789-2108; Birsa, Lucian Mihail/0000-0003-4483-873X; Stefan, Marius/0000-0002-4967-6234; Mihai, Cosmin-Teodor/0000-0002-0945-5437; Irina Neta, Gostin/0000-0003-1519-5122; Bahrin, Lucian/0000-0001-9556-2804; Mihalache, Gabriela/0000-0003-4199-0306	Romanian National Authority for Scientific Research [152PED/2017]	Romanian National Authority for Scientific Research	This work was supported by research project 152PED/2017 funded by Romanian National Authority for Scientific Research, project leader - Prof. PhD Lucian Mihail Birsa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MD, 2004, BIOCELL, V28, P31; Babii C, 2016, J APPL MICROBIOL, V120, P630, DOI 10.1111/jam.13048; Bahrin LG, 2014, BIOORG MED CHEM LETT, V24, P2315, DOI 10.1016/j.bmcl.2014.03.071; Bahrin LG, 2016, BIOORGAN MED CHEM, V24, P3166, DOI 10.1016/j.bmc.2016.05.044; Burt SA, 2003, LETT APPL MICROBIOL, V36, P162, DOI 10.1046/j.1472-765X.2003.01285.x; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Cushnie TPT, 2005, J ETHNOPHARMACOL, V101, P243, DOI 10.1016/j.jep.2005.04.014; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Haraguchi H, 1998, PHYTOCHEMISTRY, V48, P125, DOI 10.1016/S0031-9422(97)01105-9; HUGO WB, 1964, J PHARM PHARMACOL, V16, P655, DOI 10.1111/j.2042-7158.1964.tb07384.x; IKIGAI H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P132, DOI 10.1016/0005-2736(93)90323-R; JOSWICK HL, 1971, J BACTERIOL, V108, P492, DOI 10.1128/JB.108.1.492-500.1971; Kuete V, 2007, J ETHNOPHARMACOL, V112, P271, DOI 10.1016/j.jep.2007.03.008; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee KA, 2013, FOOD SCI BIOTECHNOL, V22, P1725, DOI 10.1007/s10068-013-0272-9; Mbaveng AT, 2008, J ETHNOPHARMACOL, V116, P483, DOI 10.1016/j.jep.2007.12.017; MORI A, 1987, PHYTOCHEMISTRY, V26, P2231, DOI 10.1016/S0031-9422(00)84689-0; Mosmann T., 1983, J IMMUNOL METHODS, V12, P16; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park KD, 2010, EUR J MED CHEM, V45, P1028, DOI 10.1016/j.ejmech.2009.11.045; Rukayadi Y, 2010, BIOL PHARM BULL, V33, P1489, DOI 10.1248/bpb.33.1489; Rukayadi Y, 2009, ANTIMICROB AGENTS CH, V53, P4529, DOI 10.1128/AAC.00624-09; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; San Hipolito-Luengo A, 2017, NUTR CANCER, V69, P1019, DOI 10.1080/01635581.2017.1359309; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Siddiqui ZN, 2011, BIOORG MED CHEM LETT, V21, P2860, DOI 10.1016/j.bmcl.2011.03.080; Ueckert J, 1995, INT J FOOD MICROBIOL, V28, P317, DOI 10.1016/0168-1605(95)00066-6; Wu T, 2013, BBA-BIOMEMBRANES, V1828, P2751, DOI 10.1016/j.bbamem.2013.07.029; Zhang LN, 2008, EUR J MED CHEM, V43, P1543, DOI 10.1016/j.ejmech.2007.09.008	32	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194898	10.1371/journal.pone.0194898	http://dx.doi.org/10.1371/journal.pone.0194898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617411	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800054
J	Paolini, NA; Moore, KS; di Summa, FM; Fokkema, IFAC; 't Hoen, PAC; von Lindern, M				Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; Fokkema, Ivo F. A. C.; 't Hoen, Peter A. C.; von Lindern, Marieke			Ribosome profiling uncovers selective mRNA translation associated with eIF2 phosphorylation in erythroid progenitors	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; REGULATED EIF2-ALPHA KINASE; GENE-EXPRESSION; IN-VIVO; STRESS; CELLS; REINITIATION; TRANSCRIPTS; MECHANISM; RECEPTOR	The regulation of translation initiation factor 2 (eIF2) is important for erythroid survival and differentiation. Lack of iron, a critical component of heme and hemoglobin, activates Heme Regulated Inhibitor (HRI). This results in phosphorylation of eIF2 and reduced eIF2 availability, which inhibits protein synthesis. Translation of specific transcripts such as Atf4, however, is enhanced. Upstream open reading frames (uORFs) are key to this regulation. The aim of this study is to investigate how tunicamycin treatment, that induces eIF2 phosphorylation, affects mRNA translation in erythroblasts. Ribosome profiling combined with RNA sequencing was used to determine translation initiation sites and ribosome density on individual transcripts. Treatment of erythroblasts with Tunicamycin (Tm) increased phosphorylation of eIF2 2-fold. At a false discovery rate of 1%, ribosome density was increased for 147 transcripts, among which transcriptional regulators such as Atf4, Tis7/Ifrd1, Pnrc2, Gtf2h, Mbd3, JunB and Kmt2e. Translation of 337 transcripts decreased more than average, among which Dym and Csde1. Ribosome profiling following Harringtonine treatment uncovered novel translation initiation sites and uORFs. Surprisingly, translated uORFs did not predict the sensitivity of transcripts to altered ribosome recruitment in presence or absence of Tm. The regulation of transcription and translation factors in reponse to eIF2 phosphorylation may explain the large overall response to iron deficiency in erythroblasts.	[Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; von Lindern, Marieke] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; von Lindern, Marieke] Landsteiner Lab AMC UvA, Amsterdam, Netherlands; [Fokkema, Ivo F. A. C.; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; ['t Hoen, Peter A. C.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	von Lindern, M (corresponding author), Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands.; von Lindern, M (corresponding author), Landsteiner Lab AMC UvA, Amsterdam, Netherlands.	n.vonlindern@sanquin.nl	von Lindern, Marieke/AAH-2350-2020; Hoen, Peter A 't/D-3950-2018	Hoen, Peter A 't/0000-0003-4450-3112; Moore, Kat/0000-0002-5746-4098; von Lindern, Marieke/0000-0001-6162-6320	Landsteiner Foundation for Bloodtransfusion Research (LSBR) [1140, 1239]	Landsteiner Foundation for Bloodtransfusion Research (LSBR)	This work was funded by the Landsteiner Foundation for Bloodtransfusion Research (LSBR) www.lsbr.nl [projects 1140 and 1239 to MvL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Blazquez-Domingo M, 2005, MOL CELL BIOL, V25, P8496, DOI 10.1128/MCB.25.19.8496-8506.2005; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2014, CURR OPIN HEMATOL, V21, P172, DOI 10.1097/MOH.0000000000000030; Cho H, 2015, P NATL ACAD SCI USA, V112, pE1540, DOI 10.1073/pnas.1409612112; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; de Klerk E, 2015, NUCLEIC ACIDS RES, V43, P4408, DOI 10.1093/nar/gkv281; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dragon S, 2002, AM J PHYSIOL-REG I, V282, pR1219, DOI 10.1152/ajpregu.00507.2001; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Fujishima N, 2004, INT J HEMATOL, V80, P239, DOI 10.1532/IJH97.04053; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Golovko A, 2016, CELL CYCLE, V15, P3115, DOI 10.1080/15384101.2016.1237324; Grech G, 2008, BLOOD, V112, P2750, DOI 10.1182/blood-2008-01-133140; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Harding HP, 2009, PNAS, V106, P1; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Horvathova M, 2012, HAEMATOL-HEMATOL J, V97, P1480, DOI 10.3324/haematol.2011.059550; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Michel AM, 2016, RNA BIOL, V13, P316, DOI 10.1080/15476286.2016.1141862; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Pereboom TC, 2014, EXP HEMATOL, V42, P394, DOI 10.1016/j.exphem.2013.12.010; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reid DW, 2016, MOL CELL BIOL, V36, P1868, DOI 10.1128/MCB.00190-16; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Stockel D, 2016, BIOINFORMATICS, V32, P1502, DOI 10.1093/bioinformatics/btv770; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Watson A, 2016, CELL SIGNAL, V28, P412, DOI 10.1016/j.cellsig.2016.01.014; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Zhang SP, 2018, BLOOD, V131, P450, DOI 10.1182/blood-2017-08-799908	61	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193790	10.1371/journal.pone.0193790	http://dx.doi.org/10.1371/journal.pone.0193790			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634759	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200004
J	Schiavon, S; Dalla Bona, M; Carco, G; Carraro, L; Bunger, L; Gallo, L				Schiavon, Stefano; Dalla Bona, Mirco; Carco, Giuseppe; Carraro, Luca; Bunger, Lutz; Gallo, Luigi			Effects of feed allowance and indispensable amino acid reduction on feed intake, growth performance and carcass characteristics of growing pigs	PLOS ONE			English	Article							LOW-PROTEIN DIETS; CURED HAM PRODUCTION; MEAT QUALITY; FINISHING PIGS; HEAVY PIGS; INTRAMUSCULAR FAT; DEFICIENT DIETS; FOOD-INTAKE; MUSCLE; TRAITS	The hypothesis that pigs placed on diets with reduced indispensable amino acid (AA) content attempts to offset the reduction in the nutrient density with increased feed intake was tested. In the experiment, feeds with a high or a low AA content were administrated to pigs fed ad-libitum or restrictively according to a 2 x 2 factorial design. Ninety-six barrows were housed in 8 pens (12 pigs/pen) equipped with automatic feeders. Within pen, and from 47 body weight (BW) onwards, 6 pigs were fed ad libitum. The others pigs were allowed to consume, as a maximum, the feed amounts indicated by the breeding company feeding plane to optimize the feed efficiency. In early (86-118 kg BW) and late (118-145 kg BW) finishing, the pigs of 4 pens received feeds with high indispensable AA contents (8.1 and 7.5 g lysine/kg in the two periods, respectively). The other pigs received feeds with reduced indispensable AA contents (lysine, methionine, threonine and tryptophan) by 9 and 18% in early and late finishing, respectively. Body lipid and protein (Pr) retentions were estimated from BW and back-fat depth measures recorded at the beginning and the end of each period. Nitrogen excretion was estimated as actual intake minus estimated N-retention (Pr/6.25). Pigs were slaughtered at 144 kg BW. Restricted feeding decreased feed intake (-7%), daily gain (-5%), carcass weight (-2.6%) and back -fat depth (-8.0%) but increased gain:feed ratio (+2%). The AA restriction increased feed intake (+5.9%), carcass weight (+4.9%) and intra-muscular fat (+17.6%), and reduced carcass weight variation (-36%), with no effects on the feed efficiency and the estimated Pr (142 g/d). N excreted was reduced by feed (-9%) and dietary AA (-15%) restrictions. Irrespectively of the feeding level, the pigs responded to a reduction of the dietary essential AA content by increasing their feed intake.	[Schiavon, Stefano; Dalla Bona, Mirco; Carco, Giuseppe; Carraro, Luca; Gallo, Luigi] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy; [Bunger, Lutz] Scotlands Rural Coll SRUC, Edinburgh, Midlothian, Scotland	University of Padua; Scotland's Rural College	Carco, G (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy.	giuseppe.carco@phd.unipd.it	Bunger, Lutz/A-8751-2014; Schiavon, Stefano/C-6253-2011; Bunger, Lutz/T-5647-2019	Bunger, Lutz/0000-0003-4457-8288; Schiavon, Stefano/0000-0002-5539-8947; Bunger, Lutz/0000-0003-4457-8288	University of Padua [CPDR143385/2014, DOR1655405/2016]; Regione Veneto [2105-41- 2121-2015]; Veronesi SPA (Quinto di Valpantena, Verona, Italy)	University of Padua; Regione Veneto(Regione Veneto); Veronesi SPA (Quinto di Valpantena, Verona, Italy)	This research was funded by the University of Padua under grants CPDR143385/2014 and DOR1655405/2016 (SS), and Regione Veneto under grant P.O.R.F.S.E. n. 2105-41- 2121-2015 (MD). The authors would like to thank Veronesi SPA (Quinto di Valpantena, Verona, Italy) (http://www.veronesi.it/) for financial and technical support (SS), and the Aldo Gini Foundation (Via Portello 15, Padua, Italy) for supporting the research activities of PhD student Giuseppe Carco, during his study period at the University of Zaragoza (http://www.unipd.it/fondazione-gini) (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso L, 2010, ANIMAL, V4, P1739, DOI 10.1017/S1751731110000819; (AOAC) International A of OAC, 2012, OFF METH AN ASS OFF; Black JL, 2009, VOLUNTARY FEED INTAKE IN PIGS, P323; Bosi P, 2004, ITAL J ANIM SCI, V3, P309, DOI 10.4081/ijas.2004.309; BOUCHARD J, 1988, J AGR FOOD CHEM, V36, P1188, DOI 10.1021/jf00084a016; Camara L, 2016, MEAT SCI, V114, P69, DOI 10.1016/j.meatsci.2015.12.013; Carco G, 2018, APPL ANIM BEHAV SCI, V198, P27, DOI 10.1016/j.applanim.2017.09.020; Chiba LI, 2002, LIVEST PROD SCI, V74, P93, DOI 10.1016/S0301-6226(01)00288-3; Cisneros F, 1996, ANIM SCI, V63, P517, DOI 10.1017/S1357729800015411; Council of Europe, 2005, EUROPEAN PHARMACOPOE, VVolume 5.0, P86; Dalla Bona M, 2016, ITAL J ANIM SCI, V15, P419, DOI 10.1080/1828051X.2016.1210993; Emmans G, 2001, P NUTR SOC, V60, P115, DOI 10.1079/PNS200059; Emmans G.C., 1988, BRIT SOC ANIMAL PROD, V12, P153, DOI [10.1017/S0263967X00003347, DOI 10.1017/S0263967X00003347]; Ferguson NS, 1997, ANIM SCI, V64, P365, DOI 10.1017/S1357729800015939; Ferguson NS, 2000, ANIM SCI, V70, P287, DOI 10.1017/S1357729800054746; Gallo L, 2015, LIVEST SCI, V172, P50, DOI 10.1016/j.livsci.2014.11.014; Gallo L, 2014, LIVEST SCI, V161, P130, DOI 10.1016/j.livsci.2013.12.027; He LQ, 2016, AMINO ACIDS, V48, P21, DOI 10.1007/s00726-015-2059-1; HENRY Y, 1992, J ANIM SCI, V70, P1873, DOI 10.2527/1992.7061873x; HENRY Y, 1995, ANN ZOOTECH, V44, P3, DOI 10.1051/animres:19950101; Kloareg M, 2006, ANIM SCI, V82, P241, DOI 10.1079/ASC200529; Knap PW, 2009, VOLUNTARY FEED INTAKE IN PIGS, P13; Kouba M, 2001, J ANIM SCI, V79, P81; KYRIAZAKIS I, 1991, PHYSIOL BEHAV, V50, P1197, DOI 10.1016/0031-9384(91)90582-9; Lebret B, 2008, ANIMAL, V2, P1548, DOI 10.1017/S1751731108002796; Mordenti A, 2003, ITAL J ANIM SCI, V2, P73, DOI 10.4081/ijas.2003.73; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nyachoti CM, 2004, CAN J ANIM SCI, V84, P549, DOI 10.4141/A04-001; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Pierer M, 2016, NUTR CYCL AGROECOSYS, V104, P201, DOI 10.1007/s10705-016-9767-0; Rodriguez-Sanchez JA, 2011, J ANIM SCI, V89, P3651, DOI 10.2527/jas.2010-3791; Rossi R, 2014, FOOD RES INT, V65, P88, DOI 10.1016/j.foodres.2014.03.062; Schiavon S, 2015, ANIM FEED SCI TECH, V208, P170, DOI 10.1016/j.anifeedsci.2015.07.009; Schiavon S, 2013, LIVEST SCI, V157, P462, DOI 10.1016/j.livsci.2013.09.015; Schiavon S, 2000, BRIT J NUTR, V84, P873; Schiavon S, 2015, ANIM FEED SCI TECH, V208, P86, DOI 10.1016/j.anifeedsci.2015.07.016; SLUMP P, 1991, J SCI FOOD AGR, V55, P493, DOI 10.1002/jsfa.2740550318; Steyn WJ, 2012, S AFR J ANIM SCI, V42, P178, DOI 10.4314/sajas.v42i2.11; Suarez-Belloch J, 2015, ANIMAL, V9, P1731, DOI 10.1017/S1751731115001111; Teye GA, 2006, MEAT SCI, V73, P157, DOI 10.1016/j.meatsci.2005.11.010; Topigs, 2012, FEED MAN TAL; Tous N, 2014, J ANIM SCI, V92, P129, DOI 10.2527/jas.2012-6222; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Whittemore, 2006, WHITTEMORES SCI PRAC; Wood JD, 2013, MEAT SCI, V95, P123, DOI 10.1016/j.meatsci.2013.03.001	45	24	24	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195645	10.1371/journal.pone.0195645	http://dx.doi.org/10.1371/journal.pone.0195645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621327	Green Published, Green Submitted, gold			2022-12-27	WOS:000429206800112
J	Machler, E; Osathanunkul, M; Altermatt, F				Machler, Elvira; Osathanunkul, Maslin; Altermatt, Florian			Shedding light on eDNA: neither natural levels of UV radiation nor the presence of a filter feeder affect eDNA-based detection of aquatic organisms	PLOS ONE			English	Article							ENVIRONMENTAL DNA; DREISSENA-POLYMORPHA; ULTRAVIOLET-RADIATION; DEGRADATION; ECOSYSTEMS; TEMPERATURE; RATES; RARE	The use of environmental DNA (eDNA) as a species detection tool is attracting attention from both scientific and applied fields, especially for detecting invasive or rare species. In order to use eDNA as an efficient and reliable tool, however, we need to understand its origin and state as well as factors affecting its degradation. Various biotic and abiotic environmental factors have been proposed to affect degradation of eDNA in aquatic environments and thus to influence detection rates of species. Here, we were interested in two of them, namely UV light, which can break down DNA, and the presence of filter feeders, which can remove DNA and DNA-bound particles. A few, mostly laboratory-based studies have found minor effects of UVB on the degradation of eDNA. Ultraviolet A radiation (UVA), however, has been neglected although it also causes DNA lesions and is 10- to 100-fold more prevalent than UVB when reaching the earth's surface. Filter feeders are common in aquatic ecosystem, but their effects on eDNA has hitherto been ignored. We conducted a full-factorial aquatic mesocosm experiment under near-natural outdoor conditions manipulating UV radiation as well as the presence of Dreissena polymorpha, a strong filter feeder capable of filtering cells or organelles containing DNA. Surprisingly, we found that neither UV radiation nor the presence of the filter feeder affected eDNA-based detection rates of macroinvertebrates, even though the experiment took place in summer when UV radiation intensity and filtration activity is high for the chosen experimental site and conditions. These results, in combination with studies from marine or laboratory settings finding no effect of sunlight and its UV components on the detectability of eDNA, suggest that eDNA based species assessments could be relatively robust with respect to our two factors studied.	[Machler, Elvira; Osathanunkul, Maslin; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Machler, Elvira; Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Osathanunkul, Maslin] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Osathanunkul, Maslin] Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zurich; Chiang Mai University; Chiang Mai University	Machler, E (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.; Machler, E (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	elvira.maechler@eawag.ch		Altermatt, Florian/0000-0002-4831-6958; Machler, Elvira/0000-0003-0430-6173	Velux Foundation; Eawag discretionary fund; Swiss National Science Foundation [PP00P3_150698]	Velux Foundation(Velux Fonden); Eawag discretionary fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support is provided by Velux Foundation, the Eawag discretionary fund and the Swiss National Science Foundation (Grant No. PP00P3_150698) to FA.	ALDRIDGE DW, 1995, CAN J FISH AQUAT SCI, V52, P1761, DOI 10.1139/f95-768; Altermatt F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110328; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185043; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bates D. M., 2010, LME4 MIXED EFFECTS M; Benson A, 2015, DREISSENA POLYMORPHA, V19, P2017; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; BLUMTHALER M, 1992, THEOR APPL CLIMATOL, V46, P39, DOI 10.1007/BF00866446; Blumthaler M, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P11, DOI 10.1007/978-3-7091-0136-0_2; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Drummond AJ, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0086-1; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Evans DO, 2011, J GREAT LAKES RES, V37, P36, DOI 10.1016/j.jglr.2011.04.002; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Flindt R, 2006, AMAZING NUMBERS BIOL; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Hader DP, 2003, PHOTOCH PHOTOBIO SCI, V2, P39, DOI 10.1039/b211160h; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Jackson MC, 2016, ADV ECOL RES, V55, P615, DOI 10.1016/bs.aecr.2016.08.008; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Moan J., 2001, RAD HOME OUTDOORS WO, P69; MOHLENBERG F, 1978, OPHELIA, V17, P239, DOI 10.1080/00785326.1978.10425487; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REEDERS HH, 1989, FRESHWATER BIOL, V22, P133, DOI 10.1111/j.1365-2427.1989.tb01088.x; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Seymour M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0005-3; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Strayer DL, 1999, BIOSCIENCE, V49, P19, DOI 10.2307/1313490; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; TABERLET P, 1992, NATURE, V358, P197, DOI 10.1038/358197a0; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tsuji S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176608; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Williamson Craig E., 1996, International Journal of Environmental Studies, V51, P245, DOI 10.1080/00207239608711083	50	25	27	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195529	10.1371/journal.pone.0195529	http://dx.doi.org/10.1371/journal.pone.0195529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624607	Green Published, Green Accepted, gold			2022-12-27	WOS:000429379600037
J	Belli, HM; Bresee, CS; Graff, MM; Hartmann, MJZ				Belli, Hayley M.; Bresee, Chris S.; Graff, Matthew M.; Hartmann, Mitra J. Z.			Quantifying the three-dimensional facial morphology of the laboratory rat with a focus on the vibrissae	PLOS ONE			English	Article							SEALS PHOCA-VITULINA; MORPHOMETRIC DIFFERENTIATION; MYSTACIAL VIBRISSAE; VISUAL-ACUITY; PREY CAPTURE; SIZE; GEOMETRY; BEHAVIOR; NEURONS; COLUMN	The morphology of an animal's face will have large effects on the sensory information it can acquire. Here we quantify the arrangement of cranial sensory structures of the rat, with special emphasis on the mystacial vibrissae (whiskers). Nearly all mammals have vibrissae, which are generally arranged in rows and columns across the face. The vibrissae serve a wide variety of important behavioral functions, including navigation, climbing, wake following, anemotaxis, and social interactions. To date, however, there are few studies that compare the morphology of vibrissal arrays across species, or that describe the arrangement of the vibrissae relative to other facial sensory structures. The few studies that do exist have exploited the whiskers' grid-like arrangement to quantify array morphology in terms of row and column identity. However, relying on whisker identity poses a challenge for comparative research because different species have different numbers and arrangements of whiskers. The present work introduces an approach to quantify vibrissal array morphology regardless of the number of rows and columns, and to quantify the array's location relative to other sensory structures. We use the three-dimensional locations of the whisker basepoints as fundamental parameters to generate equations describing the length, curvature, and orientation of each whisker. Results show that in the rat, whisker length varies exponentially across the array, and that a hard limit on intrinsic curvature constrains the whisker height-to-length ratio. Whiskers are oriented to "fan out" approximately equally in dorsal-ventral and rostral-caudal directions. Quantifying positions of the other sensory structures relative to the whisker basepoints shows remarkable alignment to the somatosensory cortical homunculus, an alignment that would not occur for other choices of coordinate systems (e.g., centered on the midpoint of the eyes). We anticipate that the quantification of facial sensory structures, including the vibrissae, will ultimately enable cross-species comparisons of multi-modal sensing volumes.	[Belli, Hayley M.; Hartmann, Mitra J. Z.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Bresee, Chris S.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA; [Graff, Matthew M.; Hartmann, Mitra J. Z.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Hartmann, MJZ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Hartmann, MJZ (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	hartmann@northwestern.edu	Hartmann, Mitra/B-6766-2009	Bresee, Chris/0000-0003-0139-8201	National Science Foundation: Division of Integrative Organismal Systems [CAREER IOS-0846088]; Emerging Frontiers in Research and Innovation [EFRI-0938007]; Division of Integrative Organismal Systems [IOS-1558068]; Ruth L. Kirschstein Predoctoral Individual NRSA NIH [F31-NS-090872-01A1]; NSF IGERT: Integrative Research in Motor Control and Movement Grant [DGE-0903637]; NIH [T32 HD-057845]	National Science Foundation: Division of Integrative Organismal Systems(National Science Foundation (NSF)); Emerging Frontiers in Research and Innovation(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)NSF - Emerging Frontiers in Research & Innovation (EFRI)); Division of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Ruth L. Kirschstein Predoctoral Individual NRSA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT: Integrative Research in Motor Control and Movement Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This multi-year research project was supported by a sequence of awards from the National Science Foundation: Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS), grant CAREER IOS-0846088; Emerging Frontiers in Research and Innovation (https://ww.nsf.gov/funding/pgm_summ.jsp?pims_id=13708), grant EFRI-0938007, and Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS), grant IOS-1558068 to MJZH. HMB was supported in part by Ruth L. Kirschstein Predoctoral Individual NRSA NIH F31-NS-090872-01A1 (https://researchtraining.nih.gov/programs/fellowships/F31). CSB was supported in part by NSF IGERT: Integrative Research in Motor Control and Movement Grant DGE-0903637 (http://www.igert.org),and by NIH Grant T32 HD-057845 (https://researchtraining.nih.gov/programs/training-grants/T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; Arkley K, 2014, CURR BIOL, V24, P1507, DOI 10.1016/j.cub.2014.05.036; Baverstock H, 2013, J ANAT, V223, P46, DOI 10.1111/joa.12059; Belli HM, 2017, J NEUROPHYSIOL, V117, P1807, DOI 10.1152/jn.00054.2016; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Burton RF, 2006, J ZOOL, V269, P225, DOI 10.1111/j.1469-7998.2006.00111.x; BYERS MR, 1989, J COMP NEUROL, V279, P117, DOI 10.1002/cne.902790110; Cox PG, 2008, J ANAT, V213, P583, DOI 10.1111/j.1469-7580.2008.00983.x; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; Gaspard JC, 2017, J COMP PHYSIOL A, V203, P111, DOI 10.1007/s00359-016-1142-8; GREEN DG, 1980, VISION RES, V20, P827, DOI 10.1016/0042-6989(80)90063-2; Gunduz I, 2007, MOL PHYLOGENET EVOL, V43, P916, DOI 10.1016/j.ympev.2007.02.021; Haidarliu S, 2001, J COMP NEUROL, V429, P372, DOI 10.1002/1096-9861(20010115)429:3<372::AID-CNE2>3.0.CO;2-3; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hobbs JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004109; Hobbs JA, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00356; Hobbs JA, 2015, J EXP BIOL, V218, P2551, DOI 10.1242/jeb.116186; Huet LA, 2015, J NEUROPHYSIOL, V113, P3511, DOI 10.1152/jn.00011.2015; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Khammes-El Homsi N, 2010, MAMMALIA, V74, P199, DOI 10.1515/MAMM.2010.023; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Madderson P.F.A., 1972, American Zoologist, V12, P159; Mcgovern KA, 2015, ANAT REC, V298, P750, DOI 10.1002/ar.23061; Meister Markus, 2013, F1000Res, V2, P176, DOI 10.12688/f1000research.2-176.v1; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Muchlinski MN, 2013, AM J PHYS ANTHROPOL, V150, P301, DOI 10.1002/ajpa.22206; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; O'Higgins P, 2012, EVOL BIOL, V39, P521, DOI 10.1007/s11692-012-9173-8; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pfaff C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0744; Pocock RI, 1914, P ZOOL SOC LOND, V1914, P889; Quist BW, 2012, J NEUROPHYSIOL, V107, P2298, DOI 10.1152/jn.00372.2011; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; ROBINSON R, 1981, J HERED, V72, P131, DOI 10.1093/oxfordjournals.jhered.a109445; Rodgers J., 2012, RATTUS NORVEGICUS; Ruf I, 2009, MAMM BIOL, V74, P100, DOI 10.1016/j.mambio.2008.01.002; Schlanbusch P, 2011, HYSTRIX, V22, P227, DOI 10.4404/Hystrix-22.2-4475; Seneviratne SS, 2008, BEHAV ECOL, V19, P784, DOI 10.1093/beheco/arn029; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMPSON JI, 1981, ANN NY ACAD SCI, V374, P20, DOI 10.1111/j.1749-6632.1981.tb30856.x; Sun F, 2016, AFFINE SURFACE MATHW; The L, 2013, J NEUROSCI, V33, P4815, DOI 10.1523/JNEUROSCI.4770-12.2013; Towal RB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001120; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANHORN RN, 1970, FOLIA PRIMATOL, V13, P241, DOI 10.1159/000155325; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; von Koenigswald W, 2010, J MAMM EVOL, V17, P275, DOI 10.1007/s10914-010-9140-z; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; Yang AET, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00145; Yu YSW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600716; Zhuang C, 2017, NEURAL INFO IN PRESS, V30; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	63	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194981	10.1371/journal.pone.0194981	http://dx.doi.org/10.1371/journal.pone.0194981			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621356	gold, Green Submitted, Green Published			2022-12-27	WOS:000429206800030
J	Persson-Sjodin, E; Hernlund, E; Pfau, T; Andersen, PH; Rhodin, M				Persson-Sjodin, Emma; Hernlund, Elin; Pfau, Thilo; Andersen, Pia Haubro; Rhodin, Marie			Influence of seating styles on head and pelvic vertical movement symmetry in horses ridden at trot	PLOS ONE			English	Article							RISING TROT; LAMENESS; RIDER; ASYMMETRY; BACK; EQUITATION; KINEMATICS; SADDLE	Detailed knowledge of how a rider's seating style and riding on a circle influences the movement symmetry of the horse's head and pelvis may aid rider and trainer in an early recognition of low grade lameness. Such knowledge is also important during both subjective and objective lameness evaluations in the ridden horse in a clinical setting. In this study, inertial sensors were used to assess how different rider seating styles may influence head and pelvic movement symmetry in horses trotting in a straight line and on the circle in both directions. A total of 26 horses were subjected to 15 different conditions at trot: three unridden conditions and 12 ridden conditions where the rider performed three different seating styles (rising trot, sitting trot and two point seat). Rising trot induced systematic changes in movement symmetry of the horses. The most prominent effect was decreased pelvic rise that occurred as the rider was actively rising up in the stirrups, thus creating a downward momentum counteracting the horses push off. This mimics a push off lameness in the hindlimb that is in stance when the rider sits down in the saddle during the rising trot. On the circle, the asymmetries induced by rising trot on the correct diagonal counteracted the circle induced asymmetries, rendering the horse more symmetrical. This finding offers an explanation to the equestrian tradition of rising on the 'correct diagonal.' In horses with small preexisting movement asymmetries, the asymmetry induced by rising trot, as well as the circular track, attenuated or reduced the horse's baseline asymmetry, depending on the sitting diagonal and direction on the circle. A push off hindlimb lameness would be expected to increase when the rider sits during the lame hindlimb stance whereas an impact hindlimb lameness would be expected to decrease. These findings suggest that the rising trot may be useful for identifying the type of lameness during subjective lameness assessment of hindlimb lameness. This theory needs to be studied further in clinically lame horses.	[Persson-Sjodin, Emma; Hernlund, Elin; Rhodin, Marie] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pfau, Thilo] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Andersen, Pia Haubro] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of London; University of London Royal Veterinary College; Swedish University of Agricultural Sciences	Persson-Sjodin, E (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	emma.persson.sjodin@slu.se	Rhodin, Marie/AAD-7266-2020; Andersen, Pia Haubro/B-7077-2015; Persson-Sjodin, Emma/E-5393-2016	Andersen, Pia Haubro/0000-0002-6039-7439; Hernlund, Elin/0000-0002-5769-3958; Persson-Sjodin, Emma/0000-0002-0331-6970	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was founded by the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton HM, 2017, APPL ANIM BEHAV SCI, V190, P123, DOI 10.1016/j.applanim.2017.02.011; Egenvall A, 2013, PREV VET MED, V112, P387, DOI 10.1016/j.prevetmed.2013.09.013; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Heim C, 2016, EQUINE VET J, V48, P509, DOI 10.1111/evj.12455; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2001, EQUINE VET J, V33, P446, DOI 10.2746/042516401776254781; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 2004, EQUINE VET J, V36, P734, DOI 10.2746/0425164044848028; Martin P, 2016, J BIOMECH, V49, P1027, DOI 10.1016/j.jbiomech.2016.02.016; Penell JC, 2005, VET REC, V157, P470, DOI 10.1136/vr.157.16.470; Pfau T, 2016, EQUINE VET J, V48, P83, DOI 10.1111/evj.12374; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; Rhodin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176253; Robartes H, 2013, VET J, V198, pE52, DOI 10.1016/j.tvjl.2013.09.033; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; Ross M., 2011, DIAGNOSIS MANAGEMENT, P64; Starke SD, 2012, VET J, V193, P73, DOI 10.1016/j.tvjl.2011.10.019; Symes D, 2009, VET J, V181, P34, DOI 10.1016/j.tvjl.2009.03.016; van Beek FE, 2012, VET J, V193, P193, DOI 10.1016/j.tvjl.2011.10.007; van Hoogmoed LM, 2003, EQUINE VET J, V35, P375, DOI 10.2746/042516403776014325; Vos NJ, 2008, IRISH VET J, V61, P33, DOI 10.1186/2046-0481-61-1-33	22	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195341	10.1371/journal.pone.0195341	http://dx.doi.org/10.1371/journal.pone.0195341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621299	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000429206800068
J	Gurney-Champion, OJ; Klaassen, R; Froeling, M; Barbieri, S; Stoker, J; Engelbrecht, MRW; Wilmink, JW; Besselink, MG; Bel, A; van Laarhoven, HWM; Nederveen, AJ				Gurney-Champion, Oliver J.; Klaassen, Remy; Froeling, Martijn; Barbieri, Sebastiano; Stoker, Jaap; Engelbrecht, Marc R. W.; Wilmink, Johanna W.; Besselink, Marc G.; Bel, Arjan; van Laarhoven, Hanneke W. M.; Nederveen, Aart J.			Comparison of six fit algorithms for the intravoxel incoherent motion model of diffusion-weighted magnetic resonance imaging data of pancreatic cancer patients	PLOS ONE			English	Article							FITTING ALGORITHMS; IN-VIVO; MRI; PARAMETERS; PERFUSION; LIVER; COEFFICIENT; REPRODUCIBILITY; REPEATABILITY; ACQUISITION	The intravoxel incoherent motion (IVIM) model for diffusion-weighted imaging (DWI) MRI data bears much promise as a tool for visualizing tumours and monitoring treatment response. To improve the currently poor precision of IVIM, several fit algorithms have been suggested. In this work, we compared the performance of two Bayesian IVIM fit algorithms and four other IVIM fit algorithms for pancreatic cancer imaging. DWI data were acquired in 14 pancreatic cancer patients during two MRI examinations. Three different measures of performance of the fitting algorithms were assessed: (i) uniqueness of fit parameters (Spearman's rho); (ii) precision (within-subject coefficient of variation, wCV); and (iii) contrast between tumour and normal-appearing pancreatic tissue. For the diffusivity D and perfusion fraction f, a Bayesian fit (IVIM-Bayesian-lin) offered the best trade-off between tumour contrast and precision. With the exception for IVIM-Bayesian-lin, all algorithms resulted in a very poor precision of the pseudo-diffusion coefficient D* with a wCV of more than 50%. The pseudo-diffusion coefficient D* of the Bayesian approaches were, however, significantly correlated with D and f. Therefore, the added value of fitting D* was considered limited in pancreatic cancer patients. The easier implemented least squares fit with fixed D* (IVIM-fixed) performed similar to IVIM-Bayesian-lin for f and D. In conclusion, the best performing IVIM fit algorithm was IVM-Bayesian-lin, but an easier to implement least squares fit with fixed D* performs similarly in pancreatic cancer patients.	[Gurney-Champion, Oliver J.] Inst Canc Res, Joint Dept Phys, London, England; [Gurney-Champion, Oliver J.] Royal Marsden NHS Fdn Trust, London, England; [Klaassen, Remy; Wilmink, Johanna W.; van Laarhoven, Hanneke W. M.] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Froeling, Martijn] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Froeling, Martijn; Stoker, Jaap; Engelbrecht, Marc R. W.; Nederveen, Aart J.] Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Barbieri, Sebastiano] Univ New South Wales, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Wilmink, Johanna W.] Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Besselink, Marc G.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands; [Bel, Arjan] Acad Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of New South Wales Sydney; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Gurney-Champion, OJ (corresponding author), Inst Canc Res, Joint Dept Phys, London, England.; Gurney-Champion, OJ (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	oliver.gurney.champion@gmail.com	Gurney-Champion, Oliver J/C-9838-2015; Besselink, Marc/H-3294-2019; Stoker, Jaap/AAH-7597-2019; van Laarhoven, Hanneke/AAW-3464-2021; Besselink, Marc G/R-4268-2019; Bel, Arjan/C-3736-2008; Froeling, Martijn/E-7865-2012	Gurney-Champion, Oliver J/0000-0003-1750-6617; Stoker, Jaap/0000-0002-9822-3784; Besselink, Marc G/0000-0003-2650-9350; Bel, Arjan/0000-0003-1576-6220; Froeling, Martijn/0000-0003-3841-0497; van Laarhoven, H.W.M./0000-0003-1274-5643; Nederveen, Aart/0000-0002-5477-973X	Dutch Cancer Society [UVA2013-5932]; Cancer Research UK program [C33589/A19727, C7224/A23275]	Dutch Cancer Society(KWF Kankerbestrijding); Cancer Research UK program(Cancer Research UK)	This research was in part supported by the Dutch Cancer Society (UVA2013-5932) to Hanneke W.M. van Laarhoven and Cancer Research UK program grants C33589/A19727 and C7224/A23275. There was no additional external funding received for this study.	Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Barbieri S, 2016, MAGN RESON MED, V75, P2175, DOI 10.1002/mrm.25765; Barnhart HX, 2009, TRANSL ONCOL, V2, P231, DOI 10.1593/tlo.09268; Cho GY, 2015, MAGN RESON MED, V74, P1077, DOI 10.1002/mrm.25484; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Fusco R, 2017, MAGN RESON MATER PHY, V30, P113, DOI 10.1007/s10334-016-0591-y; Fusco R, 2015, APPL MAGN RESON, V46, P551, DOI 10.1007/s00723-015-0654-7; Gaeta M, 2014, ACAD RADIOL, V21, P1286, DOI 10.1016/j.acra.2014.05.021; Gurney- Champion O, 2018, ISMRM; Gurney-Champion OJ, 2017, ACTA ONCOL, V56, P923, DOI 10.1080/0284186X.2017.1304654; Gurney-Champion OJ, 2016, MED PHYS, V43, P5603, DOI 10.1118/1.4962476; Gurney-Champion OJ, 2016, INVEST RADIOL, V51, P211, DOI 10.1097/RLI.0000000000000225; Gurney-Champion OJ, 2015, MED PHYS, V42, P2638, DOI 10.1118/1.4918753; Gustafsson O, 2018, MAGN RESON MED, V79, P1674, DOI 10.1002/mrm.26783; Heusch P, 2013, INVEST RADIOL, V48, P140, DOI 10.1097/RLI.0b013e318277bfe3; Huizinga W, 2016, MED IMAGE ANAL, V29, P65, DOI 10.1016/j.media.2015.12.004; Kakite S, 2015, J MAGN RESON IMAGING, V41, P149, DOI 10.1002/jmri.24538; Klauss M, 2015, INVEST RADIOL, V50, P792, DOI 10.1097/RLI.0000000000000187; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; Koh DM, 2014, RADIOLOGY, V272, P307, DOI 10.1148/radiol.14140714; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee Y, 2015, RADIOLOGY, V274, P405, DOI 10.1148/radiol.14140759; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Lemke A, 2009, INVEST RADIOL, V44, P769, DOI 10.1097/RLI.0b013e3181b62271; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Meeus EM, 2017, J MAGN RESON IMAGING, V45, P1325, DOI 10.1002/jmri.25411; Merisaari H, 2017, MAGN RESON MED, V77, P1249, DOI 10.1002/mrm.26169; NEIL JJ, 1993, MAGNET RESON MED, V29, P642, DOI 10.1002/mrm.1910290510; Orton MR, 2016, EUR RADIOL, V26, P1412, DOI 10.1007/s00330-015-3933-7; Orton MR, 2014, MAGN RESON MED, V71, P411, DOI 10.1002/mrm.24649; Park HJ, 2017, J MAGN RESON IMAGING, V45, P1637, DOI 10.1002/jmri.25535; Poot DHJ, 2015, IEEE T MED IMAGING, V34, P1164, DOI 10.1109/TMI.2014.2380830; Re TJ, 2011, MAGN RESON MED, V66, P1327, DOI 10.1002/mrm.22931; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Suo ST, 2015, J MAGN RESON IMAGING, V42, P362, DOI 10.1002/jmri.24799; Versteijne E, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0777-0; While PT, 2017, MAGN RESON MED, V78, P2373, DOI 10.1002/mrm.26598; Wurnig MC, 2015, MAGN RESON MED, V74, P1414, DOI 10.1002/mrm.25506	42	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194590	10.1371/journal.pone.0194590	http://dx.doi.org/10.1371/journal.pone.0194590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617445	Green Submitted, Green Published, gold			2022-12-27	WOS:000429203800038
J	Stoneham, TR; Kuhn, DD; Taylor, DP; Neilson, AP; Smith, SA; Gatlin, DM; Chu, HSS; O'Keefe, SF				Stoneham, Tyler R.; Kuhn, David D.; Taylor, Daniel P.; Neilson, Andrew P.; Smith, Stephen A.; Gatlin, Delbert M.; Chu, Hyun Sik S.; O'Keefe, Sean F.			Production of omega-3 enriched tilapia through the dietary use of algae meal or fish oil: Improved nutrient value of fillet and offal	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALPHA-LINOLENIC ACID; OREOCHROMIS-NILOTICUS; NILE TILAPIA; SCHIZOCHYTRIUM SP; FLAXSEED OIL; PROFILES; PROTEIN; DIGESTIBILITY; INGREDIENTS	The goal of this project was to increase the nutrient value of fillets, by-product muscle, and offal of aquacultured tilapia. A diet that includes seafood with a high omega-3 (n-3) fatty acid content, more specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to have numerous health benefits for consumers. Improved nutrient value of the offal may also attract new market opportunities for the aquaculture industry. Tilapia were cultured on different experimental feeds that contained various levels of n-3 fatty acids from either fish oil (FO) or algae meal (AM) that were used to replace corn oil. The experimental diets included a control (corn oil 6.3%), FO1%, FO3%, FO5%, AM1.75%, AM5.26%, and AM8.77%. All diets were formulated to be isocaloric, isonitrogenous, and isolipid. Three hundred and fifty tilapia with an initial mean weight of 158 +/- 2 g were cultured in a recirculating aquaculture system (seven diets replicated at the tank level, 14 tanks, 25 fish per tank). For all of the production performance data, no differences (P>0.05) were observed between the experimental groups which included survival (overall mean +/- standard error, 99.4 +/- 0.3%), growth per week (45.4 +/- 1.0 g/wk), food conversion ratio (1.32 +/- 0.03), fillet yield (44.4 +/- 0.2%), hepatosomatic index (1.61 +/- 0.02), viscerosomatic index (2.86 +/- 0.06), and mesenteric fat index (0.97 +/- 0.04). Fillet and rib meat tissues were collected at weeks four and eight, and liver and mesenteric fat tissues were collected at week eight. Fatty acids were extracted, methylated and identified with gas chromatography-mass spectrometry. All tissues had improved fatty acid profiles (higher n-3, lower n-6, n-6: n-3) with increasing levels of FO and AM in the diet. For example, the best diet for significantly (P<0.05) improving the lipid profile in tilapia fillets at week eight was diet AM8.77%. In the fillet, total n-3 was increased (control versus AM8.77%) from 151.2 +/- 19.0 to 438.7 +/- 14.2 mg per 4 ounce (113 g) serving and n-6: n-3 ratio was improved from 5.19 +/- 0.76 to 1.29 +/- 0.03.	[Stoneham, Tyler R.; Kuhn, David D.; Taylor, Daniel P.; Neilson, Andrew P.; Chu, Hyun Sik S.; O'Keefe, Sean F.] Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA; [Smith, Stephen A.] Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, Blacksburg, VA USA; [Gatlin, Delbert M.] Texas A&M Univ, Dept Fisheries & Wildlife Sci, College Stn, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station	Kuhn, DD (corresponding author), Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA.	davekuhn@vt.edu	taylor, daniel/GYU-3348-2022; Neilson, Andrew/T-4241-2019; Taylor, Daniel/AAM-3465-2021; Gatlin, Delbert/AAB-3615-2021; OKeefe, Sean F/N-3101-2016	Neilson, Andrew/0000-0001-5497-663X; Taylor, Daniel/0000-0001-8023-0348; OKeefe, Sean F/0000-0002-2491-7900; Chu, Hyun Sik/0000-0003-4249-6916; Kuhn, David/0000-0003-3368-0375	Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS) [14-FSMIP-VA-0012]; Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA); Virginia Tech's Open Access Subvention Fund (OASF)	Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS); Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA); Virginia Tech's Open Access Subvention Fund (OASF)	State funds for this project were matched with Federal funds under the Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS) grant 14-FSMIP-VA-0012 to David D Kuhn, U.S. Department of Agriculture (USDA). This project was also partially supported by fiscal year (FY) 2015 Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA) to David D Kuhn. Article processing costs were paid for by Virginia Tech's Open Access Subvention Fund (OASF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 1998, J AM OIL CHEM SOC, V75, P541, DOI 10.1007/s11746-998-0263-9; American Oil Chemists' Society (AOCS), 1998, AOCS OFF METH CE 1B; APHA AWWA WEF, STAND METH EX WAT WA, V22nd; Bahurmiz OM, 2007, AQUACULTURE, V262, P382, DOI 10.1016/j.aquaculture.2006.11.023; BIMBO AP, 1992, J AM OIL CHEM SOC, V69, P221, DOI 10.1007/BF02635890; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; BURDGE GC, 2006, LEUKOTRIENES ESSENTI, P161, DOI DOI 10.1016/J.PLEFA.2006.05.013; de Oliveira PRC, 2010, BRAZ ARCH BIOL TECHN, V53, P1383, DOI 10.1590/S1516-89132010000600015; de Souza NE, 2007, J SCI FOOD AGR, V87, P1677, DOI 10.1002/jsfa.2877; DeSilva SS, 1997, AQUACULTURE, V153, P273, DOI 10.1016/S0044-8486(97)00035-5; EI-Sayed A.-F.M., 2006, TILAPIA CULTURE; Folador JF, 2006, J ANIM SCI, V84, P2752, DOI 10.2527/jas.2005-560; Ganuza E, 2008, AQUACULTURE, V277, P109, DOI 10.1016/j.aquaculture.2008.02.005; Han CY, 2013, AQUACULT INT, V21, P1209, DOI 10.1007/s10499-013-9624-y; Ibrahim S. M., 2009, World Journal of Dairy & Food Sciences, V4, P28; Justi KC, 2003, FOOD CHEM, V80, P489, DOI 10.1016/S0308-8146(02)00317-5; Karapanagiotidis IT, 2007, LIPIDS, V42, P547, DOI 10.1007/s11745-007-3057-1; Kim S., 2014, SEAFOOD PROCESSING P, V1st; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kwetegyeka J, 2008, LIPIDS, V43, P1017, DOI 10.1007/s11745-008-3200-7; Li MHH, 2009, AQUACULTURE, V292, P232, DOI 10.1016/j.aquaculture.2009.04.033; Ling XP, 2015, BIORESOURCE TECHNOL, V184, P139, DOI 10.1016/j.biortech.2014.09.130; Ma XY, 2015, FISH PHYSIOL BIOCHEM, V41, P937, DOI 10.1007/s10695-015-0059-4; Miller MR, 2007, COMP BIOCHEM PHYS A, V148, P382, DOI 10.1016/j.cbpa.2007.05.018; Ng WK, 2013, REV AQUACULT, V5, P220, DOI 10.1111/raq.12014; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143622; OLSEN RE, 1990, FISH PHYSIOL BIOCHEM, V8, P261, DOI 10.1007/BF00004465; Rakocy JE, 1989, TANK CULTURE TILAPIA; RAO KSP, 1984, TOXICOL LETT, V21, P147, DOI 10.1016/0378-4274(84)90198-X; Rasoarahona JRE, 2005, FOOD CHEM, V91, P683, DOI 10.1016/j.foodchem.2004.07.001; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; Sarker PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156684; SHERIDAN MA, 1989, AQUACULTURE, V82, P191, DOI 10.1016/0044-8486(89)90408-0; Silva JFX, 2014, ANIM FEED SCI TECH, V196, P96, DOI 10.1016/j.anifeedsci.2014.06.010; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; Suganya T, 2016, RENEW SUST ENERG REV, V55, P909, DOI 10.1016/j.rser.2015.11.026; Szabo A, 2011, AQUACULT NUTR, V17, pE132, DOI 10.1111/j.1365-2095.2009.00743.x; Teoh CY, 2011, AQUACULTURE, V312, P126, DOI 10.1016/j.aquaculture.2010.12.018; Trushenski JT, 2009, N AM J AQUACULT, V71, P242, DOI 10.1577/A08-051.1; Visentainer JV, 2005, FOOD CHEM, V90, P557, DOI 10.1016/j.foodchem.2004.05.016; Wang DZ, 2008, CANCER LETT, V267, P197, DOI 10.1016/j.canlet.2008.03.004; Watters CA, 2013, ISR J AQUACULT-BAMID, V65; Xu L, 2009, ENG LIFE SCI, V9, P178, DOI 10.1002/elsc.200800111	44	30	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194241	10.1371/journal.pone.0194241	http://dx.doi.org/10.1371/journal.pone.0194241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641539	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900027
J	Pant, K; Anderson, B; Perdana, H; Malinowski, MA; Win, AT; Pabst, C; Williams, MC; Karpel, RL				Pant, Kiran; Anderson, Brian; Perdana, Hendrik; Malinowski, Matthew A.; Win, Aye T.; Pabst, Christopher; Williams, Mark C.; Karpel, Richard L.			The role of the C-domain of bacteriophage T4 gene 32 protein in ssDNA binding and dsDNA helix-destabilization: Kinetic, single-molecule, and cross-linking studies	PLOS ONE			English	Article							FORCE SPECTROSCOPY MEASUREMENTS; DOUBLE-STRANDED DNA; NUCLEIC-ACID; REPLICATION FORK; STRUCTURAL DOMAINS; GP32; RECOMBINATION; 32-PROTEIN; LATTICES; COOPERATIVITY	The model single-stranded DNA binding protein of bacteriophage T4, gene 32 protein (gp32) has well-established roles in DNA replication, recombination, and repair. gp32 is a single-chain polypeptide consisting of three domains. Based on thermodynamics and kinetics measurements, we have proposed that gp32 can undergo a conformational change where the acidic C-terminal domain binds internally to or near the single-stranded (ss) DNA binding surface in the core (central) domain, blocking ssDNA interaction. To test this model, we have employed a variety of experimental approaches and gp32 variants to characterize this conformational change. Utilizing stopped-flow methods, the association kinetics of wild type and truncated forms of gp32 with ssDNA were measured. When the C-domain is present, the log-log plot of k vs. [NaCl] shows a positive slope, whereas when it is absent (*I protein), there is little rate change with salt concentration, as expected for this model.A gp32 variant lacking residues 292-296 within the C-domain, Delta PR201, displays kinetic properties intermediate between gp32 and *I. The single molecule force-induced DNA helix-destabilizing activitiesas well as the single- and double-stranded DNA affinities of Delta PR201 and gp32 truncated at residue 295 also fall between full-length protein and *I. Finally, chemical cross linking of recombinant C-domain and gp32 lacking both N- and C-terminal domains is inhibited by increasing concentrations of a short single-stranded oligonucleotide, and the salt dependence of cross-linking mirrors that expected for the model. Taken together, these results provide the first evidence in support of this model that have been obtained through structural probes.	[Pant, Kiran; Williams, Mark C.] Northeastern Univ, Dept Phys, Dana Res Ctr, Boston, MA 02115 USA; [Anderson, Brian; Perdana, Hendrik; Malinowski, Matthew A.; Win, Aye T.; Pabst, Christopher; Karpel, Richard L.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Williams, Mark C.] Northeastern Univ, Dana Res Ctr, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Northeastern University; University System of Maryland; University of Maryland Baltimore County; Northeastern University	Karpel, RL (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	karpel@umbc.edu		Williams, Mark C./0000-0003-3219-376X	NIH [GM 52049, GM072462]; NSF [MCB-1243883]; UMBC Designated Research Initiative Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UMBC Designated Research Initiative Fund	Funding for this project was provided by NIH (GM 52049, R.L.K., GM072462, M.C.W), NSF (MCB-1243883, M.C.W), and the UMBC Designated Research Initiative Fund (R.L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by NIH (GM 52049, R.L.K., GM072462, M.C.W), NSF (MCB-1243883, M.C.W), and the UMBC Designated Research Initiative Fund (R.L.K.). We would like to thank Benyam Addissie, Kevin Molloy, Roy Richardson, Min Wu, and Betel Zigale for their assistance and Julia Wolf for her expert advice (all UMBC).	ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; ALBERTS BM, 1970, FED PROC, V29, P1154; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bosaeus N, 2014, NUCLEIC ACIDS RES, V42, P8083, DOI 10.1093/nar/gku441; CASASFINET JR, 1992, P NATL ACAD SCI USA, V89, P1050, DOI 10.1073/pnas.89.3.1050; CASASFINET JR, 1993, BIOCHEMISTRY-US, V32, P9735, DOI 10.1021/bi00088a028; Chaurasiya KR, 2010, PHYS LIFE REV, V7, P299, DOI 10.1016/j.plrev.2010.06.001; Fasman G., 1976, HDB BIOCH SELECTED D; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; HOSODA J, 1978, J BIOL CHEM, V253, P7547; HURLEY JM, 1993, J MOL BIOL, V229, P398, DOI 10.1006/jmbi.1993.1042; JENSEN DE, 1977, ANAL BIOCHEM, V80, P267, DOI 10.1016/0003-2697(77)90645-5; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; Jose D, 2015, NUCLEIC ACIDS RES, V43, P9291, DOI 10.1093/nar/gkv818; Jose D, 2015, NUCLEIC ACIDS RES, V43, P9276, DOI 10.1093/nar/gkv817; Karpel R.L., 1990, BIOL NONSPECIFIC DNA, P103; Karpel R. L., 2002, ENCY LIFE SCI, V15, P231; Karpel RL, 2002, IUBMB LIFE, V53, P161, DOI 10.1080/15216540212332; King GA, 2013, P NATL ACAD SCI USA, V110, P3859, DOI 10.1073/pnas.1213676110; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; Kozlov AG, 2017, J MOL BIOL, V429, P2790, DOI 10.1016/j.jmb.2017.07.021; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kundu SK, 1996, ANAL BIOCHEM, V235, P134, DOI 10.1006/abio.1996.0105; Lee W, 2016, NUCLEIC ACIDS RES, V44, P10691, DOI 10.1093/nar/gkw863; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; LOHMAN TM, 1984, BIOCHEMISTRY-US, V23, P4665, DOI 10.1021/bi00315a023; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; McCauley MJ, 2007, BIOPOLYMERS, V85, P154, DOI 10.1002/bip.20622; MCGHEE JD, 1976, BIOPOLYMERS, V15, P1345, DOI 10.1002/bip.1976.360150710; NEWPORT JW, 1981, J MOL BIOL, V145, P105, DOI 10.1016/0022-2836(81)90336-3; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Pant K, 2005, J MOL BIOL, V349, P317, DOI 10.1016/j.jmb.2005.03.065; Pant K, 2004, J MOL BIOL, V336, P851, DOI 10.1016/j.jmb.2003.12.025; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; Phelps C, 2017, P NATL ACAD SCI USA, V114, pE3612, DOI 10.1073/pnas.1619819114; Rouzina I, 2005, BIOPHYS J, V89, P1941, DOI 10.1529/biophysj.105.063776; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shokri L, 2008, BIOPHYS J, V95, P1248, DOI 10.1529/biophysj.108.132688; Shokri L, 2006, J BIOL CHEM, V281, P38689, DOI 10.1074/jbc.M608460200; Shokri L, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025002; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; Williams MC, 2008, METHOD CELL BIOL, V84, P517, DOI 10.1016/S0091-679X(07)84017-9; Williams MC, 2006, CURR ORG CHEM, V10, P419, DOI 10.2174/138527206776055321; Williams MC, 2004, SPECTROSC-INT J, V18, P203, DOI 10.1155/2004/403203; Wu M, 1999, J MOL BIOL, V286, P1107, DOI 10.1006/jmbi.1999.2541	52	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194357	10.1371/journal.pone.0194357	http://dx.doi.org/10.1371/journal.pone.0194357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634784	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200009
J	Yang, R; Guan, Y; Wang, WX; Chen, HJ; He, ZC; Jia, AQ				Yang, Rui; Guan, Ying; Wang, Weixin; Chen, Hongjuan; He, Zhaochun; Jia, Ai-Qun			Antioxidant capacity of phenolics in Camellia nitidissima Chi flowers and their identification by HPLC Triple TOF MS/MS	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; CORDYCEPS-MILITARIS SN-18; FLAVONOL GLYCOSIDES; BIOACTIVE COMPOUNDS; TEA; ENHANCEMENT; QUERCETIN; GLYCOSYLATION; KAEMPFEROL; SCAVENGERS	Camellia nitidissima Chi (CNC) is a valuable medicinal and edible plant in China. In this study, CNC flowers were extracted with 95% ethanol, then partitioned into dichloromethane, ethyl acetate, n-butanol, and water fractions, with the antioxidant capacity of flavonoids and other phytochemicals in CNC flowers investigated for the first time. Results showed that the ethyl acetate fraction exhibited the strongest antioxidant capacity and highest total phenolic content (TPC) compared with the other fractions. Furthermore, in the ethyl acetate fraction, the 50% effective concentrations (EC50) of ABTS(+) and DPPH radical scavenging activities were 64.24 +/- 1.80 and 78.80 +/- 0.34 mu g/mL, respectively, and the ferric reducing antioxidant power (FRAP) was 801.49 +/- 2.30 mu M FeSO4 at 1,000 mu g/mL. Pearson's correlation coefficients and principal component analyses (PCA) for the TPC and antioxidant capacity of the five fractions indicated that the phenolic compounds were the major antioxidant constituents in the flowers. To exploit the antioxidants in CNC flowers, 21 phenolic compounds in the ethanolic extract fraction were identified by HPLC Triple TOF MS/MS, next, 12 flavonoids were isolated and elucidated, of which compounds 1-5 showed potent antioxidant capacity. In addition, the potential structure-activity relationship among these 12 flavonoids showed that (1) the o-catechol group in the B-ring was primarily responsible for the antioxidant capacity of flavonoids and (2) steric hindrance, produced by glycosides and other groups, could reduce the antioxidant capacity of the flavonoids.	[Yang, Rui; Jia, Ai-Qun] Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China; [Yang, Rui; Wang, Weixin; He, Zhaochun; Jia, Ai-Qun] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China; [Guan, Ying] Suzhou Inst Measurement & Testing, Inspect & Pattern Evaluat Dept, Suzhou, Peoples R China; [Chen, Hongjuan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Hainan University; Nanjing University of Science & Technology; Nanjing University	Jia, AQ (corresponding author), Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China.; Jia, AQ (corresponding author), Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China.	aiqunj302@njust.edu.cn	Wang, Weixin/ABC-3184-2021	Jia, Ai-Qun/0000-0002-8089-6200	National Key Research and Development Program of China [2017YFD0201401]; National Natural Science Foundation of China [41766006]; Science and Technology Development Program of Modern Agriculture, Nanjing [201608052]; Six talent peaks project in Jiangsu Province; Fundamental Research Funds for the Central Universities [30916011307]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Modern Agriculture, Nanjing; Six talent peaks project in Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grants from the National Key Research and Development Program of China (2017YFD0201401, http://www.most.gov.cn/), National Natural Science Foundation of China (41766006, http://www.nsfc.gov.cn/), Science and Technology Development Program of Modern Agriculture, Nanjing (201608052, http://www.njkj.gov.cn/), Six talent peaks project in Jiangsu Province, (http://www.jshrss.gov.cn/), Fundamental Research Funds for the Central Universities (30916011307, http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak DL, 2015, BIOCATAL AGRIC BIOTE, V4, P33, DOI 10.1016/j.bcab.2014.11.003; Ablajan K, 2006, J MASS SPECTROM, V41, P352, DOI 10.1002/jms.995; Alvarez-Jubete L, 2010, FOOD CHEM, V119, P770, DOI 10.1016/j.foodchem.2009.07.032; Amakura Y, 2013, MOLECULES, V18, P5326, DOI 10.3390/molecules18055326; Amarowicz R, 2009, INT J MOL SCI, V10, P5513, DOI 10.3390/ijms10125513; Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Brodowska K.M., 2017, EUR J BIOL RES, V7, P108, DOI [10.5281/zenodo.545778, DOI 10.5281/ZENODO.545778]; CHEN YY, 2009, GUANGXI TROPICAL AGR, V1, P14, DOI DOI 10.3969/J.ISSN.2095-0764.2009.01.005; Corea G, 2003, J NAT PROD, V66, P1405, DOI 10.1021/np030226q; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dou JP, 2007, J AGR FOOD CHEM, V55, P7462, DOI 10.1021/jf0718603; El-Hawary SA, 2011, J FOOD SCI, V76, pC1195, DOI 10.1111/j.1750-3841.2011.02370.x; Fernandez SP, 2009, NEUROCHEM RES, V34, P1867, DOI 10.1007/s11064-009-9969-9; Ferreres F, 2003, PHYTOCHEM ANALYSIS, V14, P352, DOI 10.1002/pca.727; Gottumukkala Raju V S S, 2014, Int Sch Res Notices, V2014, P628196, DOI 10.1155/2014/628196; Guan Y, 2017, CYTA-J FOOD, V15, P155, DOI 10.1080/19476337.2016.1226955; Han JT, 2004, ARCH PHARM RES, V27, P390, DOI 10.1007/BF02980079; Harrison K, 2007, FOOD CHEM, V102, P932, DOI 10.1016/j.foodchem.2006.06.034; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Jang DS, 2003, J NAT PROD, V66, P1166, DOI 10.1021/np0302100; Jayasinghe ULB, 2004, NAT PROD RES, V18, P499, DOI 10.1080/14786410310001620538; Jorgensen LV, 1998, FREE RADICAL RES, V29, P339, DOI 10.1080/10715769800300381; Juan MY, 2010, FOOD MICROBIOL, V27, P586, DOI 10.1016/j.fm.2009.11.002; Kim JH, 2005, ARCH PHARM RES, V28, P195, DOI 10.1007/BF02977715; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Li YF, 2017, FOOD CHEM, V216, P282, DOI 10.1016/j.foodchem.2016.08.017; Lin AS, 2007, CHEM PHARM BULL, V55, P635, DOI 10.1248/cpb.55.635; Lv HP, 2015, J FUNCT FOODS, V19, P194, DOI 10.1016/j.jff.2015.09.047; Mcnab H, 2009, INT J MASS SPECTROM, V284, P57, DOI 10.1016/j.ijms.2008.05.039; Miller NJ, 1996, FEBS LETT, V392, P40, DOI 10.1016/0014-5793(96)00780-6; Park JS, 2006, J AGR FOOD CHEM, V54, P2951, DOI 10.1021/jf052900a; Peng Z, 2002, AUST J GRAPE WINE R, V8, P70, DOI 10.1111/j.1755-0238.2002.tb00213.x; Plumb GW, 1998, FREE RADICAL RES, V29, P351, DOI 10.1080/10715769800300391; Qiu JA, 2010, PLANT CELL REP, V29, P1325, DOI 10.1007/s00299-010-0919-4; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Silva MM, 2002, FREE RADICAL RES, V36, P1219, DOI 10.1080/198-1071576021000016472; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Song LX, 2011, FOOD CHEM, V129, P351, DOI 10.1016/j.foodchem.2011.04.083; Sun N, 2013, CHEM NAT COMPD+, V49, P49, DOI 10.1007/s10600-013-0503-6; Taamalli A, 2012, J AGR FOOD CHEM, V60, P791, DOI 10.1021/jf204233u; Tarascou I, 2006, EUR J ORG CHEM, V2006, P5367, DOI 10.1002/ejoc.200600668; Teng XF, 2008, HELV CHIM ACTA, V91, P1305, DOI 10.1002/hlca.200890142; Wan CP, 2011, ASIAN J CHEM, V23, P2893; Wang WX, 2016, FOOD CHEM, V205, P204, DOI 10.1016/j.foodchem.2016.03.019; Wang ZW, 2005, J LIQ CHROMATOGR R T, V28, P1291, DOI 10.1081/JLC-200054769; Xiao Y, 2015, INNOV FOOD SCI EMERG, V31, P216, DOI 10.1016/j.ifset.2015.06.006; Xiao Y, 2015, J FUNCT FOODS, V16, P58, DOI 10.1016/j.jff.2015.04.032; Xiao Y, 2015, J FUNCT FOODS, V12, P33, DOI 10.1016/j.jff.2014.10.033; Xiao Y, 2014, J FUNCT FOODS, V10, P210, DOI 10.1016/j.jff.2014.06.008; Xu JG, 2009, J AGR FOOD CHEM, V57, P10392, DOI 10.1021/jf902778j; Yang R, 2018, J FOOD DRUG ANAL, V26, P252, DOI 10.1016/j.jfda.2017.03.007; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Zhang LH, 2011, FOOD BIOPROD PROCESS, V89, P234, DOI 10.1016/j.fbp.2010.04.007	56	18	24	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195508	10.1371/journal.pone.0195508	http://dx.doi.org/10.1371/journal.pone.0195508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634769	Green Submitted, Green Published, gold			2022-12-27	WOS:000429522200036
J	Wali, RK; Bianchi, L; Kupfer, S; De La Cruz, M; Jovanovic, B; Weber, C; Goldberg, MJ; Rodriguez, LM; Bergan, R; Rubin, D; Tull, MB; Richmond, E; Parker, B; Khan, S; Roy, HK				Wali, Ramesh K.; Bianchi, Laura; Kupfer, Sonia; De La Cruz, Mart; Jovanovic, Borko; Weber, Christopher; Goldberg, Michael J.; Rodriguez, L. M.; Bergan, Raymond; Rubin, David; Tull, Mary Beth; Richmond, Ellen; Parker, Beth; Khan, Seema; Roy, Hemant K.			Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLORECTAL-CANCER RISK; GROWTH-FACTOR RECEPTOR; BOWEL MOVEMENT; URSODEOXYCHOLIC ACID; ADENOMATOUS POLYPS; CELL-PROLIFERATION; LAXATIVE USE; CHEMOPREVENTION; CARCINOGENESIS	Chemoprevention represents an attractive modality against colorectal cancer (CRC) although widespread clinical implementation of promising agents (e.g. aspirin/NSAIDS) have been stymied by both suboptimal efficacy and concerns over toxicity. This highlights the need for better agents. Several groups, including our own, have reported that the over-the-counter laxative polyethylene glycol (PEG) has remarkable efficacy in rodent models of colon carcinogenesis. In this study, we undertook the first randomized human trial to address the role of PEG in prevention of human colonic neoplasia. This was a double-blind, placebo-controlled, three-arm trial where eligible subjects were randomized to 8g PEG 3350 (n = 27) or 17g PEG-3350 (n = 24), or placebo (n = 24; maltodextrin) orally for a duration of six months. Our initial primary endpoint was rectal aberrant crypt foci (ACF) but this was changed during protocol period to rectal mucosal epidermal growth factor receptor (EGFR). Of the 87 patients randomized, 48 completed study primary endpoints and rectal EGFR unchanged PEG treatment. Rectal ACF had a trend suggesting potentially reduction with PEG treatment (pre-post change 1.7 in placebo versus-0.3 in PEG 8+ 17g doses, p = 0.108). Other endpoints (proliferation, apoptosis, expression of SNAIL and E-cadherin), previously noted to be modulated in rodent models, appeared unchanged with PEG treatment in this clinical trial. We conclude that PEG was generally well tolerated with the trial failing to meet primary efficacy endpoints. However, rectal ACFs demonstrated a trend (albeit statistically insignificant) for suppression with PEG. Moreover, all molecular assays including EGFR were unaltered with PEG underscoring issues with lack of translatability of biomarkers from preclinical to clinical trials. This data may provide the impetus for future clinical trials on PEG using more robust biomarkers of chemoprevention.	[Wali, Ramesh K.; De La Cruz, Mart; Richmond, Ellen; Roy, Hemant K.] Boston Univ, Dept Med, Med Ctr, Boston, MA 02215 USA; [Bianchi, Laura] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Kupfer, Sonia; Weber, Christopher; Rubin, David; Khan, Seema] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jovanovic, Borko] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Rodriguez, L. M.; Richmond, Ellen] NCI, Rockville, MD USA; [Bergan, Raymond] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	Boston University; NorthShore University Health System; University of Chicago; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon Health & Science University	Roy, HK (corresponding author), Boston Univ, Dept Med, Med Ctr, Boston, MA 02215 USA.	hkroy@bu.edu	Roy, Hemant/AAC-9096-2020; Kupfer, Sonia S/ABD-9416-2021	Weber, Christopher/0000-0002-2117-3184	United States National Institutes of Health [N01-CN-35157]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by funding from the United States National Institutes of Health N01-CN-35157. ClinicalTrials.gov number is NCT00828984, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2005, J NATL CANCER I, V97, P846, DOI 10.1093/jnci/dji144; Anderson JC, 2014, AM J GASTROENTEROL, V109, P1650, DOI 10.1038/ajg.2014.292; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; BAYERDORFFER E, 1995, GUT, V36, P268, DOI 10.1136/gut.36.2.268; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cho NL, 2008, CANCER PREV RES, V1, P21, DOI 10.1158/1940-6207.CAPR-07-0011; Citronberg J, 2014, AM J GASTROENTEROL, V109, P1640, DOI 10.1038/ajg.2014.233; Corpet D E, 2002, IARC Sci Publ, V156, P381; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Corpet DE, 1999, CARCINOGENESIS, V20, P915, DOI 10.1093/carcin/20.5.915; Croucher LJ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-54; Dorval E, 2006, GASTROEN CLIN BIOL, V30, P1196, DOI 10.1016/S0399-8320(06)73511-4; Dukas L, 2000, AM J EPIDEMIOL, V151, P958, DOI 10.1093/oxfordjournals.aje.a010139; EARNEST DL, 1994, CANCER RES, V54, P5071; Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4; Femia AP, 2015, INT J CANCER, V137, P2270, DOI 10.1002/ijc.29581; Gillen DL, 2015, CANCER PREV RES, V8, P222, DOI 10.1158/1940-6207.CAPR-14-0148; Gupta AK, 2009, GASTROINTEST ENDOSC, V70, P322, DOI 10.1016/j.gie.2008.12.060; Holt PR, 1998, JAMA-J AM MED ASSOC, V280, P1074, DOI 10.1001/jama.280.12.1074; Jalanka J, 2015, GUT, V64, P1562, DOI 10.1136/gutjnl-2014-307240; Joseph DA, 2016, CANCER-AM CANCER SOC, V122, P2479, DOI 10.1002/cncr.30070; Khare Sharad, 2009, V472, P373, DOI 10.1007/978-1-60327-492-0_17; Kim J, 2008, CANCER EPIDEM BIOMAR, V17, P1155, DOI 10.1158/1055-9965.EPI-07-2731; Lang M, 2015, DIGEST DIS, V33, P58, DOI 10.1159/000366037; Li HT, 2015, EBIOMEDICINE, V2, P447, DOI 10.1016/j.ebiom.2015.03.019; Naigamwalla D, 2000, CANCER RES, V60, P6856; O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815; Pabla B, 2015, WORLD J CLIN ONCOL, V6, P133, DOI 10.5306/wjco.v6.i5.133; PAGANELLI GM, 1991, CANCER, V68, P2451, DOI 10.1002/1097-0142(19911201)68:11<2451::AID-CNCR2820681121>3.0.CO;2-4; Parnaud G, 1999, CANCER RES, V59, P5143; Pinsky PF, 2010, CANCER PREV RES, V3, P839, DOI 10.1158/1940-6207.CAPR-09-0257; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Roy HK, 2006, MOL CANCER THER, V5, P2060, DOI 10.1158/1535-7163.MCT-06-0054; Roy HK, 2017, GUT, V66, P285, DOI 10.1136/gutjnl-2015-309996; Roy HK, 2011, INT J ONCOL, V38, P529, DOI 10.3892/ijo.2010.875; Roy HK, 2004, CANCER LETT, V215, P35, DOI 10.1016/j.canlet.2004.05.012; Sandler RS, 2000, CANCER EPIDEM BIOMAR, V9, P653; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; Simons CCJM, 2010, AM J EPIDEMIOL, V172, P1404, DOI 10.1093/aje/kwq307; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; SPORN MB, 1980, NATURE, V287, P107, DOI 10.1038/287107a0; Tache S, 2006, SCAND J GASTROENTERO, V41, P730, DOI 10.1080/00365520500380668; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tu HK, 2015, MOL CARCINOGEN, V54, P270, DOI 10.1002/mc.22096; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; Veysey MJ, 2001, GASTROENTEROLOGY, V121, P812, DOI 10.1053/gast.2001.28015; Wali RK, 2008, MOL CANCER THER, V7, P3103, DOI 10.1158/1535-7163.MCT-08-0434; Wali RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038047	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193544	10.1371/journal.pone.0193544	http://dx.doi.org/10.1371/journal.pone.0193544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617381	Green Published, gold, Green Submitted			2022-12-27	WOS:000429203800009
J	Turcsan, B; Wallis, L; Viranyi, Z; Range, F; Muller, CA; Huber, L; Riemer, S				Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie			Personality traits in companion dogs-Results from the VIDOPET	PLOS ONE			English	Article							POTENTIAL GUIDE DOGS; GERMAN-SHEPHERD DOGS; SHELTER DOGS; TEMPERAMENT TEST; DOMESTIC DOGS; BEHAVIOR TEST; PREDICTIVE-VALIDITY; AGGRESSIVE-BEHAVIOR; STARTLING STIMULI; CANIS-FAMILIARIS	Individual behavioural differences in pet dogs are of great interest from a basic and applied research perspective. Most existing dog personality tests have specific (practical) goals in mind and so focused only on a limited aspect of dogs' personality, such as identifying problematic (aggressive or fearful) behaviours, assessing suitability as working dogs, or improving the results of adoption. Here we aimed to create a comprehensive test of personality in pet dogs that goes beyond traditional practical evaluations by exposing pet dogs to a range of situations they might encounter in everyday life. The Vienna Dog Personality Test (VIDO-PET) consists of 15 subtests and was performed on 217 pet dogs. A two-step data reduction procedure (principal component analysis on each subtest followed by an exploratory factor analysis on the subtest components) yielded five factors: Sociability-obedience, Activity-independence, Novelty seeking, Problem orientation, and Frustration tolerance. A comprehensive evaluation of reliability and validity measures demonstrated excellent inter- and intra-observer reliability and adequate internal consistency of all factors. Moreover the test showed good temporal consistency when re-testing a subsample of dogs after an average of 3.8 years a considerably longer test-retest interval than assessed for any other dog personality test, to our knowledge. The construct validity of the test was investigated by analysing the correlations between the results of video coding and video rating methods and the owners' assessment via a dog personality questionnaire. The results demonstrated good convergent as well as discriminant validity. To conclude, the VIDOPET is not only a highly reliable and valid tool for measuring dog personality, but also the first test to show consistent behavioural traits related to problem solving ability and frustration tolerance in pet dogs.	[Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit, Vienna, Austria; [Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie] Univ Vienna, Vienna, Austria; [Turcsan, Borbala; Wallis, Lisa] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Turcsan, Borbala] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary; [Riemer, Stefanie] Univ Bern, Vetsuisse Fac, Div Anim Welf, Bern, Switzerland	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Bern	Turcsan, B (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit, Vienna, Austria.; Turcsan, B (corresponding author), Univ Vienna, Vienna, Austria.; Turcsan, B (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.; Turcsan, B (corresponding author), Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary.	borbala.turcsan@gmail.com	Turcsán, Borbála/I-7983-2018; Wallis, Lisa/GVS-6425-2022	Turcsán, Borbála/0000-0002-0197-5243; Wallis, Lisa/0000-0003-3931-3250; Riemer, Stefanie/0000-0001-8008-5291; Range, Friederike/0000-0003-3127-5536	Austrian Science Fund (FWF) [P21418]; FWF DK CogCom Programme; FWF [P24840, 11271]; European Science Foundation CompCog Exchange Visit Grant [4089]; Osterreichischer Austauschdienst (OeAD) [74ou3]; Hungarian Academy of Sciences Post Doctorate Research Program; Vienna Science and Technology Fund (WWTF) [CS11-005]; WWTF [CS11-026]; European Research Council (ERC) under the European Union's Horizon research and innovation programme [680040]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF DK CogCom Programme; FWF(Austrian Science Fund (FWF)); European Science Foundation CompCog Exchange Visit Grant; Osterreichischer Austauschdienst (OeAD); Hungarian Academy of Sciences Post Doctorate Research Program; Vienna Science and Technology Fund (WWTF); WWTF; European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC))	This research was supported by the Austrian Science Fund (FWF, www.fwf.ac.at) grant P21418 to L.H. and F.R.; FWF DK CogCom Programme to S.R.; FWF grant P24840 to F.R.; European Science Foundation (www.esf.org) CompCog Exchange Visit Grant (4089), the Osterreichischer Austauschdienst (OeAD, https://oead.at, project number: 74ou3) and the Hungarian Academy of Sciences Post Doctorate Research Program (http://mta.hu) to B.T.; Vienna Science and Technology Fund (WWTF, https//www.wwtf.at) grant CS11-005 to L.H.; and FWF grant 11271 and WWTF grant CS11-026 to Zs.V., and our sponsor Royal Canin. Finally, this project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No. 680040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Barnard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149831; BEAUDET R, 1994, APPL ANIM BEHAV SCI, V40, P273, DOI 10.1016/0168-1591(94)90068-X; Berry A, 2013, J ALTERN COMPLEM MED, V19, P73, DOI 10.1089/acm.2011.0835; Bollen KS, 2008, APPL ANIM BEHAV SCI, V112, P120, DOI 10.1016/j.applanim.2007.07.007; Bram M, 2008, J VET BEHAV, V3, P152, DOI 10.1016/j.jveb.2008.04.001; Carmines EdwardG., 1979, RELIABILITY VALIDITY, P17; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Christensen E, 2007, APPL ANIM BEHAV SCI, V106, P85, DOI 10.1016/j.applanim.2006.07.002; Cimarelli G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01979; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dowling-Guyer S, 2011, APPL ANIM BEHAV SCI, V130, P107, DOI 10.1016/j.applanim.2010.12.004; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gartner MC, 2015, PERS INDIV DIFFER, V75, P102, DOI 10.1016/j.paid.2014.10.042; GODDARD ME, 1985, BEHAV GENET, V15, P69, DOI 10.1007/BF01071933; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Harvey ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174261; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Head E, 1997, PHYSIOL BEHAV, V62, P963, DOI 10.1016/S0031-9384(97)00198-4; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jones A.C., 2008, THESIS; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones KE, 2004, JAVMA-J AM VET MED A, V225, P854, DOI 10.2460/javma.2004.225.854; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; King T, 2012, APPL ANIM BEHAV SCI, V137, P1, DOI 10.1016/j.applanim.2011.11.016; King T, 2009, APPL ANIM BEHAV SCI, V120, P84, DOI 10.1016/j.applanim.2009.04.011; Kis A, 2014, VET REC, V174, P196, DOI 10.1136/vr.101955; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lucidi P, 2005, APPL ANIM BEHAV SCI, V95, P103, DOI 10.1016/j.applanim.2005.04.006; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mirko E, 2013, APPL ANIM BEHAV SCI, V149, P45, DOI 10.1016/j.applanim.2013.10.003; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Mongillo P, 2015, J VET BEHAV, V10, P103, DOI 10.1016/j.jveb.2014.11.005; Muller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147753; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; Nunnally J., 1967, PSYCHOMETRIC THEORY, V226, P6; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Palestrini C, 2010, APPL ANIM BEHAV SCI, V124, P61, DOI 10.1016/j.applanim.2010.01.014; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Posluns JA, 2017, APPL ANIM BEHAV SCI, V188, P68, DOI 10.1016/j.applanim.2016.12.013; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Range F, 2009, APPL ANIM BEHAV SCI, V120, P170, DOI 10.1016/j.applanim.2009.05.012; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Riemer S, 2016, APPL ANIM BEHAV SCI, V180, P78, DOI 10.1016/j.applanim.2016.04.021; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Riemer S, 2014, ANIM COGN, V17, P815, DOI 10.1007/s10071-013-0701-4; Rintala DH, 2008, J REHABIL RES DEV, V45, P489, DOI 10.1682/JRRD.2007.06.0094; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Schosswender J., 2013, THESIS; Scott J., 1976, GUIDE DOGS BLIND THE, P39; Seksel K, 1999, APPL ANIM BEHAV SCI, V62, P335, DOI 10.1016/S0168-1591(98)00232-9; Sforzini E, 2009, J VET BEHAV, V4, P3, DOI 10.1016/j.jveb.2008.09.035; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Strandberg E, 2005, LIVEST PROD SCI, V93, P33, DOI 10.1016/j.livprodsci.2004.11.004; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Vazire S., 2007, HDB RES METHODS PERS, P190; Wan M, 2013, ANIM GENET, V44, P717, DOI 10.1111/age.12058; Wemelsfelder F, 2004, ANIM WELFARE, V13, P261; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Zilcha-Mano S, 2012, J RES PERS, V46, P571, DOI 10.1016/j.jrp.2012.06.005	88	15	15	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195448	10.1371/journal.pone.0195448	http://dx.doi.org/10.1371/journal.pone.0195448			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634747	Green Published, gold, Green Submitted			2022-12-27	WOS:000429522200031
